PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kshirsagar, R; Ghodke, I; Muniyappa, K				Kshirsagar, Rucha; Ghodke, Indrajeet; Muniyappa, K.			Saccharomyces cerevisiae Red1 protein exhibits nonhomologous DNA end-joining activity and potentiates Hop1-promoted pairing of double-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST HOP1 PROTEIN; SYNAPTONEMAL COMPLEX-FORMATION; MEIOTIC CHROMOSOME SYNAPSIS; SISTER-CHROMATID COHESION; AXIAL-ELEMENT PROTEIN; TELOMERIC DNA; BREAK REPAIR; MEK1-DEPENDENT PHOSPHORYLATION; INTERHOMOLOG RECOMBINATION; JUNCTION MIGRATION	Elucidation of the function of synaptonemal complex (SC) in Saccharomyces cerevisiae has mainly focused on in vivo analysis of recombination-defective meiotic mutants. Consequently, significant gaps remain in the mechanistic understanding of the activities of various SC proteins and the functional relationships among them. S. cerevisiae Hop1 and Red1 are essential structural components of the SC axial/lateral elements. Previous studies have demonstrated that Hop1 is a structure-selective DNA-binding protein exhibiting high affinity for the Holliday junction and promoting DNA bridging, condensation, and pairing between double-stranded DNA molecules. However, the exact mode of action of Red1 remains unclear, although it is known to interact with Hop1 and to suppress the spore viability defects of hop1 mutant alleles. Here, we report the purification and functional characterization of the full-length Red1 protein. Our results revealed that Red1 forms a stable complex with Hop1 in vitro and provided quantitative insights into their physical interactions. Mechanistically, Red1 preferentially associated with the Holliday junction and 3-way junction rather than with single-or double-stranded DNA with overhangs. Although Hop1 and Red1 exhibited similar binding affinities toward several DNA substrates, the two proteins displayed some significant differences. Notably, Red1, by itself, lacked DNA-pairing ability; however, it potentiated Hop1-promoted intermolecular pairing between double-stranded DNA molecules. Moreover, Red1 exhibited nonhomologous DNA end-joining activity, thus revealing an unexpected role for Red1 in recombination-based DNA repair. Collectively, this study presents the first direct insights into Red1's mode of action and into the mechanism underlying its role in chromosome synapsis and recombination.	[Kshirsagar, Rucha; Ghodke, Indrajeet; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			J.C. Bose National Fellowship from Department of Science and Technology, New Delhi [SR/S2/JCB-24/2005];  [SR/SO/BB-94/2010]	J.C. Bose National Fellowship from Department of Science and Technology, New Delhi; 	This work was supported by Grant SR/SO/BB-94/2010 and J.C. Bose National Fellowship SR/S2/JCB-24/2005 (to K. M.) from the Department of Science and Technology, New Delhi. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Ahuja JS, 2017, SCIENCE, V355, P408, DOI 10.1126/science.aaf4778; AJIMURA M, 1993, GENETICS, V133, P51; Anuradha S, 2005, BIOCHEM BIOPH RES CO, V336, P934, DOI 10.1016/j.bbrc.2005.08.196; Anuradha S, 2004, NUCLEIC ACIDS RES, V32, P2378, DOI 10.1093/nar/gkh559; Anuradha S, 2005, PROG NUCLEIC ACID RE, V79, P49, DOI 10.1016/S0079-6603(04)79002-9; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahoon CK, 2016, NAT STRUCT MOL BIOL, V23, P369, DOI 10.1038/nsmb.3208; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Chen C, 2014, P NATL ACAD SCI USA, V111, pE44, DOI 10.1073/pnas.1310755111; Dayani Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002083; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Eichinger CS, 2010, P NATL ACAD SCI USA, V107, P11370, DOI 10.1073/pnas.1004248107; FRIEDMAN DB, 1994, GENETICS, V136, P449; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; Ghosal G, 2007, J MOL BIOL, V372, P864, DOI 10.1016/j.jmb.2007.07.013; Herruzo E, 2016, NUCLEIC ACIDS RES, V44, P7722, DOI 10.1093/nar/gkw506; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; HOLLINGSWORTH NM, 1993, GENETICS, V133, P785; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Joshi N, 2015, MOL CELL, V57, P797, DOI 10.1016/j.molcel.2014.12.027; Kang HA, 2015, NUCLEIC ACIDS RES, V43, P3841, DOI 10.1093/nar/gkv172; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Khan K, 2013, BIOCHEMISTRY-US, V52, P5265, DOI 10.1021/bi4005528; Khan K, 2012, ACS NANO, V6, P10658, DOI 10.1021/nn3038258; Khan K, 2010, PROTEIN EXPRES PURIF, V72, P42, DOI 10.1016/j.pep.2010.03.016; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Lin FM, 2010, EMBO J, V29, P586, DOI 10.1038/emboj.2009.362; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; Lobachev KS, 1998, GENETICS, V148, P1507; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; MaoDraayer Y, 1996, GENETICS, V144, P71; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; Matos J, 2013, CELL REP, V4, P76, DOI 10.1016/j.celrep.2013.05.039; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Rampler E, 2015, J PROTEOME RES, V14, P5048, DOI 10.1021/acs.jproteome.5b00903; Rao HBDP, 2017, SCIENCE, V355, P403, DOI 10.1126/science.aaf6407; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; ROCKMILL B, 1990, GENETICS, V126, P563; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Sambrook J., 1989, MOL CLONING LAB MANU; Sansam CL, 2015, FEBS J, V282, P2431, DOI 10.1111/febs.13317; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Subramanian VV, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002369; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Szakal B, 2013, EMBO J, V32, P1155, DOI 10.1038/emboj.2013.67; THOMPSON EA, 1989, MOL GEN GENET, V218, P293, DOI 10.1007/BF00331281; Tripathi P, 2007, BIOCHEMISTRY-US, V46, P12530, DOI 10.1021/bi701078v; Tripathi P, 2006, J MOL BIOL, V364, P599, DOI 10.1016/j.jmb.2006.08.096; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Vader G, 2015, CHROMOSOMA, V124, P333, DOI 10.1007/s00412-015-0516-y; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; Venczel EA, 1996, J MOL BIOL, V257, P219, DOI 10.1006/jmbi.1996.0157; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; West SC, 2015, COLD SH Q B, V80, P103, DOI 10.1101/sqb.2015.80.027649; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Zanders S, 2011, GENETICS, V188, P511, DOI 10.1534/genetics.111.129031; Zhao WX, 2015, NUCLEIC ACIDS RES, V43, P4055, DOI 10.1093/nar/gkv259; Zickler D., 2015, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A016626	88	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13853	13866		10.1074/jbc.M117.796425	http://dx.doi.org/10.1074/jbc.M117.796425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28642366	hybrid, Green Published			2022-12-28	WOS:000407942400012
J	Shimizu, H; Tosaki, A; Ohsawa, N; Ishizuka-Katsura, Y; Shoji, S; Miyazaki, H; Oyama, F; Terada, T; Shirouzu, M; Sekine, S; Nukina, N; Yokoyama, S				Shimizu, Hideaki; Tosaki, Asako; Ohsawa, Noboru; Ishizuka-Katsura, Yoshiko; Shoji, Shisako; Miyazaki, Haruko; Oyama, Fumitaka; Terada, Takaho; Shirouzu, Mikako; Sekine, Shun-ichi; Nukina, Nobuyuki; Yokoyama, Shigeyuki			Parallel homodimer structures of the extracellular domains of the voltage-gated sodium channel beta 4 subunit explain its role in cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATION; CRYSTALLOGRAPHY; PIPELINE; SPRING-8; SYSTEM; ALPHA	Voltage-gated sodium channels (VGSCs) are transmembrane proteins required for the generation of action potentials in excitable cells and essential for propagating electrical impulses along nerve cells. VGSCs are complexes of a pore-forming alpha subunit and auxiliary beta subunits, designated as beta 1/beta 1B-beta 4 (encoded by SCN1B-4B, respectively), which also function in cell-cell adhesion. We previously reported the structural basis for the trans homophilic interaction of the beta 4 subunit, which contributes to its adhesive function. Here, using crystallo-graphic and biochemical analyses, we show that the beta 4 extracellular domains directly interact with each other in a parallel manner that involves an intermolecular disulfide bond between the unpaired Cys residues (Cys(58)) in the loop connecting strands B and C and intermolecular hydrophobic and hydrogen-bonding interactions of the N-terminal segments (Ser(30)-Val(35)). Under reducing conditions, an N-terminally deleted beta 4 mutant exhibited decreased cell adhesion compared with the wild type, indicating that the beta 4 cis dimer contributes to the trans homophilic interaction of beta 4 in cell- cell adhesion. Furthermore, this mutant exhibited increased association with the alpha subunit, indicating that the cis dimerization of beta 4 affects alpha-beta 4 complex formation. These observations provide the structural basis for the parallel dimer formation of beta 4 in VGSCs and reveal its mechanism in cell-cell adhesion.	[Shimizu, Hideaki; Ohsawa, Noboru; Ishizuka-Katsura, Yoshiko; Shoji, Shisako; Terada, Takaho; Shirouzu, Mikako; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Hideaki; Ohsawa, Noboru; Ishizuka-Katsura, Yoshiko; Shoji, Shisako; Shirouzu, Mikako; Sekine, Shun-ichi] RIKEN, Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Hideaki; Tosaki, Asako; Miyazaki, Haruko; Oyama, Fumitaka; Nukina, Nobuyuki] RIKEN, Lab Struct Neuropathol, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Miyazaki, Haruko; Nukina, Nobuyuki] Juntendo Univ, Dept Neurosci Neurodegenerat Disorders, Grad Sch Med, Tokyo 1138421, Japan; [Miyazaki, Haruko; Nukina, Nobuyuki] Doshisha Univ, Grad Sch Brain Sci, Lab Struct Neuropathol, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 6100394, Japan; [Oyama, Fumitaka] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo 1920015, Japan; [Terada, Takaho; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	RIKEN; RIKEN; RIKEN; Juntendo University; Doshisha University; Kogakuin University; RIKEN	Yokoyama, S (corresponding author), RIKEN, Struct Biol Lab, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp	Yokoyama, Shigeyuki/N-6911-2015; Nukina, Nobuyuki/GPP-6265-2022; Oyama, Fumitaka/Q-4268-2019; Shimizu, Hideaki/C-4142-2017; Shoji, Shisako/AAJ-2654-2020; Sekine, Shun-ichi/N-5450-2015; Shirouzu, Mikako/A-6521-2016; Shoji, Shisako/C-3690-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Oyama, Fumitaka/0000-0002-1095-8306; Shimizu, Hideaki/0000-0003-0174-5947; Shoji, Shisako/0000-0001-8787-2159; Sekine, Shun-ichi/0000-0001-8174-8704; Shoji, Shisako/0000-0001-8787-2159	Japan Society for the Promotion of Science [24770195, 17H01564, 16K07005]; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED); AMED [Yugo-Nou 17dm0107140h0002]; CREST from the Japan Science and Technology Agency;  [22240037];  [16H01345]; Grants-in-Aid for Scientific Research [16H01345] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED; CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) 24770195 (to H. S.), for Scientific Research (A) 17H01564 (to N. N.), and for Scientific Research (C) 16K07005 (to H. M.) from the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research on Innovative Areas 22240037 and 16H01345 (to N. N.), the Targeted Proteins Research Program (to S. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) (to S. Y.) from MEXT and the Japan Agency for Medical Research and Development (AMED); Yugo-Nou 17dm0107140h0002 (to N. N.) from AMED; and CREST (to N. N.) from the Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baroni D, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00108; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Das S, 2016, ELIFE, V5, DOI 10.7554/eLife.10960; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2009, NEUROSCI LETT, V462, P272, DOI 10.1016/j.neulet.2009.07.020; Meadows LS, 2002, J NEUROSCI, V22, P10699; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Miyazaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6525; Namadurai S, 2014, J BIOL CHEM, V289, P10797, DOI 10.1074/jbc.M113.527994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Shimizu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26618; Sugahara Michihiro, 2008, Journal of Structural and Functional Genomics, V9, P21, DOI 10.1007/s10969-008-9042-y; Tan BH, 2010, HEART RHYTHM, V7, P771, DOI 10.1016/j.hrthm.2010.01.032; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yu FH, 2003, J NEUROSCI, V23, P7577	34	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13428	13440		10.1074/jbc.M117.786509	http://dx.doi.org/10.1074/jbc.M117.786509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655765	Green Published, hybrid			2022-12-28	WOS:000407465300028
J	Shimizu, H; Toma-Fukai, S; Saijo, S; Shimizu, N; Kontani, K; Katada, T; Shimizu, T				Shimizu, Hikaru; Toma-Fukai, Sachiko; Saijo, Shinya; Shimizu, Nobutaka; Kontani, Kenji; Katada, Toshiaki; Shimizu, Toshiyuki			Structure-based analysis of the guanine nucleotide exchange factor SmgGDS reveals armadillo-repeat motifs and key regions for activity and GTPase binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; NUCLEAR-LOCALIZATION; SOLUTION SCATTERING; POLYBASIC REGION; BRAIN CYTOSOL; PROTEIN; PRENYLATION; STATINS; PURIFICATION; RESOLUTION	Small GTPases are molecular switches that have critical biological roles and are controlled by GTPase-activating proteins and guanine nucleotide exchange factors (GEFs). The smg GDP dissociation stimulator (SmgGDS) protein functions as a GEF for the RhoA and RhoC small GTPases. SmgGDS has various regulatory roles, including small GTPase trafficking and localization and as a molecular chaperone, and interacts with many small GTPases possessing polybasic regions. Two SmgGDS splice variants, SmgGDS-558 and SmgGDS-607, differ in GEF activity and binding affinity for RhoA depending on the lipidation state, but the reasons for these differences are unclear. Here we determined the crystal structure of SmgGDS-558, revealing a fold containing tandem copies of armadillo repeats not present in other GEFs. We also observed that SmgGDS harbors distinct positively and negatively charged regions, both of which play critical roles in binding to RhoA and GEF activity. This is the first report demonstrating a relationship between the molecular function and atomic structure of SmgGDS. Our findings indicate that the two SmgGDS isoforms differ in GTPase binding and GEF activity, depending on the lipidation state, thus providing useful information about the cellular functions of SmgGDS in cells.	[Shimizu, Hikaru; Toma-Fukai, Sachiko; Katada, Toshiaki; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Saijo, Shinya; Shimizu, Nobutaka] High Energy Accelerator Org, Inst Mat Struct Sci, Photon Factory, KEK, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan; [Kontani, Kenji] Meiji Pharmaceut Univ, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan	University of Tokyo; High Energy Accelerator Research Organization (KEK); Meiji Pharmaceutical University	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp		Shimizu, Nobutaka/0000-0002-3636-1663	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to K. K., T. K., and T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bergom C, 2016, J BIOL CHEM, V291, P6534, DOI 10.1074/jbc.M115.696831; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; Hauser AD, 2014, MOL CANCER RES, V12, P130, DOI 10.1158/1541-7786.MCR-13-0362; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kudo S, 2016, HYPERTENSION, V67, P878, DOI 10.1161/HYPERTENSIONAHA.115.07089; Kuhlmann N, 2016, J BIOL CHEM, V291, P5484, DOI 10.1074/jbc.M115.707091; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Minami T, 2016, CARDIOVASC RES, V109, P151, DOI 10.1093/cvr/cvv253; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Ogita Y, 2015, J BIOL CHEM, V290, P20245, DOI 10.1074/jbc.M115.637769; OMER CA, 1995, METHOD ENZYMOL, V250, P3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Shimizu N, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952937; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1591, DOI 10.1161/ATVBAHA.112.300922; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Williams CL, 2013, CELL CYCLE, V12, P2933, DOI 10.4161/cc.26230; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wilson JM, 2016, J MOL BIOL, V428, P4929, DOI 10.1016/j.jmb.2016.10.016; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	43	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13441	13448		10.1074/jbc.M117.792556	http://dx.doi.org/10.1074/jbc.M117.792556			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28630045	Green Published, hybrid			2022-12-28	WOS:000407465300029
J	Rouault, TA; Maio, N				Rouault, Tracey A.; Maio, Nunziata			Biogenesis and functions of mammalian iron-sulfur proteins in the regulation of iron homeostasis and pivotal metabolic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						energy metabolism; iron-response element (IRE); iron-sulfur protein; metalloenzyme; mitochondrial respiratory chain complex; HSC20; HSPA9; ISCU; iron-sulfur cluster biogenesis	ELEMENT-BINDING-PROTEIN; FE-S CLUSTERS; RESPONSIVE ELEMENT; CYSTEINE DESULFURASE; RESPIRATORY-CHAIN; SCAFFOLD PROTEIN; MESSENGER-RNA; TARGETED DELETION; ESCHERICHIA-COLI; HEAVY-SUBUNIT	Fe-S cofactors are composed of iron and inorganic sulfur in various stoichiometries. A complex assembly pathway conducts their initial synthesis and subsequent binding to recipient proteins. In this minireview, we discuss how discovery of the role of the mammalian cytosolic aconitase, known as iron regulatory protein 1 (IRP1), led to the characterization of the function of its Fe-S cluster in sensing and regulating cellular iron homeostasis. Moreover, we present an overview of recent studies that have provided insights into the mechanism of Fe-S cluster transfer to recipient Fe-S proteins.	[Rouault, Tracey A.; Maio, Nunziata] Eunice Kennedy Shriver NICHD, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHD, NIH, Bldg 35A,Rm 2D 824,9000 Rockville Pike, Bethesda, MD 20892 USA.	rouault@mail.nih.gov		Maio, Nunziata/0000-0002-6225-6058	Eunice Kennedy Shriver NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814, ZIAHD001602] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver NICHD Intramural Research Program. This is the third article in the Thematic Minireview series "Metals in Biology 2017: Iron transport, storage, and the ramifications." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Castello A, 2013, NAT PROTOC, V8, P491, DOI 10.1038/nprot.2013.020; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Heuer A, 2017, NAT STRUCT MOL BIOL, V24, P453, DOI 10.1038/nsmb.3396; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; Jeong SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025404; Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEIBOLD EA, 1984, J BIOL CHEM, V259, P4327; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Maio N, 2016, METALLOMICS, V8, P1032, DOI 10.1039/c6mt00167j; Maio N, 2017, CELL METAB, V25, P945, DOI 10.1016/j.cmet.2017.03.010; Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Marelja Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060869; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; O'Brien E, 2017, SCIENCE, V355, DOI 10.1126/science.aag1789; Odermatt DC, 2017, CELL REP, V18, P1434, DOI 10.1016/j.celrep.2017.01.037; Pukszta S, 2010, EMBO REP, V11, P360, DOI 10.1038/embor.2010.29; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; ROUAULT TA, 1990, P NATL ACAD SCI USA, V87, P7958, DOI 10.1073/pnas.87.20.7958; Rouault TA, 2015, NAT CHEM BIOL, V11, P442, DOI 10.1038/nchembio.1843; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Saxena N, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv287; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Schulz JB, 2013, J NEUROCHEM, V126, P1, DOI 10.1111/jnc.12327; Selbach BP, 2013, BIOCHEMISTRY-US, V52, P4089, DOI 10.1021/bi4001479; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Uhrigshardt H, 2013, J BIOL INORG CHEM, V18, P441, DOI 10.1007/s00775-013-0988-2; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wydro MM, 2013, PLANT CELL, V25, P4014, DOI 10.1105/tpc.113.117283; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372; ZAHRINGER J, 1979, FEBS LETT, V108, P317, DOI 10.1016/0014-5793(79)80554-2; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zumbrennen-Bullough KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098072	99	94	94	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12744	12753		10.1074/jbc.R117.789537	http://dx.doi.org/10.1074/jbc.R117.789537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615439	Green Published, hybrid			2022-12-28	WOS:000407220100004
J	Zhang, Z; Lei, AH; Xu, LY; Chen, L; Chen, YL; Zhang, XN; Gao, Y; Yang, XL; Zhang, M; Cao, Y				Zhang, Zan; Lei, Anhua; Xu, Liyang; Chen, Lu; Chen, Yonglong; Zhang, Xuena; Gao, Yan; Yang, Xiaoli; Zhang, Min; Cao, Ying			Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; embryo; gene expression; neurodevelopment; neurodifferentiation; Xenopus; cancer cell lines; chromatin modification factors; embryonic neural precursor cells	HISTONE LYSINE DEMETHYLASES; TO-MESENCHYMAL TRANSITION; STEM-CELLS; DNA METHYLATION; INDUCTION; PATHWAYS; NEUROGENESIS; TRANSPORTERS; METASTASIS; BETA	Cancer cells are immature cells resulting from cellular reprogramming by gene misregulation, and redifferentiation is expected to reduce malignancy. It is unclear, however, whether cancer cells can undergo terminal differentiation. Here, we show that inhibition of the epigenetic modification enzyme enhancer of zeste homolog 2 (EZH2), histone deacetylases 1 and 3 (HDAC1 and -3), lysine demethylase 1A (LSD1), or DNA methyltransferase 1 (DNMT1), which all promote cancer development and progression, leads to postmitotic neuron-like differentiation with loss of malignant features in distinct solid cancer cell lines. The regulatory effect of these enzymes in neuronal differentiation resided in their intrinsic activity in embryonic neural precursor/progenitor cells. We further found that a major part of pan-cancer-promoting genes and the signal transducers of the pan-cancer-promoting signaling pathways, including the epithelial-to-mesenchymal transition (EMT) mesenchymal marker genes, display neural specific expression during embryonic neurulation. In contrast, many tumor suppressor genes, including the EMT epithelial marker gene that encodes cadherin 1 (CDH1), exhibited non-neural or no expression. This correlation indicated that cancer cells and embryonic neural cells share a regulatory network, mediating both tumorigenesis and neural development. This observed similarity in regulatory mechanisms suggests that cancer cells might share characteristics of embryonic neural cells.	[Zhang, Zan; Lei, Anhua; Xu, Liyang; Chen, Lu; Zhang, Xuena; Gao, Yan; Yang, Xiaoli; Zhang, Min; Cao, Ying] Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China; [Zhang, Zan; Lei, Anhua; Xu, Liyang; Chen, Lu; Zhang, Xuena; Gao, Yan; Yang, Xiaoli; Zhang, Min; Cao, Ying] MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China; [Chen, Yonglong] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China	Nanjing University; Southern University of Science & Technology	Cao, Y (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	caoying@nju.edu.cn		Cao, Ying/0000-0001-8286-9591	Ministry of Science and Technology [2014CB964701]; National Science Foundation of China [31671499, 31271544]; Original and Interdisciplinary Research Fund of Nanjing University; Shenzhen Science and Technology Innovation Commission Grant [JCYJ20150331101823697]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Original and Interdisciplinary Research Fund of Nanjing University; Shenzhen Science and Technology Innovation Commission Grant	This work was supported by Ministry of Science and Technology Grant 2014CB964701, National Science Foundation of China Grants 31671499 and 31271544, and the Original and Interdisciplinary Research Fund of Nanjing University (to Y. C.). This work was also supported in part by Shenzhen Science and Technology Innovation Commission Grant JCYJ20150331101823697 (to Y.-L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aiello NM, 2016, DIS MODEL MECH, V9, P105, DOI 10.1242/dmm.023184; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Albo D, 2011, CANCER-AM CANCER SOC, V117, P4834, DOI 10.1002/cncr.26117; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Buitrago-Delgado E, 2015, SCIENCE, V348, P1332, DOI 10.1126/science.aaa3655; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Chang CB, 2007, DEVELOPMENT, V134, P3861, DOI 10.1242/dev.007179; Chen H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7367; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harris H, 2005, BIOESSAYS, V27, P833, DOI 10.1002/bies.20263; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kunisada T, 2014, BIRTH DEFECTS RES C, V102, P251, DOI 10.1002/bdrc.21079; Leung AW, 2016, DEVELOPMENT, V143, P398, DOI 10.1242/dev.130849; Li LN, 2015, PHARMACOL THERAPEUT, V150, P33, DOI 10.1016/j.pharmthera.2015.01.004; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lu L, 2015, DEV CELL, V33, P660, DOI 10.1016/j.devcel.2015.04.006; Lu R, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2016.36; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maurer MH, 2006, FEBS LETT, V580, P4430, DOI 10.1016/j.febslet.2006.07.012; Moody Sally A., 2002, TheScientificWorldJOURNAL, V2, P1147; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ozair MZ, 2013, WIRES DEV BIOL, V2, P479, DOI 10.1002/wdev.90; Parbin S, 2014, J HISTOCHEM CYTOCHEM, V62, P11, DOI 10.1369/0022155413506582; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sharma A, 2016, J NEUROSCI, V36, P1711, DOI 10.1523/JNEUROSCI.4037-15.2016; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zhang DX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10798; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	56	32	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12842	12859		10.1074/jbc.M117.785865	http://dx.doi.org/10.1074/jbc.M117.785865			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28634230	Green Published, hybrid			2022-12-28	WOS:000407220100015
J	Barclay, RA; Schwab, A; DeMarino, C; Akpamagbo, Y; Lepene, B; Kassaye, S; Iordanskiy, S; Kashanchi, F				Barclay, Robert A.; Schwab, Angela; DeMarino, Catherine; Akpamagbo, Yao; Lepene, Benjamin; Kassaye, Seble; Iordanskiy, Sergey; Kashanchi, Fatah			Exosomes from uninfected cells activate transcription of latent HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; EXTRACELLULAR VESICLES; IMMUNE ACTIVATION; CURRENT KNOWLEDGE; MATRIX PROTEIN; GENOMIC RNA; ESCRT-II; TYPE-1; EXPRESSION	HIV-1 infection causes AIDS, infecting millions worldwide. The virus can persist in a state of chronic infection due to its ability to become latent. We have previously shown a link between HIV-1 infection and exosome production. Specifically, we have reported that exosomes transport viral proteins and RNA from infected cells to neighboring uninfected cells. These viral products could then elicit an innate immune response, leading to activation of the Toll-like receptor and NF-kappa B pathways. In this study, we asked whether exosomes from uninfected cells could activate latent HIV-1 in infected cells. We observed that irrespective of combination antiretroviral therapy, both short-and long-length viral transcripts were increased in wildtype HIV-1-infected cells exposed to purified exosomes from uninfected cells. A search for a possible mechanism for this finding revealed that the exosomes increase RNA polymerase II loading onto the HIV-1 promoter in the infected cells. These viral transcripts, which include trans-activation response (TAR) RNA and a novel RNA that we termed TAR-gag, can then be packaged into exosomes and potentially be exported to neighboring uninfected cells, leading to increased cellular activation. To better decipher the exosome release pathways involved, we used siRNA to suppress expression of ESCRT (endosomal sorting complex required for transport) proteins and found that ESCRT II and IV significantly control exosome release. Collectively, these results imply that exosomes from uninfected cells activate latent HIV-1 in infected cells and that true transcriptional latency may not be possible in vivo, especially in the presence of combination antiretroviral therapy.	[Barclay, Robert A.; Schwab, Angela; DeMarino, Catherine; Akpamagbo, Yao; Iordanskiy, Sergey; Kashanchi, Fatah] George Mason Univ, Mol Virol Lab, Discovery Hall,Rm 182,10900 Univ Blvd, Manassas, VA 20110 USA; [Lepene, Benjamin] Ceres Nanosci Inc, Manassas, VA 20110 USA; [Kassaye, Seble] Georgetown Univ, Med Ctr, Dept Med, Womens Interagcy HIV Study, Washington, DC 20007 USA; [Iordanskiy, Sergey] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA	George Mason University; Georgetown University; Uniformed Services University of the Health Sciences - USA	Kashanchi, F (corresponding author), George Mason Univ, Mol Virol Lab, Discovery Hall,Rm 182,10900 Univ Blvd, Manassas, VA 20110 USA.	fkashanc@gmu.edu			NIAID, National Institutes of Health [U01-AI34994]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078859, R01AI043894, R21AI113140, R21AI127351, U01AI034994, R21AI074410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099029] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Kashanchi laboratory for experimental designs and assistance with the manuscript. Dr. Gavin Sampey also assisted with the data in Fig. 1. We are also grateful to the AIDS Research and Reference Reagent Program for the contribution of various reagents. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health: U1, J1.1, and ACH-2 cells from Dr. Thomas Folks; HIV-1 89.6 dual-tropic viral strain from Dr. Ronald Collman; and anti-HIV-1 p24 mouse monoclonal antibody from Dr. Michael Malim. Four clinical samples utilized in this study were provided by the Washington, D. C., Metropolitan Site of the Women's Interagency HIV Study Collaborative Study Group (Principal Investigator, S. K.). The Women's Interagency HIV Study is supported by NIAID, National Institutes of Health, Grant U01-AI34994. The RNA sequencing data from exosomes were generated by Dr. Jeff Chu from Applied Biological Materials Inc. (Richmond, Canada).	Abd El-Wahab EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5304; Acheson N.H., 2011, FUNDAMENTALS MOL VIR; Ahsan NA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00139; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Archin NM, 2014, NAT REV MICROBIOL, V12, P750, DOI 10.1038/nrmicro3352; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Barillari G, 2014, ANGIOGENESIS, V17, P831, DOI 10.1007/s10456-014-9430-9; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424; Cabezas SC, 2013, CELL MICROBIOL, V15, P412, DOI 10.1111/cmi.12046; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fleming A, 2014, PATHOG DIS, V71, P107, DOI 10.1111/2049-632X.12135; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Fujiwara T, 2016, BIOORGAN MED CHEM, V24, P4318, DOI 10.1016/j.bmc.2016.07.024; Ghossoub R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4477; Goff A, 2003, J VIROL, V77, P9173, DOI 10.1128/JVI.77.17.9173-9182.2003; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imamichi H, 2016, P NATL ACAD SCI USA, V113, P8783, DOI 10.1073/pnas.1609057113; Iordanskiy S, 2016, AIDS RES HUM RETROV, V32, P120, DOI [10.1089/aid.2016.0006, 10.1089/AID.2016.0006]; Ishizaka A, 2016, J VIROL, V90, P5665, DOI 10.1128/JVI.03158-15; Jadlowsky JK, 2014, MOL CELL BIOL, V34, P1911, DOI 10.1128/MCB.01013-13; Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Jones RB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005545; Kumar A, 2014, VIRUSES-BASEL, V6, P1837, DOI 10.3390/v6041837; Lagana Alessandro, 2013, Frontiers in Genetics, V4, P120, DOI 10.3389/fgene.2013.00120; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Li WH, 2014, APMIS, V122, P1080, DOI 10.1111/apm.12261; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x; MIKOVITS JA, 1992, J CLIN INVEST, V90, P1486, DOI 10.1172/JCI116016; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Nour AM, 2014, TRENDS CELL BIOL, V24, P449, DOI 10.1016/j.tcb.2014.03.006; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Rasmussen TA, 2016, CURR OPIN HIV AIDS, V11, P394, DOI 10.1097/COH.0000000000000279; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Saayman S, 2014, MOL THER, V22, P1164, DOI 10.1038/mt.2014.29; Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; SCHRIER RD, 1990, J VIROL, V64, P3280, DOI 10.1128/JVI.64.7.3280-3288.1990; Schwab A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01132; Sen S, 2015, CELL CYCLE, V14, P980, DOI 10.1080/15384101.2015.1006971; Sgarbanti M, 2013, CURR OPIN VIROL, V3, P394, DOI 10.1016/j.coviro.2013.06.001; Shan L, 2011, J VIROL, V85, P5384, DOI 10.1128/JVI.02536-10; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Teow SY, 2016, ADV VIROL, V2016, DOI 10.1155/2016/9852494; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Ung TH, 2014, CANCER SCI, V105, P1384, DOI 10.1111/cas.12534; Valiathan RR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-23; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zeringer Emily, 2013, World J Methodol, V3, P11, DOI 10.5662/wjm.v3.i1.11	77	51	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11682	11701		10.1074/jbc.M117.793521	http://dx.doi.org/10.1074/jbc.M117.793521			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28536264	hybrid, Green Published			2022-12-28	WOS:000405485600009
J	Manning, BJ; Yusufzai, T				Manning, Benjamin J.; Yusufzai, Timur			The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRANUCLEOSOMAL DNA; CHARGE-SYNDROME; PROTEIN; GENES; ACTIVATION; MUTATIONS; SEQUENCE; SWI/SNF; FAMILY; AUTISM	Proper chromatin regulation is central to genome function and maintenance. The group III chromodomain-helicase-DNA-binding (CHD) family of ATP-dependent chromatin remodeling enzymes, comprising CHD6, CHD7, CHD8, and CHD9, has well-documented roles in transcription regulation, impacting both organism development and disease etiology. These four enzymes are similar in their constituent domains, but they fill surprisingly non-redundant roles in the cell, with deficiencies in individual enzymes leading to dissimilar disease states such as CHARGE syndrome or autism spectrum disorders. The mechanisms explaining their divergent, non-overlapping functions are unclear. In this study, we performed an in-depth biochemical analysis of purified CHD6, CHD7, and CHD8 and discovered distinct differences in chromatin remodeling specificities and activities among them. We report that CHD6 and CHD7 both bind with high affinity to short linker DNA, whereas CHD8 requires longer DNA for binding. As a result, CHD8 slides nucleosomes into positions with more flanking linker DNA than CHD7. Moreover, we found that, although CHD7 and CHD8 slide nucleosomes, CHD6 disrupts nucleosomes in a distinct non-sliding manner. The different activities of these enzymes likely lead to differences in chromatin structure and, thereby, transcriptional control, at the enhancer and promoter loci where these enzymes bind. Overall, our work provides a mechanistic basis for both the non-redundant roles and the diverse mutant disease states of these enzymes in vivo.	[Yusufzai, Timur] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Yusufzai, T (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA.	timur_yusufzai@dfci.harvard.edu			National Institutes of Health Grant [R501GM114304]; Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114304] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R501GM114304 and the Dana-Farber Cancer Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Basson MA, 2015, TRENDS GENET, V31, P600, DOI 10.1016/j.tig.2015.05.009; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Bowman GD, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600183; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Butt RH, 2013, MOL CELL PROTEOMICS, V12, P3834, DOI 10.1074/mcp.M112.021881; Ceballos-Chavez M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005174; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Durak O, 2016, NAT NEUROSCI, V19, P1477, DOI 10.1038/nn.4400; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grimsley G. R., 2004, CURR PROTOC PROTEIN, DOI [10.1002/0471140864, DOI 10.1002/0471140864]; HANSEN JC, 1991, J BIOL CHEM, V266, P4276; Invitrogen, 2011, GUID BC EXPR VECT SY; Kalscheuer VM, 2008, AM J MED GENET A, V146A, P2053, DOI 10.1002/ajmg.a.32419; Kingston RE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019349; Lathrop MJ, 2010, MAMM GENOME, V21, P130, DOI 10.1007/s00335-010-9248-8; Levendosky RF, 2016, ELIFE, V5, DOI 10.7554/eLife.21356; Liu JC, 2015, J BIOL CHEM, V290, P25, DOI 10.1074/jbc.M114.609156; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1999, METH MOL B, V119, P1; Manning BJ, 2014, P NATL ACAD SCI USA, V111, P17827, DOI 10.1073/pnas.1420096111; McKnight JN, 2011, MOL CELL BIOL, V31, P4746, DOI 10.1128/MCB.05735-11; Mills AA, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026450; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; Nodelman IM, 2016, NUCLEIC ACIDS RES, V44, P7580, DOI 10.1093/nar/gkw406; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Patel A, 2013, NUCLEIC ACIDS RES, V41, P1637, DOI 10.1093/nar/gks1440; Payne S, 2015, DEV BIOL, V405, P82, DOI 10.1016/j.ydbio.2015.06.017; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Quan JH, 2014, J BIOL CHEM, V289, P20717, DOI 10.1074/jbc.M114.568568; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sen P, 2013, MOL CELL BIOL, V33, P360, DOI 10.1128/MCB.00922-12; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Subtil-Rodriguez A, 2014, NUCLEIC ACIDS RES, V42, P2185, DOI 10.1093/nar/gkt1161; Szerlong HJ, 2011, BIOCHEM CELL BIOL, V89, P24, DOI 10.1139/O10-139; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; vanHolde K.E, 1989, CHROMATIN, P289; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Yates JA, 2010, FEBS LETT, V584, P689, DOI 10.1016/j.febslet.2010.01.022; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	54	33	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11927	11936		10.1074/jbc.M117.779470	http://dx.doi.org/10.1074/jbc.M117.779470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28533432	Green Published, hybrid			2022-12-28	WOS:000405485600028
J	Zachrdla, M; Padrta, P; Rabatinova, A; Sanderova, H; Barvik, I; Krasny, L; Zidek, L				Zachrdla, Milan; Padrta, Petr; Rabatinova, Alzbeta; Sanderova, Hana; Barvik, Ivan; Krasny, Libor; Zidek, Lukas			Solution structure of domain 1.1 of the sigma(A) factor from Bacillus subtilis is preformed for binding to the RNA polymerase core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; molecular modeling; nuclear magnetic resonance (NMR); protein structure; RNA polymerase; transcription initiation factor	MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; AUTOMATED NOE ASSIGNMENT; GRAM-POSITIVE BACTERIA; N-TERMINAL DOMAIN; DELTA-SUBUNIT; NMR STRUCTURE; COMPLEX-FORMATION; DNA-BINDING; PROTEINS	Bacterial RNA polymerase (RNAP) requires sigma factors to recognize promoter sequences. Domain 1.1 of primary sigma factors (sigma 1.1) prevents their binding to promoter DNA in the absence of RNAP, and when in complex with RNAP, it occupies the DNA-binding channel of RNAP. Currently, two 3D structures of sigma 1.1 are available: from Escherichia coli in complex with RNAP and from T. maritima solved free in solution. However, these two structures significantly differ, and it is unclear whether this difference is due to an altered conformation upon RNAP binding or to differences in intrinsic properties between the proteins from these two distantly related species. Here, we report the solution structure of sigma 1.1 from the Gram-positive bacterium Bacillus subtilis. We found that B. subtilis sigma 1.1 is highly compact because of additional stabilization not present in sigma 1.1 from the other two species and that it is more similar to E. coli sigma 1.1. Moreover, modeling studies suggested that B. subtilis sigma 1.1 requires minimal conformational changes for accommodating RNAP in the DNA channel, whereas T. maritima sigma 1.1 must be rearranged to fit therein. Thus, the mesophilic species B. subtilis and E. coli share the same sigma 1.1 fold, whereas the fold of sigma 1.1 from the thermophile T. maritima is distinctly different. Finally, we describe an intriguing similarity between sigma 1.1 and , an RNAP-associated protein in B. subtilis, bearing implications for the so-far unknown binding site of on RNAP. In conclusion, our results shed light on the conformational changes of sigma 1.1 required for its accommodation within bacterial RNAP.	[Zachrdla, Milan; Padrta, Petr; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic; [Zachrdla, Milan; Padrta, Petr; Zidek, Lukas] Masaryk Univ, NCBR, Fac Sci, CZ-62500 Brno, Czech Republic; [Rabatinova, Alzbeta; Sanderova, Hana; Krasny, Libor] Czech Acad Sci, Inst Microbiol, Lab Microbial Genet & Gene Express, CZ-14220 Prague 4, Czech Republic; [Barvik, Ivan] Charles Univ Prague, Inst Phys, Div Biomol Phys, Fac Math & Phys, CZ-12116 Prague 2, Czech Republic	Masaryk University Brno; Masaryk University Brno; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Krasny, L (corresponding author), Czech Acad Sci, Inst Microbiol, Lab Microbial Genet & Gene Express, CZ-14220 Prague 4, Czech Republic.; Zidek, L (corresponding author), Masaryk Univ, CEITEC, Kamenice 5, CZ-62500 Brno, Czech Republic.	krasny@biomed.cas.cz; lzidek@chemi.muni.cz	Krasny, Libor/H-2429-2014; Padrta, Petr/AAA-7945-2019; Barvik, Ivan/G-8906-2014; Zidek, Lukas/AAB-6109-2020; Zidek, Lukas/D-7112-2012	Krasny, Libor/0000-0002-4120-4347; Zidek, Lukas/0000-0002-8013-0336; Zidek, Lukas/0000-0002-8013-0336; Sanderova, Hana/0000-0002-5436-7583	Ministry of Education, Youth and Sports of Czech Republic [LM2015043]	Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	CIISB research infrastructure project LM2015043 funded by the Ministry of Education, Youth and Sports of the Czech Republic is gratefully acknowledged for a partial financial support of the measurements at the Josef Dadok National NMRCentre, CEITEC, Masaryk University.	Bae B, 2013, P NATL ACAD SCI USA, V110, P19772, DOI 10.1073/pnas.1314576110; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; d'Auvergne EJ, 2007, MOL BIOSYST, V3, P483, DOI 10.1039/b702202f; d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demo G, 2014, J STRUCT BIOL, V187, P174, DOI 10.1016/j.jsb.2014.06.001; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Doreleijers JF, 2012, NUCLEIC ACIDS RES, V40, pD519, DOI 10.1093/nar/gkr1134; Eaton J. W., 2008, GNU OCTAVE MANUAL VE; Ferrage F, 2009, J AM CHEM SOC, V131, P6048, DOI 10.1021/ja809526q; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Hagen N, 2007, APPL OPTICS, V46, P5374, DOI 10.1364/AO.46.005374; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Keller AN, 2014, J BACTERIOL, V196, P3622, DOI 10.1128/JB.02020-14; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Long D, 2008, J AM CHEM SOC, V130, P2432, DOI 10.1021/ja710477h; Ma C, 2013, ACS CHEM BIOL, V8, P1972, DOI 10.1021/cb400231p; MacDougall IJA, 2005, J MOL GRAPH MODEL, V23, P297, DOI 10.1016/j.jmgm.2004.10.001; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Morin S, 2014, BIOINFORMATICS, V30, P2219, DOI 10.1093/bioinformatics/btu166; Morin S, 2009, J BIOMOL NMR, V45, P361, DOI 10.1007/s10858-009-9381-4; Motackova V, 2010, PROTEINS, V78, P1807, DOI 10.1002/prot.22708; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Novak P, 2010, J BIOMOL NMR, V46, P191, DOI 10.1007/s10858-009-9392-1; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Papouskova V, 2013, CHEMBIOCHEM, V14, P1772, DOI 10.1002/cbic.201300226; Pelupessy P, 2003, J MAGN RESON, V161, P258, DOI 10.1016/S1090-7807(02)00190-8; Pelupessy P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715583; Prajapati RK, 2016, J BIOL CHEM, V291, P1064, DOI 10.1074/jbc.M115.686170; Rabatinova A, 2013, J BACTERIOL, V195, P2603, DOI 10.1128/JB.00188-13; Saro F. J.Lopezde, 1995, J MOL BIOL, V252, P189; Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Weiss A, 2015, FEMS MICROBIOL REV, V39, P541, DOI 10.1093/femsre/fuv005; Weiss A, 2014, INFECT IMMUN, V82, P1424, DOI 10.1128/IAI.01508-14; Wiedermannova J, 2014, NUCLEIC ACIDS RES, V42, P5151, DOI 10.1093/nar/gku113; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	51	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11610	11617		10.1074/jbc.M117.784074	http://dx.doi.org/10.1074/jbc.M117.784074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28539362	Green Published, hybrid			2022-12-28	WOS:000405485600002
J	Martinez, KB; Leone, V; Chang, EB				Martinez, Kristina B.; Leone, Vanessa; Chang, Eugene B.			Microbial metabolites in health and disease: Navigating the unknown in search of function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ARYL-HYDROCARBON RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; GUT MICROBIOTA; MOUSE MODEL; METABOLOMICS; REVEALS; METAGENOMICS; COLITIS	The gut microbiota has been implicated in the development of a number of chronic gastrointestinal and systemic diseases. These include inflammatory bowel diseases, irritable bowel syndrome, and metabolic (i.e. obesity, non-alcoholic fatty liver disease, and diabetes) and neurological diseases. The advanced understanding of host-microbe interactions has largely been due to new technologies such as 16S rRNA sequencing to identify previously unknown microbial communities and, more importantly, their functional characteristics through metagenomic sequencing and other multi-omic technologies, such as metatranscriptomics, metaproteomics, and metabolomics. Given the vast array of newly acquired knowledge in the field and technological advances, it is expected that mechanisms underlying several disease states involving the interactions between microbes, their metabolites, and the host will be discovered. The identification of these mechanisms will allow for the development of more precise therapies to prevent or manage chronic disease. This review discusses the functional characterization of the microbiome, highlighting the advances in identifying bioactive microbial metabolites that have been directly linked to gastrointestinal and peripheral diseases.	[Martinez, Kristina B.; Leone, Vanessa; Chang, Eugene B.] Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA	University of Chicago	Chang, EB (corresponding author), Univ Chicago, Dept Med, 900 E 57th St, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu		Martinez, Kristina/0000-0002-9676-0009	GI Research Foundation, Chicago, IL; National Institutes of Health Grants from NIDDK [DK042086, DK097268, DK102872]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097268, P30DK042086, R56DK102872] Funding Source: NIH RePORTER	GI Research Foundation, Chicago, IL; National Institutes of Health Grants from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the GI Research Foundation, Chicago, IL and National Institutes of Health Grants DK042086, DK097268, and DK102872 from NIDDK (to E.B.C.). This is the second article in the Host-Microbiome metabolic interplay Minireview series. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Al-Asmakh M, 2015, J MICROBIOL BIOTECHN, V25, P1583, DOI 10.4014/jmb.1501.01039; Alisi A, 2014, ALIMENT PHARM THER, V39, P1276, DOI 10.1111/apt.12758; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bashiardes S, 2016, BIOINFORM BIOL INSIG, V10, P19, DOI 10.4137/BBI.S34610; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Carmody RN, 2014, J CLIN INVEST, V124, P4173, DOI 10.1172/JCI72335; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; COATES M E, 1975, Laboratory Animals (London), V9, P275, DOI 10.1258/002367775780957296; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; de Theije CGM, 2014, BRAIN BEHAV IMMUN, V37, P197, DOI 10.1016/j.bbi.2013.12.005; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319; Feng Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22525; Gacias M, 2016, ELIFE, V5, DOI 10.7554/eLife.13442; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Hadjithomas M, 2015, MBIO, V6, DOI 10.1128/mBio.00932-15; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hicks LC, 2015, J CROHNS COLITIS, V9, P731, DOI 10.1093/ecco-jcc/jjv102; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Ji T, 2015, DIGEST DIS SCI, V60, P1958, DOI 10.1007/s10620-015-3632-x; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Matsumoto M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00009; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/NCHEMBIO.1884, 10.1038/nchembio.1884]; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miccheli A, 2015, INT J OBESITY, V39, P1118, DOI 10.1038/ijo.2015.40; Mondot S, 2016, ANN NY ACAD SCI, V1372, P9, DOI 10.1111/nyas.13033; Nicklas W, 2015, ILAR J, V56, P241, DOI 10.1093/ilar/ilv029; Niehues M, 2009, J PHARM PHARMACOL, V61, P1303, DOI 10.1211/jpp/61.10.0005; NOZAKI M, 1972, BIOCHEM J, V128, pP24; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Samb-Ba B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087419; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhang LS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0296-x	58	73	77	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8553	8559		10.1074/jbc.R116.752899	http://dx.doi.org/10.1074/jbc.R116.752899			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389566	hybrid, Green Published			2022-12-28	WOS:000402153900003
J	Caplan, S				Caplan, Steve			Into the linker's DENN: A tyrosine's control of autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							EXCHANGE FACTOR; RAB12; DEGRADATION; MOUSE	The small GTP-binding protein Rab12 plays an important role in the initiation of starvation-induced macroautophagy (autophagy) and is activated by the guanine-nucleotide exchange factor DENND3. However, the molecular mechanism by which DENND3 becomes activated has remained elusive. Xu and McPherson now identify a novel mechanism of DENND3 intramolecular binding that is regulated by the phosphorylation of a single tyrosine residue.	[Caplan, Steve] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Caplan, S (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu			NIGMS, National Institutes of Health [R01GM074876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM074876. The author declares that he has no conflicts of interest with the contents of this article.	Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Matsui T, 2014, J BIOL CHEM, V289, P13986, DOI 10.1074/jbc.M113.546689; Matsui T, 2013, EMBO REP, V14, P450, DOI 10.1038/embor.2013.32; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Xu J, 2017, J BIOL CHEM, V292, P7274, DOI 10.1074/jbc.M116.772434; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006	8	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7283	7284		10.1074/jbc.H116.772434	http://dx.doi.org/10.1074/jbc.H116.772434			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28455410	Green Published, hybrid			2022-12-28	WOS:000400478300037
J	Littler, DR; Ang, SY; Moriel, DG; Kocan, M; Kleifeld, O; Johnson, MD; Tran, MT; Paton, AW; Paton, JC; Summers, RJ; Schembri, MA; Rossjohn, J; Beddoe, T				Littler, Dene R.; Ang, Sheng Y.; Moriel, Danilo G.; Kocan, Martina; Kleifeld, Oded; Johnson, Matthew D.; Tran, Mai T.; Paton, Adrienne W.; Paton, James C.; Summers, Roger J.; Schembri, Mark A.; Rossjohn, Jamie; Beddoe, Travis			Structure-function analyses of a pertussis-like toxin from pathogenic Escherichia coli reveal a distinct mechanism of inhibition of trimeric G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYZED ADP-RIBOSYLATION; ISLET-ACTIVATING PROTEIN; CRYSTAL-STRUCTURE; CHOLERA-TOXIN; IDENTIFICATION; BINDING; FAMILY; MUTATIONS; VIRULENCE; SUBUNIT	Pertussis-like toxins are secreted by several bacterial pathogens during infection. They belong to the AB(5) virulence factors, which bind to glycans on host cell membranes for internalization. Host cell recognition and internalization are mediated by toxin B subunits sharing a unique pentameric ring-like assembly. Although the role of pertussis toxin in whooping cough is well-established, pertussis-like toxins produced by other bacteria are less studied, and their mechanisms of action are unclear. Here, we report that some extra-intestinal Escherichia coli pathogens (i.e. those that reside in the gut but can spread to other bodily locations) encode a pertussis-like toxin that inhibits mammalian cell growth in vitro. We found that this protein, EcPlt, is related to toxins produced by both nontyphoidal and typhoidal Salmonella serovars. Pertussis-like toxins are secreted as disulfide-bonded heterohexamers in which the catalytic ADP-ribosyltransferase subunit is activated when exposed to the reducing environment in mammalian cells. We found here that the reduced EcPlt exhibits large structural rearrangements associated with its activation. We noted that inhibitory residues tethered within the NAD(+)-binding site by an intramolecular disulfide in the oxidized state dissociate upon the reduction and enable loop restructuring to form the nucleotide-binding site. Surprisingly, although pertussis toxin targets a cysteine residue within the alpha subunit of inhibitory trimeric G-proteins, we observed that activated EcPlt toxin modifies a proximal lysine/asparagine residue instead. In conclusion, our results reveal the molecular mechanism underpinning activation of pertussis-like toxins, and we also identified differences in host target specificity.	[Littler, Dene R.; Johnson, Matthew D.; Tran, Mai T.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Littler, Dene R.; Johnson, Matthew D.; Tran, Mai T.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Ang, Sheng Y.; Kocan, Martina; Summers, Roger J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Moriel, Danilo G.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Kleifeld, Oded] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Beddoe, Travis] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic 3086, Australia; [Beddoe, Travis] La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic 3086, Australia	Monash University; Monash University; Monash University; University of Queensland; Technion Israel Institute of Technology; University of Adelaide; Cardiff University; Monash University; La Trobe University; La Trobe University	Beddoe, T (corresponding author), La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic 3086, Australia.; Beddoe, T (corresponding author), La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic 3086, Australia.	jamie.rossjohn@monash.edu.au; t.beddoe@latrobe.edu.au	Summers, Roger J/F-6351-2011; Rossjohn, Jamie/F-9032-2013; Schembri, Mark A/C-7262-2009; Beddoe, Travis/F-3415-2014	Summers, Roger J/0000-0002-8367-4056; Rossjohn, Jamie/0000-0002-2020-7522; Schembri, Mark A/0000-0003-4863-9260; Beddoe, Travis/0000-0003-4550-2277; Kocan, Martina/0000-0003-3468-6197	National Institutes of Health [GM62116, GM98791 NIGMS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R24GM098791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of beamline MX2 at the Australian Synchrotron for assistance with X-ray data collection. We acknowledge the Consortium for Functional Glycomics funded by National Institutes of Health Grants GM62116 and GM98791 NIGMS for services provided by the Glycan Array Synthesis Core (The Scripps Research Institute, La Jolla, CA) that produced the mammalian glycan microarray and the Protein-Glycan Interaction Core (Emory University School of Medicine, Atlanta, GA) that assisted with analysis of samples on the array. We thank Natasha Ng for initially cloning EcPltAB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANTOINE R, 1993, J BIOL CHEM, V268, P24149; AVIGAN J, 1992, BIOCHEMISTRY-US, V31, P7736, DOI 10.1021/bi00148a039; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cummings MD, 1998, PROTEINS, V31, P282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; GRAF R, 1992, MOL PHARMACOL, V42, P760; Hausman SZ, 1996, INFECT IMMUN, V64, P4020, DOI 10.1128/IAI.64.10.4020-4026.1996; Hazes B, 1996, J MOL BIOL, V258, P661, DOI 10.1006/jmbi.1996.0277; HEWLETT EL, 1983, INFECT IMMUN, V40, P1198, DOI 10.1128/IAI.40.3.1198-1203.1983; HOSHINO S, 1990, FEBS LETT, V276, P227, DOI 10.1016/0014-5793(90)80548-W; Hossain MA, 2008, CHEMBIOCHEM, V9, P1816, DOI 10.1002/cbic.200800113; Jobling MG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw001; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KASLOW HR, 1987, BIOCHEMISTRY-US, V26, P123, DOI 10.1021/bi00375a018; KATADA T, 1982, J BIOL CHEM, V257, P7210; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; LOCHT C, 1990, J BIOL CHEM, V265, P4552; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Moriel DG, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00326-16; Ng N, 2013, ACTA CRYSTALLOGR F, V69, P912, DOI 10.1107/S1744309113018927; Ng NM, 2013, STRUCTURE, V21, P2003, DOI 10.1016/j.str.2013.08.024; Nichols KB, 2016, J BACTERIOL, V198, P1487, DOI 10.1128/JB.00791-15; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; O'Neal CJ, 2004, BIOCHEMISTRY-US, V43, P3772, DOI 10.1021/bi0360152; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Saitoh M, 2005, MICROBIOL-SGM, V151, P3089, DOI 10.1099/mic.0.27933-0; Samson AL, 2014, J BIOL CHEM, V289, P26922, DOI 10.1074/jbc.M114.570275; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Uchida I, 2009, MICROBIOL-SGM, V155, P3710, DOI 10.1099/mic.0.028399-0; Wang H, 2013, INFECT IMMUN, V81, P673, DOI 10.1128/IAI.01043-12; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; XU YR, 1994, J BIOL CHEM, V269, P9993; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	56	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15143	15158		10.1074/jbc.M117.796094	http://dx.doi.org/10.1074/jbc.M117.796094			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28663369	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000409902100036
J	Rodionova, IA; Zhang, ZG; Mehla, J; Goodacre, N; Babu, M; Emili, A; Uetz, P; Saier, MH				Rodionova, Irina A.; Zhang, Zhongge; Mehla, Jitender; Goodacre, Norman; Babu, Mohan; Emili, Andrew; Uetz, Peter; Saier, Milton H., Jr.			The phosphocarrier protein HPr of the bacterial phosphotransferase system globally regulates energy metabolism by directly interacting with multiple enzymes in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate kinase (ADK); glycolysis; phosphofructokinase; protein-protein interaction; pyruvate kinase; Histidine phosphocarrier protein; adenylate kinase; glucosamine 6-phosphate deaminase; isomerase	GLUCOSAMINE-6-PHOSPHATE DEAMINASE; ALLOSTERIC ACTIVATION; GLYCOGEN-PHOSPHORYLASE; SUBSTRATE-BINDING; PYRUVATE-KINASE; PHOSPHOENOLPYRUVATE; REPRESSION; PATHOGEN; COMPLEX; DOMAIN	The histidine-phosphorylatable phosphocarrier protein (HPr) is an essential component of the sugar-transporting phosphotransferase system (PTS) in many bacteria. Recent interactome findings suggested that HPr interacts with several carbohydrate-metabolizing enzymes, but whether HPr plays a regulatory role was unclear. Here, we provide evidence that HPr interacts with a large number of proteins in Escherichia coli. We demonstrate HPr-dependent allosteric regulation of the activities of pyruvate kinase (PykF, but not PykA), phosphofructokinase (PfkB, but not PfkA), glucosamine-6-phosphate deaminase (NagB), and adenylate kinase (Adk). HPr is either phosphorylated on a histidyl residue (HPr-P) or non-phosphorylated (HPr). PykF is activated only by non-phosphorylated HPr, which decreases the PykF K-half for phosphoenolpyruvate by 10-fold (from 3.5 to 0.36 mm), thus influencing glycolysis. PfkB activation by HPr, but not by HPr-P, resulted from a decrease in the K-half for fructose-6-P, which likely influences both gluconeogenesis and glycolysis. Moreover, NagB activation by HPr was important for the utilization of amino sugars, and allosteric inhibition of Adk activity by HPr-P, but not by HPr, allows HPr to regulate the cellular energy charge coordinately with glycolysis. These observations suggest that HPr serves as a directly interacting global regulator of carbon and energy metabolism and probably of other physiological processes in enteric bacteria.	[Rodionova, Irina A.; Zhang, Zhongge; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA; [Mehla, Jitender; Goodacre, Norman; Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Emili, Andrew] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	University of California System; University of California San Diego; Virginia Commonwealth University; University of Regina; University of Toronto	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA.	msaier@ucsd.edu	Mohan, Babu P./I-7362-2019; Mehla, Jitender/M-6165-2016; Uetz, Peter/A-7119-2012	Mehla, Jitender/0000-0002-7829-557X; Goodacre, Norman/0000-0003-4995-2822; Saier, Milton/0000-0001-5530-0017; Uetz, Peter/0000-0001-6194-4927	National Institutes of Health [GM109895]; Canadian Institutes of Health Research [MOP-106449, PJT-148831]; Natural Sciences and Engineering Research Council of Canada Grant [DG-20234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402, R01GM109895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM109895. The interactome data reported in supplemental Table S1 was supported by National Institutes of Health Grant GM109895 as well as the Canadian Institutes of Health Research Grants MOP-106449 (to A. E.) and PJT-148831 (to M. B.) and Natural Sciences and Engineering Research Council of Canada Grant DG-20234 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTAMIRANO MM, 1995, BIOCHEMISTRY-US, V34, P6074, DOI 10.1021/bi00018a010; Alvarez-Anorve LI, 2016, J BACTERIOL, V198, P1610, DOI 10.1128/JB.00870-15; Alvarez-Anorve LI, 2011, BBA-PROTEINS PROTEOM, V1814, P1846, DOI 10.1016/j.bbapap.2011.07.010; Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09; Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; BABUL J, 1978, J BIOL CHEM, V253, P4350; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Cabrera R, 2010, ARCH BIOCHEM BIOPHYS, V502, P23, DOI 10.1016/j.abb.2010.06.024; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Choe M, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43431; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Jung YS, 2012, J BIOL CHEM, V287, P23819, DOI 10.1074/jbc.M112.371492; Kim HM, 2015, MOL MICROBIOL, V96, P293, DOI 10.1111/mmi.12936; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931; Ping J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/628536; Porcheron G, 2016, CURR OPIN MICROBIOL, V30, P98, DOI 10.1016/j.mib.2016.01.008; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561; Ravcheev DA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00294; Reichenbach B, 2007, J BACTERIOL, V189, P4603, DOI 10.1128/JB.00236-07; Rodionova IA, 2012, J BACTERIOL, V194, P5552, DOI 10.1128/JB.01136-12; Ryabov Y, 2009, J AM CHEM SOC, V131, P9522, DOI 10.1021/ja902336c; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Saier M. H, 1987, ENZYMES METABOLIC PA; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; SAIER MH, 1976, J BIOL CHEM, V251, P6598; Saier MH, 1996, MICROBIOL-UK, V142, P217, DOI 10.1099/13500872-142-2-217; Schrank TP, 2013, TOP CURR CHEM, V337, P95, DOI 10.1007/128_2012_410; Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Seok YJ, 2001, J MOL MICROB BIOTECH, V3, P385; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Torres JC, 1997, BIOCHEM J, V327, P675; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Wujak M, 2015, POSTEP HIG MED DOSW, V69, P933, DOI 10.5604/17322693.1165196	44	18	18	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14250	14257		10.1074/jbc.M117.795294	http://dx.doi.org/10.1074/jbc.M117.795294			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28634232	Green Published, hybrid			2022-12-28	WOS:000408439800028
J	Han, GS; Carman, GM				Han, Gil-Soo; Carman, George M.			Yeast PAH1-encoded phosphatidate phosphatase controls the expression of CHO1-encoded phosphatidylserine synthase for membrane phospholipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; PATCH PROTEIN APP1P; SACCHAROMYCES-CEREVISIAE; LIPID-SYNTHESIS; COORDINATE REGULATION; PHOSPHATIDYLINOSITOL SYNTHASE; DIACYLGLYCEROL KINASE; MEDIATED REGULATION; ESCHERICHIA-COLI; ORTHOLOGUE PAH1P	The PAH1-encoded phosphatidate phosphatase (PAP), which catalyzes the committed step for the synthesis of triacylglycerol in Saccharomyces cerevisiae, exerts a negative regulatory effect on the level of phosphatidate used for the de novo synthesis of membrane phospholipids. This raises the question whether PAP thereby affects the expression and activity of enzymes involved in phospholipid synthesis. Here, we examined the PAP-mediated regulation of CHO1-encoded phosphatidylserine synthase (PSS), which catalyzes the committed step for the synthesis of major phospholipids via the CDP-diacylglycerol pathway. The lack of PAP in the pah1 Delta mutant highly elevated PSS activity, exhibiting a growth-dependent up-regulation from the exponential to the stationary phase of growth. Immunoblot analysis showed that the elevation of PSS activity results from an increase in the level of the enzyme encoded by CHO1. Truncation analysis and site-directed mutagenesis of the CHO1 promoter indicated that Cho1 expression in the pah1 Delta mutant is induced through the inositol-sensitive upstream activation sequence (UAS(INO)), a cis-acting element for the phosphatidate-controlled Henry (Ino2-Ino4/Opi1) regulatory circuit. The abrogation of Cho1 induction and PSS activity by a CHO1 UAS(INO) mutation suppressed pah1 Delta effects on lipid synthesis, nuclear/endoplasmic reticulum membrane morphology, and lipid droplet formation, but not on growth at elevated temperature. Loss of the DGK1-encoded diacylglycerol kinase, which converts diacylglycerol to phosphatidate, partially suppressed the pah1 Delta-mediated induction of Cho1 and PSS activity. Collectively, these data showed that PAP activity controls the expression of PSS for membrane phospholipid synthesis.	Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, Brunswick, NJ 08901 USA.	gcarman@rutgers.edu			National Institutes of Health [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Anderson MS, 1996, J BIOL CHEM, V271, P26596, DOI 10.1074/jbc.271.43.26596; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAELEE MS, 1984, J BIOL CHEM, V259, P857; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; CARMAN GM, 1981, CAN J MICROBIOL, V27, P1140, DOI 10.1139/m81-179; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Choi HS, 2004, J BIOL CHEM, V279, P12081, DOI 10.1074/jbc.M400297200; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Dey P, 2017, J LIPID RES, V58, P742, DOI 10.1194/jlr.M075036; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; HAID A, 1983, METHOD ENZYMOL, V96, P192; HAMAMATSU S, 1994, FEBS LETT, V348, P33, DOI 10.1016/0014-5793(94)00576-1; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hassaninasab A, 2017, ANAL BIOCHEM, V526, P69, DOI 10.1016/j.ab.2017.03.020; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOMANN MJ, 1987, J BACTERIOL, V169, P3276, DOI 10.1128/jb.169.7.3276-3280.1987; HOSAKA K, 1990, J BACTERIOL, V172, P2005, DOI 10.1128/jb.172.4.2005-2012.1990; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kersting MC, 2004, J BIOL CHEM, V279, P35353, DOI 10.1074/jbc.M405704200; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPING E, 1994, GENETICS, V137, P55; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; Miner GE, 2017, TRAFFIC, V18, P315, DOI 10.1111/tra.12479; MORASH SC, 1994, J BIOL CHEM, V269, P28769; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nomura W, 2017, CELL SIGNAL, V31, P146, DOI 10.1016/j.cellsig.2017.01.002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Sun YD, 2012, J CELL SCI, V125, P6157, DOI 10.1242/jcs.115741; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f	93	25	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13230	13242		10.1074/jbc.M117.801720	http://dx.doi.org/10.1074/jbc.M117.801720			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28673963	Green Published, hybrid			2022-12-28	WOS:000407465300013
J	Kim, HJ; Lee, JJ; Cho, JH; Jeong, J; Park, AY; Kang, W; Lee, KJ				Kim, Hee-Jung; Lee, Jae-Jin; Cho, Jin-Hwan; Jeong, Jaeho; Park, A. Young; Kang, Wonmo; Lee, Kong-Joo			Heterogeneous nuclear ribonucleoprotein K inhibits heat shock-induced transcriptional activity of heat shock factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); heat shock protein (HSP); mass spectrometry (MS); post-translational modification (PTM); proteomics; redox regulation; hnRNP K	HNRNP-K; ARGININE METHYLATION; C-SRC; DNA; ACTIVATION; BINDING; PROTEIN; PHOSPHORYLATION; STRESS; IDENTIFICATION	When cells are exposed to heat shock and various other stresses, heat shock factor 1 (HSF1) is activated, and the heat shock response (HSR) is elicited. To better understand the molecular regulation of the HSR, we used 2D-PAGE-based proteome analysis to screen for heat shock-induced post-translationally modified cellular proteins. Our analysis revealed that two protein spots typically present on 2D-PAGE gels and containing heterogeneous nuclear ribonucleoprotein K (hnRNP K) with trioxidized Cys(132) disappeared after the heat shock treatment and reappeared during recovery, but the total amount of hnRNP K protein remained unchanged. We next tested whether hnRNP K plays a role in HSR by regulating HSF1 and found that hnRNP K inhibits HSF1 activity, resulting in reduced expression of hsp70 and hsp27 mRNAs. hnRNP K also reduced binding affinity of HSF1 to the heat shock element by directly interacting with HSF1 but did not affect HSF1 phosphorylation-dependent activation or nuclear localization. hnRNP K lost its ability to induce these effects when its Cys(132) was substituted with Ser, Asp, or Glu. These findings suggest that hnRNP K inhibits transcriptional activity of HSF1 by inhibiting its binding to heat shock element and that the oxidation status of Cys(132) in hnRNP K is critical for this inhibition.	[Kim, Hee-Jung; Lee, Jae-Jin; Cho, Jin-Hwan; Jeong, Jaeho; Park, A. Young; Kang, Wonmo; Lee, Kong-Joo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea	Ewha Womans University	Lee, KJ (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea.	kjl@ewha.ac.kr			Global Research Lab Program Grant of the National Research Foundation of Korea [2012K1A1A2045441]; Basic Science Research Program Grant of the National Research Foundation of Korea [2016R1A6 A3A11934127]; Brain Research Program Grant of the National Research Foundation of Korea [2015M3C7A1028373]	Global Research Lab Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Brain Research Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Global Research Lab Program Grant 2012K1A1A2045441, Basic Science Research Program Grant 2016R1A6 A3A11934127, and Brain Research Program Grant 2015M3C7A1028373 of the National Research Foundation of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Barboro P, 2014, CANCER LETT, V352, P152, DOI 10.1016/j.canlet.2014.06.019; Chen YB, 2008, FEBS LETT, V582, P1761, DOI 10.1016/j.febslet.2008.04.051; Choi HS, 2008, MOL CELL PROTEOMICS, V7, P1517, DOI 10.1074/mcp.M800052-MCP200; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020252; Kim HJ, 2002, MOL CELL BIOCHEM, V229, P139, DOI 10.1023/A:1017941131744; Kim JA, 2015, CARCINOGENESIS, V36, P696, DOI 10.1093/carcin/bgv045; Kim MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073340; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Kimura Y, 2010, PROTEOMICS, V10, P3884, DOI 10.1002/pmic.201000349; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; LEE KJ, 1988, J CELL PHYSIOL, V136, P411, DOI 10.1002/jcp.1041360304; Lee SW, 2012, EMBO J, V31, P4441, DOI 10.1038/emboj.2012.293; Leopoldino AM, 2007, GENOME, V50, P451, DOI 10.1139/G07-016; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Yamamoto K, 2016, GENES CELLS, V21, P1006, DOI 10.1111/gtc.12400; Yang JH, 2014, NUCLEIC ACIDS RES, V42, P9908, DOI 10.1093/nar/gku705	43	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12801	12812		10.1074/jbc.M117.774992	http://dx.doi.org/10.1074/jbc.M117.774992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28592492	Green Published, hybrid			2022-12-28	WOS:000407220100012
J	Ponzio, G; Rezzonico, R; Bourget, I; Allan, R; Nottet, N; Popa, A; Magnone, V; Rios, G; Mari, B; Barbry, P				Ponzio, Gilles; Rezzonico, Roger; Bourget, Isabelle; Allan, Richard; Nottet, Nicolas; Popa, Alexandra; Magnone, Virginie; Rios, Geraldine; Mari, Bernard; Barbry, Pascal			A new long noncoding RNA (lncRNA) is induced in cutaneous squamous cell carcinoma and down-regulates several anticancer and cell differentiation genes in mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; long noncoding RNA (long ncRNA; lncRNA); microarray; RNA; skin	ALPHA-B-CRYSTALLIN; PLASMINOGEN-ACTIVATOR INHIBITOR-2; SPECIFICITY PHOSPHATASE 5; CORNIFIED ENVELOPE; CANCER; GROWTH; EXPRESSION; MIGRATION; IDENTIFICATION; TRANSFORMATION	Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer. Although some of the early events involved in this pathology have been identified, the subsequent steps leading to tumor development are poorly defined. We demonstrate here that the development of mouse tumors induced by the concomitant application of a carcinogen and a tumor promoter (7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA), respectively) is associated with the up-regulation of a previously uncharacterized long noncoding RNA (lncRNA), termed AK144841. We found that AK144841 expression was absent from normal skin and was specifically stimulated in tumors and highly tumorigenic cells. We also found that AK144841 exists in two variants, one consisting of a large 2-kb transcript composed of four exons and one consisting of a 1.8-kb transcript lacking the second exon. Gain- and loss-of-function studies indicated that AK144841 mainly inhibited gene expression, specifically down-regulating the expression of genes of the late cornified envelope-1 (Lce1) family involved in epidermal terminal differentiation and of anticancer genes such as Cgref1, Brsk1, Basp1, Dusp5, Btg2, Anpep, Dhrs9, Stfa2, Tpm1, SerpinB2, Cpa4, Crct1, Cryab, Il24, Csf2, and Rgs16. Interestingly, the lack of the second exon significantly decreased AK144841's inhibitory effect on gene expression. We also noted that high AK144841 expression correlated with a low expression of the aforementioned genes and with the tumorigenic potential of cell lines. These findings suggest that AK144841 could contribute to the dedifferentiation program of tumor-forming keratinocytes and to molecular cascades leading to tumor development.	[Ponzio, Gilles; Rezzonico, Roger; Allan, Richard; Nottet, Nicolas; Popa, Alexandra; Magnone, Virginie; Rios, Geraldine; Mari, Bernard; Barbry, Pascal] Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Bourget, Isabelle] Univ Cote Azur, CNRS, INSERM, Inst Res Canc & Aging, F-06000 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Ponzio, G (corresponding author), IPMC CNRS, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	ponzio@ipmc.cnrs.fr	Mari, Bernard/Q-5832-2019; Mari, Bernard P/GVS-3100-2022; Mari, Bernard P/F-8960-2013; REZZONICO, Roger/N-9626-2016; Mari, Bernard P/D-7445-2015; Barbry, Pascal/O-5021-2016	Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; REZZONICO, Roger/0000-0002-8460-1641; Mari, Bernard P/0000-0002-0422-9182; Popa, Alexandra Mariela/0000-0001-7156-272X; Barbry, Pascal/0000-0001-9632-6483; Rios Munera, Geraldine/0000-0002-2993-1859; Nottet, Nicolas/0000-0002-8699-6747	CNRS; INSERM; French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" FRANCE GENOMIQUE [ANR-10-INBS-09-03, ANR-10-INBS-09-02]; Canceropole Provence Alpes Cote d'Azur (PACA); la Ligue contre le cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" LABEX SIGNALIFE(French National Research Agency (ANR)); French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" FRANCE GENOMIQUE(French National Research Agency (ANR)); Canceropole Provence Alpes Cote d'Azur (PACA); la Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the CNRS, INSERM, the French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" LABEX SIGNALIFE (Grant ANR-11-LABX-0028-01) and FRANCE GENOMIQUE (Grants ANR-10-INBS-09-03 and ANR-10-INBS-09-02), Canceropole Provence Alpes Cote d'Azur (PACA), and la Ligue contre le cancer. The authors declare that they have no conflicts of interest with the contents of this article.	Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Bharadwaj S, 2002, CANCER LETT, V183, P205, DOI 10.1016/S0304-3835(02)00119-2; Cai C, 2015, INT J CLIN EXP MED, V8, P4186; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 2015, CELL DEATH DIFFER, V22, P12, DOI 10.1038/cdd.2014.113; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carper Miranda B, 2014, Genes Cancer, V5, P420; Cheng H, 2015, PROTEIN CELL, V6, P746, DOI 10.1007/s13238-015-0188-7; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Deng WW, 2015, INT J BIOCHEM CELL B, V65, P32, DOI 10.1016/j.biocel.2015.05.019; Deng ZZ, 2014, NEOPLASIA, V16, P656, DOI 10.1016/j.neo.2014.07.008; Dranoff G, 2003, ONCOGENE, V22, P3188, DOI 10.1038/sj.onc.1206459; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; Emmert Steffen, 2014, Adv Exp Med Biol, V810, P234; Fatima Roshan, 2015, Mol Cell Ther, V3, P5, DOI 10.1186/s40591-015-0042-6; Gastaldi C, 2014, CARCINOGENESIS, V35, P1110, DOI 10.1093/carcin/bgt490; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Gupta R, 2016, J INVEST DERMATOL, V136, P603, DOI 10.1016/j.jid.2015.12.009; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Hu L, 2016, TUMOR BIOL, V37, P837, DOI 10.1007/s13277-015-3880-6; Huang HM, 2014, J NANOMATER, V2014, DOI 10.1155/2014/180765; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Huang ZQ, 2014, MOL CARCINOGEN, V53, P777, DOI 10.1002/mc.22033; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Jiang YJ, 2014, J STEROID BIOCHEM, V144, P87, DOI 10.1016/j.jsbmb.2013.11.018; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liang XB, 2015, INT J ONCOL, V47, P1829, DOI 10.3892/ijo.2015.3177; Lim SK, 2012, CLIN EXP METASTAS, V29, P901, DOI 10.1007/s10585-012-9479-z; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Lung HL, 2008, INT J CANCER, V122, P1288, DOI 10.1002/ijc.23259; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Madden SL, 1996, CANCER RES, V56, P5384; Magne N, 2002, BRIT J CANCER, V86, P1518, DOI 10.1038/sj/bjc/6600299; Mao BJ, 2015, INT J ONCOL, V46, P459, DOI 10.3892/ijo.2014.2765; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; MUELLER BM, 1995, P NATL ACAD SCI USA, V92, P205, DOI 10.1073/pnas.92.1.205; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Owens DM, 1999, CARCINOGENESIS, V20, P1837, DOI 10.1093/carcin/20.9.1837; Panneerselvam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122439; Piipponen M, 2016, J INVEST DERMATOL, V136, P1701, DOI 10.1016/j.jid.2016.03.028; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Rentoft M, 2011, INT J ONCOL, V38, P61, DOI 10.3892/ijo_00000824; REZZONICO R, 1995, ONCOGENE, V11, P1069; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sand M, 2016, TUMOR BIOL, V37, P10595, DOI 10.1007/s13277-016-4927-z; Shin SH, 2013, AM J PATHOL, V182, P1275, DOI 10.1016/j.ajpath.2013.01.004; Smith R, 2007, WORLD J SURG, V31, P493, DOI 10.1007/s00268-006-0289-9; Sorensen KD, 2013, BRIT J CANCER, V108, P420, DOI 10.1038/bjc.2012.549; Strojan P, 2007, INT J RADIAT ONCOL, V68, P1335, DOI 10.1016/j.ijrobp.2007.02.004; Takashi M, 1998, UROL RES, V26, P395, DOI 10.1007/s002400050075; Urdinguio RG, 2013, CANCER RES, V73, P395, DOI 10.1158/0008-5472.CAN-12-0806; Wang SH, 2014, INT J CLIN EXP PATHO, V7, P7131; Wang ZZ, 2016, EXP DERMATOL, V25, P131, DOI 10.1111/exd.12900; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yoshino H, 1998, BRIT J CANCER, V78, P833, DOI 10.1038/bjc.1998.588; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhang L, 2010, MOL BIOL REP, V37, P2579, DOI 10.1007/s11033-009-9777-y	67	26	26	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12483	12495		10.1074/jbc.M117.776260	http://dx.doi.org/10.1074/jbc.M117.776260			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28596382	hybrid, Green Published			2022-12-28	WOS:000406636900013
J	Agrawal, G; Shang, HH; Xia, ZJ; Subramani, S				Agrawal, Gaurav; Shang, Helen H.; Xia, Zhi-Jie; Subramani, Suresh			Functional regions of the peroxin Pex19 necessary for peroxisome biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN BOUNDARY PREDICTION; MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; RECEPTOR PEX19P; IMPORT RECEPTOR; PEX3P; DIVISION; DISTINCT; YEAST; FARNESYLATION	The peroxins Pex19 and Pex3 play an indispensable role in peroxisomal membrane protein (PMP) biogenesis, peroxisome division, and inheritance. Pex19 plays multiple roles in these processes, but how these functions relate to the structural organization of the Pex19 domains is unresolved. To this end, using deletion mutants, we mapped the Pex19 regions required for peroxisome biogenesis in the yeast Pichia pastoris. Surprisingly, import-competent peroxisomes still formed when Pex19 domains previously believed to be required for biogenesis were deleted, although the peroxisome size was larger than that in wild-type cells. Moreover, these mutants exhibited a delay of 14-24 h in peroxisome biogenesis. The shortest functional N-terminal (NTCs) and C-terminal constructs (CTCs) were Pex19 (aa 1-150) and Pex19 (aa 89-300), respectively. Deletions of the N-terminal Pex3-binding site disrupted the direct interactions of Pex19 with Pex3, but preserved interactions with a membrane peroxisomal targeting signal (mPTS)-containing PMP, Pex10. In contrast, deletion of the C-terminal mPTSbinding domain of Pex19 disrupted its interaction with Pex10 while leaving the Pex19-Pex3 interactions intact. However, Pex11 and Pex25 retained their interactions with both Nand C-terminal deletion mutants. NTC-CTC co-expression improved growth and reversed the larger-than-normal peroxisome size observed with the single deletions. Pex25 was critical for peroxisome formation with the CTC variants, and its overexpression enhanced their interactions with Pex3 and aided the growth of both NTC and CTC Pex19 variants. In conclusion, physical segregation of the Pex3-and PMP-binding domains of Pex19 has provided novel insights into the modular architecture of Pex19. We define the minimum region of Pex19 required for peroxisome biogenesis and a unique role for Pex25 in this process.	[Agrawal, Gaurav; Shang, Helen H.; Xia, Zhi-Jie; Subramani, Suresh] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, Rm 3326,Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA; [Xia, Zhi-Jie] Shandong Normal Univ, Coll Life Sci, Jinan 250014, Shandong, Peoples R China	University of California System; University of California San Diego; Shandong Normal University	Subramani, S (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, Rm 3326,Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu	Xia, Zhijie/J-6987-2017	Xia, Zhijie/0000-0003-3018-1925	National Institutes of Health [RO1DK41737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1DK41737 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal G, 2016, BBA-MOL CELL RES, V1863, P892, DOI 10.1016/j.bbamcr.2015.09.014; Agrawal G, 2016, J CELL BIOL, V212, P335, DOI 10.1083/jcb.201506141; Agrawal G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00286; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Chen YX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6790; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Delille HK, 2008, J BIOL CHEM, V283, P31107, DOI 10.1074/jbc.M803332200; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Giannopoulou EA, 2016, BBA-MOL CELL RES, V1863, P863, DOI 10.1016/j.bbamcr.2015.09.031; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hettema EH, 2009, J CELL SCI, V122, P2331, DOI 10.1242/jcs.034363; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Joshi S, 2012, MOL BIOL CELL, V23, P1307, DOI 10.1091/mbc.E11-09-0782; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Klouwer FCC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0368-9; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; Mast FD, 2016, J BIOL CHEM, V291, P15408, DOI 10.1074/jbc.M116.728154; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Otzen ML, 2012, TRAFFIC, V13, P947, DOI 10.1111/j.1600-0854.2012.01364.x; Otzen M, 2006, FEMS YEAST RES, V6, P1157, DOI 10.1111/j.1567-1364.2006.00102.x; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sato Y, 2008, J BIOL CHEM, V283, P6136, DOI 10.1074/jbc.M706139200; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2012, TRAFFIC, V13, P1244, DOI 10.1111/j.1600-0854.2012.01380.x; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; SIBIRNY AA, 1988, J BASIC MICROB, V28, P293, DOI 10.1002/jobm.3620280503; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Tabak HF, 2013, ANNU REV BIOCHEM, V82, P723, DOI 10.1146/annurev-biochem-081111-125123; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; Tower RJ, 2011, MOL BIOL CELL, V22, P1727, DOI 10.1091/mbc.E11-01-0084; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; VEENHUIS M, 1983, ADV MICROB PHYSIOL, V24, P1, DOI 10.1016/S0065-2911(08)60384-7; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077	56	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11547	11560		10.1074/jbc.M116.774067	http://dx.doi.org/10.1074/jbc.M116.774067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28526747	hybrid, Green Published			2022-12-28	WOS:000405119600034
J	Deuss, FA; Gully, BS; Rossjohn, J; Berry, R				Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard			Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL IMMUNOEVASIN; PVR CD155; NK CELLS; MOLECULE; CYTOTOXICITY; ACTIVATION; SEQUENCE; ADHESION; LIGANDS; FAMILY	T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on the surface of natural killer (NK) cells. TIGIT recognizes nectin and nectin-like adhesion molecules and thus plays a critical role in the innate immune response to malignant transformation. Although the TIGIT nectin-like protein-5 (necl-5) interaction is well understood, how TIGIT engages nectin-2, a receptor that is broadly over-expressed in breast and ovarian cancer, remains unknown. Here, we show that TIGIT bound to the immunoglobulin domain of nectin-2 that is most distal from the membrane with an affinity of 6 mu M, which was moderately lower than the affinity observed for the TIGIT/necl-5 interaction (3.2 mu M). The TIGIT/nectin-2 binding disrupted preassembled nectin-2 oligomers, suggesting that receptor-ligand and ligand-ligand associations are mutually exclusive events. Indeed, the crystal structure of TIGIT bound to the first immunoglobulin domain of nectin-2 indicated that the receptor and ligand dock using the same molecular surface and a conserved " lock and key" binding motifs previously observed to mediate nectin/nectin homotypic interactions as well as TIGIT/necl-5 recognition. Using a mutagenesis approach, we dissected the energetic basis for the TIGIT/nectin-2 interaction and revealed that an " aromatic key" of nectin-2 is critical for this interaction, whereas variations in the lock were tolerated. Moreover, we found that the C-C' loop of the ligand dictates the TIGIT binding hierarchy. Altogether, these findings broaden our understanding of nectin/nectin receptor interactions and have implications for better understanding the molecular basis for autoimmune disease and cancer.	[Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Monash University; Cardiff University	Rossjohn, J; Berry, R (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales.	Jamie.rossjohn@monash.edu; Richard.berry@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Deuss, Felix/0000-0002-0386-4336; Gully, Benjamin/0000-0002-8197-0871; berry, richard/0000-0001-7043-0469	Australian Research Council [FL160100049]; National Health and Medical Research Council of Australia [APP1109901]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by Australian Research Council Laureate Fellowship FL160100049. To whom correspondence may be addressed. Tel.: 61-3-9902-9236; Fax: 99054699; E-mail: Jamie.rossjohn@monash.edu. 3; Supported by Career Development Fellowship Grant APP1109901 from the National Health and Medical Research Council of Australia. To whom correspondence may be addressed. Tel.: 61-3-9902-9239; E-mail: Richard.berry@monash.edu.	Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Berry R, 2014, J BIOL CHEM, V289, P23753, DOI 10.1074/jbc.M114.584128; Berry R, 2014, IMMUNOL CELL BIOL, V92, P214, DOI 10.1038/icb.2013.100; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lazetic S, 1996, J IMMUNOL, V157, P4741; Liu J, 2012, J IMMUNOL, V188, P5511, DOI 10.4049/jimmunol.1200324; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Oshima T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-60; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Sullivan LC, 2016, J BIOL CHEM, V291, P18740, DOI 10.1074/jbc.M116.737130; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	38	46	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11413	11422		10.1074/jbc.M117.786483	http://dx.doi.org/10.1074/jbc.M117.786483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515320	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000405119600024
J	Keogh, CE; Scholz, CC; Rodriguez, J; Selfridge, AC; von Kriegsheim, A; Cummins, EP				Keogh, Ciara E.; Scholz, Carsten C.; Rodriguez, Javier; Selfridge, Andrew C.; von Kriegsheim, Alexander; Cummins, Eoin P.			Carbon dioxide-dependent regulation of NF-kappa B family members RelB and p100 gives molecular insight into CO2-dependent immune regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; HYPERCAPNIC ACIDOSIS; THERAPEUTIC HYPERCAPNIA; SIGNALING PATHWAYS; SUBUNIT RELB; INFLAMMATION; PROTEIN; VENTILATION; ACTIVATION; MECHANISM	CO2 is a physiological gas normally produced in the body during aerobic respiration. Hypercapnia (elevated blood pCO(2) > approximate to 50 mm Hg) is a feature of several lung pathologies, e.g. chronic obstructive pulmonary disease. Hypercapnia is associated with increased susceptibility to bacterial infections and suppression of inflammatory signaling. The NF-kappa B pathway has been implicated in these effects; however, the molecular mechanisms underpinning cellular sensitivity of the NF-kappa B pathway to CO2 are not fully elucidated. Here, we identify several novel CO2-dependent changes in the NF-kappa B pathway. NF-kappa B family members p100 and RelB translocate to the nucleus in response to CO2. A cohort of RelB protein-protein interactions (e.g. with Raf-1 and I kappa B alpha) are altered by CO2 exposure, although others are maintained (e. g. with p100). RelB is processed by CO2 in a manner dependent on a key C-terminal domain located in its transactivation domain. Loss of the RelB transactivation domain alters NF-kappa B-dependent transcriptional activity, and loss of p100 alters sensitivity of RelB to CO2. Thus, we provide molecular insight into the CO2 sensitivity of the NF-kappa B pathway and implicate altered RelB/p100-dependent signaling in the CO2-dependent regulation of inflammatory signaling.	[Keogh, Ciara E.; Selfridge, Andrew C.; Cummins, Eoin P.] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Keogh, Ciara E.; Selfridge, Andrew C.; Cummins, Eoin P.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Scholz, Carsten C.; Rodriguez, Javier; von Kriegsheim, Alexander] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Rodriguez, Javier; von Kriegsheim, Alexander] Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Scholz, Carsten C.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	University College Dublin; University College Dublin; University College Dublin; University of Edinburgh; University of Zurich	Cummins, EP (corresponding author), Univ Coll Dublin, Sch Med, Dublin 4, Ireland.	eoin.cummins@ucd.ie	rodriguez, javier/AAB-1131-2019; Cummins, Eoin/S-7554-2019; Scholz, Carsten C./P-3185-2019; von Kriegsheim, Alex/C-2371-2016	rodriguez, javier/0000-0001-7467-8533; Cummins, Eoin/0000-0002-9346-8299; Scholz, Carsten C./0000-0001-6579-8015; Keogh, Ciara/0000-0002-5591-5633; von Kriegsheim, Alex/0000-0002-4952-8573	Science Foundation Ireland [15/CDA/3490]; University College Dublin School of Medicine; University College Dublin Research Grant [SF1146]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University College Dublin School of Medicine; University College Dublin Research Grant	This work was supported by Science Foundation Ireland Grant 15/CDA/3490, University College Dublin School of Medicine, and University College Dublin Research Grant SF1146. The authors declare that they have no conflicts of interest with the contents of this article.	Abolhassani M, 2009, AM J PHYSIOL-LUNG C, V296, pL657, DOI 10.1152/ajplung.90460.2008; Ahmadi Z, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-30; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bellet MM, 2012, CELL CYCLE, V11, P3304, DOI 10.4161/cc.21669; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Caamano J, 1999, J IMMUNOL, V163, P4453; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Costello J, 2009, CRIT CARE MED, V37, P2412, DOI 10.1097/CCM.0b013e3181a385d3; Crummy F, 2007, RESP MED, V101, P53, DOI 10.1016/j.rmed.2006.04.013; Cummins EP, 2016, EXP PHYSIOL, V101, P986, DOI 10.1113/EP085715; Cummins EP, 2014, CELL MOL LIFE SCI, V71, P831, DOI 10.1007/s00018-013-1470-6; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; Fuller BM, 2017, J CRIT CARE, V41, P29, DOI 10.1016/j.jcrc.2017.04.033; Fusco AJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad9413; Gao W, 2015, ANESTHESIOLOGY, V122, P1235, DOI 10.1097/ALN.0000000000000627; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Horie Shahd, 2016, Intensive Care Med Exp, V4, P8, DOI 10.1186/s40635-016-0081-6; Jaitovich A, 2015, J BIOL CHEM, V290, P9183, DOI 10.1074/jbc.M114.625715; Kohnlein T, 2014, LANCET RESP MED, V2, P698, DOI 10.1016/S2213-2600(14)70153-5; Kuboki M, 2015, BIOCHEM BIOPH RES CO, V456, P810, DOI 10.1016/j.bbrc.2014.12.024; Labonte L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112965; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Leidner U, 2008, BIOCHEM J, V416, P117, DOI 10.1042/BJ20080432; Leidner J, 2014, J CELL BIOCHEM, V115, P1430, DOI 10.1002/jcb.24794; Li AM, 2010, CHINESE MED J-PEKING, V123, P2254, DOI 10.3760/cma.j.issn.0366-6999.2010.16.018; Li GY, 2006, J APPL PHYSIOL, V101, P1556, DOI 10.1152/japplphysiol.01031.2005; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; Maier HJ, 2003, J BIOL CHEM, V278, P39242, DOI 10.1074/jbc.M301521200; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Masterson C, 2016, CRIT CARE MED, V44, pe207, DOI 10.1097/CCM.0000000000001376; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Otulakowski G, 2014, J PHYSIOL-LONDON, V592, P4507, DOI 10.1113/jphysiol.2014.277616; Otulakowski G, 2011, CRIT CARE MED, V39, P1581, DOI 10.1097/CCM.0b013e318215bb0a; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Tao ZH, 2014, P NATL ACAD SCI USA, V111, P15946, DOI 10.1073/pnas.1408552111; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Tzeng YS, 2015, J SURG RES, V195, P351, DOI 10.1016/j.jss.2014.12.023; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004	57	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11561	11571		10.1074/jbc.M116.755090	http://dx.doi.org/10.1074/jbc.M116.755090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28507099	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000405119600035
J	Lara, P; Ojemalm, K; Reithinger, J; Holgado, A; Maojun, Y; Hammed, A; Mattle, D; Kim, H; Nilsson, I				Lara, Patricia; Ojemalm, Karin; Reithinger, Johannes; Holgado, Aurora; Maojun, You; Hammed, Abdessalem; Mattle, Daniel; Kim, Hyun; Nilsson, IngMarie			Refined topology model of the STT3/Stt3 protein subunit of the oligosaccharyltransferase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; N-LINKED GLYCOSYLATION; TRANSMEMBRANE HELICES; BACTERIAL OLIGOSACCHARYLTRANSFERASE; TRANSLOCON COMPLEX; SEC61 TRANSLOCON; ESCHERICHIA-COLI; MOLECULAR CODE; P-GLYCOPROTEIN; STT3 SUBUNIT	The oligosaccharyltransferase complex, localized in the endoplasmic reticulum (ER) of eukaryotic cells, is responsible for the N-linked glycosylation of numerous protein substrates. The membrane protein STT3 is a highly conserved part of the oligosaccharyltransferase and likely contains the active site of the complex. However, understanding the catalytic determinants of this system has been challenging, in part because of a discrepancy in the structural topology of the bacterial versus eukaryotic proteins and incomplete information about the mechanism of membrane integration. Here, we use a glycosylation mapping approach to investigate these questions. We measured the membrane integration efficiency of the mouse STT3-A and yeast Stt3p transmembrane domains (TMDs) and report a refined topology of the N-terminal half of the mouse STT3-A. Our results show that most of the STT3 TMDs are well inserted into the ER membrane on their own or in the presence of the natural flanking residues. However, for the mouse STT3-A hydrophobic domains 4 and 6 and yeast Stt3p domains 2, 3a, 3c, and 6 we measured reduced insertion efficiency into the ER membrane. Furthermore, we mapped the first half of the STT3-A protein, finding two extra hydrophobic domains between the third and the fourthTMD. This result indicates that the eukaryotic STT3 has 13 transmembrane domains, consistent with the structure of the bacterial homolog of STT3 and setting the stage for future combined efforts to interrogate this fascinating system.	[Lara, Patricia; Ojemalm, Karin; Reithinger, Johannes; Holgado, Aurora; Maojun, You; Hammed, Abdessalem; Mattle, Daniel; Nilsson, IngMarie] Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, SE-10691 Stockholm, Sweden; [Kim, Hyun] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea	Stockholm University; Seoul National University (SNU)	Nilsson, I (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, SE-10691 Stockholm, Sweden.	ingmarie@dbb.su.se		You, Maojun/0000-0001-6665-9068; Holgado, Aurora/0000-0001-6724-2758	Swedish Cancer Foundation [130624]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT) [210/083(12), KU 2003-4674]; Swedish Strategic Foundation [A302:200, SB12-0026]; National Research Foundation of Korea [NRF-2016R1A2B2013459]; Promising-Pioneering Researcher Program through Seoul National University	Swedish Cancer Foundation; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Strategic Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Promising-Pioneering Researcher Program through Seoul National University	This work was supported by grants from the Swedish Cancer Foundation (130624; to I. N. and Gunnar von Heijne), from the Swedish Foundation for International Cooperation in Research and Higher Education (STINT) (210/083(12) and KU 2003-4674; to I. N.), from the Swedish Strategic Foundation (A302:200 and SSF-Infection Biology 2012(SB12-0026); to I. N.), and from the National Research Foundation of Korea (NRF-2016R1A2B2013459) and Promising-Pioneering Researcher Program through Seoul National University (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Chi YH, 2010, COMP BIOCHEM PHYS B, V156, P40, DOI 10.1016/j.cbpb.2010.01.017; Cuviello F, 2015, FEBS LETT, V589, P3921, DOI 10.1016/j.febslet.2015.10.030; De Marothy MT, 2015, PROTEIN SCI, V24, P1057, DOI 10.1002/pro.2698; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Enquist K, 2009, J MOL BIOL, V387, P1153, DOI 10.1016/j.jmb.2009.02.035; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; Gilmore R, 2012, TRENDS BIOCHEM SCI, V37, P303, DOI 10.1016/j.tibs.2012.05.003; Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027; Hong GZ, 1996, GENOMICS, V31, P295, DOI 10.1006/geno.1996.0051; Igura M, 2011, J BIOL CHEM, V286, P13255, DOI 10.1074/jbc.M110.213900; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Ojemalm K, 2012, MOL CELL, V45, P529, DOI 10.1016/j.molcel.2011.12.024; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pitonzo D, 2006, BBA-BIOMEMBRANES, V1758, P976, DOI 10.1016/j.bbamem.2006.04.021; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Reithinger JH, 2013, J BIOL CHEM, V288, P18058, DOI 10.1074/jbc.M113.473009; Sadlish H, 2004, J MEMBRANE BIOL, V202, P115, DOI 10.1007/s00232-004-0715-6; Sato C, 2000, J BIOCHEM-TOKYO, V127, P65, DOI 10.1093/oxfordjournals.jbchem.a022585; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wanngren J, 2014, FEBS OPEN BIO, V4, P393, DOI 10.1016/j.fob.2014.04.006; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Yasuda D, 2015, FASEB J, V29, P2412, DOI 10.1096/fj.14-267096; YOSHIDA S, 1992, MOL GEN GENET, V231, P337, DOI 10.1007/BF00292700; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	49	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11349	11360		10.1074/jbc.M117.779421	http://dx.doi.org/10.1074/jbc.M117.779421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512128	hybrid, Green Published			2022-12-28	WOS:000405119600019
J	Perlenfein, TJ; Mehlhoff, JD; Murphy, RM				Perlenfein, Tyler J.; Mehlhoff, Jacob D.; Murphy, Regina M.			Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with beta-amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; FIBRIL FORMATION; ICELANDIC TYPE; CROSS-LINKING; L68Q VARIANT; WILD-TYPE; PROTEIN; ANGIOPATHY	Cystatin C (CysC) is a versatile and ubiquitously-expressed member of the cysteine protease inhibitor family that is present at notably high concentrations in cerebrospinal fluid. Under mildly denaturing conditions, CysC forms inactive domainswapped dimers. A destabilizing mutation, L68Q, increases the rate of domain-swapping and causes a fatal amyloid disease, hereditary cystatin C amyloid angiopathy. Wild-type (wt) CysC will also aggregate into amyloid fibrils under some conditions. Propagated domain-swapping has been proposed as the mechanism by which CysC fibrils grow. We present evidence that a CysC mutant, V57N, stabilized against domain-swapping, readily forms fibrils, contradicting the propagated domain-swapping hypothesis. Furthermore, in physiological buffer, wt CysC can form oligomers without undergoing domain-swapping. These non-swapped oligomers are identical in secondary structure to CysC monomers and completely retain protease inhibitory activity. However, unlike monomers or dimers, the oligomers bind fluorescent dyes that indicate they have characteristics of pre-amyloid aggregates. Although these oligomers appear to be a pre-amyloid assembly, they are slower than CysC monomers to form fibrils. Fibrillation of CysC therefore likely initiates from the monomer and does not require domain-swapping. The non-swapped oligomers likely represent a dead-end offshoot of the amyloid pathway and must dissociate to monomers prior to rearranging to amyloid fibrils. These prefibrillar CysC oligomers were potent inhibitors of aggregation of the Alzheimer's-related peptide, beta-amyloid. This result illustrates an example where heterotypic interactions between pre-amyloid oligomers prevent the homotypic interactions that would lead to mature amyloid fibrils.	[Perlenfein, Tyler J.; Mehlhoff, Jacob D.; Murphy, Regina M.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Murphy, RM (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	regina.murphy@wisc.edu			University of Wisconsin-Madison; National Science Foundation [BIR-9512577]; National Institutes of Health [S10 RR13790]; Directorate For Engineering [1262729] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CD data were obtained at the University of Wisconsin-Madison Biophysics Instrumentation Facility, which was established with support from the University of Wisconsin-Madison and National Science Foundation Grant BIR-9512577 and National Institutes of Health Grant S10 RR13790, with technical assistance provided by Dr. Darrell McCaslin. Randall Massey provided technical assistance with TEM.h-FTAA pre-amyloid dye was a generous gift from Drs. Peter Nilsson and Per Hammarstrom (Linkoping University, Sweden).	ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; BJORK I, 1994, BIOCHEM J, V299, P219, DOI 10.1042/bj2990219; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Calero M, 2001, J NEUROCHEM, V77, P628, DOI 10.1046/j.1471-4159.2001.00256.x; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P549; CORIA F, 1987, AM J PATHOL, V129, P422; Davis PJ, 2015, J MOL BIOL, V427, P2418, DOI 10.1016/j.jmb.2015.05.014; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Gerhartz B, 1998, BIOCHEMISTRY-US, V37, P17309, DOI 10.1021/bi980873u; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Guo SL, 2014, CLIN J PAIN, V30, P331, DOI 10.1097/AJP.0b013e31829ca60b; Hakansson K, 1996, COMP BIOCHEM PHYS B, V114, P303, DOI 10.1016/0305-0491(96)00025-9; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa A, 2007, J NEUROCHEM, V100, P12, DOI 10.1111/j.1471-4159.2006.04169.x; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kayser V, 2004, J AM CHEM SOC, V126, P336, DOI 10.1021/ja035340+; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Li J, 2011, J BIOL CHEM, V286, P28988, DOI 10.1074/jbc.M111.261750; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mathews PM, 2016, AGEING RES REV, V32, P38, DOI 10.1016/j.arr.2016.06.003; McCarron MO, 2000, NEUROLOGY, V54, P242, DOI 10.1212/WNL.54.1.242; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mi WQ, 2009, J ALZHEIMERS DIS, V18, P273, DOI 10.3233/JAD-2009-1147; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Murphy RM, 2000, J STRUCT BIOL, V130, P109, DOI 10.1006/jsbi.2000.4253; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Ostner G, 2013, J BIOL CHEM, V288, P16438, DOI 10.1074/jbc.M113.469593; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Pate KM, 2017, ISR J CHEM, V57, P602, DOI 10.1002/ijch.201600078; Pecora R, 2000, J NANOPART RES, V2, P123, DOI 10.1023/A:1010067107182; Perlenfein TJ, 2016, PROTEIN EXPRES PURIF, V117, P35, DOI 10.1016/j.pep.2015.09.023; Ristiniemi N, 2010, CLIN CHEM, V56, P1424, DOI 10.1373/clinchem.2009.141663; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Sladewska A, 2011, J MOL RECOGNIT, V24, P687, DOI 10.1002/jmr.1100; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Szymanska A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00082; Szymanska A, 2009, ACTA BIOCHIM POL, V56, P455; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tsiolaki PL, 2015, J STRUCT BIOL, V191, P272, DOI 10.1016/j.jsb.2015.07.013; Tsiolaki PL, 2015, FEBS LETT, V589, P159, DOI 10.1016/j.febslet.2014.11.041; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van der Wel PCA, 2012, PRION, V6, P211, DOI 10.4161/pri.18987; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Williams J W, 1979, Methods Enzymol, V63, P437; Wine Y, 2007, BIOTECHNOL BIOENG, V98, P711, DOI 10.1002/bit.21459; Xu YK, 2015, IMMUNOL CELL BIOL, V93, P442, DOI 10.1038/icb.2014.121; Xu YK, 2014, J BIOL CHEM, V289, P9730, DOI 10.1074/jbc.M113.538041; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Zerovnik E, 2009, BIOESSAYS, V31, P597, DOI 10.1002/bies.200900012; Zhou YJ, 2015, PROTEIN EXPRES PURIF, V111, P18, DOI 10.1016/j.pep.2015.03.006	77	19	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11485	11498		10.1074/jbc.M117.786558	http://dx.doi.org/10.1074/jbc.M117.786558			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28487367	Green Published, hybrid			2022-12-28	WOS:000405119600030
J	Oberheide, K; Puchkov, D; Jentsch, TJ				Oberheide, Karina; Puchkov, Dmytro; Jentsch, Thomas J.			Loss of the Na+/H+ exchanger NHE8 causes male infertility in mice by disrupting acrosome formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE RECOMBINASE ACTIVITY; SPERM; PH; EXPRESSION; GOLGI; PROTEIN; ACIDIFICATION; RETARDATION; MUTATIONS; DELETION	Mammalian sperm feature a specialized secretory organelle on the anterior part of the sperm nucleus, the acrosome, which is essential for male fertility. It is formed by a fusion of Golgi-derived vesicles. We show here that the predominantly Golgi-resident Na+/H+ exchanger NHE8 localizes to the developing acrosome of spermatids. Similar to wild-type mice, Nhe8(-/-) mice generated Golgi-derived vesicles positive for acrosomal markers and attached to nuclei, but these vesicles failed to form large acrosomal granules and the acrosomal cap. Spermatozoa from Nhe8(-/-) mice completely lacked acrosomes, were round-headed, exhibited abnormal mitochondrial distribution, and displayed decreased motility, resulting in selective male infertility. Of note, similar features are also found in globozoospermia, one of the causes of male infertility in humans. Germ cell-specific, but not Sertoli cell-specific Nhe8 disruption recapitulated the globozoospermia phenotype, demonstrating that NHE8's role in spermiogenesis is germ cell-intrinsic. Our work has uncovered a crucial role of NHE8 in acrosome biogenesis and suggests that some forms of human globozoospermia might be caused by a loss of function of this Na+/H+ exchanger. It points to NHE8 as a candidate gene for human globozoospermia and a possible drug target for male contraception.	[Oberheide, Karina; Puchkov, Dmytro; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany; [Oberheide, Karina; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553; Puchkov, Dmytro/0000-0001-8341-4847	Deutsche Forschungsgemeinschaft [SFB 740, TP C05]; European Research Council [294435]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported, in part, by Deutsche Forschungsgemeinschaft Grant SFB 740, TP C05 (to T. J. J.) and by the European Research Council (FP7 2007-2013) ERC-Advanced Grant 294435 'CYTOVOLION' (to T. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Berruti G, 2016, SEMIN CELL DEV BIOL, V59, P46, DOI 10.1016/j.semcdb.2016.01.013; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Bourgeois S, 2010, J CLIN INVEST, V120, P1895, DOI 10.1172/JCI36581; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Condon KH, 2013, J NEUROSCI, V33, P3799, DOI 10.1523/JNEUROSCI.1930-11.2013; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Goyal S, 2005, AM J PHYSIOL-RENAL, V288, pF530, DOI 10.1152/ajprenal.00229.2004; Goyal S, 2003, AM J PHYSIOL-RENAL, V284, pF467, DOI 10.1152/ajprenal.00352.2002; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; HOLSTEIN AF, 1973, DEUT MED WOCHENSCHR, V98, P61, DOI 10.1055/s-0028-1106747; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jadeja S, 2015, INVEST OPHTH VIS SCI, V56, P3015, DOI 10.1167/iovs.14-15735; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kondapalli KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3510; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lawrence SP, 2010, MOL BIOL CELL, V21, P3540, DOI 10.1091/mbc.E09-12-1053; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Liu C, 2013, AM J PHYSIOL-CELL PH, V305, pC121, DOI 10.1152/ajpcell.00101.2013; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MEIZEL S, 1978, J HISTOCHEM CYTOCHEM, V26, P98, DOI 10.1177/26.2.24069; Modi S, 2013, NAT NANOTECHNOL, V8, P459, DOI [10.1038/nnano.2013.92, 10.1038/NNANO.2013.92]; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; Roxrud I, 2009, EXP CELL RES, V315, P3014, DOI 10.1016/j.yexcr.2009.07.012; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Schirren C.G., 1971, ANDROLOGIA, V3, P117, DOI DOI 10.1111/J.1439-0272.1971.TB02106.X; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Xia CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09358; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Xu H, 2005, AM J PHYSIOL-GASTR L, V289, pG36, DOI 10.1152/ajpgi.00552.2004; Xu H, 2015, AM J PHYSIOL-CELL PH, V308, pC330, DOI 10.1152/ajpcell.00289.2014; Xu H, 2012, AM J PHYSIOL-GASTR L, V303, pG335, DOI 10.1152/ajpgi.00146.2012; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P14132, DOI 10.1073/pnas.241245898	67	23	25	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10845	10854		10.1074/jbc.M117.784108	http://dx.doi.org/10.1074/jbc.M117.784108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476888	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000404391000009
J	Trieu, MM; Devine, EL; Lamarche, LB; Ammerman, AE; Greco, JA; Birge, RR; Theobald, DL; Oprian, DD				Trieu, Melissa M.; Devine, Erin L.; Lamarche, Lindsey B.; Ammerman, Aaron E.; Greco, Jordan A.; Birge, Robert R.; Theobald, Douglas L.; Oprian, Daniel D.			Expression, purification, and spectral tuning of RhoGC, a retinylidene/guanylyl cyclase fusion protein and optogenetics tool from the aquatic fungus Blastocladiella emersonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate cyclase (adenylyl cyclase); cyclic nucleotide; optogenetics; photoreceptor; rhodopsin; spectral tuning	RHODOPSIN-GUANYLYL CYCLASE; ADENYLYL-CYCLASE; COMPLEX; BACTERIORHODOPSIN; BILAYERS; BIOLOGY; PIGMENT; CELLS; GENE; CGMP	RhoGC is a rhodopsin (Rho)-guanylyl cyclase (GC) gene fusion molecule that is central to zoospore phototaxis in the aquatic fungus Blastocladiella emersonii. It has generated considerable excitement because of its demonstrated potential as a tool for optogenetic manipulation of cell-signaling pathways involving cyclic nucleotides. However, a reliable method for expressing and purifying RhoGC is currently lacking. We present here an expression and purification system for isolation of the full-length RhoGC protein expressed in HEK293 cells in detergent solution. The protein exhibits robust light-dependent guanylyl cyclase activity, whereas a truncated form lacking the 17- to 20-kDa N-terminal domain is completely inactive under identical conditions. Moreover, we designed several RhoGC mutants to increase the utility of the protein for optogenetic studies. The first class we generated has altered absorption spectra designed for selective activation by different wavelengths of light. Two mutants were created with blue-shifted (E254D, (max) = 390 nm; D380N, (max) = 506 nm) and one with red-shifted (D380E, (max) = 533 nm) absorption maxima relative to the wild-type protein ((max) = 527 nm). We also engineered a double mutant, E497K/C566D, that changes the enzyme to a specific, light-stimulated adenylyl cyclase that catalyzes the formation of cAMP from ATP. We anticipate that this expression/purification system and these RhoGC mutants will facilitate mechanistic and structural exploration of this important enzyme.	[Trieu, Melissa M.; Devine, Erin L.; Lamarche, Lindsey B.; Ammerman, Aaron E.; Theobald, Douglas L.; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA; [Greco, Jordan A.; Birge, Robert R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Greco, Jordan A.; Birge, Robert R.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	Brandeis University; University of Connecticut; University of Connecticut	Theobald, DL; Oprian, DD (corresponding author), Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA.	dtheobald@brandeis.edu; oprian@brandeis.edu	Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343; Ammerman, Aaron/0000-0001-9245-4015	Adar family and friends; Brandeis University Provost's research fund; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, R01GM034548, R01GM096053, R01GM094468] Funding Source: NIH RePORTER	Adar family and friends; Brandeis University Provost's research fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Adar family and friends for continued support throughout this work. We appreciate the Harold S. Schwenk, Sr. Distinguished Chair in Chemistry (University of Connecticut) and support from the Brandeis University Provost's research fund. We thank Dr. Julius Rentergent for invaluable help with the COPASI software. We also thank Dr. Leigh Plant for time and effort spent to guide us through the procedures for immunofluorescence staining of CHO cells.	APARICIO JG, 1995, PROTEIN EXPRES PURIF, V6, P501, DOI 10.1006/prep.1995.1067; Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; D'Antona AM, 2014, BIOCHEMISTRY-US, V53, P127, DOI 10.1021/bi4012995; Devine EL, 2013, P NATL ACAD SCI USA, V110, P13351, DOI 10.1073/pnas.1306826110; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fasick JI, 1999, BIOCHEMISTRY-US, V38, P11593, DOI 10.1021/bi991600h; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; MARTI T, 1991, J BIOL CHEM, V266, P18674; Mendes P, 2009, METHOD ENZYMOL, V467, P583, DOI 10.1016/S0076-6879(09)67022-1; MOGI T, 1988, P NATL ACAD SCI USA, V85, P4148, DOI 10.1073/pnas.85.12.4148; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Ranaghan MJ, 2011, J AM CHEM SOC, V133, P18318, DOI 10.1021/ja2070957; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Strassmaier T., 2002, THESIS; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Xie GF, 2011, BIOCHEMISTRY-US, V50, P10399, DOI 10.1021/bi201126r	27	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10379	10389		10.1074/jbc.M117.789636	http://dx.doi.org/10.1074/jbc.M117.789636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28473465	Green Published, hybrid			2022-12-28	WOS:000404115400005
J	Chen, R; Jin, G; McIntyre, TM				Chen, Rui; Jin, Ge; McIntyre, Thomas M.			The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; FACTOR PRECURSOR; TYROSINE KINASE; HUMAN-SERUM; IN-VITRO; METALLOPROTEASE; LIGANDS; ADAM17; CARCINOMA; FAMILY	Platelets are the sole source of EGF in circulation, yet how EGF is stored or released from stimulated cells is undefined. In fact, we found platelets did not store EGF, synthesized as a single 6-kDa domain in pro-EGF, but rather expressed intact pro-EGF precursor on granular and plasma membranes. Activated platelets released high-molecular-weight (HMW)-EGF, produced by a single cleavage between the EGF and the transmembrane domains of pro-EGF. We synthesized a fluorogenic peptide encompassing residues surrounding the putative sessile arginyl residue and found stimulated platelets released soluble activity that cleaved this pro-EGF(1020-1027) peptide. High throughput screening identified chymostatins, bacterial peptides with a central cyclic arginyl structure, as inhibitors of this activity. In contrast, the matrix metalloproteinase/TACE (tumor necrosis factor-alpha-converting enzyme) inhibitor GM6001 was ineffective. Stimulated platelets released the soluble protease ADAMDEC1, recombinant ADAMDEC1 hydrolyzed pro-EGF(1020-1027), and this activity was inhibited by chymostatin and not GM6001. Biotinylating platelet surface proteins showed ADAMDEC1 hydrolyzed surface pro-EGF to HMW-EGF that stimulated HeLa EGF receptor (EGFR) reporter cells and EGFR-dependent tumor cell migration. This proteolysis was inhibited by chymostatin and not GM6001. Metabolizing pro-EGF Arg(1023) to citrulline with recombinant polypeptide arginine deiminase 4 (PAD4) abolished ADAMDEC1-catalyzed pro-EGF(1020-1027) peptidolysis, while pretreating intact platelets with PAD4 suppressed ADAMDEC1-, thrombin-, or collagen-induced release of HMW-EGF. We conclude that activated platelets release ADAMDEC1, which hydrolyzes pro-EGF to soluble HMW-EGF, that HMW-EGF is active, that proteolytic cleavage of pro-EGF first occurs at the C-terminal arginyl residue of the EGF domain, and that proteolysis is the regulated and rate-limiting step in generating soluble EGF bioactivity from activated platelets.	[Chen, Rui; McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44195 USA; [Jin, Ge] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Res Inst, Lerner Coll Med, Dept Cellular & Mol Med, NE10,9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org		McIntyre, Thomas/0000-0001-7802-5900	CTSC Core Utilization Pilot Grant Program [4UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025284] Funding Source: NIH RePORTER	CTSC Core Utilization Pilot Grant Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We appreciate the help of Dr. E. Poptic and the Molecular Screening Core, and we greatly appreciate the help of Dr. S. Bandyopadhyay and W.-Z. Shen in the Molecular Biotechnology core for synthesis and purification of the fluorogenic pro-EGF peptide. We also thank our many blood donors. The Clinical and Translational Science Collaborative of Cleveland, 4UL1TR000439, supported the inhibitor screen under the CTSC Core Utilization Pilot Grant Program.	Ang KK, 2004, INT J RADIAT ONCOL, V58, P959, DOI 10.1016/j.ijrobp.2003.07.010; Aybay C, 2006, CYTOKINE, V35, P36, DOI 10.1016/j.cyto.2006.07.005; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; BENEZRA J, 1990, AM J PATHOL, V137, P755; Berger M, 2008, THROMB HAEMOSTASIS, V99, P905, DOI [10.1160/THOB-01-0059, 10.1160/TH08-01-0059]; Bertrand-Duchesne MP, 2010, J PERIODONTAL RES, V45, P87, DOI 10.1111/j.1600-0765.2009.01205.x; Bodnar RJ, 2013, ADV WOUND CARE, V2, P24, DOI 10.1089/wound.2011.0326; Brown GT, 2013, J IMMUNOL, V191, P5196, DOI 10.4049/jimmunol.1300354; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Discafani CM, 1999, BIOCHEM PHARMACOL, V57, P917, DOI 10.1016/S0006-2952(98)00356-6; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Durante C, 2013, VOX SANG, V105, P129, DOI 10.1111/vox.12039; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; HIRATA Y, 1979, J CLIN ENDOCR METAB, V49, P481, DOI 10.1210/jcem-49-3-481; HWANG DL, 1992, REGUL PEPTIDES, V37, P95, DOI 10.1016/0167-0115(92)90658-H; JOH T, 1986, CLIN CHIM ACTA, V158, P81, DOI 10.1016/0009-8981(86)90118-X; KIURU J, 1991, LIFE SCI, V49, P1997, DOI 10.1016/0024-3205(91)90642-O; Lamb DJ, 2004, ATHEROSCLEROSIS, V176, P21, DOI 10.1016/j.atherosclerosis.2004.04.012; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Lund J, 2015, J BIOL CHEM, V290, P6620, DOI 10.1074/jbc.M114.601724; Lund J, 2013, J BIOL CHEM, V288, P21367, DOI 10.1074/jbc.M113.474536; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; MURAMATSU H, 1995, CANCER RES, V55, P6210; O'Shea NR, 2016, J CROHNS COLITIS, V10, P1417, DOI 10.1093/ecco-jcc/jjw111; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ohnishi Y, 2008, ORAL ONCOL, V44, P1155, DOI 10.1016/j.oraloncology.2008.02.015; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; PESONEN K, 1989, J CLIN ENDOCR METAB, V68, P486, DOI 10.1210/jcem-68-2-486; Pyrc K, 2013, INFECT IMMUN, V81, P55, DOI 10.1128/IAI.00830-12; Rabie T, 2005, J BIOL CHEM, V280, P14462, DOI 10.1074/jbc.M500041200; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; SAVAGE AP, 1986, REGUL PEPTIDES, V16, P199, DOI 10.1016/0167-0115(86)90019-4; Schreier B, 2014, CURR OPIN NEPHROL HY, V23, P113, DOI 10.1097/01.mnh.0000441152.62943.29; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; TAYLOR JM, 1974, J BIOL CHEM, V249, P2188; TAYLOR JM, 1970, P NATL ACAD SCI USA, V67, P164, DOI 10.1073/pnas.67.1.164; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Umeda N, 2016, CLIN RHEUMATOL, V35, P1181, DOI 10.1007/s10067-015-3082-z; UMEZAWA H, 1970, J ANTIBIOT, V23, P425, DOI 10.7164/antibiotics.23.425; Wang S, 2013, BBA-GENE REGUL MECH, V1829, P1126, DOI 10.1016/j.bbagrm.2013.07.003; Wijten P, 2013, ARTERIOSCL THROM VAS, V33, P1635, DOI 10.1161/ATVBAHA.113.301147; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007	58	17	19	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10112	10122		10.1074/jbc.M116.771642	http://dx.doi.org/10.1074/jbc.M116.771642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455445	Green Published, hybrid			2022-12-28	WOS:000403580600022
J	Cheng, XQ; Hao, Y; Shu, WJ; Zhao, MJ; Zhao, C; Wu, Y; Peng, XD; Yao, PF; Xiao, DB; Qing, GL; Pan, ZY; Yin, L; Hu, DS; Du, HN				Cheng, Xiaoqing; Hao, Yuan; Shu, Wenjie; Zhao, Mengjie; Zhao, Chen; Wu, Yuan; Peng, Xiaodan; Yao, Pinfang; Xiao, Daibiao; Qing, Guoliang; Pan, Zhengying; Yin, Lei; Hu, Desheng; Du, Hai-Ning			Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; UBIQUITIN LIGASE; S-PHASE; CHROMATIN MODIFICATIONS; TARGETING PR-SET7/SET8; LYSINE METHYLATION; OXIDATIVE STRESS; EXPRESSION; REPLICATION; PROGRESSION	Histone modifications, including lysine methylation, are epigenetic marks that influence many biological pathways. Accordingly, many methyltransferases have critical roles in various biological processes, and their dysregulation is often associated with cancer. However, the biological functions and regulation of many methyltransferases are unclear. Here, we report that a human homolog of the methyltransferase SET (SU(var), enhancer of zeste, and trithorax) domain containing 3 (SETD3) is cell cycle-regulated; SETD3 protein levels peaked in S phase and were lowest in M phase. We found that the beta-isoform of the tumor suppressor F-box and WD repeat domain containing 7 (FBXW7 beta) specifically mediates SETD3 degradation. Aligning the SETD3 sequence with those of well known FBXW7 substrates, we identified six potential non-canonical Cdc4 phosphodegrons (CPDs), and one of them, CPD1, is primarily phosphorylated by the kinase glycogen synthase kinase 3 (GSK3 beta), which is required for FBXW7 beta-mediated recognition and degradation. Moreover, depletion or inhibition of GSK3 beta or FBXW7 beta resulted in elevated SETD3 levels. Mutations of the phosphorylated residues in CPD1 of SETD3 abolished the interaction between FBXW7 beta and SETD3 and prevented SETD3 degradation. Our data further indicated that SETD3 levels positively correlated with cell proliferation of liver cancer cells and liver tumorigenesis in a xenograft mouse model, and that overexpression of FBXW7 beta counteracts the SETD3's tumorigenic role. We also show that SETD3 levels correlate with cancer malignancy, indicated by SETD3 levels that the 54 liver tumors are 2-fold higher than those in the relevant adjacent tissues. Collectively, these data elucidated that a GSK3 beta-FBXW7 beta-dependent mechanism controls SETD3 protein levels during the cell cycle and attenuates its oncogenic role in liver tumorigenesis.	[Cheng, Xiaoqing; Shu, Wenjie; Zhao, Mengjie; Zhao, Chen; Yin, Lei; Du, Hai-Ning] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Hao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200092, Peoples R China; [Wu, Yuan; Yao, Pinfang; Hu, Desheng] Hubei Canc Hosp, Dept Radiotherapy, 116 Zhuodaoquan Rd, Wuhan 430079, Peoples R China; [Peng, Xiaodan] Peking Univ, Shenzhen Hosp, Dept Oncol, Shenzhen 518083, Peoples R China; [Xiao, Daibiao; Qing, Guoliang] Wuhan Univ, Med Res Inst, Wuhan 430071, Peoples R China; [Pan, Zhengying] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China	Wuhan University; Shanghai Jiao Tong University; Peking University; Wuhan University; Peking University; University Town of Shenzhen	Du, HN (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Hao, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200092, Peoples R China.; Hu, DS (corresponding author), Hubei Canc Hosp, Dept Radiotherapy, 116 Zhuodaoquan Rd, Wuhan 430079, Peoples R China.	haoyuan@medmail.com.cn; hds_05@163.com; hainingdu@whu.edu.cn	Du, Hai-Ning/AAI-2020-2021; du, hai-ning/AAE-5626-2022	Du, Hai-Ning/0000-0001-8062-5411; Shu, Wenjie/0000-0001-5270-055X	Major State Basic Research Development Program of China [2013CB910700]; National Natural Science Foundation of China [31271369, 81401913]; Shenzhen Science and Technology Innovation Commission [JCYJ20150422150029096]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Commission	This work was supported by Major State Basic Research Development Program of China Grant 2013CB910700 (to H.-N.D), National Natural Science Foundation of China Grants 31271369 (to H.-N.D.) and 81401913 (to Y.W.), and Shenzhen Science and Technology Innovation Commission Grant JCYJ20150422150029096 (to H.-N.D). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Binda O, 2013, EPIGENETICS-US, V8, P177, DOI 10.4161/epi.23416; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen A, 2016, BBA-GENE REGUL MECH, V1859, P420, DOI 10.1016/j.bbagrm.2016.01.003; Chen ZG, 2013, HAEMATOLOGICA, V98, P739, DOI 10.3324/haematol.2012.066977; Cohn O, 2016, SCI REP-UK, V6, DOI 10.1038/srep37115; Cooper SE, 2015, CELL CYCLE, V14, P2509, DOI 10.1080/15384101.2015.1053667; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Eom GH, 2011, J BIOL CHEM, V286, P34733, DOI 10.1074/jbc.M110.203307; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kamnasaran D, 2002, J MED GENET, V39, P81, DOI 10.1136/jmg.39.2.81; Kim DW, 2011, BIOSCI BIOTECH BIOCH, V75, P289, DOI 10.1271/bbb.100648; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Rizzardi LF, 2012, GENETICS, V192, P371, DOI 10.1534/genetics.112.142349; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Tian EM, 2014, GENE CHROMOSOME CANC, V53, P549, DOI 10.1002/gcc.22165; Trausch-Azar JS, 2015, J CELL PHYSIOL, V230, P842, DOI 10.1002/jcp.24812; Vershinin Z, 2016, J BIOL CHEM, V291, P6786, DOI 10.1074/jbc.M115.697292; Wang R, 2013, CELL RES, V23, P803, DOI 10.1038/cr.2013.42; Wang ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10185; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xu WS, 2016, SEMIN CANCER BIOL, V36, P62, DOI 10.1016/j.semcancer.2015.09.005; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867	46	32	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9022	9033		10.1074/jbc.M117.778001	http://dx.doi.org/10.1074/jbc.M117.778001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28442573	Green Published, hybrid			2022-12-28	WOS:000402538900003
J	Lou, M; Liu, Q; Ren, GP; Zeng, JL; Xiang, XP; Ding, YF; Lin, QH; Zhong, TT; Liu, X; Zhu, LJ; Qi, HY; Shen, J; Li, HR; Shao, JM				Lou, Meng; Liu, Qian; Ren, Guoping; Zeng, Jiling; Xiang, Xueping; Ding, Yongfeng; Lin, Qinghui; Zhong, Tingting; Liu, Xia; Zhu, Lijun; Qi, Hongyan; Shen, Jing; Li, Haoran; Shao, Jimin			Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CELL-GROWTH; GLUTAREDOXINS; INHIBITION; SYSTEM; PROTEIN; GLUTATHIONE; REGULATOR; MOLECULES; MECHANISM	Ribonucleotide reductase (RR) is the rate-limiting enzyme in DNA synthesis, catalyzing the reduction of ribonucleotides to deoxyribonucleotides. During each enzymatic turnover, reduction of the active site disulfide in the catalytic large subunit is performed by a pair of shuttle cysteine residues in its C-terminal tail. Thioredoxin (Trx) and glutaredoxin (Grx) are ubiquitous redox proteins, catalyzing thiol-disulfide exchange reactions. Here, immunohistochemical examination of clinical colorectal cancer (CRC) specimens revealed that human thioredoxin1 (hTrx1), but not human glutaredoxin1 (hGrx1), was up-regulated along with human RR large subunit (RRM1) in cancer tissues, and the expression levels of both proteins were correlated with cancer malignancy stage. Ectopically expressed hTrx1 significantly increased RR activity, DNA synthesis, and cell proliferation and migration. Importantly, inhibition of both hTrx1 and RRM1 produced a synergistic anticancer effect in CRC cells and xenograft mice. Furthermore, hTrx1 rather than hGrx1 was the efficient reductase for RRM1 regeneration. We also observed a direct protein-protein interaction between RRM1 and hTrx1 in CRC cells. Interestingly, besides the known two conserved cysteines, a third cysteine (Cys779) in the RRM1 C terminus was essential for RRM1 regeneration and binding to hTrx1, whereas both Cys32 and Cys35 in hTrx1 played a counterpart role. Our findings suggest that the up-regulated RRM1 and hTrx1 in CRC directly interact with each other and promote RR activity, resulting in enhancedDNAsynthesis and cancer malignancy. Wepropose that the RRM1-hTrx1 interaction might be a novel potential therapeutic target for cancer treatment.	[Lou, Meng; Liu, Qian; Lin, Qinghui; Zhong, Tingting; Liu, Xia; Qi, Hongyan; Shen, Jing; Shao, Jimin] Zhejiang Univ, Res Ctr Air Pollut & Hlth, Key Lab Dis Prote Zhejiang Prov, Dept Pathol & Pathophysiol,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Ren, Guoping; Zeng, Jiling] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Yongfeng] Zhejiang Univ, Sch Med, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Lijun] Zhejiang Univ, Sch Med, Key Lab Precis Diag & Treatment Hepatobiliary & P, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Xiang, Xueping] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Haoran] Takeda Pharmaceut Int Co, Cambridge, MA 02139 USA	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Shao, JM (corresponding author), Zhejiang Univ, Res Ctr Air Pollut & Hlth, Key Lab Dis Prote Zhejiang Prov, Dept Pathol & Pathophysiol,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	shaojimin@zju.edu.cn			National Natural Science Foundation of China [81372138, 81572384, 81472543]; National Key Research and Development Project of China [2016YFC1303401]; Foundation of Zhejiang University for International Cooperation and Exchanges	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project of China; Foundation of Zhejiang University for International Cooperation and Exchanges	This work was supported by National Natural Science Foundation of China Grants 81372138, 81572384, and 81472543; National Key Research and Development Project of China Grant 2016YFC1303401; and the Foundation of Zhejiang University for International Cooperation and Exchanges. The authors declare that they have no conflicts of interest with the contents of this article.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Ago T, 2007, ANTIOXID REDOX SIGN, V9, P679, DOI 10.1089/ars.2007.1529; Ando N, 2016, BIOCHEMISTRY-US, V55, P373, DOI 10.1021/acs.biochem.5b01207; Arnaoutov A, 2014, SCIENCE, V345, P1512, DOI 10.1126/science.1251550; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2001, FREE RADICAL BIO MED, V31, P1170, DOI 10.1016/S0891-5849(01)00698-0; Ashton JC, 2015, CANCER RES, V75, P2400, DOI 10.1158/0008-5472.CAN-14-3763; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Baker AF, 2006, J LAB CLIN MED, V147, P83, DOI 10.1016/j.lab.2005.09.001; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bouldin SD, 2012, BIOCHEM J, V446, P59, DOI 10.1042/BJ20120075; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Holmgren A, 2010, FREE RADICAL BIO MED, V49, P1617, DOI 10.1016/j.freeradbiomed.2010.09.005; Husbeck B, 2003, BIOCHEM BIOPH RES CO, V306, P469, DOI 10.1016/S0006-291X(03)00993-8; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Jordheim LP, 2011, LANCET ONCOL, V12, P693, DOI 10.1016/S1470-2045(10)70244-8; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lee JJ, 2010, LUNG CANCER, V70, P205, DOI 10.1016/j.lungcan.2010.02.005; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; LIN ANI, 1987, BIOCHEMISTRY-US, V26, P6905, DOI 10.1021/bi00396a006; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mahmood DFD, 2013, ANTIOXID REDOX SIGN, V19, P1266, DOI 10.1089/ars.2012.4757; Makhlynets O, 2014, J BIOL CHEM, V289, P6259, DOI 10.1074/jbc.M113.533554; Marks PA, 2006, SEMIN CANCER BIOL, V16, P436, DOI 10.1016/j.semcancer.2006.09.005; Mathews CK, 2016, STRUCTURE, V24, P843, DOI 10.1016/j.str.2016.05.006; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Nakamura H, 2005, ANTIOXID REDOX SIGN, V7, P823, DOI 10.1089/ars.2005.7.823; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ortenberg R, 2004, P NATL ACAD SCI USA, V101, P7439, DOI 10.1073/pnas.0401965101; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Qi HY, 2015, TUMOR BIOL, V36, P4833, DOI 10.1007/s13277-015-3137-4; Ramanathan RK, 2007, CLIN CANCER RES, V13, P2109, DOI 10.1158/1078-0432.CCR-06-2250; Said K, 2012, DIGEST DIS SCI, V57, P1163, DOI 10.1007/s10620-012-2089-4; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2013, EXPERT OPIN THER TAR, V17, P1423, DOI 10.1517/14728222.2013.840293; Spindel ON, 2012, ANTIOXID REDOX SIGN, V16, P587, DOI 10.1089/ars.2011.4137; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Wei YF, 2014, J AM CHEM SOC, V136, P9001, DOI 10.1021/ja5030194; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P2217, DOI 10.1073/pnas.0611095104	49	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9136	9149		10.1074/jbc.M117.783365	http://dx.doi.org/10.1074/jbc.M117.783365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28411237	Green Published, hybrid			2022-12-28	WOS:000402538900011
J	Pinotsis, N; Waksman, G				Pinotsis, Nikos; Waksman, Gabriel			Structure of the WipA protein reveals a novel tyrosine protein phosphatase effector from Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; FEATURES; DOMAIN; PSYCHROPHILE; PATHOGENESIS; BINDING; MOTIF; SH2	Legionnaires' disease is a severe form of pneumonia caused by the bacterium Legionella pneumophila. L. pneumophila pathogenicity relies on secretion of more than 300 effector proteins by a type IVb secretion system. Among these Legionella effectors, WipA has been primarily studied because of its dependence on a chaperone complex, IcmSW, for translocation through the secretion system, but its role in pathogenicity has remained unknown. In this study, we present the crystal structure of a large fragment of WipA, WipA435. Surprisingly, this structure revealed a serine/threonine phosphatase fold that unexpectedly targets tyrosine-phosphorylated peptides. The structure also revealed a sequence insertion that folds into an alpha-helical hairpin, the tip of which adopts a canonical coiledcoil structure. The purified protein was a dimer whose dimer interface involves interactions between the coiled coil of one WipA molecule and the phosphatase domain of another. Given the ubiquity of protein-protein interaction mediated by interactions between coiled-coils, we hypothesize that WipA can thereby transition from a homodimeric state to a heterodimeric state in which the coiled-coil region of WipA is engaged in a protein-protein interaction with a tyrosine-phosphorylated host target. In conclusion, these findings help advance our understanding of the molecular mechanisms of an effector involved in Legionella virulence and may inform approaches to elucidate the function of other effectors.	[Pinotsis, Nikos; Waksman, Gabriel] Inst Struct & Mol Biol, Dept Biol Sci, Malet St, London WC1E 7HX, England; [Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University College London	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, London WC1E 6BT, England.	g.waksman@ucl.ac.uk	Pinotsis, Nikos/AAD-4013-2019	Pinotsis, Nikos/0000-0002-5096-257X; Waksman, Gabriel/0000-0003-0708-2726	European Research Council [321630]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Grant 321630 (to G. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2016, FEBS J, V283, P1404, DOI 10.1111/febs.13600; Bunney TD, 2015, EBIOMEDICINE, V2, P194, DOI 10.1016/j.ebiom.2015.02.009; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Cutler SJ, 2007, J INFECTION, V54, P313, DOI 10.1016/j.jinf.2006.10.048; Dias AA, 2014, J CHEM EDUC, V91, P1017, DOI 10.1021/ed3006677; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Gerard FCA, 2007, BIOCHEMISTRY-US, V46, P10328, DOI 10.1021/bi7007799; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Guasch A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134569; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li YY, 2008, BIOCHEMISTRY-US, V47, P13564, DOI 10.1021/bi8017448; Lin YE, 2011, CURR OPIN INFECT DIS, V24, P350, DOI 10.1097/QCO.0b013e3283486c6e; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; MARRIE TJ, 2008, INFEC AGENT, P133; Mlynek G, 2014, AMINO ACIDS, V46, P1565, DOI 10.1007/s00726-014-1699-x; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tsuruta H, 2005, J BIOCHEM, V137, P69, DOI 10.1093/jb/mvi010; Tsuruta H, 2008, FEBS J, V275, P4317, DOI 10.1111/j.1742-4658.2008.06575.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Walavalkar NM, 2013, J BIOL CHEM, V288, P3419, DOI 10.1074/jbc.M112.431346; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Welte S, 2005, ANAL BIOCHEM, V338, P32, DOI 10.1016/j.ab.2004.11.047; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	47	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9240	9251		10.1074/jbc.M117.781948	http://dx.doi.org/10.1074/jbc.M117.781948			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28389563	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000402538900019
J	Thylur, RP; Wu, XZ; Gowda, NM; Punnath, K; Neelgund, SE; Febbraio, M; Gowda, DC				Thylur, Ramesh P.; Wu, Xianzhu; Gowda, Nagaraj M.; Punnath, Kishore; Neelgund, Shivayogeeshwara E.; Febbraio, Maria; Gowda, D. Channe			CD36 receptor regulates malaria-induced immune responses primarily at early blood stage infection contributing to parasitemia control and resistance to mortality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM; PROTECTIVE-IMMUNITY; GAMMA-INTERFERON; DENDRITIC CELLS; IFN-GAMMA; PHAGOCYTOSIS; EXPRESSION; CHABAUDI	In malaria, CD36 plays several roles, including mediating parasite sequestration to host organs, phagocytic clearance of parasites, and regulation of immunity. Although the functions of CD36 in parasite sequestration and phagocytosis have been clearly defined, less is known about its role in malaria immunity. Here, to understand the function of CD36 in malaria immunity, we studied parasite growth, innate and adaptive immune responses, and host survival in WT and Cd36(-/-) mice infected with a non-lethal strain of Plasmodium yoelii. Compared with Cd36(-/-) mice, WT mice had lower parasitemias and were resistant to death. At early but not at later stages of infection, WT mice had higher circulatory proinflammatory cytokines and lower anti-inflammatory cytokines than Cd36(-/-) mice. WT mice showed higher frequencies of proinflammatory cytokine-producing and lower frequencies of anti-inflammatory cytokine-producing dendritic cells (DCs) and natural killer cells than Cd36(-/-) mice. Cytokines produced by co-cultures of DCs from infected mice and ovalbumin-specific, MHC class II-restricted alpha/beta(OT-II)T cells reflected CD36-dependentDCfunction. WT mice also showed increased Th1 and reduced Th2 responses compared with Cd36(-/-) mice, mainly at early stages of infection. Furthermore, in infected WT mice, macrophages and neutrophils expressed higher levels of phagocytic receptors and showed enhanced phagocytosis of parasite-infected erythrocytes than those in Cd36(-/-) mice in an IFN-gamma-dependent manner. However, there were no differences in malaria- induced humoral responses betweenWTand Cd36(-/-) mice. Overall, the results show that CD36 plays a significant role in controlling parasite burden by contributing to proinflammatory cytokine responses by DCs and natural killer cells, Th1 development, phagocytic receptor expression, and phagocytic activity.	[Thylur, Ramesh P.; Wu, Xianzhu; Gowda, Nagaraj M.; Punnath, Kishore; Neelgund, Shivayogeeshwara E.; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Febbraio, Maria] Univ Alberta, Dept Dent, Edmonton, AB T6G 2E1, Canada; [Gowda, Nagaraj M.] Aurigene Discovery Technol Ltd, Immunooncol, Bangalore 560100, Karnataka, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Alberta; Aurigene Discovery Technologies Limited	Gowda, DC (corresponding author), Penn State Univ, Sch Med, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu	Puttalingaiah, Ramesh Thylur/AAH-9087-2020	Gowda, Channe/0000-0002-6860-5108	NIAID, National Institutes of Health [AI 41139]; FOGARTY INTERNATIONAL CENTER [D43TW008268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIAID, National Institutes of Health Grant AI 41139. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Augustine AD, 2009, NAT IMMUNOL, V10, P673, DOI 10.1038/ni0709-673; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Battle KE, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.12; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bernabeu M, 2016, P NATL ACAD SCI USA, V113, pE3270, DOI 10.1073/pnas.1524294113; Brugat T, 2016, J LEUKOCYTE BIOL, V99, P643, DOI 10.1189/jlb.4CE1115-494R; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cabrera A, 2014, TRENDS PARASITOL, V30, P436, DOI 10.1016/j.pt.2014.07.006; Chen QF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15118; Chung YT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084980, 10.1371/journal.pone.0070128]; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Faway E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1595-9; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Gowda NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077604; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Granucci F, 2006, EUR J IMMUNOL, V36, P2819, DOI 10.1002/eji.200636630; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Howes RE, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.16-0141; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Jespersen JS, 2016, EMBO MOL MED, V8, P839, DOI 10.15252/emmm.201606188; KAUL DK, 1994, AM J TROP MED HYG, V50, P512, DOI 10.4269/ajtmh.1994.50.512; Kim CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048126; Lagasse HAD, 2016, J LEUKOCYTE BIOL, V99, P659, DOI 10.1189/jlb.4HI0315-130RRR; Laichalk LL, 1996, FEMS IMMUNOL MED MIC, V15, P181, DOI 10.1016/0928-8244(96)00048-X; Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068; Magistrado PA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-204; Mandell GL, 1995, J CARDIOVASC PHARM, V25, pS20, DOI 10.1097/00005344-199500252-00005; Marchi LF, 2014, INT IMMUNOPHARMACOL, V18, P228, DOI 10.1016/j.intimp.2013.12.010; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; PASLOSKE BL, 1994, ANNU REV MED, V45, P283; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sebina I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005999; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith TG, 2003, INFECT IMMUN, V71, P393, DOI 10.1128/IAI.71.1.393-400.2003; Spaulding E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005975; Stanisic DI, 2015, VACCINE, V33, P7469, DOI 10.1016/j.vaccine.2015.09.057; Stegmann KA, 2015, EUR J IMMUNOL, V45, P3431, DOI 10.1002/eji.201546018; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Tangye SG, 2013, BLOOD, V121, P5109, DOI 10.1182/blood-2013-05-500074; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; WHO, 2015, WORLD MAL REP 2015; Wu XZ, 2015, J BIOL CHEM, V290, P23135, DOI 10.1074/jbc.M115.671065; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001	71	12	13	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9394	9408		10.1074/jbc.M117.781294	http://dx.doi.org/10.1074/jbc.M117.781294			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28416609	Green Published, hybrid			2022-12-28	WOS:000402538900032
J	Blundell, PA; Le, NPL; Allen, J; Watanabe, Y; Pleass, RJ				Blundell, Patricia A.; Ngoc Phuong Lan Le; Allen, Joel; Watanabe, Yasunori; Pleass, Richard J.			Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fc-gamma receptor; glycosylation; immunoglobulin G (IgG); N-linked glycosylation; sialic acid; Fc; intravenous immunoglobulin; sialoadhesin; siglec-1	IMMUNE THROMBOCYTOPENIC PURPURA; INTRAVENOUS IMMUNOGLOBULIN; ANTIINFLAMMATORY ACTIVITY; MONOCLONAL-ANTIBODIES; AUTOIMMUNE-DISEASE; CHAIN TAILPIECE; FUSION PROTEINS; IVIG; GLYCOSYLATION; SIALYLATION	Multimeric fragment crystallizable (Fc) regions and Fc-fusion proteins are actively being explored as biomimetic replacements for IVIG therapy, which is deployed to manage many diseases and conditions but is expensive and not always efficient. The Fc region of human IgG1 (IgG1-Fc) can be engineered into multimeric structures (hexa-Fcs) that bind their cognate receptors with high avidity. The critical influence of the unique N-linked glycan attached at Asn-297 on the structure and function of IgG1-Fc is well documented; however, whether the N-linked glycan has a similarly critical role in multimeric, avidly binding Fcs, is unknown. Hexa-Fc contains two N-linked sites at Asn-77 (equivalent to Asn-297 in the Fc of IgG1) and Asn-236 (equivalent to Asn-563 in the tail piece of IgM). We report here that glycosylation at Asn-297 is critical for interactions with Fc receptors and complement and that glycosylation at Asn-563 is essential for controlling multimerization. We also found that introduction of an additional fully occupied N-linked glycosylation site at the N terminus at position 1 (equivalent to Asp-221 in the Fc of IgG1) dramatically enhances overall sialic acid content of the Fc multimers. Furthermore, replacement of Cys-575 in the IgM tail piece of multimers resulted in monomers with enhanced sialic acid content and differential receptor-binding profiles. Thus insertion of additional N-linked glycans into either the hinge or tail piece of monomers or multimers leads to molecules with enhanced sialylation that may be suitable for managing inflammation or blocking pathogen invasion.	[Blundell, Patricia A.; Pleass, Richard J.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England; [Ngoc Phuong Lan Le; Allen, Joel; Watanabe, Yasunori] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford	Pleass, RJ (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	richard.pleass@lstmed.ac.uk	Pleass, Richard/N-7831-2019	Pleass, Richard/0000-0001-7438-8296; Blundell, Pat/0000-0003-3386-5660; Allen, Joel/0000-0003-2547-968X; Watanabe, Yasunori/0000-0002-7952-1268	Wellcome Trust through a Pathfinder grant [109469/Z/15/Z]; Institutional Strategic Support Fund (ISSF) Institutional grant [097830/Z/11/Z]; MRC [MC_PC_12017, MC_PC_16078] Funding Source: UKRI; Medical Research Council [MC_PC_12017, MC_PC_16078] Funding Source: researchfish	Wellcome Trust through a Pathfinder grant(Wellcome Trust); Institutional Strategic Support Fund (ISSF) Institutional grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust through a Pathfinder grant (109469/Z/15/Z) and an Institutional Strategic Support Fund (ISSF) Institutional grant (097830/Z/11/Z). The authors declare that the work discussed within is subject to patent applications GB1412821.9 and GB2015/052098.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; Atkin JD, 1996, J IMMUNOL, V157, P156; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Bazin R, 2006, BRIT J HAEMATOL, V135, P97, DOI 10.1111/j.1365-2141.2006.06245.x; BUSSEL JB, 1991, BLOOD, V77, P1884; Clynes R, 2005, J CLIN INVEST, V115, P25, DOI 10.1172/JCI200523994; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Czajkowsky DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09526; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; DAVIS AC, 1989, J IMMUNOL, V143, P1352; de Lalla C, 1998, MOL IMMUNOL, V35, P837, DOI 10.1016/S0161-5890(98)00073-X; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Dekkers G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36964; Foss S, 2016, J CONTROL RELEASE, V223, P42, DOI 10.1016/j.jconrel.2015.12.033; Jain A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4024; Krugmann S, 1997, J IMMUNOL, V159, P244; Levin D, 2015, TRENDS BIOTECHNOL, V33, P27, DOI 10.1016/j.tibtech.2014.11.001; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Liu LM, 2015, J PHARM SCI-US, V104, P1866, DOI 10.1002/jps.24444; Liu YD, 2016, BIOLOGICALS, V44, P163, DOI 10.1016/j.biologicals.2016.02.003; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mekhaiel DNA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00124; Mimura Y, 2016, J IMMUNOL METHODS, V428, P30, DOI 10.1016/j.jim.2015.11.009; Niknami M, 2013, J PERIPHER NERV SYST, V18, P141, DOI 10.1111/jns5.12022; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Ortiz DF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9418; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Quinn PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20509; Raju TS, 2014, CURR OPIN BIOTECH, V30, P147, DOI 10.1016/j.copbio.2014.06.014; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Sewald X, 2015, SCIENCE, V350, P563, DOI 10.1126/science.aab2749; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Stapleton NM, 2015, IMMUNOL REV, V268, P253, DOI 10.1111/imr.12331; TANKERSLEY DL, 1994, IMMUNOL REV, V139, P159, DOI 10.1111/j.1600-065X.1994.tb00861.x; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Thomas Richard J, 2010, Bioeng Bugs, V1, P17, DOI 10.4161/bbug.1.1.10049; van de Bovenkamp FS, 2016, J IMMUNOL, V196, P1435, DOI 10.4049/jimmunol.1502136; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375; Zuercher AW, 2016, AUTOIMMUN REV, V15, P781, DOI 10.1016/j.autrev.2016.03.018	46	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12994	13007		10.1074/jbc.M117.795047	http://dx.doi.org/10.1074/jbc.M117.795047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28620050	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000407220100027
J	Xu, ER; Blythe, EE; Fischer, G; Hyvonen, M				Xu, Emma-Ruoqi; Blythe, Emily E.; Fischer, Gerhard; Hyvoenen, Marko			Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); collagen; crystal structure; extracellular matrix protein; protein-protein interaction; signaling; CCN proteins; vWC domain	MODULATES BMP; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR REGULATION; AMINO PROPEPTIDE; IIA PROCOLLAGEN; FAMILY; GROWTH; CHORDIN; TISSUE; EXPRESSION	Bone morphogenetic proteins (BMPs) are secreted growth factors that promote differentiation processes in embryogenesis and tissue development. Regulation of BMP signaling involves binding to a variety of extracellular proteins, among which are many von Willebrand factor C (vWC) domain-containing proteins. Although the crystal structure of the complex of crossveinless-2 (CV-2) vWC1 and BMP-2 previously revealed one mode of the vWC/BMP-binding mechanism, other vWC domains may bind to BMP differently. Here, using X-ray crystallography, we present for the first time structures of the vWC domains of two proteins thought to interact with BMP-2: collagen IIA and matricellular protein CCN3. We found that these two vWC domains share a similar N-terminal fold that differs greatly from that in CV-2 vWC, which comprises its BMP-2-binding site. We analyzed the ability of these vWC domains to directly bind to BMP-2 and detected an interaction only between the collagen IIa vWC and BMP-2. Guided by the collagen IIa vWC domain crystal structure and conservation of surface residues among orthologous domains, we mapped the BMP-binding epitope on the subdomain 1 of the vWC domain. This binding site is different from that previously observed in the complex between CV-2 vWC and BMP-2, revealing an alternative mode of interaction between vWC domains and BMPs.	[Xu, Emma-Ruoqi; Blythe, Emily E.; Fischer, Gerhard; Hyvoenen, Marko] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Xu, Emma-Ruoqi] DESY, EMBL, Notkestr 85, D-22607 Hamburg, Germany; [Blythe, Emily E.] CALTECH, 1200 E Calif Blvd,MC 114-96, Pasadena, CA 91125 USA	University of Cambridge; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); California Institute of Technology	Hyvonen, M (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	mh256@cam.ac.uk	Fischer, Gerhard/B-2900-2011; Hyvonen, Marko/A-1501-2015	Fischer, Gerhard/0000-0001-9861-1528; Blythe, Emily/0000-0001-6363-2644; Hyvonen, Marko/0000-0001-8683-4070; Xu, Emma-Ruoqi/0000-0001-7300-3868	Cambridge Overseas Trust; China Scholarship Council	Cambridge Overseas Trust; China Scholarship Council(China Scholarship Council)	This work was supported by Cambridge Overseas Trust and China Scholarship Council through a postgraduate scholarship (to E.-R.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2016, BUSTER VERSION 2 11; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chang CC, 2014, WORLD J GASTROENTERO, V20, P6826, DOI 10.3748/wjg.v20.i22.6826; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui L, 2014, TUMOR BIOL, V35, P3195, DOI 10.1007/s13277-013-1418-3; El Kader TA, 2013, J CELL COMMUN SIGNAL, V7, P11, DOI 10.1007/s12079-012-0180-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiebig JE, 2013, MOLECULES, V18, P11658, DOI 10.3390/molecules181011658; Fujisawa T, 2009, BIOCHEM BIOPH RES CO, V385, P215, DOI 10.1016/j.bbrc.2009.05.041; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Janune D, 2011, FEBS LETT, V585, P3033, DOI 10.1016/j.febslet.2011.08.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Kisonaite M, 2016, BIOCHEM J, V473, P1593, DOI 10.1042/BCJ20160254; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larrain J, 2000, DEVELOPMENT, V127, P821; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Manson SR, 2015, J UROLOGY, V193, P1860, DOI 10.1016/j.juro.2014.10.117; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moura J, 2013, ARCH DERMATOL RES, V305, P557, DOI 10.1007/s00403-013-1381-2; Nakamura Y, 2007, J CLIN INVEST, V117, P3075, DOI 10.1172/JCI32001; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nolan K, 2016, CELL REP, V16, P2077, DOI 10.1016/j.celrep.2016.07.046; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; Ohgawara T, 2011, J CELL COMMUN SIGNAL, V5, P291, DOI 10.1007/s12079-011-0133-3; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Ouellet V, 2012, J CELL COMMUN SIGNAL, V6, P73, DOI 10.1007/s12079-012-0161-7; Pal A, 2012, CANCER RES, V72, P4818, DOI 10.1158/0008-5472.CAN-12-0154; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Reddi AH, 2003, ANN RHEUM DIS, V62, P73; RYAN MC, 1990, J BIOL CHEM, V265, P10334; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Troilo H, 2014, P NATL ACAD SCI USA, V111, P13063, DOI 10.1073/pnas.1404166111; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	66	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12516	12527		10.1074/jbc.M117.788992	http://dx.doi.org/10.1074/jbc.M117.788992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584056	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000406636900016
J	Lv, ZY; Yuan, LM; Atkison, JH; Aldana-Masangkay, G; Chen, Y; Olsen, SK				Lv, Zongyang; Yuan, Lingmin; Atkison, James H.; Aldana-Masangkay, Grace; Chen, Yuan; Olsen, Shaun K.			Domain alternation and active site remodeling are conserved structural features of ubiquitin E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED INHIBITION; ACTIVATING ENZYME; PROTEIN-ACTIVATION; INSIGHTS; MECHANISM; SYSTEM	E1 enzymes for ubiquitin (Ub) and Ub-like modifiers (Ubls) harbor two catalytic activities that are required for Ub/Ubl activation: adenylation and thioester bond formation. Structural studies of the E1 for the Ubl small ubiquitin-like modifier (SUMO) revealed a single active site that is transformed by a conformational switch that toggles its competency for catalysis of these two distinct chemical reactions. Although the mechanisms of adenylation and thioester bond formation revealed by SUMO E1 structures are thought to be conserved inUb E1, there is currently a lack of structural data supporting this hypothesis. Here, we present a structure of Schizosaccharomyces pombe Uba1 in which the second catalytic cysteine half-domain (SCCH domain) harboring the catalytic cysteine has undergone a 106 degrees rotation that results in a completely different network of intramolecular interactions between the SCCH and adenylation domains and translocation of the catalytic cysteine 12 angstrom closer to the Ub C terminus compared with previous Uba1 structures. SCCH domain alternation is accompanied by conformational changes within the Uba1 adenylation domains that effectively disassemble the adenylation active site. Importantly, the structural and biochemical data suggest that domain alternation and remodeling of the adenylation active site are interconnected and are intrinsic structural features of Uba1 and that the overall structural basis for adenylation and thioester bond formation exhibited bySUMO E1 is indeed conserved in Ub E1. Finally, the mechanistic insights provided by the novel conformational snapshot of Uba1 presented in this study may guide efforts to develop small molecule inhibitors of this critically important enzyme that is an active target for anticancer therapeutics.	[Lv, Zongyang; Yuan, Lingmin; Atkison, James H.; Olsen, Shaun K.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lv, Zongyang; Yuan, Lingmin; Atkison, James H.; Olsen, Shaun K.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Aldana-Masangkay, Grace; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	Medical University of South Carolina; Medical University of South Carolina; City of Hope; Beckman Research Institute of City of Hope	Olsen, SK (corresponding author), Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA.	olsensk@musc.edu	Lv, Zongyang/M-9307-2018	Lv, Zongyang/0000-0002-8862-113X; Olsen, Shaun/0000-0002-1265-7101; Yuan, Lingmin/0000-0002-2289-3175	National Institute of General Medical Sciences, National Institutes of Health Grant [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Program High-End Instrumentation Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award [S10 RR027139-01]; NATIONAL CANCER INSTITUTE [R01CA212119, T32CA193201, R01CA088932] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205, S10RR027139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM115568, R01GM086171] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health Grant; National Institutes of Health Office of Research Infrastructure Program High-End Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christopher Davies and Katelyn Williams for critically reading the manuscript. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-C beamline is funded by National Institutes of Health Office of Research Infrastructure Program High-End Instrumentation Grant S10 RR029205). This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This work is also based upon research conducted at Southeast Regional Collaborative Access Team beamline 22-ID. The X-ray crystallography facility used for this work is supported by Office of the Vice President for Research at the Medical University of South Carolina. The crystallization robotics instrument used in this study was purchased via National Institutes of Health Shared Instrumentation Award S10 RR027139-01.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; Hanzelmann P, 2012, METHODS MOL BIOL, V832, P547, DOI 10.1007/978-1-61779-474-2_39; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lv Z., 2017, MOL CELL, V65; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Schafer A, 2014, ACTA CRYSTALLOGR D, V70, P1311, DOI 10.1107/S1399004714002910; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Ungermannova D, 2012, J BIOMOL SCREEN, V17, P421, DOI 10.1177/1087057111433843; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582	32	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12089	12099		10.1074/jbc.M117.787622	http://dx.doi.org/10.1074/jbc.M117.787622			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28572513	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000406053300009
J	Wang, J; Zhao, SS; He, W; Wei, Y; Zhang, Y; Pegg, H; Shore, P; Roberts, SGE; Deng, WS				Wang, Juan; Zhao, Shasha; He, Wei; Wei, Yun; Zhang, Yang; Pegg, Henry; Shore, Paul; Roberts, Stefan G. E.; Deng, Wensheng			A transcription factor IIA-binding site differentially regulates RNA polymerase II-mediated transcription in a promoter context-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TFIIA/TBP/DNA COMPLEX; CORE PROMOTER; TATA BOX; GENERAL TRANSCRIPTION; ACTIVATED TRANSCRIPTION; DNA-BINDING; IN-VITRO; QUATERNARY COMPLEX; CRYSTAL-STRUCTURE; TBP BINDING	RNA polymerase II (pol II) is required for the transcription of all protein-coding genes and as such represents a major enzyme whose activity is tightly regulated. Transcriptional initiation therefore requires numerous general transcriptional factors and cofactors that associate with pol II at the core promoter to form a pre-initiation complex. Transcription factor IIA (TFIIA) is a general cofactor that binds TFIID and stabilizes the TFIID-DNA complex during transcription initiation. Previous studies showed that TFIIA can make contact with the DNA sequence upstream or downstream of the TATA box, and that the region bound by TFIIA could overlap with the elements recognized by another factor, TFIIB, at adenovirus major late core promoter. Whether core promoters contain a DNA motif recognized by TFIIA remains unknown. Here we have identified a core promoter element upstream of the TATA box that is recognized by TFIIA. A search of the human promoter database revealed that many natural promoters contain a TFIIA recognition element (IIARE). We show that the IIARE enhances TFIIA-promoter binding and enhances the activity of TATA-containing promoters, but represses or activates promoters that lack a TATA box. Chromatin immunoprecipitation assays revealed that the IIARE activates transcription by increasing the recruitment of pol II, TFIIA, TAF4, and P300 at TATA-dependent promoters. These findings extend our understanding of the role of TFIIA in transcription, and provide new insights into the regulatory mechanism of core promoter elements in gene transcription by pol II.	[Wang, Juan; Zhao, Shasha; He, Wei; Wei, Yun; Zhang, Yang; Deng, Wensheng] Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 430065, Hubei Province, Peoples R China; [Pegg, Henry; Shore, Paul] Univ Manchester, Sch Biol Sci, Manchester M13 9PL, Lancs, England; [Roberts, Stefan G. E.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England	Wuhan University of Science & Technology; University of Manchester; University of Bristol	Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 430065, Hubei Province, Peoples R China.; Roberts, SGE (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.	stefan.roberts@bristol.ac.uk; dengwensheng@wust.edu.cn	Roberts, Stefan GE/R-5537-2016	Roberts, Stefan GE/0000-0002-7535-6365; Shore, Paul/0000-0002-1832-5976	National Natural Science Foundation of China [31271395, 31673157]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Project Grants 31271395 and 31673157 (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Barbash ZS, 2013, MOL CELL BIOL, V33, P4395, DOI 10.1128/MCB.00553-13; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; Coleman RA, 1999, MOL CELL, V4, P451, DOI 10.1016/S1097-2765(00)80453-0; COULOMBE B, 1994, J BIOL CHEM, V269, P19962; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Deng WS, 2009, MOL CELL BIOL, V29, P1389, DOI 10.1128/MCB.01346-08; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Dion V, 2003, J BIOL CHEM, V278, P11495, DOI 10.1074/jbc.M211938200; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Dreos R, 2017, NUCLEIC ACIDS RES, V45, pD51, DOI 10.1093/nar/gkw1069; Evans R, 2001, GENE DEV, V15, P2945, DOI 10.1101/gad.206901; Ge H, 1996, METHOD ENZYMOL, V274, P57; GE H, 1994, J BIOL CHEM, V269, P17136; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; KOKUBO T, 1993, GENE DEV, V7, P1033, DOI 10.1101/gad.7.6.1033; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; MA DM, 1993, GENE DEV, V7, P2246, DOI 10.1101/gad.7.11.2246; Malecova B, 2015, TRANSCR-AUSTIN, V6, P21, DOI 10.1080/21541264.2015.1052178; Marbach-Bar N, 2016, NUCLEIC ACIDS RES, V44, P1080, DOI 10.1093/nar/gkv1032; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Mitsiou DJ, 2003, EMBO J, V22, P4501, DOI 10.1093/emboj/cdg419; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Oyama T, 2013, DEV CELL, V27, P188, DOI 10.1016/j.devcel.2013.09.025; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; Robinson MM, 2005, MOL CELL BIOL, V25, P945, DOI 10.1128/MCB.25.3.945-957.2005; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Solow S, 2001, J BIOL CHEM, V276, P15886, DOI 10.1074/jbc.M009385200; Suzuki H, 2015, NUCLEIC ACIDS RES, V43, P6285, DOI 10.1093/nar/gkv576; Takeda S, 2015, J CLIN INVEST, V125, P1203, DOI 10.1172/JCI77075; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135317; Wu SY, 1998, J BIOL CHEM, V273, P12492, DOI 10.1074/jbc.273.20.12492; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235; Zaborowska J, 2012, TRANSCR-AUSTIN, V3, P92, DOI 10.4161/trns.19783; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	56	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11873	11885		10.1074/jbc.M116.770412	http://dx.doi.org/10.1074/jbc.M116.770412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28539359	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000405485600024
J	Spies, M				Spies, Maria			A time for promiscuity in a eukaryotic recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HOMOLOGOUS RECOMBINATION	The exchange of DNA strands between broken and intact molecules lies at the heart of fundamental cellular processes ranging from repairing DNA damage by homologous recombination to generation of genetic diversity during sexual reproduction. New work by Lee and colleagues utilizes the DNA curtain method, an elegant single-molecule technique, to demonstrate common and idiosyncratic features in the DNA strand exchange mechanisms of three RecA-family recombinases, bacterial RecA, and eukaryotic Rad51 and Dmc1 proteins.	[Spies, Maria] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Spies, M (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	maria-spies@uiowa.edu		Spies, Maria/0000-0002-7375-8037	National Institutes of Health [R01 GM108617]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM108617. The author declares that she has no conflicts of interest with the contents of this article.	Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Honda M, 2014, P NATL ACAD SCI USA, V111, pE316, DOI 10.1073/pnas.1312988111; Lee JY, 2017, J BIOL CHEM, V292, P11125, DOI 10.1074/jbc.M117.787614; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; Ragunathan K, 2011, STRUCTURE, V19, P1064, DOI 10.1016/j.str.2011.06.009	8	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11136	11137		10.1074/jbc.H117.787614	http://dx.doi.org/10.1074/jbc.H117.787614			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28667173	Green Published, hybrid			2022-12-28	WOS:000404391000032
J	Guo, HJ; Novozhilova, NM; Bandini, G; Turco, SJ; Ferguson, MAJ; Beverley, SM				Guo, Hongjie; Novozhilova, Natalia M.; Bandini, Giulia; Turco, Salvatore J.; Ferguson, Michael A. J.; Beverley, Stephen M.			Genetic metabolic complementation establishes a requirement for GDP-fucose in Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; glycoconjugate; Leishmania; parasite metabolism; protozoan; virulence factor; D-Arabinopyranose; Fucose; Trypanosomatidae; nucleotide sugar	PROTOZOAN PARASITE LEISHMANIA; NUCLEOTIDE-SUGAR TRANSPORTERS; FORM TRYPANOSOMA-BRUCEI; SAND FLY INTERACTIONS; MAJOR PROMASTIGOTES; DEVELOPMENTAL MODIFICATION; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; D-ARABINOPYRANOSE; BLOOD STAGES	To survive in its sand fly vector, the trypanosomatid protozoan parasite Leishmania first attaches to the midgut to avoid excretion, but eventually it must detach for transmission by the next bite. In Leishmania major strain Friedlin, this is controlled by modifications of the stage-specific adhesin lipophosphoglycan (LPG). During differentiation to infective metacyclics, d-arabinopyranose (d-Arap) caps the LPG side-chain galactose residues, blocking interaction with the midgut lectin PpGalec, thereby leading to parasite detachment and transmission. Previously, we characterized two closely related L. major genes (FKP40 and AFKP80) encoding bifunctional proteins with kinase/pyrophosphorylase activities required for salvage and conversion of l-fucose and/or d-Arap into the nucleotide-sugar substrates required by glycosyltransferases. Whereas only AFKP80 yielded GDP-d-Arap from exogenous d-Arap, both proteins were able to salvage l-fucose to GDP-fucose. We now show that afkp80(-) null mutants ablated d-Arap modifications of LPG as predicted, whereas fkp40(-) null mutants resembled wild type (WT). Fucoconjugates had not been reported previously in L. major, but unexpectedly, we were unable to generate fkp40(-)/afkp80(-) double mutants, unless one of the A/FKPs was expressed ectopically. To test whether GDP-fucose itself was essential for Leishmania viability, we employed genetic metabolite complementation. First, the trypanosome de novo pathway enzymes GDP-mannose dehydratase (GMD) and GDP-fucose synthetase (GMER) were expressed ectopically; from these cells, the fkp40(-)/afkp80(-) double mutant was now readily obtained. As expected, the fkp40(-)/afkp80(-)/+TbGMD-GMER line lacked the capacity to generate GDP-Arap, while synthesizing abundant GDP-fucose. These results establish a requirement for GDP-fucose for L. major viability and predict the existence of an essential fucoconjugate(s).	[Guo, Hongjie; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA; [Novozhilova, Natalia M.; Turco, Salvatore J.] Univ Kentucky, Med Ctr, Dept Biochem, Lexington, KY 40536 USA; [Bandini, Giulia; Ferguson, Michael A. J.] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Bandini, Giulia] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Washington University (WUSTL); University of Kentucky; University of Dundee; Boston University	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	stephen.beverley@wustl.edu	Bandini, Giulia/ABC-4413-2021	Beverley, Stephen/0000-0001-5319-0811; Ferguson, Michael/0000-0003-1321-8714; Bandini, Giulia/0000-0002-8885-3643	Berg postdoctoral fellowship from the Department of Molecular Microbiology, Washington University School of Medicine; National Institutes of Health [R01 AI031078]; Wellcome Trust Senior Investigator Award [10182]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER	Berg postdoctoral fellowship from the Department of Molecular Microbiology, Washington University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Investigator Award(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Berg postdoctoral fellowship from the Department of Molecular Microbiology, Washington University School of Medicine (to H. G.), National Institutes of Health Grant R01 AI031078 (to S. J. T. and S. M. B.), and Wellcome Trust Senior Investigator Award 10182 (to M. A. J. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen S, 2013, J BIOL CHEM, V288, P11093, DOI 10.1074/jbc.M113.452763; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Beverley SM, 1998, TRENDS MICROBIOL, V6, P35, DOI 10.1016/S0966-842X(97)01180-3; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Butcher BA, 1996, J BIOL CHEM, V271, P20573, DOI 10.1074/jbc.271.34.20573; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; Da Silveira EX, 1998, BIOCHEM J, V329, P665; Damerow S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004205; DEIBARRA AAL, 1982, PARASITOLOGY, V85, P523, DOI 10.1017/S0031182000056304; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; Dobson DE, 2003, J BIOL CHEM, V278, P28840, DOI 10.1074/jbc.M302728200; FERGUSON MAJ, 1983, BIOCHEM J, V213, P313, DOI 10.1042/bj2130313; Goswami M, 2006, GLYCOBIOLOGY, V16, P230, DOI 10.1093/glycob/cwj054; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Guther MLS, 2009, EUKARYOT CELL, V8, P1407, DOI 10.1128/EC.00178-09; Haynes PA, 1996, GLYCOBIOLOGY, V6, P869, DOI 10.1093/glycob/6.8.869; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; KELLEHER M, 1994, MOL BIOCHEM PARASIT, V66, P187, DOI 10.1016/0166-6851(94)90146-5; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; Murta SMF, 2009, MOL MICROBIOL, V71, P1386, DOI 10.1111/j.1365-2958.2009.06610.x; Novozhilova NM, 2009, ACTA NATURAE, V1, P81, DOI 10.32607/20758251-2009-1-3-81-83; Novozhilova NM, 2008, GLYCOBIOLOGY, V18, P1005; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; NOZAKI T, 1994, MOL BIOCHEM PARASIT, V67, P91, DOI 10.1016/0166-6851(94)90099-X; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; Palatnik-de-Sousa CB, 2008, EXPERT REV VACCINES, V7, P833, DOI 10.1586/14760584.7.6.833; Park S, 1997, ANAL BIOCHEM, V244, P321, DOI 10.1006/abio.1996.9906; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; SACKS DL, 1987, J IMMUNOL, V139, P3099; Sanz S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37230; Sanz S, 2013, J BIOL CHEM, V288, P16506, DOI 10.1074/jbc.M112.439828; SCHNEIDER P, 1994, J BIOL CHEM, V269, P18332; Schneider P, 1996, BIOCHEM J, V313, P963, DOI 10.1042/bj3130963; Segawa H, 2005, J BIOL CHEM, V280, P2028, DOI 10.1074/jbc.M404915200; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Sterkers Y, 2012, MOL MICROBIOL, V86, P15, DOI 10.1111/j.1365-2958.2012.08185.x; SUGII S, 1982, CARBOHYD RES, V99, P99, DOI 10.1016/S0008-6215(00)80982-9; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; WAIT R, 1994, BRAZ J MED BIOL RES, V27, P203; Wilson IBH, 1999, MOL BIOCHEM PARASIT, V100, P207, DOI 10.1016/S0166-6851(99)00061-4; Wyder MA, 1999, J PARASITOL, V85, P771, DOI 10.2307/3285810	67	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10696	10708		10.1074/jbc.M117.778480	http://dx.doi.org/10.1074/jbc.M117.778480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28465349	Green Published, hybrid			2022-12-28	WOS:000404115400028
J	Wang, ZJ; Deba, F; Mohamed, TS; Chiara, DC; Ramos, K; Hamouda, AK				Wang, Ze-Jun; Deba, Farah; Mohamed, Tasnim S.; Chiara, David C.; Ramos, Kara; Hamouda, Ayman K.			Unraveling amino acid residues critical for allosteric potentiation of (alpha 4)3(beta 2) 2-type nicotinic acetylcholine receptor responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL SUBUNIT INTERFACES; AGONIST BINDING-SITE; THERAPEUTIC TARGETS; NERVOUS-SYSTEM; BETA-2 SUBUNIT; MODULATOR; PHARMACOLOGY; SENSITIVITY; SUBTYPES; NS9283	Neuronal nicotinic acetylcholine receptors (nAChRs) are promising drug targets to manage several neurological disorders and nicotine addiction. Growing evidence indicates that positive allosteric modulators of nAChRs improve pharmacological specificity by binding to unique sites present only in a subpopulation of nAChRs. Furthermore, nAChR positive allosteric modulators such as NS9283 and CMPI have been shown to potentiate responses of (alpha 4)3(beta 2)2 but not (alpha 4)2(beta 2)3 nAChR isoforms. This selective potentiation underlines that the alpha 4: alpha 4 interface, which is present only in the (alpha 4)3(beta 2)2 nAChR, is an important and promising drug target. In this report we used site-directed mutagenesis to substitute specific amino acid residues and computational analyses to elucidate CMPI's binding mode at the alpha 4: alpha 4 subunit extracellular interface and identified a unique set of amino acid residues that determined its affinity. We found that amino acid residues alpha 4Gly-41, alpha 4Lys-64, and alpha 4Thr-66 were critical for (alpha 4)3(beta 2)2 nAChR potentiation by CMPI, but not by NS9283, whereas amino acid substitution at alpha 4His-116, a known determinant of NS9283 and of agonist binding at the alpha 4: alpha 4 subunit interface, did not reduce CMPI potentiation. In contrast, substitutions at alpha 4Gln-124 and alpha 4Thr-126 reduced potentiation by CMPI and NS9283, indicating that their binding sites partially overlap. These results delineate the role of amino acid residues contributing to the alpha 4: alpha 4 subunit extracellular interface in nAChR potentiation. These findings also provide structural information that will facilitate the structure-based design of novel therapeutics that target selectively the (alpha 4)3(beta 2)2 nAChR.	[Wang, Ze-Jun; Deba, Farah; Mohamed, Tasnim S.; Ramos, Kara; Hamouda, Ayman K.] Texas A&M Hlth Sci Ctr, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Hamouda, Ayman K.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA; [Chiara, David C.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Harvard Medical School	Hamouda, AK (corresponding author), Texas A&M Hlth Sci Ctr, Rangel Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA.	Hamouda@tamhsc.edu		Deba, Farah/0000-0001-9154-430X	National Institutes of Health [NS-093590]; Faculty Development Fund of Texas A&M Health Sciences Center; Direct For Biological Sciences [1355034] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS093590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Development Fund of Texas A&M Health Sciences Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-093590 (NINDS; to A. K. H.). This work was also supported in part by Faculty Development Fund of Texas A&M Health Sciences Center (to A. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht BK, 2008, BIOORG MED CHEM LETT, V18, P5209, DOI 10.1016/j.bmcl.2008.08.080; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Hamouda AK, 2015, MOL PHARMACOL, V88, P1, DOI 10.1124/mol.115.098913; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Sala F, 2005, NEUROSCI LETT, V373, P144, DOI 10.1016/j.neulet.2004.10.002; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Srivastava S, 2009, J BIOL CHEM, V284, P24939, DOI 10.1074/jbc.M109.019083; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Uteshev VV, 2016, CURR PHARM DESIGN, V22, P1986, DOI 10.2174/1381612822666160201115341; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Weltzin MM, 2015, J PHARMACOL EXP THER, V354, P184, DOI 10.1124/jpet.115.223933; Wevers A, 1999, EUR J NEUROSCI, V11, P2551, DOI 10.1046/j.1460-9568.1999.00676.x; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	40	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9988	10001		10.1074/jbc.M116.771246	http://dx.doi.org/10.1074/jbc.M116.771246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446611	Green Published, hybrid			2022-12-28	WOS:000403580600012
J	Zhang, QJ; Meng, XH; Li, DL; Chen, SY; Luo, JM; Zhu, LJ; Singer, RH; Gu, W				Zhang, Qianjun; Meng, Xiuhua; Li, Delin; Chen, Shaoyin; Luo, Jianmin; Zhu, Linjie; Singer, Robert H.; Gu, Wei			Binding of DEAD-box helicase Dhh1 to the 5 '-untranslated region of ASH1 mRNA represses localized translation of ASH1 in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; STRUCTURAL ELEMENTS; GENE-EXPRESSION; PROTEIN; ELONGATION; TRANSCRIPTION; TRANSPORT; MYOSIN; PHOSPHORYLATION; IDENTIFICATION	Local translation of specific mRNAs is regulated by dynamic changes in their subcellular localization, and these changes are due to complex mechanisms controlling cytoplasmic mRNA transport. The budding yeast Saccharomyces cerevisiae is well suited to studying these mechanisms because many of its transcripts are transported from the mother cell to the budding daughter cell. Here, we investigated the translational control of ASH1 mRNA after transport and localization. We show that although ASH1 transcripts were translated after they reached the bud tip, some mRNAs were bound by the RNA-binding protein Puf6 and were non-polysomal. We also found that the DEAD-box helicase Dhh1 complexed with the untranslated ASH1 mRNA and Puf6. Loss of Dhh1 affected local translation of ASH1 mRNA and resulted in delocalization of ASH1 transcript in the bud. Forcibly shifting the non-polysomal ASH1 mRNA into polysomes was associated with Dhh1 dissociation. We further demonstrated that Dhh1 is not recruited to ASH1 mRNA co-transcriptionally, suggesting that it could bind to ASH1 mRNA within the cytoplasm. Of note, Dhh1 bound to the 5'-UTR of ASH1 mRNA and inhibited its translation in vitro. These results suggest that after localization to the bud tip, a portion of the localized ASH1 mRNA becomes translationally inactive because of binding of Dhh1 and Puf6 to the 5'- and 3'-UTRs of ASH1 mRNA.	[Zhang, Qianjun; Li, Delin; Chen, Shaoyin; Luo, Jianmin; Zhu, Linjie; Gu, Wei] Shantou Univ, Med Coll, Dept Pathophysiol, Key Immunopathol Lab Guangdong Prov, Shantou 515031, Guangdong, Peoples R China; [Meng, Xiuhua; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Shantou University; Yeshiva University; Albert Einstein College of Medicine	Gu, W (corresponding author), Shantou Univ, Med Coll, Dept Pathophysiol, Key Immunopathol Lab Guangdong Prov, Shantou 515031, Guangdong, Peoples R China.	weigu1@yahoo.com	Luo, jian/HGE-7331-2022		National Natural Science Foundation of China [31171209]; National Institutes of Health [GM57071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057071] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant 31171209 (to W. G.) and National Institutes of Health Grant GM57071 (to R. H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Chartrand P, 2001, ANNU REV CELL DEV BI, V17, P297, DOI 10.1146/annurev.cellbio.17.1.297; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Dutta A, 2011, J BIOL CHEM, V286, P27454, DOI 10.1074/jbc.M111.220251; Garcia JF, 2015, RNA, V21, P1393, DOI 10.1261/rna.051797.115; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Gu W, 2008, MOL CELL BIOL, V28, P4963, DOI 10.1128/MCB.00266-08; Hinnebusch AG, 2009, GENE DEV, V23, P891, DOI 10.1101/gad.1800509; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Ka M, 2008, BIOCHEM BIOPH RES CO, V367, P680, DOI 10.1016/j.bbrc.2007.12.169; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shahbabian K, 2014, NUCLEIC ACIDS RES, V42, P8692, DOI 10.1093/nar/gku597; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song TT, 2015, J CELL SCI, V128, P1001, DOI 10.1242/jcs.161679; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	45	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9787	9800		10.1074/jbc.M117.776492	http://dx.doi.org/10.1074/jbc.M117.776492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28450395	hybrid, Green Published			2022-12-28	WOS:000403113000027
J	Sala-Rabanal, M; Yurtsever, Z; Berry, KN; Nichols, CG; Brett, TJ				Sala-Rabanal, Monica; Yurtsever, Zeynep; Berry, Kayla N.; Nichols, Colin G.; Brett, Tom J.			Modulation of TMEM16A channel activity by the von Willebrand factor type A (VWA) domain of the calcium-activated chloride channel regulator 1 (CLCA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; ALPHA(2)DELTA SUBUNITS; INDEPENDENT ACTIVATION; AIRWAY DISEASE; PROTEIN; TRAFFICKING; EXPRESSION; IDENTIFICATION; ASSOCIATION; CONDUCTION	Calcium-activated chloride channels (CaCCs) are key players in transepithelial ion transport and fluid secretion, smooth muscle constriction, neuronal excitability, and cell proliferation. The CaCC regulator 1 (CLCA1) modulates the activity of the CaCC TMEM16A/Anoctamin 1 (ANO1) by directly engaging the channel at the cell surface, but the exact mechanism is unknown. Here we demonstrate that the von Willebrand factor type A (VWA) domain within the cleaved CLCA1 N-terminal fragment is necessary and sufficient for this interaction. TMEM16A protein levels on the cell surface were increased in HEK293T cells transfected with CLCA1 constructs containing theVWAdomain, and TMEM16A-like currents were activated. Similar currents were evoked in cells exposed to secreted VWA domain alone, and these currents were significantly knocked down byTMEM16AsiRNA. VWA-dependentTMEM16Amodulation was not modified by the S357N mutation, a VWA domain polymorphism associated with more severe meconium ileus in cystic fibrosis patients. VWA-activated currents were significantly reduced in the absence of extracellular Mg2+, and mutation of residues within the conserved metal ion-dependent adhesion site motif impaired the ability of VWA to potentiate TMEM16A activity, suggesting that CLCA1-TMEM16A interactions are Mg2+ -and metal ion-dependent adhesion site-dependent. Increase in TMEM16A activity occurred within minutes of exposure to CLCA1 or after a short treatment with nocodazole, consistent with the hypothesis that CLCA1 stabilizes TMEM16A at the cell surface by preventing its internalization. Our study hints at the therapeutic potential of the selective activation of TMEM16A by the CLCA1 VWA domain in loss-of-function chloride channelopathies such as cystic fibrosis.	[Sala-Rabanal, Monica; Nichols, Colin G.; Brett, Tom J.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.; Brett, Tom J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Yurtsever, Zeynep] Washington Univ, Sch Med, Biochem Program, St Louis, MO 63110 USA; [Yurtsever, Zeynep; Berry, Kayla N.; Brett, Tom J.] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Berry, Kayla N.] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO 63110 USA; [Brett, Tom J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Yurtsever, Zeynep] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Yurtsever, Zeynep] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Brett, TJ (corresponding author), Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	tbrett@wustl.edu	Sala-Rabanal, Monica/AAU-2383-2021; Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Yurtsever, Zeynep/0000-0001-6848-8602	National Institutes of Health [R01-HL119813, R01-HL54171, T32-GM7200, T32-HL007317]; American Lung Association [RG-196051]; Center for the Investigation of Membrane Excitability Diseases (CIMED) pilot and feasibility grant; American Heart Association Predoctoral Fellowship [14PRE19970008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317, R01HL119813, R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Center for the Investigation of Membrane Excitability Diseases (CIMED) pilot and feasibility grant; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-HL119813 (to T.J.B.), R01-HL54171 (to C.G.N.), and T32-GM7200 and T32-HL007317 (to K.N.B.); American Lung Association Grant RG-196051 (to T.J.B.); a Center for the Investigation of Membrane Excitability Diseases (CIMED) pilot and feasibility grant (to T.J.B.); and American Heart Association Predoctoral Fellowship 14PRE19970008 (to Z.Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Alvarez-Laviada A, 2014, BIOCHEM J, V458, P365, DOI 10.1042/BJ20131405; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Brett TJ, 2015, EXPERT REV RESP MED, V9, P503, DOI 10.1586/17476348.2015.1081064; Brodsky JL, 2015, CELL, V163, P17, DOI 10.1016/j.cell.2015.09.003; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Calderon-Rivera A, 2012, CELL CALCIUM, V51, P22, DOI 10.1016/j.ceca.2011.10.002; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carter SC, 2016, PHARMACOGENOMICS, V17, P1453, DOI 10.2217/pgs.16.25; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Hartzell HC, 2016, J GEN PHYSIOL, V148, P367, DOI 10.1085/jgp.201611686; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; JAY SD, 1991, J BIOL CHEM, V266, P3287; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; Macabuag N, 2015, J NEUROSCI, V35, P14636, DOI 10.1523/JNEUROSCI.3034-15.2015; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Picollo A, 2015, J MOL BIOL, V427, P94, DOI 10.1016/j.jmb.2014.09.028; Pritchard HAT, 2014, BRIT J PHARMACOL, V171, P4311, DOI 10.1111/bph.12778; Sala-Rabanal M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/497387; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Song GJ, 2014, P NATL ACAD SCI USA, V111, P4862, DOI 10.1073/pnas.1403059111; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; Vossenkamper A, 2007, AM J PHYSIOL-CELL PH, V293, pC1129, DOI 10.1152/ajpcell.00628.2006; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570	54	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9164	9174		10.1074/jbc.M117.788232	http://dx.doi.org/10.1074/jbc.M117.788232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28420732	hybrid, Green Published			2022-12-28	WOS:000402538900013
J	Brackley, AD; Sarrami, S; Gomez, R; Guerrero, KA; Jeske, NA				Brackley, Allison Doyle; Sarrami, Shayda; Gomez, Ruben; Guerrero, Kristi A.; Jeske, Nathaniel A.			Identification of a signaling cascade that maintains constitutive delta-opioid receptor incompetence in peripheral sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); G-protein-coupled receptor (GPCR); neuron; opiate opioid; pain; phosphorylation; protein kinase A (PKA); GRK2; opioid	DEPENDENT PROTEIN-KINASE; ANCHORING PROTEIN; FUNCTIONAL COMPETENCE; REGULATORY SUBUNIT; TRIGEMINAL NOCICEPTORS; AKAP150-ANCHORED PKA; SKELETAL-MUSCLE; CHRONIC PAIN; PHOSPHORYLATION; ACTIVATION	mu-Opioid receptor (MOR) agonists are often used to treat severe pain but can result in adverse side effects. To circumvent systemic side effects, targeting peripheral opioid receptors is an attractive alternative treatment for severe pain. Activation of the delta-opioid receptor (DOR) produces similar analgesia with reduced side effects. However, until primed by inflammation, peripheral DOR is analgesically incompetent, raising interest in the mechanism. We recently identified a novel role for G-protein-coupled receptor kinase 2 (GRK2) that renders DOR analgesically incompetent at the plasma membrane. However, the mechanism that maintains constitutive GRK2 association with DOR is unknown. Protein kinase A (PKA) phosphorylation of GRK2 at Ser-685 targets it to the plasma membrane. Protein kinase A-anchoring protein 79/150 (AKAP), residing at the plasma membrane in neurons, scaffolds PKA to target proteins to mediate downstream signal. Therefore, we sought to determine whether GRK2-mediated DOR desensitization is directed by PKA via AKAP scaffolding. Membrane fractions from cultured rat sensory neurons following AKAP siRNA transfection and from AKAP-knock-out mice had less PKA activity, GRK2 Ser-685 phosphorylation, and GRK2 plasma membrane targeting than controls. Site-directed mutagenesis revealed that GRK2 Ser-685 phosphorylation drives the association of GRK2 with plasma membrane-associated DOR. Moreover, overexpression studies with AKAP mutants indicated that impaired AKAP-mediated PKA scaffolding significantly reduces DOR-GRK2 association at the plasma membrane and consequently increases DOR activity in sensory neurons without a priming event. These findings suggest that AKAP scaffolds PKA to increase plasma membrane targeting and phosphorylation of GRK2 to maintain DOR analgesic incompetence in peripheral sensory neurons.	[Brackley, Allison Doyle; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Sarrami, Shayda; Gomez, Ruben; Guerrero, Kristi A.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Jeske, NA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Oral & Maxillofacial Surg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Jeske@uthscsa.edu		Dietert, Kristi/0000-0003-2338-7968; Brackley, Allison/0000-0002-9552-3159	NINDS, National Institutes of Health (NIH) [RO1 NS082746]; NIDCR, NIH [T32 DE14318, F31 DE025551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318, F31DE025551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082746] Funding Source: NIH RePORTER	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health (NIH), Grant RO1 NS082746 (to N. A. J.); NIDCR, NIH, Grant T32 DE14318 (to A. D. B.); and NIDCR, NIH, Grant F31 DE025551 (to A. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarado LT, 2007, J ENDODONT, V33, P1167, DOI 10.1016/j.joen.2007.06.018; Berg KA, 2012, MOL PHARMACOL, V81, P264, DOI 10.1124/mol.111.072702; Brackley AD, 2016, CELL REP, V16, P2686, DOI 10.1016/j.celrep.2016.07.084; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Buzas B, 1997, J NEUROCHEM, V68, P610; Byun SW, 2012, CANCER LETT, V326, P96, DOI 10.1016/j.canlet.2012.07.032; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; CORBIN JD, 1975, J BIOL CHEM, V250, P218; CORBIN JD, 1973, J BIOL CHEM, V248, P1813; CORBIN JD, 1977, J BIOL CHEM, V252, P910; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GOLDENBERG SSS, 1983, J NEUROBIOL, V14, P195, DOI 10.1002/neu.480140304; Gomez R, 2011, PAIN, V152, P1548, DOI 10.1016/j.pain.2011.02.044; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00123; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; LAW PY, 1995, J PHARMACOL EXP THER, V272, P322; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060558; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; Patwardhan AM, 2006, PAIN, V125, P114, DOI 10.1016/j.pain.2006.05.007; Pettinger L, 2013, J NEUROSCI, V33, P10762, DOI 10.1523/JNEUROSCI.0123-13.2013; POTTER RL, 1979, J BIOL CHEM, V254, P2413; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Rowan MP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-50; Rowan MP, 2009, EUR J PHARMACOL, V602, P283, DOI 10.1016/j.ejphar.2008.11.028; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; Stein C, 2001, Curr Opin Pharmacol, V1, P62, DOI 10.1016/S1471-4892(01)00005-4; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vanderah TW, 2010, CLIN J PAIN, V26, pS10, DOI 10.1097/AJP.0b013e3181c49e3a; Wang HJ, 2011, PAIN, V152, P1649, DOI 10.1016/j.pain.2011.03.010; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Xu W, 2013, LIFE SCI, V92, P1101, DOI 10.1016/j.lfs.2013.04.006; Zhao ZH, 2016, EMBO REP, V17, P739, DOI 10.15252/embr.201541532	46	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8762	8772		10.1074/jbc.M117.776799	http://dx.doi.org/10.1074/jbc.M117.776799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381559	Green Published, hybrid			2022-12-28	WOS:000402153900022
J	Tsai, CJ; Nussinov, R				Tsai, Chung-Jung; Nussinov, Ruth			Allostery modulates the beat rate of a cardiac pacemaker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CHANNEL; MUTATIONS; CAMP	The S672R mutation in heart cell ion channels leads to low heart rates and arrhythmia by an unknown route. A multifaceted NMR analysis now demonstrates that this mutant impacts allosteric coupling in domains inside of the cell to change channel activation, providing a mechanistic explanation for phenotypic outcomes.	[Tsai, Chung-Jung; Nussinov, Ruth] NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res,NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res,NIH, Frederick, MD 21702 USA.; Nussinov, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	NussinoR@mail.nih.gov		Nussinov, Ruth/0000-0002-8115-6415	NCI, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NCI, National Institutes of Health, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010442, ZIABC010441] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, National Institutes of Health, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health, Contract No. HHSN261200800001E. This work was supported in part by the Intramural Research Program of the NCI, National Institutes of Health, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Boulton S, 2017, J BIOL CHEM, V292, P6414, DOI 10.1074/jbc.M116.773697; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DiFrancesco D, 2013, J PHYSIOL-LONDON, V591, P4117, DOI 10.1113/jphysiol.2013.253765; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Verkerk AO, 2015, INT J MOL SCI, V16, P3071, DOI 10.3390/ijms16023071; Xu XP, 2012, STRUCTURE, V20, P2116, DOI 10.1016/j.str.2012.09.017	9	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6429	6430		10.1074/jbc.H116.773697	http://dx.doi.org/10.1074/jbc.H116.773697			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28411213	Green Published, hybrid			2022-12-28	WOS:000399538700034
J	Gocher, AM; Azabdaftari, G; Euscher, LM; Dai, SH; Karacosta, LG; Franke, TF; Edelman, AM				Gocher, Angela M.; Azabdaftari, Gissou; Euscher, Lindsey M.; Dai, Shuhang; Karacosta, Loukia G.; Franke, Thomas F.; Edelman, Arthur M.			Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; calmodulin (CaM); ovarian cancer; phosphorylation; protein kinase	ANDROGEN RECEPTOR; MOLECULAR-CLONING; PROSTATE-CANCER; CYCLIN D1; PATHWAY ACTIVATION; PHOSPHORYLATION; BETA; PROGRESSION; INHIBITION; SURVIVAL	Hyperactivation of Akt is associated with oncogenic changes in the growth, survival, and chemoresistance of cancer cells. The PI3K/phosphoinositide-dependent kinase (PDK) 1 pathway represents the canonical mechanism for phosphorylation of Akt at its primary activation site, Thr-308. We observed that Ca2+/calmodulin (CaM)-dependent protein kinase kinase 2 () (CaMKK2) is highly expressed in high-grade serous ovarian cancer, and we investigated its role in Akt activation in ovarian cancer (OVCa) cell lines (OVCAR-3, SKOV-3, and Caov-3). Knockdown or pharmacological inhibition of CaMKK2 produced phenotypes expected of Akt inhibition, including reductions in cell growth and cell viability and in the regulation of Akt downstream targets involved in G(1)/S transition and apoptosis. CaMKK2 knockdown or inhibition decreased Akt phosphorylation at Thr-308 and Ser-473 to extents similar to those of PDK1 knockdown or PI3K inhibition. Combined CaMKK2 and PDK1 knockdown or CaMKK and PI3K inhibition, respectively, produced additive effects on p-Akt and cell growth, consistent with direct Akt phosphorylation by CaMKK2. This conclusion was supported by the absence of effects of CaMKK2 knockdown/inhibition on alternative means of activating Akt via p-Akt Thr-450, p-PDK1 Ser-241, or p-IRS1 Ser-636/639. Recombinant CaMKK2 directly activated recombinant Akt by phosphorylation at Thr-308 in a Ca2+/CaM-dependent manner. In OVCa cells, p-Akt Thr-308 was significantly inhibited by intracellular Ca-i(2+) chelation or CaM inhibition. Ionomycin-induced Ca2+ influx promoted p-Akt, an effect blocked by PDK1, and/or CaMKK2, siRNAs, and by PI3K and/or CaMKK inhibitors. CaMKK2 knockdown potentiated the effects of the chemotherapeutic drugs carboplatin and PX-866 to reduce proliferation and survival of OVCa cells.	[Gocher, Angela M.; Euscher, Lindsey M.; Dai, Shuhang; Karacosta, Loukia G.; Edelman, Arthur M.] SUNY Bffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Azabdaftari, Gissou] Roswell Pk Canc Inst, Dept Pathol & Lab Med, Buffalo, NY 14263 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Psychiat Biochem & Mol Pharmacol, New York, NY 10016 USA	Roswell Park Cancer Institute; New York University	Edelman, AM (corresponding author), SUNY Bffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	aedelman@buffalo.edu		Dai, Shuhang/0000-0001-9607-0684	Mark Diamond Research Fund [SU-15-04]; University at Buffalo Foundation; Department of Defense [OC150368]; National Institutes of Health [OD018340]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018340] Funding Source: NIH RePORTER	Mark Diamond Research Fund; University at Buffalo Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Mark Diamond Research Fund SU-15-04 (to A. M. G.), University at Buffalo Foundation and Department of Defense Grant OC150368 (to A. M. E.), and by National Institutes of Health Grant OD018340 (to T. F. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Alvero Ayesha B., 2008, V414, P79; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Bast RC, 2012, CANCER DISCOV, V2, P16, DOI 10.1158/2159-8290.CD-11-0323; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Carden CP, 2012, MOL CANCER THER, V11, P1609, DOI 10.1158/1535-7163.MCT-11-0996; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Davis A, 2014, GYNECOL ONCOL, V133, P624, DOI 10.1016/j.ygyno.2014.02.038; De Marco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055362; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franke TF, 2000, METHOD ENZYMOL, V322, P400; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gocher A. M., 2013, THESIS; Hanrahan AJ, 2012, CANCER DISCOV, V2, P56, DOI 10.1158/2159-8290.CD-11-0170; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ihle NT, 2004, MOL CANCER THER, V3, P763; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kahl CR, 2004, J BIOL CHEM, V279, P15411, DOI 10.1074/jbc.M312543200; Karacosta LG, 2016, PROSTATE, V76, P294, DOI 10.1002/pros.23121; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; KIKUCHI Y, 1990, GYNECOL ONCOL, V39, P199, DOI 10.1016/0090-8258(90)90432-K; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Schmitt JM, 2012, J CELL BIOCHEM, V113, P1514, DOI 10.1002/jcb.24020; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xu J, 2007, HIPPOCAMPUS, V17, P525, DOI 10.1002/hipo.20289; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	67	57	57	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14188	14204		10.1074/jbc.M117.778464	http://dx.doi.org/10.1074/jbc.M117.778464			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28634229	Green Published, hybrid			2022-12-28	WOS:000408439800023
J	Tan, S; Ding, KS; Chong, QY; Zhao, JS; Liu, Y; Shao, YY; Zhang, YY; Yu, Q; Xiong, ZR; Zhang, WJ; Zhang, M; Li, GP; Li, XN; Kong, XJ; Ahmad, A; Wu, ZS; Wu, Q; Zhao, XD; Lobie, PE; Zhu, T				Tan, Sheng; Ding, Keshuo; Chong, Qing-Yun; Zhao, Junsong; Liu, Yuan; Shao, Yunying; Zhang, Yuanyuan; Yu, Qing; Xiong, Zirui; Zhang, Weijie; Zhang, Min; Li, Gaopeng; Li, Xiaoni; Kong, Xiangjun; Ahmad, Akhlaq; Wu, Zhengsheng; Wu, Qiang; Zhao, Xiaodong; Lobie, Peter E.; Zhu, Tao			Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; ALTERNATIVE POLYADENYLATION; ENDOCRINE RESISTANCE; GENE-EXPRESSION; MECHANISMS; MICRORNAS; HER-2; STABILITY; THERAPY	Tamoxifen-resistant (TAMR) estrogen receptor-positive (ER+) breast cancer is characterized by elevated Erb-B2 receptor tyrosine kinase 2 (ERBB2) expression. However, the underlying mechanisms responsible for the increased ERBB2 expression in the TAMR cells remain poorly understood. Herein, we reported that the ERBB2 expression is regulated at the post-transcriptional level by miR26a/b and the RNA-binding protein human antigen R (HuR), both of which associate with the 3'-UTR of the ERBB2 transcripts. We demonstrated that miR26a/b inhibits the translation of ERBB2 mRNA, whereas HuR enhances the stability of the ERBB2 mRNA. InTAMRER+ breast cancer cells with elevated ERBB2 expression, we observed a decrease in the level of miR26a/b and an increase in the level of HuR. The forced expression of miR26a/b or the depletion of HuR decreased ERBB2 expression in the TAMR cells, resulting in the reversal of tamoxifen resistance. In contrast, the inactivation of miR26a/b or forced expression of HuR decreased tamoxifen responsiveness of the parental ER+ breast cancer cells. We further showed that the increase in HuR expression in the TAMR ER+ breast cancer cells is attributable to an increase in the HuR mRNA isoform with shortened 3'-UTR, which exhibits increased translational activity. This shortening of the HuR mRNA 3'-UTR via alternative polyadenylation (APA) was observed to be dependent on cleavage stimulation factor subunit 2 (CSTF2/CstF-64), which is up-regulated in the TAMR breast cancer cells. Taken together, we have characterized a model in which the interplay between miR26a/b and HuR post-transcriptionally up-regulates ERBB2 expression in TAMR ER+ breast cancer cells.	[Tan, Sheng; Ding, Keshuo; Zhao, Junsong; Liu, Yuan; Shao, Yunying; Zhang, Yuanyuan; Yu, Qing; Xiong, Zirui; Zhang, Weijie; Zhang, Min; Li, Gaopeng; Li, Xiaoni; Kong, Xiangjun; Ahmad, Akhlaq; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Tan, Sheng; Yu, Qing; Zhang, Weijie; Zhang, Min; Li, Xiaoni; Kong, Xiangjun; Zhu, Tao] Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Ding, Keshuo; Wu, Zhengsheng; Wu, Qiang] Anhui Med Univ, Dept Pathol, Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Chong, Qing-Yun; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Chong, Qing-Yun; Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Hlth Syst, Natl Canc Inst Singapore, Singapore 119074, Singapore; [Zhao, Xiaodong] Shanghai Jiao Tong Univ, Sch Biomed Engn, BioID Ctr, Shanghai 200240, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Grad Sch Shenzhen, Tsinghua Berkeley Shenzhen Inst TBSI, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; National University of Singapore; National University of Singapore; National University of Singapore; Shanghai Jiao Tong University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Lobie, PE (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med MD6, 11-01K,14 Med Dr, Singapore 117599, Singapore.; Zhu, T (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	csipel@nus.edu.sg; zhut@ustc.edu.cn	Zhu, Tao/H-3495-2018; tan, sheng/GSN-2599-2022; zhang, yuanyuan/GYA-4428-2022; Ahmad, Akhlaq/GVS-1598-2022	Xiong, Zirui Ray/0000-0003-4311-3200; Zhang, Weijie/0000-0002-6462-6067	National Key R&D Program of China [2016 YFC1302305]; National Natural Science Foundation of China [81672609, 81472494, 81672615]; Specialized Research Fund for the Doctoral Program of Higher Education [20133402120032, 20133420120006]; CAS Grant [XDA01040410]; Cancer Science Institute of Singapore through National Research Foundation; Ministry of Education of Singapore; National Medical Research Council of Singapore [R-713-000-163-511, R-713-000-206-511]; Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) Grant [2015VBA031]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); CAS Grant; Cancer Science Institute of Singapore through National Research Foundation(National Research Foundation, Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) Grant	This work was supported by the National Key R&D Program of China (Grant 2016 YFC1302305); the National Natural Science Foundation of China Grants (81672609, 81472494, and 81672615); the Specialized Research Fund for the Doctoral Program of Higher Education (20133402120032 and 20133420120006); the CAS Grant XDA01040410, the Cancer Science Institute of Singapore through grants from the National Research Foundation and Ministry of Education of Singapore and grants from the National Medical Research Council of Singapore (R-713-000-163-511 and R-713-000-206-511). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) Grant 2015VBA031. To whom correspondence may be addressed: Cancer Science Institute of Singapore, National University of Singapore, Centre for Translational Medicine MD6, #11-01K, 14 Medical Dr., Singapore 117599. Tel.: 65-66011046; E-mail: csipel@nus.edu.sg.	Al-Ahmadi W, 2013, J PATHOL, V230, P28, DOI 10.1002/path.4178; Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chu I, 2005, CANCER RES, V65, P18; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dowsett M, 2001, ENDOCR-RELAT CANCER, V8, P191, DOI 10.1677/erc.0.0080191; Dowsett M, 2001, CANCER RES, V61, P8452; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Egeland NG, 2015, INT J MOL SCI, V16, P24243, DOI 10.3390/ijms161024243; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Erson-Bensan AE, 2016, MOL CANCER RES, V14, P507, DOI 10.1158/1541-7786.MCR-15-0489; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Hostetter CL, 2009, CANCER LETT, V275, P178, DOI 10.1016/j.canlet.2008.10.005; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jansen MPHM, 2012, BREAST CANCER RES TR, V133, P937, DOI 10.1007/s10549-011-1877-4; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Jin K, 2015, CANCER DISCOV, V5, P944, DOI 10.1158/2159-8290.CD-15-0090; Kang H, 2013, INT J MOL SCI, V14, P17204, DOI 10.3390/ijms140817204; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kotta-Loizou I, 2016, NEOPLASIA, V18, P674, DOI 10.1016/j.neo.2016.09.002; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li CS, 2009, AAPS J, V11, P747, DOI 10.1208/s12248-009-9145-9; Li S, 2012, NUCLEIC ACIDS RES, V40, P884, DOI 10.1093/nar/gkr715; Lipton A, 2005, CANCER, V104, P257, DOI 10.1002/cncr.21202; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mehta A, 2006, GENE DEV, V20, P939, DOI 10.1101/gad.1388706; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Tan S, 2011, FEBS LETT, V585, P2229, DOI 10.1016/j.febslet.2011.05.042; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yuan Z, 2010, HISTOL HISTOPATHOL, V25, P1331, DOI 10.14670/HH-25.1331; Zhuang R, 2013, NUCLEIC ACIDS RES, V41, P7905, DOI 10.1093/nar/gkt565; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	68	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13551	13564		10.1074/jbc.M117.780973	http://dx.doi.org/10.1074/jbc.M117.780973			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28637868	Green Published, hybrid			2022-12-28	WOS:000407942400027
J	Verissimo, AF; Khalfaoui-Hassani, B; Hwang, J; Steimle, S; Selamoglu, N; Sanders, C; Khatchikian, CE; Daldal, F				Verissimo, Andreia F.; Khalfaoui-Hassani, Bahia; Hwang, Josephine; Steimle, Stefan; Selamoglu, Nur; Sanders, Carsten; Khatchikian, Camilo E.; Daldal, Fevzi			The thioreduction component CcmG confers efficiency and the heme ligation component CcmH ensures stereo-specificity during cytochrome c maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CCMG; APOCYTOCHROME-C; RHODOBACTER-CAPSULATUS; THIOREDOXIN REDUCTASE; CATALYTIC MECHANISM; BIOGENESIS DEFECT; NULL MUTANTS; DISULFIDE; PROTEIN; SYSTEM	In many Gram-negative bacteria, including Rhodobacter capsulatus, cytochrome c maturation (Ccm) is carried out by a membrane-integral machinery composed of nine proteins (CcmA to I). During this process, the periplasmic thiol-disulfide oxidoreductase DsbA is thought to catalyze the formation of a disulfide bond between the Cys residues at the apocytochrome c heme-binding site (CXXCH). Subsequently, a Ccm-specific thioreductive pathway involving CcmG and CcmH reduces this disulfide bond to allow covalent heme ligation. Currently, the sequence of thioredox reactions occurring between these components and apocytochrome c and the identity of their active Cys residues are unknown. In this work, we first investigated protein-protein interactions among the apocytochrome c, CcmG, and the heme-ligation components CcmF, CcmH, and CcmI. We found that they all interact with each other, forming a CcmFGHI-apocytochrome c complex. Using purified wildtype CcmG, CcmH, and apocytochrome c, as well as their respective Cys mutant variants, we determined the rates of thiol-disulfide exchange reactions between selected pairs of Cys residues from these proteins. We established that CcmG can efficiently reduce the disulfide bond of apocytochrome c and also resolve a mixed disulfide bond formed between apocytochrome c and CcmH. We further show that Cys-45 of CcmH and Cys-34 of apocytochrome c are most likely to form this mixed disulfide bond, which is consistent with the stereo-specificity of the heme-apocytochrome c ligation reaction. We conclude that CcmG confers efficiency, and CcmH ensures stereo-specificity during Ccm and present a comprehensive model for thioreduction reactions that lead to heme-apocytochrome c ligation.	[Verissimo, Andreia F.; Khalfaoui-Hassani, Bahia; Hwang, Josephine; Steimle, Stefan; Selamoglu, Nur; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Sanders, Carsten] Univ Kutztown, Dept Phys Sci, Kutztown, PA 19530 USA; [Khatchikian, Camilo E.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University of Pennsylvania; University of Texas System; University of Texas El Paso	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu			Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of Department of Energy [DOE DE-FG02-91ER20052]; National Institutes of Health [GM 382375];  [G12MD007592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of Department of Energy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported primarily by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of Department of Energy Grant DOE DE-FG02-91ER20052 (to F. D.) and in part by the National Institutes of Health Grants GM 38237 (to F. D.), which supported the production of mutant proteins, and Grant 5G12MD007592 (to C. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja U, 2008, FEBS LETT, V582, P2779, DOI 10.1016/j.febslet.2008.07.007; Aitken A., 2002, PROTEIN PROTOCOLS HD, P595, DOI DOI 10.1385/1-59259-169-8:595; Allen JWA, 2003, J BIOL CHEM, V278, P52075, DOI 10.1074/jbc.M307196200; Ang SK, 2014, BIOCHEM J, V460, P199, DOI 10.1042/BJ20131540; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; Cho SH, 2009, J BIOL CHEM, V284, P11416, DOI 10.1074/jbc.M900651200; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Deshmukh M, 2003, J BACTERIOL, V185, P3361, DOI 10.1128/JB.185.11.3361-3372.2003; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Di Matteo A, 2010, PROTEINS, V78, P2213, DOI 10.1002/prot.22733; Di Silvio E, 2013, BBA-PROTEINS PROTEOM, V1834, P1554, DOI 10.1016/j.bbapap.2013.04.027; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Gao T, 2007, J BACTERIOL, V189, P6253, DOI 10.1128/JB.00656-07; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Katzen F, 2002, EMBO J, V21, P3960, DOI 10.1093/emboj/cdf405; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mavridou DAI, 2013, IUBMB LIFE, V65, P209, DOI 10.1002/iub.1123; Mavridou DAI, 2012, J BIOL CHEM, V287, P2342, DOI 10.1074/jbc.M111.313692; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Moutevelis E, 2004, PROTEIN SCI, V13, P2744, DOI 10.1110/ps.04804504; Netto LES, 2016, FREE RADICAL RES, V50, P206, DOI 10.3109/10715762.2015.1120864; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Rozhkova A, 2007, J MOL BIOL, V367, P1162, DOI 10.1016/j.jmb.2006.12.033; San Francisco B., 2014, MOL MICROBIOL, V91, P996; Sanders C, 2000, BBA-BIOENERGETICS, V1459, P131, DOI 10.1016/S0005-2728(00)00122-5; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Setterdahl AT, 2000, BIOCHEMISTRY-US, V39, P10172, DOI 10.1021/bi000663t; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Vasas A, 2015, NITRIC OXIDE-BIOL CH, V46, P93, DOI 10.1016/j.niox.2014.12.003; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Verissimo AF, 2015, J BIOL CHEM, V290, P16989, DOI 10.1074/jbc.M115.652818; Verissimo AF, 2014, BBA-BIOENERGETICS, V1837, P989, DOI 10.1016/j.bbabio.2014.03.003; Verissimo AF, 2013, J BIOL CHEM, V288, P6272, DOI 10.1074/jbc.M112.440024; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; Williamson JA, 2015, NAT STRUCT MOL BIOL, V22, P809, DOI 10.1038/nsmb.3099; Zheng XM, 2012, BBA-PROTEINS PROTEOM, V1824, P1394, DOI 10.1016/j.bbapap.2012.06.017	52	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13154	13167		10.1074/jbc.M117.794586	http://dx.doi.org/10.1074/jbc.M117.794586			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28634234	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000407465300007
J	Mast, N; Anderson, KW; Johnson, KM; Phan, TTN; Guengerich, FP; Pikuleva, IA				Mast, Natalia; Anderson, Kyle W.; Johnson, Kevin M.; Phan, Thanh T. N.; Guengerich, F. Peter; Pikuleva, Irina A.			In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						central nervous system (CNS); cholesterol; cholesterol metabolism; cytochrome P450; enzyme catalysis; glutamate	HEPATIC-MICROSOMAL CYTOCHROME; D-ASPARTATE RECEPTORS; BRAIN CHOLESTEROL; TRANSCRIPTIONAL REGULATION; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; DRUG-INTERACTION; 24-HYDROXYLASE; EXPRESSION; TURNOVER	Cytochrome P450 46A1 (CYP46A1, cholesterol 24-hydroxylase) is the enzyme responsible for the majority of cholesterol elimination from the brain. Previously, we found that the anti-HIV drug efavirenz (EFV) can pharmacologically activate CYP46A1 in mice. Herein, we investigated whether CYP46A1 could also be activated by endogenous compounds, including major neurotransmitters. In vitro experiments with purified recombinant CYP46A1 indicated that CYP46A1 is activated by l-glutamate (l-Glu), l-aspartate, -aminobutyric acid, and acetylcholine, with l-Glu eliciting the highest increase (3-fold) in CYP46A1-mediated cholesterol 24-hydroxylation. We also found that l-Glu and other activating neurotransmitters bind to the same site on the CYP46A1 surface, which differs from the EFV-binding site. The other principal differences between EFV and l-Glu in CYP46A1 activation include an apparent lack of l-Glu binding to the P450 active site and different pathways of signal transduction from the allosteric site to the active site. EFV and l-Glu similarly increased the CYP46A1 k(cat), the rate of the fast phase of the enzyme reduction by the redox partner NADPH-cytochrome P450 oxidoreductase, and the amount of P450 reduced. Spectral titrations with cholesterol, in the presence of EFV or l-Glu, suggest that water displacement from the heme iron can be affected in activator-bound CYP46A1. Moreover, EFV and l-Glu synergistically activated CYP46A1. Collectively, our in vitro data, along with those from previous cell culture and in vivo studies by others, suggest that l-Glu-induced CYP46A1 activation is of physiological relevance.	[Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA; [Anderson, Kyle W.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Johnson, Kevin M.; Phan, Thanh T. N.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA; Vanderbilt University	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	iap8@case.edu		Anderson, Kyle/0000-0002-2808-3026; Pikuleva, Irina/0000-0001-9742-6232	USPHS from the National Institutes of Health [R01 GM062882]; P30 Core Grant from the National Institutes of Health [EY011373]; National Institutes of Health [R01 GM118122]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882, R01GM118122] Funding Source: NIH RePORTER	USPHS from the National Institutes of Health; P30 Core Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by USPHS Grants R01 GM062882 (to I. A. P.), P30 Core Grant EY011373, and R01 GM118122 (to F. P. G.) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Certain commercial materials, instruments, and equipment are identified in this manuscript to specify the experimental procedure as completely as possible. In no case does such identification imply a recommendation or endorsement by the National Institute of Standards and Technology nor does it imply that the materials, instruments, or equipment identified are necessarily the best available for the purpose.	Anderson KW, 2016, J BIOL CHEM, V291, P11876, DOI 10.1074/jbc.M116.723577; Bogdanovica N, 2001, NEUROSCI LETT, V314, P45, DOI 10.1016/S0304-3940(01)02277-7; Bretillon L, 2000, J LIPID RES, V41, P840; Bretillon L, 2007, CURR EYE RES, V32, P361, DOI 10.1080/02713680701231857; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; Chali F, 2015, EUR J NEUROSCI, V41, P1345, DOI 10.1111/ejn.12911; Daniels F., 1966, PHYSICAL CHEM, P336; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Emnett CM, 2015, BRIT J PHARMACOL, V172, P1333, DOI 10.1111/bph.13007; Featherstone DE, 2010, ACS CHEM NEUROSCI, V1, P4, DOI 10.1021/cn900006n; FOUST GP, 1969, ANAL BIOCHEM, V27, P530, DOI 10.1016/0003-2697(69)90066-9; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Kotti T, 2008, P NATL ACAD SCI USA, V105, P11394, DOI 10.1073/pnas.0805556105; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Linsenbardt AJ, 2014, NEUROPHARMACOLOGY, V85, P232, DOI 10.1016/j.neuropharm.2014.05.027; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Maioli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068534; Mast N, 2004, ARCH BIOCHEM BIOPHYS, V428, P99, DOI 10.1016/j.abb.2004.05.012; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2017, J BIOL CHEM, V292, P4913, DOI 10.1074/jbc.M116.774760; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Mast N, 2013, J BIOL CHEM, V288, P4613, DOI 10.1074/jbc.M112.438754; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Milagre I, 2010, J ALZHEIMERS DIS, V22, P1209, DOI 10.3233/JAD-2010-100651; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Palfey Bruce A., 2003, P203; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; REMMER H, 1966, MOL PHARMACOL, V2, P187; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Shafaati M, 2009, BIOCHEM BIOPH RES CO, V378, P689, DOI 10.1016/j.bbrc.2008.11.103; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Sun MY, 2016, NEUROSCIENTIST, V22, P132, DOI 10.1177/1073858414568122; Sun MY, 2016, J NEUROPHYSIOL, V115, P1263, DOI 10.1152/jn.00890.2015; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	58	31	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12934	12946		10.1074/jbc.M117.794909	http://dx.doi.org/10.1074/jbc.M117.794909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28642370	Green Published, hybrid			2022-12-28	WOS:000407220100022
J	Wang, LW; Wagner, LE; Alzayady, KJ; Yule, DI				Wang, Liwei; Wagner, Larry E., II; Alzayady, Kamil J.; Yule, David I.			Region-specific proteolysis differentially regulates type 1 inositol 1,4,5-trisphosphate receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CA2+ RELEASE CHANNELS; TRISPHOSPHATE RECEPTOR; CALCIUM OSCILLATIONS; ACINAR-CELLS; FUNCTIONAL CONSEQUENCES; ENDOPLASMIC-RETICULUM; ADENINE-NUCLEOTIDES; GENE-EXPRESSION; DOWN-REGULATION	The inositol 1,4,5 trisphosphate receptor (IP3R) is an intracellular Ca2+ release channel expressed predominately on the membranes of the endoplasmic reticulum. IP(3)R1 can be cleaved by caspase or calpain into at least two receptor fragments. However, the functional consequences of receptor fragmentation are poorly understood. Our previous work has demonstrated that IP(3)R1 channels, formed following either enzymatic fragmentation or expression of the corresponding complementary polypeptide chains, retain tetrameric architecture and are still activated by IP3 binding despite the loss of peptide continuity. In this study, we demonstrate that region-specific receptor fragmentation modifies channel regulation. Specifically, the agonist-evoked temporal Ca2+ release profile and protein kinase A modulation of Ca2+ release are markedly altered. Moreover, we also demonstrate that activation of fragmented IP(3)R1 can result in a distinct functional outcome. Our work suggests that proteolysis of IP(3)R1 may represent a novel form of modulation of IP(3)R1 channel function and increases the repertoire of Ca2+ signals achievable through this channel.	[Wang, Liwei; Wagner, Larry E., II; Alzayady, Kamil J.; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, Rm 4-5320, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rm 4-5320, Rochester, NY 14642 USA.	david_yule@urmc.rochester.edu			National Institutes of Health [RO1 DE014756, DE019245]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019245, R01DE014756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants RO1 DE014756 and DE019245. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; Alzayady KJ, 2013, J BIOL CHEM, V288, P29772, DOI 10.1074/jbc.M113.502203; Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; BALCERZAK D, 1995, J CELL SCI, V108, P2077; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2010, CURR TOP MEMBR, V66, P273, DOI 10.1016/S1063-5823(10)66012-7; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bittremieux M, 2017, CELL CALCIUM, V62, P60, DOI 10.1016/j.ceca.2017.01.015; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Cathelin S, 2006, J BIOL CHEM, V281, P17779, DOI 10.1074/jbc.M600537200; Chandrasekhar R, 2016, J BIOL CHEM, V291, P4846, DOI 10.1074/jbc.M115.705301; Chandrasekhar R, 2015, BIOCHEM SOC T, V43, P364, DOI 10.1042/BST20140287; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Elkoreh G, 2012, J CELL BIOCHEM, V113, P2775, DOI 10.1002/jcb.24155; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Ivanova H, 2016, ONCOTARGET, V7, P55704, DOI 10.18632/oncotarget.11005; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kopil CM, 2011, J BIOL CHEM, V286, P35998, DOI 10.1074/jbc.M111.254177; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Luyten T, 2017, BBA-MOL CELL RES, V1864, P947, DOI 10.1016/j.bbamcr.2017.02.013; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Park HS, 2012, AM J PHYSIOL-GASTR L, V302, pG97, DOI 10.1152/ajpgi.00328.2011; Schulman JJ, 2016, J BIOL CHEM, V291, P11820, DOI 10.1074/jbc.M115.711242; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Sneyd J, 2017, P NATL ACAD SCI USA, V114, P1456, DOI 10.1073/pnas.1614613114; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szlufcik K, 2006, BIOL CELL, V98, P1, DOI 10.1042/BC20050031; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; Won JH, 2007, AM J PHYSIOL-GASTR L, V293, pG1166, DOI 10.1152/ajpgi.00352.2007; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	64	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11714	11726		10.1074/jbc.M117.789917	http://dx.doi.org/10.1074/jbc.M117.789917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28526746	Green Published, hybrid			2022-12-28	WOS:000405485600011
J	Gericke, B; Schecker, N; Amiri, M; Naim, HY				Gericke, Birthe; Schecker, Natalie; Amiri, Mahdi; Naim, Hassan Y.			Structure-function analysis of human sucrase-isomaltase identifies key residues required for catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTASE-GLUCOAMYLASE ACTIVITY; LACTASE-PHLORHIZIN HYDROLASE; AMINO-ACID-SEQUENCE; ALPHA-GLUCOSIDASE; FAMILY 31; SUBSTRATE-SPECIFICITY; STARCH DIGESTION; EXPRESSION; TRANSPORT; DOMAIN	Sucrase-isomaltase (SI) is an intestinal membrane-associated alpha-glucosidase that breaks down di-and oligosaccharides to absorbable monosaccharides. SI has two homologous functional subunits (sucrase and isomaltase) that both belong to the glycoside hydrolase family 31 (GH31) and differ in substrate specificity. All GH31 enzymes share a consensus sequence harboring an aspartic acid residue as a catalytic nucleophile. Moreover, crystallographic structural analysis of isomaltase predicts that another aspartic acid residue functions as a proton donor in hydrolysis. Here, we mutagenized the predicted proton donor residues and the nucleophilic catalyst residues in each SI subunit. We expressed these SI variants in COS-1 cells and analyzed their structural, transport, and functional characteristics. All of the mutants revealed expression levels and maturation rates comparable with those of the wild-type species and the corresponding nonmutated subunits were functionally active. Thereby we determined rate and substrate specificity for each single subunit without influence from the other subunit. This approach provides a model for functional analysis of the single subunits within a multidomain protein, achieved without the necessity to express the individual subunits separately. Of note, we also found that glucose product inhibition regulates the activities of both SI subunits. We experimentally confirmed the catalytic function of the predicted proton donor residues, and sequence analysis suggested that these residues are located in a consensus region in many GH31 family members. In summary, these findings reveal the kinetic features specific for each human SI subunit and demonstrate that the activities of these subunits are regulated via product inhibition.	[Gericke, Birthe; Schecker, Natalie; Amiri, Mahdi; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Amiri, M; Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany.	mahdi.amiri@tiho-hannover.de; hassan.naim@tiho-hannover.de	Amiri, Mahdi/L-6934-2019	Amiri, Mahdi/0000-0003-4775-9535; Gericke, Birthe/0000-0002-9181-4493				Amiri M, 2014, J INHERIT METAB DIS, V37, P929, DOI 10.1007/s10545-014-9725-4; Amiri M, 2012, J INHERIT METAB DIS, V35, P949, DOI 10.1007/s10545-012-9523-9; Amit-Romach E, 2006, INT J MOL MED, V18, P721; Cohen Stanley A, 2016, Mol Cell Pediatr, V3, P5, DOI 10.1186/s40348-015-0028-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eggert MW, 2011, APPL BIOCHEM BIOTECH, V165, P676, DOI 10.1007/s12010-011-9287-y; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822, DOI 10.1152/ajpgi.1990.259.5.G822; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRAY GM, 1979, J BIOL CHEM, V254, P6038; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HERMANS MMP, 1991, J BIOL CHEM, V266, P13507; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; IWANAMI S, 1995, BIOSCI BIOTECH BIOCH, V59, P459, DOI 10.1271/bbb.59.459; Jacob R, 2000, J CLIN INVEST, V106, P281, DOI 10.1172/JCI9677; Jacob R, 2002, J BIOL CHEM, V277, P32141, DOI 10.1074/jbc.M204116200; Jourdan N, 1998, J VIROL, V72, P7228, DOI 10.1128/JVI.72.9.7228-7236.1998; Keiser M, 2006, J BIOL CHEM, V281, P14393, DOI 10.1074/jbc.M513631200; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Liu XF, 1999, J BIOL CHEM, V274, P31155, DOI 10.1074/jbc.274.44.31155; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; NAIM HY, 1988, J BIOL CHEM, V263, P7242; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NAIM HY, 1991, J BIOL CHEM, V266, P12313; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Okuyama M, 2011, BIOSCI BIOTECH BIOCH, V75, P2269, DOI 10.1271/bbb.110610; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QUARONI A, 1976, J BIOL CHEM, V251, P3250; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Robayo-Torres CC, 2009, J PEDIATR GASTR NUTR, V48, P412, DOI 10.1097/MPG.0b013e318180cd09; Sander Petra, 2006, Hum Mutat, V27, P119, DOI 10.1002/humu.9392; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; SEMENZA G, 1965, BIOCHIM BIOPHYS ACTA, V96, P487, DOI 10.1016/0005-2787(65)90565-4; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Song KM, 2013, BIOSCI BIOTECH BIOCH, V77, P1759, DOI 10.1271/bbb.130325; Treem WR, 2012, J PEDIATR GASTR NUTR, V55, pS7, DOI 10.1097/01.mpg.0000421401.57633.90; TREEM WR, 1995, J PEDIATR GASTR NUTR, V21, P1, DOI 10.1097/00005176-199507000-00001; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Uhrich S, 2012, J PEDIATR GASTR NUTR, V55, pS34, DOI 10.1097/01.mpg.0000421408.65257.b5; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	51	18	18	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11070	11078		10.1074/jbc.M117.791939	http://dx.doi.org/10.1074/jbc.M117.791939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28522605	Green Published, hybrid			2022-12-28	WOS:000404391000027
J	Tomimatsu, N; Mukherjee, B; Harris, JL; Boffo, FL; Hardebeck, MC; Potts, PR; Khanna, KK; Burma, S				Tomimatsu, Nozomi; Mukherjee, Bipasha; Harris, Janelle Louise; Boffo, Francesca Ludovica; Hardebeck, Molly Catherine; Potts, Patrick Ryan; Khanna, Kum Kum; Burma, Sandeep			DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISMS; SCF UBIQUITIN LIGASES; PATHWAY CHOICE; COLORECTAL-CANCER; REPLICATION FORKS; GENOTOXIC STRESS; CELL-CYCLE; E3 LIGASE	End resection of DNA double-strand breaks (DSBs) to generate 3'-single-stranded DNA facilitates DSB repair via error-free homologous recombination (HR) while stymieing repair by the error-prone non-homologous end joining (NHEJ) pathway. Activation of DNA end resection involves phosphorylation of the 5' to 3' exonuclease EXO1 by the phosphoinositide 3-kinase-like kinases ATM (ataxia telangiectasia-mutated) and ATR (ATM and Rad3-related) and by the cyclin-dependent kinases 1 and 2. After activation, EXO1 must also be restrained to prevent over-resection that is known to hamper optimal HR and trigger global genomic instability. However, mechanisms by which EXO1 is restrained are still unclear. Here, we report that EXO1 is rapidly degraded by the ubiquitin-proteasome system soon after DSB induction in human cells. ATR inhibition attenuated DNA-damage-induced EXO1 degradation, indicating that ATRmediated phosphorylation of EXO1 targets it for degradation. In accord with these results, EXO1 became resistant to degradation when its SQ motifs required for ATR-mediated phosphorylation were mutated. We show that upon the induction of DNA damage, EXO1 is ubiquitinated by a member of the Skp1-Cullin1-F-box (SCF) family of ubiquitin ligases in a phosphorylation-dependent manner. Importantly, expression of degradation-resistant EXO1 resulted in hyper-resection, which attenuated both NHEJ and HR and severely compromised DSB repair resulting in chromosomal instability. These findings indicate that the coupling of EXO1 activation with its eventual degradation is a timing mechanism that limits the extent of DNA end resection for accurate DNA repair.	[Tomimatsu, Nozomi; Mukherjee, Bipasha; Hardebeck, Molly Catherine; Burma, Sandeep] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Harris, Janelle Louise; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia; [Boffo, Francesca Ludovica] Univ Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy; [Potts, Patrick Ryan] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; QIMR Berghofer Medical Research Institute; University of Naples Federico II; St Jude Children's Research Hospital	Burma, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, 2201 Inwood Rd,NC7-208, Dallas, TX 75390 USA.	sandeep.burma@utsouthwestern.edu	Potts, Patrick R/P-4707-2018	Potts, Patrick R/0000-0002-2024-8885; Boffo, Francesca Ludovica/0000-0002-9790-7148; Khanna, Kum Kum/0000-0001-8650-5381; Hancock, Janelle/0000-0001-6703-7228	National Institutes of Health [RO1CA197796, RO1CA149461, R21CA202403]; National Aeronautics and Space Administration [NNX16AD78G]; NATIONAL CANCER INSTITUTE [R01CA197796, R21CA202403, R01CA149461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA197796, RO1CA149461, and R21CA202403 (to S. B). This work was also supported by National Aeronautics and Space Administration Grant NNX16AD78G. The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Bolderson E, 2009, NUCLEIC ACIDS RES, V37, P3452, DOI 10.1093/nar/gkp194; Bologna S, 2015, CELL CYCLE, V14, P2439, DOI 10.1080/15384101.2015.1060381; Brown JS, 2015, CELL REP, V11, P704, DOI 10.1016/j.celrep.2015.03.058; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen XQ, 2015, J BIOL CHEM, V290, P12300, DOI 10.1074/jbc.M115.644005; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; El-Shemerly M, 2008, NUCLEIC ACIDS RES, V36, P511, DOI 10.1093/nar/gkm1052; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Falck J, 2012, EMBO REP, V13, P561, DOI 10.1038/embor.2012.58; Fernandez-Capetillo O, 2013, CELL, V155, P979, DOI 10.1016/j.cell.2013.10.049; Ferretti LP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12628; Ferretti Lorenza P., 2013, Frontiers in Genetics, V4, P99, DOI 10.3389/fgene.2013.00099; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goellner EM, 2015, DNA REPAIR, V32, P24, DOI 10.1016/j.dnarep.2015.04.010; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Han XZ, 2014, P NATL ACAD SCI USA, V111, P17456, DOI 10.1073/pnas.1408538111; Hannah J, 2009, DNA REPAIR, V8, P536, DOI 10.1016/j.dnarep.2009.01.011; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HSIANG YH, 1989, CANCER RES, V49, P5077; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ismail IH, 2015, NAT CELL BIOL, V17, P1446, DOI 10.1038/ncb3259; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jin GF, 2008, LUNG CANCER, V60, P340, DOI 10.1016/j.lungcan.2007.11.003; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Keijzers G, 2016, CRIT REV BIOCHEM MOL, V51, P440, DOI 10.1080/10409238.2016.1215407; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Leszczynska KB, 2016, RADIOTHER ONCOL, V121, P232, DOI 10.1016/j.radonc.2016.10.023; Liao SR, 2011, NUCLEIC ACIDS RES, V39, P5967, DOI 10.1093/nar/gkr216; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mukherjee B, 2008, DNA REPAIR, V7, P1717, DOI 10.1016/j.dnarep.2008.06.016; Mukherjee B, 2015, METHODS MOL BIOL, V1292, P67, DOI 10.1007/978-1-4939-2522-3_5; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Parameswaran B, 2015, CELL CYCLE, V14, P437, DOI 10.4161/15384101.2014.972901; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Postow L, 2013, CELL CYCLE, V12, P587, DOI 10.4161/cc.23408; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sun XM, 2002, CANCER RES, V62, P6026; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; TOLEDO LI, 2013, Patent No. 1551088; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsai MH, 2009, ORAL ONCOL, V45, pE90, DOI 10.1016/j.oraloncology.2009.03.011; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Veuger SJ, 2003, CANCER RES, V63, P6008; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wu Y, 2001, GASTROENTEROLOGY, V120, P1580, DOI 10.1053/gast.2001.25117; Xie J, 2015, J CLIN INVEST, V125, P1523, DOI 10.1172/JCI79325; Xu GQ, 2013, BIOTECHNOL GENET ENG, V29, P73, DOI 10.1080/02648725.2013.801232; Yamamoto H, 2005, CARCINOGENESIS, V26, P411, DOI 10.1093/carcin/bgh335; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang F, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv939; Zhang Ya-ni, 2009, Proceedings of the 2009 Asia Communications and Photonics Conference and Exhibition (ACP 2009); Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zheng XF, 2015, DNA REPAIR, V32, P58, DOI 10.1016/j.dnarep.2015.04.014; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zong DL, 2016, NAT STRUCT MOL BIOL, V23, P699, DOI 10.1038/nsmb.3274	99	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10779	10790		10.1074/jbc.M116.772475	http://dx.doi.org/10.1074/jbc.M116.772475			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28515316	hybrid, Green Published			2022-12-28	WOS:000404391000003
J	Essalmani, R; Susan-Resiga, D; Guillemot, J; Kim, W; Sachan, V; Awan, Z; Chamberland, A; Asselin, MC; Ly, K; Desjardins, R; Day, R; Prat, A; Seidah, NG				Essalmani, Rachid; Susan-Resiga, Delia; Guillemot, Johann; Kim, Woojin; Sachan, Vatsal; Awan, Zuhier; Chamberland, Ann; Asselin, Marie-Claude; Ly, Kevin; Desjardins, Roxane; Day, Robert; Prat, Annik; Seidah, Nabil G.			Thrombin activation of protein C requires prior processing by a liver proprotein convertase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						furin; hepatocyte; liver; serine protease; thrombin; vitamin K; anticoagulant serine pro; proprotein convertase; protein C; thrombin activation	ANTICOAGULANT ACTIVITY; MAMMALIAN-CELLS; HUMAN-PLASMA; RECEPTOR 1; FURIN; PRECURSOR; MOUSE; ACID; MICE; INHIBITION	Protein C, a secretory vitamin K-dependent anticoagulant serine protease, inactivates factors Va/VIIIa. It is exclusively synthesized in liver hepatocytes as an inactive zymogen (proprotein C). In humans, thrombin cleavage of the propeptide at PR221 results in activated protein C (APC; residues 222-461). However, the propeptide is also cleaved by a furin-like proprotein convertase(s) (PCs) at KKRSHLKR199 (underlined basic residues critical for the recognition by PCs), but the order of cleavage is unknown. Herein, we present evidence that at the surface of COS-1 cells, mouse proprotein C is first cleaved by the convertases furin, PC5/6A, and PACE4. In mice, this cleavage occurs at the equivalent site, KKRKILKR198, and requires the presence of Arg(198) at P1 and a combination of two other basic residues at either P2 (Lys(197)), P6 (Arg(193)), or P8 (Lys(191)) positions. Notably, the thrombin-resistant R221A mutant is still cleaved by these PCs, revealing that convertase cleavage can precede thrombin activation. This conclusion was supported by the fact that the APC-specific activity in the medium of COS-1 cells is exclusively dependent on prior cleavage by the convertases, because both R198A and R221A lack protein C activity. Primary cultures of hepatocytes derived from wild-type or hepatocyte-specific furin, PC5/6, or complete PACE4 knock-out mice suggested that the cleavage of overexpressed proprotein C is predominantly performed by furin intracellularly and by all three proprotein convertases at the cell surface. Indeed, plasma analyses of single-proprotein convertase-knock-out mice showed that loss of the convertase furin or PC5/6 in hepatocytes results in a approximate to 30% decrease in APC levels, with no significant contribution from PACE4. We conclude that prior convertase cleavage of protein C in hepatocytes is critical for its thrombin activation.	[Essalmani, Rachid; Susan-Resiga, Delia; Guillemot, Johann; Kim, Woojin; Sachan, Vatsal; Awan, Zuhier; Chamberland, Ann; Asselin, Marie-Claude; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Monreal, Labs Biochem Neuroendocrinol, Montreal, PQ H2W IR7, Canada; [Ly, Kevin; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Fac Med & Sci Sante, Urol Div, Inst Pharmacol Sherbrooke,Dept Surg, Sherbrooke, PQ J1K 2R1, Canada; [Awan, Zuhier] King Abdulaziz Univ, Clin Biochem Dept, Jeddah 21589, Saudi Arabia	Universite de Montreal; University of Sherbrooke; King Abdulaziz University	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Lab Biochem Neuroendocrinol, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	zawan@kau.edu.sa; seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Guillemot, Johann/O-1066-2013	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Guillemot, Johann/0000-0002-5902-9188; Awan, Zuhier/0000-0002-4176-335X	CIHR Foundation Scheme Grant [148363]; Canada Research Chair [216684]; King Abdulaziz University	CIHR Foundation Scheme Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); King Abdulaziz University	This work was supported by CIHR Foundation Scheme Grant 148363 and Canada Research Chair 216684. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by King Abdulaziz University. Present address: Clinical Biochemistry Dept., King Abdulaziz University, Jeddah 21589, Saudi Arabia. E-mail: zawan@kau.edu.sa.	ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Constam DB, 2000, GENE DEV, V14, P1146; Couture F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/824014; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; DREWS R, 1995, P NATL ACAD SCI USA, V92, P10462, DOI 10.1073/pnas.92.23.10462; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; FERNLUND P, 1982, J BIOL CHEM, V257, P2170; FOSTER DC, 1991, BIOCHEMISTRY-US, V30, P367, DOI 10.1021/bi00216a009; FOSTER DC, 1990, BIOCHEMISTRY-US, V29, P347, DOI 10.1021/bi00454a007; FOSTER DC, 1987, BIOCHEMISTRY-US, V26, P7003, DOI 10.1021/bi00396a022; GANDRILLE S, 1993, BLOOD, V82, P159, DOI 10.1182/blood.V82.1.159.bloodjournal821159; Gempeler-Messina PM, 2001, HAEMOSTASIS, V31, P266; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; GRINNELL BW, 1994, BIOCHEM J, V303, P929, DOI 10.1042/bj3030929; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Junker R, 2005, CLIN CHEM LAB MED, V43, P244, DOI 10.1515/CCLM.2005.041; Kim W, 2015, MOL CELL BIOL, V35, P3684, DOI 10.1128/MCB.00764-15; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; Ladunga I, 2000, CURR OPIN BIOTECH, V11, P13, DOI 10.1016/S0958-1669(99)00048-8; Lay AJ, 2005, J CLIN INVEST, V115, P1552, DOI 10.1172/JCI24030; Ly K, 2014, J BIOL CHEM, V289, P17732, DOI 10.1074/jbc.M113.541094; Marchesi C, 2011, J MOL MED, V89, P1103, DOI 10.1007/s00109-011-0776-9; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MCMULLEN BA, 1983, BIOCHEM BIOPH RES CO, V115, P8, DOI 10.1016/0006-291X(83)90961-0; MIYATA T, 1995, THROMB HAEMOSTASIS, V74, P1003; Navarro S, 2011, THROMB RES, V128, P410, DOI 10.1016/j.thromres.2011.08.001; Peinado JR, 2004, BIOCHEM BIOPH RES CO, V321, P601, DOI 10.1016/j.bbrc.2004.07.012; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2016, MOL NEUROENDOCRINOLO, P171; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WATANABE T, 1993, FEBS LETT, V320, P215, DOI 10.1016/0014-5793(93)80589-M; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110	48	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10564	10573		10.1074/jbc.M116.770040	http://dx.doi.org/10.1074/jbc.M116.770040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28468828	Green Published, hybrid			2022-12-28	WOS:000404115400017
J	Dickey, DM; Otto, NM; Potter, LR				Dickey, Deborah M.; Otto, Neil M.; Potter, Lincoln R.			Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; KINASE HOMOLOGY DOMAIN; NPR2 GENE; ACROMESOMELIC DYSPLASIA; HETEROZYGOUS MUTATIONS; PHOSPHORYLATION SITES; OOCYTE MEIOSIS; SHORT STATURE; CNP; DEPHOSPHORYLATION	Activating mutations in the receptor for C-type natriuretic peptide (CNP), guanylyl cyclase B (GC-B, also known as Npr2 or NPR-B), increase cellular cGMP and cause skeletal overgrowth, but how these mutations affect GTP catalysis is poorly understood. The A488P and R655C mutations were compared with the known mutation V883M. Neither mutation affected GC-B concentrations. The A488P mutation decreased the EC50 5-fold, increased V-max 2.6-fold, and decreased the K-m 13-fold, whereas the R655C mutation decreased the EC50 5-fold, increased the V-max 2.1-fold, and decreased the K-m 4.7-fold. Neither mutation affected maximum activity at saturating CNP concentrations. Activation by R655C did not require disulfide bond formation. Surprisingly, the A488P mutant only activated the receptor when it was phosphorylated. In contrast, the R655C mutation converted GC-B-7A from CNP-unresponsive to CNP-responsive. Interestingly, neither mutant was activated by ATP, and the K-m and Hill coefficient of each mutant assayed in the absence of ATP were similar to those of wild-type GC-B assayed in the presence of ATP. Finally, 1 mM 2,4,6,-trinitrophenyl ATP inhibited all three mutants by as much as 80% but failed to inhibit WT-GC-B. We conclude that 1) the A488P and R655C missense mutations result in a GC-B conformation that mimics the allosterically activated conformation, 2) GC-B phosphorylation is required for CNP-dependent activation by the A488P mutation, 3) the R655C mutation abrogates the need for phosphorylation in receptor activation, and 4) an ATP analog selectively inhibits the GC-B mutants, indicating that a pharmacologic approach could reduce GC-B dependent human skeletal overgrowth.	[Dickey, Deborah M.; Otto, Neil M.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota Twin Cities, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	potter@umn.edu			National Institutes of Health [R01GM098309]; Fund for Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01GM098309 (to L. R. P.). This work was also supported by the Fund for Science. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbey SE, 2003, ENDOCRINOLOGY, V144, P240, DOI 10.1210/en.2002-220702; Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; Antos LK, 2005, J BIOL CHEM, V280, P26928, DOI 10.1074/jbc.M505648200; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Beste KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070223; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Dickey DM, 2016, J BIOL CHEM, V291, P11385, DOI 10.1074/jbc.M115.704015; Dove S, 2014, MOL PHARMACOL, V85, P598, DOI 10.1124/mol.113.091017; Egbert JR, 2014, DEVELOPMENT, V141, P3594, DOI 10.1242/dev.112219; Hachiya R, 2007, J CLIN ENDOCR METAB, V92, P4009, DOI 10.1210/jc.2007-1101; Hannema SE, 2013, J CLIN ENDOCR METAB, V98, pE1988, DOI 10.1210/jc.2013-2358; Jaffe LA, 2017, ANNU REV PHYSIOL, V79, P237, DOI 10.1146/annurev-physiol-022516-034102; Kuhn M, 2016, PHYSIOL REV, V96, P751, DOI 10.1152/physrev.00022.2015; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Miura K, 2014, AM J MED GENET A, V164, P156, DOI 10.1002/ajmg.a.36218; Miura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042180; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Olney RC, 2006, J CLIN ENDOCR METAB, V91, P1229, DOI 10.1210/jc.2005-1949; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Robinson JW, 2013, BONE, V56, P375, DOI 10.1016/j.bone.2013.06.024; Robinson JW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003253; Shuhaibar LC, 2016, DEV BIOL, V409, P194, DOI 10.1016/j.ydbio.2015.10.025; Wang SR, 2015, HUM MUTAT, V36, P474, DOI 10.1002/humu.22773; Wang W, 2016, AM J MED GENET A, V170, P426, DOI 10.1002/ajmg.a.37463; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yoder AR, 2008, PEPTIDES, V29, P1575, DOI 10.1016/j.peptides.2008.04.020; Yoder AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036747; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	33	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10220	10229		10.1074/jbc.M117.780536	http://dx.doi.org/10.1074/jbc.M117.780536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450398	Green Published, hybrid			2022-12-28	WOS:000403580600030
J	Korge, P; Calmettes, G; John, SA; Weiss, JN				Korge, Paavo; Calmettes, Guillaume; John, Scott A.; Weiss, James N.			Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; RABBIT HEART-MITOCHONDRIA; CYTOSOLIC-FREE MAGNESIUM; FREE-RADICAL GENERATION; SUPEROXIDE-PRODUCTION; ISCHEMIA-REPERFUSION; MOLECULAR-MECHANISMS; MALATE-DEHYDROGENASE; ELECTRON-TRANSPORT; NADH FLUORESCENCE	Recent evidence has implicated succinate-driven reverse electron transport (RET) through complex I as a major source of damaging reactive oxygen species (ROS) underlying reperfusion injury after prolonged cardiac ischemia. However, this explanation may be incomplete, because RET on reperfusion is self-limiting and therefore transient. RET can only generate ROS when mitochondria are well polarized, and it ceases when permeability transition pores (PTP) open during reperfusion. Because prolonged ischemia/reperfusion also damages electron transport complexes, we investigated whether such damage could lead to ROS production after PTP opening has occurred. Using isolated cardiac mitochondria, we demonstrate a novel mechanism by which antimycin-inhibited complex III generates significant amounts of ROS in the presence of Mg2+ and NAD(+) and the absence of exogenous substrates upon inner membrane pore formation by alamethicin or Ca2+-induced PTP opening. We show that H2O2 production under these conditions is related to Mg2+-dependent NADH generation by malic enzyme. H2O2 production is blocked by stigmatellin, indicating its origin from complex III, and by piericidin, demonstrating the importance of NADH-related ubiquinone reduction for ROS production under these conditions. For maximal ROS production, the rate of NADH generation has to be equal or below that of NADH oxidation, as further increases in [NADH] elevate ubiquinol-related complex III reduction beyond the optimal range for ROS generation. These results suggest that if complex III is damaged during ischemia, PTP opening may result in succinate/malatefueled ROS production from complex III due to activation of malic enzyme by increases in matrix [Mg2+], [NAD(+)], and [ADP].	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weiss, JN (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu		John, Scott/0000-0002-1232-9140	National Institutes of Health from NHLBI [R01 HL101228, R01 HL117385]; American Heart Association Western States Affiliate [11POST6110007]; American Heart Association [16SDG31180036]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101228, R01HL117385] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Western States Affiliate(American Heart Association); American Heart Association(American Heart Association); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL101228 and R01 HL117385 from the NHLBI, American Heart Association Western States Affiliate Post-doctoral Research Fellowship 11POST6110007, American Heart Association Scientist Development Grant 16SDG31180036, and the Laubisch and Kawata Endowments. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; Aldakkak M, 2008, J CARDIOVASC PHARM, V52, P236, DOI 10.1097/FJC.0b013e3181831337; Aldakkak M, 2009, J CARDIOVASC PHARM, V54, P298, DOI 10.1097/FJC.0b013e3181b2b842; Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; BELLAMY D, 1962, BIOCHEM J, V82, P218, DOI 10.1042/bj0820218; Berkich DA, 2003, ARCH BIOCHEM BIOPHYS, V420, P279, DOI 10.1016/j.abb.2003.09.021; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; BOLLI R, 1989, P NATL ACAD SCI USA, V86, P4695, DOI 10.1073/pnas.86.12.4695; Calmettes G, 2012, J PHYSIOL-LONDON, V590, P3403, DOI 10.1113/jphysiol.2012.239376; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; DAVISSON VJ, 1985, BIOCHEM J, V225, P335, DOI 10.1042/bj2250335; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Drose S, 2011, MOL PHARMACOL, V79, P814, DOI 10.1124/mol.110.070342; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Halestrap AP, 2004, CIRCULATION, V110, pE303, DOI 10.1161/01.CIR.0000141458.28925.D2; HEADRICK JP, 1991, J MOL CELL CARDIOL, V23, P991, DOI 10.1016/0022-2828(91)91635-5; Headrick JP, 1998, J MOL CELL CARDIOL, V30, P1415, DOI 10.1006/jmcc.1998.0710; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573; Kareyeva AV, 2012, BBA-BIOENERGETICS, V1817, P1879, DOI 10.1016/j.bbabio.2012.03.033; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Korge P, 2001, AM J PHYSIOL-CELL PH, V280, pC517, DOI 10.1152/ajpcell.2001.280.3.C517; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Korge P, 2017, J BIOL CHEM, V292, P9896, DOI 10.1074/jbc.M116.768325; Korge P, 2016, FREE RADICAL BIO MED, V96, P22, DOI 10.1016/j.freeradbiomed.2016.04.002; Korge P, 2015, BBA-BIOENERGETICS, V1847, P514, DOI 10.1016/j.bbabio.2015.02.012; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; Kotlyar AB, 2004, BIOCHEM BIOPH RES CO, V318, P987, DOI 10.1016/j.bbrc.2004.04.131; Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamcr.2004.10.013; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lanciano P, 2013, BBA-BIOENERGETICS, V1827, P1332, DOI 10.1016/j.bbabio.2013.03.009; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LIN RC, 1974, J BIOL CHEM, V249, P3867; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; MURPHY E, 1989, J BIOL CHEM, V264, P5622; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; OLSON MS, 1967, J BIOL CHEM, V242, P325; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Ross T, 2013, BBA-GEN SUBJECTS, V1830, P4537, DOI 10.1016/j.bbagen.2013.05.035; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; SAUER LA, 1973, FEBS LETT, V33, P251, DOI 10.1016/0014-5793(73)80205-4; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Slodzinski MK, 2008, J MOL CELL CARDIOL, V45, P650, DOI 10.1016/j.yjmcc.2008.07.017; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	73	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9882	9895		10.1074/jbc.M116.768317	http://dx.doi.org/10.1074/jbc.M116.768317			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450391	Green Published, hybrid			2022-12-28	WOS:000403580600003
J	Chang, JK; Ni, Y; Han, L; Sinnett-Smith, J; Jacamo, R; Rey, O; Young, SH; Rozengurt, E				Chang, Jen-Kuan; Ni, Yang; Han, Liang; Sinnett-Smith, James; Jacamo, Rodrigo; Rey, Osvaldo; Young, Steven H.; Rozengurt, Enrique			Protein kinase D1 (PKD1) phosphorylation on Ser(203) by type I p21-activated kinase (PAK) regulates PKD1 localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; ACTIVATION LOOP SER(744); SMALL-MOLECULE INHIBITOR; COUPLED RECEPTOR ACTIVATION; POTENTIATES DNA-SYNTHESIS; SWISS 3T3-CELLS; PHORBOL ESTERS; TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; ANG-II	Although PKC-mediated phosphorylation of protein kinase D1 (PKD1) has been extensively characterized, little is known about PKD1 regulation by other upstream kinases. Here we report that stimulation of epithelial or fibroblastic cells with G protein-coupled receptor agonists, including angiotensin II or bombesin, induced rapid and persistent PKD1 phosphorylation at Ser(203), a highly conserved residue located within the PKD1 N-terminal domain. Exposure to PKD or PKC family inhibitors did not prevent PKD1 phosphorylation at Ser(203), indicating that it is not mediated by autophosphorylation. In contrast, several lines of evidence indicated that the phosphorylation of PKD1 at Ser(203) is mediated by kinases of the class I PAK subfamily, specifically 1) exposing cells to four structurally unrelated PAK inhibitors (PF-3758309, FRAX486, FRAX597, and IPA-3) that act via different mechanisms abrogated PKD1 phosphorylation at Ser(203), 2) siRNA-mediated knockdown of PAK1 and PAK2 in IEC-18 and Swiss 3T3 cells blunted PKD1 phosphorylation at Ser(203), 3) phosphorylation of Ser(203) markedly increased in vitro when recombinant PKD1 was incubated with either PAK1 or PAK2 in the presence of ATP. PAK inhibitors did not interfere with G protein-coupled receptor activation-induced rapid translocation of PKD1 to the plasma membrane but strikingly prevented the dissociation of PKD1 from the plasma membrane and blunted the phosphorylation of nuclear targets, including class IIa histone deacetylases. We conclude that PAK-mediated phosphorylation of PKD1 at Ser(203) triggers its membrane dissociation and subsequent entry into the nucleus, thereby regulating the phosphorylation of PKD1 nuclear targets, including class IIa histone deacetylases.	[Chang, Jen-Kuan; Ni, Yang; Han, Liang; Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Vet Affairs Greater Los Angeles Hlth Care Syst, Houston, TX 77030 USA; [Jacamo, Rodrigo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Rey, Osvaldo] Univ Buenos Aires, CONICET, Inst Immunol Genet & Metab, C1120AAR, Buenos Aires, DF, Argentina; [Ni, Yang] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250021, Peoples R China; [Han, Liang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Texas System; UTMD Anderson Cancer Center; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Shandong University; Xi'an Jiaotong University	Rozengurt, E (corresponding author), UCLA, Sch Med, Dept Med, 900 Vet Ave,Warren Hall Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu		Rey, Osvaldo/0000-0003-1575-9864	National Institutes of Health [R01DK100405, P30DK41301, P01CA163200]; Department of Veterans Affair [1I01BX001473]; Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100405, P30DK041301] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair(US Department of Veterans Affairs); Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01DK100405, P30DK41301, and P01CA163200. This work was also supported by the Department of Veterans Affair Merit Award 1I01BX001473 (to E.R.). Additional funding came from the Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research (to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Casamassima A, 1997, J BIOL CHEM, V272, P9363; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; COFFER A, 1990, FEBS LETT, V263, P80, DOI 10.1016/0014-5793(90)80710-Z; COFFER A, 1990, FEBS LETT, V275, P159, DOI 10.1016/0014-5793(90)81462-W; Dammann K, 2014, GUT, V63, P1173, DOI 10.1136/gutjnl-2014-306768; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Fan RS, 2005, J BIOL CHEM, V280, P24212, DOI 10.1074/jbc.M500716200; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guha S, 2002, CANCER RES, V62, P1632; Ha BH, 2015, J BIOL CHEM, V290, P12975, DOI 10.1074/jbc.R115.650416; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hollenbach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068033; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ishikawa E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12756; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Licciulli S, 2013, J BIOL CHEM, V288, P29105, DOI 10.1074/jbc.M113.510933; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; MILLAR JBA, 1990, J BIOL CHEM, V265, P12052; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Ni Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073149; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; Rey O, 2003, J CELL PHYSIOL, V196, P483, DOI 10.1002/jcp.10323; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rudolph J, 2015, J MED CHEM, V58, P111, DOI 10.1021/jm501613q; Salazar EP, 2001, J BIOL CHEM, V276, P17788, DOI 10.1074/jbc.M100984200; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2014, AM J PHYSIOL-CELL PH, V306, pC961, DOI 10.1152/ajpcell.00048.2014; Sinnett-Smith J, 2011, J BIOL CHEM, V286, P511, DOI 10.1074/jbc.M110.167528; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; SINNETTSMITH J, 1990, BIOCHEM J, V265, P485, DOI 10.1042/bj2650485; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; Slice LW, 2005, J BIOL CHEM, V280, P1582, DOI 10.1074/jbc.M408172200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Waldron RT, 2012, CELL SIGNAL, V24, P914, DOI 10.1016/j.cellsig.2011.12.014; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; WALSH JH, 1993, J CELL PHYSIOL, V156, P333, DOI 10.1002/jcp.1041560216; Wang J, 2016, J BIOL CHEM, V291, P17988, DOI 10.1074/jbc.M115.711275; Wang J, 2016, AM J PHYSIOL-CELL PH, V310, pC542, DOI 10.1152/ajpcell.00302.2015; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Weinreb I, 2014, NAT GENET, V46, P1166, DOI 10.1038/ng.3096; Wu SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1432, DOI 10.1152/ajpcell.00323.2001; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Young SH, 2006, AM J PHYSIOL-CELL PH, V290, pC728, DOI 10.1152/ajpcell.00310.2005; Young SH, 2014, AM J PHYSIOL-CELL PH, V306, pC298, DOI 10.1152/ajpcell.00194.2013; Young SH, 2012, AM J PHYSIOL-GASTR L, V303, pG356, DOI 10.1152/ajpgi.00025.2012; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577; ZACHARY I, 1987, EMBO J, V6, P2233, DOI 10.1002/j.1460-2075.1987.tb02495.x; ZACHARY I, 1987, J BIOL CHEM, V262, P3947; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294; Zhu GZ, 2005, J BIOL CHEM, V280, P10743, DOI 10.1074/jbc.M413159200; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	99	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9523	9539		10.1074/jbc.M116.771394	http://dx.doi.org/10.1074/jbc.M116.771394			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28408623	hybrid, Green Published			2022-12-28	WOS:000403113000007
J	Press, ER; Shao, Q; Kelly, JJ; Chin, K; Alaga, A; Laird, DW				Press, Eric R.; Shao, Qing; Kelly, John J.; Chin, Katrina; Alaga, Anton; Laird, Dale W.			Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICHTHYOSIS-DEAFNESS SYNDROME; FOCAL PALMOPLANTAR KERATODERMA; GAP-JUNCTION; HEMICHANNEL PROPERTIES; SYNDROMIC DEAFNESS; MISSENSE MUTATION; GENE-MUTATIONS; KID SYNDROME; CX26 HEMICHANNELS; INNER-EAR	Connexin26 (Cx26) is a gap junction protein that oligomerizes in the cell to form hexameric transmembrane channels called connexons. Cell surface connexons dock between adjacent cells to allow for gap junctional intercellular communication. Numerous autosomal dominant mutations in the Cx26-encoding GJB2 gene lead to many skin disorders and sensorineural hearing loss. Although some insights have been gained into the pathogenesis of these diseases, it is not fully understood how distinct GJB2 mutations result in hearing loss alone or in skin pathologies with comorbid hearing loss. Here we investigated five autosomal dominant Cx26 mutants (N14K, D50N, N54K, M163V, and S183F) linked to various syndromic or nonsyndromic diseases to uncover the molecular mechanisms underpinning these disease links. We demonstrated that when gap junction-deficient HeLa cells expressed the N14K and D50N mutants, they undergo cell death. The N54K mutant was retained primarily within intracellular compartments and displayed dominant or transdominant properties on wild-type Cx26 and coexpressed Cx30 and Cx43. The S183F mutant formed some gap junction plaques but was largely retained within the cell and exhibited only a mild transdominant reduction in gap junction communication when co-expressed with Cx30. The M163V mutant, which causes only hearing loss, exhibited impaired gap junction function and showed no transdominant interactions. These findings suggest that Cx26 mutants that promote cell death or exert transdominant effects on other connexins in keratinocytes will lead to skin diseases and hearing loss, whereas mutants having reduced channel function but exhibiting no aberrant effects on coexpressed connexins cause only hearing loss. Moreover, cell death-inducing GJB2 mutations lead to more severe syndromic disease.	[Press, Eric R.; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, 00077 Dent Sci Bldg,1151 Richmond St, London, ON N6A 5C1, Canada; [Shao, Qing; Kelly, John J.; Chin, Katrina; Alaga, Anton; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, 00077 Dent Sci Bldg,1151 Richmond St, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020	Laird, Dale W/0000-0002-4568-3285; Kelly, John Joseph/0000-0002-3626-8629	Canadian Institutes of Health Research [123228]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institutes of Health Research Grant 123228 (to D. W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Avshalumova L, 2014, INT J DERMATOL, V53, P192, DOI 10.1111/ijd.12062; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; Berger AC, 2014, J CELL SCI, V127, P1751, DOI 10.1242/jcs.138230; Bosen F, 2015, FEBS LETT, V589, P1904, DOI 10.1016/j.febslet.2015.05.047; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Burnstock G, 2012, J INVEST DERMATOL, V132, P526, DOI 10.1038/jid.2011.344; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Coggshall K, 2013, J AM ACAD DERMATOL, V69, P127, DOI 10.1016/j.jaad.2012.12.965; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Common JEA, 2003, CELL COMMUN ADHES, V10, P347, DOI 10.1080/15419060390263128; D'Adamo P, 2009, EUR J HUM GENET, V17, P284, DOI 10.1038/ejhg.2008.225; de Zwart-Storm EA, 2008, J MED GENET, V45, P161, DOI 10.1136/jmg.2007.052332; de Zwart-Storm EA, 2008, AM J PATHOL, V173, P1113, DOI 10.2353/ajpath.2008.080049; Di WL, 2005, J CELL SCI, V118, P1505, DOI 10.1242/jcs.01733; Di WL, 2001, J INVEST DERMATOL, V117, P958, DOI 10.1046/j.0022-202x.2001.01468.x; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Donnelly S, 2012, EXP DERMATOL, V21, P592, DOI 10.1111/j.1600-0625.2012.01521.x; Fasciani I, 2013, NEUROPHARMACOLOGY, V75, P479, DOI 10.1016/j.neuropharm.2013.03.040; Garcia IE, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0092-x; Garcia IE, 2016, J INVEST DERMATOL, V136, P574, DOI 10.1016/j.jid.2015.11.017; Garcia IE, 2015, J INVEST DERMATOL, V135, P1338, DOI 10.1038/jid.2015.20; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Huang T, 2013, J CELL SCI, V126, P2857, DOI 10.1242/jcs.123315; Jagger DJ, 2015, CELL TISSUE RES, V360, P633, DOI 10.1007/s00441-014-2029-z; Kelly JJ, 2015, CELL TISSUE RES, V360, P701, DOI 10.1007/s00441-014-2024-4; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lazic T, 2008, PEDIATR DERMATOL, V25, P535, DOI 10.1111/j.1525-1470.2008.00767.x; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Man YKS, 2007, J MEMBRANE BIOL, V218, P29, DOI 10.1007/s00232-007-9025-0; Marlin S, 2001, ARCH OTOLARYNGOL, V127, P927, DOI 10.1001/archotol.127.8.927; Martin PE, 2014, FEBS LETT, V588, P1304, DOI 10.1016/j.febslet.2014.02.048; Martin PEM, 2015, CELL TISSUE RES, V360, P645, DOI 10.1007/s00441-014-2094-3; Marziano NK, 2003, HUM MOL GENET, V12, P805, DOI 10.1093/hmg/ddg076; Mazereeuw-Hautier J, 2007, BRIT J DERMATOL, V156, P1015, DOI 10.1111/j.1365-2133.2007.07806.x; Mhaske PV, 2013, AM J PHYSIOL-CELL PH, V304, pC1150, DOI 10.1152/ajpcell.00374.2012; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Qu Y, 2012, BIOCHEM BIOPH RES CO, V417, P245, DOI 10.1016/j.bbrc.2011.11.093; Richard G, 2004, J INVEST DERMATOL, V123, P856, DOI 10.1111/j.0022-202X.2004.23470.x; Sanchez HA, 2016, J GEN PHYSIOL, V148, P25, DOI 10.1085/jgp.201611585; Sanchez HA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00354; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Scott CA, 2012, BBA-BIOMEMBRANES, V1818, P1952, DOI 10.1016/j.bbamem.2011.09.004; Shuja Z, 2016, J INVEST DERMATOL, V136, P225, DOI 10.1038/JID.2015.389; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024	49	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9721	9732		10.1074/jbc.M116.770917	http://dx.doi.org/10.1074/jbc.M116.770917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28428247	Green Published, hybrid			2022-12-28	WOS:000403113000022
J	Sood, R; Minzel, W; Rimon, G; Tal, S; Barki-Harrington, L				Sood, Rapita; Minzel, Waleed; Rimon, Gilad; Tal, Sharon; Barki-Harrington, Liza			Down-regulation of cyclooxygenase-2 by the carboxyl tail of the angiotensin II type 1 receptor (vol 289, pg 31473, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															United States Binational Science Foundation [2009246]; Israel Science Foundation [1445/14]	United States Binational Science Foundation; Israel Science Foundation(Israel Science Foundation)	A grant was inadvertently omitted. The corrected grant footnote should read as follows. This work was supported by United States Binational Science Foundation Grant 2009246 and Israel Science Foundation Grant 1445/14 (to L.B.-H.).	Sood R, 2014, J BIOL CHEM, V289, P31473, DOI 10.1074/jbc.M114.587576	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5736	5736		10.1074/jbc.A114.587576	http://dx.doi.org/10.1074/jbc.A114.587576			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28389577	hybrid, Green Published			2022-12-28	WOS:000398813200011
J	Tang, R; Zhang, G; Wang, YC; Mei, XH; Chen, SY				Tang, Rui; Zhang, Gui; Wang, Yung-Chun; Mei, Xiaohan; Chen, Shi-You			The long non-coding RNA GAS5 regulates transforming growth factor (TGF-)-induced smooth muscle cell differentiation via RNA Smad-binding elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; long non-coding RNA (long ncRNA; lncRNA); signal transduction; smooth muscle; TGF-; GAS5; Smad3	SERUM RESPONSE FACTOR; TGF-BETA; CANCER PROGRESSION; TRANSCRIPTION; LNCRNA; INDUCTION; MEMBRANE; INSIGHTS; GENE	Smooth muscle cell (SMC) differentiation is essential for vascular development, and TGF- signaling plays a critical role in this process. Although long non-coding RNAs (lncRNAs) regulate various cellular events, their functions in SMC differentiation remain largely unknown. Here, we demonstrate that the lncRNA growth arrest-specific 5 (GAS5) suppresses TGF-/Smad3 signaling in smooth muscle cell differentiation of mesenchymal progenitor cells. We found that forced expression of GAS5 blocked, but knockdown of GAS5 increased, the expression of SMC contractile proteins. Mechanistically, GAS5 competitively bound Smad3 protein via multiple RNA Smad-binding elements (rSBEs), which prevented Smad3 from binding to SBE DNA in TGF--responsive SMC gene promoters, resulting in suppression of SMC marker gene transcription and, consequently, in inhibition of TGF-/Smad3-mediated SMC differentiation. Importantly, other lncRNAs or artificially synthesized RNA molecules that contained rSBEs also effectively inhibited TGF-/Smad3 signaling, suggesting that lncRNA-rSBE may be a general mechanism used by cells to fine-tune Smad3 activity in both basal and TGF--stimulated states. Taken together, our results have uncovered an lncRNA-based mechanism that modulates TGF-/Smad3 signaling during SMC differentiation.	[Tang, Rui; Zhang, Gui; Wang, Yung-Chun; Mei, Xiaohan; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA; [Tang, Rui] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University System of Georgia; University of Georgia; Stanford University	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu		Wang, Yung-Chun/0000-0002-8775-3472	NHLBI, National Institutes of Health [HL119053, HL123302, HL135854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL135854, R01HL119053] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL119053, HL123302, and HL135854. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Freedman JE, 2017, ARTERIOSCL THROM VAS, V37, P21, DOI 10.1161/ATVBAHA.116.308513; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120550; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Peng WZ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0197-7; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Sehgal L, 2014, LEUKEMIA, V28, P2376, DOI 10.1038/leu.2014.126; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wang YNZ, 2016, HYPERTENSION, V68, P736, DOI 10.1161/HYPERTENSIONAHA.116.07259; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhao J., 2016, ARTERIOSCLER THROMB, V10, P2088; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011	32	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14270	14278		10.1074/jbc.M117.790030	http://dx.doi.org/10.1074/jbc.M117.790030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28659340	Green Published, hybrid			2022-12-28	WOS:000408439800030
J	Izumi, M; Mizuno, T; Yanagi, K; Sugimura, K; Okumura, K; Imamoto, N; Abe, T; Hanaoka, F				Izumi, Masako; Mizuno, Takeshi; Yanagi, Ken-ichiro; Sugimura, Kazuto; Okumura, Katsuzumi; Imamoto, Naoko; Abe, Tomoko; Hanaoka, Fumio			The Mcm2-7-interacting domain of human mini-chromosome maintenance 10 (Mcm10) protein is important for stable chromatin association and origin firing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; DNA binding protein; DNA helicase; DNA replication; DNA-protein interaction; Mcm10; Mcm2-7	EUKARYOTIC DNA-REPLICATION; INTRINSICALLY UNSTRUCTURED PROTEINS; DOUBLE-HEXAMERIC MCM2-7; POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; S-PHASE; CELL-CYCLE; CDC6 PROTEIN; BINDING PROPERTIES	The protein mini-chromosome maintenance 10 (Mcm10) was originally identified as an essential yeast protein in the maintenance of mini-chromosome plasmids. Subsequently, Mcm10 has been shown to be required for both initiation and elongation during chromosomal DNA replication. However, it is not fully understood how the multiple functions of Mcm10 are coordinated or how Mcm10 interacts with other factors at replication forks. Here, we identified and characterized the Mcm2-7-interacting domain in human Mcm10. The interaction with Mcm2-7 required the Mcm10 domain that contained amino acids 530-655, which overlapped with the domain required for the stable retention of Mcm10 on chromatin. Expression of truncated Mcm10 in HeLa cells depleted of endogenous Mcm10 via siRNA revealed that the Mcm10 conserved domain (amino acids 200-482) is essential for DNA replication, whereas both the conserved and the Mcm2-7-binding domains were required for its full activity. Mcm10 depletion reduced the initiation frequency of DNA replication and interfered with chromatin loading of replication protein A, DNA polymerase (Pol) , and proliferating cell nuclear antigen, whereas the chromatin loading of Cdc45 and Pol E was unaffected. These results suggest that human Mcm10 is bound to chromatin through the interaction with Mcm2-7 and is primarily involved in the initiation of DNA replication after loading of Cdc45 and Pol E.	[Izumi, Masako; Abe, Tomoko] RIKEN, Nishina Ctr Accelerator Based Sci, Accelerator Applicat Res Grp, Wako, Saitama 3510198, Japan; [Mizuno, Takeshi; Yanagi, Ken-ichiro; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Sugimura, Kazuto; Okumura, Katsuzumi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie 5148507, Japan; [Hanaoka, Fumio] Gakushuin Univ, Dept Life Sci, Fac Sci, Tokyo 1718588, Japan; [Hanaoka, Fumio] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan	RIKEN; RIKEN; Mie University; Gakushuin University; University of Tsukuba	Izumi, M (corresponding author), RIKEN, Nishina Ctr Accelerator Based Sci, Accelerator Applicat Res Grp, Wako, Saitama 3510198, Japan.	mizumi@riken.jp	Mizuno, Takeshi/I-4432-2017	Mizuno, Takeshi/0000-0003-3664-7212	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Hayashi Memorial Foundation for Female Natural Scientists. The authors declare that they have no conflicts of interest with the contents of this article.	Alver RC, 2014, NUCLEIC ACIDS RES, V42, P8389, DOI 10.1093/nar/gku479; Apger J, 2010, GENETICS, V185, P1151, DOI 10.1534/genetics.110.117234; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Chadha GS, 2016, CELL CYCLE, V15, P2183, DOI 10.1080/15384101.2016.1199305; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Di Perna R, 2013, BIOCHEM J, V454, P333, DOI 10.1042/BJ20130059; Douglas ME, 2016, J BIOL CHEM, V291, P5879, DOI 10.1074/jbc.M115.707802; Douglas NL, 2005, MOL BIOL REP, V32, P197, DOI 10.1007/s11033-005-2312-x; Du WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070518; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fatoba ST, 2013, NUCLEIC ACIDS RES, V41, P4065, DOI 10.1093/nar/gkt131; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Homesley L, 2000, GENE DEV, V14, P913; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, J CELL BIOCHEM, V76, P280, DOI 10.1002/(SICI)1097-4644(20000201)76:2<280::AID-JCB11>3.0.CO;2-0; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; Looke M, 2017, GENE DEV, V31, P291, DOI 10.1101/gad.291336.116; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Perez-Arnaiz P, 2016, NUCLEIC ACIDS RES, V44, P315, DOI 10.1093/nar/gkv1260; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Robertson PD, 2010, J BIOL CHEM, V285, P22942, DOI 10.1074/jbc.M110.131276; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taylor M, 2011, DNA REPAIR, V10, P1154, DOI 10.1016/j.dnarep.2011.09.001; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	72	13	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13008	13021		10.1074/jbc.M117.779371	http://dx.doi.org/10.1074/jbc.M117.779371			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28646110	hybrid, Green Published			2022-12-28	WOS:000407220100028
J	Dang, BB; Chhabra, S; Pennington, MW; Norton, RS; Kent, SBH				Dang, Bobo; Chhabra, Sandeep; Pennington, Michael W.; Norton, Raymond S.; Kent, Stephen B. H.			Reinvestigation of the biological activity of d-allo-ShK protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide chemical synthesis; protein chemistry; protein folding; protein sequence; protein synthesis; Kv1; 3 blocking activity; ShK; allo-Thr; allo-Ile; chemical protein synthesis	NATIVE CHEMICAL LIGATION; X-RAY-STRUCTURE; TOXIN; PEPTIDE; CHANNELS	ShK toxin from the sea anemone Stichodactyla helianthus is a 35-residue protein that binds to the Kv1.3 ion channel with high affinity. Recently we determined the X-ray structure of ShK toxin by racemic crystallography, in the course of which we discovered that d-ShK has a near-background IC50 value approximate to 50,000 times lower than that of the l-ShK toxin. This lack of activity was at odds with previously reported results for an ShK diastereomer designated d-allo-ShK, for which significant biological activity had been observed in a similar receptor-blocking assay. As reported, d-allo-ShK was made up of d-amino acids, but with retention of the natural stereochemistry of the chiral side chains of the Ile and Thr residues, i.e. containing d-allo-Ile and d-allo-Thr along with d-amino acids and glycine. To understand its apparent biological activity, we set out to chemically synthesize d-allo-ShK and determine its X-ray structure by racemic crystallography. Using validated allo-Thr and allo-Ile, both l-allo-ShK and d-allo-ShK polypeptide chains were prepared by total chemical synthesis. Neither the l-allo-ShK nor the d-allo-ShK polypeptides folded, whereas both l-ShK and d-ShK folded smoothly under the same conditions. Re-examination of NMR spectra of the previously reported d-allo-ShK protein revealed that diagnostic Thr and Ile signals were the same as for authentic d-ShK. On the basis of these results, we conclude that the previously reported d-allo-ShK was in fact d-ShK, the true enantiomer of natural l-ShK toxin, and that the apparent biological activity may have arisen from inadvertent contamination with trace amounts of l-ShK toxin.	[Dang, Bobo; Kent, Stephen B. H.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Pennington, Michael W.] Peptides Int Inc, Louisville, KY 40299 USA; [Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia	University of Chicago; Monash University	Dang, BB (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.	bbdang@uchicago.edu	chhabra, sandeep/R-9942-2017; Chhabra, Sandeep/T-5468-2018	Chhabra, Sandeep/0000-0002-5225-1333; pennington, michael/0000-0001-5446-3447; Norton, Raymond/0000-0001-8893-0584	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a fellowship from the National Health and Medical Research Council of Australia (to R. S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Avital-Shmilovici M, 2013, J AM CHEM SOC, V135, P3173, DOI 10.1021/ja311408y; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bunker RD, 2015, P NATL ACAD SCI USA, V112, P4310, DOI 10.1073/pnas.1422387112; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; CORNISHBOWDEN A, 1984, BIOCHEM J, V219, P345; Currier JR, 2008, CLIN VACCINE IMMUNOL, V15, P267, DOI 10.1128/CVI.00284-07; Dang BB, 2017, ANGEW CHEM INT EDIT, V56, P3324, DOI 10.1002/anie.201612398; Dang BB, 2013, J AM CHEM SOC, V135, P11911, DOI 10.1021/ja4046795; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; de Graaf MT, 2008, CYTOM PART A, V73A, P1079, DOI 10.1002/cyto.a.20636; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; MITCHELL AR, 1978, J ORG CHEM, V43, P2845, DOI 10.1021/jo00408a022; PENNINGTON MW, 1995, INT J PEPT PROT RES, V46, P354; Pohl Jan, 1995, Letters in Peptide Science, V1, P291, DOI 10.1007/BF00119770; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Yeates TO, 2012, ANNU REV BIOPHYS, V41, P41, DOI [10.1146/annurev-biophys-050511-102333, 10.1146/annurev-biophys-050511-4023]; ZAWADZKE LE, 1993, PROTEINS, V16, P301, DOI 10.1002/prot.340160308	23	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12599	12605		10.1074/jbc.M117.793943	http://dx.doi.org/10.1074/jbc.M117.793943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28596383	Green Published, hybrid			2022-12-28	WOS:000406636900024
J	Tuohetahuntila, M; Molenaar, MR; Spee, B; Brouwers, JF; Wubbolts, R; Houweling, M; Yan, C; Du, H; VanderVen, BC; Vaandrager, AB; Helms, JB				Tuohetahuntila, Maidina; Molenaar, Martijn R.; Spee, Bart; Brouwers, Jos F.; Wubbolts, Richard; Houweling, Martin; Yan, Cong; Du, Hong; VanderVen, Brian C.; Vaandrager, Arie B.; Helms, J. Bernd			Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatic stellate cell (HSC); lipase; lipid droplet; lipolysis; retinoid; vitamin A	LIPASE-DEFICIENT MICE; ACID LIPASE; RAT-LIVER; RETINYL ESTER; STORAGE DISEASE; AUTOPHAGY; TURNOVER; MACROPHAGES; HOMEOSTASIS; INHIBITORS	Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro. The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhibiting the degradation of newly synthesized TAG species as compared with a more general lipase inhibitor orlistat. Lalistat also induced the presence of RE-containing LDs in an acidic compartment. However, targeted deletion of the Lipa gene in mice decreased the liver levels of RE, most likely as the result of a gradual disappearance of HSCs in livers of Lipa(-/-) mice. Lalistat partially inhibited the induction of activation marker -smooth muscle actin (-SMA) in rat and mouse HSCs. Our data suggest that LAL/Lipa is involved in the degradation of a specific preexisting pool of LDs and that inhibition of this pathway attenuates HSC activation.	[Tuohetahuntila, Maidina; Molenaar, Martijn R.; Brouwers, Jos F.; Wubbolts, Richard; Houweling, Martin; Vaandrager, Arie B.; Helms, J. Bernd] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Yalelaan 2, NL-3584 CM Utrecht, Netherlands; [Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [VanderVen, Brian C.] Cornell Univ, Dept Microbiol & Immunol, Vet Med Ctr C5 181, Ithaca, NY 14853 USA	Utrecht University; Utrecht University; Indiana University System; Indiana University Bloomington; Cornell University	Helms, JB (corresponding author), Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Yalelaan 2, NL-3584 CM Utrecht, Netherlands.	J.B.Helms@uu.nl	Brouwers, Jos F/AAH-1444-2019; Wubbolts, Richard/ABH-6667-2020	Brouwers, Jos F/0000-0003-2924-3279; Wubbolts, Richard/0000-0001-8661-7594; Molenaar, Martijn/0000-0001-5221-608X; Vaandrager, Arie/0000-0001-9394-9239	seventh framework program of the EU-funded "LipidomicNet" project [202272]; NATIONAL CANCER INSTITUTE [R01CA152099] Funding Source: NIH RePORTER	seventh framework program of the EU-funded "LipidomicNet" project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the seventh framework program of the EU-funded "LipidomicNet" project (proposal number 202272). The authors declare that they have no conflicts of interest with the contents of this article.	Ajat M, 2017, BBA-MOL CELL BIOL L, V1862, P176, DOI 10.1016/j.bbalip.2016.10.013; Anderson RA, 1999, MOL GENET METAB, V68, P333, DOI 10.1006/mgme.1999.2904; AzaisBraesco V, 1995, BBA-LIPID LIPID MET, V1259, P271, DOI 10.1016/0005-2760(95)00173-5; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3566; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Grumet L, 2016, J BIOL CHEM, V291, P17977, DOI 10.1074/jbc.M116.724054; Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Long AP, 2012, TRAFFIC, V13, P705, DOI 10.1111/j.1600-0854.2012.01339.x; Mello T, 2008, BIOCHEM BIOPH RES CO, V374, P460, DOI 10.1016/j.bbrc.2008.07.024; MERCIER M, 1994, BBA-LIPID LIPID MET, V1212, P176, DOI 10.1016/0005-2760(94)90251-8; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Robinet P, 2013, ARTERIOSCL THROM VAS, V33, P903, DOI 10.1161/ATVBAHA.112.301041; Rosenbaum AI, 2010, J MED CHEM, V53, P5281, DOI 10.1021/jm100499s; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Schreiber R, 2012, BBA-MOL CELL BIOL L, V1821, P113, DOI 10.1016/j.bbalip.2011.05.001; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Sun Y, 2014, MOL GENET METAB, V112, P229, DOI 10.1016/j.ymgme.2014.04.006; Testerink N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034945; Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010; Tuohetahuntila M, 2016, J LIPID RES, V57, P1162, DOI 10.1194/jlr.M066415; Tuohetahuntila M, 2015, BBA-MOL CELL BIOL L, V1851, P220, DOI 10.1016/j.bbalip.2014.12.003; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; VanderVen BC, 2010, CYTOM PART A, V77A, P751, DOI 10.1002/cyto.a.20911; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; YAMAMOTO K, 1983, CELL TISSUE RES, V233, P45; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021	42	34	35	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12436	12448		10.1074/jbc.M117.778472	http://dx.doi.org/10.1074/jbc.M117.778472			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615446	Green Published, hybrid			2022-12-28	WOS:000406636900009
J	Zeng, BS; Huang, YP; Xu, J; Shiotsuki, T; Bai, H; Palli, SR; Huang, YP; Tan, AJ				Zeng, Baosheng; Huang, Yuping; Xu, Jun; Shiotsuki, Takahiro; Bai, Hua; Palli, Subba Reddy; Huang, Yongping; Tan, Anjiang			The FOXO transcription factor controls insect growth and development by regulating juvenile hormone degradation in the silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; INSULIN-RECEPTOR; LIFE-SPAN; FAT-BODY; METAMORPHOSIS; PATHWAY; CELLS; SIZE; BIOSYNTHESIS; ESTERASE	Forkhead box O (FOXO) functions as the terminal transcription factor of the insulin signaling pathway and regulates multiple physiological processes in many organisms, including life-span in insects. However, how FOXO interacts with hormone signaling to modulate insect growth and development is largely unknown. Here, using the transgene-based CRISPR/Cas9 system, we generated and characterized mutants of the silkworm Bombyx mori FOXO (BmFOXO) to elucidate its physiological functions during development of this lepidopteran insect. The BmFOXO mutant (FOXO-M) exhibited growth delays from the first larval stage and showed precocious metamorphosis, pupating at the end of the fourth instar (trimolter) rather than at the end of the fifth instar as in the wild-type (WT) animals. However, different from previous reports on precocious metamorphosis caused by juvenile hormone (JH) deficiency in silkworm mutants, the total developmental time of the larval period in the FOXO-M was comparable with that of the WT. Exogenous application of 20-hydroxyecdysone (20E) or of the JH analog rescued the trimolter phenotype. RNA-seq and gene expression analyses indicated that genes involved in JH degradation but not in JH biosynthesis were up-regulated in the FOXO-M compared with the WT animals. Moreover, we identified several FOXO-binding sites in the promoter of genes coding for JH-degradation enzymes. These results suggest that FOXO regulates JH degradation rather than its biosynthesis, which further modulates hormone homeostasis to control growth and development in B. mori. In conclusion, we have uncovered a pivotal role for FOXO in regulating JH signaling to control insect development.	[Zeng, Baosheng; Huang, Yuping; Xu, Jun; Huang, Yongping; Tan, Anjiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Zeng, Baosheng; Xu, Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shiotsuki, Takahiro] Natl Agr & Food Res Org, Inst Agrobiol Sci, Div Insect Sci, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan; [Bai, Hua] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Palli, Subba Reddy] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Agriculture & Food Research Organization - Japan; Iowa State University; University of Kentucky	Tan, AJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	ajtan01@sibs.ac.cn	PALLI, SUBBA REDDY/AAU-8289-2020; Zeng, Baosheng/AAB-7808-2022; Xu, Jun/ABD-7800-2021; Zeng, Baosheng/X-5191-2019	PALLI, SUBBA REDDY/0000-0002-0873-3247; Xu, Jun/0000-0002-7963-0253; Shiotsuki, Takahiro/0000-0001-5077-7270	Strategic Priority Research Program of Chinese Academy of Sciences [XDB11010600]; National Basic Research Program of China [2015CB755703]; National Science Foundation of China [31420103918, 31530072]; Chinese Academy of Sciences [KJZD-EW-L12-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Strategic Priority Research Program of Chinese Academy of Sciences Grant XDB11010600, National Basic Research Program of China Grant 2015CB755703, National Science Foundation of China Grants 31420103918 and 31530072, and Chinese Academy of Sciences Grant KJZD-EW-L12-02. The authors declare that they have no conflicts of interest with the contents of this article.	Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Furuta K, 2013, BIOSCI BIOTECH BIOCH, V77, P988, DOI 10.1271/bbb.120883; Gelman DB, 2002, J INSECT PHYSIOL, V48, P63, DOI 10.1016/S0022-1910(01)00146-9; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Herold MJ, 2013, EMBO REP, V14, P992, DOI 10.1038/embor.2013.152; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kingan TG, 2000, J EXP BIOL, V203, P3011; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Li ZQ, 2015, INT J BIOL SCI, V11, P176, DOI 10.7150/ijbs.10235; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ling L, 2014, INSECT BIOCHEM MOLEC, V53, P13, DOI 10.1016/j.ibmb.2014.06.011; MCCUTCHEN BF, 1995, INSECT BIOCHEM MOLEC, V25, P119, DOI 10.1016/0965-1748(94)00036-H; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rauschenbach I Yu, 2015, Genetika, V51, P1083; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Tsubota T, 2010, BIOSCI BIOTECH BIOCH, V74, P2259, DOI 10.1271/bbb.100480; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Xu J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006576; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang L, 2014, J BACTERIOL, V196, P3949, DOI 10.1128/JB.02037-14	43	46	52	7	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11659	11669		10.1074/jbc.M117.777797	http://dx.doi.org/10.1074/jbc.M117.777797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28490635	Green Published, hybrid			2022-12-28	WOS:000405485600007
J	Kogure, A; Uno, M; Ikeda, T; Nishida, E				Kogure, Akiko; Uno, Masaharu; Ikeda, Takako; Nishida, Eisuke			The microRNA machinery regulates fasting-induced changes in gene expression and longevity in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C. ELEGANS; DIETARY-RESTRICTION; LIFE-SPAN; BIOGENESIS; DROSOPHILA; PATHWAY; DISEASE; TARGETS; HEALTH; RNAS	Intermittent fasting (IF) is a dietary restriction regimen that extends the lifespans of Caenorhabditis elegans and mammals by inducing changes in gene expression. However, how IF induces these changes and promotes longevity remains unclear. One proposed mechanism involves gene regulation by microRNAs (miRNAs), small non-coding RNAs (similar to 22 nucleotides) that repress gene expression and whose expression can be altered by fasting. To test this proposition, we examined the role of the miRNA machinery in fasting-induced transcriptional changes and longevity in C. elegans. We revealed that fasting up-regulated the expression of the miRNA-induced silencing complex (miRISC) components, including Argonaute and GW182, and the miRNA-processing enzyme DRSH-1 (the ortholog of the Drosophila Drosha enzyme). Our lifespan measurements demonstrated that IF-induced longevity was suppressed by knock-out or knockdown of miRISC components and was completely inhibited by drsh-1 ablation. Remarkably, drsh-1 ablation inhibited the fasting-induced changes in the expression of the target genes of DAF-16, the insulin/IGF-1 signaling effector in C. elegans. Fasting-induced transcriptome alterations were substantially and modestly suppressed in the drsh-1 null mutant and the null mutant of ain-1, a gene encoding GW182, respectively. Moreover, miRNA array analyses revealed that the expression levels of numerous miRNAs changed after 2 days of fasting. These results indicate that components of the miRNA machinery, especially the miRNA-processing enzyme DRSH-1, play an important role in mediating IF-induced longevity via the regulation of fasting-induced changes in gene expression.	[Kogure, Akiko; Uno, Masaharu; Ikeda, Takako; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Uno, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	muno.m06@lif.kyoto-u.ac.jp	Asada, Akiko/ABF-7324-2020	Uno, Masaharu/0000-0001-7770-3941	National Institutes of Health NCRR	National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the members of our laboratory for technical comments and helpful discussion. C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health NCRR.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Bouasker S, 2012, NUCLEIC ACIDS RES, V40, P10452, DOI 10.1093/nar/gks748; BRENNER S, 1974, GENETICS, V77, P71; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Segura L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142262; Garg D, 2014, AGEING RES REV, V17, P3, DOI 10.1016/j.arr.2014.04.001; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kroeger CM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-98; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehrbach NJ, 2012, RNA, V18, P2220, DOI 10.1261/rna.035402.112; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Palmer JD, 2014, AGEING RES REV, V17, P16, DOI 10.1016/j.arr.2014.04.005; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Smith-Vikos T, 2014, CURR BIOL, V24, P2238, DOI 10.1016/j.cub.2014.08.013; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Vasquez-Rifo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033750; Vora M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003737; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641	34	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11300	11309		10.1074/jbc.M116.765065	http://dx.doi.org/10.1074/jbc.M116.765065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28507100	Green Published, hybrid			2022-12-28	WOS:000405119600014
J	Schoonaert, L; Rue, L; Roucourt, B; Timmers, M; Little, S; Chavez-Gutierrez, L; Dewilde, M; Joyce, P; Curnock, A; Weber, P; Haustraete, J; Hassanzadeh-Ghassabeh, G; De Strooper, B; Van den Bosch, L; Van Damme, P; Lemmens, R; Robberecht, W				Schoonaert, Lies; Rue, Laura; Roucourt, Bart; Timmers, Mieke; Little, Susan; Chavez-Gutierrez, Lucia; Dewilde, Maarten; Joyce, Peter; Curnock, Adam; Weber, Peter; Haustraete, Jurgen; Hassanzadeh-Ghassabeh, Gholamreza; De Strooper, Bart; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin; Robberecht, Wim			Identification and characterization of Nanobodies targeting the EphA4 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-DOMAIN ANTIBODIES; BLOOD-BRAIN-BARRIER; CORTICOSPINAL TRACT AXONS; CYCLIC PEPTIDE ANTAGONIST; SPINAL-CORD-INJURY; SMALL MOLECULES; NERVOUS-SYSTEM; EPHRIN-BINDING; FUSION PROTEIN; REGENERATION	The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as well as in the pathogenesis of several neurological disorders such as stroke, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease. Pharmacological blocking of EphA4 has been suggested to be a therapeutic strategy for these disorders. Therefore, the aim of our study was to generate potent and selective Nanobodies against the ligand-binding domain of the human EphA4 receptor. Weidentified two Nanobodies, Nb 39 and Nb 53, that bind EphA4 with affinities in the nanomolar range. These Nanobodies were most selective for EphA4, with residual binding to EphA7 only. Using Alphascreen technology, we found that both Nanobodies displaced all known EphA4-binding ephrins from the receptor. Furthermore, Nb39 andNb53 inhibited ephrin-induced phosphorylationoftheEphA4proteininacell-basedassay. Finally, in a cortical neuron primary culture, both Nanobodies were able to inhibit endogenous EphA4-mediated growth-cone collapse induced by ephrin-B3. Our results demonstrate the potential of Nanobodies to target the ligand-binding domain of EphA4. These Nanobodiesmaydeservefurtherevaluationaspotentialtherapeutics in disorders in which EphA4-mediated signaling plays a role.	[Schoonaert, Lies; Rue, Laura; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin; Robberecht, Wim] KU Leuven Univ Leuven, Dept Neurosci, Expt Neurol, B-3000 Leuven, Belgium; [Schoonaert, Lies; Rue, Laura; Timmers, Mieke; Chavez-Gutierrez, Lucia; Dewilde, Maarten; De Strooper, Bart; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin; Robberecht, Wim] Leuven Res Inst Neurosci & Dis LIND, B-3000 Leuven, Belgium; [Schoonaert, Lies; Rue, Laura; Timmers, Mieke; Chavez-Gutierrez, Lucia; Dewilde, Maarten; De Strooper, Bart; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin] VIB, Ctr Brain & Dis Res, Neurobiol Lab, B-3000 Leuven, Belgium; [Roucourt, Bart] KU Leuven Univ Leuven, Lab Signal Integrat Cell Fate Decis, B-3000 Leuven, Belgium; [Little, Susan; Joyce, Peter; Curnock, Adam; Weber, Peter] Vertex Pharmaceut Europe Ltd, Dept Biol, Abingdon OX14 4RW, Oxon, England; [Chavez-Gutierrez, Lucia; Dewilde, Maarten; De Strooper, Bart] Katholieke Univ Leuven, Dept Neurosci, B-3000 Leuven, Belgium; [Haustraete, Jurgen] Univ Ghent, Inflammat Res Ctr, Prot Serv Facil, VIB, B-9052 Ghent, Belgium; [Hassanzadeh-Ghassabeh, Gholamreza] Vrije Univ Brussel, Nanobody Serv Facil, V1B, B-1050 Brussels, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London WC1E 6BT, England; [Van Damme, Philip; Lemmens, Robin; Robberecht, Wim] Univ Hosp Leuven, Dept Neurol, B-3000 Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Vertex Pharmaceuticals; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; University of London; University College London; KU Leuven; University Hospital Leuven	Robberecht, W (corresponding author), Katholieke Univ Leuven, Neurobiol Lab, Campus Gasthuisberg,O&N4 Herestr 49 Box 602, Leuven, Belgium.	Wim.Robberecht@kuleuven.be	Weber, Peter Kilian/AAP-9517-2020; de+Strooper, Bart/Z-1638-2019; Van Damme, Philip/A-6464-2009	Weber, Peter Kilian/0000-0001-6022-6050; Van Damme, Philip/0000-0002-4010-2357; Dewilde, Maarten/0000-0002-3138-281X; Rue, Laura/0000-0001-5415-5153; Lemmens, Robin/0000-0002-4948-5956; Van Den Bosch, Ludo/0000-0003-0104-4067	VIB; KU Leuven-University of Leuven [GOA/11/014]; Vertex Pharmaceuticals Inc.; Research Foundation Flanders (FWO-Vlaanderen) [G.0996.14N]; ALS League Belgium; Thierry Latran Foundation; Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.); Laevers Fund for ALS Research; Fund "Een Hart voor ALS"; European Community [259867]; European Research Council; European's Seventh Framework Programme (FP7)/ERC [340429]; structural funding for medium-scale research infrastructure (HERCULES) [AUGE/09/040]; Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen) [101318, IWT-VIND 135043]; Cure Alzheimer's Fund; "Opening the Future" Fund from the KU Leuven-University of Leuven; Research Fund KU Leuven; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, from the KU Leuven-University of Leuven; MRC [MC_PC_17116] Funding Source: UKRI; Medical Research Council [MC_PC_17116] Funding Source: researchfish	VIB; KU Leuven-University of Leuven(KU Leuven); Vertex Pharmaceuticals Inc.(Vertex Pharmaceuticals); Research Foundation Flanders (FWO-Vlaanderen)(FWO); ALS League Belgium; Thierry Latran Foundation; Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.); Laevers Fund for ALS Research; Fund "Een Hart voor ALS"; European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); European's Seventh Framework Programme (FP7)/ERC; structural funding for medium-scale research infrastructure (HERCULES); Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Cure Alzheimer's Fund; "Opening the Future" Fund from the KU Leuven-University of Leuven; Research Fund KU Leuven(KU Leuven); E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, from the KU Leuven-University of Leuven; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from VIB, the KU Leuven-University of Leuven (GOA/11/014), Vertex Pharmaceuticals Inc., Research Foundation Flanders (FWO-Vlaanderen; G.0996.14N), the ALS League Belgium, the Thierry Latran Foundation, Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.), Laevers Fund for ALS Research, and the Fund "Een Hart voor ALS." This work was also supported by the European Community's Health Seventh Framework Programme (FP7/2007-2013) under Grant 259867, the European Research Council, and the European's Seventh Framework Programme (FP7/2007-2013)/ERC Grant 340429 and structural funding for medium-scale research infrastructure (HERCULES, AUGE/09/040). The authors declare that they have no conflicts of interest with the contents of this article. The views expressed are those of the authors and not necessarily those of the NHS (National Health Service), the NIHR (National Institute for Health Research), or the Department of Health.; Received funding from the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen; project 101318).; Supported by the Cure Alzheimer's Fund.; Received funding from the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen; project IWT-VIND 135043).; Supported by the "Opening the Future" Fund from the KU Leuven-University of Leuven.; Supported by Research Fund KU Leuven.; Supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, from the KU Leuven-University of Leuven.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Boado RJ, 2012, DRUG METAB DISPOS, V40, P2021, DOI 10.1124/dmd.112.046375; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; DIXON FJ, 1953, P SOC EXP BIOL MED, V83, P287; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Figueroa JD, 2006, J NEUROSCI RES, V84, P1438, DOI 10.1002/jnr.21048; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Gan L. S., 2013, INT J CELL BIOL, V2013; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Guo FY, 2014, PROTEINS, V82, P349, DOI 10.1002/prot.24414; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Han XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080183; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kontermann R. E., 2014, ANTIBODY ENG, V2; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Lamberto I, 2014, ACS CHEM BIOL, V9, P2787, DOI 10.1021/cb500677x; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; Lemmens R, 2013, HUM MOL GENET, V22, P2214, DOI 10.1093/hmg/ddt073; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Linneberg C, 2015, ASN NEURO, V7, DOI 10.1177/1759091415602859; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; Miyazaki K, 2011, J NEUROSCI RES, V89, P718, DOI 10.1002/jnr.22594; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noberini R, 2012, SEMIN CELL DEV BIOL, V23, P51, DOI 10.1016/j.semcdb.2011.10.023; Olson EJ, 2016, ACS MED CHEM LETT, V7, P841, DOI 10.1021/acsmedchemlett.6b00132; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ren Z, 2013, NEUROSCIENCE, V241, P89, DOI 10.1016/j.neuroscience.2013.03.010; Rissiek B, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00344; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Sheedy C, 2007, BIOTECHNOL ADV, V25, P333, DOI 10.1016/j.biotechadv.2007.02.003; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Steeland S, 2015, J BIOL CHEM, V290, P4022, DOI 10.1074/jbc.M114.617787; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Syed YA, 2016, ACTA NEUROPATHOL, V131, P281, DOI 10.1007/s00401-015-1521-1; Tognolini M, 2014, DRUG DISCOV TODAY, V19, P661, DOI 10.1016/j.drudis.2013.11.017; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Truitt L, 2011, BIOCHEM CELL BIOL, V89, P115, DOI [10.1139/O10-145, 10.1139/o10-145]; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vargas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092309; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Wu BN, 2013, CHEM BIOL, V20, P19, DOI 10.1016/j.chembiol.2012.10.015; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110	75	12	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11452	11465		10.1074/jbc.M116.774141	http://dx.doi.org/10.1074/jbc.M116.774141			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28526745	Green Published, hybrid			2022-12-28	WOS:000405119600028
J	Buzza, MS; Johnson, TA; Conway, GD; Martin, EW; Mukhopadhyay, S; Shea-Donohue, T; Antalis, TM				Buzza, Marguerite S.; Johnson, Tierra A.; Conway, Gregory D.; Martin, Erik W.; Mukhopadhyay, Subhradip; Shea-Donohue, Terez; Antalis, Toni M.			Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED INTESTINAL PERMEABILITY; NK T-CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; OXAZOLONE COLITIS; TIGHT JUNCTIONS; EXPRESSION; ACTIVATION; CLAUDIN-2; BOWEL	Compromised gastrointestinal barrier function is strongly associated with the progressive and destructive pathologies of the two main forms of irritable bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD). Matriptase is a membrane-anchored serine protease encoded by suppression of tumorigenicity-14 (ST14) gene, which is critical for epithelial barrier development and homeostasis. Matriptase barrier-protective activity is linked with the glycosylphosphatidylinositol (GPI)-anchored serine protease prostasin, which is a co-factor for matriptase zymogen activation. Here we show that mRNA and protein expression of both matriptase and prostasin are rapidly down-regulated in the initiating inflammatory phases of dextran sulfate sodium (DSS)-induced experimental colitis in mice, and, significantly, the loss of these proteases precedes the appearance of clinical symptoms, suggesting their loss may contribute to disease susceptibility. We used heterozygous St14 hypomorphic mice expressing a promoter-linked beta-gal reporter to show that inflammatory colitis suppresses the activity of the St14 gene promoter. Studies in colonic T84 cell monolayers revealed that barrier disruption by the colitis-associated Th2-type cytokines, IL-4 and IL-13, down-regulates matriptase as well as prostasin through phosphorylation of the transcriptional regulator STAT6 and that inhibition of STAT6 with suberoylanilide hydroxamic acid (SAHA) restores protease expression and reverses cytokine-induced barrier dysfunction. Both matriptase and prostasin are significantly down-regulated in colonic tissues from human subjects with active ulcerative colitis or Crohn's disease, implicating the loss of this barrier-protective protease pathway in the pathogenesis of irritable bowel disease.	[Buzza, Marguerite S.; Johnson, Tierra A.; Conway, Gregory D.; Martin, Erik W.; Mukhopadhyay, Subhradip; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Buzza, Marguerite S.; Johnson, Tierra A.; Conway, Gregory D.; Martin, Erik W.; Mukhopadhyay, Subhradip; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Antalis, TM (corresponding author), 800 West Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu		Martin, Erik/0000-0003-3979-2378	U.S. Department of Defense [PR110378]; National Institutes of Health [R01 DK081376, R01 HL118390, R01 DK83418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118390, R01HL084387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083418, R01DK081376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Department of Defense Grant PR110378 and National Institutes of Health Grants R01 DK081376 and R01 HL118390 (T. M. A.) and R01 DK83418 (T. S. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Behera J, 2015, MINI-REV MED CHEM, V15, P731, DOI 10.2174/1389557515666150521162237; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chen ML, 2016, INFLAMM BOWEL DIS, V22, P1157, DOI 10.1097/MIB.0000000000000714; Duvic M, 2016, CANCER TREAT REV, V43, P58, DOI 10.1016/j.ctrv.2015.04.003; Felice C, 2015, ALIMENT PHARM THER, V41, P26, DOI 10.1111/apt.13008; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Glauben R, 2008, GUT, V57, P613, DOI 10.1136/gut.2007.134650; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; JENKINS RT, 1988, CLIN INVEST MED, V11, P151; Kasaian MT, 2014, IMMUNOLOGY, V143, P416, DOI 10.1111/imm.12319; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Keppner A, 2016, INFLAMM BOWEL DIS, V22, P2824, DOI 10.1097/MIB.0000000000000940; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Mann ER, 2014, INFLAMM BOWEL DIS, V20, P2299, DOI 10.1097/MIB.0000000000000223; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Mildner M, 2015, J DTSCH DERMATOL GES, V13, P1165, DOI 10.1111/ddg.12812; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Randall K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162076; Rosen MJ, 2013, J IMMUNOL, V190, P1849, DOI 10.4049/jimmunol.1201373; Rosen MJ, 2011, INFLAMM BOWEL DIS, V17, P2224, DOI 10.1002/ibd.21628; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Tilg H, 2015, GUT, V64, P857, DOI 10.1136/gutjnl-2015-309464; Utech M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/484987; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0093899; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	67	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10801	10812		10.1074/jbc.M116.771469	http://dx.doi.org/10.1074/jbc.M116.771469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490634	hybrid, Green Published			2022-12-28	WOS:000404391000005
J	Itoh, E; Odakura, R; Oinuma, KI; Shimizu, M; Masuo, S; Takaya, N				Itoh, Eriko; Odakura, Rika; Oinuma, Ken-Ichi; Shimizu, Motoyuki; Masuo, Shunsuke; Takaya, Naoki			Sirtuin E is a fungal global transcriptional regulator that determines the transition from the primary growth to the stationary phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT HISTONE DEACETYLASE; CARBON CATABOLITE REPRESSION; RNA-SEQ DATA; ASPERGILLUS-NIDULANS; SIR2-LIKE PROTEINS; GENE; SIR2; NAD; CHROMATIN; ORYZAE	In response to limited nutrients, fungal cells exit the primary growth phase, enter the stationary phase, and cease proliferation. Although fundamental to microbial physiology in many environments, the regulation of this transition is poorly understood but likely involves many transcriptional regulators. These may include the sirtuins, which deacetylate acetyllysine residues of histones and epigenetically regulate global transcription. Therefore, we investigated the role of a nuclear sirtuin, sirtuin E (SirE), from the ascomycete fungus Aspergillus nidulans. An A. nidulans strain with a disrupted sirE gene (SirE Delta) accumulated more acetylated histone H3 during the stationary growth phase when sirE was expressed at increased levels in the wild type. SirE Delta exhibited decreased mycelial autolysis, conidiophore development, sterigmatocystin biosynthesis, and production of extracellular hydrolases. Moreover, the transcription of the genes involved in these processes was also decreased, indicating that SirE is a histone deacetylase that up-regulates these activities in the stationary growth phase. Transcriptome analyses indicated that SirE repressed primary carbon and nitrogen metabolism and cell-wall synthesis. Chromatin immunoprecipitation demonstrated that SirE deacetylates acetylated Lys-9 residues in histone H3 at the gene promoters of alpha-1,3-glucan synthase (agsB), glycolytic phosphofructokinase (pfkA), and glyceraldehyde 3-phosphate (gpdA), indicating that SirE represses the expression of these primary metabolic genes. In summary, these results indicate that SirE facilitates the metabolic transition from the primary growth phase to the stationary phase. Because the observed gene expression profiles in stationary phase matched those resulting from carbon starvation, SirE appears to control this metabolic transition via a mechanism associated with the starvation response.	[Itoh, Eriko; Odakura, Rika; Oinuma, Ken-Ichi; Shimizu, Motoyuki; Masuo, Shunsuke; Takaya, Naoki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	takaya.naoki.ge@u.tsukuba.ac.jp		Masuo, Shunsuke/0000-0002-0454-3315	Japan Society for the Promotion of Science KAKENHI [15H02487, 24380041]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants-in-aid for Scientific Research 15H02487 and 24380041 (to N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bernreiter A, 2007, MOL CELL BIOL, V27, P791, DOI 10.1128/MCB.00761-06; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Emri T, 2004, FOLIA MICROBIOL, V49, P277, DOI 10.1007/BF02931043; ESPESO EA, 1992, MOL MICROBIOL, V6, P1457, DOI 10.1111/j.1365-2958.1992.tb00866.x; Fernandez J, 2014, MOL MICROBIOL, V94, P70, DOI 10.1111/mmi.12743; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kawauchi M, 2014, J BIOSCI BIOENG, V118, P172, DOI 10.1016/j.jbiosc.2014.02.004; Kawauchi M, 2013, EUKARYOT CELL, V12, P1087, DOI 10.1128/EC.00003-13; Kim S, 2002, BIOSCI BIOTECH BIOCH, V66, P2168, DOI 10.1271/bbb.66.2168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee I, 2009, FUNGAL GENET BIOL, V46, P782, DOI 10.1016/j.fgb.2009.06.007; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r48; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masuo S, 2010, MOL GENET GENOMICS, V284, P415, DOI 10.1007/s00438-010-0576-x; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Motoyama T, 1997, MOL GEN GENET, V253, P520, DOI 10.1007/s004380050353; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Saikia R, 2005, CURR SCI INDIA, V89, P659; Saykhedkar S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-52; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; Shimizu M, 2012, MOL CELL BIOL, V32, P3743, DOI 10.1128/MCB.00032-12; Shroff RA, 1997, FUNGAL GENET BIOL, V22, P28, DOI 10.1006/fgbi.1997.0989; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Szilagyi M, 2010, J APPL MICROBIOL, V109, P1498, DOI 10.1111/j.1365-2672.2010.04782.x; Szilagyi M, 2013, MICROBIOL-SGM, V159, P176, DOI 10.1099/mic.0.062935-0; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Yamazaki H, 2007, CURR GENET, V51, P89, DOI 10.1007/s00294-006-0109-7; YANAI K, 1992, J BACTERIOL, V174, P7398, DOI 10.1128/jb.174.22.7398-7406.1992; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	48	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11043	11054		10.1074/jbc.M116.753772	http://dx.doi.org/10.1074/jbc.M116.753772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28465348	Green Published, hybrid			2022-12-28	WOS:000404391000025
J	Chen, HB; Giri, NC; Zhang, RH; Yamane, K; Zhang, Y; Maroney, M; Costa, M				Chen, Haobin; Giri, Nitai Charan; Zhang, Ronghe; Yamane, Kenichi; Zhang, Yi; Maroney, Michael; Costa, Max			Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers (vol 285, pg 7374, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503	1	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10743	10743		10.1074/jbc.A109.058503	http://dx.doi.org/10.1074/jbc.A109.058503			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28646124	Green Published, hybrid			2022-12-28	WOS:000404115400032
J	Mehta, MB; Shewale, SV; Sequeira, RN; Millar, JS; Hand, NJ; Rader, DJ				Mehta, Minal B.; Shewale, Swapnil V.; Sequeira, Raymond N.; Millar, John S.; Hand, Nicholas J.; Rader, Daniel J.			Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gluconeogenesis; glycogen; glycogen storage disease; glycogen synthase; glycolysis; liver; Alb-Cre; Ppp1r3b	GLUCOSE-HOMEOSTASIS; TARGETING SUBUNITS; INSULIN-RESISTANCE; LIVER; METABOLISM; PTG; VARIANTS; SYNTHASE; HEPATOCYTES; EXPRESSION	Maintenance of whole-body glucose homeostasis is critical to glycemic function. Genetic variants mapping to chromosome 8p23.1 in genome-wide association studies have been linked to glycemic traits in humans. The gene of known function closest to the mapped region, PPP1R3B (protein phosphatase 1 regulatory subunit 3B), encodes a protein (G(L)) that regulates glycogen metabolism in the liver. We therefore sought to test the hypothesis that hepatic PPP1R3B is associated with glycemic traits. We generated mice with either liver-specific deletion (Ppp1r3b(hep)) or liver-specific overexpression of Ppp1r3b. The Ppp1r3b deletion significantly reduced glycogen synthase protein abundance, and the remaining protein was predominantly phosphorylated and inactive. As a consequence, glucose incorporation into hepatic glycogen was significantly impaired, total hepatic glycogen content was substantially decreased, and mice lacking hepatic Ppp1r3b had lower fasting plasma glucose than controls. The concomitant loss of liver glycogen impaired whole-body glucose homeostasis and increased hepatic expression of glycolytic enzymes in Ppp1r3b(hep) mice relative to controls in the postprandial state. Eight hours of fasting significantly increased the expression of two critical gluconeogenic enzymes, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, above the levels in control livers. Conversely, the liver-specific overexpression of Ppp1r3b enhanced hepatic glycogen storage above that of controls and, as a result, delayed the onset of fasting-induced hypoglycemia. Moreover, mice overexpressing hepatic Ppp1r3b upon long-term fasting (12-36 h) were protected from blood ketone-body accumulation, unlike control and Ppp1r3b(hep) mice. These findings indicate a major role for Ppp1r3b in regulating hepatic glycogen stores and whole-body glucose/energy homeostasis.	[Mehta, Minal B.; Shewale, Swapnil V.; Sequeira, Raymond N.; Millar, John S.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Mehta, Minal B.; Shewale, Swapnil V.; Hand, Nicholas J.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Rader, DJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Smilow Ctr Translat Res, SCTR 11-125,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Hand, Nicholas/Q-4235-2019; Shewale, Swapnil/S-8144-2019	Hand, Nicholas/0000-0002-8172-1816; Rader, Daniel/0000-0002-9245-9876; Mehta, Minal/0000-0001-9062-8317	National Institutes of Health [RC2HL101864, R01HL089309]; American Diabetes Association [1-17-PDF-060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101864, R01HL089309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants RC2HL101864 and R01HL089309 (to D. J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an American Diabetes Association Postdoctoral Fellowship Grant 1-17-PDF-060.	Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; Cohen PTW, 2002, J CELL SCI, V115, P241; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; GAIN KR, 1981, J CLIN INVEST, V67, P1569, DOI 10.1172/JCI110188; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Hernaez R, 2013, CLIN GASTROENTEROL H, V11, P1183, DOI 10.1016/j.cgh.2013.02.011; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lopez-Soldado I, 2015, DIABETES, V64, P796, DOI 10.2337/db14-0728; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Palmer ND, 2013, HEPATOLOGY, V58, P966, DOI 10.1002/hep.26440; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Saitoh Y, 2010, HISTOCHEM CELL BIOL, V133, P229, DOI 10.1007/s00418-009-0663-4; STALMANS W, 1987, Diabetes Metabolism Reviews, V3, P127; Szymanska E, 2015, MOLEC GENET METAB RE, V4, P83, DOI 10.1016/j.ymgmr.2015.07.003; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tin A, 2016, DIABETIC MED, V33, P968, DOI 10.1111/dme.12971; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006	34	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10444	10454		10.1074/jbc.M116.766329	http://dx.doi.org/10.1074/jbc.M116.766329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28473467	Green Published, hybrid			2022-12-28	WOS:000404115400010
J	Kumar, H; Nguyen, QT; Binda, C; Mattevi, A; Fraaije, MW				Kumar, Hemant; Quoc-Thai Nguyen; Binda, Claudia; Mattevi, Andrea; Fraaije, Marco W.			Isolation and characterization of a thermostable F-420:NADPH oxidoreductase from Thermobifida fusca	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-420-DEPENDENT NADP REDUCTASE; NOCARDIOIDES-SIMPLEX FJ2-1A; METHANOBACTERIUM-THERMOAUTOTROPHICUM; MYCOBACTERIUM-TUBERCULOSIS; METHANOGENIC ARCHAEA; COENZYME F-420; COFACTOR; PURIFICATION; ENZYMES; 2,4,6-TRINITROPHENOL	F420H2-dependent enzymes reduce a wide range of substrates that are otherwise recalcitrant to enzyme-catalyzed reduction, and their potential for applications in biocatalysis has attracted increasing attention. Thermobifida fusca is a moderately thermophilic bacterium and holds high biocatalytic potential as a source for several highly thermostable enzymes. We report here on the isolation and characterization of a thermostable F-420: NADPH oxidoreductase (Tfu-FNO) from T. fusca, the first F-420-dependent enzyme described from this bacterium. Tfu-FNO was heterologously expressed in Escherichia coli, yielding up to 200 mg of recombinant enzyme per liter of culture. We found that Tfu-FNO is highly thermostable, reaching its highest activity at 65 degrees C and that Tfu-FNO is likely to act in vivo as an F-420 reductase at the expense of NADPH, similar to its counterpart in Streptomyces griseus. We obtained the crystal structure of FNO in complex with NADP(+) at 1.8 angstrom resolution, providing the first bacterial FNO structure. The overall architecture and NADP(+)-binding site of Tfu-FNO were highly similar to those of the Archaeoglobus fulgidus FNO (Af- FNO). The active site is located in a hydrophobic pocket between an N-terminal dinucleotide binding domain and a smaller C-terminal domain. Residues interacting with the 2' -phosphate of NADP (+) were probed by targeted mutagenesis, indicating that Thr-28, Ser-50, Arg-51, and Arg-55 are important for discriminating between NADP(+) and NAD(+). Interestingly, a T28A mutant increased the kinetic efficiency > 3-fold as compared with the wild-type enzyme when NADH is the substrate. The biochemical and structural data presented here provide crucial insights into the molecular recognition of the two cofactors, F-420 and NAD(P) H by FNO.	[Kumar, Hemant; Quoc-Thai Nguyen; Fraaije, Marco W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Enzymol Grp, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; [Quoc-Thai Nguyen] Scuola Univ Super IUSS Pavia, Piazza Vittoria 15, I-27100 Pavia, Italy; [Quoc-Thai Nguyen] Univ Med & Pharm, Fac Pharm, Ben Nghe Ward, 41 Dinh Tien Hoang St,Dist 1, Ho Chi Minh City, Vietnam; [Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, Via Ferrata 1, I-27100 Pavia, Italy	University of Groningen; IUSS PAVIA; Hochiminh City University of Medicine & Pharmacy; University of Pavia	Fraaije, MW (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Enzymol Grp, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl	Mattevi, Andrea/R-4469-2019; Kumar, Arun/C-9149-2009; mattevi, andrea/K-5464-2012	Mattevi, Andrea/0000-0002-9523-7128; Kumar, Arun/0000-0001-8422-0219; mattevi, andrea/0000-0002-9523-7128; Kumar, Hemant/0000-0003-4123-0374; Fraaije, Marco/0000-0001-6346-5014; Nguyen, Quoc-Thai/0000-0001-6315-2974	Erasmus Mundus action 2 "Svaagata" program from the European Commission; Ubbo Emmius scholarship from the University of Groningen, The Netherlands	Erasmus Mundus action 2 "Svaagata" program from the European Commission; Ubbo Emmius scholarship from the University of Groningen, The Netherlands(Netherlands Government)	This work was supported by an Erasmus Mundus action 2 "Svaagata" program from the European Commission via a Ph.D. scholarship (to H.K.) and a Ubbo Emmius scholarship from the University of Groningen, The Netherlands (to Q.-T.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Bair TB, 2001, ARCH MICROBIOL, V176, P37, DOI 10.1007/s002030100290; Berk H, 1997, ARCH MICROBIOL, V168, P396, DOI 10.1007/s002030050514; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahn JKB, 2017, ACS SYNTH BIOL, V6, P326, DOI 10.1021/acssynbio.6b00188; Carugo O, 1997, PROTEINS, V28, P29, DOI 10.1002/(SICI)1097-0134(199705)28:1<29::AID-PROT3>3.3.CO;2-C; CHEESEMAN P, 1972, J BACTERIOL, V112, P527, DOI 10.1128/JB.112.1.527-531.1972; Le CQ, 2015, PROTEIN J, V34, P391, DOI 10.1007/s10930-015-9633-y; DANIELS L, 1985, SYST APPL MICROBIOL, V6, P12, DOI 10.1016/S0723-2020(85)80004-7; DEWIT LEA, 1987, FEMS MICROBIOL LETT, V48, P121, DOI 10.1016/0378-1097(87)90147-9; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ebert S, 1999, J BACTERIOL, V181, P2669, DOI 10.1128/JB.181.9.2669-2674.1999; Ebert S, 2001, BIODEGRADATION, V12, P367, DOI 10.1023/A:1014447700775; EIRICH LD, 1984, BIOCHIM BIOPHYS ACTA, V802, P454; EKER APM, 1989, BIOCHIM BIOPHYS ACTA, V990, P80, DOI 10.1016/S0304-4165(89)80015-7; Elias DA, 2000, CAN J MICROBIOL, V46, P998, DOI 10.1139/cjm-46-11-998; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraaije MW, 2005, APPL MICROBIOL BIOT, V66, P393, DOI 10.1007/s00253-004-1749-5; Greening C, 2016, MICROBIOL MOL BIOL R, V80, P451, DOI 10.1128/MMBR.00070-15; Heiss G, 2002, MICROBIOL-SGM, V148, P799, DOI 10.1099/00221287-148-3-799; Hossain MS, 2015, ORG BIOMOL CHEM, V13, P5082, DOI 10.1039/c5ob00365b; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON F, 1984, BIOCHEMISTRY-US, V23, P979, DOI 10.1021/bi00300a028; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KUNOW J, 1993, ARCH MICROBIOL, V160, P199; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P2225, DOI 10.1007/s00253-014-6060-5; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOVOTNA J, 1989, FEMS MICROBIOL LETT, V59, P241; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Nguyen QT, 2017, APPL MICROBIOL BIOT, V101, P2831, DOI 10.1007/s00253-016-8038-y; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Taylor M, 2013, TRENDS BIOTECHNOL, V31, P63, DOI 10.1016/j.tibtech.2012.09.003; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; Wichmann R, 2005, ADV BIOCHEM ENG BIOT, V92, P225, DOI 10.1007/b98911; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	15	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10123	10130		10.1074/jbc.M117.787754	http://dx.doi.org/10.1074/jbc.M117.787754			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28411200	Green Published, hybrid			2022-12-28	WOS:000403580600023
J	Ren, DP; Fisher, LA; Zhao, J; Wang, L; Williams, BC; Goldberg, ML; Peng, AM				Ren, Dapeng; Fisher, Laura A.; Zhao, Jing; Wang, Ling; Williams, Byron C.; Goldberg, Michael L.; Peng, Aimin			Cell cycle-dependent regulation of Greatwall kinase by protein phosphatase 1 and regulatory subunit 3B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-PHASE ENTRY; XENOPUS EGG EXTRACTS; MITOTIC EXIT; MITOSIS; MASTL; CANCER; DEPHOSPHORYLATION; INACTIVATION; PROGRESSION; EXPRESSION	Greatwall (Gwl) kinase plays an essential role in the regulation of mitotic entry and progression. Mitotic activation of Gwl requires both cyclin-dependent kinase 1 (CDK1)-dependent phosphorylation and its autophosphorylation at an evolutionarily conserved serine this study we show that Gwl associates with protein phosphatase 1 (PP1), particularly PP1 gamma, which mediates the dephosphorylation of Gwl Ser-883. Consistent with the mitotic activation of Gwl, its association with PP1 is disrupted in mitotic cells and egg extracts. During mitotic exit, PP1-dependent dephosphorylation of Gwl Ser-883 occurs prior to dephosphorylation of other mitotic substrates; replacing endogenous Gwl with a phosphomimetic S883E mutant blocks mitotic exit. Moreover, we identified PP1 regulatory subunit 3B (PPP1R3B) as a targeting subunit that can direct PP1 activity toward Gwl. PPP1R3B bridges PP1 and Gwl association and promotes Gwl Ser-883 dephosphorylation. Consistent with the cell cycle-dependent association of Gwl and PP1, Gwl and PPP1R3B dissociate in M phase. Interestingly, up-regulation of PPP1R3B facilitates mitotic exit and blocks mitotic entry. Thus, our study suggests PPP1R3B as a new cell cycle regulator that functions by governing Gwl dephosphorylation.	[Ren, Dapeng; Fisher, Laura A.; Zhao, Jing; Wang, Ling; Peng, Aimin] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA; [Williams, Byron C.; Goldberg, Michael L.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Cornell University	Peng, AM (corresponding author), Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA.	Aimin.Peng@UNMC.edu	ren, dapeng/AAF-1737-2020	WILLIAMS, BYRON/0000-0002-1517-931X	National Institutes of Health [1R01CA172574, 5P20GM103489]; NATIONAL CANCER INSTITUTE [R01CA172574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048430, P30GM106397, P20GM103489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 1R01CA172574 and 5P20GM103489 (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; Anania MC, 2015, ONCOTARGET, V6, P34629, DOI 10.18632/oncotarget.5282; Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Blake-Hodek KA, 2012, MOL CELL BIOL, V32, P1337, DOI 10.1128/MCB.06525-11; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Della Monica R, 2015, ELIFE, V4, DOI 10.7554/eLife.10399; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Fisher LA, 2014, J BIOL CHEM, V289, P23745, DOI 10.1074/jbc.M114.572149; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Glover DM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120023; Goldberg ML, 2010, P NATL ACAD SCI USA, V107, P12409, DOI 10.1073/pnas.1006046107; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Hegarat N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004004; Heim A, 2015, EMBO REP, V16, P1501, DOI 10.15252/embr.201540876; Hunt Tim, 2013, Adv Biol Regul, V53, P173, DOI 10.1016/j.jbior.2013.04.001; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Li Y, 2015, CELL MOL BIOL, V61, P2; Lorca T, 2013, ONCOGENE, V32, P537, DOI 10.1038/onc.2012.79; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Ma S, 2016, J CELL SCI, V129, P1329, DOI 10.1242/jcs.178855; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Mochida S, 2016, CURR BIOL, V26, P3361, DOI 10.1016/j.cub.2016.10.022; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nagel R, 2015, MOL CANCER THER, V14, P1434, DOI 10.1158/1535-7163.MCT-14-0846; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peng AM, 2011, J BIOL CHEM, V286, P28996, DOI 10.1074/jbc.M111.257121; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Rebelo S, 2015, CELL SIGNAL, V27, P2589, DOI 10.1016/j.cellsig.2015.08.007; Rogers S, 2016, J CELL SCI, V129, P1340, DOI 10.1242/jcs.179754; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Vera J, 2015, ELIFE, V4, DOI 10.7554/eLife.10115; Vigneron S, 2011, MOL CELL BIOL, V31, P2262, DOI 10.1128/MCB.00753-10; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wang L, 2014, ONCOTARGET, V5, P11479, DOI 10.18632/oncotarget.2565; Wang L, 2011, HYBRIDOMA, V30, P469, DOI 10.1089/hyb.2011.0051; Wang P, 2016, CELL CYCLE, V15, P528, DOI 10.1080/15384101.2015.1127476; Wang P, 2013, J CELL BIOL, V202, P277, DOI 10.1083/jcb.201211141; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Yamamoto TM, 2011, MOL BIOL CELL, V22, P2157, DOI 10.1091/mbc.E11-01-0008; YANAGIDA M, 1992, CIBA F SYMP, V170, P130; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	52	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10026	10034		10.1074/jbc.M117.778233	http://dx.doi.org/10.1074/jbc.M117.778233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446604	Green Published, hybrid			2022-12-28	WOS:000403580600015
J	Wang, CY; Sun, MH; Yuan, XH; Ji, LF; Jin, Y; Cardona, CJ; Xing, Z				Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu; Cardona, Carol J.; Xing, Zheng			Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-alpha 1 degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR IMPORT; MOUTH-DISEASE; ANTIVIRAL RESPONSES; PROTEIN; VIRUS; ALPHA; ANTAGONIZES; INFECTION; PATHWAYS; CLEAVAGE	Enterovirus 71 (EV71) has emerged as one of the most important enteroviruses since the eradication of poliovirus, and it causes severe neurological symptoms for which no effective antiviral drugs are available. Type I interferons (IFN)alpha/beta have been used clinically as antiviral therapy as the first line of defense against virus infections successfully for decades. However, treatment with type I interferons has not been effective in patients with EV71 infection. In this study, we found that in cells pretreated with IFN-beta, EV71 infection could still lead to a cytopathic effect, and the viral replication was not affected. The mechanism by which EV71 antagonizes interferon signaling, however, has been controversial. Our study indicated that EV71 infection did not inhibit phosphorylation of STAT1/2 induced by IFN-beta stimulation, but p-STAT1/2 transport into the nucleus was significantly blocked. We showed that EV71 infection reduced the formation of STAT/karyopherin-alpha 1 (KPNA1) complex upon interferon stimulation and that the virus down-regulated the expression of KPNA1, a nuclear localization signal receptor for p-STAT1. Using specific caspase inhibitors and siRNA for caspase-3, we demonstrated that EV71 infection induced degradation of cellular KPNA1 in a caspase-3-dependent manner, which led to decreased induction of interferon-inducible genes and IFN response. Viral 2A and 3C proteases did not degrade KPNA1, inhibit the activity of ISRE or suppress the transcription of interferon-inducible genes induced by IFN-beta. Our study demonstrates a novel mechanism by which antiviral signaling is suppressed through degradation of KPNA1 by activated caspase-3 induced in an enteroviral infection.	[Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu; Xing, Zheng] Nanjing Univ, Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu; Xing, Zheng] Nanjing Univ, Jiangsu Prov Key Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Chunyang] Xian Med Univ, Clin Med Coll, Xian 710021, Peoples R China; [Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA	Nanjing University; Nanjing University; Xi'an Medical University; Nanjing Medical University; University of Minnesota System; University of Minnesota Twin Cities	Jin, Y (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing 210029, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota Twin Cities, 300D Vet Sci Bldg,1971 Commonwealth Ave, St Paul, MN 55108 USA.	jinyuldyy@163.com; zxing@umn.edu	Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China [81571993]; Natural Science Foundation of Jiangsu Province [BK20141078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grant 81571993 (to Z. X.) and Natural Science Foundation of Jiangsu Province Grant BK20141078 (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Best SM, 2002, VIROLOGY, V292, P224, DOI 10.1006/viro.2001.1238; Chi CZ, 2013, VIRUS RES, V176, P53, DOI 10.1016/j.virusres.2013.05.002; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Du YJ, 2014, J VIROL, V88, P4908, DOI 10.1128/JVI.03668-13; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93; Johnson CL, 2006, TRENDS IMMUNOL, V27, P1, DOI 10.1016/j.it.2005.11.004; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Liang CY, 2015, NAT REV MICROBIOL, V13, P7, DOI 10.1038/nrmicro3369; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Liu Y, 2014, VIRAL IMMUNOL, V27, P267, DOI 10.1089/vim.2013.0127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152177; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yi LN, 2011, ANTIVIR THER, V16, P51, DOI 10.3851/IMP1720; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	36	40	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10262	10274		10.1074/jbc.M116.745729	http://dx.doi.org/10.1074/jbc.M116.745729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455446	hybrid, Green Published			2022-12-28	WOS:000403580600034
J	Wang, JL; Saha, TT; Zhang, Y; Zhang, CY; Raikhel, AS				Wang, Jia-Lin; Saha, Tusar T.; Zhang, Yang; Zhang, Changyu; Raikhel, Alexander S.			Juvenile hormone and its receptor methoprene-tolerant promote ribosomal biogenesis and vitellogenesis in the Aedes aegypti mosquito	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL HOMOLOG 1; FAT-BODY; SACCHAROMYCES-CEREVISIAE; REPRODUCTIVE PROCESSES; GENE-EXPRESSION; YELLOW-FEVER; PROTEINS; EMERGENCE; 20-HYDROXYECDYSONE; DYNAMICS	Juvenile hormone (JH) controls many biological activities in insects, including development, metamorphosis, and reproduction. In the Aedes aegypti mosquito, a vector of dengue, yellow fever, chikungunya, and zika viruses, the metabolic tissue (the fat body, which is an analogue of the vertebrate liver) produces yolk proteins for developing oocytes. JH is important for the fat body to acquire competence for yolk protein production. However, the molecular mechanisms of how JH promotes mosquito reproduction are not completely understood. In this study we show that stimulation of the JH receptor methoprene-tolerant (Met) activates expression of genes encoding the regulator of ribosome synthesis 1 (RRS1) and six ribosomal proteins (two ribosomal large subunit proteins, two ribosomal small subunit proteins, and two mitochondrial ribosomal proteins). Moreover, RNAi-mediated depletion of RRS1 decreased biosynthesis of the ribosomal protein L32 (RpL32). Depletion of Met, RRS1, or RpL32 led to retardation of ovarian growth and reduced mosquito fecundity, which may at least in part have resulted from decreased vitellogenin protein production in the fat body. In summary, our results indicate that JH is critical for inducing the expression of ribosomal protein genes and demonstrate that RRS1 mediates the JH signal to enhance both ribosomal biogenesis and vitellogenesis.	[Wang, Jia-Lin; Saha, Tusar T.; Zhang, Yang; Zhang, Changyu; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Wang, Jia-Lin] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Saha, Tusar T.; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA; [Zhang, Yang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China; [Zhang, Changyu] Guizhou Univ, Coll Agr, Guizhou Key Lab Plant Pest Management Mt Reg, Guiyang 550025, Peoples R China	University of California System; University of California Riverside; Central China Normal University; University of California System; University of California Riverside; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Guizhou University	Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.	alexander.raikhel@ucr.edu		Zhang, Yang/0000-0002-0789-4938	National Institutes of Health [R01 AI036959]; China Scholarship Council of Chinese Ministry of Education [201506775010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council of Chinese Ministry of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI036959 (to A. S. R.). This work was also supported by Scholar Fellowship 201506775010 (to J.-L. W.) from the China Scholarship Council of Chinese Ministry of Education. The authors declare that they have no conflicts of interest regarding the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Belles X, 2005, REPRO BIOL, V12, P157; Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; Ernst KC, 2017, J MED ENTOMOL, V54, P204, DOI 10.1093/jme/tjw141; Estep AS, 2016, J INSECT PHYSIOL, V90, P17, DOI 10.1016/j.jinsphys.2016.05.001; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; He F, 2015, CHROMOSOMA, V124, P191, DOI 10.1007/s00412-014-0490-9; James A, 2013, NUCLEUS-PHILA, V4, P123, DOI 10.4161/nucl.23944; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kim M, 2010, J COMP PHYSIOL B, V180, P171, DOI 10.1007/s00360-009-0406-9; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P879, DOI 10.1016/0022-1910(86)90103-4; RAIKHEL AS, 1991, TISSUE CELL, V23, P577, DOI 10.1016/0040-8166(91)90015-L; RAIKHEL AS, 1990, GEN COMP ENDOCR, V77, P423, DOI 10.1016/0016-6480(90)90233-C; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Roy S, 2016, ADV INSECT PHYSIOL, V51, P115, DOI 10.1016/bs.aiip.2016.05.004; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhao B, 2016, INSECT BIOCHEM MOLEC, V77, P69, DOI 10.1016/j.ibmb.2016.08.003; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	40	31	31	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10306	10315		10.1074/jbc.M116.761387	http://dx.doi.org/10.1074/jbc.M116.761387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446607	Green Published, hybrid			2022-12-28	WOS:000403580600038
J	Wu, DL; Zhao, LH; Feng, ZT; Yu, C; Ding, J; Wang, LY; Wang, F; Liu, D; Zhu, HH; Xing, FY; Conaway, JW; Conaway, RC; Cai, Y; Jin, JJ				Wu, Donglu; Zhao, Linhong; Feng, Zhitong; Yu, Chao; Ding, Jian; Wang, Lingyao; Wang, Fei; Liu, Da; Zhu, Huihui; Xing, Feiyang; Conaway, Joan W.; Conaway, Ronald C.; Cai, Yong; Jin, Jingji			O-Linked N-acetylglucosamine transferase 1 regulates global histone H4 acetylation via stabilization of the nonspecific lethal protein NSL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; SUBSTRATE-SPECIFICITY; CYTOSOLIC PROTEINS; GENE-EXPRESSION; MSL COMPLEX; GLCNACYLATION; NUCLEAR; CHROMATIN; OGT; STABILITY	The human males absent on the first (MOF)-containing histone acetyltransferase nonspecific lethal (NSL) complex comprises nine subunits including the O-linked N-acetylglucosamine (O-GlcNAc) transferase, isoform 1 (OGT1). However, whether the O-GlcNAc transferase activity of OGT1 controls histone acetyltransferase activity of the NSL complex and whether OGT1 physically interacts with the other NSL complex subunits remain unclear. Here, we demonstrate that OGT1 regulates the activity of the NSL complex by mainly acetylating histone H4 Lys-16, Lys-5, and Lys-8 via O-GlcNAcylation and stabilization of the NSL complex subunit NSL3. Knocking down or overexpressing OGT1 in human cells remarkably affected the global acetylation of histone H4 residues Lys-16, Lys-5, and Lys-8. Because OGT1 is a subunit of the NSL complex, we also investigated the function of OGT1 in this complex. Co-transfection/co-immunoprecipitation experiments combined with in vitro O-GlcNAc transferase assays confirmed that OGT1 specifically binds to and O-GlcNAcylates NSL3. In addition, wheat germ agglutinin affinity purification verified the occurrence of O-GlcNAc modification on NSL3 in cells. Moreover, O-GlcNAcylation of NSL3 by wild-type OGT1 (OGT1-WT) stabilized NSL3. This stabilization was lost after co-transfection of NSL3 with an OGT1 mutant, OGT1(C964A), that lacks O-GlcNAc transferase activity. Furthermore, stabilization of NSL3 by OGT1-WT significantly increased the global acetylation levels of H4 Lys-5, Lys-8, and Lys-16 in cells. These results suggest that OGT1 regulates the activity of the NSL complex by stabilizing NSL3.	[Wu, Donglu; Zhao, Linhong; Feng, Zhitong; Yu, Chao; Ding, Jian; Wang, Lingyao; Wang, Fei; Zhu, Huihui; Xing, Feiyang; Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Sch Life Sci, Changchun 130012, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China; [Liu, Da] Changchun Univ Chinese Med, Sch Pharm, Changchun 130117, Peoples R China; [Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Lawrence, KS 66045 USA	Jilin University; Jilin University; Jilin University; Changchun University of Chinese Medicine; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Cai, Y; Jin, JJ (corresponding author), Jilin Univ, Minist Educ, Sch Life Sci, Changchun 130012, Peoples R China.; Cai, Y; Jin, JJ (corresponding author), Jilin Univ, Minist Educ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China.; Cai, Y; Jin, JJ (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China.	caiyong62@jlu.edu.cn; jjjin@jlu.edu.cn			National Natural Science Foundation of China [31571316, 31371311]; Project of Jilin Province Science and Technology Development Program [20140414057GH]; Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences [KLRB201303, KLRB201504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Jilin Province Science and Technology Development Program; Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 31571316 and 31371311; Project of Jilin Province Science and Technology Development Program Grant 20140414057GH; and Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences Grants KLRB201303 and KLRB201504. The authors declare that they have no conflicts of interest with the contents of this article.	Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Dehennaut V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00155; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Ding XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145023; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hansen BF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034274; Hardiville S, 2016, CURR OPIN CHEM BIOL, V33, P88, DOI 10.1016/j.cbpa.2016.06.005; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lercher L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8978; Liu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141014; Liu Y, 2015, ONCOTARGET, V6, P14497, DOI 10.18632/oncotarget.3988; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Meunier S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8889; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Ronningen T, 2015, GENOME RES, V25, P1825, DOI 10.1101/gr.193748.115; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhao XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003940; Zhou XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030340	36	12	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10014	10025		10.1074/jbc.M117.781401	http://dx.doi.org/10.1074/jbc.M117.781401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450392	hybrid, Green Published			2022-12-28	WOS:000403580600014
J	Pham, ND; Pang, PC; Krishnamurthy, S; Wands, AM; Grassi, P; Dell, A; Haslam, SM; Kohler, JJ				Pham, Nam D.; Pang, Poh-Choo; Krishnamurthy, Soumya; Wands, Amberlyn M.; Grassi, Paola; Dell, Anne; Haslam, Stuart M.; Kohler, Jennifer J.			Effects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; PHOTO-CROSS-LINKING; SKELETAL-MUSCLE; RIMMED VACUOLES; DISTAL MYOPATHY; MASS-SPECTROMETRY; GENE-EXPRESSION; GNE MUTATIONS; STEM-CELLS; O-GLCNAC	GNE (UDP-GlcNAc 2-epimerase/ManNAc kinase) myopathy is a rare muscle disorder associated with aging and is related to sporadic inclusion body myositis, the most common acquired muscle disease of aging. Although the cause of sporadic inclusion body myositis is unknown, GNE myopathy is associated with mutations in GNE. GNE harbors two enzymatic activities required for biosynthesis of sialic acid in mammalian cells. Mutations to both GNE domains are linked to GNE myopathy. However, correlation between mutation-associated reductions in sialic acid production and disease severity is imperfect. To investigate other potential effects of GNE mutations, we compared sialic acid production in cell lines expressing wild type or mutant forms of GNE. Although we did not detect any differences attributable to disease-associated mutations, lectin binding and mass spectrometry analysis revealed that GNE deficiency is associated with unanticipated effects on the structure of cell-surface glycans. In addition to exhibiting low levels of sialylation, GNE-deficient cells produced distinct N-linked glycan structures with increased branching and extended poly-N-acetyllactosamine. GNE deficiency may affect levels of UDPGlcNAc, a key metabolite in the nutrient-sensing hexosamine biosynthetic pathway, but this modest effect did not fully account for the change in N-linked glycan structure. Furthermore, GNE deficiency and glucose supplementation acted independently and additively to increase N-linked glycan branching. Notably, N-linked glycans produced by GNE-deficient cells displayed enhanced binding to galectin-1, indicating that changes in GNE activity can alter affinity of cell-surface glycoproteins for the galectin lattice. These findings suggest an unanticipated mechanism by which GNE activity might affect signaling through cell-surface receptors.	[Pham, Nam D.; Krishnamurthy, Soumya; Wands, Amberlyn M.; Kohler, Jennifer J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pang, Poh-Choo; Grassi, Paola; Dell, Anne; Haslam, Stuart M.] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; Imperial College London	Kohler, JJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Jennifer.Kohler@UTSouthwestern.edu	; Kohler, Jennifer/B-6589-2009	Pham, Nam/0000-0002-1954-314X; Dell, Anne/0000-0003-1380-2347; Kohler, Jennifer/0000-0001-5373-3329	National Institutes of Health [R01GM090271]; Cancer Prevention and Research Institute of Texas [RP110080]; Welch Foundation [I-1686]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; National Institutes of Health Predoctoral Fellowship [F30AG040909]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG040909] Funding Source: NIH RePORTER; BBSRC [BB/K016164/1, BB/F008309/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM090271. This work was also supported by Cancer Prevention and Research Institute of Texas (RP110080), the Welch Foundation (I-1686), and Grants BB/K016164/1 and BB/F008309/1 from the Biotechnology and Biological Sciences Research Council (to A. D. and S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Predoctoral Fellowship F30AG040909.	Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; Bond MR, 2011, BIOCONJUGATE CHEM, V22, P1811, DOI 10.1021/bc2002117; Bond MR, 2009, NAT PROTOC, V4, P1044, DOI 10.1038/nprot.2009.85; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Celeste FV, 2014, HUM MUTAT, V35, P915, DOI 10.1002/humu.22583; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cerri DG, 2008, GLYCOBIOLOGY, V18, P842, DOI 10.1093/glycob/cwn079; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Cheung P, 2007, GLYCOBIOLOGY, V17, P828, DOI 10.1093/glycob/cwm048; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Goldring K, 2002, J CELL SCI, V115, P355; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Johswich A, 2014, J BIOL CHEM, V289, P15927, DOI 10.1074/jbc.M114.563734; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Kemmner W, 2012, FASEB J, V26, P938, DOI 10.1096/fj.11-186700; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Kolarich D, 2013, MOL CELL PROTEOMICS, V12, P991, DOI 10.1074/mcp.O112.026492; Kontou M, 2008, GLYCOCONJUGATE J, V25, P237, DOI 10.1007/s10719-008-9104-1; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; Nishino I, 2015, J NEUROL NEUROSUR PS, V86, P385, DOI 10.1136/jnnp-2013-307051; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Oetke C, 2003, BIOCHEM BIOPH RES CO, V308, P892, DOI 10.1016/S0006-291X(03)01471-2; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Penner J, 2006, BIOCHEMISTRY-US, V45, P2968, DOI 10.1021/bi0522504; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Pham ND, 2015, GLYCOCONJUGATE J, V32, P515, DOI 10.1007/s10719-015-9593-7; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Weidemann W, 2010, GLYCOBIOLOGY, V20, P107, DOI 10.1093/glycob/cwp153; Yu SH, 2012, P NATL ACAD SCI USA, V109, P4834, DOI 10.1073/pnas.1114356109; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	59	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9637	9651		10.1074/jbc.M116.764597	http://dx.doi.org/10.1074/jbc.M116.764597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28424265	Green Published, hybrid			2022-12-28	WOS:000403113000015
J	Zhang, Y; Zhou, Q				Zhang, Ying; Zhou, Qi			A single-cell snapshot of cell-fate decisions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MOUSE EMBRYO	Critical steps in the specification of embryonic cell lineages occur after implantation, but gaining insight into the molecular details of these cellular processes in vivo has been challenging. Jin and co-workers now report the transcriptomic signatures and molecular heterogeneity of more than 600 single cells from mouse embryos at days 5.5 and 6.5, advancing our understanding of how early embryonic cells make cell-fate decisions into mesoderm and endoderm lineages.	[Zhang, Ying; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zhou, Q (corresponding author), 1 Beichen West Rd, Beijing 100101, Peoples R China.	qzhou@ioz.ac.cn			Key Research Projects of the Frontier Science of the Chinese Academy of Sciences [QYZDY-SSW-SMC002]	Key Research Projects of the Frontier Science of the Chinese Academy of Sciences	This work was supported in part by the Key Research Projects of the Frontier Science of the Chinese Academy of Sciences (QYZDY-SSW-SMC002 (to Q.Z.)). The authors declare that they have no conflicts of interest with the contents of this article.	Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Wen J, 2017, J BIOL CHEM, V292, P9840, DOI 10.1074/jbc.M117.780585; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	9	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9855	+		10.1074/jbc.H117.780585	http://dx.doi.org/10.1074/jbc.H117.780585			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28600307	Green Published, hybrid			2022-12-28	WOS:000403113000032
J	Tikhanovich, I; Zhao, J; Bridges, B; Kumer, S; Roberts, B; Weinman, SA				Tikhanovich, Irina; Zhao, Jie; Bridges, Brian; Kumer, Sean; Roberts, Ben; Weinman, Steven A.			Arginine methylation regulates c-Myc-dependent transcription by altering promoter recruitment of the acetyltransferase p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; MACROPHAGES; METHYLTRANSFERASE; RESPONSES; CARM1; PRMT1	Protein arginine methyltransferase 1 (PRMT1) is an essential enzyme controlling about 85% of the total cellular arginine methylation in proteins. We have shown previously that PRMT1 is an important regulator of innate immune responses and that it is required for M2 macrophage differentiation. c-Myc is a transcription factor that is critical in regulating cell proliferation and also regulates the M2 transcriptional program in macrophages. Here, we sought to determine whether c-Myc in myeloid cells is regulated by PRMT1-dependent arginine methylation. We found that PRMT1 activity was necessary for c-Myc binding to the acetyltransferase p300. PRMT1 inhibition decreased p300 recruitment to c-Myc target promoters and increased histone deacetylase 1 (HDAC1) recruitment, thereby decreasing transcription at these sites. Moreover, PRMT1 inhibition blocked c-Myc-mediated induction of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG) and mannose receptor C-type 1 (MRC1), suggesting that PRMT1 is necessary for c-Myc function in M2 macrophage differentiation. Of note, in primary human blood monocytes, p300-c-Myc binding was strongly correlated with PRMT1 expression, and in liver sections, PRMT1, c-Myc, and M2 macrophage levels were strongly correlated with each other. Both PRMT1 levels and M2 macrophage numbers were significantly lower in livers from individuals with a history of spontaneous bacterial peritonitis, known to have defective cellular immunity. In conclusion, our findings demonstrate that PRMT1 is an important regulator of c-Myc function in myeloid cells. PRMT1 loss in individuals with cirrhosis may contribute to their immune defects.	[Tikhanovich, Irina; Zhao, Jie; Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd,Mail Stop 1018, Kansas City, KS 66160 USA; [Bridges, Brian; Roberts, Ben; Weinman, Steven A.] Univ Kansas, Med Ctr, Liver Ctr, Kansas City, KS 66160 USA; [Kumer, Sean] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd,Mail Stop 1018, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Tikhanovich, Irina/GOK-0267-2022		National Institutes of Health from the National Institute on Alcohol Abuse and Alcoholism [AA012863]; NCRR/NIH from NIGMS Centers of Biomedical Research Excellence (COBRE) [P20 RR021940]; American Association for the Study of Liver Diseases (AASLD); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCRR/NIH from NIGMS Centers of Biomedical Research Excellence (COBRE); American Association for the Study of Liver Diseases (AASLD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants AA012863 from the National Institute on Alcohol Abuse and Alcoholism and NCRR/NIH P20 RR021940 from NIGMS Centers of Biomedical Research Excellence (COBRE). This work also was supported by Pinnacle Research Award 2016 from the American Association for the Study of Liver Diseases (AASLD). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ambade A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1221557; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; Cho MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8821; Croasdell A, 2015, PPAR RES, V2015, DOI 10.1155/2015/549691; Cui YL, 2013, ASIAN PAC J CANCER P, V14, P1003, DOI 10.7314/APJCP.2013.14.2.1003; Davies John Q, 2005, Methods Mol Biol, V290, P91; Eberhardt A, 2016, ONCOTARGET, V7, P63629, DOI 10.18632/oncotarget.11556; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Shirabe K, 2012, SURG TODAY, V42, P1, DOI 10.1007/s00595-011-0058-8; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Tikhanovich I, 2015, HEPATOLOGY, V62, p846A; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yeung OWH, 2015, J HEPATOL, V62, P607, DOI 10.1016/j.jhep.2014.10.029; Zingarelli B, 2005, SHOCK, V23, P393, DOI 10.1097/01.shk.0000160521.91363.88	31	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13333	13344		10.1074/jbc.M117.797928	http://dx.doi.org/10.1074/jbc.M117.797928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28652407	Green Published, hybrid			2022-12-28	WOS:000407465300020
J	Guengerich, FP				Guengerich, F. Peter			Introduction to Metals in Biology 2017: Iron transport, storage, and the ramifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						iron metabolism; metals; metal; metal homeostasis; metal ion-protein interaction; metalloprotein	MINIREVIEW SERIES METALS; PROTEINS; HOMEOSTASIS; BIOGENESIS	In this tenth Thematic Series in Metals in Biology, six Minireviews deal with aspects of iron metabolism. A number of important proteins control iron homeostasis, including hepcidin and ferroportin, in various cells. Other aspects of iron dealt with here include biogenesis of iron-sulfur proteins and chaperones that deliver iron cofactors in cells. Additionally, an iron-regulated metastasis suppressor interacts with the epidermal growth factor receptor and mediates its downstream signaling activity.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu						Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Guengerich FP, 2016, J BIOL CHEM, V291, P20838, DOI 10.1074/jbc.R116.749259; Guengerich FP, 2015, J BIOL CHEM, V290, P20700, DOI 10.1074/jbc.R115.675652; Guengerich FP, 2015, J BIOL CHEM, V290, P18943, DOI 10.1074/jbc.R115.670265; Guengerich FP, 2014, J BIOL CHEM, V289, P28094, DOI 10.1074/jbc.R114.607093; Guengerich FP, 2013, J BIOL CHEM, V288, P13164, DOI 10.1074/jbc.R113.467712; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Knutson MD, 2017, J BIOL CHEM, V292, P12735, DOI 10.1074/jbc.R117.786632; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; Philpott CC, 2017, J BIOL CHEM, V292, P12764, DOI 10.1074/jbc.R117.791962; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Tokar EJ., 2013, CASARETT DOULLS ESSE, V8th, P1009	16	2	2	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12725	12726		10.1074/jbc.R117.801332	http://dx.doi.org/10.1074/jbc.R117.801332			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615455	hybrid, Green Published			2022-12-28	WOS:000407220100001
J	Sun, Q; Zhao, Y; Yang, YX; Yang, X; Li, MH; Xu, X; Wen, D; Wang, JS; Zhang, JF				Sun, Qi; Zhao, Yue; Yang, Yunxia; Yang, Xiao; Li, Minghui; Xu, Xi; Wen, Dan; Wang, Junsong; Zhang, Jianfa			Loss of the clock protein PER2 shortens the erythrocyte life span in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; clock gene; energy metabolism; erythrocyte; Na; K plus -ATPase	RED-BLOOD-CELL; HEMOLYTIC-ANEMIA; BONE-MARROW; GENE-EXPRESSION; IN-VIVO; CIRCADIAN VARIATIONS; PEROXIREDOXIN-II; OXIDATIVE-STRESS; MEMBRANE; ATPASE	Cell proliferation and release from the bone marrow have been demonstrated to be controlled by circadian rhythms in both humans and mice. However, it is unclear whether local circadian clocks in the bone marrow influence physiological functions and life span of erythrocytes. Here, we report that loss of the clock gene Per2 significantly decreased erythrocyte life span. Mice deficient in Per2 were more susceptible to acute stresses in the erythrocytes, becoming severely anemic upon phenylhydrazine, osmotic, and H2O2 challenges. H-1 NMR-based metabolomics analysis revealed that the Per2 depletion causes significant changes in metabolic profiles of erythrocytes, including increased lactate and decreased ATP levels compared with wild-type mice. The lower ATP levels were associated with hyperfunction of Na+/K+-ATPase activity in Per2-null erythrocytes, and inhibition of Na+/K+-ATPase activity by ouabain efficiently rescued ATP levels. Per2-null mice displayed increased levels of Na+/K+-ATPase 1 (ATP1A1) in the erythrocyte membrane, and transfection of Per2 cDNA into the erythroleukemic cell line TF-1 inhibited Atp1a1 expression. Furthermore, we observed that PER2 regulates Atp1a1 transcription through interacting with trans-acting transcription factor 1 (SP1). Our findings reveal that Per2 function in the bone marrow is required for the regulation of life span in circulating erythrocytes.	[Sun, Qi; Zhao, Yue; Yang, Yunxia; Yang, Xiao; Li, Minghui; Xu, Xi; Wen, Dan; Wang, Junsong; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, 200 Xiaolingwei, Nanjing 210094, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, 200 Xiaolingwei, Nanjing 210094, Jiangsu, Peoples R China.	jfzhang@mail.njust.edu.cn	Zhao, Yue/AAJ-4026-2021	Zhao, Yue/0000-0003-2869-5257; Li, Minghui/0000-0003-4643-2303	973 Program of China [2013CB945203]; National Science Foundation of China [31671220, 31471111]	973 Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program of China Grant 2013CB945203 and National Science Foundation of China Grants 31671220 and 31471111. The authors declare that they have no conflicts of interest with the contents of this article.	Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Bae K, 2006, MOL CELLS, V22, P275; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACK JA, 1979, AM J HUM GENET, V31, P300; CASTANO JG, 1979, J BIOL CHEM, V254, P5576; Chakravarty S, 2011, CELL MOL BIOL, V57, P80, DOI 10.1170/T905; Chen YG, 2000, BIOCHEM BIOPH RES CO, V276, P724, DOI 10.1006/bbrc.2000.3536; Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111; Cho J, 2015, CELL DEATH DIFFER, V22, P1437, DOI 10.1038/cdd.2014.230; CLARK RH, 1969, SCIENCE, V166, P236, DOI 10.1126/science.166.3902.236; De Franceschi L, 2005, BLOOD, V106, P1454, DOI 10.1182/blood-2005-01-0368; DESANCHEZ VC, 1983, LIFE SCI, V33, P1057, DOI 10.1016/0024-3205(83)90661-6; DESFORGES JF, 1965, NEW ENGL J MED, V273, P1310, DOI 10.1056/NEJM196512092732405; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; ELUWA EO, 1987, BIOCHEM MED METAB B, V38, P142, DOI 10.1016/0885-4505(87)90073-9; ETIEMBLE J, 1976, HUM GENET, V31, P83, DOI 10.1007/BF00270403; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GANZONI AM, 1971, J CLIN INVEST, V50, P1373, DOI 10.1172/JCI106619; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; Hartley PS, 2009, BRIT J HAEMATOL, V146, P185, DOI 10.1111/j.1365-2141.2009.07722.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hortle E, 2016, BLOOD, V128, P1290, DOI 10.1182/blood-2015-09-666834; Huang YX, 2011, J CELL MOL MED, V15, P2634, DOI 10.1111/j.1582-4934.2011.01310.x; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kedzierska K, 2005, BIOL TRACE ELEM RES, V107, P21, DOI 10.1385/BTER:107:1:021; KEITT AS, 1969, J CLIN INVEST, V48, P1997, DOI 10.1172/JCI106165; LAERUM CD, 1988, CHRONOBIOL INT, V5, P19, DOI 10.3109/07420528809078549; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Leitch JM, 2007, AM J PHYSIOL-CELL PH, V292, pC974, DOI 10.1152/ajpcell.00335.2006; LUTHRA MG, 1982, BLOOD, V60, P1332; MAGNANI M, 1983, MECH AGEING DEV, V22, P295, DOI 10.1016/0047-6374(83)90084-2; Mairbaurl H, 2000, AM J PHYSIOL-CELL PH, V279, pC1621, DOI 10.1152/ajpcell.2000.279.5.C1621; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; NEWSOMETABATABAI R, 1984, COMP BIOCHEM PHYS A, V78, P779, DOI 10.1016/0300-9629(84)90633-9; Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13; Pasqualetti P, 1988, Quad Sclavo Diagn, V24, P89; PETERS LL, 2001, HEMATOPOIESIS DEV AP, P582; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; REINILA M, 1982, ANAL BIOCHEM, V124, P19, DOI 10.1016/0003-2697(82)90214-7; Robledo RF, 2008, BLOOD, V112, P4298, DOI 10.1182/blood-2008-05-156000; Sandoval S, 2012, BLOOD, V120, P155, DOI 10.1182/blood-2011-05-357418; Smaaland Rune, 1995, In Vivo (Attiki), V9, P379; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; SUPLOTOV SN, 1986, LAB DELO, P459; SUZUKI M, 1992, COMP BIOCHEM PHYS B, V103, P859, DOI 10.1016/0305-0491(92)90205-6; Swoyer J, 1987, Prog Clin Biol Res, V227A, P281; SYLLMRAPOPORT I, 1965, DEUT MED WOCHENSCHR, V90, P290, DOI 10.1055/s-0028-1111334; TALANSKY BE, 1987, J REPROD FERTIL, V79, P447, DOI 10.1530/jrf.0.0790447; TOZZICIANCARELLI MG, 1992, CELL MOL BIOL, V38, P303; Tsinkalovsky O, 2005, EXP HEMATOL, V33, P100, DOI 10.1016/j.exphem.2004.09.007; Tsinkalovsky O, 2007, J BIOL RHYTHM, V22, P140, DOI 10.1177/0748730406299078; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Vokurkova M, 2016, PHYSIOL RES, V65, P91, DOI 10.33549/physiolres.933326; VORGER P, 1985, COMP BIOCHEM PHYS A, V82, P221, DOI 10.1016/0300-9629(85)90730-3; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yamasaki M, 2009, J PARASITOL, V95, P1532, DOI 10.1645/GE-2036.1; Yerer MB, 2006, CLIN HEMORHEOL MICRO, V35, P143; Yokoyama U, 1971, Nihon Shonika Gakkai Zasshi, V75, P341; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102; Zhao Y, 2012, FEBS LETT, V586, P1306, DOI 10.1016/j.febslet.2012.03.034; Zhao Y, 2011, THROMB RES, V127, P122, DOI 10.1016/j.thromres.2010.11.025; Zidova Z, 2014, CELL PHYSIOL BIOCHEM, V34, P2221, DOI 10.1159/000369665	68	9	9	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12679	12690		10.1074/jbc.M117.783985	http://dx.doi.org/10.1074/jbc.M117.783985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28607147	Green Published, hybrid			2022-12-28	WOS:000406636900031
J	Mina, JG; Thye, JK; Alqaisi, AQI; Bird, LE; Dods, RH; Groftehauge, MK; Mosely, JA; Pratt, S; Shams-Eldin, H; Schwarz, RT; Pohl, E; Denny, PW				Mina, John G.; Thye, Julie K.; Alqaisi, Amjed Q. I.; Bird, Louise E.; Dods, Robert H.; Groftehauge, Morten K.; Mosely, Jackie A.; Pratt, Steven; Shams-Eldin, Hosam; Schwarz, Ralph T.; Pohl, Ehmke; Denny, Paul W.			Functional and phylogenetic evidence of a bacterial origin for the first enzyme in sphingolipid biosynthesis in a phylum of eukaryotic protozoan parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PALMITOYLTRANSFERASE; APICOMPLEXAN PARASITE; DE-NOVO; SOLUTION SCATTERING; TOXOPLASMA; SACCHAROMYCES; PROTEIN; TRAFFICKING; APICOPLAST; SEQUENCE	Toxoplasma gondii is an obligate, intracellular eukaryotic apicomplexan protozoan parasite that can cause fetal damage and abortion in both animals and humans. Sphingolipids are essential and ubiquitous components of eukaryotic membranes that are both synthesized and scavenged by the Apicomplexa. Here we report the identification, isolation, and analyses of the Toxoplasma serine palmitoyltransferase, an enzyme catalyzing the first and rate-limiting step in sphingolipid biosynthesis: the condensation of serine and palmitoyl-CoA. In all eukaryotes analyzed to date, serine palmitoyltransferase is a highly conserved heterodimeric enzyme complex. However, biochemical and structural analyses demonstrated the apicomplexan orthologue to be a functional, homodimeric serine palmitoyltransferase localized to the endoplasmic reticulum. Furthermore, phylogenetic studies indicated that it was evolutionarily related to the prokaryotic serine palmitoyltransferase, identified in the Sphingomonadaceae as a soluble homodimeric enzyme. Therefore this enzyme, conserved throughout the Apicomplexa, is likely to have been obtained via lateral gene transfer from a prokaryote.	[Mina, John G.; Alqaisi, Amjed Q. I.; Pratt, Steven; Pohl, Ehmke; Denny, Paul W.] Univ Durham, Dept Biosci, Stockton Rd, Durham DH1 3LE, England; [Thye, Julie K.; Dods, Robert H.; Groftehauge, Morten K.; Mosely, Jackie A.; Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Alqaisi, Amjed Q. I.] Univ Baghdad, Coll Sci, Dept Biol, Baghdad 10071, Iraq; [Bird, Louise E.] Rutherford Appleton Lab, Oxford Prot Prod Facil UK, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Shams-Eldin, Hosam; Schwarz, Ralph T.] Philipps Univ Marburg, Zentrum Hyg & Infekt Biol, Inst Virol, D-35043 Marburg, Germany	Durham University; Durham University; University of Baghdad; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Philipps University Marburg	Denny, PW (corresponding author), Univ Durham, Dept Biosci, Stockton Rd, Durham DH1 3LE, England.	p.w.denny@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Al-Qaisi, Amjed/ABC-2892-2020; Mosely, Jackie/GRS-3914-2022; Mina, John/AAG-2675-2021; Mina, John/N-8622-2014; Denny, Paul/B-8431-2013; Mina, John/AID-6303-2022	Pohl, Ehmke/0000-0002-9949-4471; Mina, John/0000-0003-0429-1370; Denny, Paul/0000-0002-5051-1613; Mina, John/0000-0003-0429-1370; Alqaisi, Amjed/0000-0002-4759-1085; Groftehauge, Morten/0000-0002-1823-3713; Bird, Louise/0000-0002-9846-5716	Oxford Protein Purification Facility; Biotechnology and Biological Sciences Research Council [BB/D52396X/1, BB/M024156/1] Funding Source: researchfish; Medical Research Council [MR/K018779/1] Funding Source: researchfish; BBSRC [BB/D52396X/1, BB/M024156/1] Funding Source: UKRI; MRC [MR/K018779/1] Funding Source: UKRI	Oxford Protein Purification Facility; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Department of Chemistry Mass Spectrometry Service for analytical support. Also, thanks to Martin Walsh from the Diamond Light Source; Christopher Barnes, Ian Edwards, Tim Hawkins, Joanne Robson, Catherine Bruce, and Emily Cardew from the Department of Biosciences; and Robek Pal from the Department of Chemistry for technical input, support, and many helpful discussions. We gratefully acknowledge the provision of beam time and excellent support by the BL21 staff at the Diamond Light Source. Materials were kindly provided by Prof. Dominique Soldati-Favre (Geneva), Dr. Kristin Hagar (Notre Dame), and Prof. Keith Gull (Oxford). This work was also supported by Grant-in-Aid from Oxford Protein Purification Facility.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Antolinos AD, 2015, ACTA CRYSTALLOGR D, V71, P76, DOI 10.1107/S1399004714019609; Arisue N, 2015, PARASITOL INT, V64, P254, DOI 10.1016/j.parint.2014.10.005; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7; Basham M, 2015, J SYNCHROTRON RADIAT, V22, P853, DOI 10.1107/S1600577515002283; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bird LE, 2011, METHODS, V55, P29, DOI 10.1016/j.ymeth.2011.08.002; CHOWDHURY MNH, 1986, J MED, V17, P373; Coppens I, 2014, INT J PARASITOL, V44, P109, DOI 10.1016/j.ijpara.2013.09.003; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Denny P, 1998, PROTIST, V149, P51, DOI 10.1016/S1434-4610(98)70009-4; Denny PW, 2006, J BIOL CHEM, V281, P28200, DOI 10.1074/jbc.M600796200; Denny PW, 2004, MOL MICROBIOL, V53, P725, DOI 10.1111/j.1365-2958.2004.04208.x; Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Funato K, 2002, BIOCHEMISTRY-US, V41, P15105, DOI 10.1021/bi026616d; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gerold P, 2001, MOL BIOCHEM PARASIT, V112, P29, DOI 10.1016/S0166-6851(00)00336-4; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hager KM, 1999, J CELL SCI, V112, P2631; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ikushiro H, 2003, BBA-PROTEINS PROTEOM, V1647, P116, DOI 10.1016/S1570-9639(03)00074-8; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2007, J BACTERIOL, V189, P5749, DOI 10.1128/JB.00194-07; Ikushiro H, 2009, J BIOCHEM, V146, P549, DOI 10.1093/jb/mvp100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAUER SA, 1995, P NATL ACAD SCI USA, V92, P9181, DOI 10.1073/pnas.92.20.9181; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Perry DK, 2002, BBA-MOL CELL BIOL L, V1585, P146, DOI 10.1016/S1388-1981(02)00335-9; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pfluger SL, 2005, EUKARYOT CELL, V4, P432, DOI 10.1128/EC.4.2.432-442.2005; Pratt S, 2013, MOL BIOCHEM PARASIT, V187, P43, DOI 10.1016/j.molbiopara.2012.11.007; Prieschl EE, 2000, IMMUNOL TODAY, V21, P555, DOI 10.1016/S0167-5699(00)01725-4; Pszenny V, 2016, J BIOL CHEM, V291, P3725, DOI 10.1074/jbc.M115.671974; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shams-Eldin H, 2002, MOL BIOCHEM PARASIT, V120, P73, DOI 10.1016/S0166-6851(01)00434-0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tuukkanen AT, 2016, IUCRJ, V3, P440, DOI 10.1107/S2052252516016018; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Young SA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/248135; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; Zeitvogel F, 2016, J MICROSC-OXFORD, V261, P148, DOI 10.1111/jmi.12187; Zeitvogel F., 2016, J OPEN RES SOFTWARE, V4, pe5, DOI DOI 10.5334/J0RS.89; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	62	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12208	12219		10.1074/jbc.M117.792374	http://dx.doi.org/10.1074/jbc.M117.792374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28578314	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000406053300018
J	Shindou, H; Koso, H; Sasaki, J; Nakanishi, H; Sagara, H; Nakagawa, KM; Takahashi, Y; Hishikawa, D; Iizuka-Hishikawa, Y; Tokumasu, F; Noguchi, H; Watanabe, S; Sasaki, T; Shimizu, T				Shindou, Hideo; Koso, Hideto; Sasaki, Junko; Nakanishi, Hiroki; Sagara, Hiroshi; Nakagawa, Koh M.; Takahashi, Yoshikazu; Hishikawa, Daisuke; Iizuka-Hishikawa, Yoshiko; Tokumasu, Fuyuki; Noguchi, Hiroshi; Watanabe, Sumiko; Sasaki, Takehiko; Shimizu, Takao			Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; FORCE-FIELD; LYSOPHOSPHOLIPID ACYLTRANSFERASES; RHESUS-MONKEYS; OUTER SEGMENTS; ACYL-COA; RHODOPSIN; CHARMM; MICE; PHOSPHATIDYLCHOLINE	Docosahexaenoic acid (DHA) has essential roles in photoreceptor cells in the retina and is therefore crucial to healthy vision. Although the influence of dietary DHA on visual acuity is well known and the retina has an abundance of DHA-containing phospholipids (PL-DHA), the mechanisms associated with DHA's effects on visual function are unknown. We previously identified lysophosphatidic acid acyltransferase 3 (LPAAT3) as a PL-DHA biosynthetic enzyme. Here, using comprehensive phospholipid analyses and imaging mass spectroscopy, we found that LPAAT3 is expressed in the inner segment of photoreceptor cells and that PL-DHA disappears from the outer segment in the LPAAT3-knock-out mice. Dynamic light-scattering analysis of liposomes and molecular dynamics simulations revealed that the physical characteristics of DHA reduced membrane-bending rigidity. Following loss of PL-DHA, LPAAT3-knock-out mice exhibited abnormalities in the retinal layers, such as incomplete elongation of the outer segment and decreased thickness of the outer nuclear layers and impaired visual function, as well as disordered disc morphology in photoreceptor cells. Our results indicate that PL-DHA contributes to visual function by maintaining the disc shape in photoreceptor cells and that this is a function of DHA in the retina. This study thus provides the reason why DHA is required for visual acuity and may help inform approaches for overcoming retinal disorders associated with DHA deficiency or dysfunction.	[Shindou, Hideo; Takahashi, Yoshikazu; Hishikawa, Daisuke; Iizuka-Hishikawa, Yoshiko; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo 1628655, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tokumasu, Fuyuki; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Shindou, Hideo; Sasaki, Takehiko] Agcy Med Res & Dev AMED, CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Koso, Hideto; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo 1088639, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Nakanishi, Hiroki; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Biosignal Res Ctr, Akita 0108502, Japan; [Nakanishi, Hiroki; Sasaki, Takehiko] Akita Lipid Technol LLC, Akita 0100825, Japan; [Nakagawa, Koh M.; Noguchi, Hiroshi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Akita University; Akita University; University of Tokyo	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Tokyo 1628655, Japan.	hshindou-tky@umin.net	Tokumasu, Fuyuki/GQP-4413-2022; Sagara, Hiroshi/GRX-7740-2022; Noguchi, Hiroshi/E-6052-2017; Shimizu, Takao/AAV-7052-2021	Tokumasu, Fuyuki/0000-0003-2790-1071; Sagara, Hiroshi/0000-0001-8456-8362; Noguchi, Hiroshi/0000-0003-1735-7586; Nakanishi, Hiroki/0000-0002-5108-1598; Sasaki, Takehiko/0000-0003-1837-3748; KOSO, HIDETO/0000-0002-8986-7617	JSPS KAKENHI [26460380, 26253006, 15H05899, 15K14947, 24229003]; Takeda Science Foundation; JST-CREST [16gm0710002h0104, gm0710002h0303]; AMED-CREST [16gm0710002h0104, gm0710002h0303]; Grants-in-Aid for Scientific Research [15H05897, 17K19375] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); AMED-CREST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grants 26460380 (to H.S.), 26253006 (to T. Sasaki), 15H05899 (to T. Sasaki), 15K14947 (to T. Sasaki), and 24229003 (to T. Shimizu); the Takeda Science Foundation (to T. Shimizu); JST-CREST Grant 16gm0710002h0104 (to H.S.) and Grant gm0710002h0303 (to T. Sasaki); and AMED-CREST Grant 16gm0710002h0104 (to H.S.) and Grant gm0710002h0303 (to T. Sasaki). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Allen M. P., 1989, COMPUTER SIMULATION, P182; Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; Barelli H, 2016, CURR OPIN CELL BIOL, V41, P25, DOI 10.1016/j.ceb.2016.03.012; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; BENOLKEN RM, 1973, SCIENCE, V182, P1253, DOI 10.1126/science.182.4118.1253; BIRCH DG, 1992, INVEST OPHTH VIS SCI, V33, P2365; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jeffrey BG, 2009, INVEST OPHTH VIS SCI, V50, P4360, DOI 10.1167/iovs.09-3640; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kielkowska Anna, 2014, Advances in Biological Regulation, V54, P131, DOI 10.1016/j.jbior.2013.09.001; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Koso H, 2016, GLIA, V64, P2005, DOI 10.1002/glia.23038; Kurabe Nobuya, 2016, World J Gastrointest Pathophysiol, V7, P235, DOI 10.4291/wjgp.v7.i2.235; LATIES AM, 1976, EXP EYE RES, V23, P139, DOI 10.1016/0014-4835(76)90197-4; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lim JB, 2012, J PHYS CHEM B, V116, P203, DOI 10.1021/jp207925m; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Pall S., 2014, SOLVING SOFTWARE CHA, P3; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Suh M, 2000, PEDIATR RES, V48, P524, DOI 10.1203/00006450-200010000-00017; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Takizawa Y, 2011, AUDIOL NEURO-OTOL, V16, P315, DOI 10.1159/000322308; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Wong BH, 2016, J BIOL CHEM, V291, P10501, DOI 10.1074/jbc.M116.721340; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200; Zhigaltsev IV, 2016, J LIPOSOME RES, V26, P96, DOI 10.3109/08982104.2015.1025411	55	78	79	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12054	12064		10.1074/jbc.M117.790568	http://dx.doi.org/10.1074/jbc.M117.790568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28578316	hybrid, Green Published			2022-12-28	WOS:000406053300005
J	Zurawski, Z; Page, B; Chicka, MC; Brindley, RL; Wells, CA; Preininger, AM; Hyde, K; Gilbert, JA; Cruz-Rodriguez, O; Currie, KPM; Chapman, ER; Alford, S; Hamm, HE				Zurawski, Zack; Page, Brian; Chicka, Michael C.; Brindley, Rebecca L.; Wells, Christopher A.; Preininger, Anita M.; Hyde, Karren; Gilbert, James A.; Cruz-Rodriguez, Osvaldo; Currie, Kevin P. M.; Chapman, Edwin R.; Alford, Simon; Hamm, Heidi E.			G beta gamma directly modulates vesicle fusion by competing with synaptotagmin for binding to neuronal SNARE proteins embedded in membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINUS; PRESYNAPTIC INHIBITION; CA2+-DEPENDENT BINDING; CRYSTAL-STRUCTURE; CRITICAL RESIDUES; CALCIUM CURRENTS; INSULIN-RELEASE; C2B DOMAIN; TRANSMISSION; MACHINERY	G(i/o)-coupled G protein-coupled receptors can inhibit neurotransmitter release at synapses via multiple mechanisms. In addition to G beta gamma-mediated modulation of voltage-gated calcium channels (VGCC), inhibition can also be mediated through the direct interaction of G beta gamma subunits with the soluble N-ethylmaleimide attachment protein receptor (SNARE) complex of the vesicle fusion apparatus. Binding studies with soluble SNARE complexes have shown that G beta gamma binds to both ternary SNARE complexes, t-SNARE heterodimers, and monomeric SNAREs, competing with synaptotagmin 1(syt1) for binding sites on t-SNARE. However, in secretory cells, G beta gamma, SNAREs, and synaptotagmin interact in the lipid environment of a vesicle at the plasma membrane. To approximate this environment, we show that fluorescently labeled G beta gamma interacts specifically with lipid-embedded t-SNAREs consisting of full-length syntaxin 1 and SNAP-25B at the membrane, as measured by fluorescence polarization. Fluorescently labeled syt1 undergoes competition with G beta gamma for SNARE-binding sites in lipid environments. Mutant G beta gamma subunits that were previously shown to be more efficacious at inhibiting Ca2+-triggered exocytotic release than wild-type G beta gamma were also shown to bind SNAREs at a higher affinity than wild type in a lipid environment. These mutant G beta gamma subunits were unable to inhibit VGCC currents. Specific peptides corresponding to regions on G beta and G gamma shown to be important for the interaction disrupt the interaction in a concentration-dependent manner. In in vitro fusion assays using full-length t-and v-SNAREs embedded in liposomes, G beta gamma inhibited Ca2+/synaptotagmin-dependent fusion. Together, these studies demonstrate the importance of these regions for the G beta gamma-SNARE interaction and show that the target of G beta gamma, downstream of VGCC, is the membrane-embedded SNARE complex.	[Zurawski, Zack; Wells, Christopher A.; Preininger, Anita M.; Hyde, Karren; Gilbert, James A.; Currie, Kevin P. M.; Hamm, Heidi E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Page, Brian; Alford, Simon] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53705 USA; [Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Madison, WI 53705 USA; [Brindley, Rebecca L.; Currie, Kevin P. M.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; [Cruz-Rodriguez, Osvaldo] Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Cruz-Rodriguez, Osvaldo] Univ Michigan, Inst Life Sci, Dept Biol Chem, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.	heidi.hamm@vanderbilt.edu	Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X; Alford, Simon/0000-0002-0454-4246; Brindley, Rebecca/0000-0002-4357-4413; Chapman, Edwin/0000-0001-9787-8140; Preininger, Anita/0000-0001-8011-9391	National Institutes of Health [R01NS052446, R01EY010291, R01MH101679, R01MH061876, R01MH084874]; NATIONAL EYE INSTITUTE [R01EY010291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101679, R01MH061876, R01MH084874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS052446 (NINDS), R01EY010291 (NEI), and R01MH101679, R01MH061876, and R01MH084874 (National Institute of Mental Health). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Brewer KD, 2015, NAT STRUCT MOL BIOL, V22, P555, DOI 10.1038/nsmb.3035; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Glitsch M, 2006, J NEUROPHYSIOL, V96, P86, DOI 10.1152/jn.01282.2005; Hamid E, 2014, J NEUROSCI, V34, P260, DOI 10.1523/JNEUROSCI.3633-12.2014; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kozasa T., 1995, J BIOL CHEM, V12; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Liu HS, 2014, NAT NEUROSCI, V17, P670, DOI 10.1038/nn.3681; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MANDARINO L, 1980, ENDOCRINOLOGY, V106, P430, DOI 10.1210/endo-106-2-430; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takahashi T, 1998, J NEUROSCI, V18, P3138; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Van Hook MJ, 2017, J NEUROSCI, V37, P4618, DOI 10.1523/JNEUROSCI.2948-16.2017; Waldschmidt HV, 2016, J MED CHEM, V59, P3793, DOI 10.1021/acs.jmedchem.5b02000; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wells CA, 2012, MOL PHARMACOL, V82, P1136, DOI 10.1124/mol.112.080507; WOLLHEIM CB, 1977, J CLIN INVEST, V60, P1165, DOI 10.1172/JCI108869; Yim YY, 2015, METHODS MOL BIOL, V1278, P307, DOI 10.1007/978-1-4939-2425-7_18; Yoon EJ, 2008, J NEUROPHYSIOL, V100, P2929, DOI 10.1152/jn.90839.2008; Yoon EJ, 2007, MOL PHARMACOL, V72, P1210, DOI 10.1124/mol.107.039446; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004; Zhang X.-L., 2016, PLOS ONE, V6; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhao Y., 2010, J PHYSL; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zurawski Z, 2016, MOL PHARMACOL, V89, P75, DOI 10.1124/mol.115.101600	60	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12165	12177		10.1074/jbc.M116.773523	http://dx.doi.org/10.1074/jbc.M116.773523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28515322	Green Published, hybrid			2022-12-28	WOS:000406053300015
J	Senger, M; Stripp, ST; Soboh, B				Senger, Moritz; Stripp, Sven T.; Soboh, Basem			Proteolytic cleavage orchestrates cofactor insertion and protein assembly in [NiFe]-hydrogenase biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIFE HYDROGENASE MATURATION; CIRCULAR-DICHROISM SPECTRA; ESCHERICHIA-COLI K-12; ACCESSORY PROTEINS; LARGE SUBUNIT; ACTIVE-SITE; STRUCTURAL BASIS; CATALYTIC CYCLE; CARBON-MONOXIDE; IRON	Metalloenzymes catalyze complex and essential processes, such as photosynthesis, respiration, and nitrogen fixation. For example, bacteria and archaea use [NiFe]-hydrogenases to catalyze the uptake and release of molecular hydrogen (H-2). [NiFe]-hydrogenases are redox enzymes composed of a large subunit that harbors a NiFe(CN)(2)CO metallo-center and a small subunit with three iron-sulfur clusters. The large subunit is synthesized with a C-terminal extension, cleaved off by a specific endopeptidase during maturation. The exact role of the C-terminal extension has remained elusive; however, cleavage takes place exclusively after assembly of the [NiFe]-cofactor and before large and small subunits form the catalytically active heterodimer. To unravel the functional role of the C-terminal extension, we used an enzymatic in vitro maturation assay that allows synthesizing functional [NiFe]-hydrogenase-2 of Escherichia coli from purified components. The maturation process included formation and insertion of the NiFe(CN)(2)CO cofactor into the large subunit, endoproteolytic cleavage of the C-terminal extension, and dimerization with the small subunit. Biochemical and spectroscopic analysis indicated that the C-terminal extension of the large subunit is essential for recognition by the maturation machinery. Only upon completion of cofactor insertion was removal of the C-terminal extension observed. Our results indicate that endoproteolytic cleavage is a central checkpoint in the maturation process. Here, cleavage temporally orchestrates cofactor insertion and protein assembly and ensures that only cofactor-containing protein can continue along the assembly line toward functional [NiFe]-hydrogenase.	[Senger, Moritz; Stripp, Sven T.; Soboh, Basem] Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany	Free University of Berlin	Soboh, B (corresponding author), Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany.	basem.soboh@fu-berlin.de	Senger, Moritz/O-1086-2017; Stripp, Sven Timo/O-9051-2019	Senger, Moritz/0000-0001-9225-4910; Stripp, Sven Timo/0000-0002-8412-0258	Deutsche Forschungsgemeinschaft through the priority program "Iron-Sulfur for Life" [SO 1325/5-1]	Deutsche Forschungsgemeinschaft through the priority program "Iron-Sulfur for Life"	This work was supported by the Deutsche Forschungsgemeinschaft through the priority program "Iron-Sulfur for Life," Grant SO 1325/5-1 (to B.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ash PA, 2017, ACS CATAL, V7, P2471, DOI 10.1021/acscatal.6b03182; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Binder U, 1996, ARCH MICROBIOL, V165, P69, DOI 10.1007/s002030050299; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Burstel I, 2016, P NATL ACAD SCI USA, V113, P14722, DOI 10.1073/pnas.1614656113; Butland G, 2006, FEBS LETT, V580, P677, DOI 10.1016/j.febslet.2005.12.063; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Drapal N, 1998, BIOCHEMISTRY-US, V37, P2941, DOI 10.1021/bi9720078; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Friedrich B, 2005, BIOCHEM SOC T, V33, P97, DOI 10.1042/BST0330097; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Khorasani-Motlagh M, 2017, METALLOMICS, V9, P482, DOI 10.1039/c7mt00037e; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lacasse MJ, 2016, BIOCHEMISTRY-US, V55, P6821, DOI 10.1021/acs.biochem.6b00706; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Massanz C, 1997, EUR J BIOCHEM, V245, P441, DOI 10.1111/j.1432-1033.1997.t01-3-00441.x; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; MIZUNO Y, 1989, ANAL BIOCHEM, V183, P46, DOI 10.1016/0003-2697(89)90169-3; Pardo A, 2006, J BIOL INORG CHEM, V11, P286, DOI 10.1007/s00775-005-0076-3; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Pinske C, 2011, ARCH MICROBIOL, V193, P893, DOI 10.1007/s00203-011-0726-5; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Senger M, 2016, P NATL ACAD SCI USA, V113, P8454, DOI 10.1073/pnas.1606178113; Shomura Y, 2012, J BIOL CHEM, V287, P28409, DOI 10.1074/jbc.M112.387134; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; Soboh B, 2014, BIOCHEM J, V464, P169, DOI 10.1042/BJ20140485; Soboh B, 2013, FEBS LETT, V587, P2512, DOI 10.1016/j.febslet.2013.06.055; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; Soboh B, 2012, BIOCHEM BIOPH RES CO, V424, P158, DOI 10.1016/j.bbrc.2012.06.096; Soboh B, 2010, FEBS LETT, V584, P4109, DOI 10.1016/j.febslet.2010.08.037; SORGENFREI O, 1993, EUR J BIOCHEM, V213, P1355, DOI 10.1111/j.1432-1033.1993.tb17888.x; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stripp ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133118; Stripp ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107488; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; Theodoratou E, 2000, EUR J BIOCHEM, V267, P1995, DOI 10.1046/j.1432-1327.2000.01202.x; Thomas C, 2015, J BACTERIOL, V197, P2989, DOI 10.1128/JB.00437-15; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Watanabe S, 2015, P NATL ACAD SCI USA, V112, P7701, DOI 10.1073/pnas.1503102112; Watanabe S, 2012, STRUCTURE, V20, P2124, DOI 10.1016/j.str.2012.09.018	61	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11670	11681		10.1074/jbc.M117.788125	http://dx.doi.org/10.1074/jbc.M117.788125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28539366	hybrid, Green Published			2022-12-28	WOS:000405485600008
J	Tetley, GJN; Mott, HR; Cooley, RN; Owen, D				Tetley, George J. N.; Mott, Helen R.; Cooley, R. Neil; Owen, Darerca			A dock and coalesce mechanism driven by hydrophobic interactions governs Cdc42 binding with its effector protein ACK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; NONRECEPTOR TYROSINE KINASE; ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING; P21-ACTIVATED KINASE; RATE CONSTANTS; DOMAIN; ACTIVATION; MUTATIONS; AUTOINHIBITION	Cdc42 is a Rho-family small G protein that has been widely studied for its role in controlling the actin cytoskeleton and plays a part in several potentially oncogenic signaling networks. Similar to most other small G proteins, Cdc42 binds to many downstream effector proteins to elicit its cellular effects. These effector proteins all engage the same face of Cdc42, the conformation of which is governed by the activation state of the G protein. Previously, the importance of individual residues in conferring binding affinity has been explored for residues within Cdc42 for three of its Cdc42/Rac interactive binding (CRIB) effectors, activated Cdc42 kinase (ACK), p21-activated kinase (PAK), and Wiskott-Aldrich syndrome protein (WASP). Here, in a complementary study, we have used our structure of Cdc42 bound toACKvia an intrinsically disorderedACKregion to guide an analysis of the Cdc42 interface on ACK, creating a panel of mutant proteins with which we can now describe the complete energetic landscape of the Cdc42-binding site on ACK. Our data suggest that the binding affinity ofACKrelies on several conserved residues that are critical for stabilizing the quaternary structure. These residues are centered on the CRIB region, with the complete binding region anchored at each end by hydrophobic interactions. These findings suggest that ACK adopts a dock and coalesce binding mechanism with Cdc42. In contrast to other CRIB-family effectors and indeed other intrinsically disordered proteins, hydrophobic residues likely drive Cdc42-ACK binding.	[Tetley, George J. N.; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Cooley, R. Neil] Isogenica Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England; [Cooley, R. Neil] Abcam, 330 Cambridge Sci Pk, Cambridge CB4 OFL, England	University of Cambridge; Isogenica Limited	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Tetley, George/0000-0002-7134-7066	Medical Research Council CASE Studentship [MR/K017101/1]; Medical Research Council [1366170] Funding Source: researchfish	Medical Research Council CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council CASE Studentship MR/K017101/1 (to D. O., H. R. M., and R. N. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Ash J, 2003, GENETICS, V163, P9; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Dogan J, 2014, PHYS CHEM CHEM PHYS, V16, P6323, DOI 10.1039/c3cp54226b; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Elliot-Smith AE, 2007, BIOCHEMISTRY-US, V46, P14087, DOI 10.1021/bi701539x; Gajiwala KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053994; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Gu Y, 2004, J BIOL CHEM, V279, P30507, DOI 10.1074/jbc.M313518200; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin Q, 2012, BIOCHEM J, V445, P255, DOI 10.1042/BJ20111575; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Mahajan K, 2015, ONCOGENE, V34, P4162, DOI 10.1038/onc.2014.350; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pang XD, 2016, PROTEINS, V84, P674, DOI 10.1002/prot.25018; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Pirone DM, 2000, J BIOL CHEM, V275, P22650, DOI 10.1074/jbc.M002832200; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Zhou HX, 2012, PHYS CHEM CHEM PHYS, V14, P10466, DOI 10.1039/c2cp41196b	39	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11361	11373		10.1074/jbc.M117.789883	http://dx.doi.org/10.1074/jbc.M117.789883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28539360	Green Published, hybrid			2022-12-28	WOS:000405119600020
J	Ghatak, S; Markwald, RR; Hascall, VC; Dowling, W; Lottes, RG; Baatz, JE; Beeson, G; Beeson, CC; Perrella, MA; Thannickal, VJ; Misra, S				Ghatak, Shibnath; Markwald, Roger R.; Hascall, Vincent C.; Dowling, William; Lottes, Robyn Grayson; Baatz, John E.; Beeson, Gyada; Beeson, Craig C.; Perrella, Mark A.; Thannickal, Victor J.; Misra, Suniti			Transforming growth factor 1 (TGF1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 transcription factor (AP-1); CD44; early growth response protein 1 (EGR1); extracellular-signal-regulated kinase (ERK); signaling	SMOOTH-MUSCLE-CELLS; SHORT-INTERFERING RNAS; NF-KAPPA-B; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN-CELLS; CANCER-CELLS; TRANSCRIPTION FACTORS; MULTIDRUG-RESISTANCE; LEVEL EXPRESSION	The appearance of myofibroblasts is generally thought to be the underlying cause of the fibrotic changes that underlie idiopathic pulmonary fibrosis. However, the cellular/molecular mechanisms that account for the fibroblast-myofibroblast differentiation/activation in idiopathic pulmonary fibrosis remain poorly understood. We investigated the functional role of hyaluronan receptor CD44V6 (CD44 containing variable exon 6 (v6)) for differentiation of lung fibroblast to myofibroblast phenotype. Increased hyaluronan synthesis and CD44 expression have been detected in numerous fibrotic organs. Previously, we found that the TGF1/CD44V6 pathway is important in lung myofibroblast collagen-1 and -smooth-muscle actin synthesis. Because increased EGR1 (early growth response-1) expression has been shown to appear very early and nearly coincident with the expression of CD44V6 found after TGF1 treatment, we investigated the mechanism(s) of regulation of CD44V6 expression in lung fibroblasts by TGF1. TGF1-mediated CD44V6 up-regulation was initiated through EGR1 via ERK-regulated transcriptional activation. We showed that TGF1-induced CD44V6 expression is through EGR1-mediated AP-1 (activator protein-1) activity and that the EGR1- and AP-1-binding sites in the CD44v6 promoter account for its responsiveness to TGF1 in lung fibroblasts. We also identified a positive-feedback loop in which ERK/EGR1 signaling promotes CD44V6 splicing and found that CD44V6 then sustains ERK signaling, which is important for AP-1 activity in lung fibroblasts. Furthermore, we identified that HAS2-produced hyaluronan is required for CD44V6 and TGFRI co-localization and subsequent CD44V6/ERK1/EGR1 signaling. These results demonstrate a novel positive-feedback loop that links the myofibroblast phenotype to TGF1-stimulated CD44V6/ERK/EGR1 signaling.	[Ghatak, Shibnath; Markwald, Roger R.; Dowling, William; Misra, Suniti] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Dowling, William] Coll Charleston, Charleston, SC 29424 USA; [Lottes, Robyn Grayson; Baatz, John E.] Med Univ South Carolina, Dept Pediat Neonatol, Charleston, SC 29425 USA; [Beeson, Gyada; Beeson, Craig C.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Perrella, Mark A.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Perrella, Mark A.] Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA; [Perrella, Mark A.] Harvard Med Sch, Boston, MA 02115 USA; [Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	Medical University of South Carolina; Cleveland Clinic Foundation; College of Charleston; Medical University of South Carolina; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham	Ghatak, S; Misra, S (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu			National Institutes of Health (NIH) [1R03CA167722-01A1]; NIH [1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, 1P20 GM103444, 1 R01HL113325, 1 P01HL107147]; pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina [5P30GM103339-03]; NATIONAL CANCER INSTITUTE [R03CA167722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756, R01HL113325, P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342, P20GM103444, P20GM103499, P20GM103542, P30GM103339] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant 1R03CA167722-01A1 (to S. M. and S. G.); NIH Grants 1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, and 1P20 GM103444 (to S. M., S. G., and R. R. M.); NIH Grants 1 R01HL113325 and 1 P01HL107147 (to V. C. H.); and a pilot project award (to S. M.) from the COBRE in Lipidomics and Pathobiology (NIH Grant 5P30GM103339-03) at the Medical University of South Carolina. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akamatsu T, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-15; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Fitzner B, 2004, INT J COLORECTAL DIS, V19, P414, DOI 10.1007/s00384-003-0565-1; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Foster LC, 1998, J BIOL CHEM, V273, P20341, DOI 10.1074/jbc.273.32.20341; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810; Ghatak S., 2015, INT J CELL BIOL; Ghatak S, 2017, J BIOL CHEM, V292, P10490, DOI 10.1074/jbc.M116.752469; Ghatak S, 2014, J BIOL CHEM, V289, P7856, DOI 10.1074/jbc.M113.505065; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Ghatak S, 2008, CONNECT TISSUE RES, V49, P265, DOI 10.1080/03008200802147845; Goodchild A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-40; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hebbard L, 2000, J CELL SCI, V113, P2619; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; HOFMANN M, 1993, CANCER RES, V53, P1516; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Kane S, 2002, ANTICANCER RES, V22, P1433; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Konig H, 1996, EMBO J, V15, P4030, DOI 10.1002/j.1460-2075.1996.tb00776.x; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199; Lo LW, 2001, J CELL PHYSIOL, V188, P304, DOI 10.1002/jcp.1124; Maltzman JS, 1996, J EXP MED, V183, P1747, DOI 10.1084/jem.183.4.1747; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 1998, J BIOL CHEM, V273, P26638, DOI 10.1074/jbc.273.41.26638; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Monaghan M, 2000, J PATHOL, V192, P519; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Parra E, 2011, INT J ONCOL, V39, P345, DOI 10.3892/ijo.2011.1047; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Recio JA, 2003, CANCER RES, V63, P1576; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; SANTANA A, 1995, AM J RESP CELL MOL, V13, P34, DOI 10.1165/ajrcmb.13.1.7541221; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Varga J, 2002, ARTHRITIS RHEUM-US, V46, P1703, DOI 10.1002/art.10413; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yew NS, 2005, ADV GENET, V53, P189, DOI 10.1016/S0065-2660(05)53007-4; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhao Y, 2000, EXP MOL PATHOL, V69, P67, DOI 10.1006/exmp.2000.2319	91	30	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10465	10489		10.1074/jbc.M116.752451	http://dx.doi.org/10.1074/jbc.M116.752451			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28389562	hybrid, Green Published			2022-12-28	WOS:000404115400012
J	Plain, F; Congreve, SD; Yee, RSZ; Kennedy, J; Howie, J; Kuo, CW; Fraser, NJ; Fuller, W				Plain, Fiona; Congreve, Samitha Dilini; Yee, Rachel Sue Zhen; Kennedy, Jennifer; Howie, Jacqueline; Kuo, Chien-Wen; Fraser, Niall J.; Fuller, William			An amphipathic -helix directs palmitoylation of the large intracellular loop of the sodium/calcium exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyltransferase; calcium transport; protein acylation; protein palmitoylation; sodium transport; sodium-calcium exchange	SARCOLEMMAL NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; S-PALMITOYLATION; SITES; IDENTIFICATION; INACTIVATION; RECOGNITION; PREDICTION; MECHANISM	The electrogenic sodium/calcium exchanger (NCX) mediates bidirectional calcium transport controlled by the transmembrane sodium gradient. NCX inactivation occurs in the absence of phosphatidylinositol 4,5-bisphosphate and is facilitated by palmitoylation of a single cysteine at position 739 within the large intracellular loop of NCX. The aim of this investigation was to identify the structural determinants of NCX1 palmitoylation. Full-length NCX1 (FL-NCX1) and a YFP fusion protein of the NCX1 large intracellular loop (YFP-NCX1) were expressed in HEK cells. Single amino acid changes around Cys-739 in FL-NCX1 and deletions on the N-terminal side of Cys-739 in YFP-NCX1 did not affect NCX1 palmitoylation, with the exception of the rare human polymorphism S738F, which enhanced FL-NCX1 palmitoylation, and D741A, which modestly reduced it. In contrast, deletion of a 21-amino acid segment enriched in aromatic amino acids on the C-terminal side of Cys-739 abolished YFP-NCX1 palmitoylation. We hypothesized that this segment forms an amphipathic -helix whose properties facilitate Cys-739 palmitoylation. Introduction of negatively charged amino acids to the hydrophobic face or of helix-breaking prolines impaired palmitoylation of both YFP-NCX1 and FL-NCX1. Alanine mutations on the hydrophilic face of the helix significantly reduced FL-NCX1 palmitoylation. Of note, when the helix-containing segment was introduced adjacent to cysteines that are not normally palmitoylated, they became palmitoylation sites. In conclusion, we have identified an amphipathic -helix in the NCX1 large intracellular loop that controls NCX1 palmitoylation. NCX1 palmitoylation is governed by a distal secondary structure element rather than by local primary sequence.	[Plain, Fiona; Congreve, Samitha Dilini; Yee, Rachel Sue Zhen; Kennedy, Jennifer; Howie, Jacqueline; Kuo, Chien-Wen; Fraser, Niall J.; Fuller, William] Univ Dundee, Div Mol & Clin Med, Sch Med, Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Dundee	Fuller, W (corresponding author), Ninewells Hosp, Div Mol & Clin Med, Mail Box 12,Level 5, Dundee DD1 9SY, Scotland.	w.fuller@dundee.ac.uk		Fraser, Niall/0000-0001-7349-5647; Yee, Rachel Sue Zhen/0000-0001-6737-1947; Fuller, William/0000-0002-5883-4433	British Heart Foundation [RG/12/4/29426, PG/16/33/32134, FS/14/68/30988]; British Heart Foundation [SP/16/3/32317, PG/12/6/29366, FS/13/22/30126, RG/17/15/33106] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants RG/12/4/29426 and PG/16/33/32134 (to W. F.) and Grant FS/14/68/30988 (to W. F. and N. J. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fuller W, 2016, CHANNELS, V10, P75, DOI 10.1080/19336950.2015.1099329; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lemonidis K, 2015, J BIOL CHEM, V290, P21939, DOI 10.1074/jbc.M115.657668; Lemonidis K, 2014, MOL BIOL CELL, V25, P3870, DOI 10.1091/mbc.E14-06-1169; Li SY, 2015, J CHEM INF MODEL, V55, P2015, DOI 10.1021/acs.jcim.5b00276; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reddy K. D., 2016, J BIOMOL STRUCT DYN, V2016, P1; Reilly L, 2015, FASEB J, V29, P4532, DOI 10.1096/fj.15-276493; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021	32	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10745	10752		10.1074/jbc.M116.773945	http://dx.doi.org/10.1074/jbc.M116.773945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28432123	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000404115400034
J	Kovachev, PS; Banerjee, D; Rangel, LP; Eriksson, J; Pedrote, MM; Martins-Dinis, MMDC; Edwards, K; Cordeiro, Y; Silva, JL; Sanyal, S				Kovachev, Petar Stefanov; Banerjee, Debapriya; Rangel, Luciana Pereira; Eriksson, Jonny; Pedrote, Murilo M.; Martins-Dinis, Mafalda Maria D. C.; Edwards, Katarina; Cordeiro, Yraima; Silva, Jerson L.; Sanyal, Suparna			Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION-LIKE AGGREGATION; 23S RIBOSOMAL-RNA; MUTANT P53; NUCLEIC-ACID; FOLDING ACTIVITY; WILD-TYPE; STRUCTURAL BIOLOGY; AMYLOID OLIGOMERS; THIOFLAVIN-T; ISOFORMS	Inactivation of the tumor suppressor protein p53 by mutagenesis, chemical modification, protein-protein interaction, or aggregation has been associated with different human cancers. Although DNA is the typical substrate of p53, numerous studies have reported p53 interactions with RNA. Here, we have examined the effects ofRNAof varied sequence, length, and origin on the mechanism of aggregation of the core domain of p53 (p53C) using light scattering, intrinsic fluorescence, transmission electron microscopy, thioflavin-T binding, seeding, and immunoblot assays. Our results are the first to demonstrate that RNA can modulate the aggregation of p53C and full-length p53. We found bimodal behavior of RNA in p53C aggregation. A low RNA: protein ratio (similar to 1: 50) facilitates the accumulation of large amorphous aggregates of p53C. By contrast, at a high RNA: protein ratio (>= 1: 8), the amorphous aggregation of p53C is clearly suppressed. Instead, amyloid p53C oligomers are formed that can act as seeds nucleating de novo aggregation of p53C. We propose that structured RNAs prevent p53C aggregation through surface interaction and play a significant role in the regulation of the tumor suppressor protein.	[Kovachev, Petar Stefanov; Banerjee, Debapriya; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden; [Pedrote, Murilo M.; Martins-Dinis, Mafalda Maria D. C.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Inst Nacl Ciencia Tecnol Biol Estrutural & Bioima, BR-21941902 Rio De Janeiro, Brazil; [Eriksson, Jonny; Edwards, Katarina] Uppsala Univ, Dept Chem, S-75124 Uppsala, Sweden; [Rangel, Luciana Pereira; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, Brazil	Uppsala University; Universidade Federal do Rio de Janeiro; Uppsala University; Universidade Federal do Rio de Janeiro	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se	da Cunha Martins Dinis, Mafalda Maria Duarte/S-1861-2019; Edwards, Katarina/A-1159-2012; SILVA, JERSON Lima/GRF-1442-2022; Silva, Jerson/J-8984-2014; Edwards, Katarina/AAR-7679-2021; Cordeiro, Yraima/J-7619-2012; Rangel, Luciana/E-7861-2018	Edwards, Katarina/0000-0003-0674-2219; SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; Edwards, Katarina/0000-0003-0674-2219; Cordeiro, Yraima/0000-0003-4278-212X; Dinis, Mafalda/0000-0003-0172-3086; Kovachev, Petar/0000-0003-4448-6447; /0000-0002-6154-0815; Pedrote, Murilo/0000-0001-6744-9572	Swedish Research Council [2016-06264, 2013-8778, 2010-2619]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT-Joint Brazilian-Swedish Research Collaboration) [BR2013-5223]; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) [170.027/2008]; Coordination for the Improvement of Higher Education Personnel (CAPES) [1698/2012]; National Council of Technological and Scientific Development (CNPql ) [573767/2008-4, 467500/2014-2, 470994/2012-6]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT-Joint Brazilian-Swedish Research Collaboration); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development (CNPql )	This work was supported by research grants from the Swedish Research Council (2016-06264, 2013-8778, 2010-2619), the Swedish Foundation for International Cooperation in Research and Higher Education (STINT-Joint Brazilian-Swedish Research Collaboration; BR2013-5223 (to S. S.)), the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ; 170.027/2008), Coordination for the Improvement of Higher Education Personnel (CAPES; 1698/2012), and the National Council of Technological and Scientific Development (CNPql 573767/2008-4, 467500/2014-2, 470994/2012-6; to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; Avery-Kiejda KA, 2014, CARCINOGENESIS, V35, P586, DOI 10.1093/carcin/bgt411; Banerjee D, 2014, VIRUSES-BASEL, V6, P3907, DOI 10.3390/v6103907; Banerjee D, 2014, BIOCHIMIE, V97, P194, DOI 10.1016/j.biochi.2013.10.012; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brambilla D, 2011, NANOMED-NANOTECHNOL, V7, P521, DOI 10.1016/j.nano.2011.03.008; Bruggink KA, 2012, J ALZHEIMERS DIS, V28, P735, DOI 10.3233/JAD-2011-111421; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; Colvin VL, 2007, P NATL ACAD SCI USA, V104, P8679, DOI 10.1073/pnas.0703194104; Cordeiro Y, 2005, PROTEIN PEPTIDE LETT, V12, P251, DOI 10.2174/0929866053587138; Cordeiro Yraima, 2014, Biophys Rev, V6, P97, DOI 10.1007/s12551-013-0132-0; Costa DCF, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023614; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Davidson WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-102; Dos Reis S, 2011, BIOCHIMIE, V93, P1047, DOI 10.1016/j.biochi.2011.03.002; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Forget KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069242; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gong L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1033587; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Holm M, 2016, P NATL ACAD SCI USA, V113, P978, DOI 10.1073/pnas.1517541113; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Ishimaru D, 2003, J MOL BIOL, V333, P443, DOI 10.1016/j.jmb.2003.08.026; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Kim S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003993; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Lakowicz J. R, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4_8, DOI 10.1007/978-0-387-46312-4_8, 10.1007/978-0-387-46312-4]; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Liu CL, 2011, ADV PROTEIN CHEM STR, V84, P1, DOI 10.1016/B978-0-12-386483-3.00005-7; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Moore HC, 2010, ONCOGENE, V29, P6475, DOI 10.1038/onc.2010.381; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Pang YH, 2013, J BIOL CHEM, V288, P19081, DOI 10.1074/jbc.M113.466748; Pathak BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096425; Pennisi E, 1996, SCIENCE, V274, P921, DOI 10.1126/science.274.5289.921; Petrov AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088222; Prives C, 1999, J PATHOL, V187, P112; Rangel LP, 2014, PRION, V8, P75, DOI 10.4161/pri.27776; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Riley KJL, 2007, BIOCHEMISTRY-US, V46, P2480, DOI 10.1021/bi061480v; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Sanyal SC, 2002, NUCLEIC ACIDS RES, V30, P2390, DOI 10.1093/nar/30.11.2390; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2016, J BIOL CHEM, V291, P15482, DOI 10.1074/jbc.R116.733428; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Sugimoto S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv338; Takahashi R, 2013, ONCOGENE, V32, P3165, DOI 10.1038/onc.2012.322; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2000, NAT CELL BIOL, V2, pE178, DOI 10.1038/35036427; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; Yoshida Y, 2004, ONCOGENE, V23, P4371, DOI 10.1038/sj.onc.1207583	71	38	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9345	9357		10.1074/jbc.M116.762096	http://dx.doi.org/10.1074/jbc.M116.762096			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28420731	Green Published, hybrid			2022-12-28	WOS:000402538900028
J	Machado, LESF; Shen, TL; Page, R; Peti, W				Machado, Luciana E. S. F.; Shen, Tun-Li; Page, Rebecca; Peti, Wolfgang			The KIM-family protein-tyrosine phosphatases use distinct reversible oxidation intermediates: Intramolecular or intermolecular disulfide bond formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; enzyme inactivation; nuclear magnetic resonance (NMR); oxidation-reduction (redox); tyrosine-protein phosphatase (tyrosine phosphatase)	REDOX REGULATION; HYDROGEN-PEROXIDE; IN-VIVO; NMR-SPECTROSCOPY; CATALYTIC DOMAIN; 1B; INHIBITION; P38-ALPHA; CYSTEINE; ALPHA	The kinase interaction motif (KIM) family of protein-tyrosine phosphatases (PTPs) includes hematopoietic protein-tyrosine phosphatase (HePTP), striatal-enriched protein-tyrosine phosphatase (STEP), and protein-tyrosine phosphatase receptor type R (PTPRR). KIM-PTPs bind and dephosphorylate mitogen-activated protein kinases (MAPKs) and thereby critically modulate cell proliferation and differentiation. PTP activity can readily be diminished by reactive oxygen species (ROS), e.g. H2O2, which oxidize the catalytically indispensable active-site cysteine. This initial oxidation generates an unstable sulfenic acid intermediate that is quickly converted into either a sulfinic/sulfonic acid (catalytically dead and irreversible inactivation) or a stable sulfenamide or disulfide bond intermediate (reversible inactivation). Critically, our understanding of ROS-mediated PTP oxidation is not yet sufficient to predict the molecular responses of PTPs to oxidative stress. However, identifying distinct responses will enable novel routes for PTP-selective drug design, important for managing diseases such as cancer and Alzheimer's disease. Therefore, we performed a detailed biochemical and molecular study of all KIM-PTP family members to determine their H2O2 oxidation profiles and identify their reversible inactivation mechanism(s). We show that despite having nearly identical 3D structures and sequences, each KIM-PTP family member has a unique oxidation profile. Furthermore, we also show that whereas STEP and PTPRR stabilize their reversibly oxidized state by forming an intramolecular disulfide bond, HePTP uses an unexpected mechanism, namely, formation of a reversible intermolecular disulfide bond. In summary, despite being closely related, KIM-PTPs significantly differ in oxidation profiles. These findings highlight that oxidation protection is critical when analyzing PTPs, for example, in drug screening.	[Machado, Luciana E. S. F.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Shen, Tun-Li; Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Page, Rebecca] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	Brown University; Brown University; Brown University; University of Arizona	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.; Peti, W (corresponding author), Brown Univ, Dept Chem, Providence, RI 02912 USA.	wolfgangpeti@email.arizona.edu	Machado, Luciana Elena Souza Fraga/D-3737-2017	Machado, Luciana Elena Souza Fraga/0000-0002-2475-9324	American Diabetes Association Pathway to Stop Diabetes [1-14-ACN-31]; National Institutes of Health [R01NS091336]; Brazil Initiative Brown University grant; National Institutes of Health Grant [R01GM098482]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091336] Funding Source: NIH RePORTER	American Diabetes Association Pathway to Stop Diabetes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazil Initiative Brown University grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Diabetes Association Pathway to Stop Diabetes Grant 1-14-ACN-31, National Institutes of Health Grant R01NS091336, a Brazil Initiative Brown University grant (to W. P.), and National Institutes of Health Grant R01GM098482 (to R. P). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Brito PM, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00082; Buhrman G, 2005, BIOCHEMISTRY-US, V44, P5307, DOI 10.1021/bi047449f; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Critton DA, 2011, J MOL BIOL, V405, P619, DOI 10.1016/j.jmb.2010.11.020; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Francis DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091934; Francis DM, 2014, BIOMOL NMR ASSIGN, V8, P185, DOI 10.1007/s12104-013-9480-8; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Francis DM, 2013, STRUCTURE, V21, P1612, DOI 10.1016/j.str.2013.07.003; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Jeeves M, 2008, BIOMOL NMR ASSIGN, V2, P101, DOI 10.1007/s12104-008-9095-7; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Lee CU, 2015, ANGEW CHEM INT EDIT, V54, P13796, DOI 10.1002/anie.201506338; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Parsons ZD, 2013, BIOCHEMISTRY-US, V52, P6412, DOI 10.1021/bi400451m; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Peti W, 2016, METHODS MOL BIOL, V1447, P181, DOI 10.1007/978-1-4939-3746-2_11; Roeser J, 2010, ANAL BIOANAL CHEM, V397, P3441, DOI 10.1007/s00216-010-3471-8; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Xu J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001923; Xu J, 2012, ADV PHARMACOL, V64, P303, DOI 10.1016/B978-0-12-394816-8.00009-X; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; ZANKE B, 1994, LEUKEMIA, V8, P236	49	12	12	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8786	8796		10.1074/jbc.M116.774174	http://dx.doi.org/10.1074/jbc.M116.774174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389559	Green Published, hybrid			2022-12-28	WOS:000402153900024
J	Bettoni, S; Bresin, E; Remuzzi, G; Noris, M; Donadelli, R				Bettoni, Serena; Bresin, Elena; Remuzzi, Giuseppe; Noris, Marina; Donadelli, Roberta			RETRACTION: Insights into the effects of complement factor H on the assembly and decay of the alternative pathway C3 proconvertase and C3 convertase (Retraction of Vol 292, Pg 6094, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Donadelli, Roberta/ABG-8930-2020; Bresin, Elena/ABG-2409-2020	Bresin, Elena/0000-0003-4198-2891				Bettoni S, 2016, J BIOL CHEM, V291, P8214, DOI 10.1074/jbc.M115.693119	1	0	0	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6094	6094		10.1074/jbc.A115.693119	http://dx.doi.org/10.1074/jbc.A115.693119			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28411212	Green Published, hybrid			2022-12-28	WOS:000399538700007
J	Wallin, H; Apelqvist, J; Andersson, F; Ekstrom, U; Abrahamson, M				Wallin, Hanna; Apelqvist, Jenny; Andersson, Freddi; Ekstrom, Ulf; Abrahamson, Magnus			Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE-INHIBITORS; TUMOR-SUPPRESSOR GENE; CATHEPSIN-B; EXPRESSION; IDENTIFICATION; TARGET; PROGRESSION; CLONING; SN; PROLIFERATION	The ratio between proteases and their inhibitors is unbalanced in cancer. The cysteine protease inhibitor cystatin C is internalized by some cancer cells, which affects cellular properties. Here we aimed to investigate if uptake of cystatin C and the related inhibitor cystatin E/M occur in melanoma cell lines and to evaluate to what extent the uptake affects the legumain activity that is typically increased in melanoma. First we studied the basic expression, secretion, and intracellular content of all type 2 cystatins as well as expression and activity of their possible target enzymes legumain and cathepsin B in MDA-MB-435S, A375, and C8161 melanoma cells. Legumain activity was measureable in all cell lines, and of the potential legumain inhibitors, cystatin C, E/M, and F, cystatin C was the one mainly produced. All cells internalized cystatin C added to culture media, leading to increased intracellular cystatinClevels by 120-200%. Cystatin E/M was internalized as well but at a modest rate. The effects on intracellular legumain activity were nevertheless pronounced, probably because the cells lacked this inhibitor, and its affinity for legumain is 100-fold higher than that of cystatin C. Likewise, the low-degree uptake resulted in reduced migration and invasion of A375 cells in Matrigel to an extent comparable with the W106F variant of cystatin C with optimal uptake properties and resulting in much higher intracellular levels. Thus, cystatin E/M appears to be a good candidate to efficiently downregulate the increased legumain activity, possibly important for the malignant phenotype of melanoma cells.	[Wallin, Hanna; Apelqvist, Jenny; Andersson, Freddi; Ekstrom, Ulf; Abrahamson, Magnus] Lund Univ, Dept Lab Med, SE-22185 Lund, Sweden	Lund University	Abrahamson, M (corresponding author), Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, Univ Hosp, SE-22185 Lund, Sweden.	Magnus.Abrahamson@med.lu.se	Abrahamson, Magnus/CAG-9507-2022		Faculty of Medicine and BioCARE at Lund University; national 'ALF' program grant	Faculty of Medicine and BioCARE at Lund University; national 'ALF' program grant	This work was supported by the Faculty of Medicine and BioCARE at Lund University and by a national 'ALF' program grant (to M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Ai LB, 2006, CANCER RES, V66, P7899, DOI 10.1158/0008-5472.CAN-06-0576; Alvarez-Diaz S, 2009, J CLIN INVEST, V119, P2343, DOI 10.1172/JCI37205; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; BALBIN M, 1994, J BIOL CHEM, V269, P23156; Bjork I, 1996, BIOCHEMISTRY-US, V35, P10720, DOI 10.1021/bi960420u; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; Cao X., 2015, SCI REP UK, V5, P8230; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Chen XB, 2010, BIOCHEM BIOPH RES CO, V391, P1070, DOI 10.1016/j.bbrc.2009.12.022; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008; Coulibaly S, 1999, INT J CANCER, V83, P526, DOI 10.1002/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.3.CO;2-D; D'Costa ZC, 2014, ONCOTARGET, V5, P1609, DOI 10.18632/oncotarget.1707; Ekstrom U, 2008, FEBS J, V275, P4571, DOI 10.1111/j.1742-4658.2008.06600.x; FREIJE JP, 1993, J BIOL CHEM, V268, P15737; Jiang J, 2015, TUMOR BIOL, V36, P3903, DOI 10.1007/s13277-014-3033-3; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Liu C, 2003, CANCER RES, V63, P2957; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Ni J, 1997, J BIOL CHEM, V272, P10853; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Qiu J, 2008, LAB INVEST, V88, P910, DOI 10.1038/labinvest.2008.66; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Schagdarsurengin U, 2007, ONCOGENE, V26, P3089, DOI 10.1038/sj.onc.1210107; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Sokol JP, 2004, MOL CANCER RES, V2, P183; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wallin H, 2013, J BIOL CHEM, V288, P17019, DOI 10.1074/jbc.M113.453449; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; Werle B, 2003, BIOL CHEM, V384, P281, DOI 10.1515/BC.2003.031; Yoneda K, 2009, INT J ONCOL, V35, P33, DOI 10.3892/ijo_00000310; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x; Zhang J, 2004, CANCER RES, V64, P6957, DOI 10.1158/0008-5472.CAN-04-0819	40	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14413	14424		10.1074/jbc.M117.776138	http://dx.doi.org/10.1074/jbc.M117.776138			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28630039	Green Published, hybrid			2022-12-28	WOS:000408747500010
J	Xu, L; Liu, XY; Sheng, N; Oo, KS; Liang, JX; Chionh, YH; Xu, J; Ye, FZ; Gao, YG; Dedon, PC; Fu, XY				Xu, Luang; Liu, Xinyu; Sheng, Na; Oo, Kyaw Soe; Liang, Junxin; Chionh, Yok Hian; Xu, Juan; Ye, Fuzhou; Gao, Yong-Gui; Dedon, Peter C.; Fu, Xin-Yuan			Three distinct 3-methylcytidine (m(3)C) methyltransferases modify tRNA and mRNA in mice and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN ABP140; SACCHAROMYCES-CEREVISIAE; RIBONUCLEIC-ACID; GENES; METHYLATION; SEQUENCE; YEAST; N-1-METHYLADENOSINE; EPITRANSCRIPTOME; DATABASE	Chemical RNA modifications are central features of epitran-scriptomics, highlighted by the discovery of modified ribo-nucleosides in mRNA and exemplified by the critical roles of RNA modifications in normal physiology and disease. Despite a resurgent interest in these modifications, the biochemistry of 3-methylcytidine (m(3)C) formation in mammalian RNAs is still poorly understood. However, the recent discovery of trm141 as the second gene responsible for m(3)C presence in RNA in fission yeast raises the possibility that multiple enzymes are involved in m(3)C formation in mammals as well. Here, we report the discovery and characterization of three distinct m(3)C-contributing enzymes in mice and humans. We found that methyltransferase-like (METTL) 2 and 6 contribute m(3)C in specific tRNAs and that METTL8 only contributes m(3)C to mRNA. MS analysis revealed that there is an similar to 30-40% and similar to 10-15% reduction, respectively, in METTL2 and -6 null-mutant cells, of m(3)C in total tRNA, and primer extension analysis located METTL2-modified m(3)C at position 32 of tRNA(Thr) isoacceptors and tRNA(Arg(CCU)). We also noted that METTL6 interacts with seryl-tRNA synthetase in an RNA-dependent manner, suggesting a role for METTL6 in modifying serine tRNA isoacceptors. METTL8, however, modified only mRNA, as determined by biochemical and genetic analyses in Mettl8 null-mutant mice and two human METTL8 mutant cell lines. Our findings provide the first evidence of the existence of m(3)C modification in mRNA, and the discovery of METTL8 as an mRNA m(3)C writer enzyme opens the door to future studies of other m(3)C epitranscriptomic reader and eraser functions.	[Xu, Luang; Liu, Xinyu; Oo, Kyaw Soe; Fu, Xin-Yuan] Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr, Singapore 117599, Singapore; [Sheng, Na; Xu, Juan; Fu, Xin-Yuan] Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China; [Liang, Junxin; Fu, Xin-Yuan] Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117596, Singapore; [Chionh, Yok Hian; Dedon, Peter C.] Singapore MIT Alliance Res & Technol, 1 CREATE Way, Singapore 138602, Singapore; [Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Dedon, Peter C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	National University of Singapore; Nanjing University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT)	Fu, XY (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr, Singapore 117599, Singapore.; Fu, XY (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China.; Fu, XY (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117596, Singapore.; Dedon, PC (corresponding author), Singapore MIT Alliance Res & Technol, 1 CREATE Way, Singapore 138602, Singapore.; Dedon, PC (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.	pcdedon@mit.edu; csifxy@nus.edu.sg	Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011	Gao, Yonggui/0000-0001-7298-0835; Xu, Luang/0000-0003-2606-0936	National Research Foundation Singapore; Singapore Ministry of Education under its Research Centres of Excellence Initiative; Cancer Science Institute of Singapore (CSI, Singapore) Grant [713001010271]; Office of Deputy President of National University of Singapore; Singapore-MIT Alliance for Research and Technology; National Institutes of Health from the NIEHS [ES026856]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026856] Funding Source: NIH RePORTER	National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centres of Excellence Initiative(Ministry of Education, Singapore); Cancer Science Institute of Singapore (CSI, Singapore) Grant; Office of Deputy President of National University of Singapore(National University of Singapore); Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); National Institutes of Health from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Research Foundation Singapore, the Singapore Ministry of Education under its Research Centres of Excellence Initiative, Cancer Science Institute of Singapore (CSI, Singapore) Grant 713001010271 (to X.-Y. F.), funds from the Office of Deputy President of National University of Singapore, partly under the Singapore-MIT Alliance for Research and Technology (to P. C. D.), and by National Institutes of Health Grant ES026856 from the NIEHS (to P. C. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arimbasseri AG, 2016, RNA, V22, P1400, DOI 10.1261/rna.056259.116; Chan CTY, 2015, CHEM RES TOXICOL, V28, P978, DOI 10.1021/acs.chemrestox.5b00004; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chionh YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13302; Chionh YH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt668; Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116; D'Silva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; HALL RH, 1963, BIOCHEM BIOPH RES CO, V12, P361, DOI 10.1016/0006-291X(63)90105-0; Han L, 2017, RNA, V23, P406, DOI 10.1261/rna.059667.116; Hauenschild R, 2015, NUCLEIC ACIDS RES, V43, P9950, DOI 10.1093/nar/gkv895; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jackman JE, 2013, WIRES RNA, V4, P35, DOI 10.1002/wrna.1144; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Lewis CJT, 2017, NAT REV MOL CELL BIO, V18, P202, DOI 10.1038/nrm.2016.163; Li X, 2016, EVOL BIOINFORM, V12, P1, DOI 10.4137/EBO.S37532; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MADEN BEH, 1974, J MOL BIOL, V88, P133, DOI 10.1016/0022-2836(74)90299-X; Noma A, 2011, RNA, V17, P1111, DOI 10.1261/rna.2653411; O'Connell M, 2015, RNA, V21, P703, DOI 10.1261/rna.050260.115; OLSON MV, 1981, NATURE, V291, P464, DOI 10.1038/291464a0; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Su D, 2014, NAT PROTOC, V9, P828, DOI 10.1038/nprot.2014.047; Tserovski L, 2016, METHODS, V107, P110, DOI 10.1016/j.ymeth.2016.02.012; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; WEISSENBACH J, 1977, BIOCHIMIE, V59, P381, DOI 10.1016/S0300-9084(77)80314-3; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132	36	112	118	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14695	14703		10.1074/jbc.M117.798298	http://dx.doi.org/10.1074/jbc.M117.798298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28655767	Green Published, hybrid			2022-12-28	WOS:000408747500033
J	Carlson, SM; Soulette, CM; Yang, Z; Elias, JE; Brooks, AN; Gozani, O				Carlson, Scott M.; Soulette, Cameron M.; Yang, Ze; Elias, Joshua E.; Brooks, Angela N.; Gozani, Or			RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE GENE LISTS; SR PROTEINS; PROTEOMIC ANALYSIS; CELL-CULTURE; AMINO-ACIDS; RNA; BIOINFORMATICS; ENRICHMENT; IDENTIFICATION; EXPRESSION	In eukaryotes, precursor mRNA (pre-mRNA) splicing removes non-coding intron sequences to produce mature mRNA. This removal is controlled in part by RNA-binding proteins that regulate alternative splicing decisions through interactions with the splicing machinery. RNA binding motif protein 25 (RBM25) is a putative splicing factor strongly conserved across eukaryotic lineages. However, the role of RBM25 in global splicing regulation and its cellular functions are unknown. Here we show that RBM25 is required for the viability of multiple human cell lines, suggesting that it could play a key role in pre-mRNA splicing. Indeed, transcriptome-wide analysis of splicing events demonstrated that RBM25 regulates a large fraction of alternatively spliced exons throughout the human genome. Moreover, proteomic analysis indicated that RBM25 interacts with components of the early spliceosome and regulators of alternative splicing. Previously, we identified an RBM25 species that is mono-methylated at lysine 77 (RBM25K77me1), and here we used quantitative mass spectrometry to show that RBM25K77me1 is abundant in multiple human cell lines. We also identified a region of RBM25 spanning Lys-77 that binds with high affinity to serine-and arginine-rich splicing factor 2 (SRSF2), a crucial protein in exon definition, but only when Lys-77 is unmethylated. Together, our findings uncover a pivotal role for RBM25 as an essential regulator of alternative splicing and reveal a new potential mechanism for regulation of pre-mRNA splicing by lysine methylation of a splicing factor.	[Carlson, Scott M.; Yang, Ze; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Elias, Joshua E.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Soulette, Cameron M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95060 USA; [Brooks, Angela N.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95060 USA	Stanford University; Stanford University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Gozani, O (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Brooks, AN (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95060 USA.	anbrooks@ucsc.edu; ogozani@stanford.edu		Gozani, Or/0000-0002-1365-4463	NCI, National Institutes of Health [R01CA172560, K99CA190803]; W. M. Keck Foundation Medical Research Program; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA172560, K99CA190803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058903, T32GM008646] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); W. M. Keck Foundation Medical Research Program; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NCI, National Institutes of Health Grant R01CA172560 (to O.G.). O.G. is a co-founder of EpiCypher, Inc. and Athelas Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NCI, National Institutes of Health Grant K99CA190803.; Supported by a grant from the W. M. Keck Foundation Medical Research Program.; Supported in part by a grant from the Damon Runyon Cancer Research Foundation. To whom correspondence may be addressed. E-mail: anbrooks@ucsc.edu.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Bradley T, 2015, RNA, V21, P75, DOI 10.1261/rna.043893.113; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Carlson SM, 2015, J BIOL CHEM, V290, P12040, DOI 10.1074/jbc.M115.641530; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Fortes P, 2007, FEBS LETT, V581, P3087, DOI 10.1016/j.febslet.2007.05.066; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gao G, 2011, CIRCULATION, V124, P1124, DOI 10.1161/CIRCULATIONAHA.111.044495; Gottschalk A, 1998, RNA, V4, P374; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Howard JM, 2015, WIRES RNA, V6, P93, DOI 10.1002/wrna.1260; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	43	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13381	13390		10.1074/jbc.M117.784371	http://dx.doi.org/10.1074/jbc.M117.784371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655759	Green Published, hybrid			2022-12-28	WOS:000407465300024
J	Jiang, L; Xiong, JN; Zhan, JS; Yuan, FJ; Tang, M; Zhang, CH; Cao, ZY; Chen, YC; Lu, XP; Li, YL; Wang, H; Wang, LN; Wang, JD; Zhu, WG; Wang, HY				Jiang, Lu; Xiong, Jiannan; Zhan, Junsi; Yuan, Fengjie; Tang, Ming; Zhang, Chaohua; Cao, Ziyang; Chen, Yongcan; Lu, Xiaopeng; Li, Yinglu; Wang, Hui; Wang, Lina; Wang, Jiadong; Zhu, Wei-Guo; Wang, Haiying			Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; RNA-POLYMERASE-I; SIRT7-DEPENDENT DEACETYLATION; HEPATOCELLULAR-CARCINOMA; DEPENDENT DEACETYLATION; CELL-PROLIFERATION; ACTIVATION; EXPRESSION; HAUSP; P53	Sirtuin 7 (SIRT7), a member of theNAD(+)-dependent class III histone deacetylases, is involved in the regulation of various cellular processes and in resisting various stresses, such as hypoxia, low glucose levels, and DNA damage. Interestingly, SIRT7 is linked to the control of glycolysis, suggesting a role in glucose metabolism. Given the important roles of SIRT7, it is critical to clarify how SIRT7 activity is potentially regulated. It has been reported that some transcriptional and post-transcriptional regulatory mechanisms are involved. However, little is known how SIRT7 is regulated by the post-translational modifications. Here, we identified ubiquitin-specific peptidase 7 (USP7), a deubiquitinase, as a negative regulator of SIRT7. We showed that USP7 interacts with SIRT7 both in vitro and in vivo, and we further demonstrated that SIRT7 undergoes endogenous Lys63- linked polyubiquitination, which is removed by USP7. Although the USP7-mediated deubiquitination of SIRT7 had no effect on its stability, the deubiquitination repressed its enzymatic activity. We also showed that USP7 coordinates with SIRT7 to regulate the expression of glucose-6-phosphatase catalytic subunit (G6PC), a gluconeogenic gene. USP7 depletion by RNA interference increased both G6PC expression and SIRT7 enzymatic activity. Moreover, SIRT7 targeted the G6PC promoter through the transcription factor ELK4 but not through forkhead box O1 (FoxO1). In summary, SIRT7 is a USP7 substrate and has a novel role as a regulator of gluconeogenesis. Our study may provide the basis for new clinical approaches to treat metabolic disorders related to glucose metabolism.	[Jiang, Lu; Xiong, Jiannan; Zhan, Junsi; Yuan, Fengjie; Tang, Ming; Zhang, Chaohua; Cao, Ziyang; Chen, Yongcan; Lu, Xiaopeng; Li, Yinglu; Wang, Hui; Wang, Lina; Zhu, Wei-Guo; Wang, Haiying] Peking Univ, Dept Biochem & Mol Biol,Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Zhu, Wei-Guo] Peking Tsinghua Univ, Ctr Life Sci, Beijing 100191, Peoples R China; [Wang, Jiadong] Peking Univ, Sch Basic Med Sci, Dept Radiat Med, Inst Syst Biomed, Beijing 100191, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China	Peking University; Tsinghua University; Peking University; Shenzhen University	Zhu, WG (corresponding author), Peking Univ, Dept Biochem & Mol Biol,Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.; Zhu, WG (corresponding author), Peking Tsinghua Univ, Ctr Life Sci, Beijing 100191, Peoples R China.; Zhu, WG (corresponding author), Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China.; Wang, HY (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu.cn; wendy@bjmu.edu.cn	Li, Yinglu/GWC-7573-2022	Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Haiying/0000-0001-7729-0649	National Key Basic Research Program of China [2013CB911000, 2013CB911001]; National Natural Science Foundation of China [81472627, 91319302]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of China Grants 2013CB911000 and 2013CB911001 and National Natural Science Foundation of China Grants 81472627 and 91319302.	Alonso-de Vega I, 2014, CELL CYCLE, V13, P3921, DOI 10.4161/15384101.2014.973324; Armour SM, 2013, MOL CELL BIOL, V33, P1487, DOI 10.1128/MCB.00971-12; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bellet MM, 2011, COLD SH Q B, V76, P31, DOI 10.1101/sqb.2011.76.010520; Blank MF, 2017, TRANSCR-AUSTIN, V8, P67, DOI 10.1080/21541264.2016.1276658; Blank MF, 2017, NUCLEIC ACIDS RES, V45, P2675, DOI 10.1093/nar/gkx053; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chen SF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10734; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Cioffi M, 2015, CELL REP, V12, P1594, DOI 10.1016/j.celrep.2015.08.006; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Fang MM, 2016, BBA-GENE REGUL MECH, V1859, P294, DOI 10.1016/j.bbagrm.2015.11.010; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Hall JA, 2014, MOL ENDOCRINOL, V28, P912, DOI 10.1210/me.2013-1420; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887; Hubbi ME, 2013, J BIOL CHEM, V288, P20768, DOI 10.1074/jbc.M113.476903; Hussain M, 2014, VIRUS GENES, V49, P358, DOI 10.1007/s11262-014-1101-9; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Karim MF, 2013, BIOCHEM BIOPH RES CO, V441, P157, DOI 10.1016/j.bbrc.2013.10.020; Kida Y, 2016, CAN J CARDIOL, V32, P634, DOI 10.1016/j.cjca.2015.11.022; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kiran S, 2015, CELL SIGNAL, V27, P673, DOI 10.1016/j.cellsig.2014.11.026; Kiran S, 2015, EXP CELL RES, V331, P123, DOI 10.1016/j.yexcr.2014.11.001; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Kurylowicz A, 2016, INT J OBESITY, V40, P1635, DOI 10.1038/ijo.2016.131; Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Li L, 2013, CELL RES, V23, P10, DOI 10.1038/cr.2012.112; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu GF, 2016, BBA-GENE REGUL MECH, V1859, P348, DOI 10.1016/j.bbagrm.2015.12.004; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Malik S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09841; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Paredes S, 2014, CLIN CANCER RES, V20, P1741, DOI 10.1158/1078-0432.CCR-13-1547; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Shi HY, 2016, ONCOL REP, V36, P3051, DOI 10.3892/or.2016.5063; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sun LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12497; Tang M, 2017, THERANOSTICS, V7, P1346, DOI 10.7150/thno.18804; Vakhrusheva O, 2008, J PHYSIOL PHARMACOL, V59, P201; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Wang GC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00005; Wang HY, 2012, DNA REPAIR, V11, P146, DOI 10.1016/j.dnarep.2011.10.014; Webb AE, 2013, NAT CELL BIOL, V15, P444, DOI 10.1038/ncb2749; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; Yu HY, 2014, CLIN CANCER RES, V20, P3434, DOI 10.1158/1078-0432.CCR-13-2952; Yu J, 2017, CELL REP, V18, P1229, DOI 10.1016/j.celrep.2017.01.009; Zhang C., 2017, PROTEOMICS; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143	91	33	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13296	13311		10.1074/jbc.M117.780130	http://dx.doi.org/10.1074/jbc.M117.780130			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH6KS	28655758	Green Published, hybrid			2022-12-28	WOS:000411286000001
J	Liebsch, F; Aurousseau, MRP; Bethge, T; McGuire, H; Scolari, S; Herrmann, A; Blunck, R; Bowie, D; Multhaup, G				Liebsch, Filip; Aurousseau, Mark R. P.; Bethge, Tobias; McGuire, Hugo; Scolari, Silvia; Herrmann, Andreas; Blunck, Rikard; Bowie, Derek; Multhaup, Gerd			Full-length cellular beta-secretase has a trimeric subunit stoichiometry, and its sulfur-rich transmembrane interaction site modulates cytosolic copper compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; INFLUENZA-VIRUS HEMAGGLUTININ; WILSON-DISEASE; ALZHEIMERS-DISEASE; CLEAVING ENZYME; BACE1; SEQUENCE; DOMAIN; MODEL; MICE	The beta-secretase (BACE1) initiates processing of the amyloid precursor protein (APP) into A beta peptides, which have been implicated as central players in the pathology of Alzheimer disease. BACE1 has been described as a copper-binding protein and its oligomeric state as being monomeric, dimeric, and/or multimeric, but the native cellular stoichiometry has remained elusive. Here, by using single-molecule fluorescence and in vitro cross-linking experiments with photo-activatable unnatural amino acids, we show that full-length BACE1, independently of its subcellular localization, exists as trimers in human cells. We found that trimerization requires the BACE1 transmembrane sequences (TMSs) and cytoplasmic domains, with residues Ala(463) and Cys(466) buried within the trimer interface of the sulfur-rich core of the TMSs. Our 3D model predicts that the sulfur-rich core of the trimeric BACE1 TMS is accessible to metal ions, but copper ions did not trigger trimerization. The results of functional assays of endogenous BACE1 suggest that it has a role in intracellular copper compartmentalization by transferring cytosolic copper to intracellular compartments, while leaving the overall cellular copper concentration unaltered. Adding to existing physiological models, our results provide novel insight into the atypical interactions between copper and BACE1 and into its non-enzymatic activities. In conclusion, therapeutic Alzheimer disease prevention strategies aimed at decreasing BACE1 protein levels should be regarded with caution, because adverse effects in copper homeostasis may occur.	[Liebsch, Filip; Bowie, Derek; Multhaup, Gerd] McGill Univ, Integrated Program Neurosci, Montreal, PQ H3G 0B1, Canada; [Aurousseau, Mark R. P.; Bowie, Derek; Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Bethge, Tobias] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Scolari, Silvia; Herrmann, Andreas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Bethge, Tobias] Kantonsspital Aarau, Inst Lab Med, CH-5001 Aarau, Switzerland	McGill University; McGill University; Free University of Berlin; Universite de Montreal; Humboldt University of Berlin; Kantonsspital Aarau AG (KSA)	Multhaup, G (corresponding author), McGill Univ, Integrated Program Neurosci, Montreal, PQ H3G 0B1, Canada.; Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Liebsch, Filip/AAL-3327-2020; Blunck, Rikard/AAM-3078-2020	Liebsch, Filip/0000-0002-0955-8065; Blunck, Rikard/0000-0003-4484-2907	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 04774-15]; Canada Foundation for Innovation (CFI); Canada Research Chairs (CRC) Program; International Copper Association; Studienstiftung des Deutschen Volkes and Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Canadian Institutes of Health Research (CIHR); Fonds de recherche du Quebec, Sante (FRQS); CIHR; Fonds de recherche du Quebec - Nature et technologies (FRQNT); NSERC [DG 327201-2012]; CIHR [MOP 136894]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs (CRC) Program(Canada Research Chairs); International Copper Association; Studienstiftung des Deutschen Volkes and Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec, Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Nature et technologies (FRQNT); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN 04774-15, the Canada Foundation for Innovation (CFI), Canada Research Chairs (CRC) Program, and the International Copper Association (to G. M.), Studienstiftung des Deutschen Volkes and Groupe de Recherche Axe sur la Structure des Proteines (GRASP) Ph. D. fellowships (to F.L.), operating grants from the Canadian Institutes of Health Research (CIHR) (to D. B.), and the Fonds de recherche du Quebec, Sante (FRQS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Banting and Best graduate fellowship from the CIHR.; Supported by a Fonds de recherche du Quebec - Nature et technologies (FRQNT) doctoral research grant.; Supported by NSERC Grant DG 327201-2012 and CIHR Grant MOP 136894.	Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Engel S, 2010, BIOCHEM J, V425, P567, DOI 10.1042/BJ20091388; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Gray EH, 2010, J ALZHEIMERS DIS, V21, P1101, DOI 10.3233/JAD-2010-100717; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Lutsenko S, 2016, METALLOMICS, V8, P840, DOI [10.1039/c6mt00176a, 10.1039/C6MT00176A]; Lutsenko S, 2008, BIOCHEM SOC T, V36, P1233, DOI 10.1042/BST0361233; McGuire H, 2012, J BIOL CHEM, V287, P35912, DOI 10.1074/jbc.M112.402057; MENKES JH, 1962, PEDIATRICS, V29, P764; Meyer LA, 2001, J BIOL CHEM, V276, P36857, DOI 10.1074/jbc.M105361200; Munter LM, 2013, J AM CHEM SOC, V135, P19354, DOI 10.1021/ja410812r; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nie L, 2011, J AM CHEM SOC, V133, P6177, DOI 10.1021/ja106894g; Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Vetrivel KS, 2011, J BIOL CHEM, V286, P26166, DOI 10.1074/jbc.M111.260471; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Voigt P, 2005, J BIOL CHEM, V280, P5121, DOI 10.1074/jbc.M413104200; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Zhao YJ, 2012, J BIOL CHEM, V287, P11141, DOI 10.1074/jbc.M111.330209	48	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13258	13270		10.1074/jbc.M117.779165	http://dx.doi.org/10.1074/jbc.M117.779165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637867	Green Published, hybrid			2022-12-28	WOS:000407465300015
J	Tsukamoto, H; Chen, IS; Kubo, Y; Furutani, Y				Tsukamoto, Hisao; Chen, I-Shan; Kubo, Yoshihiro; Furutani, Yuji			A ciliary opsin in the brain of a marine annelid zooplankton is ultraviolet-sensitive, and the sensitivity is tuned by a single amino acid residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; G protein-coupled receptor (GPCR); molecular evolution; photobiology; rhodopsin; ultraviolet-visible spectroscopy (UV-Vis spectroscopy)	PHOTORECEPTOR CELL; RHODOPSIN; PIGMENT; DROSOPHILA; VISION; LIGHT; GENE; EXPRESSION; RECEPTOR; DYNAMICS	Ciliary opsins were classically thought to function only in vertebrates for vision, but they have also been identified recently in invertebrates for non-visual photoreception. Larvae of the annelid Platynereis dumerilii are used as a zooplankton model, and this zooplankton species possesses a vertebrate-type ciliary opsin (named c-opsin) in the brain. Platynereis c-opsin is suggested to relay light signals for melatonin production and circadian behaviors. Thus, the spectral and biochemical characteristics of this c-opsin would be directly related to non-visual photoreception in this zooplankton model. Here we demonstrate that the c-opsin can sense UV to activate intracellular signaling cascades and that it can directly bind exogenous all-trans-retinal. These results suggest that this c-opsin regulates circadian signaling in a UV-dependent manner and that it does not require a supply of 11-cis-retinal for photoreception. Avoidance of damaging UV irradiation is a major cause of large-scale daily zooplankton movement, and the observed capability of the c-opsin to transmit UV signals and bind all-trans-retinal is ideally suited for sensing UV radiation in the brain, which presumably lacks enzymes producing 11-cis-retinal. Mutagenesis analyses indicated that a unique amino acid residue (Lys-94) is responsible for c-opsin-mediated UV sensing in the Platynereis brain. We therefore propose that acquisition of the lysine residue in the c-opsin would be a critical event in the evolution of Platynereis to enable detection of ambient UV light. In summary, our findings indicate that the c-opsin possesses spectral and biochemical properties suitable for UV sensing by the zooplankton model.	[Tsukamoto, Hisao; Furutani, Yuji] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Tsukamoto, Hisao; Furutani, Yuji] Grad Univ Adv Studies, SOKENDAI, Dept Struct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Chen, I-Shan; Kubo, Yoshihiro] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400193, Japan; [Chen, I-Shan; Kubo, Yoshihiro] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Tsukamoto, H (corresponding author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	tsukamoh@ims.ac.jp	Chen, I-Shan/ABG-2914-2021; Furutani, Yuji/J-8337-2019	Chen, I-Shan/0000-0003-3204-3921; Furutani, Yuji/0000-0001-5284-8773; Kubo, Yoshihiro/0000-0001-6707-0837	JSPS KAKENHI Grants [25840122, 17K15109, 26708002]; Uehara Memorial Foundation; Center for the Promotion of Integrated Sciences of SOKENDAI; Cooperative Study Program of the National Institute for Physiological Sciences	JSPS KAKENHI Grants; Uehara Memorial Foundation(Uehara Memorial Foundation); Center for the Promotion of Integrated Sciences of SOKENDAI; Cooperative Study Program of the National Institute for Physiological Sciences	This work was supported by JSPS KAKENHI Grants 25840122 and 17K15109 (to H. T.) and 26708002 (to Y. F.), the Uehara Memorial Foundation, the Center for the Promotion of Integrated Sciences of SOKENDAI, and the Cooperative Study Program of the National Institute for Physiological Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	ALLDREDGE AL, 1980, J EXP MAR BIOL ECOL, V44, P133, DOI 10.1016/0022-0981(80)90150-1; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Baumgartner W, 1999, BIOPHYS J, V77, P1980, DOI 10.1016/S0006-3495(99)77039-6; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Brandon CS, 2017, J MOL EVOL, V84, P12, DOI 10.1007/s00239-016-9777-1; Brierley AS, 2014, CURR BIOL, V24, pR1074, DOI 10.1016/j.cub.2014.08.054; Chen IS, 2014, J PHYSIOL-LONDON, V592, P1237, DOI 10.1113/jphysiol.2013.269803; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; Cronin TW, 2016, J EXP BIOL, V219, P2790, DOI 10.1242/jeb.128769; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; EAKIN RM, 1979, AM ZOOL, V19, P647; Fasick JI, 2002, BIOCHEMISTRY-US, V41, P6860, DOI 10.1021/bi0200413; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Friedmann D, 2015, CURR BIOL, V25, P69, DOI 10.1016/j.cub.2014.10.055; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Fujiwara Y, 2002, J GEN PHYSIOL, V120, P677, DOI 10.1085/jgp.20028663; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P3133, DOI 10.1021/bi00464a033; Futahashi R, 2015, P NATL ACAD SCI USA, V112, pE1247, DOI 10.1073/pnas.1424670112; Gartner W., 2000, HDB BIOL PHYS, V3, P297; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; Guhmann M, 2015, CURR BIOL, V25, P2265, DOI 10.1016/j.cub.2015.07.017; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; HUBBARD R, 1953, J GEN PHYSIOL, V36, P415, DOI 10.1085/jgp.36.3.415; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Kato M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163925; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kitamoto J, 2000, J EXP BIOL, V203, P2887; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0174-9; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MONTELL C, 1987, J NEUROSCI, V7, P1558; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Ni JD, 2017, NATURE, V545, P340, DOI 10.1038/nature22325; Nissila J, 2012, J COMP PHYSIOL A, V198, P833, DOI 10.1007/s00359-012-0754-x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Ramon E, 2003, J BIOL CHEM, V278, P6427, DOI 10.1074/jbc.M210929200; Randel N, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0042; Randel N, 2014, ELIFE, V3, DOI 10.7554/eLife.02730; Randel N, 2013, INTEGR COMP BIOL, V53, P7, DOI 10.1093/icb/ict046; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Sakai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141238; Salcedo E, 2003, J NEUROSCI, V23, P10873; Sato KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146275; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Schippers KJ, 2014, CELL, V159, P9, DOI 10.1016/j.cell.2014.09.004; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; Sugihara T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161215; Tada T, 2009, P NATL ACAD SCI USA, V106, P17457, DOI 10.1073/pnas.0903839106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tosches MA, 2014, CELL, V159, P46, DOI 10.1016/j.cell.2014.07.042; Townson SM, 1998, J NEUROSCI, V18, P2412; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Tsukamoto H., 2014, EVOLUTION VISUAL NON, P219, DOI DOI 10.1007/978-1-4614-4355-1_7; Tsukamoto H, 2015, J BIOL CHEM, V290, P27176, DOI 10.1074/jbc.M115.666305; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wang XY, 2012, J NEUROSCI, V32, P3485, DOI 10.1523/JNEUROSCI.5350-11.2012; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603; Yamashita T, 2014, J BIOL CHEM, V289, P3991, DOI 10.1074/jbc.M113.514075; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; ZUKER CS, 1987, J NEUROSCI, V7, P1550	76	15	15	1	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12971	12980		10.1074/jbc.M117.793539	http://dx.doi.org/10.1074/jbc.M117.793539			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28623234	Green Published, hybrid			2022-12-28	WOS:000407220100025
J	Eren, E; Berber, M; Ozoren, N				Eren, Elif; Berber, Mesut; Ozoren, Nesrin			NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; caspase 1 (CASP1); inflammasome; NLRP3; pathogen-associated molecular pattern (PAMP); ASC; NLRC3; inhibition; sterile inflammation	NF-KAPPA-B; COLD AUTOINFLAMMATORY SYNDROME; MUCKLE-WELLS-SYNDROME; NLRP3 INFLAMMASOME; ACTIVATION; CASPASE-1; CRYOPYRIN; RECOGNITION; ANTAGONIST; CRYSTALS	Inflammasomes are multiprotein complexes that sense pathogen-associated and danger-associated molecular patterns and induce inflammation in cells. The NALP3 inflammasome is tightly regulated by recently discovered control mechanisms, but other modulators still remain to be characterized. NLR family CARD-containing 3 (NLRC3) protein, a caspase recruitment domain (CARD)-containing member of the nucleotide oligomerization domain-like receptor (NLR) family, was found to down-regulate the NF-B pathway and stimulator of interferon genes (STING)-dependent cytokine secretion. However, the effect of NLRC3 on the NALP3 inflammasome or other inflammasomes is still unknown. We hypothesized that NLRC3 might inhibit NALP3 inflammasome complex assembly. Toward this end, we tested whether NLRC3 overexpression or knockdown influences NALP3 activity in human monocyte and HEK293FT cells when the complex is ectopically reconstituted. We found that NLRC3 indeed decreases NALP3-induced IL-1 maturation and secretion, pro-caspase-1 cleavage, and speck formation by apoptosis-associated speck-like protein containing a CARD (ASC) protein in response to NALP3 activators. We also show that endogenous NLRC3 interacts with both ASC and pro-caspase-1 but not with NALP3, disrupts ASC speck formation through its CARD, and impairs the ASC and pro-caspase-1 interaction. Moreover, the NLRC3 CARD alone could dampen IL-1 secretion and ASC speck formation induced by NALP3 mutants associated with autoinflammatory diseases. In conclusion, we show here that, besides its role in the inhibition of the NF-B pathway, NLRC3 interferes with the assembly and activity of the NALP3 inflammasome complex by competing with ASC for pro-caspase-1 binding.	[Eren, Elif; Berber, Mesut; Ozoren, Nesrin] Bogazici Univ, Apoptosis & Canc Immunol Lab AKIL, Dept Mol Biol & Genet, TR-34342 Bebek, Turkey; [Eren, Elif; Berber, Mesut; Ozoren, Nesrin] Bogazici Univ, Ctr Life Sci & Technol, TR-34342 Bebek, Turkey	Bogazici University; Bogazici University	Ozoren, N (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Kuzey Kampus Kuzey Pk Binasi, TR-34342 Istanbul, Turkey.	nesrin.ozoren@boun.edu.tr	EREN, Elif/AAO-2054-2020; Ozoren, Nesrin/AAS-3279-2020; Eren, Elif/A-6057-2016	EREN, Elif/0000-0002-0328-5609; OZOREN, NESRIN/0000-0002-8580-618X; Berber, Mesut/0000-0003-2157-2158	EMBO-SDIG [1468]; Bogazici University [BAP 6526 (11B01D10), BAP 7360 (13B01M3)]	EMBO-SDIG; Bogazici University(Bogazici University)	This work was supported by EMBO-SDIG 1468 and Bogazici University Research Fund Projects BAP 6526 (11B01D10) and BAP 7360 (13B01M3) (to N. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Gultekin Y, 2015, J INNATE IMMUN, V7, P25, DOI 10.1159/000363602; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Narayanan KB, 2015, APPL BIOCHEM BIOTECH, V175, P2883, DOI 10.1007/s12010-014-1471-4; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Schmidt FI, 2016, J EXP MED, V213, P771, DOI 10.1084/jem.20151790; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	32	25	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12691	12701		10.1074/jbc.M116.769695	http://dx.doi.org/10.1074/jbc.M116.769695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584053	Green Published, hybrid			2022-12-28	WOS:000406636900032
J	Gutierrez, PA; Ackermann, BE; Vershinin, M; McKenney, RJ				Gutierrez, Pedro A.; Ackermann, Bryce E.; Vershinin, Michael; McKenney, Richard J.			Differential effects of the dynein-regulatory factor Lissencephaly-1 on processive dynein-dynactin motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARGO ADAPTER COMPLEXES; CYTOPLASMIC DYNEIN; MOTOR DOMAIN; ORGANELLE TRANSPORT; CRYSTAL-STRUCTURE; AXONAL-TRANSPORT; POWER STROKE; PLUS-END; LIS1; INITIATION	Cytoplasmic dynein is the primary minus-end-directed microtubule motor protein in animal cells, performing a wide range of motile activities, including transport of vesicular cargos, mRNAs, viruses, and proteins. Lissencephaly-1 (LIS1) is a highly conserved dynein-regulatory factor that binds directly to the dynein motor domain, uncoupling the enzymatic and mechanical cycles of the motor and stalling dynein on the microtubule track. Dynactin, another ubiquitous dynein-regulatory factor, releases dynein from an autoinhibited state, leading to a dramatic increase in fast, processive dynein motility. How these opposing activities are integrated to control dynein motility is unknown. Here, we used fluorescence single-molecule microscopy to study the interaction of LIS1 with the processive dyneindynactin-BicD2N (DDB) complex. Surprisingly, in contrast to the prevailing model for LIS1 function established in the context of dynein alone, we found that binding of LIS1 to DDB does not strongly disrupt processive motility. Motile DDB complexes bound up to two LIS1 dimers, and mutational analysis suggested that LIS1 binds directly to the dynein motor domains during DDB movement. Interestingly, LIS1 enhanced DDB velocity in a concentration-dependent manner, in contrast to observations of the effect of LIS1 on the motility of isolated dynein. Thus, LIS1 exerts concentration-dependent effects on dynein motility and can synergize with dynactin to enhance processive dynein movement. Our results suggest that the effect of LIS1 on dynein motility depends on both LIS1 concentration and the presence of other regulatory factors such as dynactin and may provide new insights into the mechanism of LIS1 haploinsufficiency in the neurodevelopmental disorder lissencephaly.	[Gutierrez, Pedro A.; Ackermann, Bryce E.; McKenney, Richard J.] Univ Calif Davis, Dept Mol & Cellular Biol, 145 Briggs Hall, Davis, CA 95616 USA; [Vershinin, Michael] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Vershinin, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	University of California System; University of California Davis; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	McKenney, RJ (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, 145 Briggs Hall, Davis, CA 95616 USA.	rjmckenney@ucdavis.edu			National Science Foundation [ENG-1563280]; National Institutes of Health [R00 4R00NS089428-03]; University of California-Davis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS089428] Funding Source: NIH RePORTER; Directorate For Engineering [1563280] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Davis(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation Grant ENG-1563280 (to M.V.), National Institutes of Health Grant R00 4R00NS089428-03 (to R. J. M.), and lab start-up funding from University of California-Davis (to R. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Bassam J, 2014, METHOD ENZYMOL, V540, P131, DOI 10.1016/B978-0-12-397924-7.00008-X; Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Baumbach J, 2017, ELIFE, V6, DOI 10.7554/eLife.21768; Bhabha G, 2014, CELL, V159, P857, DOI 10.1016/j.cell.2014.10.018; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cardoso C, 2002, HUM MUTAT, V19, P4, DOI 10.1002/humu.10028; Carter AP, 2016, CURR OPIN STRUC BIOL, V37, P62, DOI 10.1016/j.sbi.2015.12.003; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Caspi M, 2003, J BIOL CHEM, V278, P38740, DOI 10.1074/jbc.M301147200; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; DeWitt MA, 2015, NAT STRUCT MOL BIOL, V22, P73, DOI 10.1038/nsmb.2930; Dix CI, 2013, J CELL BIOL, V202, P479, DOI 10.1083/jcb.201211052; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hoang HT, 2017, P NATL ACAD SCI USA, V114, pE1597, DOI 10.1073/pnas.1620141114; Hoogenraad CC, 2016, TRENDS CELL BIOL, V26, P327, DOI 10.1016/j.tcb.2016.01.001; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Imai H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9179; Jha R., 2017, BIORXIV, DOI [10.1101/126508, DOI 10.1101/126508]; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Lammers LG, 2015, J CELL BIOL, V211, P309, DOI 10.1083/jcb.201506119; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Lipka J, 2013, BIOCHEM SOC T, V41, P1605, DOI 10.1042/BST20130188; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; McKenney RJ, 2016, EMBO J, V35, P1175, DOI 10.15252/embj.201593071; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Nicholas MP, 2015, P NATL ACAD SCI USA, V112, P6371, DOI 10.1073/pnas.1417422112; Nicholls A, 2014, J COMPUT AID MOL DES, V28, P887, DOI 10.1007/s10822-014-9753-z; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nirschl JJ, 2016, CELL REP, V14, P2637, DOI 10.1016/j.celrep.2016.02.046; Nyarko A, 2012, J BIOL CHEM, V287, P24884, DOI 10.1074/jbc.M112.376038; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Reddy BJN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12259; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	67	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12245	12255		10.1074/jbc.M117.790048	http://dx.doi.org/10.1074/jbc.M117.790048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28576829	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000406053300021
J	Iizuka-Hishikawa, Y; Hishikawa, D; Sasaki, J; Takubo, K; Goto, M; Nagata, K; Nakanishi, H; Shindou, H; Okamura, T; Ito, C; Toshimori, K; Sasaki, T; Shimizu, T				Iizuka-Hishikawa, Yoshiko; Hishikawa, Daisuke; Sasaki, Junko; Takubo, Keiyo; Goto, Motohito; Nagata, Katsuyuki; Nakanishi, Hiroki; Shindou, Hideo; Okamura, Tadashi; Ito, Chizuru; Toshimori, Kiyotaka; Sasaki, Takehiko; Shimizu, Takao			Lysophosphatidic acid acyltransferase 3 tunes the membrane status of germ cells by incorporating docosahexaenoic acid during spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SEMEN QUALITY; MALE REPRODUCTION; LIPID MEDIATORS; PLASMA; SPERM; GLYCEROPHOSPHOLIPIDS; DEFICIENCY; FERTILITY; NUTRITION	Docosahexaenoic acid (DHA) is one of the essential omega-3 polyunsaturated fatty acids with a wide range of physiological roles important for human health. For example, DHA renders cell membranes more flexible and is therefore important for cellular function, but information on the mechanisms that control DHA levels in membranes is limited. Specifically, it is unclear which factors determine DHA incorporation into cell membranes and how DHA exerts biological effects. We found that lysophosphatidic acid acyltransferase 3 (LPAAT3) is required for producing DHA-containing phospholipids in various tissues, such as the testes and retina. In this study, we report that LPAAT3-KO mice display severe male infertility with abnormal sperm morphology. During germ cell differentiation, the expression of LPAAT3 was induced, and germ cells obtained more DHA-containing phospholipids. Loss of LPAAT3 caused drastic reduction of DHA-containing phospholipids in spermatids that led to excess cytoplasm around its head, which is normally removed by surrounding Sertoli cells via endocytosis at the final stage of spermatogenesis. In vitro liposome filtration assay raised the possibility that DHA in phospholipids promotes membrane deformation that is required for the rapid endocytosis. These data suggest that decreased membrane flexibility in LPAAT3KO sperm impaired the efficient removal of sperm content through endocytosis. We conclude that LPAAT3-mediated enrichment of cell membranes with DHA-containing phospholipids endows these membranes with physicochemical properties needed for normal cellular processes, as exemplified by spermatogenesis.	[Iizuka-Hishikawa, Yoshiko; Hishikawa, Daisuke; Nagata, Katsuyuki; Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo 1628655, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Takubo, Keiyo] Natl Ctr Global Hlth & Med, Dept Stem Cell Biol, Shinjuku Ku, Tokyo 1628655, Japan; [Goto, Motohito; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Lab Anim Med, Shinjuku Ku, Tokyo 1628655, Japan; [Nakanishi, Hiroki] Akita Univ, Res Ctr Biosignal, Akita 0108543, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Infect Dis, Sect Anim Models, Shinjuku Ku, Tokyo 1628655, Japan; [Ito, Chizuru; Toshimori, Kiyotaka] Chiba Univ, Grad Sch Med, Dept Reprod Biol & Med, Chiba 2608670, Japan; [Toshimori, Kiyotaka] Chiba Univ, Future Med Res Ctr, Chiba 2608670, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Takubo, Keiyo; Shindou, Hideo; Sasaki, Takehiko] Agcy Med Res & Dev AMED, CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Goto, Motohito] Cent Inst Expt Anim, Anim Resources & Tech Res Ctr, Anim Resource Dev Lab, Kawasaki, Kanagawa 2100821, Japan	National Center for Global Health & Medicine - Japan; Akita University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Akita University; National Center for Global Health & Medicine - Japan; Chiba University; Chiba University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Hishikawa, D; Shimizu, T (corresponding author), Natl Ctr Global Hlth & Med, Tokyo 1628655, Japan.	dhishikawa@ri.ncgm.go.jp; tshimizu@ri.ncgm.go.jp	Takubo, Keiyo/AAX-5546-2020; Shimizu, Takao/AAV-7052-2021	Takubo, Keiyo/0000-0002-1736-7592; Sasaki, Takehiko/0000-0003-1837-3748; Ito, Chizuru/0000-0003-2697-0382; yuan ren, hou teng/0000-0001-6288-4583; Nakanishi, Hiroki/0000-0002-5108-1598	MEXT/JSPS KAKENHI [24229003, 26115005, 15K10638, 26253006, 26460380, 15H05899]; NCGM [26-001, 26A105]; JST-CREST; AMED-CREST; Takeda Science Foundation; Grants-in-Aid for Scientific Research [17K19375, 15H05897] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NCGM; JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); AMED-CREST; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grants 24229003 (to T. Shimizu), 26115005 (to K. Takubo), 15K10638 (to C.I.), 26253006 and 26460380 (to H.S.), and 15H05899 (to T. Sasaki); NCGM Grants 26-001 (to K. Takubo) and 26A105 (to T.O.); JST-CREST (to H.S. and T. Sasaki); AMED-CREST (to H.S., T. Sasaki, and K. Takubo); and Takeda Science Foundation (to T. Shimizu). The authors declare that they have no conflicts of interest with the contents of this article.	Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Barelli H, 2016, CURR OPIN CELL BIOL, V41, P25, DOI 10.1016/j.ceb.2016.03.012; Bernhard K, 1940, J BIOL CHEM, V133, P707; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasky TM, 2013, JNCI-J NATL CANCER I, V105, P1132, DOI 10.1093/jnci/djt174; Burr G, 1932, J BIOL CHEM, V97, P1; Chavarro JE, 2014, HUM REPROD, V29, P429, DOI 10.1093/humrep/det464; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Esmaeili V, 2015, ANDROLOGY-US, V3, P450, DOI 10.1111/andr.12024; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208; Gulaya NM, 2001, ARCH ANDROLOGY, V46, P169; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jensen TK, 2013, AM J CLIN NUTR, V97, P411, DOI 10.3945/ajcn.112.042432; Kidd PM, 2007, ALTERN MED REV, V12, P207; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; MAYSHOOPES LL, 1995, BIOL REPROD, V53, P1003, DOI 10.1095/biolreprod53.5.1003; Micallef M, 2009, BRIT J NUTR, V102, P1370, DOI 10.1017/S0007114509382173; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan YJ, 2015, MOL PHARMACEUT, V12, P4375, DOI 10.1021/acs.molpharmaceut.5b00580; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Roach C, 2004, BIOCHEMISTRY-US, V43, P6344, DOI 10.1021/bi049917r; Roqueta-Rivera M, 2011, BIOL REPROD, V85, P721, DOI 10.1095/biolreprod.110.089524; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Spector AA, 2015, J LIPID RES, V56, P11, DOI 10.1194/jlr.R055095; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Teerds KJ, 2011, HUM REPROD UPDATE, V17, P667, DOI 10.1093/humupd/dmr017; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Wang S, 2016, STEM CELL REP, V7, P80, DOI 10.1016/j.stemcr.2016.05.013; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200	49	36	37	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12065	12076		10.1074/jbc.M117.791277	http://dx.doi.org/10.1074/jbc.M117.791277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28578315	Green Published, hybrid			2022-12-28	WOS:000406053300006
J	Koldewey, P; Horowitz, S; Bardwell, JCA				Koldewey, Philipp; Horowitz, Scott; Bardwell, James C. A.			Chaperone-client interactions: Non-specificity engenders multifunctionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FUSION ONCOPROTEIN AML1-ETO; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; SUBSTRATE RECOGNITION; HSP70 CHAPERONES; ATP HYDROLYSIS; GROEL-GROES; PROTEIN; BINDING; TRIC/CCT	Here, we provide an overview of the different mechanisms whereby three different chaperones, Spy, Hsp70, and Hsp60, interact with folding proteins, and we discuss how these chaperones may guide the folding process. Available evidence suggests that even a single chaperone can use many mechanisms to aid in protein folding, most likely due to the need for most chaperones to bind clients promiscuously. Chaperone mechanism may be better understood by always considering it in the context of the client's folding pathway and biological function.	[Koldewey, Philipp; Horowitz, Scott; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Rm 4007,830 N Univ Ave, Ann Arbor, MI 48109 USA; [Bardwell, James C. A.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Bardwell, JCA (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Rm 4007,830 N Univ Ave, Ann Arbor, MI 48109 USA.	jbardwel@umich.edu		Horowitz, Scott/0000-0002-1148-0105	National Institutes of Health [R01-GM102829, K99-GM120388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM120388, R01GM102829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM102829 (to J.C.A.B.) and K99-GM120388 (to S.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen WJ, 2009, ADV PROTEIN CHEM STR, V78, P51, DOI [10.1016/S1876-1623(08)78003-9, 10.1016/S1876-1623(09)78003-9]; Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Appia-Ayme C, 2012, BIOCHEM J, V442, P85, DOI 10.1042/BJ20111639; Aswathy N, 2016, COMPUT BIOL CHEM, V64, P396, DOI 10.1016/j.compbiolchem.2016.09.002; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Burmann BM, 2015, PROG NUCL MAG RES SP, V86-87, P41, DOI 10.1016/j.pnmrs.2015.02.004; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Chaudhuri TK, 2009, PROG BIOPHYS MOL BIO, V99, P42, DOI 10.1016/j.pbiomolbio.2008.10.007; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Evans ML, 2011, PRION, V5, P323, DOI [10.4161/pri.5.4.18555, 10.4161/pri.18555]; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Franzel B, 2012, PROTEOMICS, V12, P2319, DOI 10.1002/pmic.201100636; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Grahnen JA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-361; Gruber R, 2016, CHEM REV, V116, P6588, DOI 10.1021/acs.chemrev.5b00556; Gruebele M, 2005, CR BIOL, V328, P701, DOI 10.1016/j.crvi.2005.02.007; Gupta AJ, 2014, J MOL BIOL, V426, P2739, DOI 10.1016/j.jmb.2014.04.018; Hagenmaier S, 1997, J BACTERIOL, V179, P2073, DOI 10.1128/jb.179.6.2073-2076.1997; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; He LC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601625; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Horowitz S, 2016, NAT STRUCT MOL BIOL, V23, P691, DOI 10.1038/nsmb.3237; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Hu SM, 1996, ARCH BIOCHEM BIOPHYS, V332, P163, DOI 10.1006/abbi.1996.0328; Jewett AI, 2006, J MOL BIOL, V363, P945, DOI 10.1016/j.jmb.2006.08.040; Jiang Y, 2011, P NATL ACAD SCI USA, V108, P16962, DOI 10.1073/pnas.1112244108; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koldewey P, 2016, CELL, V166, P369, DOI 10.1016/j.cell.2016.05.054; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee JH, 2015, P NATL ACAD SCI USA, V112, pE4206, DOI 10.1073/pnas.1505173112; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Libich DS, 2015, P NATL ACAD SCI USA, V112, P8817, DOI 10.1073/pnas.1510083112; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Marcinowski M, 2013, J MOL BIOL, V425, P466, DOI 10.1016/j.jmb.2012.11.030; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mattoo RUH, 2014, CELL MOL LIFE SCI, V71, P3311, DOI 10.1007/s00018-014-1627-y; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; Morawe T, 2012, MOL NEUROBIOL, V46, P41, DOI 10.1007/s12035-012-8246-0; Motojima Fumihiro, 2015, Biophysics (Nagoya-shi), V11, P93, DOI 10.2142/biophysics.11.93; Perrett S, 1997, J MOL BIOL, V269, P892, DOI 10.1006/jmbi.1997.1081; Priya S, 2013, P NATL ACAD SCI USA, V110, P7199, DOI 10.1073/pnas.1219867110; Quan S, 2014, ELIFE, V3, DOI 10.7554/eLife.01584; Quan S, 2012, BIOESSAYS, V34, P973, DOI 10.1002/bies.201200059; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Roh SH, 2016, BIOPHYS J, V110, P2377, DOI 10.1016/j.bpj.2016.04.045; Roh SH, 2016, J BIOL CHEM, V291, P4732, DOI 10.1074/jbc.M115.684878; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Salmon L, 2016, J AM CHEM SOC, V138, P9826, DOI 10.1021/jacs.6b02382; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE2794, DOI 10.1073/pnas.1601846113; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sirur A, 2013, BIOPHYS J, V104, P1098, DOI 10.1016/j.bpj.2013.01.034; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Srivastava SK, 2014, GENE, V548, P142, DOI 10.1016/j.gene.2014.07.003; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tyagi NK, 2011, FEBS LETT, V585, P1969, DOI 10.1016/j.febslet.2011.05.031; Villebeck L, 2007, BIOCHEMISTRY-US, V46, P12639, DOI 10.1021/bi700658n; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Wang JM, 2003, J MOL BIOL, V334, P489, DOI 10.1016/j.jmb.2003.09.074; Warshel A, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4947037; Weaver J, 2014, J BIOL CHEM, V289, P23219, DOI 10.1074/jbc.M114.577205; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhang X, 2014, J MOL BIOL, V426, P2736, DOI 10.1016/j.jmb.2014.06.001; Zhao QY, 2017, PROG BIOPHYS MOL BIO, V125, P52, DOI 10.1016/j.pbiomolbio.2017.02.001; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	97	46	48	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12010	12017		10.1074/jbc.R117.796862	http://dx.doi.org/10.1074/jbc.R117.796862			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28620048	hybrid, Green Published			2022-12-28	WOS:000406053300001
J	Joy, M; Gau, D; Castellucci, N; Prywes, R; Roy, P				Joy, Marion; Gau, David; Castellucci, Nevin; Prywes, Ron; Roy, Partha			The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cell migration; cytoskeleton; profilin; serum-response factor (SRF); MKL; SAP-domain	SERUM RESPONSE FACTOR; BREAST-CANCER CELLS; ACTIN DYNAMICS; PROTEIN PROFILIN; MRTF-A; MIGRATION; DISTINCT; EXPRESSION; MOTILITY; ACTIVATION	Megakaryoblastic leukemia (MKL)/serum-response factor (SRF)-mediated gene transcription is a highly conserved mechanism that connects dynamic reorganization of the actin cytoskeleton to regulation of expression of a wide range of genes, including SRF itself and many important structural and regulatory components of the actin cytoskeleton. In this study, we examined the possible role of MKL/SRF in the context of regulation of profilin (Pfn), a major controller of actin dynamics and actin cytoskeletal remodeling in cells. We demonstrated that despite being located on different genomic loci, two major isoforms of Pfn (Pfn1 and Pfn2) are co-regulated by a common mechanism involving the action of MKL that is independent of its SRF-related activity. We found that MKL co-regulates the expression of Pfn isoforms indirectly by modulating signal transducer and activator of transcription 1 (STAT1) and utilizing its SAP-domain function. Unexpectedly, our studies revealed that cellular externalization, rather than transcription of Pfn1, is affected by the perturbations of MKL. We further demonstrated that MKL can influence cell migration by modulating Pfn1 expression, indicating a functional connection between MKL and Pfn1 in actin-dependent cellular processes. Finally, we provide initial evidence supporting the ability of Pfn to influence MKL and SRF expression. Collectively, these findings suggest that Pfn may play a role in a possible feedback loop of the actin/MKL/SRF signaling circuit.	[Joy, Marion; Gau, David; Castellucci, Nevin; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA; [Prywes, Ron] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Roy, P (corresponding author), Univ Pittsburgh, 306 CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA.	par19@pitt.edu	Gau, David M/G-8375-2011	Gau, David M/0000-0002-3079-3692; Roy, Partha/0000-0002-4946-8531	National Institutes of Health [2R01CA108607, 2T32HL076124]; National Science Foundation [2012139050]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant 2R01CA108607 (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Pre-doctoral Fellowship 2012139050 and National Institutes of Health Cardiovascular Bioengineering Pre-doctoral Training Grant 2T32HL076124.	Asparuhova MB, 2011, FASEB J, V25, P3477, DOI 10.1096/fj.11-187310; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Coumans JVF, 2014, OMICS, V18, P778, DOI 10.1089/omi.2014.0075; Cui XB, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0884-y; Ding Z, 2014, ONCOGENE, V33, P2065, DOI 10.1038/onc.2013.166; Ding ZJ, 2012, CELL ADHES MIGR, V6, P442, DOI 10.4161/cam.21832; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Gau D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156313; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gurbuz I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-22; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jella KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165763; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Karamchandani JR, 2015, HUM PATHOL, V46, P673, DOI 10.1016/j.humpath.2014.11.007; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Lewis TC, 2013, BBA-GENE REGUL MECH, V1829, P1147, DOI 10.1016/j.bbagrm.2013.08.002; Liao XH, 2014, CELL SIGNAL, V26, P2370, DOI 10.1016/j.cellsig.2014.07.023; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Qi YF, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-41; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Shields AR, 2014, DEVELOPMENT, V141, P73, DOI 10.1242/dev.101931; Smith EC, 2012, BLOOD, V120, P2317, DOI 10.1182/blood-2012-04-420828; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tang YN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9230; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	45	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11777	11791		10.1074/jbc.M117.781104	http://dx.doi.org/10.1074/jbc.M117.781104			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28546428	Green Published, hybrid			2022-12-28	WOS:000405485600016
J	Loiseau, L; Fyfe, C; Aussel, L; Chehade, MH; Hernandez, SB; Faivre, B; Hamdane, D; Mellot-Draznieks, C; Rascalou, B; Pelosi, L; Velours, C; Cornu, D; Lombard, M; Casadesus, J; Pierrel, F; Fontecave, M; Barras, F				Loiseau, Laurent; Fyfe, Cameron; Aussel, Laurent; Chehade, Mahmoud Hajj; Hernandez, Sara B.; Faivre, Bruno; Hamdane, Djemel; Mellot-Draznieks, Caroline; Rascalou, Berengere; Pelosi, Ludovic; Velours, Christophe; Cornu, David; Lombard, Murielle; Casadesus, Josep; Pierrel, Fabien; Fontecave, Marc; Barras, Frederic			The UbiK protein is an accessory factor necessary for bacterial ubiquinone (UQ) biosynthesis and forms a complex with the UQ biogenesis factor UbiJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL CARRIER PROTEIN-2; COENZYME-Q BIOSYNTHESIS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; WAVE COMPLEX; SALMONELLA; YEAST; MENAQUINONE	Ubiquinone (UQ), also referred to as coenzyme Q, is a widespread lipophilic molecule in both prokaryotes and eukaryotes in which it primarily acts as an electron carrier. Eleven proteins are known to participate in UQ biosynthesis in Escherichia coli, and we recently demonstrated that UQ biosynthesis requires additional, nonenzymatic factors, some of which are still unknown. Here, we report on the identification of a bacterial gene, yqiC, which is required for efficient UQ biosynthesis, and which we have renamed ubiK. Using several methods, we demonstrated that the UbiK protein forms a complex with the C-terminal part of UbiJ, another UQ biogenesis factor we previously identified. We found that both proteins are likely to contribute to global UQ biosynthesis rather than to a specific biosynthetic step, because both ubiK and ubiJ mutants accumulated octaprenylphenol, an early intermediate of the UQ biosynthetic pathway. Interestingly, we found that both proteins are dispensable for UQ biosynthesis under anaerobiosis, even though they were expressed in the absence of oxygen. We also provide evidence that the UbiK-UbiJ complex interacts with palmitoleic acid, a major lipid in E. coli. Last, in Salmonella enterica, ubiK was required for proliferation in macrophages and virulence in mice. We conclude that although the role of the UbiK-UbiJ complex remains unknown, our results support the hypothesis that UbiK is an accessory factor of Ubi enzymes and facilitates UQ biosynthesis by acting as an assembly factor, a targeting factor, or both.	[Loiseau, Laurent; Aussel, Laurent; Barras, Frederic] Aix Marseille Univ, CNRS, IMM, LCB,UMR 7283, F-13402 Marseille, France; [Fyfe, Cameron; Faivre, Bruno; Hamdane, Djemel; Mellot-Draznieks, Caroline; Lombard, Murielle; Fontecave, Marc] Univ Paris 06, Coll France, Lab Chim Proc Biol, UMR8229,CNRS, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France; [Chehade, Mahmoud Hajj; Rascalou, Berengere; Pelosi, Ludovic; Pierrel, Fabien] Univ Grenoble Alpes, TIMC IMAG, Lab Technol Ingn Med & Complexite Informat Math &, UMR 5525, F-38000 Grenoble, France; [Chehade, Mahmoud Hajj; Rascalou, Berengere; Pelosi, Ludovic; Pierrel, Fabien] TIMC IMAG, CNRS, F-38000 Grenoble, France; [Hernandez, Sara B.; Casadesus, Josep] Univ Seville, Dept Genet, E-41012 Seville, Spain; [Velours, Christophe] CNRS, UMR9198, Inst Biol Integrat Cellule, Plateforme Interact Macromol,I2BC, Bat 430F, F-91405 Orsay, France; [Cornu, David] CNRS, Inst Biol Integrat Cellule, Plateforme SICaPS, I2BC,Ctr Rech Gif,SICaPS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Fontecave, M (corresponding author), Univ Paris 06, Coll France, Lab Chim Proc Biol, UMR8229,CNRS, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.; Pierrel, F (corresponding author), Lab TIMC IMAG, F-38700 La Tronche, France.; Barras, F (corresponding author), LCB CNRS, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.	fabien.pierrel@univ-grenoble-alpes.fr; mfontecave@cea.fr; barras@imm.cnrs.fr	PIERREL, Fabien/M-6016-2014; Lombard, Murielle/E-4974-2019; Hernandez, Sara B./M-2986-2019; Pelosi, Ludovic/AAB-9832-2020; Hernandez, Sara/L-2220-2017	PIERREL, Fabien/0000-0003-2083-3002; Lombard, Murielle/0000-0002-4775-3494; Hernandez, Sara B./0000-0002-8349-360X; Pelosi, Ludovic/0000-0002-4198-5681; Hernandez, Sara/0000-0002-8349-360X; Barras, Frederic/0000-0003-3458-2574; Aussel, Laurent/0000-0001-5239-4556; Fyfe, Cameron/0000-0001-7604-8009	FRISBI [UMR 9198]	FRISBI	We thank the FB group for discussions and suggestions. This work has benefited from the facilities and expertise of the Macromolecular Interaction Platform of I2BC (UMR 9198) supported by FRISBI.	ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4750, DOI 10.1021/bi00615a024; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Aussel L, 2014, J BACTERIOL, V196, P70, DOI 10.1128/JB.01065-13; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bouveret E, 2012, METHODS MOL BIOL, V804, P15, DOI 10.1007/978-1-61779-361-5_2; Carrica MC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-95; Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Garcia FL, 2000, J MOL BIOL, V295, P595, DOI 10.1006/jmbi.1999.3355; Golemis E. A., 1994, 2 HYBRID SYSTEMS INT; Gonzalez-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; Pelosi L, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00091-16; Perez De Berti Federico, 2013, Journal of Structural and Functional Genomics, V14, P145, DOI 10.1007/s10969-013-9166-6; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Ravcheev DA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00128; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stolowich NJ, 2002, CELL MOL LIFE SCI, V59, P193, DOI 10.1007/s00018-002-8416-8; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Wang KC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01614; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004; Zhi XY, 2014, GENOME BIOL EVOL, V6, P149, DOI 10.1093/gbe/evu007	40	28	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11937	11950		10.1074/jbc.M117.789164	http://dx.doi.org/10.1074/jbc.M117.789164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28559279	Green Published, hybrid			2022-12-28	WOS:000405485600029
J	Schmidt, J; Guillaume, P; Dojcinovic, D; Karbach, J; Coukos, G; Luescher, I				Schmidt, Julien; Guillaume, Philippe; Dojcinovic, Danijel; Karbach, Julia; Coukos, George; Luescher, Immanuel			In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-IMMUNOTHERAPY; MELANOMA PATIENTS; PEPTIDE-BINDING; MASS-SPECTROMETRY; IMMUNE-RESPONSES; NY-ESO-1; PROTEIN; IMMUNOGENICITY; CD8(+); STABILITY	Tumor exomes provide comprehensive information on mutated, overexpressed genes and aberrant splicing, which can be exploited for personalized cancer immunotherapy. Of particular interest are mutated tumor antigen T-cell epitopes, because neoepitope-specific T cells often are tumoricidal. However, identifying tumor-specific T-cell epitopes is a major challenge. A widely used strategy relies on initial prediction of human leukocyte antigen-binding peptides by in silico algorithms, but the predictive power of this approach is unclear. Here, we used the human tumor antigen NY-ESO-1 (ESO) and the human leukocyte antigen variant HLA-A*0201 (A2) as a model and predicted in silico the 41 highest-affinity, A2-binding 8-11-mer peptides and assessed their binding, kinetic complex stability, and immunogenicity in A2-transgenic mice and on peripheral blood mononuclear cells from ESO-vaccinated melanoma patients. We found that 19 of the peptides strongly bound to A2, 10 of which formed stable A2-peptide complexes and induced CD8(+) T cells in A2-transgenic mice. However, only 5 of the peptides induced cognate T cells in humans; these peptides exhibited strong binding and complex stability and contained multiple large hydrophobic and aromatic amino acids. These results were not predicted by in silico algorithms and provide new clues to improving T-cell epitope identification. In conclusion, our findings indicate that only a small fraction of in silico-predicted A2-binding ESO peptides are immunogenic in humans, namely those that have high peptide-binding strength and complex stability. This observation highlights the need for improving in silico predictions of peptide immunogenicity.	[Schmidt, Julien; Guillaume, Philippe; Dojcinovic, Danijel; Coukos, George; Luescher, Immanuel] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Karbach, Julia] Krankenhaus NW Frankfurt, D-60488 Frankfurt, Germany; [Coukos, George] Univ Lausanne Hosp, Dept Oncol, CH-1011 Lausanne, Switzerland; [Dojcinovic, Danijel] Covance Cent Lab Serv Sarl, CH-1217 Meyrin, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; Krankenhaus Nordwest; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Luescher, I (corresponding author), 155 Chemin Boveresses, CH-1066 Epalinges, Switzerland.	immanuel.luescher@unil.ch	Coukos, George/ABG-7389-2020	Coukos, George/0000-0001-8813-7367	Swiss National Science Foundation Grant [310030_12533/1]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 310030_12533/1. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAM DJ, 1987, PROTEINS, V2, P130, DOI 10.1002/prot.340020207; Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Axelsson-Robertson R, 2010, IMMUNOLOGY, V129, P496, DOI 10.1111/j.1365-2567.2009.03201.x; Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Bassani-Sternberg M, 2016, CURR OPIN IMMUNOL, V41, P9, DOI 10.1016/j.coi.2016.04.005; Bioley G, 2009, CLIN CANCER RES, V15, P299, DOI 10.1158/1078-0432.CCR-08-1747; Bioley G, 2009, J IMMUNOTHER, V32, P161, DOI 10.1097/CJI.0b013e31819302f6; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Boucherma R, 2013, J IMMUNOL, V191, P583, DOI 10.4049/jimmunol.1300483; Calis JJA, 2015, IMMUNOGENETICS, V67, P85, DOI 10.1007/s00251-014-0815-0; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Pro SC, 2014, TISSUE ANTIGENS, V83, P94, DOI 10.1111/tan.12292; Chen JL, 2015, INT J CANCER, V136, pE590, DOI 10.1002/ijc.29118; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chowell D, 2015, P NATL ACAD SCI USA, V112, pE1754, DOI 10.1073/pnas.1500973112; de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Duan ZL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-259; Dutoit V, 2002, J CLIN INVEST, V110, P1813, DOI 10.1172/JCI200216428; Esfandiary A, 2015, IMMUNOTHERAPY-UK, V7, P411, DOI [10.2217/IMT.15.3, 10.2217/imt.15.3]; Fridman A, 2012, ONCOIMMUNOLOGY, V1, P1258, DOI 10.4161/onci.21355; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Gilchuk P, 2015, CURR OPIN IMMUNOL, V34, P43, DOI 10.1016/j.coi.2015.01.013; Gnjatic S, 2002, P NATL ACAD SCI USA, V99, P11813, DOI 10.1073/pnas.142417699; Guillaume P, 2003, J BIOL CHEM, V278, P4500, DOI 10.1074/jbc.M208863200; Harndahl M, 2012, EUR J IMMUNOL, V42, P1405, DOI 10.1002/eji.201141774; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Jackson H, 2006, J IMMUNOL, V176, P5908, DOI 10.4049/jimmunol.176.10.5908; Jager E, 2006, P NATL ACAD SCI USA, V103, P14453, DOI 10.1073/pnas.0606512103; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Karbach J, 2007, INT J CANCER, V121, P2042, DOI 10.1002/ijc.22957; Khan IS, 2014, J EXP MED, V211, P761, DOI 10.1084/jem.20131889; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Luft T, 2001, J IMMUNOL, V167, P2529, DOI 10.4049/jimmunol.167.5.2529; Lund O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026494; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Madura F, 2015, EUR J IMMUNOL, V45, P584, DOI 10.1002/eji.201445114; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Nascimento EJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002497; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Rasmussen M, 2016, J IMMUNOL, V197, P1517, DOI 10.4049/jimmunol.1600582; ROSEMAN MA, 1988, J MOL BIOL, V201, P621, DOI 10.1016/0022-2836(88)90642-0; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Schumacher TN, 2016, CURR OPIN IMMUNOL, V41, P98, DOI 10.1016/j.coi.2016.07.005; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Snyder A, 2015, CURR OPIN GENET DEV, V30, P7, DOI 10.1016/j.gde.2014.12.003; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Trolle T, 2016, J IMMUNOL, V196, P1480, DOI 10.4049/jimmunol.1501721; Trolle T, 2015, BIOINFORMATICS, V31, P2174, DOI 10.1093/bioinformatics/btv123; Trolle T, 2014, IMMUNOGENETICS, V66, P449, DOI 10.1007/s00251-014-0779-0; Valmori D, 2000, CANCER RES, V60, P4499; Valmori D, 2007, CLIN IMMUNOL, V122, P163, DOI 10.1016/j.clim.2006.09.005; van Buuren MM, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28836; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang SF, 2016, IMMUNOL RES, V64, P908, DOI 10.1007/s12026-016-8795-9; Wu XM, 2012, AUTOIMMUNITY, V45, P176, DOI 10.3109/08916934.2011.622014; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137	74	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11840	11849		10.1074/jbc.M117.789511	http://dx.doi.org/10.1074/jbc.M117.789511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28536262	Green Published, hybrid			2022-12-28	WOS:000405485600021
J	Carter, EL; Ramirez, Y; Ragsdale, SW				Carter, Eric L.; Ramirez, Yanil; Ragsdale, Stephen W.			The heme-regulatory motif of nuclear receptor Rev-erb beta is a key mediator of heme and redox signaling in circadian rhythm maintenance and metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; TRANSCRIPTION FACTOR; GLUCOSE-METABOLISM; LIGAND-BINDING; ALPHA; PROTEIN; DERIVATIVES; INHIBITION; EXPRESSION; MECHANISM	Rev-erb beta is a heme-responsive transcription factor that regulates genes involved in circadian rhythm maintenance and metabolism, effectively bridging these critical cellular processes. Heme binding to Rev-erb beta indirectly facilitates its interaction with the nuclear receptor co-repressor (NCoR1), resulting in repression of Rev-erb beta target genes. Fe3+-heme binds in a 6-coordinate complex with axial His and Cys ligands, the latter provided by a heme-regulatory motif (HRM). Rev-erb beta was thought to be a heme sensor based on a weak K-d value for the Rev-erb beta heme complex of 2 mu M determined with isothermal titration calorimetry. However, our group demonstrated with UV-visible difference titrations that the Kd value is in the low nanomolar range, and the Fe3+-heme off-rate is on the order of 10(-6) s(-1) making Rev-erb beta ineffective as a sensor of Fe3+-heme. In this study, we dissected the kinetics of heme binding to Rev-erb beta and provided a Kd for Fe3+-heme of similar to 0.1 nM. Loss of the HRM axial thiolate via redox processes, including oxidation to a disulfide with a neighboring cysteine or dissociation upon reduction of Fe3+-to Fe2+-heme, decreased binding affinity by >20-fold. Furthermore, as measured in a co-immunoprecipitation assay, substitution of the His or Cys heme ligands in Rev-erb beta was accompanied by a significant loss of NCoR1 binding. These results demonstrate the importance of the Rev-erb beta HRM in regulating interactions with heme and NCoR1 and advance our understanding of how signaling through HRMs affects the major cellular processes of circadian rhythm maintenance and metabolism.	[Carter, Eric L.; Ramirez, Yanil; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5220D MSRBIII, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5220D MSRBIII, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Carter, Eric/0000-0003-2877-3411	National Institutes of Health [F32HL114150, R01- GM123513]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL114150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants F32HL114150 (to E. L. C.) and R01- GM123513 (to S. W. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Atamna H, 2015, METALLOMICS, V7, P309, DOI 10.1039/c4mt00246f; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Carter EL, 2016, J BIOL CHEM, V291, P2196, DOI 10.1074/jbc.M115.670281; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Chapman SK, 1997, STRUCT BOND, V88, P39; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Dawson R.M., 1969, DATA BIOCH RES, P316; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fleischhacker AS, 2015, BIOCHEMISTRY-US, V54, P2709, DOI 10.1021/acs.biochem.5b00266; GALLAGHER WA, 1967, BIOCHEM J, V105, P461, DOI 10.1042/bj1050461; Gerhart-Hines Z, 2015, DIABETES OBES METAB, V17, P12, DOI 10.1111/dom.12510; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; GIBSON QH, 1960, BIOCHEM J, V77, P328, DOI 10.1042/bj0770328; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; HAMMES GG, 1968, BIOCHEMISTRY-US, V7, P1519, DOI 10.1021/bi00844a039; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hayasaka K, 2011, BBA-PROTEINS PROTEOM, V1814, P326, DOI 10.1016/j.bbapap.2010.09.007; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; KAWAMURAKONISHI Y, 1988, EUR J BIOCHEM, V170, P589, DOI 10.1111/j.1432-1033.1988.tb13738.x; KAWAMURAKONISHI Y, 1985, J BIOCHEM-TOKYO, V98, P1181, DOI 10.1093/oxfordjournals.jbchem.a135384; Keilin J, 1943, BIOCHEM J, V37, P281, DOI 10.1042/bj0370281; Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Le P, 2014, BIOCHEMISTRY-US, V53, P6863, DOI 10.1021/bi5005975; LIN SX, 1990, J BIOL CHEM, V265, P9670; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; MATSUMURA K, 1990, JPN J PHYSIOL, V40, P567, DOI 10.2170/jjphysiol.40.567; Matta-Camacho E, 2014, J BIOL CHEM, V289, P20054, DOI 10.1074/jbc.M113.545111; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miksanova M, 2006, BIOCHEMISTRY-US, V45, P9894, DOI 10.1021/bi060556k; Milev NB, 2015, TRENDS ENDOCRIN MET, V26, P430, DOI 10.1016/j.tem.2015.05.012; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Muraki N, 2015, J PORPHYR PHTHALOCYA, V19, P9, DOI 10.1142/S1088424614501090; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P1753, DOI 10.1021/bi00277a002; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qian JY, 2016, TRENDS ENDOCRIN MET, V27, P282, DOI 10.1016/j.tem.2016.03.005; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shen J, 2014, CELL REP, V7, P180, DOI 10.1016/j.celrep.2014.02.042; Shimizu T, 2015, CHEM REV, V115, P6491, DOI 10.1021/acs.chemrev.5b00018; Simcox JA, 2015, DIABETES, V64, P1108, DOI 10.2337/db14-0646; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	71	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11280	11299		10.1074/jbc.M117.783118	http://dx.doi.org/10.1074/jbc.M117.783118			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28500133	hybrid, Green Published			2022-12-28	WOS:000405119600013
J	Morimoto, A; Kannari, M; Tsuchida, Y; Sasaki, S; Saito, C; Matsuta, T; Maeda, T; Akiyama, M; Nakamura, T; Sakaguchi, M; Nameki, N; Gonzalez, FJ; Inoue, Y				Morimoto, Aoi; Kannari, Mana; Tsuchida, Yuichi; Sasaki, Shota; Saito, Chinatsu; Matsuta, Tsuyoshi; Maeda, Tsukasa; Akiyama, Megumi; Nakamura, Takahiro; Sakaguchi, Masakiyo; Nameki, Nobukazu; Gonzalez, Frank J.; Inoue, Yusuke			An HNF4-microRNA-194/192 signaling axis maintains hepatic cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; hepatocyte nuclear factor 4 (HNF-4); liver; microRNA (miRNA); transcription	NUCLEAR FACTOR 4-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; DOWN-REGULATION; TRANSCRIPTION FACTORS; MIR-122 EXPRESSION; HEPATOCYTE; MICRORNAS	Hepatocyte nuclear factor 4 (HNF4) controls the expression of liver-specific protein-coding genes. However, some microRNAs are also modulated by HNF4, and it is not known whether they are direct targets of HNF4 and whether they influence hepatic function. In this study, we found that HNF4 regulates microRNAs, indicated by marked down-regulation of miR-194 and miR-192 (miR-194/192) in liver-specific Hnf4a-null (Hnf4a(H)) mice. Transactivation of the shared miR-194/192 promoter was dependent on HNF4 expression, indicating that miR-194/192 is a target gene of HNF4. Screening of potential mRNAs targeted by miR-194/192 revealed that expression of genes involved in glucose metabolism (glycogenin 1 (Gyg1)), cell adhesion and migration (activated leukocyte cell adhesion molecule (Alcam)), tumorigenesis and tumor progression (Rap2b and epiregulin (Ereg)), protein SUMOylation (Sumo2), epigenetic regulation (Setd5 and Cullin 4B (Cln4b)), and the epithelial-mesenchymal transition (moesin (Msn)) was up-regulated in Hnf4a(H) mice. Moreover, we also found that miR-194/192 binds the 3-UTR of these mRNAs. siRNA knockdown of HNF4 suppressed miR-194/192 expression in human hepatocellular carcinoma (HCC) cells and resulted in up-regulation of their mRNA targets. Inhibition and overexpression experiments with miR-194/192 revealed that Gyg1, Setd5, Sumo2, Cln4b, and Rap2b are miR-194 targets, whereas Ereg, Alcam, and Msn are miR-192 targets. These findings reveal a novel HNF4 network controlled by miR-194/192 that may play a critical role in maintaining the hepatocyte-differentiated state by inhibiting expression of genes involved in dedifferentiation and tumorigenesis. These insights may contribute to the development of diagnostic markers for early HCC detection, and targeting of the miR-194/192 pathway could be useful for managing HCC.	[Morimoto, Aoi; Kannari, Mana; Tsuchida, Yuichi; Sasaki, Shota; Saito, Chinatsu; Matsuta, Tsuyoshi; Maeda, Tsukasa; Akiyama, Megumi; Nakamura, Takahiro; Nameki, Nobukazu; Inoue, Yusuke] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Lab Mol Life Sci, Kiryu, Gunma 3768515, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Rockville, MD 20852 USA	Gunma University; Okayama University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Inoue, Y (corresponding author), Gunma Univ, Fac Sci & Technol, Div Mol Sci, Lab Mol Life Sci, Kiryu, Gunma 3768515, Japan.	yinoue@gunma-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; Nameki, Nobukazu/H-1764-2013; Inoue, Yusuke/O-6207-2018	Inoue, Yusuke/0000-0002-9710-7482	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460490]; JGC-S scholarship Foundation; Gunma University; Akita University; Nagoya University; Collaborative Investigation Project; Gunma University Medical Innovation Project; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JGC-S scholarship Foundation; Gunma University; Akita University; Nagoya University; Collaborative Investigation Project; Gunma University Medical Innovation Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-aid for Scientific Research 25460490) (to Y. I.), the JGC-S scholarship Foundation (to Y. I.), Gunma University, Akita University, Nagoya University, Collaborative Investigation Project (to Y. I.), and Gunma University Medical Innovation Project (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Charafe-Jauffret E, 2007, INT J CANCER, V121, P1779, DOI 10.1002/ijc.22923; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chen YM, 2014, LIVER INT, V34, P976, DOI 10.1111/liv.12496; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Grozeva D, 2014, AM J HUM GENET, V94, P618, DOI 10.1016/j.ajhg.2014.03.006; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Jenkins RH, 2012, BIOCHEM J, V443, P407, DOI 10.1042/BJ20111861; Jin Z, 2011, ONCOGENE, V30, P1577, DOI 10.1038/onc.2010.534; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Krutzfeldt J, 2012, HEPATOLOGY, V55, P98, DOI 10.1002/hep.24658; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Ma LF, 2014, J BIOL CHEM, V289, P6921, DOI 10.1074/jbc.M113.524819; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Ning BF, 2014, HEPATOLOGY, V60, P1607, DOI 10.1002/hep.27177; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sladek F. M., 2001, HEPATOCYTE NUCL FACT, P309; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Yin C, 2013, HEPATOLOGY, V58, P1964, DOI 10.1002/hep.26573; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364; Zhao M, 2009, BIOCHEM BIOPH RES CO, V387, P239, DOI 10.1016/j.bbrc.2009.06.128; Zhou WL, 2012, J CELL SCI, V125, P3630, DOI 10.1242/jcs.102889	56	54	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10574	10585		10.1074/jbc.M117.785592	http://dx.doi.org/10.1074/jbc.M117.785592			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28465351	Green Published, hybrid			2022-12-28	WOS:000404115400018
J	Goodrich, AC; Meyers, DJ; Frueh, DP				Goodrich, Andrew C.; Meyers, David J.; Frueh, Dominique P.			Molecular impact of covalent modifications on nonribosomal peptide synthetase carrier protein communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY-LINE ENZYMOLOGY; NMR CHEMICAL-SHIFTS; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; TORSION ANGLES; DOMAIN; ADENYLATION; DYNAMICS; BIOSYNTHESIS	Nonribosomal peptide synthesis involves the interplay between covalent protein modifications, conformational fluctuations, catalysis, and transient protein-protein interactions. Delineating the mechanisms involved in orchestrating these various processes will deepen our understanding of domain-domain communication in nonribosomal peptide synthetases (NRPSs) and lay the groundwork for the rational reengineering of NRPSs by swapping domains handling different substrates to generate novel natural products. Although many structural and biochemical studies of NRPSs exist, few studies have focused on the energetics and dynamics governing the interactions in these systems. Here, we present detailed binding studies of an adenylation domain and its partner carrier protein in apo-, holo-, and substrate-loaded forms. Results from fluorescence anisotropy, isothermal titration calorimetry, and NMR titrations indicated that covalent modifications to a carrier protein modulate modifications to carrier proteins during NRPS synthesis may impart directionality to sequential NRPS domain interactions. Comparison of the structure and dynamics of an apo- aryl carrier protein with those of its modified forms revealed structural fluctuations induced by post-translational modifications and mediated by modulations of protein dynamics. The results provide a comprehensive molecular description of a carrier protein throughout its life cycle and demonstrate how a network of dynamic residues can propagate the molecular impact of chemical modifications throughout a protein and influence its affinity toward partner domains.	[Goodrich, Andrew C.; Frueh, Dominique P.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 701A Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA; [Meyers, David J.] Johns Hopkins Univ, Sch Med, Synthet Core Facil, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Frueh, DP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 701A Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	dfrueh1@jhmi.edu	; Frueh, Dominique/A-6462-2008	Meyers, David/0000-0002-7010-6930; Frueh, Dominique/0000-0003-4605-3776	National Institutes of Health [R01 GM 104257, S10 RR029191]; American Heart Association Predoctoral Fellowship [14PRE20460253]; CTSA (Clinical and Translational Science Awards) [UL1TR001079]; FAMRI (Flight Attendant Medical Research Institute) Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM104257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); CTSA (Clinical and Translational Science Awards); FAMRI (Flight Attendant Medical Research Institute) Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants R01 GM 104257 and S10 RR029191. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by American Heart Association Predoctoral Fellowship 14PRE20460253.; Supported by CTSA (Clinical and Translational Science Awards) Grant UL1TR001079 and the FAMRI (Flight Attendant Medical Research Institute) Foundation.	Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; Berlin K, 2013, J BIOMOL NMR, V57, P333, DOI 10.1007/s10858-013-9791-1; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DECRECYLAGARD V, 1995, CR ACAD SCI III-VIE, V318, P927; DELANO WL, 2002, PYMOL MOL GRAPHICS; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Goddard T. D., SPARKY 3; Goodrich AC, 2015, J AM CHEM SOC, V137, P12100, DOI 10.1021/jacs.5b07772; Goodrich AC, 2015, BIOCHEMISTRY-US, V54, P1154, DOI 10.1021/bi501433r; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haslinger K, 2015, PROTEINS, V83, P711, DOI 10.1002/prot.24758; Haslinger K, 2014, ANGEW CHEM INT EDIT, V53, P8518, DOI 10.1002/anie.201404977; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P6135, DOI 10.1021/bi00416a046; Jaremko MJ, 2015, J AM CHEM SOC, V137, P11546, DOI 10.1021/jacs.5b04525; Johnson MA, 2006, PROTEIN SCI, V15, P1030, DOI 10.1110/ps.051964606; Keller R., 2004, COMPUTER AIDED RESON, V1; Khalil S, 2009, J MOL BIOL, V393, P658, DOI 10.1016/j.jmb.2009.08.036; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Kittila T, 2016, ANGEW CHEM INT EDIT, V55, P9834, DOI 10.1002/anie.201602614; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE W, 1992, J MAGN RESON, V98, P36, DOI 10.1016/0022-2364(92)90107-I; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mofid MR, 2002, J BIOL CHEM, V277, P17023, DOI 10.1074/jbc.M200120200; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Reimer JM, 2016, NATURE, V529, P239, DOI 10.1038/nature16503; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Sundlov JA, 2013, ACTA CRYSTALLOGR D, V69, P1482, DOI 10.1107/S0907444913009372; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tufar P, 2014, CHEM BIOL, V21, P552, DOI 10.1016/j.chembiol.2014.02.014; Walker O, 2004, J MAGN RESON, V168, P336, DOI 10.1016/j.jmr.2004.03.019; Walsh C., 2003, ANTIBIOTICS ACTIONS; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Worthington AS, 2006, ORG BIOMOL CHEM, V4, P44, DOI 10.1039/b512735a; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zettler J, 2010, FEBS J, V277, P1159, DOI 10.1111/j.1742-4658.2009.07551.x; Zimmermann S, 2015, FEBS LETT, V589, P2283, DOI 10.1016/j.febslet.2015.07.008	61	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10002	10013		10.1074/jbc.M116.766220	http://dx.doi.org/10.1074/jbc.M116.766220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455448	hybrid, Green Published			2022-12-28	WOS:000403580600013
J	Pontejo, SM; Murphy, PM				Pontejo, Sergio M.; Murphy, Philip M.			Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CC-CHEMOKINE; NEUTRALIZING ANTIBODIES; BETA CHEMOKINE; IDENTIFICATION; HEPARIN; RANTES; HOMOLOG; CELLS; SITE; DISSEMINATION	Chemokines are essential for antimicrobial host defenses and tissue repair. Herpesviruses and poxviruses also encode chemokines, copied from their hosts and repurposed for multiple functions, including immune evasion. The CC chemokine MCK-2 encoded by mouse CMV (MCMV) has an atypical structure consisting of a classic chemokine domain N-terminal to a second unique domain, resulting from the splicing of MCMV ORFs m131 and m129. MCK-2 is essential for full MCMV infectivity in macrophages and for persistent infection in the salivary gland. However, information about its mechanism of action and specific biochemical roles for the two domains has been lacking. Here, using genetic, chemical, and enzymatic analyses of multiple mouse cell lines as well as primary mouse fibroblasts from salivary gland and lung, we demonstrate that MCK-2 binds glycosaminoglycans (GAGs) with affinities in the following order: heparin > heparan sulfate > chondroitin sulfate = dermatan sulfate. Both MCK-2 domains bound these GAGs independently, and computational analysis together with site-directed mutagenesis identified five basic residues distributed across the N terminus and the 30s and 50s loops of the chemokine domain that are important GAG binding determinants. Both domains were required for GAG-dependent oligomerization of fulll-ength MCK-2. Thus, MCK-2 is an atypical viral chemokine consisting of a CC chemokine domain and a unique non-chemokine domain, both of which bind GAGs and are critical for GAG-dependent oligomerization of the full-length protein.	[Pontejo, Sergio M.; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIH, Bldg 10,Rm 11N111, Bethesda, MD 20892 USA.	pmm@nih.gov	Pontejo, Sergio M./AAN-6403-2020	Pontejo, Sergio M./0000-0002-7756-9831	NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Chiuppesi F, 2015, J VIROL, V89, P11884, DOI 10.1128/JVI.01701-15; Ciferri C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005230; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Daley-Bauer LP, 2014, CELL HOST MICROBE, V15, P351, DOI 10.1016/j.chom.2014.02.002; Daley-Bauer LP, 2012, IMMUNITY, V37, P122, DOI 10.1016/j.immuni.2012.04.014; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dyer DP, 2016, GLYCOBIOLOGY, V26, P312, DOI 10.1093/glycob/cwv100; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Fleming P, 1999, J VIROL, V73, P6800, DOI 10.1128/JVI.73.8.6800-6809.1999; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Liang WGG, 2016, P NATL ACAD SCI USA, V113, P5000, DOI 10.1073/pnas.1523981113; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; MacDonald MR, 1999, J VIROL, V73, P3682, DOI 10.1128/JVI.73.5.3682-3691.1999; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833; Nogalski MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003463; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Patel DD, 2001, CLIN IMMUNOL, V99, P43, DOI 10.1006/clim.2000.4997; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Saederup N, 1999, P NATL ACAD SCI USA, V96, P10881, DOI 10.1073/pnas.96.19.10881; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salanga CL, 2014, J BIOL CHEM, V289, P14896, DOI 10.1074/jbc.M114.547737; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Soria G, 2012, NEOPLASIA, V14, P1, DOI 10.1593/neo.111122; Stahl FR, 2015, MUCOSAL IMMUNOL, V8, P57, DOI 10.1038/mi.2014.42; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Streblow DN, 2007, CURR OPIN IMMUNOL, V19, P577, DOI 10.1016/j.coi.2007.07.012; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Wagner FM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003493; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wen YX, 2014, VACCINE, V32, P3796, DOI 10.1016/j.vaccine.2014.05.004; Wussow F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004524; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; Zhao B, 2010, BIOCHEMISTRY-US, V49, P7012, DOI 10.1021/bi100549y	71	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9613	9626		10.1074/jbc.M117.785121	http://dx.doi.org/10.1074/jbc.M117.785121			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28432120	hybrid, Green Published			2022-12-28	WOS:000403113000013
J	Stern, E; Ruf-Zamojski, F; Zalepa-King, L; Pincas, H; Choi, SG; Peskin, CS; Hayot, F; Turgeon, JL; Sealfon, SC				Stern, Estee; Ruf-Zamojski, Frederique; Zalepa-King, Lisa; Pincas, Hanna; Choi, Soon Gang; Peskin, Charles S.; Hayot, Fernand; Turgeon, Judith L.; Sealfon, Stuart C.			Modeling and high-throughput experimental data uncover the mechanisms underlying Fshb gene sensitivity to gonadotropin-releasing hormone pulse frequency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIFUSED L-BETA-T2 CELLS; BETA GENE; RECEPTOR DESENSITIZATION; DIFFERENTIAL REGULATION; DICTYOSTELIUM CELLS; MATHEMATICAL-MODEL; SINGLE-CELL; EXPRESSION; GNRH; TRANSCRIPTION	Neuroendocrine control of reproduction by brain-secreted pulses of gonadotropin-releasing hormone (GnRH) represents a longstanding puzzle about extracellular signal decoding mechanisms. GnRH regulates the pituitary gonadotropin's follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are heterodimers specified by unique beta subunits (FSH beta/LH beta). Contrary to Lhb, Fshb gene induction has a preference for low-frequency GnRH pulses. To clarify the underlying regulatory mechanisms, we developed three biologically anchored mathematical models: 1) parallel activation of Fshb inhibitory factors (e.g. inhibin alpha and VGF nerve growth factor-inducible), 2) activation of a signaling component with a refractory period (e.g. Gprotein), and 3) inactivation of a factor needed for Fshb induction (e.g. growth differentiation factor 9). Simulations with all three models recapitulated the Fshb expression levels obtained in pituitary gonadotrope cells perifused with varying GnRH pulse frequencies. Notably, simulations altering average concentration, pulse duration, and pulse frequency revealed that the apparent frequency-dependent pattern of Fshb expression in model 1 actually resulted from variations in average GnRH concentration. In contrast, models 2 and 3 showed "true" pulse frequency sensing. To resolve which components of this GnRH signal induce Fshb, we developed a high-throughput parallel experimental system. We analyzed over 4,000 samples in experiments with varying near-physiological GnRH concentrations and pulse patterns. Whereas Egr1 and Fos genes responded only to variations in average GnRH concentration, Fshb levels were sensitive to both average concentration and true pulse frequency. These results provide a foundation for understanding the role of multiple regulatory factors in modulating Fshb gene activity.	[Stern, Estee; Ruf-Zamojski, Frederique; Zalepa-King, Lisa; Pincas, Hanna; Choi, Soon Gang; Hayot, Fernand; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Ctr Adv Res Diagnost Assays, New York, NY 10029 USA; [Peskin, Charles S.] NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10012 USA; [Peskin, Charles S.] NYU, Ctr Neural Sci, 550 1St Ave, New York, NY 10012 USA; [Turgeon, Judith L.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Endocrinol, Davis, CA 95616 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; New York University; University of California System; University of California Davis	Sealfon, SC (corresponding author), Icahn Sch Med Mt Sinai, Annenberg 14-44,Box 1137,One Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	choi, soon gang/AAE-3187-2019; Ruf-Zamojski, Frederique/N-5718-2015	choi, soon gang/0000-0003-0314-3958; Ruf-Zamojski, Frederique/0000-0002-2451-8598; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [DK46943]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046943, R56DK046943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK46943. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Bedecarrats GY, 2003, P NATL ACAD SCI USA, V100, P9348, DOI 10.1073/pnas.1633592100; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bertram R, 2008, B MATH BIOL, V70, P2211, DOI 10.1007/s11538-008-9341-2; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Choi SG, 2016, J BIOL CHEM, V291, P21322, DOI 10.1074/jbc.M116.740365; Choi SG, 2014, J BIOL CHEM, V289, P16164, DOI 10.1074/jbc.M113.537696; Choi SG, 2012, J BIOL CHEM, V287, P21550, DOI 10.1074/jbc.M112.348607; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; DAVIDSON JS, 1995, MOL CELL ENDOCRINOL, V107, P241, DOI 10.1016/0303-7207(94)03449-4; Dode C, 2009, EUR J HUM GENET, V17, P139, DOI 10.1038/ejhg.2008.206; FARNWORTH PG, 1995, J ENDOCRINOL, V145, P387, DOI 10.1677/joe.0.1450387; FLANAGAN CA, 1994, J BIOL CHEM, V269, P22636; Fletcher PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095613; Jonak CR, 2017, J BIOL CHEM, V292, P2646, DOI 10.1074/jbc.M116.771808; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Karakoula A, 2008, EUR J PHARMACOL, V587, P16, DOI 10.1016/j.ejphar.2008.03.047; Kitanovic S, 2001, MOL ENDOCRINOL, V15, P390, DOI 10.1210/me.15.3.390; LI YX, 1990, J THEOR BIOL, V146, P355, DOI 10.1016/S0022-5193(05)80746-5; LI YX, 1989, BIOPHYS J, V55, P125, DOI 10.1016/S0006-3495(89)82785-7; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Magill JC, 2013, MATH BIOSCI, V246, P38, DOI 10.1016/j.mbs.2013.09.006; MARSHALL JC, 1991, RECENT PROG HORM RES, V47, P155; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; McNeilly AS, 2003, REPRODUCTION, P463; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nicol L, 2004, J MOL ENDOCRINOL, V32, P467, DOI 10.1677/jme.0.0320467; Pincas H, 2014, MOL CELL ENDOCRINOL, V385, P56, DOI 10.1016/j.mce.2013.08.015; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purwana IN, 2011, BIOL REPROD, V84, P996, DOI 10.1095/biolreprod.110.088526; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Wang Q, 2013, MOL ENDOCRINOL, V27, P224, DOI 10.1210/me.2012-1310; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Xie HM, 2015, MOL ENDOCRINOL, V29, P842, DOI 10.1210/me.2014-1279; Yuen T, 2002, MOL ENDOCRINOL, V16, P1145, DOI 10.1210/me.16.6.1145; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; ZHOU W, 1995, J BIOL CHEM, V270, P18853, DOI 10.1074/jbc.270.32.18853	50	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9815	9829		10.1074/jbc.M117.783886	http://dx.doi.org/10.1074/jbc.M117.783886			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28385888	Green Published, hybrid			2022-12-28	WOS:000403113000029
J	Ding, BB; Zhong, Q				Ding, Binbin; Zhong, Qing			Zinc deficiency: An unexpected trigger for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BREAST-CANCER; DEATH	Cells respond to deprivation of certain nutrients such as glucose or nitrogen by inducing autophagy, reclaiming pieces of proteins for use in critical functions. A recent study shows that, in yeast, zinc depletion acts in a similar fashion. Depletion of this essential nutrient induces non-selective autophagy by inhibiting TORC1, leading to release and recycling of zinc from degraded proteins.	[Ding, Binbin; Zhong, Qing] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhong, Q (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA.	qing.zhong@utsouthwestern.edu		DING, BINBIN/0000-0002-6424-005X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116908] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM116908] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam S, 2012, NUTRIENTS, V4, P875, DOI 10.3390/nu4080875; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Hung HH, 2013, CELL BIOL TOXICOL, V29, P415, DOI 10.1007/s10565-013-9261-2; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Pan R, 2015, BIOL TRACE ELEM RES, V166, P89, DOI 10.1007/s12011-015-0287-6	8	18	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8531	8532		10.1074/jbc.H116.762948	http://dx.doi.org/10.1074/jbc.H116.762948			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28526691	hybrid, Green Published			2022-12-28	WOS:000401788600035
J	Ono, S				Ono, Shoichiro			A plague of actin disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							YERSINIA PROTEIN-KINASE; CYTOSKELETON; BINDING	Pathogenic Yersinia species employ several strategies to evade the host immune system, including interfering with cytoskeletal remodeling as a way to block macrophage phagocytosis. The kinase YopO binds directly to monomeric actin and phosphorylates the actin-remodeling protein gelsolin, but the functional importance of this gelsolin modification has not been clear. A combined biochemical, computational, and biophysical study now reveals that YopO-mediated phosphorylation activates host gelsolin, leading to severed actin filaments and disturbed actin dynamics.	[Ono, Shoichiro] Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA; [Ono, Shoichiro] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Ono, Shoichiro] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Ono, S (corresponding author), Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA.	sono@emory.edu	Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398	National Institutes of Health [R01AR048615]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported in part by National Institutes of Health Grant R01AR048615. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Grabowski B, 2017, VIRULENCE, V8, P1124, DOI 10.1080/21505594.2017.1303588; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Ke YH, 2015, CELL MICROBIOL, V17, P473, DOI 10.1111/cmi.12378; Lamason RL, 2017, CURR OPIN MICROBIOL, V35, P48, DOI 10.1016/j.mib.2016.11.007; Lee WL, 2015, NAT STRUCT MOL BIOL, V22, P248, DOI 10.1038/nsmb.2964; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Singaravelu P, 2017, J BIOL CHEM, V292, P8092, DOI 10.1074/jbc.M116.757971	10	3	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8101	8102		10.1074/jbc.H116.757971	http://dx.doi.org/10.1074/jbc.H116.757971			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28500241	hybrid, Green Published			2022-12-28	WOS:000401154100034
J	Hirbawi, J; Bialkowska, K; Bledzka, KM; Liu, JM; Fukuda, K; Qin, J; Plow, EF				Hirbawi, Jamila; Bialkowska, Katarzyna; Bledzka, Kamila M.; Liu, Jianmin; Fukuda, Koichi; Qin, Jun; Plow, Edward F.			The extreme C-terminal region of kindlin-2 is critical to its regulation of integrin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; integrin; membrane; protein chemistry; talin; kindlin	MONOCLONAL-ANTIBODY; FERM DOMAIN; BINDING; TALIN; ADHESION; PROTEIN; ALPHA(IIB)BETA(3); ALPHA-IIB-BETA-3; MECHANISM; PLATELETS	Kindlin-2 (K2), a 4.1R-ezrin-radixin-moesin (FERM) domain adaptor protein, mediates numerous cellular responses, including integrin activation. The C-terminal 15-amino acid sequence of K2 is remarkably conserved across species but is absent in canonical FERM proteins, including talin. In CHO cells expressing integrin IIb3, co-expression of K2 with talin head domain resulted in robust integrin activation, but this co-activation was lost after deletion of as few as seven amino acids from the K2 C terminus. This dependence on the C terminus was also observed in activation of endogenous IIb3 in human erythroleukemia (HEL) cells and 1 integrin activation in macrophage-like RAW264.1 cells. Kindlin-1 (K1) exhibited a similar dependence on its C terminus for integrin activation. Expression of the K2 C terminus as an extension of membrane-anchored P-selectin glycoprotein ligand-1 (PSGL-1) inhibited integrin-dependent cell spreading. Deletion of the K2 C terminus did not affect its binding to the integrin 3 cytoplasmic tail, but combined biochemical and NMR analyses indicated that it can insert into the F2 subdomain. We suggest that this insertion determines the topology of the K2 FERM domain, and its deletion may affect the positioning of the membrane-binding functions of the F2 subdomain and the integrin-binding properties of its F3 subdomain. Free C-terminal peptide can still bind to K2 and displace the endogenous K2 C terminus but may not restore the conformation needed for integrin co-activation. Our findings indicate that the extreme C terminus of K2 is essential for integrin co-activation and highlight the importance of an atypical architecture of the K2 FERM domain in regulating integrin activation.	[Hirbawi, Jamila; Bialkowska, Katarzyna; Bledzka, Kamila M.; Liu, Jianmin; Fukuda, Koichi; Qin, Jun; Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Plow, EF (corresponding author), Dept Mol Cardiol, NB5-50,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health SIG Grant [1S10OD019972-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL096062, P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019972] Funding Source: NIH RePORTER	National Institutes of Health SIG Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Imaging Core and the Biotechnology Core of the Lerner Research Institute for assistance. The Leica SP8 confocal microscope utilized in this work was purchased with funding from National Institutes of Health SIG Grant 1S10OD019972-01.	Ali RH, 2014, MOL PHYLOGENET EVOL, V80, P193, DOI 10.1016/j.ympev.2014.08.008; Bialkowska K, 2015, J BIOL CHEM, V290, P6226, DOI 10.1074/jbc.M114.634436; Bledzka K, 2016, J CELL BIOL, V213, P97, DOI 10.1083/jcb.201501006; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; BoudignonProudhon C, 1996, BLOOD, V87, P968, DOI 10.1182/blood.V87.3.968.bloodjournal873968; BRAY PF, 1986, P NATL ACAD SCI USA, V83, P1480, DOI 10.1073/pnas.83.5.1480; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Huet-Calderwood C, 2014, J CELL SCI, V127, P4308, DOI 10.1242/jcs.155879; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Meller J, 2015, MOL BIOL CELL, V26, P786, DOI 10.1091/mbc.E14-08-1294; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moore DT, 2012, P NATL ACAD SCI USA, V109, P793, DOI 10.1073/pnas.1117220108; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Perera H. D. D., 2010, THESIS; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Plow E. F., 2016, DISCOVERIES; Plow EF, 2014, CURR OPIN HEMATOL, V21, P241, DOI 10.1097/MOH.0000000000000042; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Pluskota E, 2013, BLOOD, V122, P2491, DOI 10.1182/blood-2013-04-497669; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rognoni E, 2016, J CELL SCI, V129, P17, DOI 10.1242/jcs.161190; SHATTIL SJ, 1987, BLOOD, V70, P307; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WOODS VL, 1986, J BIOL CHEM, V261, P5242; Xu Z, 2014, ARTERIOSCL THROM VAS, V34, P1961, DOI 10.1161/ATVBAHA.114.303851; Xu Z, 2013, BIOCHEM BIOPH RES CO, V434, P382, DOI 10.1016/j.bbrc.2013.03.086; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469	54	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14258	14269		10.1074/jbc.M117.776195	http://dx.doi.org/10.1074/jbc.M117.776195			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28652408	hybrid, Green Published			2022-12-28	WOS:000408439800029
J	Roy, A; Ansari, SA; Das, K; Prasad, R; Bhattacharya, A; Mallik, S; Mukherjee, A; Sen, P				Roy, Abhishek; Ansari, Shabbir A.; Das, Kaushik; Prasad, Ramesh; Bhattacharya, Anindita; Mallik, Suman; Mukherjee, Ashis; Sen, Prosenjit			Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to beta-catenin accumulation via the AKT/GSK3 beta pathway and contributes to breast cancer progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE FACTOR; CYCLIN D1; EXPRESSION; CELLS; MIGRATION; PROTEINS; INSIGHTS; BINDING	Cell migration and invasion are very characteristic features of cancer cells that promote metastasis, which is one of the most common causes of mortality among cancer patients. Emerging evidence has shown that coagulation factors can directly mediate cancer-associated complications either by enhancing thrombus formation or by initiating various signaling events leading to metastatic cancer progression. It is well established that, apart from its distinct role in blood coagulation, coagulation factor FVIIa enhances aggressive behaviors of breast cancer cells, but the underlying signaling mechanisms still remain elusive. To this end, we investigated FVIIa's role in the migration and invasiveness of the breast cancer cell line MDA-MB-231. Consistent with previous observations, we observed that FVIIa increased the migratory and invasive potential of these cells. We also provide molecular evidence that protease-activated receptor 2 activation followed by PI3K-AKT activation and GSK3 beta inactivation is involved in these processes and that beta-catenin, a well known tumor-regulatory protein, contributes to this signaling pathway. The pivotal role of beta-catenin was further indicated by the up-regulation of its downstream targets cyclin D1, c-Myc, COX-2, MMP-7, MMP-14, and Claudin-1. beta-Catenin knockdown almost completely attenuated the FVIIa-induced enhancement of breast cancer migration and invasion. These findings provide a new perspective to counteract the invasive behavior of breast cancer, indicating that blocking PI3K-AKT pathway-dependent beta-catenin accumulation may represent a potential therapeutic approach to control breast cancer.	[Roy, Abhishek; Ansari, Shabbir A.; Das, Kaushik; Prasad, Ramesh; Bhattacharya, Anindita; Mallik, Suman; Sen, Prosenjit] Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, India; [Mukherjee, Ashis] Netaji Subhash Chandra Bose Canc Res Inst, Kolkata 700016, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Sen, P (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, India.	bcps@iacs.res.in	Prasad, Ramesh/HDO-1128-2022; ansari, shabbir/HDO-7187-2022; Roy, Abhishek/AAA-7591-2021; Ansari, Shabbir/GNW-5542-2022	ansari, shabbir/0000-0002-1939-7066; 	Department of Science and Technology, Government of India [SR/SO/BB-0125/2012]; Indian Association for the Cultivation of Science, Kolkata, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Association for the Cultivation of Science, Kolkata, India	This work was supported by Department of Science and Technology, Government of India, Project Grant SR/SO/BB-0125/2012 and a startup grant from the Indian Association for the Cultivation of Science, Kolkata, India. The authors declare that they have no conflicts of interest with the contents of this article.	Aberg M, 2013, J THROMB HAEMOST, V11, P817, DOI 10.1111/jth.12156; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Candidus S, 1996, CANCER RES, V56, P49; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cole M, 2013, ONCOLOGIST, V18, P14, DOI 10.1634/theoncologist.2012-0322; Degen JL, 2012, THROMB RES, V129, pS1, DOI 10.1016/S0049-3848(12)70143-3; Fredersdorf S, 1997, P NATL ACAD SCI USA, V94, P6380, DOI 10.1073/pnas.94.12.6380; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kocaturk B, 2013, J THROMB HAEMOST, V11, P285, DOI 10.1111/jth.12222; Lima LG, 2013, BIOSCIENCE REP, V33, P701, DOI 10.1042/BSR20130057; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; Prasad R., 2017, J BIOMOL STRUCT DYN, V35, P1, DOI [10.1080/07391102.2017.1289125, DOI 10.1080/07391102.2017.1289125]; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Sallah S, 2001, THROMB HAEMOSTASIS, V86, P828; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Sen P, 2012, THROMB HAEMOSTASIS, V107, P951, DOI 10.1160/TH11-09-0672; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Toomey JR, 1996, BLOOD, V88, P1583; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Versteeg HH, 2008, J THROMB HAEMOST, V6, P1550, DOI 10.1111/j.1538-7836.2008.03091.x; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Versteeg HH, 2001, THROMB HAEMOSTASIS, V86, P1353; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	48	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13688	13701		10.1074/jbc.M116.764670	http://dx.doi.org/10.1074/jbc.M116.764670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28522609	hybrid, Green Published			2022-12-28	WOS:000407942400024
J	Yadav, PK; Rajasekharan, R				Yadav, Pradeep Kumar; Rajasekharan, Ram			The m(6)A methyltransferase Ime4 epitranscriptionally regulates triacylglycerol metabolism and vacuolar morphology in haploid yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PROTEIN-DEGRADATION; SPORULATION; GENE; METHYLATION; MEIOSIS; N-6-METHYLADENOSINE; TRAFFICKING; BIOGENESIS	N-6-Methyladenosine (m(6)A) is among the most common modifications in eukaryotic mRNA. The role of yeast m(6)A methyltransferase, Ime4, in meiosis and sporulation in diploid strains is very well studied, but its role in haploid strains has remained unknown. Here, with the help of an immunoblotting strategy and Ime4-GFP protein localization studies, we establish the physiological role of Ime4 in haploid cells. Our data showed that Ime4 epitranscriptionally regulates triacylglycerol metabolism and vacuolar morphology through the long-chain fatty acyl-CoA synthetase Faa1, independently of the RNA methylation complex (MIS complex). The MIS complex consists of the Ime4, Mum2, and Slz1 proteins. Our affinity enrichment strategy (methylated RNA immunoprecipitation assays) using m(6)A polyclonal antibodies coupled with mRNA isolation, quantitative real-time PCR, and standard PCR analyses confirmed the presence of m(6)A-modified FAA1 transcripts in haploid yeast cells. The term "epitranscriptional regulation" encompasses the RNA modification-mediated regulation of genes. Moreover, we demonstrate that the Aft2 transcription factor up-regulates FAA1 expression. Because the m(6)A methylation machinery is fundamentally conserved throughout eukaryotes, our findings will help advance the rapidly emerging field of RNA epitranscriptomics. The metabolic link identified here between m(6)A methylation and triacylglycerol metabolism via the Ime4 protein provides new insights into lipid metabolism and the pathophysiology of lipid-related metabolic disorders, such as obesity. Because the yeast vacuole is an analogue of the mammalian lysosome, our findings pave the way to better understand the role of m(6)A methylation in lysosome-related functions and diseases.	[Yadav, Pradeep Kumar; Rajasekharan, Ram] Cent Food Technol Res Inst, CSIR, Lipid Ctr, Dept Lipid Sci, Mysuru 570020, Karnataka, India; [Yadav, Pradeep Kumar; Rajasekharan, Ram] Cent Food Technol Res Inst, CSIR, Acad Sci & Innovat Res, Mysuru 570020, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rajasekharan, R (corresponding author), CSIR, Cent Food Technol Res Inst, Mysuru 570020, Karnataka, India.	ram@cftri.com	Rajasekharan, Ram/R-2257-2019; Yadav, Pradeep Kumar/GZA-4317-2022	Yadav, Pradeep/0000-0002-4777-4914; Ram, Rajasekharan/0000-0002-4114-0654; Rajasekharan, Ram/0000-0002-2124-6013	Council of Scientific and Industrial Research (CSIR), India under 12th 5-year plan project LIPIC [BSC0401]; CSIR, India; J.C. Bose National Fellowship	Council of Scientific and Industrial Research (CSIR), India under 12th 5-year plan project LIPIC; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); J.C. Bose National Fellowship	This work was supported by the Council of Scientific and Industrial Research (CSIR), India, under the 12th 5-year plan project LIPIC (BSC0401). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CSIR, India.; Recipient of the J.C. Bose National Fellowship. To whom correspondence should be addressed: Central Food Technological Research Institute, Council of Scientific and Industrial Research, Mysuru, Karnataka 570020, India. Tel.: 91-821-2517760; Fax: 91-821-2516308; E-mail: ram@cftri.com.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; BETZ H, 1976, EUR J BIOCHEM, V62, P65, DOI 10.1111/j.1432-1033.1976.tb10098.x; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; CHASSANG A, 1972, FOLIA MICROBIOL, V17, P241, DOI 10.1007/BF02880197; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; ILLINGWO.RF, 1973, J BACTERIOL, V113, P373, DOI 10.1128/JB.113.1.373-386.1973; JONES EW, 1984, ANNU REV GENET, V18, P233, DOI 10.1146/annurev.ge.18.120184.001313; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Roeder AD, 1996, GENETICS, V144, P445; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175; Sambri I, 2017, EMBO MOL MED, V9, P112, DOI 10.15252/emmm.201606965; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; STEELE SD, 1974, CAN J MICROBIOL, V20, P929, DOI 10.1139/m74-142; Subramanian K, 2006, J CELL SCI, V119, P2477, DOI 10.1242/jcs.02972; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang CW, 2014, J CELL BIOL, V206, P357, DOI 10.1083/jcb.201404115; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yadav PK, 2016, J BIOL CHEM, V291, P18562, DOI 10.1074/jbc.M116.733378; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhao HX, 2017, J BIOL CHEM, V292, P8507, DOI 10.1074/jbc.M116.770248; Zheng JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.77; ZUBENKO GS, 1981, GENETICS, V97, P45; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	43	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13727	13744		10.1074/jbc.M117.783761	http://dx.doi.org/10.1074/jbc.M117.783761			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655762	hybrid, Green Published			2022-12-28	WOS:000407942400033
J	Xue, Y; Schmollinger, S; Attar, N; Campos, OA; Vogelauer, M; Carey, MF; Merchant, SS; Kurdistani, SK				Xue, Yong; Schmollinger, Stefan; Attar, Narsis; Campos, Oscar A.; Vogelauer, Maria; Carey, Michael F.; Merchant, Sabeeha S.; Kurdistani, Siavash K.			Endoplasmic reticulum-mitochondria junction is required for iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OUTER-MEMBRANE; MESSENGER-RNA; CELLULAR-METABOLISM; CONTACT SITES; SMP DOMAINS; YEAST; PROTEIN; GENE; DEFICIENCY	The endoplasmic reticulum (ER)-mitochondria encounter structure (ERMES) is a protein complex that physically tethers the two organelles to each other and creates the physical basis for communication between them. ERMES functions in lipid exchange between the ER and mitochondria, protein import into mitochondria, and maintenance of mitochondrial morphology and genome. Here, we report that ERMES is also required for iron homeostasis. Loss of ERMES components activates an Aft1-dependent iron deficiency response even in iron-replete conditions, leading to accumulation of excess iron inside the cell. This function is independent of known ERMES roles in calcium regulation, phospholipid biosynthesis, or effects on mitochondrial morphology. A mutation in the vacuolar protein sorting 13 (VPS13) gene that rescues the glycolytic phenotype of ERMES mutants suppresses the iron deficiency response and iron accumulation. Our findings reveal that proper communication between the ER and mitochondria is required for appropriate maintenance of cellular iron levels.	[Xue, Yong; Attar, Narsis; Campos, Oscar A.; Vogelauer, Maria; Carey, Michael F.; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Attar, Narsis; Campos, Oscar A.; Carey, Michael F.; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Xue, Yong] Huaihai Inst Technol, Jiangsu Key Lab Marine Pharmaceut Compound Screen, Lianyungang 222005, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Jiangsu Ocean University	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA.; Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu		Carey, Michael/0000-0003-3899-6280; xue, yong/0000-0002-7229-7232; Schmollinger, Stefan/0000-0002-7487-8014	National Institutes of Health [CA178415, GM074701]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy [DE-FD02-04ER15529]; NATIONAL CANCER INSTITUTE [R01CA178415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA178415 (to S. K. K.) and GM074701 (to M. F. C.) and Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy Grant DE-FD02-04ER15529 (to S. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The aligned and raw data have been deposited in the Gene Expression Omnibus under GEO Series accession number GSE99499.	AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Cankorur-Cetinkaya A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2771-6; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Ellenrieder L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13021; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Gozzelino R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010130; Gregg C., 2009, J VIS EXP, P1417; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lang AB, 2015, J CELL BIOL, V210, P883, DOI 10.1083/jcb.201502105; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Park JS, 2016, MOL BIOL CELL, V27, P2435, DOI 10.1091/mbc.E16-02-0112; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Stroud DA, 2011, J MOL BIOL, V413, P743, DOI 10.1016/j.jmb.2011.09.012; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tan T, 2013, J CELL SCI, V126, P3563, DOI 10.1242/jcs.121244; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012	47	32	33	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13197	13204		10.1074/jbc.M117.784249	http://dx.doi.org/10.1074/jbc.M117.784249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637866	hybrid, Green Published			2022-12-28	WOS:000407465300011
J	Giladi, M; van Dijk, L; Refaeli, B; Almagor, L; Hiller, R; Man, P; Forest, E; Khananshvili, D				Giladi, Moshe; van Dijk, Liat; Refaeli, Bosmat; Almagor, Lior; Hiller, Reuben; Man, Petr; Forest, Eric; Khananshvili, Daniel			Dynamic distinctions in the Na+/Ca2+ exchanger adopting the inward- and outward-facing conformational states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; SODIUM/CALCIUM EXCHANGER; MASS-SPECTROMETRY; STRUCTURAL BASIS; MEMBRANE TRANSPORTERS; ION-TRANSPORT; NCX PROTEINS; GENE FAMILY; MECHANISMS; STOICHIOMETRY	Na+/Ca2+ exchanger (NCX) proteins operate through the alternating access mechanism, where the ion-binding pocket is exposed in succession either to the extracellular or the intracellular face of the membrane. The archaeal NCX_Mj (Methanococcus jannaschiiNCX) system was used to resolve the backbone dynamics in the inward-facing (IF) and outward-facing (OF) states by analyzing purified preparations of apo- and ion-bound forms of NCX_Mj-WT and its mutant, NCX_Mj-5L6-8. First, the exposure of extracellular and cytosolic vestibules to the bulk phase was evaluated as the reactivity of single cysteine mutants to a fluorescent probe, verifying that NCX_Mj-WT and NCX_Mj-5L6-8 preferentially adopt the OF and IF states, respectively. Next, hydrogen-deuterium exchange-mass spectrometry (HDX-MS) was employed to analyze the backbone dynamics profiles in proteins, preferentially adopting the OF (WT) and IF (5L6-8) states either in the presence or absence of ions. Characteristic differences in the backbone dynamics were identified between apo NCX_Mj-WT and NCX_Mj-5L6-8, thereby underscoring specific conformational patterns owned by the OF and IF states. Saturating concentrations of Na+ or Ca2+ specifically modify HDX patterns, revealing that the ion-bound/occluded states are much more stable (rigid) in the OF than in the IF state. Conformational differences observed in the ion-occluded OF and IF states can account for diversifying the ion-release dynamics and apparent affinity (Km) at opposite sides of the membrane, where specific structure-dynamic elements can effectively match the rates of bidirectional ion movements at physiological ion concentrations.	[Giladi, Moshe; van Dijk, Liat; Refaeli, Bosmat; Almagor, Lior; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel; [Giladi, Moshe] Tel Aviv Sourasky Med Ctr, IL-39040 Tel Aviv, Israel; [Man, Petr] Acad Sci Czech Republ, Inst Microbiol, BioCeV, CZ-14220 Prague, Czech Republic; [Man, Petr] Charles Univ Prague, Fac Sci, CZ-14220 Prague, Czech Republic; [Forest, Eric] Univ Grenoble Alpes, Inst Biol Struct, F-38044 Grenoble, France; [Forest, Eric] CNRS, IBS, F-38044 Grenoble, France; [Forest, Eric] CEA, IBS, F-38044 Grenoble, France	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il	Man, Petr/H-2451-2014	Man, Petr/0000-0002-1485-2197; Khananshvili, Daniel/0000-0002-4202-9966	Israel Science Foundation [825/14]; EU/MEYS [LQ1604, CZ.1.05/1.1.00/02.0109]; Fields Estate Foundation	Israel Science Foundation(Israel Science Foundation); EU/MEYS; Fields Estate Foundation	This work was supported in part by Israel Science Foundation Grant 825/14 (to D. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by EU/MEYS Grants LQ1604 and CZ.1.05/1.1.00/02.0109.; Supported by the Fields Estate Foundation.	Almagor L, 2014, CELL CALCIUM, V56, P276, DOI 10.1016/j.ceca.2014.08.010; Baazov D, 1999, BIOCHEMISTRY-US, V38, P1435, DOI 10.1021/bi981429u; Bai YW, 1995, METHOD ENZYMOL, V259, P344; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Chalmers MJ, 2011, EXPERT REV PROTEOMIC, V8, P43, DOI 10.1586/EPR.10.109; Demmers JAA, 2000, P NATL ACAD SCI USA, V97, P3189, DOI 10.1073/pnas.050444797; Deng D, 2016, PROTEIN SCI, V25, P546, DOI 10.1002/pro.2858; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Forrest LR, 2015, ANNU REV BIOPHYS, V44, P311, DOI 10.1146/annurev-biophys-051013-023008; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Giladi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01102-x; Giladi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111949; Giladi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20753; Giladi M, 2016, FRONT PHYSIOL, V7, DOI [10.3359/fphys.7016.00030, 10.3389/fphys.2016.00030]; Giladi M, 2015, BIOCHEM J, V465, P489, DOI 10.1042/BJ20141036; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Keller R, 2014, BIOL CHEM, V395, P1379, DOI 10.1515/hsz-2014-0224; KHANANSHVILI D, 1990, BIOCHEMISTRY-US, V29, P2437, DOI 10.1021/bi00462a001; Khananshvili D, 1996, ANN NY ACAD SCI, V779, P217, DOI 10.1111/j.1749-6632.1996.tb44789.x; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Lee SY, 2016, FASEB J, V30, P1356, DOI 10.1096/fj.15-282251; Liao J, 2016, NAT STRUCT MOL BIOL, V23, P590, DOI 10.1038/nsmb.3230; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Marinelli F, 2014, P NATL ACAD SCI USA, V111, pE5354, DOI 10.1073/pnas.1415751111; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Nie Y, 2007, J MOL BIOL, V374, P356, DOI 10.1016/j.jmb.2007.09.006; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; On C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-127; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Refaeli B, 2016, BIOCHEMISTRY-US, V55, P1673, DOI 10.1021/acs.biochem.6b00119; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; Stein WD, 1986, TRANSPORT DIFFUSION, P55; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110	49	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12311	12323		10.1074/jbc.M117.787168	http://dx.doi.org/10.1074/jbc.M117.787168			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28572509	hybrid, Green Published			2022-12-28	WOS:000406053300026
J	Zanotti, S; Yu, J; Sanjay, A; Schilling, L; Schoenherr, C; Economides, AN; Canalis, E				Zanotti, Stefano; Yu, Jungeun; Sanjay, Archana; Schilling, Lauren; Schoenherr, Chris; Economides, Aris N.; Canalis, Ernesto			Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE HISTOMORPHOMETRY; NUCLEOTIDE-SEQUENCE; GROWTH-FACTOR; MICE; DIFFERENTIATION; MUTATIONS; CELLS; GENE; PATHWAY; EXPRESSION	Individuals with Hajdu-Cheney syndrome (HCS) present with osteoporosis, and HCS is associated with NOTCH2 mutations causing deletions of the proline-, glutamic acid-, serine-, and threonine-rich (PEST) domain that are predicted to enhance NOTCH2 stability and cause gain-of-function. Previously, we demonstrated that mice harboring Notch2 mutations analogous to those in HCS (Notch2HCS) are severely osteopenic because of enhanced bone resorption. We attributed this phenotype to osteoclastic sensitization to the receptor activator of nuclear factor-kappa B ligand and increased osteoblastic tumor necrosis factor superfamily member 11 (Tnfsf11) expression. Here, to determine the individual contributions of osteoclasts and osteoblasts to HCS osteopenia, we created a conditional-by-inversion (Notch2(COIN)) model in which Cre recombination generates a Notch2(Delta PEST) allele expressing a Notch2 mutant lacking the PEST domain. Germline Notch2(COIN) inversion phenocopied the Notch2HCS mutant, validating the model. To activate Notch2 in osteoclasts or osteoblasts, Notch2(COIN) mice were bred with mice expressing Cre from the Lyz2 or the BGLAP promoter, respectively. These crosses created experimental mice harboring a Notch2(Delta PEST) allele in Cre-expressing cells and control littermates expressing a wild-type Notch2 transcript. Notch2(COIN) inversion in Lyz2-expressing cells had no skeletal consequences and did not affect the capacity of bone marrow macrophages to form osteoclasts in vitro. In contrast, Notch2(COIN) inversion in osteoblasts led to generalized osteopenia associated with enhanced bone resorption in the cancellous bone compartment and with suppressed endocortical mineral apposition rate. Accordingly, Notch2 activation in osteoblast-enriched cultures from Notch2(COIN) mice induced Tnfsf11 expression. In conclusion, introduction of the HCS mutation in osteoblasts, but not in osteoclasts, causes osteopenia.	[Zanotti, Stefano; Yu, Jungeun; Sanjay, Archana; Canalis, Ernesto] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Zanotti, Stefano; Canalis, Ernesto] UConn Hlth, Dept Med, Farmington, CT 06030 USA; [Zanotti, Stefano; Yu, Jungeun; Sanjay, Archana; Schilling, Lauren; Canalis, Ernesto] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Schoenherr, Chris; Economides, Aris N.] Regeneron Pharmaceut, Tarrytown, NY 10591 USA	Regeneron	Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.	canalis@uchc.edu			National Institutes of Health from the NIDDK [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK045227 from the NIDDK. C. S. and A. E. receive stock options from Regeneron Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adami G, 2016, BONE, V92, P150, DOI 10.1016/j.bone.2016.08.025; ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Baeten JT, 2015, J BIOL CHEM, V290, P16226, DOI 10.1074/jbc.M115.655548; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2017, J CELL BIOCHEM, V118, P1819, DOI 10.1002/jcb.25859; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2016, CURR OSTEOPOROS REP, V14, P126, DOI 10.1007/s11914-016-0311-6; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2014, BONE, V64, P273, DOI 10.1016/j.bone.2014.04.028; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; CHENEY WD, 1965, AMER J ROENTGENOL RA, V94, P595; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gray MJ, 2012, EUR J HUM GENET, V20, P122, DOI 10.1038/ejhg.2011.125; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; HAJDU N, 1948, BRIT J RADIOL, V21, P42, DOI 10.1259/0007-1285-21-241-42; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Liu ZY, 2015, DEVELOPMENT, V142, P2452, DOI 10.1242/dev.125492; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Yang MB, 2010, BONE, V47, P573, DOI 10.1016/j.bone.2010.06.002; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Yorgan T, 2016, BONE, V87, P136, DOI 10.1016/j.bone.2016.04.012; Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2014, BONE, V62, P22, DOI 10.1016/j.bone.2014.01.023; Zanotti S, 2013, J BIOL CHEM, V288, P21547, DOI 10.1074/jbc.M113.489435; Zanotti S, 2013, J BIOL CHEM, V288, P624, DOI 10.1074/jbc.M112.340455; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5	66	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12232	12244		10.1074/jbc.M117.786129	http://dx.doi.org/10.1074/jbc.M117.786129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28592489	Green Published, hybrid			2022-12-28	WOS:000406053300020
J	Nakatsu, Y; Mori, K; Matsunaga, Y; Yamamotoya, T; Ueda, K; Inoue, Y; Mitsuzaki-Miyoshi, K; Sakoda, H; Fujishiro, M; Yamaguchi, S; Kushiyama, A; Ono, H; Ishihara, H; Asano, T				Nakatsu, Yusuke; Mori, Keiichi; Matsunaga, Yasuka; Yamamotoya, Takeshi; Ueda, Koji; Inoue, Yuki; Mitsuzaki-Miyoshi, Keiko; Sakoda, Hideyuki; Fujishiro, Midori; Yamaguchi, Suguru; Kushiyama, Akifumi; Ono, Hiraku; Ishihara, Hisamitsu; Asano, Tomoichiro			The prolyl isomerase Pin1 increases beta-cell proliferation and enhances insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTIONAL ACTIVITY; ISLET HYPERPLASIA; CYCLIN D1; RESISTANCE; GROWTH; COMPENSATION; PATHOGENESIS; PROTEIN; OBESITY	The prolyl isomerase Pin1 binds to the phosphorylated Ser/Thr-Pro motif of target proteins and enhances their cis-trans conversion. This report is the first to show that Pin1 expression in pancreatic beta cells is markedly elevated by high-fat diet feeding and in ob/ob mice. To elucidate the role of Pin1 in pancreatic beta cells, we generated beta-cell-specific Pin1 KO (beta Pin1 KO) mice. These mutant mice showed exacerbation of glucose intolerance but had normal insulin sensitivity. We identified two independent factors underlying impaired insulin secretion in the beta Pin1 KO mice. Pin1 enhanced pancreatic beta-cell proliferation, as indicated by a reduced beta-cell mass in beta Pin1 KO mice compared with control mice. Moreover, a diet high in fat and sucrose failed to increase pancreatic beta-cell growth in the beta Pin1 KO mice, an observation to which up-regulation of the cell cycle protein cyclin D appeared to contribute. The other role of Pin1 was to activate the insulin-secretory step: Pin1 KO beta cells showed impairments in glucose- and KCl-induced elevation of the intracellular Ca2+ concentration and insulin secretion. We also identified salt-inducible kinase 2 (SIK2) as a Pin1-binding protein that affected the regulation of Ca2+ influx and found Pin1 to enhance SIK2 kinase activity, resulting in a decrease in p35 protein, a negative regulator of Ca2+ influx. Taken together, our observations demonstrate critical roles of Pin1 in pancreatic beta cells and that Pin1 both promotes beta-cell proliferation and activates insulin secretion.	[Nakatsu, Yusuke; Mori, Keiichi; Matsunaga, Yasuka; Yamamotoya, Takeshi; Ueda, Koji; Inoue, Yuki; Mitsuzaki-Miyoshi, Keiko; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan; [Sakoda, Hideyuki] Miyazaki Univ, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Fujishiro, Midori; Yamaguchi, Suguru; Ishihara, Hisamitsu] Nihon Univ, Sch Med, Div Diabet & Metab Dis, Tokyo 1738610, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, Tokyo 1030002, Japan; [Ono, Hiraku] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chuo Ku, 1-8-1 Inohara, Chiba, Chiba 2608670, Japan	Hiroshima University; University of Miyazaki; Nihon University; Asahi Life Foundation; Chiba University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan.	tasano@hiroshima-u.ac.jp	祐介, 中津/AAP-8396-2020; Kushiyama, Akifumi/A-6386-2011; Kushiyama, Akifumi/W-5988-2019	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276	Ministry of Education, Science, and Culture, Japan [3702]; Salt Science Research Foundation; Grants-in-Aid for Scientific Research [16J09463] Funding Source: KAKEN	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C) (to Y. N.), a Grant-in-Aid for Scientific Research on Innovative Areas (area 3702) (to T. A.), and a Grant-in-Aid for Scientific Research (B) (to T. A.) from the Ministry of Education, Science, and Culture, Japan. This work was also supported by a Grant-in-Aid from The Salt Science Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Carboneau BA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12863; Cengiz M, 2014, DIGESTION, V90, P35, DOI 10.1159/000365415; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Hirose H, 1996, J BIOL CHEM, V271, P5633, DOI 10.1074/jbc.271.10.5633; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Liu XR, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7013032; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lv L, 2013, J CELL MOL MED, V17, P989, DOI 10.1111/jcmm.12082; Min SH, 2016, ARCH PHARM RES, V39, P1609, DOI 10.1007/s12272-016-0821-x; Nakatsu Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091495; Nakatsu Y, 2015, J BIOL CHEM, V290, P24255, DOI 10.1074/jbc.M115.658559; Nakatsu Y, 2012, J BIOL CHEM, V287, P44526, DOI 10.1074/jbc.M112.397133; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Paneni F, 2015, EUR HEART J, V36, P817, DOI 10.1093/eurheartj/ehu179; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yoon WJ, 2013, J CELL PHYSIOL, V228, P2377, DOI 10.1002/jcp.24403; Zhang XB, 2005, DIABETES, V54, P712, DOI 10.2337/diabetes.54.3.712	36	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11886	11895		10.1074/jbc.M117.780726	http://dx.doi.org/10.1074/jbc.M117.780726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28566287	Green Published, hybrid			2022-12-28	WOS:000405485600025
J	Alexander, NS; Katayama, K; Sun, WY; Salom, D; Gulati, S; Zhang, JY; Mogi, M; Palczewski, K; Jastrzebska, B				Alexander, Nathan S.; Katayama, Kota; Sun, Wenyu; Salom, David; Gulati, Sahil; Zhang, Jianye; Mogi, Muneto; Palczewski, Krzysztof; Jastrzebska, Beata			Complex binding pathways determine the regeneration of mammalian green cone opsin with a locked retinal analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; COUPLED RECEPTOR RHODOPSIN; VISUAL PIGMENTS; 9-METHYL GROUP; 9-CIS-RETINYL ACETATE; CRYSTAL-STRUCTURE; RPE65 MUTATIONS; COLOR-VISION; MOUSE MODEL; HUMAN RED	Phototransduction is initiated when the absorption of light converts the 11-cis-retinal chromophore to its all-trans configuration in both rod and cone vertebrate photoreceptors. To sustain vision, 11-cis-retinal is continuously regenerated from its all-trans conformation through a series of enzymatic steps comprising the "visual or retinoid" cycle. Abnormalities in this cycle can compromise vision because of the diminished supply of 11-cis-retinal and the accumulation of toxic, constitutively active opsin. As shown previously for rod cells, attenuation of constitutively active opsin can be achieved with the unbleachable analogue, 11-cis-6-membered ring (11-cis-6mr)-retinal, which has therapeutic effects against certain degenerative retinal diseases. However, to discern the molecular mechanisms responsible for this action, pigment regeneration with this locked retinal analogue requires delineation also in cone cells. Here, we compared the regenerative properties of rod and green cone opsins with 11-cis-6mr-retinal and demonstrated that this retinal analogue could regenerate rod pigment but not green cone pigment. Based on structural modeling suggesting that Pro-205 in green cone opsin could prevent entry and binding of 11-cis-6mr-retinal, we initially mutated this residue to Ile, the corresponding residue in rhodopsin. However, this substitution did not enable green cone opsin to regenerate with 11-cis-6mr-retinal. Interestingly, deletion of 16 N-terminal amino acids in green cone opsin partially restored the binding of 11-cis-6mr-retinal. These results and our structural modeling indicate that a more complex binding pathway determines the regeneration of mammalian green cone opsin with chromophore analogues such as 11-cis-6mr-retinal.	[Alexander, Nathan S.; Katayama, Kota; Salom, David; Gulati, Sahil; Zhang, Jianye; Palczewski, Krzysztof; Jastrzebska, Beata] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Palczewski, Krzysztof; Jastrzebska, Beata] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Sun, Wenyu; Palczewski, Krzysztof] Polgenix Inc, Cleveland, OH 44106 USA; [Mogi, Muneto] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA	Case Western Reserve University; Case Western Reserve University; Novartis	Palczewski, K; Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; bxj27@case.edu		Gulati, Sahil/0000-0002-8255-479X; Salom, David/0000-0002-3208-1509	National Institutes of Health [EY025214, EY009339, EY027283, EY024864, EY025007]; Japan Society for the Promotion of Science; Alcon Research Institute; NATIONAL EYE INSTITUTE [R01EY025214, R24EY027283, R01EY009339, R24EY024864, K99EY025007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alcon Research Institute(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported National Institutes of Health Grants EY025214 (to B. J.), EY009339 and EY027283 (to K. P.), EY024864 (to T. S. Kern), and EY025007 ( to N. S. A.), Japan Society for the Promotion of Science Overseas Research Fellowship (to K. K.), and an Alcon Research Institute grant (to K. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6763; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; DEGRIP WJ, 1990, EUR J BIOCHEM, V191, P211; Estevez ME, 2009, J GEN PHYSIOL, V134, P137, DOI 10.1085/jgp.200910232; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fujimoto K, 2009, B CHEM SOC JPN, V82, P1140, DOI 10.1246/bcsj.82.1140; GANTER UM, 1989, BIOCHEMISTRY-US, V28, P5954, DOI 10.1021/bi00440a036; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gulati S, 2017, P NATL ACAD SCI USA, V114, pE2608, DOI 10.1073/pnas.1617446114; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hofmann L, 2015, PROG RETIN EYE RES, V49, P46, DOI 10.1016/j.preteyeres.2015.07.004; HU SH, 1994, BIOCHEMISTRY-US, V33, P408, DOI 10.1021/bi00168a004; Isralewitz B, 1997, BIOPHYS J, V73, P2972, DOI 10.1016/S0006-3495(97)78326-7; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jang GF, 2001, J BIOL CHEM, V276, P26148, DOI 10.1074/jbc.M102212200; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuksa V, 2002, J BIOL CHEM, V277, P42315, DOI 10.1074/jbc.M206014200; Kuwayama S, 2005, BIOCHEMISTRY-US, V44, P2208, DOI 10.1021/bi047994g; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P322, DOI 10.1167/iovs.08-2301; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4917, DOI 10.1167/iovs.09-3581; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4368, DOI 10.1167/iovs.09-3700; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Perkins BD, 2002, VISUAL NEUROSCI, V19, P257, DOI 10.1017/S0952523802192030; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salom D, 2006, J STRUCT BIOL, V156, P497, DOI 10.1016/j.jsb.2006.05.003; Senechal A, 2006, AM J OPHTHALMOL, V142, P702, DOI 10.1016/j.ajo.2006.04.057; SHICHIDA Y, 1988, BIOCHEMISTRY-US, V27, P6495, DOI 10.1021/bi00417a044; SHICHIDA Y, 1993, BIOCHEMISTRY-US, V32, P10832, DOI 10.1021/bi00091a039; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; Srinivasan S, 2016, CELL MOL LIFE SCI, V73, P1253, DOI 10.1007/s00018-015-2043-7; Srinivasan S, 2014, CHEM BIOL, V21, P369, DOI 10.1016/j.chembiol.2014.01.006; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001	61	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10983	10997		10.1074/jbc.M117.780478	http://dx.doi.org/10.1074/jbc.M117.780478			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487362	hybrid, Green Published			2022-12-28	WOS:000404391000020
J	Desmond, PF; Labuza, A; Muriel, J; Markwardt, ML; Mancini, AE; Rizzo, MA; Bloch, RJ				Desmond, Patrick F.; Labuza, Amanda; Muriel, Joaquin; Markwardt, Michele L.; Mancini, Allison E.; Rizzo, Mark A.; Bloch, Robert J.			Interactions between small ankyrin 1 and sarcolipin coordinately regulate activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA2+ TRANSPORT; PHOSPHOLAMBAN; PROTEIN; ISOFORMS; ATPASE; CELLS; FORMS; IDENTIFICATION	SERCA1, the sarco(endo) plasmic reticulum Ca2+-ATPase of skeletal muscle, is essential for muscle relaxation and maintenance of low resting Ca2+ levels in the myoplasm. We recently reported that small ankyrin 1 (sAnk1) interacts with the sarco( endo) plasmic reticulum Ca2+-ATPase in skeletal muscle (SERCA1) to inhibit its activity. We also showed that this interaction is mediated at least in part through sAnk1's transmembrane domain in a manner similar to that of sarcolipin (SLN). Earlier studies have shown that SLN and phospholamban, the other well studied small SERCA-regulatory proteins, oligomerize either alone or together. As sAnk1 is coexpressed with SLN in muscle, we sought to determine whether these two proteins interact with one another when coexpressed exogenously in COS7 cells. Coimmunoprecipitation (coIP) and anisotropy-based FRET (AFRET) assays confirmed this interaction. Our results indicated that sAnk1 and SLN can associate in the sarcoplasmic reticulum membrane and after exogenous expression in COS7 cells in vitro but that their association did not require endogenous SERCA2. Significantly, SLN promoted the interaction between sAnk1 and SERCA1 when the three proteins were coexpressed, and both coIP and AFRET experiments suggested the formation of a complex consisting of all three proteins. Ca2+-ATPase assays showed that sAnk1 ablated SLN's inhibition of SERCA1 activity. These results suggest that sAnk1 interacts with SLN both directly and in complex with SERCA1 and reduces SLN's inhibitory effect on SERCA1 activity.	[Desmond, Patrick F.; Labuza, Amanda; Muriel, Joaquin; Markwardt, Michele L.; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Desmond, Patrick F.; Bloch, Robert J.] Univ Maryland, Program Biochem & Mol Biol, Baltimore, MD 21201 USA; [Labuza, Amanda; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA; [Mancini, Allison E.; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bloch, RJ (corresponding author), HSF1 Rm 580C,685 W Baltimore St, Baltimore, MD 21201 USA.	rbloch@som.umaryland.edu		Labuza, Amanda/0000-0002-8298-1521	National Institutes of Health [RO1 DK077140, R01 HL122827A, R01 MH111527A, RO1 AR056330, T32 GM08181, T32 AR 007592]; Kahlert Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056330, T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahlert Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants RO1 DK077140, R01 HL122827A, and R01 MH111527A (to M. A. R.), National Institutes of Health Grant RO1 AR056330 (to R. J. B.), and The Kahlert Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Program in Integrative Membrane Biology Grant T32 GM08181 and Interdisciplinary Training Program in Muscle Biology Grant T32 AR 007592.	Ackermann MA, 2011, J CELL SCI, V124, P3619, DOI 10.1242/jcs.085159; Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Desmond PF, 2015, J BIOL CHEM, V290, P27854, DOI 10.1074/jbc.M115.676585; Diaz ME, 2005, CELL CALCIUM, V38, P391, DOI 10.1016/j.ceca.2005.06.017; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kosk-Kosicka Danuta, 2013, Methods Mol Biol, V937, P343; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Porter NC, 2005, MOL MEMBR BIOL, V22, P421, DOI 10.1080/09687860500244262; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt AG, 2002, CARDIOVASC RES, V56, P248, DOI 10.1016/S0008-6363(02)00541-2; Schneider JS, 2013, J MUSCLE RES CELL M, V34, P349, DOI 10.1007/s10974-013-9350-0; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Vangheluwe P, 2006, J MOL CELL CARDIOL, V41, P308, DOI 10.1016/j.yjmcc.2006.05.014; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	47	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10961	10972		10.1074/jbc.M117.783613	http://dx.doi.org/10.1074/jbc.M117.783613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487373	Green Published, hybrid			2022-12-28	WOS:000404391000018
J	Ulfig, A; Frobel, J; Lausberg, F; Blummel, AS; Heide, AK; Muller, M; Freudl, R				Ulfig, Agnes; Froebel, Julia; Lausberg, Frank; Bluemmel, Anne-Sophie; Heide, Anna Katharina; Mueller, Matthias; Freudl, Roland			The h-region of twin-arginine signal peptides supports productive binding of bacterial Tat precursor proteins to the TatBC receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; ESCHERICHIA-COLI; TARGETING DETERMINANTS; TRANSPORT-SYSTEMS; MEMBRANE-BINDING; GENETIC-ANALYSIS; FOLDED PROTEINS; EXPORT PATHWAY; SIDE-CHAIN; TRANSLOCATION	The twin-arginine translocation (Tat) pathway transports folded proteins across bacterial membranes. Tat precursor proteins possess a conserved twin-arginine (RR) motif in their signal peptides that is involved in their binding to the Tat translocase, but some facets of this interaction remain unclear. Here, we investigated the role of the hydrophobic (h-) region of the Escherichia coli trimethylamine N-oxide reductase (TorA) signal peptide in TatBC receptor binding in vivo and in vitro. We show that besides the RR motif, a minimal, functional h-region in the signal peptide is required for Tat-dependent export in Escherichia coli. Furthermore, we identified mutations in the h-region that synergistically suppressed the export defect of a TorA[KQ]-30aa-MalE Tat reporter protein in which the RR motif was replaced with a lysine-glutamine pair. Strikingly, all suppressor mutations increased the hydrophobicity of the h-region. By systematically replacing a neutral residue in the h-region with various amino acids, we detected a positive correlation between the hydrophobicity of the h-region and the translocation efficiency of the resulting reporter variants. In vitro cross-inking of residues located in the periplasmically-oriented part of the TatBC receptor to TorA[KQ]-30aa-MalE reporter variants harboring a more hydrophobic h-region in their signal peptides confirmed that unlike in TorA[KQ]-30aa-MalE with an unaltered h-region, the mutated reporters moved deep into the TatBC-binding cavity. Our results clearly indicate that, besides the Tat motif, the h-region of the Tat signal peptides is another important binding determinant that significantly contributes to the productive interaction of Tat precursor proteins with the TatBC receptor complex.	[Ulfig, Agnes; Lausberg, Frank; Heide, Anna Katharina; Freudl, Roland] Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany; [Froebel, Julia; Bluemmel, Anne-Sophie; Mueller, Matthias] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany	Helmholtz Association; Research Center Julich; University of Freiburg	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279; Ulfig, Agnes/0000-0003-2689-6311				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; ARGOS P, 1982, EUR J BIOCHEM, V128, P565; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Eisenberg D., 1982, FARADAY S CHEM SOC, V17, P109, DOI DOI 10.1039/FS9821700109; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEITMANN P, 1968, EUR J BIOCHEM, V3, P346, DOI 10.1111/j.1432-1033.1968.tb19535.x; HENGGE R, 1983, BIOCHIM BIOPHYS ACTA, V737, P443, DOI 10.1016/0304-4157(83)90009-6; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; MILLER JG, 1972, SHORT COURSE BACTERI; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; van Dalen A, 1999, J BIOL CHEM, V274, P19913, DOI 10.1074/jbc.274.28.19913; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	65	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10865	10882		10.1074/jbc.M117.788950	http://dx.doi.org/10.1074/jbc.M117.788950			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28515319	Green Published, hybrid			2022-12-28	WOS:000404391000011
J	Guzy, RD; Li, L; Smith, C; Dorry, SJ; Koo, HY; Chen, L; Ornitz, DM				Guzy, Robert D.; Li, Ling; Smith, Craig; Dorry, Samuel J.; Koo, Hyun Young; Chen, Lin; Ornitz, David M.			Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; fibroblast; fibroblast growth factor (FGF); fibroblast growth factor receptor (FGFR); lung injury; myofibroblast; pulmonary fibrosis; bleomycin	HUMAN LUNG FIBROBLASTS; TYROSINE KINASE; ANIMAL-MODELS; MURINE LUNG; BLEOMYCIN; EXPRESSION; PROLIFERATION; RECEPTOR; ADENOCARCINOMA; PIRFENIDONE	Idiopathic pulmonary fibrosis (IPF) is characterized by progressive pulmonary scarring, decline in lung function, and often results in death within 3-5 five years after diagnosis. Fibroblast growth factor (FGF) signaling has been implicated in the pathogenesis of IPF; however, the mechanism through which FGF signaling contributes to pulmonary fibrosis remains unclear. We hypothesized that FGF receptor (FGFR) signaling in fibroblasts is required for the fibrotic response to bleomycin. To test this, mice with mesenchyme-specific tamoxifen-inducible inactivation of FGF receptors 1, 2, and 3 (Col12-CreER; TCKO mice) were lineage labeled and administered intratracheal bleomycin. Lungs were collected for histologic analysis, whole lung RNA and protein, and dissociated for flow cytometry and FACS. Bleomycin-treated Col12-CreER; TCKO mice have decreased pulmonary fibrosis, collagen production, and fewer -smooth muscle actin-positive (SMA+) myofibroblasts compared with controls. Freshly isolated Col12-CreER; TCKO mesenchymal cells from bleomycin-treated mice have decreased collagen expression compared with wild type mesenchymal cells. Furthermore, lineage labeled FGFR-deficient fibroblasts have decreased enrichment in fibrotic areas and decreased proliferation. These data identify a cell autonomous requirement for mesenchymal FGFR signaling in the development of pulmonary fibrosis, and for the enrichment of the Col12-CreER-positive (Col12+) mesenchymal lineage in fibrotic tissue following bleomycin exposure. We conclude that mesenchymal FGF signaling is required for the development of pulmonary fibrosis, and that therapeutic strategies aimed directly at mesenchymal FGF signaling could be beneficial in the treatment of IPF.	[Guzy, Robert D.; Dorry, Samuel J.; Koo, Hyun Young] Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, Chicago, IL 60637 USA; [Guzy, Robert D.; Li, Ling; Smith, Craig; Ornitz, David M.] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63110 USA; [Chen, Lin] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Rehabil Med,Ctr Bone Metab & Repair, Chongqing 400042, Peoples R China	University of Chicago; Washington University (WUSTL); Army Medical University	Guzy, RD (corresponding author), 5841 S Maryland Ave,MC6076, Chicago, IL 60637 USA.	rguzy1@bsd.uchicago.edu		Guzy, Robert/0000-0001-8420-6177; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [HL111190, T32HL007317]; American Heart Association [14FTF19840029]; Washington University Hope Center Alafi Neuroimaging Lab; National Institutes of Health Shared Instrumentation Grant [S10 RR027552]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111190, T32HL007317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Washington University Hope Center Alafi Neuroimaging Lab; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL111190 and T32HL007317, American Heart Association Grant 14FTF19840029, Washington University Hope Center Alafi Neuroimaging Lab, and a National Institutes of Health Shared Instrumentation Grant S10 RR027552. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai D, 2015, J PATHOL, V235, P593, DOI 10.1002/path.4486; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Coffey E, 2013, J HISTOCHEM CYTOCHEM, V61, P671, DOI 10.1369/0022155413497366; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Gupte VV, 2009, AM J RESP CRIT CARE, V180, P424, DOI 10.1164/rccm.200811-1794OC; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; Hanumegowda C, 2012, CHEST, V142, P200, DOI 10.1378/chest.11-1962; Hokuto I, 2003, J BIOL CHEM, V278, P415, DOI 10.1074/jbc.M208328200; Hoyles RK, 2011, AM J RESP CRIT CARE, V183, P249, DOI 10.1164/rccm.201002-0279OC; Hu BA, 2015, AM J PATHOL, V185, P3066, DOI 10.1016/j.ajpath.2015.07.014; Hu BA, 2015, AM J RESP CELL MOL, V52, P418, DOI 10.1165/rcmb.2014-0108OC; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Joannes A, 2016, AM J PHYSIOL-LUNG C, V310, pL615, DOI 10.1152/ajplung.00185.2015; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Liu TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142547; MacKenzie B, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0242-2; MacKenzie B, 2015, AM J PHYSIOL-LUNG C, V308, pL1014, DOI 10.1152/ajplung.00291.2014; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Osaki T, 2001, INT J EXP PATHOL, V82, P231, DOI 10.1046/j.1365-2613.2001.00193.x; Parapuram SK, 2015, MATRIX BIOL, V43, P35, DOI 10.1016/j.matbio.2015.01.017; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Rangarajan S, 2016, AM J RESP CELL MOL, V54, P51, DOI 10.1165/rcmb.2014-0445OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Shimbori C, 2016, J PATHOL, V240, P197, DOI 10.1002/path.4768; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Sugahara K, 1998, J PATHOL, V186, P90; Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443; Tschumperlin Daniel J, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS24, DOI 10.1513/AnnalsATS.201407-320MG; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Wang J, 2012, MOL MED, V18, P992, DOI 10.2119/molmed.2011.00425; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Yin YJ, 2016, DIS MODEL MECH, V9, P563, DOI 10.1242/dmm.024760; Yin YJ, 2013, CANCER RES, V73, P5730, DOI 10.1158/0008-5472.CAN-13-0495; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu ZH, 2012, BIOL PHARM BULL, V35, P731, DOI 10.1248/bpb.35.731; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	55	38	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10364	10378		10.1074/jbc.M117.791764	http://dx.doi.org/10.1074/jbc.M117.791764			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487375	Green Published, hybrid			2022-12-28	WOS:000404115400004
J	Kanamori, Y; Murakami, M; Sugiyama, M; Hashimoto, O; Matsui, T; Funaba, M				Kanamori, Yohei; Murakami, Masaru; Sugiyama, Makoto; Hashimoto, Osamu; Matsui, Tohru; Funaba, Masayuki			Interleukin-1 beta (IL-1 beta) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein delta (C/EBP delta) expression in hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PEPTIDE HEPCIDIN; IRON-METABOLISM; ACTIVIN B; RAT-LIVER; INFLAMMATION; ANEMIA; SERUM; GENE; PROMOTER	Hepcidin is a liver-derived hormone that negatively regulates serum iron levels and is mainly regulated at the transcriptional level. Previous studies have clarified that in addition to hepatic iron levels, inflammation also efficiently increases hepatic hepcidin expression. The principle regions responsible for efficient hepcidin transcription are bone morphogenetic protein-responsive elements (BMP-REs) 1 and 2 as well as the signal transducer and activator of transcription 3-binding site (STAT-BS). Here, we show that the proinflammatory cytokine interleukin-1 beta (IL-1 beta) efficiently increases hepcidin expression in human HepG2 liver-derived cells and primary mouse hepatocytes. The primary region responsible for IL-1 beta-mediated hepcidin transcription was the putative CCAAT enhancer-binding protein (C/EBP)-binding site (C/EBP-BS) at the hepcidin promoter spanning nucleotides -329 to -320. IL-1 beta induces the expression of C/EBP delta but neither C/EBP alpha nor C/EBP beta in hepatocytes, and C/EBP delta bound to the C/EBP-BS in an IL-1 beta-dependent manner. Lipopolysaccharide (LPS) induced the expression of IL-1 beta in Kupffer cells and hepatocytes in the mouse liver; furthermore, the culture supernatants from the macrophagelike cell line RAW264.7 treated with LPS potentiated the stimulation of hepcidin expression in hepatocytes. The present study reveals that: 1) inflammation induces IL-1 beta production in Kupffer cells and hepatocytes; 2) IL-1 beta increases C/EBP delta expression in hepatocytes; and 3) induction of C/EBP delta activates hepcidin transcription via the C/EBP-BS that has been uncharacterized yet. In cooperation with the other pathways activated by inflammation, IL-1 beta pathway stimulation leads to excess production of hepcidin, which could be causative to anemia of inflammation.	[Kanamori, Yohei; Matsui, Tohru; Funaba, Masayuki] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Murakami, Masaru] Azabu Univ, Sch Vet Med, Lab Mol Biol, Sagamihara, Kanagawa 2525201, Japan; [Sugiyama, Makoto] Kitasato Univ, Sch Vet Med, Lab Vet Anat, Towada, Aomori 0348628, Japan; [Hashimoto, Osamu] Kitasato Univ, Sch Vet Med, Lab Expt Anim Sci, Towada, Aomori 0348628, Japan	Kyoto University; Azabu University; Kitasato University; Kitasato University	Funaba, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan.	mfunaba@kais.kyoto-u.ac.jp	Funaba, Masayuki/E-4676-2018	Funaba, Masayuki/0000-0002-4303-6682; SUGIYAMA, Makoto/0000-0001-9340-6015	Japan Society for the Promotion of Science KAKENHI [15J02394]; Azabu University [2014-K-6]; Tokyo Institute of Technology; Grants-in-Aid for Scientific Research [15J02394] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Azabu University; Tokyo Institute of Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 15J02394 (to Y. K.), research project Grant 2014-K-6 from Azabu University (to M. M.), and a grant from the Tokyo Institute of Technology (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Courselaud B., 2002, J BIOL CHEM, V277, P41163; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; DeCicco LA, 1998, TOXICOL LETT, V98, P115, DOI 10.1016/S0378-4274(98)00110-6; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; Duran EM, 2005, FRONT BIOSCI-LANDMRK, V10, P2955, DOI 10.2741/1751; Faux NG, 2014, MOL PSYCHIATR, V19, P1227, DOI 10.1038/mp.2013.178; Forlenza OV, 2009, DEMENT GERIATR COGN, V28, P507, DOI 10.1159/000255051; Funaba M, 2008, J BIOCHEM BIOPH METH, V70, P816, DOI 10.1016/j.jbbm.2007.10.001; Hare DJ, 2015, ACS CHEM NEUROSCI, V6, P398, DOI 10.1021/cn5003557; Hasdai D, 1996, HEART, V76, P24, DOI 10.1136/hrt.76.1.24; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hu Y, 2015, CELL PHYSIOL BIOCHEM, V36, P753, DOI 10.1159/000430135; Hunter P, 2012, EMBO REP, V13, P968, DOI 10.1038/embor.2012.142; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kanamori Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38702; Kanamori Y, 2015, BIOCHEM BIOPH RES CO, V466, P162, DOI 10.1016/j.bbrc.2015.08.123; Kanamori Y, 2014, GENE, V551, P119, DOI 10.1016/j.gene.2014.08.037; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Ko CY, 2014, NEUROBIOL AGING, V35, P24, DOI 10.1016/j.neurobiolaging.2013.07.021; Ko CY, 2012, NEUROBIOL AGING, V33, DOI [10.1016/j.neurobiolaging.2010.09.017, DOI 10.1016/J.NEUR0BI0LAGING.2010.09.017]; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meynard D, 2014, BLOOD, V123, P168, DOI 10.1182/blood-2013-06-427757; Michels K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004998; Myhre O, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/726954; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; O'Bryan MK, 2005, AM J PHYSIOL-REG I, V288, pR1744, DOI 10.1152/ajpregu.00651.2004; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Schmitt Andrea, 2005, Neuropsychiatr Dis Treat, V1, P171, DOI 10.2147/nedt.1.2.171.61048; Shanmugam NKN, 2015, J BIOL CHEM, V290, P30637, DOI 10.1074/jbc.M115.689190; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Speaker Kristin J., 2012, BMC Physiology, V12, P8, DOI 10.1186/1472-6793-12-8; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Tsutsui H, 2014, INT J MOL SCI, V15, P7711, DOI 10.3390/ijms15057711; Wang CY, 2016, CURR OPIN HEMATOL, V23, P189, DOI 10.1097/MOH.0000000000000236; Weiss G, 2015, SEMIN HEMATOL, V52, P313, DOI 10.1053/j.seminhematol.2015.07.004; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yamada M, 2007, NITRIC OXIDE-BIOL CH, V17, P98, DOI 10.1016/j.niox.2007.06.003; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378	59	46	50	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10275	10287		10.1074/jbc.M116.770974	http://dx.doi.org/10.1074/jbc.M116.770974			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28438835	hybrid, Green Published			2022-12-28	WOS:000403580600035
J	Zhang, YX; Bharathi, SS; Rardin, MJ; Lu, J; Maringer, KV; Sims-Lucas, S; Prochownik, EV; Gibson, BW; Goetzman, ES				Zhang, Yuxun; Bharathi, Sivakama S.; Rardin, Matthew J.; Lu, Jie; Maringer, Katherine V.; Sims-Lucas, Sunder; Prochownik, Edward V.; Gibson, Bradford W.; Goetzman, Eric S.			Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL; SUCCINYLATION; IDENTIFICATION; DEHYDROGENASE; ACETYLATION; OXIDATION; PATHWAY	SIRT5 is a lysine desuccinylase known to regulate mitochondrial fatty acid oxidation and the urea cycle. Here, SIRT5 was observed to bind to cardiolipin via an amphipathic helix on itsN terminus. In vitro, succinyl-CoA was used to succinylate liver mitochondrial membrane proteins. SIRT5 largely reversed the succinyl-CoA-driven lysine succinylation. Quantitative mass spectrometry of SIRT5-treated membrane proteins pointed to the electron transport chain, particularly Complex I, as being highly targeted for desuccinylation by SIRT5. Correspondingly, SIRT5(-/)-HEK293 cells showed defects in both Complex I-and Complex II-driven respiration. In mouse liver, SIRT5 expression was observed to localize strictly to the periportal hepatocytes. However, homogenates prepared from whole SIRT5(-/)-liver did show reduced Complex II-driven respiration. The enzymatic activities of Complex II and ATP synthase were also significantly reduced. Three-dimensional modeling of Complex II suggested that several SIRT5-targeted lysine residues lie at the protein-lipid interface of succinate dehydrogenase subunit B. We postulate that succinylation at these sites may disrupt Complex II subunit-subunit interactions and electron transfer. Lastly, SIRT5(-/)-mice, like humans with Complex II deficiency, were found to have mild lactic acidosis. Our findings suggest that SIRT5 is targeted to protein complexes on the inner mitochondrial membrane via affinity for cardiolipin to promote respiratory chain function.	[Zhang, Yuxun; Bharathi, Sivakama S.; Lu, Jie; Maringer, Katherine V.; Sims-Lucas, Sunder; Prochownik, Edward V.; Goetzman, Eric S.] Univ Pittsburgh, Med Ctr, Dept Pediat, Sch Med,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Amgen Inc, Discovery Attribute Sci Prote & Prot Characteriza, San Francisco, CA 94080 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Buck Institute for Research on Aging; Amgen	Goetzman, ES (corresponding author), Univ Pittsburgh, Med Ctr, Dept Pediat, Sch Med,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA.	eric.goetzman@chp.edu			National Institutes of Health [DK090242, CA174713, DK096996, DK111165]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096996, R01DK090242, F32DK111165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK090242 (to E. S. G.), CA174713 (to E. V. P.), DK096996 (to S. S.-L.), and DK111165 (to K. V. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Dudek J, 2016, EMBO MOL MED, V8, P139, DOI 10.15252/emmm.201505644; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128561; Kashfi K, 2011, BIOCHEM SOC T, V39, P833, DOI 10.1042/BST0390833; Li F, 2015, MOL CELL, V60, P661, DOI 10.1016/j.molcel.2015.10.017; Marom M, 2011, J BIOL CHEM, V286, P43809, DOI 10.1074/jbc.M111.261040; Matsushita N, 2011, GENES CELLS, V16, P190, DOI 10.1111/j.1365-2443.2010.01475.x; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Munnik Teun, 2013, Methods Mol Biol, V1009, P253, DOI 10.1007/978-1-62703-401-2_23; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Uppala R, 2017, BIOCHEM BIOPH RES CO, V482, P346, DOI 10.1016/j.bbrc.2016.11.066; Vergeade A, 2016, MITOCHONDRION, V28, P88, DOI 10.1016/j.mito.2016.04.002; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; West DB, 2015, GENOME RES, V25, P598, DOI 10.1101/gr.184184.114; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643	33	62	61	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10239	10249		10.1074/jbc.M117.785022	http://dx.doi.org/10.1074/jbc.M117.785022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28458255	hybrid, Green Published			2022-12-28	WOS:000403580600032
J	Hwang, J; Walczak, CP; Shaler, TA; Olzmann, JA; Zhang, LC; Elias, JE; Kopito, RR				Hwang, Jiwon; Walczak, Christopher P.; Shaler, Thomas A.; Olzmann, James A.; Zhang, Lichao; Elias, Joshua E.; Kopito, Ron R.			Characterization of protein complexes of the endoplasmic reticulum-associated degradation E3 ubiquitin ligase Hrd1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ER PROTEIN; SEL1L; FORMS; RETROTRANSLOCATION; QUANTIFICATION; DISLOCATION; INHIBITION; EXPRESSION; COMPONENTS	Hrd1 is the core structural component of a large endoplasmic reticulum membrane-embedded protein complex that coordinates the destruction of folding-defective proteins in the early secretory pathway. Defining the composition, dynamics, and ultimately, the structure of the Hrd1 complex is a crucial step in understanding the molecular basis of glycoprotein quality control but has been hampered by the lack of suitable techniques to interrogate this complex under native conditions. In this study we used genome editing to generate clonal HEK293 (Hrd1. KI) cells harboring a homozygous insertion of a small tandem affinity tag knocked into the endogenous Hrd1 locus. We found that steady-state levels of tagged Hrd1 in these cells are indistinguishable from those of Hrd1 in unmodified cells and that the tagged variant is functional in supporting the degradation of well characterized luminal and membrane substrates. Analysis of detergent-solubilized Hrd1. KI cells indicates that the composition and stoichiometry of Hrd1 complexes are strongly influenced by Hrd1 expression levels. Analysis of affinity-captured Hrd1 complexes from these cells by size-exclusion chromatography, immunodepletion, and absolute quantification mass spectrometry identified two major high-molecular-mass complexes with distinct sets of interacting proteins and variable stoichiometries, suggesting a hitherto unrecognized heterogeneity in the functional units of Hrd1-mediated protein degradation.	[Hwang, Jiwon; Walczak, Christopher P.; Olzmann, James A.; Kopito, Ron R.] Stanford Univ, Dept Biol, Lorry Lokey Bldg,Rm 154,337 Campus Dr, Stanford, CA 94305 USA; [Zhang, Lichao; Elias, Joshua E.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Shaler, Thomas A.] SRI Int, Menlo Pk, CA 94025 USA; [Olzmann, James A.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Stanford University; Stanford University; SRI International; University of California System; University of California Berkeley	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Lorry Lokey Bldg,Rm 154,337 Campus Dr, Stanford, CA 94305 USA.	kopito@stanford.edu		Olzmann, James/0000-0001-7751-8316	National Institutes of Health [R01GM074874]; Ruth L. Kirschstein National Research Service Award [F32GM113378]; Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074874, F32GM113378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM074874 (to R. R. K.) and a Ruth L. Kirschstein National Research Service Award F32GM113378 (to C. P. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by an Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research, Inc. These authors contributed equally to this work.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grotzke JE, 2013, P NATL ACAD SCI USA, V110, P3393, DOI 10.1073/pnas.1300328110; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hagiwara M, 2016, MOL CELL, V63, P753, DOI 10.1016/j.molcel.2016.07.014; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2016, FEBS J, V283, P157, DOI 10.1111/febs.13564; Huang CH, 2014, J BIOL CHEM, V289, P4444, DOI 10.1074/jbc.M113.519561; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Kanapin A, 2003, GENOME RES, V13, P1335, DOI 10.1101/gr.978703; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Plemper RK, 1999, J CELL SCI, V112, P4123; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; ROSEVEAR P, 1980, BIOCHEMISTRY-US, V19, P4108, DOI 10.1021/bi00558a032; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Stevenson J, 2016, ANNU REV NUTR, V36, P511, DOI 10.1146/annurev-nutr-071715-051030; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tyler RE, 2012, MOL BIOL CELL, V23, P4668, DOI 10.1091/mbc.E12-06-0428; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	56	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9104	9116		10.1074/jbc.M117.785055	http://dx.doi.org/10.1074/jbc.M117.785055			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28411238	hybrid, Green Published			2022-12-28	WOS:000402538900009
J	Lassig, C; Hopfner, KP				Laessig, Charlotte; Hopfner, Karl-Peter			Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOUBLE-STRANDED-RNA; ANTIVIRAL INNATE IMMUNITY; E3 UBIQUITIN LIGASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SINGLETON-MERTEN SYNDROME; TUMOR-SUPPRESSOR CYLD; INDUCIBLE GENE-I; NF-KAPPA-B; STRUCTURAL BASIS; VIRAL-RNA	RIG-I-like receptors ( RLRs) are cytosolic innate immune sensors that detect pathogenic RNA and induce a systemic antiviral response. During the last decade, many studies focused on their molecular characterization and the identification of RNA agonists. Therefore, it became more and more clear that RLR activation needs to be carefully regulated, because constitutive signaling or detection of endogenous RNA through loss of specificity is detrimental. Here, we review the current understanding of RLR activation and selectivity. We specifically focus upon recent findings on the function of the helicase domain in discriminating between different RNAs, and whose malfunctioning causes serious autoimmune diseases.	[Laessig, Charlotte; Hopfner, Karl-Peter] Ludwig Maximilians Univ Munchen, Gene Ctr, D-81377 Munich, Germany; [Laessig, Charlotte; Hopfner, Karl-Peter] Ludwig Maximilians Univ Munchen, Dept Biochem, D-81377 Munich, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@genzentrum.lmu.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357; Lassig, Charlotte/0000-0001-6253-7880	German Research Foundation [HO2489/8]; German Excellence Initiative Grant CIPSM; German Excellence Initiative Grant QBM; Bavarian Ministry of Education (BioSysNet)	German Research Foundation(German Research Foundation (DFG)); German Excellence Initiative Grant CIPSM; German Excellence Initiative Grant QBM; Bavarian Ministry of Education (BioSysNet)	This work was supported by German Research Foundation Grant HO2489/8, German Excellence Initiative Grants CIPSM and QBM, and the Bavarian Ministry of Education (BioSysNet). The authors declare that they have no conflicts of interest with the contents of this article.	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Anchisi S, 2015, MBIO, V6, DOI 10.1128/mBio.02349-14; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Childs KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064202; Choi SJ, 2016, EMBO J, V35, P429, DOI 10.15252/embj.201592586; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170; David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005; Fitzgerald ME, 2017, NUCLEIC ACIDS RES, V45, P1442, DOI 10.1093/nar/gkw816; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Ghodke-Puranik Yogita, 2013, Int J Clin Rheumtol, V8, DOI 10.2217/ijr.13.58; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Ibsen MS, 2015, NUCLEIC ACIDS RES, V43, P5236, DOI 10.1093/nar/gkv389; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kuniyoshi K, 2014, P NATL ACAD SCI USA, V111, P5646, DOI 10.1073/pnas.1401674111; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lincez PJ, 2015, DIABETES, V64, P2184, DOI 10.2337/db14-1223; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Looney BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0656-8; Louber J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0166-9; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P896, DOI 10.1093/nar/gkv1299; Rawling DC, 2015, ELIFE, V4, DOI 10.7554/eLife.09391; Runge S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004081; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Uchikawa E, 2016, MOL CELL, V62, P586, DOI 10.1016/j.molcel.2016.04.021; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Vela A, 2012, J BIOL CHEM, V287, P42564, DOI 10.1074/jbc.M112.385146; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yan J, 2014, J MOL CELL BIOL, V6, P154, DOI 10.1093/jmcb/mju005; Yao H, 2015, MOL CELL, V58, P541, DOI 10.1016/j.molcel.2015.03.014; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang HX, 2013, P NATL ACAD SCI USA, V110, P6459, DOI 10.1073/pnas.1304432110; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhang XQ, 2016, J MED VIROL, V88, P712, DOI 10.1002/jmv.24376; Zouk H, 2014, AUTOIMMUNITY, V47, P40, DOI 10.3109/08916934.2013.832758; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979; Zurawek M, 2015, DIABETES RES CLIN PR, V107, P259, DOI 10.1016/j.diabres.2014.11.008	99	49	49	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9000	9009		10.1074/jbc.R117.788398	http://dx.doi.org/10.1074/jbc.R117.788398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28411239	hybrid, Green Published			2022-12-28	WOS:000402538900001
J	Rotwein, P				Rotwein, Peter			Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-BINDING-PROTEINS; FACTOR-I; POSTNATAL-GROWTH; HOMOZYGOUS MUTATION; RECEPTOR; STATURE; PATIENT; AXIS; GENE; EVOLUTION	The insulin-like growth factors IGF1 and IGF2 are closely related proteins that are essential for normal growth and development in humans and other species and play critical roles in many physiological and pathophysiological processes. IGF actions are mediated by transmembrane receptors and modulated by IGF-binding proteins. The importance of IGF actions in human physiology is strengthened by the rarity of inactivating mutations in their genes and by the devastating impact caused by such mutations on normal development and somatic growth. Large-scale genome sequencing has the potential to provide new insights into human variation and disease susceptibility. Toward this end, the availability of DNA sequence data from 60,706 people through the Exome Aggregation Consortium has prompted the analyses presented here. Results reveal a broad range of potential missense and other alterations in the coding regions of every IGF family gene, but the vast majority of predicted changes were uncommon. The total number of different alleles detected per gene in the population varied over an similar to 15fold range, from 57 for IGF1 to 872 for IGF2R, although when corrected for protein length the rate ranged from 0.22 to 0.59 changes/codon among the 11 genes evaluated. Previously characterized disease-causing mutations in IGF2, IGF1R, IGF2R, or IGFALS all were found in the general population but with allele frequencies of < 1: 30,000. A few new highly prevalent amino acid polymorphisms were also identified. Collectively, these data provide a wealth of opportunities to understand the intricacies of IGF signaling and action in both physiological and pathological contexts.	[Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA		Rotwein, P (corresponding author), Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK042748-26]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grant R01 DK042748-26 (to P.R.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Bach LA, 2015, PEDIATR ENDOCR REV P, V13, P521; Bach LA, 2015, BEST PRACT RES CL EN, V29, P713, DOI 10.1016/j.beem.2015.06.002; Bahcall OG, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.121; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Baserga R, 2013, J CELL PHYSIOL, V228, P675, DOI 10.1002/jcp.24217; Batey L, 2014, J CLIN ENDOCR METAB, V99, pE153, DOI 10.1210/jc.2013-3106; Baxter RC, 2001, HORM RES, V55, P68, DOI 10.1159/000063479; Baxter RC, 2001, BEST PRACT RES CL EN, V15, P421, DOI 10.1053/beem.2001.0161; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Burkhardt S, 2015, J PEDIATR ENDOCR MET, V28, P217, DOI 10.1515/jpem-2014-0132; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Dauber A, 2014, J CLIN ENDOCR METAB, V99, P3080, DOI 10.1210/jc.2014-1506; David A, 2012, J MOL ENDOCRINOL, V49, P213, DOI 10.1530/JME-12-0086; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; Domene HM, 2011, BEST PRACT RES CL EN, V25, P101, DOI 10.1016/j.beem.2010.08.010; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Fuqua JS, 2012, HORM RES PAEDIAT, V78, P59, DOI 10.1159/000337249; Gannage-Yared MH, 2013, EUR J ENDOCRINOL, V168, pK1, DOI 10.1530/EJE-12-0701; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hoeflich A, 2015, BEST PRACT RES CL EN, V29, P685, DOI 10.1016/j.beem.2015.07.002; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Killian JK, 2001, HUM MUTAT, V18, P25, DOI 10.1002/humu.1146; Klammt J, 2011, BEST PRACT RES CL EN, V25, P191, DOI 10.1016/j.beem.2010.09.012; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kruger RP, 2016, CELL, V167, P289, DOI 10.1016/j.cell.2016.09.040; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Netchine I, 2011, BEST PRACT RES CL EN, V25, P181, DOI 10.1016/j.beem.2010.08.005; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Poukoulidou T, 2014, HORM RES PAEDIAT, V81, P422, DOI 10.1159/000358329; Prontera P, 2015, HUM MUTAT, V36, P1043, DOI 10.1002/humu.22853; Quintana-Murci L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1093-y; Ranke MB, 2015, BEST PRACT RES CL EN, V29, P701, DOI 10.1016/j.beem.2015.06.003; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Savage MO, 2010, CLIN ENDOCRINOL, V72, P721, DOI 10.1111/j.1365-2265.2009.03775.x; Schwartz TS, 2016, INTEGR COMP BIOL, V56, P171, DOI 10.1093/icb/icw046; Scott CD, 2015, BEST PRACT RES CL EN, V29, P723, DOI 10.1016/j.beem.2015.08.001; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; van Duyvenvoorde HA, 2010, J CLIN ENDOCR METAB, V95, pE363, DOI 10.1210/jc.2010-0511; Vattathil S, 2015, CELL, V163, P281, DOI 10.1016/j.cell.2015.09.042; Walenkamp MJE, 2013, ENDOCR DEV, V24, P128, DOI 10.1159/000342841; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Zou J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13293	67	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9252	9261		10.1074/jbc.M117.783639	http://dx.doi.org/10.1074/jbc.M117.783639			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28389567	hybrid, Green Published			2022-12-28	WOS:000402538900020
J	Martinez-Munoz, GA; Kane, P				Martinez-Munoz, Gloria A.; Kane, Patricia			Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast (vol 283, pg 2030, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction												martiangymzfr57@gmail.com						Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200	1	1	1	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7743	7743		10.1074/jbc.A117.710470	http://dx.doi.org/10.1074/jbc.A117.710470			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28500239	Green Published, hybrid			2022-12-28	WOS:000401154100004
J	De Nardis, C; Hendriks, LJA; Poirier, E; Arvinte, T; Gros, P; Bakker, ABH; de Kruif, J				De Nardis, Camilla; Hendriks, Linda J. A.; Poirier, Emilie; Arvinte, Tudor; Gros, Piet; Bakker, Alexander B. H.; de Kruif, John			A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; RECOGNITION; ASSEMBLIES; STRATEGIES; BINDING; MODELS	Bispecific antibodies combine two different antigen-binding sites in a single molecule, enabling more specific targeting, novel mechanisms of action, and higher clinical efficacies. Although they have the potential to outperform conventional monoclonal antibodies, many bispecific antibodies have issues regarding production, stability, and pharmacokinetic properties. Here, we describe a new approach for generating bispecific antibodies using a common light chain format and exploiting the stable architecture of human immunoglobulin G(1). We used iterative experimental validation and computational modeling to identify multiple Fc variant pairs that drive efficient heterodimerization of the antibody heavy chains. Accelerated stability studies enabled selection of one Fc variant pair dubbed "DEKK" consisting of substitutions L351D and L368E in one heavy chain combined with L351K and T366K in the other. Solving the crystal structure of the DEKK Fc region at a resolution of 2.3 angstrom enabled detailed analysis of the interactions inducing CH3 interface heterodimerization. Local shifts in the IgG backbone accommodate the introduction of lysine side chains that form stabilizing salt-bridge interactions with substituted and native residues in the opposite chain. Overall, the CH3 domain adapted to these shifts at the interface, yielding a stable Fc conformation very similar to that in wild-type IgG. Using the DEKK format, we generated the bispecific antibody MCLA-128, targeting human EGF receptors 2 and 3. MCLA-128 could be readily produced and purified at industrial scale with a standard mammalian cell culture platform and a routine purification protocol. Long-term accelerated stability assays confirmed that MCLA-128 is highly stable and has excellent biophysical characteristics.	[De Nardis, Camilla; Gros, Piet] Univ Utrecht, Crystal & Struct Chem Grp, Bijvoet Ctr Biomol Res, Dept Chem,Fac Sci, NL-3584 CH Utrecht, Netherlands; [Hendriks, Linda J. A.; Bakker, Alexander B. H.; de Kruif, John] Merus NV, NL-3584 CM Utrecht, Netherlands; [Poirier, Emilie; Arvinte, Tudor] Therapeomic Inc, CH-4002 Basel, Switzerland; [Arvinte, Tudor] Univ Geneva, CH-1211 Geneva, Switzerland	Utrecht University; University of Geneva	de Kruif, J (corresponding author), Merus NV, NL-3584 CM Utrecht, Netherlands.	j.dekruif@merus.nl	Gros, Piet/AAD-6452-2019	Gros, Piet/0000-0002-7782-2585	BioStruct-X Grant, European Union [283570]	BioStruct-X Grant, European Union	This work was supported by BioStruct-X Grant 283570 embedded in the European Union's Seventh Framework Programme FP7/2007-2013. L. H., A. B., and J. d. K. are employees and shareholders of Merus N.V.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; de Kruif J, 2010, BIOTECHNOL BIOENG, V106, P741, DOI 10.1002/bit.22763; de Kruif J, 2009, J MOL BIOL, V387, P548, DOI 10.1016/j.jmb.2009.02.009; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Demeule B, 2007, BBA-PROTEINS PROTEOM, V1774, P146, DOI 10.1016/j.bbapap.2006.10.010; Demeule B, 2007, INT J PHARMACEUT, V329, P37, DOI 10.1016/j.ijpharm.2006.08.024; Demeule B, 2009, MABS-AUSTIN, V1, P142, DOI 10.4161/mabs.1.2.7632; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Ha JH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00394; Heskamp S, 2012, MOL PHARMACEUT, V9, P2314, DOI 10.1021/mp300232n; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Kabat EA, 1991, SEQUENCES PROTEINS I; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leaver-Fay A, 2016, STRUCTURE, V24, P641, DOI 10.1016/j.str.2016.02.013; Mason M, 2012, BIOTECHNOL PROGR, V28, P846, DOI 10.1002/btpr.1542; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER S, 1990, J MOL BIOL, V216, P965, DOI 10.1016/S0022-2836(99)80014-X; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Siberil S, 2012, IMMUNOL LETT, V143, P60, DOI 10.1016/j.imlet.2012.02.002; Silva-Martin N, 2014, STRUCTURE, V22, P1595, DOI 10.1016/j.str.2014.09.001; Smith EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17943; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014	33	21	27	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14706	14717		10.1074/jbc.M117.793497	http://dx.doi.org/10.1074/jbc.M117.793497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28655766	Green Published, hybrid			2022-12-28	WOS:000408747500035
J	Jorge-Finnigan, A; Kleppe, R; Jung-KC, K; Ying, M; Marie, M; Rios-Mondragon, I; Salvatore, MF; Saraste, J; Martinez, A				Jorge-Finnigan, Ana; Kleppe, Rune; Jung-KC, Kunwar; Ying, Ming; Marie, Michael; Rios-Mondragon, Ivan; Salvatore, Michael F.; Saraste, Jaakko; Martinez, Aurora			Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						confocal microscopy; dopamine; Parkinson disease; phosphorylation; vesicles; axonal transport; tyrosine hydroxylase phosphorylated at Ser-31; tyrosine hydroxylase	VESICULAR MONOAMINE TRANSPORTER-2; SITE-SPECIFIC PHOSPHORYLATION; CHAPERONE HSC70 INTERACTS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; AXONAL-TRANSPORT; IN-SITU; CATECHOLAMINE BIOSYNTHESIS; GOLGI FRAGMENTATION; SYNAPTIC VESICLES	Tyrosine hydroxylase (TH) catalyzes the conversion of l-tyrosine into l-DOPA, which is the rate-limiting step in the synthesis of catecholamines, such as dopamine, in dopaminergergic neurons. Low dopamine levels and death of the dopaminergic neurons are hallmarks of Parkinson's disease (PD), where -synuclein is also a key player. TH is highly regulated, notably by phosphorylation of several Ser/Thr residues in the N-terminal tail. However, the functional role of TH phosphorylation at the Ser-31 site (THSer(P)-31) remains unclear. Here, we report that THSer(P)-31 co-distributes with the Golgi complex and synaptic-like vesicles in rat and human dopaminergic cells. We also found that the TH microsomal fraction content decreases after inhibition of cyclin-dependent kinase 5 (Cdk5) and ERK1/2. The cellular distribution of an overexpressed phospho-null mutant, TH1-S31A, was restricted to the soma of neuroblastoma cells, with decreased association with the microsomal fraction, whereas a phospho-mimic mutant, TH1-S31E, was distributed throughout the soma and neurites. TH1-S31E associated with vesicular monoamine transporter 2 (VMAT2) and -synuclein in neuroblastoma cells, and endogenous THSer(P)-31 was detected in VMAT2- and -synuclein-immunoprecipitated mouse brain samples. Microtubule disruption or co-transfection with -synuclein A53T, a PD-associated mutation, caused TH1-S31E accumulation in the cell soma. Our results indicate that Ser-31 phosphorylation may regulate TH subcellular localization by enabling its transport along microtubules, notably toward the projection terminals. These findings disclose a new mechanism of TH regulation by phosphorylation and reveal its interaction with key players in PD, opening up new research avenues for better understanding dopamine synthesis in physiological and pathological states.	[Jorge-Finnigan, Ana; Kleppe, Rune; Jung-KC, Kunwar; Ying, Ming; Rios-Mondragon, Ivan; Saraste, Jaakko; Martinez, Aurora] Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Jorge-Finnigan, Ana; Kleppe, Rune; Jung-KC, Kunwar; Martinez, Aurora] KG Jebsen Ctr Neuropsychiat Disorders, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Marie, Michael] Univ Bergen, Dept Mol Biol, Thormohlensgaten 55, N-5020 Bergen, Norway; [Salvatore, Michael F.] Univ North Texas, Hlth Sci Ctr, Inst Hlth Aging, Ft Worth, TX 76107 USA	University of Bergen; University of Bergen; University of North Texas System; University of North Texas Denton	Jorge-Finnigan, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.; Jorge-Finnigan, A (corresponding author), KG Jebsen Ctr Neuropsychiat Disorders, Jonas Lies Vei 91, N-5009 Bergen, Norway.	ana.jorge-finnigan@uib.no	Martinez, Aurora/M-3088-2019; Salvatore, Michael/ABC-8926-2021	Martinez, Aurora/0000-0003-1643-6506; Kleppe, Rune/0000-0002-6086-755X; K C, Kunwar Jung/0000-0002-6745-7318	Research Council of Norway [FRIMEDBIO 214012]; K. G. Jebsen Foundation; Norwegian Research Council [Yggdrasil 210731]; Fundacion Ramon Areces; Helse Vest; European Union Marie Curie IF Program [PIEF-GA-2011-299972]	Research Council of Norway(Research Council of Norway); K. G. Jebsen Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Fundacion Ramon Areces; Helse Vest; European Union Marie Curie IF Program	This work was supported by Research Council of Norway Grant FRIMEDBIO 214012 and the K. G. Jebsen Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Norwegian Research Council (Yggdrasil 210731), Fundacion Ramon Areces, Helse Vest, and European Union Marie Curie IF Program Grant PIEF-GA-2011-299972. To whom correspondence should be addressed. E-mail: ana. jorge-finnigan@uib.no.	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Alter SP, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0362-3; Alvarez D, 2003, BIOCHEMISTRY-US, V42, P7205, DOI 10.1021/bi027343p; Bellucci A, 2012, BRAIN RES, V1476, P183, DOI 10.1016/j.brainres.2012.04.014; BRIMIJOIN S, 1977, BRAIN RES, V121, P77, DOI 10.1016/0006-8993(77)90439-5; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; CLEMENTI E, 1992, EUR J NEUROSCI, V4, P944, DOI 10.1111/j.1460-9568.1992.tb00121.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dobransky T, 2005, J NEUROCHEM, V95, P305, DOI 10.1111/j.1471-4159.2005.03367.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Encalada SE, 2014, ANNU REV BIOPHYS, V43, P141, DOI 10.1146/annurev-biophys-051013-022746; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Gervasi NM, 2016, RNA, V22, P883, DOI 10.1261/rna.053272.115; Gottle M, 2013, J NEUROCHEM, V127, P805, DOI 10.1111/jnc.12366; Gondre-Lewis MC, 2012, INT REV CEL MOL BIO, V299, P27, DOI 10.1016/B978-0-12-394310-1.00002-3; Gordon SL, 2009, BBA-MOL CELL RES, V1793, P1860, DOI 10.1016/j.bbamcr.2009.10.001; Groblewski PA, 2011, BEHAV BRAIN RES, V217, P399, DOI 10.1016/j.bbr.2010.11.018; Guo JT, 2008, CELL MOL NEUROBIOL, V28, P35, DOI 10.1007/s10571-007-9227-0; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Harada K, 1996, J NEUROCHEM, V67, P629; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; Haycock JW, 2002, J NEUROCHEM, V81, P947, DOI 10.1046/j.1471-4159.2002.00881.x; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; ICHIKAWA S, 1990, BIOCHEM BIOPH RES CO, V173, P1331, DOI 10.1016/S0006-291X(05)80933-7; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Kleppe R, 2014, MOL CELL PROTEOMICS, V13, P2017, DOI 10.1074/mcp.M113.035709; Koch JC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.169; KOIKE T, 1984, J NEUROCHEM, V42, P1472, DOI 10.1111/j.1471-4159.1984.tb02812.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korner G, 2015, BRAIN, V138, P2948, DOI 10.1093/brain/awv224; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Miranda-Barrientos J, 2014, ASN NEURO, V6, DOI 10.1042/AN20140006; MITCHELL JP, 1990, J BIOL CHEM, V265, P22358; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Nakashima A, 2011, BIOCHEM BIOPH RES CO, V407, P343, DOI 10.1016/j.bbrc.2011.03.020; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Parra LA, 2016, J BIOL CHEM, V291, P17510, DOI 10.1074/jbc.M116.728782; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pifl C, 2014, J NEUROSCI, V34, P8210, DOI 10.1523/JNEUROSCI.5456-13.2014; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prado VF, 2013, BIOCHEM J, V450, P265, DOI 10.1042/BJ20121662; Requena DF, 2009, J NEUROCHEM, V110, P581, DOI 10.1111/j.1471-4159.2009.06135.x; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2014, J NEUROCHEM, V129, P548, DOI 10.1111/jnc.12652; Salvatore MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029867; Salvatore MF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008466; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Sun KH, 2008, MOL BIOL CELL, V19, P3052, DOI 10.1091/mbc.E07-11-1106; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; TERLAND O, 1980, BIOCHIM BIOPHYS ACTA, V597, P318, DOI 10.1016/0005-2736(80)90109-1; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; van Rijn RM, 2006, MOL PHARMACOL, V70, P604, DOI 10.1124/mol.105.020818; Wijemanne S, 2015, NAT REV NEUROL, V11, P414, DOI 10.1038/nrneurol.2015.86; Willemsen MA, 2010, BRAIN, V133, P1810, DOI 10.1093/brain/awq087; WOOTEN GF, 1973, J NEUROCHEM, V20, P1361, DOI 10.1111/j.1471-4159.1973.tb00248.x; Ying M, 2000, J CELL SCI, V113, P3623; Zatloukal B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096690	76	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14092	14107		10.1074/jbc.M116.762344	http://dx.doi.org/10.1074/jbc.M116.762344			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28637871	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000408439800016
J	Singh, NK; Janjanam, J; Rao, GN				Singh, Nikhlesh K.; Janjanam, Jagadeesh; Rao, Gadiparthi N.			p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell proliferation; guanine nucleotide exchange factor (GEF); NFAT transcription factor; vascular smooth muscle cells	MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXCHANGE FACTOR ARHGEF1; NEOINTIMAL HYPERPLASIA; ANGIOTENSIN-II; VAV PHOSPHORYLATION; TYROSINE KINASE; RHOA; GROWTH; RECRUITMENT; EXPRESSION	Although the involvement of Rho proteins in the pathogenesis of vascular diseases is well studied, little is known about the role of their upstream regulators, the Rho guanine nucleotide exchange factors (RhoGEFs). Here, we sought to identify the RhoGEFs involved in monocyte chemotactic protein 1 (MCP1)-induced vascular wall remodeling. We found that, among the RhoGEFs tested, MCP1 induced tyrosine phosphorylation of p115 RhoGEF but not of PDZ RhoGEF or leukemia-associated RhoGEF in human aortic smooth muscle cells (HASMCs). Moreover, p115 RhoGEF inhibition suppressed MCP1-induced HASMC migration and proliferation. Consistent with these observations, balloon injury (BI) induced p115 RhoGEF tyrosine phosphorylation in rat common carotid arteries, and siRNA-mediated down-regulation of its levels substantially attenuated BI-induced smooth muscle cell migration and proliferation, resulting in reduced neointima formation. Furthermore, depletion of p115 RhoGEF levels also abrogated MCP1- or BI-induced Rac1-NFATc1-cyclin D1-CDK6-PKN1-CDK4-PAK1 signaling, which, as we reported previously, is involved in vascular wall remodeling. Our findings also show that protein kinase N1 (PKN1) downstream of Rac1-cyclin D1/CDK6 and upstream of CDK4-PAK1 in the p115 RhoGEF-Rac1-NFATc1-cyclin D1-CDK6-PKN1-CDK4-PAK1 signaling axis is involved in the modulation of vascular wall remodeling. Of note, we also observed that CCR2-G(i/o)-Fyn signaling mediates MCP1-induced p115 RhoGEF and Rac1 GTPase activation. These findings suggest that p115 RhoGEF is critical for MCP1-induced HASMC migration and proliferation in vitro and for injury-induced neointima formation in vivo by modulating Rac1-NFATc1-cyclin D1-CDK6-PKN1-CDK4-PAK1 signaling.	[Singh, Nikhlesh K.; Janjanam, Jagadeesh; Rao, Gadiparthi N.] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 71 S Manassas St, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Singh, NK; Rao, GN (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 71 S Manassas St, Memphis, TN 38163 USA.	nsingh2@uthsc.edu; rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020	Singh, Nikhlesh/0000-0002-3665-6023	NHLBI, National Institutes of Health [HL069908, HL064165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165, R01HL069908] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL069908 and HL064165 (to G. N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Carbone ML, 2015, HYPERTENSION, V65, P1273, DOI 10.1161/HYPERTENSIONAHA.114.05065; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Dronadula N, 2005, J BIOL CHEM, V280, P3112, DOI 10.1074/jbc.M409739200; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Fabbiano S, 2014, MOL CELL BIOL, V34, P4404, DOI 10.1128/MCB.01066-14; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Fu CH, 2012, ARTERIOSCL THROM VAS, V32, P2418, DOI 10.1161/ATVBAHA.112.255786; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Gadepalli R, 2012, ARTERIOSCL THROM VAS, V32, P2652, DOI 10.1161/ATVBAHA.112.253112; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hilgers RHP, 2007, J HYPERTENS, V25, P1687, DOI 10.1097/HJH.0b013e32816f778d; Huang JY, 2000, P NATL ACAD SCI USA, V97, P10923, DOI 10.1073/pnas.97.20.10923; IKEDA U, 1995, AM J PHYSIOL-HEART C, V268, pH1021, DOI 10.1152/ajpheart.1995.268.3.H1021; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janjanam J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28687; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P22150, DOI 10.1074/jbc.M113.454082; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Singh NK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8450; Singh NK, 2012, J BIOL CHEM, V287, P36291, DOI 10.1074/jbc.M112.361220; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tonami K, 2011, J CELL SCI, V124, P1214, DOI 10.1242/jcs.072561; Turner EC, 2011, J BIOL CHEM, V286, P15440, DOI 10.1074/jbc.M110.181180; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Ying ZK, 2004, AM J HYPERTENS, V17, P981, DOI 10.1016/j.amjhyper.2004.05.006; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	55	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14080	14091		10.1074/jbc.M117.777896	http://dx.doi.org/10.1074/jbc.M117.777896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28655771	Green Published, hybrid			2022-12-28	WOS:000408439800015
J	Lima, KM; Vago, JP; Caux, TR; Negreiros-Lima, GL; Sugimoto, MA; Tavares, LP; Arribada, RG; Carmo, AAF; Galvao, I; Costa, BRC; Soriani, FM; Pinho, V; Solito, E; Perretti, M; Teixeira, MM; Sousa, LP				Lima, Katia M.; Vago, Juliana P.; Caux, Thais R.; Negreiros-Lima, Graziele Leticia; Sugimoto, Michelle A.; Tavares, Luciana P.; Arribada, Raquel G.; Carmo, Aline Alves F.; Galvao, Izabela; Costa, Bruno Rocha C.; Soriani, Frederico M.; Pinho, Vanessa; Solito, Egle; Perretti, Mauro; Teixeira, Mauro M.; Sousa, Lirlndia P.			The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FORMYL PEPTIDE RECEPTOR; 2/LIPOXIN A(4) RECEPTOR; NITRIC-OXIDE SYNTHASE; NEUTROPHIL APOPTOSIS; PROTEIN-KINASE; LIPOCORTIN 1; NUCLEOTIDE PHOSPHODIESTERASES; SIGNALING PATHWAY; DOWN-REGULATION	Annexin A1 (AnxA1) is a glucocorticoid-regulated protein known for its anti-inflammatory and pro-resolving effects. We have shown previously that the cAMP-enhancing compounds rolipram (ROL; a PDE4 inhibitor) and Bt(2)cAMP (a cAMP mimetic) drive caspase-dependent resolution of neutrophilic inflammation. In this follow-up study, we investigated whether AnxA1 could be involved in the pro-resolving properties of these compounds using a model of LPS-induced inflammation in BALB/c mice. The treatment with ROL or Bt(2)cAMP at the peak of inflammation shortened resolution intervals, improved resolution indices, and increased AnxA1 expression. In vitro studies showed that ROL and Bt(2)cAMP induced AnxA1 expression and phosphorylation, and this effect was prevented by PKA inhibitors, suggesting the involvement of PKA in ROL-induced AnxA1 expression. Akin to these in vitro findings, H89 prevented ROL- and Bt(2)cAMP-induced resolution of inflammation, and it was associated with decreased levels of intact AnxA1. Moreover, two different strategies to block the AnxA1 pathway (by using N-t-Boc-Met-Leu-Phe, a nonselective AnxA1 receptor antagonist, or by using an anti-AnxA1 neutralizing antiserum) prevented ROL-and Bt(2)cAMP-induced resolution and neutrophil apoptosis. Likewise, the ability of ROL or Bt(2)cAMP to induce neutrophil apoptosis was impaired in AnxA-knock-out mice. Finally, in in vitro settings, ROL and Bt(2)cAMP overrode the survival-inducing effect of LPS in human neutrophils in an AnxA1-dependent manner. Our results show that AnxA1 is at least one of the endogenous determinants mediating the pro-resolving properties of cAMP-elevating agents and cAMP-mimetic drugs.	[Lima, Katia M.; Vago, Juliana P.; Pinho, Vanessa; Sousa, Lirlndia P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Programa Posgrad Biol Celular, BR-31270901 Belo Horizonte, MG, Brazil; [Lima, Katia M.; Vago, Juliana P.; Caux, Thais R.; Negreiros-Lima, Graziele Leticia; Sugimoto, Michelle A.; Tavares, Luciana P.; Arribada, Raquel G.; Carmo, Aline Alves F.; Costa, Bruno Rocha C.; Pinho, Vanessa; Sousa, Lirlndia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, BR-31270901 Belo Horizonte, MG, Brazil; [Lima, Katia M.; Vago, Juliana P.; Caux, Thais R.; Negreiros-Lima, Graziele Leticia; Sugimoto, Michelle A.; Tavares, Luciana P.; Arribada, Raquel G.; Carmo, Aline Alves F.; Galvao, Izabela; Costa, Bruno Rocha C.; Pinho, Vanessa; Teixeira, Mauro M.; Sousa, Lirlndia P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, BR-31270901 Belo Horizonte, MG, Brazil; [Soriani, Frederico M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Genet, BR-31270901 Belo Horizonte, MG, Brazil; [Solito, Egle; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of London; Queen Mary University London	Sousa, LP (corresponding author), Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	lipsousa72@gmail.com	Pinho, Vanessa/AAR-1686-2021; Sugimoto, Michelle Amantea/ABB-2024-2020; Pinho, Vanessa/GXM-8532-2022; pinho, vanessa/AAC-8437-2020; DA SILVA, JULIANA PRISCILA VAGO/F-7386-2019; Soriani, Frederico M/A-8896-2013; Teixeira, Mauro M/A-4587-2008	Sugimoto, Michelle Amantea/0000-0002-4527-6065; pinho, vanessa/0000-0003-1038-2324; DA SILVA, JULIANA PRISCILA VAGO/0000-0001-8188-3738; Soriani, Frederico M/0000-0003-4720-6746; Teixeira, Mauro M/0000-0002-6944-3008; Padua Tavares, Luciana/0000-0002-5319-0210; Negreiros Lima, Graziele/0000-0001-7212-6006; Solito, Egle/0000-0001-5279-0049	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais-PRPq, Brazil; European Community [HEALTH-F4-2011-281608]; William Harvey Research Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais-PRPq, Brazil; European Community(European Commission); William Harvey Research Foundation	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil), Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais-PRPq, Brazil, and the European Community's Seventh Framework Programme (FP7-2007-2013) under Grant Agreement HEALTH-F4-2011-281608. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the William Harvey Research Foundation.	Ahmad F, 2015, ORAL DIS, V21, pE25, DOI 10.1111/odi.12275; Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Antonicelli F, 2001, EUR J BIOCHEM, V268, P62, DOI 10.1046/j.1432-1327.2001.01840.x; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246; Brancaleone V, 2011, J IMMUNOL, V186, P4905, DOI 10.4049/jimmunol.1003145; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Castro-Caldas M, 2003, MEDIAT INFLAMM, V12, P329, DOI 10.1080/09629350310001633351; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089; Ding L, 2016, SCI REP-UK, V6, DOI 10.1038/srep34374; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Ferlazzo V, 2003, INT IMMUNOPHARMACOL, V3, P1363, DOI 10.1016/S1567-5769(03)00133-4; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354; Getting SJ, 1997, BRIT J PHARMACOL, V120, P1075, DOI 10.1038/sj.bjp.0701029; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Lucas CD, 2013, FASEB J, V27, P1084, DOI 10.1096/fj.12-218990; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Minghetti L, 1999, BRIT J PHARMACOL, V126, P1307, DOI 10.1038/sj.bjp.0702423; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Montero J, 2016, FISH SHELLFISH IMMUN, V55, P632, DOI 10.1016/j.fsi.2016.06.044; Montero-Melendez T, 2013, CELL DEATH DIFFER, V20, P567, DOI 10.1038/cdd.2012.154; Montero-Melendez T, 2011, AM J PATHOL, V179, P259, DOI 10.1016/j.ajpath.2011.03.042; Murphy MP, 2015, IMMUNOL RES, V62, P225, DOI 10.1007/s12026-015-8655-z; Nadkarni S, 2011, ARTERIOSCL THROM VAS, V31, P2749, DOI 10.1161/ATVBAHA.111.235176; Oh J, 2000, FEBS LETT, V477, P244, DOI 10.1016/S0014-5793(00)01812-3; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Parkkonen J, 2008, PULM PHARMACOL THER, V21, P499, DOI 10.1016/j.pupt.2007.11.003; Parvathenani LK, 1998, J BIOL CHEM, V273, P6736, DOI 10.1074/jbc.273.12.6736; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Rossi AG, 1995, BIOCHEM BIOPH RES CO, V217, P892, DOI 10.1006/bbrc.1995.2855; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schudt C, 2011, HANDB EXP PHARMACOL, V204, P1, DOI 10.1007/978-3-642-17969-3_1; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Shishikura K, 2016, BRIT J PHARMACOL, V173, P319, DOI 10.1111/bph.13373; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Sousa LP, 2009, BIOCHEM PHARMACOL, V78, P396, DOI 10.1016/j.bcp.2009.04.030; Sousa LP, 2013, CURR OPIN PHARMACOL, V13, P625, DOI 10.1016/j.coph.2013.03.007; Sousa LP, 2005, BIOCHEM BIOPH RES CO, V337, P1065, DOI 10.1016/j.bbrc.2005.09.154; Souza DG, 2005, BRIT J PHARMACOL, V145, P246, DOI 10.1038/sj.bjp.0706190; Tabe Y, 2007, CELL DEATH DIFFER, V14, P1443, DOI 10.1038/sj.cdd.4402139; Takahashi HK, 2009, J PHARMACOL EXP THER, V331, P656, DOI 10.1124/jpet.109.157594; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; Taylor AD, 2000, ENDOCRINOLOGY, V141, P2209, DOI 10.1210/en.141.6.2209; Teixeira MM, 1997, BRIT J PHARMACOL, V121, P77, DOI 10.1038/sj.bjp.0701107; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tiwari S, 2004, BLOOD, V103, P2661, DOI 10.1182/blood-2003-06-2154; Vago JP, 2016, J IMMUNOL, V196, P1922, DOI 10.4049/jimmunol.1500886; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; WU CC, 1995, P NATL ACAD SCI USA, V92, P3473, DOI 10.1073/pnas.92.8.3473; Yang JH, 2012, EXP NEUROL, V236, P199, DOI 10.1016/j.expneurol.2012.05.008; Yazid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058963; Yazid S, 2010, ARTERIOSCL THROM VAS, V30, P1718, DOI 10.1161/ATVBAHA.110.209536; Yazid S, 2009, BIOCHEM PHARMACOL, V77, P1814, DOI 10.1016/j.bcp.2009.03.010	78	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13758	13773		10.1074/jbc.M117.800391	http://dx.doi.org/10.1074/jbc.M117.800391			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655761	Green Published, hybrid			2022-12-28	WOS:000407942400015
J	Trautz, B; Wiedemann, H; Luchtenborg, C; Pierini, V; Kranich, J; Glass, B; Krausslich, HG; Brocker, T; Pizzato, M; Ruggieri, A; Brugger, B; Fackler, OT				Trautz, Birthe; Wiedemann, Hannah; Luechtenborg, Christian; Pierini, Virginia; Kranich, Jan; Glass, Barbel; Kreausslich, Hans-Georg; Brocker, Thomas; Pizzato, Massimo; Ruggieri, Alessia; Bruegger, Britta; Fackler, Oliver T.			The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHOTGUN MASS-SPECTROMETRY; PATHOGENICITY FACTOR NEF; HEPATITIS-C VIRUS; NF-KAPPA-B; PHOSPHATIDYLSERINE RECEPTORS; IMMUNOLOGICAL SYNAPSE; LACTADHERIN BINDS; T-CELLS; MEMBRANE	The host-cell restriction factor SERINC5 potently suppresses the infectivity of HIV, type 1 (HIV-1) particles, and is counteracted by the viral pathogenesis factor Nef. However, the molecular mechanism by which SERINC5 restricts HIV-1 particle infectivity is still unclear. Because SERINC proteins have been suggested to facilitate the incorporation of serine during the biosynthesis of membrane lipids and because lipid composition of HIV particles is a major determinant of the infectious potential of the particles, we tested whether SERINC5-mediated restriction of HIV particle infectivity involves alterations of membrane lipid composition. We produced and purified HIV-1 particles from SERINC5293T cells with very low endogenous SERINC5 levels under conditions in which ectopically expressed SERINC5 restricts HIV-1 infectivity and is antagonized by Nef and analyzed both virions and producer cells with quantitative lipid MS. SERINC5 restriction and Nef antagonism were not associated with significant alterations in steady-state lipid composition of producer cells and HIV particles. Sphingosine metabolism kinetics were also unaltered by SERINC5 expression. Moreover, the levels of phosphatidylserine on the surface of HIV-1 particles, which may trigger uptake into non-productive internalization pathways in target cells, did not change upon expression of SERINC5 or Nef. Finally, saturating the phosphatidylserine-binding sites on HIV target cells did not affect SERINC5 restriction or Nef antagonism. These results demonstrate that the restriction of HIV-1 particle infectivity by SERINC5 does not depend on alterations in lipid composition and organization of HIV-1 particles and suggest that channeling serine into lipid biosynthesis may not be a cardinal cellular function of SERINC5.	[Trautz, Birthe; Pierini, Virginia; Fackler, Oliver T.] Univ Hosp Heidelberg, Dept Infect Dis, Integrat Virol, INF 324, D-69120 Heidelberg, Germany; [Glass, Barbel; Kreausslich, Hans-Georg] Univ Hosp Heidelberg, Dept Infect Dis, Virol, INF 324, D-69120 Heidelberg, Germany; [Wiedemann, Hannah; Luechtenborg, Christian; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, INF 328, D-69120 Heidelberg, Germany; [Ruggieri, Alessia] Univ Hosp Heidelberg, Dept Infect Dis, Mol Virol, INF 345, D-69120 Heidelberg, Germany; [Pizzato, Massimo] Univ Trento, Ctr Integrat Biol, I-38122 Trento, Italy; [Kranich, Jan; Brocker, Thomas] Ludwig Maximilians Univ Munchen, Inst Immunol, Grosshardener Str 9, D-82152 Planegg Martinsried, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Trento; University of Munich	Fackler, OT (corresponding author), Univ Hosp Heidelberg, Dept Infect Dis, Integrat Virol, INF 324, D-69120 Heidelberg, Germany.; Brugger, B (corresponding author), Heidelberg Univ, Biochem Ctr, INF 328, D-69120 Heidelberg, Germany.	britta.bruegger@bzh.uni-heidelberg.de; oliver.fackler@med.uni-heidelberg.de	Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Brocker, Thomas/0000-0001-7060-5433; Ruggieri, Alessia/0000-0001-9981-3308; Kranich, Jan/0000-0002-9928-4132; Fackler, Oliver Till/0000-0003-2982-4209; Krausslich, Hans-Georg/0000-0002-8756-329X	Deutsche Forschungsgemeinschaft [TRR83, SFB1129];  [RU 1950/1-1];  [FA 378/17-1];  [KR 906/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; 	This work was supported by Deutsche Forschungsgemeinschaft TRR83 Projects 1 (to B. B.), 14 (to H. G. K.), and 15 (to O. T. F.); SFB1129 Project 10 (to B. B.); as well as Projects RU 1950/1-1 (to A. R.), FA 378/17-1 (to O. T. F.), and KR 906/8-1 (to H. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham L, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-39; Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469; Arakelyan A, 2013, J CLIN INVEST, V123, P3716, DOI 10.1172/JCI67042; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borisenko GG, 2004, CELL DEATH DIFFER, V11, P943, DOI 10.1038/sj.cdd.4401421; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chan WT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002713; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Chu EPF, 2017, MOL IMMUNOL, V82, P19, DOI 10.1016/j.molimm.2016.12.007; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Fackler OT, 2015, VIRUSES-BASEL, V7, P6730, DOI 10.3390/v7122970; Fortin JF, 2004, J BIOL CHEM, V279, P39520, DOI 10.1074/jbc.M407477200; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gerl MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153009; Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004; Imle A, 2016, VIROLOGY, V498, P44, DOI 10.1016/j.virol.2016.08.012; Imle A, 2015, MBIO, V6, DOI 10.1128/mBio.01309-15; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Keppler OT, 2005, J VIROL, V79, P1655, DOI 10.1128/JVI.79.3.1655-1665.2005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009; Murrell B, 2016, J VIROL, V90, P8085, DOI 10.1128/JVI.00972-16; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ozbalci C, 2013, METHODS MOL BIOL, V1033, P3, DOI 10.1007/978-1-62703-487-6_1; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Sood C, 2017, J BIOL CHEM, V292, P6014, DOI 10.1074/jbc.M117.777714; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Wang J, 2017, J VIROL, V91, DOI 10.1128/JVI.01583-16	73	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13702	13713		10.1074/jbc.M117.797332	http://dx.doi.org/10.1074/jbc.M117.797332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28659343	Green Published, hybrid			2022-12-28	WOS:000407942400028
J	Reilly-O'Donnell, B; Robertson, GB; Karumbi, A; McIntyre, C; Bal, W; Nishi, M; Takeshima, H; Stewart, AJ; Pitt, SJ				Reilly-O'Donnell, Benedict; Robertson, Gavin B.; Karumbi, Angela; McIntyre, Connor; Bal, Wojciech; Nishi, Miyuki; Takeshima, Hiroshi; Stewart, Alan J.; Pitt, Samantha J.			Dysregulated Zn2+ homeostasis impairs cardiac type-2 ryanodine receptor and mitsugumin 23 functions, leading to sarcoplasmic reticulum Ca2+ leakage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; PKA PHOSPHORYLATION; INTRACELLULAR CA2+; HEART-FAILURE; PULMONARY-HYPERTENSION; ADENINE-NUCLEOTIDE; OXIDATIVE STRESS; ZINC	Aberrant Zn2+ homeostasis is associated with dysregulated intracellular Ca2+ release, resulting in chronic heart failure. In the failing heart a small population of cardiac ryanodine receptors (RyR2) displays sub-conductance-state gating leading to Ca2+ leakage from sarcoplasmic reticulum (SR) stores, which impairs cardiac contractility. Previous evidence suggests contribution of RyR2-independent Ca2+ leakage through an uncharacterized mechanism. We sought to examine the role of Zn2+ in shaping intracellular Ca2+ release in cardiac muscle. Cardiac SR vesicles prepared from sheep or mouse ventricular tissue were incorporated into phospholipid bilayers under voltage-clamp conditions, and the direct action of Zn2+ on RyR2 channel function was examined. Under diastolic conditions, the addition of pathophysiological concentrations of Zn2+ (>= 2 nM) caused dysregulated RyR2-channel openings. Our data also revealed that RyR2 channels are not the only SR Ca2(+)-permeable channels regulated by Zn2+. Elevating the cytosolic Zn2+ concentration to 1 nM increased the activity of the transmembrane protein mitsugumin 23 (MG23). The current amplitude of the MG23 full-open state was consistent with that previously reported for RyR2 sub-conductance gating, suggesting that in heart failure in which Zn2+ levels are elevated, RyR2 channels do not gate in a sub-conductance state, but rather MG23-gating becomes more apparent. We also show that in H9C2 cells exposed to ischemic conditions, intracellular Zn2+ levels are elevated, coinciding with increased MG23 expression. In conclusion, these data suggest that dysregulated Zn2+ homeostasis alters the function of both RyR2 and MG23 and that both ion channels play a key role in diastolic SR Ca2+ leakage.	[Reilly-O'Donnell, Benedict; Robertson, Gavin B.; Karumbi, Angela; McIntyre, Connor; Stewart, Alan J.; Pitt, Samantha J.] Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland; [Bal, Wojciech] Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, PL-02106 Warsaw, Poland; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	University of St Andrews; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Kyoto University	Pitt, SJ (corresponding author), Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland.	sjp24@st-andrews.ac.uk	Stewart, Alan J/B-6569-2008	Stewart, Alan J/0000-0003-4580-1840; Bal, Wojciech/0000-0003-3780-083X; Takeshima, Hiroshi/0000-0003-4525-3725; Pitt, Samantha/0000-0003-2257-1595; Robertson, Gavin/0000-0002-9478-1404; Reilly-O'Donnell, Benedict/0000-0003-0183-3701	British Heart Foundation [FS/14/69/31001]; Japan Society for the Promotion of Science (Core-to-Core Program); University of St Andrews 600th Anniversary Scholarship; Royal Society of Edinburgh Biomedical Fellowship	British Heart Foundation(British Heart Foundation); Japan Society for the Promotion of Science (Core-to-Core Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of St Andrews 600th Anniversary Scholarship; Royal Society of Edinburgh Biomedical Fellowship	This work was supported by the British Heart Foundation Grant FS/14/69/31001 (to S.J.P.) and the Japan Society for the Promotion of Science (Core-to-Core Program; to H.T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a University of St Andrews 600th Anniversary Scholarship.; Supported by a Royal Society of Edinburgh Biomedical Fellowship. To whom correspondence should be addressed: School of Medicine, University of St Andrews, Medical and Biological Sciences Bldg., North Haugh, St. Andrews, Fife, KY6 9TF, Scotland, United Kingdom. Tel.: 44-1334-463516; E-mail: sjp24@st-andrews.ac.uk.	ASHLEY RH, 1990, J GEN PHYSIOL, V95, P981, DOI 10.1085/jgp.95.5.981; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Ayaz M, 2006, AM J PHYSIOL-HEART C, V290, pH1071, DOI 10.1152/ajpheart.00754.2005; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Benters J, 1997, BIOCHEM J, V322, P793, DOI 10.1042/bj3220793; Bodiga VL, 2017, BIOL TRACE ELEM RES, V179, P117, DOI 10.1007/s12011-017-0957-7; BOLOGNI L, 1983, INORG CHIM A-ARTICLE, V69, P71, DOI 10.1016/S0020-1693(00)83553-7; Carter S, 2006, CIRC RES, V98, P1506, DOI 10.1161/01.RES.0000227506.43292.df; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Dipp M, 2001, CIRC RES, V89, P77, DOI 10.1161/hh1301.093616; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Galfre E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031956; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Guazzi M, 2012, CIRCULATION, V126, P975, DOI 10.1161/CIRCULATIONAHA.111.085761; Guo XB, 2003, MOL CELL BIOCHEM, V254, P163, DOI 10.1023/A:1027321130997; Hare D., 2009, BIOCHEMIST, V31, P46; Jabr RI, 1997, BRIT J PHARMACOL, V122, P21, DOI 10.1038/sj.bjp.0701326; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; KALFAKAKOU VP, 1993, BIOL TRACE ELEM RES, V38, P289, DOI 10.1007/BF02785312; KLEINFELD M, 1968, AM J PHYSIOL, V215, P593, DOI 10.1152/ajplegacy.1968.215.3.593; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; LAKATTA EG, 1992, CARDIOVASC RES, V26, P193, DOI 10.1093/cvr/26.3.193; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; LAVER DR, 1995, J MEMBRANE BIOL, V147, P7; Lin CL, 2011, CELL DEATH DIFFER, V18, P1651, DOI 10.1038/cdd.2011.80; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McCord MC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00077; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Moraes DL, 2000, CIRCULATION, V102, P1718, DOI 10.1161/01.CIR.102.14.1718; Nishi M, 1998, FEBS LETT, V432, P191, DOI 10.1016/S0014-5793(98)00864-3; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Pitt SJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004854; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Que EL, 2015, NAT CHEM, V7, P130, DOI [10.1038/NCHEM.2133, 10.1038/nchem.2133]; Santulli G, 2015, P NATL ACAD SCI USA, V112, P11389, DOI 10.1073/pnas.1513047112; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Takeshima H, 2015, J PHYSIOL-LONDON, V593, P3241, DOI 10.1113/jphysiol.2014.281881; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Tuncay E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/290381; Tuncay E, 2011, CARDIOVASC RES, V89, P634, DOI 10.1093/cvr/cvq352; Turan B, 2003, BIOL TRACE ELEM RES, V94, P49, DOI 10.1385/BTER:94:1:49; Ullrich ND, 2012, J MOL CELL CARDIOL, V53, P33, DOI 10.1016/j.yjmcc.2012.03.015; Venturi E, 2011, BIOCHEMISTRY-US, V50, P2623, DOI 10.1021/bi1019447; Walweel K, 2017, J MOL CELL CARDIOL, V104, P53, DOI 10.1016/j.yjmcc.2017.01.016; Woodier J, 2015, J BIOL CHEM, V290, P17599, DOI 10.1074/jbc.M115.661280; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xu L, 1996, CIRC RES, V79, P1100, DOI 10.1161/01.RES.79.6.1100; Yamazaki T, 2010, BIOCHEM BIOPH RES CO, V392, P196, DOI 10.1016/j.bbrc.2010.01.013; Yi T, 2013, AM J PHYSIOL-HEART C, V305, pH706, DOI 10.1152/ajpheart.00025.2013; Yi T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-135; Zhao L, 2015, NATURE, V524, P356, DOI 10.1038/nature14620; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	65	15	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13361	13373		10.1074/jbc.M117.781708	http://dx.doi.org/10.1074/jbc.M117.781708			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28630041	Green Published, hybrid			2022-12-28	WOS:000407465300022
J	Braymer, JJ; Lill, R				Braymer, Joseph J.; Lill, Roland			Iron-sulfur cluster biogenesis and trafficking in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						acyl carrier protein (ACP); chaperone; fatty acid metabolism; frataxin; mitochondrial disease; cysteine desulfurase; ferredoxin; glutaredoxin; lipoic acid; metal biology	AZOTOBACTER-VINELANDII (NIF)ISCA; MONOTHIOL GLUTAREDOXINS FUNCTION; ACYL CARRIER PROTEIN; FE-S PROTEINS; CYSTEINE DESULFURASE; SCAFFOLD PROTEIN; FUNCTIONAL-CHARACTERIZATION; INTERACTING PROTEIN; ASSEMBLY MACHINERY; 4FE-4S CLUSTERS	The biogenesis of iron-sulfur (Fe/S) proteins in eukaryotes is a multistage, multicompartment process that is essential for a broad range of cellular functions, including genome maintenance, protein translation, energy conversion, and the antiviral response. Genetic and cell biological studies over almost 2 decades have revealed some 30 proteins involved in the synthesis of cellular [2Fe-2S] and [4Fe-4S] clusters and their incorporation into numerous apoproteins. Mechanistic aspects of Fe/S protein biogenesis continue to be elucidated by biochemical and ultrastructural investigations. Here, we review recent developments in the pursuit of constructing a comprehensive model of Fe/S protein assembly in the mitochondrion.	[Braymer, Joseph J.; Lill, Roland] Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany; [Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, Hans Meerwein Str, D-35043 Marburg, Germany	Philipps University Marburg	Lill, R (corresponding author), Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.; Lill, R (corresponding author), LOEWE Zentrum Synthet Mikrobiol SynMikro, Hans Meerwein Str, D-35043 Marburg, Germany.	lill@staff.uni-marburg.de		Lill, Roland/0000-0002-8345-6518; Braymer, Joseph J./0000-0003-1404-4066	European Union [659325]; Deutsche Forschungsgemeinschaft [LI 415/5, SFB 987, SPP 1710, SPP 1927]; LOEWE program of State Hessen; German-Israeli Foundation (GIF)	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of State Hessen; German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie agreement Grant 659325 (to J. J. B.) and generous financial support (to R. L.) from the Deutsche Forschungsgemeinschaft (Koselleck Grant, LI 415/5, SFB 987, SPP 1710, and SPP 1927), LOEWE program of State Hessen, and German-Israeli Foundation (GIF). This is the fourth article in the Thematic Minireview series "Metals in Biology 2017: Iron transport, storage, and the ramifications." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Andreini C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171279; Angerer Heike, 2015, Biology-Basel, V4, P133, DOI 10.3390/biology4010133; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brancaccio D, 2014, J AM CHEM SOC, V136, P16240, DOI 10.1021/ja507822j; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Cai K, 2017, ACS CHEM BIOL, V12, P918, DOI 10.1021/acschembio.6b01005; Cai K, 2016, STRUCTURE, V24, P2080, DOI 10.1016/j.str.2016.08.020; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Couturier J, 2015, BBA-MOL CELL RES, V1853, P1513, DOI 10.1016/j.bbamcr.2014.09.018; Debray FG, 2015, J INHERIT METAB DIS, V38, P1147, DOI 10.1007/s10545-015-9857-1; di Maio D, 2017, BBA-GEN SUBJECTS, V1861, P3154, DOI 10.1016/j.bbagen.2016.07.020; Dzul SP, 2017, METALLOMICS, V9, P48, DOI 10.1039/c6mt00163g; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3871, DOI 10.1021/bi5014485; Freibert SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13932; Fuss JO, 2015, BBA-MOL CELL RES, V1853, P1253, DOI 10.1016/j.bbamcr.2015.01.018; Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542; Gao HY, 2013, BIOCHEMISTRY-US, V52, P6633, DOI 10.1021/bi4007622; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Iametti S, 2015, J BIOL INORG CHEM, V20, P1039, DOI 10.1007/s00775-015-1285-z; Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053; Kim KD, 2010, BIOCHEM BIOPH RES CO, V392, P467, DOI 10.1016/j.bbrc.2010.01.051; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lossos A, 2015, NEUROLOGY, V84, P659, DOI 10.1212/WNL.0000000000001270; Maio N, 2016, METALLOMICS, V8, P1032, DOI 10.1039/c6mt00167j; Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Manicki M, 2014, J BIOL CHEM, V289, P30268, DOI 10.1074/jbc.M114.596726; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Mettert EL, 2015, ANNU REV MICROBIOL, V69, P505, DOI 10.1146/annurev-micro-091014-104457; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Pagnier A, 2015, BBA-MOL CELL RES, V1853, P1457, DOI 10.1016/j.bbamcr.2014.10.015; Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007; Pandey A, 2015, J BIOL CHEM, V290, P640, DOI 10.1074/jbc.M114.610402; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Pukszta S, 2010, EMBO REP, V11, P360, DOI 10.1038/embor.2010.29; Py B, 2015, BBA-MOL CELL RES, V1853, P1429, DOI 10.1016/j.bbamcr.2014.12.024; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Roret T, 2014, J BIOL CHEM, V289, P24588, DOI 10.1074/jbc.M114.572701; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Saha PP, 2015, J BIOL CHEM, V290, P25876, DOI 10.1074/jbc.M115.678508; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Shakamuri P, 2012, J AM CHEM SOC, V134, P15213, DOI 10.1021/ja306061x; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Uzarska MA, 2016, ELIFE, V5, DOI 10.7554/eLife.16673; Uzarska MA, 2013, MOL BIOL CELL, V24, P1830, DOI 10.1091/mbc.E12-09-0644; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Vranish JN, 2016, ACS CHEM BIOL, V11, P3114, DOI 10.1021/acschembio.6b00632; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; Yeung N, 2011, BIOCHEMISTRY-US, V50, P8957, DOI 10.1021/bi2008883; Yoon H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005135; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	100	207	209	10	86	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12754	12763		10.1074/jbc.R117.787101	http://dx.doi.org/10.1074/jbc.R117.787101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615445	hybrid, Green Published			2022-12-28	WOS:000407220100005
J	Johnson, CW; Reid, D; Parker, JA; Salter, S; Knihtila, R; Kuzmic, P; Mattos, C				Johnson, Christian W.; Reid, Derion; Parker, Jillian A.; Salter, Shores; Knihtila, Ryan; Kuzmic, Petr; Mattos, Carla			The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; conformational change; enzyme catalysis; enzyme structure; oncogene; Ras protein	ACTIVATING PROTEINS; GTP HYDROLYSIS; CONFORMATIONAL STATES; EVOLUTIONARY TREE; ESCHERICHIA-COLI; STRUCTURAL BASIS; NUCLEOTIDE-FREE; P21; EXPRESSION; PHOSPHATE	H-Ras, K-Ras, and N-Ras are small GTPases that are important in the control of cell proliferation, differentiation, and survival, and their mutants occur frequently in human cancers. The G-domain, which catalyzes GTP hydrolysis and mediates downstream signaling, is 95% conserved between the Ras isoforms. Because of their very high sequence identity, biochemical studies done on H-Ras have been considered representative of all three Ras proteins. We show here that this is not a valid assumption. Using enzyme kinetic assays under identical conditions, we observed clear differences between the three isoforms in intrinsic catalysis of GTP by Ras in the absence and presence of the Ras-binding domain (RBD) of the c-Raf kinase protein (Raf-RBD). Given their identical active sites, isoform G-domain differences must be allosteric in origin, due to remote isoform-specific residues that affect conformational states. We present the crystal structure of N-Ras bound to a GTP analogue and interpret the kinetic data in terms of structural features specific for H-, K-, and N-Ras.	[Johnson, Christian W.; Reid, Derion; Parker, Jillian A.; Salter, Shores; Knihtila, Ryan; Mattos, Carla] Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA; [Kuzmic, Petr] BioKin Ltd, Watertown, MA 02472 USA	Northeastern University	Mattos, C (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA.	c.mattos@northeastern.edu		Kuzmic, Petr/0000-0001-5250-8381; Johnson, Christian/0000-0002-6521-3803	National Science Foundation [DBI-1228897]; Northeastern University; Div Of Molecular and Cellular Bioscience [1517295] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Northeastern University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Prof. Lee Makowski for allowing use of the isothermal titration calorimeter and Yasmin Chishti for training J. A. P. on data collection for determination of K<INF>d</INF> and thermodynamic parameters for the H-, K-, and N-Ras complexes with Raf-RBD. X-ray data were collected on equipment purchased by National Science Foundation Grant DBI-1228897 with matching funds from Northeastern University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Araki M, 2011, J BIOL CHEM, V286, P39644, DOI 10.1074/jbc.M111.227074; Bates DM, 1988, NONLINEAR REGRESSION, P1, DOI [10.1002/9780470316757.ch1, DOI 10.1002/9780470316757.CH1]; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, P1; Cox Adrienne D, 2010, Small GTPases, V1, P2; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; FEUERSTEIN J, 1987, J BIOL CHEM, V262, P8455; Ford B, 2006, STRUCTURE, V14, P427, DOI 10.1016/j.str.2005.12.010; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Holzapfel G, 2012, BIOCHEMISTRY-US, V51, P6114, DOI 10.1021/bi300509j; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1989, J BIOL CHEM, V264, P13086; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHN J, 1988, J BIOL CHEM, V263, P11792; Johnson CW, 2016, DATA BRIEF, V6, P423, DOI 10.1016/j.dib.2015.12.007; Johnson CW, 2013, ENZYMES, V33, P41, DOI 10.1016/B978-0-12-416749-0.00003-8; Kalbitzer HR, 2013, ENZYMES, V33, P69, DOI 10.1016/B978-0-12-416749-0.00004-X; Kapoor A, 2015, PROTEINS, V83, P1091, DOI 10.1002/prot.24805; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Knihtila R, 2015, J BIOL CHEM, V290, P31025, DOI 10.1074/jbc.M115.679860; Kotting C, 2008, P NATL ACAD SCI USA, V105, P6260, DOI 10.1073/pnas.0712095105; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; LEUPOLD CM, 1983, EUR J BIOCHEM, V135, P237, DOI 10.1111/j.1432-1033.1983.tb07643.x; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; LOWE PN, 1991, J BIOL CHEM, V266, P1672; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Marcus K, 2015, CLIN CANCER RES, V21, P1810, DOI 10.1158/1078-0432.CCR-14-2148; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; NEAL SE, 1988, J BIOL CHEM, V263, P19718; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; Newlaczyl AU, 2014, BIOCHEM SOC T, V42, P742, DOI 10.1042/BST20140057; NIXON AE, 1995, BIOCHEMISTRY-US, V34, P15592, DOI 10.1021/bi00047a026; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JA, 2015, MOL CANCER RES, V13, P595, DOI 10.1158/1541-7786.MCR-14-0535; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Sayyed-Ahmad A, 2017, PROTEINS, V85, P1618, DOI 10.1002/prot.25317; SCHEFFLER JE, 1994, J BIOL CHEM, V269, P22340; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; SHACTER E, 1984, ANAL BIOCHEM, V138, P416, DOI 10.1016/0003-2697(84)90831-5; Shutes A, 2002, BIOCHEMISTRY-US, V41, P3828, DOI 10.1021/bi0119464; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Ting PY, 2015, FASEB J, V29, P3750, DOI 10.1096/fj.15-271510; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Vatansever S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37012; WATTS DG, 1994, METHOD ENZYMOL, V240, P23; WEBB MR, 1992, BIOCHEM J, V287, P555, DOI 10.1042/bj2870555; Wellbrock C, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00033; ZHONG JM, 1995, J BIOL CHEM, V270, P10002, DOI 10.1074/jbc.270.17.10002	81	72	74	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12981	12993		10.1074/jbc.M117.778886	http://dx.doi.org/10.1074/jbc.M117.778886			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28630043	hybrid, Green Published			2022-12-28	WOS:000407220100026
J	Khaliullin, B; Ayikpoe, R; Tuttle, M; Latham, JA				Khaliullin, Bulat; Ayikpoe, Richard; Tuttle, Mason; Latham, John A.			Mechanistic elucidation of the mycofactocin-biosynthetic radical S-adenosylmethionine protein, MftC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; iron-sulfur protein; peptide biosynthesis; radical; S-adenosylmethionine (SAM); MftC; mycofactocin	THIOETHER BOND FORMATION; SAM ENZYME; CROSS-LINK; POSTTRANSLATIONAL MODIFICATION; PEPTIDE CHAPERONE; NMR-SPECTRA; C-ALPHA; CATALYZES; PQQD; MATURATION	Ribosomally synthesized and posttranslationally modified peptide (RiPP) pathways produce a diverse array of natural products. A subset of these pathways depends on radical S-adenosylmethionine proteins to modify the RiPP-produced peptide. Mycofactocin biosynthesis is one example of an S-adenosylmethionine protein-dependent RiPP pathway. Recently, it has been shown that MftC catalyzes the oxidative decarboxylation of the C-terminal tyrosine (Tyr-30) on the mycofactocin precursor peptide MftA; however, this product has not been verified by techniques other than MS. Herein, we provide a more detailed study of MftC catalysis and report a revised mechanism for MftC chemistry. We show that MftC catalyzes the formation of two isomeric products. Using a combination of MS, isotope labeling, and H-1 and C-13 NMR techniques, we established that the major product, MftA*, is a tyramine-valine-cross-linked peptide formed by MftC through two S-adenosylmethionine-dependent turnovers. In addition, we show that the hydroxyl group on MftA Tyr-30 is required for MftC catalysis. Furthermore, we show that a substitution in the penultimate MftA Val-29 position causes the accumulation of an MftA** minor product. The H-1 NMR spectrum indicates that this minor product contains an -unsaturated bond that likely arises from an aborted intermediate of MftA* synthesis. The finding that MftA* is the major product formed during MftC catalysis could have implications for the further elucidation of mycofactocin biosynthesis.	[Khaliullin, Bulat; Ayikpoe, Richard; Tuttle, Mason; Latham, John A.] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Latham, JA (corresponding author), Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA.	john.latham@du.edu		Latham, John/0000-0002-3034-1768	University of Denver	University of Denver	This work was supported by the University of Denver. The authors declare that they have no conflicts of interest with the contents of this article.	Aires-de-Sousa J, 2002, ANAL CHEM, V74, P80, DOI 10.1021/ac010737m; Banfi D, 2008, CHIMIA, V62, P280, DOI 10.2533/chimia.2008.280; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2016, CHEM COMMUN, V52, P6249, DOI 10.1039/c6cc01317a; Bhandari DM, 2016, J AM CHEM SOC, V138, P16184, DOI 10.1021/jacs.6b06139; Bruender NA, 2017, J BIOL CHEM, V292, P4371, DOI 10.1074/jbc.M116.762062; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P4131, DOI 10.1021/acs.biochem.6b00598; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Castillo AM, 2011, J MAGN RESON, V209, P123, DOI 10.1016/j.jmr.2010.12.008; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Goossen LJ, 2008, ANGEW CHEM INT EDIT, V47, P8492, DOI 10.1002/anie.200803068; Haft DH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41074; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Iwasaki T, 2012, J AM CHEM SOC, V134, P19731, DOI 10.1021/ja308049u; Khaliullin B, 2016, FEBS LETT, V590, P2538, DOI 10.1002/1873-3468.12249; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Snider BB, 2000, J ORG CHEM, V65, P793, DOI 10.1021/jo991454l; Wang YY, 2017, J AM CHEM SOC, V139, P1742, DOI 10.1021/jacs.6b10901; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032	26	36	39	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13022	13033		10.1074/jbc.M117.795682	http://dx.doi.org/10.1074/jbc.M117.795682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28634235	Green Published, hybrid			2022-12-28	WOS:000407220100029
J	Knutson, MD				Knutson, Mitchell D.			Iron transport proteins: Gateways of cellular and systemic iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						bone marrow; heme; hepatocyte; iron; macrophage	TRANSFERRIN-BOUND IRON; DUODENAL CYTOCHROME-B; HEME EXPORTER; HEREDITARY HEMOCHROMATOSIS; FUNCTIONAL-PROPERTIES; INTESTINAL RECEPTOR; HEMOGLOBIN IRON; FERROPORTIN 1; FERRITIN H; RAT-LIVER	Cellular iron homeostasis is maintained by iron and heme transport proteins that work in concert with ferrireductases, ferroxidases, and chaperones to direct the movement of iron into, within, and out of cells. Systemic iron homeostasis is regulated by the liver-derived peptide hormone, hepcidin. The interface between cellular and systemic iron homeostasis is readily observed in the highly dynamic iron handling of four main cell types: duodenal enterocytes, erythrocyte precursors, macrophages, and hepatocytes. This review provides an overview of how these cell types handle iron, highlighting how iron and heme transporters mediate the exchange and distribution of body iron in health and disease.	[Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Knutson, MD (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	mknutson@ufl.edu						Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; BRISSOT P, 1985, J CLIN INVEST, V76, P1463, DOI 10.1172/JCI112125; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Darwich AS, 2014, DRUG METAB DISPOS, V42, P2016, DOI 10.1124/dmd.114.058404; Dhungana S, 2004, BIOCHEMISTRY-US, V43, P205, DOI 10.1021/bi0353631; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; FLOWERS CH, 1989, J LAB CLIN MED, V114, P368; Frazer DM, 2005, BLOOD, V106, P4413, DOI 10.1182/blood-2005-07-2923; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; GARBY L, 1959, J CLIN INVEST, V38, P1484, DOI 10.1172/JCI103926; Gottlieb Y, 2012, HAEMATOL-HEMATOL J, V97, P1489, DOI 10.3324/haematol.2012.063651; GRASBECK R, 1979, SCAND J HAEMATOL, V23, P5; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunshin H, 2005, BLOOD, V106, P2879, DOI 10.1182/blood-2005-02-0716; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; KINO K, 1980, J BIOL CHEM, V255, P9616; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Korolnek T, 2015, BLOOD, V125, P2893, DOI 10.1182/blood-2014-12-567776; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Le Lan C, 2005, BLOOD, V105, P4527, DOI 10.1182/blood-2004-09-3468; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; OSAKI S, 1971, J BIOL CHEM, V246, P3018; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; RANDELL EW, 1994, J BIOL CHEM, V269, P16046; RAPER NR, 1984, J AM DIET ASSOC, V84, P783; Sangkhae V, 2017, ADV NUTR, V8, P126, DOI 10.3945/an.116.013961; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Searle S, 1998, J CELL SCI, V111, P2855; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shawki A, 2016, AM J PHYSIOL-GASTR L, V311, pG423, DOI 10.1152/ajpgi.00167.2016; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tang LL, 2012, BRIT J HAEMATOL, V157, P151, DOI 10.1111/j.1365-2141.2011.08936.x; TENHUNEN R, 1980, INT J BIOCHEM, V12, P713, DOI 10.1016/0020-711X(80)90149-4; Tolosano E, 2005, BLOOD, V105, P3353, DOI 10.1182/blood-2004-07-2814; Tripathi AK, 2015, FREE RADICAL BIO MED, V84, P322, DOI 10.1016/j.freeradbiomed.2015.03.037; Vanoaica L, 2010, CELL METAB, V12, P273, DOI 10.1016/j.cmet.2010.08.003; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Vinchi F, 2014, GASTROENTEROLOGY, V146, P1325, DOI 10.1053/j.gastro.2014.01.053; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang CY, 2013, HEPATOLOGY, V58, P788, DOI 10.1002/hep.26401; WEINTRAUB LR, 1968, J CLIN INVEST, V47, P531, DOI 10.1172/JCI105749; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Zhang DL, 2011, BLOOD, V118, P2868, DOI 10.1182/blood-2011-01-330241; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746; ZIMELMAN AP, 1977, GASTROENTEROLOGY, V72, P129	100	68	71	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12735	12743		10.1074/jbc.R117.786632	http://dx.doi.org/10.1074/jbc.R117.786632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615441	hybrid, Green Published			2022-12-28	WOS:000407220100003
J	Corby, MJ; Stoneman, MR; Biener, G; Paprocki, JD; Kolli, R; Raicu, V; Frick, DN				Corby, M. J.; Stoneman, Michael R.; Biener, Gabriel; Paprocki, Joel D.; Kolli, Rajesh; Raicu, Valerica; Frick, David N.			Quantitative microspectroscopic imaging reveals viral and cellular RNA helicase interactions in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; ANTIVIRAL SIGNAL-TRANSDUCTION; INNATE IMMUNE SENSOR; I-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; NS3 HELICASE; LIVING CELLS; QUATERNARY STRUCTURE; PATTERN-RECOGNITION	Human cells detect RNA viruses through a set of helicases called RIG-I-like receptors (RLRs) that initiate the interferon response via a mitochondrial signaling complex. Many RNA viruses also encode helicases, which are sometimes covalently linked to proteases that cleave signaling proteins. One unresolved question is how RLRs interact with each other and with viral proteins in cells. This study examined the interactions among the hepatitis C virus (HCV) helicase and RLR helicases in live cells with quantitative microspectroscopic imaging (Q-MSI), a technique that determines FRET efficiency and subcellular donor and acceptor concentrations. HEK293T cells were transfected with various vector combinations to express cyan fluorescent protein (CFP) or YFP fused to either biologically active HCV helicase or one RLR (i. e. RIG-I, MDA5, or LGP2), expressed in the presence or absence of polyinosinicpolycytidylic acid (poly(I: C)), which elicits RLR accumulation at mitochondria. Q-MSI confirmed previously reported RLR interactions and revealed an interaction between HCV helicase and LGP2. Mitochondria in CFP-RIG-I: YFP-RIG-I cells, CFPMDA5: YFP-MDA5 cells, and CFP-MDA5: YFP-LGP2 cells had higher FRET efficiencies in the presence of poly(I: C), indicating that RNA causes these proteins to accumulate at mitochondria in higher-order complexes than those formed in the absence of poly(I: C). However, mitochondria in CFP-LGP2: YFP-LGP2 cells had lower FRET signal in the presence of poly(I: C), suggesting that LGP2 oligomers disperse so that LGP2 can bind MDA5. Data support a new model where an LGP2-MDA5 oligomer shuttles NS3 to the mitochondria to block antiviral signaling.	[Corby, M. J.; Kolli, Rajesh; Frick, David N.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA; [Stoneman, Michael R.; Biener, Gabriel; Paprocki, Joel D.; Raicu, Valerica] Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA; [Raicu, Valerica] Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Frick, DN (corresponding author), Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA.; Raicu, V (corresponding author), Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA.; Raicu, V (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	vraicu@uwm.edu; frickd@uwm.edu		Frick, David/0000-0002-2434-7223	National Institutes of Health [RO1AI088001]; University of Wisconsin-Milwaukee Research Growth Innitiative [101X333]; National Science Foundation Major Research Instrumentation Program Grant [PHY-1126386]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Milwaukee Research Growth Innitiative; National Science Foundation Major Research Instrumentation Program Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant RO1AI088001 (to D. N. F.), University of Wisconsin-Milwaukee Research Growth Innitiative Grant 101X333 (to D. N. F. and V. R.), and National Science Foundation Major Research Instrumentation Program Grant PHY-1126386 (to V. R.). Dr. Raicu is a co-founder of Aurora Spectral Technologies LLC (AST), which commercializes OptiMiS technology used in this work. Dr. Stoneman was employed by AST in the past and occasionally consults for them. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Bruns AM, 2015, CYTOKINE, V74, P198, DOI 10.1016/j.cyto.2015.02.010; Bruns AM, 2014, CYTOKINE GROWTH F R, V25, P507, DOI 10.1016/j.cytogfr.2014.07.006; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5; Fitzgerald ME, 2014, CURR OPIN MICROBIOL, V20, P76, DOI 10.1016/j.mib.2014.05.004; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2010, METHODS MOL BIOL, V587, P223, DOI 10.1007/978-1-60327-355-8_16; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Louber J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108770; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Neumann-Haefelin C, 2008, J VIROL, V82, P3438, DOI 10.1128/JVI.01700-07; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Patowary S, 2015, BIOPHYS J, V108, P1613, DOI 10.1016/j.bpj.2015.02.021; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Raicu V, 2005, BIOCHEM J, V385, P265, DOI 10.1042/BJ20040226; Raicu V, 2013, BIOPHYS J, V105, P1937, DOI 10.1016/j.bpj.2013.09.015; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Rodriguez KR, 2014, J VIROL, V88, P8194, DOI 10.1128/JVI.00640-14; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Singh DR, 2013, INTEGR BIOL-UK, V5, P312, DOI 10.1039/c2ib20218b; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Stoneman M, 2011, JOVE-J VIS EXP, DOI 10.3791/2247; Stoneman MR, 2017, BBA-BIOMEMBRANES, V1859, P1456, DOI 10.1016/j.bbamem.2016.12.008; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Uchikawa E, 2016, MOL CELL, V62, P586, DOI 10.1016/j.molcel.2016.04.021; Vazquez C, 2015, J VIROL, V89, P6974, DOI 10.1128/JVI.01918-14; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Zhang HX, 2013, P NATL ACAD SCI USA, V110, P6459, DOI 10.1073/pnas.1304432110; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	67	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11165	11177		10.1074/jbc.M117.777045	http://dx.doi.org/10.1074/jbc.M117.777045			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28483922	hybrid, Green Published			2022-12-28	WOS:000405119600004
J	Benjdia, A; Decamps, L; Guillot, A; Kubiak, X; Ruffie, P; Sandstrom, C; Berteau, O				Benjdia, Alhosna; Decamps, Laure; Guillot, Alain; Kubiak, Xavier; Ruffie, Pauline; Sandstrom, Corine; Berteau, Olivier			Insights into the catalysis of a lysine-tryptophan bond in bacterial peptides by a SPASM domain radical S-adenosylmethionine (SAM) peptide cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATASE-MATURATING ENZYMES; H-ATOM ABSTRACTION; POSTTRANSLATIONAL MODIFICATION; IRON-SULFUR; LIPOYL SYNTHASE; ADOMET ENZYME; BIOSYNTHESIS; CHEMISTRY; THIOSTREPTON; PROKARYOTES	Radical S-adenosylmethionine (SAM) enzymes are emerging as a major superfamily of biological catalysts involved in the biosynthesis of the broad family of bioactive peptides called ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes have been shown to catalyze unconventional reactions, such as methyl transfer to electrophilic carbon atoms, sulfur to C-alpha atom thioether bonds, or carbon-carbon bond formation. Recently, a novel radical SAM enzyme catalyzing the formation of a lysine-tryptophanbondhas been identified in Streptococcus thermophilus, and a reaction mechanism has been proposed. By combining site-directed mutagenesis, biochemical assays, and spectroscopic analyses, we show here that this enzyme, belonging to the emerging family of SPASM domain radical SAM enzymes, likely contains three [4Fe-4S] clusters. Notably, our data support that the seven conserved cysteine residues, present within the SPASM domain, are critical for enzyme activity. In addition, we uncovered the minimum substrate requirements and demonstrate that KW cyclic peptides are more widespread than anticipated, notably in pathogenic bacteria. Finally, we show a strict specificity of the enzyme for lysine and tryptophan residues and the dependence of an eight-amino acid leader peptide for activity. Altogether, our study suggests novel mechanistic links among SPASM domain radical SAM enzymes and supports the involvement of non-cysteinyl ligands in the coordination of auxiliary clusters.	[Benjdia, Alhosna; Decamps, Laure; Guillot, Alain; Kubiak, Xavier; Ruffie, Pauline; Berteau, Olivier] Univ Paris Saclay, AgroParisTech, Micalis Inst, ChemSyBio,INRA, F-78350 Jouy En Josas, France; [Sandstrom, Corine] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Mol Sci, POB 7015, S-75007 Uppsala, Sweden	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swedish University of Agricultural Sciences	Benjdia, A; Berteau, O (corresponding author), Univ Paris Saclay, AgroParisTech, Micalis Inst, ChemSyBio,INRA, F-78350 Jouy En Josas, France.	Alhosna.Benjdia@inra.fr; Olivier.Berteau@inra.fr	Benjdia, Alhosna/AAM-7415-2021; Decamps, Laure/ABH-2891-2020; Berteau, Olivier/AAF-9080-2019	Benjdia, Alhosna/0000-0002-3544-2541; Berteau, Olivier/0000-0002-3434-5168	European Research Council [617053]	European Research Council(European Research Council (ERC)European Commission)	This work was supported in part by European Research Council Consolidator Grant 617053 (to O. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2007, FEBS LETT, V581, P1009, DOI 10.1016/j.febslet.2007.01.076; Benjdia A, 2017, NAT CHEM, V9, P698, DOI [10.1038/NCHEM.2714, 10.1038/nchem.2714]; Benjdia A, 2016, CHEM COMMUN, V52, P6249, DOI 10.1039/c6cc01317a; Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Berteau O, 2017, PHOTOCHEM PHOTOBIOL, V93, P67, DOI 10.1111/php.12702; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Cheng VWT, 2013, BBA-BIOENERGETICS, V1827, P1141, DOI 10.1016/j.bbabio.2013.05.004; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Harmer JE, 2014, BIOCHEM J, V464, P123, DOI 10.1042/BJ20140895; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; McLaughlin MI, 2016, P NATL ACAD SCI USA, V113, P9446, DOI 10.1073/pnas.1602486113; Mehta AP, 2015, J BIOL CHEM, V290, P3980, DOI 10.1074/jbc.R114.623793; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Qi WB, 2011, COORDIN CHEM REV, V255, P688, DOI 10.1016/j.ccr.2010.10.016; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	34	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10835	10844		10.1074/jbc.M117.783464	http://dx.doi.org/10.1074/jbc.M117.783464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476884	Green Published, hybrid			2022-12-28	WOS:000404391000008
J	Chisuga, T; Miyanaga, A; Kudo, F; Eguchi, T				Chisuga, Taichi; Miyanaga, Akimasa; Kudo, Fumitaka; Eguchi, Tadashi			Structural analysis of the dual-function thioesterase SAV606 unravels the mechanism of Michael addition of glycine to an alpha,beta-unsaturated thioester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER PROTEIN DEHYDRATASE; POLYKETIDE SYNTHASE; STREPTOMYCES-AVERMITILIS; PSEUDOMONAS-AERUGINOSA; STARTER UNIT; ACTIVE-SITE; BIOSYNTHESIS; REVEALS; ENZYMES; GENOME	Thioesterases catalyze hydrolysis of acyl thioesters to release carboxylic acid or macrocyclization to produce the corresponding macrocycle in the biosynthesis of fatty acids, polyketides, or nonribosomal peptides. Recently, we reported that the thioesterase CmiS1 from Streptomyces sp. MJ635-86F5 catalyzes the Michael addition of glycine to an alpha,beta-unsaturated fatty acyl thioester followed by thioester hydrolysis in the biosynthesis of the macrolactam antibiotic cremimycin. However, the molecular mechanisms of CmiS1-catalyzed reactions are unclear. Here, we report on the functional and structural characterization of the CmiS1 homolog SAV606 from Streptomyces avermitilis MA-4680. In vitro analysis indicated that SAV606 catalyzes the Michael addition of glycine to crotonic acid thioester and subsequent hydrolysis yielding (R)-N-carboxymethyl-3-aminobutyric acid. We also determined the crystal structures of SAV606 both in ligandfree form at 2.4 angstrom resolution and in complex with (R)-N-carboxymethyl-3-aminobutyric acid at 2.0 angstrom resolution. We found that SAV606 adopts an alpha/beta hotdog fold and has an active site at the dimeric interface. Examining the complexed structure, we noted that the substrate-binding loop comprising Tyr-53-Asn-61 recognizes the glycine moiety of (R)-N-carboxymethyl-3-aminobutyric acid. Moreover, we found that SAV606 does not contain an acidic residue at the active site, which is distinct from canonical hotdog thioesterases. Site-directed mutagenesis experiments revealed that His-59 plays a crucial role in both the Michael addition and hydrolysis via a water molecule. These results allow us to propose the reaction mechanism of the SAV606-catalyzed Michael addition and thioester hydrolysis and provide new insight into the multiple functions of a thioesterase family enzyme.	[Chisuga, Taichi; Eguchi, Tadashi] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Miyanaga, Akimasa; Kudo, Fumitaka; Eguchi, Tadashi] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Eguchi, T (corresponding author), Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan.	eguchi@chem.titech.ac.jp	Miyanaga, Akimasa/C-1472-2015; Eguchi, Tadashi/B-9339-2015	Miyanaga, Akimasa/0000-0003-2219-6051; Eguchi, Tadashi/0000-0002-7830-7104; Chisuga, Taichi/0000-0001-8584-5368	Ministry of Education, Culture, Sports, Science and Technology [16H06451]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was performed with the approval of the Photon Factory Program Advisory Committee (Proposals 2014G530 and 2016G624) and was supported in part by Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research in Innovative Areas 16H06451 (to T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Amagai K, 2013, CHEMBIOCHEM, V14, P1998, DOI 10.1002/cbic.201300370; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cantu DC, 2011, NUCLEIC ACIDS RES, V39, pD342, DOI 10.1093/nar/gkq1072; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finzel K, 2015, CHEMBIOCHEM, V16, P528, DOI 10.1002/cbic.201402578; Gehret JJ, 2011, J BIOL CHEM, V286, P14445, DOI 10.1074/jbc.M110.214635; He HY, 2014, J AM CHEM SOC, V136, P4488, DOI 10.1021/ja500942y; Horsman ME, 2016, NAT PROD REP, V33, P183, DOI 10.1039/c4np00148f; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ikeda H, 2014, J IND MICROBIOL BIOT, V41, P233, DOI 10.1007/s10295-013-1327-x; Jorgensen H, 2010, APPL ENVIRON MICROB, V76, P283, DOI 10.1128/AEM.00744-09; Jorgensen H, 2009, CHEM BIOL, V16, P1109, DOI 10.1016/j.chembiol.2009.09.014; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Korman TP, 2010, P NATL ACAD SCI USA, V107, P6246, DOI 10.1073/pnas.0913531107; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Labonte JW, 2013, CHEM REV, V113, P2182, DOI 10.1021/cr300169a; Lackner G, 2013, CHEM BIOL, V20, P1101, DOI 10.1016/j.chembiol.2013.07.009; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lou LL, 2012, BIOCHEMISTRY-US, V51, P4, DOI 10.1021/bi2015025; Miyanaga A, 2016, CURR OPIN CHEM BIOL, V35, P58, DOI 10.1016/j.cbpa.2016.08.030; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Moynie L, 2013, J MOL BIOL, V425, P365, DOI 10.1016/j.jmb.2012.11.017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Vagstad AL, 2012, CHEM BIOL, V19, P1525, DOI 10.1016/j.chembiol.2012.10.002; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Wu R, 2014, BIOCHEMISTRY-US, V53, P4788, DOI 10.1021/bi500334v; Zhu YG, 2015, CHEMBIOCHEM, V16, P2086, DOI 10.1002/cbic.201500281	35	11	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10926	10937		10.1074/jbc.M117.792549	http://dx.doi.org/10.1074/jbc.M117.792549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28522606	hybrid, Green Published			2022-12-28	WOS:000404391000015
J	Sato, O; Komatsu, S; Sakai, T; Tsukasaki, Y; Tanaka, R; Mizutani, T; Watanabe, TM; Ikebe, R; Ikebe, M				Sato, Osamu; Komatsu, Satoshi; Sakai, Tsuyoshi; Tsukasaki, Yoshikazu; Tanaka, Ryosuke; Mizutani, Takeomi; Watanabe, Tomonobu M.; Ikebe, Reiko; Ikebe, Mitsuo			Human myosin VIIa is a very slow processive motor protein on various cellular actin structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USHER 1B SYNDROME; GLOBULAR TAIL DOMAIN; ATPASE ACTIVITY; ARP2/3 COMPLEX; F-ACTIN; MUTATIONS; SHAKER-1; GENE; CONFORMATION; ORGANIZATION	Human myosin VIIa (MYO7A) is an actin-linked motor protein associated with human Usher syndrome (USH) type 1B, which causes human congenital hearing and visual loss. Although it has been thought that the role of human myosin VIIa is critical for USH1 protein tethering with actin and transportation along actin bundles in inner-ear hair cells, myosin VIIa's motor function remains unclear. Here, we studied the motor function of the tail-truncated human myosin VIIa dimer (HM7A Delta Tail/LZ) at the single-molecule level. We found that the HM7A Delta Tail/LZ moves processively on single actin filaments with a step size of 35 nm. Dwell-time distribution analysis indicated an average waiting time of 3.4 s, yielding similar to 0.3 s(-1) for the mechanical turnover rate; hence, the velocity of HM7A Delta Tail/LZ was extremely slow, at 11 nm.s(-1). We also examined HM7A Delta Tail/LZ movement on various actin structures in demembranated cells. HM7A Delta Tail/LZ showed unidirectional movement on actin structures at cell edges, such as lamellipodia and filopodia. However, HM7A Delta Tail/LZ frequently missed steps on actin tracks and exhibited bidirectional movement at stress fibers, which was not observed with tail-truncated myosin Va. These results suggest that the movement of the human myosin VIIa motor protein is more efficient on lamellipodial and filopodial actin tracks than on stress fibers, which are composed of actin filaments with different polarity, and that the actin structures influence the characteristics of cargo transportation by human myosin VIIa. In conclusion, myosin VIIa movement appears to be suitable for translocating USH1 proteins on stereocilia actin bundles in inner-ear hair cells.	[Sato, Osamu; Komatsu, Satoshi; Sakai, Tsuyoshi; Tsukasaki, Yoshikazu; Ikebe, Reiko; Ikebe, Mitsuo] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Hwy 271, Tyler, TX 75708 USA; [Tsukasaki, Yoshikazu] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Tanaka, Ryosuke] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Mizutani, Takeomi] Hokkaido Univ, Fac Adv Life Sci, Dept Adv Transdisciplinary Sci, Sapporo, Hokkaido 0600810, Japan; [Watanabe, Tomonobu M.] RIKEN Quantitat Biol Ctr, Lab Comprehens Bioimaging, Suita, Osaka 5650874, Japan	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hokkaido University; Hokkaido University; RIKEN	Ikebe, M (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Hwy 271, Tyler, TX 75708 USA.	Mitsuo.Ikebe@uthct.edu		Sato, Osamu/0000-0001-9913-1745; Watanabe, Tomonobu/0000-0002-2420-4230	National Institutes of Health [R01 DC006103]; University of Texas System TEXAS STARS PLUS award; Grants-in-Aid for Scientific Research [25287106] Funding Source: KAKEN; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas System TEXAS STARS PLUS award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grant R01 DC006103 and by the University of Texas System TEXAS STARS PLUS award (to M. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MY, 2013, TRAFFIC, V14, P70, DOI 10.1111/tra.12017; Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; BRYAN J, 1982, METHOD CELL BIOL, V25, P175, DOI 10.1016/S0091-679X(08)61425-9; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; El-Amraoui A., 2008, MYOS SUP MOL MOT, V7, P353; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Morgan CP, 2016, ELIFE, V5, DOI 10.7554/eLife.18312; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Olney JJ, 1996, J BIOL CHEM, V271, P20375, DOI 10.1074/jbc.271.34.20375; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tamagawa Y, 2002, ADV OTO-RHINO-LARYNG, V61, P79; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P9505, DOI 10.1021/bi8007142; Watanabe TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012224; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	61	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10950	10960		10.1074/jbc.M116.765966	http://dx.doi.org/10.1074/jbc.M116.765966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28507101	hybrid, Green Published			2022-12-28	WOS:000404391000017
J	Chang, JS; Ha, K				Chang, Ji Suk; Ha, Kyoungsoo			An unexpected role for the transcriptional coactivator isoform NT-PGC-1 alpha in the regulation of mitochondrial respiration in brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN CREB; GENE-EXPRESSION; ADAPTIVE THERMOGENESIS; ADIPOSE-TISSUE; T3 RECEPTOR; COMPLEX-I; PGC-1-ALPHA; BIOGENESIS; DNA; DIFFERENTIATION	Brown adipose tissue dissipates energy as heat, a process that relies on a high abundance of mitochondria and high levels of electron transport chain (ETC) complexes within these mitochondria. Two regulators of mitochondrial respiration and heat production in brown adipocytes are the transcriptional coactivator PGC-1 alpha and its splicing isoform NT-PGC-1 alpha, which control mitochondrial gene expression in the nucleus. Surprisingly, we found that, in brown adipocytes, some NT-PGC-1 alpha localizes to mitochondria, whereas PGC-1 alpha resides in the nucleus. Here we sought to investigate the role of NT-PGC-1 alpha in brown adipocyte mitochondria. Immunocytochemistry, immunotransmission electron microscopy, and biochemical analyses indicated that NT-PGC-1 alpha was located in the mitochondrial matrix in brown adipocytes. NT-PGC-1 alpha was specifically enriched at the D-loop region of the mtDNA, which contains the promoters for several essential ETC complex genes, and was associated with LRP130, an activator of mitochondrial transcription. Selective expression of NT-PGC-1 alpha and PGC-1 alpha in PGC-1 alpha(-/-) brown adipocytes similarly induced expression of nuclear DNA-encoded mitochondrial ETC genes, including the key mitochondrial transcription factor A(TFAM). Despite having comparable levels of TFAM expression, PGC-1 alpha(-/-) brown adipocytes expressing NT-PGC-1 alpha had higher expression of mtDNA-encoded ETC genes than PGC-1 alpha(-/-) brown adipocytes expressing PGC-1 alpha, suggesting a direct effect of NT-PGC-1 alpha on mtDNA transcription. Moreover, this increase in mtDNA-encoded ETC gene expression was associated with enhanced respiration in NT-PGC-1 alpha-expressing PGC-1 alpha(-/-) brown adipocytes. Our findings reveal a previously unappreciated and isoform-specific role for NT-PGC-1 alpha in the regulation of mitochondrial transcription in brown adipocytes and provide new insight into the transcriptional control of mitochondrial respiration.	[Chang, Ji Suk; Ha, Kyoungsoo] Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Chang, JS (corresponding author), Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	jisuk.chang@pbrc.edu	Chang, Ji Suk/N-1957-2017		COBRE grant from the National Institutes of Health [NIH8 1P30GM118430-01]; NORC (National Institutes of Health) center grant from the National Institutes of Health [1P30-DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104748, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	COBRE grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC (National Institutes of Health) center grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Tom Gettys (Pennington Biomedical Research Center) for kindly providing anti-PGC-1 alpha and anti-UCP1 antibodies. We also thank Ying Xiao (LSU Socolofsky Microscopy Center) for technical assistance and Cindi Tramonte for administrative support. We used Cell Biology and Bioimaging and Genomics Core facilities that are supported in part by COBRE (NIH8 1P30GM118430-01) and NORC (National Institutes of Health 1P30-DK072476) center grants from the National Institutes of Health.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bereziat V, 2005, BIOCHIMIE, V87, P951, DOI 10.1016/j.biochi.2005.05.010; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; Chang JS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13013; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; Jun HJ, 2014, DIABETES, V63, P3615, DOI 10.2337/db13-1837; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159990; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Macias E, 2014, J INVEST DERMATOL, V134, P1971, DOI 10.1038/jid.2014.68; Montoya J, 1997, MOL CELL BIOCHEM, V174, P227, DOI 10.1023/A:1006812625445; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pessemesse L, 2012, FASEB J, V26, P748, DOI 10.1096/fj.11-195933; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	39	14	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9958	9966		10.1074/jbc.M117.778373	http://dx.doi.org/10.1074/jbc.M117.778373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28473468	Green Published, hybrid			2022-12-28	WOS:000403580600009
J	Arcario, MJ; Mayne, CG; Tajkhorshid, E				Arcario, Mark J.; Mayne, Christopher G.; Tajkhorshid, Emad			A membrane-embedded pathway delivers general anesthetics to two interacting binding sites in the Gloeobacter violaceus ion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; MOLECULAR-DYNAMICS; TRANSMEMBRANE DOMAIN; STRUCTURAL BASIS; LIPID-BILAYER; FORCE-FIELD; OPEN STATE; ACETYLCHOLINE; MECHANISMS; RECEPTORS	General anesthetics exert their effects on the central nervous system by acting on ion channels, most notably pentameric ligand-gated ion channels. Although numerous studies have focused on pentameric ligand-gated ion channels, the details of anesthetic binding and channel modulation are still debated. A better understanding of the anesthetic mechanism of action is necessary for the development of safer and more efficacious drugs. Herein, we present a computational study identifying two anesthetic binding sites in the transmembrane domain of the Gloeobacter violaceus ligand-gated ion channel (GLIC) channel, characterize the putative binding pathway, and observe structural changes associated with channel function. Molecular simulations of desflurane reveal a binding pathway to GLIC via a membrane-embedded tunnel using an intrasubunit protein lumen as the conduit, an observation that explains the Meyer-Overton hypothesis, or why the lipophilicity of an anesthetic and its potency are generally proportional. Moreover, employing high concentrations of ligand led to the identification of a second transmembrane site (TM2) that inhibits dissociation of anesthetic from the TM1 site and is consistent with the high concentrations of anesthetics required to achieve clinical effects. Finally, asymmetric binding patterns of anesthetic to the channel were found to promote an iris-like conformational change that constricts and dehydrates the ion pore, creating a 13.5 kcal/mol barrier to ion translocation. Together with previous studies, the simulations presented herein demonstrate a novel anesthetic binding site in GLIC that is accessed through a membrane-embedded tunnel and interacts with a previously known site, resulting in conformational changes that produce a non-conductive state of the channel.	[Arcario, Mark J.; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Arcario, Mark J.; Tajkhorshid, Emad] Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; [Arcario, Mark J.; Mayne, Christopher G.; Tajkhorshid, Emad] Univ Illinois, Coll Med, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tajkhorshid, E (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Tajkhorshid, E (corresponding author), Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA.; Tajkhorshid, E (corresponding author), Univ Illinois, Coll Med, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	emad@life.illinois.edu	Tajkhorshid, Emad/AAN-8323-2021	Arcario, Mark/0000-0001-5017-1519	National Science Foundation [ACI-1548562]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, R01GM086749, R01GM101048] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Claudio Grosman and Giovanni Gonzalez-Gutierrez for insightful discussion. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), supported by the National Science Foundation (ACI-1548562), specifically the allocation for Mechanistic Studies of Biological Macromolecules (MCA06N060).	Arcario MJ, 2014, BIOPHYS J, V107, P2059, DOI 10.1016/j.bpj.2014.09.022; Arcario MJ, 2014, J PHYS CHEM B, V118, P12075, DOI 10.1021/jp502716m; Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2013, BBA-BIOMEMBRANES, V1828, P398, DOI 10.1016/j.bbamem.2012.09.014; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Bromstrup T, 2013, STRUCTURE, V21, P1307, DOI 10.1016/j.str.2013.06.018; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cheng MHY, 2010, J AM CHEM SOC, V132, P16442, DOI 10.1021/ja105001a; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Cymes GD, 2012, NAT CHEM BIOL, V8, P975, DOI [10.1038/NCHEMBIO.1092, 10.1038/nchembio.1092]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Ghosh B, 2013, J BIOL CHEM, V288, P17420, DOI 10.1074/jbc.M113.464040; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Herold KE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00050; Herold KF, 2017, P NATL ACAD SCI USA, V114, P3109, DOI 10.1073/pnas.1611717114; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meyer HZur, 1899, ARCH EXP PATHOL PHAR, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; Miller KW, 2002, BRIT J ANAESTH, V89, P17, DOI 10.1093/bja/aef167; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Murail S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002710; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Raju SG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003090; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; SEEMAN P, 1972, PHARMACOL REV, V24, P583; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tibbs GR, 2013, J PHARMACOL EXP THER, V345, P363, DOI 10.1124/jpet.113.203620; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vemparala S, 2008, BIOPHYS J, V94, P4260, DOI 10.1529/biophysj.107.119958; Vemparala S, 2006, BIOPHYS J, V91, P2815, DOI 10.1529/biophysj.106.085324; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Zhu FQ, 2012, BIOPHYS J, V103, P219, DOI 10.1016/j.bpj.2012.06.003; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	63	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9480	9492		10.1074/jbc.M117.780197	http://dx.doi.org/10.1074/jbc.M117.780197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28420728	Green Published, hybrid			2022-12-28	WOS:000403113000004
J	Liu, CY; Yu, T; Huang, YJ; Cui, L; Hong, WJ				Liu, Chen-Ying; Yu, Tong; Huang, Yuji; Cui, Long; Hong, Wanjin			ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; OSTEOGENIC DIFFERENTIATION; ANDROGEN RECEPTOR; GENE FUSIONS; COMPLEX; EXPRESSION; GROWTH; PROLIFERATION; TUMORIGENESIS; MOTILITY	Prostate cancer is a very common malignant disease and a leading cause of death for men in the Western world. Tumorigenesis and progression of prostate cancer involves multiple signaling pathways, including the Hippo pathway. Yes-associated protein (YAP) is the downstream transcriptional co-activator of the Hippo pathway, is overexpressed in prostate cancer, and plays a vital role in the tumorigenesis and progression of prostate cancer. However, the role of the YAP paralog and another downstream effector of the Hippo pathway, transcriptional coactivator with PDZ-binding motif (TAZ), in prostate cancer has not been fully elucidated. Here, we show that TAZ is a basal cell marker for the prostate epithelium. We found that overexpression of TAZ promotes the epithelial-mesenchymal transition (EMT), cell migration, and anchorage-independent growth in the RWPE1 prostate epithelial cells. Of note, knock down of TAZ in the DU145 prostate cancer cells inhibited cell migration and metastasis. Wealso found that SH3 domain binding protein 1 (SH3BP1), a RhoGAP protein that drives cell motility, is a direct target gene of TAZ in the prostate cancer cells, mediating TAZ function in enhancing cell migration. Moreover, the prostate cancer-related oncogenic E26 transformation-specific (ETS) transcription factors, ETV1, ETV4, and ETV5, were required for TAZ gene transcription in PC3 prostate cancer cells. MAPK inhibitor U0126 treatment decreased TAZ expression in RWPE1 cells, and ETV4 overexpression rescued TAZ expression in RWPE1 cells with U0126 treatment. Our results show a regulatory mechanism of TAZ transcription and suggest a significant role for TAZ in the progression of prostate cancer.	[Liu, Chen-Ying; Yu, Tong; Huang, Yuji; Cui, Long] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal & Anal Surg, Shanghai 200092, Peoples R China; [Liu, Chen-Ying; Hong, Wanjin] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore	Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liu, CY; Cui, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal & Anal Surg, Shanghai 200092, Peoples R China.; Liu, CY; Hong, WJ (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	cyliu_eric@126.com; longcuidr@126.com; mcbhwj@imcb.a-star.edu.sg		Hong, Wanjin/0000-0002-1719-8960; cui, long/0000-0003-1838-4471; Liu, Chen-Ying/0000-0002-8930-6182	National Natural Science Foundation of China [81672517, 81372636]; Medical Engineering Interdisciplinary Grant of Shanghai Jiao Tong University [YG2014MS71]; Agency for Science, Technology and Research (A*STAR) funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Engineering Interdisciplinary Grant of Shanghai Jiao Tong University; Agency for Science, Technology and Research (A*STAR) funds(Agency for Science Technology & Research (A*STAR))	This work was supported by National Natural Science Foundation of China Grants 81672517 and 81372636 and Medical Engineering Interdisciplinary Grant YG2014MS71 of Shanghai Jiao Tong University. This study was also supported by the Agency for Science, Technology and Research (A*STAR) funds (to W. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Byun MR, 2014, BONE, V58, P72, DOI 10.1016/j.bone.2013.09.024; Byun MR, 2013, EUR J PHARMACOL, V718, P181, DOI 10.1016/j.ejphar.2013.08.035; Chen GY, 2016, ONCOL LETT, V12, P1821, DOI 10.3892/ol.2016.4829; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Elbediwy A, 2012, J CELL BIOL, V198, P677, DOI 10.1083/jcb.201202094; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst Peter C, 2011, Genes Cancer, V1, P1044; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Jeong GO, 2013, CELL PHYSIOL BIOCHEM, V32, P253, DOI 10.1159/000354434; Kim TD, 2016, J CLIN INVEST, V126, P706, DOI 10.1172/JCI78132; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, P1975, DOI DOI 10.1093/JNCI/DJV048; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li N, 2016, CANCER RES, V76, P831, DOI 10.1158/0008-5472.CAN-15-0906; Liu CY, 2016, ONCOTARGET, V7, P13706, DOI 10.18632/oncotarget.7333; Liu Y, 2016, ONCOGENE, V35, P2789, DOI 10.1038/onc.2015.342; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Tang W, 2014, BRIT J CANCER, V110, P450, DOI 10.1038/bjc.2013.724; Tao YM, 2016, ONCOTARGET, V7, P18356, DOI 10.18632/oncotarget.7786; Thoma Clemens, 2015, Nat Rev Urol, V12, P596, DOI 10.1038/nrurol.2015.240; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Xin L, 2013, ONCOGENE, V32, P3655, DOI 10.1038/onc.2012.541; Xue P, 2013, BIOCHEM BIOPH RES CO, V433, P226, DOI 10.1016/j.bbrc.2013.02.088; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang L, 2015, MOL CELL BIOL, V35, P1350, DOI 10.1128/MCB.00102-15; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	36	35	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9420	9430		10.1074/jbc.M117.783787	http://dx.doi.org/10.1074/jbc.M117.783787			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28408625	hybrid, Green Published			2022-12-28	WOS:000402538900034
J	Ma, ZY; Chalkley, RJ; Vosseller, K				Ma, Zhiyuan; Chalkley, Robert J.; Vosseller, Keith			Hyper-O-GlcNAcylation activates nuclear factor kappa-light-chainenhancer of activated B cells (NF-kappa B) signaling through interplay with phosphorylation and acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL ACTIVITY; CANCER DEVELOPMENT; GLCNAC; ACETYLGLUCOSAMINE; GLYCOSYLATION; SITES; COMPLEX; GLUCOSE	O-GlcNAcylation is the covalent addition of an O-linked beta-N-acetylglucosamine (O-GlcNAc) sugar moiety to hydroxyl groups of serine/threonine residues of cytosolic and nuclear proteins. O-GlcNAcylation, analogous to phosphorylation, plays critical roles in gene expression through direct modification of transcription factors, such as NF-kappa B. Aberrantly increased NF-kappa B O-GlcNAcylation has been linked to NF-kappa B constitutive activation and cancer development. Therefore, it is of a great biological and clinical significance to dissect the molecular mechanisms that tune NF-kappa B activity. Recently, we and others have shown that O-GlcNAcylation affects the phosphorylation and acetylation of NF-kappa B subunit p65/ RelA. However, the mechanism of how O-GlcNAcylation activates NF-kappa B signaling through phosphorylation and acetylation is not fully understood. In this study, we mappedO-GlcNAcylation sites of p65 at Thr-305, Ser319, Ser-337, Thr-352, and Ser-374. O-GlcNAcylation of p65 at Thr-305 and Ser-319 increased CREB-binding protein (CBP)/ p300-dependent activating acetylation of p65 at Lys-310, contributing to NF-kappa B transcriptional activation. Moreover, elevation of O-GlcNAcylation by overexpression of OGT increased the expression of p300, IKK alpha, and IKK beta and promoted IKKmediated activating phosphorylation of p65 at Ser-536, contributing to NF-kappa B activation. In addition, we also identified phosphorylation of p65 at Thr-308, which might impair the O-GlcNAcylation of p65 at Thr-305. These results indicate mechanisms through which both non-pathological and oncogenicO- GlcNAcylation regulate NF-kappa Bsignaling through interplay with phosphorylation and acetylation.	[Ma, Zhiyuan; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,New Coll Bldg, Philadelphia, PA 19102 USA; [Chalkley, Robert J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Drexel University; University of California System; University of California San Francisco	Vosseller, K (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,New Coll Bldg, Philadelphia, PA 19102 USA.; Ma, ZY (corresponding author), Duke Univ, Div Cardiol, Med Ctr, 303 Res Dr,Sands Bldg,Rm 318, Durham, NC 27710 USA.	zhiyuan.ma@dm.duke.edu; kvosseller@gmail.com	Ma, ZhiYuan/GWN-1061-2022; Ma, Zhiyuan/I-6678-2015	Chalkley, Robert/0000-0002-9757-7302; Ma, Zhiyuan/0000-0002-0381-7804				Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Cervantes CF, 2011, J MOL BIOL, V405, P754, DOI 10.1016/j.jmb.2010.10.055; Chalkley RJ, 2005, METHOD ENZYMOL, V402, P289, DOI 10.1016/S0076-6879(05)02009-4; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Fan YH, 2009, J BIOL CHEM, V284, P29290, DOI 10.1074/jbc.M109.018994; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Wang BL, 2015, J BIOL CHEM, V290, P20336, DOI 10.1074/jbc.M115.639849; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang YR, 2015, ONCOTARGET, V6, P12529, DOI 10.18632/oncotarget.3725; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	37	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9150	9163		10.1074/jbc.M116.766568	http://dx.doi.org/10.1074/jbc.M116.766568			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28416608	Green Published, hybrid			2022-12-28	WOS:000402538900012
J	Feinberg, H; Jegouzo, SAF; Rex, MJ; Drickamer, K; Weis, WI; Taylor, ME				Feinberg, Hadar; Jegouzo, Sabine A. F.; Rex, Maximus J.; Drickamer, Kurt; Weis, William I.; Taylor, Maureen E.			Mechanism of pathogen recognition by human dectin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; STRUCTURAL-BASIS; HOST-DEFENSE; BINDING PROTEINS; LIGAND-BINDING; DC-SIGN; RECEPTOR; EXPRESSION; IDENTIFICATION; GLYCANS	Dectin-2, a C-type lectin on macrophages and other cells of the innate immune system, functions in response to pathogens, particularly fungi. The carbohydrate-recognition domain (CRD) in dectin-2 is linked to a transmembrane sequence that interacts with the common Fc receptor gamma subunit to initiate immune signaling. The molecular mechanism by which dectin-2 selectively binds to pathogens has been investigated by characterizing the CRD expressed in a bacterial system. Competition binding studies indicated that the CRD binds to monosaccharides with modest affinity and that affinity was greatly enhanced for mannose-linked alpha 1-2 or alpha 1-4 to a second mannose residue. Glycan array analysis confirmed selective binding of the CRD to glycans that contain Man alpha 1-2Man epitopes. Crystals of the CRD in complex with a mammalian-type high-mannose Man(9)GlcNAc(2) oligosaccharide exhibited interaction with Man alpha 1-2Man on two different termini of the glycan, with the reducing-end mannose residue ligated to Ca2+ in a primary binding site and the nonreducing terminal mannose residue occupying an adjacent secondary site. Comparison of the binding sites in DC-SIGN and langerin, two other pathogen-binding receptors of the innate immune system, revealed why these two binding sites accommodate only terminal Man alpha 1-2Man structures, whereas dectin-2 can bind Man alpha 1-2Man in internal positions in mannans and other polysaccharides. The specificity and geometry of the dectin-2-binding site provide the molecular mechanism for binding of dectin-2 to fungal mannans and also to bacterial lipopolysaccharides, capsular polysaccharides, and lipoarabinomannans that contain the Man alpha 1-2Man disaccharide unit.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Jegouzo, Sabine A. F.; Rex, Maximus J.; Drickamer, Kurt; Taylor, Maureen E.] Imperial Coll London, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England	Stanford University; Stanford University; Imperial College London	Taylor, ME (corresponding author), Imperial Coll London, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	; Weis, William/G-1437-2011	Jegouzo, Sabine/0000-0001-7768-0102; Taylor, Maureen/0000-0001-8300-4987; Weis, William/0000-0002-5583-6150	Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NCRR Grant [P41RR001209]; BBSRC [BB/K007718/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K007718/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM062116] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Brian Matthews and Dawn Torgerson of the Glycobiology Institute, University of Oxford, for preparation of the oligosaccharide ligand and David Smith and Jamie Molinaro of the Consortium for Functional Glycomics for glycan array analysis. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS Grant P41GM103393, and NCRR Grant P41RR001209.	ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Bloem K, 2014, IMMUNOL LETT, V158, P33, DOI 10.1016/j.imlet.2013.11.007; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Fernandes MJ, 1999, CANCER RES, V59, P2709; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Gavino ACP, 2005, EXP DERMATOL, V14, P281, DOI 10.1111/j.0906-6705.2005.00312.x; GORDON JA, 1972, FEBS LETT, V24, P193, DOI 10.1016/0014-5793(72)80765-8; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Heimburg-Molinaro Jamie, 2011, Curr Protoc Protein Sci, VChapter 12, DOI 10.1002/0471140864.ps1210s64; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Ikuta K, 1997, BIOCHEM J, V323, P297, DOI 10.1042/bj3230297; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Jegouzo SAF, 2015, J BIOL CHEM, V290, P16759, DOI 10.1074/jbc.M115.660613; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Jegouzo SAF, 2013, GLYCOBIOLOGY, V23, P853, DOI 10.1093/glycob/cwt022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanazawa N, 2004, J INVEST DERMATOL, V122, P1522, DOI 10.1111/j.0022-202X.2004.22602.x; Katzenellenbogen E, 2001, FEMS IMMUNOL MED MIC, V30, P223; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Levitzki A., 1997, PROTEIN FUNCTION PRA, P101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFadden D. C., 2017, EUKARYOT CELL, V8, P1464; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Nagae M, 2013, J BIOL CHEM, V288, P33598, DOI 10.1074/jbc.M113.513572; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Parsons MW, 2014, J IMMUNOL, V192, P1361, DOI 10.4049/jimmunol.1301809; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; San-Blas G, 2005, MED MYCOL, V43, P153, DOI 10.1080/13693780410001731556; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Shang FF, 2011, J BIOL CHEM, V286, P757, DOI 10.1074/jbc.M110.175265; Shibata N, 2010, CHEM PHARM BULL, V58, P1386, DOI 10.1248/cpb.58.1386; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wittmann A, 2016, J BIOL CHEM, V291, P17629, DOI 10.1074/jbc.M116.741256; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	59	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13402	13414		10.1074/jbc.M117.799080	http://dx.doi.org/10.1074/jbc.M117.799080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28652405	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000407465300026
J	Shmuel-Galia, L; Klug, Y; Porat, Z; Charni, M; Zarmi, B; Shai, Y				Shmuel-Galia, Liraz; Klug, Yoel; Porat, Ziv; Charni, Meital; Zarmi, Batya; Shai, Yechiel			Intramembrane attenuation of the TLR4-TLR6 dimer impairs receptor assembly and reduces microglia-mediated neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; ESCHERICHIA-COLI; HUMAN PROSTATE; TUMOR-GROWTH; CELL-LINE; ACTIVATION; INFLAMMATION; PEPTIDE	Recently, a single study revealed a new complex composed of Toll-like receptor 4 (TLR4), TLR6, and CD36 induced by fibrillary A beta peptides, the hallmark of Alzheimer's disease. Unlike TLRs located on the plasma membrane that dimerize on the membrane after ligand binding to their extracellular domain, the TLR4-TLR6-CD36 complex assembly has been suggested to be induced by intracellular signals from CD36, similar to integrin inside-out signaling. However, the assembly site of TLR4-TLR6-CD36 and the domains participating in A beta-induced signaling is still unknown. By interfering with TLR4-TLR6 dimerization using a TLR4-derived peptide, we show that receptor assembly is abrogated within the plasma membrane. Furthermore, we reveal that the transmembrane domains of TLR4 and TLR6 have an essential role in receptor dimerization and activation. Inhibition of TLR4-TLR6 assembly was associated with reduced secretion of proinflammatory mediators from microglia cells, ultimately rescuing neurons from death. Our findings support TLR4-TLR6 dimerization induced by A beta. Moreover, we shed new light on TLR4-TLR6 assembly and localization and show the potential of inhibiting TLR4-TLR6 dimerization as a treatment of Alzheimer's disease.	[Shmuel-Galia, Liraz; Klug, Yoel; Charni, Meital; Zarmi, Batya; Shai, Yechiel] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Porat, Ziv] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	yechiel.shai@weizmann.ac.il	Porat, Ziv/K-1672-2012; Klug, Yoel/GRS-5957-2022	Porat, Ziv/0000-0003-3059-181X; Charni-Natan, Meital/0000-0003-0221-1664	Benoziyo Center for Neurological Diseases at the Weizmann Institute of science; Israel Science Foundation [1409/12]	Benoziyo Center for Neurological Diseases at the Weizmann Institute of science; Israel Science Foundation(Israel Science Foundation)	This work was supported by the Benoziyo Center for Neurological Diseases at the Weizmann Institute of science and partially by the Israel Science Foundation (Grant 1409/12). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alam Q, 2016, CURR PHARM DESIGN, V22, P541, DOI 10.2174/1381612822666151125000300; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016/j.intimp.2011.05.006; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Combs CK, 2009, J NEUROIMMUNE PHARM, V4, P380, DOI 10.1007/s11481-009-9165-3; Dmitrova M, 1998, MOL GEN GENET, V257, P205; Fink A, 2013, J IMMUNOL, V190, P6410, DOI 10.4049/jimmunol.1202033; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fukata M, 2013, MUCOSAL IMMUNOL, V6, P451, DOI 10.1038/mi.2013.13; Gambuzza ME, 2014, CNS NEUROL DISORD-DR, V13, P1542, DOI 10.2174/1871527313666140806124850; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Gold M, 2015, SEMIN IMMUNOPATHOL, V37, P607, DOI 10.1007/s00281-015-0518-0; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Li J, 2013, PHARMACOL THERAPEUT, V138, P441, DOI 10.1016/j.pharmthera.2013.03.003; Liu F, 2004, BIOCHEMISTRY-US, V43, P3679, DOI 10.1021/bi036214l; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Qi YP, 1997, J NEUROSCI, V17, P1217; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; Reuven EM, 2014, BBA-BIOMEMBRANES, V1838, P1586, DOI 10.1016/j.bbamem.2014.01.020; Rotem E, 2016, BIOCHEMISTRY-US, V55, P1049, DOI 10.1021/acs.biochem.5b01307; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Shmuel-Galia L, 2016, EMBO J, V35, P685, DOI 10.15252/embj.201592649; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tan LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003966; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Vadillo E, 2012, REV INVEST CLIN, V64, P461; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	45	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13415	13427		10.1074/jbc.M117.784983	http://dx.doi.org/10.1074/jbc.M117.784983			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655763	hybrid, Green Published			2022-12-28	WOS:000407465300027
J	Franke, B; James, AM; Mobli, M; Colgrave, ML; Mylne, JS; Rosengren, KJ				Franke, Bastian; James, Amy M.; Mobli, Mehdi; Colgrave, Michelle L.; Mylne, Joshua S.; Rosengren, K. Johan			Two proteins for the price of one: Structural studies of the dual-destiny protein preproalbumin with sunflower trypsin inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic peptide; nuclear magnetic resonance (NMR); plant biochemistry; post-translational modification (PTM); protein processing; preproalbumin with SFTI-1 (PawS1); sunflower trypsin inhibitor-1 (SFTI-1); asparaginyl endopeptidase (AEP); seed storage albumin	SEED STORAGE ALBUMINS; ASPARAGINYL-ENDOPEPTIDASE; PEPTIDE MACROCYCLIZATION; CYCLIC-PEPTIDES; BIOSYNTHESIS; CRYSTALLOGRAPHY; STABILITY; PRECURSOR; RAPESEED; BACKBONE	Seed storage proteins are both an important source of nutrition for humans and essential for seedling establishment. Interestingly, unusual napin-type 2S seed storage albumin precursors in sunflowers contain a sequence that is released as a macrocyclic peptide during post-translational processing. The mechanism by which such peptides emerge from linear precursor proteins has received increased attention; however, the structural characterization of intact precursor proteins has been limited. Here, we report the 3D NMR structure of the Helianthus annuus PawS1 (preproalbumin with sunflower trypsin inhibitor-1) and provide new insights into the processing of this remarkable dual-destiny protein. In seeds, PawS1 is matured by asparaginyl endopeptidases (AEPs) into the cyclic peptide SFTI-1 (sunflower trypsin inhibitor-1) and a heterodimeric 2S albumin. The structure of PawS1 revealed that SFTI-1 and the albumin are independently folded into well-defined domains separated by a flexible linker. PawS1 was cleaved in vitro with recombinant sunflower HaAEP1 and in situ using a sunflower seed extract in a way that resembled the expected in vivo cleavages. Recombinant HaAEP1 cleaved PawS1 at multiple positions, and in situ, its flexible linker was removed, yielding fully mature heterodimeric albumin. Liberation and cyclization of SFTI-1, however, was inefficient, suggesting that specific seed conditions or components may be required for in vivo biosynthesis of SFTI-1. In summary, this study has revealed the 3D structure of a macrocyclic precursor protein and provided important mechanistic insights into the maturation of sunflower proalbumins into an albumin and a macrocyclic peptide.	[Franke, Bastian; Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [James, Amy M.; Mylne, Joshua S.] Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia; [James, Amy M.; Mylne, Joshua S.] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Colgrave, Michelle L.] CSIRO Agr & Food, Brisbane, Qld 4067, Australia	University of Queensland; University of Queensland; University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rosengren, KJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	j.rosengren@uq.edu.au	Mylne, Josh/GMX-4544-2022; Mylne, Joshua S/A-5581-2009; Rosengren, K. Johan/P-4450-2016; Colgrave, Michelle/A-5710-2012; Mobli, Mehdi/O-7244-2014	Mylne, Josh/0000-0003-4957-6388; Mylne, Joshua S/0000-0003-4957-6388; Rosengren, K. Johan/0000-0002-5007-8434; Colgrave, Michelle/0000-0001-8463-805X; Mobli, Mehdi/0000-0003-2420-4262; Franke, Bastian/0000-0001-8029-4069; James, Amy/0000-0001-9978-0876	Australian Research Council [DP120103369, FT110100925, FT120100013, FT130100890]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP120103369 (to J.S.M. and K.J.R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Research Council Future Fellowships FT110100925, FT120100013, and FT130100890, respectively.	[Anonymous], 1999, SEED PROTEINS; Bernath-Levin K, 2015, CHEM BIOL, V22, P571, DOI 10.1016/j.chembiol.2015.04.010; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 2016, BIOPOLYMERS, V106, P825, DOI 10.1002/bip.22977; Elliott AG, 2014, PLANT CELL, V26, P981, DOI 10.1105/tpc.114.123620; ERICSON ML, 1986, J BIOL CHEM, V261, P4576; Franke B, 2016, J PROTEOMICS, V147, P177, DOI 10.1016/j.jprot.2016.05.004; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harris KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10199; Himeno K, 2015, BIOCHEMISTRY-US, V54, P4863, DOI 10.1021/acs.biochem.5b00196; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; Hoch JC, 1996, NMR DATA PROCESSING; Jayasena AS, 2016, THEOR APPL GENET, V129, P613, DOI 10.1007/s00122-015-2653-3; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; KORTT AA, 1991, EUR J BIOCHEM, V195, P329, DOI 10.1111/j.1432-1033.1991.tb15710.x; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; Li DF, 2008, J STRUCT BIOL, V162, P50, DOI 10.1016/j.jsb.2007.12.007; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mylne JS, 2014, FUNCT PLANT BIOL, V41, P671, DOI 10.1071/FP14035; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nguyen GKT, 2014, NAT CHEM BIOL, V10, P732, DOI [10.1038/NCHEMBIO.1586, 10.1038/nchembio.1586]; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P16036, DOI 10.1021/bi048069x; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P6976, DOI 10.1021/bi0496900; Pantoja-Uceda D, 2003, BIOCHEMISTRY-US, V42, P13839, DOI 10.1021/bi0352217; Rico M, 1996, BIOCHEMISTRY-US, V35, P15672, DOI 10.1021/bi961748q; Rundqvist L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046435; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wuthrich K, 1986, NMR PROTEINS NUCL AC	42	8	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12398	12411		10.1074/jbc.M117.776955	http://dx.doi.org/10.1074/jbc.M117.776955			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28536266	hybrid, Green Published			2022-12-28	WOS:000406636900006
J	Martin, B; Wang, R; Cong, WN; Daimon, CM; Wu, WW; Ni, B; Becker, KG; Lehrmann, E; Wood, WH; Zhang, YQ; Etienne, H; van Gastel, J; Azmi, A; Janssens, J; Maudsley, S				Martin, Bronwen; Wang, Rui; Cong, Wei-Na; Daimon, Caitlin M.; Wu, Wells W.; Ni, Bin; Becker, Kevin G.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Etienne, Harmonie; van Gastel, Jaana; Azmi, Abdelkrim; Janssens, Jonathan; Maudsley, Stuart			Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE DENSITY; CA1 PYRAMIDAL NEURONS; RECESSIVE INTELLECTUAL DISABILITY; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; SYNAPTIC PLASTICITY; MOUSE MODEL; METABOLIC SYNDROME; CREB PHOSPHORYLATION	The type 1 taste receptor member 3 (T1R3) is a G protein-coupled receptor involved in sweet-taste perception. Besides the tongue, the T1R3 receptor is highly expressed in brain areas implicated in cognition, including the hippocampus and cortex. As cognitive decline is often preceded by significant metabolic or endocrinological dysfunctions regulated by the sweet-taste perception system, we hypothesized that a disruption of the sweet-taste perception in the brain could have a key role in the development of cognitive dysfunction. To assess the importance of the sweet-taste receptors in the brain, we conducted transcriptomic and proteomic analyses of cortical and hippocampal tissues isolated from T1R3 knock-out (T1R3KO) mice. The effect of an impaired sweet-taste perception system on cognition functions were examined by analyzing synaptic integrity and performing animal behavior on T1R3KO mice. Although T1R3KO mice did not present a metabolically disrupted phenotype, bioinformatic interpretation of the high-dimensionality data indicated a strong neurodegenerative signature associated with significant alterations in pathways involved in neuritogenesis, dendritic growth, and synaptogenesis. Furthermore, a significantly reduced dendritic spine density was observed inT1R3KO mice together with alterations in learning and memory functions as well as sociability deficits. Taken together our data suggest that the sweet-taste receptor system plays an important neurotrophic role in the extralingual central nervous tissue that underpins synaptic function, memory acquisition, and social behavior.	[Martin, Bronwen; Wang, Rui; Cong, Wei-Na; Daimon, Caitlin M.; Wu, Wells W.] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Ni, Bin; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Etienne, Harmonie; van Gastel, Jaana; Azmi, Abdelkrim; Janssens, Jonathan; Maudsley, Stuart] Univ Antwerp VIB, Dept Mol Genet, Translat Neurobiol Grp, AN-2610 Antwerp, Belgium; [Etienne, Harmonie; van Gastel, Jaana; Azmi, Abdelkrim; Janssens, Jonathan; Maudsley, Stuart] Univ Antwerp, Dept Biomed Sci, AN-2610 Antwerp, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Flanders Institute for Biotechnology (VIB); University of Antwerp	Maudsley, S (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	stuart.maudsley@molgen.vib-ua.be	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Wang, Rui/I-5643-2019	Maudsley, Stuart/0000-0002-1868-184X; Wang, Rui/0000-0001-7015-0272; Lehrmann, Elin/0000-0002-9869-9475; Martin, Bronwen/0000-0002-9185-6925; AZMI, ASFAR/0000-0003-1178-9505	National Institutes of Health Intramural Research Program Grants from the NIA [AG000915-01, AG000917-01]; FWO Odysseus Program; Flemish Government Inter-university VIND (Flemish Impulse Funding for Networks in Dementia Research) Initiative; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program Grants from the NIA; FWO Odysseus Program; Flemish Government Inter-university VIND (Flemish Impulse Funding for Networks in Dementia Research) Initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Intramural Research Program Grants AG000915-01 and AG000917-01 from the NIA. This work also was supported by the FWO Odysseus Program and the Flemish Government Inter-university VIND (Flemish Impulse Funding for Networks in Dementia Research) Initiative. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed RM, 2014, JAMA NEUROL, V71, P1540, DOI 10.1001/jamaneurol.2014.1931; Akram A, 2008, NEUROBIOL AGING, V29, P1296, DOI 10.1016/j.neurobiolaging.2007.03.007; Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Auffret A, 2009, J NEUROSCI, V29, P10144, DOI 10.1523/JNEUROSCI.1856-09.2009; Baroukh C, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-15; Barrios FA, 2007, NEUROREPORT, V18, P73, DOI 10.1097/WNR.0b013e3280102302; Behnke J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030612; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015477; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; Bohnen NI, 2013, J NEURAL TRANSM, V120, P571, DOI 10.1007/s00702-012-0956-y; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Borroto-Escuela DO, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00037; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Butterfield DA, 2006, J ALZHEIMERS DIS, V10, P391; Cahana-Amitay D, 2015, J INT NEUROPSYCH SOC, V21, P116, DOI 10.1017/S1355617715000028; Cai H, 2014, FRONT HORM RES, V42, P134, DOI 10.1159/000358322; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062665; Chen H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00008; Cheung WA, 2012, GENOME MED, V4, DOI 10.1186/gm376; Choi KJ, 2014, J BIOSCIENCES, V39, P97, DOI 10.1007/s12038-013-9406-8; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; COLOMBARI E, 1995, BRAIN RES, V677, P110, DOI 10.1016/0006-8993(95)00131-9; Cong WN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070257; Cong WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047240; Copland D., 2015, FRONT HUM NEUR C ABS, DOI [10.3389/conf.fnhum.2015.217.00165, DOI 10.3389/CONF.FNHUM.2015.217.00165]; Countryman RA, 2007, LEARN MEMORY, V14, P350, DOI 10.1101/lm.524907; Counts SE, 2014, NEUROPHARMACOLOGY, V79, P172, DOI 10.1016/j.neuropharm.2013.10.018; Daimon CM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00324; Dang YH, 2015, NEUROSCI LETT, V607, P40, DOI 10.1016/j.neulet.2015.08.026; Darcy MJ, 2014, HIPPOCAMPUS, V24, P315, DOI 10.1002/hipo.22225; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Davis SA, 2017, NEUROBIOL DIS, V103, P154, DOI 10.1016/j.nbd.2017.04.012; Decker JM, 2010, NEUROSCIENCE, V169, P8, DOI 10.1016/j.neuroscience.2010.04.064; del Valle J, 2012, J ALZHEIMERS DIS, V32, P233, DOI 10.3233/JAD-2012-120718; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehninger D, 2011, BEHAV GENET, V41, P357, DOI 10.1007/s10519-010-9398-1; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Euskirchen P, 2014, J NEUROL SCI, V345, P278, DOI 10.1016/j.jns.2014.07.054; Exalto LG, 2015, J NEUROL SCI, V351, P18, DOI 10.1016/j.jns.2015.02.004; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Fukai R, 2014, AM J MED GENET A, V164, P1021, DOI 10.1002/ajmg.a.36377; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Goeldner C, 2013, NEUROPHARMACOLOGY, V64, P337, DOI 10.1016/j.neuropharm.2012.08.001; Green E, 2015, BRAIN RES, V1620, P57, DOI 10.1016/j.brainres.2015.03.034; Hamr SC, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0604-7; Heese K, 2004, J CELL BIOCHEM, V91, P1030, DOI 10.1002/jcb.20010; Heyanka DJ, 2014, APPL NEUROPSYCH-ADUL, V21, P176, DOI 10.1080/09084282.2013.782031; Hotokezaka Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.90; Huey ED, 2006, NEUROLOGY, V66, P17, DOI 10.1212/01.wnl.0000191304.55196.4d; Iqbal Z, 2015, AM J HUM GENET, V96, P386, DOI 10.1016/j.ajhg.2015.01.010; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jacova C, 2013, NEUROLOGY, V81, P1322, DOI 10.1212/WNL.0b013e3182a8237e; James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224; Janssens J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0246-7; Jaramillo TC, 2014, AUTISM RES, V7, P264, DOI 10.1002/aur.1362; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim YN, 2014, FREE RADICAL BIO MED, V69, P181, DOI 10.1016/j.freeradbiomed.2014.01.006; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Kojima I, 2014, ENDOCRINOL METAB, V29, P12, DOI 10.3803/EnM.2014.29.1.12; Kumar D, 2015, AGE, V37, DOI 10.1007/s11357-015-9752-6; Lai JK, 2016, J COMP NEUROL, V524, P807, DOI 10.1002/cne.23868; Lauvin M-A, 2012, Diagn Interv Imaging, V93, P139, DOI 10.1016/j.diii.2012.01.007; Laws SM, 2007, AM J PSYCHIAT, V164, P1577, DOI 10.1176/appi.ajp.2007.06091456; Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lin N, 2014, BEHAV BRAIN RES, V258, P8, DOI 10.1016/j.bbr.2013.10.010; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Martin B, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00191; Martin B, 2012, J BIOL CHEM, V287, P31766, DOI 10.1074/jbc.M112.387316; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Maudsley S, 2016, METHODS, V92, P51, DOI 10.1016/j.ymeth.2015.05.013; McNay EC, 2004, DIABETES, V53, P418, DOI 10.2337/diabetes.53.2.418; Melachroinou K, 2013, NEUROBIOL AGING, V34, P2853, DOI 10.1016/j.neurobiolaging.2013.06.006; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Meyer-Gerspach AC, 2014, FRONT HORM RES, V42, P123, DOI 10.1159/000358321; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miura Y, 2012, BBA-GEN SUBJECTS, V1820, P1678, DOI 10.1016/j.bbagen.2012.06.013; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Mohajeri MH, 2009, NEUROCHEM RES, V34, P717, DOI 10.1007/s11064-009-9919-6; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morris KA, 2013, EXP GERONTOL, V48, P115, DOI 10.1016/j.exger.2012.11.010; Morris KA, 2010, NEUROBIOL AGING, V31, P2136, DOI 10.1016/j.neurobiolaging.2008.12.003; Murmu RP, 2015, J NEUROSCI, V35, P287, DOI 10.1523/JNEUROSCI.0244-14.2015; Nagaoka S, 1995, PROG NEURO-PSYCHOPH, V19, P1251, DOI 10.1016/0278-5846(95)00264-2; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Nie DY, 2015, J NEUROSCI, V35, P10762, DOI 10.1523/JNEUROSCI.4796-14.2015; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pedros I, 2015, J NUTR HEALTH AGING, V19, P403, DOI 10.1007/s12603-014-0574-5; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Prasad S, 2008, BIOCHEM BIOPH RES CO, V376, P347, DOI 10.1016/j.bbrc.2008.08.155; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Richards P, 2011, CELL DEATH DIFFER, V18, P191, DOI 10.1038/cdd.2010.127; Riise J, 2015, J NEURAL TRANSM, V122, P1303, DOI 10.1007/s00702-015-1375-7; Rinne JO, 2002, NEUROLOGY, V58, P1489, DOI 10.1212/WNL.58.10.1489; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sabater L, 2005, J NEUROIMMUNOL, V170, P186, DOI 10.1016/j.jneuroim.2005.08.011; Seltman RE, 2012, CNS DRUGS, V26, P841, DOI 10.2165/11640070-000000000-00000; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Song JM, 2016, J ALZHEIMERS DIS, V51, P591, DOI 10.3233/JAD-150717; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spreckley Eleanor, 2015, Front Nutr, V2, P23, DOI 10.3389/fnut.2015.00023; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Talevi A, 2012, BIOORG MED CHEM LETT, V22, P4072, DOI 10.1016/j.bmcl.2012.04.076; Teich AF, 2015, NEUROTHERAPEUTICS, V12, P29, DOI 10.1007/s13311-014-0327-5; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Tomasevic G, 2012, J NEUROSURG, V116, P1368, DOI 10.3171/2012.2.JNS11888; Tordoff MG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00496; Tordoff MG, 2008, PHYSIOL GENOMICS, V34, P338, DOI 10.1152/physiolgenomics.90200.2008; Tran PV, 2015, AM J PHYSIOL-REG I, V308, pR276, DOI 10.1152/ajpregu.00429.2014; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Varadarajulu J, 2011, BEHAV BRAIN RES, V220, P305, DOI 10.1016/j.bbr.2011.02.012; Verfaillie SCJ, 2015, EUR RADIOL, V25, P3050, DOI 10.1007/s00330-015-3696-1; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Wagner MJ, 2017, NATURE, V544, P96, DOI 10.1038/nature21726; Waltl S, 2015, CLIN GENET, V88, P136, DOI 10.1111/cge.12610; Wang R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00231; Warmus BA, 2014, J NEUROSCI, V34, P16482, DOI 10.1523/JNEUROSCI.3418-14.2014; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Winocur G, 1998, NEUROBIOL AGING, V19, P233, DOI 10.1016/S0197-4580(98)00057-8; Woolley JD, 2007, NEUROLOGY, V69, P1424, DOI 10.1212/01.wnl.0000277461.06713.23; Wu K, 2012, NEUROBIOL LEARN MEM, V97, P69, DOI 10.1016/j.nlm.2011.09.006; Wu WW, 2012, J PROTEOMICS, V75, P2480, DOI 10.1016/j.jprot.2012.02.027; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yamashita N, 2016, J CELL SCI, V129, P1802, DOI 10.1242/jcs.184580; Yang L, 2016, BRAIN BEHAV IMMUN, V56, P352, DOI 10.1016/j.bbi.2016.03.001; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yasuda R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005611; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	173	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11508	11530		10.1074/jbc.M116.773820	http://dx.doi.org/10.1074/jbc.M116.773820			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28522608	hybrid, Green Published			2022-12-28	WOS:000405119600032
J	Gu, JL; Chen, F; Iqbal, K; Gong, CX; Wang, XL; Liu, F				Gu, Jianlan; Chen, Feng; Iqbal, Khalid; Gong, Cheng-Xin; Wang, Xinglong; Liu, Fei			Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; Alzheimer disease; TAR DNA-binding protein 43 (TDP-43) (TARDBP); tau protein (tau); tauopathy	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; PICKS-DISEASE; SR PROTEINS; MUTATIONS; PATHOLOGY; GENE; PHOSPHORYLATION; NEURODEGENERATION	Hyperphosphorylation and aggregation of the neuronal protein tau are responsible for neurodegenerative diseases called tauopathies. Dysregulation of the alternative splicing of tau exon 10 results in alterations of the ratio of two tau isoforms, 3R-tau and 4R-tau, which have been seen in several tauopathies. Transactive response DNA-binding protein of 43 kDa (TDP-43) is involved in the regulation of RNA processing, including splicing. Cytoplasmic aggregation of TDP-43 has been observed in the brains of individuals with chronic traumatic encephalopathy or Alzheimer's disease, diseases in which neurofibrillary tangles of hyperphosphorylated tau are hallmarks. Here, we investigated the role of TDP-43 in tau exon 10 splicing. We found that TDP-43 promoted tau exon 10 inclusion, which increased production of the 4R-tau isoform. Moreover, TDP-43 could bind to intron 9 of tau pre-mRNA. Deletion of the TDP-43 N or C terminus promoted its cytoplasmic aggregation and abolished or diminished TDP-43-promoted tau exon 10 inclusion. Several TDP-43 mutations associated with amyotrophic lateral sclerosis or frontotemporal lobar degeneration with ubiquitin inclusions promoted tau exon 10 inclusion more effectively than wild-type TDP-43 but did not affect TDP-43 cytoplasmic aggregation in cultured cells. The ratio of 3R-tau/4R-tau was decreased in transgenic mouse brains expressing human TDP-43 and increased in the brains expressing the disease-causing mutation TDP-43(M337V), in which cytoplasmic TDP-43 was increased. These findings suggest that TDP-43 promotes tau exon 10 inclusion and 4R-tau expression and that disease-related changes of TDP-43, truncations and mutations, affect its function in tau exon 10 splicing, possibly because of TDP-43 mislocalization to the cytoplasm.	[Gu, Jianlan; Chen, Feng; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Coinnovat Ctr Neuroregenerat, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Gu, Jianlan; Chen, Feng; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Gu, Jianlan] Nantong Univ, Sch Med, Dept Biochem & Mol Biol, Nantong 226001, Jiangsu, Peoples R China; [Gu, Jianlan; Chen, Feng; Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; [Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Nantong University; Nantong University; Nantong University; Institute for Basic Research in Developmental Disabilities; Case Western Reserve University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com			Nantong University; New York State Office for People With Developmental Disabilities; National Natural Science Foundation of China [81030059, 31671046]; Natural Science Foundation from Jiangsu Education Department [16KJB310013]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); United States Alzheimer's Association Grant [DSAD-15-363172]	Nantong University; New York State Office for People With Developmental Disabilities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation from Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); United States Alzheimer's Association Grant	This work was supported by Nantong University, the New York State Office for People With Developmental Disabilities, National Natural Science Foundation of China Grants 81030059 and 31671046, Natural Science Foundation from Jiangsu Education Department Grant 16KJB310013, a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD), and United States Alzheimer's Association Grant DSAD-15-363172. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Borroni B, 2010, REJUV RES, V13, P509, DOI 10.1089/rej.2010.1017; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; CHOI DW, 1987, J NEUROSCI, V7, P357; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; DEGARCINI EM, 1986, BIOCHIM BIOPHYS ACTA, V881, P456, DOI 10.1016/0304-4165(86)90039-5; Ding SH, 2012, NEUROBIOL AGING, V33, P1389, DOI 10.1016/j.neurobiolaging.2010.11.021; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gregory JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031899; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gu JL, 2017, NUCLEIC ACIDS RES, V45, P6177, DOI 10.1093/nar/gkx175; Gu JL, 2012, FEBS LETT, V586, P2239, DOI 10.1016/j.febslet.2012.05.046; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kirby J, 2010, NEUROGENETICS, V11, P217, DOI 10.1007/s10048-009-0218-9; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2001, ANN NEUROL, V50, P503, DOI 10.1002/ana.1223; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Niblock M, 2016, NEUROBIOL AGING, V37, P45, DOI 10.1016/j.neurobiolaging.2015.09.022; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Passoni M, 2012, J MOL BIOL, V415, P46, DOI 10.1016/j.jmb.2011.11.003; Pickering-Brown S, 2000, ANN NEUROL, V48, P859, DOI 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1; Qian W, 2014, NEUROSCI BULL, V30, P367, DOI 10.1007/s12264-013-1411-2; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Umeda T, 2013, AM J PATHOL, V183, P211, DOI 10.1016/j.ajpath.2013.03.015; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Yen SH, 1999, BRAIN PATHOL, V9, P695; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	58	47	48	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10600	10612		10.1074/jbc.M117.783498	http://dx.doi.org/10.1074/jbc.M117.783498			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487370	Green Published, hybrid			2022-12-28	WOS:000404115400020
J	Talwar, T; Vidhyasagar, V; Qing, J; Guo, MH; Kariem, A; Lu, Y; Singh, RS; Lukong, KE; Wu, YL				Talwar, Tanu; Vidhyasagar, Venkatasubramanian; Qing, Jennifer; Guo, Manhong; Kariem, Ahmad; Lu, Yi; Singh, Ravi Shankar; Lukong, Kiven Erique; Wu, Yuliang			The DEAD-box protein DDX43 (HAGE) is a dual RNA-DNA helicase and has a K-homology domain required for full nucleic acid unwinding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA enzyme; DNA helicase; DNA-protein interaction; RNA; RNA-binding protein; RNA helicase; RNA metabolism	FRAGILE-X-SYNDROME; MELANOMA-INITIATING CELLS; C-TERMINAL DOMAIN; MOLECULAR INSIGHTS; BINDING PROTEINS; SPLICING FACTOR; MESSENGER-RNAS; ATP HYDROLYSIS; BREAST-CANCER; GENERAL RNA	The K-homology (KH) domain is a nucleic acid-binding domain present in many proteins but has not been reported in helicases. DDX43, also known as HAGE (helicase antigen gene), is a member of the DEAD-box protein family. It contains a helicase core domain in its C terminus and a potential KH domain in its N terminus. DDX43 is highly expressed in many tumors and is, therefore, considered a potential target for immunotherapy. Despite its potential as a therapeutic target, little is known about its activities. Here, we purified recombinant DDX43 protein to near homogeneity and found that it exists as a monomer in solution. Biochemical assays demonstrated that it is an ATP-dependent RNA and DNA helicase. Although DDX43 was active on duplex RNA regardless of the orientation of the single-stranded RNA tail, it preferred a 5 to 3 polarity on RNA and a 3 to 5 direction on DNA. Truncation mutations and site-directed mutagenesis confirmed that the KH domain in DDX43 is responsible for nucleic acid binding. Compared with the activity of the full-length protein, the C-terminal helicase domain had no unwinding activity on RNA substrates and had significantly reduced unwinding activity on DNA. Moreover, the full-length DDX43 protein, with single amino acid change in the KH domain, had reduced unwinding and binding activates on RNA and DNA substrates. Our results demonstrate that DDX43 is a dual helicase and the KH domain is required for its full unwinding activity.	[Talwar, Tanu; Vidhyasagar, Venkatasubramanian; Qing, Jennifer; Guo, Manhong; Kariem, Ahmad; Lu, Yi; Singh, Ravi Shankar; Lukong, Kiven Erique; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Wu, YL (corresponding author), Univ Saskatchewan, Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	yuliang.wu@usask.ca	Vidhyasagar, Venkatasubramanian/M-9442-2013; Singh, Ravi Shankar/ADM-2908-2022	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021; Singh, Ravi Shankar/0000-0001-8698-4562	Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by the Canadian Breast Cancer Foundation (to Y. W. and K. E. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Fatah TMA, 2014, BRIT J CANCER, V110, P2450, DOI 10.1038/bjc.2014.168; Abdel-Fatah TMA, 2016, CLIN CANCER RES, V22, P905, DOI 10.1158/1078-0432.CCR-15-0610; Adams SP, 2002, LEUKEMIA, V16, P2238, DOI 10.1038/sj.leu.2402732; Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chen Qin, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P1171; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; COMBEAU C, 1989, J BIOL CHEM, V264, P19017; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140755; FLORESROZAS H, 1993, J BIOL CHEM, V268, P21372; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Gilhooly NS, 2014, NUCLEIC ACIDS RES, V42, P5633, DOI 10.1093/nar/gku188; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; Guo MH, 2016, METHODS, V108, P118, DOI 10.1016/j.ymeth.2016.04.023; Guo MH, 2014, J BIOL CHEM, V289, P10551, DOI 10.1074/jbc.M113.538892; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jankowsky E, 2010, METHODS MOL BIOL, V587, P245, DOI 10.1007/978-1-60327-355-8_18; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kawaoka J, 2005, NUCLEIC ACIDS RES, V33, P644, DOI 10.1093/nar/gki208; Kellner JN, 2015, NUCLEIC ACIDS RES, V43, P2813, DOI 10.1093/nar/gkv106; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Li L, 2008, MOL CELL BIOL, V28, P6413, DOI 10.1128/MCB.01053-08; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Linley AJ, 2012, J BIOL CHEM, V287, P13633, DOI 10.1074/jbc.M111.308973; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; Mallam AL, 2014, ELIFE, V3, DOI 10.7554/eLife.04630; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Martelange V, 2000, CANCER RES, V60, P3848; Mathieu MG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.29; Mathieu Morgan G, 2010, Cancer Immun, V10, P2; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Patrick EM, 2017, NAT CHEM BIOL, V13, P99, DOI [10.1038/NCHEMBIO.2234, 10.1038/nchembio.2234]; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rocak S, 2005, NUCLEIC ACIDS RES, V33, P999, DOI 10.1093/nar/gki244; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rossler OG, 2001, NUCLEIC ACIDS RES, V29, P2088, DOI 10.1093/nar/29.10.2088; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Steimer L, 2013, NUCLEIC ACIDS RES, V41, P6259, DOI 10.1093/nar/gkt323; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tuteja N, 2014, PLANT MOL BIOL, V85, P639, DOI 10.1007/s11103-014-0209-6; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Yan XM, 2003, MOL CELL BIOL, V23, P414, DOI 10.1128/MCB.23.1.414-423.2003; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3	84	19	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10429	10443		10.1074/jbc.M117.774950	http://dx.doi.org/10.1074/jbc.M117.774950			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28468824	Green Published, hybrid			2022-12-28	WOS:000404115400009
J	Dolezal, JM; Wang, HB; Kulkarni, S; Jackson, L; Lu, J; Ranganathan, S; Goetzman, ES; Bharathi, SS; Beezhold, K; Byersdorfer, CA; Prochownik, EV				Dolezal, James M.; Wang, Huabo; Kulkarni, Sucheta; Jackson, Laura; Lu, Jie; Ranganathan, Sarangarajan; Goetzman, Eric S.; Bharathi, Sivakama S.; Beezhold, Kevin; Byersdorfer, Craig A.; Prochownik, Edward V.			Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INITIATING CELLS; GLUTAMINE-METABOLISM; GENOMIC INSTABILITY; MELANOMA-CELLS; NONCODING RNA; LIVER-CELLS; DNA-DAMAGE; IN-VITRO; CANCER; PROTEIN	Hepatocellular carcinoma (HCC) is a common cancer that frequently overexpresses the c-Myc (Myc) oncoprotein. Using a mouse model of Myc-induced HCC, we studied the metabolic, biochemical, and molecular changes accompanying HCC progression, regression, and recurrence. These involved altered rates of pyruvate and fatty acid beta-oxidation and the likely re-directing of glutamine into biosynthetic rather than energy-generating pathways. Initial tumors also showed reduced mitochondrial mass and differential contributions of electron transport chain complexes I and II to respiration. The uncoupling of complex II's electron transport function from its succinate dehydrogenase activity also suggested a mechanism by which Myc generates reactive oxygen species. RNA sequence studies revealed an orderly progression of transcriptional changes involving pathways pertinent to DNA damage repair, cell cycle progression, insulin-like growth factor signaling, innate immunity, and further metabolic re-programming. Only a subset of functions deregulated in initial tumors was similarly deregulated in recurrent tumors thereby indicating that the latter can "normalize" some behaviors to suit their needs. An inter-active and freely available software tool was developed to allow continued analyses of these and other transcriptional profiles. Collectively, these studies define the metabolic, biochemical, and molecular events accompanyingHCCevolution, regression, and recurrence in the absence of any potentially confounding therapies.	[Dolezal, James M.; Wang, Huabo; Kulkarni, Sucheta; Lu, Jie; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA; [Jackson, Laura] UPMC, Childrens Hosp Pittsburgh, Div Newborn Med, Pittsburgh, PA 15224 USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15224 USA; [Goetzman, Eric S.; Bharathi, Sivakama S.] UPMC, Childrens Hosp Pittsburgh, Div Human Genet, Pittsburgh, PA 15224 USA; [Beezhold, Kevin; Byersdorfer, Craig A.] UPMC, Childrens Hosp Pittsburgh, Div Bone Marrow & Stem Cell Transplantat, Pittsburgh, PA 15224 USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh UPMC, Hematol Oncol Sect, Rangos Res Ctr, Rm 5124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Ranganathan, Sarangarajan/0000-0001-6214-9167; Jackson, Laura/0000-0001-9088-576X; Dolezal, James/0000-0002-6788-7203; Beezhold, Kevin/0000-0001-9305-9324	National Institutes of Health [R01CA174713, R01DK090242, K08HL123631]; NATIONAL CANCER INSTITUTE [U54CA199092, R01CA174713] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL123631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01CA174713 (to E.V.P.), R01DK090242 (to E.S.G.), and K08HL123631 (to C.A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alajez NM, 2012, ONCOTARGET, V3, P1641; Allain C, 2016, CANCER RES, V76, P6374, DOI 10.1158/0008-5472.CAN-16-1559; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Beck J, 1996, LEUKEMIA, V10, P426; Bei YQ, 2017, CELL MOL NEUROBIOL, V37, P889, DOI 10.1007/s10571-016-0426-4; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; CHIU JH, 1992, J CLIN INVEST, V89, P539, DOI 10.1172/JCI115618; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Edmunds LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134049; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Grandhi MS, 2016, SURG ONCOL, V25, P74, DOI 10.1016/j.suronc.2016.03.002; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Greten TF, 2005, BRIT J CANCER, V92, P1862, DOI 10.1038/sj.bjc.6602590; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Han S, 2013, ANAL BIOANAL CHEM, V405, P1821, DOI 10.1007/s00216-012-6413-9; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Helmke C, 2016, ONCOGENE, V35, P135, DOI 10.1038/onc.2015.105; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Keepers TR, 2007, INFECT IMMUN, V75, P1229, DOI 10.1128/IAI.01663-06; Konsavage WM, 2012, AM J PHYSIOL-LUNG C, V302, pL27, DOI 10.1152/ajplung.00174.2011; Kuniyasu H, 2003, CLIN CANCER RES, V9, P4802; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Li Q, 1999, MOL CELL BIOL, V19, P5339; Li R, 2015, ONCOTARGET, V6, P30968, DOI 10.18632/oncotarget.5038; Lin DC, 2017, CANCER RES, V77, P2255, DOI 10.1158/0008-5472.CAN-16-2822; Liu J, 2014, ONCOTARGET, V5, P2635, DOI 10.18632/oncotarget.1862; Lu LC, 2016, LIVER CANCER, V5, P128, DOI 10.1159/000367754; Madan V, 2016, LEUKEMIA, V30, P2430, DOI 10.1038/leu.2016.237; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Martinez-Quetglas I, 2016, GASTROENTEROLOGY, V151, P1192, DOI 10.1053/j.gastro.2016.09.001; Maschietto M, 2014, ONCOTARGET, V5, P8014, DOI 10.18632/oncotarget.2485; Masetti R, 2016, ONCOTARGET, V7, P56746, DOI 10.18632/oncotarget.10778; Matouk I, 2013, INT J MOL SCI, V14, P4298, DOI 10.3390/ijms14024298; NAGASUE N, 1992, BRIT J SURG, V79, P667, DOI 10.1002/bjs.1800790723; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Pickard A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00025; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Riegler J L, 1996, Semin Gastrointest Dis, V7, P74; Riehmer V, 2014, GENE CHROMOSOME CANC, V53, P589, DOI 10.1002/gcc.22169; Rua S, 1996, CANCER-AM CANCER SOC, V78, P1195, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1195::AID-CNCR5>3.3.CO;2-3; Santoni-Rugiu E, 1999, AM J PATHOL, V154, P1693, DOI 10.1016/S0002-9440(10)65425-9; Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Tornesello ML, 2013, GENOMICS, V102, P74, DOI 10.1016/j.ygeno.2013.04.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Turato C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17701; Tykwinska K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070612; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Valero V, 2015, J HEPATOCELL CARCINO, V2, P69, DOI 10.2147/JHC.S48505; van den Bent MJ, 2015, NEURO-ONCOLOGY, V17, P935, DOI 10.1093/neuonc/nov013; Vilchez V, 2016, WORLD J GASTROENTERO, V22, P823, DOI 10.3748/wjg.v22.i2.823; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang JY, 2015, ONCOTARGET, V6, P20636, DOI 10.18632/oncotarget.4114; Wang X, 2017, RADIAT RES, V187, P50, DOI 10.1667/RR14503.1; Watanabe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067234; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Wilson KE, 2016, GENES, V7; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047; Xu XL, 2010, CARCINOGENESIS, V31, P167, DOI 10.1093/carcin/bgp232; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017149; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2001, CANCER RES, V61, P6487; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7	103	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10068	10086		10.1074/jbc.M117.782052	http://dx.doi.org/10.1074/jbc.M117.782052			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28432125	Green Published, hybrid			2022-12-28	WOS:000403580600019
J	Scherer, SL; Cain, MD; Kanai, SM; Kaltenbronn, KM; Blumer, KJ				Scherer, Stephanie L.; Cain, Matthew D.; Kanai, Stanley M.; Kaltenbronn, Kevin M.; Blumer, Kendall J.			Regulation of neurite morphogenesis by interaction between R7 regulator of G protein signaling complexes and G protein subunit G alpha(13)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; ON-BIPOLAR CELLS; RGS PROTEINS; PLASMA-MEMBRANE; NEURONAL CELLS; LYSOPHOSPHATIDIC ACID; R7-BINDING PROTEIN; LIVING CELLS; BRAIN; RECEPTOR	The R7 regulator of G protein signaling family (R7-RGS) critically regulates nervous system development and function. Mice lacking all R7-RGS subtypes exhibit diverse neurological phenotypes, and humans bearing mutations in the retinal R7-RGS isoform RGS9-1 have vision deficits. Although each R7-RGS subtype forms heterotrimeric complexes with G beta(5) and R7-RGS-binding protein (R7BP) that regulate G protein-coupled receptor signaling by accelerating deactivation of G(i/o) alpha-subunits, several neurological phenotypes of R7-RGS knock-out mice are not readily explained by dysregulated G(i/o) signaling. Accordingly, we used tandem affinity purification and LC-MS/MS to search for novel proteins that interact with R7-RGS heterotrimers in the mouse brain. Among several proteins detected, we focused on G alpha(13) because it had not been linked to R7-RGS complexes before. Split-luciferase complementation assays indicated that G alpha(13) in its active or inactive state interacts with R7-RGS heterotrimers containing any R7-RGS isoform. LARG (leukemia-associated Rho guanine nucleotide exchange factor (GEF)), PDZ-RhoGEF, and p115RhoGEF augmented interaction between activated G alpha(13) and R7-RGS heterotrimers, indicating that these effector RhoGEFs can engage G alpha(13).R7-RGS complexes. Because G alpha(13)/R7-RGS interaction required R7BP, we analyzed phenotypes of neuronal cell lines expressing RGS7 and G beta(5) with or without R7BP. We found that neurite retraction evoked by G alpha(12/13)-dependent lysophosphatidic acid receptors was augmented in R7BP-expressing cells. R7BP expression blunted neurite formation evoked by serum starvation by signaling mechanisms involving G alpha(12/13) but not G alpha(i/o). These findings provide the first evidence that R7-RGS heterotrimers interact with G alpha(13) to augment signaling pathways that regulate neurite morphogenesis. This mechanism expands the diversity of functions whereby R7-RGS complexes regulate critical aspects of nervous system development and function.	[Scherer, Stephanie L.; Cain, Matthew D.; Kanai, Stanley M.; Kaltenbronn, Kevin M.; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu			National Institutes of Health [GM044592, HL075632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM044592 and HL075632 (to K. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Gold SJ, 1997, J NEUROSCI, V17, P8024; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Huang J, 2014, ONCOGENE, V33, P3604, DOI 10.1038/onc.2013.324; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jia LJ, 2014, J BIOL CHEM, V289, P6249, DOI 10.1074/jbc.M113.531475; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Jordan J. D., 2005, J BIOL; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Moers A, 2008, MOL CELL BIOL, V28, P1480, DOI 10.1128/MCB.00651-07; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Nini Lylia, 2007, BMC Biochemistry, V8, P18, DOI 10.1186/1471-2091-8-18; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sayas CL, 2002, J NEUROSCI, V22, P6863; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Sun Y, 2011, MOL CELLS, V31, P483, DOI 10.1007/s10059-011-1036-0; Tayou J, 2016, J BIOL CHEM, V291, P9133, DOI 10.1074/jbc.M115.694075; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Yamazaki J, 2008, BIOL PHARM BULL, V31, P2216, DOI 10.1248/bpb.31.2216; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang JH, 2000, J NEUROCHEM, V75, P393, DOI 10.1046/j.1471-4159.2000.0750393.x; Zhang JH, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0004.2000; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zheng M, 2011, MOL CELL BIOL, V31, P4887, DOI 10.1128/MCB.05690-11; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	60	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9906	9918		10.1074/jbc.M116.771923	http://dx.doi.org/10.1074/jbc.M116.771923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28432124	Green Published, hybrid			2022-12-28	WOS:000403580600005
J	Bondar, A; Lazar, J				Bondar, Alexey; Lazar, Josef			The G protein G(i1) exhibits basal coupling but not preassembly with G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CB1 CANNABINOID RECEPTOR; LIVING CELLS; INTACT-CELLS; LIVE CELLS; ACTIVATION; AGONIST; MODEL; GPCR; LOCALIZATION	The G(i/o) protein family transduces signals from a diverse group of G protein-coupled receptors (GPCRs). The observed specificity of G(i/o)-GPCR coupling and the high rate of G(i/o) signal transduction have been hypothesized to be enabled by the existence of stable associates between G(i/o) proteins and their cognate GPCRs in the inactive state (G(i/o)-GPCR preassembly). To test this hypothesis, we applied the recently developed technique of two-photon polarization microscopy (2PPM) to G alpha(i1) subunits labeled with fluorescent proteins and four GPCRs: the alpha(2A)-adrenergic receptor, GABA(B), cannabinoid receptor type 1 (CB1R), and dopamine receptor type 2. Our experiments with non-dissociating mutants of fluorescently labeled G alpha(i1) subunits (exhibiting impaired dissociation from activated GPCRs) showed that 2PPM is capable of detecting GPCR-G protein interactions. 2PPM experiments with non-mutated fluorescently labeled G alpha(i1) subunits and alpha(2A)-adrenergic receptor, GABA(B), or dopamine receptor type 2 receptors did not reveal any interaction between the G(i1) protein and the non-stimulated GPCRs. In contrast, non-stimulated CB1R exhibited an interaction with the G(i1) protein. Further experiments revealed that this interaction is caused solely by CB1R basal activity; no preassembly between CB1R and the G(i1) protein could be observed. Our results demonstrate that four diverse GPCRs do not preassemble with non-active G(i1). However, we also show that basal GPCR activity allows interactions between non-stimulated GPCRs and G(i1) (basal coupling). These findings suggest that G(i1) interacts only with active GPCRs and that the well known high speed of GPCR signal transduction does not require preassembly between G proteins and GPCRs.	[Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic; [Lazar, Josef] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic; [Lazar, Josef] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Bondar, A (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic.	bondar@nh.cas.cz	Lazar, Josef/H-7487-2014; Lazar, Josef/AAI-7246-2020; Bondar, Alexey/G-9459-2014; Lazar, Josef/D-8523-2012	Lazar, Josef/0000-0002-6285-3995; Bondar, Alexey/0000-0002-1980-2930; Lazar, Josef/0000-0002-8579-8589	Czech Science Foundation [P205/13-10799S, P303/17-14413Y]; University of South Bohemia	Czech Science Foundation(Grant Agency of the Czech Republic); University of South Bohemia	This work was supported by Czech Science Foundation Grants P205/13-10799S (to J.NL.) and P303/17-14413Y (to A. B.) and a University of South Bohemia fellowship (A. B.). J. L. is a founder and co-owner of Innovative Bioimaging LLC.	Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Bondar A, 2014, J BIOL CHEM, V289, P1271, DOI 10.1074/jbc.M113.493643; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Challiss RAJ, 2011, NAT CHEM BIOL, V7, P657, DOI 10.1038/nchembio.665; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113873; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Masharina A, 2012, J AM CHEM SOC, V134, P19026, DOI 10.1021/ja306320s; NEUBIG RR, 1988, BIOCHEMISTRY-US, V27, P2374, DOI 10.1021/bi00407a019; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Scott CE, 2013, PROTEIN SCI, V22, P101, DOI 10.1002/pro.2192; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Simon AC, 2013, J MOL CELL BIOL, V5, P250, DOI 10.1093/jmcb/mjt014; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Vasquez C, 1999, J NEUROSCI, V19, P9271; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Wu YL, 2004, J BIOL CHEM, V279, P35287, DOI 10.1074/jbc.M404896200; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	39	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9690	9698		10.1074/jbc.M116.768127	http://dx.doi.org/10.1074/jbc.M116.768127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28438833	Green Published, hybrid			2022-12-28	WOS:000403113000019
J	Ben-Ami, I; Yao, Z; Naor, Z; Seger, R				Ben-Ami, Ido; Yao, Zhong; Naor, Zvi; Seger, Rony			RETRACTION: G(q) protein-induced apoptosis is mediated by AKT kinase inhibition that leads to protein kinase C-induced c-Jun N-terminal kinase activation (Retraction of Vol 286, Pg 31022, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Ben-Ami I, 2011, J BIOL CHEM, V286, P31022, DOI 10.1074/jbc.M111.247726	1	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8848	8848		10.1074/jbc.A111.247726	http://dx.doi.org/10.1074/jbc.A111.247726			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550134	Green Published, hybrid			2022-12-28	WOS:000402153900031
J	Brown, JM; Hazen, SL				Brown, J. Mark; Hazen, Stanley L.			Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRIMETHYLAMINE-N-OXIDE; CONTAINING MONOOXYGENASE 3; HIGH-FAT-DIET; CHRONIC KIDNEY-DISEASE; HUMAN GUT MICROBIOME; INTESTINAL MICROBIOTA; CARDIOVASCULAR-DISEASE; HEART-FAILURE; L-CARNITINE; PROGNOSTIC VALUE	Recent advances in metabolomic and genome mining approaches have uncovered a poorly understood metabolome that originates solely or in part from bacterial enzyme sources. Whether living on exposed surfaces or within our intestinal tract, our microbial inhabitants produce a remarkably diverse set of natural products and small molecule metabolites that can impact human health and disease. Highlighted here, the gut microbe-derived metabolite trimethylamine N-oxide has been causally linked to the development of cardiovascular diseases. Recent studies reveal drugging this pathway can inhibit atherosclerosis development in mice. Building on this example, we discuss challenges and untapped potential of targeting bacterial enzymology for improvements in human health.	[Brown, J. Mark; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Brown, J. Mark; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Brown, JM; Hazen, SL (corresponding author), Cleveland Clin, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	brownm5@ccf.org; hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021		National Institutes of Health Grants from NHLBI [R01 HL122283, P50 AA024333, R01 HL103866, P01 HL076491, R01DK10600, R01HL126827]; Office of Dietary Supplements; Esperion; Proctor Gamble; Takeda; Astra Zeneca; Pfizer; Roche Diagnostics; Cleveland Heart Laboratory; Frantz Biomarkers, LLC; Siemens; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122283, P01HL076491, R01HL126827, R01HL103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024333] Funding Source: NIH RePORTER	National Institutes of Health Grants from NHLBI; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esperion; Proctor Gamble(Procter & Gamble); Takeda(Takeda Pharmaceutical Company Ltd); Astra Zeneca(AstraZeneca); Pfizer(Pfizer); Roche Diagnostics; Cleveland Heart Laboratory; Frantz Biomarkers, LLC; Siemens(Siemens AG); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants R01 HL122283 (to J.M.B.), P50 AA024333 (to J.M.B.), R01 HL103866 (to S.L.H.), P01 HL076491 (to S.L.H.), R01DK10600 (to S.L.H.), and R01HL126827 (to S.L.H.) from NHLBI and Office of Dietary Supplements. This is the third article in the Host-Microbiome metabolic interplay Minireview series. Dr. Hazen reports being listed as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. Dr. Hazen reports having been paid as a consultant for the following companies: Esperion, Proctor & Gamble, and Takeda. Dr. Hazen reports receiving research funds from Astra Zeneca, Pfizer, Proctor & Gamble, Roche Diagnostics, and Takeda. Dr. Hazen reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics and therapeutics for the following companies: Cleveland Heart Laboratory, Esperion, Frantz Biomarkers, LLC, and Siemens. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bingol K, 2016, BIOANALYSIS, V8, P557, DOI 10.4155/bio-2015-0004; Boutagy NE, 2015, NUTR RES, V35, P858, DOI 10.1016/j.nutres.2015.07.002; Brown JM, 2015, ANNU REV MED, V66, P343, DOI 10.1146/annurev-med-060513-093205; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; Chen YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19076; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins HL, 2016, ATHEROSCLEROSIS, V244, P29, DOI 10.1016/j.atherosclerosis.2015.10.108; Cooper MA, 2015, NAT REV DRUG DISCOV, V14, P587, DOI 10.1038/nrd4706; da Silva RR, 2015, P NATL ACAD SCI USA, V112, P12549, DOI 10.1073/pnas.1516878112; Dambrova M, 2016, EXP CLIN ENDOCR DIAB, V124, P251, DOI 10.1055/s-0035-1569330; Davies J.E., 2004, MICROBIOL AUST, V25, P8; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Durgan DJ, 2016, HYPERTENSION, V67, P469, DOI 10.1161/HYPERTENSIONAHA.115.06672; Falony G, 2015, ANNU REV MICROBIOL, V69, P305, DOI 10.1146/annurev-micro-091014-104422; FLEMING SE, 1989, AM J CLIN NUTR, V50, P93, DOI 10.1093/ajcn/50.1.93; Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001; Gest H, 2004, NOTES REC ROY SOC, V58, P187, DOI 10.1098/rsnr.2004.0055; Gregory JC, 2015, J BIOL CHEM, V290, P5647, DOI 10.1074/jbc.M114.618249; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johnson SR, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00022; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kim RB, 2016, KIDNEY INT, V89, P1144, DOI 10.1016/j.kint.2016.01.014; Koch R., 1880, NEW SYNDENHAM SOC; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LAW RO, 1992, BIOCHIM BIOPHYS ACTA, V1133, P268, DOI 10.1016/0167-4889(92)90047-F; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lever M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114969; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li JY, 2016, J CLIN INVEST, V126, P2049, DOI 10.1172/JCI86062; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mafune A, 2016, CLIN EXP NEPHROL, V20, P731, DOI 10.1007/s10157-015-1207-y; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mente A, 2015, CAN J CARDIOL, V31, P1189, DOI 10.1016/j.cjca.2015.06.016; Meyer KA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003970; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Miller PE, 2016, JAIDS-J ACQ IMM DEF, V72, P114, DOI 10.1097/QAI.0000000000000937; Missailidis C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141738; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Organ CL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002314; Pellock SJ, 2017, J BIOL CHEM, V292, P8569, DOI 10.1074/jbc.R116.767434; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Randrianarisoa E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26745; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Rohrmann S, 2016, J NUTR, V146, P283, DOI 10.3945/jn.115.220103; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Seldin MM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002767; Senthong V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002816; Senthong V, 2016, J AM COLL CARDIOL, V67, P2620, DOI 10.1016/j.jacc.2016.03.546; Shafi T, 2017, J AM SOC NEPHROL, V28, P321, DOI 10.1681/ASN.2016030374; Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Skagen K, 2016, ATHEROSCLEROSIS, V247, P64, DOI 10.1016/j.atherosclerosis.2016.01.033; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Stubbs JR, 2016, J AM SOC NEPHROL, V27, P305, DOI 10.1681/ASN.2014111063; Tang WHW, 2015, J CARD FAIL, V21, P91, DOI 10.1016/j.cardfail.2014.11.006; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ufnal M, 2014, CAN J CARDIOL, V30, P1700, DOI 10.1016/j.cjca.2014.09.010; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warrier M, 2015, CELL REP, V10, P326, DOI 10.1016/j.celrep.2014.12.036; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Yamazaki H, 2013, BIOCHEM PHARMACOL, V85, P1588, DOI 10.1016/j.bcp.2013.03.020; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yin J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002699; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zheng Y, 2016, AM J CLIN NUTR, V104, P173, DOI 10.3945/ajcn.116.131771; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433	101	62	64	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8560	8568		10.1074/jbc.R116.765388	http://dx.doi.org/10.1074/jbc.R116.765388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389555	Green Published, hybrid			2022-12-28	WOS:000402153900004
J	Kim, HG; Hwang, SY; Aaronson, SA; Mandinova, A; Lee, SW				Kim, Hyung-Gu; Hwang, So Young; Aaronson, Stuart A.; Mandinova, Anna; Lee, Sam W.			DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation (Expression of Concern of Vol 286, Pg 17672, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612	1	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7162	7162		10.1074/jbc.A111.236612	http://dx.doi.org/10.1074/jbc.A111.236612			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28455409	Green Published, hybrid			2022-12-28	WOS:000400478300027
J	Pinskey, JM; Franks, NE; McMellen, AN; Giger, RJ; Allen, BL				Pinskey, Justine M.; Franks, Nicole E.; McMellen, Alexandra N.; Giger, Roman J.; Allen, Benjamin L.			Neuropilin-1 promotes Hedgehog signaling through a novel cytoplasmic motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIA; TRANSCRIPTIONAL ACTIVITY; CELL-PROLIFERATION; NEURAL-TUBE; IN-VIVO; PATHWAY; DOMAIN; GROWTH; PROTEINS; BINDING	Hedgehog (HH) signaling critically regulates embryonic and postnatal development as well as adult tissue homeostasis, and its perturbation can lead to developmental disorders, birth defects, and cancers. Neuropilins (NRPs), which have well-defined roles in Semaphorin and VEGF signaling, positively regulate HH pathway function, although their mechanism of action in HH signaling remains unclear. Here, using luciferase-based reporter assays, we provide evidence that NRP1 regulates HH signaling specifically at the level of GLI transcriptional activator function. Moreover, we show that NRP1 localization to the primary cilium, a key platform for HH signal transduction, does not correlate with HH signal promotion. Rather, a structurefunction analysis suggests that the NRP1 cytoplasmic and transmembrane domains are necessary and sufficient to regulate HH pathway activity. Furthermore, we identify a previously uncharacterized, 12-amino acid region within the NRP1 cytoplasmic domain that mediates HH signal promotion. Overall, our results provide mechanistic insight into NRP1 function within and potentially beyond the HH signaling pathway. These insights have implications for the development of novel modulators of HH- driven developmental disorders and diseases.	[Pinskey, Justine M.; Franks, Nicole E.; McMellen, Alexandra N.; Giger, Roman J.; Allen, Benjamin L.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Allen, BL (corresponding author), Univ Michigan, Med Sch, Dept Cell & Dev Biol, 3047 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	benallen@umich.edu		McMellen, Alexandra/0000-0001-6197-8318	NCI, National Institutes of Health [P30CA046592]; Rackham Merit Fellowship; Benard Maas Fellowship; Bradley Merrill Patten Fellowship; Organogenesis Training Grant [T32 HD007505]; Ruth L. Kirschstein National Research Service Award [F31 NS096734]; Adelson Medical Foundation; Craig H. Neilsen Foundation; National Institutes of Health [R01 NS081281, R01 DC014428, R01 CA198074, R01 GM118751]; MCubed research grant from the University of Michigan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA198074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118751] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rackham Merit Fellowship; Benard Maas Fellowship; Bradley Merrill Patten Fellowship; Organogenesis Training Grant; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adelson Medical Foundation; Craig H. Neilsen Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MCubed research grant from the University of Michigan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NCI, National Institutes of Health Grant P30CA046592. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Rackham Merit Fellowship, Benard Maas Fellowship, Bradley Merrill Patten Fellowship, Organogenesis Training Grant T32 HD007505, and Ruth L. Kirschstein National Research Service Award F31 NS096734.; Supported by the Adelson Medical Foundation, Craig H. Neilsen Foundation, National Institutes of Health Grant R01 NS081281, and an MCubed research grant from the University of Michigan.; Supported by National Institutes of Health Grants R01 DC014428, R01 CA198074, and R01 GM118751, and an MCubed research grant from the University of Michigan.	Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Cackowski FC, 2004, GENOMICS, V84, P82, DOI 10.1016/j.ygeno.2004.02.001; Cai HB, 1999, J NEUROSCI, V19, P6519; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Creanga A, 2012, GENE DEV, V26, P1312, DOI 10.1101/gad.191866.112; D'Angelo G, 2015, DEV CELL, V32, P290, DOI 10.1016/j.devcel.2014.12.004; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Ge XC, 2015, ELIFE, V4, DOI [10.7554/eLife.07068.001, 10.7554/eLife.07068]; Geffand NI. V., 2014, ELIFE, V3; Gephart MGH, 2013, J NEURO-ONCOL, V115, P161, DOI 10.1007/s11060-013-1216-1; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YH, 2015, P NATL ACAD SCI USA, V112, P6383, DOI 10.1073/pnas.1421628112; Hatanaka Y, 2009, J COMP NEUROL, V514, P215, DOI 10.1002/cne.22021; Hillman RT, 2011, GENE DEV, V25, P2333, DOI 10.1101/gad.173054.111; Holtz AM, 2015, J CELL BIOL, V209, P739, DOI 10.1083/jcb.201411024; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kwong L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5849; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Luchetti G, 2016, ELIFE, V5, DOI 10.7554/eLife.20304; Mathew E, 2014, CELL REP, V9, P484, DOI 10.1016/j.celrep.2014.09.010; Mauti O, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-32; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Megason SG, 2002, DEVELOPMENT, V129, P2087; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Mille F, 2014, DEV CELL, V31, P34, DOI 10.1016/j.devcel.2014.08.010; Mo R, 1997, DEVELOPMENT, V124, P113; Muhl L, 2017, J CELL SCI, V130, P1365, DOI 10.1242/jcs.200493; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Nauli SM, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/376281; Nechipurenko IV, 2013, MOL CELLS, V36, P288, DOI 10.1007/s10059-013-0246-z; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ortmann C, 2015, J CELL SCI, V128, P4462, DOI 10.1242/jcs.182360; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pang HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5904; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Sawma P, 2014, J MOL BIOL, V426, P4099, DOI 10.1016/j.jmb.2014.10.007; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Seerapu HR, 2013, FEBS LETT, V587, P3392, DOI 10.1016/j.febslet.2013.08.040; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Song J. X., 2015, CHINA ADV METEOROL, V2015, P1; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Willnow TE, 2012, DEVELOPMENT, V139, P4311, DOI 10.1242/dev.084467; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	90	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15192	15204		10.1074/jbc.M117.783845	http://dx.doi.org/10.1074/jbc.M117.783845			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28667171	hybrid, Green Published			2022-12-28	WOS:000410809800003
J	Green, DS; Young, HA; Valencia, JC				Green, Daniel S.; Young, Howard A.; Valencia, Julio C.			Current prospects of type II interferon signaling and autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						autoimmune disease; autoimmunity; interferon; signal transducers and activators of transcription 1 (STAT1); signaling	SYSTEMIC-LUPUS-ERYTHEMATOSUS; NUCLEAR-LOCALIZATION SEQUENCE; IFN-GAMMA RECEPTOR; COLLAGEN-INDUCED ARTHRITIS; GENE-EXPRESSION; T-CELLS; STAT1-INDEPENDENT PATHWAYS; VIRUS-INFECTION; DOWN-REGULATION; ACTIVATION	Interferon (IFN) is a pleiotropic protein secreted by immune cells. IFN signals through the IFN receptor, a protein complex that mediates downstream signaling events. Studies into IFN signaling have provided insight into the general concepts of receptor signaling, receptor internalization, regulation of distinct signaling pathways, and transcriptional regulation. Although IFN is the central mediator of the adaptive immune response to pathogens, it has been shown to be involved in several non-infectious physiological processes. This review will provide an introduction into IFN signaling biology and the functional roles of IFN in the autoimmune response.	[Green, Daniel S.] NCI, Womens Malignancy Branch, Translat Genom Sect, Ctr Canc,NIH, Bethesda, MD 20892 USA; [Young, Howard A.; Valencia, Julio C.] NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Young, HA (corresponding author), NCI, Ctr Canc Res, NIH, Bldg 560,Rm 31-23, Frederick, MD 21702 USA.; Valencia, JC (corresponding author), NCI, Ctr Canc Res, NIH, Bldg 560,Rm 31-32, Frederick, MD 21702 USA.	Younghow@nih.gov; valencij@mail.nih.gov	Young, Howard/R-5140-2019; Young, Howard/A-6350-2008	Young, Howard/0000-0002-3118-5111	Intramural Research Program of the NCI; Cancer and Inflammation Program, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009283] Funding Source: NIH RePORTER	Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer and Inflammation Program, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the NCI, Cancer and Inflammation Program, Center for Cancer Research, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adorini L, 2003, CLIN EXP IMMUNOL, V132, P185, DOI 10.1046/j.1365-2249.2003.02144.x; Ahmed CML, 2003, J CELL SCI, V116, P3089, DOI 10.1242/jcs.00528; Alsayed Y, 2000, J IMMUNOL, V164, P1800, DOI 10.4049/jimmunol.164.4.1800; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Backlund J, 2013, ANN RHEUM DIS, V72, P1225, DOI 10.1136/annrheumdis-2012-202055; BADER T, 1994, P NATL ACAD SCI USA, V91, P11831, DOI 10.1073/pnas.91.25.11831; Bae HR, 2016, HEPATOLOGY, V64, P1189, DOI 10.1002/hep.28641; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Blouin CM, 2016, CELL, V166, P920, DOI 10.1016/j.cell.2016.07.003; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Cheallaigh CN, 2016, IMMUNITY, V44, P368, DOI 10.1016/j.immuni.2016.01.019; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; da Silva HB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/202816; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Goropevsek A, 2017, CLIN REV ALLERG IMMU, V52, P164, DOI 10.1007/s12016-016-8550-y; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117; Hodge DL, 2014, J AUTOIMMUN, V53, P33, DOI 10.1016/j.jaut.2014.02.003; Hoeksema MA, 2015, J IMMUNOL, V194, P3909, DOI 10.4049/jimmunol.1402077; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Johnson DB, 2016, JAMA ONCOL, V2, P234, DOI 10.1001/jamaoncol.2015.4368; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; KIERSZENBAUM F, 1995, PARASITE IMMUNOL, V17, P207, DOI 10.1111/j.1365-3024.1995.tb00890.x; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Larkin J, 2001, J INTERF CYTOK RES, V21, P341, DOI 10.1089/107999001750277817; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Lee Sylvia, 2011, Cancers (Basel), V3, P3856, DOI 10.3390/cancers3043856; Lees JR, 2015, CYTOKINE, V74, P18, DOI 10.1016/j.cyto.2014.10.014; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Lin WS, 2010, J NEUROSCI RES, V88, P2569, DOI 10.1002/jnr.22425; Liu J, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.18; Lu RF, 2016, J AUTOIMMUN, V74, P182, DOI 10.1016/j.jaut.2016.06.001; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Matsuzawa T, 2014, IMMUNOLOGY, V141, P61, DOI 10.1111/imm.12168; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; NIAID National Institutes of Health, 2002, AUT DIS COORD COMM A; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; O'Donnell LA, 2015, J NEUROCHEM, V135, P309, DOI 10.1111/jnc.13250; Oyler-Yaniv J, 2017, MOL CELL, V66, P635, DOI 10.1016/j.molcel.2017.05.011; Pollard KM, 2013, DISCOV MED, V16, P123; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Randal M, 2001, STRUCTURE, V9, P155, DOI 10.1016/S0969-2126(01)00567-6; Rauch I, 2015, MOL CELL BIOL, V35, P2332, DOI 10.1128/MCB.01498-14; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Regis G, 2006, TRENDS IMMUNOL, V27, P96, DOI 10.1016/j.it.2005.12.002; Reynolds AR, 2010, DOSE-RESPONSE, V8, P253, DOI 10.2203/dose-response.09-049.Reynolds; Rigamonti L, 2000, J IMMUNOL, V164, P201, DOI 10.4049/jimmunol.164.1.201; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Sadir R, 2001, CYTOKINE, V14, P19, DOI 10.1006/cyto.2000.0854; SANCEAU J, 1987, P NATL ACAD SCI USA, V84, P2906, DOI 10.1073/pnas.84.9.2906; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; Shachar I, 2013, J LEUKOCYTE BIOL, V93, P51, DOI 10.1189/jlb.0612293; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SMITH MR, 1990, J IMMUNOL, V144, P1777; Smyth D, 2011, LAB INVEST, V91, P764, DOI 10.1038/labinvest.2010.208; Spencer NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162497; Subramaniam PS, 2002, J IMMUNOL, V169, P1959, DOI 10.4049/jimmunol.169.4.1959; Subramaniam PS, 2001, J INTERF CYTOK RES, V21, P951, DOI 10.1089/107999001753289569; Subramaniam PS, 2000, J CELL SCI, V113, P2771; TALMADGE JE, 1987, CANCER RES, V47, P2563; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Trilling M, 2009, J VIROL, V83, P3684, DOI 10.1128/JVI.02042-08; Uddin S, 1997, BIOCHEM BIOPH RES CO, V235, P83, DOI 10.1006/bbrc.1997.6741; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; WHEELOCK EF, 1965, SCIENCE, V149, P310, DOI 10.1126/science.149.3681.310; Wildbaum G, 2010, AM J PATHOL, V176, P2764, DOI 10.2353/ajpath.2010.090855; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Wu C, 2014, J IMMUNOL, V193, P3036, DOI 10.4049/jimmunol.1302379; You M, 1997, J BIOL CHEM, V272, P23376, DOI 10.1074/jbc.272.37.23376; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017	88	85	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13925	13933		10.1074/jbc.R116.774745	http://dx.doi.org/10.1074/jbc.R116.774745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28652404	Green Published, hybrid			2022-12-28	WOS:000408439800003
J	Li, ZH; Li, DC; Choi, EY; Lapidus, R; Zhang, L; Huang, SM; Shapiro, P; Wang, HB				Li, Zhihui; Li, Daochuan; Choi, Eun Yong; Lapidus, Rena; Zhang, Lei; Huang, Shiew-Mei; Shapiro, Paul; Wang, Hongbing			Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-CITRATE LYASE; GENOMIC ORGANIZATION; FUNCTIONAL FEATURES; INSULIN-RESISTANCE; HEPATIC STEATOSIS; MAMMALIAN-CELLS; TRANSPORTER; METABOLISM; RECEPTOR; NACT	The solute carrier family 13 member 5 (SLC13A5), a sodium-coupled citrate transporter, plays a key role in importing citrate from the circulation into liver cells. Recent evidence has revealed that SLC13A5 deletion protects mice from high-fat diet-induced hepatic steatosis and that mutation of the SLC13A5 orthologues in Drosophila melanogaster and Caenorhabditis elegans promotes longevity. However, despite the emerging importance of SLC13A5 in energy homeostasis, whether perturbation of SLC13A5 affects the metabolism and malignancy of hepatocellular carcinoma is unknown. Here, we sought to determine whether SLC13A5 regulates hepatic energy homeostasis and proliferation of hepatoma cells. RNAi-mediated silencing of SLC13A5 expression in two human hepatoma cell lines, HepG2 and Huh7, profoundly suppressed cell proliferation and colony formation, and induced cell cycle arrest accompanied by increased expression of cyclin-dependent kinase inhibitor p21 and decreased expression of cyclin B1. Furthermore, such suppressive effects were also observed on the growth of HepG2 cell-derived xenografts expressing SLC13A5-shRNA in nude mice. Metabolically, knockdown of SLC13A5 in HepG2 and Huh7 cells was associated with a decrease in intracellular levels of citrate, the ratio of ATP/ADP, phospholipid content, and ATP citrate lyase expression. Moreover, both in vitro and in vivo assays demonstrated that SLC13A5 depletion promotes activation of the AMP-activated protein kinase, which was accompanied by deactivation of oncogenic mechanistic target of rapamycin signaling. Together, our findings expand the role of SLC13A5 from facilitating hepatic energy homeostasis to influencing hepatoma cell proliferation and suggest a potential role of SLC13A5 in the progression of human hepatocellular carcinoma.	[Li, Zhihui; Shapiro, Paul; Wang, Hongbing] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA; [Choi, Eun Yong; Lapidus, Rena; Shapiro, Paul; Wang, Hongbing] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, 20 Penn St, Baltimore, MD 21201 USA; [Zhang, Lei; Huang, Shiew-Mei] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Off Translat Sci, Silver Spring, MD 20993 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Wang, HB (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	hongbing.wang@rx.umaryland.edu			National Institutes of Health [GM107058]; Research Participation Program at the Center for Drug Evaluation and Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Participation Program at the Center for Drug Evaluation and Research	The study was partially supported by National Institutes of Health Grant GM107058 (to H.W.). This work was also supported in part by the Research Participation Program at the Center for Drug Evaluation and Research, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U. S. Department of Energy and FDA (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the FDA.	Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Brito AF, 2012, CHEMOTHERAPY, V58, P381, DOI 10.1159/000343656; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dai BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1404; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Inoue K, 2002, BIOCHEM BIOPH RES CO, V299, P465, DOI 10.1016/S0006-291X(02)02669-4; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Lee JH, 2015, FEBS J, V282, P361, DOI 10.1111/febs.13139; Li LH, 2015, MOL PHARMACOL, V87, P674, DOI 10.1124/mol.114.097287; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Migita T, 2014, INT J CANCER, V135, P37, DOI 10.1002/ijc.28652; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Neuschafer-Rube F, 2015, TOXICOLOGY, V337, P1, DOI 10.1016/j.tox.2015.08.007; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pesta DH, 2015, AGING-US, V7, P1086, DOI 10.18632/aging.100854; Rodriguez-Enriquez S, 2009, MOL NUTR FOOD RES, V53, P29, DOI 10.1002/mnfr.200700470; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; von Loeffelholz C, 2017, HEPATOLOGY, V66, P616, DOI 10.1002/hep.29089; Yang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130953; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zulato E, 2014, BRIT J CANCER, V111, P25, DOI 10.1038/bjc.2014.274	47	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13890	13901		10.1074/jbc.M117.783860	http://dx.doi.org/10.1074/jbc.M117.783860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655760	hybrid, Green Published			2022-12-28	WOS:000407942400014
J	Coffey, R; Ganz, T				Coffey, Richard; Ganz, Tomas			Iron homeostasis: An anthropocentric perspective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						erythropoiesis; hepatocyte; infection; inflammation; iron metabolism	TRANSFERRIN-BOUND IRON; METAL-ION TRANSPORTER; MORPHOGENETIC PROTEIN 6; HEPCIDIN EXPRESSION; HEREDITARY HEMOCHROMATOSIS; MOUSE MODEL; JUVENILE HEMOCHROMATOSIS; MESSENGER-RNA; ERYTHROFERRONE CONTRIBUTES; FUNCTIONAL-PROPERTIES	The regulation of iron metabolism in biological systems centers on providing adequate iron for cellular function while limiting iron toxicity. Because mammals cannot excrete iron, mechanisms have evolved to control iron acquisition, storage, and distribution at both systemic and cellular levels. Hepcidin, the master regulator of iron homeostasis, controls iron flows into plasma through inhibition of the only known mammalian cellular iron exporter ferroportin. Hepcidin is feedback-regulated by iron status and strongly modulated by inflammation and erythropoietic demand. This review highlights recent advances that have changed our understanding of iron metabolism and its regulation.	[Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ganz, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	tganz@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020		National Institutes of Health [T32 HL072752, R01DK065029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Fellowship T32 HL072752 (to R. C.) and Grant R01DK065029 (to T. G.). This is the first article in the Thematic Minireview series "Metals in Biology 2017: Iron transport, storage, and the ramifications." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arezes J, 2015, CELL HOST MICROBE, V17, P47, DOI 10.1016/j.chom.2014.12.001; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Bellelli R, 2016, CELL REP, V14, P411, DOI 10.1016/j.celrep.2015.12.065; Blanc L, 2015, AM J HEMATOL, V90, P235, DOI 10.1002/ajh.23920; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Brittenham GM, 2014, AM J CLIN NUTR, V100, P813, DOI 10.3945/ajcn.113.081505; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; Chen AC, 2015, P NATL ACAD SCI USA, V112, P11714, DOI 10.1073/pnas.1511701112; Choi J, 2012, J NUTR, V142, P1929, DOI 10.3945/jn.112.160358; Coffey R, 2017, AM J PHYSIOL-CELL PH, V312, pC169, DOI 10.1152/ajpcell.00116.2016; Delaby C, 2008, BIOCHEM J, V411, P123, DOI 10.1042/BJ20071474; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Frydlova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148540; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Ghanem LR, 2016, MOL CELL BIOL, V36, P304, DOI 10.1128/MCB.00936-15; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Gottlieb Y, 2012, HAEMATOL-HEMATOL J, V97, P1489, DOI 10.3324/haematol.2012.063651; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO B, 1994, J BIOL CHEM, V269, P24252; Hamdi A, 2016, BBA-MOL CELL RES, V1863, P2859, DOI 10.1016/j.bbamcr.2016.09.008; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Herbison CE, 2009, AM J PHYSIOL-CELL PH, V297, pC1567, DOI 10.1152/ajpcell.00649.2008; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Iolascon A, 2009, SEMIN HEMATOL, V46, P358, DOI 10.1053/j.seminhematol.2009.06.005; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kautz L, 2015, BLOOD, V126, P2031, DOI 10.1182/blood-2015-07-658419; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Knutson MD, 2000, J NUTR, V130, P621, DOI 10.1093/jn/130.3.621; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Lakhal-Littleton S, 2016, ELIFE, V5, DOI 10.7554/eLife.19804; Lakhal-Littleton S, 2015, P NATL ACAD SCI USA, V112, P3164, DOI 10.1073/pnas.1422373112; Latour C, 2016, HEPATOLOGY, V63, P126, DOI 10.1002/hep.28254; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mayeur C, 2014, BLOOD, V124, P2116, DOI 10.1182/blood-2014-04-572644; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Sabelli M, 2017, HEPATOLOGY, V65, P1512, DOI 10.1002/hep.29007; Salojin KV, 2011, BLOOD, V117, P4895, DOI 10.1182/blood-2010-04-279653; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Shawki A, 2016, AM J PHYSIOL-GASTR L, V311, pG423, DOI 10.1152/ajpgi.00167.2016; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Soe-Lin S, 2010, EXP HEMATOL, V38, P609, DOI 10.1016/j.exphem.2010.04.003; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; van Eijk LT, 2014, BLOOD, V124, P2643, DOI 10.1182/blood-2014-03-559484; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Walter PB, 2002, P NATL ACAD SCI USA, V99, P2264, DOI 10.1073/pnas.261708798; Wang CY, 2013, HEPATOLOGY, V58, P788, DOI 10.1002/hep.26401; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Wu XG, 2014, BLOOD, V124, P1335, DOI 10.1182/blood-2014-01-552281; Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	100	98	101	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12727	12734		10.1074/jbc.R117.781823	http://dx.doi.org/10.1074/jbc.R117.781823			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615456	hybrid, Green Published			2022-12-28	WOS:000407220100002
J	Asatryan, A; Bazan, NG				Asatryan, Aram; Bazan, Nicolas G.			Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cell death; lipid signaling; neurodegenerative disease; NF-kB transcription factor; retina	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PROLIFERATOR-ACTIVATED RECEPTORS; PIGMENT EPITHELIAL-CELLS; DOCOSAHEXAENOIC ACID; C-REL; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; OXIDIZED OMEGA-3-FATTY-ACIDS; GENE-EXPRESSION	Docosahexaenoic acid, enriched in the brain and retina, generates docosanoids in response to disruptions of cellular homeostasis. Docosanoids include neuroprotectin D1 (NPD1), which is decreased in the CA1 hippocampal area of patients with early-stage Alzheimer's disease (AD). We summarize here how NPD1 elicits neuroprotection by up-regulating c-REL, a nuclear factor (NF)-B subtype that, in turn, enhances expression of BIRC3 (baculoviral inhibitor of apoptosis repeat-containing protein 3) in the retina and in experimental stroke, leading to neuroprotection. Elucidating the mechanisms of action of docosanoids will contribute to managing diseases, including stroke, AD, age-related macular degeneration, traumatic brain injury, Parkinson's disease, and other neurodegenerations.	[Asatryan, Aram; Bazan, Nicolas G.] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, NG (corresponding author), Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health from NIGMS [GM103340]; National Institutes of Health from NEI [EY005121]; National Institutes of Health from NINDS [NS046741]; Eye, Ear, Nose & Throat Foundation; Research to Prevent Blindness, Inc., New York; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046741] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from NEI; National Institutes of Health from NINDS; Eye, Ear, Nose & Throat Foundation; Research to Prevent Blindness, Inc., New York(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in whole or in part by National Institutes of Health Grants GM103340 from NIGMS, EY005121 from NEI, and NS046741 from NINDS, the Eye, Ear, Nose & Throat Foundation, and in part by an unrestricted departmental grant from Research to Prevent Blindness, Inc., New York. This is the third article in the Thematic Minireview Series: "Inflammatory transcription confronts homeostatic disruptions." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BAZAN NG, 1982, BIOCHIM BIOPHYS ACTA, V712, P702, DOI 10.1016/0005-2760(82)90301-0; BAZAN NG, 1992, ADV EXP MED BIOL, V318, P295; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BAZAN NG, 1985, RETINAL DEGENERATION, P159; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; BOK D, 1993, J CELL SCI, P189; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Calandria JM, 2015, CELL DEATH DIFFER, V22, P1363, DOI 10.1038/cdd.2014.233; Calandria JM, 2012, J BIOL CHEM, V287, P23726, DOI 10.1074/jbc.M111.287078; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Eady TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046151; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fatehi-Hassanabad Zahra, 2005, Nutr Metab (Lond), V2, P1, DOI 10.1186/1743-7075-2-1; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Guadagno JV, 2003, BRIT MED BULL, V65, P145, DOI 10.1093/bmb/65.1.145; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; HANNINK M, 1990, ONCOGENE, V5, P1843; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hong SH, 2014, J NEUROL SCI, V338, P135, DOI 10.1016/j.jns.2013.12.033; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kolko M, 2007, INVEST OPHTH VIS SCI, V48, P1401, DOI 10.1167/iovs.06-0865; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Martin AG, 2001, J BIOL CHEM, V276, P15840, DOI 10.1074/jbc.M011313200; Mattson MP, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P663; Mishra A, 2004, ARTERIOSCL THROM VAS, V24, P1621, DOI 10.1161/01.ATV.0000137191.02577.86; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Sahlin C, 2007, EUR J NEUROSCI, V26, P882, DOI 10.1111/j.1460-9568.2007.05719.x; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Sarnico I, 2009, INT REV NEUROBIOL, V85, P351, DOI 10.1016/S0074-7742(09)85024-1; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stark DT, 2011, J NEUROSCI, V31, P13710, DOI 10.1523/JNEUROSCI.3544-11.2011; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Turrens J., 2011, J PHYSL, V8, P695; UEBERLA K, 1993, J ACQ IMMUN DEF SYND, V6, P227; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Viswanathan M, 1996, GENE, V170, P271, DOI 10.1016/0378-1119(95)00773-3; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Xu M, 2016, ACTA PHARMACOL SIN, V37, P246, DOI 10.1038/aps.2015.125; Zhang J., 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.1042/BSR20160076; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	91	50	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12390	12397		10.1074/jbc.R117.783076	http://dx.doi.org/10.1074/jbc.R117.783076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615451	hybrid, Green Published			2022-12-28	WOS:000406636900005
J	Yi, JJ; Paranjape, SR; Walker, MP; Choudhury, R; Wolter, JM; Fragola, G; Emanuele, MJ; Major, MB; Zylka, MJ				Yi, Jason J.; Paranjape, Smita R.; Walker, Matthew P.; Choudhury, Rajarshi; Wolter, Justin M.; Fragola, Giulia; Emanuele, Michael J.; Major, Michael B.; Zylka, Mark J.			The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/-catenin pathway by inhibiting the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autism; -catenin; proteasome; proteomics; Wnt signaling; E6-AP; UBE3A	BETA-CATENIN; ANGELMAN SYNDROME; 26S PROTEASOME; SPECTRUM DISORDER; PROTEIN COMPLEXES; E6-AP; EXPRESSION; MUTATIONS; SUBSTRATE; E6	UBE3A is a HECT domain E3 ubiquitin ligase whose dysfunction is linked to autism, Angelman syndrome, and cancer. Recently, we characterized a de novo autism-linked UBE3A mutant (UBE3A(T485A)) that disrupts phosphorylation control of UBE3A activity. Through quantitative proteomics and reporter assays, we found that the UBE3A(T485A) protein ubiquitinates multiple proteasome subunits, reduces proteasome subunit abundance and activity, stabilizes nuclear -catenin, and stimulates canonical Wnt signaling more effectively than wild-type UBE3A. We also found that UBE3A(T485A) activates Wnt signaling to a greater extent in cells with low levels of ongoing Wnt signaling, suggesting that cells with low basal Wnt activity are particularly vulnerable to UBE3A(T485A) mutation. Ligase-dead UBE3A did not stimulate Wnt pathway activation. Overexpression of several proteasome subunits reversed the effect of UBE3A(T485A) on Wnt signaling. We also observed that subunits that interact with UBE3A and affect Wnt signaling are located along one side of the 19S regulatory particle, indicating a previously unrecognized spatial organization to the proteasome. Altogether, our findings indicate that UBE3A regulates Wnt signaling in a cell context-dependent manner and that an autism-linked mutation exacerbates these signaling effects. Our study has broad implications for human disorders associated with UBE3A gain or loss of function and suggests that dysfunctional UBE3A might affect additional proteins and pathways that are sensitive to proteasome activity.	[Yi, Jason J.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Paranjape, Smita R.; Walker, Matthew P.; Wolter, Justin M.; Fragola, Giulia; Major, Michael B.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Paranjape, Smita R.; Wolter, Justin M.; Fragola, Giulia; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [Zylka, Mark J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Choudhury, Rajarshi; Emanuele, Michael J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Walker, Matthew P.; Choudhury, Rajarshi; Emanuele, Michael J.; Major, Michael B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Zylka, MJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.; Zylka, MJ (corresponding author), Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022; Paranjape, Smita R/L-2658-2019	Major, Michael/0000-0002-6753-8513; Wolter, Justin/0000-0002-3021-3993	Angelman Syndrome Foundation; National Institute of Mental Health [R01MH093372]; National Institutes of Health Pioneer Award [DP1ES024088]; Simons Foundation Autism Research Initiative Bridge to Independence Award [387972]; Lymphoma Research Foundation; Susan G. Komen Foundation [CCR14298820]; National Institutes of Health [R01GM120309, R01CA187799]; Gabrielle's Angel Foundation; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA187799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES024088, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER	Angelman Syndrome Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative Bridge to Independence Award; Lymphoma Research Foundation; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by grants from the Angelman Syndrome Foundation (to M. J. Z.), National Institute of Mental Health Grant R01MH093372 (to M. J. Z.), and National Institutes of Health Pioneer Award DP1ES024088 (to M. J. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of the Simons Foundation Autism Research Initiative Bridge to Independence Award 387972.; Supported by a fellowship from the Lymphoma Research Foundation.; Supported by Susan G. Komen Foundation Grant CCR14298820 and National Institutes of Health Grant R01GM120309.; Supported by a grant from the Gabrielle's Angel Foundation and National Institutes of Health Grant R01CA187799.	Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Judson MC, 2014, J COMP NEUROL, V522, P1874, DOI 10.1002/cne.23507; Kim H, 2015, CELL REP, V11, P1151, DOI 10.1016/j.celrep.2015.04.048; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kuslansky Y, 2016, J GEN VIROL, V97, P3313, DOI 10.1099/jgv.0.000624; LaSalle JM, 2015, EPIGENOMICS-UK, V7, P1213, DOI 10.2217/epi.15.70; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madan B, 2016, P NATL ACAD SCI USA, V113, pE2945, DOI 10.1073/pnas.1605691113; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Packer A, 2016, NEUROSCI BIOBEHAV R, V64, P185, DOI 10.1016/j.neubiorev.2016.03.002; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Puram SV, 2013, CELL REP, V4, P19, DOI 10.1016/j.celrep.2013.06.006; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sell GL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00322; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Sominsky S, 2014, VIROLOGY, V468, P510, DOI 10.1016/j.virol.2014.09.007; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tomaic V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.572; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Walker MP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005654; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wiltse J, 2005, CRIT REV TOXICOL, V35, P727, DOI 10.1080/10408440591007403; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107	69	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12503	12515		10.1074/jbc.M117.788448	http://dx.doi.org/10.1074/jbc.M117.788448			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	FC1ZM	28559284	Green Published, hybrid			2022-12-28	WOS:000406636900015
J	Iyer, BR; Zadafiya, P; Vetal, PV; Mahalakshmi, R				Iyer, Bharat Ramasubramanian; Zadafiya, Punit; Vetal, Pallavi Vijay; Mahalakshmi, Radhakrishnan			Energetics of side-chain partitioning of beta-signal residues in unassisted folding of a transmembrane beta-barrel protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; ASSEMBLY MACHINERY COMPLEX; DEPENDENT K+ CHANNEL; HYDROPHOBICITY SCALE; HYDROCARBON RULER; WATER INTERFACE; THERMODYNAMIC STABILITY; GLOBULAR-PROTEINS; ESCHERICHIA-COLI; ENZYME PAGP	The free energy of water-to-interface amino acid partitioning is a major contributing factor in membrane protein folding and stability. The interface residues at the C terminus of transmembrane beta-barrels form the beta-signal motif required for assisted beta-barrel assembly in vivo but are believed to be less important for beta-barrel assembly in vitro. Here, we experimentally measured the thermodynamic contribution of all 20 amino acids at the beta-signal motif to the unassisted folding of the model beta-barrel protein PagP. We obtained the partitioning free energy for all 20 amino acids at the lipid-facing interface (Delta Delta G(0) w, i(phi)) and the protein-facing interface (Delta Delta G(0) w, i(phi)) residues and found that hydrophobic amino acids are most favorably transferred to the lipid-facing interface, whereas charged and polar groups display the highest partitioning energy. Furthermore, the change in non-polar surface area correlated directly with the partitioning free energy for the lipid-facing residue and inversely with the protein-facing residue. We also demonstrate that the interface residues of the beta-signal motif are vital for in vitro barrel assembly, because they exhibit a side chain-specific energetic contribution determined by the change in nonpolar accessible surface. Wefurther establish that folding cooperativity and hydrophobic collapse are balanced at the membrane interface for optimal stability of the PagP beta-barrel scaffold. We conclude that the PagP C-terminal beta-signal motif influences the folding cooperativity and stability of the folded beta-barrel and that the thermodynamic contributions of the lipid-and protein-facing residues in the transmembrane protein beta-signal motif depend on the nature of the amino acid side chain.	[Iyer, Bharat Ramasubramanian; Zadafiya, Punit; Vetal, Pallavi Vijay; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Rm 324,3 Fl,Block C,Acad Bldg 3, Bhopal 462066, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Rm 324,3 Fl,Block C,Acad Bldg 3, Bhopal 462066, India.	maha@iiserb.ac.in	Mahalakshmi, Radhakrishnan/B-3143-2008	Mahalakshmi, Radhakrishnan/0000-0003-1549-7550; Vetal, Pallavi/0000-0002-9001-7943	Wellcome Trust/DBT India Alliance Grant [IA/I/14/1/501305]; University Grants Commission, Government of India	Wellcome Trust/DBT India Alliance Grant; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by Wellcome Trust/DBT India Alliance Grant IA/I/14/1/501305 (to R.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a senior research fellowship from the University Grants Commission, Government of India.	Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cheng X, 2013, J CHEM INF MODEL, V53, P2171, DOI 10.1021/ci4002684; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cuesta-Seijo JA, 2010, STRUCTURE, V18, P1210, DOI 10.1016/j.str.2010.06.014; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; Domene C, 2006, BIOPHYS J, V90, pL1, DOI 10.1529/biophysj.105.072116; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Elazar A, 2016, ELIFE, V5, DOI 10.7554/eLife.12125; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Evanics F, 2006, J AM CHEM SOC, V128, P8256, DOI 10.1021/ja0610075; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Fleming KG, 2017, FASEB J, V31; Fleming KG, 2014, ANNU REV BIOPHYS, V43, P233, DOI 10.1146/annurev-biophys-051013-022926; Frey L, 2017, ANGEW CHEM INT EDIT, V56, P380, DOI 10.1002/anie.201608246; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Gupta A, 2015, RSC ADV, V5, P1227, DOI 10.1039/c4ra11207e; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Hong H, 2013, BIOCHEMISTRY-US, V52, P4413, DOI 10.1021/bi400344b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Iyer BR, 2015, BIOCHEMISTRY-US, V54, P5712, DOI 10.1021/acs.biochem.5b00543; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Khan MA, 2007, BIOCHEMISTRY-US, V46, P4565, DOI 10.1021/bi602526k; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leyton DL, 2015, METHODS MOL BIOL, V1329, P1, DOI 10.1007/978-1-4939-2871-2_1; Lin MS, 2016, J AM CHEM SOC, V138, P2592, DOI 10.1021/jacs.5b10307; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; McDonald SK, 2016, BIOCHEMISTRY-US, V55, P6133, DOI 10.1021/acs.biochem.6b00652; McMorran LM, 2013, J MOL BIOL, V425, P3178, DOI 10.1016/j.jmb.2013.06.017; Miller AS, 2004, BIOCHEMISTRY-US, V43, P1763, DOI 10.1021/bi0360206; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Moon CP, 2011, METHOD ENZYMOL, V492, P189, DOI 10.1016/B978-0-12-381268-1.00018-5; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Nolandt OV, 2012, BBA-BIOMEMBRANES, V1818, P1142, DOI 10.1016/j.bbamem.2012.01.007; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; Ojemalm K, 2016, P NATL ACAD SCI USA, V113, P10559, DOI 10.1073/pnas.1606776113; Ojemalm K, 2011, P NATL ACAD SCI USA, V108, pE359, DOI 10.1073/pnas.1100120108; Plummer AM, 2016, TRENDS BIOCHEM SCI, V41, P872, DOI 10.1016/j.tibs.2016.06.005; Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z; Popot JL, 2016, BIOCHEMISTRY-US, V55, P5, DOI 10.1021/acs.biochem.5b01134; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; ROSE GD, 1978, NATURE, V272, P586, DOI 10.1038/272586a0; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; SCHMIDT CF, 1981, BIOCHEMISTRY-US, V20, P4792, DOI 10.1021/bi00519a041; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Shiota T, 2015, SCIENCE, V349, P1544, DOI 10.1126/science.aac6428; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; Wrabl J, 1999, NAT STRUCT BIOL, V6, P876	82	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12351	12365		10.1074/jbc.M117.789446	http://dx.doi.org/10.1074/jbc.M117.789446			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28592485	Green Published, hybrid			2022-12-28	WOS:000406053300029
J	Fettelschoss, V; Burda, P; Sagne, C; Coelho, D; De Laet, C; Lutz, S; Suormala, T; Fowler, B; Pietrancosta, N; Gasnier, B; Bornhauser, B; Froese, DS; Baumgartner, MR				Fettelschoss, Victoria; Burda, Patricie; Sagne, Corinne; Coelho, David; De Laet, Corinne; Lutz, Seraina; Suormala, Terttu; Fowler, Brian; Pietrancosta, Nicolas; Gasnier, Bruno; Bornhauser, Beat; Froese, D. Sean; Baumgartner, Matthias R.			Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B-12-trafficking proteins ABCD4 and LMBD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; fluorescence resonance energy transfer (FRET); homology modeling; inborn error of metabolism; protein-protein interaction; ABCD4; LMBD1; cblF; cblJ; vitamin B-12	PEROXISOMAL MEMBRANE-PROTEIN; GREEN FLUORESCENT PROTEIN; BINDING CASSETTE PROTEIN; INBORN ERROR; SUBCELLULAR-LOCALIZATION; METHYLMALONIC ACIDURIA; ENDOPLASMIC-RETICULUM; COENZYME B-12; LIVING CELLS; FOLLOW-UP	Vitamin B-12 (cobalamin (Cbl)), in the cofactor forms methyl-Cbl and adenosyl-Cbl, is required for the function of the essential enzymes methionine synthase and methylmalonyl-CoA mutase, respectively. Cbl enters mammalian cells by receptor-mediated endocytosis of protein-bound Cbl followed by lysosomal export of free Cbl to the cytosol and further processing to these cofactor forms. The integral membrane proteins LMBD1 and ABCD4 are required for lysosomal release of Cbl, and mutations in the genes LMBRD1 and ABCD4 result in the cobalamin metabolism disorders cblF and cblJ. We report a new (fifth) patient with the cblJ disorder who presented at 7 days of age with poor feeding, hypotonia, methylmalonic aciduria, and elevated plasma homocysteine and harbored the mutations c.1667_1668delAG [p.Glu556Glyfs*27] and c.1295G > A [p.Arg432Gln] in the ABCD4 gene. Cbl cofactor forms are decreased in fibroblasts from this patient but could be rescued by overexpression of either ABCD4 or, unexpectedly, LMBD1. Using a sensitive live-cell FRET assay, we demonstrated selective interaction between ABCD4 and LMBD1 and decreased interaction when ABCD4 harbored the patient mutations p.Arg432Gln or p.Asn141Lys or when artificial mutations disrupted the ATPase domain. Finally, we showed that ABCD4 lysosomal targeting depends on co-expression of, and interaction with, LMBD1. These data broaden the patient and mutation spectrum of cblJ deficiency, establish a sensitive live-cell assay to detect the LMBD1-ABCD4 interaction, and confirm the importance of this interaction for proper intracellular targeting of ABCD4 and cobalamin cofactor synthesis.	[Fettelschoss, Victoria; Burda, Patricie; Lutz, Seraina; Suormala, Terttu; Fowler, Brian; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, Steinweisstr 75, CH-8032 Zurich, Switzerland; [Fettelschoss, Victoria; Burda, Patricie; Lutz, Seraina; Suormala, Terttu; Fowler, Brian; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp, Childrens Res Ctr, Steinweisstr 75, CH-8032 Zurich, Switzerland; [Sagne, Corinne; Gasnier, Bruno] Paris Descartes Univ, Sorbonne Paris Cite, CNRS, Neurophoton Lab,UMR 8250, F-75006 Paris, France; [Coelho, David] Nancy Univ, Fac Med, Nutr Genet Environm Risk Exposure, UMR S UL,INSERM,U954, Nancy, France; [Coelho, David] Nancy Univ, Fac Med, Reference Ctr Inborn Metab Dis, Nancy, France; [Coelho, David] Univ Hosp Ctr, Nancy, France; [De Laet, Corinne] Free Univ Brussels ULB, Queen Fabiola Childrens Univ Hosp, Nutr & Metab Unit, B-1020 Brussels, Belgium; [Pietrancosta, Nicolas] Paris Descartes Univ, CNRS, Sorbonne Paris Cite, CBMIT Team,UMR 8601, F-75006 Paris, France; [Bornhauser, Beat] Univ Childrens Hosp, Dept Oncol, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Froese, D. Sean; Baumgartner, Matthias R.] Univ Zurich, Clin Res Prior Program Rare Dis, Rare Dis Initiat Zurich Radiz, CH-8006 Zurich, Switzerland; [Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Froese, DS; Baumgartner, MR (corresponding author), Univ Childrens Hosp, Div Metab, Steinweisstr 75, CH-8032 Zurich, Switzerland.; Froese, DS; Baumgartner, MR (corresponding author), Univ Childrens Hosp, Childrens Res Ctr, Steinweisstr 75, CH-8032 Zurich, Switzerland.	sean.froese@kispi.uzh.ch; matthias.baumgartner@kispi.uzh.ch	Nicolas, PIetrancosta/P-4645-2017; Sagne, Corinne/K-7601-2017; Gasnier, Bruno/AAD-9124-2022; Coelho, David/AAE-9547-2020; pietrancosta, nicolas/AAC-2777-2019; Bornhauser, Beat/M-4437-2014; pietrancosta, nicolas/B-5235-2019; Coelho, David/F-6680-2011; Sagné, Corinne/AAY-1819-2021; Froese, D. Sean Sean/AAW-6899-2021; Baumgartner, Matthias/Q-2855-2017	Nicolas, PIetrancosta/0000-0002-9934-7818; Gasnier, Bruno/0000-0003-4458-6296; pietrancosta, nicolas/0000-0002-9934-7818; pietrancosta, nicolas/0000-0002-9934-7818; Coelho, David/0000-0001-7010-5789; Sagné, Corinne/0000-0001-5971-4831; Froese, D. Sean Sean/0000-0003-1557-3517; Baumgartner, Matthias/0000-0002-9270-0826; Bornhauser, Beat/0000-0003-2890-3191	Swiss National Science Foundation [SNSF 31003A_156907]; Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland	This work was supported by the Swiss National Science Foundation (SNSF 31003A_156907; to M. R. B.) and the Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland. The authors declare that they have no conflicts of interest with the contents of this article.	Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Alfadhel M, 2011, AM J MED GENET A, V155A, P2571, DOI 10.1002/ajmg.a.34220; Armour CM, 2013, PEDIATRICS, V132, pE257, DOI 10.1542/peds.2013-0105; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Bassila C, 2017, BBA-MOL BASIS DIS, V1863, P103, DOI 10.1016/j.bbadis.2016.10.016; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Burda P, 2017, J INHERIT METAB DIS, V40, P297, DOI 10.1007/s10545-016-9987-0; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Deme JC, 2014, MOL MEMBR BIOL, V31, P250, DOI 10.3109/09687688.2014.990998; DUFOUR E, 1990, FEBS LETT, V277, P223, DOI 10.1016/0014-5793(90)80850-I; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Froese DS, 2015, J BIOL CHEM, V290, P29167, DOI 10.1074/jbc.M115.683268; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gailus S, 2010, J INHERIT METAB DIS, V33, P17, DOI 10.1007/s10545-009-9032-7; Hagen N, 2014, MOL CELL PROTEOMICS, V13, P1676, DOI 10.1074/mcp.M113.036301; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hatzimichael E, 2016, INT J HEMATOL, V103, P479, DOI 10.1007/s12185-016-1977-3; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jesina, 2016, J INHERIT METAB DIS, V39, P35; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jusufi J, 2014, J INHERIT METAB DIS, V37, P841, DOI 10.1007/s10545-014-9709-4; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Kawaguchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30183; Kim JC, 2012, MOL GENET METAB, V107, P664, DOI 10.1016/j.ymgme.2012.10.005; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee A, 2014, BIOCHEM BIOPH RES CO, V453, P612, DOI 10.1016/j.bbrc.2014.09.133; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Oladipo O, 2011, PEDIATRICS, V128, pE1636, DOI 10.1542/peds.2010-3518; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Pahadiya Hans Raj, 2016, J Family Med Prim Care, V5, P485; Quadros EV, 2013, BIOCHIMIE, V95, P1008, DOI 10.1016/j.biochi.2013.02.004; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Santra Gouranga, 2014, J Assoc Physicians India, V62, P714; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Takeichi T, 2015, BRIT J DERMATOL, V172, P1111, DOI 10.1111/bjd.13413; Thyrock A, 2010, BIOCHEM BIOPH RES CO, V396, P679, DOI 10.1016/j.bbrc.2010.04.161; Tseng LTL, 2013, J BIOL CHEM, V288, P32424, DOI 10.1074/jbc.M113.479527; WATKINS D, 1986, AM J HUM GENET, V39, P404; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103; Zhao CG, 2006, N-S ARCH PHARMACOL, V372, P444, DOI 10.1007/s00210-005-0028-z	64	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11980	11991		10.1074/jbc.M117.784819	http://dx.doi.org/10.1074/jbc.M117.784819			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28572511	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000405485600033
J	McDaniel, K; Huang, L; Sato, K; Wu, N; Annable, T; Zhou, TH; Ramos-Lorenzo, S; Wan, Y; Huang, QB; Francis, H; Glaser, S; Tsukamoto, H; Alpini, G; Meng, FY				McDaniel, Kelly; Huang, Li; Sato, Keisaku; Wu, Nan; Annable, Tami; Zhou, Tianhao; Ramos-Lorenzo, Sugeily; Wan, Ying; Huang, Qiaobing; Francis, Heather; Glaser, Shannon; Tsukamoto, Hidekazu; Alpini, Gianfranco; Meng, Fanyin			The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; LET-7; FIBROSIS; LIN28; OVEREXPRESSION; MECHANISMS; MICRORNAS	The let-7/Lin28 axis is associated with the regulation of key cellular regulatory genes known as microRNAs in various human disorders and cancer development. This study evaluated the role of the let-7/Lin28 axis in regulating a mesenchymal phenotype of hepatic stellate cells in alcoholic liver injury. Weidentified that ethanol feeding significantly down-regulated several members of the let-7 family in mouse liver, including let-7a and let-7b. Similarly, the treatment of human hepatic stellate cells (HSCs) with lipopolysaccharide (LPS) and transforming growth factor-beta (TGF-beta) significantly decreased the expressions of let-7a and let-7b. Conversely, overexpression of let-7a and let-7b suppressed the myofibroblastic activation of cultured human HSCs induced by LPS and TGF-beta, as evidenced by repressed ACTA2 (alpha-actin 2), COL1A1 (collagen 1A1), TIMP1 (TIMP metallopeptidase inhibitor 1), and FN1 (fibronectin 1); this supports the notion that HSC activation is controlled by let-7. A combination of bioinformatics, dual-luciferase reporter assay, and Western blot analysis revealed that Lin28B and highmobility group AT-hook (HMGA2) were the direct targets of let-7a and let-7b. Furthermore, Lin28B deficiency increased the expression of let-7a/let-7b as well as reduced HSC activation and liver fibrosis in mice with alcoholic liver injury. This feedback regulation of let-7 by Lin28B is verified in hepatic stellate cells isolated by laser capture microdissection from the model. The identification of the let-7/Lin28 axis as an important regulator of HSC activation as well as its upstream modulators and down-stream targets will provide insights into the involvement of altered microRNA expression in contributing to the pathogenesis of alcoholic liver fibrosis and novel therapeutic approaches for human alcoholic liver diseases.	[McDaniel, Kelly; Zhou, Tianhao; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Cent Texas Vet Hlth Care Syst, Div Res, Temple, TX 76504 USA; [McDaniel, Kelly; Sato, Keisaku; Wu, Nan; Zhou, Tianhao; Wan, Ying; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Texas A&M Hlth Sci Ctr, Baylor Scott & White Digest Dis Res Ctr, Dept Med, Digest Dis Res Ctr, Temple, TX 76504 USA; [McDaniel, Kelly; Sato, Keisaku; Wu, Nan; Zhou, Tianhao; Wan, Ying; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Baylor Scott & White Hosp, Temple, TX 76504 USA; [McDaniel, Kelly; Annable, Tami; Ramos-Lorenzo, Sugeily; Wan, Ying; Francis, Heather; Meng, Fanyin] Baylor Scott & White Hlth, Res Inst, Temple, TX 76504 USA; [Huang, Li] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China; [Annable, Tami] Temple Biosci Dist, Temple, TX 76504 USA; [Wan, Ying; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Key Lab Shock & Microcirculat Res Guangdong Prov, Guangzhou 510515, Guangdong, Peoples R China; [Tsukamoto, Hidekazu] Univ Southern Calif, Keck Sch Med, Southern Calif Res Ctr Alcohol Liver & Pancreat D, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90089 USA	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Baylor Health Care System; Sun Yat Sen University; Southern Medical University - China; University of Southern California	Alpini, G; Meng, FY (corresponding author), Baylor Scott & White Hlth, Cent Texas Vet Hlth Care Syst, Dept Med, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.; Alpini, G; Meng, FY (corresponding author), Baylor Scott & White Hlth, Cent Texas Vet Hlth Care Syst, Baylor Scott & White Digest Dis Res Ctr DDRC, Div Res, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.; Alpini, G; Meng, FY (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.	galpini@tamu.edu; fmeng@tamu.edu	Zhou, Tianhao/AAO-3542-2021	Zhou, Tianhao/0000-0002-5722-6954	National Institutes of Health [P50AA011999]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054811, P30DK048522, R01DK108959, R01DK076898, R01DK107310, R01DK058411, R01DK062975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018663, P50AA011999] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001991, I01BX000574, I01BX003031, I01BX001724, I01BX002192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	We express our deepest appreciation for the animal core and its tissue sharing program of the Southern California Research Center for ALPD and Cirrhosis (National Institutes of Health Grant P50AA011999) for assistance with the animal studies for this project. We also acknowledge Adam C. Stephens in the Publication Department of Baylor Scott & White Health for editing assistance. This material is the result of work supported by resources at the Central Texas Veterans Health Care System.	Bansal MB, 2016, HEPATOL INT, V10, P902, DOI 10.1007/s12072-016-9758-x; Chen YM, 2016, TOXICOLOGY, V368, P80, DOI 10.1016/j.tox.2016.08.005; Cheng SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080053; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Francis H, 2014, J BIOL CHEM, V289, P27526, DOI 10.1074/jbc.M114.602383; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Han YY, 2016, J HEPATOL, V64, P1295, DOI 10.1016/j.jhep.2016.02.024; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Karin D, 2016, DIFFERENTIATION, V92, P84, DOI 10.1016/j.diff.2016.07.001; Lazaro R, 2015, HEPATOLOGY, V61, P129, DOI 10.1002/hep.27383; Lee SH, 2014, BBA-GENE REGUL MECH, V1839, P374, DOI 10.1016/j.bbagrm.2014.02.017; Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Mathews S, 2014, AM J PHYSIOL-GASTR L, V306, pG819, DOI 10.1152/ajpgi.00041.2014; Mavila N, 2014, HEPATOLOGY, V60, P941, DOI 10.1002/hep.27203; McDaniel K, 2016, AM J PHYSIOL-GASTR L, V310, pG757, DOI 10.1152/ajpgi.00080.2016; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Omar R, 2016, REV PHYSIOL BIOCH P, V172, P1, DOI 10.1007/112_2016_6; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Taura K, 2016, J CLIN MED, V5, DOI 10.3390/jcm5010009; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YP, 2013, HEPATOLOGY, V58, P1349, DOI 10.1002/hep.26467; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2013, MOL CELL ENDOCRINOL, V375, P53, DOI 10.1016/j.mce.2013.04.022	31	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11336	11347		10.1074/jbc.M116.773291	http://dx.doi.org/10.1074/jbc.M116.773291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28536261	Green Published, hybrid			2022-12-28	WOS:000405119600017
J	Nishimoto, Y; Nakajima, S; Tateya, S; Saito, M; Ogawa, W; Tamori, Y				Nishimoto, Yuki; Nakajima, Shinsuke; Tateya, Sanshiro; Saito, Masayuki; Ogawa, Wataru; Tamori, Yoshikazu			Cell death-inducing DNA fragmentation factor A-like effector A and fat-specific protein 27 beta coordinately control lipid droplet size in brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; DEFICIENT MICE; ACID OXIDATION; FSP27; PROMOTES; STORAGE; CIDEA; CREBH	Adipose tissue stores neutral lipids and is a major metabolic organ involved in regulating whole-body energy homeostasis. Triacylglycerol is stored as unilocular large lipid droplets (LDs) in white adipocytes and as multilocular small LDs in brown adipocytes. Proteins of the cell death-inducing DNA fragmentation factor A-like effector (Cide) family include CideA, CideB, and fat-specific protein of 27 (FSP27). Of these, FSP27 has been shown to play a crucial role in the formation of unilocular large LDs in white adipocytes. However, the mechanisms by which brown adipocytes store small and multilocular LDs remain unclear. An FSP27 isoform, FSP27 beta, was recently identified. We herein report that CideA and FSP27 beta are mainly expressed in brown adipose tissue and that FSP27 beta overexpression inhibits CideA-induced LD enlargements in a dose-dependent manner in COS cells. Furthermore, RNAi-mediated FSP27 beta depletion resulted in enlarged LDs in HB2 adipocytes, which possess the characteristics of brown adipocytes. Brown adipocytes in FSP27-knock-out mice that express CideA, but not FSP27 beta, had larger and fewer LDs. Moreover, we confirmed that FSP27 beta and CideA form a complex in brown adipose tissue. Our results suggest that FSP27 beta negatively regulates CideA-promoted enlargement of LD size in brown adipocytes. FSP27 beta appears to be responsible for the formation of small and multilocular LDs in brown adipose tissue, a morphology facilitating free fatty acid transport to mitochondria adjacent to LDs for oxidation in brown adipocytes.	[Nishimoto, Yuki; Nakajima, Shinsuke; Tateya, Sanshiro; Ogawa, Wataru; Tamori, Yoshikazu] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Dept Internal Med, Kobe, Hyogo 6500017, Japan; [Tateya, Sanshiro] Kakogawa Cent City Hosp, Div Diabet, Dept Internal Med, Kakogawa, Hyogo 6758611, Japan; [Saito, Masayuki] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan; [Tamori, Yoshikazu] Chibune Gen Hosp, Div Diabet & Endocrinol, Dept Internal Med, Osaka 5550001, Japan	Kobe University; Hokkaido University	Tamori, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Dept Internal Med, Kobe, Hyogo 6500017, Japan.; Tamori, Y (corresponding author), Chibune Gen Hosp, Div Diabet & Endocrinol, Dept Internal Med, Osaka 5550001, Japan.	tamori@med.kobe-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020		Japan Society for the Promotion of Science KAKENHI [16K09748]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant 16K09748 (to Y. T.) The authors declare that they have no conflicts of interest with the contents of this manuscript.	Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; Cohen P, 2016, MOL BIOL CELL, V27, P2523, DOI 10.1091/mbc.E15-10-0749; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lee SM, 2013, BIOCHEM BIOPH RES CO, V439, P564, DOI 10.1016/j.bbrc.2013.09.018; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tamori Y, 2016, FEBS LETT, V590, P750, DOI 10.1002/1873-3468.12114; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	24	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10824	10834		10.1074/jbc.M116.768820	http://dx.doi.org/10.1074/jbc.M116.768820			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490632	hybrid, Green Published			2022-12-28	WOS:000404391000007
J	Kim, HS; Lee, K; Bae, S; Park, J; Lee, CK; Kim, M; Kim, E; Kim, M; Kim, S; Kim, C; Kim, JS				Kim, Heon Seok; Lee, Kyungjin; Bae, Sangsu; Park, Jeongbin; Lee, Chong-Kyo; Kim, Meehyein; Kim, Eunji; Kim, Minju; Kim, Seokjoong; Kim, Chonsaeng; Kim, Jin-Soo			CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; host-pathogen interaction; poliovirus; RNA virus; sialic acid; CRISPR screen; Enterovirus D68; whole-genome sequencing	RNA-GUIDED ENDONUCLEASES; HUMAN-CELLS; ENTEROVIRUS D68; LIBRARY; GLYCOSYLATION; RESISTANCE; COMPLEX	Several groups have used genome-wide libraries of lentiviruses encoding small guide RNAs (sgRNAs) for genetic screens. In most cases, sgRNA expression cassettes are integrated into cells by using lentiviruses, and target genes are statistically estimated by the readout of sgRNA sequences after targeted sequencing. We present a new virus-free method for human gene knockout screens using a genome-wide library of CRISPR/Cas9 sgRNAs based on plasmids and target gene identification via whole-genome sequencing (WGS) confirmation of authentic mutations rather than statistical estimation through targeted amplicon sequencing. We used 30,840 pairs of individually synthesized oligonucleotides to construct the genome-scale sgRNA library, collectively targeting 10,280 human genes (i.e. three sgRNAs per gene). These plasmid libraries were co-transfected with a Cas9-expression plasmid into human cells, which were then treated with cytotoxic drugs or viruses. Only cells lacking key factors essential for cytotoxic drug metabolism or viral infection were able to survive. Genomic DNA isolated from cells that survived these challenges was subjected to WGS to directly identify CRISPR/Cas9-mediated causal mutations essential for cell survival. With this approach, we were able to identify known and novel genes essential for viral infection in human cells. We propose that genome-wide sgRNA screens based on plasmids coupled with WGS are powerful tools for forward genetics studies and drug target discovery.	[Kim, Heon Seok; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea; [Kim, Heon Seok; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lee, Kyungjin; Lee, Chong-Kyo; Kim, Chonsaeng] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea; [Kim, Meehyein] Korea Res Inst Chem Technol, Virus Res & Testing Ctr, Daejeon 34114, South Korea; [Bae, Sangsu; Park, Jeongbin] Hanyang Univ, Dept Chem, Seoul 04763, South Korea; [Kim, Eunji; Kim, Minju; Kim, Seokjoong] ToolGen Inc, Byucksan Kyoungin Digital Valley 2 Cha, Seoul 153023, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT); Hanyang University	Kim, JS (corresponding author), Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.; Kim, C (corresponding author), Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea.	chonskim@krict.re.kr; jskim01@snu.ac.kr	Bae, Sangsu/E-5324-2017; Park, Jeongbin/ABC-5703-2021; KIM, Jin-Soo/M-6918-2013; Park, Jeongbin/AAL-4022-2021	Bae, Sangsu/0000-0003-3615-8566; KIM, Jin-Soo/0000-0003-4847-1306; Park, Jeongbin/0000-0002-9064-4912; Kim, Meehyein/0000-0002-2851-5298	IBS Grant [IBS-R021-D1]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant [2016R1C1B2009585]; National Research Council of Science and Technology by the Korean government Grant [CRC-16-01-KRICT]	IBS Grant; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant; National Research Council of Science and Technology by the Korean government Grant	This work was supported by IBS Grant IBS-R021-D1 (to J. S. K.), Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning Grant 2016R1C1B2009585, and National Research Council of Science and Technology by the Korean government Grant CRC-16-01-KRICT (to C. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim JH, 2002, ANTIVIR RES, V54, P163, DOI 10.1016/S0166-3542(01)00221-2; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kim YK, 2013, NAT STRUCT MOL BIOL, V20, P1458, DOI 10.1038/nsmb.2701; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Pallansch M., 2007, ENTEROVIRUSES POLIOV; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Principi N, 2015, EXPERT REV RESP MED, V9, P711, DOI 10.1586/17476348.2015.1109451; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	22	26	28	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10664	10671		10.1074/jbc.M117.782425	http://dx.doi.org/10.1074/jbc.M117.782425			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28446605	Green Published, hybrid			2022-12-28	WOS:000404115400025
J	Shibata, T; Hadano, J; Kawasaki, D; Dong, XQ; Kawabata, S				Shibata, Toshio; Hadano, Jinki; Kawasaki, Daichi; Dong, Xiaoqing; Kawabata, Shun-ichiro			Drosophila TG-A transglutaminase is secreted via an unconventional Golgi-independent mechanism involving exosomes and two types of fatty acylations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; exosome (vesicle); protein myristoylation; protein palmitoylation; protein secretion; transglutaminase	TERMINAL N-MYRISTOYLATION; PROTEIN CROSS-LINKING; CLOTTING PROTEIN; PLASMA-MEMBRANE; TRANSFERRIN RECEPTOR; ALPHA-SUBUNIT; PALMITOYLATION; IDENTIFICATION; LOCALIZATION; SYSTEM	Transglutaminases (TGs) play essential intracellular and extracellular roles by covalently cross-linking many proteins. Drosophila TG is encoded by one gene and has two alternative splicing-derived isoforms, TG-A and TG-B, which contain distinct N-terminal 46- and 38-amino acid sequences, respectively. The TGs identified to date do not have a typical endoplasmic reticulum (ER)-signal peptide, and the molecular mechanisms of their secretion under physiologic conditions are unclear. Immunocytochemistry revealed that TG-A localizes to multivesicular-like structures, whereas TG-B localizes to the cytosol. We also found that TG-A, but not TG-B, was modified concomitantly by N-myristoylation and S-palmitoylation, and N-myristoylation was a pre-requisite for S-palmitoylation. Moreover, TG-A, but not TG-B, was secreted in response to calcium signaling induced by Ca2+ ionophores and uracil, a pathogenic bacteria-derived substance. Brefeldin A and monensin, inhibitors of the ER/Golgi-mediated conventional pathway, did not suppress TG-A secretion, whereas inhibition of S-palmitoylation by 2-bromopalmitate blocked TG-A secretion. Ultracentrifugation, electron microscopy analyses, and treatments with inhibitors of multivesicular body formation revealed that TG-A was secreted via exosomes together with co-transfected mammalian CD63, an exosomal marker, and the secreted TG-A was taken up by other cells. The 8-residue N-terminal fragment of TG-A containing the fatty acylation sites was both necessary and sufficient for the exosome-dependent secretion of TG-A. In conclusion, TG-A is secreted through an unconventional ER/Golgi-independent pathway involving two types of fatty acylations and exosomes.	[Shibata, Toshio; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8190395, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8190395, Japan; [Hadano, Jinki; Kawasaki, Daichi; Dong, Xiaoqing; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan	Kyushu University; Kyushu University; Kyushu University	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8190395, Japan.; Kawabata, S (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan.	skawascb@kyudai.jp			Qdai-jump Research Program (TT type) Grant [26701];  [15H04353];  [26860333]	Qdai-jump Research Program (TT type) Grant; ; 	This work was supported by Grant-in-Aid for Scientific Research (B) 15H04353 (to S. K.), Grant-in-Aid for Young Scientists (B) 26860333 (to T. S.), and the Qdai-jump Research Program (TT type) Grant 26701 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; ALLAND L, 1994, J BIOL CHEM, V269, P16701; Bannan Barbra A, 2008, Fly (Austin), V2, P198; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bastos-Amador P, 2012, J LEUKOCYTE BIOL, V91, P751, DOI 10.1189/jlb.0111054; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; Demuny M.A., 2015, TRANSGLUTAMINASES MU, P1, DOI [10.1007/978-4-431-55825-5_1, DOI 10.1007/978-4-431-55825-5_1]; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Diaz-Hidalgo L, 2016, BBA-MOL CELL RES, V1863, P2084, DOI 10.1016/j.bbamcr.2016.05.005; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Ezure T, 2007, PROTEOMICS, V7, P4424, DOI 10.1002/pmic.200700774; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Furutani Y., 2015, TRANSGLUTAMINASES, P43, DOI DOI 10.1007/978-4-431-55825-5_2; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HALLAK H, 1994, J BIOL CHEM, V269, P4571; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Ichikawa A, 2010, BIOSCI BIOTECH BIOCH, V74, P2494, DOI 10.1271/bbb.100449; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Kalinin A, 2001, J CELL SCI, V114, P3069; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lindgren M, 2008, J INSECT PHYSIOL, V54, P586, DOI 10.1016/j.jinsphys.2007.12.008; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; MERESSE S, 1995, J CELL SCI, V108, P3349; Moriya K, 2010, INSECT MOL BIOL, V19, P291, DOI 10.1111/j.1365-2583.2009.00982.x; NASSARGENTINA V, 1994, CELL CALCIUM, V16, P475, DOI 10.1016/0143-4160(94)90077-9; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Phan HP, 2008, BIOSCI BIOTECH BIOCH, V72, P1847, DOI 10.1271/bbb.80108; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Shibata T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005244; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Suzuki T, 2007, PROTEOMICS, V7, P1942, DOI 10.1002/pmic.200700237; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zlatkine P, 1997, J CELL SCI, V110, P673	68	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10723	10734		10.1074/jbc.M117.779710	http://dx.doi.org/10.1074/jbc.M117.779710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28476891	Green Published, hybrid			2022-12-28	WOS:000404115400030
J	Kerros, C; Tripathi, SC; Zha, DX; Mehrens, JM; Sergeeva, A; Philips, AV; Qiao, N; Peters, HL; Katayama, H; Sukhumalchandra, P; Ruisaard, KE; Perakis, AA; John, LSS; Lu, SJ; Mittendorf, EA; Clise-Dwyer, K; Herrmann, AC; Alatrash, G; Toniatti, C; Hanash, SM; Ma, Q; Molldrem, JJ				Kerros, Celine; Tripathi, Satyendra C.; Zha, Dongxing; Mehrens, Jennifer M.; Sergeeva, Anna; Philips, Anne V.; Qiao, Na; Peters, Haley L.; Katayama, Hiroyuki; Sukhumalchandra, Pariya; Ruisaard, Kathryn E.; Perakis, Alexander A.; John, Lisa S. St.; Lu, Sijie; Mittendorf, Elizabeth A.; Clise-Dwyer, Karen; Herrmann, Amanda C.; Alatrash, Gheath; Toniatti, Carlo; Hanash, Samir M.; Ma, Qing; Molldrem, Jeffrey J.			Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; END-RULE PEPTIDES; CATHEPSIN-G; MYELOID MALIGNANCIES; IMMUNE-RESPONSE; T-CELLS; RECEPTOR; PR1; PROGRESSION; LEUKEMIA	Neutrophil elastase (NE) can be rapidly taken up by tumor cells that lack endogenous NE expression, including breast cancer, which results in cross-presentation of PR1, an NE-derived HLA-A2-restricted peptide that is an immunotherapy target in hematological and solid tumor malignancies. The mechanism of NE uptake, however, remains unknown. Using the mass spectrometry-based approach, we identify neuropilin-1 (NRP1) as a NE receptor that mediates uptake and PR1 cross-presentation in breast cancer cells. We demonstrated that soluble NE is a specific, high-affinity ligand for NRP1 with a calculated Kd of 38.7nM. Furthermore, we showed that NRP1 binds to the RRXR motif in NE. Notably, NRP1 knockdown with interfering RNA or CRISPR-cas9 system and blocking using anti-NRP1 antibody decreased NE uptake and, subsequently, susceptibility to lysis by PR1-specific cytotoxic T cells. Expression of NRP1 in NRP1 deficient cells was sufficient to induce NE uptake. Altogether, because NRP1 is broadly expressed in tumors, our findings suggest a role for this receptor in immunotherapy strategies that target cross-presented antigens.	[Kerros, Celine; Tripathi, Satyendra C.; Zha, Dongxing; Mehrens, Jennifer M.; Sergeeva, Anna; Philips, Anne V.; Qiao, Na; Peters, Haley L.; Katayama, Hiroyuki; Sukhumalchandra, Pariya; Ruisaard, Kathryn E.; Perakis, Alexander A.; John, Lisa S. St.; Lu, Sijie; Mittendorf, Elizabeth A.; Clise-Dwyer, Karen; Herrmann, Amanda C.; Alatrash, Gheath; Toniatti, Carlo; Hanash, Samir M.; Ma, Qing; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Molldrem, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Sect Transplantat Immunol, Unit 900, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jmolldre@mdanderson.org	Tripathi, Satyendra Chandra/L-9352-2017	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Toniatti, Carlo/0000-0001-9493-344X; Perakis, Alexander/0000-0002-8172-7281; Alatrash, Gheath/0000-0002-7648-4377; kerros, celine/0000-0002-7826-4167	Leukemia and Lymphoma Society Translational Research Program Grant [6030-12]; National Institutes of Health (NIH) SPORE [P50 CA100632]; NIH Training Program in Cancer Immunobiology [T32 CA009598]; National Cancer Institute Grant [P30CA16672];  [P01 CA049639];  [P01 CA148600]; NATIONAL CANCER INSTITUTE [P50CA100632, T32CA009598, P30CA016672, P01CA148600, P01CA049639] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Translational Research Program Grant(Leukemia and Lymphoma Society); National Institutes of Health (NIH) SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Program in Cancer Immunobiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Leukemia and Lymphoma Society Translational Research Program Grant (6030-12), National Institutes of Health (NIH) SPORE (P50 CA100632), Research Program Project (P01 CA049639 and P01 CA148600) grants (to J. J. M), NIH Training Program in Cancer Immunobiology T32 CA009598 (to H. L. P and C. K.), and National Cancer Institute Grant P30CA16672 (to the South Campus Flow Cytometry & Cell Sorting Core Facility and the Characterized Cell Line Core Facility at MDACC). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akizuki M, 2007, NEOPLASIA, V9, P260, DOI 10.1593/neo.06808; Alatrash G, 2012, J IMMUNOL, V189, P5476, DOI 10.4049/jimmunol.1201221; Alatrash G, 2012, J IMMUNOTHER, V35, P309, DOI 10.1097/CJI.0b013e31824b3b14; Bagheri-Yarmand R, 2010, CANCER RES, V70, P5074, DOI 10.1158/0008-5472.CAN-09-4094; CAMPBELL EJ, 1982, P NATL ACAD SCI-BIOL, V79, P6941, DOI 10.1073/pnas.79.22.6941; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Cheng W, 2014, TUMOR BIOL, V35, P6089, DOI 10.1007/s13277-014-1806-3; Djordjevic S, 2013, DRUG DISCOV TODAY, V18, P447, DOI 10.1016/j.drudis.2012.11.013; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Gregory AD, 2012, J BIOL CHEM, V287, P35341, DOI 10.1074/jbc.M112.385617; Hattar K, 2014, CANCER IMMUNOL IMMUN, V63, P1297, DOI 10.1007/s00262-014-1606-z; Henriksen PA, 2014, CURR OPIN HEMATOL, V21, P23, DOI 10.1097/MOH.0000000000000001; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Li LH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0291-5; Ma Q, 2016, CYTOTHERAPY, V18, P985, DOI 10.1016/j.jcyt.2016.05.001; MCGOWAN SE, 1983, AM REV RESPIR DIS, V128, P688; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Mittendorf EA, 2012, CANCER RES, V72, P3153, DOI 10.1158/0008-5472.CAN-11-4135; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nawa M, 2012, ANTICANCER RES, V32, P13; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Qazilbash MH, 2017, LEUKEMIA, V31, P697, DOI 10.1038/leu.2016.254; Rezvani K, 2011, HAEMATOL-HEMATOL J, V96, P432, DOI 10.3324/haematol.2010.031674; Sato Nagato, 2007, Nihon Kokyuki Gakkai Zasshi, V45, P237; Sergeeva A, 2016, LEUKEMIA, V30, P1475, DOI 10.1038/leu.2016.57; Sergeeva A, 2011, BLOOD, V117, P4262, DOI 10.1182/blood-2010-07-299248; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Taguchi K, 2014, BIOANALYSIS, V6, P1679, DOI 10.4155/bio.14.120; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Yamashita JI, 2006, BREAST J, V12, P288, DOI 10.1111/j.1075-122X.2006.00265.x; Zanuy D, 2013, J STRUCT BIOL, V182, P78, DOI 10.1016/j.jsb.2013.02.006; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736	44	22	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10295	10305		10.1074/jbc.M116.773051	http://dx.doi.org/10.1074/jbc.M116.773051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28468826	Green Published, hybrid			2022-12-28	WOS:000403580600037
J	Singh, R; Jamdar, SN; Goyal, VD; Kumar, A; Ghosh, B; Makde, RD				Singh, Rahul; Jamdar, Sahayog N.; Goyal, Venuka Durani; Kumar, Ashwani; Ghosh, Biplab; Makde, Ravindra D.			Structure of the human aminopeptidase XPNPEP3 and comparison of its in vitro activity with Icp55 orthologs: Insights into diverse cellular processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STABILITY; ESCHERICHIA-COLI; MITOCHONDRIA; EXPRESSION; ENZYME; CRYSTALLOGRAPHY; PROTEOLYSIS; PEPTIDASES; PROTEASES; BRAIN	The human aminopeptidase XPNPEP3 is associated with cystic kidney disease and TNF-TNFR2 cellular signaling. Its yeast and plant homolog Icp55 processes several imported mitochondrial matrix proteins leading to their stabilization. However, the molecular basis for the diverse roles of these enzymes in the cell is unknown. Here, we report the crystal structure of human XPNPEP3 with bound apstatin product at 1.65 angstrom resolution, and we compare its in vitro substrate specificity with those of fungal Icp55 enzymes. In contrast to the suggestions by earlier in vivo studies of mitochondrial processing, we found that these enzymes are genuine Xaa-Pro aminopeptidases, which hydrolyze peptides with proline at the second position (P1'). The mitochondrial processing activity involving cleavage of peptides lacking P1' proline was also detected in the purified enzymes. A wide proline pocket as well as molecular complementarity and capping at the S1 substrate site of XPNPEP3 provide the necessary structural features for processing the mitochondrial substrates. However, this activity was found to be significantly lower as compared with Xaa-Pro aminopeptidase activity. Because of similar activity profiles of Icp55 and XPNPEP3, we propose that XPNPEP3 plays the same mitochondrial role in humans as Icp55 does in yeast. Both Xaa-Pro aminopeptidase and mitochondrial processing activities of XPNPEP3 have implications toward mitochondrial fitness and cystic kidney disease. Furthermore, the presence of both these activities in Icp55 elucidates the unexplained processing of the mitochondrial cysteine desulfurase Nfs1 in yeast. The enzymatic and structural analyses reported here provide a valuable molecular framework for understanding the diverse cellular roles of XPNPEP3.	[Singh, Rahul; Goyal, Venuka Durani; Kumar, Ashwani; Ghosh, Biplab; Makde, Ravindra D.] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Mumbai 400085, Maharashtra, India; [Jamdar, Sahayog N.] Bhabha Atom Res Ctr, Food Technol Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Makde, RD (corresponding author), Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Mumbai 400085, Maharashtra, India.; Jamdar, SN (corresponding author), Bhabha Atom Res Ctr, Food Technol Div, Mumbai 400085, Maharashtra, India.	snjam@barc.gov.in; ravimakde@rrcat.gov.in	Goyal, Venuka/AAR-7525-2020	kumar, ashwani/0000-0002-7526-1569; Goyal, Venuka/0000-0001-7838-572X; Makde, Ravindra D./0000-0001-7020-0065; Ghosh, Biplab/0000-0003-2265-5211; Singh, Rahul/0000-0003-4871-3600				Are VN, 2017, BBA-PROTEINS PROTEOM, V1865, P153, DOI 10.1016/j.bbapap.2016.10.016; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Carrie C, 2015, J EXP BOT, V66, P2691, DOI 10.1093/jxb/erv064; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ersahin C, 2005, ARCH BIOCHEM BIOPHYS, V435, P303, DOI 10.1016/j.abb.2004.12.023; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang SB, 2015, PLANT PHYSIOL, V168, P415, DOI 10.1104/pp.15.00300; Inoue M, 2015, J CELL SCI, V128, P656, DOI 10.1242/jcs.149385; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kumar A, 2016, J SYNCHROTRON RADIAT, V23, P629, DOI 10.1107/S160057751600076X; La Corte ALC, 2011, HUM MUTAT, V32, P1326, DOI 10.1002/humu.21579; Li X, 2008, J BIOL CHEM, V283, P22858, DOI 10.1074/jbc.M710274200; MARUYAMA S, 1994, BIOSCI BIOTECH BIOCH, V58, P2107, DOI 10.1271/bbb.58.2107; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vogtle FN, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1533, DOI 10.1016/B978-0-12-382219-2.00345-8; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; YARON A, 1968, BIOCHEM BIOPH RES CO, V32, P658, DOI 10.1016/0006-291X(68)90289-1; YOSHIMOTO T, 1994, ARCH BIOCHEM BIOPHYS, V311, P28, DOI 10.1006/abbi.1994.1204; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957	39	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10035	10047		10.1074/jbc.M117.783357	http://dx.doi.org/10.1074/jbc.M117.783357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28476889	Green Published, hybrid			2022-12-28	WOS:000403580600016
J	Inoue, M; Fukui, K; Fujii, Y; Nakagawa, N; Yano, T; Kuramitsu, S; Masui, R				Inoue, Masao; Fukui, Kenji; Fujii, Yuki; Nakagawa, Noriko; Yano, Takato; Kuramitsu, Seiki; Masui, Ryoji			The Lon protease-like domain in the bacterial RecA paralog RadA is required for DNA binding and repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; GENE-TRANSFER; DEINOCOCCUS-RADIODURANS; THERMUS-THERMOPHILUS; CATALYZED-REACTIONS; MISMATCH REPAIR; LA PROTEASE; SPECIFICITY	Homologous recombination (HR) plays an essential role in the maintenance of genome integrity. RecA/Rad51 paralogs have been recognized as an important factor of HR. Among them, only one bacterial RecA/Rad51 paralog, RadA, is involved in HR as an accessory factor of RecA recombinase. RadA has a unique Lon protease-like domain (LonC) at its C terminus, in addition to a RecA-like ATPase domain. Unlike Lon protease, RadA's LonC domain does not show protease activity but is still essential for RadA-mediated DNA repair. Reconciling these two facts has been difficult because RadA's tertiary structure and molecular function are unknown. Here, we describe the hexameric ring structure of RadA's LonC domain, as determined by X-ray crystallography. The structure revealed the two positively charged regions unique to the LonC domain of RadA are located at the intersubunit cleft and the central hole of a hexameric ring. Surprisingly, a functional domain analysis demonstrated the LonC domain of RadA binds DNA, with site-directed mutagenesis showing that the two positively charged regions are critical for this DNA-binding activity. Interestingly, only the intersubunit cleft was required for the DNA-dependent stimulation of ATPase activity of RadA, and at least the central hole was essential for DNA repair function. Our data provide the structural and functional features of the LonC domain and their function in RadA-mediated DNA repair.	[Inoue, Masao; Nakagawa, Noriko; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan; [Fukui, Kenji; Yano, Takato] Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan; [Fujii, Yuki] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Masui, Ryoji] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan	Osaka University; Osaka Medical College; Osaka University; Osaka Metropolitan University	Masui, R (corresponding author), Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	rmasui@sci.osaka-cu.ac.jp		Fujii, Yuki/0000-0002-8992-9902; Fukui, Kenji/0000-0003-2463-7578; Inoue, Masao/0000-0001-5484-0767				Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; AMERIK AY, 1991, FEBS LETT, V287, P211, DOI 10.1016/0014-5793(91)80053-6; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Bell JC, 2016, TRENDS BIOCHEM SCI, V41, P491, DOI 10.1016/j.tibs.2016.04.002; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Brigulla M, 2010, APPL MICROBIOL BIOT, V86, P1027, DOI 10.1007/s00253-010-2489-3; Brimacombe CA, 2015, J BACTERIOL, V197, P2653, DOI 10.1128/JB.00332-15; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Carrasco B, 2004, J BACTERIOL, V186, P5557, DOI 10.1128/JB.186.17.5557-5566.2004; Chen LT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000858; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cooper DL, 2016, ELIFE, V5, DOI 10.7554/eLife.10807; Cooper DL, 2015, MOL MICROBIOL, V95, P769, DOI 10.1111/mmi.12899; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; DIVER WP, 1982, INT J RADIAT BIOL, V42, P339, DOI 10.1080/09553008214551251; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erill I, 2004, NUCLEIC ACIDS RES, V32, P6617, DOI 10.1093/nar/gkh996; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Gwinn ML, 1998, J BACTERIOL, V180, P746, DOI 10.1128/JB.180.3.746-748.1998; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Jovanovic M, 2002, NUCLEIC ACIDS RES, V30, P5065, DOI 10.1093/nar/gkf670; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruger E, 1997, MICROBIOL-SGM, V143, P1309, DOI 10.1099/00221287-143-4-1309; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Kurumizaka H, 1996, J BIOL CHEM, V271, P33515, DOI 10.1074/jbc.271.52.33515; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee AYL, 2014, ACTA CRYSTALLOGR D, V70, P218, DOI 10.1107/S139900471302631X; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lin YC, 2009, BIOCHEM BIOPH RES CO, V388, P62, DOI 10.1016/j.bbrc.2009.07.118; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lovett S, 2006, DNA REPAIR, V5, P1421, DOI 10.1016/j.dnarep.2006.06.008; Maraboeuf F, 1995, J BIOL CHEM, V270, P30927, DOI 10.1074/jbc.270.52.30927; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025; Rasulova FS, 1998, FEBS LETT, V432, P179, DOI 10.1016/S0014-5793(98)00859-X; Robertson A, 2006, J BIOL CHEM, V281, P8399, DOI 10.1074/jbc.M509184200; Rotanova TV, 2004, EUR J BIOCHEM, V271, P4865, DOI 10.1111/j.1432-1033.2004.04452.x; Rudyak SG, 2001, BIOCHEMISTRY-US, V40, P9317, DOI 10.1021/bi0102508; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shin DS, 2004, DNA REPAIR, V3, P863, DOI 10.1016/j.dnarep.2004.03.022; Shinohara T, 2015, NUCLEIC ACIDS RES, V43, P973, DOI 10.1093/nar/gku1364; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Song YH, 1996, J BACTERIOL, V178, P5045, DOI 10.1128/jb.178.16.5045-5048.1996; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Taylor MRG, 2015, CELL, V162, P271, DOI 10.1016/j.cell.2015.06.015; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; Vieux EF, 2013, P NATL ACAD SCI USA, V110, pE2002, DOI 10.1073/pnas.1307066110; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhou Q, 2006, CHINESE SCI BULL, V51, P2993, DOI 10.1007/s11434-006-2209-7	67	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9801	9814		10.1074/jbc.M116.770180	http://dx.doi.org/10.1074/jbc.M116.770180			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28432121	Green Published, hybrid			2022-12-28	WOS:000403113000028
J	Goto, T; Hirata, M; Aoki, Y; Iwase, M; Takahashi, H; Kim, M; Li, YJ; Jheng, H; Nomura, W; Takahashi, N; Kim, CS; Yu, R; Seno, S; Matsuda, H; Aizawa-Abe, M; Ebihara, K; Itoh, N; Kawada, T				Goto, Tsuyoshi; Hirata, Mariko; Aoki, Yumeko; Iwase, Mari; Takahashi, Haruya; Kim, Minji; Li, Yongjia; Jheng, Huei-Fen; Nomura, Wataru; Takahashi, Nobuyuki; Kim, Chu-Sook; Yu, Rina; Seno, Shigeto; Matsuda, Hideo; Aizawa-Abe, Megumi; Ebihara, Ken; Itoh, Nobuyuki; Kawada, Teruo			The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-alpha agonist-induced amelioration of metabolic disorders in obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; FATTY-ACID-METABOLISM; PPAR-ALPHA; INSULIN SENSITIVITY; SKELETAL-MUSCLE; BETA-KLOTHO; WHITE FAT; ENERGY-EXPENDITURE; PLASMA-GLUCOSE; COLD-EXPOSURE	Obesity causes excess fat accumulation in white adipose tissues (WAT) and also in other insulin-responsive organs such as the skeletal muscle, increasing the risk for insulin resistance, which can lead to obesity-related metabolic disorders. Peroxisome proliferator-activated receptor-alpha (PPAR alpha) is a master regulator of fatty acid oxidation whose activator is known to improve hyperlipidemia. However, the molecular mechanisms underlying PPAR alpha activator-mediated reduction in adiposity and improvement of metabolic disorders are largely unknown. In this study we investigated the effects of PPAR alpha agonist (fenofibrate) on glucose metabolism dysfunction in obese mice. Fenofibrate treatment reduced adiposity and attenuated obesity-induced dysfunctions of glucose metabolism in obese mice fed a high-fat diet. However, fenofibrate treatment did not improve glucose metabolism in lipodystrophic A-Zip/F1 mice, suggesting that adipose tissue is important for the fenofibrate-mediated amelioration of glucose metabolism, although skeletal muscle actions could not be completely excluded. Moreover, we investigated the role of the hepatokine fibroblast growth factor 21 (FGF21), which regulates energy metabolism in adipose tissue. In WAT of WT mice, but not of FGF21-deficient mice, fenofibrate enhanced the expression of genes related to brown adipocyte functions, such as Ucp1, Pgc1a, and Cpt1b. Fenofibrate increased energy expenditure and attenuated obesity, whole body insulin resistance, and adipocyte dysfunctions in WAT in high-fat-diet-fed WT mice but not in FGF21-defi-the fenofibrate-mediated improvement of whole body glucose metabolism in obese mice via the amelioration of WAT dysfunctions.	[Goto, Tsuyoshi; Hirata, Mariko; Aoki, Yumeko; Iwase, Mari; Takahashi, Haruya; Kim, Minji; Li, Yongjia; Jheng, Huei-Fen; Nomura, Wataru; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto 6110011, Japan; [Goto, Tsuyoshi; Nomura, Wataru; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Res Unit Physiol Chem, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068501, Japan; [Kim, Chu-Sook; Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan 680749, South Korea; [Seno, Shigeto; Matsuda, Hideo] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Aizawa-Abe, Megumi; Ebihara, Ken] Kyoto Univ Hosp, Inst Advancement Clin & Translat Sci, Kyoto 6068507, Japan; [Itoh, Nobuyuki] Kyoto Univ, Dept Genet Biochem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	Kyoto University; Kyoto University; University of Ulsan; Osaka University; Kyoto University; Kyoto University	Goto, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto 6110011, Japan.	tgoto@kais.kyoto-u.ac.jp	Seno, Shigeto/W-1426-2019; Takahashi, Nobuyuki/AAX-8671-2021; Goto, Tsuyoshi/AAY-2344-2020; Iwase, Mari/GZH-2961-2022	Seno, Shigeto/0000-0003-3861-6444; Takahashi, Nobuyuki/0000-0002-9705-662X; Goto, Tsuyoshi/0000-0003-1283-147X; Iwase, Mari/0000-0002-6494-8787; Matsuda, Hideo/0000-0002-4701-3779	HPCI System Research Project [hp160218]	HPCI System Research Project	We thank M. Komori and S. Shinotoh for technical assistance and secretarial support. We are grateful to Prof. M. Saito, Prof. K. Kimura, Prof. Y. Okamatsu-Ogura, and Dr. K. Fukano (Hokkaido University) for kind technical advice and useful discussions. This research used computational resources through the HPCI System Research Project (Project ID: hp160218).	Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; ALBERTI KGMM, 1990, J CARDIOVASC PHARM, V16, pS21, DOI 10.1097/00005344-199000169-00005; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Brocker CN, 2017, AM J PHYSIOL-GASTR L, V312, pG283, DOI 10.1152/ajpgi.00205.2016; Calderon-Dominguez M, 2016, ADIPOCYTE, V5, P98, DOI 10.1080/21623945.2015.1122857; Chan SMH, 2015, BBA-MOL BASIS DIS, V1852, P1511, DOI 10.1016/j.bbadis.2015.04.005; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Goto T, 2011, AM J PHYSIOL-ENDOC M, V301, pE1022, DOI 10.1152/ajpendo.00061.2011; Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; JONES IR, 1990, DIABETES CARE, V13, P855, DOI 10.2337/diacare.13.8.855; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee P, 2013, J CLIN ENDOCR METAB, V98, pE98, DOI 10.1210/jc.2012-3107; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Lucas EA, 2011, BRIT J NUTR, V106, P1495, DOI 10.1017/S0007114511002066; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; Mazzucotelli A, 2007, DIABETES, V56, P2467, DOI 10.2337/db06-1465; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Miura Y, 2005, BRIT J NUTR, V93, P559, DOI 10.1079/BJN20041384; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ribet C, 2010, ENDOCRINOLOGY, V151, P123, DOI 10.1210/en.2009-0726; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schoonjans K, 1996, J LIPID RES, V37, P907; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Takahashi H, 2015, J LIPID RES, V56, P254, DOI 10.1194/jlr.M052464; Tenenbaum A, 2006, ARCH INTERN MED, V166, P737, DOI 10.1001/archinte.166.7.737; Tenenbaum A, 2004, CIRCULATION, V109, P2197, DOI 10.1161/01.CIR.0000126824.12785.B6; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	66	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9175	9190		10.1074/jbc.M116.767590	http://dx.doi.org/10.1074/jbc.M116.767590			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28404815	Green Published, hybrid			2022-12-28	WOS:000402538900014
J	Huang, GC; Kaufman, AJ; Xu, K; Manova, K; Singh, B				Huang, Guochang; Kaufman, Andrew J.; Xu, Ke; Manova, Katia; Singh, Bhuvanesh			Squamous cell carcinoma-related oncogene (SCCRO) neddylates Cul3 protein to selectively promote midbody localization and activity of Cul3(KLHL21) protein complex during abscission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B; CULLIN NEDDYLATION; UBIQUITIN LIGASES; NEDD8-ACTIVATING ENZYME; S PHASE; NEDD8; CYTOKINESIS; CANCER; CONJUGATION; ACTIVATION	Squamous cell carcinoma-related oncogene (SCCRO)/DCUN1D1, a component of the neddylation E3 complex, regulates the activity of the cullin-RING-ligase type of ubiquitination E3s by promoting neddylation of cullin family members. Studies have shown that SCCRO regulates proliferation in vitro and in vivo. Here we show that inactivation of SCCRO results in prolonged mitotic time because of delayed and/or failed abscission. The effects of SCCRO on abscission involve its role in neddylation and localization of Cul3 to the midbody. The Cul3 adaptor KLHL21 mediates the effects of SCCRO on abscission, as it fails to localize to the midbody in SCCRO-deficient cells during abscission, and its inactivation resulted in phenotypic changes identical to SCCRO inactivation. Ubiquitination-promoted turnover of Aurora B at the midbody was deficient in SCCRO-and KLHL21-deficient cells, suggesting that it is the target of Cul3KLHL21 at the midbody. Correction of abscission delays in SCCRO-deficient cells with addition of an Aurora B inhibitor at the midbody stage suggests that Aurora B is the target of SCCRO-promoted Cul3KLHL21 activity. The activity of other Cul3-anchored complexes, including Cul3KLHL9/KLHL13, was intact in SCCRO-deficient cells, suggesting that SCCRO selectively, rather than collectively, neddylates cullins in vivo. Combined, these findings support a model in which the SCCRO, substrate, and substrate adaptors cooperatively provide tight control of neddylation and cullin-RING-ligase activity in vivo.	[Huang, Guochang; Kaufman, Andrew J.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA; [Xu, Ke; Manova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10065 USA; [Kaufman, Andrew J.] Mt Sinai Med Ctr, Dept Cardiothorac Surg, New York, NY 10029 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	singhb@mskcc.org		Xu, Ke/0000-0003-2628-2061	NCI, National Institutes of Health Cancer Center Support Grant [P30 CA008748]; Hackers for Hope; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI, National Institutes of Health Cancer Center Support Grant; Hackers for Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health Cancer Center Support Grant P30 CA008748 and by a research grant from the Hackers for Hope. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bommelje CC, 2014, CLIN CANCER RES, V20, P372, DOI 10.1158/1078-0432.CCR-13-1252; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fu WM, 2016, J BIOL CHEM, V291, P6200, DOI 10.1074/jbc.M115.692756; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Glotzer NI., 2005, SCIENCE, V307, P1735; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Han K, 2016, ONCOTARGET, V7, P23812, DOI 10.18632/oncotarget.8068; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Heir P, 2013, MOL CELL BIOL, V33, P1621, DOI 10.1128/MCB.01342-12; Huang GC, 2014, J BIOL CHEM, V289, P34728, DOI 10.1074/jbc.M114.585505; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Jackman J., 2001, CURR PROTOC CELL BIO; Kawakami I., 2011, EMBO J, V20, P4003; Keuss MJ, 2016, J CELL SCI, V129, P1441, DOI 10.1242/jcs.181784; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Leck YC, 2010, BIOCHEM BIOPH RES CO, V398, P588, DOI 10.1016/j.bbrc.2010.06.128; Li LH, 2013, BIOCHEM BIOPH RES CO, V432, P494, DOI 10.1016/j.bbrc.2013.02.028; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Mathieu J, 2013, DEV CELL, V26, P250, DOI 10.1016/j.devcel.2013.07.005; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2017, NAT CHEM BIOL, V13, P850, DOI 10.1038/nchembio.2386; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Zhang Y, 2016, ONCOTARGET, V7, P45263, DOI 10.18632/oncotarget.9481; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	48	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15254	15265		10.1074/jbc.M117.778530	http://dx.doi.org/10.1074/jbc.M117.778530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28620047	Green Published, hybrid			2022-12-28	WOS:000410809800008
J	Rosado, LA; Wahni, K; Degiacomi, G; Pedre, B; Young, D; de la Rubia, AG; Boldrin, F; Martens, E; Marcos-Pascual, L; Sancho-Vaello, E; Albesa-Jove, D; Provvedi, R; Martin, C; Makarov, V; Versees, W; Verniest, G; Guerin, ME; Mateos, LM; Manganelli, R; Messens, J				Rosado, Leonardo Astolfi; Wahni, Khadija; Degiacomi, Giulia; Pedre, Brandan; Young, David; de la Rubia, Alfonso G.; Boldrin, Francesca; Martens, Edo; Marcos-Pascual, Laura; Sancho-Vaello, Enea; Albesa-Jove, David; Provvedi, Roberta; Martin, Charlotte; Makarov, Vadim; Versees, Wim; Verniest, Guido; Guerin, Marcelo E.; Mateos, Luis M.; Manganelli, Riccardo; Messens, Joris			The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SULFOXIDE REDUCTASE; CORYNEBACTERIUM-GLUTAMICUM; THIOL REDOX; PROTEIN; GLUTAREDOXIN; THIOREDOXIN; MECHANISM; CYSTEINE; DSBA; SITE	The Mycobacterium tuberculosis rv2466c gene encodes an oxidoreductase enzyme annotated as DsbA. It has a CPWC active-site motif embedded within its thioredoxin fold domain and mediates the activation of the prodrug TP053, a thienopyrimidine derivative that kills both replicating and nonreplicating bacilli. However, its mode of action and actual enzymatic function in M. tuberculosis have remained enigmatic. In this study, we report that Rv2466c is essential for bacterial survival under H2O2 stress. Further, we discovered that Rv2466c lacks oxidase activity; rather, it receives electrons through the mycothiol/mycothione reductase/NADPH pathway to activate TP053, preferentially via a dithiol-disulfide mechanism. We also found that Rv2466c uses a monothiol-disulfide exchange mechanism to reduce S-mycothiolated mixed disulfides and intramolecular disulfides. Genetic, phylogenetic, bioinformatics, structural, and biochemical analyses revealed that Rv2466c is a novel mycothiol-dependent reductase, which represents a mycoredoxin cluster of enzymes within the DsbA family different from the glutaredoxin cluster to which mycoredoxin-1 (Mrx1 or Rv3198A) belongs. To validate this DsbA-myco-redoxin cluster, we also characterized a homologous enzyme of Corynebacterium glutamicum (NCgl2339) and observed that it demycothiolates and reduces a mycothiol arsenate adduct with kinetic properties different from those of Mrx1. In conclusion, our work has uncovered a DsbA-like mycoredoxin that promotes mycobacterial resistance to oxidative stress and reacts with free mycothiol and mycothiolated targets. The characterization of the DsbA-like mycoredoxin cluster reported here now paves the way for correctly classifying similar enzymes from other organisms.	[Rosado, Leonardo Astolfi; Wahni, Khadija; Pedre, Brandan; Young, David; Martens, Edo; Versees, Wim; Messens, Joris] VIB, Ctr Struct Biol, B-1050 Brussels, Belgium; [Rosado, Leonardo Astolfi; Wahni, Khadija; Pedre, Brandan; Young, David; Martens, Edo; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Rosado, Leonardo Astolfi; Wahni, Khadija; Pedre, Brandan; Young, David; Martens, Edo; Versees, Wim; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Martin, Charlotte; Verniest, Guido] Vrije Univ Brussel, Res Grp Organ Chem, B-1050 Brussels, Belgium; [Degiacomi, Giulia; Boldrin, Francesca] Univ Padua, Dept Mol Med, Via Gabelli 63, I-35121 Padua, Italy; [Provvedi, Roberta] Univ Padua, Dept Biol, I-35121 Padua, Italy; [de la Rubia, Alfonso G.; Marcos-Pascual, Laura; Mateos, Luis M.] Univ Leon, Area Microbiol, Dept Mol Biol, Leon 24071, Spain; [Sancho-Vaello, Enea; Albesa-Jove, David; Guerin, Marcelo E.] Univ Basque Country, CSIC, Ctr Mixto Consejo Super Invest Cient, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain; [Sancho-Vaello, Enea; Albesa-Jove, David; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa 48940, Bizkaia, Spain; [Albesa-Jove, David; Guerin, Marcelo E.] CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio 48160, Spain; [Albesa-Jove, David; Makarov, Vadim; Guerin, Marcelo E.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Provvedi, Roberta] Russian Acad Sci, AN Bakh Inst Biochem, Moscow 119071, Russia	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; University of Padua; University of Padua; Universidad de Leon; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; CIC bioGUNE; Basque Foundation for Science; Research Center of Biotechnology RAS; Russian Academy of Sciences	Messens, J (corresponding author), VIB, Ctr Struct Biol, B-1050 Brussels, Belgium.; Manganelli, R (corresponding author), Univ Padua, Dept Mol Med, Via Gabelli 63, I-35121 Padua, Italy.	riccardo.manganelli@unipd.it; joris.messens@vib-vub.be	Albesa-Jové, David/F-5683-2016; Albesa-Jové, David/O-3822-2019; Degiacomi, Giulia/ABC-7235-2020; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Sancho-Vaello, Enea/O-2968-2018; Manganelli, Riccardo/A-7361-2009; Guerin, Marcelo M/N-7245-2016; Makarov, Vadim/AAE-5483-2021; Makarov, Vadim/HGB-7756-2022; Pedre, Brandan/E-7591-2013; Messens, Joris/AAH-3008-2020	Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Degiacomi, Giulia/0000-0002-3626-8311; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Sancho-Vaello, Enea/0000-0003-1383-2001; Manganelli, Riccardo/0000-0003-0940-7336; Guerin, Marcelo M/0000-0001-9524-3184; Makarov, Vadim/0000-0001-8746-2694; Makarov, Vadim/0000-0001-8746-2694; Pedre, Brandan/0000-0003-2158-2807; Messens, Joris/0000-0002-2128-8264; PROVVEDI, ROBERTA/0000-0003-1164-9676; Young, David/0000-0002-2586-3502; Astolfi Rosado, Leonardo/0000-0002-4349-0244; Versees, Wim/0000-0002-4695-696X; Gonzalo de la Rubia, Alfonso/0000-0002-5383-6034	European Commission [HEALTH-F3-2011-260872]; Spanish Ministry of Economy and Competitiveness [BIO2013-49022-C2-2-R]; Basque Government; Agentschap voor Innovatie door Wetenschap en Technologie (IWT); Vlaams Instituut voor Biotechnologie (VIB); Vrije Universiteit Brussel (VUB); Research Foundation Flanders (FWO); Flanders Hercules Foundation [HERC16]; Junta Castilla y Leon [LE326U14, ULE-UXXI-2016/00127]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Agentschap voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaams Instituut voor Biotechnologie (VIB); Vrije Universiteit Brussel (VUB); Research Foundation Flanders (FWO)(FWO); Flanders Hercules Foundation; Junta Castilla y Leon(Junta de Castilla y Leon)	This work was supported by grants from the European Commission (More Medicines for Tuberculosis, Contract HEALTH-F3-2011-260872) (to M. E. G. and R. M), the Spanish Ministry of Economy and Competitiveness (Contract BIO2013-49022-C2-2-R), the Basque Government (to M. E. G.), Agentschap voor Innovatie door Wetenschap en Technologie (IWT) (to B. P.), Vlaams Instituut voor Biotechnologie (VIB) (to J. M.), the SRP34 project of the Vrije Universiteit Brussel (VUB) (to J. M. and W. V.), Research Foundation Flanders (FWO) (to J. M.), Flanders Hercules Foundation (Grant HERC16) for the purification platform (to J. M.), and Junta Castilla y Leon Grants LE326U14 and ULE-UXXI-2016/00127 (to L. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Albesa-Jove D, 2015, J BIOL CHEM, V290, P31077, DOI 10.1074/jbc.M115.677039; Albesa-Jove D, 2014, ACS CHEM BIOL, V9, P1567, DOI 10.1021/cb500149m; Antelmann H, 2012, MOL MICROBIOL, V86, P759, DOI 10.1111/mmi.12031; Chi BK, 2014, ANTIOXID REDOX SIGN, V20, P589, DOI 10.1089/ars.2013.5423; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Fahey RC, 2001, ANNU REV MICROBIOL, V55, P333, DOI 10.1146/annurev.micro.55.1.333; FERRIGE AG, 1991, RAPID COMMUN MASS SP, V5, P374, DOI 10.1002/rcm.1290050810; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; GreinerStoeffele T, 1996, ANAL BIOCHEM, V240, P24, DOI 10.1006/abio.1996.0326; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Jacobi A, 1997, J BIOL CHEM, V272, P21692, DOI 10.1074/jbc.272.35.21692; Jensen KS, 2014, BIOCHEMISTRY-US, V53, P2533, DOI 10.1021/bi4016633; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; LeMaster DM, 1996, BIOCHEMISTRY-US, V35, P14876, DOI 10.1021/bi961607o; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Maciag A, 2007, J BACTERIOL, V189, P4974, DOI 10.1128/JB.00593-07; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Newton GL, 2008, MOL MICROBIOL, V68, P805, DOI 10.1111/j.1365-2958.2008.06222.x; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pedre B, 2015, MOL MICROBIOL, V96, P1176, DOI 10.1111/mmi.12998; Porat A, 2007, BIOCHEMISTRY-US, V46, P3366, DOI 10.1021/bi6024353; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Reyes AM, 2018, ANTIOXID REDOX SIGN, V28, P487, DOI 10.1089/ars.2017.7074; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rohr AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069411; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma SV, 2016, CHEMBIOCHEM, V17, P1689, DOI 10.1002/cbic.201600228; Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tjernberg A, 2006, J BIOMOL SCREEN, V11, P131, DOI 10.1177/1087057105284218; Tossounian MA, 2015, J BIOL CHEM, V290, P11365, DOI 10.1074/jbc.M114.632596; Trivedi A, 2012, ADV MICROB PHYSIOL, V60, P263, DOI 10.1016/B978-0-12-398264-3.00004-8; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286; Wei YF, 2014, P NATL ACAD SCI USA, V111, pE3756, DOI 10.1073/pnas.1414396111; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	65	18	18	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13097	13110		10.1074/jbc.M117.797837	http://dx.doi.org/10.1074/jbc.M117.797837			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28620052	Green Published, hybrid			2022-12-28	WOS:000407465300002
J	Rose, BA; Yokota, T; Chintalgattu, V; Ren, SX; Iruela-Arispe, L; Khakoo, AY; Minamisawa, S; Wang, YB				Rose, Beth A.; Yokota, Tomohiro; Chintalgattu, Vishnu; Ren, Shuxun; Iruela-Arispe, Luisa; Khakoo, Aarif Y.; Minamisawa, Susumu; Wang, Yibin			Cardiac myocyte p38 kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; cardiac hypertrophy; cardiomyocyte; p38 MAPK; vascular endothelial growth factor (VEGF); cross-talk	ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR EXPRESSION; INDUCIBLE FACTOR-I; MAP KINASES; PRESSURE-OVERLOAD; VEGF EXPRESSION; HYPOXIA; PATHWAY; HYPERTROPHY	Stress-induced p38 mitogen-activated protein kinase (MAPK) activity is implicated in pathological remodeling in the heart. For example, constitutive p38 MAPK activation in cardiomyocytes induces pathological features, including myocyte hypertrophy, apoptosis, contractile dysfunction, and fetal gene expression. However, the physiological function of cardiomyocyte p38 MAPK activity in beneficial compensatory vascular remodeling is unclear. This report investigated the functional role and the underlying mechanisms of cardiomyocyte p38 MAPK activity in cardiac remodeling induced by chronic stress. Using both in vitro and in vivo model systems, we found that p38 MAPK activity is required for hypoxia-induced pro-angiogenic activity from cardiomyocytes and that p38 MAPK activation in cardiomyocyte is sufficient to promote paracrine signaling-mediated, pro-angiogenic activity. We further demonstrate that VEGF is a paracrine factor responsible for the p38 MAPK-mediated pro-angiogenic activity from cardiomyocytes and that p38 MAPK pathway activation is sufficient for inducing VEGF secretion from cardiomyocytes in an Sp1-dependent manner. More significantly, cardiomyocyte-specific inactivation of p38 in mouse heart impaired compensatory angiogenesis after pressure overload and promoted early onset of heart failure. In summary, p38MAPK has a critical role in the cross-talk between cardiomyocytes and vasculature by regulating stress-induced VEGF expression and secretion in cardiomyocytes. We conclude that as part of a stress-induced signaling pathway, p38 MAPK activity significantly contributes to both pathological and compensatory remodeling in the heart.	[Rose, Beth A.; Yokota, Tomohiro; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Rose, Beth A.; Yokota, Tomohiro; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Physiol, Los Angeles, CA 90095 USA; [Rose, Beth A.; Yokota, Tomohiro; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Med, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan; [Chintalgattu, Vishnu; Khakoo, Aarif Y.] Amgen Inc, Metab Disorders, San Francisco, CA 94080 USA; [Iruela-Arispe, Luisa] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Inst Mol Biol, Sch Life Sci, Los Angeles, CA 90095 USA; [Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Minato Ku, 25-8 Nishi Shimbashi, Tokyo 1058461, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Waseda University; Amgen; University of California System; University of California Los Angeles; Jikei University	Wang, YB (corresponding author), CHS, Rm BH 569,650 Charles E Young Dr,Box 957115, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Yokota, Tomohiro/0000-0003-2540-3810; Minamisawa, Susumu/0000-0003-4728-2116; Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [HL070079, HL103205, HL098954]; UCLA Cardiovascular Research Laboratories; National Institutes of Health Molecular, Cellular, and Integrated Physiology Predoctoral Fellowship; NHLBI-UCLA Vascular Biology Training Fellowship; Construction of Lab-exchange Type Health and Biomedical Science Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070079, R01HL098954, R01HL103205] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H01529] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Cardiovascular Research Laboratories; National Institutes of Health Molecular, Cellular, and Integrated Physiology Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI-UCLA Vascular Biology Training Fellowship; Construction of Lab-exchange Type Health and Biomedical Science Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health Grants HL070079, HL103205, and HL098954. This work was also supported by the UCLA Cardiovascular Research Laboratories. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a National Institutes of Health Molecular, Cellular, and Integrated Physiology Predoctoral Fellowship and an NHLBI-UCLA Vascular Biology Training Fellowship.; Supported by Construction of Lab-exchange Type Health and Biomedical Science Research Consortium.	Angelis E, 2008, CIRC RES, V102, P1222, DOI 10.1161/CIRCRESAHA.107.163550; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Birk DM, 2008, VASC ENDOVASC SURG, V42, P517, DOI 10.1177/1538574408322755; Caretti A, 2007, EXP BIOL MED, V232, P887; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Isowa S, 2010, ANTICANCER RES, V30, P2755; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Oak MH, 2003, ARTERIOSCL THROM VAS, V23, P1001, DOI 10.1161/01.ATV.0000070101.70534.38; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Singh S, 2015, J BIOL CHEM, V290, P950, DOI 10.1074/jbc.M114.589325; Sodhi A, 2000, CANCER RES, V60, P4873; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Veeranki S, 2014, AM J PHYSIOL-HEART C, V306, pH1116, DOI 10.1152/ajpheart.00003.2014; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Westerhof N, 2006, PHYSIOL REV, V86, P1263, DOI 10.1152/physrev.00029.2005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Yamamoto T, 2002, ARCH BIOCHEM BIOPHYS, V398, P1, DOI 10.1006/abbi.2001.2632; Yamamoto T, 2001, J CELL BIOCHEM, V82, P591, DOI 10.1002/jcb.1179; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang JC, 2014, MOL MED REP, V10, P1231, DOI 10.3892/mmr.2014.2341	47	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12787	12800		10.1074/jbc.M117.784553	http://dx.doi.org/10.1074/jbc.M117.784553			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28637870	Green Published, hybrid			2022-12-28	WOS:000407220100011
J	Huang, WC; Lee, CY; Hsieh, TS				Huang, Wan-Chen; Lee, Chun-Ying; Hsieh, Tao-shih			Single-molecule Forster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; DNA topoisomerase; enzyme kinetics; protein dynamic; protein-DNA interaction; single-molecule biophysics; DNA gate dynamics; single-molecule Forster Resonance Energy Transfer	STEADY-STATE ANALYSIS; STRUCTURAL BASIS; ATPASE ACTIVITY; PROTEIN CLAMP; GATE-DNA; MECHANISM; CLEAVAGE; INHIBITION; HYDROLYSIS; TRANSPORT	Topoisomerases play crucial roles in DNA replication, transcription, and recombination. For instance, topoisomerase II (Top2) is critically important for resolving DNA tangles during cell division, and as such, it is a broad anticancer drug target. Top2 regulates DNA topology by transiently breaking one double-stranded DNA molecule (cleavage), allowing a second double strand to pass through the opened DNA gate (opening), and then closing the gate by rejoining the broken ends. Drugs that modulate Top2 catalysis may therefore affect enzymatic activity at several different steps. Previous studies have focused on examining DNA cleavage and ligation; however, the dynamic opening and closing of the DNA gate has been less explored. Here, we used the single-molecule Forster resonance energy transfer (smFRET) method to observe the open and closed state of the DNA gate and to measure dwell times in each state. Our results show that Top2 binds and bends DNA to increase the energy transfer efficiency (E-FRET), and ATP treatment further induces the fluctuation of E-FRET, representing the gate opening and closing. Additionally, our results demonstrate that both types of Top2-targeting anticancer drugs, the catalytic inhibitor dexrazoxane (ICRF187) and mechanistic poison teniposide (VM26), can interfere with DNA gate dynamics and shorten the dwell time in the closed state. Moreover, Top2 bound to the nonhydrolyzable ATP analog 5-adenylyl-,-imidodiphosphate exhibits altered DNA gate dynamics, but the DNA gate appears to open and close even after N-gate closure. In summary, we have utilized single-molecule detection to unravel Top2 DNA gate dynamics and reveal previously unknown effects of Top2 drugs on these dynamics.	[Huang, Wan-Chen; Lee, Chun-Ying; Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lee, Chun-Ying; Hsieh, Tao-shih] Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan; [Hsieh, Tao-shih] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA	Academia Sinica - Taiwan; National Taiwan University; Duke University	Huang, WC (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	wchuang1@gate.sinica.edu.tw	Huang, Wan-Chen/N-2472-2019	Huang, Wan-Chen/0000-0002-7341-4373	Ministry of Science and Technology Taiwan MOST Grant [105-2321-B-001-006]; Academia Sinica intramural funding Grant [AS-105-TP-B04]	Ministry of Science and Technology Taiwan MOST Grant; Academia Sinica intramural funding Grant	This work was supported by Ministry of Science and Technology Taiwan MOST Grant 105-2321-B-001-006 and Academia Sinica intramural funding Grant AS-105-TP-B04 (to T. S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Collins TRL, 2009, NUCLEIC ACIDS RES, V37, P712, DOI 10.1093/nar/gkn1059; Deweese JE, 2010, METALLOMICS, V2, P450, DOI 10.1039/c003759a; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Hardin AH, 2011, NUCLEIC ACIDS RES, V39, P5729, DOI 10.1093/nar/gkr109; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7292, DOI 10.1021/bi9729099; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Huang KC, 2001, J BIOL CHEM, V276, P44488, DOI 10.1074/jbc.M104383200; Jensen LH, 2000, J BIOL CHEM, V275, P2137, DOI 10.1074/jbc.275.3.2137; Lee S, 2012, P NATL ACAD SCI USA, V109, P2925, DOI 10.1073/pnas.1115704109; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Morris SK, 1999, J BIOL CHEM, V274, P30690, DOI 10.1074/jbc.274.43.30690; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Olland S, 1999, J BIOL CHEM, V274, P21688, DOI 10.1074/jbc.274.31.21688; OSHEROFF N, 1991, BIOESSAYS, V13, P269, DOI 10.1002/bies.950130603; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang L, 2002, ENVIRON MOL MUTAGEN, V39, P348, DOI 10.1002/em.10072; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117	37	3	4	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12589	12598		10.1074/jbc.M117.792861	http://dx.doi.org/10.1074/jbc.M117.792861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28630044	hybrid, Green Published			2022-12-28	WOS:000406636900023
J	Fetherolf, MM; Boyd, SD; Taylor, AB; Kim, HJ; Wohlschlegel, JA; Blackburn, NJ; Hart, PJ; Winge, DR; Winkler, DD				Fetherolf, Morgan M.; Boyd, Stefanie D.; Taylor, Alexander B.; Kim, Hee Jong; Wohlschlegel, James A.; Blackburn, Ninian J.; Hart, P. John; Winge, Dennis R.; Winkler, Duane D.			Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; CRYSTAL-STRUCTURE; CHAPERONE CCS; CU,ZN-SUPEROXIDE DISMUTASE; ATOMIC-RESOLUTION; HSOD1 MATURATION; SOD1; PROTEOMICS; MUTANTS; ABSENCE	Metallochaperones are a diverse family of trafficking molecules that provide metal ions to protein targets for use as cofactors. The copper chaperone for superoxide dismutase (Ccs1) activates immature copper-zinc superoxide dismutase (Sod1) by delivering copper and facilitating the oxidation of the Sod1 intramolecular disulfide bond. Here, we present structural, spectroscopic, and cell-based data supporting a novel copper-induced mechanism for Sod1 activation. Ccs1 binding exposes an electropositive cavity and proposed "entry site" for copper ion delivery on immature Sod1. Copper-mediated sulfenylation leads to a sulfenic acid intermediate that eventually resolves to form the Sod1 disulfide bond with concomitant release of copper into the Sod1 active site. Sod1 is the predominant disulfide bond-requiring enzyme in the cytoplasm, and this copper-induced mechanism of disulfide bond formation obviates the need for a thiol/disulfide oxidoreductase in that compartment.	[Fetherolf, Morgan M.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Sch Med, Salt Lake City, UT 84132 USA; [Fetherolf, Morgan M.; Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Boyd, Stefanie D.; Winkler, Duane D.] Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Vet Affairs, South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Kim, Hee Jong; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Blackburn, Ninian J.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97239 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University	Winkler, DD (corresponding author), Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	duane.winkler@utdallas.edu		Kim, Hee Jong/0000-0002-0823-5301; Taylor, Alexander/0000-0003-3517-6033; Winkler, Duane D./0000-0003-1045-0323	National Institutes of Health [R01 GM110755, R01 GM054803, R01 NS39112, R01 GM112763, R01 GM120252]; United States Department of Veterans Affairs Merit Review Award [I01 BX002580]; Robert A. Welch Foundation [AQ-1399]; National Institutes of Health Training Grant [T32 DK007115]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054803, P41GM103403, R01GM120252, R01GM089778, P41GM103393, R01GM110755, R01GM112763, R01GM123725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R01 GM110755, R01 GM054803, R01 NS39112, R01 GM112763, and R01 GM120252 (to D.R.W., N.J.B., P.J.H., J.A.W., and D.D.W., respectively); United States Department of Veterans Affairs Merit Review Award I01 BX002580 (to P.J.H.); and Robert A. Welch Foundation Grant AQ-1399 (to P.J.H.). The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 DK007115.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; ASCONE I, 1993, FEBS LETT, V322, P165, DOI 10.1016/0014-5793(93)81560-M; Banci L, 2013, CHEMBIOCHEM, V14, P1839, DOI 10.1002/cbic.201300042; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; Bauman AT, 2011, BIOCHEMISTRY-US, V50, P10819, DOI 10.1021/bi201193j; Binsted N, 1996, J SYNCHROTRON RADIAT, V3, P185, DOI 10.1107/S0909049596005651; BLACKBURN NJ, 1984, BIOCHEM J, V219, P985, DOI 10.1042/bj2190985; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GEORGE GN, 1995, EXAFSPAK; GURMAN SJ, 1995, J SYNCHROTRON RADIAT, V2, P56, DOI 10.1107/S0909049594009179; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P1589, DOI 10.1021/bi992822i; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; Luk E, 2003, J BIOL INORG CHEM, V8, P803, DOI 10.1007/s00775-003-0482-3; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Polticelli F, 1998, PROTEIN SCI, V7, P2354, DOI 10.1002/pro.5560071112; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; RICHARDSON JS, 1975, P NATL ACAD SCI USA, V72, P1349, DOI 10.1073/pnas.72.4.1349; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Sea KW, 2013, J BIOL INORG CHEM, V18, P985, DOI 10.1007/s00775-013-1047-8; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Zempel KEC, 2016, J PROTEOME RES, V15, P4436, DOI 10.1021/acs.jproteome.6b00521	62	37	39	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12025	12040		10.1074/jbc.M117.775981	http://dx.doi.org/10.1074/jbc.M117.775981			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28533431	Green Published, hybrid			2022-12-28	WOS:000406053300003
J	Parashar, S; Mukhopadhyay, A				Parashar, Smriti; Mukhopadhyay, Amitabha			GTPase Sar1 regulates the trafficking and secretion of the virulence factor gp63 in Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEASE GP63; ENDOPLASMIC-RETICULUM; HEMOGLOBIN ENDOCYTOSIS; PLASMODIUM-FALCIPARUM; METALLOPROTEASE GP63; SELECTIVE EXPORT; FLAGELLAR POCKET; CYTOPLASMIC TAIL; COAT PROTEINS; VESICLE COAT	Metalloprotease gp63 (Leishmania donovani gp63 (Ldgp63)) is a critical virulence factor secreted by Leishmania. However, how newly synthesized Ldgp63 exits the endoplasmic reticulum (ER) and is secreted by this parasite is unknown. Here, we cloned, expressed, and characterized the GTPase LdSar1 and other COPII components like LdSec23, LdSec24, LdSec13, and LdSec31 from Leishmania to understand their role in ER exit of Ldgp63. Using dominant-positive (LdSar1: H74L) and dominant-negative (LdSar1: T34N) mutants of LdSar1, we found that GTP-bound LdSar1 specifically binds to LdSec23, which binds, in turn, with LdSec24(1-702) to form a prebudding complex. Moreover, LdSec13 specifically interacted with His(6)-LdSec31(1-603), and LdSec31 bound the prebudding complex via LdSec23. Interestingly, dileucine 594/595 and valine 597 residues present in the Ldgp63 C-terminal domain were critical for binding with LdSec24(703-966), and GFP-Ldgp63(L594A/) (L595A) or GFP-Ldgp63(V597S) mutants failed to exit from the ER. Moreover, Ldgp63-containing COPII vesicle budding from the ER was inhibited by LdSar1: T34N in an in vitro budding assay, indicating that GTP-bound LdSar1 is required for budding of Ldgp63-containing COPII vesicles. To directly demonstrate the function of LdSar1 in Ldgp63 trafficking, we coexpressed RFP-Ldgp63 along with LdSar1: WT-GFP or LdSar1: T34N-GFP and found that LdSar1: T34N overexpression blocks Ldgp63 trafficking and secretion in Leishmania. Finally, we noted significantly compromised survival of LdSar1: T34N-GFP-overexpressing transgenic parasites in macrophages. Taken together, these results indicated that Ldgp63 interacts with the COPII complex via LdSec24 for Ldgp63 ER exit and subsequent secretion.	[Parashar, Smriti; Mukhopadhyay, Amitabha] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in			National Institute of Immunology (NII) from the Department of Biotechnology, Government of India; Department of Science and Technology, Government of India [SR/S2/JCB-24/2009]; Council of Scientific and Industrial Research, Government of India [09/485(0236)/2012-EMR-1]	National Institute of Immunology (NII) from the Department of Biotechnology, Government of India; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a core grant of the National Institute of Immunology (NII) from the Department of Biotechnology, Government of India and JC Bose Fellowship SR/S2/JCB-24/2009 from the Department of Science and Technology, Government of India (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Council of Scientific and Industrial Research, Government of India, Fellowship 09/485(0236)/2012-EMR-1.	Adisa A, 2001, J CELL SCI, V114, P3377; Agarwal S, 2013, BBA-MOL CELL RES, V1833, P1065, DOI 10.1016/j.bbamcr.2013.01.006; Bahl S, 2015, J BIOL CHEM, V290, P29993, DOI 10.1074/jbc.M115.670018; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bhattacharya N, 2012, J MOL BIOL, V420, P324, DOI 10.1016/j.jmb.2012.04.024; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Ding JZ, 2016, MOL BIOL CELL, V27, P127, DOI 10.1091/mbc.E15-09-0631; Duncan R., 2011, MOL BIOL INT, V2011; Ellis M, 2002, J BIOL CHEM, V277, P27968, DOI 10.1074/jbc.M202047200; Faso C, 2013, CELL MICROBIOL, V15, P537, DOI 10.1111/cmi.12054; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Guha R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006406; Isnard A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00072; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; MCGWIRE B, 1994, MOL BIOCHEM PARASIT, V66, P345, DOI 10.1016/0166-6851(94)90160-0; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; MOSSER DM, 1985, J IMMUNOL, V135, P2785; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1994, J BIOCHEM-TOKYO, V116, P243, DOI 10.1093/oxfordjournals.jbchem.a124513; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Patel N, 2008, P NATL ACAD SCI USA, V105, P3980, DOI 10.1073/pnas.0800404105; Rastogi R, 2016, J BIOL CHEM, V291, P14732, DOI 10.1074/jbc.M116.716514; RUSSELL DG, 1986, J IMMUNOL, V136, P2613; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Shanmugam SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37058; Sharma DK, 2000, BIOCHEM J, V351, P717, DOI 10.1042/0264-6021:3510717; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Struck NS, 2008, J CELL SCI, V121, P2123, DOI 10.1242/jcs.021154; Wickert H, 2003, MOL BIOCHEM PARASIT, V129, P209, DOI 10.1016/S0166-6851(03)00117-8; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0	56	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12111	12125		10.1074/jbc.M117.784033	http://dx.doi.org/10.1074/jbc.M117.784033			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28576830	Green Published, hybrid			2022-12-28	WOS:000406053300011
J	Sato, M; Liebschner, D; Yamada, Y; Matsugaki, N; Arakawa, T; Wills, SS; Hattie, M; Stubbs, KA; Ito, T; Senda, T; Ashida, H; Fushinobu, S				Sato, Mayo; Liebschner, Dorothee; Yamada, Yusuke; Matsugaki, Naohiro; Arakawa, Takatoshi; Wills, Siobhan S.; Hattie, Mitchell; Stubbs, Keith A.; Ito, Tasuku; Senda, Toshiya; Ashida, Hisashi; Fushinobu, Shinya			The first crystal structure of a family 129 glycoside hydrolase from a probiotic bacterium reveals critical residues and metal cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASE; CARBOHYDRATE-ACTIVE ENZYMES; HUMAN-MILK OLIGOSACCHARIDES; GUT MICROBIOTA; BIFIDOBACTERIUM-BIFIDUM; L-ARABINOFURANOSIDASE; MUCIN DEGRADATION; MOLECULAR-CLONING; INSIGHTS; COMPLEX	The alpha-N-acetylgalactosaminidase from the probiotic bacterium Bifidobacterium bifidum (NagBb) belongs to the glycoside hydrolase family 129 and hydrolyzes the glycosidic bond of Tnantigen (GalNAc alpha 1-Ser/Thr). NagBb is involved in assimilation of O-glycans on mucin glycoproteins by B. bifidum in the human gastrointestinal tract, but its catalytic mechanism has remained elusive because of a lack of sequence homology around putative catalytic residues and of other structural information. Here we report the X-ray crystal structure of NagBb, representing the first GH129 family structure, solved by the single-wavelength anomalous dispersion method based on sulfur atoms of the native protein. We determined ligand-free, GalNAc, and inhibitor complex forms of NagBb and found that Asp-435 and Glu-478 are located in the catalytic domain at appropriate positions for direct nucleophilic attack at the anomeric carbon and proton donation for the glycosidic bond oxygen, respectively. A highly conserved Asp-330 forms a hydrogen bond with the O4 hydroxyl of GalNAc in the -1 subsite, and Trp-398 provides a stacking platform for the GalNAc pyranose ring. Interestingly, a metal ion, presumably Ca2+, is involved in the recognition of the GalNAc N-acetyl group. Mutations at Asp-435, Glu-478, Asp-330, and Trp-398 and residues involved in metal coordination (including an all-Ala quadruple mutant) significantly reduced the activity, indicating that these residues and the metal ion play important roles in substrate recognition and catalysis. Interestingly, NagBb exhibited some structural similarities to the GH101 endo-alpha-N-acetylgalactosaminidases, but several critical differences in substrate recognition and reaction mechanism account for the different activities of these two enzymes.	[Sato, Mayo; Arakawa, Takatoshi; Ito, Tasuku; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Liebschner, Dorothee; Yamada, Yusuke; Matsugaki, Naohiro; Senda, Toshiya] High Energy Accelerator Res Org, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan; [Wills, Siobhan S.; Hattie, Mitchell; Stubbs, Keith A.] Univ Western Australia, Sch Mol Sci, Crawley, WA 6009, Australia; [Ashida, Hisashi] Kindai Univ, Fac Biol Oriented Sci & Technol, 930 Nishimitani, Kinokawa, Wakayama 6496493, Japan; [Liebschner, Dorothee] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Ito, Tasuku] Yamada Apiculture Ctr Inc, 194 Ichiba, Kagamino, Okayama 7080393, Japan	University of Tokyo; High Energy Accelerator Research Organization (KEK); University of Western Australia; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Stubbs, Keith/H-5909-2014; Arakawa, Takatoshi/K-9739-2013; Ashida, Hisashi/HCI-0293-2022; Fushinobu, Shinya/E-4987-2011; Liebschner, Dorothee/AAH-2189-2019	Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435; Senda, Toshiya/0000-0002-5153-928X; Yamada, Yusuke/0000-0002-2651-4005; Stubbs, Keith/0000-0001-6899-402X; Matsugaki, Naohiro/0000-0001-9640-1949; Ashida, Hisashi/0000-0001-5844-4075	JSPS-KAKENHI [15H02443, 26660083, 15K07448]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry Grant [25010A]; Australian Postgraduate Awards from the University of Western Australia; Bruce and Betty Green scholarship; Jean Rogerson postgraduate scholarship; Australian Research Council; Japan Agency for Medical Research and Development;  [16J03683]	JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry Grant; Australian Postgraduate Awards from the University of Western Australia; Bruce and Betty Green scholarship; Jean Rogerson postgraduate scholarship; Australian Research Council(Australian Research Council); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); 	This work was supported by JSPS-KAKENHI Grants 15H02443 and 26660083 (to S. F.) and 15K07448 (to H. A.), by Grant-in-aid for JSPS Research Fellow Grant 16J03683 (to M. S.), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry Grant 25010A, Australian Postgraduate Awards from the University of Western Australia (to S. S. W. and M. H.), a Bruce and Betty Green scholarship (to S. S. W.), a Jean Rogerson postgraduate scholarship (to M. H.), and the Australian Research Council (to K. A. S.). This work was supported in part by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamson C, 2016, ANGEW CHEM INT EDIT, V55, P14978, DOI 10.1002/anie.201607431; Amorelli B, 2008, BIOORG MED CHEM LETT, V18, P2944, DOI 10.1016/j.bmcl.2008.03.067; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Best D, 2010, TETRAHEDRON LETT, V51, P2222, DOI 10.1016/j.tetlet.2010.02.063; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fitter J, 2005, CELL MOL LIFE SCI, V62, P1925, DOI 10.1007/s00018-005-5079-2; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gregg KJ, 2015, J BIOL CHEM, V290, P25657, DOI 10.1074/jbc.M115.680470; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hiraki M, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952852; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Katayama T, 2016, BIOSCI BIOTECH BIOCH, V80, P621, DOI 10.1080/09168451.2015.1132153; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Liebschner D, 2016, ACTA CRYSTALLOGR D, V72, P728, DOI 10.1107/S2059798316005349; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Mulakala C, 2002, PROTEINS, V49, P125, DOI 10.1002/prot.10206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nerinckx W, 2005, FEBS LETT, V579, P302, DOI 10.1016/j.febslet.2004.12.021; Okuyama M, 2014, FEBS LETT, V588, P3213, DOI 10.1016/j.febslet.2014.07.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siguier B, 2014, J BIOL CHEM, V289, P5261, DOI 10.1074/jbc.M113.528133; Stubbs KA, 2009, ANGEW CHEM INT EDIT, V48, P1300, DOI 10.1002/anie.200804583; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Sumida T, 2011, J BIOL CHEM, V286, P14065, DOI 10.1074/jbc.M110.182592; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Varrot A, 2005, J MOL BIOL, V346, P423, DOI 10.1016/j.jmb.2004.11.058; Yamada Y., 2013, PHYS C SER, V425; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	57	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12126	12138		10.1074/jbc.M117.777391	http://dx.doi.org/10.1074/jbc.M117.777391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28546425	Green Published, hybrid			2022-12-28	WOS:000406053300012
J	Agostino, M; Poh, SOG; Dharmarajan, A				Agostino, Mark; Poh, Sebastian Otther-Gee; Dharmarajan, Arun			Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN BINDING; DISHEVELLED DEP DOMAIN; SIDE-CHAIN; CELLS; INHIBITION; PATHWAY; CANCER; RECOGNITION; SELECTIVITY; ANTAGONIST	Wnt signaling pathways are of significant interest in development and oncogenesis. The first step in these pathways typically involves the binding of a Wnt protein to the cysteine-rich domain (CRD) of a Frizzled receptor. Wnt-Frizzled interactions can be antagonized by secreted Frizzled-related proteins (SFRPs), which also contain a Frizzled-like CRD. The large number of Wnts, Frizzleds, and SFRPs, as well as the hydrophobic nature of Wnt, poses challenges to laboratory-based investigations of interactions involving Wnt. Here, utilizing structural knowledge of a representative Wnt-FrizzledCRDinteraction, as well as experimentally determined binding affinities for a selection of Wnt-Frizzled CRD interactions, we generated homology models of Wnt-Frizzled CRD interactions and developed a quantitative structure-activity relationship for predicting their binding affinities. The derived model incorporates a small selection of terms derived from scoring functions used in proteinprotein docking, as well as an energetic term considering the contribution made by the lipid ofWntto the Wnt-Frizzled binding affinity. Validation with an external test set suggests that the model can accurately predict binding affinity for 75% of cases and that the error associated with the predictions is comparable with the experimental error. The model was applied to predict the binding affinities of the full range of mouse and human WntFrizzled and Wnt-SFRP interactions, indicating trends in Wnt binding affinity for Frizzled and SFRP CRDs. The comprehensive predictions made in this study provide the basis for laboratory- based studies of previously unexplored Wnt-Frizzled and Wnt-SFRP interactions, which, in turn, may reveal further Wnt signaling pathways.	[Agostino, Mark; Poh, Sebastian Otther-Gee; Dharmarajan, Arun] Curtin Univ, Sch Biomed Sci, Stem Cell & Canc Biol Lab, Kent St, Bentley, WA 6102, Australia; [Agostino, Mark; Poh, Sebastian Otther-Gee; Dharmarajan, Arun] Curtin Univ, Curtin Hlth Innovat Res Inst, Kent St, Bentley, WA 6102, Australia; [Agostino, Mark] Curtin Univ, Curtin Inst Computat, Kent St, Bentley, WA 6102, Australia	Curtin University; Curtin University; Curtin University	Agostino, M (corresponding author), Curtin Univ, Curtin Inst Computat, Kent St, Bentley, WA 6102, Australia.; Agostino, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Stem Cell & Canc Biol Lab, Kent St, Bentley, WA 6102, Australia.	Mark.Agostino@curtin.edu.au	Pohl, Sebastian Other-Gee/J-9455-2019; Agostino, Mark/H-5481-2019	Pohl, Sebastian Other-Gee/0000-0002-4294-9498; Agostino, Mark/0000-0002-1799-0392; Dharmarajan, Arun/0000-0002-6715-6005	National Health and Medical Research Council [GNT1054245]; Cancer Council of Western Australia Suzanne Cavanagh Early Career Investigator Grant; Raine Priming Grant; Curtin Institute for Computation; Curtin Research Fellowship; Rotary Club of Belmont; Australian Rotary Health Research Fund; Curtin University School of Biomedical Sciences; School of Biomedical Sciences (Curtin University); Commercialisation Advisory Board of Curtin University; Cancer Council of Western Australia; Actinogen Ltd., Perth, Western Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia Suzanne Cavanagh Early Career Investigator Grant; Raine Priming Grant; Curtin Institute for Computation; Curtin Research Fellowship; Rotary Club of Belmont; Australian Rotary Health Research Fund; Curtin University School of Biomedical Sciences; School of Biomedical Sciences (Curtin University); Commercialisation Advisory Board of Curtin University; Cancer Council of Western Australia(Cancer Council Western Australia); Actinogen Ltd., Perth, Western Australia	Recipient of National Health and Medical Research Council C. J. Martin Early Career Fellowship GNT1054245, a Cancer Council of Western Australia Suzanne Cavanagh Early Career Investigator Grant, a Raine Priming Grant, Operational Research Support from the Curtin Institute for Computation, and a Curtin Research Fellowship. To whom correspondence should be addressed: Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute and Curtin Institute of Computation, Curtin University, Kent St., Bentley, Western Australia 6102, Australia. Tel.: 61892669719; E-mail: Mark. Agostino@curtin.edu.au.; Supported by funds from the Rotary Club of Belmont, Australian Rotary Health Research Fund, and Curtin University School of Biomedical Sciences.; Supported by strategic research funds from the School of Biomedical Sciences (Curtin University), Commercialisation Advisory Board of Curtin University, Cancer Council of Western Australia, and Actinogen Ltd., Perth, Western Australia.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agostino M, 2015, GLYCOBIOLOGY, V25, P101, DOI 10.1093/glycob/cwu095; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bertalovitz Alexander C, 2016, J Mol Signal, V11, P1, DOI 10.5334/1750-2187-11-1; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Chang TH, 2015, ELIFE, V4, DOI 10.7554/eLife.06554; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Constantinou Thecla, 2008, J Mol Signal, V3, P10, DOI 10.1186/1750-2187-3-10; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Green J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009175; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Henry C, 2015, J CANCER RES CLIN, V141, P243, DOI 10.1007/s00432-014-1824-y; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Komiya Yuko, 2008, Organogenesis, V4, P68; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Madrzak J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7718; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moal IH, 2015, BIOINFORMATICS, V31, P123, DOI 10.1093/bioinformatics/btu594; Mukherjee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp318; Muley A, 2010, AM J PATHOL, V176, P1505, DOI 10.2353/ajpath.2010.090465; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Ohta K, 2011, P NATL ACAD SCI USA, V108, P14962, DOI 10.1073/pnas.1100513108; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Perumal V, 2016, EXP CELL RES, V341, P218, DOI 10.1016/j.yexcr.2016.02.008; Perumal V, 2015, INT J BIOCHEM CELL B, V64, P91, DOI 10.1016/j.biocel.2015.03.010; Pohl S, 2015, TUMOR BIOL, V36, P143, DOI 10.1007/s13277-014-2956-z; Pohl SG, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.14; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Veerasamy R., 2011, INT J DRUG DISCOV, V3, P511, DOI DOI 10.1016/J.FEBSLET.2005.06.031; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YS, 1996, J BIOL CHEM, V271, P4468; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Warrier S, 2013, ONCOL RES, V21, P93, DOI 10.3727/096504013X13786659070154; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wolf V, 1997, FEBS LETT, V417, P385, DOI 10.1016/S0014-5793(97)01324-0; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Yu AA, 2010, STRUCTURE, V18, P1311, DOI 10.1016/j.str.2010.07.010; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	94	21	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11218	11229		10.1074/jbc.M117.786269	http://dx.doi.org/10.1074/jbc.M117.786269			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28533339	hybrid, Green Published			2022-12-28	WOS:000405119600008
J	Bergqvist, N; Nyman, E; Cedersund, G; Stenkula, KG				Bergqvist, Niclas; Nyman, Elin; Cedersund, Gunnar; Stenkula, Karin G.			A systems biology analysis connects insulin receptor signaling with glucose transporter translocation in rat adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; PLASMA-MEMBRANE; ADIPOSE-CELLS; SUBCELLULAR TRAFFICKING; GLUT4 TRANSLOCATION; PHOSPHORYLATION; FUSION; EXOCYTOSIS; RESISTANCE; MUSCLE	Type 2 diabetes is characterized by insulin resistance, which arises from malfunctions in the intracellular insulin signaling network. Knowledge of the insulin signaling network is fragmented, and because of the complexity of this network, little consensus has emerged for the structure and importance of the different branches of the network. To help overcome this complexity, systems biology mathematical models have been generated for predicting both the activation of the insulin receptor (IR) and the redistribution of glucose transporter 4 (GLUT4) to the plasma membrane. Although the insulin signal transduction between IR and GLUT4 has been thoroughly studied with modeling and time-resolved data in human cells, comparable analyses in cells from commonly used model organisms such as rats and mice are lacking. Here, we combined existing data and models for rat adipocytes with new data collected for the signaling network between IR and GLUT4 to create a model also for their interconnections. To describe all data (>140 data points), the model needed three distinct pathways from IR to GLUT4: (i) via protein kinase B (PKB) and Akt substrate of 160 kDa (AS160), (ii) via an AS160-independent pathway from PKB, and (iii) via an additional pathway from IR, e.g. affecting the membrane constitution. The developed combined model could describe data not used for training the model and was used to generate predictions of the relative contributions of the pathways from IR to translocation of GLUT4. The combined model provides a systems-level understanding of insulin signaling in rat adipocytes, which, when combined with corresponding models for human adipocytes, may contribute to model-based drug development for diabetes.	[Bergqvist, Niclas; Nyman, Elin; Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Clin & Expt Med & Biomed Engn, SE-58185 Linkoping, Sweden; [Nyman, Elin] AstraZeneca R&D, Cardiovasc & Metab Dis Innovat Med & Early Dev Bi, SE-43183 Gothenburg, Sweden; [Stenkula, Karin G.] Lund Univ, Biomed Ctr, Dept Expt Med Sci, Glucose Transport & Prot Trafficking, SE-22184 Lund, Sweden	Linkoping University; Linkoping University; AstraZeneca; Lund University	Cedersund, G (corresponding author), Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden.; Stenkula, KG (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C11, S-22384 Lund, Sweden.	gunnar.cedersund@liu.se; karin.stenkula@med.lu.se	Nyman, Elin/I-3363-2019	Nyman, Elin/0000-0002-4261-0291; Stenkula, Karin/0000-0002-0739-1150	Swedish Research Council [2013-3542]; AstraZeneca; Diabetes Foundation; Craaford Foundation; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca); Diabetes Foundation; Craaford Foundation; Royal Physiographic Society in Lund	This work was supported by Swedish Research Council Grant 2013-3542 (to K. G. S.), AstraZeneca, the Diabetes Foundation, the Craaford Foundation, and the Royal Physiographic Society in Lund. The salary for E. N. was paid through a grant from AstraZeneca.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Brewer PD, 2014, J BIOL CHEM, V289, P17280, DOI 10.1074/jbc.M114.555714; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Bryant NJ, 2011, TRAFFIC, V12, P657, DOI 10.1111/j.1600-0854.2011.01163.x; Buren J, 2008, ARCH BIOCHEM BIOPHYS, V474, P91, DOI 10.1016/j.abb.2008.02.034; Cedersund G, 2016, STUD MECHANOBIOL TIS, V17, P449, DOI 10.1007/978-3-319-21296-8_17; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; CLARK AE, 1991, BIOCHEM J, V278, P235, DOI 10.1042/bj2780235; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Frayn KN, 2001, P NUTR SOC, V60, P375, DOI 10.1079/PNS200195; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Govers R, 2014, DIABETES METAB, V40, P400, DOI 10.1016/j.diabet.2014.01.005; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2012, FEBS J, V279, P987, DOI 10.1111/j.1742-4658.2012.08488.x; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Rajan MR, 2016, J BIOL CHEM, V291, P15806, DOI 10.1074/jbc.M116.715763; RODBELL M, 1964, J BIOL CHEM, V239, P375; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; [No title captured]	44	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11206	11217		10.1074/jbc.M117.787515	http://dx.doi.org/10.1074/jbc.M117.787515			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495883	hybrid, Green Published			2022-12-28	WOS:000405119600007
J	Li, C; Park, S; Zhang, XW; Dai, W; Xu, DZ				Li, Cen; Park, Soyoung; Zhang, Xiaowen; Dai, Wei; Xu, Dazhong			Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INDUCIBLE KINASE; DNA-DAMAGE; PLK3; POLO-LIKE-KINASE-3; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; PHOSPHORYLATION; DEGRADATION; HIF-1-ALPHA; STABILITY	Elevated cellular response to hypoxia, which contributes to cell transformation and tumor progression, is a prominent feature of malignant cells in solid tumors. Polo-like kinase 3 (Plk3) is a serine/threonine protein kinase known to inhibit the cellular response to hypoxia and tumorigenesis. Nickel compounds are well-established human carcinogens that induce tumorigenesis partly through their hypoxia-mimicking effects. Despite previous research efforts, the role of Plk3 in the hypoxic response induced by hypoxia or nickel is not completely understood. Here, we show that NiCl2 (Ni(II)) or hypoxia reduces the protein level and shortens the half-life of cytoplasmic Plk3 in a ubiquitin- proteasome-dependent manner. We identify SIAH2, a RING finger E3 ubiquitin ligase associated with the cellular hypoxic response, to be the ubiquitin E3 ligase that mediates the degradation of Plk3. We show that SIAH2 binds to Plk3 and mediates its ubiquitination primarily through its polo-box domain. We report that USP28, a deubiquitinase known to be inhibitable by Ni(II) or hypoxia, may also contribute to the suppression of the Plk3 protein by Ni(II). We also show that Plk3 in turn suppresses the SIAH2 protein level in a kinase activity-dependent manner. Our study revealed an interesting mutual regulation between Plk3 and SIAH2 and uncovered a regulatory network that functions to fine-tune the cellular hypoxic response. We propose that suppression of Plk3 expression contributes to carcinogenesis and tumor progression induced by nickel compounds.	[Li, Cen; Park, Soyoung; Zhang, Xiaowen; Xu, Dazhong] New York Med Coll, Dept Pathol, Sch Med, 15 Dana Rd, Valhalla, NY 10595 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	New York Medical College; New York University	Xu, DZ (corresponding author), New York Med Coll, Dept Pathol, Sch Med, 15 Dana Rd, Valhalla, NY 10595 USA.	dazhong_xu@nymc.edu		Xu, Dazhong/0000-0001-9264-3342; Dai, Wei/0000-0003-0169-8327	National Institutes of Health [R21ES023862]; New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under College's Intramural Research Support Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under College's Intramural Research Support Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant R21ES023862 (to D. X.), a startup fund from the New York Medical College (to D. X.), and funds from the New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program (to D. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alberts GF, 2004, CELL CYCLE, V3, P678; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bett JS, 2016, ESSAYS BIOCHEM, V60, P143, DOI 10.1042/EBC20160001; Chase D, 1998, BIOCHEM J, V333, P655, DOI 10.1042/bj3330655; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Dai W, 2002, INT J ONCOL, V20, P121; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Glover DM, 1996, J CELL BIOL, V135, P1681, DOI 10.1083/jcb.135.6.1681; Helmke C, 2016, ONCOGENE, V35, P135, DOI 10.1038/onc.2015.105; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Iida M, 2008, BIOCHEM J, V411, P27, DOI 10.1042/BJ20071394; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008531; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Park S, 2016, ONCOTARGET, V7, P8916, DOI 10.18632/oncotarget.6866; Perez M, 2012, J MOL CELL BIOL, V4, P316, DOI 10.1093/jmcb/mjs047; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Ske-Hohlfeld I. B., 2008, CANC EPIDEMIOLOGY MO, P3; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Wiest J, 2001, GENE CHROMOSOME CANC, V32, P384, DOI 10.1002/gcc.1204; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Xu DZ, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-5; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	41	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11431	11444		10.1074/jbc.M116.767178	http://dx.doi.org/10.1074/jbc.M116.767178			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515325	Green Published, hybrid			2022-12-28	WOS:000405119600026
J	Hsu, KS; Zhao, X; Cheng, XW; Guan, DY; Mahabeleshwar, GH; Liu, Y; Borden, E; Jain, MK; Kao, HY				Hsu, Kuo-Sheng; Zhao, Xuan; Cheng, Xiwen; Guan, Dongyin; Mahabeleshwar, Ganapati H.; Liu, Yu; Borden, Ernest; Jain, Mukesh K.; Kao, Hung-Ying			Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon alpha-mediated inhibition of angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; TNF-ALPHA; RAR-ALPHA; GENE; EXPRESSION; ACTIVATION; NETWORK; INDUCTION; APOPTOSIS	IFNs are effective in inhibiting angiogenesis in preclinical models and in treating several angioproliferative disorders. However, the detailed mechanisms of IFN alpha-mediated anti-angiogenesis are not completely understood. Stat1/2/3 and PML are IFN alpha downstream effectors and are pivotal regulators of angiogenesis. Here, we investigated PML's role in the regulation of Stat1/2/3 activity. In Pml knock-out (KO) mice, ablation of Pml largely reduces IFN alpha angiostatic ability in Matrigel plug assays. This suggested an essential role for PML in IFN alpha's anti-angiogenic function. We also demonstrated that PML shared a large cohort of regulatory genes with Stat1 and Stat3, indicating an important role of PML in regulating Stat1 and Stat3 activity. Using molecular tools and primary endothelial cells, we demonstrated that PML positively regulates Stat1 and Stat2 isgylation, a ubiquitination-like protein modification. Accordingly, manipulation of the isgylation system by knocking down USP18 altered IFN alpha-PML axis-mediated inhibition of endothelial cell migration and network formation. Furthermore, PMLpromotes turnover of nuclear Stat3, and knockdown of PML mitigates the effect of LLL12, a selective Stat3 inhibitor, on IFN alpha-mediated anti-angiogenic activity. Taken together, we elucidated an unappreciated mechanism in which PML, an IFN alpha-inducible effector, possess potent angiostatic activity, doing so in part by forming a positive feedforward loop with Stat1/2 and a negative feedback loop with Stat3. The interplay between PML, Stat1/Stat2, and Stat3 contributes to IFN alpha-mediated inhibition of angiogenesis, and disruption of this network results in aberrant IFN alpha signaling and altered angiostatic activity.	[Hsu, Kuo-Sheng; Zhao, Xuan; Cheng, Xiwen; Guan, Dongyin; Liu, Yu; Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Mahabeleshwar, Ganapati H.; Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Borden, Ernest] Cleveland Clin Lerner Coll Med CWRU, Taussig Canc Inst, Cleveland Clin Case Comprehens Canc Ctr, Cleveland, OH 44195 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Ctr Comprehens Canc, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp Cleveland, 10900 Euclid Ave, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Kao, HY (corresponding author), Case Western Reserve Univ, Ctr Comprehens Canc, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Kao, HY (corresponding author), Univ Hosp Cleveland, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Hsu, Kuo-Sheng/0000-0002-5700-6943	National Institutes of Health [HL093269, HL086548, R01DK111468, R35HL135789, R01HL086548, R01HL123098, HL126626, P30DK097948]; Crohn's and Colitis Foundation of America Senior Research Award [421904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135789, R01HL093269, R01HL123098, R01HL086548, R01HL126626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Senior Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Grants HL093269 (to H.-Y.K) and HL086548, R01DK111468, R35HL135789, R01HL086548, and R01HL123098 (to M.K.J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants HL126626 and P30DK097948 (Cleveland Digestive Diseases Research Core Center Pilot/Feasibility award) and a Crohn's and Colitis Foundation of America Senior Research Award 421904.	Abdolhosseinzadeh S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10160; Albini A, 2000, AM J PATHOL, V156, P1381, DOI 10.1016/S0002-9440(10)65007-9; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Balestrieri ML, 2008, CARDIOVASC RES, V78, P250, DOI 10.1093/cvr/cvn029; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Cheng XW, 2012, J BIOL CHEM, V287, P23356, DOI 10.1074/jbc.M112.340505; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; DVORAK HF, 1989, J NATL CANCER I, V81, P497, DOI 10.1093/jnci/81.7.497; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Fabunmi RP, 2001, J CELL SCI, V114, P29; Fan JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep12704; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Grotzinger T, 1996, EUR J BIOCHEM, V238, P554, DOI 10.1111/j.1432-1033.1996.0554z.x; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hamik A, 2006, ARTERIOSCL THROM VAS, V26, P1936, DOI 10.1161/01.ATV.0000232542.42968.e3; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Hsu KS, 2016, CELL DEATH DIFFER, V23, P469, DOI 10.1038/cdd.2015.114; Huang YF, 2014, CELL CYCLE, V13, P2200, DOI 10.4161/cc.29209; Hurley D, 2012, NUCLEIC ACIDS RES, V40, P2377, DOI 10.1093/nar/gkr902; Icardi L, 2012, FASEB J, V26, P240, DOI 10.1096/fj.11-191122; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kato M, 2015, BIOCHEM BIOPH RES CO, V461, P366, DOI 10.1016/j.bbrc.2015.04.040; Kawasaki A, 2003, BLOOD, V101, P3668, DOI 10.1182/blood-2002-08-2474; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu F, 2016, J MOL NEUROSCI, V58, P170, DOI 10.1007/s12031-015-0653-z; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; MILLER JW, 1993, OPHTHALMOLOGY, V100, P9; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Nie L, 2013, J CLIN INVEST, V123, P5082, DOI 10.1172/JCI67752; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Richer E, 2010, J IMMUNOL, V185, P3593, DOI 10.4049/jimmunol.1000890; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sahin U, 2014, J PATHOL, V234, P289, DOI 10.1002/path.4426; Santin I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.158; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Sgonc R, 1998, INT ARCH ALLERGY IMM, V117, P209; Sgorbissa A, 2012, CYTOKINE GROWTH F R, V23, P307, DOI 10.1016/j.cytogfr.2012.07.003; SIDKY YA, 1987, CANCER RES, V47, P5155; Stadler M, 1995, ONCOGENE, V11, P2565; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wolyniec K, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00124; Yamada N, 2014, BBA-GENE REGUL MECH, V1839, P1256, DOI 10.1016/j.bbagrm.2014.09.002; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	69	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10048	10060		10.1074/jbc.M116.771071	http://dx.doi.org/10.1074/jbc.M116.771071			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28432122	Green Published, hybrid			2022-12-28	WOS:000403580600017
J	Kaur, K; Park, H; Pandey, N; Azuma, Y; De Guzman, RN				Kaur, Kawaljit; Park, Hyewon; Pandey, Nootan; Azuma, Yoshiaki; De Guzman, Roberto N.			Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-INTERACTION MOTIFS; TOPOISOMERASE-II; MITOTIC CHROMOSOMES; BINDING SURFACE; SUMOYLATION; COMPLEX; UBC9; RECOGNITION; CONJUGATION; INSIGHTS	Small ubiquitin-like modifier (SUMO) conjugation is a reversible post-translational modification process implicated in the regulation of gene transcription, DNA repair, and cell cycle. SUMOylation depends on the sequential activities of E1 activating, E2 conjugating, and E3 ligating enzymes. SUMO E3 ligases enhance transfer of SUMO from the charged E2 enzyme to the substrate. Wehave previously identified PIASy, a member of the Siz/protein inhibitor of activated STAT (PIAS) RING family of SUMO E3 ligases, as essential for mitotic chromosomal SUMOylation in frog egg extracts and demonstrated that it can mediate effective SUMOylation. To address how PIASy catalyzes SUMOylation, we examined various truncations of PIASy for their ability to mediate SUMOylation. Using NMR chemical shift mapping and mutagenesis, we identified a new SUMO-interacting motif (SIM) in PIASy. The new SIM and the currently known SIM are both located at the C terminus of PIASy, and both are required for the full ligase activity of PIASy. Our results provide novel insights into the mechanism of PIASy-mediated SUMOylation. PIASy adds to the growing list of SUMO E3 ligases containing multiple SIMs that play important roles in the E3 ligase activity.	[Kaur, Kawaljit; Park, Hyewon; Pandey, Nootan; Azuma, Yoshiaki; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA	University of Kansas	Azuma, Y; De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	azumay@ku.edu; rdguzman@ku.edu	Pandey, Nootan/AAF-8227-2019	Pandey, Nootan/0000-0001-6525-4085	National Institutes of Health [P30-GM110761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761, R01GM080278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Asokan Anbanandam for assistance with NMR spectroscopy and Mark Richter for the use of the fluorescence spectrophotometer. The University of Kansas Biomolecular NMR Core Facility was supported by Grant P30-GM110761 from the National Institutes of Health.	Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding HS, 2005, BIOCHEMISTRY-US, V44, P2790, DOI 10.1021/bi0477586; Eisenhardt N, 2015, NAT STRUCT MOL BIOL, V22, P959, DOI 10.1038/nsmb.3114; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Jardin C, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2597-1; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Mascle XH, 2013, J BIOL CHEM, V288, P36312, DOI 10.1074/jbc.M113.486845; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; Ryu H, 2010, J BIOL CHEM, V285, P32576, DOI 10.1074/jbc.M110.153817; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	32	12	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10230	10238		10.1074/jbc.M117.789982	http://dx.doi.org/10.1074/jbc.M117.789982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455449	Green Published, hybrid			2022-12-28	WOS:000403580600031
J	Chauhan, N; Han, GS; Somashekarappa, N; Gable, K; Dunn, T; Kohlwein, SD				Chauhan, Neha; Han, Gongshe; Somashekarappa, Niranjanakumari; Gable, Kenneth; Dunn, Teresa; Kohlwein, Sepp D.			Regulation of sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1 (vol 291, pg 2524, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															Austrian Science Funds (FWF) [SFB F3005 LIPOTOX]; National Institutes of Health [R21HD080181]; NAWI Graz; DK Molecular Enzymology Project [W901]	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NAWI Graz; DK Molecular Enzymology Project	This work was supported by Austrian Science Funds (FWF) Projects SFB F3005 LIPOTOX and DK Molecular Enzymology Project W901 and NAWI Graz (to S. D. K.) and by National Institutes of Health Grant R21HD080181 (to T. D.).	NEHA CH, 2016, J BIOL CHEM, V291, P2524	1	2	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9431	9431		10.1074/jbc.A115.693200	http://dx.doi.org/10.1074/jbc.A115.693200			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28576886	Green Published, hybrid			2022-12-28	WOS:000402538900035
J	Ilkan, Z; Wright, JR; Goodall, AH; Gibbins, JM; Jones, CI; Mahaut-Smith, MP				Ilkan, Zeki; Wright, Joy R.; Goodall, Alison H.; Gibbins, Jonathan M.; Jones, Chris I.; Mahaut-Smith, Martyn P.			Evidence for shear-mediated Ca2+ entry through mechanosensitive cation channels in human platelets and a megakaryocytic cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ACTIVATED ION-CHANNEL; GLYCOPROTEIN-IB; ADHESION MOLECULE-1; CALCIUM SIGNALS; PIEZO1; RECEPTORS; AGGREGATION; MEMBRANE; PROTEINS	The role of mechanosensitive (MS) Ca2+ -permeable ion channels in platelets is unclear, despite the importance of shear stress in platelet function and life-threatening thrombus formation. We therefore sought to investigate the expression and functional relevance ofMSchannels in human platelets. The effect of shear stress on Ca2+ entry in human platelets and Meg-01 megakaryocytic cells loaded with Fluo-3 was examined by confocal microscopy. Cells were attached to glass coverslips within flow chambers that allowed applications of physiological and pathological shear stress. Arterial shear (1002.6 s(-1)) induced a sustained increase in [Ca2+] i in Meg-01 cells and enhanced the frequency of repetitive Ca2+ transients by 80% in platelets. These Ca2+ increases were abrogated by the MS channel inhibitor Grammostola spatulata mechanotoxin 4 (GsMTx-4) or by chelation of extracellular Ca2+. Thrombus formation was studied on collagen-coated surfaces using DiOC(6)-stained platelets. In addition, [Ca2+](i) and functional responses of washed platelet suspensions were studied with Fura-2 and light transmission aggregometry, respectively. Thrombus size was reduced 50% by GsMTx-4, independently of P2X1 receptors. In contrast, GsMTx-4 had no effect on collagen-induced aggregation or on Ca2+ influx via TRPC6 or Orai1 channels and caused only a minor inhibition of P2X1-dependent Ca2+ entry. The Piezo1 agonist, Yoda1, potentiated shear-dependent platelet Ca2+ transients by 170%. Piezo1 mRNA transcripts and protein were detected with quantitative RT-PCR and Western blotting, respectively, in both platelets and Meg-01 cells. We conclude that platelets and Meg-01 cells express the MS cation channel Piezo1, which may contribute to Ca2+ entry and thrombus formation under arterial shear.	[Ilkan, Zeki; Wright, Joy R.; Mahaut-Smith, Martyn P.] Univ Leicester, Dept Mol & Cell Biol, Leicester LE1 7RH, Leics, England; [Wright, Joy R.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Wright, Joy R.; Goodall, Alison H.] Glenfield Hosp, Cardiovasc Biomed Res Unit, NIHR, Leicester LE3 9QP, Leics, England; [Gibbins, Jonathan M.; Jones, Chris I.] Univ Reading, Sch Biol Sci, Reading RG6 6AS, Berks, England	University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Reading	Mahaut-Smith, MP (corresponding author), Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England.	mpms1@le.ac.uk		Goodall, Alison/0000-0002-7883-9645; Wright, Joy R/0000-0002-1140-6503; Jones, Chris/0000-0001-7537-1509; Ilkan, Zeki/0000-0001-5092-2458; Gibbins, Jonathan/0000-0002-0372-5352	British Heart Foundation [PG/11/56]; Leicester National Institute for Health Research Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital (Leicester, UK); British Heart Foundation [RG/15/2/31224, PG/11/56/29001, RG/09/011/28094] Funding Source: researchfish; Medical Research Council [1335076] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Leicester National Institute for Health Research Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital (Leicester, UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grant PG/11/56 and the Leicester National Institute for Health Research Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital (Leicester, UK). The authors declare that they have no conflicts of interest with the contents of this article.	Agboh KC, 2009, NEUROPHARMACOLOGY, V56, P230, DOI 10.1016/j.neuropharm.2008.05.018; Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Amisten S, 2012, METHODS MOL BIOL, V788, P155, DOI 10.1007/978-1-61779-307-3_12; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Ashour F, 2006, NEUROSCI LETT, V397, P120, DOI 10.1016/j.neulet.2005.12.004; AUTHI KS, 1993, BIOCHEM J, V294, P119, DOI 10.1042/bj2940119; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Boyanova Desislava, 2012, Blood, V119, pe22, DOI 10.1182/blood-2011-10-387308; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; CHOW TW, 1992, BLOOD, V80, P113; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Gibbins Jonathan M, 2004, Methods Mol Biol, V273, P139; Glenn JR, 2005, PLATELETS, V16, P159, DOI 10.1080/09537100500063889; Gnanasambandam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125503; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang PD, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/862618; Jones CI, 2014, ARTERIOSCL THROM VAS, V34, P1968, DOI 10.1161/ATVBAHA.114.304097; Jones CI, 2012, PLATELETS, V23, P331, DOI 10.3109/09537104.2011.626091; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; King S, 2016, VASC PHARMACOL, V78, P10, DOI 10.1016/j.vph.2015.07.008; Kroll MH, 1996, BLOOD, V88, P1525; LEVENSON J, 1990, CLIN SCI, V79, P613, DOI 10.1042/cs0790613; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; Mahaut-Smith MP, 2012, J THROMB HAEMOST, V10, P1722, DOI 10.1111/j.1538-7836.2012.04837.x; Mahaut-Smith Martyn P, 2004, Methods Mol Biol, V273, P277; MAHAUTSMITH MP, 1995, J PHYSIOL-LONDON, V484, P15, DOI 10.1113/jphysiol.1995.sp020644; Mazzucato M, 2002, BLOOD, V100, P2793, DOI 10.1182/blood-2002-02-0514; Miyazaki Y, 1996, BLOOD, V88, P3456, DOI 10.1182/blood.V88.9.3456.bloodjournal8893456; Morris CE, 2001, CELL MOL BIOL LETT, V6, P703; Mountford JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7535; Nesbitt WS, 2002, J BIOL CHEM, V277, P2965, DOI 10.1074/jbc.M110070200; OGURA M, 1985, BLOOD, V66, P1384; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; PRAKASH YS, 1994, NEUROIMAGE, V1, P325, DOI 10.1006/nimg.1994.1017; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Rolf MG, 2001, THROMB HAEMOSTASIS, V85, P303, DOI 10.1055/s-0037-1615684; Schafer A.I, 1994, THROMBOSIS HEMORRHAG; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; Soves CP, 2014, BONE, V66, P111, DOI 10.1016/j.bone.2014.05.015; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Thon JN, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1838; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wright A, 2016, J IMMUNOL, V196, P4877, DOI 10.4049/jimmunol.1501585; Wright JR, 2016, THROMB HAEMOSTASIS, V116, P272, DOI 10.1160/TH15-11-0891; Yap CL, 2002, BLOOD, V99, P151, DOI 10.1182/blood.V99.1.151; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	67	47	52	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9204	9217		10.1074/jbc.M116.766196	http://dx.doi.org/10.1074/jbc.M116.766196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28416610	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000402538900016
J	Kohnhorst, CL; Kyoung, M; Jeon, M; Schmitt, DL; Kennedy, EL; Ramirez, J; Bracey, SM; Luu, BT; Russell, SJ; An, S				Kohnhorst, Casey L.; Kyoung, Minjoung; Jeon, Miji; Schmitt, Danielle L.; Kennedy, Erin L.; Ramirez, Julio; Bracey, Syrena M.; Bao Tran Luu; Russell, Sarah J.; An, Songon			Identification of a multienzyme complex for glucose metabolism in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; TUMOR-GROWTH; FRUCTOSE 1,6-BISPHOSPHATASE; MUSCLE ALDOLASE; BREAST-CANCER; PROTEIN; ENZYME; PHOSPHOFRUCTOKINASE; MEMBRANE; FBPASE	Sequential metabolic enzymes in glucose metabolism have long been hypothesized to form multienzyme complexes that regulate glucose flux in living cells. However, it has been challenging to directly observe these complexes and their functional roles in living systems. In this work, we have used wide-field and confocal fluorescence microscopy to investigate the spatial organization of metabolic enzymes participating in glucose metabolism in human cells. We provide compelling evidence that human liver-type phosphofructokinase 1 (PFKL), which catalyzes a bottleneck step of glycolysis, forms various sizes of cytoplasmic clusters in human cancer cells, independent of protein expression levels and of the choice of fluorescent tags. We also report that these PFKL clusters colocalize with other ratelimiting enzymes in both glycolysis and gluconeogenesis, supporting the formation of multienzyme complexes. Subsequent biophysical characterizations with fluorescence recovery after photobleaching and FRET corroborate the formation of multienzyme metabolic complexes in living cells, which appears to be controlled by post-translational acetylation on PFKL. Importantly, quantitative high-content imaging assays indicated that the direction of glucose flux between glycolysis, the pentose phosphate pathway, and serine biosynthesis seems to be spatially regulated by the multienzyme complexes in a clustersize-dependent manner. Collectively, our results reveal a functionally relevant, multienzyme metabolic complex for glucose metabolism in living human cells.	[Kohnhorst, Casey L.; Kyoung, Minjoung; Jeon, Miji; Schmitt, Danielle L.; Kennedy, Erin L.; Ramirez, Julio; Bracey, Syrena M.; Bao Tran Luu; Russell, Sarah J.; An, Songon] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	An, S (corresponding author), UMBC, Dept Chem & Biochem, Chem 462A, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	san@umbc.edu			UMBC start-up funds; AACR-Bayer Innovation; Discovery Grant [16-80-44-ANSO]; NIGMS, National Institutes of Health [T32GM066706, MARCU*STAR 2T34GM008663]; Howard Hughes Medical Institute undergraduate education grant; NIGMS, National Institutes of Health Initiative for Maximizing Student Development Grant [2R25GM55036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036, T32GM066706, T34GM008663] Funding Source: NIH RePORTER	UMBC start-up funds; AACR-Bayer Innovation; Discovery Grant; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute undergraduate education grant; NIGMS, National Institutes of Health Initiative for Maximizing Student Development Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by UMBC start-up funds (to S.A.). This work was also supported in part by 2016 AACR-Bayer Innovation and Discovery Grant 16-80-44-ANSO (to S.A.); NIGMS, National Institutes of Health Grant T32GM066706 (to C.L.K., M.J., and D.L.S.); NIGMS, National Institutes of Health Grant MARCU*STAR 2T34GM008663 for enhancing minority access to research careers (to S.M.B.); a Howard Hughes Medical Institute undergraduate education grant (to S.M.B.); and NIGMS, National Institutes of Health Initiative for Maximizing Student Development Grant 2R25GM55036 (to E.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Araiza-Olivera D, 2013, FEBS J, V280, P3887, DOI 10.1111/febs.12387; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; Borlak J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1312-z; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chan CY, 2015, P NATL ACAD SCI USA, V112, P1368, DOI 10.1073/pnas.1423009112; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Criscitiello C, 2012, ANN ONCOL, V23, P13, DOI 10.1093/annonc/mds188; Delgado TC, 2004, MAGN RESON MED, V51, P1283, DOI 10.1002/mrm.20096; EMERK K, 1975, ARCH BIOCHEM BIOPHYS, V168, P210, DOI 10.1016/0003-9861(75)90243-X; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Ginger ML, 2010, PHILOS T R SOC B, V365, P831, DOI 10.1098/rstb.2009.0259; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; KELLEHER JA, 1995, NEUROCHEM RES, V20, P785, DOI 10.1007/BF00969690; KOERNER TAW, 1977, FEBS LETT, V84, P207, DOI 10.1016/0014-5793(77)80689-3; Kyoung M, 2015, BIOCHEMISTRY-US, V54, P870, DOI 10.1021/bi501480d; Lewis IA, 2009, P NATL ACAD SCI USA, V106, P18515, DOI 10.1073/pnas.0905999106; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mamczur P, 2005, FEBS LETT, V579, P1607, DOI 10.1016/j.febslet.2005.01.071; Mamczur P, 2007, CELL BIOL INT, V31, P1122, DOI 10.1016/j.cellbi.2007.03.029; MARTINO G, 1993, EUR J IMMUNOL, V23, P1023, DOI 10.1002/eji.1830230506; MOWBRAY J, 1976, EUR J BIOCHEM, V66, P25, DOI 10.1111/j.1432-1033.1976.tb10421.x; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Park SH, 2016, CANCER RES, V76, P3802, DOI 10.1158/0008-5472.CAN-15-2498; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; PETTE D, 1962, BIOCHEM BIOPH RES CO, V7, P419, DOI 10.1016/0006-291X(62)90327-3; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; PROFFITT RT, 1976, BIOCHEMISTRY-US, V15, P2918, DOI 10.1021/bi00658a034; Puchulu-Campanella E, 2013, J BIOL CHEM, V288, P848, DOI 10.1074/jbc.M112.428573; Rakus D, 2000, BIOCHEM BIOPH RES CO, V275, P611, DOI 10.1006/bbrc.2000.3308; Rakus D, 2003, BIOCHEM BIOPH RES CO, V311, P294, DOI 10.1016/j.bbrc.2003.09.209; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/NMETH.1855, 10.1038/nmeth.1855]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOLING HD, 1977, ARCH BIOCHEM BIOPHYS, V182, P563, DOI 10.1016/0003-9861(77)90538-0; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Sullivan DT, 2003, J EXP BIOL, V206, P2031, DOI 10.1242/jeb.00367; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; UYEDA K, 1974, J BIOL CHEM, V249, P4562; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wang J, 1997, EXP CELL RES, V237, P445, DOI 10.1006/excr.1997.3811; Xiong Y., 2011, COLD SPRING HARB SYM, V76, P285, DOI DOI 10.1101/SQB.2011.76.010942; Xu YP, 2014, CANCER RES, V74, P3630, DOI 10.1158/0008-5472.CAN-13-3615; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	61	57	58	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9191	9203		10.1074/jbc.M117.783050	http://dx.doi.org/10.1074/jbc.M117.783050			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28424264	Green Published, hybrid			2022-12-28	WOS:000402538900015
J	Howarth, M				Howarth, Mark			Smart superglue in streptococci? The proof is in the pulling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BONDS; THIOESTER	Gram-positive bacteria use reactive thioester-containing proteins to form covalent bonds, which may enable strong adhesion to host surfaces, but how these proteins selectively adhere to different surfaces is not clear. The Editors' Pick by Echelman et al. applied single-molecule force spectroscopy to show that an adhesin protein can regenerate its thioester in the absence of pulling. This selective interaction would represent a new principle of mechanical proof-reading, whereby only reactions supporting anchorage of the bacterium are maintained.	[Howarth, Mark] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England	University of Oxford	Howarth, M (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	mark.howarth@bioch.ox.ac.uk			University of Oxford Department of Biochemistry	University of Oxford Department of Biochemistry	This work was supported by the University of Oxford Department of Biochemistry. The author declares that he has no conflicts of interest with the content of this article.	Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Echelman DJ, 2017, J BIOL CHEM, V292, P8988, DOI 10.1074/jbc.M117.777466; Hinnebusch BJ, 2016, INFECT IMMUN, V84, P1932, DOI 10.1128/IAI.00188-16; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Law SKA, 1997, PROTEIN SCI, V6, P263; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638	10	0	0	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8998	8999		10.1074/jbc.H117.777466	http://dx.doi.org/10.1074/jbc.H117.777466			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550142	hybrid, Green Published			2022-12-28	WOS:000402153900050
J	Konson, A; Pradeep, S; D'Acunto, CW; Seger, R				Konson, Alexander; Pradeep, Sunila; D'Acunto, Cosimo Walter; Seger, Rony			RETRACTION: Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrest (Retraction of Vol 286, Pg 3540, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Konson A, 2011, J BIOL CHEM, V286, P3540, DOI 10.1074/jbc.M110.151548	1	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8849	8849		10.1074/jbc.A110.151548	http://dx.doi.org/10.1074/jbc.A110.151548			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550135	hybrid, Green Published			2022-12-28	WOS:000402153900032
J	Pellock, SJ; Redinbo, MR				Pellock, Samuel J.; Redinbo, Matthew R.			Glucuronides in the gut: Sugar-driven symbioses between microbe and host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-GLUCURONIDASE; ETHYL GLUCURONIDE; ENTEROHEPATIC CIRCULATION; INTESTINAL BACTERIA; URINARY-EXCRETION; HUMAN LIVER; BILE-ACIDS; IN-VITRO; METABOLISM; ENZYMES	The intestinal milieu is astonishingly complex and home to a constantly changing mixture of small and large molecules, along with an abundance of bacteria, viral particles, and eukaryotic cells. Such complexity makes it difficult to develop testable molecular hypotheses regarding host-microbe interactions. Fortunately, mammals and their associated gastrointestinal (GI) microbes contain complementary systems that are ideally suited for mechanistic studies. Mammalian systems inactivate endobiotic and xenobiotic compounds by linking them to a glucuronic acid sugar for GI excretion. In the GI tract, the microbiota express -glucuronidase enzymes that remove the glucuronic acid as a carbon source, effectively reversing the actions of mammalian inactivation. Thus, by probing the actions of microbial-glucuronidases, and by understanding which substrate glucuronides they process, molecular insights into mammalian-microbial symbioses may be revealed amid the complexity of the intestinal tract. Here, we focus on glucuronides in the gut and the microbial proteins that process them.	[Pellock, Samuel J.; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Campus Box 3290, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Campus Box 3290, Chapel Hill, NC 27599 USA.	redinbo@unc.edu			National Institutes of Health Grants [CA207416, CA098468]; Cellular and Molecular Biophysics Program of University of North Carolina Grant [5T32GM008570-20]; NATIONAL CANCER INSTITUTE [R01CA098468, R01CA207416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biophysics Program of University of North Carolina Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA207416 and CA098468 and Cellular and Molecular Biophysics Program of University of North Carolina Grant 5T32GM008570-20. This is the fourth article in the Host-Microbiome metabolic interplay Minireview series. The authors of this publication have equity ownership (M.R.R.) or are inventors of technologies (S.J.P. and M.R.R.) related to Symberix, Inc., a pharmaceutical company creating microbiome-targeted therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALME B, 1980, J STEROID BIOCHEM, V13, P907, DOI 10.1016/0022-4731(80)90164-8; Anne M, 2013, ONCOTARGETS THER, V6, P1613, DOI 10.2147/OTT.S30773; [Anonymous], 1980, GLUCURONIDATION DRUG; Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Babiker R, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-111; Baranowski S, 2008, INT J LEGAL MED, V122, P389, DOI 10.1007/s00414-008-0229-3; BARUA AB, 1986, AM J CLIN NUTR, V43, P481, DOI 10.1093/ajcn/43.4.481; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Boelsterli UA, 2013, TOXICOL SCI, V131, P654, DOI 10.1093/toxsci/kfs310; BYRD GD, 1992, DRUG METAB DISPOS, V20, P192; Cantore M, 2004, ONCOLOGY-BASEL, V67, P93, DOI 10.1159/000080993; Castellino S, 2012, DRUG METAB DISPOS, V40, P139, DOI 10.1124/dmd.111.040949; Chakdar H, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0457-z; Chen G, 2010, CANCER RES, V70, P7543, DOI 10.1158/0008-5472.CAN-09-4582; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; DISTEFANO JJ, 1993, AM J PHYSIOL, V264, pE966, DOI 10.1152/ajpendo.1993.264.6.E966; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Femia AP, 2008, PLANTA MED, V74, P1602, DOI 10.1055/s-2008-1074577; FEVERY J, 1983, HEPATOLOGY, V3, P177; FLEMSTROM G, 1993, GASTROENTEROLOGY, V104, P825, DOI 10.1016/0016-5085(93)91019-E; GADELLE D, 1985, APPL ENVIRON MICROB, V49, P682, DOI 10.1128/AEM.49.3.682-685.1985; Gloux K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148291; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; GOLDIN BR, 1986, ANNU REV MICROBIOL, V40, P367, DOI 10.1146/annurev.mi.40.100186.002055; GOLDIN BR, 1976, J NATL CANCER I, V57, P371, DOI 10.1093/jnci/57.2.371; GOLDIN BR, 1984, AM J CLIN NUTR, V39, P756, DOI 10.1093/ajcn/39.5.756; GRAEF V, 1977, CLIN CHEM, V23, P532; Grosse L, 2013, CANCER RES, V73, P6963, DOI 10.1158/0008-5472.CAN-13-1462; Gu D, 2010, CHEM RES TOXICOL, V23, P788, DOI 10.1021/tx900436m; Halter CC, 2008, INT J LEGAL MED, V122, P123, DOI 10.1007/s00414-007-0180-8; HASKEL Y, 1994, DIGEST DIS SCI, V39, P2364, DOI 10.1007/BF02087652; HAZENBERG MP, 1988, FEMS MICROBIOL LETT, V54, P9; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Kim DH, 2000, ARCH PHARM RES, V23, P172, DOI 10.1007/BF02975509; Kim DH, 2001, ARCH PHARM RES, V24, P564, DOI 10.1007/BF02975166; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; KREEK MJ, 1963, BIOCHIM BIOPHYS ACTA, V74, P418, DOI 10.1016/0006-3002(63)91385-4; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Krishnaswamy S, 2003, XENOBIOTICA, V33, P169, DOI 10.1080/0049825021000048809; Kwa M., 2016, JNCI-J NATL CANCER I, V108, P1; LAQUEUR GL, 1981, J NATL CANCER I, V67, P1053; Little JM, 2004, J LIPID RES, V45, P1694, DOI 10.1194/jlr.M400103-JLR200; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; LOMBARDI P, 1978, J STEROID BIOCHEM, V9, P795, DOI 10.1016/0022-4731(78)90203-0; MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010; Marsh C.A., 1966, GLUCURONIC ACID FREE, P3; MATERN S, 1984, J CLIN INVEST, V74, P402, DOI 10.1172/JCI111435; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; Megaraj V, 2014, CHEM RES TOXICOL, V27, P656, DOI 10.1021/tx4004769; Morini L, 2006, J MASS SPECTROM, V41, P34, DOI 10.1002/jms.943; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P487, DOI 10.1111/j.1348-0421.2002.tb02723.x; Palmer RB, 2009, SEMIN DIAGN PATHOL, V26, P18, DOI 10.1053/j.semdp.2008.12.005; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Plotnikoff Gregory A, 2014, Glob Adv Health Med, V3, P33, DOI 10.7453/gahmj.2014.021; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; PRAKASH C, 1992, BIOCHEM BIOPH RES CO, V185, P728, DOI 10.1016/0006-291X(92)91686-K; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Robert J, 1998, DRUGS TODAY, V34, P777, DOI 10.1358/dot.1998.34.9.485276; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Russell WM, 2001, APPL ENVIRON MICROB, V67, P1253, DOI 10.1128/AEM.67.3.1253-1261.2001; Saitta KS, 2014, XENOBIOTICA, V44, P28, DOI 10.3109/00498254.2013.811314; SALYERS AA, 1980, J BACTERIOL, V143, P772, DOI 10.1128/JB.143.2.772-780.1980; SANDBERG AA, 1967, AM J PHYSIOL, V213, P1138, DOI 10.1152/ajplegacy.1967.213.5.1138; SCHMITT G, 1995, J ANAL TOXICOL, V19, P91, DOI 10.1093/jat/19.2.91; Shen HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17450; Sher A, 2000, ARCH PHARM RES, V23, P513, DOI 10.1007/BF02976582; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; Somasundaram S, 1997, GUT, V41, P344, DOI 10.1136/gut.41.3.344; Sperker B, 1997, CLIN PHARMACOKINET, V33, P18, DOI 10.2165/00003088-199733010-00003; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TAKADA H, 1982, CANCER RES, V42, P331; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Valle L., 2012, PROD APPL BIOPOLYM, DOI [10.5772/33783, DOI 10.5772/33783]; Vitek L, 2003, EUR J CLIN INVEST, V33, P799, DOI 10.1046/j.1365-2362.2003.01214.x; Vitek L, 2000, J PEDIATR GASTR NUTR, V30, P294, DOI 10.1097/00005176-200003000-00015; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wilson K. J., 1992, ESCHERICHIA COLI GUS, P7; WINTER J, 1987, J STEROID BIOCHEM, V27, P1145, DOI 10.1016/0022-4731(87)90201-9; Yamanaka H, 2007, DRUG METAB DISPOS, V35, P1642, DOI 10.1124/dmd.107.016097; Ye FQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150519; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zheng Z, 2002, DRUG METAB DISPOS, V30, P397, DOI 10.1124/dmd.30.4.397	91	102	107	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8569	8576		10.1074/jbc.R116.767434	http://dx.doi.org/10.1074/jbc.R116.767434			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389557	Green Published, hybrid			2022-12-28	WOS:000402153900005
J	Dogan, T; Gnad, F; Chan, J; Phu, L; Young, A; Chen, MJ; Doll, S; Stokes, MP; Belvin, M; Friedman, LS; Kirkpatrick, DS; Hoeflich, KP; Hatzivassiliou, G				Dogan, Taner; Gnad, Florian; Chan, Jocelyn; Phu, Lilian; Young, Amy; Chen, Mark J.; Doll, Sophia; Stokes, Matthew P.; Belvin, Marcia; Friedman, Lori S.; Kirkpatrick, Donald S.; Hoeflich, Klaus P.; Hatzivassiliou, Georgia			Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SUBSTRATE RECOGNITION; TUMOR-GROWTH; PHOSPHORYLATION; PROTEIN; UBIQUITYLATION; INHIBITION; APOPTOSIS; IDENTIFICATION; PROTEOLYSIS	The interconnected PI3K and MAPK signaling pathways are commonly perturbed in cancer. Dual inhibition of these pathways by the small-molecule PI3K inhibitor pictilisib (GDC-0941) and the MEK inhibitor cobimetinib (GDC-0973) suppresses cell proliferation and induces cell death better than either single agent in several preclinical models. Using mass spectrometry-based phosphoproteomics, we have identified the RING finger E3 ubiquitin ligase RNF157 as a target at the intersection of PI3K and MAPK signaling. We demonstrate that RNF157 phosphorylation downstream of the PI3K and MAPK pathways influences the ubiquitination and stability of RNF157 during the cell cycle in an anaphase-promoting complex/cyclosome-CDH1-dependent manner. Deletion of these phosphorylation-targeted residues on RNF157 disrupts binding to CDH1 and protects RNF157 from ubiquitination and degradation. Expression of the cyclin-dependent kinase 2 (CDK2), itself a downstream target of PI3K/MAPK signaling, leads to increased phosphorylation of RNF157 on the same residues modulated by PI3K andMAPKsignaling. Inhibition of PI3K and MEK in combination or of CDK2 by their respective small-molecule inhibitors reduces RNF157 phosphorylation at these residues and attenuates RNF157 interaction with CDH 1 and its subsequent degradation. Knockdown of endogenous RNF157 in melanoma cells leads to late S phase and G(2)/M arrest and induces apoptosis, the latter further potentiated by concurrent PI3K/MEK inhibition, consistent with a role for RNF157 in the cell cycle. We propose that RNF157 serves as a novel node integrating oncogenic signaling pathways with the cell cycle machinery and promoting optimal cell cycle progression in transformed cells.	[Dogan, Taner; Chan, Jocelyn; Young, Amy; Belvin, Marcia; Friedman, Lori S.; Hoeflich, Klaus P.; Hatzivassiliou, Georgia] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Gnad, Florian; Chen, Mark J.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Phu, Lilian; Doll, Sophia; Kirkpatrick, Donald S.] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Belvin, Marcia] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Stokes, Matthew P.] Cell Signaling Technol, Danvers, MA 01923 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hoeflich, KP (corresponding author), Blueprint Med, 38 Sidney St,Suite 200, Cambridge, MA 02139 USA.; Hatzivassiliou, G (corresponding author), Genentech Inc, 1 DNA Way,MS231A, San Francisco, CA 94080 USA.	khoeflich@blueprintmedicines.com; georgiah@gene.com	Chen, Mark/O-3937-2014	Chen, Mark/0000-0003-1169-563X; Gnad, Florian/0000-0002-2287-2251; Kirkpatrick, Donald/0000-0003-3091-2804				Aguzzi A, 2009, CELL, V137, P994, DOI 10.1016/j.cell.2009.05.041; Aviner R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005554; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cooray SN, 2011, ENDOCRINOLOGY, V152, P4224, DOI 10.1210/en.2011-0147; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Gnad F, 2013, MOL CELL PROTEOMICS, V12, P2070, DOI 10.1074/mcp.M112.027052; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jarvis MA, 2016, METHODS MOL BIOL, V1342, P287, DOI 10.1007/978-1-4939-2957-3_18; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Kirkpatrick DS, 2013, P NATL ACAD SCI USA, V110, P19426, DOI 10.1073/pnas.1309473110; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lents NH, 2002, J BIOL CHEM, V277, P47469, DOI 10.1074/jbc.M207425200; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Matz A, 2015, CELL DEATH DIFFER, V22, P626, DOI 10.1038/cdd.2014.163; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Overton JD, 2011, J BIOL CHEM, V286, P18914, DOI 10.1074/jbc.M111.224592; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wierod L, 2007, CELL PROLIFERAT, V40, P475, DOI 10.1111/j.1365-2184.2007.00451.x; Wu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5961; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou JLX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131043; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	48	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14311	14324		10.1074/jbc.M117.792754	http://dx.doi.org/10.1074/jbc.M117.792754			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28655764	Green Published, hybrid			2022-12-28	WOS:000408747500001
J	Bratkowski, M; Yang, X; Liu, X				Bratkowski, Matthew; Yang, Xin; Liu, Xin			Polycomb repressive complex 2 in an autoinhibited state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; PRC2; EZH2; METHYLATION; H3K27ME3; MUTATION; GAIN; RNA	Polycomb-group proteins control many fundamental biological processes, such as anatomical development in mammals and vernalization in plants. Polycomb repressive complex 2 (PRC2) is responsible for methylation of histone H3 lysine 27 (H3K27), and trimethylated H3K27 (H3K27me3) is implicated in epigenetic gene silencing. Recent genomic, biochemical, and structural data indicate that PRC2 is broadly conserved from yeast to human in many aspects. Here, we determined the crystal structure of an apo-PRC2 from the fungus Chaetomium thermophilum captured in a bona fide autoinhibited state, which represents a novel conformation of PRC2 associated with enzyme regulation in light of the basal and stimulated states that we reported previously. We found that binding by the cofactor S-adenosylmethionine mitigates this autoinhibited structural state. Using steady-state enzyme kinetics, we also demonstrated that disrupting the autoinhibition results in a vastly activated enzyme complex. Autoinhibition provides a novel structural platform that may enable control of PRC2 activity in response to diverse transcriptional states and chromatin contexts and set a ground state to allow PRC2 activation by other cellular mechanisms as well.	[Liu, Xin] UT SW Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; UT SW Med Ctr, Basic Res Div, Dept Obstet & Gynecol, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, X (corresponding author), UT SW Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.	xin.liu@utsouthwestern.edu			Office of Science, Office of Basic Energy Sciences, of the United States DOE [DE-AC02-05CH11231]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM114576, R01GM121662] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States DOE(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lianying Jiao and Siming Chen from the Liu laboratory for helpful advice regarding expression and purification of PRC2 complexes. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States DOE under Contract DE-AC02-05CH11231. Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Boriack-Sjodin PA, 2016, BIOCHEMISTRY-US, V55, P1557, DOI 10.1021/acs.biochem.5b01129; Bricogne G., 2016, BUSTER VERSION 2 10; Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Connolly LR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003916; Dumesic PA, 2015, CELL, V160, P204, DOI 10.1016/j.cell.2014.11.039; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Horowitz S, 2013, J AM CHEM SOC, V135, P15536, DOI 10.1021/ja407140k; Jamieson K, 2016, GENOME RES, V26, P97, DOI 10.1101/gr.194555.115; Jamieson K, 2013, P NATL ACAD SCI USA, V110, P6027, DOI 10.1073/pnas.1303750110; Janke R, 2015, ANNU REV CELL DEV BI, V31, P473, DOI 10.1146/annurev-cellbio-100814-125544; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kaneko S, 2014, GENE DEV, V28, P1983, DOI 10.1101/gad.247940.114; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Majer CR, 2012, FEBS LETT, V586, P3448, DOI 10.1016/j.febslet.2012.07.066; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737	33	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13323	13332		10.1074/jbc.M117.787572	http://dx.doi.org/10.1074/jbc.M117.787572			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28607149	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000407465300019
J	Kerr, H; Wong, E; Makou, E; Yang, Y; Marchbank, K; Kavanagh, D; Richards, A; Herbert, AP; Barlow, PN				Kerr, Heather; Wong, Edwin; Makou, Elisavet; Yang, Yi; Marchbank, Kevin; Kavanagh, David; Richards, Anna; Herbert, Andrew P.; Barlow, Paul N.			Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; TRANSLATIONAL MINIREVIEW SERIES; ALTERNATIVE PATHWAY; FUNCTIONAL-CHARACTERIZATION; DECAY ACCELERATION; STRUCTURAL BASIS; BINDING-SITES; C-TERMINUS; PROTEIN; RISK	Spontaneous activation enables the complement system to respond very rapidly to diverse threats. This activation is efficiently suppressed by complement factor H (CFH) on self-surfaces but not on foreign surfaces. The surface selectivity of CFH, a soluble protein containing 20 complement-control protein modules (CCPs 1-20), may be compromised by disease-linked mutations. However, which of the several functions of CFH drives this self-surface selectivity remains unknown. To address this, we expressed human CFH mutants in Pichia pastoris. We found that recombinant I62-CFH (protective against age-related macular degeneration) and V62-CFH functioned equivalently, matching or outperforming plasma-derived CFH, whereas R53H-CFH, linked to atypical hemolytic uremic syndrome (aHUS), was defective in C3bBb decay-accelerating activity (DAA) and factor I cofactor activity (CA). The aHUS-linked CCP 19 mutant D1119G-CFH had virtually no CA on (self-like) sheep erythrocytes (E-S) but retained DAA. The aHUS-linked CCP 20 mutant S1191L/V1197A-CFH (LA-CFH) had dramatically reduced CA on ES but was less compromised in DAA. D1119G-CFH and LA-CFH both performed poorly at preventing complement-mediated hemolysis of ES. PspCN, a CFH-binding Streptococcus pneumoniae protein domain, binds CFH tightly and increases accessibility of CCPs 19 and 20. PspCN did not improve the DAA of any CFH variant on ES. Conversely, PspCN boosted the CA, on ES, of I62-CFH, R53H-CFH, and LA-CFH and also enhanced hemolysis protection by I62-CFH and LA-CFH. We conclude that CCPs 19 and 20 are critical for efficient CA on self-surfaces but less important for DAA. Exposing CCPs 19 and 20 with PspCN and thus enhancing CA on self-surfaces may reverse deficiencies of some CFH variants.	[Barlow, Paul N.] Univ Edinburgh, Sch Chem, Joseph Black Bldg,David Brewster Rd, Edinburgh EH9 3FJ, Midlothian, Scotland; Univ Edinburgh, Sch Biol Sci, Joseph Black Bldg,David Brewster Rd, Edinburgh EH9 3FJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Barlow, PN (corresponding author), Univ Edinburgh, Sch Chem, Joseph Black Bldg,David Brewster Rd, Edinburgh EH9 3FJ, Midlothian, Scotland.	Paul.Barlow@ed.ac.uk	Herbert, Andrew P/C-4755-2008	Herbert, Andrew P/0000-0002-4549-6965; marchbank, kevin james/0000-0003-1312-5411; Wong, Edwin/0000-0003-4867-6117	Leverhulme Trust [RPG-2015-109]; Biotechnology and Biological Sciences Research Council [BB/024403/1]; Biotechnology and Biological Sciences Research Council [BB/L024403/1] Funding Source: researchfish; Kidney Research UK [ST5/2009, JF1/2011, RP7/2015] Funding Source: researchfish; Medical Research Council [MR/K023519/1, G1001971] Funding Source: researchfish; National Institute for Health Research [CL-2016-01-005] Funding Source: researchfish; BBSRC [BB/L024403/1] Funding Source: UKRI; MRC [G1001971, MR/K023519/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Leverhulme Trust (RPG-2015-109) and by Biotechnology and Biological Sciences Research Council Grant BB/024403/1. A.P.H. and P.N.B. are consultants for, and scientific founders of, Gemini Therapeutics.	BARLOW PN, 1991, BIOCHEMISTRY-US, V30, P997, DOI 10.1021/bi00218a016; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Buttner-Mainik A, 2011, PLANT BIOTECHNOL J, V9, P373, DOI 10.1111/j.1467-7652.2010.00552.x; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Cordoba SR, 2010, BLOOD, V115, P158, DOI 10.1182/blood-2009-11-252627; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Ferreira V. P., J IMMUNOL, V182, P7009; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; GORDON DL, 1995, J IMMUNOL, V155, P348; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Harris CL, 2012, TRENDS IMMUNOL, V33, P513, DOI 10.1016/j.it.2012.06.001; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Herbert AP, 2015, J IMMUNOL, V195, P4986, DOI 10.4049/jimmunol.1501388; Herbert AP, 2012, BIOCHEMISTRY-US, V51, P1874, DOI 10.1021/bi201689j; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hourcade DE, 1999, IMMUNOPHARMACOLOGY, V42, P167, DOI 10.1016/S0162-3109(99)00005-3; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Jozsi M, 2015, TRENDS IMMUNOL, V36, P374, DOI 10.1016/j.it.2015.04.008; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kavanagh D, 2013, SEMIN NEPHROL, V33, P508, DOI 10.1016/j.semnephrol.2013.08.003; Kavanagh D, 2010, PEDIATR NEPHROL, V25, P2431, DOI 10.1007/s00467-010-1555-5; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Michelfelder S, 2017, J AM SOC NEPHROL, V28, P1462, DOI 10.1681/ASN.2015070745; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Pechtl IC, 2011, J BIOL CHEM, V286, P11082, DOI 10.1074/jbc.M110.211839; Richards A, 2007, ADV IMMUNOL, V96, P141, DOI 10.1016/S0065-2776(07)96004-6; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; SAHU A, 1994, BIOCHEM J, V302, P429, DOI 10.1042/bj3020429; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548; Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002; SHARMA AK, 1994, GENE, V143, P301, DOI 10.1016/0378-1119(94)90116-3; Smith RJH, 2011, MOL IMMUNOL, V48, P1604, DOI 10.1016/j.molimm.2011.04.005; STOSSEL TP, 1975, J EXP MED, V141, P1329, DOI 10.1084/jem.141.6.1329; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wong EKS, 2014, J AM SOC NEPHROL, V25, P2425, DOI 10.1681/ASN.2013070732; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	65	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13345	13360		10.1074/jbc.M117.795088	http://dx.doi.org/10.1074/jbc.M117.795088			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637873	Green Published, hybrid			2022-12-28	WOS:000407465300021
J	Badur, AH; Plutz, MJ; Yalamanchili, G; Jagtap, SS; Schweder, T; Unfried, F; Markert, S; Polz, MF; Hehemann, JH; Rao, CV				Badur, Ahmet H.; Plutz, Matthew J.; Yalamanchili, Geethika; Jagtap, Sujit Sadashiv; Schweder, Thomas; Unfried, Frank; Markert, Stephanie; Polz, Martin F.; Hehemann, Jan-Hendrik; Rao, Christopher V.			Exploiting fine-scale genetic and physiological variation of closely related microbes to reveal unknown enzyme functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; alginate lyase; bacteria; enzyme kinetics; mass spectrometry (MS); nuclear magnetic resonance (NMR); Vibrio splendidus	VIBRIO-SPLENDIDUS; MARINE BACTERIUM; POLYSACCHARIDE LYASE; SIGNAL PEPTIDES; ALGINATE LYASE; ORGANIC-MATTER; OLIGOSACCHARIDES; DEGRADATION; ACID; CLASSIFICATION	Polysaccharide degradation by marine microbes represents one of the largest and most rapid heterotrophic transformations of organic matter in the environment. Microbes employ systems of complementary carbohydrate-specific enzymes to deconstruct algal or plant polysaccharides (glycans) into monosaccharides. Because of the high diversity of glycan substrates, the functions of these enzymes are often difficult to establish. One solution to this problem may lie within naturally occurring microdiversity; varying numbers of enzymes, due to gene loss, duplication, or transfer, among closely related environmental microbes create metabolic differences akin to those generated by knock-out strains engineered in the laboratory used to establish the functions of unknown genes. Inspired by this natural fine-scale microbial diversity, we show here that it can be used to develop hypotheses guiding biochemical experiments for establishing the role of these enzymes in nature. In this work, we investigated alginate degradation among closely related strains of the marine bacterium Vibrio splendidus. One strain, V. splendidus 13B01, exhibited high extracellular alginate lyase activity compared with other V. splendidus strains. To identify the enzymes responsible for this high extracellular activity, we compared V. splendidus 13B01 with the previously characterized V. splendidus 12B01, which has low extracellular activity and lacks two alginate lyase genes present in V. splendidus 13B01. Using a combination of genomics, proteomics, biochemical, and functional screening, we identified a polysaccharide lyase family 7 enzyme that is unique to V. splendidus 13B01, secreted, and responsible for the rapid digestion of extracellular alginate. These results demonstrate the value of querying the enzymatic repertoires of closely related microbes to rapidly pinpoint key proteins with beneficial functions.	[Badur, Ahmet H.; Plutz, Matthew J.; Yalamanchili, Geethika; Jagtap, Sujit Sadashiv; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA; [Hehemann, Jan-Hendrik] Univ Bremen, Ctr Marine Environm Sci, MARUM, Leobener Str 8, D-28359 Bremen, Germany; [Hehemann, Jan-Hendrik] Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany; [Schweder, Thomas; Unfried, Frank; Markert, Stephanie] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Pharmaceut Biotechnol, D-17489 Greifswald, Germany; [Polz, Martin F.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Bremen; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Massachusetts Institute of Technology (MIT)	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.; Hehemann, JH (corresponding author), Univ Bremen, Ctr Marine Environm Sci, MARUM, Leobener Str 8, D-28359 Bremen, Germany.	jhhehemann@marum.de; cvrao@illinois.edu	Polz, Martin/ABE-7199-2020; Jagtap, Sujit/D-9092-2011; Markert, Stephanie/AAL-5591-2021	Jagtap, Sujit/0000-0001-9402-2259; Markert, Stephanie/0000-0003-0923-3305; Unfried, Frank/0000-0002-9304-4947; Polz, Martin/0000-0002-4975-2946; Schweder, Thomas/0000-0002-7213-3596; Hehemann, Jan-Hendrik/0000-0002-8700-2564	Deutsche Forschungsgemeinschaft (DFG) [HE 7217/1-1]; United States Department of Energy, Office of Science, Office of Biological and Environmental Research [ER65474]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant HE 7217/1-1 (to J.-H.H.) and United States Department of Energy, Office of Science, Office of Biological and Environmental Research, Award ER65474 (to M. F. P. and C. V. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Badur AH, 2015, APPL ENVIRON MICROB, V81, P1856, DOI 10.1128/AEM.03460-14; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chhatbar M, 2009, CARBOHYD POLYM, V76, P650, DOI 10.1016/j.carbpol.2008.11.033; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Doi H, 2017, APPL MICROBIOL BIOT, V101, P1581, DOI 10.1007/s00253-016-8021-7; Ertesvag H, 1998, J BACTERIOL, V180, P3779; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; Hehemann JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12860; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Iversen MH, 2010, DEEP-SEA RES PT I, V57, P771, DOI 10.1016/j.dsr.2010.03.007; Jagtap SS, 2014, APPL ENVIRON MICROB, V80, P4207, DOI 10.1128/AEM.01285-14; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kam N, 2011, CAN J MICROBIOL, V57, P1032, DOI [10.1139/w11-106, 10.1139/W11-106]; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lundqvist LCE, 2012, CARBOHYD RES, V352, P44, DOI 10.1016/j.carres.2012.02.014; MacDonald LC, 2014, J BIOL CHEM, V289, P312, DOI 10.1074/jbc.M113.489195; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Mitulla M, 2016, ENVIRON MICROBIOL, V18, P4369, DOI 10.1111/1462-2920.13314; Muntel J, 2012, RAPID COMMUN MASS SP, V26, P701, DOI 10.1002/rcm.6147; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Neumann AM, 2015, ENVIRON MICROBIOL, V17, P3857, DOI 10.1111/1462-2920.12862; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PREISS J, 1962, J BIOL CHEM, V237, P309; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryu M, 2011, J IND ENG CHEM, V17, P853, DOI 10.1016/j.jiec.2011.08.001; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Torode TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118366; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Xing P, 2015, ISME J, V9, P1410, DOI 10.1038/ismej.2014.225; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yuan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050689; Zhang ZQ, 2004, CARBOHYD RES, V339, P1475, DOI 10.1016/j.carres.2004.03.010; Zhu YT, 2017, ENVIRON MICROBIOL, V19, P2164, DOI 10.1111/1462-2920.13699; Zimmerman AE, 2013, ISME J, V7, P1187, DOI 10.1038/ismej.2012.176; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	62	9	9	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13056	13067		10.1074/jbc.M117.787192	http://dx.doi.org/10.1074/jbc.M117.787192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28592491	Green Published, hybrid			2022-12-28	WOS:000407220100032
J	Bazan, NG; Carman, GM				Bazan, Nicolas G.; Carman, George M.			Thematic Minireview Series: Inflammatory transcription confronts homeostatic disruptions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						fatty acid; gene transcription; inflammation; neurobiology; neuroinflammation; polyunsaturated fatty acid (PUFA)		In this Thematic Minireview Series, three stimulating articles are presented: one on long non-coding RNAs, another on the ligand-activated transcription factor aryl hydrocarbon receptor, and the third on how docosanoids modulate transcriptionally modulated homeostasis and ultimately cell survival in the retina and brain.	[Bazan, Nicolas G.] Louisianan State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bazan, NG (corresponding author), Louisianan State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health [GM103340, EY005121, NS046741]; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM103340, EY005121, and NS046741 (to N.G.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asatryan A, 2017, J BIOL CHEM, V292, P12390, DOI 10.1074/jbc.R117.783076; Cannon W.B., 1932, WISDOM BODY; Mathy NW, 2017, J BIOL CHEM, V292, P12375, DOI 10.1074/jbc.R116.760884; Wheeler MA, 2017, J BIOL CHEM, V292, P12383, DOI 10.1074/jbc.R116.767723	4	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12373	12374		10.1074/jbc.R117.801753	http://dx.doi.org/10.1074/jbc.R117.801753			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615440	Green Published, hybrid			2022-12-28	WOS:000406636900002
J	Gao, SM; Wang, ZQ; Wang, WC; Hu, XL; Chen, PL; Li, JW; Feng, XH; Wong, JM; Du, JX				Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Feng, Xinhua; Wong, Jiemin; Du, James X.			The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; receptor; signal transduction; SMAD transcription factor; transcription regulation	HISTONE METHYLATION; CANCER; PHOSPHORYLATION; DIFFERENTIATION; MECHANISMS; EXPRESSION; INSIGHTS; PATHWAY; ROLES; CELLS	Lysine methylation of chromosomal and nuclear proteins is a well-known mechanism of epigenetic regulation, but relatively little is known about the role of this protein modification in signal transduction. Using an RNAi-based functional screening of the SMYD family of lysine methyltransferases (KMTs), we identified SMYD2 as a KMT essential for robust bone morphogenic protein (BMP)- but not TGF-induced target gene expression in HaCaT keratinocyte cells. A role for SMYD2 in BMP-induced gene expression was confirmed by shRNA knockdown and CRISPR/Cas9-mediated knock-out of SMYD2. We further demonstrate that SMYD2 knockdown or knock-out impairs BMP-induced phosphorylation of the signal-transducing protein SMAD1/5 and SMAD1/5 nuclear localization and interaction with SMAD4. The SMYD2 KMT activity was required to facilitate BMP-mediated signal transduction, as treatment with the SMYD2 inhibitor AZ505 suppressed BMP2-induced SMAD1/5 phosphorylation. Furthermore, we present evidence that SMYD2 likely modulates the BMP response through its function in the cytosol. We show that, although SMYD2 interacted with multiple components in the BMP pathway, it specifically methylated the kinase domain of BMP type II receptor BMPR2. Taken together, our findings suggest that SMYD2 may promote BMP signaling by directly methylating BMPR2, which, in turn, stimulates BMPR2 kinase activity and activation of the BMP pathway.	[Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Wong, Jiemin; Du, James X.] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Wong, Jiemin; Du, James X.] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Wong, Jiemin] East China Normal Univ, Joint Res Ctr Translat Med, Shanghai 201499, Peoples R China; [Wong, Jiemin] Shanghai Fengxian Dist Cent Hosp, Shanghai 201499, Peoples R China; [Feng, Xinhua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xinhua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xinhua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Feng, Xinhua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	East China Normal University; East China Normal University; East China Normal University; Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Wong, JM; Du, JX (corresponding author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.; Wong, JM; Du, JX (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Wong, JM (corresponding author), East China Normal Univ, Joint Res Ctr Translat Med, Shanghai 201499, Peoples R China.; Wong, JM (corresponding author), Shanghai Fengxian Dist Cent Hosp, Shanghai 201499, Peoples R China.	jmweng@bio.ecnu.edu.cn; jxdu@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X	Ministry of Science and Technology of China [2015CB910402]; National Natural Science Foundation of China [91419303]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grant 2015CB910402 (to J.W.), National Natural Science Foundation of China Grant 91419303, and Science and Technology Commission of Shanghai Municipality Grants 14XD1401700 and 11DZ2260300. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed H, 2016, J PROTEOME RES, V15, P2052, DOI 10.1021/acs.jproteome.6b00220; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; ELBENDARY A, 1994, CELL GROWTH DIFFER, V5, P1301; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu XH, 2013, ISRN MATH PHYS, V2013, P1, DOI DOI 10.1016/J.MICR0REL.2012.06.140; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nakakido M, 2015, NEOPLASIA, V17, P367, DOI 10.1016/j.neo.2015.03.002; Nimura K, 2010, J MOL MED, V88, P1213, DOI 10.1007/s00109-010-0668-4; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pradhan S, 2009, EPIGENETICS, V4, P383, DOI DOI 10.4161/EPI.4.6.9450; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Xu GL, 2015, J BIOL CHEM, V290, P5414, DOI 10.1074/jbc.M114.610345; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu ST, 2011, J MOL CELL BIOL, V3, P293, DOI 10.1093/jmcb/mjr015; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4	37	19	19	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12702	12712		10.1074/jbc.M117.776278	http://dx.doi.org/10.1074/jbc.M117.776278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28588028	Green Published, hybrid			2022-12-28	WOS:000406636900033
J	Xu, ML; Bi, CWC; Liu, EYL; Dong, TTX; Tsim, KWK				Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.			Wnt3a induces the expression of acetylcholinesterase during osteoblast differentiation via the Runx2 transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase (AChE); differentiation; DNA methylation; osteoblast; Wnt signaling; Runx2	MEMBRANE-ANCHOR PRIMA; MYOGENIC DIFFERENTIATION; CULTURED OSTEOBLASTS; BONE-DEVELOPMENT; MATRIX PROTEINS; GENE-EXPRESSION; CPG METHYLATION; MESSENGER-RNA; CELLS; GLYCOSYLATION	Acetylcholinesterase (AChE) hydrolyzes acetylcholine to terminate cholinergic transmission in neurons. Apart from this AChE activity, emerging evidence suggests that AChE could also function in other, non-neuronal cells. For instance, in bone, AChE exists as a proline-rich membrane anchor (PRiMA)-linked globular form in osteoblasts, in which it is proposed to play a noncholinergic role in differentiation. However, this hypothesis is untested. Here, we found that in cultured rat osteoblasts, AChE expression was increased in parallel with osteoblastic differentiation. Because several lines of evidence indicate that AChE activity in osteoblast could be triggered by Wnt/-catenin signaling, we added recombinant human Wnt3a to cultured osteoblasts and found that this addition induced expression of the ACHE gene and protein product. This Wnt3a-induced AChE expression was blocked by the Wnt-signaling inhibitor Dickkopf protein-1 (DKK-1). We hypothesized that the Runt-related transcription factor 2 (Runx2), a downstream transcription factor in Wnt/-catenin signaling, is involved in AChE regulation in osteoblasts, confirmed by the identification of a Runx2-binding site in the ACHE gene promoter, further corroborated by ChIP. Of note, Runx2 overexpression in osteoblasts induced AChE expression and activity of the ACHE promoter tagged with the luciferase gene. Moreover, deletion of the Runx2-binding site in the ACHE promoter reduced its activity during osteoblastic differentiation, and addition of 5-azacytidine and trichostatin A to differentiating osteoblasts affected AChE expression, suggesting epigenetic regulation of the ACHE gene. We conclude that AChE plays a role in osteoblastic differentiation and is regulated by both Wnt3a and Runx2.	[Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China; [Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China; [Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518000, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.; Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk		XU, Miranda/0000-0001-7660-0051	Hong Kong Research Council Theme-based Research Scheme Grant [T13-607/12R]; TUYF Charitable Trust [TUYF15SC01]; Science and Technology Plan of Shenzhen [JCYJ20160229205726699, JCYJ20160229205812004];  [663012];  [662713];  [M-HKUST604/13]	Hong Kong Research Council Theme-based Research Scheme Grant; TUYF Charitable Trust; Science and Technology Plan of Shenzhen; ; ; 	This work was supported by Hong Kong Research Council Theme-based Research Scheme Grant T13-607/12R, General Research Fund Grants 663012, 662713, M-HKUST604/13, the TUYF Charitable Trust grant TUYF15SC01, and Science and Technology Plan of Shenzhen Grants JCYJ20160229205726699 (to K.T.) and JCYJ20160229205812004 (to T.D.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Angus LM, 2001, J BIOL CHEM, V276, P17603, DOI 10.1074/jbc.M100916200; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Choi R. C., 2010, J MOL NEUROSCI, V40, P1; Choi RCY, 2003, J NEUROSCI, V23, P4445; Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FROST HM, 1990, ANAT RECORD, V226, P433, DOI 10.1002/ar.1092260405; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; Grisaru D, 1999, MOL CELL BIOL, V19, P788; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Guo AJY, 2011, J BIOL CHEM, V286, P27882, DOI 10.1074/jbc.M111.236281; Hupkes M, 2011, FASEB J, V25, P3861, DOI 10.1096/fj.11-186122; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Kang MI, 2007, J CELL BIOCHEM, V102, P224, DOI 10.1002/jcb.21291; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krane SM, 2005, J EXP MED, V201, P841, DOI 10.1084/jem.20050354; Kuhlwilm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083218; LAPIDOTLIFSON Y, 1989, P NATL ACAD SCI USA, V86, P4715, DOI 10.1073/pnas.86.12.4715; Lau KM, 2016, BRAIN RES, V1642, P114, DOI 10.1016/j.brainres.2016.03.013; Layer P G, 1990, Acta Histochem Suppl, V38, P145; Leung KW, 2009, FEBS J, V276, P3031, DOI 10.1111/j.1742-4658.2009.07022.x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luk WKW, 2012, FEBS J, V279, P3229, DOI 10.1111/j.1742-4658.2012.08708.x; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Ofek K, 2013, CHEM-BIOL INTERACT, V203, P113, DOI 10.1016/j.cbi.2012.07.007; Perry C, 2002, ONCOGENE, V21, P8428, DOI 10.1038/sj.onc.1205945; Sato M, 1998, J BONE MINER RES, V13, P1221, DOI 10.1359/jbmr.1998.13.8.1221; Siow NL, 2002, J BIOL CHEM, V277, P36129, DOI 10.1074/jbc.M206498200; Spieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161675; Stains JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-222; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; UMEZU Y, 1993, ARCH HISTOL CYTOL, V56, P217, DOI 10.1679/aohc.56.217; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Xu ML, 2016, CHEM-BIOL INTERACT, V259, P295, DOI 10.1016/j.cbi.2016.03.025; Xu ML, 2015, J MOL NEUROSCI, V57, P486, DOI 10.1007/s12031-015-0629-z; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	45	26	27	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12667	12678		10.1074/jbc.M117.777581	http://dx.doi.org/10.1074/jbc.M117.777581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28607150	hybrid, Green Published			2022-12-28	WOS:000406636900030
J	Duong, M; Yu, XJ; Teng, B; Schroder, P; Haller, H; Eschenburg, S; Schiffer, M				Duong, Michelle; Yu, Xuejiao; Teng, Beina; Schroder, Patricia; Haller, Hermann; Eschenburg, Susanne; Schiffer, Mario			Protein kinase C is an element of stabilizes beta-catenin and regulates its subcellular localization in podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR SLIT DIAPHRAGM; EMBRYONIC STEM-CELLS; IN-VIVO; THERAPEUTIC TARGET; SIGNALING PATHWAY; EPSILON ISOFORM; E-CADHERIN; DIFFERENTIATION; WNT; PHOSPHORYLATION	Kidney disease has been linked to dysregulated signaling via PKC in kidney cells such as podocytes. PKC alpha is a conventional isoform of PKC and a well-known binding partner of beta-catenin, which promotes its degradation. beta-Catenin is the main effector of the canonical Wnt pathway and is critical in cell adhesion. However, whether other PKC isoforms interact with beta-catenin has not been studied systematically. Here we demonstrate that PKC is an element of-deficient mice, which develop proteinuria and glomerulosclerosis, display lower beta-catenin expression compared with PKC wild-type mice, consistent with an altered phenotype of podocytes in culture. Remarkably, beta-catenin showed a reversed subcellular localization pattern: Although beta-catenin exhibited a perinuclear pattern in undifferentiated wild-type cells, it predominantly localized to the nucleus in PKC is an element of knockout cells. Phorbol 12-myristate 13-acetate stimulation of both cell types revealed that PKC is an element of positively regulates beta-catenin expression and stabilization in a glycogen synthase kinase 3 beta-independent manner. Further, beta-catenin overexpression in PKC is an element of-deficient podocytes could restore the wild-type phenotype, similar to rescue with a PKC is an element of construct. This effect was mediated by up-regulation of P-cadherin and the beta-catenin downstream target fascin1. Zebrafish studies indicated three PKC is an element of-specific phosphorylation sites in beta-catenin that are required for full beta-catenin function. Co-immunoprecipitation and pulldown assays confirmed PKC is an element of and beta-catenin as binding partners and revealed that ablation of the three PKC is an element of phosphorylation sites weakens their interaction. In summary, we identified a novel pathway for regulation of beta-catenin levels and definePKC is an element of as an important beta-catenin interaction partner and signaling opponent of other PKC isoforms in podocytes.	[Duong, Michelle; Yu, Xuejiao; Teng, Beina; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Dept Hypertens & Nephrol, D-30625 Hannover, Germany; [Schroder, Patricia] Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; [Eschenburg, Susanne] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Hannover Medical School; Mount Desert Island Biological Laboratory; Hannover Medical School	Schiffer, M (corresponding author), Dept Hypertens & Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019	Schiffer, Mario/0000-0002-8414-1470	German research council [Schi587/3-6]; German Federal Ministry for Education and Research (BMBF) [01GM1518A]; Institutional Development Awards (IDeA) from NIGMS of the National Institutes of Health [P20GM0103423, P20GM104318]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423, P20GM104318] Funding Source: NIH RePORTER	German research council(German Research Foundation (DFG)); German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Institutional Development Awards (IDeA) from NIGMS of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by German research council Grant Schi587/3-6 and German Federal Ministry for Education and Research (BMBF) Grant 01GM1518A (to M.S.). Zebrafish experiments were supported by Institutional Development Awards (IDeA) from NIGMS of the National Institutes of Health under Grants P20GM0103423 and P20GM104318. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Choi SW, 2015, J BIOL CHEM, V290, P9863, DOI 10.1074/jbc.M114.606756; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gwak J, 2006, J CELL SCI, V119, P4702, DOI 10.1242/jcs.03256; Gwak J, 2009, J CELL MOL MED, V13, P2171, DOI 10.1111/j.1582-4934.2009.00683.x; Hao JJ, 2013, CELL REP, V4, P898, DOI 10.1016/j.celrep.2013.07.047; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hernandez-Maqueda JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058540; Inagaki K, 2006, CARDIOVASC RES, V70, P222, DOI 10.1016/j.cardiores.2006.02.015; Jayo A, 2010, INT J BIOCHEM CELL B, V42, P1614, DOI 10.1016/j.biocel.2010.06.019; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Meier M, 2007, J AM SOC NEPHROL, V18, P1190, DOI 10.1681/ASN.2005070694; Meier M, 2007, DIABETES, V56, P346, DOI 10.2337/db06-0891; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0098-x; Orsulic S, 1999, J CELL SCI, V112, P1237; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Schiffer M, 2015, NAT MED, V21, P601, DOI 10.1038/nm.3843; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Teng BN, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00179; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	36	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12100	12110		10.1074/jbc.M117.775700	http://dx.doi.org/10.1074/jbc.M117.775700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28539358	Green Published, hybrid			2022-12-28	WOS:000406053300010
J	Siempelkamp, BD; Rathinaswamy, MK; Jenkins, ML; Burke, JE				Siempelkamp, Braden D.; Rathinaswamy, Manoj K.; Jenkins, Meredith L.; Burke, John E.			Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; G-BETA-GAMMA; FUNCTIONAL-ANALYSIS; PHOSPHOLIPASE A(2); RAS MUTATIONS; P110-ALPHA; PROTEIN; BINDING; DISTINCT; SPECIFICITY	Class IA PI3Ks are involved in the generation of the key lipid signaling molecule phosphatidylinositol 3,4,5-trisphosphate (PIP3), and inappropriate activation of this pathway is implicated in a multitude of human diseases, including cancer, inflammation, and primary immunodeficiencies. Class IA PI3Ks are activated downstream of the Ras superfamily of GTPases, and Ras-PI3K interaction plays a key role in promoting tumor formation and maintenance in Ras-driven tumors. Investigating the detailed molecular events in the Ras-PI3K interaction has been challenging because it occurs on a membrane surface. Here, using maleimide-functionalized lipid vesicles, we successfully generated membrane-resident HRas and evaluated its effect on PI3K signaling in lipid kinase assays and through analysis with hydrogen-deuterium exchange MS. We screened all class IA PI3K isoforms and found that HRas activates both p110 alpha and p110 delta isoforms but does not activate p110 beta. The p110 alpha and p110 delta activation by Ras was synergistic with activation by a soluble phosphopeptide derived from receptor tyrosine kinases. Hydrogen-deuterium exchange MS revealed that membrane-resident HRas, but not soluble HRas, enhances conformational changes associated with membrane binding by increasing membrane recruitment of both p110 alpha and p110 delta. Together, these results afford detailed molecular insight into the Ras-PI3K signaling complex, provide a framework for screening Ras inhibitors, and shed light on the isoform specificity of Ras-PI3K interactions in a native membrane context.	[Siempelkamp, Braden D.; Rathinaswamy, Manoj K.; Jenkins, Meredith L.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada	University of Victoria	Burke, JE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada.	jeburke@uvic.ca	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Jenkins, Meredith/0000-0002-0685-5048	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada [NSERC-2014-05218]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by a new investigator grant from the Canadian Institutes of Health Research and a discovery research grant from the Natural Sciences and Engineering Research Council of Canada (NSERC-2014-05218).	Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; Castellano E, 2013, CANCER CELL, V24, P617, DOI 10.1016/j.ccr.2013.09.012; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Dornan GL, 2017, P NATL ACAD SCI USA, V114, P1982, DOI 10.1073/pnas.1617244114; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Mazhab-Jafari MT, 2013, J AM CHEM SOC, V135, P3367, DOI 10.1021/ja312508w; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Murillo MM, 2014, J CLIN INVEST, V124, P3601, DOI 10.1172/JCI74134; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Vadas O, 2017, METHOD ENZYMOL, V583, P143, DOI 10.1016/bs.mie.2016.09.008; Vadas O, 2015, BIOCHEM SOC T, V43, P773, DOI 10.1042/BST20150065; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Welsch ME, 2017, CELL, V168, P878, DOI 10.1016/j.cell.2017.02.006	39	39	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12256	12266		10.1074/jbc.M117.789263	http://dx.doi.org/10.1074/jbc.M117.789263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28515318	Green Published, hybrid			2022-12-28	WOS:000406053300022
J	Landry, AP; Ballou, DP; Banerjee, R				Landry, Aaron P.; Ballou, David P.; Banerjee, Ruma			H2S oxidation by nanodisc-embedded human sulfide quinone oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; flavin; flavin adenine dinucleotide (FAD); oxidation-reduction (redox); pre-steady-state kinetics; glutathione; hydrogen sulfide	HYDROGEN-SULFIDE; KINETIC-ANALYSIS; LIPID-BILAYERS; SULFANE SULFUR; OXIDASE; TOXICITY; BRAIN; SULFURTRANSFERASE; PROMISCUITY; DIOXYGENASE	Buildup of hydrogen sulfide (H2S), which functions as a signaling molecule but is toxic at high concentrations, is averted by its efficient oxidation by the mitochondrial sulfide oxidation pathway. The first step in this pathway is catalyzed by a flavoprotein, sulfide quinone oxidoreductase (SQR), which converts H2S to a persulfide and transfers electrons to coenzyme Q via a flavin cofactor. All previous studies on human SQR have used detergent-solubilized protein. Here, we embedded human SQR in nanodiscs (ndSQR) and studied highly homogenous preparations by steady-state and rapid-kinetics techniques. ndSQR exhibited higher catalytic rates in its membranous environment than in its solubilized state. Stopped-flow spectroscopic data revealed that transfer of the sulfane sulfur from an SQR-bound cysteine persulfide intermediate to a small-molecule acceptor is the rate-limiting step. The physiological acceptor of sulfane sulfur from SQR has been the subject of controversy; we report that the kinetic analysis of ndSQR is consistent with glutathione rather than sulfite being the predominant acceptor at physiologically relevant concentrations of the respective metabolites. The identity of the acceptor has an important bearing on how the sulfide oxidation pathway is organized. Our data are more consistent with the reaction sequence for sulfide oxidation being: H2S -> glutathione persulfide -> sulfite -> sulfate, than with a more convoluted route that would result if sulfite were the primary acceptor of sulfane sulfur. In summary, nanodisc-incorporated human SQR exhibits enhanced catalytic performance, and pre-steady-state kinetics characterization of the complete SQR catalytic cycle indicates that GSH serves as the physiologically relevant sulfur acceptor.	[Landry, Aaron P.; Ballou, David P.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [GM112455, F32GM122357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455, F32GM122357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM112455 (to R. B.) and F32GM122357 (to A. P. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Augustyn KDC, 2017, BIOCHEMISTRY-US, V56, P986, DOI 10.1021/acs.biochem.6b01093; Banerjee R, 2017, CURR OPIN CHEM BIOL, V37, P115, DOI 10.1016/j.cbpa.2017.02.021; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Cherney MM, 2010, J MOL BIOL, V398, P292, DOI 10.1016/j.jmb.2010.03.018; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; GUNNISON AF, 1981, FOOD COSMET TOXICOL, V19, P667, DOI 10.1016/0015-6264(81)90519-8; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JI AJ, 1995, CLIN CHEM, V41, P897; Johnson-Winters K, 2010, BIOCHEMISTRY-US, V49, P1290, DOI 10.1021/bi9020296; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Mishanina TV, 2015, J BIOL CHEM, V290, P25072, DOI 10.1074/jbc.M115.682369; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nowak K, 2004, PLANT CELL PHYSIOL, V45, P1889, DOI 10.1093/pcp/pch212; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STAMMATI A, 1992, FOOD ADDIT CONTAM, V9, P551, DOI 10.1080/02652039209374109; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; TOGAWA T, 1992, CHEM PHARM BULL, V40, P3000, DOI 10.1248/cpb.40.3000; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Vitvitsky VM, 2012, BBA-MOL BASIS DIS, V1822, P1671, DOI 10.1016/j.bbadis.2012.07.004; Woo WH, 2003, BIOCHEM BIOPH RES CO, V305, P619, DOI 10.1016/S0006-291X(03)00833-7; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177	38	39	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11641	11649		10.1074/jbc.M117.788547	http://dx.doi.org/10.1074/jbc.M117.788547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28512131	hybrid, Green Published			2022-12-28	WOS:000405485600005
J	El Qaidi, S; Chen, K; Halim, A; Siukstaite, L; Rueter, C; Hurtado-Guerrero, R; Clausen, H; Hardwidge, PR				El Qaidi, Samir; Chen, Kangming; Halim, Adnan; Siukstaite, Lina; Rueter, Christian; Hurtado-Guerrero, Ramon; Clausen, Henrik; Hardwidge, Philip R.			NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and Salmonella enterica display distinct differences in host substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN	Many Gram-negative bacterial pathogens use a syringe-like apparatus called a type III secretion system to inject virulence factors into host cells. Some of these effectors are enzymes that modify host proteins to subvert their normal functions. NleB is a glycosyltransferase that modifies host proteins with N-acetyl-Dglucosamine to inhibit antibacterial and inflammatory host responses. NleB is conserved among the attaching/effacing pathogens enterohemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli (EPEC), and Citrobacter rodentium. Moreover, Salmonella enterica strains encode up to three NleB orthologs named SseK1, SseK2, and SseK3. However, there are conflicting reports regarding the activities and host protein targets among the NleB/SseK orthologs. Therefore, here we performed in vitro glycosylation assays and cell culture experiments to compare the activities and substrate specificities of these effectors. SseK1, SseK3, EHEC NleB1, EPEC NleB1, and C. rodentium NleB blocked TNF-mediated NF-kappa B pathway activation, whereas SseK2 and NleB2 did not. C. rodentium NleB, EHEC NleB1, and SseK1 glycosylated host GAPDH. C. rodentium NleB, EHEC NleB1, EPEC NleB1, and SseK2 glycosylated the FADD (Fas-associated death domain protein). SseK3 and NleB2 were not active against either substrate. We also found that EHEC NleB1 glycosylated two GAPDH arginine residues, Arg197 and Arg200, and that these two residues were essential for GAPDH-mediated activation of TNF receptorassociated factor 2 ubiquitination. These results provide evidence that members of this highly conserved family of bacterial virulence effectors target different host protein substrates and exhibit distinct cellular modes of action to suppress host responses.	[El Qaidi, Samir; Chen, Kangming; Hardwidge, Philip R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Halim, Adnan; Siukstaite, Lina; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Halim, Adnan; Siukstaite, Lina; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Mol Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Halim, Adnan] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Rueter, Christian] Univ Munster, Ctr Mol Biol Inflammat, Inst Infectiol, D-48149 Munster, Germany; [Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Quim Fis Rocasolano, Consejo Super Invest Cient Joint Unit, Fdn ARAID, Edificio CEEI ARAGON, Zaragoza 500018, Spain; [Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Quim Fis Rocasolano, Consejo Super Invest Cient Joint Unit, Inst Biocomputat & Phys Complex Syst, Edificio CEEI ARAGON, Zaragoza 500018, Spain	Kansas State University; University of Copenhagen; University of Copenhagen; Rockefeller University; University of Munster; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza	Hardwidge, PR (corresponding author), Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA.	hardwidg@vet.k-state.edu	clausen, henrik/AAD-8016-2021	Siukstaite, Lina/0000-0002-0899-1916; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; Clausen, Henrik/0000-0002-0915-5055; Halim, Adnan/0000-0003-1629-187X	NIAID, National Institutes of Health [AI093913, AI127973]; Danish National Research Foundation [DNRF107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093913, R21AI127973, R01AI099002] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants AI093913 and AI127973 from the NIAID, National Institutes of Health (to P. R. H.) and Danish National Research Foundation Grant DNRF107 (to A. H. and H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Kidwai AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070753; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Yang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138529; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231	16	42	50	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11423	11430		10.1074/jbc.M117.790675	http://dx.doi.org/10.1074/jbc.M117.790675			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28522607	Green Published, hybrid			2022-12-28	WOS:000405119600025
J	Krementsova, EB; Furuta, K; Oiwa, K; Trybus, KM; Ali, MY				Krementsova, Elena B.; Furuta, Ken'ya; Oiwa, Kazuhiro; Trybus, Kathleen M.; Ali, M. Yusuf			Small teams of myosin Vc motors coordinate their stepping for efficient cargo transport on actin bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW DUTY RATIO; TUG-OF-WAR; MOLECULAR MOTORS; CYTOPLASMIC DYNEIN; IN-VITRO; VA; ENSEMBLES; INTERSECTIONS; MICROTUBULES; PROCESSIVITY	Myosin Vc (myoVc) is unique among vertebrate class V myosin isoforms in that it requires teams of motors to move continuously on single actin filaments. Single molecules of myoVc cannot take multiple hand-over-hand steps from one actin-binding site to the next without dissociating, in stark contrast to the well studied myosin Va (myoVa) isoform. At low salt, single myoVc motors can, however, move processively on actin bundles, and at physiologic ionic strength, even teams of myoVc motors require actin bundles to sustain continuous motion. Here, we linked defined numbers of myoVc or myoVa molecules to DNA nanostructures as synthetic cargos. Using total internal reflectance fluorescence microscopy, we compared the stepping behavior of myoVc versus myoVa ensembles and myoVc stepping patterns on single actin filaments versus actin bundles. Run lengths of both myoVc and myoVa teams increased with motor number, but only multiple myoVc motors showed a run-length enhancement on actin bundles compared with actin filaments. By resolving the stepping behavior of individual myoVc motors with a quantum dot bound to the motor domain, we found that coupling of two myoVc motors significantly decreased the futile back and side steps that were frequently observed for single myoVc motors. Changes in the inter-motor distance between two coupled myoVc motors affected stepping dynamics, suggesting that mechanical tension coordinates the stepping behavior of two myoVc motors for efficient directional motion. Our study provides a molecular basis to explain how teams of myoVc motors are suited to transport cargos such as zymogen granules on actin bundles.	[Krementsova, Elena B.; Trybus, Kathleen M.; Ali, M. Yusuf] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Furuta, Ken'ya; Oiwa, Kazuhiro] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan	University of Vermont; National Institute of Information & Communications Technology (NICT) - Japan	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil 132, Burlington, VT 05405 USA.; Ali, MY (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil 131, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu; yusuf.ali@med.uvm.edu	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X	American Heart Association [12SDG11930002]; National Institutes of Health [GM078097];  [15KT0155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 12SDG11930002 (to M. Y. A.), Grant-in-aid for Scientific Research, Japan, 15KT0155 (to K. F.), and National Institutes of Health Grant GM078097 (to K. M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Ali MY, 2016, BIOPHYS J, V111, P2228, DOI 10.1016/j.bpj.2016.09.046; Ali MY, 2013, TRAFFIC, V14, P70, DOI 10.1111/tra.12017; Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Berger F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208101; Bui H, 2010, NANO LETT, V10, P3367, DOI 10.1021/nl101079u; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Driller-Colangelo AR, 2016, CYTOSKELETON, V73, P693, DOI 10.1002/cm.21339; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Geron E, 2013, P NATL ACAD SCI USA, V110, P10652, DOI 10.1073/pnas.1303796110; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gunther LK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04907; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Larson AG, 2009, PHYS CHEM CHEM PHYS, V11, P4890, DOI 10.1039/b900968j; Lu HL, 2012, J BIOL CHEM, V287, P27753, DOI 10.1074/jbc.M112.371393; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE3986, DOI 10.1073/pnas.1406535111; Nelson SR, 2011, METHODS MOL BIOL, V778, P111, DOI 10.1007/978-1-61779-261-8_8; Oguchi Y, 2010, NAT CHEM BIOL, V6, P300, DOI [10.1038/NCHEMBIO.322, 10.1038/nchembio.322]; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Sladewski TE, 2016, CURR BIOL, V26, P2202, DOI 10.1016/j.cub.2016.06.029; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	39	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10998	11008		10.1074/jbc.M117.780791	http://dx.doi.org/10.1074/jbc.M117.780791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476885	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000404391000021
J	Qin, YW; Peng, YZ; Zhao, W; Pan, JP; Ksiezak-Reding, H; Cardozo, C; Wu, YJ; Pajevic, PD; Bonewald, LF; Bauman, WA; Qin, WP				Qin, Yiwen; Peng, Yuanzhen; Zhao, Wei; Pan, Jianping; Ksiezak-Reding, Hanna; Cardozo, Christopher; Wu, Yingjie; Pajevic, Paola Divieti; Bonewald, Lynda F.; Bauman, William A.; Qin, Weiping			Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; MASS; OSTEOCLASTOGENESIS; DENSITY; SYSTEM; PLASMA; RANKL; MICE	Muscle and bone are closely associated in both anatomy and function, but the mechanisms that coordinate their synergistic action remain poorly defined. Myostatin, a myokine secreted by muscles, has been shown to inhibit muscle growth, and the disruption of the myostatin gene has been reported to cause muscle hypertrophy and increase bone mass. Extracellular vesicle-exosomes that carry microRNA (miRNA), mRNA, and proteins are known to perform an important role in cell-cell communication. We hypothesized that myostatin may play a crucial role in muscle-bone interactions and may promote direct effects on osteocytes and on osteocyte-derived exosomal miRNAs, thereby indirectly influencing the function of other bone cells. We report herein that myostatin promotes expression of several bone regulators such as sclerostin (SOST), DKK1, and RANKL in cultured osteocytic (Ocy454) cells, concomitant with the suppression of miR-218 in both parent Ocy454 cells and derived exosomes. Exosomes produced by Ocy454 cells that had been pre-treated with myostatin could be taken up by osteoblastic MC3T3 cells, resulting in a marked reduction of Runx2, a key regulator of osteoblastic differentiation, and in decreased osteoblastic differentiation via the down-regulation of the Wnt signaling pathway. Importantly, the inhibitory effect of myostatin-modified osteocytic exosomes on osteoblast differentiation is completely reversed by expression of exogenous miR-218, through a mechanism involving miR-218-mediated inhibition of SOST. Together, our findings indicate that myostatin directly influences osteocyte function and thereby inhibits osteoblastic differentiation, at least in part, through the suppression of osteocyte-derived exosomal miR-218, suggesting a novel mechanism in muscle-bone communication.	[Qin, Yiwen; Peng, Yuanzhen; Zhao, Wei; Pan, Jianping; Cardozo, Christopher; Bauman, William A.; Qin, Weiping] James J Peters Vet Affairs Med Ctr, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA; [Cardozo, Christopher; Wu, Yingjie; Bauman, William A.; Qin, Weiping] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Cardozo, Christopher; Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Ksiezak-Reding, Hanna] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Wu, Yingjie] Dalian Med Univ, Inst Gene Engn Anim Models Human Dis, Dalian 116044, Peoples R China; [Pajevic, Paola Divieti] Boston Univ, Dept Mol & Cell Biol, Boston, MA 02215 USA; [Bonewald, Lynda F.] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Dalian Medical University; Boston University; Indiana University System; Indiana University Bloomington	Qin, WP (corresponding author), James J Peters Vet Affairs Med Ctr, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	weiping.qin@mssm.edu	Zhao, Wei/A-2206-2010; Cardozo, Christopher/R-6021-2019; Bonewald, Lynda/Q-3638-2019; Pajevic, Paola Divieti/M-3236-2019	Cardozo, Christopher/0000-0003-4013-2537; Zhao, Wei/0000-0002-3449-2395; Divieti Pajevic, Paola/0000-0001-9853-9837	Veterans Health Administration, Rehabilitation Research, and Development Service [5I01RX001313, I01RX002089, 5I01RX000687, B9212-C, B2020-C]; NIH [UH3AR059655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH3AR059655] Funding Source: NIH RePORTER; Veterans Affairs [I01RX002089, I01RX001313, I01RX000687] Funding Source: NIH RePORTER	Veterans Health Administration, Rehabilitation Research, and Development Service(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Veterans Health Administration, Rehabilitation Research, and Development Service (Grants 5I01RX001313, I01RX002089, and 5I01RX000687 to W. Q.; B9212-C and B2020-C to W. A. B.). This work was also supported by NIH-UH3AR059655 to P. D P. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews N. A., 2013, IBMS BONEKEY, V10, P377, DOI [10.1038/bonekey.2013.111, DOI 10.1038/BONEKEY.2013.111]; Arounleut P, 2013, EXP GERONTOL, V48, P898, DOI 10.1016/j.exger.2013.06.004; Batra N, 2014, J BIOL CHEM, V289, P10582, DOI 10.1074/jbc.M114.550608; Bauman W.A., 2013, OSTEOPOROSIS, VFourth, P1139, DOI DOI 10.1016/B978-0-12-415853-5.00047-9; Bauman WA, 1999, OSTEOPOROSIS INT, V10, P123, DOI 10.1007/s001980050206; Bloomfield Susan A, 2010, Curr Osteoporos Rep, V8, P91, DOI 10.1007/s11914-010-0013-4; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bowser M, 2013, EXP GERONTOL, V48, P290, DOI 10.1016/j.exger.2012.11.004; Brown JC, 2016, J CACHEXIA SARCOPENI, V7, P290, DOI 10.1002/jcsm.12073; Buehring B, 2013, CURR OSTEOPOROS REP, V11, P407, DOI 10.1007/s11914-013-0160-5; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Clarke BL, 2010, RADIOL CLIN N AM, V48, P483, DOI 10.1016/j.rcl.2010.02.014; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Dankbar B, 2015, NAT MED, V21, P1085, DOI 10.1038/nm.3917; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hamrick MW, 2010, J MUSCULOSKEL NEURON, V10, P64; Hamrick Mark W, 2012, Bonekey Rep, V1, P60, DOI 10.1038/bonekey.2012.60; Hamrick MW, 2011, EXERC SPORT SCI REV, V39, P43, DOI 10.1097/JES.0b013e318201f601; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302; Jahn K, 2012, EUR CELLS MATER, V24, P197; Jiang SD, 2006, CLIN ENDOCRINOL, V65, P555, DOI 10.1111/j.1365-2265.2006.02683.x; Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Karinkanta S, 2010, NAT REV ENDOCRINOL, V6, P396, DOI 10.1038/nrendo.2010.70; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; Kogure Takayuki, 2013, Methods Mol Biol, V1024, P11, DOI 10.1007/978-1-62703-453-1_2; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Leigey D, 2009, SPORTS HEALTH, V1, P508, DOI 10.1177/1941738109347979; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Qin WP, 2013, J BIOL CHEM, V288, P13511, DOI 10.1074/jbc.M113.454892; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; Qin Weiping, 2010, Curr Osteoporos Rep, V8, P212, DOI 10.1007/s11914-010-0029-9; Rittweger J, 2000, BONE, V27, P319, DOI 10.1016/S8756-3282(00)00327-6; Schoenau E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P232; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zeringer Emily, 2013, World J Methodol, V3, P11, DOI 10.5662/wjm.v3.i1.11; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	66	133	153	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11021	11033		10.1074/jbc.M116.770941	http://dx.doi.org/10.1074/jbc.M116.770941			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28465350	Green Published, hybrid			2022-12-28	WOS:000404391000023
J	Galaz-Montoya, M; Wright, SJ; Rodriguez, GJ; Lichtarge, O; Wensel, TG				Galaz-Montoya, Monica; Wright, Sara J.; Rodriguez, Gustavo J.; Lichtarge, Olivier; Wensel, Theodore G.			beta(2)-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; BETA-ARRESTIN; CYCLIC-AMP; G-PROTEINS; ISOPROTERENOL; STIMULATION; PHOSPHORYLATION; PHARMACOLOGY; INCREASES; SUBTYPES	Beta adrenergic receptors (beta ARs) are G-protein-coupled receptors essential for physiological responses to the hormones/neurotransmitters epinephrine and norepinephrine which are found in the nervous system and throughout the body. They are the targets of numerous widely used drugs, especially in the case of the most extensively studied beta AR, beta(2)AR, whose ligands are used for asthma and cardiovascular disease. beta ARs signal through G alpha(s) G-proteins and via activation of adenylyl cyclase and cAMP-dependent protein kinase, but some alternative downstream pathways have also been proposed that could be important for understanding normal physiological functioning of beta AR signaling and its disruption in disease. Using fluorescence-based Ca2+ flux assays combined with pharmacology and gene knock-out methods, we discovered a previously unrecognized endogenous pathway in HEK-293 cells whereby beta(2)AR activation leads to robust Ca2+ mobilization from intracellular stores via activation of phospholipase C and opening of inositol trisphosphate (InsP(3)) receptors. This pathway did not involve cAMP, G alpha(s), or G alpha(i) or the participation of the other members of the canonical beta(2)AR signaling cascade and, therefore, constitutes a novel signaling mechanism for this receptor. This newly uncovered mechanism for Ca2+ mobilization by beta(2)AR has broad implications for adrenergic signaling, cross-talk with other signaling pathways, and the effects of beta AR-directed drugs.	[Galaz-Montoya, Monica; Wright, Sara J.; Rodriguez, Gustavo J.; Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rodriguez, Gustavo J.] Kite Pharma, 2225 Colorado Ave, Santa Monica, CA 90404 USA	Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu		Wensel, Theodore/0000-0003-3518-9352	Cell-Based Assay Screening Service core at Baylor College of Medicine; NIH [P30 CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123, P30CA014236] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM066099] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1356569] Funding Source: National Science Foundation	Cell-Based Assay Screening Service core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Dr. Michael X. Zhu of the University of the Texas Health Science Center at Houston for kindly sharing his HEK-TRPC4 beta and HEK-mu OR-TRBC4 beta cells. Special thanks to Dr. James Mancuso for helpful comments on the manuscript and to Dr. Melina A. Agosto for invaluable help and suggestions throughout the development of this project and preparation of the manuscript. We thank Tyler Hilton of Baylor College of Medicine for preparing CEL1 nuclease. This project was supported by the Cell-Based Assay Screening Service core (with special thanks to Drs. D. Liu and J. Xu) at Baylor College of Medicine with funding from the NIH (P30 CA125123).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P122, DOI 10.1101/pdb.prot072801; BYLUND DB, 1994, PHARMACOL REV, V46, P121; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; COOK DI, 1988, PFLUG ARCH EUR J PHY, V413, P67, DOI 10.1007/BF00581230; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; HELMAN J, 1987, EUR J PHARMACOL, V143, P65, DOI 10.1016/0014-2999(87)90735-7; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HORN VJ, 1988, J BIOL CHEM, V263, P12454; Kang HJ, 2014, J BIOL CHEM, V289, P29961, DOI 10.1074/jbc.M114.574483; Kurian N, 2009, J PHARMACOL EXP THER, V330, P502, DOI 10.1124/jpet.109.153619; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; MILLIGAN G, 1994, BIOCHEM PHARMACOL, V48, P1059; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Pereira L, 2012, J MOL CELL CARDIOL, V52, P283, DOI 10.1016/j.yjmcc.2011.10.016; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Soltoff SP, 2010, J BIOL CHEM, V285, P13337, DOI 10.1074/jbc.M110.112094; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Summers RJ, 1997, J AUTON PHARMACOL, V17, P331, DOI 10.1046/j.1365-2680.1997.00055.x; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Tojyo Y, 1998, EUR J PHARMACOL, V360, P73, DOI 10.1016/S0014-2999(98)00651-7; Weitl N, 2008, J PHARMACOL EXP THER, V327, P760, DOI 10.1124/jpet.108.143412; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; WU DQ, 1995, J BIOL CHEM, V270, P16008, DOI 10.1074/jbc.270.27.16008	35	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9967	9974		10.1074/jbc.M117.787119	http://dx.doi.org/10.1074/jbc.M117.787119			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28442571	Green Published, hybrid			2022-12-28	WOS:000403580600010
J	Chirieleison, SM; Marsh, RA; Kumar, P; Rathkey, JK; Dubyak, GR; Abbott, DW				Chirieleison, Steven M.; Marsh, Rebecca A.; Kumar, Prathna; Rathkey, Joseph K.; Dubyak, George R.; Abbott, Derek W.			Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; XIAP DEFICIENCY; CROHNS-DISEASE; STRUCTURAL BASIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; CARD15 MUTATIONS; LIGASE ACTIVITY; GENE-MUTATIONS	The X-linked inhibitor of apoptosis (XIAP) protein has been identified as a key genetic driver of two distinct inflammatory disorders, X-linked lymphoproliferative syndrome 2 (XLP-2) and very-early-onset inflammatory bowel disease (VEO-IBD). Molecularly, the role of XIAP mutations in the pathogenesis of these disorders is unclear. Recent work has consistently shown XIAP to be critical for signaling downstream of the Crohn's disease susceptibility protein nucleotide-binding oligomerization domain-containing 2 (NOD2); however, the reported effects of XLP-2 and VEO-IBD XIAP mutations on cell death have been inconsistent. In this manuscript, we describe a CRISPR-mediated genetic system for cells of the myeloid lineage in which XIAP alleles can be replaced with disease-associated XIAP variants expressed at endogenous levels to simultaneously study inflammation-related cell death and NOD2 signaling. We show that, consistent with previous studies, NOD2 signaling is critically dependent on the BIR2 domain of XIAP. We further used this system to reconcile the aforementioned inconsistent XIAP cell death data to show that XLP-2 and VEO-IBD XIAP mutations that exhibit a loss-of-function NOD2 phenotype also lower the threshold for inflammatory cell death. Last, we identified and studied three novel patient XIAP mutations and used this system to characterize NOD2 and cell death phenotypes driven by XIAP. The results of this work support the role of XIAP in mediating NOD2 signaling while reconciling the role of XLP-2 and VEO-IBD XIAP mutations in inflammatory cell death and provide a set of tools and framework to rapidly test newly discovered XIAP variants.	[Chirieleison, Steven M.; Kumar, Prathna; Rathkey, Joseph K.; Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Marsh, Rebecca A.] Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA	Case Western Reserve University; Case Western Reserve University; Cincinnati Children's Hospital Medical Center	Abbott, DW (corresponding author), Rm 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu		Abbott, Derek/0000-0003-4387-8094; Dubyak, George/0000-0001-9720-4226; Chirieleison, Steven/0000-0002-3997-5652	National Institutes of Health [R01 GM086550, P01 DK091222]; Case Western Reserve University National Institutes of Health Medical Scientist Training Program [T32 GM007250]; Case Western Reserve University Immunology Training Program [T32 AI089474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, P30DK097948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550, T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University National Institutes of Health Medical Scientist Training Program; Case Western Reserve University Immunology Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM086550 and P01 DK091222 (to D. W. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Case Western Reserve University National Institutes of Health Medical Scientist Training Program Grant T32 GM007250 and Case Western Reserve University Immunology Training Program Grant T32 AI089474.	Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, P1131, DOI 10.1016/j.jaci.2014.04.031; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chirieleison SM, 2016, J IMMUNOL, V196, P4291, DOI 10.4049/jimmunol.1502631; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Duan W, 2010, J ALLERGY CLIN IMMUN, V126, P1284, DOI 10.1016/j.jaci.2010.09.021; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Dziadzio M, 2015, J CLIN IMMUNOL, V35, P439, DOI 10.1007/s10875-015-0166-0; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Flygare JA, 2012, J MED CHEM, V55, P4101, DOI 10.1021/jm300060k; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsieh WC, 2014, BLOOD, V124, P2847, DOI 10.1182/blood-2014-03-564609; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Jiang MY, 2016, EXP THER MED, V12, P1341, DOI 10.3892/etm.2016.3498; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Marsh RA, 2013, BLOOD, V121, P877, DOI 10.1182/blood-2012-06-432500; Marsh RA, 2010, BLOOD, V116, P1079, DOI 10.1182/blood-2010-01-256099; Marsh RA, 2009, CYTOM PART B-CLIN CY, V76B, P334, DOI 10.1002/cyto.b.20473; Mufti AR, 2006, MOL CELL, V21, P775, DOI 10.1016/j.molcel.2006.01.033; Negroni A, 2009, INFLAMM BOWEL DIS, V15, P1145, DOI 10.1002/ibd.20907; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Prakash H, 2010, J BIOL CHEM, V285, P20291, DOI 10.1074/jbc.M109.096297; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Schurmann M, 2003, EUR RESPIR J, V22, P748, DOI 10.1183/09031936.03.00040602; Schwerd T, 2017, GUT, V66, P1060, DOI 10.1136/gutjnl-2015-310382; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Speckmann C, 2013, CLIN IMMUNOL, V149, P133, DOI 10.1016/j.clim.2013.07.004; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tigno-Aranjuez JT, 2014, J BIOL CHEM, V289, P29651, DOI 10.1074/jbc.M114.591388; Tigno-Aranjuez JT, 2012, BBA-MOL CELL RES, V1823, P2022, DOI 10.1016/j.bbamcr.2012.03.017; Tsuma Y, 2015, PEDIATR TRANSPLANT, V19, pE25, DOI 10.1111/petr.12405; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yao QP, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3462; Zeissig Y, 2015, GUT, V64, P66, DOI 10.1136/gutjnl-2013-306520	68	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9666	9679		10.1074/jbc.M117.781500	http://dx.doi.org/10.1074/jbc.M117.781500			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28404814	hybrid, Green Published			2022-12-28	WOS:000403113000017
J	Mulinta, R; Yao, SYM; Ng, AML; Cass, CE; Young, JD				Mulinta, Ras; Yao, Sylvia Y. M.; Ng, Amy M. L.; Cass, Carol E.; Young, James D.			Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED GLUTAMATE RESIDUES; CRYSTAL-STRUCTURE; NUCLEOBASE TRANSPORT; MECHANISTIC INSIGHTS; MOLECULAR-CLONING; RECOMBINANT HUMAN; NA+; IDENTIFICATION; PURINE; EXPRESSION	The human SLC28 family of concentrative nucleoside transporter (CNT) proteins has three members: hCNT1, hCNT2, and hCNT3. Na+-coupled hCNT1 and hCNT2 transport pyrimidine and purine nucleosides, respectively, whereas hCNT3 transports both pyrimidine and purine nucleosides utilizing Na+ and/or H+ electrochemical gradients. Escherichia coli CNT family member NupC resembles hCNT1 in permeant selectivity but is H+-coupled. Using heterologous expression in Xenopus oocytes and the engineered cysteine-less hCNT3 protein hCNT3(C-), substituted cysteine accessibility method analysis with the membrane-impermeant thiol reactive reagent p-chloromercuribenzene sulfonate was performed on the transport domain (interfacial helix 2, hairpin 1, putative transmembrane domain (TM) 7, and TM8), as well as TM9 of the scaffold domain of the protein. This systematic scan of the entire C-terminal half of hCNT3(C-) together with parallel studies of the transport domain of wild-type hCNT1 and the corresponding TMs of cysteine-less NupC(C-) yielded results that validate the newly developed structural homology model of CNT membrane architecture for human CNTs, revealed extended conformationally mobile regions within transport-domain TMs, identified porelining residues of functional importance, and provided evidence of an emerging novel elevator-type mechanism of transporter function.	[Mulinta, Ras; Yao, Sylvia Y. M.; Ng, Amy M. L.; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Young, JD (corresponding author), Univ Alberta, Dept Physiol, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Wellcome Trust.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; CHE MX, 1995, J BIOL CHEM, V270, P13596, DOI 10.1074/jbc.270.23.13596; Coincon M, 2016, NAT STRUCT MOL BIOL, V23, P248, DOI 10.1038/nsmb.3164; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Johnson ZL, 2014, ELIFE, V3, DOI 10.7554/eLife.03604; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; McCoy JG, 2016, STRUCTURE, V24, P956, DOI 10.1016/j.str.2016.04.003; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Mulligan C, 2016, NAT STRUCT MOL BIOL, V23, P256, DOI 10.1038/nsmb.3166; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Slugoski MD, 2009, J BIOL CHEM, V284, P17266, DOI 10.1074/jbc.M109.009613; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Vergara-Jaque A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00183; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058, DOI 10.1152/ajprenal.1997.273.6.F1058; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wohlert D, 2015, ELIFE, V4, DOI 10.7554/eLife.09375; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAN RT, 1993, CELL, V75, P37, DOI 10.1016/S0092-8674(05)80082-0; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yao S. Y. M., 2000, MEMBRANE TRANSPORT P; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2011, J BIOL CHEM, V286, P32552, DOI 10.1074/jbc.M111.236117; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	58	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9505	9522		10.1074/jbc.M116.743997	http://dx.doi.org/10.1074/jbc.M116.743997			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28385889	Green Published, hybrid			2022-12-28	WOS:000403113000006
J	Li, Y; Mayer, FP; Hasenhuetl, PS; Burtscher, V; Schicker, K; Sitte, HH; Freissmuth, M; Sandtner, W				Li, Yang; Mayer, Felix P.; Hasenhuetl, Peter S.; Burtscher, Verena; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter			Occupancy of the zinc-binding site by transition metals decreases the substrate affinity of the human dopamine transporter by an allosteric mechanism (vol 292, pg 4235, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Schicker, Klaus/0000-0002-3068-7830; Freissmuth, Michael/0000-0001-9398-1765; Mayer, Felix/0000-0001-9837-8973; Burtscher, Verena/0000-0002-0464-0799	Vienna Science and Technology Fund [CS15-033]	Vienna Science and Technology Fund	Yang Li (Y. L.) received support from the Vienna Science and Technology Fund (grant CS15-033) and not Chinese Scholarship Council Grant 201308310446.	Li Y, 2017, J BIOL CHEM, V292, P4235, DOI 10.1074/jbc.M116.760140	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7161	7161		10.1074/jbc.A116.760140	http://dx.doi.org/10.1074/jbc.A116.760140			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28455408	hybrid, Green Published			2022-12-28	WOS:000400478300026
J	Zhang, CG; Liu, ZY; Bunker, E; Ramirez, A; Lee, S; Peng, YH; Tan, AC; Eckhardt, SG; Chapnick, DA; Liu, XD				Zhang, Conggang; Liu, Zeyu; Bunker, Eric; Ramirez, Adrian; Lee, Schuyler; Peng, Yinghua; Tan, Aik-Choon; Eckhardt, S. Gail; Chapnick, Douglas A.; Liu, Xuedong			Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BCL-2 FAMILY PROTEINS; HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; PARKINSONS-DISEASE; MITOPHAGY; CANCER; PINK1; DEPOLARIZATION; APOPTOSIS	Sorafenib (Nexavar) is a broad-spectrum multikinase inhibitor that proves effective in treating advanced renal-cell carcinoma and liver cancer. Despite its well-characterized mechanism of action on several established cancer-related protein kinases, sorafenib causes variable responses among human tumors, although the cause for this variation is unknown. In an unbiased screening of an oncology drug library, we found that sorafenib activates recruitment of the ubiquitin E3 ligase Parkin to damaged mitochondria. We show that sorafenib inhibits the activity of both complex II/III of the electron transport chain and ATP synthase. Dual inhibition of these complexes, but not inhibition of each individual complex, stabilizes the serine-threonine protein kinase PINK1 on the mitochondrial outer membrane and activates Parkin. Unlike the protonophore carbonyl cyanide m-chlorophenylhydrazone, which activates the mitophagy response, sorafenib treatment triggers PINK1/Parkin-dependent cellular apoptosis, which is attenuated upon Bcl-2 overexpression. In summary, our results reveal a new mechanism of action for sorafenib as a mitocan and suggest that high Parkin activity levels could make tumor cells more sensitive to sorafenib's actions, providing one possible explanation why Parkin may be a tumor suppressor gene. These insights could be useful in developing new rationally designed combination therapies with sorafenib.	[Zhang, Conggang; Liu, Zeyu; Bunker, Eric; Ramirez, Adrian; Lee, Schuyler; Peng, Yinghua; Chapnick, Douglas A.; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80309 USA; [Tan, Aik-Choon; Eckhardt, S. Gail] Univ Colorado, Dept Med, Div Med Oncol, Dev Therapeut Program, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80309 USA.	Xuedong.Liu@colorado.edu	Tan, Aik Choon/A-3135-2011; , tanglang/AAD-3372-2020	Tan, Aik Choon/0000-0003-2955-8369; Chapnick, Douglas/0000-0003-3317-5432; LIU, XUEDONG/0000-0001-7209-4964	National Institutes of Health from NCRR [S10 RR026680]; BioFrontiers Advanced Light Microscopy Core; National Institutes of Health [S10 OD021601]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113141] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021601] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; BioFrontiers Advanced Light Microscopy Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Stratford May, Jie Shen, Stefan Constantinescu, Schuyler Van Engelenburg, Jennifer Lippincott-Schwartz, and Sabrina Spencer for providing critical reagents. We thank Drs. Natalie Ahn, Amy Palmer, and Douglas Chapnick for discussion. We thank Graycen Wheeler for critical reading of the manuscript. We thank Steve Wiltgen and Vipat Raksakulthai of Molecular Devices for their help with development of MetaXpress journals for automated imaging analysis. The ImageXpress MicroXL was supported by National Institutes of Health Grant S10 RR026680 from NCRR. We thank Joseph Dragavon and BioFrontiers Advanced Light Microscopy Core for their support. The FACSAria cell sorter was supported by National Institutes of Health Grant S10 OD021601.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bartolom? F., 2015, PROBING MITOCHONDRIA, P263; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bull VH, 2012, J PROTEOME RES, V11, P1609, DOI 10.1021/pr200790e; Cabanillas ME, 2010, J CLIN ENDOCR METAB, V95, P2588, DOI 10.1210/jc.2009-1923; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mehdi SJ, 2011, MED ONCOL, V28, P1520, DOI 10.1007/s12032-010-9633-x; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Prieto-Dominguez N, 2016, J PINEAL RES, V61, P396, DOI 10.1111/jpi.12358; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014	32	47	48	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15105	15120		10.1074/jbc.M117.783175	http://dx.doi.org/10.1074/jbc.M117.783175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28673964	hybrid, Green Published			2022-12-28	WOS:000409902100032
J	Goh, BC; Singhal, V; Herrera, AJ; Tomlinson, RE; Kim, S; Faugere, MC; Germain-Lee, EL; Clemens, TL; Lee, SJ; DiGirolamo, DJ				Goh, Brian C.; Singhal, Vandana; Herrera, Angelica J.; Tomlinson, Ryan E.; Kim, Soohyun; Faugere, Marie-Claude; Germain-Lee, Emily L.; Clemens, Thomas L.; Lee, Se-Jin; DiGirolamo, Douglas J.			Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSTATIN-DEFICIENT MICE; SKELETAL-MUSCLE MASS; TGF-BETA SUPERFAMILY; MINERAL DENSITY; MYOBLAST PROLIFERATION; MATRIX MINERALIZATION; POSTMENOPAUSAL WOMEN; ENRICHED CULTURES; SATELLITE CELLS; MYOGENIN GENE	Bone and skeletal muscle mass are highly correlated in mammals, suggesting the existence of common anabolic signaling networks that coordinate the development of these two anatomically adjacent tissues. The activin signaling pathway is an attractive candidate to fulfill such a role. Here, we generated mice with conditional deletion of activin receptor (ACVR) type 2A, ACVR2B, or both, in osteoblasts, to determine the contribution of activin receptor signaling in regulating bone mass. Immunohistochemistry localized ACVR2A and ACVR2B to osteoblasts and osteocytes. Primary osteoblasts expressed activin signaling components, including ACVR2A, ACVR2B, and ACVR1B (ALK4) and demonstrated increased levels of phosphorylated Smad2/3 upon exposure to activin ligands. Osteoblasts lacking ACVR2B did not show significant changes in vitro. However, osteoblasts deficient in ACVR2A exhibited enhanced differentiation indicated by alkaline phosphatase activity, mineral deposition, and transcriptional expression of osterix, osteocalcin, and dentin matrix acidic phosphoprotein 1. To investigate activin signaling in osteoblasts in vivo, we analyzed the skeletal phenotypes of mice lacking these receptors in osteoblasts and osteocytes (osteocalcin-Cre). Similar to the lack of effect in vitro, ACVR2B-deficient mice demonstrated no significant change in any bone parameter. By contrast, mice lacking ACVR2A had significantly increased femoral trabecular bone volume at 6 weeks of age. Moreover, mutant mice lacking both ACVR2A and ACVR2B demonstrated sustained increases in trabecular bone volume, similar to those in ACVR2A single mutants, at 6 and 12 weeks of age. Taken together, these results indicate that activin receptor signaling, predominantly through ACVR2A, directly and negatively regulates bone mass in osteoblasts.	[Goh, Brian C.; Singhal, Vandana; Herrera, Angelica J.; Tomlinson, Ryan E.; Kim, Soohyun; Clemens, Thomas L.; DiGirolamo, Douglas J.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21287 USA; [Lee, Se-Jin] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21287 USA; [Faugere, Marie-Claude] Univ Kentucky, Albert B Chandler Med Ctr, Lexington, KY 40536 USA; [Germain-Lee, Emily L.] Univ Connecticut, Sch Med, UConn Hlth, Dept Pediat, Farmington, CT 06030 USA; [Germain-Lee, Emily L.] Connecticut Childrens Med Ctr, Div Pediat Endocrinol, Hartford, CT 06106 USA; [Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; University of Kentucky; University of Connecticut; Connecticut Children's Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	DiGirolamo, DJ (corresponding author), 601 N Caroline St,JHOC 5252, Baltimore, MD 21287 USA.	ddigiro2@jhmi.edu	Tomlinson, Ryan/AAN-7597-2021; Goh, Brian/AAM-2690-2020	Tomlinson, Ryan/0000-0002-6713-6047; Germain-Lee, Emily/0000-0002-5727-610X; Herrera, Angelica/0000-0003-2310-5908; Goh, Brian/0000-0001-7224-2613	NIAMS National Institutes of Health [R01AR062074, R01AR060636]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062074, R01AR060636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NIAMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIAMS National Institutes of Health Grants R01AR062074 (to D.J.D.) and R01AR060636 (to S.-J.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN RE, 1990, P SOC EXP BIOL MED, V194, P81; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Aykul S, 2016, J BIOL CHEM, V291, P10792, DOI 10.1074/jbc.M115.713487; Aykul S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114954; Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; Blain H, 2010, EXP GERONTOL, V45, P679, DOI 10.1016/j.exger.2010.04.006; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; CENTRELLA M, 1991, MOL CELL BIOL, V11, P250, DOI 10.1128/MCB.11.1.250; CENTRELLA M, 1991, MOL CELL BIOL, V11, P4490, DOI 10.1128/MCB.11.9.4490; DiGirolamo DJ, 2013, J BONE MINER RES, V28, P1509, DOI 10.1002/jbmr.1969; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Fajardo RJ, 2010, BONE, V46, P64, DOI 10.1016/j.bone.2009.09.018; Formica CA, 1997, CALCIFIED TISSUE INT, V61, P129; Hamrick MW, 2000, BONE, V27, P343, DOI 10.1016/S8756-3282(00)00339-2; Hamrick MW, 2003, J ORTHOP RES, V21, P1025, DOI 10.1016/S0736-0266(03)00105-0; Hamrick MW, 2002, CALCIFIED TISSUE INT, V71, P63, DOI 10.1007/s00223-001-1109-8; Hamrick MW, 2003, ANAT REC PART A, V272A, P388, DOI 10.1002/ar.a.10044; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kablar B, 1998, BIOCHEM CELL BIOL, V76, P1079, DOI 10.1139/bcb-76-6-1079; Khatri Ismail A, 2008, J Clin Neuromuscul Dis, V10, P11, DOI 10.1097/CND.0b013e318183e0fa; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; KRUMMEN LA, 1993, ENDOCRINOLOGY, V132, P431, DOI 10.1210/en.132.1.431; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Licona P, 2006, DEV DYNAM, V235, P1124, DOI 10.1002/dvdy.20707; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Lowery JW, 2015, J CELL SCI, V128, P1308, DOI 10.1242/jcs.156737; Marin RV, 2010, J CLIN DENSITOM, V13, P96, DOI 10.1016/j.jocd.2009.12.001; MAYO KE, 1994, TRENDS ENDOCRIN MET, V5, P407, DOI 10.1016/1043-2760(95)92523-L; MCCARTHY SA, 1993, J BIOL CHEM, V268, P23066; McCullagh DR, 1932, SCIENCE, V76, P19, DOI 10.1126/science.76.1957.19; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Montgomery E, 2005, ANAT REC PART A, V286A, P814, DOI 10.1002/ar.a.20224; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; OUE Y, 1994, BONE, V15, P361, DOI 10.1016/8756-3282(94)90301-8; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Rantalainen T, 2008, EUR J APPL PHYSIOL, V102, P215, DOI 10.1007/s00421-007-0575-8; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Sakai R, 1999, BONE, V25, P191, DOI 10.1016/S8756-3282(99)00152-0; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schriefer JL, 2005, J BIOMECH, V38, P467, DOI 10.1016/j.jbiomech.2004.04.020; Singhal V., 2011, J BONE MINER RES, V26; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; VALE W, 1988, RECENT PROG HORM RES, V44, P1; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vale W., 1990, INHIBIN ACTIVIN FAMI; van den Berg LEM, 2010, BONE, V47, P643, DOI 10.1016/j.bone.2010.06.021; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	61	35	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13809	13822		10.1074/jbc.M117.782128	http://dx.doi.org/10.1074/jbc.M117.782128			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28659341	Green Published, hybrid			2022-12-28	WOS:000407942400007
J	Manteca, A; Alonso-Caballero, A; Fertin, M; Poly, S; De Sancho, D; Perez-Jimenez, R				Manteca, Aitor; Alonso-Caballero, Alvaro; Fertin, Marie; Poly, Simon; De Sancho, David; Perez-Jimenez, Raul			The influence of disulfide bonds on the mechanical stability of proteins is context dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; DYNAMICS; KINETICS; DOMAIN; FOLD	Disulfide bonds play a crucial role in proteins, modulating their stability and constraining their conformational dynamics. A particularly important case is that of proteins that need to withstand forces arising from their normal biological function and that are often disulfide bonded. However, the influence of disulfides on the overall mechanical stability of proteins is poorly understood. Here, we used single-molecule force spectroscopy (smFS) to study the role of disulfide bonds in different mechanical proteins in terms of their unfolding forces. For this purpose, we chose the pilus protein FimG from Gram-negative bacteria and a disulfide-bonded variant of the I91 human cardiac titin polyprotein. Our results show that disulfide bonds can alter the mechanical stability of proteins in different ways depending on the properties of the system. Specifically, disulfide- bonded FimG undergoes a 30% increase in its mechanical stability compared with its reduced counterpart, whereas the unfolding force of I91 domains experiences a decrease of 15% relative to the WT form. Using a coarse-grained simulation model, we rationalized that the increase in mechanical stability of FimG is due to a shift in the mechanical unfolding pathway. The simple topology-based explanation suggests a neutral effect in the case of titin. In summary, our results indicate that disulfide bonds in proteins act in a context-dependent manner rather than simply as mechanical lockers, underscoring the importance of considering disulfide bonds both computationally and experimentally when studying the mechanical properties of proteins.	[Manteca, Aitor; Alonso-Caballero, Alvaro; Fertin, Marie; De Sancho, David; Perez-Jimenez, Raul] CIC NanoGUNE, Nanobiomech Lab, Donostia San Sebastian 20018, Spain; [Poly, Simon] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [De Sancho, David; Perez-Jimenez, Raul] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Eberhard Karls University of Tubingen; Basque Foundation for Science	De Sancho, D; Perez-Jimenez, R (corresponding author), CIC NanoGUNE, Nanobiomech Lab, Donostia San Sebastian 20018, Spain.; De Sancho, D; Perez-Jimenez, R (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.	d.desancho@nanogune.eu; r.perezjimenez@nanogune.eu	Alonso-Caballero, Alvaro/AAX-4317-2020; de Sancho, David/C-4995-2009; Perez-Jimenez, Raul/C-3085-2017	Alonso-Caballero, Alvaro/0000-0003-0284-2562; de Sancho, David/0000-0002-8985-2685; Perez-Jimenez, Raul/0000-0001-7094-6799; FERTIN, Marie J/0000-0002-2245-1617; Manteca, Aitor/0000-0002-8650-0465	Ministry of Economy and Competitiveness (MINECO) [BIO2016-77390-R, BFU2015-71964, CTQ2015-65320-R]; European Commission grant CIG Marie Curie Reintegration program FP7-PEOPLE; predoctoral program of the Basque Government; CIC nanoGUNE; Ikerbasque Foundation for Science	Ministry of Economy and Competitiveness (MINECO); European Commission grant CIG Marie Curie Reintegration program FP7-PEOPLE; predoctoral program of the Basque Government; CIC nanoGUNE; Ikerbasque Foundation for Science	This work was supported in part by Ministry of Economy and Competitiveness (MINECO) Grant BIO2016-77390-R, BFU2015-71964 (to R.P.-J.), and CTQ2015-65320-R (to D.D.), and European Commission grant CIG Marie Curie Reintegration program FP7-PEOPLE-2014 (to R.P.-J.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the predoctoral program of the Basque Government.; Supported by CIC nanoGUNE and Ikerbasque Foundation for Science.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P436, DOI 10.1021/ja077851s; Allen WJ, 2013, J MOL BIOL, V425, P958, DOI 10.1016/j.jmb.2012.12.024; Anjukandi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108812; Baldus IB, 2012, BIOPHYS J, V102, P622, DOI 10.1016/j.bpj.2011.12.039; Beeser SA, 1998, J MOL BIOL, V284, P1581, DOI 10.1006/jmbi.1998.2240; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Best RB, 2008, J PHYS CHEM B, V112, P5968, DOI 10.1021/jp075955j; Best RB, 2008, J AM CHEM SOC, V130, P3706, DOI 10.1021/ja0762691; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; de Sancho D, 2016, J PHYS CHEM LETT, V7, P3798, DOI 10.1021/acs.jpclett.6b01722; DOIG AJ, 1991, J MOL BIOL, V217, P389, DOI 10.1016/0022-2836(91)90551-G; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5; Garcia-Manyes S, 2011, J AM CHEM SOC, V133, P3104, DOI 10.1021/ja109865z; Graham TGW, 2011, J PHYS CHEM B, V115, P1546, DOI 10.1021/jp110738m; Grutzner A, 2009, BIOPHYS J, V97, P825, DOI 10.1016/j.bpj.2009.05.037; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P19309, DOI 10.1073/pnas.0709760104; Jobst MA, 2015, ELIFE, V4, DOI 10.7554/eLife.10319; Kahn TB, 2015, J BIOL CHEM, V290, P14518, DOI 10.1074/jbc.M115.646000; Karanicolas J, 2002, PROTEIN SCI, V11, P2351, DOI 10.1110/ps.0205402; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LI YB, 2016, SCI REP UK, V6; Liang J, 2011, J AM CHEM SOC, V133, P3528, DOI 10.1021/ja109684q; Perez-Jimenez R, 2014, ACS NANO, V8, P10313, DOI 10.1021/nn503557w; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Santiveri CM, 2008, CHEM-EUR J, V14, P488, DOI 10.1002/chem.200700845; Sharma D, 2007, P NATL ACAD SCI USA, V104, P9278, DOI 10.1073/pnas.0700351104; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Zhou BF, 2014, BIOPHYS J, V107, P672, DOI 10.1016/j.bpj.2014.06.025	45	23	23	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13374	13380		10.1074/jbc.M117.784934	http://dx.doi.org/10.1074/jbc.M117.784934			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28642368	hybrid, Green Published			2022-12-28	WOS:000407465300023
J	Pradhan, S; Khatlani, T; Nairn, AC; Vijayan, KV				Pradhan, Subhashree; Khatlani, Tanvir; Nairn, Angus C.; Vijayan, K. Vinod			The heterotrimeric G protein G beta(1) interacts with the catalytic subunit of protein phosphatase 1 and modulates G protein-coupled receptor signaling in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ACTIVATION; PHOSPHORYLATION; INTEGRIN; DEPHOSPHORYLATION; G-ALPHA(12); INHIBITION; PI3K-GAMMA; DEFECTS; 1-BETA	Thrombosis is caused by the activation of platelets at the site of ruptured atherosclerotic plaques. This activation involves engagement of G protein-coupled receptors (GPCR) on platelets that promote their aggregation. Although it is known that protein kinases and phosphatases modulate GPCR signaling, how serine/threonine phosphatases integrate with G protein signaling pathways is less understood. Because the subcellular localization and substrate specificity of the catalytic subunit of protein phosphatase 1 (PP1c) is dictated by PP1c-interacting proteins, here we sought to identify new PP1c interactors. GPCRs signal via the canonical heterotrimeric G alpha and G beta gamma subunits. Using a yeast two-hybrid screen, we discovered an interaction between PP1c alpha and the heterotrimeric G protein G beta(1) subunit. Co-immunoprecipitation studies with epitope-tagged PP1c and G beta(1) revealed that G beta(1) interacts with the PP1c alpha, beta, and gamma 1 isoforms. Purified PP1c bound to recombinant G beta(1)-GST protein, and PP1c co-immunoprecipitated with G beta(1) in unstimulated platelets. Thrombin stimulation of platelets induced the dissociation of the PP1c-G beta(1) complex, which correlated with an association of PP1c with phospholipase C beta(3) (PLC beta 3), along with a concomitant dephosphorylation of the inhibitory Ser(1105) residue in PLC beta 3. siRNA-mediated depletion of GNB1 (encoding G beta(1)) in murine megakaryocytes reduced protease-activated receptor 4, activating peptide-induced soluble fibrinogen binding. Thrombin-induced aggregation was decreased in PP1c alpha(-/-) murine platelets and in human platelets treated with a small-molecule inhibitor of G beta gamma. Finally, disruption of PP1c-G beta(1) complexes with myristoylated G beta(1) peptides containing the PP1c binding site moderately decreased throm-bin-induced human platelet aggregation. These findings suggest that G beta(1) protein enlists PP1c to modulate GPCR signaling in platelets.	[Pradhan, Subhashree; Khatlani, Tanvir; Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Vijayan, K. Vinod] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Vijayan, K. Vinod] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Pradhan, Subhashree; Khatlani, Tanvir] MEDVAMC, CTRID, Houston, TX 77030 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Khatlani, Tanvir] KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh 11426, Saudi Arabia	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Yale University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs	Vijayan, KV (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.; Vijayan, KV (corresponding author), MEDVAMC, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.	vvijayan@bcm.edu		Nairn, Angus/0000-0002-7075-0195	National Institutes of Health [HL081613, GM112806]; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL081613 and GM112806. K. V. V. is supported by the Mary R. Gibson Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or the National Institutes of Health.	Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chatterjee J, 2012, ANGEW CHEM INT EDIT, V51, P10054, DOI 10.1002/anie.201204308; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cohen PTW, 2002, J CELL SCI, V115, P241; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Estevez B, 2015, ARTERIOSCL THROM VAS, V35, P24, DOI 10.1161/ATVBAHA.114.303411; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gehret AU, 2013, ACS CHEM BIOL, V8, P588, DOI 10.1021/cb3004513; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Gushiken FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008304; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Lee SB, 1996, BLOOD, V88, P1684; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Liu RJ, 2015, J MOL CELL CARDIOL, V87, P204, DOI 10.1016/j.yjmcc.2015.08.018; Ma PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119496; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Poll F, 2011, J BIOL CHEM, V286, P32931, DOI 10.1074/jbc.M111.224899; RAO AK, 1989, BLOOD, V74, P664; Shankar H, 2006, CURR DRUG TARGETS, V7, P1253, DOI 10.2174/138945006778559166; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stalker TJ, 2014, CURR OPIN HEMATOL, V21, P410, DOI 10.1097/MOH.0000000000000070; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang X, 1996, BLOOD, V88, P1676; You DJ, 2010, MOL CELLS, V30, P527, DOI 10.1007/s10059-010-0155-3; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Yue CP, 2000, J BIOL CHEM, V275, P30220, DOI 10.1074/jbc.M004276200; Yue CP, 1998, J BIOL CHEM, V273, P18023, DOI 10.1074/jbc.273.29.18023; Zhu DG, 2004, J BIOL CHEM, V279, P54983, DOI 10.1074/jbc.C400508200	35	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13133	13142		10.1074/jbc.M117.796656	http://dx.doi.org/10.1074/jbc.M117.796656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28615442	Green Published, hybrid			2022-12-28	WOS:000407465300005
J	Mowrey, DD; Xu, L; Mei, YW; Pasek, DA; Meissner, G; Dokholyan, NV				Mowrey, David D.; Xu, Le; Mei, Yingwu; Pasek, Daniel A.; Meissner, Gerhard; Dokholyan, Nikolay V.			Ion-pulling simulations provide insights into the mechanisms of channel opening of the skeletal muscle ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium transport; conformational change; molecular dynamics; molecular modeling; ryanodine receptor	CALCIUM-RELEASE CHANNEL; STEERED MOLECULAR-DYNAMICS; AMINO-ACID-RESIDUES; SARCOPLASMIC-RETICULUM; CA2+ RELEASE; INOSITOL 1,4,5-TRISPHOSPHATE; ELECTROSTATICS CALCULATIONS; ENDOPLASMIC-RETICULUM; POTASSIUM CHANNEL; PROTEIN STABILITY	The type 1 ryanodine receptor (RyR1) mediates Ca2+ release from the sarcoplasmic reticulum to initiate skeletal muscle contraction and is associated with muscle diseases, malignant hyperthermia, and central core disease. To better understand RyR1 channel function, we investigated the molecular mechanisms of channel gating and ion permeation. An adequate model of channel gating requires accurate, high-resolution models of both open and closed states of the channel. To this end, we generated an open-channel RyR1 model using molecular simulations to pull Ca2+ through the pore constriction site of a closed-channel RyR1 structure determined at 3.8-angstrom resolution. Importantly, we find that our open-channel model is consistent with the RyR1 and cardiac RyR (RyR2) open-channel structures reported while this paper was in preparation. Both our model and the published structures show similar rotation of the upper portion of the pore-lining S6 helix away from the 4-fold channel axis and twisting of Ile-4937 at the channel constriction site out of the channel pore. These motions result in a minimum open-channel pore radius of approximate to 3 angstrom formed by Gln-4933, rather than Ile-4937 in the closed-channel structure. We also present functional support for our model by mutations around the closed- and open-channel constriction sites (Gln-4933 and Ile-4937). Our results indicate that use of ion-pulling simulations produces a RyR1 open-channel model, which can provide insights into the mechanisms of channel opening complementing those from the structural data.	[Mowrey, David D.; Xu, Le; Mei, Yingwu; Pasek, Daniel A.; Meissner, Gerhard; Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Mei, Yingwu] Zhengzhou Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Zhengzhou 450001, Henan, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Zhengzhou University	Meissner, G; Dokholyan, NV (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu; dokh@unc.edu	Xu, Le/HDN-9623-2022; Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [AR018687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR018687. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Euden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066542; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marcoline FV, 2015, STRUCTURE, V23, P1526, DOI 10.1016/j.str.2015.05.014; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mei YW, 2015, J BIOL CHEM, V290, P17535, DOI 10.1074/jbc.M115.659672; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Monticelli L, 2004, FEBS LETT, V564, P325, DOI 10.1016/S0014-5793(04)00271-6; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; RADERMACHER M, 1992, BIOPHYS J, V61, P936, DOI 10.1016/S0006-3495(92)81900-8; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Seo MD, 2015, BBA-MOL CELL RES, V1853, P1980, DOI 10.1016/j.bbamcr.2014.11.023; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; Sutko JL, 1997, PHARMACOL REV, V49, P53; Swanson JMJ, 2007, J CHEM THEORY COMPUT, V3, P170, DOI 10.1021/ct600216k; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	54	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12947	12958		10.1074/jbc.M116.760199	http://dx.doi.org/10.1074/jbc.M116.760199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28584051	hybrid, Green Published			2022-12-28	WOS:000407220100023
J	Orth, C; Niemann, N; Hennig, L; Essen, LO; Batschauer, A				Orth, Christian; Niemann, Nils; Hennig, Lars; Essen, Lars-Oliver; Batschauer, Alfred			Hyperactivity of the Arabidopsis cryptochrome (cry1) L407F mutant is caused by a structural alteration close to the cry1 ATP-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; cryptochrome; nucleotide; photobiology; plant biochemistry; nucleotide binding	BLUE-LIGHT PHOTORECEPTORS; ELECTRON-TRANSFER; SIGNALING STATE; DNA PHOTOLYASE; DOMAIN; PROTEIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; RECOGNITION; MECHANISMS	Plant cryptochromes (cry) act as UV-A/blue light receptors. The prototype, Arabidopsis thaliana cry1, regulates several light responses during the life cycle, including de-etiolation, and is also involved in regulating flowering time. The cry1 photocycle is initiated by light absorption by its FAD chromophore, which is most likely fully oxidized (FAD(ox)) in the dark state and photoreduced to the neutral flavin semiquinone (FADH degrees) in its lit state. Cryptochromes lack the DNA-repair activity of the closely related DNA photolyases, but they retain the ability to bind nucleotides such as ATP. The previously characterized L407F mutant allele of Arabidopsis cry1 is biologically hyperactive and seems to mimic the ATP-bound state of cry1, but the reason for this phenotypic change is unclear. Here, we show that cry1L407F can still bind ATP, has less pronounced photoreduction and formation of FADH degrees than wild-type cry1, and has a dark reversion rate 1.7 times lower than that of the wild type. The hyperactivity of cry1L407F is not related to a higher FADH degrees occupancy of the photoreceptor but is caused by a structural alteration close to the ATP-binding site. Moreover, we show that ATP binds to cry1 in both the dark and the lit states. This binding was not affected by cry1's C-terminal extension, which is important for signal transduction. Finally, we show that a recently discovered chemical inhibitor of cry1, 3-bromo-7-nitroindazole, competes for ATP binding and thereby diminishes FADH degrees formation, which demonstrates that both processes are important for cry1 function.	[Orth, Christian; Niemann, Nils; Batschauer, Alfred] Philipps Univ, Fac Biol, Dept Plant Physiol & Photobiol, D-35032 Marburg, Germany; [Essen, Lars-Oliver] Philipps Univ, Fac Chem, Dept Biochem, D-35032 Marburg, Germany; [Hennig, Lars] Swedish Univ Agr Sci, Dept Plant Biol, SE-75007 Uppsala, Sweden; [Hennig, Lars] Linnean Ctr Plant Biol, SE-75007 Uppsala, Sweden	Philipps University Marburg; Philipps University Marburg; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Batschauer, A (corresponding author), Philipps Univ, Fac Biol, Dept Plant Physiol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	batschau@staff.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016; Hennig, Lars/G-2081-2011	Essen, Lars-Oliver/0000-0003-4272-4026; Hennig, Lars/0000-0002-6645-1862	Deutsche Forschungsgemeinschaft (DFG) within Priority Program "Flowering time control: from natural variation to crop improvement" [BA985/14-1]; Deutsche Forschungsgemeinschaft (DFG) within Collaborative Research Center 987	Deutsche Forschungsgemeinschaft (DFG) within Priority Program "Flowering time control: from natural variation to crop improvement"(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) within Collaborative Research Center 987(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant BA985/14-1 (to A. B.) within Priority Program "Flowering time control: from natural variation to crop improvement," and grants within Collaborative Research Center 987 (to A. B. and L.-O. E.). The authors declare that they have no conflicts of interest with the contents of this article.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; BLATT MR, 1987, J MEMBRANE BIOL, V98, P257, DOI 10.1007/BF01871188; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Bouly JP, 2003, EUR J BIOCHEM, V270, P2921, DOI 10.1046/j.1432-1033.2003.03691.x; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; Cailliez F, 2014, J AM CHEM SOC, V136, P12974, DOI 10.1021/ja506084f; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; El-Esawi M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1063758; Engelhard C, 2014, PLANT CELL, V26, P4519, DOI 10.1105/tpc.114.129809; Exner V, 2010, PLANT PHYSIOL, V154, P1633, DOI 10.1104/pp.110.160895; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Gao J, 2015, P NATL ACAD SCI USA, V112, P9135, DOI 10.1073/pnas.1504404112; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; He SB, 2015, MOL PLANT, V8, P822, DOI 10.1016/j.molp.2015.02.008; Hense A, 2015, J BIOL CHEM, V290, P1743, DOI 10.1074/jbc.M114.606327; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Kondoh M, 2011, J MOL BIOL, V413, P128, DOI 10.1016/j.jmb.2011.08.031; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; Liu BB, 2016, J PLANT RES, V129, P137, DOI 10.1007/s10265-015-0782-z; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mei QM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135940; Moore PK, 1996, METHOD ENZYMOL, V268, P393; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Muller P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05175; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Nsa IY, 2015, GENETICS, V199, P233, DOI 10.1534/genetics.114.169441; Olmedo M, 2010, FUNGAL GENET BIOL, V47, P352, DOI 10.1016/j.fgb.2009.11.004; Ong WD, 2017, PLANT CELL PHYSIOL, V58, P95, DOI 10.1093/pcp/pcw181; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Perrotta G, 2001, PLANT CELL ENVIRON, V24, P991, DOI 10.1046/j.0016-8025.2001.00736.x; Pokorny R, 2005, ACTA CRYSTALLOGR F, V61, P935, DOI 10.1107/S1744309105028897; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Procopio M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00888; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shalitin D, 2003, PLANT CELL, V15, P2421, DOI 10.1105/tpc.013011; Shalitin D, 2002, NATURE, V417, P763, DOI 10.1038/nature00815; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tan ST, 2013, PLANT CELL, V25, P2618, DOI 10.1105/tpc.113.114322; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; Veluchamy S, 2008, FUNGAL GENET BIOL, V45, P1265, DOI 10.1016/j.fgb.2008.06.004; Wang Q, 2015, MOL PLANT, V8, P631, DOI 10.1016/j.molp.2015.03.005; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 2017, PHOTOCHEM PHOTOBIOL, V93, P112, DOI 10.1111/php.12663; Zhang M, 2016, SCIENCE, V354, P209, DOI 10.1126/science.aah6071	62	4	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12906	12920		10.1074/jbc.M117.788869	http://dx.doi.org/10.1074/jbc.M117.788869			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28634231	hybrid, Green Published			2022-12-28	WOS:000407220100020
J	Gu, X; Yan, Y; Novick, SJ; Kovach, A; Goswami, D; Ke, JY; Tan, MHE; Wang, LL; Li, XD; de Waal, PW; Webb, MR; Griffin, PR; Xu, HE; Melcher, K				Gu, Xin; Yan, Yan; Novick, Scott J.; Kovach, Amanda; Goswami, Devrishi; Ke, Jiyuan; Tan, M. H. Eileen; Wang, Lili; Li, Xiaodan; de Waal, Parker W.; Webb, Martin R.; Griffin, Patrick R.; Xu, H. Eric; Melcher, Karsten			Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; AMP-activated kinase (AMPK); ATP; energy metabolism; protein kinase; CBS; HDX-MS; NADPH	PARKINSON-WHITE-SYNDROME; GAMMA-SUBUNIT ISOFORMS; ACETYL-COA CARBOXYLASE; STRUCTURAL BASIS; METABOLIC DISEASES; EXERCISE MIMETICS; GLYCOGEN-STORAGE; R225W MUTATION; ENERGY-CHARGE; LIFE-SPAN	AMP-activated protein kinase (AMPK) is a central cellular energy sensor that adapts metabolism and growth to the energy state of the cell. AMPK senses the ratio of adenine nucleotides (adenylate energy charge) by competitive binding of AMP, ADP, and ATP to three sites (CBS1, CBS3, and CBS4) in its -subunit. Because these three binding sites are functionally interconnected, it remains unclear how nucleotides bind to individual sites, which nucleotides occupy each site under physiological conditions, and how binding to one site affects binding to the other sites. Here, we comprehensively analyze nucleotide binding to wild-type and mutant AMPK protein complexes by quantitative competition assays and by hydrogen-deuterium exchange MS. We also demonstrate that NADPH, in addition to the known AMPK ligand NADH, directly and competitively binds AMPK at the AMP-sensing CBS3 site. Our findings reveal how AMP binding to one site affects the conformation and adenine nucleotide binding at the other two sites and establish CBS3, and not CBS1, as the high affinity exchangeable AMP/ADP/ATP-binding site. We further show that AMP binding at CBS4 increases AMP binding at CBS3 by 2 orders of magnitude and reverses the AMP/ATP preference of CBS3. Together, these results illustrate how the three CBS sites collaborate to enable highly sensitive detection of cellular energy states to maintain the tight ATP homeostastis required for cellular metabolism.	[Gu, Xin; Yan, Yan; Kovach, Amanda; Ke, Jiyuan; Tan, M. H. Eileen; Wang, Lili; Li, Xiaodan; de Waal, Parker W.; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Labs Struct Sci & Struct Biol & Biochem, 333 Bostwick Ave Northeast, Grand Rapids, MI 49503 USA; [Yan, Yan; Xu, H. Eric] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Novick, Scott J.; Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Translat Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Tan, M. H. Eileen; Webb, Martin R.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England	Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Scripps Research Institute; Francis Crick Institute	Melcher, K (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Labs Struct Sci & Struct Biol & Biochem, 333 Bostwick Ave Northeast, Grand Rapids, MI 49503 USA.	karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; de Waal, Parker/M-1138-2017	Melcher, Karsten/0000-0002-9125-4027; de Waal, Parker/0000-0001-6922-9768; Webb, Martin/0000-0002-0134-9621; Xu, H. Eric/0000-0002-6829-8144	Francis Crick Institute; Cancer Research UK [FC001211]; United Kingdom Medical Research Council [FC001211]; Wellcome Trust [FC001211]; Van Andel Research Institute; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; National Science Foundation [91217311]; National Institute of Health [DK071662, GM102545, GM104212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104212, R01GM102545] Funding Source: NIH RePORTER; The Francis Crick Institute [10211] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Van Andel Research Institute; Ministry of Science and Technology (China)(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); The Francis Crick Institute	This work was supported by the Francis Crick Institute with funding from Cancer Research UK Grant FC001211, United Kingdom Medical Research Council Grant FC001211, Wellcome Trust Grant FC001211 (to M.R.W.), grants from the Van Andel Research Institute (to H.E.X. and K.M.), Ministry of Science and Technology (China) Grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001, National Science Foundation Grant 91217311 (to H.E.X.), and National Institute of Health Grants DK071662 (to H.E.X.) and GM102545 and GM104212 (to K.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bullon P, 2016, EXPERIENTIA SUPPL, V107, P129, DOI 10.1007/978-3-319-43589-3_6; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen L, 2013, NATURE, V498, pE8, DOI 10.1038/nature12189; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Cheng J, 2016, BBA-REV CANCER, V1866, P232, DOI 10.1016/j.bbcan.2016.09.006; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Crawford SA, 2010, DIABETOLOGIA, V53, P1986, DOI 10.1007/s00125-010-1788-7; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Daskalopoulos EP, 2016, EXPERIENTIA SUPPL, V107, P179, DOI 10.1007/978-3-319-43589-3_8; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DiCarlo SE, 2001, ADV PHYSIOL EDUC, V25, P71; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Granlund A, 2010, EXP PHYSIOL, V95, P541, DOI 10.1113/expphysiol.2009.051326; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hinson JT, 2016, CELL REP, V17, P3292, DOI 10.1016/j.celrep.2016.11.066; Kim M, 2014, CIRC RES, V114, P966, DOI 10.1161/CIRCRESAHA.114.302364; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Wall CE, 2016, J MOL ENDOCRINOL, V57, pR49, DOI 10.1530/JME-16-0073; Wang ZY, 2016, EXPERIENTIA SUPPL, V107, P203, DOI 10.1007/978-3-319-43589-3_9; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; Weikel KA, 2016, METABOLISM, V65, P634, DOI 10.1016/j.metabol.2016.01.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yang XD, 2016, J BIOL CHEM, V291, P23428, DOI 10.1074/jbc.M116.738591; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005	49	31	34	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12653	12666		10.1074/jbc.M117.793018	http://dx.doi.org/10.1074/jbc.M117.793018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615457	Green Published, hybrid			2022-12-28	WOS:000406636900029
J	Li, X; Anderson, M; Collin, D; Muegge, I; Wan, J; Brennan, D; Kugler, S; Terenzio, D; Kennedy, C; Lin, SQ; Labadia, ME; Cook, B; Hughes, R; Farrow, NA				Li, Xiang; Anderson, Marie; Collin, Delphine; Muegge, Ingo; Wan, John; Brennan, Debra; Kugler, Stanley; Terenzio, Donna; Kennedy, Charles; Lin, Siqi; Labadia, Mark E.; Cook, Brian; Hughes, Robert; Farrow, Neil A.			Structural studies unravel the active conformation of apo ROR gamma t nuclear receptor and a common inverse agonism of two diverse classes of ROR gamma t inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; drug discovery; nuclear magnetic resonance (NMR); nuclear receptor; protein drug interaction; x-ray crystallography; retinoid acid receptor-related orphan receptor t (RORt)	GENOME-WIDE ASSOCIATION; PROTEIN; DIFFERENTIATION; DISCOVERY; LIGAND; IL-17; IDENTIFICATION; BINDING; CELLS; SUSCEPTIBILITY	The nuclear receptor retinoid acid receptor-related orphan receptor gamma t (ROR gamma t) is a master regulator of the Th17/IL-17 pathway that plays crucial roles in the pathogenesis of autoimmunity. ROR gamma t has recently emerged as a highly promising target for treatment of a number of autoimmune diseases. Through high-throughput screening, we previously identified several classes of inverse agonists for ROR gamma t. Here, we report the crystal structures for the ligand-binding domain of ROR gamma t in both apo and ligand-bound states. We show that apo ROR gamma t adopts an active conformation capable of recruiting coactivator peptides and present a detailed analysis of the structural determinants that stabilize helix 12 (H12) of ROR gamma t in the active state in the absence of a ligand. The structures of ligand-bound ROR gamma t reveal that binding of the inverse agonists disrupts critical interactions that stabilize H12. This destabilizing effect is supported by ab initio calculations and experimentally by a normalized crystallographic B-factor analysis. Of note, the H12 destabilization in the active state shifts the conformational equilibrium of ROR gamma t toward an inactive state, which underlies the molecular mechanism of action for the inverse agonists reported here. Our findings highlight that nuclear receptor structure and function are dictated by a dynamic conformational equilibrium and that subtle changes in ligand structures can shift this equilibrium in opposite directions, leading to a functional switch from agonists to inverse agonists.	[Li, Xiang; Anderson, Marie; Collin, Delphine; Muegge, Ingo; Wan, John; Brennan, Debra; Kugler, Stanley; Terenzio, Donna; Kennedy, Charles; Lin, Siqi; Cook, Brian; Hughes, Robert; Farrow, Neil A.] Boehringer Ingelheim Pharmaceut Inc, Dept Small Mol Discovery Res, 900 Ridgebury Rd,POB 368, Ridgefield, CT 06877 USA; [Labadia, Mark E.] Boehringer Ingelheim Pharmaceut Inc, Dept Immunol & Resp Dis, Ridgefield, CT 06877 USA	Boehringer Ingelheim; Boehringer Ingelheim	Li, X (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Small Mol Discovery Res, 900 Ridgebury Rd,POB 368, Ridgefield, CT 06877 USA.	xiang.li@boehringer-ingelheim.com		Farrow, Neil/0000-0002-1469-0466				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; Attia A, 2017, CLIN DRUG INVEST, V37, P439, DOI 10.1007/s40261-017-0500-9; Bochevarov AD, 2013, INT J QUANTUM CHEM, V113, P2110, DOI 10.1002/qua.24481; Bronner SM, 2017, EXPERT OPIN THER PAT, V27, P101, DOI 10.1080/13543776.2017.1236918; Burkett PR, 2016, CELL, V167, P1669, DOI 10.1016/j.cell.2016.11.044; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cyr P, 2016, BIOORG MED CHEM LETT, V26, P4387, DOI 10.1016/j.bmcl.2016.08.012; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Edwards TA, 2011, AMINO ACIDS, V41, P743, DOI 10.1007/s00726-011-0880-8; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enyedy IJ, 2016, BIOORG MED CHEM LETT, V26, P2459, DOI 10.1016/j.bmcl.2016.03.109; Fauber BP, 2014, J MED CHEM, V57, P5871, DOI 10.1021/jm401901d; Fauber BP, 2013, BIOORG MED CHEM LETT, V23, P6604, DOI 10.1016/j.bmcl.2013.10.054; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Fenwick RB, 2014, P NATL ACAD SCI USA, V111, pE445, DOI 10.1073/pnas.1323440111; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fujioka M, 2012, DRUG DISCOV TODAY, V17, P1133, DOI 10.1016/j.drudis.2012.06.010; Fujita-Sato S, 2011, J BIOL CHEM, V286, P31409, DOI 10.1074/jbc.M111.254003; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gallastegui N, 2015, TRENDS BIOCHEM SCI, V40, P25, DOI 10.1016/j.tibs.2014.11.002; Glocker E, 2010, CURR OPIN ALLERGY CL, V10, P542, DOI 10.1097/ACI.0b013e32833fd74f; Glocker EO, 2011, IMMUNOL CELL BIOL, V89, P823, DOI 10.1038/icb.2011.39; Gustafsson JA, 2016, J STEROID BIOCHEM, V157, P3, DOI 10.1016/j.jsbmb.2015.03.004; Hirata K, 2016, ACS MED CHEM LETT, V7, P23, DOI 10.1021/acsmedchemlett.5b00253; Hohenstein EG, 2008, J CHEM THEORY COMPUT, V4, P1996, DOI 10.1021/ct800308k; Hu X, 2015, NAT CHEM BIOL, V11, P141, DOI [10.1038/NCHEMBIO.1714, 10.1038/nchembio.1714]; Hwang TL, 1997, J MAGN RESON, V124, P250, DOI 10.1006/jmre.1996.1049; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Johnson BA, 2000, J MOL BIOL, V298, P187, DOI 10.1006/jmbi.2000.3636; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Kashem MA, 2007, J BIOMOL SCREEN, V12, P70, DOI 10.1177/1087057106296047; Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kupce E, 2007, J MAGN RESON, V187, P258, DOI 10.1016/j.jmr.2007.05.009; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lim HW, 2015, J EXP MED, V212, P607, DOI 10.1084/jem.20132378; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Marcotte DJ, 2016, BMC STRUCT BIOL, V16, DOI 10.1186/s12900-016-0059-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Muegge I, 2015, BIOORG MED CHEM LETT, V25, P1892, DOI 10.1016/j.bmcl.2015.03.042; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rastinejad F, 2015, TRENDS BIOCHEM SCI, V40, P16, DOI 10.1016/j.tibs.2014.10.011; Rastinejad F, 2013, J MOL ENDOCRINOL, V51, pT1, DOI 10.1530/JME-13-0173; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rene O, 2015, ACS MED CHEM LETT, V6, P276, DOI 10.1021/ml500420y; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Sarkar S, 2010, RHEUM DIS CLIN N AM, V36, P345, DOI 10.1016/j.rdc.2010.02.006; Scheepstra M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9833; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang WY, 2008, PROTEIN ENG DES SEL, V21, P425, DOI 10.1093/protein/gzn017; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993	81	28	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11618	11630		10.1074/jbc.M117.789024	http://dx.doi.org/10.1074/jbc.M117.789024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28546429	Green Published, hybrid			2022-12-28	WOS:000405485600003
J	Sopha, P; Ren, HY; Grove, DE; Cyr, DM				Sopha, Pattarawut; Ren, Hong Yu; Grove, Diane E.; Cyr, Douglas M.			Endoplasmic reticulum stress-induced degradation of DNAJB12 stimulates BOK accumulation and primes cancer cells for apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); endoplasmic reticulum stress (ER stress); endoplasmic reticulum-associated protein degradation (ERAD); post-transcriptional regulation; proteostasis; Hsp40; protein quality control	UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; MEMBRANE-PROTEINS; UBIQUITIN LIGASE; HSP70; PATHWAY; COMPLEX; CFTR; INHIBITOR	DNAJB12 (JB12) is an endoplasmic reticulum (ER)-associated Hsp40 family protein that recruits Hsp70 to the ER surface to coordinate the function of ER-associated and cytosolic chaperone systems in protein quality control. Hsp70 is stress-inducible, but paradoxically, we report here that JB12 was degraded by the proteasome during severe ER stress. Destabilized JB12 was degraded by ER-associated degradation complexes that contained HERP, Sel1L, and gp78. JB12 was the only ER-associated chaperone that was destabilized by reductive stress. JB12 knockdown by siRNA led to the induction of caspase processing but not the unfolded protein response. ER stress-induced apoptosis is regulated by the highly labile and ER-associated BCL-2 family member BOK, which is controlled at the level of protein stability by ER-associated degradation components. We found that JB12 was required in human hepatoma cell line 7 (Huh-7) liver cancer cells to maintain BOK at low levels, and BOK was detected in complexes with JB12 and gp78. Depletion of JB12 during reductive stress or by shRNA from Huh-7 cells was associated with accumulation of BOK and activation of Caspase 3, 7, and 9. The absence of JB12 sensitized Huh-7 to death caused by proteotoxic agents and the proapoptotic chemotherapeutic LCL-161. In summary, JB12 is a stress-sensitive Hsp40 whose degradation during severe ER stress provides a mechanism to promote BOK accumulation and induction of apoptosis.	[Sopha, Pattarawut; Ren, Hong Yu; Grove, Diane E.; Cyr, Douglas M.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Sopha, Pattarawut] Chulabhorn Grad Inst, Program Appl Biol Sci, 54 Kamphaeng Phet 6, Bangkok 10210, Thailand	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Chulabhorn Graduate Institute	Sopha, P; Cyr, DM (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Sopha, P (corresponding author), Chulabhorn Grad Inst, Program Appl Biol Sci, 54 Kamphaeng Phet 6, Bangkok 10210, Thailand.	pattarawut@cgi.ac.th; dmcyr@med.unc.edu		Sopha, Pattarawut/0000-0001-8092-5828	National Institutes of Health [2RO1 GM56981]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 2RO1 GM56981. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bhat TA, 2017, BBA-REV CANCER, V1867, P58, DOI 10.1016/j.bbcan.2016.12.002; Chipuk JE, 2016, CURR BIOL, V26, pR473, DOI 10.1016/j.cub.2016.04.003; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Fernandez-Marrero Y, 2016, P NATL ACAD SCI USA, V113, pE492, DOI 10.1073/pnas.1516347113; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hazari YM, 2016, TUMOR BIOL, V37, P14381, DOI 10.1007/s13277-016-5343-0; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Houck SA, 2014, MOL CELL, V54, P166, DOI 10.1016/j.molcel.2014.02.025; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Kausar H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-186; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li K, 2017, MOL CELL, V65, P52, DOI 10.1016/j.molcel.2016.10.027; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Llambi F, 2016, CELL, V165, P421, DOI 10.1016/j.cell.2016.02.026; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Qin Q, 2014, TUMOR BIOL, V35, P2565, DOI 10.1007/s13277-013-1338-2; Sabnis AJ, 2016, P NATL ACAD SCI USA, V113, P9015, DOI 10.1073/pnas.1603883113; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; West AC, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.26; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamoto Y, 2010, CELL STRUCT FUNCT, V35, P107, DOI 10.1247/csf.10023; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	41	24	25	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11792	11803		10.1074/jbc.M117.785113	http://dx.doi.org/10.1074/jbc.M117.785113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28536268	Green Published, hybrid			2022-12-28	WOS:000405485600017
J	Ivanova, AA; Caspary, T; Seyfried, NT; Duong, DM; West, AB; Liu, ZY; Kahn, RA				Ivanova, Anna A.; Caspary, Tamara; Seyfried, Nicholas T.; Duong, Duc M.; West, Andrew B.; Liu, Zhiyong; Kahn, Richard A.			Biochemical characterization of purified mammalian ARL13B protein indicates that it is an atypical GTPase and ARL3 guanine nucleotide exchange factor (GEF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; ARF FAMILY GTPASES; BINDING PROTEINS; JOUBERT-SYNDROME; ACTIVATING PROTEIN; FACTOR-I; ACID PHOSPHOLIPIDS; P-LOOP; RAS; HYDROLYSIS	Primary cilia play central roles in signaling during metazoan development. Several key regulators of ciliogenesis and ciliary signaling are mutated in humans, resulting in a number of ciliopathies, including Joubert syndrome (JS). ARL13B is a ciliary GTPase with at least three missense mutations identified in JS patients. ARL13B is a member of the ADP ribosylation factor family of regulatory GTPases, but is atypical in having a non-homologous, C-terminal domain of similar to 20 kDa and at least one key residue difference in the consensus GTP-binding motifs. For these reasons, and to establish a solid biochemical basis on which to begin to model its actions in cells and animals, we developed preparations of purified, recombinant, murine Arl13b protein. We report results from assays for solution-based nucleotide binding, intrinsic and GTPase-activating protein-stimulated GTPase, and ARL3 guanine nucleotide exchange factor activities. Biochemical analyses of three human missense mutations found in JS and of two consensus GTPase motifs reinforce the atypical properties of this regulatory GTPase. We also discovered that murine Arl13b is a substrate for casein kinase 2, a contaminant in our preparation from human embryonic kidney cells. This activity, and the ability of casein kinase 2 to use GTP as a phosphate donor, may be a source of differences between our data and previously published results. These results provide a solid framework for further research into ARL13B on which to develop models for the actions of this clinically important cell regulator.	[Ivanova, Anna A.; Seyfried, Nicholas T.; Duong, Duc M.; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA; [Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [West, Andrew B.; Liu, Zhiyong] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Emory University; Emory University; University of Alabama System; University of Alabama Birmingham	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Ivanova, Anna/GZK-6458-2022; Kahn, Richard/ABD-2666-2020; Caspary, Tamara/AAH-5625-2020	Kahn, Richard/0000-0002-0259-0601; Caspary, Tamara/0000-0002-6579-7589; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [R01 GM110663, R01 NS064934]; Proteomics Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; Emory Integrated Proteomics Core (EIPC) - Emory University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110663, R35GM122568, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Proteomics Core of the Emory Neuroscience NINDS Core Facilities Grant; Emory Integrated Proteomics Core (EIPC) - Emory University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 GM110663 (to A. A. I., R. A. K., and T. C.) and R01 NS064934 (to A. B. W. and Z. L.), Proteomics Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077 (to R. A. K., N. T. S., and D. M. D.), and in part by the Emory Integrated Proteomics Core (EIPC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Bichet P, 2000, PROTEIN EXPRES PURIF, V19, P197, DOI 10.1006/prep.2000.1239; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; Bostrom SL, 2009, BIOCHEM BIOPH RES CO, V390, P1154, DOI 10.1016/j.bbrc.2009.10.107; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cuvillier A, 2000, J CELL SCI, V113, P2065; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Francis JW, 2017, J BIOL CHEM, V292, P4336, DOI 10.1074/jbc.M116.770909; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; GSCHWENDT M, 1995, BIOCHEM BIOPH RES CO, V206, P614, DOI 10.1006/bbrc.1995.1087; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hori Y, 2008, BIOCHEM BIOPH RES CO, V373, P119, DOI 10.1016/j.bbrc.2008.06.001; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Ivanova AA, 2014, J BIOL CHEM, V289, P11111, DOI 10.1074/jbc.M114.548529; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kuai J, 2000, J BIOL CHEM, V275, P4022, DOI 10.1074/jbc.275.6.4022; Kuai J, 2002, METHOD ENZYMOL, V345, P359; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Miertzschke M, 2014, BIOCHEM J, V457, P301, DOI 10.1042/BJ20131097; Newman LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099270; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Paoli P, 2000, BIOCHEM J, V349, P43, DOI 10.1042/0264-6021:3490043; PAPAGEORGE A, 1982, J VIROL, V44, P509, DOI 10.1128/JVI.44.2.509-519.1982; Parisi M., 1993, GENEREVIEWS, P1993; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; TERUI T, 1994, J BIOL CHEM, V269, P28130; Thomas S, 2015, EUR J HUM GENET, V23, P621, DOI 10.1038/ejhg.2014.156; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; WEISS O, 1989, J BIOL CHEM, V264, P21066; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24534; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	86	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11091	11108		10.1074/jbc.M117.784025	http://dx.doi.org/10.1074/jbc.M117.784025			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487361	hybrid, Green Published			2022-12-28	WOS:000404391000029
J	Teramoto, T; Balasubramanian, A; Choi, KH; Padmanabhan, R				Teramoto, Tadahisa; Balasubramanian, Anuradha; Choi, Kyung H.; Padmanabhan, Radhakrishnan			Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LINKER REGION; TYPE-2; POLYMERASE; HELICASE; METHYLTRANSFERASE; PROTEASE; 5'-TRIPHOSPHATASE; TRIPHOSPHATASE; FLEXIBILITY	Four serotypes of mosquito-borne dengue virus (DENV), evolved from a common ancestor, are human pathogens of global significance for which there is no vaccine or antiviral drug available. The N-terminal domain of DENV NS5 has guanylyltransferase and methyltransferase (MTase), and the C-terminal region has the polymerase (POL), all of which are important for 5 '-capping and RNA replication. The crystal structure of NS5 shows it as a dimer, but the functional evidence for NS5 dimer is lacking. Our studies showed that the substitution of DENV2 NS5 MTase or POL for DENV4 NS5 within DENV2 RNA resulted in a severe attenuation of replication in the transfected BHK-21 cells. A replication-competent species was evolved with the acquired mutations in the DENV2 and DENV4 NS5 MTase or POL domain or in the DENV2 NS3 helicase domain in the DENV2 chimera RNAs by repeated passaging of infected BHK-21 or mosquito cells. The linker region of seven residues in NS5, rich in serotype-specific residues, is important for the recovery of replication fitness in the chimera RNA. Our results, taken together, provide genetic evidence for a serotype-specific interaction between NS3 and NS5 as well as specific interdomain interaction within NS5 required for RNA replication. Genome-wide RNAseq analysis revealed the distribution of adaptive mutations in RNA quasispecies. Those within NS3 and NS5 are located at the surface and/or within the NS5 dimer interface, providing a functional significance to the crystal structure NS5 dimer.	[Teramoto, Tadahisa; Balasubramanian, Anuradha; Padmanabhan, Radhakrishnan] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Choi, Kyung H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Georgetown University; University of Texas System; University of Texas Medical Branch Galveston	Padmanabhan, R (corresponding author), Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA.	rp55@georgetown.edu			National Institutes of Health [R01 AI087856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI087856 (to K. H. C. and R. P). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Borderia AV, 2016, CURR TOP MICROBIOL, V392, P303, DOI 10.1007/82_2015_483; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Furio V, 2005, P NATL ACAD SCI USA, V102, P10233, DOI 10.1073/pnas.0501062102; Gebhard LG, 2014, NUCLEIC ACIDS RES, V42, P11668, DOI 10.1093/nar/gku812; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010; Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Padmanabhan R, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P13; Padmanabhan R, 2015, METHODS, V91, P20, DOI 10.1016/j.ymeth.2015.08.002; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sierra B, 2010, CELL IMMUNOL, V262, P134, DOI 10.1016/j.cellimm.2010.02.005; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Tan CSE, 2013, J GEN VIROL, V94, P1961, DOI 10.1099/vir.0.054395-0; Teramoto T, 2014, J BIOL CHEM, V289, P22385, DOI 10.1074/jbc.M114.584466; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006; Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08; Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15; Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682	48	10	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9465	9479		10.1074/jbc.M117.775643	http://dx.doi.org/10.1074/jbc.M117.775643			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28396347	Green Published, hybrid			2022-12-28	WOS:000403113000003
J	VanderLinden, RT; Hemmis, CW; Yao, TT; Robinson, H; Hill, CP				VanderLinden, Ryan T.; Hemmis, Casey W.; Yao, Tingting; Robinson, Howard; Hill, Christopher P.			Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; 26S PROTEASOME; RECEPTOR RPN13; PROTEIN; ADRM1; ACTIVATION; DOMAIN; OVEREXPRESSION; IDENTIFICATION; AMPLIFICATION	The 26S proteasome is a large cellular assembly that mediates the selective degradation of proteins in the nucleus and cytosol and is an established target for anticancer therapeutics. Protein substrates are typically targeted to the proteasome through modification with a polyubiquitin chain, which can be recognized by several proteasome-associated ubiquitin receptors. One of these receptors, RPN13/ADRM1, is recruited to the proteasome through direct interaction with the large scaffolding protein RPN2 within the 19S regulatory particle. To better understand the interactions between RPN13, RPN2, and ubiquitin, we used human proteins to map the RPN13-binding epitope to the C-terminal 14 residues of RPN2, which, like ubiquitin, binds the N-terminal pleckstrin-like receptor of ubiquitin (PRU) domain of RPN13. We also report the crystal structures of the RPN13 PRU domain in complex with peptides corresponding to the RPN2 C terminus and ubiquitin. Through mutational analysis, we validated the RPN2-binding interface revealed by our structures and quantified binding interactions with surface plasmon resonance and fluorescence polarization. In contrast to a previous report, we find that RPN13 binds ubiquitin with an affinity similar to that of other proteasome-associated ubiquitin receptors and that RPN2, ubiquitin, and the deubiquitylase UCH37 bind to RPN13 with independent energetics. These findings provide a detailed characterization of interactions that are important for proteasome function, indicate ubiquitin affinities that are consistent with the role of RPN13 as a proteasomal ubiquitin receptor, and have major implications for the development of novel anticancer therapeutics.	[VanderLinden, Ryan T.; Hemmis, Casey W.; Hill, Christopher P.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Yao, Tingting] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; Colorado State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu			National Institutes of Health from the NCRR [P41RR012408]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41RR001209]; NCRR; Department of Energy Office of Basic Energy Sciences [DE-AC02-76SF00515]; National Institutes of Health; National Institutes of Health from the NCI [P30CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014, R21CA191929] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059135, R01GM098401] Funding Source: NIH RePORTER	National Institutes of Health from the NCRR; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Frank Whitby, Heidi Schubert, Erik Kish-Trier, Kath Ferrell, Binita Shakya, Ira Baci, and Matt Sdano for technical assistance. Wealso thank Mark Peterson for peptide synthesis and Bob Cohen (Colorado State University) for generous gifts and helpful comments on the manuscript. Portions of this research were performed at the National Synchrotron Light Source (NSLS) and the Stanford Synchrotron Radiation Lightsource (SSRL). The NSLS is funded by National Institutes of Health Grant P41RR012408 from the NCRR. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health Grant P41RR001209 from NIGMS and the NCRR. Use of the NSLS and SSRL is supported by the Department of Energy Office of Basic Energy Sciences (SSRL Contract No. DE-AC02-76SF00515). NSLS operations are also supported by the National Institutes of Health. Mass spectrometry validation of purified proteins was performed by the University of Utah Mass Spectrometry and Proteomics Core Facility, which is supported by National Institutes of Health Grant P30CA042014 from the NCI. Sequencing of constructs used in this work was performed at the DNA Sequencing Core Facility, University of Utah.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Boudreaux DA, 2010, P NATL ACAD SCI USA, V107, P9117, DOI 10.1073/pnas.0910870107; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Chen X, 2016, CHINA FOUNDRY, V13, P1, DOI 10.1007/s41230-016-5104-0; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Fejzo MS, 2015, GENE CHROMOSOME CANC, V54, P506, DOI 10.1002/gcc.22262; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hamazaki J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005401; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jang SH, 2014, CLIN EXP METASTAS, V31, P727, DOI 10.1007/s10585-014-9663-4; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Kortuem KM, 2013, BLOOD, V121, P893, DOI 10.1182/blood-2012-10-459883; Kumar S, 2008, BLOOD, V112, P2177, DOI 10.1182/blood-2008-07-167767; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lu SQ, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-13; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140518; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Ryu H, 2014, CELL REP, V7, P1842, DOI 10.1016/j.celrep.2014.05.009; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schweitzer A, 2016, P NATL ACAD SCI USA, V113, P7816, DOI 10.1073/pnas.1608050113; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Song Y, 2016, LEUKEMIA, V30, P1877, DOI 10.1038/leu.2016.97; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Trader DJ, 2015, J AM CHEM SOC, V137, P6312, DOI 10.1021/jacs.5b02069; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Yang X, 2012, ONCOL REP, V28, P283, DOI 10.3892/or.2012.1767; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zheng XH, 2015, ACTA HAEMATOL-BASEL, V134, P88, DOI 10.1159/000369916	70	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9493	9504		10.1074/jbc.M117.785287	http://dx.doi.org/10.1074/jbc.M117.785287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28442575	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000403113000005
J	Lai, AL; Clerico, EM; Blackburn, ME; Patel, NA; Robinson, CV; Borbat, PP; Freed, JH; Gierasch, LM				Lai, Alex L.; Clerico, Eugenia M.; Blackburn, Mandy E.; Patel, Nisha A.; Robinson, Carol V.; Borbat, Peter P.; Freed, Jack H.; Gierasch, Lila M.			Key features of an Hsp70 chaperone allosteric landscape revealed by ion-mobility native mass spectrometry and double electron-electron resonance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); allosteric regulation; chaperone DnaK (DnaK); conformational change; molecular chaperone; Hsp70; double electron-electron resonance; energy landscape; ion-mobility mass spectrometry	PAIR DISTANCE DISTRIBUTIONS; COLLISION CROSS-SECTIONS; SUBSTRATE-BINDING DOMAIN; GAS-PHASE; DNAK CHAPERONE; CONFORMATIONAL DYNAMICS; TIKHONOV REGULARIZATION; MOLECULAR CHAPERONES; MITOCHONDRIAL HSP70; MEMBRANE-PROTEINS	Proteins are dynamic entities that populate conformational ensembles, and most functions of proteins depend on their dynamic character. Allostery, in particular, relies on ligand-modulated shifts in these conformational ensembles. Hsp70s are allosteric molecular chaperones with conformational landscapes that involve large rearrangements of their two domains (viz. the nucleotide-binding domain and substrate-binding domain) in response to adenine nucleotides and substrates. However, it remains unclear how the Hsp70 conformational ensemble is populated at each point of the allosteric cycle and how ligands control these populations. We have mapped the conformational species present under different ligand-binding conditions throughout the allosteric cycle of the Escherichia coli Hsp70 DnaK by two complementary methods, ion-mobility mass spectrometry and double electron-electron resonance. Our results obtained under biologically relevant ligand-bound conditions confirm the current picture derived from NMR and crystallographic data of domain docking upon ATP binding and undocking in response to ADP and substrate. Additionally, we find that the helical lid of DnaK is a highly dynamic unit of the structure in all ligand-bound states. Importantly, we demonstrate that DnaK populates a partially docked state in the presence of ATP and substrate and that this state represents an energy minimum on the DnaK allosteric landscape. Because Hsp70s are emerging as potential drug targets for many diseases, fully mapping an allosteric landscape of a molecular chaperone like DnaK will facilitate the development of small molecules that modulate Hsp70 function via allosteric mechanisms.	[Lai, Alex L.; Borbat, Peter P.; Freed, Jack H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Clerico, Eugenia M.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA; [Blackburn, Mandy E.] Univ Cent Missouri, Sch Environm Phys & Appl Sci, Warrensburg, MO 64093 USA; [Patel, Nisha A.; Robinson, Carol V.] Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England	Cornell University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University Central Missouri; University of Oxford	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA.; Gierasch, LM (corresponding author), Univ Massachusetts, Dept Chem, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Borbat, Petr P/A-8658-2014	robinson, carol/0000-0001-7829-5505	NIBIB/National Institutes of Health (NIH) [R01EB003150]; NIGMS/NIH [P41GM103521]; NIH [R01GM027616, R35GM118161]; Medical Research Council (MRC) [98101]; Wellcome Trust [WT008150, WT099141]; European Research Council (ERC) (IMPRESS) grant; MRC [MR/N020413/1, G1000819] Funding Source: UKRI; Medical Research Council [MR/N020413/1, G1000819] Funding Source: researchfish; Wellcome Trust [104633/Z/14/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616, P41GM103521, R35GM118161] Funding Source: NIH RePORTER	NIBIB/National Institutes of Health (NIH); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC) (IMPRESS) grant(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIBIB/National Institutes of Health (NIH), Grant R01EB003150 and NIGMS/NIH Grant P41GM103521 (to J. H. F.); NIH Grants R01GM027616 and R35GM118161 (to L. M. G); and Medical Research Council (MRC) Grant 98101, Wellcome Trust Grants WT008150 and WT099141, and a European Research Council (ERC) (IMPRESS) grant (to C. V. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9551; Arakawa A, 2011, PROTEIN SCI, V20, P1367, DOI 10.1002/pro.663; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Banerjee R, 2016, FEBS J, V283, P2853, DOI 10.1111/febs.13769; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Borbat PP, 2007, METHOD ENZYMOL, V423, P52, DOI 10.1016/S0076-6879(07)23003-4; Borbat PP, 2014, STRUCT BOND, V152, P1, DOI 10.1007/430_2012_82; Borbat PP, 1997, J MAGN RESON, V127, P155, DOI 10.1006/jmre.1997.1201; Breuker K, 2008, P NATL ACAD SCI USA, V105, P18145, DOI 10.1073/pnas.0807005105; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Dobo A, 2001, ANAL CHEM, V73, P4763, DOI 10.1021/ac010713f; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kaltashov IA, 2005, ANAL CHEM, V77, P5370, DOI 10.1021/ac050511+; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Krug U, 2016, STRUCTURE, V24, P43, DOI 10.1016/j.str.2015.11.007; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu ZL, 2016, PHYS CHEM CHEM PHYS, V18, P5819, DOI 10.1039/c5cp04556h; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marklund EG, 2015, STRUCTURE, V23, P791, DOI 10.1016/j.str.2015.02.010; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Pacholarz KJ, 2014, ANGEW CHEM INT EDIT, V53, P7765, DOI 10.1002/anie.201402863; Pagel K, 2013, ANGEW CHEM INT EDIT, V52, P361, DOI 10.1002/anie.201203047; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pierpaoli EV, 1998, BIOCHEMISTRY-US, V37, P16741, DOI 10.1021/bi981762y; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Schiffrin B, 2016, NAT STRUCT MOL BIOL, V23, P786, DOI 10.1038/nsmb.3266; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sikor M, 2013, EMBO J, V32, P1639, DOI 10.1038/emboj.2013.89; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Zhou M, 2014, NAT CHEM, V6, P208, DOI [10.1038/nchem.1868, 10.1038/NCHEM.1868]; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	54	38	38	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8773	8785		10.1074/jbc.M116.770404	http://dx.doi.org/10.1074/jbc.M116.770404			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28428246	Green Published, hybrid			2022-12-28	WOS:000402153900023
J	Marunaka, K; Furukawa, C; Fujii, N; Kimura, T; Furuta, T; Matsunaga, T; Endo, S; Hasegawa, H; Anzai, N; Yamazaki, Y; Yamaguchi, M; Ikari, A				Marunaka, Kana; Furukawa, Chisa; Fujii, Naoko; Kimura, Toru; Furuta, Takumi; Matsunaga, Toshiyuki; Endo, Satoshi; Hasegawa, Hajime; Anzai, Naohiko; Yamazaki, Yasuhiro; Yamaguchi, Masahiko; Ikari, Akira			The RING finger- and PDZ domain-containing protein PDZRN3 controls localization of the Mg2+ regulator claudin-16 in renal tube epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; kidney; magnesium; protein phosphorylation; tight junction	CLATHRIN-DEPENDENT ENDOCYTOSIS; THICK ASCENDING LIMB; E3 UBIQUITIN LIGASE; TIGHT-JUNCTION; KINASE-A; HYPERTENSIVE-RATS; FAMILY PROTEINS; HENLES LOOP; PHOSPHORYLATION; PARACELLIN-1	Ion exchange in the renal tubules is fundamental to the maintenance of physiological ion levels. Claudin-16 (CLDN16) regulates the paracellular reabsorption of Mg2+ in the thick ascending limb of Henle's loop in the kidney, with dephosphorylation of CLDN16 increasing its intracellular distribution and decreasing paracellular Mg2+ permeability. CLDN16 is located in the tight junctions, but the mechanism regulating its localization is unclear. Using yeast two-hybrid systems, we found that CLDN16 binds to PDZRN3, a protein containing both RING-finger and PDZ domains. We also observed that the carboxyl terminus of the cytoplasmic CLDN16 region was required for PDZRN3 binding. PZDRN3 was mainly distributed in the cytosol of rat kidney cells and upon cell treatment with the protein kinase A inhibitor H-89, colocalized with CLDN16. H-89 also increased mono-ubiquitination and the association of CLDN16 with PDZRN3. Mono-ubiquitination levels of a K275A mutant were lower, and its association with PDZRN3 was reduced compared with wild-type (WT) CLDN16 and a K261A mutant, indicating that Lys-275 is the major ubiquitination site. An S217A mutant, a dephosphorylated form of CLDN16, localized to the cytosol along with PDZRN3 and the endosomal marker Rab7. PDZRN3 siRNA increased cell-surface localization of WT CLDN16 in H-89-treated cells or containing the S217A mutant and also suppressed CLDN16 endocytosis. Of note, H-89 decreased paracellular Mg2+ flux in WT CLDN16 cells, and PDZRN3 siRNA increased Mg2+ flux in the H-89-treated WT CLDN16 and S217A mutant cells. These results suggest that PDZRN3 mediates endocytosis of dephosphorylated CLDN16 and represents an important component of the CLDN16-trafficking machinery in the kidney.	[Marunaka, Kana; Furukawa, Chisa; Fujii, Naoko; Matsunaga, Toshiyuki; Endo, Satoshi; Ikari, Akira] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan; [Kimura, Toru] Kyorin Univ, Dept Pharmacol & Toxicol, Sch Med, Tokyo 1818611, Japan; [Furuta, Takumi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Hasegawa, Hajime] Saitama Med Univ, Saitama Med Ctr, Saitama 3508550, Japan; [Anzai, Naohiko] Chiba Univ, Dept Pharmacol, Grad Sch Med, Chiba 3210293, Japan; [Yamazaki, Yasuhiro; Yamaguchi, Masahiko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Gifu Pharmaceutical University; Kyorin University; Kyoto University; Saitama Medical University; Chiba University; University of Shizuoka	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Endo, Satoshi/F-8059-2011; ANZAI, NAOHIKO/K-9492-2017	Endo, Satoshi/0000-0003-0578-9672; ANZAI, NAOHIKO/0000-0003-0605-0458	JSPS KAKENHI [15H04657]; Salt Science Research Foundation [1627]; Mishima Kaiun Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This work was supported in part by JSPS KAKENHI Grant 15H04657 (to A. I.) and grants from the Salt Science Research Foundation (1627) and the Mishima Kaiun Memorial Foundation (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; Bender J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136768; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Fujii N, 2016, J BIOL CHEM, V291, P24787, DOI 10.1074/jbc.M116.728196; Gong YF, 2015, MOL BIOL CELL, V26, P4333, DOI 10.1091/mbc.E15-06-0422; Gong YF, 2015, P NATL ACAD SCI USA, V112, P4340, DOI 10.1073/pnas.1421441112; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Gunzel D, 2009, ANN NY ACAD SCI, V1165, P152, DOI 10.1111/j.1749-6632.2009.04051.x; Honda T, 2013, AM J PHYSIOL-CELL PH, V304, pC1091, DOI 10.1152/ajpcell.00343.2012; Honda T, 2010, MOL BIOL CELL, V21, P3269, DOI 10.1091/mbc.E10-02-0117; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Hou JH, 2007, J BIOL CHEM, V282, P17114, DOI 10.1074/jbc.M700632200; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Ikari A, 2004, J BIOL CHEM, V279, P54826, DOI 10.1074/jbc.M406331200; Ikari A, 2001, BIOCHEM BIOPH RES CO, V287, P671, DOI 10.1006/bbrc.2001.5644; Ikari A, 2008, J CELL PHYSIOL, V214, P221, DOI 10.1002/jcp.21178; Ikari A, 2006, J PHYSIOL SCI, V56, P379, DOI 10.2170/physiolsci.SC008906; Ikari A, 2014, BBA-MOL CELL RES, V1843, P2079, DOI 10.1016/j.bbamcr.2014.05.017; Ikari A, 2014, J BIOL CHEM, V289, P13112, DOI 10.1074/jbc.M113.541193; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jian YK, 2015, BIOCHEM BIOPH RES CO, V466, P356, DOI 10.1016/j.bbrc.2015.09.028; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; Katoh M, 2004, INT J MOL MED, V13, P607; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Ko JA, 2006, J CELL SCI, V119, P5106, DOI 10.1242/jcs.03290; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Konrad M, 2008, J AM SOC NEPHROL, V19, P171, DOI 10.1681/ASN.2007060709; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li J, 2015, INT J CLIN EXP PATHO, V8, P12225; Marracci S, 2016, INT J DEV BIOL, V60, P57, DOI 10.1387/ijdb.150381ld; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller D, 2006, J CLIN ENDOCR METAB, V91, P3076, DOI 10.1210/jc.2006-0200; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ohta H, 2006, J VET MED SCI, V68, P453, DOI 10.1292/jvms.68.453; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; UMEMURA S, 1986, J HYPERTENS, V4, P19, DOI 10.1097/00004872-198602000-00004; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; WU XY, 1995, CLIN EXP HYPERTENS, V17, P989, DOI 10.3109/10641969509033647; Zhang P, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.21	55	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13034	13044		10.1074/jbc.M117.779405	http://dx.doi.org/10.1074/jbc.M117.779405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28623232	Green Published, hybrid			2022-12-28	WOS:000407220100030
J	Fossum, SL; Mutolo, MJ; Tugores, A; Ghosh, S; Randell, SH; Jones, LC; Leir, SH; Harris, A				Fossum, Sara L.; Mutolo, Michael J.; Tugores, Antonio; Ghosh, Sujana; Randell, Scott H.; Jones, Lisa C.; Leir, Shih-Hsing; Harris, Ann			Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; CYSTIC-FIBROSIS; CELL-DIFFERENTIATION; MODIFIER LOCI; LUNG; INFLAMMATION; EXPRESSION; GENE; SEVERITY; CHILDREN	The airway epithelium forms a barrier between the internal and external environments. Epithelial dysfunction is critical in the pathology of many respiratory diseases, including cystic fibrosis. Ets homologous factor (EHF) is a key member of the transcription factor network that regulates gene expression in the airway epithelium in response to endogenous and exogenous stimuli. EHF, which has altered expression in inflammatory states, maps to the 5' end of an intergenic region on Chr11p13 that is implicated as a modifier of cystic fibrosis airway disease. Here we determine the functions of EHF in primary human bronchial epithelial (HBE) cells and relevant airway cell lines. Using EHF ChIP followed by deep sequencing (ChIP-seq) and RNA sequencing after EHF depletion, we show that EHF targets in HBE cells are enriched for genes involved in inflammation and wound repair. Furthermore, changes in gene expression impact cell phenotype because EHF depletion alters epithelial secretion of a neutrophil chemokine and slows wound closure in HBE cells. EHF activates expression of the SAM pointed domain-containing ETS transcription factor, which contributes to goblet cell hyperplasia. Our data reveal a critical role for EHF in regulating epithelial function in lung disease.	[Fossum, Sara L.; Mutolo, Michael J.; Ghosh, Sujana; Leir, Shih-Hsing; Harris, Ann] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60614 USA; [Fossum, Sara L.; Mutolo, Michael J.; Ghosh, Sujana; Leir, Shih-Hsing; Harris, Ann] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tugores, Antonio] Complejo Hosp Univ Insular Materno Infantil, Unidad Invest, Las Palmas Gran Canaria 35016, Spain; [Randell, Scott H.; Jones, Lisa C.] Univ N Carolina, Cyst Fibrosis Ctr, Marsico Lung Inst, Chapel Hill, NC 27599 USA; [Leir, Shih-Hsing; Harris, Ann] Case Western Reserve Univ, Dept Genet & Genome Sci, 10900 Euclid Ave, Cleveland, OH 44016 USA	Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University	Harris, A (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, 10900 Euclid Ave, Cleveland, OH 44016 USA.	ann.harris@case.edu	Leir, Shih-Hsing/O-6739-2019; Leir, Shih-Hsing/AAG-1086-2019; Tugores, Antonio/AAE-7939-2021	Leir, Shih-Hsing/0000-0001-9524-3379; Tugores, Antonio/0000-0002-1849-9239	National Institutes of Health [R01HL117843, R01HL094585, R01HD068901, F30HL124925, T32GM008061, P30DK065988]; Cystic Fibrosis Foundation [Harris14P0, CFF-Bouch15P0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL126458, R01HL117843, R01HL094585, F30HL124925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL117843, R01HL094585, and R01HD068901 (to A. H.); F30HL124925 (to S. F.); T32GM008061; and P30DK065988. This work was also supported by Cystic Fibrosis Foundation Grants Harris14P0 (to A. H) and CFF-Bouch15P0). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Durieu I, 1998, AM J RESP CRIT CARE, V158, P580, DOI 10.1164/ajrccm.158.2.9707126; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fossum SL, 2014, NUCLEIC ACIDS RES, V42, P13588, DOI 10.1093/nar/gku1146; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/ajrccm.165.8.2104090; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Itokazu Y, 2014, AM J PHYSIOL-CELL PH, V306, pC819, DOI 10.1152/ajpcell.00168.2013; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Karmel A., 2014, HOMER IDR 2 PASS UPD, DOI [10.5281/zenodo.11619, DOI 10.5281/ZENODO.11619]; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kerschner JL, 2014, EPIGENETICS-US, V9, P557, DOI 10.4161/epi.27696; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Korfhagen TR, 2012, P NATL ACAD SCI USA, V109, P16630, DOI 10.1073/pnas.1208092109; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Mollard R, 2000, INT J DEV BIOL, V44, P457; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Regamey N, 2011, THORAX, V66, P624, DOI 10.1136/thx.2009.134106; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Taniue K, 2011, EMBO REP, V12, P682, DOI 10.1038/embor.2011.81; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Widdicombe JH, 2015, PHYSIOL REV, V95, P1241, DOI 10.1152/physrev.00039.2014; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yang HH, 2002, DEVELOPMENT, V129, P2233; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	65	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10938	10949		10.1074/jbc.M117.775304	http://dx.doi.org/10.1074/jbc.M117.775304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28461336	Green Published, hybrid			2022-12-28	WOS:000404391000016
J	Kuttel, MM; Cescutti, P; Distefano, M; Rizzo, R				Kuttel, Michelle M.; Cescutti, Paola; Distefano, Marco; Rizzo, Roberto			Fluorescence and NMR spectroscopy together with molecular simulations reveal amphiphilic characteristics of a Burkholderia biofilm exopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEPACIA COMPLEX; FORCE-FIELD; DYNAMICS; MATRIX; PROTEINS; POLYSACCHARIDES; STRATEGIES; BINDING; PROBES; WATER	Biofilms are a collective mode of bacterial life in which a self-produced matrix confines cells in close proximity to each other. Biofilms confer many advantages, including protection from chemicals (including antibiotics), entrapment of useful extracellular enzymes and nutrients, as well as opportunities for efficient recycling of molecules from dead cells. Biofilm matrices are aqueous gel-like structures composed of polysaccharides, proteins, and DNA stabilized by intermolecular interactions that may include non-polar connections. Recently, polysaccharides extracted from biofilms produced by species of the Burkholderia cepacia complex were shown to possess clusters of rhamnose, a 6-deoxy sugar with non-polar characteristics. Molecular dynamics simulations are well suited to characterizing the structure and dynamics of polysaccharides, but only relatively few such studies exist of their interaction with non-polar molecules. Here we report an investigation into the hydrophobic properties of the exopolysaccharide produced by Burkholderia multivorans strain C1576. Fluorescence experiments with two hydrophobic fluorescent probes established that this polysaccharide complexes hydrophobic species, and NMR experiments confirmed these interactions. Molecular simulations to model the hydrodynamics of the polysaccharide and the interaction with guest species revealed a very flexible, amphiphilic carbohydrate chain that has frequent dynamic interactions with apolar molecules; both hexane and a long-chain fatty acid belonging to the quorum-sensing system of B. multivorans were tested. A possible role of the non-polar domains of the exopolysaccharide in facilitating the diffusion of aliphatic species toward specific targets within the biofilm aqueous matrix is proposed.	[Kuttel, Michelle M.] Univ Cape Town, Dept Comp Sci, ZA-7701 Rondebosch, South Africa; [Cescutti, Paola; Distefano, Marco; Rizzo, Roberto] Univ Trieste, Dept Life Sci, Via Licio Giorgieri 1, I-34127 Trieste, Italy	University of Cape Town; University of Trieste	Rizzo, R (corresponding author), Univ Trieste, Dept Life Sci, Via Licio Giorgieri 1, I-34127 Trieste, Italy.	rizzor@units.it	Kuttel, Michelle/B-2941-2009	Kuttel, Michelle/0000-0003-0554-4632; Cescutti, Paola/0000-0003-3744-2198	South African Medical Research Council [SIR 415983]; University of Trieste	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Trieste	The South African Medical Research Council funding agency provided financial support for the modeling component of this work (SIR 415983). The University of Trieste is kindly acknowledged for financial support (FRA2013 and FRA2015). The authors declare that they have no conflicts of interest with the contents of this article.	Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Bryce RA, 2001, BIOPHYS J, V81, P1373, DOI 10.1016/S0006-3495(01)75793-1; Cescutti P, 2000, BIOCHEM BIOPH RES CO, V273, P1088, DOI 10.1006/bbrc.2000.3059; Cheon HS, 2007, CHEMBIOCHEM, V8, P353, DOI 10.1002/cbic.200600499; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Colombo G, 2004, CARBOHYD RES, V339, P985, DOI 10.1016/j.carres.2003.10.030; CRESCENZI V, 1986, GAZZ CHIM ITAL, V116, P435; Cuzzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094372; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Deng YY, 2010, APPL ENVIRON MICROB, V76, P4675, DOI 10.1128/AEM.00480-10; Dolfi S, 2015, CARBOHYD RES, V411, P42, DOI 10.1016/j.carres.2015.04.012; EDELMAN GM, 1968, ACCOUNTS CHEM RES, V1, P65, DOI 10.1021/ar50003a001; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4040041; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Galochkina T, 2016, CHEMPHYSCHEM, V17, P2839, DOI 10.1002/cphc.201600524; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hawver LA, 2016, FEMS MICROBIOL REV, V40, P738, DOI 10.1093/femsre/fuw014; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuttel MM, 2016, J COMPUT CHEM, V37, P2098, DOI 10.1002/jcc.24428; Kuttel MM, 2015, CARBOHYD RES, V406, P27, DOI 10.1016/j.carres.2014.12.013; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Liu L, 2012, CHEM-EUR J, V18, P12059, DOI 10.1002/chem.201201222; Marques CNH, 2015, PHARMACEUTICALS-BASE, V8, P816, DOI 10.3390/ph8040816; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCCLURE WO, 1967, BIOCHEMISTRY-US, V6, P559, DOI 10.1021/bi00854a025; Poveda A, 1998, CHEM SOC REV, V27, P133, DOI 10.1039/a827133z; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8	40	9	9	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11034	11042		10.1074/jbc.M117.785048	http://dx.doi.org/10.1074/jbc.M117.785048			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28468829	Green Published, hybrid			2022-12-28	WOS:000404391000024
J	Desjardins, CA; Naya, FJ				Desjardins, Cody A.; Naya, Francisco J.			Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyocyte; differentiation; gene regulation; transcription factor; transcriptomics; antagonistic	CARDIAC MORPHOGENESIS; IN-VITRO; HEART; MUSCLE; NOTCH; PROLIFERATION; DEFICIENCY; EXPRESSION; MYOGENESIS; COSTAMERE	Cardiomyocytes acquire their primary specialized function (contraction) before exiting the cell cycle. In this regard, proliferation and differentiation must be precisely coordinated for proper cardiac morphogenesis. Here, we have investigated the complex transcriptional mechanisms employed by cardiomyocytes to coordinate antagonistic cell-cycle and differentiation gene programs through the molecular dissection of the core cardiac transcription factor, MEF2. Knockdown of individual MEF2 proteins, MEF2A, -C, and -D, in primary neonatal cardiomyocytes resulted in radically distinct and opposite effects on cellular homeostasis and gene regulation. MEF2A and MEF2D were absolutely required for cardiomyocyte survival, whereas MEF2C, despite its major role in cardiac morphogenesis and direct reprogramming, was dispensable for this process. Inhibition of MEF2A or -D also resulted in the activation of cell-cycle genes and down-regulation of markers of terminal differentiation. In striking contrast, the regulation of cell-cycle and differentiation gene programs by MEF2C was antagonistic to that of MEF2A and -D. Computational analysis of regulatory regions from MEF2 isoform-dependent gene sets identified the Notch and Hedgehog signaling pathways as key determinants in coordinating MEF2 isoform-specific control of antagonistic gene programs. These results reveal that mammalian MEF2 family members have distinct transcriptional functions in cardiomyocytes and suggest that these differences are critical for proper development and maturation of the heart. Analysis of MEF2 isoform-specific function in neonatal cardiomyocytes has yielded insight into an unexpected transcriptional regulatory mechanism by which these specialized cells utilize homologous members of a core cardiac transcription factor to coordinate cell-cycle and differentiation gene programs.	[Desjardins, Cody A.; Naya, Francisco J.] Boston Univ, Program Cell & Mol Biol, Dept Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304]; Boston University Bioinformatics CTSI Grant [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Bioinformatics CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL73304 (to F. J. N.) and Boston University Bioinformatics CTSI Grant U54-TR001012. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abad M, 2017, STEM CELL REP, V8, P548, DOI 10.1016/j.stemcr.2017.01.025; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Conway SJ, 2010, PEDIATR CARDIOL, V31, P318, DOI 10.1007/s00246-009-9608-x; Desjardins CA, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3030026; Di Giorgio E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006752; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Estrella NL, 2015, J BIOL CHEM, V290, P24367, DOI 10.1074/jbc.M115.666461; Estrella NL, 2015, J BIOL CHEM, V290, P1256, DOI 10.1074/jbc.M114.589838; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Gaborit N, 2012, DEVELOPMENT, V139, P4007, DOI 10.1242/dev.081703; Guo YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087294; Hinits Y, 2012, DEV BIOL, V369, P199, DOI 10.1016/j.ydbio.2012.06.019; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Murphy AM, 1996, CARDIOVASC RES, V31, pE25; Murray TVA, 2014, TRENDS CARDIOVAS MED, V24, P113, DOI 10.1016/j.tcm.2013.09.003; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Niu Z, 2007, CURR OPIN CELL BIOL, V19, P618, DOI 10.1016/j.ceb.2007.09.013; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Paige SL, 2015, CIRC RES, V116, P341, DOI 10.1161/CIRCRESAHA.116.302752; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; VanDusen NJ, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.03.002; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Voronova A, 2012, NUCLEIC ACIDS RES, V40, P3329, DOI 10.1093/nar/gkr1232; Waardenberg AJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013839; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Zacchigna S, 2014, CARDIOVASC RES, V102, P312, DOI 10.1093/cvr/cvu057	44	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10613	10629		10.1074/jbc.M117.776153	http://dx.doi.org/10.1074/jbc.M117.776153			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28473466	hybrid, Green Published			2022-12-28	WOS:000404115400021
J	Liu, GY; Moon, SH; Jenkins, CM; Li, MY; Sims, HF; Guan, SP; Gross, RW				Liu, Gao-Yuan; Moon, Sung Ho; Jenkins, Christopher M.; Li, Maoyin; Sims, Harold F.; Guan, Shaoping; Gross, Richard W.			The phospholipase iPLA(2)gamma is a major mediator releasing oxidized aliphatic chains from cardiolipin, integrating mitochondrial bioenergetics and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; lipid metabolism; lipid oxidation; lipid signaling; mass spectrometry (MS)	CALCIUM-INDEPENDENT PHOSPHOLIPASE-A(2)GAMMA; BARTH-SYNDROME; A(2)GAMMA IPLA(2)GAMMA; SHOTGUN LIPIDOMICS; CYTOCHROMES P450; FATTY-ACIDS; BIOSYNTHESIS; METABOLISM; DYSFUNCTION; SUBSTRATE	Cardiolipin (CL) is a dimeric phospholipid with critical roles in mitochondrial bioenergetics and signaling. Recently, inhibition of the release of oxidized fatty acyl chains from CL by the calcium-independent phospholipase A(2) (iPLA(2))-selective inhibitor (R)-BEL suggested that iPLA(2) is responsible for the hydrolysis of oxidized CL and subsequent signaling mediated by the released oxidized fatty acids. However, chemical inhibition by BEL is subject to off-target pharmacologic effects. Accordingly, to unambiguously determine the role of iPLA(2) in the hydrolysis of oxidized CL, we compared alterations in oxidized CLs and the release of oxidized aliphatic chains from CL in experiments with purified recombinant iPLA(2), germ-line iPLA(2)(-/-) mice, cardiac myocyte-specific iPLA(2) transgenic mice, and wild-type mice. Using charge-switch high mass accuracy LC-MS/MS with selected reaction monitoring and product ion accurate masses, we demonstrated that iPLA(2) is the major enzyme responsible for the release of oxidized aliphatic chains from CL. Our results also indicated that iPLA(2) selectively hydrolyzes 9-hydroxy-octadecenoic acid in comparison to 13-hydroxy-octadecenoic acid from oxidized CLs. Moreover, oxidative stress (ADP, NADPH, and Fe3+) resulted in the robust production of oxidized CLs in intact mitochondria from iPLA(2)(-/-) mice. In sharp contrast, oxidized CLs were readily hydrolyzed in mitochondria from wild-type mice during oxidative stress. Finally, we demonstrated that CL activates the iPLA(2)-mediated hydrolysis of arachidonic acid from phosphatidylcholine, thereby integrating the production of lipid messengers from different lipid classes in mitochondria. Collectively, these results demonstrate the integrated roles of CL and iPLA(2) in lipid second-messenger production and mitochondrial bioenergetics during oxidative stress.	[Liu, Gao-Yuan; Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Moon, Sung Ho; Jenkins, Christopher M.; Li, Maoyin; Sims, Harold F.; Guan, Shaoping; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med, St Louis, MO 63110 USA; [Li, Maoyin] Newomics Inc, 5980 Horton St, Emeryville, CA 94608 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu		Li, Maoyin/0000-0002-9976-1349	National Institutes of Health [R01HL118639]; LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01HL118639. R. W. G.. has financial relationships with LipoSpectrum and Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Buland JR, 2016, AM J PHYSIOL-LUNG C, V311, pL303, DOI 10.1152/ajplung.00038.2016; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; Fauland A, 2013, J SEP SCI, V36, P744, DOI 10.1002/jssc.201200708; Gaspard GJ, 2015, CHEM PHYS LIPIDS, V193, P1, DOI 10.1016/j.chemphyslip.2015.09.005; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Gross R W, 1979, Trans Assoc Am Physicians, V92, P136; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P491, DOI 10.1016/j.jasms.2004.12.015; KAYAR SR, 1987, RESP PHYSIOL, V70, P275, DOI 10.1016/0034-5687(87)90010-7; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kim J, 2011, J LIPID RES, V52, P389, DOI 10.1194/jlr.D010587; Liu XP, 2016, CELL CHEM BIOL, V23, P1217, DOI 10.1016/j.chembiol.2016.08.009; Liu XP, 2013, ANAL BIOCHEM, V442, P40, DOI 10.1016/j.ab.2013.06.014; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Moon SH, 2016, J BIOL CHEM, V291, P19687, DOI 10.1074/jbc.M116.740597; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; NARABAYASHI H, 1982, BIOCHEM J, V202, P97, DOI 10.1042/bj2020097; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; PFEIFER PM, 1972, J BIOL CHEM, V247, P6763; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Raja V, 2017, J BIOL CHEM, V292, P1092, DOI 10.1074/jbc.M116.753624; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Shen ZN, 2017, J BIOL CHEM, V292, P2916, DOI 10.1074/jbc.M116.753574; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; WHEELDON LW, 1965, J LIPID RES, V6, P481; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Yin HY, 2012, FREE RADICAL RES, V46, P959, DOI 10.3109/10715762.2012.676642	54	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10672	10684		10.1074/jbc.M117.783068	http://dx.doi.org/10.1074/jbc.M117.783068			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28442572	hybrid, Green Published			2022-12-28	WOS:000404115400026
J	Varnum, MM; Clayton, KA; Yoshii-Kitahara, A; Yonemoto, G; Koro, L; Ikezu, S; Ikezu, T				Varnum, Megan M.; Clayton, Kevin A.; Yoshii-Kitahara, Asuka; Yonemoto, Grant; Koro, Lacin; Ikezu, Seiko; Ikezu, Tsuneya			A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; cell culture; genetic polymorphism; microglia; phagocytosis; plasmid; Alzheimer's disease	FLUID SOLUBLE TREM2; NASU-HAKOLA-DISEASE; ALZHEIMERS-DISEASE; MYELOID CELLS-2; SCLEROSING LEUKOENCEPHALOPATHY; FRONTOTEMPORAL DEMENTIA; APOPTOTIC NEURONS; RECEPTOR FAMILY; CUTTING EDGE; MICROGLIA	Triggering receptor expressed on myeloid cells 2 (TREM2) is a single transmembrane molecule uniquely expressed in microglia. TREM2 mutations are genetically linked to Nasu-Hakola disease and associated with multiple neurodegenerative disorders, including Alzheimer's disease. TREM2 may regulate microglial inflammation and phagocytosis through coupling to the adaptor protein TYRO protein-tyrosine kinase-binding protein (TYROBP). However, there is no functional system for monitoring this protein-protein interaction. We developed a luciferase-based modality for real-time monitoring of TREM2-TYROBP coupling in live cells that utilizes split-luciferase complementation technology based on TREM2 and TYROBP fusion to the C- or N-terminal portion of the Renilla luciferase gene. Transient transfection of human embryonic kidney 293 cells with this reporter vector increased luciferase activity upon stimulation with an anti-TREM2 antibody, which induces their homodimerization. This was confirmed by ELISA-based analysis of the TREM2-TYROBP interaction. Antibody-mediated TREM2 stimulation enhanced spleen tyrosine kinase (SYK) activity and uptake of Staphylococcus aureus in microglial cell line BV-2 in a kinase-dependent manner. Interestingly, the TREM2 T66M mutation significantly enhanced luciferase activity without stimulation, indicating constitutive coupling to TYROBP. Finally, flow cytometry analyses indicated significantly lower surface expression of T66M TREM2 variant than wild type or other TREM2 variants. These results demonstrate that our TREM2 reporter vector is a novel tool for monitoring the TREM2-TYROBP interaction in real time.	[Varnum, Megan M.; Clayton, Kevin A.; Yoshii-Kitahara, Asuka; Yonemoto, Grant; Koro, Lacin; Ikezu, Seiko; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 72 East Concord St,L-606B, Boston, MA 02118 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, 72 East Concord St,L-606B, Boston, MA 02118 USA	Boston University; Boston University	Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 72 East Concord St,L-606B, Boston, MA 02118 USA.; Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 East Concord St,L-606B, Boston, MA 02118 USA.	tikezu@bu.edu		Ikezu, Tsuneya/0000-0002-3979-8596	National Institutes of Health [5T32 GM008541, RF1 AG054199-01]; Henry I. Russek Award; Boston University Undergraduate Research Opportunities Program Awards; Alzheimer's Association; BrightFocus Foundation; Massachusetts Neuroscience Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry I. Russek Award; Boston University Undergraduate Research Opportunities Program Awards; Alzheimer's Association(Alzheimer's Association); BrightFocus Foundation(BrightFocus Foundation); Massachusetts Neuroscience Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Predoctoral Training Grant 5T32 GM008541 (to M. M. V. and K. A. C.) and Grant RF1 AG054199-01 (to T. I.), a Henry I. Russek Award (to M. M. V.), Boston University Undergraduate Research Opportunities Program Awards (to G. Y. and L. K.), the Alzheimer's Association (to T. I.), the BrightFocus Foundation (to T. I.), and the Massachusetts Neuroscience Consortium (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Deng QJ, 2011, J VIROL METHODS, V176, P108, DOI 10.1016/j.jviromet.2011.04.028; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heslegrave A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0071-x; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Iqbal K, 1998, J NEURAL TRANSM-SUPP, P169; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055754; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Mizuno N, 1975, Nihon Hifuka Gakkai Zasshi, V85, P587; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Piccio L, 2016, ACTA NEUROPATHOL, V131, P925, DOI 10.1007/s00401-016-1533-5; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Rizvi SM, 2010, TRAFFIC, V11, P332, DOI 10.1111/j.1600-0854.2009.01025.x; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	52	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10651	10663		10.1074/jbc.M116.759159	http://dx.doi.org/10.1074/jbc.M116.759159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28490631	hybrid, Green Published			2022-12-28	WOS:000404115400024
J	Head, PE; Zhang, H; Bastien, AJ; Koyen, AE; Withers, AE; Daddacha, WB; Cheng, XD; Yu, DS				Head, PamelaSara E.; Zhang, Hui; Bastien, Amanda J.; Koyen, Allyson E.; Withers, Allison E.; Daddacha, Waaqo B.; Cheng, Xiaodong; Yu, David S.			Sirtuin 2 mutations in human cancers impair its function in genome maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION STRESS-RESPONSE; RESECTED PANCREATIC-CANCER; AMINO-ACID SUBSTITUTIONS; AFFECT PROTEIN FUNCTION; DNA-DAMAGE RESPONSE; TUBULIN DEACETYLASE; EXPRESSION; SEARCH; IDENTIFICATION; DEGRADATION	Sirtuin 2 (SIRT2) is a sirtuin family deacetylase, which maintains genome integrity and prevents tumorigenesis. Although Sirt2 deficiency in mice leads to tumorigenesis, the functional significance of somatic SIRT2 mutations in human tumors is unclear. Using structural insight combined with bioinformatics and functional analyses, we show that naturally occurring cancer-associated SIRT2 mutations at evolutionarily conserved sites disrupt its deacetylation of DNA-damage response proteins by impairing SIRT2 catalytic activity or protein levels but not its localization or binding with substrate. We observed that these SIRT2 mutant proteins fail to restore the replication stress sensitivity, impairment in recovery from replication stress, and impairment in ATR-interacting protein (ATRIP) focus accumulation of SIRT2 deficiency. Moreover, the SIRT2 mutant proteins failed to rescue the spontaneous induction of DNA damage and micronuclei of SIRT2 deficiency in cancer cells. Our findings support a model for SIRT2's tumor-suppressive function in which somatic mutations in SIRT2 contribute to genomic instability by impairing its deacetylase activity or diminishing its protein levels in the DNA-damage response. In conclusion, our work provides a mechanistic basis for understanding the biological and clinical significance of SIRT2 mutations in genome maintenance and tumor suppression.	[Head, PamelaSara E.; Zhang, Hui; Bastien, Amanda J.; Koyen, Allyson E.; Withers, Allison E.; Daddacha, Waaqo B.; Yu, David S.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University	Yu, DS (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	dsyu@emory.edu		Head, PamelaSara/0000-0002-9822-9414	NCI, National Institutes of Health [R01CA178999, R01CA178999S1]; Basser Center for BRCA Innovation Award [32356]; Winship Cancer Institute/Brenda Nease Breast Cancer Research Fund Pilot Award [53237]; NATIONAL CANCER INSTITUTE [R01CA178999] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Basser Center for BRCA Innovation Award; Winship Cancer Institute/Brenda Nease Breast Cancer Research Fund Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grants R01CA178999 and R01CA178999S1, Basser Center for BRCA Innovation Award 32356, and Winship Cancer Institute/Brenda Nease Breast Cancer Research Fund Pilot Award 53237 (all to D. S. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bartosch C, 2016, ONCOTARGET, V7, P1144, DOI 10.18632/oncotarget.6691; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Colbert LE, 2014, CANCER RES, V74, P2677, DOI 10.1158/0008-5472.CAN-13-1996; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hall WA, 2014, ONCOGENE, V33, P5450, DOI 10.1038/onc.2013.488; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li ZM, 2016, ONCOTARGET, V7, P18927, DOI 10.18632/oncotarget.7816; Li ZM, 2013, LUNG CANCER, V82, P9, DOI 10.1016/j.lungcan.2013.05.013; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Rumpf T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7263; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Serrano L, 2013, GENE DEV, V27, P639, DOI 10.1101/gad.211342.112; Smith SC, 2014, NUCLEIC ACIDS RES, V42, P11517, DOI 10.1093/nar/gku840; Song HY, 2016, ONCOTARGET, V7, P80336, DOI 10.18632/oncotarget.12015; Suematsu T, 2014, BIOCHEM BIOPH RES CO, V453, P588, DOI 10.1016/j.bbrc.2014.09.128; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Temel M, 2016, TUMOR BIOL, V37, P6429, DOI 10.1007/s13277-015-4522-8; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang H, 2016, CELL CYCLE, V15, P2089, DOI 10.1080/15384101.2016.1184517; Zhang H, 2016, CELL REP, V14, P1435, DOI 10.1016/j.celrep.2016.01.018; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110	43	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9919	9931		10.1074/jbc.M116.772566	http://dx.doi.org/10.1074/jbc.M116.772566			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28461331	Green Published, hybrid			2022-12-28	WOS:000403580600006
J	Hwang, S; Nguyen, AD; Jo, Y; Engelking, LJ; Brugarolas, J; DeBose-Boyd, RA				Hwang, Seonghwan; Nguyen, Andrew D.; Jo, Youngah; Engelking, Luke J.; Brugarolas, James; DeBose-Boyd, Russell A.			Hypoxia-inducible factor 1 alpha activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG COA REDUCTASE; COENZYME-A REDUCTASE; ACCELERATED DEGRADATION; CHOLESTEROL-SYNTHESIS; FEEDBACK-REGULATION; MESSENGER-RNA; BINDING; PROTEIN; OXYGEN; UBIQUITINATION	Cholesterol synthesis is a highly oxygen-consuming process. As such, oxygen deprivation (hypoxia) limits cholesterol synthesis through incompletely understood mechanisms mediated by the oxygen-sensitive transcription factor hypoxia-inducible factor 1 alpha (HIF-1 alpha). We show here that HIF-1 alpha links pathways for oxygen sensing and feedback control of cholesterol synthesis in human fibroblasts by directly activating transcription of the INSIG-2 gene. Insig-2 is one of two endoplasmic reticulum membrane proteins that inhibit cholesterol synthesis by mediating sterol-induced ubiquitination and subsequent endoplasmic reticulum-associated degradation of the rate-limiting enzyme in the pathway, HMG-CoA reductase (HMGCR). Consistent with the results in cultured cells, hepatic levels of Insig-2 mRNA were enhanced in mouse models of hypoxia. Moreover, pharmacologic stabilization of HIF-1 alpha in the liver stimulatedHMGCRdegradation via a reaction that requires the protein's prior ubiquitination and the presence of the Insig-2 protein. In summary, our results show that HIF-1 alpha activates INSIG-2 transcription, leading to accumulation of Insig-2 protein, which binds to HMGCR and triggers its accelerated ubiquitination and degradation. These results indicate that HIF-mediated induction of Insig-2 and degradation of HMGCR are physiologically relevant events that guard against wasteful oxygen consumption and inappropriate cell growth during hypoxia.	[Hwang, Seonghwan; Nguyen, Andrew D.; Jo, Youngah; Engelking, Luke J.; DeBose-Boyd, Russell A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Brugarolas, James] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Nguyen, Andrew/0000-0002-9492-9472; Brugarolas, James/0000-0002-8575-499X; Engelking, Luke/0000-0002-1355-4964	National Institutes of Health [HL020948, CA196516, DK102652]; NATIONAL CANCER INSTITUTE [P50CA196516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK102652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL020948 (to R. A. D. B.), CA196516 (to J. B.), and DK102652 (to L. J. E.). J. B. is a member of the Scientific Advisory Board for Bethyl Laboratories. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLOCH K, 1953, HARVEY LECT, V48, P68; Dolt KS, 2007, BIOCHEM BIOPH RES CO, V354, P148, DOI 10.1016/j.bbrc.2006.12.159; Drabkin HA, 2012, CURR OPIN PHARMACOL, V12, P742, DOI 10.1016/j.coph.2012.08.002; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gruenbacher G, 2015, CANCER LETT, V356, P192, DOI 10.1016/j.canlet.2014.01.013; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang S, 2016, J BIOL CHEM, V291, P13479, DOI 10.1074/jbc.M116.728469; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LISCUM L, 1983, J BIOL CHEM, V258, P8450; McFarlane MR, 2014, J BIOL CHEM, V289, P2148, DOI 10.1074/jbc.M113.524041; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Tugnoli Vitaliano, 2004, Ital J Biochem, V53, P169; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhu J, 2014, J LIPID RES, V55, P431, DOI 10.1194/jlr.M043521	41	51	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9382	9393		10.1074/jbc.M117.788562	http://dx.doi.org/10.1074/jbc.M117.788562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28416613	Green Published, hybrid			2022-12-28	WOS:000402538900031
J	Xiao, XJ; Jones, G; Sevilla, WA; Stolz, DB; Magee, KE; Haughney, M; Mukherjee, A; Wang, Y; Lowe, ME				Xiao, Xunjun; Jones, Gabrielle; Sevilla, Wednesday A.; Stolz, Donna B.; Magee, Kelsey E.; Haughney, Margaret; Mukherjee, Amitava; Wang, Yan; Lowe, Mark E.			A carboxyl ester lipase (CEL) mutant causes chronic pancreatitis by forming intracellular aggregates that activate apoptosis (vol 291, pg 23224, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Mukherjee, Amitava/AAK-4002-2020	Mukherjee, Amitava/0000-0001-5603-5147; Xiao, Xunjun/0000-0001-5930-4664				XIAO XJ, 2016, CARBOXYL ESTER LIPAS, V291, P23224, DOI DOI 10.1074/JBC.A116.734384	1	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7744	7744		10.1074/jbc.A116.734384	http://dx.doi.org/10.1074/jbc.A116.734384			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28500240	Green Published, hybrid			2022-12-28	WOS:000401154100005
J	Ha, S; Jeong, SH; Yi, K; Chung, KM; Hong, CJ; Kim, SW; Kim, EK; Yu, SW				Ha, Shinwon; Jeong, Seol-Hwa; Yi, Kyungrim; Chung, Kyung Min; Hong, Caroline Jeeyeon; Kim, Seong Who; Kim, Eun-Kyoung; Yu, Seong-Woon			Phosphorylation of p62 by AMP-activated protein kinase mediates autophagic cell death in adult hippocampal neural stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN WITHDRAWAL; MITOPHAGY; P62/SQSTM1; DEGRADATION; APOPTOSIS; PATHWAY; SURVIVAL; PROLIFERATION; MITOCHONDRIA; MECHANISMS	In the adult brain, programmed death of neural stem cells is considered to be critical for tissue homeostasis and cognitive function and is dysregulated in neurodegeneration. Previously, we have reported that adult rat hippocampal neural (HCN) stem cells undergo autophagic cell death (ACD) following insulin withdrawal. Because the apoptotic capability of the HCN cells was intact, our findings suggested activation of unique molecular mechanisms linking insulin withdrawal to ACD rather than apoptosis. Here, we report that phosphorylation of autophagy-associated protein p62 by AMP-activated protein kinase (AMPK) drives ACD and mitophagy in HCN cells. Pharmacological inhibition of AMPK or genetic ablation of the AMPK alpha 2 subunit by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing suppressed ACD, whereas AMPK activation promoted ACD in insulin-deprived HCN cells. We found that following insulin withdrawal AMPK phosphorylated p62 at a novel site, Ser-293/Ser-294 (in rat and human p62, respectively). Phosphorylated p62 translocated to mitochondria and induced mitophagy and ACD. Interestingly, p62 phosphorylation at Ser-293 was not required for staurosporine-induced apoptosis in HCN cells. To the best of our knowledge, this is the first report on the direct phosphorylation of p62 by AMPK. Our data suggest that AMPK-mediated p62 phosphorylation is an ACD-specific signaling event and provide novel mechanistic insight into the molecular mechanisms in ACD.	[Ha, Shinwon; Jeong, Seol-Hwa; Yi, Kyungrim; Chung, Kyung Min; Hong, Caroline Jeeyeon; Kim, Eun-Kyoung; Yu, Seong-Woon] Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu 42988, South Korea; [Kim, Eun-Kyoung; Yu, Seong-Woon] Gyeongbuk Inst Sci & Technol, Neurometab Res Ctr, Daegu 42988, South Korea; [Kim, Seong Who] Univ Ulsan, Dept Biochem & Mol Biol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea	University of Ulsan	Yu, SW (corresponding author), DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea.	yusw@dgist.ac.kr			Bio and Medical Technology Development Program of the National Research Foundation of Korea [2012M3A9C6049935, 2013M3C7A1056099]; Korea Brain Research Institute Basic Research Program [17-BR-04]; Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program of the Ministry of Science, ICT and Future Planning of Korea [17-BD-04]	Bio and Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea); Korea Brain Research Institute Basic Research Program; Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program of the Ministry of Science, ICT and Future Planning of Korea	This work was supported by Bio and Medical Technology Development Program of the National Research Foundation of Korea Grants (2012M3A9C6049935 and 2013M3C7A1056099), Korea Brain Research Institute Basic Research Program (17-BR-04), and Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program (17-BD-04) of the Ministry of Science, ICT and Future Planning of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Baek SH, 2009, AUTOPHAGY, V5, P277, DOI 10.4161/auto.5.2.7641; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chung KM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00116; Chung KM, 2015, STEM CELLS, V33, P3052, DOI 10.1002/stem.2082; Chung KM, 2013, BMB REP, V46, P383, DOI 10.5483/BMBRep.2013.46.8.164; Clarke PGH, 2012, AUTOPHAGY, V8, P867, DOI 10.4161/auto.20380; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha S, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0119-9; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hong CJ, 2016, BRAIN RES, V1649, P166, DOI 10.1016/j.brainres.2016.02.048; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim NY, 2014, ANIM CELLS SYST, V18, P183, DOI 10.1080/19768354.2014.923045; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Linares JF, 2011, MOL CELL BIOL, V31, P105, DOI 10.1128/MCB.00620-10; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitani T, 2015, CELL SIGNAL, V27, P1994, DOI 10.1016/j.cellsig.2015.07.009; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Sinha RA, 2015, AUTOPHAGY, V11, P1341, DOI 10.1080/15548627.2015.1061849; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yeo BK, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0212-8; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153	68	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13795	13808		10.1074/jbc.M117.780874	http://dx.doi.org/10.1074/jbc.M117.780874			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655770	Green Published, hybrid			2022-12-28	WOS:000407942400008
J	Vig, AT; Foldi, I; Szikora, S; Migh, E; Gombos, R; Toth, MA; Huber, T; Pinter, R; Talian, GC; Mihaly, J; Bugyi, B				Vig, Andrea Terez; Foldi, Istvan; Szikora, Szilard; Migh, Ede; Gombos, Rita; Toth, Monika Agnes; Huber, Tamas; Pinter, Reka; Talian, Gabor Csaba; Mihaly, Jozsef; Bugyi, Beata			The activities of the C-terminal regions of the formin protein disheveled-associated activator of morphogenesis (DAAM) in actin dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMINS; FILAMENT BARBED END; CAPPING PROTEIN; HOMOLOGY-2 DOMAIN; FILOPODIA FORMATION; STRUCTURAL BASIS; BINDING PROTEIN; MOUSE FORMIN; FH2 DOMAIN; WH2 DOMAIN	Disheveled-associated activator of morphogenesis (DAAM) is a diaphanous-related formin protein essential for the regulation of actin cytoskeleton dynamics in diverse biological processes. The conserved formin homology 1 and 2 (FH1-FH2) domains of DAAM catalyze actin nucleation and processively mediate filament elongation. These activities are indirectly regulated by the N- and C-terminal regions flanking the FH1-FH2 domains. Recently, the C-terminal diaphanous-autoregulatory domain (DAD) and the C terminus (CT) of formins have also been shown to regulate actin assembly by directly interacting with actin. Here, to better understand the biological activities of DAAM, we studied the role of DAD-CT regions of Drosophila DAAM in its interaction with actin with in vitro biochemical and in vivo genetic approaches. We found that the DAD-CT region binds actin in vitro and that its main actin-binding element is the CT region, which does not influence actin dynamics on its own. However, we also found that it can tune the nucleating activity and the filament end-interaction properties of DAAM in an FH2 domain-dependent manner. We also demonstrate that DAD-CT makes the FH2 domain more efficient in antagonizing with capping protein. Consistently, in vivo data suggested that the CT region contributes to DAAM-mediated filopodia formation and dynamics in primary neurons. In conclusion, our results demonstrate that the CT region of DAAM plays an important role in actin assembly regulation in a biological context.	[Vig, Andrea Terez; Toth, Monika Agnes; Huber, Tamas; Pinter, Reka; Talian, Gabor Csaba; Bugyi, Beata] Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary; [Foldi, Istvan; Szikora, Szilard; Migh, Ede; Gombos, Rita; Mihaly, Jozsef] Hungarian Acad Sci, Inst Genet, Biol Res Ctr, MTA SZBK NAP B Axon Growth & Regenerat Grp, Temesvari Krt 62, H-6726 Szeged, Hungary; [Bugyi, Beata] Szentagothai Res Ctr, Ifjusag Str 34, H-7624 Pecs, Hungary	University of Pecs; Hungarian Academy of Sciences; Hungarian Biological Research Center	Bugyi, B (corresponding author), Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	beata.bugyi@aok.pte.hu		Mihaly, Jozsef/0000-0003-3399-2424; Migh, Ede/0000-0002-8312-6463	Hungarian Science Foundation (OTKA) [K109689, K109330]; Hungarian Brain Research Program Grant [KTIA_NAP_13-2-2014-0007]; National Research, Development, and Innovation Office [GINOP-2.3.2-15-2016-00001]; National Innovation Office "Baross Gabor" Program [REG-DD-09-1-2009-0009]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]; Ministry of Human Capacities; New National Excellence Program of the Ministry of Human Capacities [UNKP-16-4]	Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program Grant; National Research, Development, and Innovation Office; National Innovation Office "Baross Gabor" Program; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Ministry of Human Capacities; New National Excellence Program of the Ministry of Human Capacities	This work was supported by Hungarian Science Foundation (OTKA) Grants K109689 (to B. B.) and K109330 (to J. M.); Hungarian Brain Research Program Grant KTIA_NAP_13-2-2014-0007 (to J. M.); National Research, Development, and Innovation Office Grant GINOP-2.3.2-15-2016-00001 (to J. M.); National Innovation Office "Baross Gabor" Program Grant REG-DD-09-1-2009-0009 Tirfm 09 (to B. B.); grants from the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program"; New National Excellence Program of the Ministry of Human Capacities (to B. B. and T. H.); and UNKP-16-4 New National Excellence Program of the Ministry of Human Capacities (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bao BH, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-63; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Bombardier JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9707; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Bugyi B, 2010, EMBO J, V29, P14, DOI 10.1038/emboj.2009.316; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; HANSON J, 1963, J MOL BIOL, V6, P46, DOI 10.1016/S0022-2836(63)80081-9; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; ISENBERG G, 1980, NATURE, V288, P455, DOI 10.1038/288455a0; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Molnar I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004166; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Renault L, 2013, CYTOSKELETON, V70, P686, DOI 10.1002/cm.21140; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Toth MA, 2016, J BIOL CHEM, V291, P667, DOI 10.1074/jbc.M115.683904; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Vogler G, 2014, J CELL BIOL, V206, P909, DOI 10.1083/jcb.201405075; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	61	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13566	13583		10.1074/jbc.M117.799247	http://dx.doi.org/10.1074/jbc.M117.799247			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28642367	Green Published, hybrid			2022-12-28	WOS:000407942400030
J	Vo, T; Wang, S; Poon, GMK; Wilson, WD				Vo, Tam; Wang, Shuo; Poon, Gregory M. K.; Wilson, W. David			Electrostatic control of DNA intersegmental translocation by the ETS transcription factor ETV6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC ACID INTERACTIONS; LAC REPRESSOR; FACILITATED DIFFUSION; BINDING DOMAINS; PROTEIN; KINETICS; ASSOCIATION; SITES; AUTOINHIBITION; SEQUENCE	To find their DNA target sites in complex solution environments containing excess heterogeneous DNA, sequence-specific DNA-binding proteins execute various translocation mechanisms known collectively as facilitated diffusion. For proteins harboring a single DNA contact surface, long-range translocation occurs by jumping between widely spaced DNA segments. We have configured biosensor-based surface plasmon resonance to directly measure the affinity and kinetics of this intersegmental jumping by the ETS-family transcription factor ETS variant 6 (ETV6). To isolate intersegmental target binding in a functionally defined manner, we pre-equilibrated ETV6 with excess salmon sperm DNA, a heterogeneous polymer, before exposing the nonspecifically bound protein to immobilized oligomeric DNA harboring a high-affinity ETV6 site. In this way, the mechanism of ETV6-target association could be toggled electrostatically through varying NaCl concentration in the bulk solution. Direct measurements of association and dissociation kinetics of the site-specific complex indicated that 1) freely diffusive binding by ETV6 proceeds through a nonspecificlike intermediate, 2) intersegmental jumping is rate-limited by dissociation from the nonspecific polymer, and 3) dissociation of the specific complex is independent of the history of complex formation. These results show that target searches by proteins with an ETS domain, such as ETV6, whose single DNA-binding domain cannot contact both source and destination sites simultaneously, are nonetheless strongly modulated by intersegmental jumping in heterogeneous site environments. Our findings establish biosensors as a general technique for directly and specifically measuring target site search by DNA-binding proteins via intersegmental translocation.	[Vo, Tam; Wang, Shuo; Poon, Gregory M. K.; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Poon, Gregory M. K.; Wilson, W. David] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Poon, GMK; Wilson, WD (corresponding author), POB 3965, Atlanta, GA 30302 USA.	gpoon@gsu.edu; wdw@gsu.edu			National Science Foundation [MCB 15451600]; National Institutes of Health [GM 111749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111749] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 15451600 (to G. M. K. P.) and National Institutes of Health Grant GM 111749 (to W. D. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALMA NCM, 1983, J MOL BIOL, V163, P47, DOI 10.1016/0022-2836(83)90029-3; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARKLEY MD, 1981, BIOCHEMISTRY-US, V20, P3833, DOI 10.1021/bi00516a026; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1978, BIOPHYS CHEM, V8, P271, DOI 10.1016/0301-4622(78)80010-6; BRESLOFF JL, 1975, J MOL BIOL, V95, P103, DOI 10.1016/0022-2836(75)90339-3; Coyne HJ, 2012, J MOL BIOL, V421, P67, DOI 10.1016/j.jmb.2012.05.010; Davis TM, 2000, ANAL BIOCHEM, V284, P348, DOI 10.1006/abio.2000.4726; De S, 2016, J MOL BIOL, V428, P1515, DOI 10.1016/j.jmb.2016.02.020; Del S, 2014, J MOL BIOL, V426, P1390, DOI 10.1016/j.jmb.2013.11.031; FRIED MG, 1984, J MOL BIOL, V172, P263, DOI 10.1016/S0022-2836(84)80026-1; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2013, J BIOL CHEM, V288, P24550, DOI 10.1074/jbc.M113.477018; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; JELTSCH A, 1994, BIOCHEMISTRY-US, V33, P10215, DOI 10.1021/bi00200a001; Kemme CA, 2015, BIOCHEMISTRY-US, V54, P6684, DOI 10.1021/acs.biochem.5b00967; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656; LOHMAN TM, 1978, BIOPHYS CHEM, V8, P281, DOI 10.1016/0301-4622(78)80011-8; Munde M, 2013, J MOL BIOL, V425, P1655, DOI 10.1016/j.jmb.2013.02.010; Pollak AJ, 2015, BIOCHEMISTRY-US, V54, P2181, DOI 10.1021/bi501344r; Pollak AJ, 2014, J MOL BIOL, V426, P3539, DOI 10.1016/j.jmb.2014.08.002; Poon GMK, 2004, BIOCHEMISTRY-US, V43, P16337, DOI 10.1021/bi0480786; Rau DC, 2010, J MOL BIOL, V395, P408, DOI 10.1016/j.jmb.2009.10.049; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Stephens DC, 2016, NUCLEIC ACIDS RES, V44, P8671, DOI 10.1093/nar/gkw528; Stephens DC, 2016, NUCLEIC ACIDS RES, V44, P4005, DOI 10.1093/nar/gkw229; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tsodikov OV, 2001, BIOPHYS J, V81, P1960, DOI 10.1016/S0006-3495(01)75847-X; Wang S, 2015, METHODS MOL BIOL, V1334, P313, DOI 10.1007/978-1-4939-2877-4_20; Wang S, 2014, J BIOL CHEM, V289, P21605, DOI 10.1074/jbc.M114.575340	38	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13187	13196		10.1074/jbc.M117.792887	http://dx.doi.org/10.1074/jbc.M117.792887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28592487	Green Published, hybrid			2022-12-28	WOS:000407465300010
J	Wang, Q; Tang, YM; Xu, Y; Xu, SL; Jiang, Y; Dong, QP; Zhou, YS; Ge, WS				Wang, Qian; Tang, Yiman; Xu, Yue; Xu, Shilei; Jiang, Yong; Dong, Qiuping; Zhou, Yongsheng; Ge, Wenshu			The X-linked deubiquitinase USP9X is an integral component of centrosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centrosome; deubiquitylation (deubiquitination); protein stability; protein-protein interaction; proteomics	NEURONAL MIGRATION; HUMAN-DISEASE; PROTEIN; EXPRESSION; MIDBODY; CEP55; BRAIN; GENE; MONOUBIQUITINATION; STABILIZATION	The X-linked deubiquitinase USP9X has been implicated in multiple pathological disorders including malignancies and X-linked intellectual disability. However, its biological function and substrate repertoire remain to be investigated. In this study, we utilized the tandem mass tag labeling assay to identify USP9X-regulated proteins and revealed that the expression of multiple genes is altered in USP9X-deficient cells. Interestingly, we showed that USP9X promotes stabilization of centrosome proteins PCM1 and CEP55 through its catalytic activity. Remarkably, we demonstrated that USP9X is physically associated and spatially co-localized with PCM1 and CEP55 in the centrosome, and we revealed that either PCM1 or CEP55 loss resulted in impairment of USP9X centrosome localization. Moreover, we showed that USP9X is required for centrosome duplication, and this effect is dependent on its catalytic activity and its N-terminal module, which is responsible for physical association of USP9X with PCM1 and CEP55. Collectively, our experiments identified USP9X as an integral component of the centrosome where it functions to stabilize PCM1 and CEP55 and promote centrosome biogenesis.	[Jiang, Yong; Ge, Wenshu] Peking Univ Sch & Hosp Stomatol, Dept Gen Dent 2, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Tang, Yiman; Zhou, Yongsheng] Peking Univ Sch & Hosp Stomatol, Dept Prosthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Wang, Qian; Xu, Yue; Xu, Shilei; Dong, Qiuping] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China; [Zhou, Yongsheng] Beijing Key Lab Digital Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing 100081, Peoples R China	Peking University; Peking University; Tianjin Medical University	Ge, WS (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Gen Dent 2, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.; Zhou, YS (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Prosthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.	kqzhouysh@hsc.pku.edu.cn; esther1234@hsc.pku.edu.cn			National Natural Science Foundation of China [81200763, 81670963]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81200763 and 81670963 (to W. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Baumann K, 2012, NAT REV MOL CELL BIO, V13, DOI [10.1038/nrm3418, 10.1038/nrm3422]; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; David R, 2011, NAT REV MOL CELL BIO, V12, P466, DOI 10.1038/nrm3158; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Gomez-Ferreria MA, 2012, CELL CYCLE, V11, P3555, DOI 10.4161/cc.21574; Grasso D, 2011, J BIOL CHEM, V286, P8308, DOI 10.1074/jbc.M110.197301; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Hori A, 2017, CELL MOL LIFE SCI, V74, P213, DOI 10.1007/s00018-016-2315-x; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jeffery J, 2016, ONCOGENE, V35, P683, DOI 10.1038/onc.2015.128; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Jung JK, 2016, CELL CYCLE, V15, P584, DOI 10.1080/15384101.2016.1138185; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14866; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Luders J, 2012, NAT CELL BIOL, V14, P1126, DOI 10.1038/ncb2617; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Naik E, 2014, J EXP MED, V211, P1947, DOI 10.1084/jem.20140860; Ou Y, 2004, CELL MOTIL CYTOSKEL, V57, P1, DOI 10.1002/cm.10154; Paemka L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005022; Park Y, 2013, P NATL ACAD SCI USA, V110, P9433, DOI 10.1073/pnas.1221925110; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Svinkina T, 2015, MOL CELL PROTEOMICS, V14, P2429, DOI 10.1074/mcp.O114.047555; Swaminathan S, 2004, NAT CELL BIOL, V6, P383, DOI 10.1038/ncb0504-383; Takayanagi H, 2015, ACTA CRYSTALLOGR F, V71, P175, DOI 10.1107/S2053230X14028143; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047; Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223; Wang S, 2014, P NATL ACAD SCI USA, V111, P4251, DOI 10.1073/pnas.1322198111; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Xu J, 2005, EUR J NEUROSCI, V21, P3017, DOI 10.1111/j.1460-9568.2005.04134.x; Xu J, 2005, J NEUROSCI RES, V80, P47, DOI 10.1002/jnr.20429; Zarrizi R, 2014, CANCER RES, V74, P6499, DOI 10.1158/0008-5472.CAN-14-0221; Zhang Y, 2012, J CLIN INVEST, V122, P4362, DOI 10.1172/JCI63084; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001	59	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12874	12884		10.1074/jbc.M116.769943	http://dx.doi.org/10.1074/jbc.M116.769943			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28620049	Green Published, hybrid			2022-12-28	WOS:000407220100017
J	Gonzales-Zubiate, FA; Okuda, EK; Da Cunha, JPC; Oliveira, CC				Gonzales-Zubiate, Fernando A.; Okuda, Ellen K.; Da Cunha, Julia P. C.; Oliveira, Carla Columbano			Identification of karyopherins involved in the nuclear import of RNA exosome subunit Rrp6 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; LARGE GENE LISTS; HUMAN PM-SCL; LOCALIZATION SIGNALS; BINDING PROTEIN; CELL-CYCLE; SYSTEMATIC IDENTIFICATION; MASS-SPECTROMETRY; YEAST EXOSOME; COMPLEX	The exosome is a conserved multiprotein complex essential for RNA processing and degradation. The nuclear exosome is a key factor for pre-rRNA processing through the activity of its catalytic subunits, Rrp6 and Rrp44. In Saccharomyces cerevisiae, Rrp6 is exclusively nuclear and has been shown to interact with exosome cofactors. With the aim of analyzing proteins associated with the nuclear exosome, in this work, we purified the complex with Rrp6-TAP, identified the co-purified proteins by mass spectrometry, and found karyopherins to be one of the major groups of proteins enriched in the samples. By investigating the biological importance of these protein interactions, we identified Srp1, Kap95, and Sxm1 as the most important karyopherins for Rrp6 nuclear import and the nuclear localization signals recognized by them. Based on the results shown here, we propose a model of multiple pathways for the transport of Rrp6 to the nucleus.	[Gonzales-Zubiate, Fernando A.; Okuda, Ellen K.; Oliveira, Carla Columbano] Univ Sao Paulo, Inst Chem, Dept Biochem, Ave Prof Lineu Prestes 748, BR-05508000 Sao Paulo, SP, Brazil; [Da Cunha, Julia P. C.] Ctr Res Toxins Immune Response & Cell Signaling C, Butantan Inst, Ctr Toxins Immune Response & Cell Signaling, Cell Cycle Lab, BR-05503900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto Butantan	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Ave Prof Lineu Prestes 748, BR-05508000 Sao Paulo, SP, Brazil.	ccoliv@iq.usp.br	da Cunha, Julia PC/K-8553-2017; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Gonzales-Zubiate, Fernando A/O-2709-2014; Oliveira, Carla C/F-2323-2011	da Cunha, Julia PC/0000-0003-0466-8879; Gonzales-Zubiate, Fernando A/0000-0001-9519-4079; Oliveira, Carla C/0000-0002-1098-9241	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51842-3, 15/06477-9]; FAPESP Postdoctoral Fellowship [2012/50196-6.]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Postdoctoral Fellowship	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 10/51842-3 and 15/06477-9 (to C. C. O.).; Supported by FAPESP Postdoctoral Fellowship 2012/50196-6.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Bakhrat A, 2006, J BIOL CHEM, V281, P12218, DOI 10.1074/jbc.M600238200; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Caesar S, 2006, MOL CELL BIOL, V26, P3170, DOI 10.1128/MCB.26.8.3170-3180.2006; Canavan R, 2007, NUCLEIC ACIDS RES, V35, P6268, DOI 10.1093/nar/gkm691; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Franke J, 2001, J CELL SCI, V114, P2641; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P535, DOI 10.1016/0378-1119(88)90186-2; Goldfeder MB, 2010, FEBS J, V277, P2838, DOI 10.1111/j.1742-4658.2010.07701.x; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodges JL, 2005, MOL BIOL CELL, V16, P3200, DOI 10.1091/mbc.E04-11-0990; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kimura M, 2014, TRAFFIC, V15, P727, DOI 10.1111/tra.12174; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lourenco RF, 2013, J PROTEOME RES, V12, P5912, DOI 10.1021/pr400972x; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Luz JS, 2007, BIOCHIMIE, V89, P686, DOI 10.1016/j.biochi.2007.01.011; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Makino DL, 2015, NATURE, V524, P54, DOI 10.1038/nature14865; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morehouse H, 1999, P NATL ACAD SCI USA, V96, P12542, DOI 10.1073/pnas.96.22.12542; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Sambrook J., 2001, MOL CLONING LAB MANU; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schaper S, 2005, J CELL SCI, V118, P1473, DOI 10.1242/jcs.01739; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; Synowsky SA, 2009, J MOL BIOL, V385, P1300, DOI 10.1016/j.jmb.2008.11.011; Tran EJ, 2014, BBA-MOL CELL RES, V1843, P2784, DOI 10.1016/j.bbamcr.2014.08.003; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283	77	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12267	12284		10.1074/jbc.M116.772376	http://dx.doi.org/10.1074/jbc.M116.772376			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28539363	hybrid, Green Published			2022-12-28	WOS:000406053300023
J	Zempel, H; Dennissen, FJA; Kumar, Y; Luedtke, J; Biernat, J; Mandelkow, EM; Mandelkow, E				Zempel, Hans; Dennissen, Frank J. A.; Kumar, Yatender; Luedtke, Julia; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard			Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; POLARIZED NEURONS; DIFFUSION BARRIER; DENDRITIC SPINES; NERVOUS-SYSTEM; PROTEIN-TAU; EXPRESSION; MICE; MICROTUBULES	Subcellular mislocalization of the microtubule-associated protein Tau is a hallmark of Alzheimer disease (AD) and other tauopathies. Six Tau isoforms, differentiated by the presence or absence of a second repeat or of N-terminal inserts, exist in the human CNS, but their physiological and pathological differences have long remained elusive. Here, we investigated the properties and distributions of human and rodent Tau isoforms in primary forebrain rodent neurons. We found that the Tau diffusion barrier (TDB), located within the axon initial segment (AIS), controls retrograde (axon-to-soma) and anterograde (soma-to-axon) traffic of Tau. Tau isoforms without the N-terminal inserts were sorted efficiently into the axon. However, the longest isoform (2N4R-Tau) was partially retained in cell bodies and dendrites, where it accelerated spine and dendrite growth. The TDB (located within the AIS) was impaired when AIS components (ankyrin G, EB1) were knocked down or when glycogen synthase kinase-3 beta (GSK3 beta; an AD-associated kinase tethered to the AIS) was overexpressed. Using superresolution nanoscopy and live-cell imaging, we observed that microtubules within the AIS appeared highly dynamic, a feature essential for the TDB. Pathomechanistically, amyloid-beta insult caused cofilin activation and F-actin remodeling and decreased microtubule dynamics in the AIS. Concomitantly with these amyloid-beta-induced disruptions, the AIS/TDB sorting function failed, causing AD-like Tau missorting. In summary, we provide evidence that the human and rodent Tau isoforms differ in axodendritic sorting and amyloid-beta-induced missorting and that the axodendritic distribution of Tau depends on AIS integrity.	[Zempel, Hans; Dennissen, Frank J. A.; Kumar, Yatender; Luedtke, Julia; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, Ludwig Erhard Allee 2, D-53127 Bonn, Germany; [Zempel, Hans; Dennissen, Frank J. A.; Luedtke, Julia; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] CAESAR Res Ctr, D-53175 Bonn, Germany; [Zempel, Hans; Kumar, Yatender; Mandelkow, Eva-Maria; Mandelkow, Eckhard] Max Planck Inst Metab Res, D-50931 Cologne, Germany; [Zempel, Hans] Univ Bonn, D-53113 Bonn, Germany; [Kumar, Yatender] NSIT, New Delhi, India	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Bonn; Netaji Subhas University of Technology	Zempel, H; Mandelkow, E (corresponding author), German Ctr Neurodegenerat Dis DZNE, Ludwig Erhard Allee 2, D-53127 Bonn, Germany.	hans.zempel@dzne.de; eckhard.mandelkow@dzne.de	Kumar, Yatender/AAG-1920-2020	Dennissen, Frank/0000-0001-7446-122X	German Center for Neurodegenerative Diseases (DZNE); Max-Planck Society (MPG); Metlife Foundation; Tau Consortium	German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); Max-Planck Society (MPG)(Max Planck Society); Metlife Foundation; Tau Consortium	This work was supported by the German Center for Neurodegenerative Diseases (DZNE), Max-Planck Society (MPG), Metlife Foundation, and Tau Consortium. The authors declare that they have no conflicts of interest with the contents of this article.	Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Baas PW, 2011, DEV NEUROBIOL, V71, P403, DOI 10.1002/dneu.20818; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bender KJ, 2012, ANNU REV NEUROSCI, V35, P249, DOI 10.1146/annurev-neuro-062111-150339; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Chen Q, 2012, NEUROCHEM INT, V60, P233, DOI 10.1016/j.neuint.2011.12.013; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; Cruz DA, 2009, J COMP NEUROL, V514, P353, DOI 10.1002/cne.22006; Dawson HN, 2001, J CELL SCI, V114, P1179; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hara M, 2013, ACTA NEUROPATHOL, V125, P565, DOI 10.1007/s00401-013-1097-6; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jones SL, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6808293; Jones SL, 2014, J CELL BIOL, V205, P67, DOI 10.1083/jcb.201401045; Kam TI, 2014, CELL MOL LIFE SCI, V71, P4803, DOI 10.1007/s00018-014-1706-0; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Leterrier C, 2016, CURR TOP MEMBR, V77, P185, DOI 10.1016/bs.ctm.2015.10.005; Leterrier C, 2011, P NATL ACAD SCI USA, V108, P8826, DOI 10.1073/pnas.1018671108; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Medina M, 2014, EXPERT OPIN THER TAR, V18, P69, DOI 10.1517/14728222.2013.843670; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Riano E, 2009, J NEUROCHEM, V108, P1277, DOI 10.1111/j.1471-4159.2009.05875.x; Sayas CL, 2015, J NEUROCHEM, V133, P653, DOI 10.1111/jnc.13091; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tapia M, 2013, CELL MOL LIFE SCI, V70, P105, DOI 10.1007/s00018-012-1059-5; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zempel H, 2017, METHODS MOL BIOL, V1523, P335, DOI 10.1007/978-1-4939-6598-4_21; Zempel H, 2017, METHODS MOL BIOL, V1523, P327, DOI 10.1007/978-1-4939-6598-4_20; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004	67	66	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12192	12207		10.1074/jbc.M117.784702	http://dx.doi.org/10.1074/jbc.M117.784702			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28536263	Green Published, hybrid			2022-12-28	WOS:000406053300017
J	Chitty, JL; Blake, KL; Blundell, RD; Koh, YQAE; Thompson, M; Robertson, AAB; Butler, MS; Cooper, MA; Kappler, U; Williams, SJ; Kobe, B; Fraser, JA				Chitty, Jessica L.; Blake, Kirsten L.; Blundell, Ross D.; Koh, Y. Q. Andre E.; Thompson, Merinda; Robertson, Avril A. B.; Butler, Mark S.; Cooper, Matthew A.; Kappler, Ulrike; Williams, Simon J.; Kobe, Bostjan; Fraser, James A.			Cryptococcus neoformans ADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme kinetics; fungi; nucleoside; nucleotide biosynthesis; pathogenesis; adenylosuccinate lyase; virulence	ADENYLOSUCCINATE LYASE; CEREBROSPINAL-FLUID; GMP SYNTHASE; DEFICIENCY; PURINE; GENE; BIOSYNTHESIS; METABOLISM; RESISTANCE; ACID	There is significant clinical need for new antifungal agents to manage infections with pathogenic species such as Cryptococcus neoformans. Because the purine biosynthesis pathway is essential for many metabolic processes, such as synthesis of DNA and RNA and energy generation, it may represent a potential target for developing new antifungals. Within this pathway, the bifunctional enzyme adenylosuccinate (ADS) lyase plays a role in the formation of the key intermediates inosine monophosphate and AMP involved in the synthesis of ATP and GTP, prompting us to investigate ADS lyase in C. neoformans. Here, we report that ADE13 encodes ADS lyase in C. neoformans. We found that an ade13 Delta mutant is an adenine auxotroph and is unable to successfully cause infections in a murine model of virulence. Plate assays revealed that production of a number of virulence factors essential for dissemination and survival of C. neoformans in a host environment was compromised even with the addition of exogenous adenine. Purified recombinant C. neoformans ADS lyase shows catalytic activity similar to its human counterpart, and its crystal structure, the first fungal ADS lyase structure determined, shows a high degree of structural similarity to that of human ADS lyase. Two potentially important amino acid differences are identified in the C. neoformans crystal structure, in particular a threonine residue that may serve as an additional point of binding for a fungal enzyme-specific inhibitor. Besides serving as an antimicrobial target, C. neoformans ADS lyase inhibitors may also serve as potential therapeutics for metabolic disease; rather than disrupt ADS lyase, compounds that improve the stability the enzyme may be used to treat ADS lyase deficiency disease.	[Chitty, Jessica L.; Blake, Kirsten L.; Blundell, Ross D.; Koh, Y. Q. Andre E.; Thompson, Merinda; Cooper, Matthew A.; Kappler, Ulrike; Williams, Simon J.; Kobe, Bostjan; Fraser, James A.] Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Chitty, Jessica L.; Robertson, Avril A. B.; Butler, Mark S.; Cooper, Matthew A.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Kappler, Ulrike] Univ Queensland, Ctr Met Biol, St Lucia, Qld 4072, Australia; [Williams, Simon J.] Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia	University of Queensland; University of Queensland; University of Queensland; Australian National University	Fraser, JA (corresponding author), Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	jafraser@uq.edu.au	Chitty, Jessica/U-6619-2019; Kappler, Ulrike/A-9483-2013; Fraser, James A/B-4918-2012; Cooper, Matthew A./C-7988-2009; Robertson, Avril/A-4043-2012; Williams, Simon/F-7447-2011; Butler, Mark S./D-9973-2011; McMahon, Kirsten/M-8735-2017; Kobe, Bostjan/D-1292-2009	Chitty, Jessica/0000-0003-1776-1618; Kappler, Ulrike/0000-0002-2642-1319; Fraser, James A/0000-0001-5724-5285; Cooper, Matthew A./0000-0003-3147-3460; Robertson, Avril/0000-0002-9652-8357; Williams, Simon/0000-0003-4781-6261; Butler, Mark S./0000-0001-6689-4236; McMahon, Kirsten/0000-0001-8254-0235; Kobe, Bostjan/0000-0001-9413-9166	National Health and Medical Research Council (NHMRC) [APP1049716]; NHMRC [1003325, 1110971]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (NHMRC) Grant APP1049716 (to J. A. F. and M. S. B.). The authors declare that they have no conflicts of interest with the contents of this article.; NHMRC Principal Research Fellow supported by Grants 1003325 and 1110971.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ariyananda LDZ, 2008, BIOCHEMISTRY-US, V47, P2923, DOI 10.1021/bi701400c; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Auclair JR, 2010, P NATL ACAD SCI USA, V107, P21394, DOI 10.1073/pnas.1015463107; Banerjee S, 2014, FEBS J, V281, P1642, DOI 10.1111/febs.12730; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Blundell RD, 2016, ACS INFECT DIS, V2, P651, DOI 10.1021/acsinfecdis.6b00121; Boitz JM, 2013, J BIOL CHEM, V288, P8977, DOI 10.1074/jbc.M112.431486; Brosius JL, 2000, BIOCHEMISTRY-US, V39, P13336, DOI 10.1021/bi001488j; Bulusu V, 2009, BBA-PROTEINS PROTEOM, V1794, P642, DOI 10.1016/j.bbapap.2008.11.021; Carlyll H B, 1911, Proc R Soc Med, V4, P147; CARTER CE, 1956, J BIOL CHEM, V222, P17; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chitty JL, 2017, J BIOL CHEM, V292, P3049, DOI [10.1074/jbc.M116.767533, 10.1074/jbc.m116.767533]; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Donti TR, 2016, MOL GENET METAB REP, V8, P61, DOI 10.1016/j.ymgmr.2016.07.007; DORFMAN BZ, 1969, GENETICS, V61, P377; Edery P, 2003, AM J MED GENET A, V120A, P185, DOI 10.1002/ajmg.a.20176; EELLS JT, 1983, NEUROCHEM RES, V8, P1451; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Friese G, 2001, AIDS, V15, P2344, DOI 10.1097/00002030-200111230-00026; Garrod A B, 1848, Med Chir Trans, V31, P83; Garrod A.E., 1909, INBORN ERRORS METABO; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Henneke M, 2010, NMR BIOMED, V23, P441, DOI 10.1002/nbm.1480; HITCHCOCK CA, 1990, BIOCHEM J, V266, P475, DOI 10.1042/bj2660475; JACKSON RC, 1976, LIFE SCI, V18, P1043, DOI 10.1016/0024-3205(76)90136-3; JACKSON RC, 1977, CANCER RES, V37, P3057; JAEKEN J, 1984, LANCET, V2, P1058; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jiang LH, 2010, FEMS YEAST RES, V10, P199, DOI 10.1111/j.1567-1364.2009.00600.x; Jurecka A, 2008, MOL GENET METAB, V94, P435, DOI 10.1016/j.ymgme.2008.04.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley Roger E, 2014, Handb Clin Neurol, V120, P827, DOI 10.1016/B978-0-7020-4087-0.00055-3; Kmoch S, 2000, HUM MOL GENET, V9, P1501, DOI 10.1093/hmg/9.10.1501; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Loyse A, 2013, J ANTIMICROB CHEMOTH, V68, P2435, DOI 10.1093/jac/dkt221; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; MACK DO, 1985, BIOCHEM MED METAB B, V34, P327, DOI 10.1016/0006-2944(85)90095-X; MACKENZIE DY, 1959, BRIT MED J, V1, P90, DOI 10.1136/bmj.1.5114.90; Marie S, 1999, HUM MUTAT, V13, P197, DOI 10.1002/(SICI)1098-1004(1999)13:3<197::AID-HUMU3>3.0.CO;2-D; Marshall VM, 1997, MOL BIOCHEM PARASIT, V88, P237, DOI 10.1016/S0166-6851(97)00054-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mendelsohn LG, 1996, INVEST NEW DRUG, V14, P287, DOI 10.1007/BF00194532; MILLER RW, 1959, J BIOL CHEM, V234, P1806; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Park J., 2014, UPDATE GLOBAL BURDEN; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Ray SP, 2012, BIOCHEMISTRY-US, V51, P6701, DOI 10.1021/bi300796y; REED VL, 1987, CLIN BIOCHEM, V20, P349, DOI 10.1016/S0009-9120(87)80085-1; Rodriguez-Suarez R, 2007, CHEM BIOL, V14, P1163, DOI 10.1016/j.chembiol.2007.09.009; RODRIGUEZNUNEZ A, 1993, ACTA PAEDIATR, V82, P849, DOI 10.1111/j.1651-2227.1993.tb12577.x; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shi WX, 1997, BIOCHEMISTRY-US, V36, P9136, DOI 10.1021/bi9704515; Simmonds HA, 1997, J INHERIT METAB DIS, V20, P214, DOI 10.1023/A:1005308923168; SIMPSON A, 1994, NAT STRUCT BIOL, V1, P724, DOI 10.1038/nsb1094-724; SKIPPER HE, 1954, CANCER RES, V14, P294; STONE RL, 1993, J BIOL CHEM, V268, P19710; SWEENEY MJ, 1972, CANCER RES, V32, P1803; Tsai M, 2007, J MOL BIOL, V370, P541, DOI 10.1016/j.jmb.2007.04.052; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Weaver T, 1996, BIOCHEMISTRY-US, V35, P13955, DOI 10.1021/bi9614702; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu CY, 2014, J INT MED RES, V42, P85, DOI 10.1177/0300060513504365; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zikanova M, 2010, HUM MUTAT, V31, P445, DOI 10.1002/humu.21212	77	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11829	11839		10.1074/jbc.M117.787994	http://dx.doi.org/10.1074/jbc.M117.787994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28559277	Green Published, hybrid			2022-12-28	WOS:000405485600020
J	Cho, JH; Kim, SA; Seo, YS; Park, SG; Park, BC; Kim, JH; Kim, S				Cho, Jin Hwa; Kim, Sung Ah; Seo, Yeon-Soo; Park, Sung Goo; Park, Byoung Chul; Kim, Jeong-Hoon; Kim, Sunhong			The p90 ribosomal S6 kinase-UBR5 pathway controls Toll-like receptor signaling via miRNA-induced translational inhibition of tumor necrosis factor receptor-associated factor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; microRNA (miRNA); phosphorylation; post-translational modification (PTM); Toll-like receptor (TLR); RISC; TRAF3; UBR5; p90RSK	DNA-DAMAGE RESPONSE; HYPERPLASTIC-DISCS; E3 LIGASE; DEUBIQUITINASE DUBA; UBIQUITIN LIGASE; PROTEIN-KINASES; BINDING-PROTEIN; EDD; FAMILY; CELLS	MicroRNAs (miRNAs) are small, noncoding RNAs that post-transcriptionally regulate gene expression. For example, miRNAs repress gene expression by recruiting the miRNA-induced silencing complex (miRISC), a ribonucleoprotein complex that contains miRNA-engaged Argonaute (Ago) and the scaffold protein GW182. Recently, ubiquitin-protein ligase E3 component N-recognin 5 (UBR5) has been identified as a component of miRISC. UBR5 directly interacts with GW182 proteins and participates in miRNA silencing by recruiting downstream effectors, such as the translation regulator DEAD-box helicase 6 (DDX6) and transducer of ERBB2,1/2,2 (Tob1/2), to the Ago-GW182 complex. However, the regulation of miRISC-associated UBR5 remains largely elusive. In the present study, we showed that UBR5 down-regulates the levels of TNF receptor-associated factor 3 (TRAF3), a key component of Toll-like receptor signaling, via the miRNA pathway. We further demonstrated that p90 ribosomal S6 kinase (p90RSK) is an upstream regulator of UBR5. p90RSK phosphorylates UBR5 at Thr(637), Ser(1227), and Ser(2483), and this phosphorylation is required for the translational repression of TRAF3 mRNA. Phosphorylated UBR5 co-localized with GW182 and Ago2 in cytoplasmic speckles, which implies that miRISC is affected by phospho-UBR5. Collectively, these results indicated that the p90RSK-UBR5 pathway stimulates miRNA-mediated translational repression of TRAF3. Our work has added another layer to the regulation of miRISC.	[Cho, Jin Hwa; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Cho, Jin Hwa; Kim, Sung Ah; Park, Sung Goo; Park, Byoung Chul; Kim, Sunhong] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon 34141, South Korea; [Kim, Sung Ah; Park, Sung Goo; Kim, Jeong-Hoon] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Sch Biosci, Dept Funct Genom, Daejeon 34113, South Korea; [Park, Byoung Chul] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Sch Biosci, Dept Bioanalyt Sci, Daejeon 34113, South Korea; [Kim, Jeong-Hoon] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea; [Kim, Sunhong] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Sch Biosci, Dept Biomol Sci, Daejeon 34113, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Park, BC; Kim, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon 34141, South Korea.; Kim, JH (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea.	parkbc@kribb.re.kr; jhoonkim@kribb.re.kr; sunhong@kribb.re.kr	Seo, Yeonsoo/C-1605-2011		National Research Council of Science and Technology, Ministry of Science, ICT, and Future Planning, Korea [CAP-15-11-KRICT]; KRIBB (Korea Research Institute of Bioscience and Biotechnology)	National Research Council of Science and Technology, Ministry of Science, ICT, and Future Planning, Korea; KRIBB (Korea Research Institute of Bioscience and Biotechnology)	This work was supported by Grant CAP-15-11-KRICT from the National Research Council of Science and Technology, Ministry of Science, ICT, and Future Planning, Korea and by a grant from the KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program. The authors declare that they have no conflicts of interest with the contents of this article.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Benavides M, 2013, BBA-MOL CELL RES, V1833, P21, DOI 10.1016/j.bbamcr.2012.10.007; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen HW, 2013, BBA-GENE REGUL MECH, V1829, P1309, DOI 10.1016/j.bbagrm.2013.10.006; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gu H, 2015, TOXICOL SCI, V144, P186, DOI 10.1093/toxsci/kfu271; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mishra R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-131; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Perkins DJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003479; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	43	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11804	11814		10.1074/jbc.M117.785170	http://dx.doi.org/10.1074/jbc.M117.785170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28559278	Green Published, hybrid			2022-12-28	WOS:000405485600018
J	Guo, X; Niemi, NM; Coon, JJ; Pagliarini, DJ				Guo, Xiao; Niemi, Natalie M.; Coon, Joshua J.; Pagliarini, David J.			Integrative proteomics and biochemical analyses define Ptc6p as the Saccharomyces cerevisiae pyruvate dehydrogenase phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-Q; PHOSPHORYLATION SITES; COMPLEX; KINASE; ADAPTATION; EXPRESSION; PHOSPHOPROTEOME; BIOSYNTHESIS; DEFICIENCY; REGULATORS	The pyruvate dehydrogenase complex (PDC) is the primary metabolic checkpoint connecting glycolysis and mitochondrial oxidative phosphorylation and is important for maintaining cellular and organismal glucose homeostasis. Phosphorylation of the PDC E1 subunit was identified as a key inhibitory modification in bovine tissue similar to 50 years ago, and this regulatory process is now known to be conserved throughout evolution. Although Saccharomyces cerevisiae is a pervasive model organism for investigating cellular metabolism and its regulation by signaling processes, the phosphatase(s) responsible for activating the PDC in S. cerevisiae has not been conclusively defined. Here, using comparative mitochondrial phosphoproteomics, analyses of protein-protein interactions by affinity enrichment-mass spectrometry, and in vitro biochemistry, we define Ptc6p as the primary PDC phosphatase in S. cerevisiae. Our analyses further suggest additional substrates for related S. cerevisiae phosphatases and describe the overall phosphoproteomic changes that accompany mitochondrial respiratory dysfunction. In summary, our quantitative proteomics and biochemical analyses have identified Ptc6p as the primary-and likely sole-S. cerevisiae PDC phosphatase, closing a key knowledge gap about the regulation of yeast mitochondrial metabolism. Our findings highlight the power of integrative omics and biochemical analyses for annotating the functions of poorly characterized signaling proteins.	[Guo, Xiao; Niemi, Natalie M.; Coon, Joshua J.; Pagliarini, David J.] Morgridge Inst Res, 2268 Discovery Bldg,330 N Orchard St, Madison, WI 53715 USA; [Guo, Xiao; Coon, Joshua J.] Univ Wisconsin Madison, Dept Chem, Madison, WI 53706 USA; [Niemi, Natalie M.; Pagliarini, David J.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin Madison, Dept Biomol Chem, Madison, WI 53706 USA; [Coon, Joshua J.] Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pagliarini, DJ (corresponding author), Morgridge Inst Res, 2268 Discovery Bldg,330 N Orchard St, Madison, WI 53715 USA.	dpagliarini@morgridge.org	Niemi, Natalie/AAH-6963-2021	Niemi, Natalie/0000-0002-5174-4005; Pagliarini, David J./0000-0002-0001-0087	National Institutes of Health [R01DK098672, R35GM118110]; United Mitochondrial Disease Foundation (UMDF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation (UMDF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK098672 (to D.J.P.) and R35GM118110 (to J.J.C.) and a United Mitochondrial Disease Foundation (UMDF) grant (to N.M.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; BROWN JP, 1976, BIOCHEM J, V155, P419, DOI 10.1042/bj1550419; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Guo X, 2017, CELL REP, V18, P307, DOI 10.1016/j.celrep.2016.12.049; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Heo HJ, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.70; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Humphrey SJ, 2015, TRENDS ENDOCRIN MET, V26, P676, DOI 10.1016/j.tem.2015.09.013; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; Lee YJ, 2012, MOL CELL BIOL, V32, P4705, DOI 10.1128/MCB.00897-12; LIN K, 1995, J BIOL CHEM, V270, P26833, DOI 10.1074/jbc.270.45.26833; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Oliveira AP, 2012, FEMS YEAST RES, V12, P104, DOI 10.1111/j.1567-1364.2011.00765.x; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Phillips D, 2011, BIOCHEMISTRY-US, V50, P2515, DOI 10.1021/bi101434x; Piccinini M, 2005, OBES RES, V13, P678, DOI 10.1038/oby.2005.76; Renvoise M, 2014, J PROTEOMICS, V106, P140, DOI 10.1016/j.jprot.2014.04.022; Rose CM, 2012, MOL CELL PROTEOMICS, V11, P724, DOI 10.1074/mcp.M112.019208; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SALE GJ, 1982, BIOCHEM J, V206, P221, DOI 10.1042/bj2060221; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Smith M. G., 2006, CURRE PROTOC HUM GEN, DOI [10.1002/0471142905.hg1506s48, DOI 10.1002/0471142905.HG1506S48]; Stefely JA, 2016, NAT BIOTECHNOL, V34, P1191, DOI 10.1038/nbt.3683; UHLINGER DJ, 1986, BIOCHEMISTRY-US, V25, P5673, DOI 10.1021/bi00367a049; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; Vogtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; WANG HT, 1994, J BACTERIOL, V176, P7091, DOI 10.1128/JB.176.22.7091-7095.1994; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	50	14	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11751	11759		10.1074/jbc.M117.787341	http://dx.doi.org/10.1074/jbc.M117.787341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28539364	Green Published, hybrid			2022-12-28	WOS:000405485600014
J	Calles-Garcia, D; Yang, M; Soya, N; Melero, R; Menade, M; Ito, Y; Vargas, J; Lukacs, GL; Kollman, JM; Kozlov, G; Gehring, K				Calles-Garcia, Daniel; Yang, Meng; Soya, Naoto; Melero, Roberto; Menade, Marie; Ito, Yukishige; Vargas, Javier; Lukacs, Gergely L.; Kollman, Justin M.; Kozlov, Guennadi; Gehring, Kalle			Single-particle electron microscopy structure of UDP-glucose: glycoprotein glucosyltransferase suggests a selectivity mechanism for misfolded proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLDING-SENSOR ENZYME; GLUCOSEGLYCOPROTEIN GLUCOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; QUALITY-CONTROL; RECOGNITION; DOMAIN; ER; BINDING; CALRETICULIN	The enzyme UDP-glucose: glycoprotein glucosyltransferase (UGGT) mediates quality control of glycoproteins in the endoplasmic reticulum by attaching glucose to N-linked glycan of misfolded proteins. As a sensor, UGGT ensures that misfolded proteins are recognized by the lectin chaperones and do not leave the secretory pathway. The structure of UGGT and the mechanism of its selectivity for misfolded proteins have been unknown for 25 years. Here, we used negative-stain electron microscopy and small-angle X-ray scattering to determine the structure of UGGT from Drosophila melanogaster at 18-angstrom resolution. Three-dimensional reconstructions revealed a cagelike structure with a large central cavity. Particle classification revealed flexibility that precluded determination of a high-resolution structure. Introduction of biotinylation sites into a fungal UGGT expressed in Escherichia coli allowed identification of the catalytic and first thioredoxin-like domains. We also used hydrogen-deuterium exchange mass spectrometry to map the binding site of an accessory protein, Sep15, to the first thioredoxin-like domain. The UGGT structural features identified suggest that the central cavity contains the catalytic site and is lined with hydrophobic surfaces. This enhances the binding of misfolded substrates with exposed hydrophobic residues and excludes folded proteins with hydrophilic surfaces. In conclusion, we have determined the UGGT structure, which enabled us to develop a plausible functional model of the mechanism for UGGT's selectivity for misfolded glycoproteins.	[Calles-Garcia, Daniel; Yang, Meng; Menade, Marie; Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Soya, Naoto; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Melero, Roberto; Vargas, Javier] Ctr Nacl Biotectnol, Biocomp Unit, Madrid 28049, Spain; [Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Vargas, Javier] Univ San Pablo CEU, Escuela Politecn Super, Bioengn Lab, Madrid 28668, Spain; [Kollman, Justin M.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	McGill University; McGill University; RIKEN; San Pablo CEU University; University of Washington; University of Washington Seattle	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Vargas, Javier/L-5546-2015; Ito, Yukishige/ACL-6203-2022; Ito, Yukishige/M-5119-2014; Gehring, Kalle/I-4403-2013; Soya, Naoto/B-2821-2011; Melero, Roberto/J-8780-2014	Gehring, Kalle/0000-0001-6500-1184; Vargas, Javier/0000-0001-7519-6106; Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249; Gehring, Kalle/0000-0001-6500-1184; Soya, Naoto/0000-0003-0086-4389; Melero, Roberto/0000-0001-9467-9381; Yang, Meng/0000-0002-1371-5844; Lukacs, Gergely/0000-0003-0900-0675	Natural Sciences and Engineering Research Council of Canada [RPGIN 2014-04686]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RPGIN 2014-04686 (to K.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; Arnold SM, 2003, J BIOL CHEM, V278, P43320, DOI 10.1074/jbc.M305800200; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin PR, 2007, J STRUCT BIOL, V157, P250, DOI 10.1016/j.jsb.2006.06.002; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; Choudhury P, 1997, J BIOL CHEM, V272, P13446, DOI 10.1074/jbc.272.20.13446; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Dedola S, 2014, ANGEW CHEM INT EDIT, V53, P2883, DOI 10.1002/anie.201309665; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Guerin M, 2003, J BIOL CHEM, V278, P20540, DOI 10.1074/jbc.M300891200; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Labunskyy VM, 2005, J BIOL CHEM, V280, P37839, DOI 10.1074/jbc.M508685200; Lau PW, 2012, STRUCTURE, V20, P1995, DOI 10.1016/j.str.2012.10.019; Ohara K, 2015, BIOCHEMISTRY-US, V54, P4909, DOI 10.1021/acs.biochem.5b00785; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Sakono M, 2012, BIOCHEM BIOPH RES CO, V426, P504, DOI 10.1016/j.bbrc.2012.08.112; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Takeda Y, 2014, GLYCOBIOLOGY, V24, P344, DOI 10.1093/glycob/cwt163; Takeda Y, 2009, CURR OPIN CHEM BIOL, V13, P582, DOI 10.1016/j.cbpa.2009.09.011; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tannous A, 2015, MOL BIOL CELL, V26, P390, DOI 10.1091/mbc.E14-08-1254; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Taylor SC, 2003, EMBO REP, V4, P405, DOI 10.1038/sj.embor.embor797; Tessier DC, 2000, GLYCOBIOLOGY, V10, P403, DOI 10.1093/glycob/10.4.403; Totani K, 2005, ANGEW CHEM INT EDIT, V44, P7950, DOI 10.1002/anie.200502723; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; TRATHNIGG B, 1995, PROG POLYM SCI, V20, P615, DOI 10.1016/0079-6700(95)00005-Z; TROMBETTA S E, 1991, Glycobiology, V1, P155, DOI 10.1093/glycob/1.2.155; Vargas J, 2014, BIOINFORMATICS, V30, P2891, DOI 10.1093/bioinformatics/btu404; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108; Zhu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07322	49	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11499	11507		10.1074/jbc.M117.789495	http://dx.doi.org/10.1074/jbc.M117.789495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28490633	Green Published, hybrid			2022-12-28	WOS:000405119600031
J	Hong, WC; Yano, H; Hiranita, T; Chin, FT; McCurdy, CR; Su, TP; Amara, SG; Katz, JL				Hong, Weimin Conrad; Yano, Hideaki; Hiranita, Takato; Chin, Frederick T.; McCurdy, Christopher R.; Su, Tsung-Ping; Amara, Susan G.; Katz, Jonathan L.			The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-LIKE-I; NEUROTRANSMITTER TRANSPORTERS; MEMBRANE-PROTEINS; UPTAKE INHIBITORS; LIVING CELLS; OLIGOMERIZATION; CHANNEL; DISEASE; LIGAND; SITE	The dopamine transporter (DAT) regulates dopamine (DA) neurotransmission by recapturing DA into the presynaptic terminals and is a principal target of the psychostimulant cocaine. The sigma-1 receptor (sigma R-1) is a molecular chaperone, and its ligands have been shown to modulate DA neuronal signaling, although their effects on DAT activity are unclear. Here, we report that the prototypical sigma R-1 agonist (+)-pentazocine potentiated the dose response of cocaine self-administration in rats, consistent with the effects of the sigma R agonists PRE-084 and DTG (1,3-di-o-tolylguanidine) reported previously. These behavioral effects appeared to be correlated with functional changes of DAT. Preincubation with (+)-pentazocine or PRE084 increased the B-max values of [ 3H] WIN35428 binding toDAT in rat striatal synaptosomes and transfected cells. A specific interaction between sigma R-1 andDATwas detected by co-immunoprecipitation and bioluminescence resonance energy transfer assays. Mutational analyses indicated that the transmembrane domain of sigma R-1 likely mediated this interaction. Furthermore, cysteine accessibility assays showed that sigma R-1 agonist preincubation potentiated cocaine-induced changes in DAT conformation, which were blocked by the specific sigma R-1 antagonist CM304. Moreover, sigma R-1 ligands had distinct effects on sigma R-1 multimerization. CM304 increased the proportion of multimeric sigma(1)Rs, whereas (+)-pentazocine increased monomeric sigma(1)Rs. Together these results support the hypothesis that sigma R-1 agonists promote dissociation of sigma R-1 multimers into monomers, which then interact with DAT to stabilize an outward-facing DAT conformation and enhance cocaine binding. We propose that this novel molecular mechanism underlies the behavioral potentiation of cocaine self-administration by sigma R-1 agonists in animal models.	[Hong, Weimin Conrad] Butler Univ, Dept Pharmaceut Sci, PB351,4600 Sunset Ave, Indianapolis, IN 46208 USA; [Yano, Hideaki; Hiranita, Takato; Su, Tsung-Ping; Katz, Jonathan L.] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Chin, Frederick T.] Stanford Univ, Dept Radiol, MIPS, Stanford, CA 94305 USA; [McCurdy, Christopher R.] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA; [Amara, Susan G.] NIMH, Lab Mol & Cellular Neurobiol, Bethesda, MD 20892 USA	Butler University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Stanford University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hong, WC (corresponding author), Butler Univ, Dept Pharmaceut Sci, PB351,4600 Sunset Ave, Indianapolis, IN 46208 USA.	chong@butler.edu		Amara, Susan/0000-0001-8914-1106; McCurdy, Christopher Robert/0000-0001-8695-2915; Yano, Hideaki/0000-0001-9242-3884	Butler University; Butler University Faculty Startup Fund; Butler University Holcomb Research Award; National Institutes of Health Intramural Research Programs [R37 DA007595, R01 DA023205, P20 GM104932]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023205, R37DA007595, ZIADA000206] Funding Source: NIH RePORTER	Butler University; Butler University Faculty Startup Fund; Butler University Holcomb Research Award; National Institutes of Health Intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Butler University Faculty Startup Fund and Holcomb Research Award (to W. C. H.), National Institutes of Health Intramural Research Programs (to H. Y., T. H., T. P. S., S. G. A., and J. L. K.), Grant R37 DA007595 (to S. G. A.), and in part by Grants R01 DA023205 (to C. R. M.) and P20 GM104932 (to C. R. M.). C. R. M. and F. T. C. are co-inventors and patent holders of CM304. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Bermingham DP, 2016, PHARMACOL REV, V68, P888, DOI 10.1124/pr.115.012260; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Chae PS, 2012, CHEM-EUR J, V18, P9485, DOI 10.1002/chem.201200069; Fontanilla D, 2008, BIOCHEMISTRY-US, V47, P7205, DOI 10.1021/bi800564j; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; GONZALEZALVEAR GM, 1994, J PHARMACOL EXP THER, V271, P212; Gromek KA, 2014, J BIOL CHEM, V289, P20333, DOI 10.1074/jbc.M113.537993; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hiranita T, 2013, NEUROPSYCHOPHARMACOL, V38, P605, DOI 10.1038/npp.2012.224; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; Hiranita T, 2009, J PHARMACOL EXP THER, V329, P677, DOI 10.1124/jpet.108.145813; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; James ML, 2012, J MED CHEM, V55, P8272, DOI 10.1021/jm300371c; Katz JL, 2016, J PHARMACOL EXP THER, V358, P109, DOI 10.1124/jpet.116.232728; Katz JL, 2016, BEHAV PHARMACOL, V27, P100, DOI 10.1097/FBP.0000000000000209; KAVANAUGH MP, 1988, P NATL ACAD SCI USA, V85, P2844, DOI 10.1073/pnas.85.8.2844; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MCCANN DJ, 1991, J PHARMACOL EXP THER, V257, P547; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Narayanan S, 2011, CURR TOP MED CHEM, V11, P1128, DOI 10.2174/156802611795371323; Navarro G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061245; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; Robson MJ, 2012, CURR PHARM DESIGN, V18, P902; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; SCHUSTER DI, 1995, BRAIN RES, V670, P14, DOI 10.1016/0006-8993(94)01123-Y; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sulzer D, 2016, BASAL GANGLIA, V6, P123, DOI 10.1016/j.baga.2016.02.001; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; WALKER JM, 1990, PHARMACOL REV, V42, P355; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025	52	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11250	11261		10.1074/jbc.M116.774075	http://dx.doi.org/10.1074/jbc.M116.774075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495886	Green Published, hybrid			2022-12-28	WOS:000405119600011
J	Taylor, AB; Roberts, KM; Cao, XH; Clark, NE; Holloway, SP; Donati, E; Polcaro, CM; Pica-Mattoccia, L; Tarpley, RS; McHardy, SF; Cioli, D; LoVerde, PT; Fitzpatrick, PF; Hart, PJ				Taylor, Alexander B.; Roberts, Kenneth M.; Cao, Xiaohang; Clark, Nathaniel E.; Holloway, Stephen P.; Donati, Enrica; Polcaro, Chiara M.; Pica-Mattoccia, Livia; Tarpley, Reid S.; McHardy, Stanton F.; Cioli, Donato; LoVerde, Philip T.; Fitzpatrick, Paul F.; Hart, P. John			Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBSTRATE-INHIBITION; SULFOTRANSFERASE; OXAMNIQUINE; MECHANISM; MANSONI; COMPLEX	The antischistosomal prodrug oxamniquine is activated by a sulfotransferase (SULT) in the parasitic flatworm Schistosoma mansoni. Of the three main human schistosome species, only S. mansoni is sensitive to oxamniquine therapy despite the presence of SULT orthologs in Schistosoma hematobium and Schistosoma japonicum. The reason for this species-specific drug action has remained a mystery for decades. Here we present the crystal structures of S. hematobium and S. japonicum SULTs, including S. hematobium SULT in complex with oxamniquine. We also examined the activity of the three enzymes in vitro; surprisingly, all three are active toward oxamniquine, yet we observed differences in catalytic efficiency that implicate kinetics as the determinant for species-specific toxicity. These results provide guidance for designing oxamniquine derivatives to treat infection caused by all species of schistosome to combat emerging resistance to current therapy.	[Taylor, Alexander B.; Cao, Xiaohang; Clark, Nathaniel E.; Holloway, Stephen P.; LoVerde, Philip T.; Fitzpatrick, Paul F.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [LoVerde, Philip T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Roberts, Kenneth M.] Univ South Carolina, Dept Chem & Phys, Aiken, SC 29801 USA; [Donati, Enrica; Polcaro, Chiara M.; Cioli, Donato] CNR, Inst Chem Methodol, Via Solaria Km 29-500, I-00015 Rome, Italy; [Pica-Mattoccia, Livia] CNR, Inst Cell Biol & Neurobiol, Via E Ramarini 32, I-00015 Rome, Italy; [Tarpley, Reid S.; McHardy, Stanton F.] Univ Texas San Antonio, Ctr Innovat Drug Discovery, Dept Chem, San Antonio, TX 78249 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Taylor, AB; Fitzpatrick, PF; Hart, PJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	taylorab@uthscsa.edu; fitzpatrickp@uthscsa.edu; hartp@uthscsa.edu		Taylor, Alexander/0000-0003-3517-6033; Roberts, Kenneth/0000-0001-7389-0559	University of Texas Health Science Center at San Antonio Office of the Vice President for Research; Cancer Therapy and Research Center (National Institutes of Health) [P30 CA054174]; National Institute of General Medical Sciences, National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio Office of the Vice President for Research; Cancer Therapy and Research Center (National Institutes of Health); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for the X-ray Crystallography Core Laboratory by the University of Texas Health Science Center at San Antonio Office of the Vice President for Research and the Cancer Therapy and Research Center (National Institutes of Health Grant P30 CA054174) is gratefully acknowledged. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnett AC, 2004, J BIOL CHEM, V279, P18799, DOI 10.1074/jbc.M312253200; Beck L, 2001, MEM I OSWALDO CRUZ, V96, P165, DOI 10.1590/S0074-02762001000900025; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7; CIOLI D, 1992, EXP PARASITOL, V75, P425, DOI 10.1016/0014-4894(92)90255-9; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gentile R, 2008, ACTA TROP, V108, P175, DOI 10.1016/j.actatropica.2008.09.003; Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231; Gulcan HO, 2011, ARCH BIOCHEM BIOPHYS, V507, P232, DOI 10.1016/j.abb.2010.12.027; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; KATZ N., 1973, Revista da Sociedade Brasileira de Medicina Tropical, V7, P381, DOI 10.1590/S0037-86821973000600008; KAYE B, 1976, ANN TROP MED PARASIT, V70, P323, DOI 10.1080/00034983.1976.11687128; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lu LY, 2008, MOL PHARMACOL, V73, P660, DOI 10.1124/mol.107.041038; Marforio TD, 2015, BIOCHEMISTRY-US, V54, P4404, DOI 10.1021/acs.biochem.5b00343; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Pica-Mattoccia L, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000900048; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P2672, DOI 10.1021/bi500267c; ROGERS SH, 1971, SCIENCE, V172, P1057, DOI 10.1126/science.172.3987.1057; Stjernschantz E, 2010, MOL CELL ENDOCRINOL, V317, P127, DOI 10.1016/j.mce.2009.12.001; Taylor AB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004132; Teramoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2593; Teramoto T, 2009, BIOCHEM BIOPH RES CO, V383, P83, DOI 10.1016/j.bbrc.2009.03.146; Valentim CLL, 2013, SCIENCE, V342, P1385, DOI 10.1126/science.1243106	31	16	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11154	11164		10.1074/jbc.M116.766527	http://dx.doi.org/10.1074/jbc.M116.766527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28536265	Green Published, hybrid			2022-12-28	WOS:000405119600003
J	French, ME; Klosowiak, JL; Aslanian, A; Reed, SI; Yates, JR; Hunter, T				French, Michael E.; Klosowiak, Julian L.; Aslanian, Aaron; Reed, Steven I.; Yates, John R., III; Hunter, Tony			Mechanism of ubiquitin chain synthesis employed by a HECT domain ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; polyubiquitin chain; protein degradation; ubiquitin; ubiquitylation (ubiquitination); HECT	CONJUGATING ENZYMES E2S; E3 LIGASE; POLYUBIQUITIN CHAINS; MEMBRANE-PROTEIN; BINDING PROTEINS; LYS63 LINKAGES; DEGRADATION; FAMILY; NEDD4; UBIQUITYLATION	Homologous to E6AP C-terminal (HECT) ubiquitin (Ub) ligases (E3s) are a large class of enzymes that bind to their substrates and catalyze ubiquitination through the formation of a Ub thioester intermediate. The mechanisms by which these E3s assemble polyubiquitin chains on their substrates remain poorly defined. We report here that the Nedd4 family HECT E3, WWP1, assembles substrate-linked Ub chains containing Lys-63, Lys-48, and Lys-11 linkages (Lys-63 > Lys-48 > Lys-11). Our results demonstrate that WWP1 catalyzes the formation of Ub chains through a sequential addition mechanism, in which Ub monomers are transferred in a successive fashion to the substrate, and that ubiquitination by WWP1 requires the presence of a low-affinity, noncovalent Ub-binding site within the HECT domain. Unexpectedly, we find that the formation of Ub chains by WWP1 occurs in two distinct phases. In the first phase, chains are synthesized in a unidirectional manner and are linked exclusively through Lys-63 of Ub. In the second phase, chains are elongated in a multidirectional fashion characterized by the formation of mixed Ub linkages and branched structures. Our results provide new insight into the mechanism of Ub chain formation employed by Nedd4 family HECT E3s and suggest a framework for understanding how this family of E3s generates Ub signals that function in proteasome-independent and proteasome-dependent pathways.	[French, Michael E.; Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [French, Michael E.; Reed, Steven I.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Klosowiak, Julian L.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Salk Institute; Scripps Research Institute; Scripps Research Institute; Northwestern University; Feinberg School of Medicine	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu		Klosowiak, Julian/0000-0003-0880-7848	National Institutes of Health [P30CA014195, R01CA080100, R01CA082683]; National Institutes of Health Grant [R01GM072656, P41GM103533, R01GM115170]; American Cancer Society; George E. Hewitt Foundation for Medical Research; Helmsley Center for Genomic Medicine at the Salk Institute; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA082683, R01CA080100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072656, P41GM103533, R01GM115170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); George E. Hewitt Foundation for Medical Research; Helmsley Center for Genomic Medicine at the Salk Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants P30CA014195, R01CA080100, and R01CA082683 (to T. H.); National Institutes of Health Grant R01GM072656 (in support of J. L. K., to Dr. Sarah Rice); National Institutes of Health Grant P41GM103533 (to J. R. Y.); and National Institutes of Health Grant R01GM115170 (to S. I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by postdoctoral fellowships from the American Cancer Society and the George E. Hewitt Foundation for Medical Research. Additional financial support was provided by the Helmsley Center for Genomic Medicine at the Salk Institute.	Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Cao XX, 2011, J BIOL CHEM, V286, P33447, DOI 10.1074/jbc.M111.225565; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dores MR, 2015, MOL BIOL CELL, V26, P4660, DOI 10.1091/mbc.E15-05-0284; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Grice GL, 2015, CELL REP, V12, P545, DOI 10.1016/j.celrep.2015.06.061; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kathman SG, 2015, J AM CHEM SOC, V137, P12442, DOI 10.1021/jacs.5b06839; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Valkevich EM, 2014, BIOCHEMISTRY-US, V53, P4979, DOI 10.1021/bi5006305; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	72	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10398	10413		10.1074/jbc.M117.789479	http://dx.doi.org/10.1074/jbc.M117.789479			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28461335	hybrid, Green Published			2022-12-28	WOS:000404115400007
J	Liu, M; Yuan, C; Jensen, JK; Zhao, BY; Jiang, YB; Jiang, LG; Huang, MD				Liu, Min; Yuan, Cai; Jensen, Jan K.; Zhao, Baoyu; Jiang, Yunbin; Jiang, Longguang; Huang, Mindong			The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition (vol 292, pg 8412, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Liu M, 2017, J BIOL CHEM, V292, P8412, DOI 10.1074/jbc.M117.779256	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10744	10744		10.1074/jbc.A117.779256	http://dx.doi.org/10.1074/jbc.A117.779256			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28646125	Green Published, hybrid			2022-12-28	WOS:000404115400033
J	Pattabiraman, G; Panchal, R; Medvedev, AE				Pattabiraman, Goutham; Panchal, Rahul; Medvedev, Andrei E.			The R753Q polymorphism in Toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; macrophage; signal transduction; SNP; Toll-like receptor (TLR)	NF-KAPPA-B; TYROSINE PHOSPHORYLATION; ARG753GLN POLYMORPHISM; BORRELIA-BURGDORFERI; CELLULAR ACTIVATION; GENE-EXPRESSION; TUBERCULOSIS; MACROPHAGES; PHAGOCYTOSIS; RECOGNITION	Toll-like receptor 2 (TLR2) plays a critical role in host defenses against mycobacterial infections. The R753Q TLR2 polymorphism has been associated with increased incidence of tuberculosis and infections with non-tuberculous mycobacteria in human populations, but the mechanisms by which this polymorphism affects TLR2 signaling are unclear. In this study, we determined the impact of the R753Q TLR2 polymorphism on macrophage sensing of Mycobacterium smegmatis. Upon infection with M. smegmatis, macrophages from knock-in mice harboring R753Q TLR2 expressed lower levels of TNF-, IL-1, IL-6, and IL-10 compared with cells from WT mice, but both R753Q TLR2- and WT-derived macrophages exhibited comparable bacterial burdens. The decreased cytokine responses in R753Q TLR2-expressing macrophages were accompanied by impaired phosphorylation of IL-1R-associated kinase 1 (IRAK-1), p38, ERK1/2 MAPKs, and p65 NF-B, suggesting that the R753Q TLR2 polymorphism alters the functions of the myeloid differentiation primary response protein 88 (MyD88)-IRAK-dependent signaling axis. Supporting this notion, HEK293 cells stably transfected with YFP-tagged R753Q TLR2 displayed reduced recruitment of MyD88 to TLR2, decreased NF-B activation, and impaired IL-8 expression upon exposure to M. smegmatis. Collectively, our results indicate that the R753Q polymorphism alters TLR2 signaling competence, leading to impaired MyD88-TLR2 assembly, reduced phosphorylation of IRAK-1, diminished activation of MAPKs and NF-B, and deficient induction of cytokines in macrophages infected with M. smegmatis.	[Pattabiraman, Goutham; Panchal, Rahul; Medvedev, Andrei E.] Univ Connecticut, Ctr Hlth, Dept Immunol, L Bldg,Rm 3019,263 Farmington Ave, Farmington, CT 06030 USA	University of Connecticut	Medvedev, AE (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, L Bldg,Rm 3019,263 Farmington Ave, Farmington, CT 06030 USA.	medvedev@uchc.edu		Pattabiraman, Goutham/0000-0002-5196-8279	National Institutes of Health [R56 AI097210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole by National Institutes of Health Grant R56 AI097210 (to A. E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Berdeli A, 2005, J MOL MED, V83, P535, DOI 10.1007/s00109-005-0677-x; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Fujiwara N, 2012, TUBERCULOSIS, V92, P187, DOI 10.1016/j.tube.2011.10.001; Gianni T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004477; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Herrtwich L, 2016, CELL, V167, P1264, DOI 10.1016/j.cell.2016.09.054; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang TJ, 2004, IMMUNOLOGY, V112, P674, DOI 10.1111/j.1365-2567.2004.01926.x; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Means TK, 1999, J IMMUNOL, V163, P3920; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poyhonen L, 2015, ACTA PAEDIATR, V104, P485, DOI 10.1111/apa.12927; Rahman MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086886; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Singh RP, 2009, INDIAN J MICROBIOL, V49, P276, DOI 10.1007/s12088-009-0045-6; Soylu A, 2011, INFLAMMATION, V34, P379, DOI 10.1007/s10753-010-9245-9; Stamm CE, 2015, IMMUNOL REV, V264, P204, DOI 10.1111/imr.12263; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wang TY, 2000, J IMMUNOL, V165, P6308, DOI 10.4049/jimmunol.165.11.6308; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Yam Wing-Cheong, 2013, Methods Mol Biol, V943, P171, DOI 10.1007/978-1-60327-353-4_12; Yim JJ, 2008, HUM IMMUNOL, V69, P572, DOI 10.1016/j.humimm.2008.06.003; Yim JJ, 2004, FEMS IMMUNOL MED MIC, V40, P163, DOI 10.1016/S0928-8244(03)00342-0	60	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10685	10695		10.1074/jbc.M117.784470	http://dx.doi.org/10.1074/jbc.M117.784470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28442574	Green Published, hybrid			2022-12-28	WOS:000404115400027
J	Shrestha, R; Lockless, SW; Sorg, JA				Shrestha, Ritu; Lockless, Steve W.; Sorg, Joseph A.			A Clostridium difficile alanine racemase affects spore germination and accommodates serine as a substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; bacterial genetics; bacterial pathogenesis; bacterial signal transduction; microbiology; physiology; clostridium difficile; germination; racemase; spore	BACILLUS-ANTHRACIS; ACID; RECEPTORS; INITIATION; INHIBITOR; ANALOGS	Clostridium difficile has become one of the most common bacterial pathogens in hospital-acquired infections in the United States. Although C. difficile is strictly anaerobic, it survives in aerobic environments and transmits between hosts via spores. C. difficile spore germination is triggered in response to certain bile acids and glycine. Although glycine is the most effective co-germinant, other amino acids can substitute with varying efficiencies. Of these, l-alanine is an effective co-germinant and is also a germinant for most bacterial spores. Many endospore-forming bacteria embed alanine racemases into their spore coats, and these enzymes are thought to convert the l-alanine germinant into d-alanine, a spore germination inhibitor. Although the C. difficile Alr2 racemase is the sixth most highly expressed gene during C. difficile spore formation, a previous study reported that Alr2 has little to no role in germination of C. difficile spores in rich medium. Here, we hypothesized that Alr2 could affect C. difficilel-alanine-induced spore germination in a defined medium. We found that alr2 mutant spores more readily germinate in response to l-alanine as a co-germinant. Surprisingly, d-alanine also functioned as a co-germinant. Moreover, we found that Alr2 could interconvert l- and d-serine and that Alr2 bound to l- and d-serine with approximate to 2-fold weaker affinity to that of l- and d-alanine. Finally, we demonstrate that l- and d-serine are also co-germinants for C. difficile spores. These results suggest that C. difficile spores can respond to a diverse set of amino acid co-germinants and reveal that Alr2 can accommodate serine as a substrate.	[Shrestha, Ritu; Lockless, Steve W.; Sorg, Joseph A.] Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sorg, JA (corresponding author), Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77843 USA.	jsorg@bio.tamu.edu		Sorg, Joseph/0000-0001-7822-2656	NIAID, National Institutes of Health [5R01AI116895, 1U01AI124290]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116895, U01AI124290] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards 5R01AI116895 and 1U01AI124290 from the NIAID, National Institutes of Health (to J. A. S.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003165; Akoachere M, 2007, J BIOL CHEM, V282, P12112, DOI 10.1074/jbc.M611432200; Asojo OA, 2014, ACTA CRYSTALLOGR D, V70, P1922, DOI 10.1107/S1399004714009419; Bhattacharjee D, 2016, J BACTERIOL, V198, P2767, DOI 10.1128/JB.00405-16; Bhattacharjee D, 2016, J BACTERIOL, V198, P777, DOI 10.1128/JB.00908-15; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; Centers for Disease Control and Prevention, 2013, ANT ANT RES BIGG THR; Chesnokova ON, 2009, J BACTERIOL, V191, P1303, DOI 10.1128/JB.01098-08; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dodatko T, 2010, MICROBIOL-SGM, V156, P1244, DOI 10.1099/mic.0.030270-0; Donnelly ML, 2017, MBIO, V8, DOI 10.1128/mBio.02085-16; Fimlaid KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005239; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Francis MB, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00306-16; Francis MB, 2015, J BACTERIOL, V197, P2276, DOI 10.1128/JB.02575-14; Francis MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073653; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Girinathan BP, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00383-16; Gutelius D, 2014, MICROBIOL-SGM, V160, P209, DOI 10.1099/mic.0.072454-0; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; McKevitt MT, 2007, INFECT IMMUN, V75, P5726, DOI 10.1128/IAI.00727-07; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Radkov AD, 2014, APPL MICROBIOL BIOT, V98, P5363, DOI 10.1007/s00253-014-5726-3; Ramirez N, 2010, J BACTERIOL, V192, P4215, DOI 10.1128/JB.00488-10; Ramirez N, 2010, J BACTERIOL, V192, P418, DOI 10.1128/JB.01226-09; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.TBS-0003-2012; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; STEDMAN RL, 1956, SCIENCE, V124, P403, DOI 10.1126/science.124.3218.403; Stoltz KL, 2017, J MED CHEM, V60, P3451, DOI 10.1021/acs.jmedchem.7b00295; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; TITBALL RW, 1987, J APPL BACTERIOL, V62, P269, DOI 10.1111/j.1365-2672.1987.tb02408.x; YASUDA Y, 1984, MICROBIOL IMMUNOL, V28, P197, DOI 10.1111/j.1348-0421.1984.tb00671.x	41	26	31	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10735	10742		10.1074/jbc.M117.791749	http://dx.doi.org/10.1074/jbc.M117.791749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487371	hybrid, Green Published			2022-12-28	WOS:000404115400031
J	Ye, Q; Ji, QQ; Yan, W; Yang, F; Wang, ED				Ye, Qing; Ji, Quan-Quan; Yan, Wei; Yang, Fang; Wang, En-Duo			Acetylation of lysine E-amino groups regulates aminoacyl-tRNA synthetase activity in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; amino acid; aminoacyl tRNA synthetase; catalysis; transfer RNA (tRNA); translation	C-TERMINAL DOMAIN; PROTEIN ACETYLATION; SIGNATURE SEQUENCE; GENE CLONING; CRUCIAL ROLE; CP1 DOMAIN; PURIFICATION; SUCCINYLATION; ACTIVATION; DYNAMICS	Previous proteomic analyses have shown that aminoacyl-tRNA synthetases in many organisms can be modified by acetylation of Lys. In this present study, leucyl-tRNA synthetase and arginyl-tRNA synthetase from Escherichia coli (EcLeuRS and EcArgRS) were overexpressed and purified and found to be acetylated on Lys residues by MS. Gln scanning mutagenesis revealed that Lys(619), Lys(624), and Lys(809) in EcLeuRS and Lys(126) and Lys(408) in EcArgRS might play important roles in enzyme activity. Furthermore, we utilized a novel protein expression system to obtain enzymes harboring acetylated Lys at specific sites and investigated their catalytic activity. Acetylation of these Lys residues could affect their aminoacylation activity by influencing amino acid activation and/or the affinity for tRNA. In vitro assays showed that acetyl-phosphate nonenzymatically acetylates EcLeuRS and EcArgRS and suggested that the sirtuin class deacetylase CobB might regulate acetylation of these two enzymes. These findings imply a potential regulatory role for Lys acetylation in controlling the activity of aminoacyl-tRNA synthetases and thus protein synthesis.	[Ye, Qing; Ji, Quan-Quan; Yan, Wei; Yang, Fang; Wang, En-Duo] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, En-Duo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Wang, ED (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	edwang@sibcb.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences Grant [XDB19000000]; National Natural Science Foundation of China [31570792, 31130064, 91440204]	Strategic Priority Research Program of the Chinese Academy of Sciences Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000 and National Natural Science Foundation of China Grants 31570792, 31130064, and 91440204. The authors declare that they have no conflicts of interest with the contents of this article.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Cao XY, 2017, P NATL ACAD SCI USA, V114, P687, DOI 10.1073/pnas.1608488114; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Geslain R, 2003, BIOCHEMISTRY-US, V42, P15092, DOI 10.1021/bi035581u; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Li J, 2003, BIOCHEM J, V376, P773, DOI 10.1042/BJ20030957; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; LIN SX, 1988, BIOCHEMISTRY-US, V27, P6343, DOI 10.1021/bi00417a022; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu MF, 1999, BIOCHEMISTRY-US, V38, P11006, DOI 10.1021/bi990392q; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MECHULAM Y, 1991, J MOL BIOL, V217, P465, DOI 10.1016/0022-2836(91)90750-Z; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Mizuno Y, 2016, MICROBIOLOGYOPEN, V5, P152, DOI 10.1002/mbo3.320; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; Sekine S, 2001, J BIOL CHEM, V276, P3723, DOI 10.1074/jbc.C000756200; Shimada A, 2001, ACTA CRYSTALLOGR D, V57, P272, DOI 10.1107/S0907444900016255; Sissler M, 1996, EMBO J, V15, P5069, DOI 10.1002/j.1460-2075.1996.tb00887.x; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Tan M, 2013, BIOCHEM J, V449, P123, DOI 10.1042/BJ20121258; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tu S, 2015, ELIFE, V4, DOI 10.7554/eLife.05322; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wu JF, 1999, ACTA BIOCH BIOPH SIN, V31, P226; Yan W, 2015, J BIOL CHEM, V290, P12256, DOI 10.1074/jbc.M115.639492; Ye Q, 2015, J BIOL CHEM, V290, P24391, DOI 10.1074/jbc.M115.672824; [叶青 Ye Qingi], 2016, [生命科学, Chinese Bulletin of Life Sciences], V28, P427; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng YG, 2004, NUCLEIC ACIDS RES, V32, P3294, DOI 10.1093/nar/gkh665; Zhu B, 2007, RNA, V13, P15, DOI 10.1261/rna.228707	64	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10709	10722		10.1074/jbc.M116.770826	http://dx.doi.org/10.1074/jbc.M116.770826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28455447	Green Published, hybrid			2022-12-28	WOS:000404115400029
J	Ding, LA; Zhang, LF; Kim, M; Byzova, T; Podrez, E				Ding, Liang; Zhang, Lifang; Kim, Michael; Byzova, Tatiana; Podrez, Eugene			Akt3 kinase suppresses pinocytosis of low-density lipoprotein by macrophages via a novel WNK/SGK1/Cdc42 protein pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID-PHASE PINOCYTOSIS; FOAM CELL-FORMATION; CHOLESTEROL ACCUMULATION; ATHEROSCLEROTIC LESIONS; DEPENDENT REGULATION; FAMILY-MEMBERS; CANCER CELLS; IN-VITRO; ACTIN; MACROPINOCYTOSIS	Fluid-phase pinocytosis of LDL by macrophages is regarded as a novel promising target to reduce macrophage cholesterol accumulation in atherosclerotic lesions. The mechanisms of regulation of fluid-phase pinocytosis in macrophages and, specifically, the role of Akt kinases are poorly understood. We have found previously that increased lipoprotein uptake via the receptor-independent process in Akt3 kinase-deficient macrophages contributes to increased atherosclerosis in Akt3(-/-) mice. The mechanism by which Akt3 deficiency promotes lipoprotein uptake in macrophages is unknown. Wenow report that Akt3 constitutively suppresses macropinocytosis in macrophages through a novel WNK1/SGK1/Cdc42 pathway. Mechanistic studies have demonstrated that the lack of Akt3 expression in murine and human macrophages results in increased expression of with-no-lysine kinase 1 (WNK1), which, in turn, leads to increased activity of serum and glucocorticoid-inducible kinase 1 (SGK1). SGK1 promotes expression of the Rho family GTPase Cdc42, a positive regulator of actin assembly, cell polarization, and pinocytosis. Individual suppression of WNK1 expression, SGK1, or Cdc42 activity in Akt3-deficient macrophages rescued the phenotype. These results demonstrate that Akt3 is a specific negative regulator of macropinocytosis in macrophages.	[Ding, Liang; Zhang, Lifang; Byzova, Tatiana; Podrez, Eugene] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kim, Michael] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Podrez, E (corresponding author), Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA.; Podrez, E (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB5-87, Cleveland, OH 44195 USA.	podreze@ccf.org		Kim, Michael/0000-0003-0087-0199; Byzova, Tatiana/0000-0002-2615-875X	National Institutes of Health [HL077213, HL126738, 5P01HL073311, HL071625]; American Heart Association [13POST17240041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077213, R01HL071625, R01HL126738, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL077213, HL126738, and 5P01HL073311 (to E. P.) and HL071625 (to T. B.) and American Heart Association Grant 13POST17240041 (to L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Anzinger JJ, 2010, ARTERIOSCL THROM VAS, V30, P2022, DOI 10.1161/ATVBAHA.110.210849; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Babaev VR, 2014, J LIPID RES, V55, P2296, DOI 10.1194/jlr.M050633; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; Zhao B, 2006, J BIOL CHEM, V281, P15757, DOI 10.1074/jbc.M510714200; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CANO ML, 1991, J CELL BIOL, V115, P677, DOI 10.1083/jcb.115.3.677; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Ferraro DA, 2013, P NATL ACAD SCI USA, V110, P1815, DOI 10.1073/pnas.1220763110; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Fujii M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02385; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Ghoshal P., 2017, ANTIOXID REDOX SIGN, DOI [10.1089/ars.2017.7059, DOI 10.1089/ARS.2017.7059]; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Heise CJ, 2010, J BIOL CHEM, V285, P25161, DOI 10.1074/jbc.M110.103432; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Huang YQ, 2016, CELL PHYSIOL BIOCHEM, V40, P1521, DOI 10.1159/000453202; KAGAYA K, 1992, J MED VET MYCOL, V30, P179; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kruth HS, 2013, CURR PHARM DESIGN, V19, P5865; Kruth HS, 2011, CURR OPIN LIPIDOL, V22, P386, DOI 10.1097/MOL.0b013e32834adadb; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lang F, 2013, HORM-INT J ENDOCRINO, V12, P160, DOI 10.14310/horm.2002.1401; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; Levin MC, 2011, CIRC RES, V109, P1210, DOI 10.1161/CIRCRESAHA.111.246702; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mc F. A., 1958, NATURE, V182, P53; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Oh YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9698; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Redelman-Sidi G, 2013, CANCER RES, V73, P1156, DOI 10.1158/0008-5472.CAN-12-1882; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Rotllan N, 2015, FASEB J, V29, P597, DOI 10.1096/fj.14-262097; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Shelly C, 2002, J CELL SCI, V115, P1985; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; SWANSON JA, 1985, J CELL BIOL, V100, P851, DOI 10.1083/jcb.100.3.851; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Ulrich V, 2016, EMBO MOL MED, V8, P643, DOI 10.15252/emmm.201506031; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wilson SM, 2010, BRIT J PHARMACOL, V159, P678, DOI 10.1111/j.1476-5381.2009.00564.x; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yoshida S, 2015, J CELL BIOL, V211, P159, DOI 10.1083/jcb.201504097; Yoshida S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00008	67	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9283	9293		10.1074/jbc.M116.773739	http://dx.doi.org/10.1074/jbc.M116.773739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28389565	Green Published, hybrid			2022-12-28	WOS:000402538900023
J	de Castro, RO; Previato, L; Goitea, V; Felberg, A; Guiraldelli, MF; Filiberti, A; Pezza, RJ				de Castro, Rodrigo O.; Previato, Luciana; Goitea, Victor; Felberg, Anna; Guiraldelli, Michel F.; Filiberti, Adrian; Pezza, Roberto J.			The chromatin-remodeling subunit Baf200 promotes homology-directed DNA repair and regulates distinct chromatin-remodeling complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SWI/SNF COMPLEX; HEPATOCELLULAR-CARCINOMA; PBAF; GENOME; ROLES; GENE; SPERMATOGENESIS; SPECIFICITY; GAMMA-H2AX	The efficiency and type of pathway chosen to repair DNA double-strand breaks (DSBs) are critically influenced by the nucleosome packaging and the chromatin architecture surrounding the DSBs. The Swi/Snf (PBAF and BAF) chromatin-remodeling complexes contribute to DNA damage-induced nucleosome remodeling, but the mechanism by which it contributes to this function is poorly understood. Herein, we report how the Baf200 (Arid2) PBAF-defining subunit regulates DSB repair. We used cytological and biochemical approaches to show that Baf200 plays an important function by facilitating homologous recombination-dependent processes, such as recruitment of Rad51 (a key component of homologous recombination) to DSBs, homology-directed repair, and cell survival after DNA damage. Furthermore, we observed that Baf200 and Rad51 are present in the same complex and that this interaction is mediated by C-terminal sequences in both proteins. It has been recognized previously that the interplay between distinct forms of Swi/Snf has profound functional consequences, but we understand little about the composition of complexes formed by PBAF protein subunits. Our biochemical analyses reveal that Baf200 forms at least two distinct complexes. One is a canonical form of PBAF including the Swi/Snf-associated Brg1 catalytic subunit, and the other contains Baf180 but not Brg1. This distinction of PBAF complexes based on their unique composition provides the foundation for future studies on the specific contributions of the PBAF forms to the regulation of DNA repair.	[de Castro, Rodrigo O.; Previato, Luciana; Goitea, Victor; Felberg, Anna; Guiraldelli, Michel F.; Filiberti, Adrian; Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Cell Cycle & Canc Biol Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Pezza, RJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Cell Cycle & Canc Biol Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA.; Pezza, RJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA.	Roberto-Pezza@omrf.org		Felberg, Anna/0000-0001-6271-6483; Goitea, Victor/0000-0002-1564-4111	National Institutes of Health [GM103636]; March of Dimes [FY14-256]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by the National Institutes of Health Grant GM103636 and March of Dimes Grant FY14-256 (to R. J. P.). The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Brechalov AV, 2014, CELL CYCLE, V13, P1970, DOI 10.4161/cc.28922; Brownlee PM, 2015, DNA REPAIR, V32, P127, DOI 10.1016/j.dnarep.2015.04.023; Choi KY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.129; Courilleau C, 2012, J CELL BIOL, V199, P1067, DOI 10.1083/jcb.201205059; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Gerhold CB, 2015, J MOL BIOL, V427, P637, DOI 10.1016/j.jmb.2014.10.015; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; He LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109493; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jeggo PA, 2014, EXP CELL RES, V329, P69, DOI 10.1016/j.yexcr.2014.09.023; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; Kim Y, 2012, DEVELOPMENT, V139, P1133, DOI 10.1242/dev.073478; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Narayanan R, 2014, CELL TISSUE RES, V356, P575, DOI 10.1007/s00441-013-1791-7; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Qi WJ, 2015, J CELL SCI, V128, P317, DOI 10.1242/jcs.159103; Raab JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005748; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21776; Wang JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097097; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Xu FH, 2012, J BIOL CHEM, V287, P5033, DOI 10.1074/jbc.M111.279968; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhang XM, 2006, BIOCHEM BIOPH RES CO, V346, P794, DOI 10.1016/j.bbrc.2006.05.211; Zhao H, 2011, ONCOTARGET, V2, P886; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	40	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8459	8471		10.1074/jbc.M117.778183	http://dx.doi.org/10.1074/jbc.M117.778183			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28381560	hybrid, Green Published			2022-12-28	WOS:000401788600029
J	Basu, R; Bose, A; Thomas, D; Das Sarma, J				Basu, Rahul; Bose, Abhishek; Thomas, Deepthi; Das Sarma, Jayasri			Microtubule-assisted altered trafficking of astrocytic gap junction protein connexin 43 is associated with depletion of connexin 47 during mouse hepatitis virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; NONDEMYELINATING STRAINS; CULTURED ASTROCYTES; MULTIPLE CONNEXINS; CYTOPLASMIC DYNEIN; CALCIUM WAVES; GLIAL-CELLS; IN-VITRO; EXPRESSION; MEMBRANE	Gap junctions (GJs) are important for maintenance of CNS homeostasis. GJ proteins, connexin 43 (Cx43) and connexin 47 (Cx47), play a crucial role in production and maintenance of CNS myelin. Cx43 is mainly expressed by astrocytes in the CNS and forms gap junction intercellular communications between astrocytes-astrocytes (Cx43-Cx43) and between astrocytes-oligodendrocytes (Cx43-Cx47). Mutations of these connexin (Cx) proteins cause dysmyelinating diseases in humans. Previously, it has been shown that Cx43 localization and expression is altered due to mouse hepatitis virus (MHV)-A59 infection both in vivo and in vitro; however, its mechanism and association with loss of myelin protein was not elaborated. Thus, we explored potential mechanisms by which MHV-A59 infection alters Cx43 localization and examined the effects of viral infection on Cx47 expression and its association with loss of the myelin marker proteolipid protein. Immunofluorescenceandtotalinternalreflectionfluo-rescence microscopy confirmed that MHV-A59 used microtubules (MTs) as a conduit to reach the cell surface and restricted MT-mediated Cx43 delivery to the cell membrane. Co-immunoprecipitation experiments demonstrated that Cx43-beta-tubulin molecular interaction was depleted due to protein-protein interaction between viral particles and MTs. During acute MHV-A59 infection, oligodendrocytic Cx47, which is mainly stabilized by Cx43 in vivo, was down-regulated, and its characteristic staining remained disrupted even at chronic phase. The loss of Cx47 was associated with loss of proteolipid protein at the chronic stage of MHV-A59 infection.	[Basu, Rahul; Bose, Abhishek; Thomas, Deepthi; Das Sarma, Jayasri] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Das Sarma, J (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, India.	dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020		Wellcome Trust DBT-India Alliance [IA/I/13/1/500885 T]	Wellcome Trust DBT-India Alliance(Wellcome Trust)	We thank the Indian Institute of Science Education and Research Kolkata apoptome and confocal facility and Ritabrata Ghosh for apoptome and confocal microscopy assistance. We also thank Dr. Bidisha Sinha and Arikta Biswas for the TIRF facility and for assistance in TIRF imaging. We also thank Kenneth S. Shindler for critically reading and editing the manuscript. The IISER-K TIRF facility is supported by Wellcome Trust DBT-India Alliance Grant IA/I/13/1/500885 T.	Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Arishima H, 2002, J NEUROPATH EXP NEUR, V61, P1048, DOI 10.1093/jnen/61.12.1048; Basu R, 2016, J VIROL, V90, P2586, DOI 10.1128/JVI.02420-15; Biswas K, 2014, J VIROL, V88, P3043, DOI 10.1128/JVI.02545-13; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bugiani M, 2006, NEUROLOGY, V67, P273, DOI 10.1212/01.wnl.0000223832.66286.e4; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma Jayasri, 2010, Interdiscip Perspect Infect Dis, V2010, P109239, DOI 10.1155/2010/109239; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Fatemi SH, 2008, SCHIZOPHR RES, V98, P163, DOI 10.1016/j.schres.2007.09.031; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Iacobas DA, 2003, PHYSIOL GENOMICS, V15, P177, DOI 10.1152/physiolgenomics.00062.2003; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kenyon LC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00488; Kleopa KA, 2013, CLIN EXP NEUROIM SS1, V4, P45; Koester-Patzlaff C, 2007, BRAIN RES, V1184, P316, DOI 10.1016/j.brainres.2007.09.062; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; LAVI E, 1987, MICROB PATHOGENESIS, V3, P79, DOI 10.1016/0882-4010(87)90066-0; Li XB, 2008, EUR J NEUROSCI, V28, P1503, DOI 10.1111/j.1460-9568.2008.06431.x; Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; Marek R, 2008, J NEUROSCI METH, V175, P108, DOI 10.1016/j.jneumeth.2008.08.016; Markoullis K, 2012, ACTA NEUROPATHOL, V123, P873, DOI 10.1007/s00401-012-0978-4; Markoullis K, 2012, GLIA, V60, P1053, DOI 10.1002/glia.22334; Martin PEM, 2001, J CELL SCI, V114, P3845; May D, 2013, J NEUROSCI, V33, P7985, DOI 10.1523/JNEUROSCI.5874-12.2013; Mingo RM, 2012, J VIROL, V86, P7084, DOI 10.1128/JVI.00463-12; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Parenti R, 2010, GLIA, V58, P1594, DOI 10.1002/glia.21032; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; Qu CY, 2009, EXP CELL RES, V315, P1683, DOI 10.1016/j.yexcr.2009.03.001; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tabernero A, 1996, GLIA, V16, P187, DOI 10.1002/(SICI)1098-1136(199603)16:3<187::AID-GLIA1>3.0.CO;2-#; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; Xiao PJ, 2012, J VIROL, V86, P10462, DOI 10.1128/JVI.00935-12; Xu AM, 2000, EMBO J, V19, P6465, DOI 10.1093/emboj/19.23.6465; Yea C, 2007, J VIROL, V81, P6899, DOI 10.1128/JVI.02330-05	54	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14747	14763		10.1074/jbc.M117.786491	http://dx.doi.org/10.1074/jbc.M117.786491			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28566289	Green Published, hybrid			2022-12-28	WOS:000409902100003
J	Koppula, P; Zhang, YL; Shi, JJ; Li, W; Gan, BY				Koppula, Pranavi; Zhang, Yilei; Shi, Jiejun; Li, Wei; Gan, Boyi			The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; glucose; glutamate; reactive oxygen species (ROS); tumor metabolism; SLC7A11; xCT	STRESS-RESPONSE; ENERGY STRESS; TUMOR-GROWTH; INHIBITION; METABOLISM; TUMORIGENESIS; OPPORTUNITIES; CHECKPOINT; ADDICTION; OXIDATION	Cancer cells with specific genetic alterations may be highly dependent on certain nutrients for survival, which can inform therapeutic strategies to target these cancer-specific metabolic vulnerabilities. The glutamate/cystine antiporter solute carrier family 7 member 11 (SLC7A11, also called xCT) is overexpressed in several cancers. Contrasting the established pro-survival roles of SLC7A11 under other stress conditions, here we report the unexpected finding that SLC7A11 overexpression enhances cancer cell dependence on glucose and renders cancer cells more sensitive to glucose starvation-induced cell death and, conversely, that SLC7A11 deficiency by either knockdown or pharmacological inhibition promotes cancer cell survival upon glucose starvation. We further show that glucose starvation induces SLC7A11 expression through ATF4 and NRF2 transcription factors and, correspondingly, that ATF4 or NRF2 deficiency also renders cancer cells more resistant to glucose starvation. Finally, we show that SLC7A11 overexpression decreases whereas SLC7A11 deficiency increases intracellular glutamate levels because of SLC7A11-mediated glutamate export and that supplementation of -ketoglutarate, a key downstream metabolite of glutamate, fully restores survival in SLC7A11-overexpressing cells under glucose starvation. Together, our results support the notion that both glucose and glutamate have important roles in maintaining cancer cell survival and uncover a previously unappreciated role of SLC7A11 to promote cancer cell dependence on glucose. Our study therefore informs therapeutic strategies to target the metabolic vulnerability in tumors with high SLC7A11 expression.	[Koppula, Pranavi; Zhang, Yilei; Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Koppula, Pranavi; Gan, Boyi] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Shi, Jiejun; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Shi, Jiejun; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Zhang, YL; Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.; Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Gan, BY (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	YZhang43@mdanderson.org; bgan@mdanderson.org	Shi, Jiejun/P-3329-2019; Zhang, Yilei/I-8997-2014; Gan, Boyi/HDM-4206-2022; Koppula, Pranavi/P-7226-2019	Shi, Jiejun/0000-0001-9777-1183; Zhang, Yilei/0000-0003-1407-0301; Koppula, Pranavi/0000-0002-7567-1891	Andrew Sabin Family Fellow Award; institutional research grant from the University of Texas MD Anderson Cancer Center, National Institutes of Health Grant [CA181196]; Anna Fuller Fund; Ellison Medical Foundation [AG-NS-0973-13]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA181196] Funding Source: NIH RePORTER	Andrew Sabin Family Fellow Award; institutional research grant from the University of Texas MD Anderson Cancer Center, National Institutes of Health Grant; Anna Fuller Fund; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Andrew Sabin Family Fellow Award, an institutional research grant from the University of Texas MD Anderson Cancer Center, National Institutes of Health Grant CA181196, the Anna Fuller Fund, and Ellison Medical Foundation Grant AG-NS-0973-13) (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Lee H, 2016, ONCOTARGET, V7, P19134, DOI 10.18632/oncotarget.8102; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lim JC, 2011, EXP EYE RES, V92, P162, DOI 10.1016/j.exer.2010.05.007; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Liu XW, 2016, CELL CYCLE, V15, P3471, DOI 10.1080/15384101.2016.1249545; Liu XW, 2016, NAT CELL BIOL, V18, P431, DOI 10.1038/ncb3328; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Polewski MD, 2016, MOL CANCER RES, V14, P1229, DOI 10.1158/1541-7786.MCR-16-0028; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Zhang ZH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.14	33	114	118	5	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14240	14249		10.1074/jbc.M117.798405	http://dx.doi.org/10.1074/jbc.M117.798405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28630042	Green Published, hybrid			2022-12-28	WOS:000408439800027
J	Button, RW; Roberts, SL; Willis, TL; Hanemann, CO; Luo, SQ				Button, Robert W.; Roberts, Sheridan L.; Willis, Thea L.; Hanemann, C. Oliver; Luo, Shouqing			Accumulation of autophagosomes confers cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; HUNTINGTONS-DISEASE; INTERACTING PROTEIN; PARKINSONS-DISEASE; BECLIN 1; INHIBITION; COMPLEX; MACROAUTOPHAGY; MATURATION; APOPTOSIS	Autophagy comprises the processes of autophagosome synthesis and lysosomal degradation. In certain stress conditions, increased autophagosome synthesis may be associated with decreased lysosomal activity, which may result in reduced processing of the excessive autophagosomes by the rate-limiting lysosomal activity. Thus, the excessive autophagosomes in such situations may be largely unfused to lysosomes, and their formation/accumulation under these conditions is assumed to be futile for autophagy. The role of cytotoxicity in accumulating autophagosomes (representing synthesis of autophagosomes subsequently unfused to lysosomes) has not been investigated previously. Here, we found that accumulation of autophagosomes compromised cell viability, and this effect was alleviated by depletion of autophagosome machinery proteins. We tested whether reduction in autophagosome synthesis could affect cell viability in cell models expressing mutant huntingtin and alpha-synuclein, given that both of these proteins cause increased autophagosome biogenesis and compromised lysosomal activity. Importantly, partial depletion of autophagosome machinery proteins Atg16L1 and Beclin 1 significantly ameliorated cell death in these conditions. Our data suggest that production/accumulation of autophagosomes subsequently unfused to lysosomes (or accumulation of autophagosomes) directly induces cellular toxicity, and this process may be implicated in the pathogenesis of neurodegenerative diseases. Therefore, lowering the accumulation of autophagosomes may represent a therapeutic strategy for tackling such diseases.	[Luo, Shouqing] Univ Plymouth, Inst Translat & Stratified Med, Peninsula Sch Med, Res Way, Plymouth PL6 8BU, Devon, England; Univ Plymouth, Inst Translat & Stratified Med, Peninsula Sch Dent, Res Way, Plymouth PL6 8BU, Devon, England	University of Plymouth; University of Plymouth	Luo, SQ (corresponding author), Univ Plymouth, Inst Translat & Stratified Med, Peninsula Sch Med, Res Way, Plymouth PL6 8BU, Devon, England.	shouqing.luo@plymouth.ac.uk	Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025; Willis, Thea/0000-0002-1794-7490	Medical Research Council [MR/M023605/1]; BRACE Charity; Arthritis Research UK (ARUK); Plymouth University; MRC [MR/M023605/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BRACE Charity; Arthritis Research UK (ARUK)(Versus Arthritis); Plymouth University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/M023605/1, BRACE Charity, Arthritis Research UK (ARUK), and Plymouth University. The authors declare that they have no conflicts of interest with the contents of this article.	Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Button RW, 2016, ONCOTARGET, V7, P5157, DOI 10.18632/oncotarget.6986; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Heng MY, 2010, AUTOPHAGY, V6, P1206, DOI 10.4161/auto.6.8.13617; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Macintosh RL, 2013, SEMIN CANCER BIOL, V23, P344, DOI 10.1016/j.semcancer.2013.05.006; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Rosenbaum C, 1998, NEUROBIOL DIS, V5, P55, DOI 10.1006/nbdi.1998.0179; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Zhen YL, 2015, AUTOPHAGY, V11, P1608, DOI 10.1080/15548627.2015.1072669; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	62	92	92	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13599	13614		10.1074/jbc.M117.782276	http://dx.doi.org/10.1074/jbc.M117.782276			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28673965	Green Published, hybrid			2022-12-28	WOS:000407942400002
J	Corkins, ME; Wilson, S; Cocuron, JC; Alonso, AP; Bird, AJ				Corkins, Mark E.; Wilson, Stevin; Cocuron, Jean-Christophe; Alonso, Ana P.; Bird, Amanda J.			The gluconate shunt is an alternative route for directing glucose into the pentose phosphate pathway in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTNER-DOUDOROFF PATHWAY; SCHIZOSACCHAROMYCES-POMBE; HUMAN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MASS-SPECTROMETRY; ESCHERICHIA-COLI; ZINC; DEHYDROGENASE; METABOLISM; BINDING; GENE	Glycolysis and the pentose phosphate pathway both play a central role in the degradation of glucose in all domains of life. Another metabolic route that can facilitate glucose breakdown is the gluconate shunt. In this shunt glucose dehydrogenase and gluconate kinase catalyze the two-step conversion of glucose into the pentose phosphate pathway intermediate 6-phosphogluconate. Despite the presence of these enzymes in many organisms, their only established role is in the production of 6-phosphogluconate for the Entner-Doudoroff pathway. In this report we performed metabolic profiling on a strain of Schizosaccharomyces pombe lacking the zinc-responsive transcriptional repressor Loz1 with the goal of identifying metabolic pathways that were altered by cellular zinc status. This profiling revealed that loz1 Delta cells accumulate higher levels of gluconate. We show that the altered gluconate levels in loz1 Delta cells result from increased expression of gcd1. By analyzing the activity of recombinant Gcd1 in vitro and by measuring gluconate levels in strains lacking enzymes of the gluconate shunt we demonstrate that Gcd1 encodes a novel NADP(+)-dependent glucose dehydrogenase that acts in a pathway with the Idn1 gluconate kinase. We also find that cells lacking gcd1 and zwf1, which encode the first enzyme in the pentose phosphate pathway, have a more severe growth phenotype than cells lacking zwf1. We propose that in S. pombe Gcd1 and Idn1 act together to shunt glucose into the pentose phosphate pathway, creating an alternative route for directing glucose into the pentose phosphate pathway that bypasses hexokinase and the rate-limiting enzyme glucose-6-phosphate dehydrogenase.	[Corkins, Mark E.; Wilson, Stevin; Cocuron, Jean-Christophe; Alonso, Ana P.; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, 1787 Neil Ave, Columbus, OH 43210 USA; [Cocuron, Jean-Christophe; Alonso, Ana P.] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Bird, Amanda J.] Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA; [Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bird, AJ (corresponding author), Ohio State Univ, Dept Mol Genet, 1787 Neil Ave, Columbus, OH 43210 USA.; Bird, AJ (corresponding author), Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Alonso, Ana Paula/W-4283-2019; Bird, Amanda Jane/ABD-2295-2021	Alonso, Ana Paula/0000-0003-4696-1811; Bird, Amanda Jane/0000-0002-1846-7050; Wilson, Stevin/0000-0002-9662-5501	NIGMS, National Institutes of Health [R01GM105695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105695] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant R01GM105695 (to A. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAUTISTA JM, 1995, FEBS LETT, V366, P61, DOI 10.1016/0014-5793(95)00474-N; CAMPBELL DP, 1982, ARCH BIOCHEM BIOPHYS, V215, P289, DOI 10.1016/0003-9861(82)90307-1; CAVENER DR, 1983, P NATL ACAD SCI-BIOL, V80, P6286, DOI 10.1073/pnas.80.20.6286; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen X, 2016, P NATL ACAD SCI USA, V113, P5441, DOI 10.1073/pnas.1521916113; Cocuron JC, 2014, METHODS MOL BIOL, V1090, P131, DOI 10.1007/978-1-62703-688-7_9; Corkins ME, 2013, P NATL ACAD SCI USA, V110, P15371, DOI 10.1073/pnas.1300853110; Cosgrove MS, 2000, BIOCHEMISTRY-US, V39, P15002, DOI 10.1021/bi0014608; Costello LC, 2004, PROSTATE CANCER P D, V7, P111, DOI 10.1038/sj.pcan.4500712; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Ehrensberger KM, 2014, J BIOL CHEM, V289, P18087, DOI 10.1074/jbc.M114.551333; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Ferri Stefano, 2011, J Diabetes Sci Technol, V5, P1068; FLIEGE R, 1992, APPL ENVIRON MICROB, V58, P3826, DOI 10.1128/AEM.58.12.3826-3829.1992; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Harrison DC, 1931, BIOCHEM J, V25, P1016, DOI 10.1042/bj0251016; Heiland S, 2000, J BACTERIOL, V182, P2153, DOI 10.1128/JB.182.8.2153-2162.2000; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kotaka M, 2005, ACTA CRYSTALLOGR D, V61, P495, DOI 10.1107/S0907444905002350; Koubaa M, 2013, ANAL BIOCHEM, V436, P151, DOI 10.1016/j.ab.2013.01.027; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; METZGER RP, 1964, J BIOL CHEM, V239, P1769; Ng CY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-68; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Rohatgi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098760; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P155, DOI 10.1006/abbi.1995.1023; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P163, DOI 10.1006/abbi.1995.1024; Wilson S, 2016, ARCH BIOCHEM BIOPHYS, V611, P30, DOI 10.1016/j.abb.2016.02.031; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036	37	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13823	13832		10.1074/jbc.M117.798488	http://dx.doi.org/10.1074/jbc.M117.798488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28667014	Green Published, hybrid			2022-12-28	WOS:000407942400003
J	Dornevil, K; Davis, I; Fielding, AJ; Terrell, JR; Ma, L; Liu, AM				Dornevil, Kednerlin; Davis, Ian; Fielding, Andrew J.; Terrell, James R.; Ma, Li; Liu, Aimin			Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Mycobacterium tuberculosis proceeds through a catalytic shunt pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; ALLENE OXIDE SYNTHASE; SUBSTRATE HYDROXYLATION; REACTION-MECHANISM; CRYSTAL-STRUCTURES; GENOME SEQUENCE; PEROXO COMPLEX; ACTIVE-SITE; OXYGEN; HEME	CYP121, the cytochrome P450 enzyme in Mycobacterium tuberculosis that catalyzes a single intramolecular C-C cross-linking reaction in the biosynthesis of mycocyclosin, is crucial for the viability of this pathogen. This C-C coupling reaction represents an expansion of the activities carried out by P450 enzymes distinct from oxygen insertion. Although the traditional mechanism for P450 enzymes has been well studied, it is unclear whether CYP121 follows the general P450 mechanism or uses a different catalytic strategy for generating an iron-bound oxidant. To gain mechanistic insight into the CYP121-catalyzed reaction, we tested the peroxide shunt pathway by using rapid kinetic techniques to monitor the enzyme activity with its substrate dicyclotyrosine (cYY) and observed the formation of the cross-linked product mycocyclosin by LC-MS. In stopped-flow experiments, we observed that cYY binding to CYP121 proceeds in a two-step process, and EPR spectroscopy indicates that the binding induces active site reorganization and uniformity. Using rapid freeze-quenching EPR, we observed the formation of a high-spin intermediate upon the addition of peracetic acid to the enzyme-substrate complex. This intermediate exhibits a high-spin (S = 5/2) signal with g values of 2.00, 5.77, and 6.87. Likewise, iodosylbenzene could also produce mycocyclosin, implicating compound I as the initial oxidizing species. Moreover, we also demonstrated that CYP121 performs a standard peroxidase type of reaction by observing substrate-based radicals. On the basis of these results, we propose plausible free radical-based mechanisms for the C-C bond coupling reaction.	[Dornevil, Kednerlin; Davis, Ian; Fielding, Andrew J.; Ma, Li; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Dornevil, Kednerlin; Davis, Ian; Terrell, James R.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.	Feradical@utsa.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Dornevil, Kednerlin/0000-0003-2451-6661; Davis, Ian/0000-0002-1566-4972	National Institutes of Health [GM108988, GM107529]; Southern Regional Education Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529, R01GM108988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Regional Education Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grants GM108988 and GM107529 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a doctoral fellowship from the Southern Regional Education Board.	AMANN T, 1995, HETEROCYCLES, V40, P425; Balding PR, 2008, J PHYS CHEM A, V112, P12911, DOI 10.1021/jp802087w; Barry BA, 2015, BBA-BIOENERGETICS, V1847, P46, DOI 10.1016/j.bbabio.2014.09.003; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Boeglin WE, 2012, J BIOL CHEM, V287, P24139, DOI 10.1074/jbc.M112.364216; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; BRUICE TC, 1983, J CHEM SOC CHEM COMM, P14, DOI 10.1039/c39830000014; Cho KB, 2011, ARCH BIOCHEM BIOPHYS, V507, P14, DOI 10.1016/j.abb.2010.07.016; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Duffell KM, 2013, ANAL CHEM, V85, P5707, DOI 10.1021/ac400236z; Dumas VG, 2014, PROTEINS, V82, P1004, DOI 10.1002/prot.24474; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; Fonvielle M, 2013, J BIOL CHEM, V288, P17347, DOI 10.1074/jbc.M112.443853; Geng JF, 2015, ANGEW CHEM INT EDIT, V54, P3692, DOI 10.1002/anie.201410247; Geng JF, 2013, P NATL ACAD SCI USA, V110, P9639, DOI 10.1073/pnas.1301544110; Ghiladi RA, 1999, J AM CHEM SOC, V121, P9885, DOI 10.1021/ja992296i; Ghiladi RA, 2001, J AM CHEM SOC, V123, P6183, DOI 10.1021/ja010602y; Giessen TW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00785; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; GUSTAFSSON JA, 1979, BIOCHEMISTRY-US, V18, P865, DOI 10.1021/bi00572a020; Hammes-Schiffer S, 2015, J AM CHEM SOC, V137, P8860, DOI 10.1021/jacs.5b04087; Hudson SA, 2013, CHEMMEDCHEM, V8, P1451, DOI 10.1002/cmdc.201300219; Hudson SA, 2012, ANGEW CHEM INT EDIT, V51, P9311, DOI 10.1002/anie.201202544; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kavanagh ME, 2016, CHEMMEDCHEM, V11, P1924, DOI 10.1002/cmdc.201600248; Kavanagh ME, 2016, J MED CHEM, V59, P3272, DOI 10.1021/acs.jmedchem.6b00007; Lehnert N, 2001, J AM CHEM SOC, V123, P12802, DOI 10.1021/ja011450+; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Li FF, 2011, J AM CHEM SOC, V133, P7256, DOI 10.1021/ja111742z; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Mathe C, 2002, J AM CHEM SOC, V124, P4966, DOI 10.1021/ja025707v; Matsumoto M, 2007, CURR TOP MED CHEM, V7, P499, DOI 10.2174/156802607780059727; MCCANDLISH E, 1980, J AM CHEM SOC, V102, P4268, DOI 10.1021/ja00532a053; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Mizutani M, 2011, ARCH BIOCHEM BIOPHYS, V507, P194, DOI 10.1016/j.abb.2010.09.026; NORDBLOM GD, 1976, ARCH BIOCHEM BIOPHYS, V175, P524, DOI 10.1016/0003-9861(76)90541-5; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; Roelfes G, 2003, INORG CHEM, V42, P2639, DOI 10.1021/ic034065p; Segel IH., 1993, ENZYME KINETICS BEHA; Shin KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P109, DOI 10.1006/abbi.2000.2083; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Souter A, 2000, J CHEM TECHNOL BIOT, V75, P933, DOI 10.1002/1097-4660(200010)75:10<933::AID-JCTB301>3.0.CO;2-C; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Su J, 2009, J AM CHEM SOC, V131, P12979, DOI 10.1021/ja902473r; Sundaramurthi JC, 2011, BIOINFORMATION, V7, P130; Ullrich V, 2003, ARCH BIOCHEM BIOPHYS, V409, P45, DOI 10.1016/S0003-9861(02)00410-1; Warren JJ, 2012, COORDIN CHEM REV, V256, P2478, DOI 10.1016/j.ccr.2012.03.032; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; WHITE RE, 1980, J BIOL CHEM, V255, P1108; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966	60	23	23	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13645	13657		10.1074/jbc.M117.794099	http://dx.doi.org/10.1074/jbc.M117.794099			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28667013	Green Published, hybrid			2022-12-28	WOS:000407942400004
J	Chao, JR; Knight, K; Engel, AL; Jankowski, C; Wang, YK; Manson, MA; Gu, HW; Djukovic, D; Raftery, D; Hurley, JB; Du, JH				Chao, Jennifer R.; Knight, Kaitlen; Engel, Abbi L.; Jankowski, Connor; Wang, Yekai; Manson, Megan A.; Gu, Haiwei; Djukovic, Danijel; Raftery, Daniel; Hurley, James B.; Du, Jianhai			Human retinal pigment epithelial cells prefer proline as a nutrient and transport metabolic intermediates to the retinal side	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; metabolic regulation; metabolic tracer; metabolism; metabolomics; retina; retinal metabolism	ORNITHINE CYTOTOXICITY; GLUTAMATE TRANSPORTER; MACULAR DEGENERATION; GYRATE ATROPHY; EXPRESSION; CULTURE; CITRATE; MODEL; DIFFERENTIATION; DISTRIBUTIONS	Metabolite transport is a major function of the retinal pigment epithelium (RPE) to support the neural retina. RPE dysfunction plays a significant role in retinal degenerative diseases. We have used mass spectrometry with C-13 tracers to systematically study nutrient consumption and metabolite transport in cultured human fetal RPE. LC/MS-MS detected 120 metabolites in the medium from either the apical or basal side. Surprisingly, more proline is consumed than any other nutrient, including glucose, taurine, lipids, vitamins, or other amino acids. Besides being oxidized through the Krebs cycle, proline is used to make citrate via reductive carboxylation. Citrate, made either from C-13 proline or from C-13 glucose, is preferentially exported to the apical side and is taken up by the retina. In conclusion, RPE cells consume multiple nutrients, including glucose and taurine, but prefer proline, and they actively synthesize and export metabolic intermediates to the apical side to nourish the outer retina.	[Chao, Jennifer R.; Knight, Kaitlen; Engel, Abbi L.; Manson, Megan A.; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98109 USA; [Jankowski, Connor; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98109 USA; [Gu, Haiwei; Djukovic, Danijel; Raftery, Daniel] Univ Washington, Northwest Metabol Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98109 USA; [Wang, Yekai; Du, Jianhai] West Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA; [Wang, Yekai; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; West Virginia University; West Virginia University	Chao, JR (corresponding author), 750 Republican St,Box 358058, Seattle, WA 98109 USA.; Du, JH (corresponding author), WVU Eye Inst, 1 Med Ctr Dr,POB 9193, Morgantown, WV 26505 USA.	jrchao@uw.edu; jianhai.du@wvumedicine.org		Jankowski, Connor/0000-0003-1247-4548	National Institutes of Health [EY026030, EY06641, EY017863, EY019714]; Brightfocus Foundation; NATIONAL EYE INSTITUTE [K08EY019714, R01EY017863, F32EY006641, R01EY026030, R01EY006641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brightfocus Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants EY026030 (to J. D., J. B. H., and J. R. C.), EY06641 and EY017863 (to J. B. H.), and EY019714 (to J. R. C.) and the Brightfocus Foundation (to J. D. and J. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Akrami Hassan, 2009, J Ophthalmic Vis Res, V4, P134; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Ando A, 2000, EXP EYE RES, V70, P89, DOI 10.1006/exer.1999.0750; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Du JH, 2015, METHOD ENZYMOL, V561, P149, DOI 10.1016/bs.mie.2015.04.002; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Duvvari MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152047; El-Sherbeny A, 2004, INVEST OPHTH VIS SCI, V45, P694, DOI 10.1167/iovs.03-0503; Fernandez-Godino R, 2016, ADV EXP MED BIOL, V854, P53, DOI 10.1007/978-3-319-17121-0_8; Fronk AH, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416650838; GABRIELIAN K, 1992, CURR EYE RES, V11, P481, DOI 10.3109/02713689209001804; Gamm DM, 2008, INVEST OPHTH VIS SCI, V49, P788, DOI 10.1167/iovs.07-0777; Gu HW, 2016, ANGEW CHEM INT EDIT, V55, P15646, DOI 10.1002/anie.201609236; Guziewicz KE, 2017, PROG RETIN EYE RES, V58, P70, DOI 10.1016/j.preteyeres.2017.01.005; Hillenkamp J, 2004, INVEST OPHTH VIS SCI, V45, P4099, DOI 10.1167/iovs.04-0624; HIRATA A, 1992, INVEST OPHTH VIS SCI, V33, P2079; Hu J, 2001, MOL VIS, V7, P14; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Jiang L, 2017, METAB ENG, V43, P198, DOI 10.1016/j.ymben.2016.11.004; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Lehmann GL, 2014, EXP EYE RES, V126, P5, DOI 10.1016/j.exer.2014.04.021; LI W, 1984, EXP EYE RES, V38, P291, DOI 10.1016/0014-4835(84)90167-2; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Maenpaa H, 2004, CURR EYE RES, V28, P159, DOI 10.1076/ceyr.28.3.159.26244; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Maminishkis Arvydas, 2010, J Vis Exp, DOI 10.3791/2032; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; MIYAMOTO Y, 1994, INVEST OPHTH VIS SCI, V35, P3589; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; Ochrietor JD, 2004, DEV NEUROSCI-BASEL, V26, P380, DOI 10.1159/000082280; ODONNELL JJ, 1978, SCIENCE, V200, P200, DOI 10.1126/science.635581; OKA MS, 1984, EXP CELL RES, V154, P537, DOI 10.1016/0014-4827(84)90178-2; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Ruggiero L, 2014, ADV EXP MED BIOL, V801, P91, DOI 10.1007/978-1-4614-3209-8_12; Scerri TS, 2017, NAT GENET, V49, P559, DOI 10.1038/ng.3799; SONNEWALD U, 1991, NEUROSCI LETT, V128, P235, DOI 10.1016/0304-3940(91)90268-X; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; SUGASAWA K, 1994, CELL STRUCT FUNCT, V19, P21, DOI 10.1247/csf.19.21; Udawatte C, 2008, MOL VIS, V14, P1940; Ueda M, 1998, INVEST OPHTH VIS SCI, V39, P820; Wang T, 1996, J CLIN INVEST, V97, P2753, DOI 10.1172/JCI118730; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Westergaard N, 2017, NEUROCHEM RES, V42, P1583, DOI 10.1007/s11064-016-2159-7; Wood JPM, 2004, INVEST OPHTH VIS SCI, V45, P1272, DOI 10.1167/iovs.03-0693; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhu JJ, 2014, J PROTEOME RES, V13, P4120, DOI 10.1021/pr500494u	56	51	54	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12895	12905		10.1074/jbc.M117.788422	http://dx.doi.org/10.1074/jbc.M117.788422			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615447	hybrid, Green Published			2022-12-28	WOS:000407220100019
J	Qian, YF; Johnson, KA				Qian, Yufeng; Johnson, Kenneth A.			The human mitochondrial single-stranded DNA-binding protein displays distinct kinetics and thermodynamics of DNA binding and exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; DNA replication; kinetics; mitochondrial DNA (mtDNA); pre-steady-state kinetics; DNA binding kinetics; DNA binding mechanism; Global data fitting; SSB; transient kinetics	ESCHERICHIA-COLI SSB; PLASMODIUM-FALCIPARUM SSB; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; REPLICATION; POLYMERASE; MODES; RECONSTITUTION; TETRAMERS; MAINTENANCE	The human mitochondrial ssDNA-binding protein (mtSSB) is a homotetrameric protein, involved in mtDNA replication and maintenance. Although mtSSB is structurally similar to SSB from Escherichia coli (EcoSSB), it lacks the C-terminal disordered domain, and little is known about the biophysics of mtSSB-ssDNA interactions. Here, we characterized the kinetics and thermodynamics of mtSSB binding to ssDNA by equilibrium titrations and stopped-flow kinetic measurements. We show that the mtSSB tetramer can bind to ssDNA in two distinct binding modes: (SSB)(30) and (SSB)(60), defined by DNA binding site sizes of 30 and 60 nucleotides, respectively. We found that the binding mode is modulated by magnesium ion and NaCl concentration, but unlike EcoSSB, the mtSSB does not show negative intersubunit cooperativity. Global fitting of both the equilibrium and kinetic data afforded estimates for the rate and equilibrium constants governing the formation of (SSB)(60) and (SSB)(30) complexes and for the transitions between the two binding modes. We found that the mtSSB tetramer binds to ssDNA with a rate constant near the diffusion limit (2 x 10(9) m(-1) s(-1)) and that longer DNA (60 nucleotides) rapidly wraps around all four monomers, as revealed by FRET assays. We also show that the mtSSB tetramer can directly transfer from one ssDNA molecule to another via an intermediate with two DNA molecules bound to the mtSSB. In conclusion, our results indicate that human mtSSB shares many physicochemical properties with EcoSSB and that the differences may be explained by the lack of an acidic, disordered C-terminal tail in human mtSSB protein.	[Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA; Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Qian, Yufeng] Pacific Biosci, 1380 Willow Rd, Menlo Pk, CA 94025 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			Welch Foundation [F-1604]; National Institutes of Health [R01 GM114223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114223] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant F-1604 and National Institutes of Health Grant R01 GM114223. K. A. J. is the President of KinTek Corp., which provided the AutoSF-120 stopped flow instrument and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; Antony E, 2013, J MOL BIOL, V425, P4802, DOI 10.1016/j.jmb.2013.08.021; Antony E, 2012, J MOL BIOL, V420, P284, DOI 10.1016/j.jmb.2012.04.022; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; Brandis JW, 2009, PROTEIN EXPRES PURIF, V63, P120, DOI 10.1016/j.pep.2008.09.018; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Eggington JM, 2006, BIOCHEMISTRY-US, V45, P14490, DOI 10.1021/bi061178m; FERRARI ME, 1994, J MOL BIOL, V236, P106, DOI 10.1006/jmbi.1994.1122; Grove DE, 2006, J BIOL CHEM, V281, P2087, DOI 10.1074/jbc.M510884200; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kozlov AG, 1998, J MOL BIOL, V278, P999, DOI 10.1006/jmbi.1998.1738; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P8266, DOI 10.1021/bi100920w; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Lee HR, 2008, J BIOL CHEM, V283, P14402, DOI 10.1074/jbc.M705007200; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; LOHMAN TM, 1988, BIOCHEMISTRY-US, V27, P2260, DOI 10.1021/bi00407a002; Lohman TM, 1996, BIOCHEMISTRY-US, V35, P5272, DOI 10.1021/bi9527606; LOHMAN TM, 1988, TRENDS BIOCHEM SCI, V13, P250; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1988, BIOCHEM PHARMACOL, V37, P1781, DOI 10.1016/0006-2952(88)90443-1; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; Qian YF, 2013, BIOPHYS J, V104, p74A, DOI 10.1016/j.bpj.2012.11.448; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Springer T, 2010, NUCLEIC ACIDS RES, V38, P7343, DOI 10.1093/nar/gkq577; Steen KW, 2012, DNA REPAIR, V11, P82, DOI 10.1016/j.dnarep.2011.10.026; Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Witte G, 2008, BIOPHYS J, V94, P2269, DOI 10.1529/biophysj.107.121533; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	47	17	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13068	13084		10.1074/jbc.M117.791392	http://dx.doi.org/10.1074/jbc.M117.791392			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615444	Green Published, hybrid			2022-12-28	WOS:000407220100033
J	Jones, DR; Uddin, MS; Gruninger, RJ; Pham, TTM; Thomas, D; Boraston, AB; Briggs, J; Pluvinage, B; McAllister, TA; Forster, RJ; Tsang, A; Selinger, LB; Abbott, DW				Jones, Darryl R.; Uddin, Muhammed Salah; Gruninger, Robert J.; Thi Thanh My Pham; Thomas, Dallas; Boraston, Alisdair B.; Briggs, Jonathan; Pluvinage, Benjamin; McAllister, Tim A.; Forster, Robert J.; Tsang, Adrian; Selinger, L. Brent; Abbott, D. Wade			Discovery and characterization of family 39 glycoside hydrolases from rumen anaerobic fungi with polyspecific activity on rare arabinosyl substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; enzyme; fungi; galactose; glycoside hydrolase; arabinose; rumen	PLANT-CELL WALL; L-ARABINOFURANOSIDASE; POLYSACCHARIDE; ENZYMES; COMPLEX; PECTIN; ARABINOXYLANS; DEGRADATION; ARABINANASE; EXPRESSION	Enzyme activities that improve digestion of recalcitrant plant cell wall polysaccharides may offer solutions for sustainable industries. To this end, anaerobic fungi in the rumen have been identified as a promising source of novel carbohydrate active enzymes (CAZymes) that modify plant cell wall polysaccharides and other complex glycans. Many CAZymes share insufficient sequence identity to characterized proteins from other microbial ecosystems to infer their function; thus presenting challenges to their identification. In this study, four rumen fungal genes (nf2152, nf2215, nf2523, and pr2455) were identified that encode family 39 glycoside hydrolases (GH39s), and have conserved structural features with GH51s. Two recombinant proteins, NF2152 and NF2523, were characterized using a variety of biochemical and structural techniques, and were determined to have distinct catalytic activities. NF2152 releases a single product, 1,2-arabinobiose (Ara(2)) from sugar beet arabinan (SBA), and 1,2-Ara(2) and -1,2-galactoarabinose (Gal-Ara) from rye arabinoxylan (RAX). NF2523 exclusively releases -1,2-Gal-Ara from RAX, which represents the first description of a galacto-(-1,2)-arabinosidase. Both -1,2-Ara(2) and -1,2-Gal-Ara are disaccharides not previously described within SBA and RAX. In this regard, the enzymes studied here may represent valuable new biocatalytic tools for investigating the structures of rare arabinosyl-containing glycans, and potentially for facilitating their modification in industrial applications.	[Jones, Darryl R.; Uddin, Muhammed Salah; Gruninger, Robert J.; Thomas, Dallas; McAllister, Tim A.; Forster, Robert J.; Abbott, D. Wade] Agr & Agrifood Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB T1J 4B1, Canada; [Uddin, Muhammed Salah; Selinger, L. Brent; Abbott, D. Wade] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 6T5, Canada; [Thi Thanh My Pham; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; [Boraston, Alisdair B.; Pluvinage, Benjamin] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Briggs, Jonathan] Newcastle Univ, Sch Biol, Ridley Bldg 2,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Agriculture & Agri Food Canada; University of Lethbridge; Concordia University - Canada; University of Victoria; Newcastle University - UK	Abbott, DW (corresponding author), Agr & Agrifood Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB T1J 4B1, Canada.; Abbott, DW (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 6T5, Canada.	wade.abbott@agr.gc.ca	Briggs, Jonathon/AAT-5145-2020; McAllister, Tim A./R-9201-2017	Briggs, Jonathon/0000-0003-4181-2809; McAllister, Tim A./0000-0002-8266-6513; Boraston, Alisdair/0000-0001-6417-0592; Abbott, Wade/0000-0003-4893-5799	Agriculture and Agri-Food Canada (AAFC) through Agriculture Innovation Program [AIP-P022]; Elanco Animal Health; Natural Sciences and Engineering Research Council of Canada [FRN 04355]	Agriculture and Agri-Food Canada (AAFC) through Agriculture Innovation Program(Agriculture & Agri Food Canada); Elanco Animal Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Agriculture and Agri-Food Canada (AAFC) through Agriculture Innovation Program Grant AIP-P022 and Elanco Animal Health, and Natural Sciences and Engineering Research Council of Canada Discovery Grant FRN 04355 (to A. B. B.). The intellectual property surrounding the field of use for these enzymes has been protected with a United States provisional patent (No. 62/380,741 under AAFC's patent docket, PAT-13830). D. R. J., M. S. U., T. A. M., A. T., and D. W. A. are co-inventors on this patent.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Badhan A, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-31; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Peled C., 2008, BIOMASS RECALCITRANC, V94-187, P94, DOI DOI 10.1002/9781444305418.CH5; BENGTSSON S, 1992, CARBOHYD POLYM, V17, P277, DOI 10.1016/0144-8617(92)90170-U; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Couger MB, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0390-0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dai X, 2015, APPL ENVIRON MICROB, V81, P1375, DOI 10.1128/AEM.03682-14; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto Z, 2013, BIOSCI BIOTECH BIOCH, V77, P1363, DOI 10.1271/bbb.130183; Fujita K, 2014, J BIOL CHEM, V289, P5240, DOI 10.1074/jbc.M113.528711; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Gao NG, 2005, METHODS, V35, P323, DOI 10.1016/j.ymeth.2004.10.003; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gruninger RJ, 2014, FEMS MICROBIOL ECOL, V90, P1, DOI 10.1111/1574-6941.12383; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Im DH, 2012, BIOSCI BIOTECH BIOCH, V76, P423, DOI 10.1271/bbb.110902; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Jones L, 2003, P NATL ACAD SCI USA, V100, P11783, DOI 10.1073/pnas.1832434100; JOSELEAU JP, 1977, CARBOHYD RES, V58, P165, DOI 10.1016/S0008-6215(00)83412-6; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean R, 2015, J BIOL CHEM, V290, P21231, DOI 10.1074/jbc.M115.664847; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Morgavi DP, 2013, ANIMAL, V7, P184, DOI 10.1017/S1751731112000419; Morrison JM, 2016, PEERJ, V4, DOI 10.7717/peerj.2289; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paes G, 2008, BIOCHEMISTRY-US, V47, P7441, DOI 10.1021/bi800424e; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Rambaut A, 2014, FIGTREE TREE FIGURE; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Ribeiro GO, 2016, ANIM FRONT, V6, P20, DOI 10.2527/af.2016-0019; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3319, DOI 10.1128/AEM.67.7.3319-3321.2001; Santos CR, 2014, J BIOL CHEM, V289, P7362, DOI 10.1074/jbc.M113.537167; Santos CR, 2012, ACTA CRYSTALLOGR D, V68, P1339, DOI 10.1107/S0907444912028491; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi H, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-35; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon KV, 2016, SCIENCE, V351, P1192, DOI 10.1126/science.aad1431; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; VINKX CJA, 1993, CEREAL CHEM, V70, P311; Vinkx CJA, 1996, J CEREAL SCI, V24, P1, DOI 10.1006/jcrs.1996.0032; Woods Group, 2017, CARB BUILD GLYCAM WE; Yapo BM, 2011, POLYM REV, V51, P391, DOI 10.1080/15583724.2011.615962; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	71	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12606	12620		10.1074/jbc.M117.789008	http://dx.doi.org/10.1074/jbc.M117.789008			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28588026	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000406636900025
J	Hobley, L; Li, B; Wood, JL; Kim, SH; Naidoo, J; Ferreira, AS; Khomutov, M; Khomutov, A; Stanley-Wall, NR; Michael, AJ				Hobley, Laura; Li, Bin; Wood, Jennifer L.; Kim, Sok Ho; Naidoo, Jacinth; Ferreira, Ana Sofia; Khomutov, Maxim; Khomutov, Alexey; Stanley-Wall, Nicola R.; Michael, Anthony J.			Spermidine promotes Bacillus subtilis biofilm formation by activating expression of the matrix regulator slrR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-P; AGROBACTERIUM-TUMEFACIENS; POLYAMINE BIOSYNTHESIS; VIBRIO-CHOLERAE; EF-P; PROTEIN; IDENTIFICATION; PATHWAY; GROWTH; TRANSLATION	Ubiquitous polyamine spermidine is not required for normal planktonic growth of Bacillus subtilis but is essential for robust biofilm formation. However, the structural features of spermidine required for B. subtilis biofilm formation are unknown and so are the molecular mechanisms of spermidine-stimulated biofilm development. We report here that in a spermidine-deficient B. subtilis mutant, the structural analogue norspermidine, but not homospermidine, restored biofilm formation. Intracellular biosynthesis of another spermidine analogue, aminopropylcadaverine, from exogenously supplied homoagmatine also restored biofilm formation. The differential ability of C-methylated spermidine analogues to functionally replace spermidine in biofilm formation indicated that the aminopropyl moiety of spermidine is more sensitive to C-methylation, which it is essential for biofilm formation, but that the length and symmetry of the molecule is not critical. Transcriptomic analysis of a spermidine-depleted B. subtilis speD mutant uncovered a nitrogen-, methionine-, and S-adenosylmethionine-sufficiency response, resulting in repression of gene expression related to purine catabolism, methionine and S-adenosylmethionine biosynthesis and methionine salvage, and signs of altered membrane status. Consistent with the spermidine requirement in biofilm formation, single-cell analysis of this mutant indicated reduced expression of the operons for production of the exopolysaccharide and TasA protein biofilm matrix components and SinR antagonist slrR. Deletion of sinR or ectopic expression of slrR in the spermidine-deficient Delta speD background restored biofilm formation, indicating that spermidine is required for expression of the biofilm regulator slrR. Our results indicate that spermidine functions in biofilm development by activating transcription of the biofilm matrix exopolysaccharide and TasA operons through the regulator slrR.	[Hobley, Laura; Li, Bin; Kim, Sok Ho; Michael, Anthony J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Li, Bin; Naidoo, Jacinth; Michael, Anthony J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hobley, Laura; Wood, Jennifer L.; Ferreira, Ana Sofia; Stanley-Wall, Nicola R.] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD15EH, Scotland; [Khomutov, Maxim; Khomutov, Alexey] Russian Acad Sci, Engelhardt Inst Mol Biol, Vavilov St 32, Moscow 119991, Russia; [Hobley, Laura] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland; [Kim, Sok Ho] Realtox Labs, Reisterstown, MD 21136 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Dundee; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Queens University Belfast	Michael, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Michael, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Stanley-Wall, NR (corresponding author), Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD15EH, Scotland.	n.r.stanleywall@dundee.ac.uk; anthony.michael@utsouthwestern.edu	Khomutov, Alex/G-2128-2015	Hobley, Laura/0000-0002-2153-0946; Khomutov, Alex/0000-0001-6833-7855; Stanley-Wall, Nicola/0000-0002-5936-9721; Khomutov, Maxim/0000-0003-2833-9834	University of Texas Southwestern Medical Center at Dallas; Biotechnology and Biological Sciences Research Council, UK [BB/1019464/1]; SULSA LEADERS award; Russian Science Foundation [RSF 14-14-01099, 14-50-00060]	University of Texas Southwestern Medical Center at Dallas; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SULSA LEADERS award; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by University of Texas Southwestern Medical Center at Dallas (to A.J.M), Biotechnology and Biological Sciences Research Council, UK Grant BB/1019464/1 (to N.R.S.-W.), a SULSA LEADERS award (to L.H.), and Grants RSF 14-14-01099 and RSF 14-50-00060 from the Russian Science Foundation (to M.K. and A.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Beier L, 2002, J BACTERIOL, V184, P3232, DOI 10.1128/JB.184.12.3232-3241.2002; Bottcher T, 2013, J AM CHEM SOC, V135, P2927, DOI 10.1021/ja3120955; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Cairns LS, 2014, MOL MICROBIOL, V93, P587, DOI 10.1111/mmi.12697; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Cybulski LE, 2002, MOL MICROBIOL, V45, P1379, DOI 10.1046/j.1365-2958.2002.03103.x; Diethmaier C, 2014, J BACTERIOL, V196, P265, DOI 10.1128/JB.00826-13; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Ding YZ, 2014, APPL ENVIRON MICROB, V80, P1498, DOI 10.1128/AEM.03461-13; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dominguez-Escobar J, 2014, MOL MICROBIOL, V92, P716, DOI 10.1111/mmi.12586; Feichtinger K, 1998, J ORG CHEM, V63, P3804, DOI 10.1021/jo980425s; FERRARI FA, 1985, P NATL ACAD SCI USA, V82, P2647, DOI 10.1073/pnas.82.9.2647; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Green R, 2011, MOL MICROBIOL, V81, P1109, DOI 10.1111/j.1365-2958.2011.07757.x; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hagan AK, 2016, MOL MICROBIOL, V102, P196, DOI 10.1111/mmi.13465; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; Hobley L, 2014, CELL, V156, P844, DOI 10.1016/j.cell.2014.01.012; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Hofer U, 2014, NAT REV MICROBIOL, V12, P234, DOI 10.1038/nrmicro3233; HONJO M, 1990, J BACTERIOL, V172, P1783, DOI 10.1128/jb.172.4.1783-1790.1990; ISHII I, 1994, CELL MOL BIOL, V40, P925; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kim SH, 2016, ACS CHEM BIOL, V11, P491, DOI 10.1021/acschembio.5b00893; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li B, 2016, ACS CHEM BIOL, V11, P2782, DOI 10.1021/acschembio.6b00629; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Meeske AJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002341; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; Murray EJ, 2009, J BACTERIOL, V191, P6822, DOI 10.1128/JB.00618-09; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; Oves-Costales D, 2009, CHEM COMMUN, P1389, DOI 10.1039/b823147h; Park JH, 2003, J BIOL CHEM, V278, P32683, DOI 10.1074/jbc.M304247200; PARK MH, 1988, J BIOL CHEM, V263, P15264; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Potter AJ, 2014, J BACTERIOL, V196, P3556, DOI 10.1128/JB.01981-14; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; TROWSDALE J, 1978, J BACTERIOL, V135, P99, DOI 10.1128/JB.135.1.99-113.1978; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Verhamme DT, 2009, J BACTERIOL, V191, P100, DOI 10.1128/JB.01236-08; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang Y, 2016, J BACTERIOL, V198, P2682, DOI 10.1128/JB.00265-16; Weber MHW, 2001, MOL MICROBIOL, V39, P1321, DOI 10.1046/j.1365-2958.2001.02322.x; Winkelman JT, 2013, MOL MICROBIOL, V88, P984, DOI 10.1111/mmi.12235; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x	67	26	27	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12041	12053		10.1074/jbc.M117.789644	http://dx.doi.org/10.1074/jbc.M117.789644			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28546427	Green Published, hybrid			2022-12-28	WOS:000406053300004
J	Larsen, ISB; Narimatsu, Y; Joshi, HJ; Yang, Z; Harrison, OJ; Brasch, J; Shapiro, L; Honig, B; Vakhrushev, SY; Clausen, H; Halim, A				Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Yang, Zhang; Harrison, Oliver J.; Brasch, Julia; Shapiro, Lawrence; Honig, Barry; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan			Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; ALPHA-DYSTROGLYCAN; GLYCAN STRUCTURES; MANNOSE GLYCOPROTEOME; MUSCULAR-DYSTROPHY; RIBITOL-PHOSPHATE; GLYCOSYLATION; POMT1; RECOGNITION; MUTATIONS	Protein O-mannosylation is found in yeast and metazoans, and a family of conserved orthologous protein O-mannosyltransferases is believed to initiate this important post-translational modification. We recently discovered that the cadherin superfamily carries O-linked mannose (O-Man) glycans at highly conserved residues in specific extracellular cadherin domains, and it was suggested that the function of E-cadherin was dependent on the O-Man glycans. Deficiencies in enzymes catalyzing O-Man biosynthesis, including the two human protein O-mannosyltransferases, POMT1 and POMT2, underlie a subgroup of congenital muscular dystrophies designated alpha-dystroglycanopathies, because deficient O-Man glycosylation of alpha-dystroglycan disrupts laminin interaction with alpha-dystroglycan and the extracellular matrix. To explore the functions of O-Man glycans on cadherins and protocadherins, we used a combinatorial gene-editing strategy in multiple cell lines to evaluate the role of the two POMTs initiating O-Man glycosylation and the major enzyme elongating O-Man glycans, the protein O-mannose alpha-1,2-N-acetylglucosaminyltransferase, POMGnT1. Surprisingly, O-mannosylation of cadherins and protocadherins does not require POMT1 and/or POMT2 in contrast to alpha-dystroglycan, and moreover, the O-Man glycans on cadherins are not elongated. Thus, the classical and evolutionarily conserved POMT O-mannosylation pathway is essentially dedicated to alpha-dystroglycan and a few other proteins, whereas a novel O-mannosylation process in mammalian cells is predicted to serve the large cadherin superfamily and other proteins.	[Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Yang, Zhang; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Harrison, Oliver J.; Brasch, Julia; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Syst Biol, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	University of Copenhagen; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Halim, A (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.	halim@sund.ku.dk	clausen, henrik/AAD-8016-2021; Shapiro, Lawrence/AAE-7172-2019; Vakhrushev, Sergey Y/A-7638-2014; Yang, Zhang/I-8934-2016; Narimatsu, Yoshiki/G-8388-2019; Joshi, Hiren/B-5739-2016	Vakhrushev, Sergey Y/0000-0002-0418-5765; Clausen, Henrik/0000-0002-0915-5055; Yang, Zhang/0000-0002-4756-5813; Narimatsu, Yoshiki/0000-0003-1428-5695; Joshi, Hiren/0000-0002-8192-2829; Halim, Adnan/0000-0003-1629-187X; Honig, Barry/0000-0002-1835-1031	A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal; Kirsten og Freddy Johansen Fonden; Carlsberg Foundation; Novo Nordisk Foundation; European Union [704228]; Danish Research Councils; National Science Foundation (NSF) [MCB-1412472]; National Institutes of Health [R01-GM10751, R01GM118584]; University of Copenhagen Program of Excellence; Danish National Research Foundation [DNRF107]; Novo Nordisk Fonden [NNF15OC0016548] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118584, R01GM107571] Funding Source: NIH RePORTER; Direct For Biological Sciences [1412472] Funding Source: National Science Foundation	A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal; Kirsten og Freddy Johansen Fonden; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Danish Research Councils(Det Frie Forskningsrad (DFF)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen Program of Excellence; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal, Kirsten og Freddy Johansen Fonden, The Carlsberg Foundation, The Novo Nordisk Foundation, The European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Grant 704228, The Danish Research Councils, National Science Foundation (NSF) Grant MCB-1412472 (to B. H.), National Institutes of Health Grants R01-GM10751 and R01GM118584 (to L. S.), the University of Copenhagen Program of Excellence, and the Danish National Research Foundation Grant DNRF107. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Avsar-Ban E, 2010, GLYCOBIOLOGY, V20, P1089, DOI 10.1093/glycob/cwq069; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartels MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166119; Bausewein D, 2016, J BIOL CHEM, V291, P18006, DOI 10.1074/jbc.M116.739128; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Breloy I, 2012, BIOL CHEM, V393, P709, DOI 10.1515/hsz-2012-0214; Carvalho S, 2016, ONCOTARGET, V7, P65231, DOI 10.18632/oncotarget.11245; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; FINNE J, 1979, J BIOL CHEM, V254, P295; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Halmo SM, 2017, J BIOL CHEM, V292, P2101, DOI 10.1074/jbc.M116.764712; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Martinez T, 2007, J CHROMATOGR A, V1156, P183, DOI 10.1016/j.chroma.2007.04.050; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mercuri E, 2006, NEUROMUSCULAR DISORD, V16, P446, DOI 10.1016/j.nmd.2006.03.016; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; Neubert P, 2016, CURR OPIN CELL BIOL, V41, P100, DOI 10.1016/j.ceb.2016.04.010; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Rubinstein R, 2015, CELL, V163, P629, DOI 10.1016/j.cell.2015.09.026; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Toledo AG, 2012, GLYCOBIOLOGY, V22, P1413, DOI 10.1093/glycob/cws109; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; van Meel E, 2014, P NATL ACAD SCI USA, V111, P3532, DOI 10.1073/pnas.1401417111; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	62	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11586	11598		10.1074/jbc.M117.794487	http://dx.doi.org/10.1074/jbc.M117.794487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512129	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000405119600037
J	Wang, CX; Pallan, PS; Zhang, W; Lei, L; Yoshimoto, FK; Waterman, MR; Egli, M; Guengerich, FP				Wang, Chunxue; Pallan, Pradeep S.; Zhang, Wei; Lei, Li; Yoshimoto, Francis K.; Waterman, Michael R.; Egli, Martin; Guengerich, F. Peter			Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							21-HYDROXYLASE DEFICIENCY; CIRCULAR-DICHROISM; MUTATIONS; 17,20-LYASE; B(5); STEROIDOGENESIS; DEUTERIUM; P450C17	Cytochrome P450 (P450, CYP) 21A2 is the major steroid 21-hydroxylase, converting progesterone to 11-deoxycorticosterone and 17 alpha-hydroxyprogesterone (17 alpha-OH-progesterone) to 11-deoxycortisol. More than 100 CYP21A2 variants give rise to congenital adrenal hyperplasia (CAH). We previously reported a structure of WT human P450 21A2 with bound progesterone and now present a structure bound to the other substrate (17 alpha-OH-progesterone). We found that the 17 alpha-OH-progesterone-and progesterone-bound complex structures are highly similar, with only some minor differences in surface loop regions. Twelve P450 21A2 variants associated with either salt-wasting or nonclassical forms of CAH were expressed, purified, and analyzed. The catalytic activities of these 12 variants ranged from 0.00009% to 30% of WT P450 21A2 and the extent of heme incorporation from 10% to 95% of the WT. Substrate dissociation constants (K-s) for four variants were 37-13,000-fold higher than for WT P450 21A2. Cytochrome b(5), which augments several P450 activities, inhibited P450 21A2 activity. Similar to the WT enzyme, high noncompetitive intermolecular kinetic deuterium isotope effects (>= 5.5) were observed for all six P450 21A2 variants examined for 21-hydroxylation of 21-d(3)-progesterone, indicating that C-H bond breaking is a rate-limiting step over a 104-fold range of catalytic efficiency. Using UV-visible and CD spectroscopy, we found that P450 21A2 thermal stability assessed in bacterial cells and with purified enzymes differed among salt-wasting-and nonclassical-associated variants, but these differences did not correlate with catalytic activity. Our in-depth investigation of CAH-associated P450 21A2 variants reveals critical insight into the effects of disease-causing mutations on this important enzyme.	[Wang, Chunxue; Pallan, Pradeep S.; Zhang, Wei; Lei, Li; Yoshimoto, Francis K.; Waterman, Michael R.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wang, Chunxue] Vanderbilt Univ, Med Ctr, Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Yoshimoto, Francis K.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA	Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas at San Antonio (UTSA)	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.; Egli, M (corresponding author), Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu; f.guengerich@vanderbilt.edu	Wang, Chunxue/E-1840-2018	Wang, Chunxue/0000-0002-7462-9077; Yoshimoto, Francis/0000-0002-2308-2999; Zhang, Wei/0000-0001-9459-680X	National Institutes of Health [R01 GM103937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM103937 (to M. E. and F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Daniels F., 1966, PHYS CHEM, P612; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Haider S, 2013, P NATL ACAD SCI USA, V110, P2605, DOI 10.1073/pnas.1221133110; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Johnston Wayne A, 2013, Methods Mol Biol, V987, P189, DOI 10.1007/978-1-62703-321-3_17; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; New MI, 2003, MOL CELL ENDOCRINOL, V211, P75, DOI 10.1016/j.mce.2003.09.013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pallan PS, 2015, MOL ENDOCRINOL, V29, P1375, DOI 10.1210/ME.2015-1127; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Parsa AA, 2017, J STEROID BIOCHEM, V165, P2, DOI 10.1016/j.jsbmb.2016.06.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	32	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10767	10778		10.1074/jbc.M117.792465	http://dx.doi.org/10.1074/jbc.M117.792465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28539365	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000404391000002
J	Khananshvili, D				Khananshvili, Daniel			How a helix imposes palmitoylation of a membrane protein: What one can learn from NCX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NA+/CA2+ EXCHANGER	Palmitoylation is a critical post-translational modification that anchors proteins to, and regulates transport across, the lipid bilayer. Palmitoylation enzymes have been assumed to select their substrates based on a protein's primary sequence, but a consensus sequence has been slow to emerge. A study of the sodium/calcium exchanger now suggests that secondary structure may hold the key to understanding the determinants of this modification.	[Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dhanan@post.tau.ac.il		Khananshvili, Daniel/0000-0002-4202-9966				Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Giladi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01102-x; Giladi M, 2016, FRONT PHYSIOL, V7, DOI [10.3359/fphys.7016.00030, 10.3389/fphys.2016.00030]; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Plain F, 2017, J BIOL CHEM, V292, P10745, DOI 10.1074/jbc.M116.773945; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007	10	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10753	10754		10.1074/jbc.H116.773945	http://dx.doi.org/10.1074/jbc.H116.773945			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28646126	Green Published, hybrid			2022-12-28	WOS:000404115400035
J	Taghiyar, L; Hesaraki, M; Sayahpour, FA; Satarian, L; Hosseini, S; Aghdami, N; Baghaban Eslaminejad, M				Taghiyar, Leila; Hesaraki, Mahdi; Sayahpour, Forough Azam; Satarian, Leila; Hosseini, Samaneh; Aghdami, Naser; Baghaban Eslaminejad, Mohamadreza			Msh homeobox 1 (Msx1)- and Msx2-overexpressing bone marrow-derived mesenchymal stem cells resemble blastema cells and enhance regeneration in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; bone; differentiation; mesenchymal stem cells (MSCs); regeneration; blastema cells; bone differentiation; bone marrow-derived mesenchymal stem cells; limb regeneration; Msx gene transduction	MOUSE DIGIT TIP; LIMB REGENERATION; TRANSCRIPTION FACTOR; STROMAL CELLS; EXPRESSION; DIFFERENTIATION; AXOLOTL; MSX1; AMPUTATION; INDUCTION	Amputation of the proximal region in mammals is not followed by regeneration because blastema cells (BCs) and expression of regenerative genes, such as Msh homeobox (Msx) genes, are absent in this animal group. The lack of BCs and positional information in other cells is therefore the main obstacle to therapeutic approaches for limb regeneration. Hence, this study aimed to create blastema-like cells (BlCs) by overexpressing Msx1 and Msx2 genes in mouse bone marrow-derived mesenchymal stem cells (mBMSCs) to regenerate a proximally amputated digit tip. We transduced mBMSCs with Msx1 and Msx2 genes and compared osteogenic activity and expression levels of several Msx-regulated genes (Bmp4, Fgf8, and keratin 14 (K14)) in BlC groups, including MSX1, MSX2, and MSX1/2 (in a 1:1 ratio) with those in mBMSCs and BCs in vitro and in vivo following injection into the amputation site. We found that Msx gene overexpression increased expression of specific blastemal markers and enhanced the proliferation rate and osteogenesis of BlCs compared with mBMSCs and BCs via activation of Fgf8 and Bmp4. Histological analyses indicated full regrowth of digit tips in the Msx-overexpressing groups, particularly in MSX1/2, through endochondral ossification 6 weeks post-injection. In contrast, mBMSCs and BCs formed abnormal bone and nail. Full digit tip was regenerated only in the MSX1/2 group and was related to boosted Bmp4, Fgf8, and K14 gene expression and to limb-patterning properties resulting from Msx1 and Msx2 overexpression. We propose that Msx-transduced cells that can regenerate epithelial and mesenchymal tissues may potentially be utilized in limb regeneration.	[Taghiyar, Leila; Hesaraki, Mahdi; Sayahpour, Forough Azam; Satarian, Leila; Hosseini, Samaneh; Aghdami, Naser; Baghaban Eslaminejad, Mohamadreza] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran 1665659911, Iran; [Taghiyar, Leila] Univ Sci & Culture, Dept Dev Biol, Tehran 13145871, Iran	Academic Center for Education, Culture & Research (ACECR)	Baghaban Eslaminejad, M (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran 1665659911, Iran.	eslami@royaninstitute.org	Satarian, Leila/M-3835-2017; Eslaminejad, Mohamadreza Baghaban/S-3645-2017; Aghdami, Nasser/ABH-7238-2020; Hosseini, Samaneh/I-1232-2019	Satarian, Leila/0000-0002-5068-5031; Eslaminejad, Mohamadreza Baghaban/0000-0002-1036-0072; Hosseini, Samaneh/0000-0002-5701-6666	Royan Institute; Iranian Council of Stem Cell Research and Technology (ICSCR)	Royan Institute; Iranian Council of Stem Cell Research and Technology (ICSCR)	The present research was supported by the Royan Institute and the Iranian Council of Stem Cell Research and Technology (ICSCR). The authors declare that they have no conflicts of interest with the contents of this article.	Allan CH, 2006, WOUND REPAIR REGEN, V14, P398, DOI 10.1111/j.1743-6109.2006.00139.x; Bajek A, 2016, ARCH IMMUNOL THER EX, V64, P443, DOI 10.1007/s00005-016-0394-x; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barker DM, 2009, DEV DYNAM, V238, P1366, DOI 10.1002/dvdy.21923; Bensoussan-Trigano V, 2011, DEV DYNAM, V240, P1190, DOI 10.1002/dvdy.22619; Cai TY, 2013, MOL MED REP, V8, P1323, DOI 10.3892/mmr.2013.1668; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; Dehghan S, 2016, NEUROSCIENCE, V318, P178, DOI 10.1016/j.neuroscience.2016.01.028; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Han MJ, 2001, DEV DYNAM, V220, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1085>3.0.CO;2-8; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Ide H, 2012, DEV DYNAM, V241, P435, DOI 10.1002/dvdy.23728; Klinker MW, 2015, WORLD J STEM CELLS, V7, P556, DOI 10.4252/wjsc.v7.i3.556; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Maleki Masoud, 2014, International Journal of Stem Cells, V7, P118, DOI 10.15283/ijsc.2014.7.2.118; Masaki H, 2007, DEV GROWTH DIFFER, V49, P89, DOI 10.1111/j.1440-169X.2007.00909.x; Muller I, 2008, BLOOD CELL MOL DIS, V40, P25, DOI 10.1016/j.bcmd.2007.06.021; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; Ono I, 2004, WOUND REPAIR REGEN, V12, P67, DOI 10.1111/j.1067-1927.2004.012113.x-1; Penfornis P, 2011, METHODS MOL BIOL, V698, P11, DOI 10.1007/978-1-60761-999-4_2; Pizette S, 2001, DEVELOPMENT, V128, P4463; Rao N, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-32; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Satoh A, 2016, DEV BIOL, V417, P114, DOI 10.1016/j.ydbio.2016.07.005; SHAH M, 1995, J CELL SCI, V108, P985; SIMON HG, 1993, DEVELOPMENT, V117, P1397; Stoltz JF, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/734731; Suzuki M, 2006, THESCIENTIFICWORLDJO, V6, P26, DOI 10.1100/tsw.2006.325; Taghiyar L., 2017, CELL YAKHTE IN PRESS; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vojnits K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17355; WANG YQ, 1995, DEV BIOL, V168, P374, DOI 10.1006/dbio.1995.1087; Wu XH, 2013, ONCOL REP, V30, P2211, DOI 10.3892/or.2013.2687; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424	41	13	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10520	10533		10.1074/jbc.M116.774265	http://dx.doi.org/10.1074/jbc.M116.774265			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28461333	hybrid, Green Published			2022-12-28	WOS:000404115400014
J	Salat-Canela, C; Paulo, E; Sanchez-Mir, L; Carmona, M; Ayte, J; Oliva, B; Hidalgo, E				Salat-Canela, Claudia; Paulo, Esther; Sanchez-Mir, Laura; Carmona, Merce; Ayte, Jose; Oliva, Baldo; Hidalgo, Elena			Deciphering the role of the signal- and Sty1 kinase-dependent phosphorylation of the stress-responsive transcription factor Atf1 on gene activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; PAP1; PATHWAY; ANTIOXIDANT; EXPRESSION	Adaptation to stress triggers the most dramatic shift in gene expression in fission yeast (Schizosaccharomyces pombe), and this response is driven by signaling via the MAPK Sty1. Upon activation, Sty1 accumulates in the nucleus and stimulates expression of hundreds of genes via the nuclear transcription factor Atf1, including expression of atf1 itself. However, the role of stress-induced, Sty1-mediated Atf1 phosphorylation in transcriptional activation is unclear. To this end, we expressed Atf1 phosphorylation mutants from a constitutive promoter to uncouple Atf1 activity from endogenous, stress-activated Atf1 expression. We found that cells expressing a nonphosphorylatable Atf1 variant are sensitive to oxidative stress because of impaired transcription of a subset of stress genes whose expression is also controlled by another transcription factor, Pap1. Furthermore, cells expressing a phospho-mimicking Atf1 mutant display enhanced stress resistance, and although expression of the Pap1-dependent genes still relied on stress induction, another subset of stress-responsive genes was constitutively expressed in these cells. We also observed that, in cells expressing the phospho-mimicking Atf1 mutant, the presence of Sty1 was completely dispensable, with all stress defects of Sty1-deficient cells being suppressed by expression of the Atf1 mutant. We further demonstrated that Sty1-mediated Atf1 phosphorylation does not stimulate binding of Atf1 to DNA but, rather, establishes a platform of interactions with the basal transcriptional machinery to facilitate transcription initiation. In summary, our results provide evidence that Atf1 phosphorylation by the MAPK Sty1 is required for oxidative stress responses in fission yeast cells by promoting transcription initiation.	[Salat-Canela, Claudia; Paulo, Esther; Sanchez-Mir, Laura; Carmona, Merce; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Dr Aiguader 88, Barcelona 08003, Spain; [Oliva, Baldo] Univ Pompeu Fabra, Struct Bioinformat Lab GRIB, C Dr Aiguader 88, Barcelona 08003, Spain	Pompeu Fabra University; Pompeu Fabra University	Hidalgo, E (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Dr Aiguader 88, Barcelona 08003, Spain.	elena.hidalgo@upf.edu	Paulo Mirasol, Esther/C-8607-2017; Mir, Laura Sanchez/H-5409-2015; Hidalgo, Elena/K-2919-2014	Paulo Mirasol, Esther/0000-0002-8108-3957; Mir, Laura Sanchez/0000-0002-3898-5840; Hidalgo, Elena/0000-0002-3768-6785; Salat Canela, Claudia/0000-0003-3825-7672	Ministerio de Economia y Competitividad (Spain); PLAN E; FEDER [BFU2015-68350-P]; Generalitat de Catalunya (Spain); ICREA Academia Award (Generalitat de Catalunya, Spain)	Ministerio de Economia y Competitividad (Spain); PLAN E; FEDER(European Commission); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); ICREA Academia Award (Generalitat de Catalunya, Spain)(ICREA)	This work was supported by the Ministerio de Economia y Competitividad (Spain), PLAN E and FEDER (BFU2015-68350-P to E. H.), and by 2014-SGR-154 from Generalitat de Catalunya (Spain) (to E. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an ICREA Academia Award (Generalitat de Catalunya, Spain). To whom correspondence should be addressed. Tel.: 34-93-316-0848; Fax: 34-93-316-0901; E-mail: elena.hidalgo@upf.edu.	Alfa C, 1993, EXPT FISSION YEAST L; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brewster JL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005458; Calvo IA, 2012, NUCLEIC ACIDS RES, V40, P4816, DOI 10.1093/nar/gks141; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Castillo EA, 2003, J BIOL CHEM, V278, P40565, DOI 10.1074/jbc.M305859200; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davidson MK, 2004, J BIOL CHEM, V279, P50857, DOI 10.1074/jbc.M409079200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eshaghi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011620; Fernandez-Vazquez J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003647; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Lawrence CL, 2009, CURR BIOL, V19, P1907, DOI 10.1016/j.cub.2009.09.044; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Paulo E, 2014, MOL MICROBIOL, V92, P246, DOI 10.1111/mmi.12548; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Sanso M, 2011, MOL MICROBIOL, V82, P542, DOI 10.1111/j.1365-2958.2011.07851.x; Sanso M, 2011, NUCLEIC ACIDS RES, V39, P6369, DOI 10.1093/nar/gkr255; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	40	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13635	13644		10.1074/jbc.M117.794339	http://dx.doi.org/10.1074/jbc.M117.794339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28652406	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000407942400025
J	Yang, J; Kasberg, WC; Celo, A; Liang, Z; Quispe, K; Stack, MS				Yang, Jing; Kasberg, William C.; Celo, Angela; Liang, Zhong; Quispe, Kristal; Stack, M. Sharon			Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; MICROENVIRONMENTAL REGULATION; EXTRACELLULAR-MATRIX; CARCINOMA CELLS; INVASION; EXPRESSION; METASTASIS; ADHESION; PHOSPHORYLATION; ANGIOGENESIS	Membrane type 1 matrix metalloproteinase (MT1-MMP, MMP-14) is a transmembrane collagenase highly expressed in metastatic ovarian cancer and correlates with poor survival. Accumulating evidence shows that the cytoplasmic tail of MT1-MMP is subjected to phosphorylation, and this post-translational modification regulates enzymatic activity at the cell surface. To investigate the potential role of MT1-MMPcytoplasmic residue Thr(567) phosphorylation in regulation of metastasis-associated behaviors, ovarian cancer cells that express low endogenous levels of MT1-MMP were engineered to express wild-type MT1-MMP, a phosphomimetic mutant (T567E), or a phosphodeficient mutant (T567A). Results show that Thr(567)modulation influences behavior of both individual cells and multicellular aggregates (MCAs). The acquisition of either wild-type or mutant MT1-MMP expression results in altered cohesion of epithelial sheets and the formation of more compact MCAs relative to parental cells. Cells expressing MT1-MMP-T567E phosphomimetic mutants exhibit enhanced cell migration. Furthermore, MCAs formed from MT1-MMP-T567E-expressing cells adhere avidly to both intact ex vivo peritoneal explants and three-dimensional collagen gels. Interaction of these MCAs with peritoneal mesothelium disrupts mesothelial integrity, exposing the submesothelial collagen matrix on which MT1-MMP-T567E MCAs rapidly disperse. Together, these findings suggest that post-translational regulation of the Thr(567) in the MT1-MMP cytoplasmic tail may function as a regulatory mechanism to impact ovarian cancer metastatic success.	[Yang, Jing; Kasberg, William C.; Liang, Zhong; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46617 USA; [Yang, Jing; Kasberg, William C.; Celo, Angela; Quispe, Kristal; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN 46617 USA	University of Notre Dame; University of Notre Dame	Stack, MS (corresponding author), Univ Notre Dame, 1234 Notre Dame Ave,A200 Harper Hall, South Bend, IN 46617 USA.	sstack@nd.edu		Kasberg, William/0000-0003-3553-7505	National Institutes of Health [RO1CA109545, RO1CA086984]; Leo and Anne Albert Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA109545, R01CA086984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leo and Anne Albert Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants RO1CA109545 (to M. S. S.) and RO1CA086984 (to M. S. S) and the Leo and Anne Albert Charitable Trust (to M. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Annabi B, 2001, BIOCHEM J, V353, P547, DOI 10.1042/0264-6021:3530547; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2013, J BIOL CHEM, V288, P141, DOI 10.1074/jbc.M112.431411; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Bruney L, 2016, ONCOTARGET, V7, P21968, DOI 10.18632/oncotarget.7880; Bruney L, 2014, BIOL CHEM, V395, P1221, DOI 10.1515/hsz-2014-0155; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Coffman LG, 2016, TRANSL RES, V175, P92, DOI 10.1016/j.trsl.2016.03.016; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Doi T, 2011, EXP MOL PATHOL, V90, P91, DOI 10.1016/j.yexmp.2010.10.008; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Kaimal R, 2013, CANCER RES, V73, P2457, DOI 10.1158/0008-5472.CAN-12-1426; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Klymenko Y, 2017, NEOPLASIA, V19, P549, DOI 10.1016/j.neo.2017.04.002; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Liu YY, 2015, CANCER RES, V75, P5046, DOI 10.1158/0008-5472.CAN-15-0706; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sakata K, 2000, INT J ONCOL, V17, P673; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sieracki N. A., 2013, GENETIC MANIPULATION, P381; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069	50	13	13	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13111	13121		10.1074/jbc.M117.800904	http://dx.doi.org/10.1074/jbc.M117.800904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655772	hybrid, Green Published			2022-12-28	WOS:000407465300003
J	Yan, L; Li, Y; Shi, ZX; Lu, XY; Ma, J; Hu, BY; Jiao, JW; Wang, HM				Yan, Long; Li, Yue; Shi, Zixiao; Lu, Xiaoyin; Ma, Jiao; Hu, Baoyang; Jiao, Jianwei; Wang, Hongmei			The zinc finger E-box-binding homeobox 1 (Zeb1) promotes the conversion of mouse fibroblasts into functional neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell therapy; fibroblasts; neurons; reprogramming; transcription factor; Zeb1; transdifferentiation	EPITHELIAL-MESENCHYMAL TRANSITION; KEY DETERMINANT; INDUCTION; CELLS; CROSSROADS; METASTASIS; EXPRESSION; GENERATION; PHENOTYPE; PROTEIN	The zinc finger E-box-binding transcription factor Zeb1 plays a pivotal role in the epithelial-mesenchymal transition. Numerous studies have focused on the molecular mechanisms by which Zeb1 contributes to this process. However, the functions of Zeb1 beyond the epithelial-mesenchymal transition remain largely elusive. Using a transdifferentiation system to convert mouse embryonic fibroblasts (MEFs) into functional neurons via the neuronal transcription factors achaete-scute family bHLH (basic helix-loop-helix) transcription factor1 (Ascl1), POU class 3 homeobox 2 (POU3F2/Brn2), and neurogenin 2 (Neurog2, Ngn2) (ABN), we found that Zeb1 was up-regulated during the early stages of transdifferentiation. Knocking down Zeb1 dramatically attenuated the transdifferentiation efficiency, whereas Zeb1 overexpression obviously increased the efficiency of transdifferentiation from MEFs to neurons. Interestingly, Zeb1 improved the transdifferentiation efficiency induced by even a single transcription factor (e.g. Asc1 or Ngn2). Zeb1 also rapidly promoted the maturation of induced neuron cells to functional neurons and improved the formation of neuronal patterns and electrophysiological characteristics. Induced neuron cells could form functional synapse in vivo after transplantation. Genome-wide RNA arrays showed that Zeb1 overexpression up-regulated the expression of neuron-specific genes and down-regulated the expression of epithelial-specific genes during conversion. Taken together, our results reveal a new role for Zeb1 in the transdifferentiation of MEFs into neurons.	[Yan, Long; Shi, Zixiao; Lu, Xiaoyin; Ma, Jiao; Hu, Baoyang; Jiao, Jianwei; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Shi, Zixiao; Lu, Xiaoyin; Ma, Jiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Li, Yue] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100191, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Jiao, JW; Wang, HM (corresponding author), 1 Beichen West Rd, Beijing 100101, Peoples R China.	jwjiao@ioz.ac.cn; wanghm@ioz.ac.cn	Hu, Baoyang/R-8374-2016; Lu, Xiaoyin/AAO-5561-2021; Jiao, Jianwei/I-1452-2013; Jiao, Jianwei/AAA-7902-2020	Hu, Baoyang/0000-0003-3993-4014; Lu, Xiaoyin/0000-0002-9244-325X; Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020102]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020102). The authors declare that they have no conflicts of interest with the contents of this article.	Ali FR, 2014, DEVELOPMENT, V141, P2216, DOI 10.1242/dev.106377; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chanda S, 2013, P NATL ACAD SCI USA, V110, P16622, DOI 10.1073/pnas.1316240110; Chang YC, 2014, J CELL MOL MED, V18, P698, DOI 10.1111/jcmm.12219; Darling DS, 2003, GENE EXPR PATTERNS, V3, P709, DOI 10.1016/S1567-133X(03)00147-9; Fu JJ, 2010, J BIOL CHEM, V285, P10870, DOI 10.1074/jbc.M109.004200; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Gubelmann C, 2014, ELIFE, V3, DOI 10.7554/eLife.03346; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Jiang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10100; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pirinen E, 2014, APMIS, V122, P530, DOI 10.1111/apm.12187; Ren J, 2013, J CELL BIOCHEM, V114, P1395, DOI 10.1002/jcb.24481; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Shenoy Archana, 2012, F1000 Biol Rep, V4, P3, DOI 10.3410/B4-3; Shi ZX, 2014, J BIOL CHEM, V289, P6415, DOI 10.1074/jbc.M113.515601; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Thoma EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038651; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang PJ, 2015, CELL CYCLE, V14, P481, DOI 10.1080/15384101.2015.1006048; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	38	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12959	12970		10.1074/jbc.M116.771493	http://dx.doi.org/10.1074/jbc.M116.771493			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28500132	Green Published, hybrid			2022-12-28	WOS:000407220100024
J	Wheeler, MA; Rothhammer, V; Quintana, FJ				Wheeler, Michael A.; Rothhammer, Veit; Quintana, Francisco J.			Control of immune-mediated pathology via the aryl hydrocarbon receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aryl hydrocarbon receptor (AhR); astrocyte; immunology; lymphocyte; neuroimmunology	REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ORAL LAQUINIMOD; DENDRITIC CELLS; TH17 CELLS; ENVIRONMENTAL-CONTROL; B-CELLS; C-MAF	Genetic and environmental factors contribute to the development of immune-mediated diseases. Although numerous genetic factors contributing to autoimmunity have been identified in recent years, our knowledge on environmental factors contributing to the pathogenesis of autoimmune diseases and the mechanisms involved is still limited. In this context, the diet, microbiome, geographical location, as well as environmental pollutants have been shown to modulate autoimmune disease development. These environmental factors interact with cellular components of the immune system in distinct and defined ways and can influence immune responses at the transcriptional and protein level. Moreover, endogenous metabolites generated from basic cellular processes such as glycolysis and oxidative phosphorylation also contribute to the shaping of the immune response. In this minireview, we highlight recent progress in our understanding of the modulation of the immune response by the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor whose activity is regulated by small molecules provided by diet, commensal flora, environmental pollutants, and metabolism. We focus on the role of AhR in integrating signals from the diet and the intestinal flora to modulate ongoing inflammation in the central nervous system, and we also discuss the potential therapeutic value of AhR agonists for multiple sclerosis and other autoimmune diseases.	[Wheeler, Michael A.; Rothhammer, Veit; Quintana, Francisco J.] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 60 Fenwood Rd, Boston, MA 02115 USA; [Quintana, Francisco J.] Broad Inst MIT& Harvard, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Quintana, FJ (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, 60 Fenwood Rd, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		National Institutes of Health [NS087867, ES025530, AI126880, AI093903, T32CA207021]; National Multiple Sclerosis Society [RG4111A1, JF2161-A-5]; American Cancer Society [126566-RSG-14-198-01-LIB]; International Progressive MS Alliance [PA-1604-08459]; Mallinkrodt Pharmaceuticals Educational Grant [A219074]; German Research Foundation Fellowship [DFG RO4866 1/1]; NATIONAL CANCER INSTITUTE [T32CA207021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093903, R01AI126880, R01AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Cancer Society(American Cancer Society); International Progressive MS Alliance; Mallinkrodt Pharmaceuticals Educational Grant; German Research Foundation Fellowship(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants NS087867, ES025530, AI126880, and AI093903, National Multiple Sclerosis Society Grants RG4111A1 and JF2161-A-5, American Cancer Society Grant 126566-RSG-14-198-01-LIB), and International Progressive MS Alliance Grant PA-1604-08459 (to F.J.Q.). This is the second article in the Thematic Minireview Series: "Inflammatory transcription confronts homeostatic disruptions." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32CA207021.; Supported by Mallinkrodt Pharmaceuticals Educational Grant A219074 and German Research Foundation Fellowship DFG RO4866 1/1.	Aguilera-Montilla N, 2013, BLOOD, V121, pE108, DOI 10.1182/blood-2012-07-445106; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bakshi R, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000200; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Berg J, 2016, J NEUROIMMUNOL, V298, P9, DOI 10.1016/j.jneuroim.2016.06.003; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brambilla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-213; Bruck W, 2013, NAT REV NEUROL, V9, P664, DOI 10.1038/nrneurol.2013.234; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Busbee PB, 2013, NUTR REV, V71, P353, DOI 10.1111/nure.12024; Calabrese M, 2015, NAT REV NEUROSCI, V16, P147, DOI 10.1038/nrn3900; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Charcot J.-M., 1868, COMPTES RENDUS SEANC, V33; Cibrian D, 2016, NAT IMMUNOL, V17, P985, DOI 10.1038/ni.3504; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Clarner T, 2011, J NEUROENDOCRINOL, V23, P601, DOI 10.1111/j.1365-2826.2011.02140.x; Colonna M, 2014, IMMUNITY, V40, P863, DOI 10.1016/j.immuni.2014.06.001; De Keyser J, 2010, NEUROCHEM INT, V57, P446, DOI 10.1016/j.neuint.2010.02.012; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Fischer R, 2014, GLIA, V62, P272, DOI 10.1002/glia.22605; Gacias M, 2016, ELIFE, V5, DOI 10.7554/eLife.13442; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Jm C., 1868, GAZ HOPITAUX, P554; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Liao WT, 2017, J MOL MED, V95, P395, DOI 10.1007/s00109-016-1493-1; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Ludwin SK, 2016, MULT SCLER J, V22, P1114, DOI 10.1177/1352458516643396; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Marcus RS, 1998, J PHARMACOL EXP THER, V287, P1113; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Moreno M, 2014, J NEUROSCI, V34, P8175, DOI 10.1523/JNEUROSCI.1137-14.2014; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nguyen NT, 2013, SEMIN IMMUNOPATHOL, V35, P637, DOI 10.1007/s00281-013-0392-6; Palma JA, 2012, NEW ENGL J MED, V366, P2527, DOI 10.1056/NEJMc1204658; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Paul D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-10; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2013, SEMIN IMMUNOPATHOL, V35, P627, DOI 10.1007/s00281-013-0397-1; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Quintana FJ, 2012, J NEUROIMMUNOL, V248, P53, DOI 10.1016/j.jneuroim.2012.01.002; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rothhammer V, 2016, CURR OPIN IMMUNOL, V43, P46, DOI 10.1016/j.coi.2016.09.002; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sherr DH, 2013, SEMIN IMMUNOPATHOL, V35, P705, DOI 10.1007/s00281-013-0390-8; Singh NP, 2016, J IMMUNOL, V196, P1108, DOI 10.4049/jimmunol.1501727; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Takenaka MC, 2016, TRENDS IMMUNOL, V37, P427, DOI 10.1016/j.it.2016.04.009; Tanaka G, 2005, INT IMMUNOL, V17, P797, DOI 10.1093/intimm/dxh260; Tian JJ, 2015, ENVIRON SCI TECHNOL, V49, P9518, DOI 10.1021/acs.est.5b00385; Torchinsky MB, 2010, CELL MOL LIFE SCI, V67, P1407, DOI 10.1007/s00018-009-0248-3; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Varrin-Doyer M, 2014, EXP NEUROL, V262, P66, DOI 10.1016/j.expneurol.2014.04.002; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Villa M, 2017, EMBO J, V36, P116, DOI 10.15252/embj.201695027; Vogel CFA, 2013, IMMUNOL CELL BIOL, V91, P568, DOI 10.1038/icb.2013.43; Vollmer TL, 2014, J NEUROL, V261, P773, DOI 10.1007/s00415-014-7264-4; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023618; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	95	55	55	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12383	12389		10.1074/jbc.R116.767723	http://dx.doi.org/10.1074/jbc.R116.767723			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615443	Green Published, hybrid			2022-12-28	WOS:000406636900004
J	Traba, J; Geiger, SS; Kwarteng-Siaw, M; Han, K; Ra, OH; Siegel, RM; Gius, D; Sack, MN				Traba, Javier; Geiger, Sarah S.; Kwarteng-Siaw, Miriam; Han, Kim; Ra, One Hyuk; Siegel, Richard M.; Gius, David; Sack, Michael N.			Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM CALORIE RESTRICTION; INSULIN-RESISTANCE; SIGNALING NETWORKS; SIRTUIN 3; DISEASE; OBESITY; STRESS; DNA; DEACETYLATION; EXPRESSION	Twenty-four hours of fasting is known to blunt activation of the human NLRP3 inflammasome. This effect might be mediated by SIRT3 activation, controlling mitochondrial reactive oxygen species. To characterize the molecular underpinnings of this fasting effect, we comparatively analyzed the NLRP3 inflammasome response to nutrient deprivation in wild-type and SIRT3 knock-out mice. Consistent with previous findings for human NLRP3, prolonged fasting blunted the inflammasome in wild-type mice but not in SIRT3 knock-out mice. In SIRT3 knock-out bone marrow-derived macrophages, NLRP3 activation promoted excess cytosolic extrusion of mitochondrial DNA along with increased reactive oxygen species and reduced superoxide dismutase 2 (SOD2) activity. Interestingly, the negative regulatory effect of SIRT3 on NLRP3 was not due to transcriptional control or priming of canonical inflammasome components but, rather, occurred via SIRT3-mediated deacetylation of mitochondrial SOD2, leading to SOD2 activation. We also found that siRNA knockdown of SIRT3 or SOD2 increased NLRP3 supercomplex formation and activation. Moreover, overexpression of wild-type and constitutively active SOD2 similarly blunted inflammasome assembly and activation, effects that were abrogated by acetylation mimic-modified SOD2. Finally, in vivo administration of lipopolysaccharide increased liver injury and the levels of peritoneal macrophage cytokines, including IL-1 beta, in SIRT3 KO mice. These results support the emerging concept that enhancing mitochondrial resilience against damage-associated molecular patterns may play a pivotal role in preventing inflammation and that the anti-inflammatory effect of fasting-mimetic diets may be mediated, in part, through SIRT3-directed blunting of NLRP3 inflammasome assembly and activation.	[Traba, Javier; Kwarteng-Siaw, Miriam; Han, Kim; Ra, One Hyuk; Sack, Michael N.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Geiger, Sarah S.; Siegel, Richard M.] NIAMS, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Gius, David] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwestern University; Feinberg School of Medicine	Sack, MN (corresponding author), NHLBI, NIH, Lab Mitochondrial Biol & Metab, Bldg 10 CRC,Rm 5-3150,10 Ctr Dr,MSC 1454, Bethesda, MD 20892 USA.	sackm@nih.gov	Traba, Javier/AAA-9287-2020; Siegel, Richard/AAX-1779-2020; Sack, Michael/AAG-1000-2020	Traba, Javier/0000-0002-7855-3540; Siegel, Richard/0000-0001-5953-9893; Kwarteng-Siaw, Miriam/0000-0001-7656-8258	NHLBI, National Institutes of Health Division of Intramural Research [HL006047-06, HL005102-11]; NATIONAL CANCER INSTITUTE [R01CA168292, R01CA214025, R01CA152799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, Z01HL005102, ZIAHL005102, ZIAHL006047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041133, ZIAAR041175] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health Division of Intramural Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by Grants HL006047-06 and HL005102-11 from the NHLBI, National Institutes of Health Division of Intramural Research (to M. N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Goossens GH, 2012, MOL IMMUNOL, V50, P142, DOI 10.1016/j.molimm.2012.01.005; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kheirandish-Gozal L, 2014, J CLIN ENDOCR METAB, V99, P656, DOI 10.1210/jc.2013-3327; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lu JQ, 2015, FREE RADICAL BIO MED, V85, P114, DOI 10.1016/j.freeradbiomed.2015.04.011; Lu ZP, 2015, J BIOL CHEM, V290, P2466, DOI 10.1074/jbc.M114.606228; Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Qiao AM, 2016, ONCOTARGET, V7, P43390, DOI 10.18632/oncotarget.9717; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Schupp M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-758; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Webster BR, 2013, J CELL SCI, V126, P4843, DOI 10.1242/jcs.131300; Webster BR, 2012, FREE RADICAL BIO MED, V52, P281, DOI 10.1016/j.freeradbiomed.2011.10.484; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Won JH, 2015, J BIOL CHEM, V290, P27425, DOI 10.1074/jbc.M115.667063; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhao WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33201; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	52	70	71	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12153	12164		10.1074/jbc.M117.791715	http://dx.doi.org/10.1074/jbc.M117.791715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28584055	Green Published, hybrid			2022-12-28	WOS:000406053300014
J	Lin, AE; Autran, CA; Szyszka, A; Escajadillo, T; Huang, M; Godula, K; Prudden, AR; Boons, GJ; Lewis, AL; Doran, KS; Nizet, V; Bode, L				Lin, Ann E.; Autran, Chloe A.; Szyszka, Alexandra; Escajadillo, Tamara; Huang, Mia; Godula, Kamil; Prudden, Anthony R.; Boons, Geert-Jan; Lewis, Amanda L.; Doran, Kelly S.; Nizet, Victor; Bode, Lars			Human milk oligosaccharides inhibit growth of group B Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL-ANALYSIS; UNITED-STATES; INFANTS; DISEASE; POLYSACCHARIDE; MENINGITIS; INVASION; IMMUNITY	Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of invasive bacterial infections in newborns, typically acquired vertically during childbirth secondary to maternal vaginal colonization. Human milk oligosaccharides (HMOs) have important nutritional and biological activities that guide the development of the immune system of the infant and shape the composition of normal gut microbiota. In this manner, HMOs help protect against pathogen colonization and reduce the risk of infection. In the course of our studies of HMO-microbial interactions, we unexpectedly uncovered a novel HMO property to directly inhibit the growth of GBS independent of host immunity. By separating different HMO fractions through multidimensional chromatography, we found the bacteriostatic activity to be confined to specific non-sialylated HMO sand synergistic with a number of conventional antibiotic agents. Phenotypic screening of a GBS transposon insertion library identified a mutation within a GBS-specific gene encoding a putative glycosyltransferase that confers resistance to HMOs, suggesting that HMOs may function as an alternative substrate to modify a GBS component in a manner that impairs growth kinetics. Our study uncovers a unique antibacterial role for HMOs against a leading neonatal pathogen and expands the potential therapeutic utility of these versatile molecules.	[Lin, Ann E.; Escajadillo, Tamara; Doran, Kelly S.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, La Jolla, CA 92093 USA; [Autran, Chloe A.; Szyszka, Alexandra; Bode, Lars] Univ Calif San Diego, Dept Pediat, Div Neonatol, La Jolla, CA 92093 USA; [Autran, Chloe A.; Szyszka, Alexandra; Bode, Lars] Univ Calif San Diego, Dept Pediat, Div Gastroenterol Hepatol & Nutr, La Jolla, CA 92093 USA; [Huang, Mia; Godula, Kamil] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Bode, Lars] Univ Calif San Diego, Larsson Rosenquist Fdn, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA; [Nizet, Victor; Bode, Lars] Rady Childrens Hosp, San Diego, CA 92123 USA; [Prudden, Anthony R.; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University System of Georgia; University of Georgia; Washington University (WUSTL); Washington University (WUSTL); California State University System; San Diego State University; California State University System; San Diego State University	Bode, L (corresponding author), Univ Calif San Diego, Dept Pediat, Div Neonatol, La Jolla, CA 92093 USA.; Bode, L (corresponding author), Univ Calif San Diego, Dept Pediat, Div Gastroenterol Hepatol & Nutr, La Jolla, CA 92093 USA.; Bode, L (corresponding author), Univ Calif San Diego, Larsson Rosenquist Fdn, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA.; Bode, L (corresponding author), Rady Childrens Hosp, San Diego, CA 92123 USA.	lbode@ucsd.edu	Boons, Geert-Jan P H/J-3211-2016; Nizet, Victor/AAF-3190-2019	Boons, Geert-Jan P H/0000-0003-3111-5954; Nizet, Victor/0000-0003-3847-0422; Lewis, Amanda/0000-0001-6195-3030	NHLBI, National Institutes of Health Programs of Excellence in Glycosciences [HL107150]; NIDDK, National Institutes of Health [P50DK064540]; German Academic Exchange Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health Programs of Excellence in Glycosciences; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Programs of Excellence in Glycosciences Grant HL107150 (to V. N.), NIDDK, National Institutes of Health Grant P50DK064540 (PI: Hultgren) (to A. L. L.), and a PROMO fellowship from the German Academic Exchange Service (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baltimore RS, 2007, SEMIN PERINATOL, V31, P33, DOI 10.1053/j.semperi.2007.01.005; Bedford H, 2001, BRIT MED J, V323, P533, DOI 10.1136/bmj.323.7312.533; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bode L, 2012, ADV NUTR, V3, p383S, DOI 10.3945/an.111.001404; Castor ML, 2008, INFECT DIS OBSTET GY, V2008; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Dotz V, 2015, MOL NUTR FOOD RES, V59, P355, DOI 10.1002/mnfr.201400160; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Edwards Morven S, 2006, Semin Pediatr Infect Dis, V17, P149, DOI 10.1053/j.spid.2006.06.007; Goehring KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101692; HALLGREN P, 1977, J BIOL CHEM, V252, P1014; He YY, 2016, GUT, V65, P33, DOI 10.1136/gutjnl-2014-307544; Heath PT, 2007, BEST PRACT RES CL OB, V21, P411, DOI 10.1016/j.bpobgyn.2007.01.003; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; Jantscher-Krenn E, 2012, BRIT J NUTR, V108, P1839, DOI 10.1017/S0007114511007392; Leipold MD, 2007, J BIOL CHEM, V282, P26786, DOI 10.1074/jbc.M704131200; Li M, 2014, ISME J, V8, P1609, DOI 10.1038/ismej.2014.10; Lin AE, 2014, J INFECT DIS, V209, P389, DOI 10.1093/infdis/jit464; Martin-Sosa S, 2002, J NUTR, V132, P3067, DOI 10.1093/jn/131.10.3067; Miyake K, 2004, ADV BIOCHEM ENG BIOT, V90, P89; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; NEWBURG DS, 1990, J INFECT DIS, V162, P1075, DOI 10.1093/infdis/162.5.1075; PARKER CT, 1992, J BACTERIOL, V174, P930, DOI 10.1128/jb.174.3.930-934.1992; Pfenninger A, 2002, J AM SOC MASS SPECTR, V13, P1341, DOI 10.1016/S1044-0305(02)00646-3; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Rudloff S, 2006, GLYCOBIOLOGY, V16, P477, DOI 10.1093/glycob/cwj092; Ruhaak LR, 2014, ANAL BIOANAL CHEM, V406, P5775, DOI 10.1007/s00216-014-8025-z; Shainheit MG, 2015, J BACTERIOL, V197, P1781, DOI 10.1128/JB.02602-14; Yim HH, 1997, ADV EXP MED BIOL, V418, P995	31	93	97	3	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11243	11249		10.1074/jbc.M117.789974	http://dx.doi.org/10.1074/jbc.M117.789974			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28416607	Green Published, hybrid			2022-12-28	WOS:000405119600010
J	Singh, KH; Jha, B; Dwivedy, A; Choudhary, E; Arpitha, GN; Ashraf, A; Arora, D; Agarwal, N; Biswal, BK				Singh, Khundrakpam Herojit; Jha, Bhavya; Dwivedy, Abhisek; Choudhary, Eira; Arpitha, G. N.; Ashraf, Anam; Arora, Divya; Agarwal, Nisheeth; Biswal, Bichitra Kumar			Characterization of a secretory hydrolase from Mycobacterium tuberculosis sheds critical insight into host lipid utilization by M. tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPASE ACTIVITY; PROTEIN; TRIACYLGLYCEROL; PERSISTENCE; FAMILY; WALL	Mycobacterium tuberculosis causes tuberculosis in humans and predominantly infects alveolar macrophages. To survive inside host lesions and to evade immune surveillance, this pathogen has developed many strategies. For example, M. tuberculosis uses host-derived lipids/fatty acids as nutrients for prolonged persistence within hypoxic host microenvironments. M. tuberculosis imports these metabolites through its respective transporters, and in the case of host fatty acids, a pertinent question arises: does M. tuberculosis have the enzyme(s) for cleavage of fatty acids from host lipids? We show herein that a previously uncharacterized membrane-associated M. tuberculosis protein encoded by Rv2672 is conserved exclusively in actinomycetes, exhibits both lipase and protease activities, is secreted into macrophages, and catalyzes host lipid hydrolysis. In light of these functions, we annotated Rv2672 as mycobacterial secreted hydrolase 1 (Msh1). Furthermore, we found that this enzyme is up-regulated both in an in vitro model of hypoxic stress and in a mouse model of M. tuberculosis infection, suggesting that the pathogen requires Msh1 under hypoxic conditions. Silencing Msh1 expression compromised the ability of M. tuberculosis to proliferate inside lipid-rich foamy macrophages but not under regular culture conditions in vitro, underscoring Msh1' s importance for M. tuberculosis persistence in lipid-rich microenvironments. Of note, this is the first report providing insight into the mechanism of host lipid catabolism by an M. tuberculosis enzyme, augmenting our current understanding of how M. tuberculosis meets its nutrient requirements under hypoxic conditions.	[Singh, Khundrakpam Herojit; Jha, Bhavya; Dwivedy, Abhisek; Arpitha, G. N.; Ashraf, Anam; Arora, Divya; Biswal, Bichitra Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, Delhi 110067, India; [Choudhary, Eira; Agarwal, Nisheeth] Vaccine & Infect Dis Res Ctr, Translat Hlth Sci & Technol Inst, Faridabad 121001, Haryana, India; [Choudhary, Eira] Symbiosis Int Univ, Symbiosis Sch Biomed Sci, Pune 412115, Maharashtra, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Symbiosis International University; Symbiosis School of Biological Sciences (SSBS)	Biswal, BK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, Delhi 110067, India.	bbiswal@nii.ac.in	International, Symbiosis School of Biological Sciences Symbiosis/AAD-7708-2019; Dwivedy, Abhisek/AAV-4406-2021	Herojit Singh, Khundrakpam/0000-0001-9699-2187; Dwivedy, Abhisek/0000-0001-9745-8138; Biswal, Bichitra/0000-0002-5927-3244; Jha, Bhavya/0000-0002-0944-4279	National Institute of Immunology (NII), New Delhi; Department of Biotechnology, Government of India [BT/PR8616/MED/29/793/2013]	National Institute of Immunology (NII), New Delhi; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by core grants from the National Institute of Immunology (NII), New Delhi (to B. K. B.) and Department of Biotechnology, Government of India Extramural Grant BT/PR8616/MED/29/793/2013 (to N. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Department of Biotechnology, Government of India.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Falcone DJ, 1998, J BIOL CHEM, V273, P31480, DOI 10.1074/jbc.273.47.31480; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Guo J, 2015, ENZYME MICROB TECH, V71, P8, DOI 10.1016/j.enzmictec.2015.01.005; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hoppe A, 1996, PHYTOCHEMISTRY, V42, P973, DOI 10.1016/0031-9422(96)00051-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mori M, 2001, J LIPID RES, V42, P1771; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pencreach G, 1996, ENZYME MICROB TECH, V18, P417, DOI 10.1016/0141-0229(95)00120-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; Zhao QJ, 2014, J INTERF CYTOK RES, V34, P686, DOI 10.1089/jir.2013.0071	38	26	28	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11326	11335		10.1074/jbc.M117.794297	http://dx.doi.org/10.1074/jbc.M117.794297			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515317	Green Published, hybrid			2022-12-28	WOS:000405119600016
J	Goulas, T; Ksiazek, M; Garcia-Ferrer, I; Sochaj-Gregorczyk, AM; Waligorska, I; Wasylewski, M; Potempa, J; Gomis-Ruth, FX				Goulas, Theodoros; Ksiazek, Miroslaw; Garcia-Ferrer, Irene; Sochaj-Gregorczyk, Alicja M.; Waligorska, Irena; Wasylewski, Marcin; Potempa, Jan; Gomis-Rueth, F. Xavier			A structure-derived snap-trap mechanism of a multispecific serpin from the dysbiotic human oral microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANTITHROMBIN-III; REACTIVE CENTER LOOP; CRYSTAL-STRUCTURE; TANNERELLA-FORSYTHIA; PORPHYROMONAS-GINGIVALIS; STRUCTURE REFINEMENT; TREPONEMA-DENTICOLA; PROTEASE COMPLEX; MACROMOLECULAR CRYSTALLOGRAPHY; 3-DIMENSIONAL STRUCTURE	Enduring host-microbiome relationships are based on adaptive strategies within a particular ecological niche. Tannerella forsythia is a dysbiotic member of the human oral microbiome that inhabits periodontal pockets and contributes to chronic periodontitis. To counteract endopeptidases from the host or microbial competitors, T. forsythia possesses a serpin-type proteinase inhibitor called miropin. Although serpins from animals, plants, and viruses have been widely studied, those from prokaryotes have received only limited attention. Here we show that miropin uses the serpin-type suicidal mechanism. We found that, similar to a snap trap, the protein transits from a metastable native form to a relaxed triggered or induced form after cleavage of a reactive-site target bond in an exposed reactive-center loop. The prey peptidase becomes covalently attached to the inhibitor, is dragged 75 angstrom apart, and is irreversibly inhibited. This coincides with a large conformational rearrangement of miropin, which inserts the segment upstream of the cleavage site as an extra beta-strand in a central beta-sheet. Standard serpins possess a single target bond and inhibit selected endopeptidases of particular specificity and class. In contrast, miropin uniquely blocked many serine and cysteine endopeptidases of disparate architecture and substrate specificity owing to several potential target bonds within the reactive-center loop and to plasticity in accommodating extra beta-strands of variable length. Phylogenetic studies revealed a patchy distribution of bacterial serpins incompatible with a vertical descent model. This finding suggests that miropin was acquired from the host through horizontal gene transfer, perhaps facilitated by the long and intimate association of T. forsythia with the human gingiva.	[Goulas, Theodoros; Garcia-Ferrer, Irene; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, E-08028 Barcelona, Spain; [Ksiazek, Miroslaw; Sochaj-Gregorczyk, Alicja M.; Waligorska, Irena; Wasylewski, Marcin; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Sochaj-Gregorczyk, Alicja M.] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Ksiazek, Miroslaw; Potempa, Jan] Univ Louisville, Dept Oral Immunol & Infect Dis, Sch Dent, Louisville, KY 40202 USA; [Garcia-Ferrer, Irene] EMBL Outstn Grenoble, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Jagiellonian University; Jagiellonian University; University of Louisville; European Molecular Biology Laboratory (EMBL)	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, E-08028 Barcelona, Spain.	xgrcri@ibmb.csic.es	Potempa, Jan/AAA-6850-2021; Goulas, Theodoros/H-1951-2015	Goulas, Theodoros/0000-0002-6938-5493; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Potempa, Jan/0000-0002-3600-7461	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2015-64487-R, MDM-2014-0435, BIO2013-49320-EXP]; Narodowe Centrum Nauki [2015/17/B/NZ1/00666, 1306/MOB/IV/2015/0, 2012/04/A/NZ1/00051, 2016/21/B/NZ1/00292]; Ministerstwo Nauki i Szkolnictwa Wyzszego Grant [2975/7.PR/13/2014/2]; Seventh Framework Programme Grant [FP7-HEALTH-2012-306029-2]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014SGR9]; National Institute of Dental and Craniofacial Research, National Institutes of Health [R21DE026280]; Spanish Ministry for Economy and Competitiveness [JCI-2012-13573]; European Synchrotron Radiation Facility; Ministry of Science and Higher Education; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE026280] Funding Source: NIH RePORTER	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Narodowe Centrum Nauki(National Science Centre, Poland); Ministerstwo Nauki i Szkolnictwa Wyzszego Grant; Seventh Framework Programme Grant; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Spanish Ministry for Economy and Competitiveness(Spanish Government); European Synchrotron Radiation Facility; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by Secretaria de Estado de Investigacion, Desarrollo e Innovacion Grants BFU2015-64487-R, MDM-2014-0435, and BIO2013-49320-EXP; Narodowe Centrum Nauki Grants 2015/17/B/NZ1/00666, "Mobility Plus" 1306/MOB/IV/2015/0, 2012/04/A/NZ1/00051, and 2016/21/B/NZ1/00292; Ministerstwo Nauki i Szkolnictwa Wyzszego Grant 2975/7.PR/13/2014/2; Seventh Framework Programme Grant FP7-HEALTH-2012-306029-2 "TRIGGER"; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya Grant 2014SGR9; National Institute of Dental and Craniofacial Research, National Institutes of Health Grant R21DE026280; Spanish Ministry for Economy and Competitiveness "Juan de la Cierva" Research Contract JCI-2012-13573 (to T. G.); and funding from the European Synchrotron Radiation Facility. The Structural Biology Unit of Molecular Biology Institute of Barcelona is a "Maria de Maeztu" Unit of Excellence of the Spanish Ministry of Economy, Innovation and Competitiveness. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Baird TT, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2594, DOI 10.1016/B978-0-12-382219-2.00575-5; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x; BAUMANN U, 1992, J MOL BIOL, V226, P1207, DOI 10.1016/0022-2836(92)91062-T; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De La Fuente C, 2013, ARCHAEOMETRY, V55, DOI 10.1111/j.1475-4754.2012.00707.x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Engh RA, 1995, TRENDS BIOTECHNOL, V13, P503, DOI 10.1016/S0167-7799(00)89013-7; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fulton KF, 2005, J BIOL CHEM, V280, P8435, DOI 10.1074/jbc.M410206200; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Garcia-Ferrer I, 2015, P NATL ACAD SCI USA, V112, P8290, DOI 10.1073/pnas.1506538112; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P3634, DOI 10.1021/bi00410a017; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Goulas T, 2017, BIOL CHEM, V398, P975, DOI 10.1515/hsz-2016-0329; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Graycar TP., 2013, HDB PROTEOLYTIC ENZY, V3rd ed., P3148, DOI [DOI 10.1016/B978-0-12-382219-2.00693-1, 10.1016/B978-0-12-382219-2.00693-1]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington James A., 2001, Science Progress, V84, P125, DOI 10.3184/003685001783239032; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Ishihara K, 2010, BIOL CHEM, V391, P1047, DOI 10.1515/BC.2010.113; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ksiazek M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00312; Ksiazek M, 2015, J BIOL CHEM, V290, P658, DOI 10.1074/jbc.M114.601716; Kuo LC, 2008, PUBLIC HEALTH, V122, P417, DOI 10.1016/j.puhe.2007.07.004; Lang EK, 2013, INT J SYST EVOL MICR, V63, P4354, DOI 10.1099/ijs.0.056440-0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Leevvenhoeck A., 1683, PHILOS T, V14, P568; Leishman Shaneen J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5781; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Mailhot JM, 1998, J CLIN PERIODONTOL, V25, P578, DOI 10.1111/j.1600-051X.1998.tb02491.x; Maixner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099994; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson D, 1999, J BIOL CHEM, V274, P12245, DOI 10.1074/jbc.274.18.12245; Nonaka M, 2014, FEMS MICROBIOL LETT, V354, P60, DOI 10.1111/1574-6968.12426; O'Flynn C, 2015, GENOME BIOL EVOL, V7, P3397, DOI 10.1093/gbe/evv220; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Riewald M, 1996, J BIOL CHEM, V271, P14526, DOI 10.1074/jbc.271.24.14526; Roberts TH, 2004, J MOL EVOL, V59, P437, DOI 10.1007/s00239-004-2635-6; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Shimotahira N, 2013, INFECT IMMUN, V81, P1198, DOI 10.1128/IAI.00983-12; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; Staniec D, 2015, J BIOL CHEM, V290, P27248, DOI 10.1074/jbc.M115.648782; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Topic Berislav, 2012, Acta Med Acad, V41, P119, DOI 10.5644/ama2006-124.45; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Warinner C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0376; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Whisstock J, 1998, TRENDS BIOCHEM SCI, V23, P63, DOI 10.1016/S0968-0004(97)01172-9; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhang QW, 2008, J MOL BIOL, V376, P1348, DOI 10.1016/j.jmb.2007.12.050; Zhang Q, 2007, EMBO REP, V8, P658, DOI 10.1038/sj.embor.7400986; Zheng B, 2009, BIOCHEM BIOPH RES CO, V380, P143, DOI 10.1016/j.bbrc.2009.01.057; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	107	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10883	10898		10.1074/jbc.M117.786533	http://dx.doi.org/10.1074/jbc.M117.786533			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28512127	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000404391000012
J	Lee, JY; Steinfeld, JB; Qi, Z; Kwon, Y; Sung, P; Greene, EC				Lee, Ja Yil; Steinfeld, Justin B.; Qi, Zhi; Kwon, YoungHo; Sung, Patrick; Greene, Eric C.			Sequence imperfections and base triplet recognition by the Rad51/RecA family of recombinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; BRANCH MIGRATION; ATP HYDROLYSIS; EVOLUTION; POLARITY; REPAIR; DMC1; REPLICATION	Homologous recombination plays key roles in double-strand break repair, rescue, and repair of stalled replication forks and meiosis. The broadly conserved Rad51/RecA family of recombinases catalyzes the DNA strand invasion reaction that takes place during homologous recombination. We have established single-stranded (ss) DNA curtain assays for measuring individual base triplet steps during the early stages of strand invasion. Here, we examined how base triplet stepping by RecA, Rad51, and Dmc1 is affected by DNA sequence imperfections, such as single and multiple mismatches, abasic sites, and single nucleotide insertions. Our work reveals features of base triplet stepping that are conserved among these three phylogenetic lineages of the Rad51/RecA family and also reveals lineage-specific behaviors reflecting properties that are unique to each recombinase. These findings suggest that Dmc1 is tolerant of single mismatches, multiple mismatches, and even abasic sites, whereas RecA and Rad51 are not. Interestingly, the presence of single nucleotide insertion abolishes recognition of an adjacent base triplet by all three recombinases. On the basis of these findings, we describe models for how sequence imperfections may affect base triplet recognition by Rad51/RecA family members, and we discuss how these models and our results may relate to the different biological roles of RecA, Rad51, and Dmc1.	[Lee, Ja Yil; Steinfeld, Justin B.; Qi, Zhi; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Kwon, YoungHo; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Lee, Ja Yil] UNIST, Sch Life Sci, Ulsan 689798, South Korea; [Qi, Zhi] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Qi, Zhi] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Columbia University; Yale University; Ulsan National Institute of Science & Technology (UNIST); Peking University; Peking University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R35GM118026, R01ES007061, P01CA92584, F31CA210663]; NATIONAL CANCER INSTITUTE [F31CA210663, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R35GM118026 (to E. C. G.) and Grants R01ES007061 and P01CA92584 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant F31CA210663. Present address: School of Life Science, Ulsan National Institute of Science and Technology (UNIST), Ulsan 689-798, Republic of Korea.	Anand R, 2017, NATURE, V544, P377, DOI 10.1038/nature22046; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bianco P R, 1998, Front Biosci, V3, pD570; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; CameriniOtero RD, 1995, ANNU REV GENET, V29, P509, DOI 10.1146/annurev.genet.29.1.509; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Danilowicz C, 2015, NUCLEIC ACIDS RES, V43, P6473, DOI 10.1093/nar/gkv610; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee JY, 2016, J BIOL CHEM, V291, P22218, DOI 10.1074/jbc.M116.740563; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Murayama Y, 2011, GENE DEV, V25, P516, DOI 10.1101/gad.1997511; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Namsaraev EA, 2000, J BIOL CHEM, V275, P3970, DOI 10.1074/jbc.275.6.3970; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Ortiz-Barrientos D, 2016, TRENDS ECOL EVOL, V31, P226, DOI 10.1016/j.tree.2015.12.016; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Prentiss M, 2015, CRIT REV BIOCHEM MOL, V50, P453, DOI 10.3109/10409238.2015.1092943; Qi Z, 2016, METHODS, V105, P62, DOI 10.1016/j.ymeth.2016.03.027; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; WEST SC, 1981, P NATL ACAD SCI-BIOL, V78, P6149, DOI 10.1073/pnas.78.10.6149; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	47	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11125	11135		10.1074/jbc.M117.787614	http://dx.doi.org/10.1074/jbc.M117.787614			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476890	hybrid, Green Published			2022-12-28	WOS:000404391000031
J	Pinto, APA; Pereira, HM; Zeraik, AE; Ciol, H; Ferreira, FM; Brandao-Neto, J; DeMarco, R; Navarro, MVAS; Risi, C; Galkin, VE; Garratt, RC; Araujo, APU				Pinto, Andressa P. A.; Pereira, Humberto M.; Zeraik, Ana E.; Ciol, Heloisa; Ferreira, Frederico M.; Brandao-Neto, Jose; DeMarco, Ricardo; Navarro, Marcos V. A. S.; Risi, Cristina; Galkin, Vitold E.; Garratt, Richard C.; Araujo, Ana P. U.			Filaments and fingers: Novel structural aspects of the single septin from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING; SCHISTOSOMA-MANSONI; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; G-PROTEINS; FORCHLORFENURON; ORGANIZATION; INSIGHTS; YEAST; LOCALIZATION	Septins are filament-forming GTP-binding proteins involved in many essential cellular events related to cytoskeletal dynamics and maintenance. Septins can self-assemble into heterocomplexes, which polymerize into highly organized, cell membrane-interacting filaments. The number of septin genes varies among organisms, and although their structure and function have been thoroughly studied in opisthokonts (including animals and fungi), no structural studies have been reported for other organisms. This makes the single septin from Chlamydomonas (CrSEPT) a particularly attractive model for investigating whether functional homopolymeric septin filaments also exist. CrSEPT was detected at the base of the flagella in Chlamydomonas, suggesting that CrSEPT is involved in the formation of a membrane-diffusion barrier. Using transmission electron microscopy, we observed that recombinant CrSEPT forms long filaments with dimensions comparable with those of the canonical structure described for opisthokonts. The GTP-binding domain of CrSEPT purified as a nucleotide-free monomer that hydrolyzes GTP and readily binds its analog guanosine 5'-3-O-(thio) triphosphate. We also found that upon nucleotide binding, CrSEPT formed dimers that were stabilized by an interface involving the ligand (G-interface). Across this interface, one monomer supplied a catalytic arginine to the opposing subunit, greatly accelerating the rate of GTP hydrolysis. This is the first report of an arginine finger observed in a septin and suggests that CrSEPT may act as its own GTP-activating protein. The finger is conserved in all algal septin sequences, suggesting a possible correlation between the ability to form homopolymeric filaments and the accelerated rate of hydrolysis that it provides.	[Pinto, Andressa P. A.; Pereira, Humberto M.; Zeraik, Ana E.; Ciol, Heloisa; DeMarco, Ricardo; Navarro, Marcos V. A. S.; Garratt, Richard C.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil; [Pinto, Andressa P. A.; Araujo, Ana P. U.] Univ Fed Sao Carlos, Programa Posgrad Genet Evolut & Biol Mol, BR-13565905 Sao Carlos, SP, Brazil; [Ferreira, Frederico M.] Univ Santo Amaro, BR-04829300 Sao Paulo, SP, Brazil; [Brandao-Neto, Jose] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Risi, Cristina; Galkin, Vitold E.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade de Santo Amaro (UNISA); Diamond Light Source; Eastern Virginia Medical School	Garratt, RC; Araujo, APU (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Ciencia Interdisciplinar, Ave Joao Dagnone 1100,POB 369, BR-13563120 Sao Carlos, SP, Brazil.	richard@ifsc.usp.br; anapaula@ifsc.usp.br	Navarro, Marcos VAS/C-9141-2013; garratt, richard c/F-6921-2011; DeMarco, Ricardo/A-7773-2008; Araujo, Ana Paula U/I-6664-2012; Galkin, Vitold/AAD-2844-2019; Ferreira, Frederico/A-4622-2013	DeMarco, Ricardo/0000-0001-8944-1301; Araujo, Ana Paula U/0000-0001-5455-084X; Ferreira, Frederico/0000-0002-7403-9165; Zeraik, Ana Eliza/0000-0001-9508-4283; garratt, richard/0000-0002-2016-3179; Brandao-Neto, Jose/0000-0001-6015-320X; Ciol, Heloisa/0000-0002-7539-023X; Navarro, Marcos/0000-0002-2461-0431	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/10152-7, 2014/15546-1, 2012/14223-9, 12/21259-0, 2013/20715-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under Grants 2011/10152-7 (to A. P. U. A.), 2014/15546-1 (to R. C. G. and A. P. U. A.), and 2012/14223-9 (to H. M. P.) and Fellowships 12/21259-0 and 2013/20715-4 (to H. C. and A. E. Z., respectively). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Serrao VHB, 2011, FEBS LETT, V585, P3868, DOI 10.1016/j.febslet.2011.10.043; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Clark AM, 2007, J CHEM INF MODEL, V47, P1933, DOI 10.1021/ci7001473; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; Hoober J. K., 1989, CHLAMYDOMONAS SOURCE, P241; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; John CM, 2007, EMBO J, V26, P3296, DOI 10.1038/sj.emboj.7601775; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEEFE LJ, 1993, P NATL ACAD SCI USA, V90, P3275, DOI 10.1073/pnas.90.8.3275; Keller LC, 2010, CYTOSKELETON, V67, P504, DOI 10.1002/cm.20462; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Miao WY, 1996, J BIOL CHEM, V271, P15322, DOI 10.1074/jbc.271.26.15322; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Quarmby L.M., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition, P43, DOI [10.1016/b978-0-12-370873-1.00040-x, DOI 10.1016/B978-0-12-370873-1.00040-X]; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; SECKLER R, 1990, J BIOL CHEM, V265, P7655; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Valadares NF, 2016, METHOD CELL BIOL, V136, P321, DOI 10.1016/bs.mcb.2016.03.017; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WEISS RL, 1977, J CELL BIOL, V72, P133, DOI 10.1083/jcb.72.1.133; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wloga D, 2008, EUKARYOT CELL, V7, P1373, DOI 10.1128/EC.00085-08; Yamazaki T, 2013, PLANT J, V74, P605, DOI 10.1111/tpj.12147; Zent E, 2014, BIOL CHEM, V395, P169, DOI 10.1515/hsz-2013-0268; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082; Zeraik AE, 2014, INT J PARASITOL, V44, P523, DOI 10.1016/j.ijpara.2014.03.010; Zeraik AE, 2014, J BIOL CHEM, V289, P7799, DOI 10.1074/jbc.M113.525352; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609	61	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10899	10911		10.1074/jbc.M116.762229	http://dx.doi.org/10.1074/jbc.M116.762229			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476887	Green Published, hybrid			2022-12-28	WOS:000404391000013
J	Irimia, JM; Meyer, CM; Segvich, DM; Surendran, S; DePaoli-Roach, AA; Morral, N; Roach, PJ				Irimia, Jose M.; Meyer, Catalina M.; Segvich, Dyann M.; Surendran, Sneha; DePaoli-Roach, Anna A.; Morral, Nuria; Roach, Peter J.			Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; glycogen; glycogen storage disease; insulin resistance; lipogenesis; fatty liver	DE-NOVO LIPOGENESIS; MUSCLE GLYCOGEN; FATTY LIVER; METABOLIC SYNDROME; GLUCOSE-TRANSPORT; DISEASE; SYNTHASE; SENSITIVITY; PROTEINS; PHOSPHORYLATION	Disruption of the Gys2 gene encoding the liver isoform of glycogen synthase generates a mouse strain (LGSKO) that almost completely lacks hepatic glycogen, has impaired glucose disposal, and is pre-disposed to entering the fasted state. This study investigated how the lack of liver glycogen increases fat accumulation and the development of liver insulin resistance. Insulin signaling in LGSKO mice was reduced in liver, but not muscle, suggesting an organ-specific defect. Phosphorylation of components of the hepatic insulin-signaling pathway, namely IRS1, Akt, and GSK3, was decreased in LGSKO mice. Moreover, insulin stimulation of their phosphorylation was significantly suppressed, both temporally and in an insulin dose response. Phosphorylation of the insulin-regulated transcription factor FoxO1 was somewhat reduced and insulin treatment did not elicit normal translocation of FoxO1 out of the nucleus. Fat overaccumulated in LGSKO livers, showing an aberrant distribution in the acinus, an increase not explained by a reduction in hepatic triglyceride export. Rather, when administered orally to fasted mice, glucose was directed toward hepatic lipogenesis as judged by the activity, protein levels, and expression of several fatty acid synthesis genes, namely, acetyl-CoA carboxylase, fatty acid synthase, SREBP1c, chREBP, glucokinase, and pyruvate kinase. Furthermore, using cultured primary hepatocytes, we found that lipogenesis was increased by 40% in LGSKO cells compared with controls. Of note, the hepatic insulin resistance was not associated with increased levels of pro-inflammatory markers. Our results suggest that loss of liver glycogen synthesis diverts glucose toward fat synthesis, correlating with impaired hepatic insulin signaling and glucose disposal.	[Irimia, Jose M.; Meyer, Catalina M.; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Surendran, Sneha; Morral, Nuria] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Irimia, Jose M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Endocrinol & Metab, Duarte, CA 91010 USA; [Meyer, Catalina M.] Lilly Res Labs, Indianapolis, IN 46225 USA; [Surendran, Sneha] IUPUI, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; City of Hope; Beckman Research Institute of City of Hope; Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iupui.edu	Morral, Nuria/AAC-7149-2020		National Institutes of Health [DK 27221, NS 056454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK027221, P30DK097512, R37DK027221, R01DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 27221 and NS 056454. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Bandsma RHJ, 2008, PEDIATR RES, V63, P702, DOI 10.1203/PDR.0b013e31816c9013; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Derave W, 1999, AM J PHYSIOL-ENDOC M, V277, pE1103, DOI 10.1152/ajpendo.1999.277.6.E1103; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Grefhorst A, 2005, AM J PHYSIOL-GASTR L, V289, pG592, DOI 10.1152/ajpgi.00063.2005; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; LUDVIK B, 1995, J CLIN INVEST, V95, P2232, DOI 10.1172/JCI117913; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Park Jae-Seung, 2011, BMC Res Notes, V4, P8, DOI 10.1186/1756-0500-4-8; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P139; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Ros S, 2010, J BIOL CHEM, V285, P37170, DOI 10.1074/jbc.M110.157396; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006; Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009	47	46	46	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10455	10464		10.1074/jbc.M117.786525	http://dx.doi.org/10.1074/jbc.M117.786525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28483921	Green Published, hybrid			2022-12-28	WOS:000404115400011
J	Droescher, M; Begitt, A; Marg, A; Zacharias, M; Vinkemeier, U				Droescher, Mathias; Begitt, Andreas; Marg, Andreas; Zacharias, Martin; Vinkemeier, Uwe			Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO) (vol 286, pg 18731, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Droescher M, 2011, J BIOL CHEM, V286, P18731, DOI 10.1074/jbc.M111.235978	1	0	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10317	10317		10.1074/jbc.A111.235978	http://dx.doi.org/10.1074/jbc.A111.235978			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28623195	hybrid, Green Published			2022-12-28	WOS:000403580600040
J	Korge, P; John, SA; Calmettes, G; Weiss, JN				Korge, Paavo; John, Scott A.; Calmettes, Guillaume; Weiss, James N.			Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; SUCCINATE-DEHYDROGENASE; ROS PRODUCTION; SUPEROXIDE-PRODUCTION; FUMARATE REDUCTASE; REPERFUSION; ISCHEMIA; MECHANISM; HEART; INHIBITION	Succinate-driven reverse electron transport (RET) through complex I is hypothesized to be a major source of reactive oxygen species (ROS) that induces permeability transition pore (PTP) opening and damages the heart during ischemia/reperfusion. Because RET can only generate ROS when mitochondria are fully polarized, this mechanism is self-limiting once PTP opens during reperfusion. In the accompanying article (Korge, P., Calmettes, G., John, S. A., and Weiss, J. N. (2017) J. Biol. Chem. 292, 9882-9895), we showed that ROS production after PTP opening can be sustained when complex III is damaged (simulated by antimycin). Here we show that complex II can also contribute to sustained ROS production in isolated rabbit cardiac mitochondria following inner membrane pore formation induced by either alamethicin or calcium-induced PTP opening. Two conditions are required to maximize malonate-sensitive ROS production by complex II in isolated mitochondria: (a) complex II inhibition by atpenin A5 or complex III inhibition by stigmatellin that results in succinate-dependent reduction of the dicarboxylate-binding site of complex II (site IIf); (b) pore opening in the inner membrane resulting in rapid efflux of succinate/fumarate and other dicarboxylates capable of competitively binding to site IIf. The decrease in matrix [dicarboxylate] allows O-2 access to reduced site IIf, thereby making electron donation to O-2 possible, explaining the rapid increase in ROS production provided that site IIf is reduced. Because ischemia is known to inhibit complexes II and III and increase matrix succinate/fumarate levels, we hypothesize that by allowing dicarboxylate efflux from the matrix, PTP opening during reperfusion may activate sustained ROS production by this mechanism after RET-driven ROS production has ceased.	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weiss, JN (corresponding author), UCLA, Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu		John, Scott/0000-0002-1232-9140	National Institutes of Health from NHLBI [R01 HL101228, R01 HL117385]; American Heart Association Western States Affiliate [11POST6110007]; American Heart Association [16SDG31180036]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101228, R01HL117385] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Western States Affiliate(American Heart Association); American Heart Association(American Heart Association); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL101228 and R01 HL117385 from the NHLBI, American Heart Association Western States Affiliate Post-doctoral Research Fellowship 11POST6110007, American Heart Association Scientist Development Grant 16SDG31180036, and the Laubisch and Kawata Endowments. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; Aldakkak M, 2008, J CARDIOVASC PHARM, V52, P236, DOI 10.1097/FJC.0b013e3181831337; Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Berkich DA, 2003, ARCH BIOCHEM BIOPHYS, V420, P279, DOI 10.1016/j.abb.2003.09.021; Calmettes G, 2012, J PHYSIOL-LONDON, V590, P3403, DOI 10.1113/jphysiol.2012.239376; Chen CL, 2008, J BIOL CHEM, V283, P27991, DOI 10.1074/jbc.M802691200; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Grivennikova VG, 2017, BBA-BIOENERGETICS, V1858, P109, DOI 10.1016/j.bbabio.2016.10.008; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Korge P, 2001, AM J PHYSIOL-CELL PH, V280, pC517, DOI 10.1152/ajpcell.2001.280.3.C517; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Korge P, 2017, J BIOL CHEM, V292, P9882, DOI 10.1074/jbc.M116.768317; Korge P, 2016, FREE RADICAL BIO MED, V96, P22, DOI 10.1016/j.freeradbiomed.2016.04.002; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; KSENZENKO M, 1984, FEBS LETT, V175, P105, DOI 10.1016/0014-5793(84)80579-7; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00320; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Petrosillo G, 2005, BBA-BIOENERGETICS, V1710, P78, DOI 10.1016/j.bbabio.2005.10.003; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Slodzinski MK, 2008, J MOL CELL CARDIOL, V45, P650, DOI 10.1016/j.yjmcc.2008.07.017; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Stepanova A, 2016, BBA-BIOENERGETICS, V1857, P1561, DOI 10.1016/j.bbabio.2016.06.002; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tretter L, 2012, FREE RADICAL BIO MED, V53, P2119, DOI 10.1016/j.freeradbiomed.2012.09.029; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; VEITCH K, 1992, BIOCHEM J, V281, P709, DOI 10.1042/bj2810709; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	52	35	35	0	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9896	9905		10.1074/jbc.M116.768325	http://dx.doi.org/10.1074/jbc.M116.768325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450394	Green Published, hybrid			2022-12-28	WOS:000403580600004
J	Yao, ZQ; Lei, W; Duan, R; Li, YY; Luo, L; Boyce, BF				Yao, Zhenqiang; Lei, Wei; Duan, Rong; Li, Yanyun; Luo, Lu; Boyce, Brendan F.			RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; GROWTH-FACTOR-BETA; BONE-RESORPTION; TGF-BETA; DEFECTIVE INTERLEUKIN-1; RHEUMATOID-ARTHRITIS; T-CELLS; C-FOS; ACTIVATION	Cytokines, including receptor activator of nuclear factor kappa B ligand (RANKL) and TNF, induce increased osteoclast (OC) formation and bone loss in postmenopausal osteoporosis and inflammatory arthritides. RANKL and TNF can independently induce OC formation in vitro from WT OC precursors via TNF receptor-associated factor (TRAF) adaptor proteins, which bind to their receptors. Of these, only TRAF6 is required for RANKL-induced osteoclastogenesis in vitro. However, the molecular mechanisms involved remain incompletely understood. Here we report that RANKL induced the formation of bone-resorbing OCs from TRAF6(-/-) OC precursors when cultured on bone slices but not on plastic. The mechanisms involved increased TNF production by TRAF6(-/-) OC precursors resulting from their interaction with bone matrix and release of active TGF beta from the resorbed bone, coupled with RANKL-induced autophagolysosomal degradation of TRAF3, a known inhibitor of OC formation. Consistent with these findings, RANKL enhanced TNF-induced OC formation from TRAF6(-/-) OC precursors. Moreover, TNF induced significantly more OCs from mice with TRAF3 conditionally deleted in myeloid lineage cells, and it did not inhibit RANKL-induced OC formation from these cells. TRAF6(-/-) OC precursors that overexpressed TRAF3 or were treated with the autophagolysosome inhibitor chloroquine formed significantly fewer OCs in response to TNF alone or in combination with RANKL. We conclude that RANKL can enhance TNF-induced OC formation independently of TRAF6 by degrading TRAF3. These findings suggest that preventing TRAF3 degradation with drugs like chloroquine could reduce excessive OC formation in diseases in which bone resorption is increased in response to elevated production of these cytokines.	[Yao, Zhenqiang; Lei, Wei; Duan, Rong; Li, Yanyun; Luo, Lu; Boyce, Brendan F.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Yao, Zhenqiang; Boyce, Brendan F.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Lei, Wei] Henan Univ, Affiliated Hosp 1, Dept Med Imaging, 357 Ximen St, Kaifeng 475001, Henan, Peoples R China	University of Rochester; University of Rochester; Henan University	Yao, ZQ; Boyce, BF (corresponding author), Dept Pathol & Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	zhenqiang_yao@urmc.rochester.edu; Brendan_Boyce@urmc.rochester.edu		Yao, Zhenqiang/0000-0002-4664-3648; Luo, Lu/0000-0002-6749-6616	NIAMS, National Institutes of Health [R01AR43510, P30 AR069655, 1S10RR027340]; NIA, National Institutes of Health [R01AG049994]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, P30AR069655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049994] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIAMS, National Institutes of Health Grant R01AR43510 (to B. F. B.) and NIA, National Institutes of Health Grant R01AG049994 (to B. F. B. and Z. Y.). This work was also supported by NIAMS Grants P30 AR069655 and 1S10RR027340 (to. B. F. B) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Agbanoma G, 2012, J IMMUNOL, V188, P1307, DOI 10.4049/jimmunol.1100625; Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Danks L, 2016, ANN RHEUM DIS, V75, P1187, DOI 10.1136/annrheumdis-2014-207137; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Funakoshi-Tago M, 2009, CYTOKINE, V45, P72, DOI 10.1016/j.cyto.2008.10.010; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gravallese EM, 2001, ARTHRITIS RES, V3, P6, DOI 10.1186/ar134; Itonaga I, 2004, BONE, V34, P57, DOI 10.1016/j.bone.2003.08.008; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Mease PJ, 2002, ANN RHEUM DIS, V61, P298, DOI 10.1136/ard.61.4.298; Meednu N, 2016, ARTHRITIS RHEUMATOL, V68, P805, DOI 10.1002/art.39489; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Pihusch V, 2005, THROMB RES, V116, P233, DOI 10.1016/j.thromres.2004.12.010; Ruocco MG, 2007, ADV EXP MED BIOL, V602, P125; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Salmon CR, 2013, J PROTEOMICS, V91, P544, DOI 10.1016/j.jprot.2013.08.016; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Toossi Z, 1996, J IMMUNOL, V156, P3461; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Xiu Y, 2014, J CLIN INVEST, V124, P297, DOI 10.1172/JCI66947; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhao ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135728	65	41	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10169	10179		10.1074/jbc.M116.771816	http://dx.doi.org/10.1074/jbc.M116.771816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28438834	Green Published, hybrid			2022-12-28	WOS:000403580600027
J	Bradshaw, NJ; Yerabham, ASK; Marreiros, R; Zhang, T; Nagel-Steger, L; Korth, C				Bradshaw, Nicholas J.; Yerabham, Antony S. K.; Marreiros, Rita; Zhang, Tao; Nagel-Steger, Luitgard; Korth, Carsten			An unpredicted aggregation-critical region of the actin-polymerizing protein TRIOBP-1/Tara, determined by elucidation of its domain structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; BINDING-PROTEIN; MENTAL DISEASE; COILED COILS; PREDICTION; SCHIZOPHRENIA; EXPRESSION; SEQUENCE; TARA	Aggregation of specific proteins in the brains of patients with chronic mental illness as a result of disruptions in proteostasis is an emerging theme in the study of schizophrenia in particular. Proteins including DISC1 (disrupted in schizophrenia 1) and dysbindin-1B are found in insoluble forms within brain homogenates from such patients. We recently identified TRIOBP-1 (Trio-binding protein 1, also known as Tara) to be another such protein through an epitope discovery and proteomics approach by comparing post-mortem brain material from schizophrenia patients and control individuals. We hypothesized that this was likely to occur as a result of a specific subcellular process and that it, therefore, should be possible to identify a region of the TRIOBP-1 protein that is essential for its aggregation to occur. Here, we probe the domain organization of TRIOBP-1, finding it to possess two distinct coiled-coil domains: the central and C-terminal domains. The central domain inhibits the depolymerization of F-actin and is also responsible for oligomerization of TRIOBP-1. Along with an N-terminal pleckstrin homology domain, the central domain affects neurite outgrowth. In neuroblastoma cells it was found that the aggregation propensity of TRIOBP-1 arises from its central domain, with a short "linker" region narrowed to within amino acids 324-348, between its first two coiled coils, as essential for the formation of TRIOBP-1 aggregates. TRIOBP-1 aggregation, therefore, appears to occur through one or more specific cellular mechanisms, which therefore have the potential to be of physiological relevance for the biological process underlying the development of chronic mental illness.	[Bradshaw, Nicholas J.; Yerabham, Antony S. K.; Marreiros, Rita; Korth, Carsten] Heinrich Heine Univ, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Heinrich Heine Univ, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Bradshaw, Nicholas J.] Univ Rijeka, Dept Biotechnol, Rijeka 51000, Croatia	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Rijeka	Bradshaw, NJ (corresponding author), Univ Rijeka, Dept Biotechnol, Rijeka 51000, Croatia.; Bradshaw, NJ (corresponding author), Sveuciliste Rijeci, Odjel Biotehnol, Radmile Matejcic 2, Rijeka 51000, Croatia.; Korth, C (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Neuropathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	nicholas.bradshaw@hhu.de; ckorth@hhu.de	Zhang, Tao/O-6541-2019; Nagel-Steger, Luitgard/H-6415-2013; Bradshaw, Nicholas J./A-5625-2009	Zhang, Tao/0000-0003-2970-0468; Nagel-Steger, Luitgard/0000-0001-5232-2149; Bradshaw, Nicholas J./0000-0001-5581-8828; Yerabham, Antony Sravan Kumar/0000-0003-4194-8386	Fritz Thyssen Stiftung [10.14.2.140]; Heinrich Heine University, Dusseldorf; Forschungskommission der Medizinischen Fakultat [9772547]; EU [60761]; Brain Behavior Research Foundation [20350]	Fritz Thyssen Stiftung; Heinrich Heine University, Dusseldorf; Forschungskommission der Medizinischen Fakultat; EU(European Commission); Brain Behavior Research Foundation(NARSAD)	This work was supported by the Fritz Thyssen Stiftung (10.14.2.140; to N. J. B.), the Heinrich Heine University, Dusseldorf (graduate school "iBrain" (to C. K.) and Grant 9772547 from the Forschungskommission der Medizinischen Fakultat; to N. J. B.), the EU Seventh Framework Program (MC-IN "INSENS" 60761; to C. K.), and the Brain Behavior Research Foundation (NARSAD Independent Investigator Award 20350 (to C. K.)). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Bader V, 2012, HUM MOL GENET, V21, P4406, DOI 10.1093/hmg/dds273; Bao JJ, 2013, BIOCHEMISTRY-US, V52, P5256, DOI 10.1021/bi400585h; Bradshaw NJ, 2017, CELL MOL LIFE SCI, V74, P1191, DOI 10.1007/s00018-016-2395-7; Bradshaw NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111196; Brandon NJ, 2005, MOL CELL NEUROSCI, V28, P613, DOI 10.1016/j.mcn.2004.11.003; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Fang YP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-314; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hong JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31827; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kazmierczak M, 2017, J NEUROSCI, V37, P3447, DOI 10.1523/JNEUROSCI.2711-16.2017; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Korth C, 2012, PRION, V6, P134, DOI 10.4161/pri.18989; Lee SH, 2011, J CELL PHYSIOL, V226, P1850, DOI 10.1002/jcp.22510; Lee YJ, 2012, BBA-MOL CELL RES, V1823, P971, DOI 10.1016/j.bbamcr.2011.12.011; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Li XX, 2007, PROTEIN EXPRES PURIF, V55, P84, DOI 10.1016/j.pep.2007.05.004; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Nucifora Leslie G, 2016, Mol Neuropsychiatry, V2, P133; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seipel K, 2001, J CELL SCI, V114, P389; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tamura M, 2011, PROTEIN EXPRES PURIF, V78, P1, DOI 10.1016/j.pep.2010.09.007; Trossbach SV, 2016, MOL PSYCHIATR, V21, P1561, DOI 10.1038/mp.2015.194; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yang W, 2016, NEUROSCIENCE, V333, P78, DOI 10.1016/j.neuroscience.2016.07.008; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yu J, 2008, BIOCHEM BIOPH RES CO, V367, P805, DOI 10.1016/j.bbrc.2008.01.022; Yu L, 2014, MOL PSYCHIATR, V19, P7, DOI 10.1038/mp.2012.192; Zhu CY, 2015, NEUROSCIENCE, V291, P301, DOI 10.1016/j.neuroscience.2015.02.016; Zhu Y, 2012, J NANOMATER, V2012, DOI 10.1155/2012/307496	48	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9583	9598		10.1074/jbc.M116.767939	http://dx.doi.org/10.1074/jbc.M116.767939			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28438837	Green Published, hybrid			2022-12-28	WOS:000403113000011
J	Kim, HT; Goldberg, AL				Kim, Hyoung Tae; Goldberg, Alfred L.			The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 26S PROTEASOMES; PROTEINS ACTIVATE; 20S PROTEASOME; ATP; DEGRADATION; ATPASES; BINDING; UBP6; REVEALS; GATE	The proteasome-associated deubiquitinating enzyme Usp14/Ubp6 inhibits protein degradation by catalyzing substrate deubiquitination and by poorly understood allosteric actions. However, upon binding a ubiquitin chain, Usp14 enhances proteasomal degradation by stimulating ATP and peptide degradation. These studies were undertaken to clarify these seemingly opposite regulatory roles of Usp14 and their importance. To learn how the presence of Usp14 on 26S proteasomes influences its different activities, we compared enzymatic and regulatory properties of 26S proteasomes purified from wild-type mouse embryonic fibroblast cells and those lacking Usp14. The proteasomes lacking Usp14 had higher basal peptidase activity than WT 26S, and this activity was stimulated to a greater extent by adenosine 5'-O-(thiotriphosphate) (ATP gamma S) than with WT particles. These differences were clear even though Usp14 is present on only a minor fraction (30-40%) of the 26S in WT mouse embryonic fibroblast cells. Addition of purified Usp14 to the WT and Usp14-defficient proteasomes reduced both their basal peptidase activity and the stimulation by ATP gamma S. Usp14 inhibits these processes allosterically because a catalytically inactive Usp14 mutant also inhibited them. Proteasomes lacking Usp14 also exhibited greater deubiquitinating activity by Rpn11 and greater basal ATPase activity than WT particles. ATP hydrolysis by WT proteasomes is activated if they bind a ubiquitinated protein, which is loosely folded. Surprisingly, proteasomes lacking Usp14 could be activated by such proteins even without a ubiquitin chain present. Furthermore, proteasomes lacking Usp14 are much more active in degrading non-ubiquitinated proteins (e.g. Sic1) than WT particles. Thus, without a ubiquitinated substrate present, Usp14 suppresses multiple proteasomal activities, especially basal ATP consumption and degradation of non-ubiquitinated proteins. These allosteric effects thus reduce ATP hydrolysis by inactive proteasomes and nonspecific proteolysis and enhance proteasomal specificity for ubiquitinated proteins.	[Kim, Hyoung Tae; Goldberg, Alfred L.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu		HyoungTae, Kim/0000-0002-2482-6064; Kim, Hyoung Tae/0000-0002-0270-2749	NIGMS, National Institutes of Health [R01 GM51923]; Cure Alzheimer's Fund; Project ALS Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cure Alzheimer's Fund; Project ALS Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM51923, by the Cure Alzheimer's Fund, and by the Project ALS Foundation (2015-06). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Berko D, 2014, J BIOL CHEM, V289, P5609, DOI 10.1074/jbc.M113.509380; Besche HC, 2012, METHODS MOL BIOL, V832, P423, DOI 10.1007/978-1-61779-474-2_29; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brocca S, 2009, PROTEINS, V76, P731, DOI 10.1002/prot.22385; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Fabre B, 2014, J PROTEOME RES, V13, P3027, DOI 10.1021/pr500193k; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee BH, 2016, NATURE, V532, P398, DOI 10.1038/nature17433; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; MENON AS, 1987, J BIOL CHEM, V262, P14929; Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wyndham AM, 1999, PROTEIN SCI, V8, P1268, DOI 10.1110/ps.8.6.1268; Xu DC, 2016, GENE DEV, V30, P1718, DOI 10.1101/gad.285122.116; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao JH, 2016, NATURE, V529, pE1, DOI 10.1038/nature16472; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	54	45	49	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9830	9839		10.1074/jbc.M116.763128	http://dx.doi.org/10.1074/jbc.M116.763128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28416611	hybrid, Green Published			2022-12-28	WOS:000403113000030
J	Lin, LF; Lo, LHY; Lyu, Q; Lai, KO				Lin, Lianfeng; Lo, Louisa Hoi-Ying; Lyu, Quanwei; Lai, Kwok-On			Determination of dendritic spine morphology by the striatin scaffold protein STRN4 through interaction with the phosphatase PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGILE-X-SYNDROME; MESSENGER-RNA TRANSPORT; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; IN-VIVO; STRUCTURAL PLASTICITY; STE20-LIKE KINASE; AMPA RECEPTOR; PHOSPHORYLATION; AUTISM	Dendritic spines are heterogeneous and exist with various morphologies. Altered spine morphology might underlie the cognitive deficits in neurodevelopmental disorders such as autism, but how different subtypes of dendritic spines are selectively maintained along development is still poorly understood. Spine maturation requires spontaneous activity of N-methyl-D-aspartate (NMDA) receptor and local dendritic protein synthesis. STRN4 (also called zinedin) belongs to the striatin family of scaffold proteins, and some of the potential striatin-interacting proteins are encoded by autism risk genes. Although previous studies have demonstrated their localization in dendritic spines, the function of various striatin family members in the neuron remains unknown. Here, we demonstrate that Strn4 mRNA is present in neuronal dendrites, and the local expression of STRN4 protein depends on NMDA receptor activation. Notably, STRN4 is preferentially expressed in mushroom spines, and STRN4 specifically maintains mushroom spines but not thin spines and filopodia through interaction with the phosphatase PP2A. Our findings have therefore unraveled the local expression of STRN4 as a novel mechanism for the control of dendritic spine morphology.	[Lin, Lianfeng; Lo, Louisa Hoi-Ying; Lyu, Quanwei; Lai, Kwok-On] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Lai, Kwok-On] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lai, KO (corresponding author), Univ Hong Kong, Fac Med, Sch Biomed Sci, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	laiko@hku.hk	Lai, Kwok On/ABC-8046-2021; Lai, Kwok-On/L-7468-2019	Lai, Kwok-On/0000-0002-4069-054X	Research Grants Council of Hong Kong General Research Fund [16100814, 17135816]; Early Career Scheme [27119715]; University of Hong Kong Seed Funding Programme for Basic Research [201407159004, 201511159170]	Research Grants Council of Hong Kong General Research Fund(Hong Kong Research Grants Council); Early Career Scheme; University of Hong Kong Seed Funding Programme for Basic Research(University of Hong Kong)	This work was supported by Research Grants Council of Hong Kong General Research Fund 16100814 and 17135816, Early Career Scheme Grant 27119715, and the University of Hong Kong Seed Funding Programme for Basic Research Grants 201407159004 and 201511159170. The authors declare that they have no conflicts of interest with the contents of this article.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bar J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37136; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Benoist M, 2008, J NEUROCHEM, V106, P969, DOI 10.1111/j.1471-4159.2008.05448.x; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Butko MT, 2013, P NATL ACAD SCI USA, V110, pE726, DOI 10.1073/pnas.1300424110; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chen YK, 2012, MOL BIOL CELL, V23, P4383, DOI 10.1091/mbc.E12-05-0365; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gardoni F, 2012, J CELL SCI, V125, P1401, DOI 10.1242/jcs.097576; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kim H, 2016, J NEUROSCI, V36, P4888, DOI 10.1523/JNEUROSCI.4204-15.2016; Kim SH, 2008, P NATL ACAD SCI USA, V105, P4429, DOI 10.1073/pnas.0800257105; Lai KO, 2015, J BIOL CHEM, V290, P14637, DOI 10.1074/jbc.M114.627117; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13282; Liu XR, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7013032; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McNair K, 2010, J NEUROSCI, V30, P3508, DOI 10.1523/JNEUROSCI.5386-09.2010; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Orefice LL, 2013, J NEUROSCI, V33, P11618, DOI 10.1523/JNEUROSCI.0012-13.2013; PAPA M, 1995, J NEUROSCI, V15, P1; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Phillips M, 2015, NEUROSCI LETT, V601, P30, DOI 10.1016/j.neulet.2015.01.011; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Schouten M, 2014, JOVE-J VIS EXP, DOI 10.3791/51276; Spiga S, 2014, P NATL ACAD SCI USA, V111, pE3745, DOI 10.1073/pnas.1406768111; Spires TL, 2005, CEREB CORTEX, V15, P385, DOI 10.1093/cercor/bhh141; Strack S, 1997, J NEUROCHEM, V68, P2119; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Ultanir SK, 2014, NEURON, V84, P968, DOI 10.1016/j.neuron.2014.10.025; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Weyer SW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-36; Yang K, 2013, BRAIN STRUCT FUNCT, V218, P669, DOI 10.1007/s00429-012-0420-7; Yoon YJ, 2016, P NATL ACAD SCI USA, V113, pE6877, DOI 10.1073/pnas.1614267113; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	66	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9451	9464		10.1074/jbc.M116.772442	http://dx.doi.org/10.1074/jbc.M116.772442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28442576	hybrid, Green Published			2022-12-28	WOS:000403113000002
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series: Host-microbiome metabolic interplay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Long before the recent thrust of scientific research on the microbiome, the importance of its interface with the host was being acknowledged by practices such as probiotic supplementation, e.g. after a course of antibiotics, which has the unwanted side effect of depleting commensal bacteria. The shared metabolite capital between the host and the microbiome is extensive and tightly controlled. However, despite the influence of microbe-derived metabolites on many aspects of host physiology, behavior, and pathology, our understanding of this metabolic interface is still in its infancy and its therapeutic targeting is largely untapped. In this Thematic Minireview Series, JBC presents six exciting articles discussing a range of approaches for identifying microbial natural products, and elucidating their biosynthetic pathways and their physiological effects, which could potentially be leveraged for developing new therapeutics.	[Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Sch, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, HL58984, GM112455]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK45776, HL58984, and GM112455 (to R.B.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown JM, 2017, J BIOL CHEM, V292, P8560, DOI 10.1074/jbc.R116.765388; Krautkramer KA, 2017, J BIOL CHEM, V292, P8582, DOI 10.1074/jbc.R116.761577; Martinez KB, 2017, J BIOL CHEM, V292, P8553, DOI 10.1074/jbc.R116.752899; Olsan EE, 2017, J BIOL CHEM, V292, P8577, DOI 10.1074/jbc.R116.752295; Pellock SJ, 2017, J BIOL CHEM, V292, P8569, DOI 10.1074/jbc.R116.767434; Wilson MR, 2017, J BIOL CHEM, V292, P8546, DOI 10.1074/jbc.R116.762906	6	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8544	8545		10.1074/jbc.R117.786137	http://dx.doi.org/10.1074/jbc.R117.786137			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389560	Green Published, hybrid			2022-12-28	WOS:000402153900001
J	Chernov, KG; Neuvonen, M; Brock, I; Ikonen, E; Verkhusha, VV				Chernov, Konstantin G.; Neuvonen, Maarit; Brock, Ivonne; Ikonen, Elina; Verkhusha, Vladislav V.			Introducing inducible fluorescent split cholesterol oxidase to mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol metabolism; cholesterol regulation; cholesterol-binding protein; enzyme	PROTEIN-PROTEIN INTERACTIONS; CHROMOBACTERIUM SP DS-1; LOW-DENSITY-LIPOPROTEIN; LIPID RAFTS; STRUCTURAL-CHARACTERIZATION; LIVING ANIMALS; ACTIVE-SITE; ANNEXIN-V; COMPLEMENTATION; EXPRESSION	Cholesterol oxidase (COase) is a bacterial enzyme catalyzing the first step in the biodegradation of cholesterol. COase is an important biotechnological tool for clinical diagnostics and production of steroid drugs and insecticides. It is also used for tracking intracellular cholesterol; however, its utility is limited by the lack of an efficient temporal control of its activity. To overcome this we have developed a regulatable fragment complementation system for COase cloned from Chromobacterium sp. The enzyme was split into two moieties that were fused to FKBP (FK506-binding protein) and FRB (rapamycin-binding domain) pair and split GFP fragments. The addition of rapamycin reconstituted a fluorescent enzyme, termed split GFP-COase, the fluorescence level of which correlated with its oxidation activity. A rapid decrease of cellular cholesterol induced by intracellular expression of the split GFP-COase promoted the dissociation of a cholesterol biosensor D4H from the plasma membrane. The process was reversible as upon rapamycin removal, the split GFP-COase fluorescence was lost, and cellular cholesterol levels returned to normal. These data demonstrate that the split GFP-COase provides a novel tool to manipulate cholesterol in mammalian cells.	[Chernov, Konstantin G.; Verkhusha, Vladislav V.] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, FIN-00290 Helsinki, Finland; [Neuvonen, Maarit; Brock, Ivonne; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, FIN-00290 Helsinki, Finland; [Neuvonen, Maarit; Brock, Ivonne; Ikonen, Elina] Minerva Fdn, Inst Med Res, Helsinki 00290, Finland; [Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of Helsinki; University of Helsinki; Yeshiva University; Albert Einstein College of Medicine	Ikonen, E (corresponding author), Univ Helsinki, Fac Med, Dept Anat, FIN-00290 Helsinki, Finland.; Verkhusha, VV (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	elina.ikonen@helsinki.fi; vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121; Ikonen, Elina/0000-0001-8382-1135; Neuvonen, Maarit/0000-0002-7209-3029	Academy of Finland [263371, 266992, 272130, 284667]; EU FP7 program [ERC-2013-ADG-340233]	Academy of Finland(Academy of Finland); EU FP7 program(European Commission)	This work was supported by Academy of Finland Grants 263371 and 266992 (to V. V. V.) and 272130 and 284667 (to E. I.) and by an EU FP7 program ERC-2013-ADG-340233 grant (to V. V. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BERNHEIMER AW, 1987, BIOCHEM BIOPH RES CO, V148, P260, DOI 10.1016/0006-291X(87)91104-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Doukyu N, 2009, APPL MICROBIOL BIOT, V82, P479, DOI 10.1007/s00253-008-1775-9; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Gadda G, 1997, EUR J BIOCHEM, V250, P369, DOI 10.1111/j.1432-1033.1997.0369a.x; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gniadecki R, 2004, BIOCHEM BIOPH RES CO, V320, P165, DOI 10.1016/j.bbrc.2004.05.145; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuypers FA, 1996, BLOOD, V87, P1179, DOI 10.1182/blood.V87.3.1179.bloodjournal8731179; Lajoie Patrick, 2013, Methods Mol Biol, V1017, P229, DOI 10.1007/978-1-62703-438-8_17; LANGE Y, 1992, J LIPID RES, V33, P315; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.324; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Martell JD, 2016, NAT BIOTECHNOL, V34, P774, DOI 10.1038/nbt.3563; Mathieu JM, 2012, BIOTECHNOL BIOENG, V109, P2409, DOI 10.1002/bit.24506; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Neuvonen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103743; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paulmurugan R, 2005, CANCER RES, V65, P7413, DOI 10.1158/0008-5472.CAN-05-0588; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pollegioni L, 2009, FEBS J, V276, P6857, DOI 10.1111/j.1742-4658.2009.07379.x; PORN MI, 1995, BIOCHEM J, V308, P269; Pratt MR, 2007, P NATL ACAD SCI USA, V104, P11209, DOI 10.1073/pnas.0700816104; Sagermann M, 2010, J STRUCT BIOL, V170, P32, DOI 10.1016/j.jsb.2010.01.012; Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Vrielink A, 2009, FEBS J, V276, P6826, DOI 10.1111/j.1742-4658.2009.07377.x; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wehr MC, 2016, DRUG DISCOV TODAY, V21, P415, DOI 10.1016/j.drudis.2015.11.004; Wustner D, 2015, BBA-BIOMEMBRANES, V1848, P1908, DOI 10.1016/j.bbamem.2015.05.010; Yue QK, 1999, BIOCHEMISTRY-US, V38, P4277, DOI 10.1021/bi982497j; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhuang LY, 2002, CANCER RES, V62, P2227; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	54	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8811	8822		10.1074/jbc.M116.761718	http://dx.doi.org/10.1074/jbc.M116.761718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28391244	hybrid, Green Published			2022-12-28	WOS:000402153900026
J	Wachter, RM				Wachter, Rebekka M.			A peptide adhesive molded by magnesium glues Rubisco's subunits together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Rubisco enzymes play central roles in carbon fixation, with potential importance in biotechnology, but have eluded a full description of their multistep assembly and function. A new article describes the fascinating discovery that some archaeal Rubiscos contain a built-in assembly domain inserted into an otherwise canonical Rubisco fold, providing a tremendous expansion of our understanding of the diversity of naturally occurring Rubiscos.	[Wachter, Rebekka M.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Wachter, Rebekka M.] Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wachter, RM (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Wachter, RM (corresponding author), Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA.	rwachter@asu.edu			U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Systems Grant [DE-FG02-09-ER16123]	U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Systems Grant(United States Department of Energy (DOE))	This work was supported by a grant from the U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Systems Grant DE-FG02-09-ER16123 (to R. M. W.). The author declares that she has no conflicts of interest with the contents of this article.	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Gunn LH, 2017, J BIOL CHEM, V292, P6838, DOI 10.1074/jbc.M116.767145; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999	8	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6851	6852		10.1074/jbc.H116.767145	http://dx.doi.org/10.1074/jbc.H116.767145			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28432177	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000399813400034
J	Mhashal, AR; Vardi-Kilshtain, A; Kohen, A; Major, DT				Mhashal, Anil R.; Vardi-Kilshtain, Alexandra; Kohen, Amnon; Major, Dan Thomas			The role of the Met(20) loop in the hydride transfer in Escherichia coli dihydrofolate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; molecular dynamics; protein dynamic; quantum chemistry; reductase; dihydrofolate reductase	MECHANICAL/MOLECULAR-MECHANICAL CHARACTERIZATION; MOLECULAR-DYNAMICS SIMULATIONS; ACTIVE-SITE; FREE-ENERGY; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; TRANSITION-STATE; COMBINED QUANTUM; FUNCTIONAL-ROLE; CONFORMATIONAL-CHANGES	A key question concerning the catalytic cycle of Escherichia coli dihydrofolate reductase (ecDHFR) is whether the Met(20) loop is dynamically coupled to the chemical step during catalysis. A more basic, yet unanswered question is whether the Met(20) loop adopts a closed conformation during the chemical hydride transfer step. To examine the most likely conformation of the Met(20) loop during the chemical step, we studied the hydride transfer in wild type (WT) ecDHFR using hybrid quantum mechanics-molecular mechanics free energy simulations with the Met(20) loop in a closed and disordered conformation. Additionally, we investigated three mutant forms (I14X; X = Val, Ala, Gly) of the enzyme that have increased active site flexibility and donor-acceptor distance dynamics in closed and disordered Met(20) loop states. We found that the conformation of the Met(20) loop has a dramatic effect on the ordering of active site hydration, although the Met(20) loop conformation only has a moderate effect on the hydride transfer rate and donor-acceptor distance dynamics. Finally, we evaluated the pK(a) of the substrate N5 position in closed and disordered Met(20) loop states and found a strong correlation between N5 basicity and the conformation of the Met(20) loop.	[Mhashal, Anil R.; Vardi-Kilshtain, Alexandra; Major, Dan Thomas] Bar Ilan Univ, Dept Chem, IL-5290002 Ramat Gan, Israel; [Mhashal, Anil R.; Vardi-Kilshtain, Alexandra; Major, Dan Thomas] Bar Ilan Univ, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-5290002 Ramat Gan, Israel; [Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	Bar Ilan University; Bar Ilan University; University of Iowa	Major, DT (corresponding author), Bar Ilan Univ, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-5290002 Ramat Gan, Israel.	majort@biu.ac.il	Mhashal, Anil/ABA-7245-2021; Major, Dan T/J-8761-2014	Major, Dan T/0000-0002-9231-0676; Mhashal, Anil/0000-0002-8232-8135	Israel Science Foundation [2146/15]; United States-Israel Binational Science Foundation [2012340]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Israel Science Foundation Grant 2146/15 and United States-Israel Binational Science Foundation Grant 2012340. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal PK, 2002, J PHYS CHEM B, V106, P3283, DOI 10.1021/jp020190v; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Arora K, 2013, TOP CURR CHEM, V337, P165, DOI 10.1007/128_2012_408; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN KA, 1992, FARADAY DISCUSS, V93, P217, DOI 10.1039/fd9929300217; BYSTROFF C, 1990, BIOCHEMISTRY-US, V29, P3263, DOI 10.1021/bi00465a018; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; Castillo R, 1999, J AM CHEM SOC, V121, P12140, DOI 10.1021/ja9843019; Cummins PL, 1996, J COMPUT CHEM, V17, P1598, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1598::AID-JCC2>3.0.CO;2-G; DEWAR MJS, 1985, J PHYS CHEM-US, V89, P2145, DOI 10.1021/j100257a004; Doron D, 2015, J PHYS CHEM B, V119, P906, DOI 10.1021/jp5059963; Doron D, 2012, J CHEM THEORY COMPUT, V8, P2484, DOI 10.1021/ct300235k; Doron D, 2011, J CHEM THEORY COMPUT, V7, P3420, DOI 10.1021/ct2004808; Fan Y, 2013, BIOCHEMISTRY-US, V52, P2036, DOI 10.1021/bi301559q; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Ferrer S, 2003, J PHYS CHEM B, V107, P14036, DOI 10.1021/jp0354898; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Francis K., 2016, CURR BIOTECHNOL, V4, P77; GAO JL, 1992, J PHYS CHEM-US, V96, P537, DOI 10.1021/j100181a009; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Garcia-Viloca M, 2003, J MOL BIOL, V327, P549, DOI 10.1016/S0022-2836(03)00123-2; Hockney R. W., 1970, Methods in computational physics. IX. Plasma physics, P135; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Ruiz-Pernia JJ, 2013, J AM CHEM SOC, V135, P18689, DOI 10.1021/ja410519h; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khavrutskii IV, 2007, PROTEIN SCI, V16, P1087, DOI 10.1110/ps.062724307; Kohen A, 2015, ACCOUNTS CHEM RES, V48, P466, DOI 10.1021/ar500322s; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee H, 1996, BIOCHEMISTRY-US, V35, P7012, DOI 10.1021/bi960028g; Li GH, 2003, J PHYS CHEM B, V107, P14521, DOI 10.1021/jp0356158; LI LY, 1992, BIOCHEMISTRY-US, V31, P7826, DOI 10.1021/bi00149a012; Liu CT, 2014, P NATL ACAD SCI USA, V111, P18231, DOI 10.1073/pnas.1415940111; Loveridge EJ, 2012, NAT CHEM, V4, P292, DOI 10.1038/nchem.1296; Loveridge EJ, 2011, CHEMBIOCHEM, V12, P1258, DOI 10.1002/cbic.201000794; Luk LYP, 2013, P NATL ACAD SCI USA, V110, P16344, DOI 10.1073/pnas.1312437110; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MAHARAJ G, 1990, BIOCHEMISTRY-US, V29, P4554, DOI 10.1021/bi00471a008; Major DT, 2017, RSC THEOR COMPUT CHE, V9, P340; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miller GP, 1998, CHEM BIOL, V5, pR105, DOI 10.1016/S1074-5521(98)90616-0; Miller GP, 2001, BIOCHEMISTRY-US, V40, P867, DOI 10.1021/bi001608n; Miller GP, 1998, BIOCHEMISTRY-US, V37, P6336, DOI 10.1021/bi973065w; Nam K, 2005, J CHEM THEORY COMPUT, V1, P2, DOI 10.1021/ct049941i; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Radkiewicz JL, 2000, J AM CHEM SOC, V122, P225, DOI 10.1021/ja9913838; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; REYES VM, 1995, BIOCHEMISTRY-US, V34, P2710, DOI 10.1021/bi00008a039; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; ROSSI I, 1995, CHEM PHYS LETT, V233, P231, DOI 10.1016/0009-2614(94)01450-A; Roston D, 2014, J COMPUT CHEM, V35, P1411, DOI 10.1002/jcc.23629; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, BIOCHEMISTRY-US, V43, P374, DOI 10.1021/bi035464z; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Stojkovic V, 2010, CHEM COMMUN, V46, P8974, DOI 10.1039/c0cc02988b; Thorpe IF, 2005, J AM CHEM SOC, V127, P12997, DOI 10.1021/ja053558l; Thorpe IF, 2003, J PHYS CHEM B, V107, P14042, DOI 10.1021/jp035734n; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wan Q, 2014, P NATL ACAD SCI USA, V111, P18225, DOI 10.1073/pnas.1415856111; WARREN MS, 1991, BIOCHEMISTRY-US, V30, P11092, DOI 10.1021/bi00110a011; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1986, BIOCHEMISTRY-US, V25, P8368, DOI 10.1021/bi00374a006; Watney JB, 2003, J AM CHEM SOC, V125, P3745, DOI 10.1021/ja028487u	73	19	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14229	14239		10.1074/jbc.M117.777136	http://dx.doi.org/10.1074/jbc.M117.777136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28620051	Green Published, hybrid			2022-12-28	WOS:000408439800026
J	Yanatori, I; Richardson, DR; Toyokuni, S; Kishi, F				Yanatori, Izumi; Richardson, Des R.; Toyokuni, Shinya; Kishi, Fumio			The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; CRYSTAL-STRUCTURE; POLY(C)-BINDING PROTEINS; CARBON-MONOXIDE; KH DOMAINS; EXPRESSION; MECHANISM; IDENTIFICATION; ABSORPTION; TRANSPORT	Mammals incorporate a major proportion of absorbed iron as heme, which is catabolized by the heme oxygenase 1 (HO1)-NADPH-cytochrome P450 reductase (CPR) complex into biliverdin, carbon monoxide, and ferrous iron. Moreover, intestinal iron is incorporated as ferrous iron, which is transported via the iron importer, divalent metal transporter 1 (DMT1). Recently, we demonstrated that the iron chaperone poly(rC)-binding protein 2 (PCBP2) can directly receive ferrous iron from DMT1 or transfer iron to the iron exporter, ferroportin 1. To promote intracellular iron flux, an iron chaperone may be essential for receiving iron generated by heme catabolism, but this hypothesis is untested so far. Herein, we demonstrate that HO1 binds to PCBP2, but not to other PCBP family members, namely PCBP1, PCBP3, or PCBP4. Interestingly, HO1 formed a complex with either CPR or PCBP2, and it was demonstrated that PCBP2 competes with CPR for HO1 binding. Using PCBP2-deletion mutants, we demonstrated that the PCBP2 K homology 3 domain is important for the HO1/PCBP2 interaction. In heme-loaded cells, heme prompted HO1-CPR complex formation and decreased the HO1/PCBP2 interaction. Furthermore, in vitro reconstitution experiments with purified recombinant proteins indicated that HO1 could bind to PCBP2 in the presence of heme, whereas loading of PCBP2 with ferrous iron caused PCBP2 to lose its affinity for HO1. These results indicate that ferrous iron released from heme can be bound by PCBP2 and suggest a model for an integrated heme catabolism and iron transport metabolon.	[Yanatori, Izumi; Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Richardson, Des R.; Toyokuni, Shinya] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan	Kawasaki Medical School; University of Sydney; Nagoya University	Kishi, F (corresponding author), Kawasaki Med Sch, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fkishi-ygc@umin.ac.jp	Yanatori, Izumi/AAE-1482-2019; Toyokuni, Shinya/ABE-7714-2021; Toyokuni, Shinya/C-1358-2010	Yanatori, Izumi/0000-0002-1945-5473; Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	Japan Agency for Medical Research and Development (AMED) [22591052]; Kawasaki Medical School [27-50, 28-18]; National Health and Medical Research Council (NHMRC) Australia [APP1128152, APP1060482]; NHMRC [APP1062607]; Japan Society for the Promotion of Science (JSPS)	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kawasaki Medical School; National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (C) 22591052, the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED), and Research Project Grants from Kawasaki Medical School 27-50 and 28-18. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of National Health and Medical Research Council (NHMRC) Australia for Project Grants (APP1128152 and APP1060482) and an NHMRC Senior Principal Research Fellowship (APP1062607). Also the recipient of an Invitation Fellowship from the Japan Society for the Promotion of Science (JSPS).	Abate A, 2007, BIOCHEM BIOPH RES CO, V354, P757, DOI 10.1016/j.bbrc.2007.01.050; Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Andrade BB, 2010, J IMMUNOL, V185, P1196, DOI 10.4049/jimmunol.0904179; Ayer A, 2016, PHYSIOL REV, V96, P1449, DOI 10.1152/physrev.00003.2016; AZIZ N, 1986, NUCLEIC ACIDS RES, V14, P915, DOI 10.1093/nar/14.2.915; Becker E, 2001, INT J BIOCHEM CELL B, V33, P1, DOI 10.1016/S1357-2725(00)00067-4; Burke JM, 2000, INVEST OPHTH VIS SCI, V41, P1945; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P444, DOI 10.1089/ars.2006.8.444; Calo LA, 2015, INT J CLIN EXP MED, V8, P7487; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Choi K, 2004, NUCLEIC ACIDS RES, V32, P1308, DOI 10.1093/nar/gkh300; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; FINCH CA, 1959, J CLIN INVEST, V38, P392, DOI 10.1172/JCI103813; Fujimura K, 2008, RNA, V14, P425, DOI 10.1261/rna.780708; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ghanem LR, 2016, MOL CELL BIOL, V36, P304, DOI 10.1128/MCB.00936-15; Ghattas MH, 2002, INT J BIOCHEM CELL B, V34, P1619, DOI 10.1016/S1357-2725(02)00097-3; Gisk B, 2010, BIOCHEM J, V425, P425, DOI 10.1042/BJ20090775; Gottlieb Y, 2012, HAEMATOL-HEMATOL J, V97, P1489, DOI 10.3324/haematol.2012.063651; GREEN R, 1968, AM J MED, V45, P336, DOI 10.1016/0002-9343(68)90069-7; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; Higashimoto Y, 2006, J BIOL CHEM, V281, P31659, DOI 10.1074/jbc.M606163200; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hurrell R, 2010, INT J VITAM NUTR RES, V80, P279, DOI 10.1024/0300-9831/a000035; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; ITOMAKI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P253, DOI 10.1006/abbi.1995.1160; Kalinowski DS, 2016, BBA-MOL CELL RES, V1863, P727, DOI 10.1016/j.bbamcr.2016.01.026; Kida Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P175, DOI 10.1006/abbi.1997.0553; Kishi F, 1997, MOL IMMUNOL, V34, P839, DOI 10.1016/S0161-5890(97)00110-7; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Lane DJR, 2015, NUTRIENTS, V7, P2274, DOI 10.3390/nu7042274; Lane Darius J R, 2014, Biochem J, V462, pe1, DOI 10.1042/BJ20140720; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lemberg R., 1949, METABOLISM FUNCTION, P93; Li C, 2012, FREE RADICAL BIO MED, V53, P366, DOI 10.1016/j.freeradbiomed.2012.03.007; Liping Z., 2013, PLOS ONE, V8; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1986, J BIOL CHEM, V261, P411; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 2000, GENOMICS, V67, P301, DOI 10.1006/geno.2000.6244; MCCOUBREY WK, 1992, ARCH BIOCHEM BIOPHYS, V295, P13, DOI 10.1016/0003-9861(92)90481-B; Munoz-Sanchez J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/604981; Murahashi M, 2016, BIOCHEM BIOPH RES CO, V476, P445, DOI 10.1016/j.bbrc.2016.05.142; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Parfenova H, 2012, J CEREBR BLOOD F MET, V32, P1024, DOI 10.1038/jcbfm.2012.13; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Prawan A, 2005, ANTIOXID REDOX SIGN, V7, P1688, DOI 10.1089/ars.2005.7.1688; RAFFIN SB, 1974, J CLIN INVEST, V54, P1344, DOI 10.1172/JCI107881; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Sakamoto H, 2002, EUR J BIOCHEM, V269, P5231, DOI 10.1046/j.1432-1033.2002.03230.x; SARDANA MK, 1987, P NATL ACAD SCI USA, V84, P2464, DOI 10.1073/pnas.84.8.2464; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; SUN J, 1994, BIOCHEMISTRY-US, V33, P13734, DOI 10.1021/bi00250a026; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Walter BL, 1999, RNA, V5, P1570, DOI 10.1017/S1355838299991483; Wardrop SL, 1999, EUR J BIOCHEM, V263, P41, DOI 10.1046/j.1432-1327.1999.00447.x; Watts RN, 2004, BBA-MOL CELL RES, V1692, P1, DOI 10.1016/j.bbamcr.2004.02.004; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Xiao GR, 2014, ELIFE, V3, DOI 10.7554/eLife.03191; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; Yanatori I, 2015, CELL BIOL INT, V39, P427, DOI 10.1002/cbin.10403; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; YORK JD, 1994, J BIOL CHEM, V269, P19992; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; ZAHRINGER J, 1976, P NATL ACAD SCI USA, V73, P857, DOI 10.1073/pnas.73.3.857; Zhou WP, 2009, INT J MOL MED, V23, P379, DOI 10.3892/ijmm_00000142; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307; Zukor H, 2009, J NEUROCHEM, V109, P776, DOI 10.1111/j.1471-4159.2009.06007.x	100	38	41	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13205	13229		10.1074/jbc.M117.776021	http://dx.doi.org/10.1074/jbc.M117.776021			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655775	Green Published, hybrid			2022-12-28	WOS:000407465300012
J	O'Donnell, BM; Mackie, TD; Subramanya, AR; Brodsky, JL				O'Donnell, Brighid M.; Mackie, Timothy D.; Subramanya, Arohan R.; Brodsky, Jeffrey L.			Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); endoplasmic reticulum-associated protein degradation (ERAD); ER quality control; proteasome; Saccharomyces cerevisiae; yeast; Cdc48	TRANSMEMBRANE CONDUCTANCE REGULATOR; ALPHA-SYNUCLEIN TOXICITY; K+ CHANNEL; PROTEIN-DEGRADATION; AAA-ATPASE; MOLECULAR CHAPERONES; SURFACE EXPRESSION; IN-VITRO; SACCHAROMYCES-CEREVISIAE; APOLIPOPROTEIN-B	Type II Bartter syndrome is caused by mutations in the renal outer medullary potassium (ROMK) channel, but the molecular mechanisms underlying this disease are poorly defined. To rapidly screen for ROMK function, we developed a yeast expression system and discovered that yeast cells lacking endogenous potassium channels could be rescued by WT ROMK but not by ROMK proteins containing any one of four Bartter mutations. We also found that the mutant proteins were significantly less stable than WT ROMK. However, their degradation was slowed in the presence of a proteasome inhibitor or when yeast cells contained mutations in the CDC48 or SSA1 gene, which is required for endoplasmic reticulum (ER)-associated degradation (ERAD). Consistent with these data, sucrose gradient centrifugation and indirect immunofluorescence microscopy indicated that most ROMK protein was ER-localized. To translate these findings to a more relevant cell type, we measured the stabilities of WT ROMK and the ROMK Bartter mutants in HEK293 cells. As in yeast, the Bartter mutant proteins were less stable than the WT protein, and their degradation was slowed in the presence of a proteasome inhibitor. Finally, we discovered that low-temperature incubation increased the steady-state levels of a Bartter mutant, suggesting that the disease-causing mutation traps the protein in a folding-deficient conformation. These findings indicate that the underlying pathology for at least a subset of patients with type II Bartter syndrome is linked to the ERAD pathway and that future therapeutic strategies should focus on correcting deficiencies in ROMK folding.	[O'Donnell, Brighid M.; Mackie, Timothy D.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA; [O'Donnell, Brighid M.; Subramanya, Arohan R.] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643	National Institutes of Health [GM75061, DK79307, DK098145, 5T32 DK71492-10, 4K12HD052892-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098145, P30DK079307, T32DK071492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM75061 and DK79307 (University of Pittsburgh George O'Brien Kidney Research Center) (to J. L. B.), DK098145 (to A. R. S.), and 5T32 DK71492-10 and 4K12HD052892-10 (to B. M. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Brandvold KR, 2015, J MOL BIOL, V427, P2931, DOI 10.1016/j.jmb.2015.05.010; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choe H, 1997, AM J PHYSIOL-RENAL, V273, pF516, DOI 10.1152/ajprenal.1997.273.4.F516; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Fallen K, 2009, CHANNELS, V3, P57, DOI 10.4161/chan.3.1.7817; Fang LA, 2010, AM J PHYSIOL-RENAL, V299, pF1359, DOI 10.1152/ajprenal.00257.2010; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Fremont OT, 2012, WORLD J PEDIATR, V8, P25, DOI 10.1007/s12519-012-0333-9; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; HEBERT SC, 1984, AM J PHYSIOL, V246, pF745, DOI 10.1152/ajprenal.1984.246.6.F745; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huang CL, 2007, AM J PHYSIOL-RENAL, V293, pF1761, DOI 10.1152/ajprenal.00400.2007; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kleta R, 2006, NEPHRON PHYSIOL, V104, P73, DOI 10.1159/000094001; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Kolb AR, 2011, AM J PHYSIOL-RENAL, V301, pF1, DOI 10.1152/ajprenal.00141.2011; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Li K, 2017, MOL CELL, V65, P52, DOI 10.1016/j.molcel.2016.10.027; Lin DH, 2002, AM J PHYSIOL-RENAL, V283, pF671, DOI 10.1152/ajprenal.00160.2002; Lin DH, 2002, J BIOL CHEM, V277, P44278, DOI 10.1074/jbc.M203702200; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; McNicholas CM, 1996, AM J PHYSIOL-RENAL, V271, pF275, DOI 10.1152/ajprenal.1996.271.2.F275; MCNICHOLAS CM, 1994, P NATL ACAD SCI USA, V91, P8077, DOI 10.1073/pnas.91.17.8077; McNicholas CM, 1998, AM J PHYSIOL-RENAL, V275, pF972, DOI 10.1152/ajprenal.1998.275.6.F972; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Molinari M, 2015, SEMIN CELL DEV BIOL, V41, P70, DOI 10.1016/j.semcdb.2015.05.009; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakamura RL, 1998, METHOD ENZYMOL, V293, P89; Nakatsukasa K, 2010, METHODS MOL BIOL, V619, P365, DOI 10.1007/978-1-60327-412-8_21; Narayan P, 2014, NAT CHEM BIOL, V10, P911, DOI [10.1038/NCHEMBIO.1663, 10.1038/nchembio.1663]; Needham PG, 2015, J MOL BIOL, V427, P2948, DOI 10.1016/j.jmb.2015.04.010; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Perri ER, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00080; Peters M, 2003, KIDNEY INT, V64, P923, DOI 10.1046/j.1523-1755.2003.00153.x; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sackin H, 2006, BIOPHYS J, V90, P3582, DOI 10.1529/biophysj.105.076653; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Seyberth HW, 2011, PEDIATR NEPHROL, V26, P1789, DOI 10.1007/s00467-011-1871-4; Shuck ME, 1997, J BIOL CHEM, V272, P586; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Srivastava S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.160; Starremans PGJF, 2002, PFLUG ARCH EUR J PHY, V443, P466, DOI 10.1007/s004240100708; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vendruscolo M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a010454; Wang J, 2016, CELL SIGNAL, V28, P1099, DOI 10.1016/j.cellsig.2016.05.007; Wang WH, 2004, CURR OPIN NEPHROL HY, V13, P549, DOI 10.1097/00041552-200409000-00011; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Welling P., 2016, ION CHANNELS TRANSPO, P643; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xiao XJ, 2017, J BIOL CHEM, V292, P7744, DOI 10.1074/jbc.A116.734384; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zaks-Makhina E, 2009, J BIOL CHEM, V284, P15432, DOI 10.1074/jbc.M901586200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	113	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12813	12827		10.1074/jbc.M117.786376	http://dx.doi.org/10.1074/jbc.M117.786376			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28630040	hybrid, Green Published			2022-12-28	WOS:000407220100013
J	Starbird, CA; Maklashina, E; Sharma, P; Qualls-Histed, S; Cecchini, G; Iverson, TM				Starbird, C. A.; Maklashina, Elena; Sharma, Pankaj; Qualls-Histed, Susan; Cecchini, Gary; Iverson, T. M.			Structural and biochemical analyses reveal insights into covalent flavinylation of the Escherichia coli Complex II homolog quinol:fumarate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; flavin adenine dinucleotide (FAD); membrane enzyme; oxidation-reduction (redox); protein assembly; protein structure; respiratory chain; Complex II	FUMARATE REDUCTASE; SUCCINATE-DEHYDROGENASE; CATALYTIC-ACTIVITY; ASSEMBLY FACTOR; BOUND FLAVIN; FACTOR SDH5; BINDING; REDOX; IDENTIFICATION; SCATTERING	The Escherichia coli Complex II homolog quinol:fumarate reductase (QFR, FrdABCD) catalyzes the interconversion of fumarate and succinate at a covalently attached FAD within the FrdA subunit. The SdhE assembly factor enhances covalent flavinylation of Complex II homologs, but the mechanisms underlying the covalent attachment of FAD remain to be fully elucidated. Here, we explored the mechanisms of covalent flavinylation of the E. coli QFR FrdA subunit. Using a sdhE E. coli strain, we show that the requirement for the assembly factor depends on the cellular redox environment. We next identified residues important for the covalent attachment and selected the FrdA(E245) residue, which contributes to proton shuttling during fumarate reduction, for detailed biophysical and structural characterization. We found that QFR complexes containing FrdA(E245Q) have a structure similar to that of the WT flavoprotein, but lack detectable substrate binding and turnover. In the context of the isolated FrdA subunit, the anticipated assembly intermediate during covalent flavinylation, FrdA(E245) variants had stability similar to that of WT FrdA, contained noncovalent FAD, and displayed a reduced capacity to interact with SdhE. However, small-angle X-ray scattering (SAXS) analysis of WT FrdA cross-linked to SdhE suggested that the FrdA(E245) residue is unlikely to contribute directly to the FrdA-SdhE protein-protein interface. We also found that no auxiliary factor is absolutely required for flavinylation, indicating that the covalent flavinylation is autocatalytic. We propose that multiple factors, including the SdhE assembly factor and bound dicarboxylates, stimulate covalent flavinylation by preorganizing the active site to stabilize the quinone-methide intermediate.	[Starbird, C. A.] Vanderbilt Univ, Grad Program Chem & Phys Biol, Nashville, TN 37232 USA; [Sharma, Pankaj; Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Qualls-Histed, Susan] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Iverson, TM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.; Cecchini, G (corresponding author), Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA.; Cecchini, G (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	Gary.Cecchini@ucsf.edu; tina.iverson@vanderbilt.edu			National Institutes of Health [S10 RR026915]; DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; National Institute of Health project MINOS Grant [R01GM105404]; High-End Instrumentation Grant [S10OD018483]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606, R01GM105404, T32GM008320, R25GM062459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; National Institute of Health project MINOS Grant; High-End Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank B. Damon for interpreting the CD spectroscopy data in Matlab and I. Yamakawa for assistance with the FrdA-SdhE cross-linking. The Vanderbilt crystallization facility is supported by National Institutes of Health Grant S10 RR026915. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817. SAXS data were collected at the SIBYLS beamline at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Additional support comes from National Institute of Health project MINOS Grant R01GM105404 and High-End Instrumentation Grant S10OD018483.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Bayley JP, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-39; Bezawork-Geleta A, 2016, J BIOL CHEM, V291, P21414, DOI 10.1074/jbc.C116.755017; Bezawork-Geleta A, 2014, FASEB J, V28, P1794, DOI 10.1096/fj.13-242420; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BLAUT M, 1989, J BIOL CHEM, V264, P13599; BRANDSCH R, 1989, EUR J BIOCHEM, V182, P125, DOI 10.1111/j.1432-1033.1989.tb14808.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cheng VWT, 2015, BIOCHEMISTRY-US, V54, P1043, DOI 10.1021/bi501350j; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Efimov I, 2001, BIOCHEMISTRY-US, V40, P2155, DOI 10.1021/bi001644m; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Heffron K., 2001, THESIS; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Kim HJ, 2012, J BIOL CHEM, V287, P40670, DOI 10.1074/jbc.M112.405704; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kounosu A, 2014, FEBS LETT, V588, P1058, DOI 10.1016/j.febslet.2014.02.022; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Luna-Chavez C, 2000, PROTEIN EXPRES PURIF, V19, P188, DOI 10.1006/prep.2000.1238; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2016, J BIOL CHEM, V291, P2904, DOI 10.1074/jbc.M115.690396; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil MB, 2013, BIOCHEMISTRY-US, V52, P7628, DOI 10.1021/bi401006a; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Reid GA, 2000, BBA-BIOENERGETICS, V1459, P310, DOI 10.1016/S0005-2728(00)00166-3; Robinson KM, 1996, J BIOL CHEM, V271, P4055; SCHRODER I, 1991, J BIOL CHEM, V266, P13572; Starbird C. A., 2015, FLAVOENZYMES COVALEN; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Tomasiak TM, 2011, J BIOL CHEM, V286, P3047, DOI 10.1074/jbc.M110.192849; WALKER WH, 1969, FEBS LETT, V5, P237, DOI 10.1016/0014-5793(69)80342-X; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zafreen L, 2016, ARCH BIOCHEM BIOPHYS, V604, P47, DOI 10.1016/j.abb.2016.06.006	50	11	11	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12921	12933		10.1074/jbc.M117.795120	http://dx.doi.org/10.1074/jbc.M117.795120			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615448	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000407220100021
J	Cheng, MH; Garcia-Olivares, J; Wasserman, S; DiPietro, J; Bahar, I				Cheng, Mary Hongying; Garcia-Olivares, Jennie; Wasserman, Steven; DiPietro, Jennifer; Bahar, Ivet			Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; dopamine transporter; molecular dynamics; mutagenesis; protein assembly	HUMAN SEROTONIN TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; RAT GABA TRANSPORTER-1; MOLECULAR-DYNAMICS; NEUROTRANSMITTER TRANSPORTERS; OLIGOMER FORMATION; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; LIVING CELLS; BINDING-SITE	The human dopamine (DA) transporter (hDAT) is a key regulator of neurotransmission and a target for antidepressants and addictive drugs. Despite the recent resolution of dDAT structures from Drosophila melanogaster, complete understanding of its mechanism of function and even information on its biological assembly is lacking. The resolved dDAT structures are monomeric, but growing evidence suggests that hDAT might function as a multimer, and its oligomerization may be relevant to addictive drug effects. Here, using structure-based computations, we examined the possible mechanisms of hDAT dimerization and its dynamics in a lipid bilayer. Using a combination of site-directed mutagenesis, DA-uptake, and cross-linking experiments that exploited the capacity of Cys-306 to form intermonomeric disulfide bridges in the presence of an oxidizing agent, we tested the effects of mutations at transmembrane segment (TM) 6 and 12 helices in HEK293 cells. The most probable structural model for hDAT dimer suggested by computations and experiments differed from the dimeric structure resolved for the bacterial homolog, LeuT, presumably because of a kink at TM12 preventing favorable monomer packing. Instead, TM2, TM6, and TM11 line the dimer interface. Molecular dynamics simulations of the dimeric hDAT indicated that the two subunits tend to undergo cooperative structural changes, both on local (extracellular gate opening/closure) and global (transition between outward-facing and inward-facing states) scales. These observations suggest that hDAT transport properties may be allosterically modulated under conditions promoting dimerization. Our study provides critical insights into approaches for examining the oligomerization of neurotransmitter transporters and sheds light on their drug modulation.	[Cheng, Mary Hongying; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Garcia-Olivares, Jennie; Wasserman, Steven; DiPietro, Jennifer] NIMH, Lab Mol & Cellular Neurobiol, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST 3,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020; Cheng, Mary Hongying/AAU-3768-2021	Cheng, Mary Hongying/0000-0001-5833-8221	National Institutes of Health [R01-GM099738, P30DA035778, P41GM103712]; ZIA [MH002946-04]; Anton machine [P41GM103712]; NSF TeraGrid [TG-MCB130006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712, R01GM099738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA035778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZIA; Anton machine; NSF TeraGrid(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01-GM099738, P30DA035778, and P41GM103712 (to I.B.) and ZIA MH002946-04 (to S. G. Amara and J. G.-O.) and by the Anton machine (P41GM103712). This work was also supported by a computing award from the NSF TeraGrid (TG-MCB130006). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Anderluh A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14089; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; BERGER SP, 1994, MOL PHARMACOL, V46, P726; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Cheng MH, 2015, STRUCTURE, V23, P2171, DOI 10.1016/j.str.2015.09.001; Cheng MHY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00134; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Gur M, 2017, J PHYS CHEM B, V121, P3657, DOI 10.1021/acs.jpcb.6b09876; Gur M, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4936133; Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reith M. E., 2002, NEUROTRANSMITTER TRA; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2015, J NEUROCHEM, V133, P163, DOI 10.1111/jnc.13086; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Thomas JR, 2012, BIOPHYS J, V103, pL01, DOI 10.1016/j.bpj.2012.05.002; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555; Zomot E, 2012, J BIOL CHEM, V287, P31823, DOI 10.1074/jbc.M112.397364	59	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12471	12482		10.1074/jbc.M116.763565	http://dx.doi.org/10.1074/jbc.M116.763565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584050	Green Published, hybrid			2022-12-28	WOS:000406636900012
J	Jiang, YF; AkhavanAghdam, Z; Tsimring, LS; Hao, N				Jiang, Yanfei; AkhavanAghdam, Zohreh; Tsimring, Lev S.; Hao, Nan			Coupled feedback loops control the stimulus-dependent dynamics of the yeast transcription factor Msn2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); cell signaling; computer modeling; protein kinase A (PKA); systems biology; feedback regulation; signaling circuits; single-cell imaging analysis	SNF1 PROTEIN-KINASE; GENE-EXPRESSION PROGRAMS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; NUCLEOCYTOPLASMIC OSCILLATIONS; FACTOR TRANSLOCATION; SIGNALING DYNAMICS; GLUCOSE STARVATION; NETWORK MOTIFS; ACTIVATION	Information about environmental stimuli often can be encoded by the dynamics of signaling molecules or transcription factors. In the yeast Saccharomyces cerevisiae, different types of stresses induce distinct nuclear translocation dynamics of the general stress-responsive transcription factor Msn2, but the underlying mechanisms remain unclear. Using deterministic and stochastic modeling, we reproduced in silico the different dynamic responses of Msn2 to glucose limitation and osmotic stress observed in vivo and found that a positive feedback loop on protein kinase A mediated by the AMP-activated protein kinase Snf1 is coupled with a negative feedback loop to generate the characteristic pulsatile dynamics of Msn2. The model predicted that the stimulus-specific positive feedback loop could be responsible for the difference between Msn2 dynamics induced by glucose limitation and osmotic stress. This prediction was further verified experimentally by time-lapse microscopic examinations of the snf1 strain. In this mutant lacking the Snf1-mediated positive feedback loop, Msn2 responds similarly to glucose limitation and osmotic stress, and its pulsatile translocation is largely abrogated. Our combined computational and experimental analysis reveals a regulatory mechanism by which cells can encode information about environmental cues into distinct signaling dynamics through stimulus-specific network architectures.	[Jiang, Yanfei; AkhavanAghdam, Zohreh; Hao, Nan] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Tsimring, Lev S.; Hao, Nan] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hao, N (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	nhao@ucsd.edu	; Hao, Nan/O-3462-2016	Tsimring, Lev/0000-0003-0709-3548; Hao, Nan/0000-0003-2857-4789; AkhavanAghdam, Zohreh/0000-0003-3307-7541	National Institutes of Health [R01 GM111458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM111458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM111458. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AkhavanAghdam Z, 2016, ELIFE, V5, DOI 10.7554/eLife.18458; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bardwell L, 2007, BIOPHYS J, V92, P3425, DOI 10.1529/biophysj.106.090084; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Besozzi D, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-10; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gonze D, 2008, J R SOC INTERFACE, V5, pS95, DOI 10.1098/rsif.2008.0141.focus; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hansen AS, 2016, CURR BIOL, V26, pR269, DOI 10.1016/j.cub.2016.02.058; Hansen AS, 2015, CELL REP, V12, P1226, DOI 10.1016/j.celrep.2015.07.035; Hansen AS, 2015, NAT PROTOC, V10, P1181, DOI 10.1038/nprot.2015.079; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicastro R, 2015, J BIOL CHEM, V290, P24715, DOI 10.1074/jbc.M115.658005; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pescini D, 2012, BIOTECHNOL ADV, V30, P99, DOI 10.1016/j.biotechadv.2011.06.014; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Shashkova S, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov026; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	40	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12366	12372		10.1074/jbc.C117.800896	http://dx.doi.org/10.1074/jbc.C117.800896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28637875	Green Published, hybrid			2022-12-28	WOS:000406636900001
J	Lee, KH; Jeong, J; Koo, YJ; Jang, AH; Lee, CH; Yoo, CG				Lee, Kyoung-Hee; Jeong, Jiyeong; Koo, Yoon-Jung; Jang, An-Hee; Lee, Chang-Hoon; Yoo, Chul-Gyu			Exogenous neutrophil elastase enters bronchial epithelial cells and suppresses cigarette smoke extract-induced heme oxygenase-1 by cleaving sirtuin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						antioxidant; chronic obstructive pulmonary disease (COPD); oxidative stress; pathogenesis; sirtuin 1 (SIRT1); cigarette smoke extract; heme oxygenase 1; neutrophil elastase		An imbalance between oxidative stress and antioxidant activity plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Cigarette smoke, a major risk factor of COPD, induces cellular oxidative stress, but levels of antioxidants such as heme oxygenase-1 (HO-1) are reduced in individuals with severe COPD. In this study, we evaluated the molecular mechanism of reduced HO-1 expression in human bronchial epithelial cells. We found that cigarette smoke extract (CSE) increases HO-1 levels via activation of NFE2-related factor 2 (Nrf2). However, pretreating cells with the protease neutrophil elastase (NE) suppressed the CSE-induced expression of HO-1 mRNA and protein. NE also decreased the sirtuin 1 (SIRT1) level, but did not inhibit CSE-induced nuclear translocation and DNA-binding activity of Nrf2. Transfection of cells with a Myc/His-tagged SIRT1 expression vector completely blocked the NE-mediated suppression of HO-1 expression. We further noted that the NE-induced down-regulation of SIRT1 was not due to decreased transcription or proteasomal/lysosomal degradation or loss of solubility. Immunofluorescence staining revealed that NE enters the cell cytoplasm, and we observed that NE directly cleaved SIRT1 in vitro, indicating that SIRT1 levels are decreased via direct degradation by internalized NE. Of note, we observed decreased SIRT1 levels in NE-treated primary human bronchial epithelial cells and in lung homogenates from both smokers and patients with COPD. In conclusion, NE suppresses CSE-induced HO-1 expression by cleaving SIRT1. This finding indicates the importance of cross-talk between oxidative stress and protease responses in the pathogenesis of COPD.	[Lee, Kyoung-Hee; Jeong, Jiyeong; Koo, Yoon-Jung; Jang, An-Hee; Lee, Chang-Hoon; Yoo, Chul-Gyu] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul 110744, South Korea; [Lee, Chang-Hoon; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoo, CG (corresponding author), Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul 110744, South Korea.; Yoo, CG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea.	cgyoo@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021						0	15	15	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11970	11979		10.1074/jbc.M116.771089	http://dx.doi.org/10.1074/jbc.M116.771089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28588027	hybrid, Green Published			2022-12-28	WOS:000405485600032
J	Niu, GD; Franca, C; Zhang, GW; Roobsoong, W; Nguitragool, W; Wang, XH; Prachumsri, J; Butler, NS; Li, J				Niu, Guodong; Franca, Caio; Zhang, Genwei; Roobsoong, Wanlapa; Nguitragool, Wang; Wang, Xiaohong; Prachumsri, Jetsumon; Butler, Noah S.; Li, Jun			The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						infection; ligand-binding protein; malaria; parasite; vaccine; malaria transmission-blocking vaccine	PLASMODIUM-FALCIPARUM; CANDIDATES; ANTIBODIES	FREP1 in mosquito midguts facilitates Plasmodium falciparum parasite transmission. The fibrinogen-like (FBG) domain of FREP1 is highly conserved (>90% identical) among Anopheles species from different continents, suggesting that anti-FBG antibodies may block malaria transmission to all anopheline mosquitoes. Using standard membrane-feeding assays, anti-FREP1 polyclonal antibodies significantly blocked transmission of Plasmodium berghei and Plasmodium vivax to Anopheles gambiae and Anopheles dirus, respectively. Furthermore, in vivo studies of mice immunized with FBG achieved >75% blocking efficacy of P. berghei to A. gambiae without triggering immunopathology. Anti-FBG serum also reduced >81% of P. falciparum infection to A. gambiae. Finally, we showed that FBG interacts with Plasmodium gametocytes and ookinetes, revealing the molecular mechanism of its antibody transmission-blocking activity. Collectively, our data support that FREP1-mediated Plasmodium transmission to mosquitoes is a conserved pathway and that targeting the FBG domain of FREP1 will limit the transmission of multiple Plasmodium species to multiple Anopheles species.	[Franca, Caio; Zhang, Genwei; Li, Jun] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Roobsoong, Wanlapa; Nguitragool, Wang; Prachumsri, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Ctr, Bangkok 10400, Thailand; [Butler, Noah S.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Niu, Guodong; Wang, Xiaohong; Li, Jun] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	University of Oklahoma System; University of Oklahoma - Norman; Mahidol University; University of Iowa; State University System of Florida; Florida International University	Li, J (corresponding author), Florida Int Univ, Biomol Sci Inst, Dept Biol Sci, 11200 SW 8th St,OE 214, Miami, FL 33199 USA.	lij@fiu.edu	Prachumsri, Jetsumon/AAZ-7732-2021; Zhang, Genwei/AAB-3853-2022	Zhang, Genwei/0000-0002-5737-8413; Butler, Noah/0000-0002-1429-0796; Sattabongkot, Jetsumon/0000-0002-3938-4588; Nguitragool, Wang/0000-0002-5484-7130; Roobsoong, Wanlapa/0000-0002-1789-0439; Barbalho de Franca, Caio Martinelle/0000-0002-5056-7983	National Institutes of Health [R21AI115178]; National Science Foundation [1742644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125657, R21AI115178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21AI115178 and National Science Foundation Career Award 1742644. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000398; Armistead JS, 2014, INFECT IMMUN, V82, P818, DOI 10.1128/IAI.01222-13; Birkett AJ, 2013, VACCINE, V31, pB233, DOI 10.1016/j.vaccine.2013.02.040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Kapulu MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11193; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Li J, 2013, P NATL ACAD SCI USA, V110, P20675, DOI 10.1073/pnas.1321024110; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Miura K, 2013, INFECT IMMUN, V81, P4377, DOI 10.1128/IAI.01056-13; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Niu GD, 2015, SCI REP-UK, V5, DOI 10.1038/srep14694; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Zhang GW, 2015, J BIOL CHEM, V290, P16490, DOI 10.1074/jbc.M114.623165	20	22	22	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11960	11969		10.1074/jbc.M116.773564	http://dx.doi.org/10.1074/jbc.M116.773564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28533429	Green Published, hybrid			2022-12-28	WOS:000405485600031
J	Serfass, JM; Takahashi, Y; Zhou, ZX; Kawasawa, YI; Liu, Y; Tsotakos, N; Young, MM; Tang, ZY; Yang, LL; Atkinson, JM; Chroneos, ZC; Wang, HG				Serfass, Jacob M.; Takahashi, Yoshinori; Zhou, Zhixiang; Kawasawa, Yuka Imamura; Liu, Ying; Tsotakos, Nikolaos; Young, Megan M.; Tang, Zhenyuan; Yang, Linlin; Atkinson, Jennifer M.; Chroneos, Zissis C.; Wang, Hong-Gang			Endophilin B2 facilitates endosome maturation in response to growth factor stimulation, autophagy induction, and influenza A virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING FACTOR-I; CONFORMATIONAL-CHANGE; DECREASED EXPRESSION; BIF-1; PROTEIN; B1; ENDOCYTOSIS; TRAFFICKING; ACTIVATION; MACHINERY	Endocytosis, and the subsequent trafficking of endosomes, requires dynamic physical alterations in membrane shape that are mediated in part by endophilin proteins. The endophilin B family of proteins contains an N-terminal Bin/amphiphysin/Rvs (N-BAR) domain that induces membrane curvature to regulate intracellular membrane dynamics. Whereas endophilin B1 (SH3GLB1/Bif-1) is known to be involved in a number of cellular processes, including apoptosis, autophagy, and endocytosis, the cellular function of endophilin B2 (SH3GLB2) is not well understood. In this study, we used genetic approaches that revealed that endophilin B2 is not required for embryonic development in vivo but that endophilin B2 deficiency impairs endosomal trafficking in vitro, as evidenced by suppressed endosome acidification, EGFR degradation, autophagic flux, and influenza A viral RNA nuclear entry and replication. Mechanistically, although the loss of endophilin B2 did not affect endocytic internalization and lysosomal function, endophilin B2 appeared to regulate the trafficking of endocytic vesicles and autophago-somes to late endosomes or lysosomes. Moreover, we also found that despite having an intracellular localization and tissue distribution similar to endophilin B1, endophilin B2 is dispensable for mitochondrial apoptosis. Taken together, our findings suggest that endophilin B2 positively regulates the endocytic pathway in response to growth factor signaling, autophagy induction, and viral entry.	[Serfass, Jacob M.; Kawasawa, Yuka Imamura; Liu, Ying; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Takahashi, Yoshinori; Zhou, Zhixiang; Tsotakos, Nikolaos; Young, Megan M.; Tang, Zhenyuan; Yang, Linlin; Atkinson, Jennifer M.; Chroneos, Zissis C.; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Chroneos, Zissis C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Zhou, Zhixiang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing University of Technology	Wang, HG (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.; Takahashi, Y; Wang, HG (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA.	ytakahashi@pennstatehealth.psu.edu; hwang3@pennstatehealth.psu.edu	Atkinson, Jennifer/AAE-5466-2019; Tsotakos, Nikolaos/AAZ-4789-2020	Atkinson, Jennifer/0000-0001-5164-5114; Tsotakos, Nikolaos/0000-0002-1028-3062; Young, Megan/0000-0003-1751-9979; Serfass, Jacob/0000-0002-5726-5718; Takahashi, Yoshinori/0000-0002-8004-4817; , Zissis/0000-0002-9841-7917	National Institutes of Health [CA82197, CA129682, HL128746]; Lois High Berstler Endowment Fund; Four Diamonds Fund of the Pennsylvania State University College of Medicine; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL CANCER INSTITUTE [R01CA082197, R01CA129682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL128746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lois High Berstler Endowment Fund; Four Diamonds Fund of the Pennsylvania State University College of Medicine; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants CA82197 and CA129682 (to H.G.W.) and HL128746 (to Z.C.) and by the Lois High Berstler Endowment Fund and the Four Diamonds Fund of the Pennsylvania State University College of Medicine. Core facility services and instruments used in this project were funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Coppola D, 2008, CLIN GENITOURIN CANC, V6, P117, DOI 10.3816/CGC.2008.n.018; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dutta Dipannita, 2012, Cell Logist, V2, P203; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hahn DR, 2014, AM J RESP CELL MOL, V51, P400, DOI 10.1165/rcmb.2013-0437OC; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hrabchak C, 2007, BIOCHEMISTRY-US, V46, P4635, DOI 10.1021/bi6025837; Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kerr M, 2014, SEMIN CELL DEV BIOL, V31, P11, DOI 10.1016/j.semcdb.2014.03.027; Kim SY, 2008, PATHOLOGY, V40, P553, DOI 10.1080/00313020802320440; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee JW, 2006, PATHOLOGY, V38, P312, DOI 10.1080/00313020600820880; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu Y., 2016, EVID-BASED COMPL ALT, V2016, P1, DOI DOI 10.1007/S10291-016-0529-X; Loebrich S, 2016, CURR BIOL, V26, P296, DOI 10.1016/j.cub.2015.11.071; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; MAEDA T, 1980, FEBS LETT, V122, P283, DOI 10.1016/0014-5793(80)80457-1; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Pinilla-Macua I, 2015, METHOD CELL BIOL, V130, P347, DOI 10.1016/bs.mcb.2015.05.008; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Runkle KB, 2012, CANCER BIOL THER, V13, P956, DOI 10.4161/cbt.20951; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Sever-Chroneos Z, 2011, ANTIVIR RES, V92, P319, DOI 10.1016/j.antiviral.2011.08.022; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; Takahashi Y, 2013, BLOOD, V121, P1622, DOI 10.1182/blood-2012-10-459826; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Tooze Sharon A, 2015, Methods Mol Biol, V1270, P155, DOI 10.1007/978-1-4939-2309-0_12; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Vannier C, 2013, J BIOL CHEM, V288, P27619, DOI 10.1074/jbc.M113.485482; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang DB, 2015, BRAIN, V138, P2005, DOI 10.1093/brain/awv128; Wang DB, 2014, J NEUROSCI, V34, P2674, DOI 10.1523/JNEUROSCI.4074-13.2014; Wang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25153; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Wu W, 2016, VIROLOGY, V497, P41, DOI 10.1016/j.virol.2016.06.021; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Zhang CL, 2011, J BIOL CHEM, V286, P9373, DOI 10.1074/jbc.M110.207720	67	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10097	10111		10.1074/jbc.M117.792747	http://dx.doi.org/10.1074/jbc.M117.792747			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455444	Green Published, hybrid			2022-12-28	WOS:000403580600021
J	Espinoza-Lewis, RA; Yang, QM; Liu, JM; Huang, ZP; Hu, XY; Chen, DW; Wang, DZ				Espinoza-Lewis, Ramon A.; Yang, Qiumei; Liu, Jianming; Huang, Zhan-Peng; Hu, Xiaoyun; Chen, Daiwen; Wang, Da-Zhi			Poly(C)-binding protein 1 (Pcbp1) regulates skeletal muscle differentiation by modulating microRNA processing in myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; HEPATOMA-CELL LINE; MESSENGER-RNA; FIBER-TYPE; RIBONUCLEOPROTEIN-PARTICLES; 3'-UNTRANSLATED REGION; ANDROGEN RECEPTOR; ENERGY-METABOLISM; GENE-EXPRESSION; P-BODIES	Regulation of gene expression during muscle development and disease remains incompletely understood. microRNAs are a class of small non-coding RNAs that regulate gene expression and function post-transcriptionally. The poly(C)-binding protein1 (Pcbp1, hnRNP-E1, or alpha CP-1) is an RNA-binding protein that has been reported to bind the 3'-UTRs of target genes to regulate mRNA stability and protein translation. However, Pcbp1's biological function and the general mechanism of action remain largely undetermined. Here, we report that Pcbp1 is a component of the miRNA-processing pathway that regulates miRNA biogenesis. siRNA-based inhibition of Pcbp1 in mouse skeletal muscle myoblasts led to dysregulated cellular proliferation and differentiation. We also found that Pcbp1 null mutant mice exhibit early embryonic lethality, indicating that Pcbp1 is indispensable for embryonic development. Interestingly, hypomorphic Pcbp1 mutant mice displayed defects in muscle growth due to defects in the proliferation and differentiation of myoblasts and muscle satellite cells, in addition to a slow to fast myofibril switch. Moreover, Pcbp1 modulated the processing of muscle-enriched miR-1, miR-133, and miR-206 by physically interacting with argonaute 2 (AGO2) and other miRNA pathway components. Our study, therefore, uncovers the important function of Pcbp1 in skeletal muscle and the microRNA pathway, signifying its potential as a therapeutic target for muscle disease.	[Espinoza-Lewis, Ramon A.; Yang, Qiumei; Liu, Jianming; Huang, Zhan-Peng; Hu, Xiaoyun; Wang, Da-Zhi] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Yang, Qiumei; Chen, Daiwen] Sichuan Agr Univ, Anim Nutr Inst, Chengdu 6111130, Sichuan, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Sichuan Agricultural University	Wang, DZ (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	Zhan-Peng, Huang/I-2318-2017	Zhan-Peng, Huang/0000-0001-7054-655X; Espinoza-Lewis, Ramon/0000-0003-3068-5517	National Institutes of Health [HL085635, HL116919]; American Heart Association; Muscular Dystrophy Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125925, R01HL085635, T32HL007572, R01HL116919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085635 and HL116919. This work was also supported by the American Heart Association and Muscular Dystrophy Association. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AASHEIM HC, 1994, NUCLEIC ACIDS RES, V22, P959, DOI 10.1093/nar/22.6.959; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Cloke B, 2010, ENDOCRINOLOGY, V151, P3954, DOI [10.1210/en.2009-1264, 10.1210//en.2009-1264]; Comai G, 2014, CURR TOP DEV BIOL, V110, P1, DOI 10.1016/B978-0-12-405943-6.00001-4; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Ding J, 2015, NAT GENET, V47, P776, DOI 10.1038/ng.3324; Diniz GP, 2016, COMPR PHYSIOL, V6, P1279, DOI 10.1002/cphy.c150041; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Ghanem LR, 2016, MOL CELL BIOL, V36, P304, DOI 10.1128/MCB.00936-15; Ghanem LR, 2014, GENE EXPR PATTERNS, V14, P78, DOI 10.1016/j.gep.2014.01.004; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hongbing Wang, 2010, 2010 Proceedings of 22nd International Conference on Tools with Artificial Intelligence (ICTAI 2010), P3, DOI 10.1109/ICTAI.2010.9; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kasim V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059445; Kirby TJ, 2015, FRONT BIOSCI-LANDMRK, V20, P37, DOI 10.2741/4298; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lian WX, 2012, FEBS LETT, V586, P1431, DOI 10.1016/j.febslet.2012.04.016; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wang CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024242; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WILK HE, 1985, EUR J BIOCHEM, V146, P71, DOI 10.1111/j.1432-1033.1985.tb08621.x; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-72; Zheng DH, 2011, RNA, V17, P1619, DOI 10.1261/rna.2789611	52	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9540	9550		10.1074/jbc.M116.773671	http://dx.doi.org/10.1074/jbc.M116.773671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28381556	Green Published, hybrid			2022-12-28	WOS:000403113000008
J	Anasir, MI; Caria, S; Skinner, MA; Kvansakul, M				Anasir, Mohd Ishtiaq; Caria, Sofia; Skinner, Michael A.; Kvansakul, Marc			Structural basis of apoptosis inhibition by the fowlpox virus protein FPV039	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; BCL-2 FAMILY; PHYLOGENETIC ANALYSIS; BH3-ONLY PROTEINS; PROSURVIVAL BCL-2; INFECTED-CELLS; VIRAL HOMOLOG; BH3 DOMAIN; F1L; ENCODES	Programmed cell death or apoptosis of infected host cells is an important defense mechanism in response to viral infections. This process is regulated by proapoptotic and prosurvival members of the B-cell lymphoma 2 (Bcl-2) protein family. To counter premature death of a virus-infected cell, poxviruses use a range of different molecular strategies including the mimicry of prosurvival Bcl-2 proteins. One such viral prosurvival protein is the fowlpox virus protein FPV039, which is a potent apoptosis inhibitor, but the precise molecular mechanism by which FPV039 inhibits apoptosis is unknown. To understand how fowlpox virus inhibits apoptosis, we examined FPV039 using isothermal titration calorimetry, small-angle X-ray scattering, and X-ray crystallography. Here, we report that the fowlpox virus prosurvival protein FPV039 promiscuously binds to cellular proapoptotic Bcl-2 and engages all major proapoptotic Bcl-2 proteins. Unlike other identified viral Bcl-2 proteins to date, FPV039 engaged with cellular proapoptotic Bcl-2 with affinities comparable with those of Bcl-2's endogenous cellular counterparts. Structural studies revealed that FPV039 adopts the conserved Bcl-2 fold observed in cellular prosurvival Bcl-2 proteins and closely mimics the structure of the prosurvival Bcl-2 family protein Mcl-1. Our findings suggest that FPV039 is a pan-Bcl-2 protein inhibitor that can engage all host BH3-only proteins, as well as Bcl-2-associated X, apoptosis regulator (Bax) and Bcl-2 antagonist/killer (Bak) proteins to inhibit premature apoptosis of an infected host cell. This work therefore provides a mechanistic platform to better understand FPV039-mediated apoptosis inhibition.	[Anasir, Mohd Ishtiaq; Caria, Sofia; Kvansakul, Marc] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Skinner, Michael A.] Imperial Coll London, Fac Med, Sect Virol, London W2 1PZ, England	La Trobe University; Imperial College London	Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019	Kvansakul, Marc/0000-0003-2639-2498; Caria, Sofia/0000-0001-7289-2093; Skinner, Michael/0000-0002-0050-4167	National Health and Medical Research Council Australia [APP1007918]; Australian Research Council Fellowship [FT130101349]; La Trobe University scholarship; United Kingdom Biotechnology and Biosciences Research Council [BB/K002465/1]; Biotechnology and Biological Sciences Research Council [BB/K002465/1] Funding Source: researchfish; BBSRC [BB/K002465/1] Funding Source: UKRI	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); La Trobe University scholarship; United Kingdom Biotechnology and Biosciences Research Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Health and Medical Research Council Australia Project Grant APP1007918 (to M. K.), Australian Research Council Fellowship FT130101349 (to M. K.), and a La Trobe University scholarship (to M. I. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by United Kingdom Biotechnology and Biosciences Research Council Grant BB/K002465/1 ("Developing Rapid Responses to Emerging Virus Infections of Poultry (DRREVIP)").	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aouacheria A, 2003, VIROLOGY, V316, P256, DOI 10.1016/j.virol.2003.08.014; Banadyga L, 2007, J VIROL, V81, P11032, DOI 10.1128/JVI.00734-07; Banadyga L, 2011, J VIROL, V85, P1922, DOI 10.1128/JVI.01959-10; Banadyga L, 2009, J VIROL, V83, P7085, DOI 10.1128/JVI.00437-09; Banjara S, 2017, J VIROL, V91, DOI 10.1128/JVI.02228-16; Brun A, 1996, VIROLOGY, V225, P227, DOI 10.1006/viro.1996.0592; Burton DR, 2015, ACTA CRYSTALLOGR D, V71, P1593, DOI 10.1107/S1399004715009402; Campbell S, 2014, J VIROL, V88, P8667, DOI 10.1128/JVI.01092-14; Caria S, 2016, J BIOL CHEM, V291, P14600, DOI 10.1074/jbc.M116.726851; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CHIOU SK, 1994, J VIROL, V68, P6553, DOI 10.1128/JVI.68.10.6553-6566.1994; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Danthi P, 2016, ANNU REV VIROL, V3, P533, DOI 10.1146/annurev-virology-110615-042435; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desbien AL, 2009, P NATL ACAD SCI USA, V106, P5663, DOI 10.1073/pnas.0901036106; Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferrer PE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002083; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; GRAHAM KA, 1992, VIROLOGY, V191, P112, DOI 10.1016/0042-6822(92)90172-L; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gyuranecz M, 2013, J VIROL, V87, P4938, DOI 10.1128/JVI.03183-12; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Jarmin S, 2006, J GEN VIROL, V87, P2191, DOI 10.1099/vir.0.81738-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kirby NM, 2014, CURR OPIN STRUC BIOL, V28, P41, DOI 10.1016/j.sbi.2014.07.007; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Kvansakul M, 2016, METHODS MOL BIOL, V1491, P213, DOI 10.1007/978-1-4939-3581-9_16; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Marshall B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.52; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto T, 2012, J VIROL, V86, P11501, DOI 10.1128/JVI.01115-12; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Procko E, 2014, CELL, V157, P1644, DOI 10.1016/j.cell.2014.04.034; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Rautureau GJP, 2010, PROTEINS, V78, P2181, DOI 10.1002/prot.22728; Santiveri CM, 2012, J MOL RECOGNIT, V25, P665, DOI 10.1002/jmr.2240; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Tulman ER, 2004, J VIROL, V78, P353, DOI 10.1128/JVI.78.1.353-366.2004; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wang GH, 1999, J GEN VIROL, V80, P2737, DOI 10.1099/0022-1317-80-10-2737; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07; Westphal D, 2009, APOPTOSIS, V14, P1317, DOI 10.1007/s10495-009-0403-1; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	74	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9010	9021		10.1074/jbc.M116.768879	http://dx.doi.org/10.1074/jbc.M116.768879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28411240	Green Published, hybrid			2022-12-28	WOS:000402538900002
J	Kraus, S; Benard, O; Naor, Z; Seger, R				Kraus, Sarah; Benard, Outhiriaradjou; Naor, Zvi; Seger, Rony			RETRACTION: c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells (Retraction of Vol 278, Pg 32618, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200	1	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8851	8851		10.1074/jbc.A117.303886	http://dx.doi.org/10.1074/jbc.A117.303886			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550137	Green Published, hybrid			2022-12-28	WOS:000402153900034
J	Kaufmann, JCD; Krause, BS; Grimm, C; Ritter, E; Hegemann, P; Bartl, FJ				Kaufmann, Joel C. D.; Krause, Benjamin S.; Grimm, Christiane; Ritter, Eglof; Hegemann, Peter; Bartl, Franz J.			Proton transfer reactions in the red light-activatable channelrhodopsin variant ReaChR and their relevance for its function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; Fourier transform IR (FTIR); gating; ion channel; photobiology; ultraviolet-visible spectroscopy (UV-vis spectroscopy); channelrhodopsin; photocycle; proton dynamics; proton transfer	RETINAL CHROMOPHORE STRUCTURE; INDUCED STRUCTURAL-CHANGES; RESONANCE RAMAN; PHOTOACTIVE SITE; ION SELECTIVITY; DARK ADAPTATION; OPEN STATES; CHANNEL; CHLAMYDOMONAS; PHOTOCYCLE	Channelrhodopsins (ChRs) are light-gated ion channels widely used for activating selected cells in large cellular networks. ChR variants with a red-shifted absorption maximum, such as the modified Volvox carteri ChR1 red-activatable channelrhodopsin (ReaChR, (max) = 527 nm), are of particular interest because longer wavelengths allow optical excitation of cells in deeper layers of organic tissue. In all ChRs investigated so far, proton transfer reactions and hydrogen bond changes are crucial for the formation of the ion-conducting pore and the selectivity for protons versus cations, such as Na+, K+, and Ca2+ (1). By using a combination of electrophysiological measurements and UV-visible and FTIR spectroscopy, we characterized the proton transfer events in the photocycle of ReaChR and describe their relevance for its function. 1) The central gate residue Glu(130) (Glu(90) in Chlamydomonas reinhardtii (Cr) ChR2) (i) undergoes a hydrogen bond change in D K transition and (ii) deprotonates in K M transition. Its negative charge in the open state is decisive for proton selectivity. 2) The counter-ion Asp(293) (Asp(253) in CrChR2) receives the retinal Schiff base proton during M-state formation. Starting from M, a photocycle branching occurs involving (i) a direct M D transition and (ii) formation of late photointermediates N and O. 3) The DC pair residue Asp(196) (Asp(156) in CrChR2) deprotonates in N O transition. Interestingly, the D196N mutation increases 15-syn-retinal at the expense of 15-anti, which is the predominant isomer in the wild type, and abolishes the peak current in electrophysiological measurements. This suggests that the peak current is formed by 15-anti species, whereas 15-syn species contribute only to the stationary current.	[Kaufmann, Joel C. D.; Bartl, Franz J.] Charite Univ Med Berlin, Inst Med Phys & Biophys, Chariteplatz 1, D-10117 Berlin, Germany; [Krause, Benjamin S.; Grimm, Christiane; Ritter, Eglof; Hegemann, Peter] Humboldt Univ, Inst Biol Experimentelle Biophys, Invalidenstr 42, D-10115 Berlin, Germany; [Bartl, Franz J.] Humboldt Univ, Inst Biol Biophysikal Chem, Invalidenstr 42, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Kaufmann, JCD; Bartl, FJ (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Chariteplatz 1, D-10117 Berlin, Germany.	joel.kaufmann@charite.de; franz.bartl@hu-berlin.de		Kaufmann, Joel/0000-0003-4926-7438; Grimm, Christiane/0000-0002-2407-6152	Deutsche Forschungsgemeinschaft via Sonderforschungsbereich [1078]; Cluster of Excellence 314 "Unifying Concepts in Catalysis" [E4/D4]; Bundesministerium fur Bildung und Forschung [05K16KH1]; Hertie Foundation	Deutsche Forschungsgemeinschaft via Sonderforschungsbereich(German Research Foundation (DFG)); Cluster of Excellence 314 "Unifying Concepts in Catalysis"; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	This work was supported in part by the Deutsche Forschungsgemeinschaft via Sonderforschungsbereich 1078 Projects B2 (to P. H.) and B5 (to F. J. B.) and Cluster of Excellence 314 "Unifying Concepts in Catalysis" Project E4/D4 (to P. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Bundesministerium fur Bildung und Forschung Grant 05K16KH1.; Hertie Senior Professor for Neuroscience and supported by the Hertie Foundation.	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Becker-Baldus J, 2015, P NATL ACAD SCI USA, V112, P9896, DOI 10.1073/pnas.1507713112; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruun S, 2015, BIOCHEMISTRY-US, V54, P5389, DOI 10.1021/acs.biochem.5b00597; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; FARRAR MR, 1993, BIOPHYS J, V65, P310, DOI 10.1016/S0006-3495(93)81065-8; Govorunova EG, 2013, J BIOL CHEM, V288, P29911, DOI 10.1074/jbc.M113.505495; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Guo Y, 2016, CHEM SCI, V7, P3879, DOI 10.1039/c6sc00468g; HARBISON GS, 1984, P NATL ACAD SCI-BIOL, V81, P1706, DOI 10.1073/pnas.81.6.1706; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Inaguma A, 2015, J BIOL CHEM, V290, P11623, DOI 10.1074/jbc.M115.642256; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kawanabe A, 2009, SENSORS-BASEL, V9, P9741, DOI 10.3390/s91209741; Krause BS, 2017, BIOPHYS J, V112, P1166, DOI 10.1016/j.bpj.2017.02.001; Kuhne J, 2015, ANGEW CHEM INT EDIT, V54, P4953, DOI 10.1002/anie.201410180; Li H, 2014, BIOPHYS J, V106, P1607, DOI 10.1016/j.bpj.2014.03.002; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lorenz-Fonfria VA, 2015, J AM CHEM SOC, V137, P1850, DOI 10.1021/ja5108595; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Muders V, 2014, FEBS LETT, V588, P2301, DOI 10.1016/j.febslet.2014.05.019; Mullen K.M., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I03; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nie BN, 2005, BIOPHYS J, V88, P2833, DOI 10.1529/biophysj.104.047639; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Ogren JI, 2015, J BIOL CHEM, V290, P12719, DOI 10.1074/jbc.M114.634840; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Oshima K, 2015, PHOTOCH PHOTOBIO SCI, V14, P1694, DOI 10.1039/c5pp00154d; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1984, P NATL ACAD SCI-BIOL, V81, P2055, DOI 10.1073/pnas.81.7.2055; SMITH SO, 1985, J MEMBRANE BIOL, V85, P95, DOI 10.1007/BF01871263; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Szundi I, 2015, J BIOL CHEM, V290, P16585, DOI 10.1074/jbc.M115.653071; Szundi I, 2015, J BIOL CHEM, V290, P16573, DOI 10.1074/jbc.M114.631614; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Wand A, 2013, ANNU REV PHYS CHEM, V64, P437, DOI 10.1146/annurev-physchem-040412-110148; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; Wietek J, 2016, J BIOL CHEM, V291, P4121, DOI 10.1074/jbc.M115.699637; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375	64	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14205	14216		10.1074/jbc.M117.779629	http://dx.doi.org/10.1074/jbc.M117.779629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28659342	hybrid, Green Published			2022-12-28	WOS:000408439800024
J	Asciolla, JJ; Miele, MM; Hendrickson, RC; Resh, MD				Asciolla, James J.; Miele, Matthew M.; Hendrickson, Ronald C.; Resh, Marilyn D.			An in vitro fatty acylation assay reveals a mechanism for Wnt recognition by the acyltransferase Porcupine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG ACYLTRANSFERASE; SONIC-HEDGEHOG; IDENTIFICATION; CANCER; PALMITOYLATION; PROTEINS; RESIDUES; WLS	Wnt proteins are a family of secreted signaling proteins that play key roles in regulating cell proliferation in both embryonic and adult tissues. Production of active Wnt depends on attachment of palmitoleate, a monounsaturated fatty acid, to a conserved serine by the acyltransferase Porcupine (PORCN). Studies of PORCN activity relied on cell-based fatty acylation and signaling assays as no direct enzyme assay had yet been developed. Here, we present the first in vitro assay that accurately recapitulates PORCN-mediated fatty acylation of a Wnt substrate. The critical feature is the use of a double disulfide-bonded Wnt peptide that mimics the two-dimensional structure surrounding the Wnt acylation site. PORCN-mediated Wnt acylation was abolished when the Wnt peptide was treated with DTT, and did not occur with a linear (non-disulfide-bonded) peptide, or when the double disulfide-bonded Wnt peptide contained Ala substituted for the Ser acylation site. We exploited this in vitro Wnt acylation assay to provide direct evidence that the small molecule LGK974, which is in clinical trials for managing Wnt-driven tumors, is a bona fide PORCN inhibitor whose IC50 for inhibition of Wnt fatty acylation in vitro closely matches that for inhibition of Wnt signaling. Side-by-side comparison of PORCN and Hedgehog acyltransferase (HHAT), two enzymes that attach 16-carbon fatty acids to secreted proteins, revealed that neither enzyme will accept the other's fatty acyl-CoA or peptide substrates. These findings illustrate the unique enzyme-substrate selectivity exhibited by members of the membrane-bound O-acyl transferase family.	[Asciolla, James J.; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA; [Miele, Matthew M.; Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Prote & Microchem Core Lab, New York, NY 10065 USA; [Asciolla, James J.; Resh, Marilyn D.] Weill Cornell Grad Sch Med Sci, Biochem Cell Biol & Mol Biol Grad Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	reshm@mskcc.org		Resh, Marilyn/0000-0001-6118-9466; Miele, Matthew/0000-0001-7495-2133	Cancer Center Core Support Grant from National Institutes of Health [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539, R01GM116860] Funding Source: NIH RePORTER	Cancer Center Core Support Grant from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Raisa Louft-Nisenbaum for expert technical assistance, and Dr. San-San Yi for initial input into the synthesis and analysis of double disulfide-bonded peptides. Memorial Sloan Kettering Cancer Center is funded by Cancer Center Core Support Grant P30 CA008748 from the National Institutes of Health.	Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Janda CY, 2015, BIOCHEM SOC T, V43, P211, DOI 10.1042/BST20140249; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Langton PF, 2016, TRENDS CELL BIOL, V26, P756, DOI 10.1016/j.tcb.2016.05.011; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Tuladhar R, 2015, BIOCHEM SOC T, V43, P235, DOI 10.1042/BST20140282; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	21	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13507	13513		10.1074/jbc.C117.800136	http://dx.doi.org/10.1074/jbc.C117.800136			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655768	Green Published, hybrid			2022-12-28	WOS:000407942400001
J	Vishnivetskiy, SA; Lee, RJ; Zhou, XE; Franz, A; Xu, QY; Xu, HE; Gurevich, VV				Vishnivetskiy, Sergey A.; Lee, Regina J.; Zhou, X. Edward; Franz, Andreas; Xu, Qiuyi; Xu, H. Eric; Gurevich, Vsevolod V.			Functional role of the three conserved cysteines in the N domain of visual arrestin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; conformational change; photoreceptor; phototransduction; rhodopsin; activation; cysteines	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION-RECOGNITION; CONFORMATIONAL-CHANGES; BETA-ARRESTIN; RHODOPSIN; BINDING; ACTIVATION; SELECTIVITY; MECHANISM	Arrestins specifically bind active and phosphorylated forms of their cognate G protein-coupled receptors, blocking G protein coupling and often redirecting the signaling to alternative pathways. High-affinity receptor binding is accompanied by two major structural changes in arrestin: release of the C-tail and rotation of the two domains relative to each other. The first requires detachment of the arrestin C-tail from the body of the molecule, whereas the second requires disruption of the network of charge-charge interactions at the interdomain interface, termed the polar core. These events can be facilitated by mutations destabilizing the polar core or the anchoring of the C-tail that yield preactivated arrestins that bind phosphorylated and unphosphorylated receptors with high affinity. Here we explored the functional role in arrestin activation of the three native cysteines in the N domain, which are conserved in all arrestin subtypes. Using visual arrestin-1 and rhodopsin as a model, we found that substitution of these cysteines with serine, alanine, or valine virtually eliminates the effects of the activating polar core mutations on the binding to unphosphorylated rhodopsin while only slightly reducing the effects of the C-tail mutations. Thus, these three conserved cysteines play a role in the domain rotation but not in the C-tail release.	[Vishnivetskiy, Sergey A.; Lee, Regina J.; Franz, Andreas; Xu, Qiuyi; Gurevich, Vsevolod V.] Vanderbilt Univ, Nashville, TN 37232 USA; [Zhou, X. Edward; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Zhou, X. Edward; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Lee, Regina J.] NIDDK, Bioorgan Chem Lab, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA; [Franz, Andreas] Free Univ Berlin, Takustr 6, D-14195 Berlin, Germany	Vanderbilt University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Free University of Berlin	Gurevich, VV (corresponding author), Vanderbilt Univ, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020; Xu, H. Eric/ABD-7487-2021; Cote, Rick H/G-3363-2013	Gurevich, Vsevolod/0000-0002-3950-5351; Cote, Rick H/0000-0002-1573-6526; Lee, Regina/0000-0001-6091-8057; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [EY011500, GM077561, GM109955, R35 GM122491, DK071662]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122491, R01GM077561, R01GM109955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants EY011500, GM077561, and GM109955 (the latter two were replaced with R35 GM122491 (to V. V. G.) and DK071662 (to H. E. X.)). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Granzin J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15808; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Sullivan LS, 2017, INVEST OPHTH VIS SCI, V58, P2774, DOI 10.1167/iovs.16-21341; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P11741, DOI 10.1074/jbc.M113.450031; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	40	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12496	12502		10.1074/jbc.M117.790386	http://dx.doi.org/10.1074/jbc.M117.790386			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28536260	Green Published, hybrid			2022-12-28	WOS:000406636900014
J	Yonezawa, T; Takahashi, H; Shikata, S; Liu, XX; Tamura, M; Asada, S; Fukushima, T; Fukuyama, T; Tanaka, Y; Sawasaki, T; Kitamura, T; Goyama, S				Yonezawa, Taishi; Takahashi, Hirotaka; Shikata, Shiori; Liu, Xiaoxiao; Tamura, Moe; Asada, Shuhei; Fukushima, Tsuyoshi; Fukuyama, Tomofusa; Tanaka, Yosuke; Sawasaki, Tatsuya; Kitamura, Toshio; Goyama, Susumu			The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; E3 ubiquitin ligase; leukemia; nuclear transport; post-translational modification (PTM); protein degradation; transcription factor; ubiquitin ligase; ubiquitin-dependent protease; ubiquitylation (ubiquitination)	ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; RAR-ALPHA; DEGRADATION; PROTEIN; CHIP; CELLS; DIFFERENTIATION; UBIQUITYLATION; PROMOTES	RUNX1 is a member of RUNX transcription factors and plays important roles in hematopoiesis. Disruption of RUNX1 activity has been implicated in the development of hematopoietic neoplasms. Chromosomal translocations involving the RUNX1 gene are associated with several types of leukemia, including acute myeloid leukemia driven by a leukemogenic fusion protein RUNX1-RUNX1T1. Previous studies have shown that RUNX1 is an unstable protein and is subjected to proteolytic degradation mediated by the ubiquitin-proteasome pathway. However, the precise mechanisms of RUNX1 ubiquitination have not been fully understood. Furthermore, much less is known about the mechanisms to regulate the stability of RUNX1-RUNX1T1. In this study, we identified several RUNX1-interacting E3 ubiquitin ligases using a novel high-throughput binding assay. Among them, we found that STUB1 bound to RUNX1 and induced its ubiquitination and degradation mainly in the nucleus. Immunofluorescence analyses revealed that the STUB1-induced ubiquitination also promoted nuclear export of RUNX1, which probably contributes to the reduced transcriptional activity of RUNX1 in STUB1-overexpressing cells. STUB1 also induced ubiquitination of RUNX1-RUNX1T1 and down-regulated its expression. Importantly, STUB1 overexpression showed a substantial growth-inhibitory effect in myeloid leukemia cells that harbor RUNX1-RUNX1T1, whereas it showed only a marginal effect in other non-RUNX1-RUNX1T1 leukemia cells and normal human cord blood cells. Taken together, these data suggest that the E3 ubiquitin ligase STUB1 is a negative regulator of both RUNX1 and RUNX1-RUNX1T1. Activation of STUB1 could be a promising therapeutic strategy for RUNX1-RUNX1T1 leukemia.	[Yonezawa, Taishi; Shikata, Shiori; Liu, Xiaoxiao; Tamura, Moe; Asada, Shuhei; Fukushima, Tsuyoshi; Fukuyama, Tomofusa; Tanaka, Yosuke; Kitamura, Toshio; Goyama, Susumu] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan	University of Tokyo; Ehime University	Goyama, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	goyama@ims.u-tokyo.ac.jp	Asada, Shuhei/GOZ-2495-2022; Kitamura, Toshio/AAA-2071-2021	Asada, Shuhei/0000-0001-6116-7996; Yonezawa, Taishi/0000-0002-7963-9434; Liu, Xiaoxiao/0000-0002-0023-4013; Fukuyama, Tomofusa/0000-0002-0709-3188; Sawasaki, Tatsuya/0000-0002-7952-0556	Leukemia Research Fund; Children's Cancer Association of Japan;  [15H06162]; Grants-in-Aid for Scientific Research [16H04729, 16H06579, 15H04855] Funding Source: KAKEN	Leukemia Research Fund; Children's Cancer Association of Japan; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Research Activity 15H06162 start-up (to S. G.), a grant from Leukemia Research Fund (to S. G.), and a grant from Children's Cancer Association of Japan (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barseguian K, 2002, P NATL ACAD SCI USA, V99, P15434, DOI 10.1073/pnas.242588499; Ben-Ami O, 2013, CELL REP, V4, P1131, DOI 10.1016/j.celrep.2013.08.020; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Dandekar DH, 2005, ANAL BIOCHEM, V342, P341, DOI 10.1016/j.ab.2005.02.006; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Goyama S, 2016, LEUKEMIA, V30, P728, DOI 10.1038/leu.2015.275; Goyama S, 2015, ONCOGENE, V34, P3483, DOI 10.1038/onc.2014.305; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Goyama S, 2011, INT J HEMATOL, V94, P126, DOI 10.1007/s12185-011-0858-z; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang G, 2011, BLOOD, V118, P6544, DOI 10.1182/blood-2010-11-317909; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kramer OH, 2008, FASEB J, V22, P1369, DOI 10.1096/fj.06-8050com; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Link KA, 2010, J CELL PHYSIOL, V222, P50, DOI 10.1002/jcp.21950; LU J, 1995, MOL CELL BIOL, V15, P1651; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mulloy JC, 2003, BLOOD, V102, P4369, DOI 10.1182/blood-2003-05-1762; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nagel S, 2002, J HEMATOTH STEM CELL, V11, P401, DOI 10.1089/152581602753658583; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seo J, 2016, NAT CELL BIOL, V18, P291, DOI 10.1038/ncb3314; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; Takahashi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156718; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang S, 2013, EUR J IMMUNOL, V43, P1034, DOI 10.1002/eji.201242554; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	41	12	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12528	12541		10.1074/jbc.M117.785675	http://dx.doi.org/10.1074/jbc.M117.785675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28536267	Green Published, hybrid			2022-12-28	WOS:000406636900017
J	Mittra, B; Laranjeira-Silva, MF; Miguel, DC; de Menezes, JPB; Andrews, NW				Mittra, Bidyottam; Laranjeira-Silva, Maria Fernanda; Miguel, Danilo Ciccone; de Menezes, Juliana Perrone Bezerra; Andrews, Norma W.			The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METACYCLIC PROMASTIGOTES; HYDROGEN-PEROXIDE; AMAZONENSIS; GENERATION; DIFFERENTIATION; TRANSPORTER; METABOLISM; SURVIVAL; CHAGASI; DEATH	Leishmaniasis is one of the leading globally neglected diseases, affecting millions of people worldwide. Leishmania infection depends on the ability of insect-transmitted metacyclic promastigotes to invade mammalian hosts, differentiate into amastigotes, and replicate inside macrophages. To counter the hostile oxidative environment inside macrophages, these protozoans contain anti-oxidant systems that include iron-dependent superoxide dismutases (SODs) in mitochondria and glycosomes. Increasing evidence suggests that in addition to this protective role, Leishmania mitochondrial SOD may also initiate H2O2-mediated redox signaling that regulates gene expression and metabolic changes associated with differentiation into virulent forms. To investigate this hypothesis, we examined the specific role of SODA, the mitochondrial SOD isoform in Leishmania amazonensis. Our inability to generate L. amazonensis SODA null mutants and the lethal phenotype observed following RNAi-mediated silencing of the Trypanosoma brucei SODA ortholog suggests that SODA is essential for trypanosomatid survival. L. amazonensis metacyclic promastigotes lacking one SODA allele failed to replicate in macrophages and were severely attenuated in their ability to generate cutaneous lesions in mice. Reduced expression of SODA also resulted in mitochondrial oxidative damage and failure of SODA/Delta sodA promastigotes to differentiate into axenic amastigotes. SODA expression above a critical threshold was also required for the development of metacyclic promastigotes, as SODA/Delta sodA cultures were strongly depleted in this infective form and more susceptible to reactive oxygen species (ROS)-induced stress. Collectively, our data suggest that SODA promotes Leishmania virulence by protecting the parasites against mitochondrion-generated oxidative stress and by initiating ROS-mediated signaling mechanisms required for the differentiation of infective forms.	[Mittra, Bidyottam; Laranjeira-Silva, Maria Fernanda; Miguel, Danilo Ciccone; de Menezes, Juliana Perrone Bezerra; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, 2134 Biosci Res Bldg, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Andrews, NW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 2134 Biosci Res Bldg, College Pk, MD 20742 USA.	andrewsn@umd.edu	Miguel, Danilo Ciccone/C-1484-2012; de Menezes, Juliana Perrone Bezerra/AAO-5290-2021; Laranjeira-Silva, Maria Fernanda/H-9056-2012	Miguel, Danilo Ciccone/0000-0003-0522-6562; de Menezes, Juliana Perrone Bezerra/0000-0002-9380-8839; Laranjeira-Silva, Maria Fernanda/0000-0002-7128-6208; Andrews, Norma/0000-0002-0611-2412	National Institutes of Health [R01 AI067979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI067979 (to N. W. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 2013, ANTIOXID REDOX SIGN, V19, P746, DOI 10.1089/ars.2012.4745; Alzate JF, 2007, MOL BIOCHEM PARASIT, V152, P192, DOI 10.1016/j.molbiopara.2007.01.006; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Boitz JM, 2013, J BIOL CHEM, V288, P8977, DOI 10.1074/jbc.M112.431486; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Diebold L, 2016, FREE RADICAL BIO MED, V100, P86, DOI 10.1016/j.freeradbiomed.2016.04.198; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Flannery AR, 2011, J BIOL CHEM, V286, P23266, DOI 10.1074/jbc.M111.229674; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gaur U, 2009, EXP PARASITOL, V122, P182, DOI 10.1016/j.exppara.2009.03.014; Getachew F, 2007, MOL BIOCHEM PARASIT, V154, P62, DOI 10.1016/j.molbiopara.2007.04.007; Getachew F, 2012, MOL BIOCHEM PARASIT, V183, P42, DOI 10.1016/j.molbiopara.2012.01.005; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Kima PE, 2014, MICROBES INFECT, V16, P721, DOI 10.1016/j.micinf.2014.07.012; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; da Silva MFL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034022; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Miguel DC, 2013, INFECT IMMUN, V81, P3620, DOI 10.1128/IAI.00687-13; Mittra B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005340; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Oyola SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051300; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Pinto-da-Silva LH, 2005, INT J PARASITOL, V35, P757, DOI 10.1016/j.ijpara.2005.03.004; Plewes KA, 2003, INFECT IMMUN, V71, P5910, DOI 10.1128/IAI.71.10.5910-5920.2003; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Tabbara KS, 2005, INFECT IMMUN, V73, P4714, DOI 10.1128/IAI.73.8.4714-4722.2005; Taylor MC, 2010, PARASITOLOGY, V137, P899, DOI 10.1017/S0031182009991880; Tsigankov P, 2012, PARASITOLOGY, V139, P1146, DOI 10.1017/S0031182012000157; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Turco SJ, 2003, METHOD ENZYMOL, V363, P377; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; WHO, 2010, WHO TECH REP SER, V949, P1; WILSON ME, 1994, INFECT IMMUN, V62, P5133, DOI 10.1128/IAI.62.11.5133-5141.1994; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	53	37	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12324	12338		10.1074/jbc.M116.772624	http://dx.doi.org/10.1074/jbc.M116.772624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28550086	Green Published, hybrid			2022-12-28	WOS:000406053300027
J	Hernandez-Vasquez, MN; Adame-Garcia, SR; Hamoud, N; Chidiac, R; Reyes-Cruz, G; Gratton, JP; Cote, JF; Vazquez-Prado, J				Nohemi Hernandez-Vasquez, Magda; Rafael Adame-Garcia, Sendi; Hamoud, Noumeira; Chidiac, Rony; Reyes-Cruz, Guadalupe; Gratton, Jean Philippe; Cote, Jean-Francois; Vazquez-Prado, Jose			Cell adhesion controlled by adhesion G protein-coupled receptor GPR124/ADGRA2 is mediated by a protein complex comprising intersectins and Elmo-Dock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; NUCLEOTIDE EXCHANGE FACTOR; ENDOTHELIAL-CELLS; SCAFFOLD PROTEINS; CNS ANGIOGENESIS; EPS15 HOMOLOGY; RAC ACTIVATION; RHO-GTPASES; GPR124; MIGRATION	Developmental angiogenesis and the maintenance of the blood-brain barrier involve endothelial cell adhesion, which is linked to cytoskeletal dynamics. GPR124 (also known as TEM5/ADGRA2) is an adhesion G protein-coupled receptor family member that plays a pivotal role in brain angiogenesis and in ensuring a tight blood-brain barrier. However, the signaling properties of GPR124 remain poorly defined. Here, we show that ectopic expression of GPR124 promotes cell adhesion, additive to extracellular matrix-dependent effect, coupled with filopodia and lamellipodia formation and an enrichment of a pool of the G protein-coupled receptor at actin-rich cellular protrusions containing VASP, a filopodial marker. Accordingly, GPR124-expressing cells also displayed increased activation of both Rac and Cdc42 GTPases. Mechanistically, we uncover novel direct interactions between endogenous GPR124 and the Rho guanine nucleotide exchange factors Elmo/Dock and intersectin (ITSN). Small fragments of either Elmo or ITSN1 that bind GPR124 blocked GPR124-induced cell adhesion. In addition, G beta gamma interacts with the C-terminal tail of GPR124 and promotes the formation of a GPR124-Elmo complex. Furthermore, GPR124 also promotes the activation of the Elmo-Dock complex, as measured by Elmo phosphorylation on a conserved C-terminal tyrosine residue. Interestingly, Elmo and ITSN1 also interact with each other independently of their GPR124-recognition regions. Moreover, endogenous phospho-Elmo and ITSN1 co-localize with GPR124 at lamellipodia of adhering endothelial cells, where GPR124 expression contributes to polarity acquisition during wound healing. Collectively, our results indicate that GPR124 promotes cell adhesion via Elmo-Dock and ITSN. This constitutes a previously unrecognized complex formed of atypical and conventional Rho guanine nucleotide exchange factors for Rac and Cdc42 that is putatively involved in GPR124-dependent angiogenic responses.	[Nohemi Hernandez-Vasquez, Magda; Vazquez-Prado, Jose] Natl Polytech Inst CINVESTAV IPN, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City 14740, DF, Mexico; [Rafael Adame-Garcia, Sendi; Reyes-Cruz, Guadalupe] Natl Polytech Inst CINVESTAV IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 14740, DF, Mexico; [Hamoud, Noumeira; Cote, Jean-Francois] Univ Montreal, Fac Med, Inst Rech Clin Montreal, Montreal, PQ H3T 1J4, Canada; [Chidiac, Rony; Gratton, Jean Philippe] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3T 1J4, Canada	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Vazquez-Prado, J (corresponding author), CINVESTAV IPN, Dept Pharmacol, Ave Inst Politecn Nacl 2508, Mexico City, DF 14740, Mexico.	jvazquez@cinvestav.mx	VAZQUEZ-PRADO, JOSE/C-1630-2017	VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643; Gratton, Jean-Philippe/0000-0001-9877-8520; Hernandez Vasquez, Magda Nohemi/0000-0002-5449-3598	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [152434, 240119]; Canadian Institutes of Health Research; PNPC (en el marco del "Programa de Fortalecimiento Academico del Posgrado de Alta Calidad"); FRQS (Fonds de recherche du Quebec - Sante) Senior Career Award; CONACyT fellowship	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PNPC (en el marco del "Programa de Fortalecimiento Academico del Posgrado de Alta Calidad"); FRQS (Fonds de recherche du Quebec - Sante) Senior Career Award; CONACyT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) Grants 152434 (to J. V.-P.) and 240119 (to G. R.-C.), a Canadian Institutes of Health Research grant (to J. F. C.), and PNPC (en el marco del "Programa de Fortalecimiento Academico del Posgrado de Alta Calidad"). The authors declare that they have no conflicts of interest with the contents of this article.; Graduate student supported by a CONACyT fellowship.; Supported by ITABEC (Instituto Tamaulipeco de Becas, Estimulos y Creditos Educativos) of the Tamaulipas State Government.; Recipient of an FRQS (Fonds de recherche du Quebec - Sante) Senior Career Award; holder of the Transat Chair in Breast Cancer Research.	Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bardita C, 2013, JOVE-J VIS EXP, DOI 10.3791/50316; Barzik M, 2014, MOL BIOL CELL, V25, P2604, DOI 10.1091/mbc.E14-02-0712; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chang JL, 2017, NAT MED, V23, P450, DOI 10.1038/nm.4309; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gryaznova T, 2015, CELL SIGNAL, V27, P1499, DOI 10.1016/j.cellsig.2015.03.006; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Herrero-Garcia E, 2017, BBA-MOL CELL RES, V1864, P23, DOI 10.1016/j.bbamcr.2016.10.005; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Mu L, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/181536; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Savdie C, 2006, CELL TISSUE RES, V324, P69, DOI 10.1007/s00441-005-0102-3; St Croix B, 2000, SCIENCE, V289, P1197; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Summers L, 2013, MOL CELL NEUROSCI, V57, P93, DOI 10.1016/j.mcn.2013.10.007; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Vazquez-Prado J, 2016, MOL PHARMACOL, V90, P573, DOI 10.1124/mol.116.105338; Wang Y, 2014, CURR MOL MED, V14, P543, DOI 10.2174/1566524014666140414205943; Wang YH, 2016, J CANCER, V7, P973, DOI 10.7150/jca.15118; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018	59	15	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12178	12191		10.1074/jbc.M117.780304	http://dx.doi.org/10.1074/jbc.M117.780304			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28600358	Green Published, hybrid			2022-12-28	WOS:000406053300016
J	Peng, YZ; Yuan, JJ; Zhang, ZC; Chang, X				Peng, Yuanzheng; Yuan, Juanjuan; Zhang, Zhenchao; Chang, Xing			Cytoplasmic poly(A)-binding protein 1 (PABPC1) interacts with the RNA-binding protein hnRNPLL and thereby regulates immunoglobulin secretion in plasma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; B-CELL; ALTERNATIVE CLEAVAGE; ELONGATION-FACTOR; DIFFERENTIATION; POLYADENYLATION; RIBONUCLEOPROTEIN; TRANSLATION; TRANSCRIPTION; REPRESSION	Increasing evidence indicates that alternative processing of mRNA, including alternative splicing, 3 ' alternative polyadenylation, and regulation of mRNA stability/translation, represents a major mechanism contributing to protein diversification. For example, in alternative polyadenylation, the 3 ' end of the immunoglobulin heavy chain mRNA is processed during B cell differentiation, and this processing involves RNA-binding proteins. hnRNPLL (heterogeneous nuclear ribonucleoprotein L-like protein) is an RNA-binding protein expressed in terminally differentiated lymphocytes, such as memory T cells and plasma cells. hnRNPLL regulates various processes of RNA metabolism, including alternative pre-mRNA splicing and RNA stability. In plasma cells, hnRNPLL also regulates the transition from the membrane isoform of the immunoglobulin heavy-chain (mIgH) to the secreted isoform (sIgH), but the precise mechanism remains to be identified. In this study, we report that hnRNPLL specifically associates with cytoplasmic PABPC1 (poly(A)-binding protein 1) in both T cells and plasma cells. We found that although PABPC1 is not required for the alternative splicing of CD45, a primary target of hnRNPLL in lymphocytes, PABPC1 does promote the binding of hnRNPLL to the immunoglobulin mRNA and regulates switching from mIgH to sIgH in plasma cells. Given the recently identified role of PABPC1 in mRNA alternative polyadenylation, our findings suggest that PABPC1 recruits hnRNPLL to the 3 ' -end of RNA and regulates the transition from membrane Ig to secreted Ig through mRNA alternative polyadenylation. In conclusion, our study has revealed a mechanism that regulates immunoglobulin secretion in B cells via cooperation between a plasma cell-specific RBP (hnRNPLL) and a universally expressed RBP (PABPC1).	[Peng, Yuanzheng; Yuan, Juanjuan; Zhang, Zhenchao; Chang, Xing] Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China; [Peng, Yuanzheng; Yuan, Juanjuan; Zhang, Zhenchao; Chang, Xing] Univ Chinese Acad Sci, Chinese Acad Sci, Sch Med, Shanghai Jiao Tong Univ, Shanghai 200031, Peoples R China; [Peng, Yuanzheng; Yuan, Juanjuan; Chang, Xing] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Syst Biomed, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chang, X (corresponding author), Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China.; Chang, X (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Sch Med, Shanghai Jiao Tong Univ, Shanghai 200031, Peoples R China.; Chang, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Syst Biomed, Shanghai 200031, Peoples R China.	changxing@sibs.ac.cn		Chang, Xing/0000-0002-5072-9225	National Science Foundation of China [31370858, 81671552]; Ministry of Science and Technology, China [2014CB943600]; Science and Technology Commission of Shanghai Municipality [13PJ1409300, 17ZR449700]; National Thousand Talents Program for Distinguished Young Scholars (China)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Thousand Talents Program for Distinguished Young Scholars (China)	This work was supported by Grants 31370858 and 81671552 from the National Science Foundation of China, 2014CB943600 from Ministry of Science and Technology, China, 13PJ1409300 and 17ZR449700 from Science and Technology Commission of Shanghai Municipality, and National Thousand Talents Program for Distinguished Young Scholars (China).	ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Benson MJ, 2012, P NATL ACAD SCI USA, V109, P16252, DOI 10.1073/pnas.1214414109; Bruce SR, 2003, RNA, V9, P1264, DOI 10.1261/rna.5820103; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chang X, 2016, WIRES RNA, V7, P295, DOI 10.1002/wrna.1335; Chang X, 2015, P NATL ACAD SCI USA, V112, pE1888, DOI 10.1073/pnas.1422490112; Cho V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r26; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kini HK, 2016, RNA, V22, P61, DOI 10.1261/rna.053447.115; Kumar GR, 2010, MOL CELL BIOL, V30, P4996, DOI 10.1128/MCB.00600-10; Li WC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005166; Ma JL, 2006, RNA, V12, P122, DOI 10.1261/rna.2159506; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Peterson ML, 2007, IMMUNOL RES, V37, P33, DOI 10.1007/BF02686094; Peterson Martha L., 1992, Gene Expression, V2, P319; Safaee N, 2012, MOL CELL, V48, P375, DOI 10.1016/j.molcel.2012.09.001; Shankarling G, 2013, BIOCHEM J, V453, P271, DOI 10.1042/BJ20130432; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Wang HH, 2016, CHIN CONT DECIS CONF, P1, DOI 10.1109/CCDC.2016.7530945; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Yabas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026440; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010	37	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12285	12295		10.1074/jbc.M117.794834	http://dx.doi.org/10.1074/jbc.M117.794834			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28611064	Green Published, hybrid			2022-12-28	WOS:000406053300024
J	Strand, DD; Fisher, N; Kramer, DM				Strand, Deserah D.; Fisher, Nicholas; Kramer, David M.			The higher plant plastid NAD(P)H dehydrogenase-like complex (NDH) is a high efficiency proton pump that increases ATP production by cyclic electron flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-LIKE FOLD; RESPIRATORY COMPLEX; PHOTOSYSTEM-I; NONPHOTOCHEMICAL REDUCTION; PLASTOQUINONE POOL; PHOTOSYNTHESIS; TOBACCO; TRANSPORT; STRESS; STATE	Cyclic electron flow around photosystem I (CEF) is critical for balancing the photosynthetic energy budget of the chloroplast by generating ATP without net production of NADPH. We demonstrate that the chloroplast NADPH dehydrogenase complex, a homolog to respiratory Complex I, pumps approximately two protons from the chloroplast stroma to the lumen per electron transferred from ferredoxin to plastoquinone, effectively increasing the efficiency of ATP production via CEF by 2-fold compared with CEF pathways involving non-proton-pumping plastoquinone reductases. By virtue of this proton-pumping stoichiometry, we hypothesize that NADPH dehydrogenase not only efficiently contributes to ATP production but operates near thermodynamic reversibility, with potentially important consequences for remediating mismatches in the thylakoid energy budget.	[Strand, Deserah D.; Fisher, Nicholas; Kramer, David M.] Michigan State Univ, MSU DOE Plant Res Lab, 612 Wilson Rd, E Lansing, MI 48823 USA; [Kramer, David M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA	Michigan State University; United States Department of Energy (DOE); Michigan State University	Kramer, DM (corresponding author), Michigan State Univ, MSU DOE Plant Res Lab, 612 Wilson Rd, E Lansing, MI 48823 USA.	kramerd8@msu.edu	Kramer, David/B-9588-2016	Kramer, David/0000-0003-2181-6888	Photosynthetic Systems program from Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-11ER16220]	Photosynthetic Systems program from Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Grant DE-FG02-11ER16220 from the Photosynthetic Systems program from Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to D. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Bennoun P, 2002, PHOTOSYNTH RES, V73, P273, DOI 10.1023/A:1020479920622; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; COBLEY JG, 1976, BIOCHEM J, V156, P481, DOI 10.1042/bj1560481c; Cramer WA, 2011, BBA-BIOENERGETICS, V1807, P788, DOI 10.1016/j.bbabio.2011.02.006; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; DAVENPORT JW, 1986, BIOCHIM BIOPHYS ACTA, V851, P136, DOI 10.1016/0005-2728(86)90256-2; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; DINER BA, 1977, BIOCHIM BIOPHYS ACTA, V460, P247, DOI 10.1016/0005-2728(77)90211-0; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fan DY, 2007, PHOTOSYNTH RES, V94, P347, DOI 10.1007/s11120-006-9127-z; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Fisher N, 2014, BBA-BIOENERGETICS, V1837, P1944, DOI 10.1016/j.bbabio.2014.09.005; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Friedrich T, 2014, J BIOENERG BIOMEMBR, V46, P255, DOI 10.1007/s10863-014-9566-8; Gotoh E, 2010, PHOTOSYNTH RES, V103, P111, DOI 10.1007/s11120-009-9525-0; GROOM QJ, 1993, PHOTOSYNTH RES, V36, P205, DOI 10.1007/BF00033039; Hall C.C., 2013, PHOTOSYNTHESIS RES F, P184, DOI DOI 10.1007/978-3-642-3234-73_38; Hertle AP, 2013, MOL CELL, V49, P511, DOI 10.1016/j.molcel.2012.11.030; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Horvath EM, 2000, PLANT PHYSIOL, V123, P1337, DOI 10.1104/pp.123.4.1337; Hu P, 2013, FEBS LETT, V587, P2340, DOI 10.1016/j.febslet.2013.05.040; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; JACKSON JB, 1968, BIOCHEM BIOPH RES CO, V32, P908, DOI 10.1016/0006-291X(68)90113-7; Joliot P, 2011, P NATL ACAD SCI USA, V108, P13317, DOI 10.1073/pnas.1110189108; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Kramer DM, 2004, ADV PHOTO RESPIRAT, V19, P251; Lascano HR, 2003, PLANT PHYSIOL, V132, P256, DOI 10.1104/pp.103.020321; Li XG, 2004, PLANT CELL PHYSIOL, V45, P103, DOI 10.1093/pcp/pch011; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; PELTIER G, 1988, BIOCHIM BIOPHYS ACTA, V936, P319, DOI 10.1016/0005-2728(88)90007-2; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Poetsch A, 2003, BBA-BIOMEMBRANES, V1618, P59, DOI 10.1016/j.bbamem.2003.10.007; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sacksteder CA, 2000, P NATL ACAD SCI USA, V97, P14283, DOI 10.1073/pnas.97.26.14283; Sazanov LA, 1998, FEBS LETT, V429, P115, DOI 10.1016/S0014-5793(98)00573-0; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Seigneurin-Berny Daphne, 2008, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0330s40; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Strand DD, 2016, BBA-BIOENERGETICS, V1857, P1, DOI 10.1016/j.bbabio.2015.07.012; Strand DD, 2014, ADV PHOTOSYNTH RESP, V40, P387, DOI 10.1007/978-94-017-9032-1_18; Strand DD, 2015, P NATL ACAD SCI USA, V112, P5539, DOI 10.1073/pnas.1418223112; Suorsa M, 2009, MOL PLANT, V2, P1127, DOI 10.1093/mp/ssp052; Takabayashi A, 2005, P NATL ACAD SCI USA, V102, P16898, DOI 10.1073/pnas.0507095102; Wang CJ, 2015, BBA-BIOENERGETICS, V1847, P931, DOI 10.1016/j.bbabio.2014.11.013; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Yamamoto H, 2013, J BIOL CHEM, V288, P36328, DOI 10.1074/jbc.M113.511584; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291	71	62	63	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11850	11860		10.1074/jbc.M116.770792	http://dx.doi.org/10.1074/jbc.M116.770792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28559282	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000405485600022
J	Hu, XY; Binns, D; Reese, ML				Hu, Xiaoyu; Binns, Derk; Reese, Michael L.			The coccidian parasites Toxoplasma and Neospora dysregulate mammalian lipid droplet biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; BINDING PROTEIN 5; FATTY-ACID UPTAKE; CORE PROTEIN; HOST; METABOLISM; CELLS; TRANSCRIPTION; EXPRESSION; INFECTION	Upon infection, the intracellular parasite Toxoplasma gondii co-opts critical functions of its host cell to avoid immune clearance and gain access to nutritional resources. One route by which Toxoplasma co-opts its host cell is through hijacking host organelles, many of which have roles in immunomodulation. Here we demonstrate that Toxoplasma infection results in increased biogenesis of host lipid droplets through rewiring of multiple components of host neutral lipid metabolism. These metabolic changes cause increased responsiveness of host cells to free fatty acid, leading to a radical increase in the esterification of free fatty acids into triacylglycerol. We identified c-Jun kinase and mammalian target of rapamycin (mTOR) as components of two distinct host signaling pathways that modulate the parasite-induced lipid droplet accumulation. We also found that, unlike many host processes dysregulated during Toxoplasma infection, the induction of lipid droplet generation is conserved not only during infection with genetically diverse Toxoplasma strains but also with Neospora caninum, which is closely related to Toxoplasma but has a restricted host range and uses different effector proteins to alter host signaling. Finally, by showing that a Toxoplasma strain deficient in exporting a specific class of effectors is unable to induce lipid droplet accumulation, we demonstrate that the parasite plays an active role in this process. These results indicate that, despite their different host ranges, Toxoplasma and Neospora use a conserved mechanism to co-opt these host organelles, which suggests that lipid droplets play a critical role at the coccidian host-pathogen interface.	[Hu, Xiaoyu; Binns, Derk; Reese, Michael L.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Reese, ML (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	michael.reese@UTSouthwestern.edu		Reese, Michael/0000-0001-9401-9594; Hu, Xiaoyu/0000-0002-6030-0019	National Institutes of Health [1K22AI097345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI097345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part by National Institutes of Health Grant 1K22AI097345 (to M. L. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Aflaki E, 2011, J BIOL CHEM, V286, P7418, DOI 10.1074/jbc.M110.175703; Anand P, 2012, ELIFE, V1, DOI 10.7554/eLife.00003; Araujo-Santos T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000873; Barbosa AD, 2015, CURR OPIN CELL BIOL, V35, P91, DOI 10.1016/j.ceb.2015.04.017; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003296; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Brown KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004180; Cartwright BR, 2015, MOL BIOL CELL, V26, P726, DOI 10.1091/mbc.E14-08-1303; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Charron AJ, 2002, J CELL SCI, V115, P3049; Cheng B, 2014, MICROB PATHOGENESIS, V69-70, P1, DOI 10.1016/j.micpath.2014.03.001; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Crawford SE, 2016, CURR OPIN VIROL, V19, P11, DOI 10.1016/j.coviro.2016.05.008; D'Andrea S, 2016, BIOCHIMIE, V120, P17, DOI 10.1016/j.biochi.2015.07.010; Dansako H, 2014, VIROLOGY, V462, P166, DOI 10.1016/j.virol.2014.05.017; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Franco M, 2016, MBIO, V7, DOI 10.1128/mBio.02231-15; Franco M, 2014, EUKARYOT CELL, V13, P483, DOI 10.1128/EC.00316-13; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; Gilk SD, 2012, ADV EXP MED BIOL, V984, P199, DOI 10.1007/978-94-007-4315-1_10; Gomes AF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-47; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; Kawaguchi K, 2016, BIOCHEM J, V473, P449, DOI 10.1042/BJ20150926; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Morgado P, 2011, INFECT IMMUN, V79, P4401, DOI 10.1128/IAI.05562-11; Mota LAM, 2014, MEM I OSWALDO CRUZ, V109, P767, DOI 10.1590/0074-0276140119; Muniz-Feliciano L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003809; Olias P, 2016, CELL HOST MICROBE, V20, P72, DOI 10.1016/j.chom.2016.06.006; Pernas L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001845; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sinai AP, 1997, J CELL SCI, V110, P2117; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Toledo DAM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00174; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu Jinhai, 2015, Biophys Rep, V1, P41; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhang YW, 2015, IMMUNITY, V42, P953, DOI 10.1016/j.immuni.2015.04.016; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	63	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11009	11020		10.1074/jbc.M116.768176	http://dx.doi.org/10.1074/jbc.M116.768176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487365	hybrid, Green Published			2022-12-28	WOS:000404391000022
J	Lei, W; Mullen, N; McCarthy, S; Brann, C; Richard, P; Cormier, J; Edwards, K; Bilsky, EJ; Streicher, JM				Lei, Wei; Mullen, Nathan; McCarthy, Sarah; Brann, Courtney; Richard, Philomena; Cormier, James; Edwards, Katie; Bilsky, Edward J.; Streicher, John M.			Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; extracellular-signal-regulated kinase (ERK); heat-shock protein 90 (Hsp90); opiate opioid; pain; 17-AAG; anti-nociception; -opioid receptor	NEUROPATHIC PAIN; BIASED LIGAND; IN-VIVO; MORPHINE; RECEPTOR; TOLERANCE; DEPENDENCE; TRV130; MICE; SENSITIZATION	Recent advances in developing opioid treatments for pain with reduced side effects have focused on the signaling cascades of the -opioid receptor (MOR). However, few such signaling targets have been identified for exploitation. To address this need, we explored the role of heat-shock protein 90 (Hsp90) in opioid-induced MOR signaling and pain, which has only been studied in four previous articles. First, in four cell models of MOR signaling, we found that Hsp90 inhibition for 24 h with the inhibitor 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) had different effects on protein expression and opioid signaling in each line, suggesting that cell models may not be reliable for predicting pharmacology with this protein. We thus developed an in vivo model using CD-1 mice with an intracerebroventricular injection of 17-AAG for 24 h. We found that Hsp90 inhibition strongly blocked morphine-induced anti-nociception in models of post-surgical and HIV neuropathic pain but only slightly blocked anti-nociception in a naive tail-flick model, while enhancing morphine-induced precipitated withdrawal. Seeking a mechanism for these changes, we found that Hsp90 inhibition blocks ERK MAPK activation in the periaqueductal gray and caudal brain stem. We tested these signaling changes by inhibiting ERK in the above-mentioned pain models and found that ERK inhibition could account for all of the changes in anti-nociception induced by Hsp90 inhibition. Taken together, these findings suggest that Hsp90 promotes opioid-induced anti-nociception by an ERK mechanism in mouse brain and that Hsp90 could be a future target for improving the therapeutic index of opioid drugs.	[Lei, Wei; Streicher, John M.] Univ Arizona, Coll Med, Dept Pharmacol, Box 245050,Life Sci North 563,1501 N Campbell Ave, Tucson, AZ 85724 USA; [Mullen, Nathan; McCarthy, Sarah; Brann, Courtney; Richard, Philomena; Cormier, James; Edwards, Katie; Bilsky, Edward J.] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA; [Bilsky, Edward J.] Pacific Northwest Univ, Coll Osteopath Med, Dept Biomed Sci, Yakima, WA 98901 USA	University of Arizona; University of New England - Maine	Streicher, JM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Box 245050,Life Sci North 563,1501 N Campbell Ave, Tucson, AZ 85724 USA.	jstreicher@email.arizona.edu	McCarthy, Sarah/HCI-8963-2022	Streicher, John/0000-0002-4173-7362; Lei, Wei/0000-0002-0374-8642	University of New England; University of Arizona; National Institutes of Health Pilot Project Grant under an institutional COBRE award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103643] Funding Source: NIH RePORTER	University of New England; University of Arizona; National Institutes of Health Pilot Project Grant under an institutional COBRE award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of New England and the University of Arizona and by National Institutes of Health Pilot Project Grant P20GM103643 (Ian Meng PI) under an institutional COBRE award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abul-Husn NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025535; Ananthan S, 2012, J MED CHEM, V55, P8350, DOI 10.1021/jm300686p; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Zeni ALB, 2012, PHARMACOL BIOCHEM BE, V103, P181, DOI 10.1016/j.pbb.2012.08.020; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Breivik H, 2009, ANN ONCOL, V20, P1420, DOI 10.1093/annonc/mdp001; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen XT, 2013, J MED CHEM, V56, P8019, DOI 10.1021/jm4010829; Chen Y, 2008, J NEUROSCI, V28, P5836, DOI 10.1523/JNEUROSCI.4170-07.2008; Dai RP, 2011, ANESTHESIOLOGY, V115, P604, DOI 10.1097/ALN.0b013e3182242045; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gudasheva TA, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0198-z; Hutchinson MR, 2009, NEUROSCIENCE, V164, P1821, DOI 10.1016/j.neuroscience.2009.09.046; Jhaveri K, 2014, EXPERT OPIN INV DRUG, V23, P611, DOI 10.1517/13543784.2014.902442; Kim N, 2015, NEUROSCIENCE, V284, P912, DOI 10.1016/j.neuroscience.2014.11.010; Koshimizu T, 2010, BIOCHEM BIOPH RES CO, V392, P603, DOI 10.1016/j.bbrc.2010.01.089; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016/S0304-3959(00)00290-6; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Lowery JJ, 2011, J PHARMACOL EXP THER, V336, P767, DOI 10.1124/jpet.110.172866; Macey TA, 2009, J PHARMACOL EXP THER, V331, P412, DOI 10.1124/jpet.109.152157; McConnell JR, 2013, BIOORG MED CHEM LETT, V23, P1923, DOI 10.1016/j.bmcl.2013.02.014; Mouledous L, 2007, PHARMACOL BIOCHEM BE, V88, P39, DOI 10.1016/j.pbb.2007.07.002; National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain), 2012, OP PALL CAR SAF EFF; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Ossipov MH, 2000, ANN NY ACAD SCI, V909, P12; Ota A, 2010, CIRC RES, V106, P1404, DOI 10.1161/CIRCRESAHA.109.213769; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Qin WJ, 2013, INT J NEUROPSYCHOPH, V16, P647, DOI 10.1017/S1461145712000557; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Tillu DV, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-5; TRAYNOR J, 2012, Patent No. 121173; Urban MJ, 2010, ASN NEURO, V2, DOI 10.1042/AN20100015; Vanderah TW, 2008, EUR J PHARMACOL, V583, P62, DOI 10.1016/j.ejphar.2008.01.011; Viscusi ER, 2016, PAIN, V157, P264, DOI 10.1097/j.pain.0000000000000363; Wang Q, 2013, MOL PHARMACOL, V83, P512, DOI 10.1124/mol.112.081992; Wang WQ, 2016, CANCER SCI, V107, P782, DOI 10.1111/cas.12934; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P703, DOI 10.1038/nrd2335; Yuan SB, 2014, ANN NEUROL, V75, P837, DOI 10.1002/ana.24139; Yue X, 2006, EUR J PHARMACOL, V540, P57, DOI 10.1016/j.ejphar.2006.04.033; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934	45	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10414	10428		10.1074/jbc.M116.769489	http://dx.doi.org/10.1074/jbc.M116.769489			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28450396	hybrid, Green Published			2022-12-28	WOS:000404115400008
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			Origin single-stranded DNA releases Sld3 protein from the Mcm2-7 complex, allowing the GINS tetramer to bind the Mcm2-7 complex (vol 286, pg 18602, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10318	10318		10.1074/jbc.A111.226332	http://dx.doi.org/10.1074/jbc.A111.226332			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28623196	Green Published, hybrid			2022-12-28	WOS:000403580600041
J	Parent, L				Parent, Lucie			A helical segment makes potassium channels go-go	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRAFFICKING; MECHANISM	More than 500 variants in the KCNH2 gene, which encodes the cardiac human ether-a-go-go (hERG) ion channel, have been associated with sudden cardiac death, but only a subset of these variants have been investigated. Matthew D. Perry and colleagues now combine NMR spectroscopy and electrophysiological experiments to explore the functional properties of mutations within an overlooked hERG helix, finding important contributions to channel function.	[Parent, Lucie] Univ Montreal, Inst Cardiol Montreal, Ctr Rech, Dept Pharmacol & Physiol,Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Institut de Cardiologie de Montreal	Parent, L (corresponding author), Univ Montreal, Inst Cardiol Montreal, Ctr Rech, Dept Pharmacol & Physiol,Fac Med, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca			Canadian Institutes of Health Research; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	Supported by the Canadian Institutes of Health Research and the Canadian Heart and Stroke Foundation. To whom correspondence should be addressed. E-mail: lucie.parent@umontreal.ca.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Phan K, 2017, J BIOL CHEM, V292, P7688, DOI 10.1074/jbc.M117.779298; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wilde AAM, 2005, HEART, V91, P1352, DOI 10.1136/hrt.2004.046334	9	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7706	7707		10.1074/jbc.H117.779298	http://dx.doi.org/10.1074/jbc.H117.779298			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28476926	Green Published, hybrid			2022-12-28	WOS:000400761300035
J	Gaytan-Cervantes, J; Gonzalez-Torres, C; Maldonado, V; Zampedri, C; Ceballos-Cancino, G; Melendez-Zajgla, J				Gaytan-Cervantes, Javier; Gonzalez-Torres, Carolina; Maldonado, Vilma; Zampedri, Cecilia; Ceballos-Cancino, Gisela; Melendez-Zajgla, Jorge			Protein Sam68 regulates the alternative splicing of survivin DEx3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CELL; EXPRESSION; VARIANTS; PHOSPHORYLATION; TARGET; SURVIVIN-DELTA-EX3; SPECIFICITY; PREDICTS	Messenger RNA alternative splicing (AS) regulates the expression of a variety of genes involved in both physiological and pathological processes. AS of the anti-apoptotic and proliferation-associated survivin (BIRC5) gene generates six isoforms, which regulate key aspects of cancer initiation and progression. One of the isoforms is survivin DEx3, in which the exclusion of exon 3 generates a unique carboxyl terminus with specific anti-apoptotic functions. This isoform is highly expressed in advanced stages of breast and cervical tumors. Therefore, understanding the mechanisms that regulate survivin DEx3 mRNA AS is clearly important. To this end, we designed a minigene (M), and in combination with a series of deletions and site-directed mutations, we determined that the first 22 bp of exon 3 contain cis-acting elements that enhance the exclusion of exon 3 to generate the survivin DEx3 mRNA isoform. Furthermore, using pulldown assays, we discovered that Sam68 is a possible trans-acting factor that binds to this region and regulates exon 3 splicing. This result was corroborated using a cell line in which the Sam68 binding site in the survivin gene was mutated with the CRISPR/Cas system. This work provides the first clues regarding the regulation of survivin DEx3 mRNA splicing.	[Gaytan-Cervantes, Javier; Zampedri, Cecilia; Ceballos-Cancino, Gisela; Melendez-Zajgla, Jorge] Natl Inst Genom Med INMEGEN, Lab Funct Genom, Mexico City 14610, DF, Mexico; [Gonzalez-Torres, Carolina; Maldonado, Vilma] Natl Inst Genom Med INMEGEN, Lab Epigenet, Mexico City 14610, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Ceballos-Cancino, G; Melendez-Zajgla, J (corresponding author), Natl Inst Genom Med INMEGEN, Lab Funct Genom, Mexico City 14610, DF, Mexico.	gceballos@inmegen.gob.mx; jmelendez@inmegen.gob.mx	Melendez-Zajgla, Jorge/A-5708-2008; Ceballos, Gisela/AAR-2437-2021	ZAMPEDRI, CECILIA/0000-0002-4434-605X; Gaytan Cervantes, Fco. Javier/0000-0003-3386-2849; GONZALEZ, CAROLINA/0000-0003-0688-9333	Consejo Nacional de Ciencia y Tecnologia [132931]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 132931. The authors declare that they have no conflicts of interest with the contents of this article.	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bielli P, 2014, NUCLEIC ACIDS RES, V42, P12070, DOI 10.1093/nar/gku922; Bielli P, 2014, EMBO REP, V15, P419, DOI 10.1002/embr.201338241; Bonomi Serena, 2013, Int J Cell Biol, V2013, P962038, DOI 10.1155/2013/962038; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Carter BZ, 2012, BLOOD, V120, P173, DOI 10.1182/blood-2012-02-409888; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Necochea-Campion R, 2013, CANCER LETT, V339, P167, DOI 10.1016/j.canlet.2013.06.007; Douglas AGL, 2011, BRIEF FUNCT GENOMICS, V10, P151, DOI 10.1093/bfgp/elr020; Espinosa M, 2012, CANCER LETT, V318, P61, DOI 10.1016/j.canlet.2011.12.002; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Fredericks AM, 2015, BIOMOLECULES, V5, P893, DOI 10.3390/biom5020893; Frisone P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/528954; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; Kechris K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-551; Krieg A, 2002, BRIT J CANCER, V86, P737, DOI 10.1038/sj.bjc.6600153; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopergolo A, 2012, CANCER RES, V72, P3251, DOI 10.1158/0008-5472.CAN-11-4035; Malcles MH, 2007, BRIT J CANCER, V96, P1659, DOI 10.1038/sj.bjc.6603768; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nouraee N, 2009, UROL J, V6, P101; Pavlidou A, 2014, WORLD J CLIN ONCOL, V5, P883, DOI 10.5306/wjco.v5.i5.883; Pavlidou A, 2011, WORLD J GASTROENTERO, V17, P1614, DOI [10.3748/wjg.v17.i12.1614, 10.3748/wjg.v17.i12. 1614]; Piva F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/humu.21609; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Sanchez SE, 2011, RNA BIOL, V8, P954, DOI 10.4161/rna.8.6.17336; Siddharth S, 2016, CLIN EXP METASTAS, V33, P661, DOI 10.1007/s10585-016-9809-7; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; TALUKDAR I, 2011, PLOS ONE, V6, DOI DOI 10.1101/GR.849004; Taubert H, 2005, ONCOGENE, V24, P5258, DOI 10.1038/sj.onc.1208702; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Waligorska-Stachura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100534; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE, DOI DOI 10.1371/JOURNAL.PONE.0027869; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	50	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13745	13757		10.1074/jbc.M117.800318	http://dx.doi.org/10.1074/jbc.M117.800318			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655776	Green Published, hybrid			2022-12-28	WOS:000407942400006
J	McClatchie, T; Meredith, M; Ouedraogo, MO; Slow, S; Lever, M; Mann, MRW; Zeisel, SH; Trasler, JM; Baltz, JM				McClatchie, Taylor; Meredith, Megan; Ouedraogo, Mariame O.; Slow, Sandy; Lever, Michael; Mann, Mellissa R. W.; Zeisel, Steven H.; Trasler, Jacquetta M.; Baltz, Jay M.			Betaine is accumulated via transient choline dehydrogenase activation during mouse oocyte meiotic maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-VOLUME REGULATION; ORGANIC OSMOLYTE; HOMOCYSTEINE METHYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; RAT-LIVER; TRANSPORTER; GLYCINE; EMBRYOS; CULTURE; PROTEIN	Betaine (N,N,N-trimethylglycine) plays key roles in mouse eggs and preimplantation embryos first in a novel mechanism of cell volume regulation and second as a major methyl donor in blastocysts, but its origin is unknown. Here, we determined that endogenous betaine was present at low levels in germinal vesicle (GV) stage mouse oocytes before ovulation and reached high levels in the mature, ovulated egg. However, no betaine transport into oocytes was detected during meiotic maturation. Because betaine can be synthesized in mammalian cells via choline dehydrogenase (CHDH; EC 1.1.99.1), we assessed whether this enzyme was expressed and active. Chdh transcripts and CHDH protein were expressed in oocytes. No CHDH enzyme activity was detected in GV oocyte lysate, but CHDH became highly active during oocyte meiotic maturation. It was again inactive after fertilization. We then determined whether oocytes synthesized betaine and whether CHDH was required. Isolated maturing oocytes autonomously synthesized betaine in vitro in the presence of choline, whereas this failed to occur in Chdh(-/-) oocytes, directly demonstrating a requirement for CHDH for betaine accumulation in oocytes. Overall, betaine accumulation is a previously unsuspected physiological process during mouse oocyte meiotic maturation whose underlying mechanism is the transient activation of CHDH.	[McClatchie, Taylor; Meredith, Megan; Ouedraogo, Mariame O.; Baltz, Jay M.] Ottawa Hosp, Res Inst, 501 Smyth Rd,Mail Box 411, Ottawa, ON K1H 8L6, Canada; [McClatchie, Taylor; Meredith, Megan; Ouedraogo, Mariame O.; Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, Ottawa, ON K1H 8M5, Canada; [McClatchie, Taylor; Meredith, Megan; Ouedraogo, Mariame O.; Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Slow, Sandy] Univ Otago, Dept Pathol, Christchurch 8140, New Zealand; [Lever, Michael] Univ Canterbury, Dept Chem, Christchurch 8041, New Zealand; [Mann, Mellissa R. W.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Mann, Mellissa R. W.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Inst Nutr Res, Dept Nutr, Chapel Hill, NC 27599 USA; [Zeisel, Steven H.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Trasler, Jacquetta M.] Montreal Childrens Hosp, Montreal, PQ H4A 3J1, Canada; [Trasler, Jacquetta M.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pediat, Montreal, PQ H3A 1B1, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1B1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Otago; University of Canterbury; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; McGill University; McGill University; McGill University; McGill University; McGill University	Baltz, JM (corresponding author), Ottawa Hosp, Res Inst, 501 Smyth Rd,Mail Box 411, Ottawa, ON K1H 8L6, Canada.	jbaltz@ohri.ca	Mann, Mellissa/L-9006-2015	Mann, Mellissa/0000-0002-8075-3824; Baltz, Jay/0000-0002-9749-2480	Canadian Institutes of Health Research (CIHR) [MOP97972]; NIDDK, National Institutes of Health [DK056350]; CIHR Training Program in Reproduction, Early Development, and the Impact on Health [TGF96122]; Queen Elizabeth II Graduate Scholarship in Science and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CIHR Training Program in Reproduction, Early Development, and the Impact on Health(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship in Science and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant MOP97972. The production of Chdh null mice was supported by NIDDK, National Institutes of Health, Grant DK056350 (to S. H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Scholarship from the CIHR Training Program in Reproduction, Early Development, and the Impact on Health (TGF96122) and a Queen Elizabeth II Graduate Scholarship in Science and Technology.	Anas MKI, 2007, J CELL PHYSIOL, V210, P266, DOI 10.1002/jcp.20872; Anas MKI, 2008, DEVELOPMENT, V135, P4123, DOI 10.1242/dev.026575; ANBARI K, 1993, MOL REPROD DEV, V35, P24, DOI 10.1002/mrd.1080350105; Baltz JM, 2012, MOL REPROD DEV, V79, P821, DOI 10.1002/mrd.22117; Baltz Jay M, 2013, Methods Mol Biol, V957, P163, DOI 10.1007/978-1-62703-191-2_11; BARLOW P, 1985, BIOCHEM PHARMACOL, V34, P3117, DOI 10.1016/0006-2952(85)90156-X; BIGGERS JD, 1993, MOL REPROD DEV, V34, P380, DOI 10.1002/mrd.1080340406; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; CHERN MK, 1995, BIOCHEM BIOPH RES CO, V213, P561, DOI 10.1006/bbrc.1995.2168; Corbett HE, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116939; Dawson KM, 1998, BIOL REPROD, V59, P225, DOI 10.1095/biolreprod59.2.225; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; EDWARDS RG, 1959, J ENDOCRINOL, V18, P292, DOI 10.1677/joe.0.0180292; EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1; Erdogan S, 2005, DEV BIOL, V286, P352, DOI 10.1016/j.ydbio.2005.08.009; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; GROSSMAN EB, 1989, AM J PHYSIOL, V256, pF107; HAGHIGHAT N, 1990, J EXP ZOOL, V253, P71, DOI 10.1002/jez.1402530110; Hammer MA, 2002, MOL REPROD DEV, V62, P195, DOI 10.1002/mrd.10088; HAUBRICH DR, 1981, BIOCHEM PHARMACOL, V30, P2993, DOI 10.1016/0006-2952(81)90265-3; Ikeda S, 2012, J REPROD DEVELOP, V58, P38, DOI 10.1262/jrd.2011-002; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Lee MB, 2012, J BIOL CHEM, V287, P33094, DOI 10.1074/jbc.M112.365478; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; McEntyre CJ, 2015, ANN CLIN BIOCHEM, V52, P352, DOI 10.1177/0004563214545346; McGinnis LA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127027; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; PETRONINI PG, 1994, BIOCHEM J, V300, P45, DOI 10.1042/bj3000045; Pietruszko R, 2001, CHEM-BIOL INTERACT, V130, P193, DOI 10.1016/S0009-2797(00)00277-5; Riveros-Rosas H, 2013, CHEM-BIOL INTERACT, V202, P51, DOI 10.1016/j.cbi.2012.11.015; SALUSTRI A, 1983, J REPROD FERTIL, V68, P335, DOI 10.1530/jrf.0.0680335; Salvi F, 2013, ARCH BIOCHEM BIOPHYS, V537, P243, DOI 10.1016/j.abb.2013.07.018; Schwahn BC, 2004, BIOCHEM J, V382, P831, DOI 10.1042/BJ20030822; SELLENS MH, 1981, J REPROD FERTIL, V61, P307, DOI 10.1530/jrf.0.0610307; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Steeves CL, 2003, P NATL ACAD SCI USA, V100, P13982, DOI 10.1073/pnas.2334537100; Tartia AP, 2009, DEVELOPMENT, V136, P2247, DOI 10.1242/dev.036756; VANWINKLE LJ, 1993, BIOCHIM BIOPHYS ACTA, V1146, P38, DOI 10.1016/0005-2736(93)90335-W; VANWINKLE LJ, 1990, J EXP ZOOL, V253, P215, DOI 10.1002/jez.1402530211; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Verlhac MH, 1996, DEVELOPMENT, V122, P815; WASSARMAN PM, 1976, J CELL SCI, V22, P531; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zhang BH, 2015, FASEB J, V29, P1069, DOI 10.1096/fj.14-261131; Zhou CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007417	52	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13784	13794		10.1074/jbc.M117.803080	http://dx.doi.org/10.1074/jbc.M117.803080			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28663368	Green Published, hybrid			2022-12-28	WOS:000407942400018
J	Petersen, J; Inoue, S; Kelly, SM; Sullivan, S; Kinoshita, T; Christie, JM				Petersen, Jan; Inoue, Shin-ichiro; Kelly, Sharon M.; Sullivan, Stuart; Kinoshita, Toshinori; Christie, John M.			Functional characterization of a constitutively active kinase variant of Arabidopsis phototropin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT RECEPTOR; LOV2 DOMAIN; CONFORMATIONAL-CHANGES; MUTATIONAL ANALYSIS; STRUCTURAL-CHANGES; VOLTAGE DOMAINS; BINDING DOMAINS; PLANT-GROWTH; PHOTORECEPTOR; OXYGEN	Phototropins (phots) are plasma membrane-associated serine/threonine kinases that coordinate a range of processes linked to optimizing photosynthetic efficiency in plants. These photoreceptors contain two light-, oxygen-, or voltage-sensing (LOV) domains within their N terminus, with each binding one molecule of flavin mononucleotide as a UV/blue light-absorbing chromophore. Although phots contain two LOV domains, light-induced activation of the C-terminal kinase domain and subsequent receptor autophosphorylation is controlled primarily by the A'alpha-LOV2-J alpha photosensory module. Mutations that disrupt interactions between the LOV2 core and its flanking helical segments can uncouple this mode of light regulation. However, the impact of these mutations on phot function in Arabidopsis has not been explored. Here we report that histidine substitution of Arg-472 located within the A'alpha-helix of Arabidopsis phot1 constitutively activates phot1 kinase activity in vitro without affecting LOV2 photochemistry. Expression analysis of phot1 R472H in the phot-deficient mutant confirmed that it is autophosphorylated in darkness in vivo but unable to initiate phot1 signaling in the absence of light. Instead, we found that phot1 R472H is poorly functional under low-light conditions but can restore phototropism, chloroplast accumulation, stomatal opening, and leaf positioning and expansion at higher light intensities. Our findings suggest that Arabidopsis can adapt to the elevated phosphorylation status of the phot1 R472H mutant in part by reducing its stability, whereas the activity of the mutant under high-light conditions can be attributed to additional increases in LOV2-mediated photoreceptor autophosphorylation.	[Petersen, Jan; Kelly, Sharon M.; Sullivan, Stuart; Christie, John M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Inoue, Shin-ichiro; Kinoshita, Toshinori] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kinoshita, Toshinori] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	University of Glasgow; Nagoya University; Nagoya University	Christie, JM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland.	john.christie@glasgow.ac.uk	Sullivan, Stuart/AAC-5816-2019; Kinoshita, Toshinori/C-2891-2012; Inoue, Shin-ichiro/I-7215-2014	Sullivan, Stuart/0000-0002-1042-7855; Kinoshita, Toshinori/0000-0001-7621-1259; Petersen, Jan/0000-0002-8469-6679; Christie, John/0000-0002-9976-0055; Kelly, Sharon/0000-0002-3516-1387	UK Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128/1]; Ministry of Education, Culture, Sports, Science, and Technology, Japan KAKENHI [15H05956, 15K21750]; Bellahouston travel fellowship; BBSRC [BB/J016047/1, BB/M002128/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M002128/1, BB/J016047/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Education, Culture, Sports, Science, and Technology, Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bellahouston travel fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by UK Biotechnology and Biological Sciences Research Council Grants BB/J016047/1 and BB/M002128/1 (to J.M.C.) and the Ministry of Education, Culture, Sports, Science, and Technology, Japan KAKENHI Grants 15H05956 and 15K21750 (to T.K.). This work was also supported by a Bellahouston travel fellowship (to J.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2015, PLANT CELL PHYSIOL, V56, P401, DOI 10.1093/pcp/pcu196; Christie JM, 2013, AM J BOT, V100, P35, DOI 10.3732/ajb.1200340; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; de Wit M, 2016, ANNU REV PLANT BIOL, V67, P513, DOI 10.1146/annurev-arplant-043015-112252; Doi M, 2004, J EXP BOT, V55, P517, DOI 10.1093/jxb/erh044; Fankhauser C, 2015, CURR BIOL, V25, pR384, DOI 10.1016/j.cub.2015.03.020; Freddolino PL, 2013, PHOTOCH PHOTOBIO SCI, V12, P1158, DOI 10.1039/c3pp25400c; Haga K, 2015, PLANT CELL, V27, P1098, DOI 10.1105/tpc.15.00178; Halavaty AS, 2013, ACTA CRYSTALLOGR F, V69, P1316, DOI 10.1107/S1744309113029199; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Herman E, 2015, BIOCHEMISTRY-US, V54, P1484, DOI 10.1021/bi501509z; Inoue S, 2008, MOL PLANT, V1, P15, DOI 10.1093/mp/ssm001; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Jones MA, 2008, PLANT SIGNAL BEHAV, V3, P44, DOI 10.4161/psb.3.1.4848; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Knieb E, 2005, PHOTOCHEM PHOTOBIOL, V81, P177, DOI 10.1562/2004-04-03-RA-133.1; Kong SG, 2007, PLANT J, V51, P862, DOI 10.1111/j.1365-313X.2007.03187.x; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Liscum E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00827; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Okajima K, 2014, J BIOL CHEM, V289, P413, DOI 10.1074/jbc.M113.515403; Onodera A, 2005, PLANT CELL PHYSIOL, V46, P367, DOI 10.1093/pcp/pci037; Pedmale UV, 2007, J BIOL CHEM, V282, P19992, DOI 10.1074/jbc.M702551200; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Preuten T, 2015, NEW PHYTOL, V206, P1038, DOI 10.1111/nph.13299; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sharma S, 2014, PLANT PHYSIOL, V164, P2030, DOI 10.1104/pp.113.232306; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Sullivan S, 2016, PLANT J, V88, P907, DOI 10.1111/tpj.13313; Sullivan S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00290; Sullivan S, 2016, NEW PHYTOL, V209, P612, DOI 10.1111/nph.13640; Sullivan S, 2010, PLANT SIGNAL BEHAV, V5, P184, DOI 10.4161/psb.5.2.11082; Sullivan S, 2009, FEBS LETT, V583, P2187, DOI 10.1016/j.febslet.2009.06.011; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takeda K, 2013, J PHYS CHEM B, V117, P15606, DOI 10.1021/jp406109j; Takemiya A, 2005, PLANT CELL, V17, P1120, DOI 10.1105/tpc.104.030049; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037	62	11	11	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13843	13852		10.1074/jbc.M117.799643	http://dx.doi.org/10.1074/jbc.M117.799643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28663371	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000407942400022
J	Karpowicz, RJ; Haney, CM; Mihaila, TS; Sandler, RM; Petersson, EJ; Lee, VMY				Karpowicz, Richard J., Jr.; Haney, Conor M.; Mihaila, Tiberiu S.; Sandler, Raizel M.; Petersson, E. James; Lee, Virginia M. -Y.			Selective imaging of internalized proteopathic alpha-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; LEWY BODY; NEURODEGENERATIVE DISEASES; SPECTROSCOPIC PROPERTIES; AXONAL-TRANSPORT; DNA TRANSFECTION; MOUSE MODEL; CHLOROQUINE; FIBRILS; CELLS	Direct cell-to-cell transmission of proteopathic alpha-synuclein (alpha-syn) aggregates is thought to underlie the progression of neuro-degenerative synucleinopathies. However, the specific intracellular processes governing this transmission remain unclear because currently available model systems are limited. For example, in cell culture models of alpha-syn-seeded aggregation, it is difficult to discern intracellular from extracellular exogenously applied alpha-syn seed species. Herein, we employed fluorescently labeled alpha-syn preformed fibrils (pffs) in conjunction with the membrane-impermeable fluorescence quencher trypan blue to selectively image internalized alpha-syn seeds in cultured primary neurons and to quantitatively characterize the concentration dependence, time course, and inhibition of pff uptake. To study the long-term fates of exogenous alpha-syn pffs in neurons, we developed a pff species labeled at amino acid residue 114 with the environmentally insensitive fluorophore BODIPY or the pH-sensitive dye pHrodo red. We found that pffs are rapidly trafficked along the endolysosomal pathway, where most of the material remains for days. We also found that brief pharmacological perturbation of lysosomes shortly after the pff treatment causes aberrations in intracellular processing of pff seeds concomitant with an increased rate of inclusion formation via recruitment of endogenous alpha-syn to a relatively small number of exogenous seeds. Our results validate a quantitative assay for pff uptake in primary neurons, implicate lysosomal processing as the major fate of internalized proteopathic seeds, and suggest lysosomal integrity as a significant rate-determining step in the transmission of alpha-syn pathology. Further, lysosomal processing of transmitted seeds may represent a new therapeutic target to combat the spread of synucleinopathies.	[Karpowicz, Richard J., Jr.; Sandler, Raizel M.; Lee, Virginia M. -Y.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Haney, Conor M.; Mihaila, Tiberiu S.; Petersson, E. James] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, VMY (corresponding author), 3600 Spruce St,3 Maloney Bldg, Philadelphia, PA 19104 USA.	vmylee@upenn.edu	Haney, Conor/AAP-6396-2020	Mihaila, Tiberiu/0000-0003-4900-7214; Frasier, Raizel/0000-0002-8956-9345	National Science Foundation (NSF) [DMR05-20020]; NSF [MRI-0820996]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081033, P50NS053488, R56NS081033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dawn M. Riddle for providing primary neurons, Matthew D. Byrne and Kyle J. McKee for technical assistance, Anna Steiber for the immuno-EM experiments, and Dr. Andrea Stout for helpful discussions regarding confocal microscopy experiments. All confocal images were acquired with instruments from the University of Pennsylvania Cell and Developmental Biology Microscopy Core. Instruments supported by the National Science Foundation (NSF) include the CD spectrometer (NSF Grant DMR05-20020) and the MALDI mass spectrometer (NSF Grant MRI-0820996).	Abounit S, 2016, EMBO J, V35, P2120, DOI 10.15252/embj.201593411; Apetri MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153020; Bae EJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.283; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bieri G, 2018, NEUROBIOL DIS, V109, P219, DOI 10.1016/j.nbd.2017.03.007; Bourdenx M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00083; Brahic M, 2016, ACTA NEUROPATHOL, V131, P539, DOI 10.1007/s00401-016-1538-0; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dehay B, 2012, AUTOPHAGY, V8, P1389, DOI 10.4161/auto.21011; Erbacher P, 1996, EXP CELL RES, V225, P186, DOI 10.1006/excr.1996.0169; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Flavin WP, 2017, ACTA NEUROPATHOL, V134, P629, DOI 10.1007/s00401-017-1722-x; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Frohlich E, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-26; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Haney CM, 2016, ORG BIOMOL CHEM, V14, P1584, DOI 10.1039/c5ob02329g; Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; HED J, 1987, J IMMUNOL METHODS, V101, P119, DOI 10.1016/0022-1759(87)90224-9; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; KAROLIN J, 1994, J AM CHEM SOC, V116, P7801, DOI 10.1021/ja00096a042; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; LOIKE JD, 1983, J IMMUNOL METHODS, V57, P373, DOI 10.1016/0022-1759(83)90097-2; Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Pacheco C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00297; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Rosenbloom B, 2011, BLOOD CELL MOL DIS, V46, P95, DOI 10.1016/j.bcmd.2010.10.006; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Samuel F, 2016, J BIOL CHEM, V291, P4374, DOI 10.1074/jbc.M115.705095; Schenborn E T, 2000, Methods Mol Biol, V130, P147; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stopa B, 2003, ACTA BIOCHIM POL, V50, P1213; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	61	87	87	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13482	13497		10.1074/jbc.M117.780296	http://dx.doi.org/10.1074/jbc.M117.780296			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28611062	Green Published, hybrid			2022-12-28	WOS:000407465300033
J	Jang, H; Banerjee, A; Chavan, T; Gaponenko, V; Nussinov, R				Jang, Hyunbum; Banerjee, Avik; Chavan, Tanmay; Gaponenko, Vadim; Nussinov, Ruth			Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); fluorescence; GTPase Kras (KRAS); molecular dynamics; nuclear magnetic resonance (NMR); post-translational modification (PTM); KRAS-driven adenocarcinoma; PI3K; hypervariable region; prenylation	FREE-ENERGY CALCULATIONS; SMALL GTPASE K-RAS4B; MOLECULAR-DYNAMICS; RAS ISOFORMS; K-RAS; ONCOGENIC MUTATIONS; STRUCTURAL BASIS; CALCIUM SENSOR; H-RAS; BINDING	In calmodulin (CaM)-rich environments, oncogenic KRAS plays a critical role in adenocarcinomas by promoting PI3K/Akt signaling. We previously proposed that at elevated calcium levels in cancer, CaM recruits PI3K to the membrane and extracts K-Ras4B from the membrane, organizing a K-Ras4B-CaM-PI3K ternary complex. CaM can thereby replace a missing receptor-tyrosine kinase signal to fully activate PI3K. Recent experimental data show that CaM selectively promotes K-Ras signaling but not of N-Ras or H-Ras. How CaM specifically targets K-Ras and how it extracts it from the membrane in KRAS-driven cancer is unclear. Obtaining detailed structural information for a CaM-K-Ras complex is still challenging. Here, using molecular dynamics simulations and fluorescence experiments, we observed that CaM preferentially binds unfolded K-Ras4B hypervariable regions (HVRs) and not -helical HVRs. The interaction involved all three CaM domains including the central linker and both lobes. CaM specifically targeted the highly polybasic anchor region of the K-Ras4B HVR that stably wraps around CaM's acidic linker. The docking of the farnesyl group to the hydrophobic pockets located at both CaM lobes further enhanced CaM-HVR complex stability. Both CaM and K-Ras4B HVR are highly flexible molecules, suggesting that their interactions permit highly dynamic flexible-body motions. We, therefore, anticipate that the flexible-body interaction is required to extract K-Ras4B from the membrane, as conformational plasticity enables CaM to orient efficiently to the polybasic HVR anchor, which is partially diffused into the liquid-phase membrane. Our structural model of the CaM-K-Ras4B HVR association provides plausible clues to CaM's regulatory action in PI3K activation involving the ternary complex in cell proliferation signaling by oncogenic K-Ras.	[Jang, Hyunbum; Nussinov, Ruth] Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, NCI Frederick, Frederick, MD 21702 USA; [Banerjee, Avik] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Chavan, Tanmay] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University; Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, NCI Frederick, Frederick, MD 21702 USA.; Gaponenko, V (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	vadimg@uic.edu; NussinoR@helix.nih.gov	Gaponenko, Vadim/K-9729-2019	Banerjee, Avik/0000-0002-0668-5480; Chavan, Tanmay/0000-0002-2702-6863; Jang, Hyunbum/0000-0001-9402-4051; Nussinov, Ruth/0000-0002-8115-6415; Gaponenko, Vadim/0000-0002-7891-9223	National Institutes of Health [HHSN261200800001E]; Intramural Research Program of National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010441, R01CA188427, ZIABC010442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health under Contract HHSN261200800001E (Frederick National Laboratory for Cancer Research) and by the Intramural Research Program of National Institutes of Health, Frederick National Laboratory for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the United States government. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government.	Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Alvarez-Moya Blanca, 2011, Small GTPases, V2, P99; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrabarti M, 2016, J PHYS CHEM B, V120, P667, DOI 10.1021/acs.jpcb.5b11110; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chavan TS, 2015, BIOPHYS J, V109, P2602, DOI 10.1016/j.bpj.2015.09.034; Chavan TS, 2013, MOLECULES, V18, P7103, DOI 10.3390/molecules18067103; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chung SI, 2016, ONCOTARGET, V7, P7354, DOI 10.18632/oncotarget.6931; Erwin N, 2016, PHYS CHEM CHEM PHYS, V18, P30020, DOI 10.1039/c6cp06553h; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Grayson P, 2003, BIOPHYS J, V85, P36, DOI 10.1016/S0006-3495(03)74452-X; Haiech J., 2000, TOPICS FLUORESCENCE, P175; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Komeiji Y, 2002, FEBS LETT, V521, P133, DOI 10.1016/S0014-5793(02)02853-3; Li ZL, 2017, STRUCTURE, V25, P679, DOI 10.1016/j.str.2017.02.007; Liao JH, 2006, J BIOL CHEM, V281, P29730, DOI 10.1074/jbc.M600668200; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Lu SY, 2016, CHEM SOC REV, V45, P4929, DOI 10.1039/c5cs00911a; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Lu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21949; Lu SY, 2015, J BIOL CHEM, V290, P28887, DOI 10.1074/jbc.M115.664755; Mageean CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142674; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Muratcioglu S, 2017, J PHYS CHEM B, V121, P5917, DOI 10.1021/acs.jpcb.7b03035; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nussinov R, 2016, SEMIN CELL DEV BIOL, V58, P79, DOI 10.1016/j.semcdb.2016.04.001; Nussinov R, 2016, EXPERT OPIN THER TAR, V20, P831, DOI 10.1517/14728222.2016.1135131; Nussinov R, 2016, CANCER RES, V76, P18, DOI 10.1158/0008-5472.CAN-15-1536; Nussinov R, 2015, MOL CANCER RES, V13, P1265, DOI 10.1158/1541-7786.MCR-15-0165; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; Sperlich B, 2016, BIOPHYS J, V111, P113, DOI 10.1016/j.bpj.2016.05.042; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang W, 2000, J MOL BIOL, V303, P567, DOI 10.1006/jmbi.2000.4057; Weise K, 2012, J AM CHEM SOC, V134, P11503, DOI 10.1021/ja305518h; Wu LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021929; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528	59	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12544	12559		10.1074/jbc.M117.785063	http://dx.doi.org/10.1074/jbc.M117.785063			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28623230	Green Published, hybrid			2022-12-28	WOS:000406636900020
J	Pirone, L; Ripoll-Rozada, J; Leone, M; Ronca, R; Lombardo, F; Fiorentino, G; Andersen, JF; Pereira, PJB; Arca, B; Pedone, E				Pirone, Luciano; Ripoll-Rozada, Jorge; Leone, Marilisa; Ronca, Raffaele; Lombardo, Fabrizio; Fiorentino, Gabriella; Andersen, John F.; Pereira, Pedro Jose Barbosa; Arca, Bruno; Pedone, Emilia			Functional analyses yield detailed insight into the mechanism of thrombin inhibition by the antihemostatic salivary protein cE5 from Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme inhibitor; hemostasis; intrinsically disordered protein; protein-protein interaction; Anopheles; mosquito saliva	PEPTIDES; SEQUENCE; TRIFLUOROETHANOL; IDENTIFICATION; DATABASE; BINDING; CLONING; SYSTEM	Saliva of blood-feeding arthropods carries several antihemostatic compounds whose physiological role is to facilitate successful acquisition of blood. The identification of novel natural anticoagulants and the understanding of their mechanism of action may offer opportunities for designing new antithrombotics disrupting blood clotting. We report here an in-depth structural and functional analysis of the anophelin family member cE5, a salivary protein from the major African malaria vector Anopheles gambiae that specifically, tightly, and quickly binds and inhibits thrombin. Using calorimetry, functional assays, and complementary structural techniques, we show that the central region of the protein, encompassing amino acids Asp-31-Arg-62, is the region mainly responsible for -thrombin binding and inhibition. As previously reported for the Anopheles albimanus orthologue anophelin, cE5 binds both thrombin exosite I with segment Glu-35-Asp-47 and the catalytic site with the region Pro-49-Arg-56, which includes the highly conserved DPGR tetrapeptide. Moreover, the N-terminal Ala-1-Ser-30 region of cE5 (which includes an RGD tripeptide) and the additional C-terminal serine-rich Asn-63-Glu-82 region (absent in orthologues from anophelines of the New World species A. albimanus and Anopheles darlingi) also played some functionally relevant role. Indeed, we observed decreased thrombin binding and inhibitory properties even when using the central cE5 fragment (Asp-31-Arg-62) alone. In summary, these results shed additional light on the mechanism of thrombin binding and inhibition by this family of salivary anticoagulants from anopheline mosquitoes.	[Pirone, Luciano; Leone, Marilisa; Pedone, Emilia] CNR, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy; [Ripoll-Rozada, Jorge; Pereira, Pedro Jose Barbosa] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Ripoll-Rozada, Jorge; Pereira, Pedro Jose Barbosa] Univ Porto, Inst Invest & Inovacao Saude, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Ronca, Raffaele; Fiorentino, Gabriella] Univ Napoli Federico II, Dept Biol, Via Cinthia, I-80126 Naples, Italy; [Lombardo, Fabrizio; Arca, Bruno] Sapienza Univ Rome, Div Parasitol, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Andersen, John F.] NIAID, NIH, Lab Malaria & Vector Res, Rockville, MD 20852 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Naples Federico II; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pedone, E (corresponding author), CNR, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy.; Arca, B (corresponding author), Sapienza Univ Rome, Div Parasitol, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	bruno.arca@uniroma1.it; empedone@unina.it	Pereira, Pedro/F-8972-2011; Pirone, Luciano/ABG-2892-2020; Rozada, Jorge Ripoll/AAA-8049-2020; Ripoll Rozada, Jorge/L-1574-2016; Pedone, Emilia Maria/K-2229-2015; Pedone, Emilia/HDN-2342-2022; Lombardo, Fabrizio/J-8511-2014; FIORENTINO, Gabriella/E-2843-2017; Arca, Bruno/C-8383-2012	Pereira, Pedro/0000-0003-0969-5438; Pirone, Luciano/0000-0002-7014-4689; Rozada, Jorge Ripoll/0000-0001-7235-317X; Ripoll Rozada, Jorge/0000-0001-7235-317X; Pedone, Emilia Maria/0000-0003-0203-8611; Pedone, Emilia/0000-0003-0203-8611; Lombardo, Fabrizio/0000-0002-8563-0612; FIORENTINO, Gabriella/0000-0002-4089-3822; LEONE, MARILISA/0000-0002-3811-6960; Arca, Bruno/0000-0002-4029-0984	European Community [227764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012] Funding Source: NIH RePORTER	European Community(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge J. M. C. Ribeiro for kindly providing the anophelin peptide, the European Synchrotron Radiation Facility (ESRF) for provision of synchrotron radiation facilities, and the ESRF staff for help with data collection. Transnational Access to the High Throughput Crystallization Laboratory of the European Molecular Biology Laboratory Grenoble Outstation was supported by the European Community-Seventh Framework Program (FP7/2007-2013) Grant Protein Production Platform (PCUBE Agreement 227764).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8; Assumpcao TCF, 2012, TOXINS, V4, P296, DOI 10.3390/toxins4050296; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Contursi P, 2014, NUCLEIC ACIDS RES, V42, P5993, DOI 10.1093/nar/gku215; De Cristofaro R, 2003, J THROMB THROMBOLYS, V15, P151, DOI 10.1023/B:THRO.0000011370.80989.7b; de Paola I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Figueiredo AC, 2012, P NATL ACAD SCI USA, V109, pE3649, DOI 10.1073/pnas.1211614109; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Goddard T. D., SPARKY 3; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Gruet A, 2016, FEBS J, V283, P576, DOI 10.1111/febs.13631; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Liu CC, 2007, J AM CHEM SOC, V129, P10648, DOI 10.1021/ja0735002; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Maestro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056904; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pellecchia M, 2005, CHEM BIOL, V12, P961, DOI 10.1016/j.chembiol.2005.08.013; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Raffler NA, 2003, CHEM BIOL, V10, P69, DOI 10.1016/S1074-5521(02)00309-5; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ronca R, 2012, INSECT BIOCHEM MOLEC, V42, P610, DOI 10.1016/j.ibmb.2012.04.008; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stark KR, 1996, PARASITOL TODAY, V12, P430, DOI 10.1016/0169-4758(96)10064-8; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Williams J W, 1979, Methods Enzymol, V63, P437; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zaccaro L, 2009, CURR MED CHEM, V16, P780, DOI 10.2174/092986709787549307	50	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12632	12642		10.1074/jbc.M117.788042	http://dx.doi.org/10.1074/jbc.M117.788042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28592490	hybrid, Green Published			2022-12-28	WOS:000406636900027
J	Sleno, R; Devost, D; Petrin, D; Zhang, A; Bourque, K; Shinjo, Y; Aoki, J; Inoue, A; Hebert, TE				Sleno, Rory; Devost, Dominic; Petrin, Darlaine; Zhang, Alice; Bourque, Kyla; Shinjo, Yuji; Aoki, Junken; Inoue, Asuka; Hebert, Terence E.			Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2 alpha receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; SINGLE-MOLECULE ANALYSIS; A GPCR DIMERS; CRYSTAL-STRUCTURE; LIVING CELLS; FUNCTIONAL SELECTIVITY; ADRENERGIC-RECEPTORS; SIGNALING COMPLEXES; PLASMA-MEMBRANE	G protein-coupled receptors (GPCRs) are conformationally dynamic proteins transmitting ligand-encoded signals in multiple ways. This transmission is highly complex and achieved through induction of distinct GPCR conformations, which preferentially drive specific receptor-mediated signaling events. This conformational capacity can be further enlarged via allosteric effects between dimers, warranting further study of these effects. Using GPCR conformation-sensitive biosensors, we investigated allosterically induced conformational changes in the recently reported F prostanoid (FP)/angiotensin II type 1 receptor (AT1R) heterodimer. Ligand occupancy of the AT1R induced distinct conformational changes in FP compared with those driven by PGF2 alpha in bioluminescence resonance energy transfer (BRET)-based FP biosensors engineered with Renilla luciferase (RLuc) as an energy donor in the C-tail and fluorescein arsenical hairpin binder (FlAsH)-labeled acceptors at different positions in the intracellular loops. We also found that this allosteric communication is mediated through G alpha(q) andmay also involve proximal (phospholipase C) but not distal (protein kinase C) signaling partners. Interestingly, beta-arrestin-biased AT1R agonists could also transmit a G alpha(q)-dependent signal to FP without activation of downstream G alpha(q) signaling. This transmission of information was specific to the AT1R/FP complex, as activation of G alpha(q) by the oxytocin receptor did not recapitulate the same phenomenon. Finally, information flow was asymmetric in the sense that FP activation had negligible effects on AT1R-based conformational biosensors. The identification of partner-induced GPCR conformations may help identify novel allosteric effects when investigating multiprotein receptor signaling complexes.	[Sleno, Rory; Devost, Dominic; Petrin, Darlaine; Zhang, Alice; Bourque, Kyla; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Shinjo, Yuji; Aoki, Junken; Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	McGill University; Tohoku University; Japan Science & Technology Agency (JST)	Hebert, TE (corresponding author), Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca			Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research Grant [MOP-130309]; PRESTO, Japan Science and Technology Agency; AMED-CREST, AMED; McGill-Canadian Institutes of Health Research (CIHR) Drug Development Training Program	Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); AMED-CREST, AMED; McGill-Canadian Institutes of Health Research (CIHR) Drug Development Training Program	This work was supported in part by a grant from the Consortium Quebecois sur la Decouverte du Medicament and the Canadian Institutes of Health Research Grant MOP-130309 (to T. E. H.), grants from PRESTO, Japan Science and Technology Agency (to A. I.), and AMED-CREST, AMED (to J. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the McGill-Canadian Institutes of Health Research (CIHR) Drug Development Training Program.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bird IM, 1997, ENDOCRINOLOGY, V138, P490, DOI 10.1210/en.138.1.490; Borghi C, 2015, HIGH BLOOD PRESS CAR, V22, P429, DOI 10.1007/s40292-015-0120-5; Bourque K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00061; Bouvier M, 2014, J PHYSIOL-LONDON, V592, P2439, DOI 10.1113/jphysiol.2014.272252; Bouvier M, 2014, J PHYSIOL-LONDON, V592, P2447, DOI 10.1113/jphysiol.2014.274233; Bouvier M, 2013, NAT STRUCT MOL BIOL, V20, P539, DOI 10.1038/nsmb.2584; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; COX BE, 1993, J CLIN INVEST, V92, P2240, DOI 10.1172/JCI116827; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Devost D, 2003, J MOL ENDOCRINOL, V31, P461, DOI 10.1677/jme.0.0310461; Devost D, 2017, J BIOL CHEM, V292, P5443, DOI 10.1074/jbc.M116.763854; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Felce JH, 2014, BIOPHYS J, V106, pL41, DOI 10.1016/j.bpj.2014.04.061; Gavalas A, 2013, MOL PHARMACOL, V84, P346, DOI 10.1124/mol.113.086868; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Goupil E, 2012, MINI-REV MED CHEM, V12, P817, DOI 10.2174/138955712800959143; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Goupil E, 2013, BRIT J PHARMACOL, V168, P1101, DOI 10.1111/bph.12040; Goupil E, 2010, J BIOL CHEM, V285, P25624, DOI 10.1074/jbc.M110.115196; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hebert RL, 2005, J BIOL CHEM, V280, P35028, DOI 10.1074/jbc.M505852200; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; JENKIN G, 1992, J REPROD FERTIL, P97; Jonas KC, 2015, J BIOL CHEM, V290, P3875, DOI 10.1074/jbc.M114.622498; Kawano K, 2013, ANAL CHEM, V85, P3454, DOI 10.1021/ac400177a; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2449, DOI 10.1113/jphysiol.2014.274241; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Lan TH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10166; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lane JR, 2014, NAT CHEM BIOL, V10, P745, DOI [10.1038/nchembio.1593, 10.1038/NCHEMBIO.1593]; Levitz J, 2016, NEURON, V92, P143, DOI 10.1016/j.neuron.2016.08.036; Liedman R, 2009, GYNECOL ENDOCRINOL, V25, P188, DOI 10.1080/09513590802573213; Lu HK, 1996, AM J PHYSIOL-CELL PH, V271, pC1340, DOI 10.1152/ajpcell.1996.271.4.C1340; Maier-Peuschel M, 2010, J BIOL CHEM, V285, P8793, DOI 10.1074/jbc.M109.098517; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mejia R, 2015, MOL ENDOCRINOL, V29, P238, DOI 10.1210/me.2014-1324; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Namkung Y, 2016, METHODS, V92, P5, DOI 10.1016/j.ymeth.2015.04.010; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rattan S, 2003, EXP BIOL MED, V228, P972, DOI 10.1177/153537020322800814; Rebois RV, 2012, CELL SIGNAL, V24, P2051, DOI 10.1016/j.cellsig.2012.06.011; Robertson DN, 2016, METHODS, V92, P19, DOI 10.1016/j.ymeth.2015.07.011; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sleno R, 2016, METHODS, V92, P11, DOI 10.1016/j.ymeth.2015.05.003; Tesmer JJG, 2016, NAT REV MOL CELL BIO, V17, P439, DOI 10.1038/nrm.2016.36; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yamaleyeva LM, 2013, PLACENTA, V34, P497, DOI 10.1016/j.placenta.2013.03.008; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	68	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12139	12152		10.1074/jbc.M117.793877	http://dx.doi.org/10.1074/jbc.M117.793877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28584054	Green Published, hybrid			2022-12-28	WOS:000406053300013
J	Stevens, CM; Rayani, K; Singh, G; Lotfalisalmasi, B; Tieleman, DP; Tibbits, GF				Stevens, Charles M.; Rayani, Kaveh; Singh, Gurpreet; Lotfalisalmasi, Bairam; Tieleman, D. Peter; Tibbits, Glen F.			Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSITIZING MUTATIONS; HYPERTROPHIC CARDIOMYOPATHY; REGULATORY DOMAIN; CA2+ BINDING; N-DOMAIN; DILATED CARDIOMYOPATHY; STRUCTURAL TRANSITION; HIGH-THROUGHPUT; FORCE-FIELD; SIMULATIONS	Cardiac troponin C (cTnC) is the regulatory protein that initiates cardiac contraction in response to Ca2+. TnC binding Ca2+ initiates a cascade of protein-protein interactions that begins with the opening of the N-terminal domain of cTnC, followed by cTnC binding the troponin I switch peptide (TnI(SW)). We have evaluated, through isothermal titration calorimetry and molecular-dynamics simulation, the effect of several clinically relevant mutations (A8V, L29Q, A31S, L48Q, Q50R, and C84Y) on the Ca2+ affinity, structural dynamics, and calculated interaction strengths between cTnC and each of Ca2+ and TnI(SW). Surprisingly the Ca2+ affinity measured by isothermal titration calorimetry was only significantly affected by half of these mutations including L48Q, which had a 10-fold higher affinity than WT, and the Q50R and C84Y mutants, each of which had affinities 3-fold higher than wild type. This suggests that Ca2+ affinity of the N-terminal domain of cTnC in isolation is insufficient to explain the pathogenicity of these mutations. Molecular-dynamics simulation was used to evaluate the effects of these mutations on Ca2+ binding, structural dynamics, and TnI interaction independently. Many of the mutations had a pronounced effect on the balance between the open and closed conformations of the TnC molecule, which provides an indirect mechanism for their pathogenic properties. Our data demonstrate that the structural dynamics of the cTnC molecule are key in determining myofilament Ca2+ sensitivity. Our data further suggest that modulation of the structural dynamics is the underlying molecular mechanism for many disease mutations that are far from the regulatory Ca2+-binding site of cTnC.	[Stevens, Charles M.; Tibbits, Glen F.] British Columbia Childrens Hosp, Res Inst, Cardiovasc Sci, Vancouver, BC V5Z 4H4, Canada; [Stevens, Charles M.; Rayani, Kaveh; Lotfalisalmasi, Bairam; Tibbits, Glen F.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Tibbits, Glen F.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A IS6, Canada; [Singh, Gurpreet; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Singh, Gurpreet; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	BC Childrens Hospital; University of British Columbia; Simon Fraser University; Simon Fraser University; University of Calgary; University of Calgary	Tibbits, GF (corresponding author), Simon Fraser Univ, Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	tibbits@sfu.ca		Tibbits, Glen/0000-0002-2586-3115	Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (to G. F. T. and to D. P. T.) and Canadian Institute of Health Research (to G. F. T.). The authors declare that they have no conflicts of interest with the contents of this article.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cerutti DS, 2009, J CHEM THEORY COMPUT, V5, P2322, DOI 10.1021/ct9001015; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Dewan S, 2016, J PHYS CHEM B, V120, P8264, DOI 10.1021/acs.jpcb.6b01950; Dong WJ, 1997, BIOPHYS J, V72, P850, DOI 10.1016/S0006-3495(97)78719-8; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Feest ER, 2014, J MOL CELL CARDIOL, V72, P219, DOI 10.1016/j.yjmcc.2014.03.015; Genge CE, 2016, GENOME BIOL EVOL, V8, P994, DOI 10.1093/gbe/evw044; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gillis TE, 2003, BIOCHEMISTRY-US, V42, P6418, DOI 10.1021/bi0340494; Gillis TE, 2007, PHYSIOL GENOMICS, V32, P16, DOI 10.1152/physiolgenomics.00197.2007; Harada K, 2004, JPN J PHYSIOL, V54, P307, DOI 10.2170/jjphysiol.54.307; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Hwang PM, 2014, P NATL ACAD SCI USA, V111, P14412, DOI 10.1073/pnas.1410775111; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Kekenes-Huskey PM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002777; Kirschenlohr HL, 2000, BIOCHEM J, V346, P385, DOI 10.1042/0264-6021:3460385; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Li AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079363; Li H, 2015, J PHYS CHEM B, V119, P9401, DOI 10.1021/jp510560k; Li MX, 2015, GENE, V571, P153, DOI 10.1016/j.gene.2015.07.074; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lindert S, 2015, BIOPHYS J, V108, P395, DOI 10.1016/j.bpj.2014.11.3461; Lindert S, 2012, BIOPHYS J, V103, P1784, DOI 10.1016/j.bpj.2012.08.058; Lindert S, 2012, J PHYS CHEM B, V116, P8449, DOI 10.1021/jp212173f; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Marques MD, 2017, J BIOL CHEM, V292, P2379, DOI 10.1074/jbc.M116.765362; Martins AS, 2015, CIRC-CARDIOVASC GENE, V8, P653, DOI 10.1161/CIRCGENETICS.114.000957; McKay RT, 2000, BIOCHEMISTRY-US, V39, P12731, DOI 10.1021/bi001240u; Messer AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00315; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robertson IM, 2015, J MOL CELL CARDIOL, V87, P257, DOI 10.1016/j.yjmcc.2015.08.017; Robertson IM, 2014, BIOPHYS J, V106, p723A, DOI 10.1016/j.bpj.2013.11.3996; Schlecht W, 2016, CHEM BIOL DRUG DES, V87, P171, DOI 10.1111/cbdd.12651; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sevrieva I, 2014, J MOL CELL CARDIOL, V75, P181, DOI 10.1016/j.yjmcc.2014.07.015; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Skowronsky RA, 2013, J BIOL INORG CHEM, V18, P49, DOI 10.1007/s00775-012-0948-2; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Stevens CM, 2016, BIOPHYS J, V111, P38, DOI 10.1016/j.bpj.2016.05.029; Suarez MC, 2003, BIOCHEMISTRY-US, V42, P5522, DOI 10.1021/bi027102h; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Wang D, 2012, BIOCHEMISTRY-US, V51, P4473, DOI 10.1021/bi3003007; Yap Kyoko L, 2002, Methods Mol Biol, V173, P317; Zhang XL, 2013, ACTA CRYSTALLOGR D, V69, P722, DOI 10.1107/S0907444913001182; Zot HG, 2016, ARCH BIOCHEM BIOPHYS, V601, P97, DOI 10.1016/j.abb.2016.03.011	69	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11915	11926		10.1074/jbc.M116.770776	http://dx.doi.org/10.1074/jbc.M116.770776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28533433	hybrid, Green Published			2022-12-28	WOS:000405485600027
J	Rossner, R; Kaeberlein, M; Leiser, SF				Rossner, Ryan; Kaeberlein, Matt; Leiser, Scott F.			Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRIMETHYLAMINE-N-OXIDE; EXTENDS LIFE-SPAN; ADULT HUMAN LIVER; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; L-CARNITINE; C. ELEGANS; DEPENDENT MONOOXYGENASES; LIPID-METABOLISM; STRESS-RESPONSE	Flavin-containing monooxygenases (FMOs) are primarily studied as xenobiotic metabolizing enzymes with a prominent role in drug metabolism. In contrast, endogenous functions and substrates of FMOs are less well understood. A growing body of recent evidence, however, implicatesFMOsin aging, several diseases, and metabolic pathways. The evidence suggests an important role for these well-conserved proteins in multiple processes and raises questions about the endogenous substrate(s) and regulation of FMOs. Here, we present an overview of evidence for FMOs' involvement in aging and disease, discussing the biological context and arguing for increased investigation into the function of these enzymes.	[Rossner, Ryan; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Leiser, Scott F.] Univ Michigan, Dept Mol & Integrat Physiol, 3027 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Leiser, Scott F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Leiser, SF (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, 3027 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	leiser@umich.edu		Kaeberlein, Matt/0000-0002-1311-3421	National Institutes of Health [R00AG045200, P30AG024824, R01AG038518, T32AG000057]; NATIONAL INSTITUTE ON AGING [T32AG000057, R00AG045200, R01AG038518, P30AG024824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R00AG045200 and P30AG024824 (to S. F. L.), National Institutes of Health Grant R01AG038518 (to M. K.), and National Institutes of Health Training Grant T32AG000057 (to R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Barber M, 2000, AM J HEMATOL, V65, P149, DOI 10.1002/1096-8652(200010)65:2<149::AID-AJH10>3.0.CO;2-B; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Borbas T, 2006, EUR J PHARM SCI, V28, P51, DOI 10.1016/j.ejps.2005.12.011; Bozzoni V, 2016, FUNCT NEUROL, V31, P7, DOI 10.11138/fneur/2016.31.1.007; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; CASHMAN JR, 1993, DRUG METAB DISPOS, V21, P492; Celius T, 2010, TOXICOL APPL PHARM, V247, P60, DOI 10.1016/j.taap.2010.05.018; Celius T, 2008, DRUG METAB DISPOS, V36, P2499, DOI 10.1124/dmd.108.023457; Chandler-Brown D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00316; Cho HJ, 2011, J STRUCT BIOL, V175, P39, DOI 10.1016/j.jsb.2011.04.007; Collins HL, 2016, ATHEROSCLEROSIS, V244, P29, DOI 10.1016/j.atherosclerosis.2015.10.108; Coppin H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r221; Dolan C, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-41; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; FALLS JG, 1995, J BIOCHEM TOXICOL, V10, P171, DOI 10.1002/jbt.2570100308; Fiorentini F, 2016, ACS CHEM BIOL, V11, P1039, DOI 10.1021/acschembio.5b01016; Fukami K, 2015, J CARDIOVASC PHARM, V65, P289, DOI 10.1097/FJC.0000000000000197; Gagliardi S., 2016, ANN NEURODEGENER DIS, V1, P1014; Gibrat C, 2011, PROG NEURO-PSYCHOPH, V35, P380, DOI 10.1016/j.pnpbp.2010.11.023; GUAN SH, 1991, BIOCHEMISTRY-US, V30, P9892, DOI 10.1021/bi00105a012; GUT I, 1993, BIOCHEM PHARMACOL, V46, P239, DOI 10.1016/0006-2952(93)90409-P; Hao D, 2009, GENETICA, V137, P173, DOI 10.1007/s10709-009-9382-y; Henderson MC, 2004, CHEM RES TOXICOL, V17, P633, DOI 10.1021/tx034253s; Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/00008571-200402000-00006; Hibar DP, 2013, BRAIN IMAGING BEHAV, V7, P102, DOI 10.1007/s11682-012-9199-7; Hines RN, 2002, MOL PHARMACOL, V62, P320, DOI 10.1124/mol.62.2.320; Hirani N, 2016, BIOL OPEN, V5, P537, DOI 10.1242/bio.017400; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Houseman L, 2008, THESIS; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Kaeberlein M, 2015, SCIENCE, V350, P1191, DOI 10.1126/science.aad3267; Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5; Klick DE, 2008, BIOCHEM PHARMACOL, V76, P268, DOI 10.1016/j.bcp.2008.05.002; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koukouritaki SB, 2002, PEDIATR RES, V51, P236, DOI 10.1203/00006450-200202000-00018; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Kumar A, 2011, J BIOL CHEM, V286, P21779, DOI 10.1074/jbc.M111.228072; Lattard V, 2004, MOL PHARMACOL, V65, P1517, DOI 10.1124/mol.65.6.1517; Mascotti ML, 2016, J MOL BIOL, V428, P3131, DOI 10.1016/j.jmb.2016.07.003; Mascotti ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132689; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Leiser SF, 2015, SCIENCE, V350, P1375, DOI 10.1126/science.aac9257; Li BY, 2014, NEUROSCI LETT, V566, P11, DOI 10.1016/j.neulet.2013.11.036; Li CY, 2017, MOL MICROBIOL, V103, P992, DOI 10.1111/mmi.13605; Luo ZH, 2001, MOL PHARMACOL, V60, P1421, DOI 10.1124/mol.60.6.1421; Malagon SGG, 2015, BIOCHEM PHARMACOL, V96, P267, DOI 10.1016/j.bcp.2015.05.013; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Matzkin LM, 2009, GENETICS, V182, P1279, DOI 10.1534/genetics.109.104927; McConnell HW, 1997, SEIZURE, V6, P317, DOI 10.1016/S1059-1311(97)80080-5; McCully KS, 2016, COMPR PHYSIOL, V6, P471, DOI 10.1002/cphy.c150021; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Motika MS, 2007, EXPERT OPIN DRUG MET, V3, P831, DOI 10.1517/17425255.3.6.831; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Neuhoff C, 2015, MEAT SCI, V108, P67, DOI 10.1016/j.meatsci.2015.05.025; Novick RM, 2010, BIOCHEM PHARMACOL, V79, P1345, DOI 10.1016/j.bcp.2009.12.020; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Park HC, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23488, 10.4161/psb.24495]; Park MC, 2010, BIOCHEM BIOPH RES CO, V396, P382, DOI 10.1016/j.bbrc.2010.04.101; Petalcorin MIR, 2005, GENE, V346, P83, DOI 10.1016/j.gene.2004.09.021; Petriello MC, 2017, REV ENVIRON HEALTH, V32, P105, DOI 10.1515/reveh-2016-0050; PHILLIPS IR, 1995, CHEM-BIOL INTERACT, V96, P17, DOI 10.1016/0009-2797(94)03580-2; Pitt JN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002176; Pitt JN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002131; Poloni Soraia, 2015, Biology-Basel, V4, P383, DOI 10.3390/biology4020383; Robinson-Cohen C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161074; Rooseboom M, 2001, CHEM RES TOXICOL, V14, P127, DOI 10.1021/tx0001326; SADEQUE AJM, 1993, BIOCHIM BIOPHYS ACTA, V1162, P127, DOI 10.1016/0167-4838(93)90138-H; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; SCHLENK D, 1993, AQUAT TOXICOL, V26, P157, DOI 10.1016/0166-445X(93)90027-X; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680; Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006; Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012; Suh JK, 1996, ARCH BIOCHEM BIOPHYS, V336, P268, DOI 10.1006/abbi.1996.0557; Suh JK, 1999, P NATL ACAD SCI USA, V96, P2687, DOI 10.1073/pnas.96.6.2687; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Takamura T, 2004, DIABETOLOGIA, V47, P638, DOI 10.1007/s00125-004-1366-y; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tomasova L, 2016, MOLECULES, V21, DOI 10.3390/molecules21111558; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Ufnal M, 2015, NUTRITION, V31, P1317, DOI 10.1016/j.nut.2015.05.006; Ufnal M, 2014, CAN J CARDIOL, V30, P1700, DOI 10.1016/j.cjca.2014.09.010; Umbreit JN, 2002, AM J PHYSIOL-GASTR L, V282, pG534, DOI 10.1152/ajpgi.00199.2001; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Vahabzadeh M., 2015, J CLIN TOXICOL, V5, P1, DOI DOI 10.4172/2161-0495.1000233; Veeravalli S, 2014, BIOCHEM PHARMACOL, V90, P88, DOI 10.1016/j.bcp.2014.04.007; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warrier M, 2015, CELL REP, V10, P326, DOI 10.1016/j.celrep.2014.12.036; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; Zhang J, 2009, DRUG METAB DISPOS, V37, P462, DOI 10.1124/dmd.108.025338; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011; Ziegler D M, 1979, Ciba Found Symp, P191; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	100	29	31	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11138	11146		10.1074/jbc.R117.779678	http://dx.doi.org/10.1074/jbc.R117.779678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515321	Green Published, hybrid			2022-12-28	WOS:000405119600001
J	Takeda, T; Komiya, Y; Koga, T; Ishida, T; Ishii, Y; Kikuta, Y; Nakaya, M; Kurose, H; Yokomizo, T; Shimizu, T; Uchi, H; Furue, M; Yamada, H				Takeda, Tomoki; Komiya, Yukiko; Koga, Takayuki; Ishida, Takumi; Ishii, Yuji; Kikuta, Yasushi; Nakaya, Michio; Kurose, Hitoshi; Yokomizo, Takehiko; Shimizu, Takao; Uchi, Hiroshi; Furue, Masutaka; Yamada, Hideyuki			Dioxin-induced increase in leukotriene B4 biosynthesis through the aryl hydrocarbon receptor and its relevance to hepatotoxicity owing to neutrophil infiltration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AHR); dioxin; leukotriene; liver injury; metabolomics	2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; B-4 RECEPTOR; MICE LACKING; AH RECEPTOR; FATTY-ACIDS; INFLAMMATION; INDUCTION; TOXICITY; MOUSE; LIVER	Dioxin and related chemicals alter the expression of a number of genes by activating the aryl hydrocarbon receptors (AHR) to produce a variety of disorders including hepatotoxicity. However, it remains largely unknown how these changes in gene expression are linked to toxicity. To address this issue, we initially examined the effect of 2,3,7,8-tetrachrolodibenzo-p-dioxin (TCDD), a most toxic dioxin, on the hepatic and serum metabolome in male pubertal rats and found that TCDD causes many changes in the level of fatty acids, bile acids, amino acids, and their metabolites. Among these findings was the discovery that TCDD increases the content of leukotriene B4 (LTB4), an inducer of inflammation due to the activation of leukocytes, in the liver of rats and mice. Further analyses suggested that an increase in LTB4 comes from a dual mechanism consisting of an induction of arachidonate lipoxygenase-5, a rate-limiting enzyme in LTB4 synthesis, and the down-regulation of LTC4 synthase, an enzyme that converts LTA4 to LTC4. The above changes required AHR activation, because the same was not observed in AHR knock-out rats. In agreement with LTB4 accumulation, TCDD caused the marked infiltration of neutrophils into the liver. However, deleting LTB4 receptors (BLT1) blocked this effect. A TCDD-produced increase in the mRNA expression of inflammatory markers, including tumor-necrosis factor and hepatic damage, was also suppressed in BLT1-null mice. The above observations focusing on metabolomic changes provide novel evidence that TCDD accumulates LTB4 in the liver by an AHR-dependent induction of LTB4 biosynthesis to cause hepatotoxicity through neutrophil activation.	[Takeda, Tomoki; Komiya, Yukiko; Koga, Takayuki; Ishida, Takumi; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Nakaya, Michio; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Uchi, Hiroshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Kikuta, Yasushi] Fukuyama Univ, Dept Appl Biol Sci, Hiroshima 7290292, Japan; [Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo 1138421, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo 1628655, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo 1130033, Japan; [Furue, Masutaka] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin, Fukuoka 8128582, Japan; [Koga, Takayuki] Daiichi Univ Pharm, Fac Pharmaceut Sci, Fukuoka 8158511, Japan; [Ishida, Takumi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan	Kyushu University; Kyushu University; Kyushu University; Fukuyama University; Juntendo University; National Center for Global Health & Medicine - Japan; University of Tokyo; Kyushu University; Sojo University	Takeda, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takeda@phar.kyushu-u.ac.jp	Yokomizo, Takehiko/P-5673-2016; Ishii, Yuji/AAU-3300-2021; Shimizu, Takao/AAV-7052-2021	Yokomizo, Takehiko/0000-0002-5219-1553; Koga, Takayuki/0000-0001-9782-6746	ONO Pharmaceutical Co.; Shimadzu Corp.; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	ONO Pharmaceutical Co.; Shimadzu Corp.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Lipidomics Department of the University of Tokyo is funded by ONO Pharmaceutical Co. and Shimadzu Corp.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; AUGUSTINE PC, 1979, AVIAN DIS, V23, P854, DOI 10.2307/1589601; BAILIE MB, 1995, TOXICOLOGY, V100, P139, DOI 10.1016/0300-483X(95)03060-S; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Chiba N, 1999, BIOL PHARM BULL, V22, P1047; Cho KJ, 2011, MOL CELLS, V32, P1, DOI 10.1007/s10059-011-1021-7; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Falck JR, 2011, J MED CHEM, V54, P4109, DOI 10.1021/jm200132q; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Forgacs AL, 2012, TOXICOL SCI, V125, P41, DOI 10.1093/toxsci/kfr262; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; Gasiewicz TA., 1991, HDB PESTICIDE TOXICO, V3, P1217; GERMOLEC DR, 1995, BIOCHEM PHARMACOL, V50, P1495, DOI 10.1016/0006-2952(95)02062-4; Harrill JA, 2013, TOXICOL APPL PHARM, V272, P503, DOI 10.1016/j.taap.2013.06.024; HARRIS M W, 1973, Environmental Health Perspectives, V5, P101, DOI 10.2307/3428118; Ishida T, 2005, TOXICOL APPL PHARM, V205, P89, DOI 10.1016/j.taap.2004.09.014; Kakizuka S, 2015, BIOL PHARM BULL, V38, P1484, DOI 10.1248/bpb.b15-00235; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kennedy GD, 2014, TOXICOL SCI, V140, P135, DOI 10.1093/toxsci/kfu065; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040322; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Lin SH, 2011, MOL BIOSYST, V7, P1956, DOI 10.1039/c1mb05057e; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mitoma C, 2015, ENVIRON INT, V82, P41, DOI 10.1016/j.envint.2015.05.004; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; NEBERT DW, 1972, NATURE-NEW BIOL, V236, P107, DOI 10.1038/newbio236107a0; Nishimura N, 2009, TOXICOL APPL PHARM, V236, P301, DOI 10.1016/j.taap.2009.01.025; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Pande K, 2005, MOL PHARMACOL, V67, P1393, DOI 10.1124/mol.105.010983; Pierre S, 2014, TOXICOL SCI, V137, P114, DOI 10.1093/toxsci/kft236; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; POLAND A, 1976, J BIOL CHEM, V251, P4936; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; STOHS SJ, 1990, FREE RADICAL BIO MED, V9, P79, DOI 10.1016/0891-5849(90)90052-K; Strassburg K., 2015, WATERS APPL NOTES, V147, P20; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; Takeda T, 2014, MOL PHARMACOL, V85, P74, DOI 10.1124/mol.113.088575; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Tsujimoto S, 2013, BBA-GEN SUBJECTS, V1830, P3616, DOI 10.1016/j.bbagen.2013.03.008; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; Warner M, 2011, ENVIRON HEALTH PERSP, V119, P1700, DOI 10.1289/ehp.1103720; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; Yi SW, 2014, ENVIRON RES, V133, P56, DOI 10.1016/j.envres.2014.04.027; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	61	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10586	10599		10.1074/jbc.M116.764332	http://dx.doi.org/10.1074/jbc.M116.764332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487374	Green Published, hybrid			2022-12-28	WOS:000404115400019
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			RETRACTION: The replication initiation protein Sld3/Treslin orchestrates the assembly of the replication fork helicase during S phase (Retraction of Vol 290, Pg 27414, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Bruck I, 2015, J BIOL CHEM, V290, P27414, DOI 10.1074/jbc.M115.688424	1	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10319	10319		10.1074/jbc.A115.688424	http://dx.doi.org/10.1074/jbc.A115.688424			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28623197	Green Published, hybrid			2022-12-28	WOS:000403580600042
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			RETRACTION: The Dbf4-Cdc7 kinase promotes Mcm2-7 ring opening to allow for single-stranded DNA extrusion and helicase assembly (Retraction of Vol 290, Pg 1210, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232	1	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10320	10320		10.1074/jbc.A114.608232	http://dx.doi.org/10.1074/jbc.A114.608232			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28623198	Green Published, hybrid			2022-12-28	WOS:000403580600043
J	Bussiere, R; Lacampagne, A; Reiken, S; Liu, XP; Scheuerman, V; Zalk, R; Martin, C; Checler, F; Marks, AR; Chami, M				Bussiere, Renaud; Lacampagne, Alain; Reiken, Steven; Liu, Xiaoping; Scheuerman, Valerie; Zalk, Ran; Martin, Cecile; Checler, Frederic; Marks, Andrew R.; Chami, Mounia			Amyloid beta production is regulated by beta 2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM LEAK; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; TAU PATHOLOGY; MITOCHONDRIAL DYSFUNCTION; ADRENERGIC-RECEPTOR; COGNITIVE DEFICITS; PRECURSOR PROTEIN; CORTICAL-NEURONS	Alteration of ryanodine receptor (RyR)-mediated calcium (Ca2+) signaling has been reported in Alzheimer disease (AD) models. However, the molecular mechanisms underlying altered RyR-mediated intracellular Ca2+ release in AD remain to be fully elucidated. We report here that RyR2 undergoes post-translational modifications (phosphorylation, oxidation, and nitrosylation) in SH-SY5Y neuroblastoma cells expressing the beta-amyloid precursor protein (beta APP) harboring the familial double Swedish mutations (APPswe). RyR2 macromolecular complex remodeling, characterized by depletion of the regulatory protein calstabin2, resulted in increased cytosolic Ca2+ levels and mitochondrial oxidative stress. We also report a functional interplay between amyloid beta (A beta), beta-adrenergic signaling, and altered Ca2+ signaling via leaky RyR2 channels. Thus, post-translational modifications of RyR occur downstream of A beta through a beta 2-adrenergic signaling cascade that activates PKA. RyR2 remodeling in turn enhances beta APP processing. Importantly, pharmacological stabilization of the binding of calstabin2 to RyR2 channels, which prevents Ca2+ leakage, or blocking the beta 2-adrenergic signaling cascade reduced beta APP processing and the production of A beta in APPswe-expressing SH-SY5Y cells. We conclude that targeting RyR-mediated Ca2+ leakage may be a therapeutic approach to treat AD.	[Bussiere, Renaud; Martin, Cecile; Checler, Frederic; Chami, Mounia] Univ Cote Azur, CNRS, IPMC, 660 Route Lucioles, F-06560 Valbonne, France; [Lacampagne, Alain; Scheuerman, Valerie] Univ Montpellier, CHRU Montpellier, CNRS LIA1185, INSERM U1046,CNRS UMR9214, F-34295 Montpellier, France; [Reiken, Steven; Liu, Xiaoping; Zalk, Ran; Marks, Andrew R.] Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Columbia University	Chami, M (corresponding author), Univ Cote Azur, CNRS, IPMC, 660 Route Lucioles, F-06560 Valbonne, France.; Marks, AR (corresponding author), Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	arm42@columbia.edu; mchami@ipmc.cnrs.fr	Chami, Mounia/S-6471-2019; Lacampagne, Alain/S-3719-2016; Bussiere, Renaud/O-3856-2018; Checler, Frederic/C-1241-2009	Chami, Mounia/0000-0003-1498-7187; Lacampagne, Alain/0000-0003-0264-1787; Bussiere, Renaud/0000-0002-2202-8536; Checler, Frederic/0000-0003-2098-1750	National Institutes of Health [R01HL061503, R01HL102040, R01AR060037, NIH T32 HL120826, R25NS076445]; Fondation Leducq; INSERM; Philippe Foundation; Columbia University; LECMA (Ligue Europe enne Contre la Maladie d'Alzheimer); LABEX (Laboratory of excellence, program investment for the future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); Hospital University Federation (FHU OncoAge); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, T32HL120826, R01HL102040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS076445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Philippe Foundation; Columbia University; LECMA (Ligue Europe enne Contre la Maladie d'Alzheimer); LABEX (Laboratory of excellence, program investment for the future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); Hospital University Federation (FHU OncoAge); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01HL061503 (NHLBI; to A. R. M.), R01HL102040 (NHLBI; to A. R. M.), R01AR060037 (NIAMS; to A. R. M.), NIH T32 HL120826 (to A. R. M.), and R25NS076445 (NINDS; to A. R. M). This work was also supported by Fondation Leducq and a generous donation from Carol Stix (A. R. M.) and grants from INSERM, the Philippe Foundation, and a Schaefer Award from Columbia University (to A. L.), LECMA (Ligue Europe enne Contre la Maladie d'Alzheimer) (to M. C.), LABEX (Laboratory of excellence, program investment for the future), DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease) (to F. C.), and Hospital University Federation (FHU OncoAge) (to F. C.). A. R. M. is a board member and owns shares in ARMGO Pharma Inc., which is targeting RyR channels for therapeutic purposes. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADUNSKY A, 1995, J GERONTOL A-BIOL, V50, pB201, DOI 10.1093/gerona/50A.4.B201; Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Barage SH, 2015, NEUROPEPTIDES, V52, P1, DOI 10.1016/j.npep.2015.06.008; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bezprozvanny I, 2012, J BIOL CHEM, V287, P20469, DOI 10.1074/jbc.L112.356790; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P83, DOI 10.1101/pdb.top066050; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P126, DOI 10.1101/pdb.prot072827; Branca C, 2014, NEUROBIOL AGING, V35, P2726, DOI 10.1016/j.neurobiolaging.2014.06.011; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brunello L, 2009, J CELL MOL MED, V13, P3358, DOI 10.1111/j.1582-4934.2009.00755.x; Bull R, 2008, J NEUROSCI, V28, P9463, DOI 10.1523/JNEUROSCI.2286-08.2008; Chakroborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052056; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Christensen RA, 2004, J BIOL CHEM, V279, P53524, DOI 10.1074/jbc.M408473200; Dang V, 2014, BIOL PSYCHIAT, V75, P179, DOI 10.1016/j.biopsych.2013.05.024; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Del Prete D, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-21; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dobarro M, 2013, INT J NEUROPSYCHOPH, V16, P2245, DOI 10.1017/S1461145713000631; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Eftekharzadeh B, 2012, BEHAV BRAIN RES, V226, P301, DOI 10.1016/j.bbr.2011.08.015; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; GOLDE TE, 1993, ANN NY ACAD SCI, V695, P103, DOI 10.1111/j.1749-6632.1993.tb23036.x; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Hayley M, 2009, BBA-BIOMEMBRANES, V1788, P1933, DOI 10.1016/j.bbamem.2009.05.015; Hayrapetyan V, 2008, CELL CALCIUM, V44, P507, DOI 10.1016/j.ceca.2008.03.004; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hidalgo C, 2011, ANTIOXID REDOX SIGN, V14, P1203, DOI 10.1089/ars.2010.3711; Ho Michael, 2010, Int J Alzheimers Dis, V2011, P950932, DOI 10.4061/2011/950932; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; IVERSEN LL, 1983, NEUROSCI LETT, V39, P95, DOI 10.1016/0304-3940(83)90171-4; Jardanhazi-Kurutz D, 2010, NEUROCHEM INT, V57, P375, DOI 10.1016/j.neuint.2010.02.001; Jensen LE, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00036; KALARIA RN, 1989, J NEUROCHEM, V53, P1772, DOI 10.1111/j.1471-4159.1989.tb09242.x; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee Sun Young, 2006, FASEB J, V20, P151, DOI 10.1096/fj.05-4017fje;1; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Li SM, 2013, NEURON, V77, P929, DOI 10.1016/j.neuron.2012.12.040; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Marambaud P, 1999, BRIT J PHARMACOL, V126, P1186, DOI 10.1038/sj.bjp.0702406; Marambaud P, 1998, MOL MED, V4, P715, DOI 10.1007/BF03401766; Marks Andrew R, 2006, Novartis Found Symp, V274, P132; Martinez M, 1999, BRAIN RES, V846, P265, DOI 10.1016/S0006-8993(99)01981-2; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51; Mikami M, 2008, EUR J PHARMACOL, V589, P14, DOI 10.1016/j.ejphar.2008.04.045; Muresan Z, 2007, MOL BIOL CELL, V18, P3835, DOI 10.1091/mbc.E06-07-0625; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Peng J, 2012, NEUROSCI LETT, V516, P274, DOI 10.1016/j.neulet.2012.04.008; Prapong T, 2001, EXP NEUROL, V167, P59, DOI 10.1006/exnr.2000.7519; Probst G, 2013, J MED CHEM, V56, P5261, DOI 10.1021/jm301741t; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; Ross JA, 2015, NEUROBIOL STRESS, V2, P73, DOI 10.1016/j.ynstr.2015.09.002; Rybalchenko V, 2008, INT J BIOCHEM CELL B, V40, P84, DOI 10.1016/j.biocel.2007.06.023; SanMartin CD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00013; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shilling D, 2014, J NEUROSCI, V34, P6910, DOI 10.1523/JNEUROSCI.5441-13.2014; Shilling D, 2012, J BIOL CHEM, V287, P10933, DOI 10.1074/jbc.M111.300491; Stieren E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011992; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Su Y, 2003, FEBS LETT, V546, P407, DOI 10.1016/S0014-5793(03)00645-8; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ueda K, 1996, NEUROSCI LETT, V203, P175, DOI 10.1016/0304-3940(95)12288-5; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; Wang DY, 2013, J BIOL CHEM, V288, P10298, DOI 10.1074/jbc.M112.415141; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wisely EV, 2014, HUM MOL GENET, V23, P4024, DOI 10.1093/hmg/ddu116; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Yu NN, 2010, BRAIN RES, V1317, P305, DOI 10.1016/j.brainres.2009.12.087; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	97	36	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10153	10168		10.1074/jbc.M116.743070	http://dx.doi.org/10.1074/jbc.M116.743070			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28476886	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000403580600026
J	Ye, F; Yang, C; Kim, J; MacNevin, CJ; Hahn, KM; Park, D; Ginsberg, MH; Kim, C				Ye, Feng; Yang, Chansik; Kim, Jiyoon; MacNevin, Christopher J.; Hahn, Klaus M.; Park, Dongeun; Ginsberg, Mark H.; Kim, Chungho			Epigallocatechin gallate has pleiotropic effects on transmembrane signaling by altering the embedding of transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN TEA CATECHINS; (-)-EPIGALLOCATECHIN GALLATE; INTEGRIN ACTIVATION; EGF RECEPTOR; MEMBRANE; EGCG; COMPLEX; TALIN; MECHANISMS; PROTEINS	Epigallocatechin gallate (EGCG) is the principal bioactive ingredient in green tea and has been reported to have many health benefits. EGCG influences multiple signal transduction pathways related to human diseases, including redox, inflammation, cell cycle, and cell adhesion pathways. However, the molecular mechanisms of these varying effects are unclear, limiting further development and utilization of EGCG as a pharmaceutical compound. Here, we examined the effect of EGCG on two representative transmembrane signaling receptors, integrin alpha IIb beta 3 and epidermal growth factor receptor (EGFR). We report that EGCG inhibits talin-induced integrin alpha IIb beta 3 activation, but it activates alpha IIb beta 3 in the absence of talin both in a purified system and in cells. This apparent paradox was explained by the fact that the activation state of alpha IIb beta 3 is tightly regulated by the topology of beta 3 transmembrane domain (TMD); increases or decreases in TMD embedding can activate integrins. Talin increases the embedding of integrin beta 3 TMD, resulting in integrin activation, whereas we observed here that EGCG decreases the embedding, thus opposing talin-induced integrin activation. In the absence of talin, EGCG decreases the TMD embedding, which can also disrupt the integrin alpha-beta TMD interaction, leading to integrin activation. EGCG exhibited similar paradoxical behavior in EGFR signaling. EGCG alters the topology of EGFR TMD and activates the receptor in the absence of EGF, but inhibits EGF-induced EGFR activation. Thus, this widely ingested polyphenol exhibits pleiotropic effects on transmembrane signaling by modifying the topology of TMDs.	[Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Yang, Chansik; Kim, Jiyoon; Kim, Chungho] Korea Univ, Dept Life Sci, Seoul 136701, South Korea; [Yang, Chansik; Park, Dongeun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [MacNevin, Christopher J.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [MacNevin, Christopher J.; Hahn, Klaus M.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of California System; University of California San Diego; Korea University; Seoul National University (SNU); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ginsberg, MH (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Kim, C (corresponding author), Korea Univ, Dept Life Sci, Seoul 136701, South Korea.	mhginsberg@ucsd.edu; chungho@korea.ac.kr		Hahn, Klaus/0000-0002-1970-7562	National Research Foundation of Korea [NRF-2016R1A2B4009755]; Korea Health Industry Development Institute [HI14C0209]; National Institutes of Health [CA-142833, P41-EB002025, HL 078784, HL 117807]; NATIONAL CANCER INSTITUTE [R01CA142833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117807, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS092521] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (Grant NRF-2016R1A2B4009755) (to C.K.), by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (Grant HI14C0209) (to C. K.), and by National Institutes of Health Grants CA-142833 and P41-EB002025 (to K. M. H.) and HL 078784 and HL 117807 (to M. H. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim CH, 2012, J CELL BIOL, V197, P605, DOI 10.1083/jcb.201112141; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kuriyama S, 2008, J NUTR, V138, P1548; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Lill G, 2003, FEBS LETT, V546, P265, DOI 10.1016/S0014-5793(03)00599-4; MacNevin CJ, 2013, BIOCONJUGATE CHEM, V24, P215, DOI 10.1021/bc3005073; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Patra SK, 2008, J PHYSIOL PHARMACOL, V59, P217; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shimizu M, 2011, MOL NUTR FOOD RES, V55, P832, DOI 10.1002/mnfr.201000622; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sirk TW, 2009, J AGR FOOD CHEM, V57, P6720, DOI 10.1021/jf900951w; Sun Y, 2009, BIOPHYS J, V96, P1026, DOI 10.1016/j.bpj.2008.11.007; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tamba Y, 2007, BIOPHYS J, V92, P3178, DOI 10.1529/biophysj.106.097105; Uekusa Y, 2011, BBA-BIOMEMBRANES, V1808, P1654, DOI 10.1016/j.bbamem.2011.02.014; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	38	6	6	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9858	9864		10.1074/jbc.C117.787309	http://dx.doi.org/10.1074/jbc.C117.787309			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28487468	hybrid, Green Published			2022-12-28	WOS:000403580600001
J	Lee, BH; Stallcup, MR				Lee, Brian H.; Stallcup, Michael R.			Glucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN RECEPTOR; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL EXPRESSION; OSTEOBLAST PHENOTYPE; CONFERS RESISTANCE; GENE-EXPRESSION; LIM PROTEIN; IN-SITU; COACTIVATOR; DNA	The steroid hormone-activated glucocorticoid receptor (GR) regulates cellular stress pathways by binding to genomic regulatory elements of target genes and recruiting coregulator proteins to remodel chromatin and regulate transcription complex assembly. The coregulator hydrogen peroxide-inducible clone 5 (Hic-5) is required for glucocorticoid (GC) regulation of some genes but not others and blocks the regulation of a third gene set by inhibiting GR binding. How Hic-5 exerts these gene-specific effects and specifically how it blocks GR binding to some genes but not others is unclear. Here we show that site-specific blocking of GR binding is due to gene-specific requirements for ATP-dependent chromatin remodeling enzymes. By depletion of 11 different chromatin remodelers, we found that ATPases chromodomain helicase DNA-binding protein 9 (CHD9) and Brahma homologue (BRM, a product of the SMARCA2 gene) are required for GC-regulated expression of the blocked genes but not for other GC-regulated genes. Furthermore, CHD9 and BRM were required for GR occupancy and chromatin remodeling at GR-binding regions associated with blocked genes but not at GR-binding regions associated with other GC-regulated genes. Hic-5 selectively inhibits GR interaction with CHD9 and BRM, thereby blocking chromatin remodeling and robust GR binding at GR-binding sites associated with blocked genes. Thus, Hic-5 regulates GR binding site selection by a novel mechanism, exploiting gene-specific requirements for chromatin remodeling enzymes to selectively influence DNA occupancy and gene regulation by a transcription factor.	[Lee, Brian H.; Stallcup, Michael R.] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA	University of Southern California	Stallcup, MR (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA.	stallcup@usc.edu			National Institutes of Health [R37DK055274, R01DK043093]; Cancer Center Support Grant [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093, R37DK055274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R37DK055274 and R01DK043093 (to M. R. S.) and Cancer Center Support Grant P30CA014089 (to the USC Norris Comprehensive Cancer Center, which supported the Molecular Genomics, Bioreagent, Biostatistics, and Molecular and Cell Biology Core Facilites used in this project). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghajanova L, 2009, ENDOCRINOLOGY, V150, P3863, DOI 10.1210/en.2009-0008; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chodankar R, 2015, MOL ENDOCRINOL, V29, P716, DOI 10.1210/me.2014-1403; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Engel KB, 2011, MOL CELL BIOL, V31, P3267, DOI 10.1128/MCB.05351-11; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Glass CK, 2000, GENE DEV, V14, P121; Ishino M, 2000, FEBS LETT, V474, P179, DOI 10.1016/S0014-5793(00)01597-0; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Nguyen KH, 2015, STEM CELLS, V33, P3028, DOI 10.1002/stem.2064; Kim-Kaneyama J, 2012, J ATHEROSCLER THROMB, V19, P601, DOI 10.5551/jat.10736; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leach DA, 2014, MOL CELL ENDOCRINOL, V384, P185, DOI 10.1016/j.mce.2014.01.004; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Lutz T, 2006, FEBS LETT, V580, P5851, DOI 10.1016/j.febslet.2006.09.049; Marom R, 2006, J CELL PHYSIOL, V207, P628, DOI 10.1002/jcp.20611; Maudsley S, 2006, NEUROENDOCRINOLOGY, V84, P285, DOI 10.1159/000098402; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; POCKWINSE SM, 1995, EXP CELL RES, V216, P244, DOI 10.1006/excr.1995.1031; Pradhan SK, 2016, MOL CELL, V61, P27, DOI 10.1016/j.molcel.2015.10.039; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wang X, 2002, J BIOL CHEM, V277, P15426, DOI 10.1074/jbc.M111218200; Wiechens N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005940; Won J.K., 2012, MOL ENDOCRINOL, V26, P955; Wu Dai-Ying, 2014, Nucl Recept Signal, V12, pe002, DOI 10.1621/nrs.12002; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200; Yang L, 2000, MOL BIOL CELL, V11, P2007, DOI 10.1091/mbc.11.6.2007; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413	62	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9320	9334		10.1074/jbc.M117.782607	http://dx.doi.org/10.1074/jbc.M117.782607			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28381557	hybrid, Green Published			2022-12-28	WOS:000402538900026
J	Wolf, I; Rubinfeld, H; Yoon, S; Marmor, G; Hanoch, T; Seger, R				Wolf, Ido; Rubinfeld, Hadara; Yoon, Seunghee; Marmor, Goldie; Hanoch, Tamar; Seger, Rony			RETRACTION: Involvement of the activation loop of ERK in the detachment from cytosolic anchoring (Retraction of Vol 276, Pg 24490, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200	1	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8853	8853		10.1074/jbc.A117.103352	http://dx.doi.org/10.1074/jbc.A117.103352			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550139	Green Published, hybrid			2022-12-28	WOS:000402153900036
J	Tedbury, PR; Sarafianos, SG				Tedbury, Philip R.; Sarafianos, Stefan G.			Exposing HIV's weaknesses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SERINC5; NEF; INFECTIVITY; TRIMERS; VIRUS	The viral restriction factor SERINC5 inhibits HIV-1 infection via unknown mechanisms. Sood and co-workers now show that SERINC5 suppresses HIV-1 fusogenicity and increases sensitivity to neutralizing antibodies by perturbing the folding of the fusion machinery. This work advances our understanding of host-virus interactions and provides a compelling case for considering the host immune system in studies of restriction factor mechanisms.	[Tedbury, Philip R.; Sarafianos, Stefan G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Tedbury, Philip R.; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tedbury, PR; Sarafianos, SG (corresponding author), 471d Bond Life Sci Ctr,1201 E Rollins Str, Columbia, MO 65211 USA.	tedburyp@missouri.edu; sarafianoss@missouri.edu	Tedbury, Philip/H-3945-2019	Tedbury, Philip/0000-0001-8151-4967	National Institutes of Health [AI120860, GM103368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants AI120860 and GM103368. The authors declare that they have no conflicts of interest with the contents of this article.	Beitari S, 2017, J VIROL, V91, DOI 10.1128/JVI.02214-16; Chande A, 2016, P NATL ACAD SCI USA, V113, P13197, DOI 10.1073/pnas.1612044113; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Sood C, 2017, J BIOL CHEM, V292, P6014, DOI 10.1074/jbc.M117.777714; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400	10	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					6027	6028		10.1074/jbc.H117.777714	http://dx.doi.org/10.1074/jbc.H117.777714			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28389578	Green Published, hybrid			2022-12-28	WOS:000398813200035
J	Munoz-Munoz, J; Cartmell, A; Terrapon, N; Basle, A; Henrissat, B; Gilbert, HJ				Munoz-Munoz, Jose; Cartmell, Alan; Terrapon, Nicolas; Basle, Arnaud; Henrissat, Bernard; Gilbert, Harry J.			An evolutionarily distinct family of polysaccharide lyases removes rhamnose capping of complex arabinogalactan proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT MICROBIOTA; UNSATURATED GLUCURONYL HYDROLASE; BETA-ELIMINATION MECHANISM; CRYSTAL-STRUCTURE; PECTATE LYASE; ACTIVE-SITE; URONIC-ACID; METABOLISM; MODEL; EXO-BETA-1,3-D-GALACTANASE	The human gut microbiota utilizes complex carbohydrates as major nutrients. The requirement for efficient glycan degrading systems exerts a major selection pressure on this microbial community. Thus, we propose that this microbial ecosystem represents a substantial resource for discovering novel carbohydrate active enzymes. To test this hypothesis we screened the potential enzymatic functions of hypothetical proteins encoded by genes of Bacteroides thetaiotaomicron that were up-regulated by arabinogalactan proteins or AGPs. Although AGPs are ubiquitous in plants, there is a paucity of information on their detailed structure, the function of these glycans in planta, and the mechanisms by which they are depolymerized in microbial ecosystems. Here we have discovered a new polysaccharide lyase family that is specific for the L-rhamnose-alpha 1,4-D-glucuronic acid linkage that caps the side chains of complex AGPs. The reaction product generated by the lyase, Delta 4,5-unsaturated uronic acid, is removed from AGP by a glycoside hydrolase located in family GH105, producing the final product 4-deoxy-beta-L-threo-hex-4-enepyranosyl- uronic acid. The crystal structure of a member of the novel lyase family revealed a catalytic domain that displays an (alpha/alpha)(6) barrel-fold. In the center of the barrel is a deep pocket, which, based on mutagenesis data and amino acid conservation, comprises the active site of the lyase. A tyrosine is the proposed catalytic base in the beta-elimination reaction. This study illustrates how highly complex glycans can be used as a scaffold to discover new enzyme families within microbial ecosystems where carbohydrate metabolism is a major evolutionary driver.	[Munoz-Munoz, Jose; Cartmell, Alan; Basle, Arnaud; Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Terrapon, Nicolas; Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, Architecture & Fonct Macromol Biol USC1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 23218, Saudi Arabia	Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University	Gilbert, HJ (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk	Terrapon, Nicolas/O-3630-2014; Henrissat, Bernard/J-2475-2012; Terrapon, Nicolas/AAA-9033-2019; Munoz-Munoz, Jose/G-3506-2016	Terrapon, Nicolas/0000-0002-3693-6017; Henrissat, Bernard/0000-0002-3434-8588; Terrapon, Nicolas/0000-0002-3693-6017; Munoz-Munoz, Jose/0000-0003-0010-948X; Basle, Arnaud/0000-0002-4899-3086; Cartmell, Alan/0000-0002-5512-249X	European Research Council (ERC) [322820]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by the European Research Council (ERC) Grant Agreement 322820. The authors declare that they have no conflicts of interest with the contents of this article.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Collen PN, 2014, J BIOL CHEM, V289, P6199, DOI 10.1074/jbc.M113.537480; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ichinose H, 2006, BIOSCI BIOTECH BIOCH, V70, P2745, DOI 10.1271/bbb.60365; Inaba M, 2015, CARBOHYD RES, V415, P1, DOI 10.1016/j.carres.2015.07.002; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jongkees SAK, 2014, J BIOL CHEM, V289, P11385, DOI 10.1074/jbc.M113.545293; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nie SP, 2013, FOOD HYDROCOLLOID, V32, P221, DOI 10.1016/j.foodhyd.2012.12.027; Nie SP, 2013, FOOD HYDROCOLLOID, V31, P42, DOI 10.1016/j.foodhyd.2012.09.014; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PREISS J, 1962, J BIOL CHEM, V237, P309; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P1701, DOI 10.1007/s00253-011-3219-1; Seyedarabi A, 2010, BIOCHEMISTRY-US, V49, P539, DOI 10.1021/bi901503g; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Thompson AJ, 2015, ACTA CRYSTALLOGR D, V71, P408, DOI 10.1107/S1399004714026443; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Verbeken D, 2003, APPL MICROBIOL BIOT, V63, P10, DOI 10.1007/s00253-003-1354-z; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	55	21	23	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13271	13283		10.1074/jbc.M117.794578	http://dx.doi.org/10.1074/jbc.M117.794578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637865	Green Published, hybrid			2022-12-28	WOS:000407465300016
J	Yadav, V; Gao, XH; Willard, B; Hatzoglou, M; Banerjee, R; Kabil, O				Yadav, Vinita; Gao, Xing-Huang; Willard, Belinda; Hatzoglou, Maria; Banerjee, Ruma; Kabil, Omer			Hydrogen sulfide modulates eukaryotic translation initiation factor 2 alpha (eIF2 alpha) phosphorylation status in the integrated stress-response pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE BETA-SYNTHASE; TO-MESENCHYMAL TRANSITION; UNFOLDED PROTEIN RESPONSE; INDUCED HEART-FAILURE; CARDIAC DYSFUNCTION; IN-VITRO; H2S; CELLS	Hydrogen sulfide (H2S) regulates various physiological processes, including neuronal activity, vascular tone, inflammation, and energy metabolism. Moreover, H2S elicits cytoprotective effects against stressors in various cellular models of injury. However, the mechanism of the signaling pathways mediating the cytoprotective functions of H2S is not well understood. We previously uncovered a heme-dependent metabolic switch for transient induction of H2S production in the trans-sulfuration pathway. Here, we demonstrate that increased endogenous H2S production or its exogenous administration modulates major components of the integrated stress response promoting a metabolic state primed for stress response. We show that H2S transiently increases phosphorylation of eukaryotic translation initiation factor 2 (eIF2 alpha) resulting in inhibition of general protein synthesis. The H2S-induced increase in eIF2 alpha phosphorylation was mediated at least in part by inhibition of protein phosphatase-1 (PP1c) via persulfidation at Cys-127. Overexpression of a PP1c cysteine mutant (C127S-PP1c) abrogated the H2S effect on eIF2 alpha phosphorylation. Our data support a model in which H2S exerts its cytoprotective effect on ISR signaling by inducing a transient adaptive reprogramming of global mRNA translation. Although a transient increase in endogenous H2S production provides cytoprotection, its chronic increase such as in cystathionine beta-synthase deficiency may pose a problem.	[Yadav, Vinita; Banerjee, Ruma; Kabil, Omer] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gao, Xing-Huang; Hatzoglou, Maria] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Prote & Metabol Lab, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University; Cleveland Clinic Foundation	Kabil, O (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA.	omerk@umich.edu	Yadav, Vinita/J-3605-2019; Kabil, Omer/AAJ-1435-2020	Yadav, Vinita/0000-0003-1026-5697; 	American Heart Association [13SDG17070096]; National Institutes of Health [DK53307, DK60596, HL58984, GM112455]; American Diabetes Association [1-17-PDF-129]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK060596, R01DK053307, R01DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 13SDG17070096 (to O. K.), National Institutes of Health Grants DK53307 and DK60596 (to M. H.) and HL58984 and GM112455 (to R. B.), and American Diabetes Association Postdoctoral Fellowship 1-17-PDF-129 (to X. H. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Ansari SB, 2016, CHEM-BIOL INTERACT, V252, P28, DOI 10.1016/j.cbi.2016.03.036; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Barr LA, 2015, NITRIC OXIDE-BIOL CH, V46, P145, DOI 10.1016/j.niox.2014.12.013; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Chen BF, 2013, ANALYST, V138, P946, DOI 10.1039/c2an36113b; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Cohen PTW, 2002, J CELL SCI, V115, P241; Dello Russo C, 2000, J NEUROENDOCRINOL, V12, P225; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fawcett EM, 2015, AGING CELL, V14, P92, DOI 10.1111/acel.12301; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Gong QH, 2011, J ALZHEIMERS DIS, V24, P173, DOI 10.3233/JAD-2011-110128; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Horsman JW, 2016, J BIOL CHEM, V291, P5320, DOI 10.1074/jbc.M115.697102; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kabil O, 2016, J BIOL CHEM, V291, P16418, DOI 10.1074/jbc.C116.742213; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Krokowski D, 2015, J BIOL CHEM, V290, P17822, DOI 10.1074/jbc.M114.636217; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Li XH, 2016, INT J MOL MED, V38, P1152, DOI 10.3892/ijmm.2016.2701; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Majumder M, 2015, INT J BIOCHEM CELL B, V59, P135, DOI 10.1016/j.biocel.2014.12.004; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pereira SR, 2013, FEBS J, V280, P674, DOI 10.1111/j.1742-4658.2011.08454.x; Polhemus DJ, 2013, CIRC-HEART FAIL, V6, P1077, DOI 10.1161/CIRCHEARTFAILURE.113.000299; Shelkovnikova TA, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.199; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Snyder S. H., 2009, SCI SIGNAL, V2; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vorobets VS, 2002, RUSS J APPL CHEM+, V75, P229, DOI 10.1023/A:1016152117662; Wei HL, 2010, ANTIOXID REDOX SIGN, V12, P1079, DOI 10.1089/ars.2009.2898; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Xie L, 2012, AM J PHYSIOL-CELL PH, V303, pC81, DOI 10.1152/ajpcell.00281.2011; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Ying R, 2016, LIFE SCI, V144, P208, DOI 10.1016/j.lfs.2015.11.025; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	68	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13143	13153		10.1074/jbc.M117.778654	http://dx.doi.org/10.1074/jbc.M117.778654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637872	Green Published, hybrid			2022-12-28	WOS:000407465300006
J	Menezes, SV; Sahni, S; Kovacevic, Z; Richardson, DR				Menezes, Sharleen V.; Sahni, Sumit; Kovacevic, Zaklina; Richardson, Des R.			Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer therapy; cell signaling; epidermal growth factor receptor (EGFR); iron; metastasis; NDRG1	TUMOR-CELL MIGRATION; EPITHELIAL-MESENCHYMAL TRANSITION; SELECTIVE ANTITUMOR-ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; PROSTATE-CANCER; GENE-1 NDRG1; PANCREATIC-CANCER; TYROSINE KINASES; BREAST-CANCER; TGF-BETA	The iron-regulated metastasis suppressor N-myc downstream-regulated gene 1 (NDRG1) has been shown to inhibit numerous oncogenic signaling pathways in cancer cells. Recent findings have demonstrated that NDRG1 inhibits the ErbB family of receptors, which function as key inducers of carcinogenesis. NDRG1 attenuates ErbB signaling by inhibiting formation of epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor 2 (HER2) and HER2/HER3 heterodimers and by down-regulating EGFR via a mechanism involving its degradation. Understanding the complex interplay between NDRG1, iron, and ErbB signaling is vital for identifying novel, more effective targets for cancer therapy.	[Menezes, Sharleen V.; Sahni, Sumit; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia	University of Sydney	Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.	zaklina.kovacevic@sydney.edu.au; d.richardson@med.usyd.edu.au	Kovacevic, Zaklina/ABD-9581-2021	Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0003-0960-6415; Sahni, Sumit/0000-0002-2900-8845; Richardson, Des/0000-0002-5506-3274	University of Sydney Postgraduate Award; National Health and Medical Research Council of Australia [1021607]; National Health and Medical Research Council of Australia Senior Principal Research Fellowship [1062607]; National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation; Cure Cancer Australia Young Investigator Priority-driven Collaborative Cancer research grant; Peter Doherty post-doctoral fellowship from the National Health and Medical Research Council of Australia; Cancer Institute of New South Wales Early Career Fellowship; Priority-driven Collaborative Cancer Research Scheme [1086449]; Cure Cancer Australia Foundation of Australia; Cancer Australia; National Breast Cancer Foundation [PS-16-030] Funding Source: researchfish	University of Sydney Postgraduate Award(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation; Cure Cancer Australia Young Investigator Priority-driven Collaborative Cancer research grant; Peter Doherty post-doctoral fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales Early Career Fellowship; Priority-driven Collaborative Cancer Research Scheme; Cure Cancer Australia Foundation of Australia; Cancer Australia; National Breast Cancer Foundation	This work was supported in part by a University of Sydney Postgraduate Award (to S. V. M.), Project Grant 1021607 from the National Health and Medical Research Council of Australia (to D. R. R.), National Health and Medical Research Council of Australia Senior Principal Research Fellowship 1062607 (to D. R. R.), and a National Breast Cancer Foundation and Avner Pancreatic Cancer Foundation project grant (to D. R. R.). This is the sixth article in the Thematic Minireview series "Metals in Biology 2017: Iron transport, storage, and the ramifications." D. R. R. is a stakeholder in Oncochel Therapeutics LLC and Pty. Ltd., which is developing the thiosemicarbazone, DpC, for the treatment of advanced and resistant cancer.; Recipient of a Cure Cancer Australia Young Investigator Priority-driven Collaborative Cancer research grant.; Supported by a Peter Doherty post-doctoral fellowship from the National Health and Medical Research Council of Australia, a Cancer Institute of New South Wales Early Career Fellowship, and a grant awarded through the 2014 round of the Priority-driven Collaborative Cancer Research Scheme (Grant 1086449) and co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia. To whom correspondence may be addressed. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: zaklina.kovacevic@sydney.edu.au.	Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; Ai RN, 2016, CANCER BIOL THER, V17, P943, DOI 10.1080/15384047.2016.1210734; Aizen J, 2015, J ENDOCRINOL, V225, P59, DOI 10.1530/JOE-14-0576; Amanchy R, 2009, MOL ONCOL, V3, P439, DOI 10.1016/j.molonc.2009.07.001; Ambrosio S, 2017, ONCOTARGET, V8, P3854, DOI 10.18632/oncotarget.12924; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Appert-Collin A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00283; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Cahill MA, 2016, BBA-REV CANCER, V1866, P339, DOI 10.1016/j.bbcan.2016.07.004; Cahill MA, 2016, ONCOTARGET, V7, P50822, DOI 10.18632/oncotarget.10691; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Fan YX, 2005, BIOCHEM J, V392, P417, DOI 10.1042/BJ20051122; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Fouani L, 2017, PHARMACOL RES, V115, P275, DOI 10.1016/j.phrs.2016.12.001; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hagist S, 2009, HEPATOLOGY, V49, P378, DOI 10.1002/hep.22677; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kabe Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11030; Kalinowski DS, 2007, J MED CHEM, V50, P6212, DOI 10.1021/jm070839q; Kalinowski DS, 2007, CHEM RES TOXICOL, V20, P715, DOI 10.1021/tx700039c; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Leu TH, 2003, FRONT BIOSCI-LANDMRK, V8, pS28, DOI 10.2741/980; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Lu XX, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2476842; Ma W, 2015, MOL MED REP, V12, P1050, DOI 10.3892/mmr.2015.3492; Mashimo T, 1998, P NATL ACAD SCI USA, V95, P11307, DOI 10.1073/pnas.95.19.11307; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; MORGAN EH, 1981, MOL ASPECTS MED, V4, P1, DOI 10.1016/0098-2997(81)90003-0; Moussa RS, 2015, ONCOTARGET, V6, P29694, DOI 10.18632/oncotarget.5088; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Park E, 2015, NAT STRUCT MOL BIOL, V22, P703, DOI 10.1038/nsmb.3074; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Pinkas-Kramarski R, 1998, MOL CELL BIOL, V18, P7602, DOI 10.1128/MCB.18.12.7602; Ren GF, 2014, HISTOL HISTOPATHOL, V29, P535, DOI 10.14670/HH-29.10.535; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salnikow K, 2004, TOXICOL APPL PHARM, V196, P258, DOI 10.1016/j.taap.2004.01.003; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Verma N, 2017, CANCER RES, V77, P86, DOI 10.1158/0008-5472.CAN-16-1797; Wang B, 2016, ADV MATH PHYS, V2016, DOI 10.1155/2016/7345325; Wang JB, 2014, ONCOTARGET, V5, P8478, DOI 10.18632/oncotarget.2328; Wang ZH, 2013, ACS CHEM BIOL, V8, P2372, DOI 10.1021/cb4005707; Wangpu XZ, 2016, MOL PHARMACOL, V89, P521, DOI 10.1124/mol.115.103044; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yu XD, 2016, COMPUT BIOL CHEM, V61, P251, DOI 10.1016/j.compbiolchem.2016.02.015; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang P, 2007, CANCER RES, V67, P9125, DOI 10.1158/0008-5472.CAN-07-1525; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; ZHU GC, 1993, J BIOL CHEM, V268, P1775	99	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12772	12782		10.1074/jbc.R117.776393	http://dx.doi.org/10.1074/jbc.R117.776393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615452	Green Published, hybrid			2022-12-28	WOS:000407220100007
J	Vessichelli, M; Mariggio, S; Varone, A; Zizza, P; Di Santo, A; Amore, C; Dell'Elba, G; Cutignano, A; Fontana, A; Cacciapuoti, C; Di Costanzo, G; Zannini, M; de Cristofaro, T; Evangelista, V; Corda, D				Vessichelli, Mariangela; Mariggio, Stefania; Varone, Alessia; Zizza, Pasquale; Di Santo, Angelomaria; Amore, Concetta; Dell'Elba, Giuseppe; Cutignano, Adele; Fontana, Angelo; Cacciapuoti, Carmela; Di Costanzo, Gaetano; Zannini, Mariastella; de Cristofaro, Tiziana; Evangelista, Virgilio; Corda, Daniela			The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lipid signaling; lipopolysaccharide (LPS); monocyte; NF-B (NF-KB); pharmacology; second messenger; sepsis; tissue factor; transcription regulation	NF-KAPPA-B; TANDEM MASS-SPECTROMETRY; GENE-EXPRESSION; TISSUE FACTOR; POSSIBLE MECHANISM; HUMAN MONOCYTES; IN-VITRO; ACTIVATION; RESOLUTION; BINDING	Inflammatory responses are elicited through lipid products of phospholipase A(2) activity that acts on the membrane phospholipids, including the phosphoinositides, to form the proinflammatory arachidonic acid and, in parallel, the glycerophosphoinositols. Here, we investigate the role of the glycerophosphoinositol in the inflammatory response. We show that it is part of a negative feedback loop that limits proinflammatory and prothrombotic responses in human monocytes stimulated with lipopolysaccharide. This inhibition is exerted both on the signaling cascade initiated by the lipopolysaccharide with the glycerophosphoinositol-dependent decrease in IB kinase /, p38, JNK, and Erk1/2 kinase phosphorylation and at the nuclear level with decreased NF-B translocation and binding to inflammatory gene promoters. In a model of endotoxemia in the mouse, treatment with glycerophosphoinositol reduced TNF- synthesis, which supports the concept that glycerophosphoinositol inhibits the de novo synthesis of proinflammatory and prothrombotic compounds and might thus have a role as an endogenous mediator in the resolution of inflammation. As indicated, this effect of glycerophosphoinositol can also be exploited in the treatment of manifestations of severe inflammation by exogenous administration of the compound.	[Vessichelli, Mariangela; Mariggio, Stefania; Varone, Alessia; Zizza, Pasquale; Corda, Daniela] CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy; [Di Santo, Angelomaria; Amore, Concetta; Dell'Elba, Giuseppe; Evangelista, Virgilio] Consorzio & Fdn Mario Negri Sud, Lab Vasc Biol & Pharmacol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy; [Cutignano, Adele; Fontana, Angelo] CNR, Inst Biomol Chem, Via Campi Flegrei 34, I-80078 Naples, Italy; [Cacciapuoti, Carmela; Di Costanzo, Gaetano] Ist Ricovero & Cura Carattere Sci, Transfus Serv, Dept Hematol Oncol, Natl Canc Inst,G Pascale Fdn, Via M Semmola 52, I-80131 Naples, Italy; [Cacciapuoti, Carmela; Di Costanzo, Gaetano] Ist Ricovero & Cura Carattere Sci, Stem Cell Transplantat Unit, Natl Canc Inst, G Pascale Fdn, Via M Semmola 52, I-80131 Naples, Italy; [Zannini, Mariastella; de Cristofaro, Tiziana] CNR, Inst Expt Endocrinol & Oncol, Via S Pansini 5, I-80131 Naples, Italy; [Zizza, Pasquale] Regina Elena Inst Canc Res, Oncogen & Epigenet Unit, Via E Chianesi 53, I-00144 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Corda, D (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.; Evangelista, V (corresponding author), Consorzio & Fdn Mario Negri Sud, Lab Vasc Biol & Pharmacol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	evangelista59gino@gmail.com; d.corda@ibp.cnr.it	Mariggio', Stefania/H-5467-2015; Zizza, Pasquale/K-3292-2018; Zannini, Mariastella/I-1735-2012; Fontana, Angelo/AAO-2741-2021; Fontana, Angelo/C-3354-2012; De+Cristofaro, Tiziana/AAX-4405-2020; Cutignano, Adele/C-3343-2012; CORDA, DANIELA/K-6385-2016	Mariggio', Stefania/0000-0002-6397-3016; Zizza, Pasquale/0000-0001-7281-6090; Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Cutignano, Adele/0000-0003-3035-9252; DECRISTOFARO, TIZIANA/0000-0003-0121-0002; ZANNINI, MARIASTELLA/0000-0002-5740-9769; CORDA, DANIELA/0000-0002-3614-751X	Italian Association for Cancer Research (Milan, Italy) [IG10341, IG14675]; Ministry for Education, Universities and Research Project "FaReBio di Qualita"; Programma Operativo Nazionale Project [01-00862]; Research Projects of National Interest Project [2012CK5RPF_05]; National Research Plan-National Research Council Aging Program; Progetto Bandiera "Epigen"; Programma Operativo Regionale Project OcKey; Italian Foundation for Cancer Research (Milan, Italy)	Italian Association for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Ministry for Education, Universities and Research Project "FaReBio di Qualita"; Programma Operativo Nazionale Project; Research Projects of National Interest Project; National Research Plan-National Research Council Aging Program; Progetto Bandiera "Epigen"; Programma Operativo Regionale Project OcKey; Italian Foundation for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by Italian Association for Cancer Research (Milan, Italy) Grants IG10341 and IG14675, the Ministry for Education, Universities and Research Project "FaReBio di Qualita," Programma Operativo Nazionale Project 01-00862, Research Projects of National Interest Project 2012CK5RPF_05, National Research Plan-National Research Council Aging Program 2012-2014, Progetto Bandiera "Epigen," and the Programma Operativo Regionale Project OcKey. D. Corda, P. Zizza, and S. Mariggio are authors of United States Patent 9351983, Use of Glycerophosphoinositols for the Treatment of Septic Shock.; Recipients of fellowships from the Italian Foundation for Cancer Research (Milan, Italy).	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Berrie CP, 2002, EUR J CANCER, V38, P2463, DOI 10.1016/S0959-8049(02)00485-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Colgan SP, 2015, SEMIN IMMUNOL, V27, P177, DOI 10.1016/j.smim.2015.03.007; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 1996, ANTICANCER RES, V16, P1341; Corda D, 2016, [No title captured], Patent No. [9351983 B2, 9351983]; Corda D, 2012, BIOCHEM SOC T, V40, P101, DOI 10.1042/BST20110679; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Cucullo L, 2004, BRAIN RES, V997, P147, DOI 10.1016/j.brainres.2003.09.079; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; di Santo A, 2011, J THROMB HAEMOST, V9, P1029, DOI 10.1111/j.1538-7836.2011.04236.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Faenza I, 2013, FEBS J, V280, P6311, DOI 10.1111/febs.12450; Falasca M, 1998, ONCOGENE, V16, P2357, DOI 10.1038/sj.onc.1201758; Filippi BM, 2008, BBA-MOL CELL RES, V1783, P2311, DOI 10.1016/j.bbamcr.2008.07.021; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grauso L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123198; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kim JH, 2008, CHEM-BIOL INTERACT, V171, P133, DOI 10.1016/j.cbi.2007.07.008; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Levi M, 2014, INT J LAB HEMATOL, V36, P228, DOI 10.1111/ijlh.12221; Lewin SR, 1997, J VIROL, V71, P2114, DOI 10.1128/JVI.71.3.2114-2119.1997; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Mancini R, 2003, MOL BIOL CELL, V14, P503, DOI 10.1091/mbc.E02-04-0179; Mariggio S, 2006, FEBS LETT, V580, P6789, DOI 10.1016/j.febslet.2006.11.039; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Natoli G., 2009, COLD SPRING HARB PER, V1; NEMERSON Y, 1988, BLOOD, V71, P1; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; Patrussi L, 2007, CELL SIGNAL, V19, P2351, DOI 10.1016/j.cellsig.2007.07.014; Patrussi L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00213; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Suzuki T, 2000, BLOOD, V96, P2584; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zizza P, 2012, J BIOL CHEM, V287, P16849, DOI 10.1074/jbc.M111.309419	56	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12828	12841		10.1074/jbc.M116.773861	http://dx.doi.org/10.1074/jbc.M116.773861			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28600357	Green Published, hybrid			2022-12-28	WOS:000407220100014
J	Ghosh, S; Kaushik, A; Khurana, S; Varshney, A; Singh, AK; Dahiya, P; Thakur, JK; Sarin, SK; Gupta, D; Malhotra, P; Mukherjee, SK; Bhatnagar, RK				Ghosh, Subhanita; Kaushik, Abhinav; Khurana, Sachin; Varshney, Aditi; Singh, Avishek Kumar; Dahiya, Pradeep; Thakur, Jitendra K.; Sarin, Shiv Kumar; Gupta, Dinesh; Malhotra, Pawan; Mukherjee, Sunil K.; Bhatnagar, Raj K.			An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug discovery; drug screening; flow cytometry; hepatitis B virus (HBV; Hep B); molecular dynamics; RNA interference (RNAi); short hairpin RNA (shRNA); surface plasmon resonance (SPR); viral protein; small molecule inhibitor; viral RNAi suppressor; HBx; antiviral agent	INFLUENZA-A VIRUS; X-PROTEIN; HBX PROTEIN; IN-VIVO; INTERFERING RNAS; VIRAL SUPPRESSOR; MAMMALIAN-CELLS; GENE; PREDICTION; INFECTION	Persistent or chronic infection with the hepatitis B virus (HBV) represents one of the most common viral diseases in humans. The hepatitis B virus deploys the hepatitis B virus X protein (HBx) as a suppressor of host defenses consisting of RNAi-based silencing of viral genes. Because of its critical role in countering host defenses, HBx represents an attractive target for antiviral drugs. Here, we developed and optimized a loss-of-function screening procedure, which identified a potential pharmacophore that abrogated HBx RNAi suppression activity. In a survey of 14,400 compounds in the Maybridge Screening Collection, we prioritized candidate compounds via high-throughput screening based on reversal of green fluorescent protein (GFP)-reported, RNAi-mediated silencing in a HepG2/GFP-shRNA RNAi sensor line. The screening yielded a pharmacologically active compound, N-(2,4-difluorophenyl)-N-[3-(1H-imidazol-1-yl) propyl] thiourea (IR415), which blocked HBx-mediated RNAi suppression indicated by the GFP reporter assay. We also found that IR415 reversed the inhibitory effect of HBx protein on activity of the Dicer endoribonuclease. We further confirmed the results of the primary screen in IR415-treated, HBV-infected HepG2 cells, which exhibited a marked depletion of HBV core protein synthesis and down-regulation of pre-genomic HBV RNA. Using a molecular interaction analysis system, we confirmed that IR415 selectively targets HBx in a concentration-dependent manner. The screening assay presented here allows rapid and improved detection of small-molecule inhibitors of HBx and related viral proteins. The assay may therefore potentiate the development of next-generation RNAi pathway-based therapeutics and promises to accelerate our search for novel and effective drugs in antiviral research.	[Ghosh, Subhanita; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, Insect Resistance Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Kaushik, Abhinav; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Translat Bioinformat Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Khurana, Sachin; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, Malaria Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Varshney, Aditi; Singh, Avishek Kumar; Sarin, Shiv Kumar] Inst Liver & Biliary Sci, D-1, New Delhi 110070, India; [Dahiya, Pradeep; Thakur, Jitendra K.] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India; [Mukherjee, Sunil K.] Indian Agr Res Inst, Div Plant Pathol, New Delhi 110012, India; [Ghosh, Subhanita] Univ Massachusetts, Program Mol Med, Sch Med, 373 Plantation St, Worcester, MA 01605 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Institute of Liver & Biliary Sciences (ILBS); Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Massachusetts System; University of Massachusetts Worcester	Bhatnagar, RK (corresponding author), Int Ctr Genet Engn & Biotechnol, Insect Resistance Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Mukherjee, SK (corresponding author), Indian Agr Res Inst, Div Plant Pathol, New Delhi 110012, India.	pawanmal@gmail.com; sunilm@icgeb.res.in; raj@icgeb.res.in	Bhatnagar, Raj/AAP-2311-2021; Dahiya, Pradeep/AAF-1283-2021; Gupta, Dinesh/C-1079-2009; Gupta, Dinesh/AAW-4243-2020; Singh, Avishek Kumar/AAA-4913-2021; Thakur, Jitendra/AAN-8674-2021	Dahiya, Pradeep/0000-0003-0178-5375; Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835; kaushik, abhinav/0000-0001-5682-0209; Ghosh, Subhanita/0000-0002-7919-1043; Thakur, Jitendra Kumar/0000-0001-7874-1923	Government of India, Department of Biotechnology Grant [BT/PR10673/AGR/36/579/2008]; Bioinformatics Infrastructure (BIF) Grant [BT/BI/25/066/2012]	Government of India, Department of Biotechnology Grant; Bioinformatics Infrastructure (BIF) Grant	This work was supported by Government of India, Department of Biotechnology Grant BT/PR10673/AGR/36/579/2008 and Bioinformatics Infrastructure (BIF) Grant BT/BI/25/066/2012. The authors declare that they have no conflicts of interest with the contents of this article.	BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; BLUM HE, 1991, J VIROL, V65, P1836, DOI 10.1128/JVI.65.4.1836-1842.1991; Bouchard MJ, 2003, J VIROL, V77, P7713, DOI 10.1128/JVI.77.14.7713-7719.2003; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Carmona S, 2006, MOL THER, V13, P411, DOI 10.1016/j.ymthe.2005.10.013; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chinnappan M, 2014, BIOCHEM J, V462, P347, DOI 10.1042/BJ20140316; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; Dasgupta T, 2009, ACS CHEM BIOL, V4, P29, DOI 10.1021/cb8002804; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamasaki K, 2003, FEBS LETT, V543, P51, DOI 10.1016/S0014-5793(03)00400-9; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12; Karjee S, 2010, J VIROL, V84, P10395, DOI 10.1128/JVI.00748-10; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Major LL, 2011, MOL BIOL INT, V2011; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Nicolas FE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003089; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Singh G, 2009, FASEB J, V23, P1845, DOI 10.1096/fj.08-125120; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Terradillos O, 1998, ONCOGENE, V17, P2115, DOI 10.1038/sj.onc.1202432; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wahome PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049075; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHO, 2017, WHO PUBLISHES LIST B; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; Zoutendijk R, 2011, J INFECT DIS, V204, P415, DOI 10.1093/infdis/jir282	54	7	7	5	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12577	12588		10.1074/jbc.M117.775155	http://dx.doi.org/10.1074/jbc.M117.775155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584057	hybrid, Green Published			2022-12-28	WOS:000406636900022
J	Razavi, AM; Delemotte, L; Berlin, JR; Carnevale, V; Voelz, VA				Razavi, Asghar M.; Delemotte, Lucie; Berlin, Joshua R.; Carnevale, Vincenzo; Voelz, Vincent A.			Molecular simulations and free-energy calculations suggest conformation-dependent anion binding to a cytoplasmic site as a mechanism for Na+/K+-ATPase ion selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; molecular dynamics; Na+; K+-ATPase; potassium transport; sodium transport; anion binding site; free energy perturbation; membrane transporter; protonation; selectivity	SODIUM-POTASSIUM PUMP; SARCOPLASMIC-RETICULUM CA2+-ATPASE; POLARIZABLE FORCE-FIELD; CRYSTAL-STRUCTURE; K+-ATPASE; ADENOSINE-TRIPHOSPHATASE; ALPHA-SUBUNIT; NA/K PUMP; NA,K-ATPASE; TRANSPORT	Na+/K+-ATPase transports Na+ and K+ ions across the cell membrane via an ion-binding site becoming alternatively accessible to the intra- and extracellular milieu by conformational transitions that confer marked changes in ion-binding stoichiometry and selectivity. To probe the mechanism of these changes, we used molecular simulation and free-energy perturbation approaches to identify probable protonation states of Na+- and K+-coordinating residues in E1P and E2P conformations of Na+/K+-ATPase. Analysis of these simulations revealed a molecular mechanism responsible for the change in protonation state: the conformation-dependent binding of an anion (a chloride ion in our simulations) to a previously unrecognized cytoplasmic site in the loop between transmembrane helices 8 and 9, which influences the electrostatic potential of the crucial Na+-coordinating residue Asp(926). This mechanistic model is consistent with experimental observations and provides a molecular-level picture of how E1P to E2P enzyme conformational transitions are coupled to changes in ion-binding stoichiometry and selectivity.	[Razavi, Asghar M.; Carnevale, Vincenzo; Voelz, Vincent A.] Temple Univ, Dept Chem, Beury 240,1901 N 13th St, Philadelphia, PA 19122 USA; [Delemotte, Lucie; Carnevale, Vincenzo; Voelz, Vincent A.] Temple Univ, Inst Computat Mol Sci, SERC 704C,N 12th St, Philadelphia, PA 19122 USA; [Delemotte, Lucie] KTH Royal Inst Technol, Dept Theoret Phys, Sci Life Lab, S-11428 Stockholm, Sweden; [Berlin, Joshua R.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Royal Institute of Technology; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Voelz, VA (corresponding author), Temple Univ, Dept Chem, Beury 240,1901 N 13th St, Philadelphia, PA 19122 USA.; Carnevale, V (corresponding author), Temple Univ, Inst Computat Mol Sci, SERC 704C,N 12th St, Philadelphia, PA 19122 USA.	vincenzo.carnevale@temple.edu; voelz@temple.edu	Voelz, Vincent/HCI-4181-2022	Delemotte, Lucie/0000-0002-0828-3899; Voelz, Vincent/0000-0002-1054-2124	National Science Foundation [ACI-1614804, MCB-1412508]; National Institutes of Health [GM057253, S10OD020095]; National Science Foundation Major Research Instrumentation Grant [CNS-09-58854]; European Union [PIOF-GA-2012-329534]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057253] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020095] Funding Source: NIH RePORTER; Direct For Biological Sciences [1412508] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants ACI-1614804 (to V. C.) and MCB-1412508 (to A. M. R. and V. A. V.), National Institutes of Health Grants GM057253 (to J. R. B.), and S10OD020095 (to V. C. and V. A. V.), and National Science Foundation Major Research Instrumentation Grant CNS-09-58854. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of funding from European Union Seventh Framework Program 979 "Voltsens" Grant PIOF-GA-2012-329534.	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Clarke RJ, 2015, BIOPHYS J, V109, P1513, DOI 10.1016/j.bpj.2015.08.022; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiorin G, 2013, MOL PHYS, V111, P3345, DOI 10.1080/00268976.2013.813594; Ganea C, 1999, BIOPHYS J, V77, P267, DOI 10.1016/S0006-3495(99)76888-8; Grossfield A, 2003, J AM CHEM SOC, V125, P15671, DOI 10.1021/ja037005r; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jorgensen PL, 1997, ANN NY ACAD SCI, V834, P161, DOI 10.1111/j.1749-6632.1997.tb52248.x; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Klimovich PV, 2015, J COMPUT AID MOL DES, V29, P397, DOI 10.1007/s10822-015-9840-9; KLODOS I, 1994, J BIOL CHEM, V269, P1734; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li H, 2015, J PHYS CHEM B, V119, P9401, DOI 10.1021/jp510560k; Lim HH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001441; Mahmmoud YA, 2015, J BIOL CHEM, V290, P3720, DOI 10.1074/jbc.M114.577486; Milanick MA, 2002, J GEN PHYSIOL, V120, P497, DOI 10.1085/jgp.20028573; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST RL, 1965, J BIOL CHEM, V240, P1437; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Rui H, 2016, ELIFE, V5, DOI 10.7554/eLife.16616; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schwinger RHG, 2003, CARDIOVASC RES, V57, P913, DOI 10.1016/S0008-6363(02)00767-8; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Suzuki K, 1997, J GEN PHYSIOL, V109, P537, DOI 10.1085/jgp.109.5.537; Tadini-Buoninsegni F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14282; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Weigand KM, 2014, BBA-BIOMEMBRANES, V1838, P1693, DOI 10.1016/j.bbamem.2014.03.022; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	51	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12412	12423		10.1074/jbc.M117.779090	http://dx.doi.org/10.1074/jbc.M117.779090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28588025	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000406636900007
J	Bruntz, RC; Lane, AN; Higashi, RM; Fan, TWM				Bruntz, Ronald C.; Lane, Andrew N.; Higashi, Richard M.; Fan, Teresa W. -M.			Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer; isotopic tracer; mass spectrometry (MS); metabolism; metabolomics; nuclear magnetic resonance (NMR)	CELL LUNG-CANCER; PENTOSE-PHOSPHATE PATHWAY; FATTY-ACID SYNTHESIS; GLUTAMINE-METABOLISM; NEOADJUVANT CHEMOTHERAPY; PYRUVATE CARBOXYLATION; HUMAN GLIOBLASTOMA; PANCREATIC TUMORS; DEFICIENT CELLS; GLUCOSE	Metabolic reprogramming is a hallmark of cancer. The changes in metabolism are adaptive to permit proliferation, survival, and eventually metastasis in a harsh environment. Stable isotope-resolved metabolomics (SIRM) is an approach that uses advanced approaches of NMR and mass spectrometry to analyze the fate of individual atoms from stable isotope-enriched precursors to products to deduce metabolic pathways and networks. The approach can be applied to a wide range of biological systems, including human subjects. This review focuses on the applications of SIRM to cancer metabolism and its use in understanding drug actions.	[Bruntz, Ronald C.; Lane, Andrew N.; Higashi, Richard M.; Fan, Teresa W. -M.] Univ Kentucky, Ctr Environm & Syst Biochem, Markey Canc Ctr, Lexington, KY 40506 USA; [Bruntz, Ronald C.; Lane, Andrew N.; Higashi, Richard M.; Fan, Teresa W. -M.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	Lane, AN; Fan, TWM (corresponding author), Univ Kentucky, Todd Bldg,789 S Limestone St, Lexington, KY 40536 USA.	andrew.lane@uky.edu; twmfan@gmail.com			National Institutes of Health [T32CA165990, 1R01ES022191-01, 1P01CA163223-01A1]; NATIONAL CANCER INSTITUTE [T32CA165990, P01CA163223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants T32CA165990 (to R. C. B.), 1R01ES022191-01 (to T. W. M. F. and R. M. H.), and 1P01CA163223-01A1 (to A. N. L. and T. W. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boros LG, 2003, CURR CANCER DRUG TAR, V3, P445, DOI 10.2174/1568009033481769; Boros LG, 2005, PANCREAS, V31, P337, DOI 10.1097/01.mpa.0000186524.53253.fb; BOS JL, 1989, CANCER RES, V49, P4682; Brunelli L, 2014, ONCOTARGET, V5, P4722, DOI 10.18632/oncotarget.1958; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Cetinbas NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep32606; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cowin GJ, 1996, BBA-MOL CELL RES, V1310, P32, DOI 10.1016/0167-4889(95)00142-5; Crown SB, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-43; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Fan T. W.-M., 2016, BIO-PROTOCOL, V6, pe1730, DOI [DOI 10.21769/BI0PR0T0C.1730, 10.21769/BioProtoc.1730, DOI 10.21769/BIOPROTOC.1730]; Fan TWM, 2008, PROG NUCL MAG RES SP, V52, P69, DOI 10.1016/j.pnmrs.2007.03.002; Fan TWM, 2005, METABOLOMICS, V1, P325, DOI 10.1007/s11306-005-0012-0; Fan TWM, 2016, PROG NUCL MAG RES SP, V92-93, P18, DOI 10.1016/j.pnmrs.2016.01.005; Fan TWM, 2012, PHARMACOL THERAPEUT, V133, P366, DOI 10.1016/j.pharmthera.2011.12.007; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Fan TWM, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000893; Fan TWM, 2012, METABOLOMICS, V8, P517, DOI 10.1007/s11306-011-0337-9; Fan TWM, 2011, J BIOMOL NMR, V49, P267, DOI 10.1007/s10858-011-9484-6; Fan TWM, 2010, METABOLOMICS, V6, P165, DOI 10.1007/s11306-010-0208-9; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Higashi Richard M, 2014, Methods Mol Biol, V1198, P147, DOI 10.1007/978-1-4939-1258-2_11; Hiller K, 2010, ANAL CHEM, V82, P6621, DOI 10.1021/ac1011574; Hou Y, 2014, MOL BIOSYST, V10, P2126, DOI 10.1039/c4mb00054d; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Izquierdo-Garcia JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108289; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Kurland IJ, 2000, J BIOL CHEM, V275, P36787, DOI 10.1074/jbc.M004739200; Lane AN, 2008, METHOD CELL BIOL, V84, P541, DOI 10.1016/S0091-679X(07)84018-0; Lane AN, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1065-y; Lane AN, 2009, ANAL CHIM ACTA, V651, P201, DOI 10.1016/j.aca.2009.08.032; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Liu HP, 2004, CURR OPIN GENET DEV, V14, P55, DOI 10.1016/j.gde.2003.11.005; Lorkiewicz P, 2012, METABOLOMICS, V8, P930, DOI 10.1007/s11306-011-0388-y; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Miccheli A, 2006, BIOCHIMIE, V88, P437, DOI 10.1016/j.biochi.2005.10.004; Moseley HNB, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-37; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nicolay BN, 2015, GENE DEV, V29, P1875, DOI 10.1101/gad.264127.115; Nicolay BN, 2013, GENE DEV, V27, P182, DOI 10.1101/gad.206227.112; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Qi JS, 2012, J LIPID RES, V53, P1106, DOI 10.1194/jlr.M020156; Reynolds MR, 2014, ONCOGENE, V33, P556, DOI 10.1038/onc.2012.635; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Saxena N, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv287; Schoenheimer R, 1935, J BIOL CHEM, V111, P175; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Serkova N, 2005, AM J PHARMACOGENOMIC, V5, P293, DOI 10.2165/00129785-200505050-00002; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Telang S, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-77; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1923, BIOCHEM Z, V142, P317; Wei SW, 2013, MOL ONCOL, V7, P297, DOI 10.1016/j.molonc.2012.10.003; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072179; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang J, 2014, METHOD ENZYMOL, V542, P369, DOI 10.1016/B978-0-12-416618-9.00019-4; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250; Zheng L, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-12	100	65	66	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11601	11609		10.1074/jbc.R117.776054	http://dx.doi.org/10.1074/jbc.R117.776054			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28592486	hybrid, Green Published			2022-12-28	WOS:000405485600001
J	Harada, K; Kitaguchi, T; Kamiya, T; Aung, KH; Nakamura, K; Ohta, K; Tsuboi, T				Harada, Kazuki; Kitaguchi, Tetsuya; Kamiya, Taichi; Aung, Kyaw Htet; Nakamura, Kazuaki; Ohta, Kunihiro; Tsuboi, Takashi			Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID RECEPTOR; ENDOTHELIAL-CELLS; MEDIATED PHOSPHORYLATION; PROTEIN EXPRESSION; GLUTAG CELLS; F-ACTIN; GPR55; LYSOPHOSPHOLIPIDS; ISLETS; ACID	The lysophosphatidylinositol (LPI) has crucial roles in multiple physiological processes, including insulin exocytosis from pancreatic islets. However, the role of LPI in secretion of glucagon-like peptide-1 (GLP-1), a hormone that enhances glucose-induced insulin secretion, is unclear. Here, we used the murine enteroendocrine L cell line GLUTag and primary murine small intestinal cells to elucidate the mechanism of LPI-induced GLP-1 secretion. Exogenous LPI addition increased intracellular Ca2+ concentrations ([Ca2+](i)) in GLUTag cells and induced GLP-1 secretion from both GLUTag and acutely prepared primary intestinal cells. The [Ca2+](i) increase was suppressed by an antagonist for G protein-coupled receptor 55 (GPR55) and by silencing of GPR55 expression, indicating involvement of Gq and G12/13 signaling pathways in the LPI-induced increased [Ca2+](i) levels and GLP-1 secretion. However, GPR55 agonists did not mimic many of the effects of LPI. We also found that phospholipase C inhibitor and Rho-associated kinase inhibitor suppressed the [Ca2+](i) increase and that LPI increased the number of focal adhesions, indicating actin reorganization. Of note, blockage or silencing of transient receptor potential cation channel subfamily V member 2 (TRPV2) channels suppressed both the LPI-induced [Ca2+](i) increase and GLP-1 secretion. Furthermore, LPI accelerated TRPV2 translocation to the plasma membrane, which was significantly suppressed by a GPR55 antagonist. These findings suggest that TRPV2 activation via actin reorganization induced by Gq and G12/13 signaling is involved in LPI-stimulated GLP-1 secretion in enteroendocrine L cells. Because GPR55 agonists largely failed to mimic the effects of LPI, its actions on L cells are at least partially independent of GPR55 activation.	[Harada, Kazuki; Kamiya, Taichi; Ohta, Kunihiro; Tsuboi, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Kitaguchi, Tetsuya] Waseda Biosci Res Inst Singapore WABIOS, Cell Signaling Grp, Singapore 138667, Singapore; [Kitaguchi, Tetsuya] Waseda Univ, Comprehens Res Org, Tokyo 1620041, Japan; [Aung, Kyaw Htet; Nakamura, Kazuaki] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	University of Tokyo; Waseda University; National Center for Child Health & Development - Japan	Tsuboi, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	takatsuboi@bio.c.u-tokyo.ac.jp	Kitaguchi, Tetsuya/F-5260-2017; TSUBOI, Takashi/AAD-7976-2019; KITAGUCHI, TETSUYA/AAR-1895-2021	Kitaguchi, Tetsuya/0000-0001-6701-1933; TSUBOI, Takashi/0000-0001-8290-2021; KITAGUCHI, TETSUYA/0000-0001-6701-1933; Harada, Kazuki/0000-0002-0793-6851	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26460289, 26291018]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research (26460289 (to T. T.) and 26291018 (to K. O.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; AlSuleimani YM, 2015, BRIT J PHARMACOL, V172, P3043, DOI 10.1111/bph.13107; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V462, P245, DOI 10.1007/s00424-011-0977-7; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Claustre J, 1999, J ENDOCRINOL, V162, P271, DOI 10.1677/joe.0.1620271; CRUCIANI RA, 1993, P NATL ACAD SCI USA, V90, P3019, DOI 10.1073/pnas.90.7.3019; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; GETTYS TW, 1995, METABOLISM, V44, P771, DOI 10.1016/0026-0495(95)90191-4; Harada K, 2015, BIOCHEM BIOPH RES CO, V460, P1053, DOI 10.1016/j.bbrc.2015.03.151; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hou JC, 2006, J BIOL CHEM, V281, P23307, DOI 10.1074/jbc.M603127200; Imbernon M, 2014, MOL CELL ENDOCRINOL, V383, P159, DOI 10.1016/j.mce.2013.12.011; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kiuchi T, 2015, NAT METHODS, V12, P743, DOI [10.1038/nmeth.3466, 10.1038/NMETH.3466]; Kuipers D, 2014, J CELL SCI, V127, P1229, DOI 10.1242/jcs.138289; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Ma MT, 2010, J NEURAL TRANSM, V117, P301, DOI 10.1007/s00702-009-0355-1; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Martin NP, 2004, CELL SIGNAL, V16, P1397, DOI 10.1016/j.cellsig.2004.05.002; Matsuda N, 2000, N-S ARCH PHARMACOL, V361, P53, DOI 10.1007/s002109900169; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; Meadows A., 2015, INT J OBES LOND, V40, P417, DOI DOI 10.1038/IJ0.2015.209; METZ SA, 1986, BIOCHEM BIOPH RES CO, V138, P720, DOI 10.1016/S0006-291X(86)80556-3; METZ SA, 1988, BIOCHIM BIOPHYS ACTA, V968, P239, DOI 10.1016/0167-4889(88)90013-4; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pan CY, 2007, J NEUROCHEM, V102, P944, DOI 10.1111/j.1471-4159.2007.04584.x; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Tsuchiya A, 2015, J PHARMACOL SCI, V128, P179, DOI 10.1016/j.jphs.2015.07.001; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	49	18	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10855	10864		10.1074/jbc.M117.788653	http://dx.doi.org/10.1074/jbc.M117.788653			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28533434	Green Published, hybrid			2022-12-28	WOS:000404391000010
J	Tabaja, N; Yuan, ZY; Oswald, F; Kovall, RA				Tabaja, Nassif; Yuan, Zhenyu; Oswald, Franz; Kovall, Rhett A.			Structure-function analysis of RBP-J-interacting and tubulin-associated (RITA) reveals regions critical for repression of Notch target genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; isothermal titration calorimetry (ITC); Notch pathway; protein-protein interaction; signal transduction; transcription corepressor; transcription factor; X-ray crystallography	SECONDARY STRUCTURE ANALYSES; TRANSCRIPTION; BINDING; PROTEIN; DOMAIN; SUPPRESSOR; INSIGHTS; COMPLEX	The Notch pathway is a cell-to-cell signaling mechanism that is essential for tissue development and maintenance, and aberrant Notch signaling has been implicated in various cancers, congenital defects, and cardiovascular diseases. Notch signaling activates the expression of target genes, which are regulated by the transcription factor CSL (CBF1/RBP-J, Su(H), Lag-1). CSL interacts with both transcriptional corepressor and coactivator proteins, functioning as both a repressor and activator, respectively. Although Notch activation complexes are relatively well understood at the structural level, less is known about how CSL interacts with corepressors. Recently, a new RBP-J (mammalian CSL ortholog)-interacting protein termed RITA has been identified and shown to export RBP-J out of the nucleus, thereby leading to the down-regulation of Notch target gene expression. However, the molecular details of RBP-J/RITA interactions are unclear. Here, using a combination of biochemical/cellular, structural, and biophysical techniques, we demonstrate that endogenous RBP-J and RITA proteins interact in cells, map the binding regions necessary for RBP-JRITA complex formation, and determine the X-ray structure of the RBP-JRITA complex bound to DNA. To validate the structure and glean more insights into function, we tested structure-based RBP-J and RITA mutants with biochemical/cellular assays and isothermal titration calorimetry. Whereas our structural and biophysical studies demonstrate that RITA binds RBP-J similarly to the RAM (RBP-J-associated molecule) domain of Notch, our biochemical and cellular assays suggest that RITA interacts with additional regions in RBP-J. Taken together, these results provide molecular insights into the mechanism of RITA-mediated regulation of Notch signaling, contributing to our understanding of how CSL functions as a transcriptional repressor of Notch target genes.	[Tabaja, Nassif; Yuan, Zhenyu; Kovall, Rhett A.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Oswald, Franz] Univ Med Ctr Ulm, Ctr Internal Med, Dept Internal Med 1, D-89081 Ulm, Germany	University System of Ohio; University of Cincinnati; Ulm University	Kovall, RA (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu	Oswald, Franz/AAO-9584-2020		DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA178974] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Kovall and Oswald laboratories for technical assistance. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Brockmann B, 2014, HEREDITAS, V151, P209, DOI 10.1111/hrd2.00074; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Choi SH, 2012, STRUCTURE, V20, P340, DOI 10.1016/j.str.2011.12.011; Collins KJ, 2014, STRUCTURE, V22, P70, DOI 10.1016/j.str.2013.10.010; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Friedmann DR, 2010, PROTEIN SCI, V19, P34, DOI 10.1002/pro.280; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; LING PD, 1995, J VIROL, V69, P1944, DOI 10.1128/JVI.69.3.1944-1950.1995; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Wacker SA, 2011, EMBO J, V30, P43, DOI 10.1038/emboj.2010.289; Wang HH, 2012, ONCOL RES, V20, P437, DOI 10.3727/096504013X13685487925059; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287	43	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10549	10563		10.1074/jbc.M117.791707	http://dx.doi.org/10.1074/jbc.M117.791707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487372	hybrid, Green Published			2022-12-28	WOS:000404115400016
J	Soofi, A; Wolf, KI; Emont, MP; Qi, N; Martinez-Santibanez, G; Grimley, E; Ostwani, W; Dressler, GR				Soofi, Abdul; Wolf, Katherine I.; Emont, Margo P.; Qi, Nathan; Martinez-Santibanez, Gabriel; Grimley, Edward; Ostwani, Wesam; Dressler, Gregory R.			The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; INDIRECT CALORIMETRY; BMP; DIFFERENTIATION; THERMOGENESIS; ADIPOGENESIS; ARCHITECTURE; ADIPOCYTES; FIBROSIS	Obesity and its associated complications such as insulin resistance and non-alcoholic fatty liver disease are reaching epidemic proportions. In mice, the TGF-beta superfamily is implicated in the regulation of white and brown adipose tissue differentiation. The kielin/chordin-like protein (KCP) is a secreted regulator of the TGF-beta superfamily pathways that can inhibit both TGF-beta and activin signals while enhancing bone morphogenetic protein (BMP) signaling. However, KCP's effects on metabolism and obesity have not been studied in animal models. Therefore, we examined the effects of KCP loss or gain of function in mice that were maintained on either a regular or a high-fat diet. KCP loss sensitized the mice to obesity and associated complications such as glucose intolerance and adipose tissue inflammation and fibrosis. In contrast, transgenic mice that expressed KCP in the kidney, liver, and adipose tissues were resistant to developing high-fat diet-induced obesity and had significantly reduced white adipose tissue. Moreover, KCP overexpression shifted the pattern of SMAD signaling in vivo, increasing the levels of phospho (P)-SMAD1 and decreasing P-SMAD3. Adipocytes in culture showed a cell-autonomous effect in response to added TGF-beta 1 or BMP7. Metabolic profiling indicated increased energy expenditure in KCP-overexpressing mice and reduced expenditure in the KCP mutants with no effect on food intake or activity. These findings demonstrate that shifting the TGF-beta superfamily signaling with a secreted protein can alter the physiology and thermogenic properties of adipose tissue to reduce obesity even when mice are fed a high-fat diet.	[Soofi, Abdul; Wolf, Katherine I.; Grimley, Edward; Dressler, Gregory R.] Univ Michigan, Dept Pathol, 109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA; [Emont, Margo P.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Qi, Nathan] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Martinez-Santibanez, Gabriel] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Martinez-Santibanez, Gabriel] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Ostwani, Wesam] Univ Florida, Dept Cardiovasc Sci, Gainesville, FL 32610 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Dressler, GR (corresponding author), Univ Michigan, Dept Pathol, 109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA.	dressler@umich.edu		Grimley, Edward/0000-0003-0438-506X; Emont, Margo/0000-0001-9873-2784	National Institutes of Health [DK020572, DK089503]; NATIONAL CANCER INSTITUTE [T32CA140044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK110768, R01DK054740, F31DK112625, P60DK020572, P30DK020572, P30DK089503, R01DK062914, R01DK073722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Limback and the University of Michigan Animal Phenotyping Core for metabolic analyses, J. Poore and J. Harrison from the University of Michigan Microscopy and Imaging Analysis core for histology and imaging, S. Reilly for discussion and insights, T. Mergian and J. DelProposto for help with the glucose tolerance test, and E. Ranghini for advice and assistance. The core services were supported by National Institutes of Health Grants DK020572 and DK089503 (to the University of Michigan).	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Asrih M, 2015, MOL CELL ENDOCRINOL, V418, P55, DOI 10.1016/j.mce.2015.02.018; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Budi EH, 2016, METHODS MOL BIOL, V1344, P1, DOI 10.1007/978-1-4939-2966-5_1; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Emont MP, 2015, ENDOCRINOLOGY, V156, P4761, DOI 10.1210/en.2015-1567; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Larrain J, 2000, DEVELOPMENT, V127, P821; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JM, 2006, MOL CELL BIOL, V26, P4577, DOI 10.1128/MCB.02127-05; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; SASAI Y, 1995, NATURE, V378, P419, DOI 10.1038/378419d0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Soofi A, 2016, AM J PHYSIOL-GASTR L, V311, pG587, DOI 10.1152/ajpgi.00165.2016; Soofi A, 2013, J AM SOC NEPHROL, V24, P897, DOI 10.1681/ASN.2012070759; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yadav Hariom, 2012, Front Endocrinol (Lausanne), V3, P35, DOI 10.3389/fendo.2012.00035; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018	52	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9051	9062		10.1074/jbc.M116.771428	http://dx.doi.org/10.1074/jbc.M116.771428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28424263	Green Published, hybrid			2022-12-28	WOS:000402538900005
J	Huang, C; Alapa, M; Shu, P; Nagarajan, N; Wu, CG; Sadoshima, J; Kholodovych, V; Li, H; Beuve, A				Huang, Can; Alapa, Maryam; Shu, Ping; Nagarajan, Narayani; Wu, Changgong; Sadoshima, Junichi; Kholodovych, Vladyslav; Li, Hong; Beuve, Annie			Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; S-NITROSYLATION; CATALYTIC DOMAINS; BINDING-SITE; RECEPTOR; DESENSITIZATION; ACTIVATION; MECHANISM; STRESS; SYSTEM	Nitric oxide (NO) modulates many physiological events through production of cGMP from its receptor, the NO-sensitive guanylyl cyclase (GC1). NO also appears to function in a cGMP-independent manner, via S-nitrosation (SNO), a redox-based modification of cysteine thiols. Previously, we have shown that S-nitrosated GC1 (SNO-GC1) is desensitized to NO stimulation following prolonged NO exposure or under oxidative/nitrosative stress. In animal models of nitrate tolerance and angiotensin II-induced hypertension, decreased vasodilation in response to NO correlates with GC1 thiol oxidation, but the physiological mechanism that resensitizes GC1 to NO and restores basal activity is unknown. Because GC1 interacts with the oxidoreductase protein-disulfide isomerase, we hypothesized that thioredoxin-1 (Trx1), a cytosolic oxidoreductase, could be involved in restoring GC1 basal activity and NO sensitivity because the Trx/thioredoxin reductase (TrxR) system maintains thiol redox homeostasis. Here, by manipulating activity and levels of the Trx1/TrxR system and by using a Trx1-Trap assay, we demonstrate that Trx1 modulates cGMP synthesis through an association between Trx1 and GC1 via a mixed disulfide. A proximity ligation assay confirmed the endogenous Trx1-GC1 complex in cells. Mutational analysis suggested that Cys(609) in GC1 is involved in the Trx1-GC1 association and modulation of GC1 activity. Functionally, we established that Trx1 protects GC1 from S-nitrosocysteine-induced desensitization. A computational model of Trx1-GC1 interaction illustrates a possible mechanism for Trx1 to maintain basal GC1 activity and prevent/rescue GC1 desensitization to NO. The etiology of some oxidative vascular diseases may very well be explained by the dysfunction of the Trx1-GC1 association.	[Huang, Can; Alapa, Maryam; Shu, Ping; Beuve, Annie] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Nagarajan, Narayani; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Wu, Changgong; Li, Hong] Rutgers New Jersey Med Sch, Ctr Adv Prote Res, Dept Microbiol Biochem & Mol Genet, Ctr Canc, Newark, NJ 07103 USA; [Kholodovych, Vladyslav] Rutgers State Univ, Off Adv & Res Comp, Piscataway, NJ 08854 USA; [Kholodovych, Vladyslav] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Beuve, A (corresponding author), Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, MSB, 185 S Orange Ave, Newark, NJ USA.	beuveav@njms.rutgers.edu	Li, Hong/K-8436-2013; Huang, Can/HGB-4695-2022; Huang, Can/AAG-9168-2019	Huang, Can/0000-0003-1734-0450; Sadoshima, Junichi/0000-0003-3724-4132; Li, Hong/0000-0001-5731-5335	National Institutes of Health [GM112415, GM067640]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640, R01GM112415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM112415 (to A. B. and H. L.) and GM067640 (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baskaran P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026976; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Beuve A, 2017, ANTIOXID REDOX SIGN, V26, P137, DOI 10.1089/ars.2015.6591; Beuve A, 2016, J PROTEOMICS, V138, P40, DOI 10.1016/j.jprot.2016.02.009; Case D. A., 2017, AMBER 2017; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Choi H, 2011, J CARDIOVASC PHARM, V58, P522, DOI 10.1097/FJC.0b013e31822d80a5; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Crassous PA, 2012, AM J PHYSIOL-HEART C, V303, pH597, DOI 10.1152/ajpheart.00138.2012; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Engelman R, 2016, FREE RADICAL BIO MED, V97, P375, DOI 10.1016/j.freeradbiomed.2016.06.032; Ghosh A, 2017, ANTIOXID REDOX SIGN, V26, P182, DOI 10.1089/ars.2016.6690; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Heckler EJ, 2013, BIOCHEM J, V452, P161, DOI 10.1042/BJ20130298; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hobbs A., GUANYLYL CYCLASES GC; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kumar V, 2013, BIOCHEMISTRY-US, V52, P3601, DOI 10.1021/bi301657w; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Maron BA, 2009, J BIOL CHEM, V284, P7665, DOI 10.1074/jbc.M809460200; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Riego JA, 2009, FREE RADICAL BIO MED, V47, P269, DOI 10.1016/j.freeradbiomed.2009.04.027; Sayed N, 2008, CIRC RES, V103, P606, DOI 10.1161/CIRCRESAHA.108.175133; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437	37	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14362	14370		10.1074/jbc.M117.787390	http://dx.doi.org/10.1074/jbc.M117.787390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28659344	Green Published, hybrid			2022-12-28	WOS:000408747500005
J	Gao, Y; Westfield, G; Erickson, JW; Cerione, RA; Skiniotis, G; Ramachandran, S				Gao, Yang; Westfield, Gerwin; Erickson, Jon W.; Cerione, Richard A.; Skiniotis, Georgios; Ramachandran, Sekar			Isolation and structure-function characterization of a signaling-active rhodopsin-G protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; G protein-coupled receptor (GPCR); rhodopsin; signal transduction; structural biology; EM; G-protein; SAXS; photo-transduction; transducin	SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; ALPHA-SUBUNIT; MONOMERIC RHODOPSIN; ADRENERGIC-RECEPTOR; ARRESTIN-1 BINDING; MEMBRANE-PROTEINS; HIGH-RESOLUTION; TRANSDUCIN	The visual photo-transduction cascade is a prototypical G protein-coupled receptor (GPCR) signaling system, in which light-activated rhodopsin (Rho*) is the GPCR catalyzing the exchange of GDP for GTP on the heterotrimeric G protein transducin (G(T)). This results in the dissociation of G(T) into its component (T)-GTP and (11) subunit complex. Structural information for the Rho*-G(T) complex will be essential for understanding the molecular mechanism of visual photo-transduction. Moreover, it will shed light on how GPCRs selectively couple to and activate their G protein signaling partners. Here, we report on the preparation of a stable detergent-solubilized complex between Rho* and a heterotrimer (G(T)*) comprising a G(T)/G(i1) chimera ((T)*) and (11). The complex was formed on native rod outer segment membranes upon light activation, solubilized in lauryl maltose neopentyl glycol, and purified with a combination of affinity and size-exclusion chromatography. We found that the complex is fully functional and that the stoichiometry of Rho* to G(T)* is 1:1. The molecular weight of the complex was calculated from small-angle X-ray scattering data and was in good agreement with a model consisting of one Rho* and one G(T)*. The complex was visualized by negative-stain electron microscopy, which revealed an architecture similar to that of the (2)-adrenergic receptor-G(S) complex, including a flexible (T)* helical domain. The stability and high yield of the purified complex should allow for further efforts toward obtaining a high-resolution structure of this important signaling complex.	[Gao, Yang; Erickson, Jon W.; Cerione, Richard A.; Ramachandran, Sekar] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Westfield, Gerwin; Skiniotis, Georgios] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; [Westfield, Gerwin; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Skiniotis, Georgios] Stanford Univ, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA	Cornell University; Cornell University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Cote, Rick H/G-3363-2013; Ramachandran, Sekar/AAP-2287-2020	Cote, Rick H/0000-0002-1573-6526; Ramachandran, Sekar/0000-0002-2243-1368; Westfield, Gerwin/0000-0001-9634-2336; Gao, Yang/0000-0002-8758-0954; Skiniotis, Georgios/0000-0003-0238-7846	National Institutes of Health Grant [GM103485]	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Cindy Westmiller for expert secretarial assistance. The MacCHESS facility was the recipient of National Institutes of Health Grant GM103485.	Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KUHN H, 1981, P NATL ACAD SCI-BIOL, V78, P6873, DOI 10.1073/pnas.78.11.6873; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Ma P, 2002, NAT REV DRUG DISCOV, V1, P571, DOI 10.1038/nrd884; Maeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098714; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Perez J, 2015, ACTA CRYSTALLOGR D, V71, P86, DOI 10.1107/S1399004714016678; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; Ramachandran S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.166538; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; STRYER L, 1991, J BIOL CHEM, V266, P10711; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vishnivetskiy SA, 2013, CELL SIGNAL, V25, P2155, DOI 10.1016/j.cellsig.2013.07.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xie GF, 2011, BIOCHEMISTRY-US, V50, P10399, DOI 10.1021/bi201126r; Xu S., 2007, P SOC PHOTO-OPT INS, V6665, P1; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	50	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14280	14289		10.1074/jbc.M117.797100	http://dx.doi.org/10.1074/jbc.M117.797100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28655769	Green Published, hybrid			2022-12-28	WOS:000408439800032
J	Hoben, JP; Lubner, CE; Ratzloff, MW; Schut, GJ; Nguyen, DMN; Hempel, KW; Adams, MWW; King, PW; Miller, AF				Hoben, John P.; Lubner, Carolyn E.; Ratzloff, Michael W.; Schut, Gerrit J.; Nguyen, Diep M. N.; Hempel, Karl W.; Adams, Michael W. W.; King, Paul W.; Miller, Anne-Frances			Equilibrium and ultrafast kinetic studies manipulating electron transfer: A short-lived flavin semiquinone is not sufficient for electron bifurcation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron transfer; energetics; flavin; flavoprotein; fluorescence; electron bifurcation; transient absorption spectroscopy	EXCITED-STATE DYNAMICS; DESULFOVIBRIO-VULGARIS; NADH OXIDASE; FLAVODOXIN; BINDING; PROTEIN; ACID; PHOTOACTIVATION; NITROREDUCTASE; PURIFICATION	Flavin-based electron transfer bifurcation is emerging as a fundamental and powerful mechanism for conservation and deployment of electrochemical energy in enzymatic systems. In this process, a pair of electrons is acquired at intermediate reduction potential (i.e. intermediate reducing power), and each electron is passed to a different acceptor, one with lower and the other with higher reducing power, leading to bifurcation. It is believed that a strongly reducing semiquinone species is essential for this process, and it is expected that this species should be kinetically short-lived. We now demonstrate that the presence of a short-lived anionic flavin semiquinone (ASQ) is not sufficient to infer the existence of bifurcating activity, although such a species may be necessary for the process. We have used transient absorption spectroscopy to compare the rates and mechanisms of decay of ASQ generated photochemically in bifurcating NADH-dependent ferredoxin-NADP(+) oxidoreductase and the non-bifurcating flavoproteins nitroreductase, NADH oxidase, and flavodoxin. We found that different mechanisms dominate ASQ decay in the different protein environments, producing lifetimes ranging over 2 orders of magnitude. Capacity for electron transfer among redox cofactors versus charge recombination with nearby donors can explain the range of ASQ lifetimes that we observe. Our results support a model wherein efficient electron propagation can explain the short lifetime of the ASQ of bifurcating NADH-dependent ferredoxin-NADP(+) oxidoreductase I and can be an indication of capacity for electron bifurcation.	[Hoben, John P.; Hempel, Karl W.; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Lubner, Carolyn E.; Ratzloff, Michael W.; King, Paul W.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Schut, Gerrit J.; Nguyen, Diep M. N.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of Kentucky; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University System of Georgia; University of Georgia	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afmill3r2@gmail.com	King, Paul W./D-9979-2011	King, Paul W./0000-0001-5039-654X	Biological and Electron Transfer and Catalysis (BETCy) EFRC, an Energy Frontier Research Center - United States Department of Energy, Office of Science [DE-SC0012518]; U. S. Department of Energy [DE-AC36-08-GO28308]; National Renewable Energy Laboratory	Biological and Electron Transfer and Catalysis (BETCy) EFRC, an Energy Frontier Research Center - United States Department of Energy, Office of Science(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE))	This work is supported as part of the Biological and Electron Transfer and Catalysis (BETCy) EFRC, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science (DE-SC0012518). This work was also supported by the U. S. Department of Energy under Contract DE-AC36-08-GO28308 with the National Renewable Energy Laboratory (to C. E. L., M. W. R., and P. W. K.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Aliverti A, 1999, METH MOL B, V131, P9; Armenta-Armenta ME, 2005, ENVIRON SCI TECHNOL, V39, P5872, DOI 10.1021/es048104n; Artali R, 2002, ACTA CRYSTALLOGR D, V58, P1787, DOI 10.1107/S0907444902012234; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chobot V, 2015, J ORGANOMET CHEM, V782, P103, DOI 10.1016/j.jorganchem.2015.01.005; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Cui D., 2010, THESIS; CURLEY GP, 1991, EUR J BIOCHEM, V202, P1091, DOI 10.1111/j.1432-1033.1991.tb16475.x; Demmer JK, 2015, J BIOL CHEM, V290, P21985, DOI 10.1074/jbc.M115.656520; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Enescu M, 1998, PHOTOCHEM PHOTOBIOL, V68, P150, DOI 10.1111/j.1751-1097.1998.tb02482.x; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Gauden M, 2007, BIOCHEMISTRY-US, V46, P7405, DOI 10.1021/bi7006433; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Hardman SJO, 2013, BIOPHYS J, V105, P2549, DOI 10.1016/j.bpj.2013.10.015; Hay S, 2009, ANGEW CHEM INT EDIT, V48, P1452, DOI 10.1002/anie.200805502; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; He TF, 2013, BIOCHEMISTRY-US, V52, P9120, DOI 10.1021/bi401137u; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; Huang JJ, 2010, APPL ENVIRON MICROB, V76, P7717, DOI 10.1128/AEM.01143-10; Koder Jr R. L., 1998, BIOCHIM BIOPHYS ACTA, V1387, P394; Koder RL, 2002, BIOCHEMISTRY-US, V41, P14197, DOI 10.1021/bi025805t; Koder RL, 1998, PROTEIN EXPRES PURIF, V13, P53, DOI 10.1006/prep.1997.0866; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; La Mer VK, 1923, J BIOL CHEM, V57, P613; Lakowicz J. R., 2010, PRINCIPLES FLUORESCE, P280; Liu ZY, 2013, P NATL ACAD SCI USA, V110, P12966, DOI 10.1073/pnas.1311073110; Lubner CE, 2017, NAT CHEM BIOL, V13, P655, DOI 10.1038/nchembio.2348; Lukacs A, 2012, J PHYS CHEM B, V116, P5810, DOI 10.1021/jp2116559; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Mathes T, 2012, J BIOL CHEM, V287, P31725, DOI 10.1074/jbc.M112.391896; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; Montilla F, 2003, LANGMUIR, V19, P10241, DOI 10.1021/la0346705; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; PARK HJ, 1992, EUR J BIOCHEM, V205, P881, DOI 10.1111/j.1432-1033.1992.tb16853.x; Penzkofer A, 2007, CHEM PHYS, V336, P14, DOI 10.1016/j.chemphys.2007.05.009; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petushkov VN, 2003, J PHYS CHEM B, V107, P10934, DOI 10.1021/jp034266e; Pitsawong W, 2014, J BIOL CHEM, V289, P15203, DOI 10.1074/jbc.M113.547117; Sarma R, 2016, CHEM COMMUN, V52, P8834, DOI 10.1039/c6cc01479h; Schoepp-Cothenet B, 2013, BBA-BIOENERGETICS, V1827, P79, DOI 10.1016/j.bbabio.2012.09.005; Scott JD, 2004, MICROBIOL-SGM, V150, P117, DOI 10.1099/mic.0.26603-0; Siebner M., 1997, THESIS; SWENSON RP, 1994, BIOCHEMISTRY-US, V33, P8505, DOI 10.1021/bi00194a015; Syrokomsky WS, 1936, J AM CHEM SOC, V58, P928, DOI 10.1021/ja01297a024	53	17	17	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14039	14049		10.1074/jbc.M117.794214	http://dx.doi.org/10.1074/jbc.M117.794214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28615449	Green Published, hybrid			2022-12-28	WOS:000408439800012
J	Smith, TH; Li, JG; Dores, MR; Trejo, J				Smith, Thomas H.; Li, Julia G.; Dores, Michael R.; Trejo, JoAnn			Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of beta-arrestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2Y(12) RECEPTORS; PLATELET ACTIVATION; ADP RECEPTOR; THROMBIN; HETERODIMER; TRAFFICKING; CLEAVAGE; KINETICS; CLONING; MOTIF	Vascular inflammation and thrombosis require the concerted actions of several different agonists, many of which act on G protein-coupled receptors (GPCRs). GPCR dimerization is a well-established phenomenon that can alter protomer function. In platelets and other cell types, protease-activated receptor-4 (PAR4) has been shown to dimerize with the purinergic receptor P2Y12 to coordinate beta-arrestin-mediated Akt signaling, an important mediator of integrin activation. However, the mechanism by which the PAR4-P2Y12 dimer controls beta-arrestin-dependent Akt signaling is not known. We now report that PAR4 and P2Y12 heterodimer internalization is required for beta-arrestin recruitment to endosomes and Akt signaling. Using bioluminescence resonance energy transfer, immunofluorescence microscopy, and co-immunoprecipitation in cells expressing receptors exogenously and endogenously, we demonstrate that PAR4 and P2Y12 specifically interact and form dimers expressed at the cell surface. We also found that activation of PAR4 but not of P2Y12 drives internalization of the PAR4-P2Y12 heterodimer. Remarkably, activated PAR4 internalization was required for recruitment of beta-arrestin to endocytic vesicles, which was dependent on co-expression of P2Y12. Interestingly, stimulation of the PAR4-P2Y12 heterodimer promotes beta-arrestin and Akt co-localization to intracellular vesicles. Moreover, activated PAR4-P2Y12 internalization is required for sustained Akt activation. Thus, internalization of the PAR4-P2Y12 heterodimer is necessary for beta-arrestin recruitment to endosomes and Akt signaling and lays the foundation for examining whether blockade of PAR4 internalization reduces integrin and platelet activation.	[Smith, Thomas H.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smith, Thomas H.; Li, Julia G.; Dores, Michael R.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA; [Dores, Michael R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hofstra University	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu			National Institutes of Health (NIGMS) [R01 GM090689]; NHLBI, National Institutes of Health [F31 HL116187]; San Diego IRACDA Program National Institutes of Health Grant [K12 GM06852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL116187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM090689, K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); San Diego IRACDA Program National Institutes of Health Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health R01 GM090689 (NIGMS; to J. T.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NHLBI, National Institutes of Health F31 HL116187 Predoctoral Fellowship.; Supported by the San Diego IRACDA Program National Institutes of Health Grant K12 GM06852.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Arachiche A, 2013, J BIOL CHEM, V288, P32553, DOI 10.1074/jbc.M113.472373; Baqi Y, 2009, J MED CHEM, V52, P3784, DOI 10.1021/jm9003297; Cattaneo M, 2015, J THROMB HAEMOST, V13, pS10, DOI 10.1111/jth.12952; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Hamilton JR, 2017, ANNU REV PHARMACOL, V57, P349, DOI 10.1146/annurev-pharmtox-011613-140016; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Kufareva Irina, 2013, Methods Mol Biol, V1013, P93, DOI 10.1007/978-1-62703-426-5_7; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Lin HL, 2013, PHARMACOL REV, V65, P1198, DOI 10.1124/pr.111.004747; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Remijn JA, 2002, ARTERIOSCL THROM VAS, V22, P686, DOI 10.1161/01.ATV.0000012805.49079.23; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Smith TH, 2016, J BIOL CHEM, V291, P18453, DOI 10.1074/jbc.M116.729285; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Withey JME, 2005, BRIT J HAEMATOL, V129, P377, DOI 10.1111/j.1365-2141.2005.05468.x; Wong PC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5294; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhong XT, 2004, FEBS LETT, V562, P111, DOI 10.1016/S0014-5793(04)00191-7	34	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13867	13878		10.1074/jbc.M117.782359	http://dx.doi.org/10.1074/jbc.M117.782359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28652403	hybrid, Green Published			2022-12-28	WOS:000407942400026
J	Keck, KM; Moquin, SA; He, A; Fernandez, SG; Somberg, JJ; Liu, SM; Martinez, DM; Miranda, JJL				Keck, Kristin M.; Moquin, Stephanie A.; He, Amanda; Fernandez, Samantha G.; Somberg, Jessica J.; Liu, Stephanie M.; Martinez, Delsy M.; Miranda, J. J. L.			Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS E2 PROTEIN; HOST MITOTIC CHROMOSOMES; VIRAL-DNA; BRD4; LATENCY; REACTIVATION; HERPESVIRUS; ACTIVATION; EXPRESSION; HIV	Lytic infection by the Epstein-Barr virus (EBV) poses numerous health risks, such as infectious mononucleosis and lymphoproliferative disorder. Proteins in the bromodomain and extraterminal (BET) family regulate multiple stages of viral life cycles and provide promising intervention targets. Synthetic small molecules can bind to the bromodomains and disrupt function by preventing recognition of acetylated lysine substrates. We demonstrate that JQ1 and other BET inhibitors block two different steps in the sequential cascade of the EBV lytic cycle. BET inhibitors prevent expression of the viral immediate-early protein BZLF1. JQ1 alters transcription of genes controlled by the host protein BACH1, and BACH1 knockdown reduces BZLF1 expression. BET proteins also localize to the lytic origin of replication (OriLyt) genetic elements, and BET inhibitors prevent viral late gene expression. There JQ1 reduces BRD4 recruitment during reactivation to preclude replication initiation. This represents a rarely observed dual mode of action for drugs.	[Moquin, Stephanie A.; He, Amanda; Martinez, Delsy M.; Miranda, J. J. L.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Keck, Kristin M.; Moquin, Stephanie A.; He, Amanda; Fernandez, Samantha G.; Somberg, Jessica J.; Liu, Stephanie M.; Martinez, Delsy M.; Miranda, J. J. L.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Fernandez, Samantha G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Somberg, Jessica J.] Yale Univ, New Haven, CT 06520 USA; [Liu, Stephanie M.] Permanente Med Grp Inc, Oakland, CA 94612 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; Yale University; Permanente Medical Groups	Miranda, JJL (corresponding author), UCSF, Cellular & Mol Pharmacol, Box 2280,600 16th St, San Francisco, CA 94143 USA.	jj.miranda@ucsf.edu		Moquin, Stephanie/0000-0002-8696-4315; He, Amanda/0000-0003-4869-7903	National Institutes of Health [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Alison J. Sinclair (University of Sussex) for the Akata-Zta cell line, James E. Bradner (Harvard Medical School) for JQ1 in preliminary experiments, and Melanie Ott (Gladstone Institutes) for helpful discussions. We are grateful to the UCSF Center for Advanced Technology and the Gladstone Genomics Core for use of shared equipment. Statistical analysis of human RNA-seq data was conducted by Alex G. Williams at the Gladstone Bioinformatics Core. Flow cytometry experiments were made possible with help from the UCSF-Gladstone Center for AIDS Research (CFAR), a National Institutes of Health-funded program (Grant P30 AI027763).	Alfonso-Dunn R, 2017, CELL HOST MICROBE, V21, P507, DOI 10.1016/j.chom.2017.03.007; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; CHEN HS, 2017, PLOS PATHOG, V13; Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Fernandez SG, 2016, LEUKEMIA LYMPHOMA, V57, P1208, DOI 10.3109/10428194.2015.1079317; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Holdorf MM, 2011, VIROLOGY, V415, P1, DOI 10.1016/j.virol.2011.04.004; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kenney SC, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P403; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Palermo RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002334; Phan AT, 2017, GENOM DATA, V13, P5, DOI 10.1016/j.gdata.2017.05.012; Phan AT, 2016, BIOCHEM BIOPH RES CO, V474, P71, DOI 10.1016/j.bbrc.2016.04.070; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Ramasubramanyan S, 2015, NUCLEIC ACIDS RES, V43, P3563, DOI 10.1093/nar/gkv212; Ren K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005950; Sun XP, 2013, J VIROL, V87, P10126, DOI 10.1128/JVI.01671-13; Tolani B, 2014, ONCOGENE, V33, P2928, DOI 10.1038/onc.2013.242; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Wang X, 2009, JOVE-J VIS EXP, V32, pe1499, DOI DOI 10.3791/1499; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Williams Alexander G, 2014, Curr Protoc Hum Genet, V83, DOI 10.1002/0471142905.hg1113s83; Wollebo HS, 2016, J NEUROVIROL, V22, P615, DOI 10.1007/s13365-016-0435-6; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	43	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13284	13295		10.1074/jbc.M116.751644	http://dx.doi.org/10.1074/jbc.M116.751644			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28588024	hybrid, Green Published			2022-12-28	WOS:000407465300017
J	Li, SM; Zhou, J; Bu, JH; Ning, K; Zhang, LY; Li, J; Guo, YL; He, X; He, H; Cai, XX; Chen, YX; Reinach, PS; Liu, ZG; Li, W				Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Reinach, Peter Sol; Liu, Zuguo; Li, Wei			Ectodysplasin A protein promotes corneal epithelial cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; GROWTH-FACTOR RECEPTOR; INTERNATIONAL WORKSHOP; DRY EYE; KAPPA-B; INVOLVEMENT; EXPRESSION; EDAR; MICE; IDENTIFICATION	The EDA gene encodes ectodysplasin A (Eda), which if mutated causes X-linked hypohidrotic ectodermal dysplasia (XLHED) disease in humans. Ocular surface changes occur in XLHED patients whereas its underlying mechanism remains elusive. In this study, we found Eda was highly expressed in meibomian glands, and it was detected in human tears but not serum. Corneal epithelial integrity was defective and the thickness was reduced in the early postnatal stage of Eda mutant Tabby mice. Corneal epithelial cell proliferation decreased and the epithelial wound healing was delayed in Tabby mice, whereas it was restored by exogenous Eda. Eda exposure promoted mouse corneal epithelial wound healing during organ culture, whereas scratch wound assay showed that it did not affect human corneal epithelial cell line migration. Epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and phosphorylated ERK1/2 (p-ERK) were down-regulated in Tabby mice corneal epithelium. Eda treatment up-regulated the expression of Ki67, EGFR, p-EGFR, and p-ERK in human corneal epithelial cells in a dose-dependent manner. In conclusion, Eda protein can be secreted from meibomian glands and promotes corneal epithelial cell proliferation through regulation of the EGFR signaling pathway. Eda release into the tears plays an essential role in the maintenance of corneal epithelial homeostasis.	[Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Liu, Zuguo; Li, Wei] Xiamen Univ, Eye Inst, 4th Floor,Chengyi Bldg,Xiangan Campus, Xiamen 361102, Fujian, Peoples R China; [Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Liu, Zuguo; Li, Wei] Xiamen Univ, Med Coll, Xiamen 361102, Fujian, Peoples R China; [Liu, Zuguo; Li, Wei] Xiamen Univ, Xiamen Eye Ctr, Xiamen 361000, Fujian, Peoples R China; [Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Liu, Zuguo; Li, Wei] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen 361102, Fujian, Peoples R China; [Reinach, Peter Sol] Wenzhou Med Univ, Wenzhou 325000, Zhejiang, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Wenzhou Medical University	Li, W (corresponding author), Xiamen Univ, Eye Inst, 4th Floor,Chengyi Bldg,Xiangan Campus, Xiamen 361102, Fujian, Peoples R China.	wei1018@xmu.edu.cn	Li, Wei/P-8985-2015; Reinach, Peter/AAI-3582-2021	Li, Wei/0000-0001-7458-2590; Bu, Jinghua/0000-0001-9815-9623; Zhou, Jing/0000-0002-8475-7179	Chinese National Key Scientific Research Project [2013CB967003]; National Natural Science Foundation of China (NSFC) [81270977, 81470602, 81330022]; Fundamental Research Funds for the Central Universities of China [2012121049, 20720150171]	Chinese National Key Scientific Research Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported in part by Chinese National Key Scientific Research Project Grant 2013CB967003 (to W. L.), National Natural Science Foundation of China (NSFC) Grants 81270977 and 81470602 (to W. L.), and 81330022 (to Z. L.), and Fundamental Research Funds for the Central Universities of China Grants 2012121049 and 20720150171 (to W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bron A J, 2004, Ocul Surf, V2, P149; Butovich IA, 2009, PROG RETIN EYE RES, V28, P483, DOI 10.1016/j.preteyeres.2009.07.002; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Cui CY, 2006, P NATL ACAD SCI USA, V103, P9142, DOI 10.1073/pnas.0509678103; Cui CY, 2005, AM J PATHOL, V167, P89, DOI 10.1016/S0002-9440(10)62956-2; Cui CY, 2002, HUM MOL GENET, V11, P1763, DOI 10.1093/hmg/11.15.1763; Dietz J, 2013, EUR J PEDIATR, V172, P1023, DOI 10.1007/s00431-013-1985-8; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jacob JT, 2008, OCUL SURF, V6, P175, DOI 10.1016/S1542-0124(12)70178-7; Kaercher T, 2004, GRAEF ARCH CLIN EXP, V242, P495, DOI 10.1007/s00417-004-0868-0; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Koppinen P, 2001, EXP CELL RES, V269, P180, DOI 10.1006/excr.2001.5331; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Laurikkala J, 2002, DEVELOPMENT, V129, P2541; Lefebvre S, 2012, J INVEST DERMATOL, V132, P1094, DOI 10.1038/jid.2011.453; Melnick M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-32; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Tanihara H, 2002, CORNEA, V21, pS62, DOI 10.1097/01.ico.0000263121.45898.d2; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Tyagi P., 2011, BMJ CASE REP; Vargas GA, 1996, J CLIN INVEST, V97, P2426, DOI 10.1172/JCI118689; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wang YC, 2016, AM J PATHOL, V186, P32, DOI 10.1016/j.ajpath.2015.09.019; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346	33	15	15	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13391	13401		10.1074/jbc.M117.803809	http://dx.doi.org/10.1074/jbc.M117.803809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655773	hybrid, Green Published			2022-12-28	WOS:000407465300025
J	Dong, XH; Li, JY; He, LQQ; Gu, C; Jia, WS; Yue, YY; Li, J; Zhang, QX; Chu, LL; Zhao, QS				Dong, Xiaohua; Li, Jingyun; He, Luqingqing; Gu, Chun; Jia, Wenshuang; Yue, Yunyun; Li, Jun; Zhang, Qinxin; Chu, Lele; Zhao, Qingshun			Zebrafish Znfl1 proteins control the expression of hoxb1b gene in the posterior neuroectoderm by acting upstream of pou5f3 and sall4 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; homeobox; neurodevelopment; transcription factor; zebrafish; zinc finger	RETINOIC ACID; DISTINCT ROLES; HINDBRAIN SEGMENTATION; EMBRYONIC-DEVELOPMENT; NEURAL DEVELOPMENT; MAMMALIAN OCT4; DEFAULT MODEL; INDUCTION; SPIEL-OHNE-GRENZEN/POU2; XENOPUS	Transcription factors play crucial roles in patterning posterior neuroectoderm. Previously, zinc finger transcription factor znfl1 was reported to be expressed in the posterior neuroectoderm of zebrafish embryos. However, its roles remain unknown. Here, we report that there are 13 copies of znfl1 in the zebrafish genome, and all the paralogues share highly identical protein sequences and cDNA sequences. When znfl1s are knocked down using a morpholino to inhibit their translation or dCas9-Eve to inhibit their transcription, the zebrafish gastrula displays reduced expression of hoxb1b, the marker gene for the posterior neuroectoderm. Further analyses reveal that diminishing znfl1s produces the decreased expressions of pou5f3, whereas overexpression of pou5f3 effectively rescues the reduced expression of hoxb1b in the posterior neuroectoderm. Additionally, knocking down znfl1s causes the reduced expression of sall4, a direct regulator of pou5f3, in the posterior neuroectoderm, and overexpression of sall4 rescues the expression of pou5f3 in the knockdown embryos. In contrast, knocking down either pou5f3 or sall4 does not affect the expressions of znfl1s. Taken together, our results demonstrate that zebrafish znfl1s control the expression of hoxb1b in the posterior neuroectoderm by acting upstream of pou5f3 and sall4.	[Dong, Xiaohua; He, Luqingqing; Gu, Chun; Jia, Wenshuang; Yue, Yunyun; Zhang, Qinxin; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study,, Nanjing 210061, Jiangsu, Peoples R China; [Li, Jingyun; Li, Jun] Nanjing Med Univ, Obstet & Gynecol Hosp, Dept Plast & Cosmet Surg, Maternal & Child Hlth Med Inst, Nanjing 210004, Jiangsu, Peoples R China; [Dong, Xiaohua; Chu, Lele] Nanjing YSY Biotech Co, Inst Genome Editing, Nanjing 211812, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			National Natural Science Foundation of China [31471355, 31271569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grants 31471355 and 31271569. The authors declare that they have no conflicts of interest with the contents of this article.	Belting HG, 2001, DEVELOPMENT, V128, P4165; Burgess S, 2002, DEVELOPMENT, V129, P905; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Harvey SA, 2006, DEVELOPMENT, V133, P1165, DOI 10.1242/dev.02259; Hauptmann G, 2002, DEVELOPMENT, V129, P1645; Ishioka A, 2011, DEV BIOL, V350, P154, DOI 10.1016/j.ydbio.2010.10.011; Kam MKM, 2015, DEV GROWTH DIFFER, V57, P158, DOI 10.1111/dgd.12199; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klymkowsky MW, 2010, CELL ADHES MIGR, V4, P595, DOI 10.4161/cam.4.4.12962; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Li JY, 2014, DEV DYNAM, V243, P1544, DOI 10.1002/dvdy.24181; Li JY, 2012, ANAT REC, V295, P268, DOI 10.1002/ar.21520; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; Long LJ, 2015, CELL RES, V25, P638, DOI 10.1038/cr.2015.35; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Paik EJ, 2013, STEM CELL REP, V1, P425, DOI 10.1016/j.stemcr.2013.10.001; Parker HJ, 2016, BIOESSAYS, V38, P526, DOI 10.1002/bies.201600010; Parvin MS, 2008, DEV DYNAM, V237, P1373, DOI 10.1002/dvdy.21539; Reim G, 2002, DEVELOPMENT, V129, P917; Robles V, 2011, ZEBRAFISH, V8, P57, DOI 10.1089/zeb.2010.0684; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Tallafuss A, 2001, DEVELOPMENT, V128, P4021; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Xu F, 2009, MECH DEVELOP, V126, P771, DOI 10.1016/j.mod.2009.09.001; Xu S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1038-5; Yoda H, 2003, DIFFERENTIATION, V71, P152, DOI 10.1046/j.1432-0436.2003.710206.x; Young JJ, 2014, DEVELOPMENT, V141, P1683, DOI 10.1242/dev.099374; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zigman M, 2014, DEVELOPMENT, V141, P639, DOI 10.1242/dev.098731	38	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13045	13055		10.1074/jbc.M117.777094	http://dx.doi.org/10.1074/jbc.M117.777094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28623229	hybrid, Green Published			2022-12-28	WOS:000407220100031
J	Gupta, D; Jetton, TL; LaRock, K; Monga, N; Satish, B; Lausier, J; Peshavaria, M; Leahy, JL				Gupta, Dhananjay; Jetton, Thomas L.; LaRock, Kyla; Monga, Navjot; Satish, Basanthi; Lausier, James; Peshavaria, Mina; Leahy, Jack L.			Temporal characterization of cell-adaptive and -maladaptive mechanisms during chronic high-fat feeding in C57BL/6NTac mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell; gene expression; insulin secretion; peroxisome proliferator-activated receptor (PPAR); unfolded protein response (UPR); adaptation; high-fat diet	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TYPE-2 DIABETES-MELLITUS; DIET-INDUCED OBESE; BETA-CELLS; INSULIN-RESISTANCE; ER STRESS; RECEPTOR EXPRESSION; INDUCED APOPTOSIS; MASS	The onset of type 2 diabetes is characterized by transition from successful to failed insulin secretory compensation to obesity-related insulin resistance and dysmetabolism. Energy-rich diets in rodents are commonly studied models of compensatory increases in both insulin secretion and cell mass. However, the mechanisms of these adaptive responses are incompletely understood, and it is also unclear why these responses eventually fail. We measured the temporal trends of glucose homeostasis, insulin secretion, cell morphometry, and islet gene expression in C57BL/6NTac mice fed a 60% high-fat diet (HFD) or control diet for up to 16 weeks. A 2-fold increased hyperinsulinemia was maintained for the first 4 weeks of HFD feeding and then further increased through 16 weeks. cell mass increased progressively starting at 4 weeks, principally through nonproliferative growth. Insulin sensitivity was not significantly perturbed until 11 weeks of HFD feeding. Over the first 8 weeks, we observed two distinct waves of increased expression of cell functional and prodifferentiation genes. This was followed by activation of the unfolded protein response at 8 weeks and overt cell endoplasmic reticulum stress at 12-16 weeks. In summary, cell adaptation to an HFD in C57BL/6NTac mice entails early insulin hypersecretion and a robust growth phase along with hyperexpression of related genes that begin well before the onset of observed insulin resistance. However, continued HFD exposure results in cessation of gene hyperexpression, cell functional failure, and endoplasmic reticulum stress. These data point to a complex but not sustainable integration of cell-adaptive responses to nutrient overabundance, obesity development, and insulin resistance.	[Gupta, Dhananjay; Jetton, Thomas L.; LaRock, Kyla; Monga, Navjot; Satish, Basanthi; Lausier, James; Peshavaria, Mina; Leahy, Jack L.] Univ Vermont, Div Endocrinol Diabet & Metab, Burlington, VT 05446 USA	University of Vermont	Leahy, JL (corresponding author), Univ Vermont, Larner Coll Med, Colchester Res Facil, 360 South Pk Dr, Colchester, VT 05446 USA.	jleahy@uvm.edu			American Diabetes Association; National Institutes of Health [DK56818]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056818, R01DK056818] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the American Diabetes Association (to J. L. L.) and National Institutes of Health Grant DK56818 (to J. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Gonzalez A, 2013, ENDOCRINOLOGY, V154, P3515, DOI 10.1210/en.2013-1424; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Gupta D, 2013, J BIOL CHEM, V288, P25440, DOI 10.1074/jbc.M113.486852; Gupta D, 2010, DIABETES, V59, P1445, DOI 10.2337/db09-1655; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Jalali S, 2008, BBA-MOL CELL RES, V1783, P2344, DOI 10.1016/j.bbamcr.2008.08.014; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jetton TL, 2001, DIABETOLOGIA, V44, P2056, DOI 10.1007/s001250100011; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050128; Leahy J. L., 2014, THERAPY DIABETES MEL, V6th, P92; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Mahmazi S, 2013, INT J DIABETES DEV C, V33, P219, DOI 10.1007/s13410-013-0152-0; Mathijs I, 2014, MOL NUTR FOOD RES, V58, P1980, DOI 10.1002/mnfr.201400211; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Mosser RE, 2015, AM J PHYSIOL-ENDOC M, V308, pE573, DOI 10.1152/ajpendo.00460.2014; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Paulsen SJ, 2010, OBESITY, V18, P266, DOI 10.1038/oby.2009.245; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sharma RB, 2015, J CLIN INVEST, V125, P3831, DOI 10.1172/JCI79264; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stamateris RE, 2013, AM J PHYSIOL-ENDOC M, V305, pE149, DOI 10.1152/ajpendo.00040.2013; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Takatani T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28177; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Wagner R, 2014, MOL METAB, V3, P676, DOI 10.1016/j.molmet.2014.07.001; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215	56	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12449	12459		10.1074/jbc.M117.781047	http://dx.doi.org/10.1074/jbc.M117.781047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28487366	Green Published, hybrid			2022-12-28	WOS:000406636900010
J	Piechotta, A; Parthier, C; Kleinschmidt, M; Gnoth, K; Pillot, T; Lues, I; Demuth, HU; Schilling, S; Rahfeld, JU; Stubbs, MT				Piechotta, Anke; Parthier, Christoph; Kleinschmidt, Martin; Gnoth, Kathrin; Pillot, Thierry; Lues, Inge; Demuth, Hans-Ulrich; Schilling, Stephan; Rahfeld, Jens-Ulrich; Stubbs, Milton T.			Structural and functional analyses of pyroglutamate-amyloid--specific antibodies as a basis for Alzheimer immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (A); crystal structure; drug development; monoclonal antibody; thermodynamics; ligand binding	A-BETA OLIGOMERS; STRUCTURE REVEALS; DISEASE; PEPTIDE; PROTEIN; MOUSE; BAPINEUZUMAB; DEPOSITION; PLAQUES; MODEL	Alzheimer disease is associated with deposition of the amyloidogenic peptide A in the brain. Passive immunization using A-specific antibodies has been demonstrated to reduce amyloid deposition both in vitro and in vivo. Because N-terminally truncated pyroglutamate (pE)-modified A species (A(pE3)) exhibit enhanced aggregation potential and propensity to form toxic oligomers, they represent particularly attractive targets for antibody therapy. Here we present three separate monoclonal antibodies that specifically recognize A(pE3) with affinities of 1-10 nm and inhibit A(pE3) fibril formation in vitro. In vivo application of one of these resulted in improved memory in A(pE3) oligomer-treated mice. Crystal structures of F-ab-A(pE3) complexes revealed two distinct binding modes for the peptide. Juxtaposition of pyroglutamate pE3 and the F4 side chain (the pEF head) confers a pronounced bulky hydrophobic nature to the A(pE3) N terminus that might explain the enhanced aggregation properties of the modified peptide. The deep burial of the pEF head by two of the antibodies explains their high target specificity and low cross-reactivity, making them promising candidates for the development of clinical antibodies.	[Piechotta, Anke; Kleinschmidt, Martin; Gnoth, Kathrin; Lues, Inge; Demuth, Hans-Ulrich; Schilling, Stephan; Rahfeld, Jens-Ulrich] Probiodrug AG, Weinbergweg 22, D-06120 Halle, Saale, Germany; [Piechotta, Anke; Parthier, Christoph; Stubbs, Milton T.] Martin Luther Univ Halle Wittenberg, Inst Biotechnol, D-06108 Halle, Germany; [Piechotta, Anke; Kleinschmidt, Martin; Gnoth, Kathrin; Demuth, Hans-Ulrich; Schilling, Stephan; Rahfeld, Jens-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Biochem & Therapy, Weinbergweg 22, D-06120 Halle, Germany; [Pillot, Thierry] SynAging SAS, F-54518 Vandoeuvre Les Nancy, France	Vivoryon Therapeutics; Martin Luther University Halle Wittenberg; Fraunhofer Gesellschaft	Rahfeld, JU (corresponding author), Probiodrug AG, Weinbergweg 22, D-06120 Halle, Saale, Germany.; Stubbs, MT (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Saale, Germany.	jens-ulrich.rahfeld@probiodrug.de; stubbs@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013	Deutsche Forschungsgemeinschaft [GRK1026]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by funds from the Deutsche Forschungsgemeinschaft GRK1026 Conformational Transitions in Macromolecular Interactions (to M. T. S.). M. K., H.-U. D., S. S., and J.-U. R. are consultants and former employees of Probiodrug. I. L. and H.-U. D. are shareholders and I. L. is chief development officer of Probiodrug.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Antonyuk SV, 2011, P NATL ACAD SCI USA, V108, P15780, DOI 10.1073/pnas.1109051108; Basi GS, 2010, J BIOL CHEM, V285, P3417, DOI 10.1074/jbc.M109.045187; Bibl M, 2012, PROTEOM CLIN APPL, V6, P163, DOI 10.1002/prca.201100082; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Bouter Y, 2015, ACTA NEUROPATHOL, V130, P713, DOI 10.1007/s00401-015-1489-x; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Bussiere T., 2014, Patent, Patent No. [WO2014089500, 2014089500]; Dammers C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139710; DeMattos RB, 2012, NEURON, V76, P908, DOI 10.1016/j.neuron.2012.10.029; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; ELMORE MA, 1990, NEUROPEPTIDES, V15, P31, DOI 10.1016/0143-4179(90)90157-T; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feinberg H, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt261; Frost JL, 2015, NEUROBIOL AGING, V36, P3187, DOI 10.1016/j.neurobiolaging.2015.08.021; Frost JL, 2012, NEURODEGENER DIS, V10, P265, DOI 10.1159/000335913; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams LK, 2012, J MED CHEM, V55, P10177, DOI 10.1021/jm301273u; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wu GX, 2014, NEURODEGENER DIS, V14, P53, DOI 10.1159/000353634; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005	58	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12713	12724		10.1074/jbc.M117.777839	http://dx.doi.org/10.1074/jbc.M117.777839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28623233	hybrid, Green Published			2022-12-28	WOS:000406636900034
J	Liu, Y; Du, SY; Ding, M; Dou, X; Zhang, FF; Wu, ZY; Qian, SW; Zhang, W; Tang, QQ; Xu, CJ				Liu, Yang; Du, Shao-Yue; Ding, Meng; Dou, Xin; Zhang, Fei-Fei; Wu, Zhi-Yong; Qian, Shu-Wen; Zhang, Wei; Tang, Qi-Qun; Xu, Cong-Jian			The BMP4-Smad signaling pathway regulates hyperandrogenism development in a female mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; STAT 1 PIAS1; ANDROGEN RECEPTOR; PROTEIN INHIBITOR; CELLS; HORMONE; WOMEN; AND-7; BETA; PCOS	Polycystic ovary syndrome is a common endocrine disorder and a major cause of anovulatory sterility in women at reproductive age. Most patients with polycystic ovary syndrome have hyperandrogenism, caused by excess androgen synthesis. Bone morphogenetic protein 4 (BMP4) is an essential regulator of embryonic development and organ formation, and recent studies have also shown that BMP4 may be involved in female steroidogenesis process. However, the effect of BMP4 on hyperandrogenism remains unknown. Here, using a female mouse model of hyperandrogenism, we found that ovarian BMP4 levels were significantly decreased in hyperandrogenism. Elevated androgens inhibited BMP4 expression via activation of androgen receptors. Moreover, BMP4 treatment suppressed androgen synthesis in theca cells and promoted estrogen production in granulosa cells by regulating the expression of steroidogenic enzymes, including CYP11A, HSD3B2, CYP17A1, and CYP19A1. Consistently, knockdown of BMP4 augmented androgen levels and inhibited estrogen levels. Mechanistically, Smad signaling rather than the p38 MAPK pathway regulated androgen and estrogen formation, thereby mediating the effect of BMP4. Of note, BMP4-transgenic mice were protected against hyperandrogenism. Our observations clarify a vital role of BMP4 in controlling sex hormone levels and offer new insights into intervention for managing hyperandrogenism by targeting the BMP4-Smad signaling pathway.	[Liu, Yang; Du, Shao-Yue; Zhang, Fei-Fei; Wu, Zhi-Yong; Zhang, Wei; Xu, Cong-Jian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200090, Peoples R China; [Liu, Yang; Ding, Meng; Dou, Xin; Qian, Shu-Wen; Tang, Qi-Qun] Fudan Univ, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Tang, QQ (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China.; Xu, CJ (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, 419 Fangxie Rd, Shanghai 200011, Peoples R China.	qqtang@shmu.edu.cn; xucj@hotmail.com			National Key Basic Research Project [2011CB910201, 2013CB530601, 2016YFC1303100]; State Key Program of National Natural Science Foundation [31030048C120114, 81390350]; National Natural Science Foundation of China [81601251]; China Postdoctoral Science Foundation	National Key Basic Research Project(National Basic Research Program of China); State Key Program of National Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported partially by National Key Basic Research Project Grants 2011CB910201 and 2013CB530601 and The State Key Program of National Natural Science Foundation 31030048C120114 and 81390350 (to Q.-Q.T.); National Natural Science Foundation of China Grant 81601251 and Project funded by China Postdoctoral Science Foundation (to Y.L.); National Key Basic Research Project Grant 2016YFC1303100 (to C.-J.X.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2016, Nat Rev Dis Primers, V2, P16058, DOI 10.1038/nrdp.2016.58; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Davey Rachel A, 2016, Clin Biochem Rev, V37, P3; Deplewski D, 2000, ENDOCR REV, V21, P363, DOI 10.1210/er.21.4.363; Diaz Rosanne, 2011, Nat Rev Endocrinol, V7, P437, DOI 10.1038/nrendo.2011.98; Dooley CA, 2000, J CLIN ENDOCR METAB, V85, P3331, DOI 10.1210/jc.85.9.3331; Erickson Gregory F, 2003, Reprod Biol Endocrinol, V1, P9, DOI 10.1186/1477-7827-1-9; ESCOBARMORREALE H, 1994, FERTIL STERIL, V62, P521; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Li DH, 2007, MOL CELL BIOL, V27, P6669, DOI 10.1128/MCB.00355-07; Li H, 2013, ENDOCRINE, V43, P184, DOI 10.1007/s12020-012-9739-3; Liu Y, 2015, DIABETES, V64, P4061, DOI 10.2337/db15-0278; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Lizneva D, 2016, BEST PRACT RES CL OB, V37, P98, DOI 10.1016/j.bpobgyn.2016.05.003; Luque-Ramirez M, 2015, EXPERT OPIN THER TAR, V19, P1545, DOI 10.1517/14728222.2015.1075511; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moran LJ, 2015, TRENDS ENDOCRIN MET, V26, P136, DOI 10.1016/j.tem.2014.12.003; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Palomba S, 2016, HUM REPROD, V31, P223, DOI 10.1093/humrep/dev284; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Rosenfield RL, 2016, ENDOCR REV, V37, P467, DOI 10.1210/er.2015-1104; Shohat-Tal A, 2015, NAT REV ENDOCRINOL, V11, P429, DOI 10.1038/nrendo.2015.64; Sirmans SM, 2014, CLIN EPIDEMIOL, V6, P1, DOI 10.2147/CLEP.S37559; STEINKAMPF MP, 1987, MOL ENDOCRINOL, V1, P465, DOI 10.1210/mend-1-7-465; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; van de Wijngaart DJ, 2012, MOL CELL ENDOCRINOL, V352, P57, DOI 10.1016/j.mce.2011.08.007; Wickenheisser JK, 2004, MOL ENDOCRINOL, V18, P588, DOI 10.1210/me.2003-0090; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Yu C, 2013, MOL ENDOCRINOL, V27, P966, DOI 10.1210/me.2012-1364	36	18	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11740	11750		10.1074/jbc.M117.781369	http://dx.doi.org/10.1074/jbc.M117.781369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28572510	hybrid, Green Published			2022-12-28	WOS:000405485600013
J	Trotta, AP; Gelles, JD; Serasinghe, MN; Loi, P; Arbiser, JL; Chipuk, JE				Trotta, Andrew P.; Gelles, Jesse D.; Serasinghe, Madhavika N.; Loi, Patrick; Arbiser, Jack L.; Chipuk, Jerry E.			Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCHRONIC TOXICITY; MAGNOLIA PLANT; MEK INHIBITION; CANCER CELLS; HONOKIOL; BRAF; ACTIVATION; PHOSPHORYLATION; VEMURAFENIB; RESISTANCE	The mitochondrial network is a major site of ATP production through the coupled integration of the electron transport chain (ETC) with oxidative phosphorylation. In melanoma arising from the V600E mutation in the kinase v-RAF murine sarcoma viral oncogene homolog B (BRAF(V600E)), oncogenic signaling enhances glucose-dependent metabolism while reducing mitochondrial ATP production. Likewise, when BRAF(V600E) is pharmacologically inhibited by targeted therapies (e.g. PLX-4032/vemurafenib), glucose metabolism is reduced, and cells increase mitochondrial ATP production to sustain survival. Therefore, collateral inhibition of oncogenic signaling and mitochondrial respiration may help enhance the therapeutic benefit of targeted therapies. Honokiol (HKL) is a well tolerated small molecule that disrupts mitochondrial function; however, its underlying mechanisms and potential utility with targeted anticancer therapies remain unknown. Using wild-type BRAF and BRAF(V600E) melanoma model systems, we demonstrate here that HKL administration rapidly reduces mitochondrial respiration by broadly inhibiting ETC complexes I, II, and V, resulting in decreased ATP levels. The subsequent energetic crisis induced two cellular responses involving cyclin-dependent kinases (CDKs). First, loss of CDK1-mediated phosphorylation of the mitochondrial division GTPase dynamin-related protein 1 promoted mitochondrial fusion, thus coupling mitochondrial energetic status and morphology. Second, HKL decreased CDK2 activity, leading to G(1) cell cycle arrest. Importantly, although pharmacological inhibition of oncogenic MAPK signaling increased ETC activity, co-treatment with HKL ablated this response and vastly enhanced the rate of apoptosis. Collectively, these findings integrate HKL action with mitochondrial respiration and shape and substantiate a pro-survival role of mitochondrial function in melanoma cells after oncogenic MAPK inhibition.	[Trotta, Andrew P.; Gelles, Jesse D.; Serasinghe, Madhavika N.; Loi, Patrick; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA; [Trotta, Andrew P.; Serasinghe, Madhavika N.; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Gelles, Jesse D.; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Arbiser, Jack L.] Atlanta Vet Adm Med Ctr, Winship Canc Inst, Atlanta, GA 30322 USA; [Arbiser, Jack L.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University	Chipuk, JE (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	jerry.chipuk@mssm.edu		Chipuk, Jerry Edward/0000-0002-1337-842X	Cancer Center Support Grant from the National Institutes of Health [p30 CA196521]; J. E. C. laboratory; NATIONAL CANCER INSTITUTE [R01CA157740, P30CA196521, R01CA206005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA024681] Funding Source: NIH RePORTER	Cancer Center Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. E. C. laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank everyone in the J. E. C. laboratory for assistance and support. Wealso thank Dr. Robert Fisher and members of his laboratory (Icahn School of Medicine at Mount Sinai) for critical reagents and assistance. The Tisch Center Institute was supported by the Cancer Center Support Grant p30 CA196521 from the National Institutes of Health.	Abildgaard C, 2015, TRENDS MOL MED, V21, P164, DOI 10.1016/j.molmed.2014.12.007; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Baudy AR, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-22; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Cerella Claudia, 2013, Int J Cell Biol, V2013, P639401, DOI 10.1155/2013/639401; Chen TS, 2015, AM J PHYSIOL-HEART C, V308, pH424, DOI 10.1152/ajpheart.00454.2014; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Deng JF, 2008, LIVER INT, V28, P1458, DOI 10.1111/j.1478-3231.2008.01767.x; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; Gelles JD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.332; Haarberg H Eirik, 2014, Drug Discov Today Technol, V11, P27, DOI 10.1016/j.ddtec.2013.12.004; Hahm ER, 2007, MOL CANCER THER, V6, P2686, DOI 10.1158/1535-7163.MCT-07-0217; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Karoulia Z, 2016, CANCER CELL, V30, P485, DOI 10.1016/j.ccell.2016.06.024; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kasznicki J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.01; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lin CJ, 2016, TOXICOL APPL PHARM, V304, P59, DOI 10.1016/j.taap.2016.05.018; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Liu ZP, 2007, REGUL TOXICOL PHARM, V49, P160, DOI 10.1016/j.yrtph.2007.06.006; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McArthur GA, 2012, J CLIN ONCOL, V30, P1628, DOI 10.1200/JCO.2011.39.1938; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Pan J, 2014, CANCER PREV RES, V7, P1149, DOI 10.1158/1940-6207.CAPR-14-0091; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prasad R, 2016, ADV EXP MED BIOL, V928, P245, DOI 10.1007/978-3-319-41334-1_11; Prasad R, 2016, ONCOTARGET, V7, P7899, DOI 10.18632/oncotarget.6860; Renault TT, 2013, METHODS, V61, P146, DOI 10.1016/j.ymeth.2013.03.030; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Singh T, 2015, ONCOTARGET, V6, P21268, DOI 10.18632/oncotarget.4178; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wieder SY, 2015, J INVEST DERMATOL, V135, P2544, DOI 10.1038/jid.2015.196; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Xie L, 2016, BRIT J PHARMACOL, V173, P344, DOI 10.1111/bph.13375; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhang QQ, 2015, REGUL TOXICOL PHARM, V71, P428, DOI 10.1016/j.yrtph.2014.11.007; Zhang YB, 2014, ONCOL REP, V32, P2038, DOI 10.3892/or.2014.3434; Zhou B, 2017, BIOCHEM PHARMACOL, V128, P12, DOI 10.1016/j.bcp.2016.12.022	55	44	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11727	11739		10.1074/jbc.M117.786442	http://dx.doi.org/10.1074/jbc.M117.786442			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28546431	hybrid, Green Published			2022-12-28	WOS:000405485600012
J	Pathak, P; Liu, HL; Boehme, S; Xie, C; Krausz, KW; Gonzalez, F; Chiang, JYL				Pathak, Preeti; Liu, Hailiang; Boehme, Shannon; Xie, Cen; Krausz, Kristopher W.; Gonzalez, Frank; Chiang, John Y. L.			Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROENDOCRINE CELL-LINE; FATTY LIVER-DISEASE; CHOLESTEROL 7-ALPHA-HYDROXYLASE; OBETICHOLIC ACID; GENE-EXPRESSION; GASTRIC BYPASS; MICE; ACTIVATION; SECRETION; GLUCOSE	The bile acid-activated receptors, nuclear farnesoid X receptor (FXR) and the membrane Takeda G-protein receptor 5(TGR5), are known to improve glucose and insulin sensitivity in obese and diabetic mice. However, the metabolic roles of these two receptors and the underlying mechanisms are incompletely understood. Here, we studied the effects of the dual FXR and TGR5 agonist INT-767 on hepatic bile acid synthesis and intestinal secretion of glucagon-like peptide-1 (GLP-1) in wild-type, Fxr(-/-), and Tgr5(-/-) mice. INT-767 efficaciously stimulated intracellular Ca2+ levels, cAMP activity, and GLP-1 secretion and improved glucose and lipid metabolism more than did the FXR-selective obeticholic acid and TGR5-selective INT-777 agonists. Interestingly, INT-767 reduced expression of the genes in the classic bile acid synthesis pathway but induced those in the alternative pathway, which is consistent with decreased taurocholic acid and increased tauromuricholic acids in bile. Furthermore, FXR activation induced expression of FXR target genes, including fibroblast growth factor 15, and unexpectedly Tgr5 and prohormone convertase 1/3 gene expression in the ileum. We identified an FXR-responsive element on the Tgr5 gene promoter. Fxr(-/-) and Tgr5(-/-) mice exhibited reduced GLP-1 secretion, which was stimulated by INT-767 in the Tgr5(-/-) mice but not in the Fxr(-/-) mice. Our findings uncovered a novel mechanism in which INT-767 activation of FXR induces Tgr5 gene expression and increases Ca2+ levels and cAMP activity to stimulate GLP-1 secretion and improve hepatic glucose and lipid metabolism in high-fat diet-induced obese mice. Activation of both FXR and TGR5 may therefore represent an effective therapy for managing hepatic steatosis, obesity, and diabetes.	[Pathak, Preeti; Liu, Hailiang; Boehme, Shannon; Chiang, John Y. L.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Coll Med, 4209 SR 44, Rootstown, OH 44272 USA; [Xie, Cen; Krausz, Kristopher W.; Gonzalez, Frank] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Northeast Ohio Medical University (NEOMED); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chiang, JYL (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Coll Med, 4209 SR 44, Rootstown, OH 44272 USA.	jchiang@neomed.edu		Chiang, John/0000-0001-9360-7650	National Institutes of Health from NIDDK [DK58379, DK44442]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058379, R01DK044442, R56DK044442, R01DK058379] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK58379 and DK44442 from NIDDK (to J. Y. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537; Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Dufer M, 2012, DIABETES, V61, P1479, DOI 10.2337/db11-0815; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; FEHMANN HC, 1992, ENDOCRINOLOGY, V130, P159, DOI 10.1210/en.130.1.159; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Miyazaki-Anzai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108270; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Renga B, 2010, BBA-MOL BASIS DIS, V1802, P363, DOI 10.1016/j.bbadis.2010.01.002; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xu Y, 2016, HEPATOLOGY, V64, P1072, DOI 10.1002/hep.28712	43	130	142	5	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11055	11069		10.1074/jbc.M117.784322	http://dx.doi.org/10.1074/jbc.M117.784322			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28478385	hybrid, Green Published			2022-12-28	WOS:000404391000026
J	Taniguchi, T; Woodward, AM; Magnelli, P; McColgan, NM; Lehoux, S; Jacobo, SMP; Mauris, J; Argueso, P				Taniguchi, Takazumi; Woodward, Ashley M.; Magnelli, Paula; McColgan, Nicole M.; Lehoux, Sylvain; Jacobo, Sarah Melissa P.; Mauris, Jerome; Argueso, Pablo			N-Glycosylation affects the stability and barrier function of the MUC16 mucin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; OVARIAN-CANCER ANTIGEN; CELL-SURFACE; CONJUNCTIVAL EPITHELIA; HUMAN CORNEAL; GALECTIN-3; EXPRESSION; DISEASE; IDENTIFICATION; RECOGNITION	Transmembrane mucins are highly O-glycosylated glycoproteins that coat the apical glycocalyx on mucosal surfaces and represent the first line of cellular defense against infection and injury. Relatively low levels of N-glycans are found on transmembrane mucins, and their structure and function remain poorly characterized. We previously reported that carbohydrate-dependent interactions of transmembrane mucins with galectin-3 contribute to maintenance of the epithelial barrier at the ocular surface. Now, using MALDI-TOF mass spectrometry, we report that transmembrane mucin N-glycans in differentiated human corneal epithelial cells contain primarily complex-type structures with N-acetyllactosamine, a preferred galectin ligand. In N-glycosylation inhibition experiments, we find that treatment with tunicamycin and siRNA-mediated knockdown of the Golgi N-acetylglucosaminyl transferase I gene (MGAT1) induce partial loss of both total and cell-surface levels of the largest mucin, MUC16, and a concomitant reduction in glycocalyx barrier function. Moreover, we identified a distinct role for N-glycans in promoting MUC16's binding affinity toward galectin-3 and in causing retention of the lectin on the epithelial cell surface. Taken together, these studies define a role for N-linked oligosaccharides in supporting the stability and function of transmembrane mucins on mucosal surfaces.	[Taniguchi, Takazumi; Woodward, Ashley M.; McColgan, Nicole M.; Jacobo, Sarah Melissa P.; Mauris, Jerome; Argueso, Pablo] Harvard Med Sch, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA; [Taniguchi, Takazumi; Woodward, Ashley M.; McColgan, Nicole M.; Jacobo, Sarah Melissa P.; Mauris, Jerome; Argueso, Pablo] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA; [Magnelli, Paula] New England Biolabs Inc, Ipswich, MA 01938 USA; [Lehoux, Sylvain] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; New England Biolabs; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Argueso, P (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.; Argueso, P (corresponding author), Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA.	pablo_argueso@meei.harvard.edu		Argueso, Pablo/0000-0001-7321-9503	National Institutes of Health (NEI) [R01EY014847, R01EY026147]; NEI [P30EY003790]; National Center for Functional Glycomics (NIGMS) [P41GM103694]; NATIONAL EYE INSTITUTE [R01EY014847, R01EY026147, P30EY003790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103694] Funding Source: NIH RePORTER	National Institutes of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Functional Glycomics (NIGMS); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants R01EY014847 and R01EY026147 (NEI; to P. A.), NEI Core Grant P30EY003790, and the National Center for Functional Glycomics Grant P41GM103694 (NIGMS; to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argueso Pablo, 2006, V347, P277; Arguso P, 2012, METHODS MOL BIOL, V842, P313, DOI 10.1007/978-1-61779-513-8_19; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bravo-Osuna I, 2012, PHARM RES-DORDR, V29, P2329, DOI 10.1007/s11095-012-0761-1; Chachadi VB, 2015, GLYCOBIOLOGY, V25, P963, DOI 10.1093/glycob/cwv030; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Cummings RD., 2009, ESSENTIALS GLYCOBIOL, P513; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Das S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09759; Dharmaraj N, 2014, HUM REPROD, V29, P1730, DOI 10.1093/humrep/deu146; Dogru M, 2008, ALLERGY, V63, P1324, DOI 10.1111/j.1398-9995.2008.01781.x; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Fang H, 2006, CELL RES, V16, P82, DOI 10.1038/sj.cr.7310011; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gipson IK, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12840; Haridas D, 2014, FASEB J, V28, P4183, DOI 10.1096/fj.14-257352; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; KUI WN, 2003, J BIOL CHEM, V278, P28619, DOI DOI 10.1074/JBC.M302741200; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lloyd KO, 1997, INT J CANCER, V71, P842, DOI 10.1002/(SICI)1097-0215(19970529)71:5<842::AID-IJC24>3.0.CO;2-8; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Mauris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072304; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Mori Y, 2015, J BIOL CHEM, V290, P26125, DOI 10.1074/jbc.M115.651489; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Saldova R, 2013, INT J MOL SCI, V14, P15636, DOI 10.3390/ijms140815636; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Sindrewicz P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00079; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Uchino Y, 2015, AM J OPHTHALMOL, V159, P1027, DOI 10.1016/j.ajo.2015.02.008; Ujita M, 1999, J BIOL CHEM, V274, P16717, DOI 10.1074/jbc.274.24.16717; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Woodward AM, 2014, INVEST OPHTH VIS SCI, V55, P6132, DOI 10.1167/iovs.14-15269; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065218	46	44	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11079	11090		10.1074/jbc.M116.770123	http://dx.doi.org/10.1074/jbc.M116.770123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487369	hybrid, Green Published			2022-12-28	WOS:000404391000028
J	Pan, S; Nikolakakis, K; Adamczyk, PA; Pan, M; Ruby, EG; Reed, JL				Pan, Shu; Nikolakakis, Kiel; Adamczyk, Paul A.; Pan, Min; Ruby, Edward G.; Reed, Jennifer L.			Model-enabled gene search (MEGS) allows fast and direct discovery of enzymatic and transport gene functions in the marine bacterium Vibrio fischeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACID TRANSPORT; RECONSTRUCTION; COLONIZATION; SYSTEMS; OPTIMIZATION; COLLECTION; METABOLISM; EXPRESSION; SEQUENCE	Where as genomes can be rapidly sequenced, the functions of many genes are incompletely or erroneously annotated because of a lack of experimental evidence or prior functional knowledge in sequence databases. To address this weakness, we describe here a model-enabled gene search (MEGS) approach that (i) identifies metabolic functions either missing from an organism's genome annotation or incorrectly assigned to an ORF by using discrepancies between metabolic model predictions and experimental culturing data; (ii) designs functional selection experiments for these specific metabolic functions; and (iii) selects a candidate gene(s) responsible for these functions from a genomic library and directly interrogates this gene's function experimentally. To discover gene functions, MEGS uses genomic functional selections instead of relying on correlations across large experimental datasets or sequence similarity as do other approaches. When applied to the bioluminescent marine bacterium Vibrio fischeri, MEGS successfully identified five genes that are responsible for four metabolic and transport reactions whose absence from a draft metabolic model of V. fischeri caused inaccurate modeling of high-throughput experimental data. This work demonstrates that MEGS provides a rapid and efficient integrated computational and experimental approach for annotating metabolic genes, including those that have previously been uncharacterized or misannotated.	[Pan, Shu; Nikolakakis, Kiel; Adamczyk, Paul A.; Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, 3639 Engn Hall,1415 Engn Dr, Madison, WI 53706 USA; [Pan, Min] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Ruby, Edward G.] Univ Hawaii, Pacific Biosci Res Ctr, Manoa, HI 96813 USA	University of Wisconsin System; University of Wisconsin Madison; Southeast University - China; University of Hawaii System; University of Hawaii Manoa	Reed, JL (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 3639 Engn Hall,1415 Engn Dr, Madison, WI 53706 USA.	jennifer.reed@wisc.edu	Reed, Jennifer L/E-5137-2011	Reed, Jennifer L/0000-0001-7854-6220; Pan, Shu/0000-0003-3914-9278	Gordon and Betty Moore Foundation [3396]; National Institutes of Health Ruth L. Kirschstein National Research Service Award from the NIGMS [F32GM112214]; National Science Foundation [CBET 1053712]; National Institutes of Health from NIAID [AI50661]; Office of the Director Grant [OD011024]; Div Of Chem, Bioeng, Env, & Transp Sys [1053712] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050661, R01AI050661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011024] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health Ruth L. Kirschstein National Research Service Award from the NIGMS; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Director Grant; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Gordon and Betty Moore Foundation Grant 3396, National Institutes of Health Ruth L. Kirschstein National Research Service Award F32GM112214 from the NIGMS (to K. N.), National Science Foundation Grant CBET 1053712 (to J. L. R.), National Institutes of Health Grant AI50661 from NIAID, and Office of the Director Grant OD011024 (to E. G. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bongrand C, 2016, ISME J, V10, P2907, DOI 10.1038/ismej.2016.69; Brooks JF, 2014, P NATL ACAD SCI USA, V111, P17284, DOI 10.1073/pnas.1415957111; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; Deutschbauer A, 2014, J BACTERIOL, V196, P3643, DOI 10.1128/JB.01836-14; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Dunn AK, 2012, ADV MICROB PHYSIOL, V61, P37, DOI 10.1016/B978-0-12-394423-8.00002-0; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fondi M, 2015, ENVIRON MICROBIOL, V17, P751, DOI 10.1111/1462-2920.12513; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Gaida SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8045; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Golyshev Mikhail A., 2015, Advances in Bioinformatics, V2015, P635437, DOI 10.1155/2015/635437; Green ML, 2007, BIOINFORMATICS, V23, pI205, DOI 10.1093/bioinformatics/btm213; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW100, DOI 10.1093/nar/gkh464; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; Hsieh JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024366; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Johnston JW, 2007, MOL MICROBIOL, V66, P26, DOI 10.1111/j.1365-2958.2007.05890.x; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; LEE KH, 1994, APPL ENVIRON MICROB, V60, P1565, DOI 10.1128/AEM.60.5.1565-1571.1994; Liao CZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10754; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026835; Long CP, 2014, ANAL CHEM, V86, P9423, DOI 10.1021/ac502734e; Mandel MJ, 2012, APPL ENVIRON MICROB, V78, P4620, DOI 10.1128/AEM.00377-12; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Miranda-Santos I, 2015, ANAL CHEM, V87, P617, DOI 10.1021/ac503305w; Neidhardt F. C., 1996, ESCHERICHIA COLI SAL, P359; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Ong WK, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-31; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pan M, 2015, MBIO, V6, DOI 10.1128/mBio.00811-15; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; QUAY SC, 1977, J BACTERIOL, V129, P1257, DOI 10.1128/JB.129.3.1257-1265.1977; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shibata S, 2012, J BACTERIOL, V194, P185, DOI 10.1128/JB.05926-11; Simon C, 2009, APPL ENVIRON MICROB, V75, P2964, DOI 10.1128/AEM.02644-08; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186; Tervo CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r116; Thompson LR, 2017, ENVIRON MICROBIOL, V19, P1845, DOI 10.1111/1462-2920.13684; Varaljay VA, 2016, ENVIRON MICROBIOL, V18, P1187, DOI 10.1111/1462-2920.13138; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	68	4	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10250	10261		10.1074/jbc.M116.763193	http://dx.doi.org/10.1074/jbc.M116.763193			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446608	hybrid, Green Published			2022-12-28	WOS:000403580600033
J	Zhao, L; Fan, J; Xia, SY; Pan, YZ; Liu, SP; Qian, GQ; Qian, ZY; Kang, HB; Arbiser, JL; Pollack, BP; Kudchadkar, RR; Lawson, DH; Rossi, M; Abdel-Wahab, O; Merghoub, T; Khoury, HJ; Khuri, FR; Boise, LH; Lonial, S; Chen, FP; Chen, J; Lin, RT				Zhao, Liang; Fan, Jun; Xia, Siyuan; Pan, Yaozhu; Liu, Shuangping; Qian, Guoqing; Qian, Zhiyu; Kang, Hee-Bum; Arbiser, Jack L.; Pollack, Brian P.; Kudchadkar, Ragini R.; Lawson, David H.; Rossi, Michael; Abdel-Wahab, Omar; Merghoub, Taha; Khoury, Hanna J.; Khuri, Fadlo R.; Boise, Lawrence H.; Lonial, Sagar; Chen, Fangping; Chen, Jing; Lin, Ruiting			HMG-CoA synthase 1 is a synthetic lethal partner of BRAF(V600E) in human cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAF V600E MUTATION; KETOGENESIS	Contributions of metabolic changes to cancer development and maintenance have received increasing attention in recent years. Although many human cancers share similar metabolic alterations, it remains unclear whether oncogene-specific metabolic alterations are required for tumor development. Using an RNAi-based screen targeting the majority of the known metabolic proteins, we recently found that oncogenic BRAF(V600E) up-regulates HMG-CoA lyase (HMGCL), which converts HMG-CoA to acetyl-CoA and a ketone body, acetoacetate, that selectively enhances BRAF(V600E)-dependent MEK1 activation in human cancer. Here, we identified HMG-CoA synthase 1 (HMGCS1), the upstream ketogenic enzyme of HMGCL, as an additional "synthetic lethal" partner of BRAF(V600E). Although HMGCS1 expression did not correlate with BRAF(V600E) mutation in human melanoma cells, HMGCS1 was selectively important for proliferation of BRAF(V600E)-positive melanoma and colon cancer cells but not control cells harboring activeN/KRAS mutants, and stable knockdown of HMGCS1 only attenuated colony formation and tumor growth potential of BRAF(V600E) melanoma cells. Moreover, cytosolic HMGCS1 that co-localized with HMGCL and BRAF(V600E) was more important than the mitochondrial HMGCS2 isoform in BRAF(V600E)-expressing cancer cells in terms of acetoacetate production. Interestingly, HMGCL knockdown did not affect HMGCS1 expression levels, whereas HMGCS1 knockdown caused a compensating increase in HMGCL protein level because of attenuated protein degradation. However, this increase did not reverse the reduced ketogenesis in HMGCS1 knockdown cells. Mechanistically, HMGCS1 inhibition decreased intracellular acetoacetate levels, leading to reduced BRAF(V600E)-MEK1 binding and consequent MEK1 activation. We conclude that the ketogenic HMGCS1-HMGCL-acetoacetate axis may represent a promising therapeutic target for managing BRAF(V600E)-positive human cancers.	[Zhao, Liang; Xia, Siyuan; Pan, Yaozhu; Liu, Shuangping; Qian, Guoqing; Qian, Zhiyu; Kang, Hee-Bum; Kudchadkar, Ragini R.; Lawson, David H.; Rossi, Michael; Khoury, Hanna J.; Khuri, Fadlo R.; Boise, Lawrence H.; Lonial, Sagar; Chen, Jing; Lin, Ruiting] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Fan, Jun] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Arbiser, Jack L.; Pollack, Brian P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Arbiser, Jack L.; Pollack, Brian P.] Atlanta Vet Adm Med Ctr, Decatur, GA 30033 USA; [Abdel-Wahab, Omar; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Zhao, Liang; Chen, Fangping] Cent S Univ, Xiangya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China	Emory University; Emory University; Emory University; Memorial Sloan Kettering Cancer Center; Central South University	Chen, FP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China.; Chen, J (corresponding author), 1365-C Clifton Rd NE C3002, Atlanta, GA 30322 USA.	hope058@163.com; jchen@emory.edu	Boise, Lawrence/AAD-2314-2019; Merghoub, Taha/ABD-8362-2021; Xia, Siyuan/AAM-9606-2020; Qian, Guoqing/ABH-1307-2021; Khuri, Fadlo R./AAU-4942-2020	Qian, Guoqing/0000-0003-1804-7993; Khuri, Fadlo R./0000-0002-8638-7618; Zhao, Liang/0000-0002-8077-4510; Kang, Hee-Bum/0000-0002-3781-6893; Boise, Lawrence/0000-0001-9436-8815; Xia, Siyuan/0000-0001-6756-3519	National Institutes of Health [CA140515, CA183594, CA174786, AR47901]; T.J. Martell Foundation/Winship Cancer Institute; Jamie Rabinowitch-Davis Foundation for Melanoma Research; Charles Harris Run For Leukemia, Inc.; Melanoma Research Foundation; Winship Cancer Institute Melanoma & Skin Cancer Fund; Joel A. Katz Music Medicine Fund; NATIONAL CANCER INSTITUTE [R01CA140515, P30CA008748, R01CA174786, R01CA183594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T.J. Martell Foundation/Winship Cancer Institute; Jamie Rabinowitch-Davis Foundation for Melanoma Research; Charles Harris Run For Leukemia, Inc.; Melanoma Research Foundation; Winship Cancer Institute Melanoma & Skin Cancer Fund; Joel A. Katz Music Medicine Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants CA140515, CA183594, CA174786 (J.C.), and AR47901 (J.L.A.); Joel A. Katz Music Medicine Fund supported by the T.J. Martell Foundation/Winship Cancer Institute (J.C. and R.L.); the Jamie Rabinowitch-Davis Foundation for Melanoma Research (J.L.A.); the Charles Harris Run For Leukemia, Inc. (H.J.K.); and the Melanoma Research Foundation and the Winship Cancer Institute Melanoma & Skin Cancer Fund (B.P.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arcaini L, 2012, BLOOD, V119, P188, DOI 10.1182/blood-2011-08-368209; BALASSE EO, 1989, DIABETES METAB REV, V5, P247, DOI 10.1002/dmr.5610050304; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Gibney GT, 2013, NAT REV CLIN ONCOL, V10, P390, DOI 10.1038/nrclinonc.2013.83; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kang HB, 2015, MOL CELL, V59, P345, DOI 10.1016/j.molcel.2015.05.037; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xia SY, 2017, CELL METAB, V25, P358, DOI 10.1016/j.cmet.2016.12.010	16	20	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10142	10152		10.1074/jbc.M117.788778	http://dx.doi.org/10.1074/jbc.M117.788778			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28468827	Green Published, hybrid			2022-12-28	WOS:000403580600025
J	Korasick, DA; Gamage, TT; Christgen, S; Stiers, KM; Beamer, LJ; Henzl, MT; Becker, DF; Tanner, JJ				Korasick, David A.; Gamage, Thameesha T.; Christgen, Shelbi; Stiers, Kyle M.; Beamer, Lesa J.; Henzl, Michael T.; Becker, Donald F.; Tanner, John J.			Structure and characterization of a class 3B proline utilization A: Ligand-induced dimerization and importance of the C-terminal domain for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; DEHYDROGENASE DOMAIN; ESCHERICHIA-COLI; BRADYRHIZOBIUM-JAPONICUM; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURES; REDOX PROPERTIES; PUTA PROTEIN; IDENTIFICATION; FLAVOPROTEIN	The bifunctional flavoenzyme proline utilization A (PutA) catalyzes the two-step oxidation of proline to glutamate using separate proline dehydrogenase (PRODH) and L-glutamate-gamma-semialdehyde dehydrogenase active sites. Because PutAs catalyze sequential reactions, they are good systems for studying how metabolic enzymes communicate via substrate channeling. Although mechanistically similar, PutAs vary widely in domain architecture, oligomeric state, and quaternary structure, and these variations represent different structural solutions to the problem of sequestering a reactive metabolite. Here, we studied PutA from Corynebacterium freiburgense (CfPutA), which belongs to the uncharacterized 3B class of PutAs. A 2.7 angstrom resolution crystal structure showed the canonical arrangement of PRODH, L-glutamate-gamma-semialdehyde dehydrogenase, and C-terminal domains, including an extended interdomain tunnel associated with substrate channeling. The structure unexpectedly revealed a novel open conformation of the PRODH active site, which is interpreted to represent the non-activated conformation, an elusive form of PutA that exhibits suboptimal channeling. Nevertheless, CfPutA exhibited normal substrate-channeling activity, indicating that it isomerizes into the active state under assay conditions. Sedimentation-velocity experiments provided insight into the isomerization process, showing that CfPutA dimerizes in the presence of a proline analog and NAD(+). These results are consistent with the morpheein model of enzyme hysteresis, in which substrate binding induces conformational changes that promote assembly of a high-activity oligomer. Finally, we used domain deletion analysis to investigate the function of the C-terminal domain. Although this domain contains neither catalytic residues nor substrate sites, its removal impaired both catalytic activities, suggesting that it may be essential for active-site integrity.	[Korasick, David A.; Stiers, Kyle M.; Beamer, Lesa J.; Henzl, Michael T.; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Gamage, Thameesha T.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Christgen, Shelbi; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Christgen, Shelbi; Becker, Donald F.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X; Korasick, David/0000-0002-6337-2085; Stiers, Kyle/0000-0001-5542-022X	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065546, R01GM061068, T32GM008396, P30GM103335] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jay Nix for help with X-ray diffraction data collection. Part of this work was conducted at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson KS, 1999, METHOD ENZYMOL, V308, P111; Andreotti G, 2015, DRUG TEST ANAL, V7, P831, DOI 10.1002/dta.1798; Arentson BW, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160435; Arentson BW, 2014, BIOCHEMISTRY-US, V53, P5150, DOI 10.1021/bi5007404; Arentson BW, 2012, FRONT BIOSCI-LANDMRK, V17, P375, DOI 10.2741/3932; Becker DF, 2001, BIOCHEMISTRY-US, V40, P4714, DOI 10.1021/bi0019491; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DEJONG E, 1992, EUR J BIOCHEM, V208, P651; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gu D, 2004, J BIOL CHEM, V279, P31171, DOI 10.1074/jbc.M403701200; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Krishnan N, 2005, BIOCHEMISTRY-US, V44, P9130, DOI 10.1021/bi050629k; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luo M, 2016, J BIOL CHEM, V291, P24065, DOI 10.1074/jbc.M116.756965; Luo M, 2014, BIOCHEMISTRY-US, V53, P5661, DOI 10.1021/bi500693a; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Patel D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23748; Pemberton TA, 2014, BIOCHEMISTRY-US, V53, P1350, DOI 10.1021/bi500048b; Sanyal N, 2015, J BIOL CHEM, V290, P2225, DOI 10.1074/jbc.M114.625483; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Singh RK, 2012, FRONT BIOSCI-LANDMRK, V17, P556, DOI 10.2741/3943; Singh RK, 2011, J BIOL CHEM, V286, P43144, DOI 10.1074/jbc.M111.292474; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Srivastava D, 2010, BIOCHEMISTRY-US, V49, P560, DOI 10.1021/bi901717s; Tang L., 2005, J BIOL CHEM, V280; Tanner J. J., 2017, ANTIOXID RE IN PRESS; Tanner JJ, 2013, HANDBOOK OF FLAVOPROTEINS, VOL 1: OXIDASES, DEHYDROGENASES AND RELATED SYSTEMS, P31; Team RC, 2013, R LANGUAGE ENV STAT; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thompson NJ, 2014, STRUCTURE, V22, P281, DOI 10.1016/j.str.2013.11.010; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084; Zhu WD, 2002, ARCH BIOCHEM BIOPHYS, V408, P131, DOI 10.1016/S0003-9861(02)00535-0; Zhu WD, 2013, BIOCHEMISTRY-US, V52, P4482, DOI 10.1021/bi400396g	57	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9652	9665		10.1074/jbc.M117.786855	http://dx.doi.org/10.1074/jbc.M117.786855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28420730	Green Published, hybrid			2022-12-28	WOS:000403113000016
J	Bak, LK				Bak, Lasse K.			Astrocytes take the stage in a tale of signaling-metabolism coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLYCOLYSIS	Astrocytes are crucial cells in the brain that are intimately coupled with neuronal metabolism. A new paper from San Martin et al. provides evidence that physiological levels of the gaseous signal molecule NO can rapidly and reversibly increase astrocyte metabolism of glucose and production of lactate. A proposed neurological coupling-from the potential source of NO, endothelial cells, to the potential beneficiary from the lactate, neurons-prompts new questions regarding the controversial role of lactate in the brain.	[Bak, Lasse K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, 2 Univ Pk, DK-2100 Copenhagen, Denmark	University of Copenhagen	Bak, LK (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, 2 Univ Pk, DK-2100 Copenhagen, Denmark.	laba@sund.ku.dk		Bak, Lasse K./0000-0003-0784-7864				Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Bak LK, 2017, J NEUROSCI RES, V95, P2098, DOI 10.1002/jnr.23994; Dienel GA, 2017, J NEUROSCI RES, V95, P2103, DOI 10.1002/jnr.24015; Martin M, 2017, J BIOL CHEM, V292, P3433, DOI 10.1074/jbc.M116.740258; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Satrustegui J, 2015, NEUROCHEM RES, V40, P2425, DOI 10.1007/s11064-015-1652-8; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102	9	2	2	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9439	9440		10.1074/jbc.H117.777243	http://dx.doi.org/10.1074/jbc.H117.777243			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28576887	hybrid, Green Published			2022-12-28	WOS:000402538900037
J	Matsui, T; Kodama, T; Mori, T; Tadakoshi, T; Noguchi, H; Abe, I; Morita, H				Matsui, Takashi; Kodama, Takeshi; Mori, Takahiro; Tadakoshi, Tetsuhiro; Noguchi, Hiroshi; Abe, Ikuro; Morita, Hiroyuki			2-Alkylquinolone alkaloid biosynthesis in the medicinal plant Evodia rutaecarpa involves collaboration of two novel type III polyketide synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; BENZALACETONE SYNTHASE; MOLECULAR REPLACEMENT; SIGNALING MOLECULES; QUINOLONE ALKALOIDS; ENZYMATIC FORMATION; ACID BIOSYNTHESIS; CHALCONE SYNTHASE; RHEUM-PALMATUM; ORYZA-SATIVA	2-Alkylquinolone (2AQ) alkaloids are pharmaceutically and biologically important natural products produced by both bacteria and plants, with a wide range of biological effects, including antibacterial, cytotoxic, anticholinesterase, and quorum-sensing signaling activities. These diverse activities and 2AQ occurrence in vastly different phyla have raised much interest in the biosynthesis pathways leading to their production. Previous studies in plants have suggested that type III polyketide synthases (PKSs) might be involved in 2AQ biosynthesis, but this hypothesis is untested. To this end, we cloned two novel type III PKSs, alkyldiketide-CoA synthase (ADS) and alkylquinolone synthase (AQS), from the 2AQ-producing medicinal plant, Evodia rutaecarpa (Rutaceae). Functional analyses revealed that collaboration of ADS and AQS produces 2AQ via condensations of N-methylanthraniloyl-CoA, a fatty acyl-CoA, with malonyl-CoA. We show that ADS efficiently catalyzes the decarboxylative condensation of malonyl-CoA with a fatty acyl-CoA to produce an alkyldiketide-CoA, whereas AQS specifically catalyzes the decarboxylative condensation of an alkyldiketide acid with N-methylanthraniloyl-CoA to generate the 2AQ scaffold via C-C/C-N bond formations. Remarkably, the ADS and AQS crystal structures at 1.80 and 2.20 angstrom resolutions, respectively, indicated that the unique active-site architecture with Trp-332 and Cys-191 and the novel CoA-binding tunnel with Tyr-215 principally control the substrate and product specificities of ADS and AQS, respectively. These results provide additional insights into the catalytic versatility of the type III PKSs and their functional and evolutionary implications for 2AQ biosynthesis in plants and bacteria.	[Matsui, Takashi; Kodama, Takeshi; Tadakoshi, Tetsuhiro; Morita, Hiroyuki] Univ Toyama, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan; [Mori, Takahiro; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Noguchi, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, 52-1 Yada, Shizuoka 4228526, Japan	University of Toyama; University of Tokyo; University of Shizuoka	Morita, H (corresponding author), Univ Toyama, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.; Abe, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	abei@mol.f.u-tokyo.ac.jp; hmorita@inm.u-toyama.ac.jp	Noguchi, Hiroshi/AAV-8527-2020; Abe, Ikuro/E-4449-2010	Abe, Ikuro/0000-0002-3640-888X; Matsui, Takashi/0000-0002-4496-2389	Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI) [JP15H01836, JP16H06443, JP25242067, JP26282210, JP26560435]; Institute of Natural Medicine, University of Toyama; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [16K18501, 16H06443] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI); Institute of Natural Medicine, University of Toyama; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI Grants JP15H01836, JP16H06443, JP25242067, JP26282210, and JP26560435); by Grants-in-Aid for the Cooperative Research Project from the Institute of Natural Medicine, University of Toyama, in 2013 (to H. N. and H. M.) and in 2015 (to T. M. and H. M.); and by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v; Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2004, PHYTOCHEMISTRY, V65, P2447, DOI 10.1016/j.phytochem.2004.08.005; Abe I, 2006, ORG LETT, V8, P6063, DOI 10.1021/ol0625233; Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardoso-Lopes EM, 2010, MOLECULES, V15, P9205, DOI 10.3390/molecules15129205; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COPPOLA GM, 1985, J HETEROCYCLIC CHEM, V22, P491, DOI 10.1002/jhet.5570220256; Drees SL, 2016, J BIOL CHEM, V291, P6610, DOI 10.1074/jbc.M115.708453; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Giddens AC, 2008, TETRAHEDRON, V64, P1242, DOI 10.1016/j.tet.2007.11.075; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katsuyama Y, 2007, J BIOL CHEM, V282, P37702, DOI 10.1074/jbc.M707569200; Katsuyama Y, 2011, J BIOL CHEM, V286, P6659, DOI 10.1074/jbc.M110.196279; Katsuyama Y, 2009, J BIOL CHEM, V284, P11160, DOI 10.1074/jbc.M900070200; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mori T, 2013, J BIOL CHEM, V288, P28845, DOI 10.1074/jbc.M113.493155; Morita H, 2010, P NATL ACAD SCI USA, V107, P19778, DOI 10.1073/pnas.1011499107; Morita H, 2010, P NATL ACAD SCI USA, V107, P669, DOI 10.1073/pnas.0909982107; Nevarez DM, 2009, J AM CHEM SOC, V131, P5994, DOI 10.1021/ja900545m; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tang MC, 2013, ACS CATAL, V3, P444, DOI 10.1021/cs300819e; Taura F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2015.01452; Taura F, 2009, FEBS LETT, V583, P2061, DOI 10.1016/j.febslet.2009.05.024; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang CF, 2014, MOLECULES, V19, P20128, DOI 10.3390/molecules191220128; Wang J, 2016, ORG LETT, V18, P3550, DOI 10.1021/acs.orglett.6b01501; Wang XX, 2013, FITOTERAPIA, V89, P1, DOI 10.1016/j.fitote.2013.04.007	39	9	11	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9117	9135		10.1074/jbc.M117.778977	http://dx.doi.org/10.1074/jbc.M117.778977			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28411241	hybrid, Green Published			2022-12-28	WOS:000402538900010
J	Bardwell, AJ; Lagunes, L; Zebarjedi, R; Bardwell, L				Bardwell, A. Jane; Lagunes, Leonila; Zebarjedi, Ronak; Bardwell, Lee			The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell signaling; extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); protein complex; protein kinase; protein-protein interaction; scaffold protein; IQGAP1	PROLINE-RICH LIGANDS; HIGH-AFFINITY INTERACTION; YES-ASSOCIATED PROTEIN; DOCKING SITES; SUBSTRATE PHOSPHORYLATION; TRANSCRIPTION FACTOR; C-JUN; KINASE; ACTIVATION; CANCER	Mitogen-activated protein kinase (MAPK) scaffold proteins, such as IQ motif containing GTPase activating protein 1 (IQGAP1), are promising targets for novel therapies against cancer and other diseases. Such approaches require accurate information about which domains on the scaffold protein bind to the kinases in the MAPK cascade. Results from previous studies have suggested that the WW domain of IQGAP1 binds to the cancer-associated MAPKs ERK1 and ERK2, and that this domain might thus offer a new tool to selectively inhibit MAPK activation in cancer cells. The goal of this work was therefore to critically evaluate which IQGAP1 domains bind to ERK1/2. Here, using quantitative in vitro binding assays, we show that the IQ domain of IQGAP1 is both necessary and sufficient for binding to ERK1 and ERK2, as well as to the MAPK kinases MEK1 and MEK2. Furthermore, we show that the WW domain is not required for ERK-IQGAP1 binding, and contributes little or no binding energy to this interaction, challenging previous models of how WW-based peptides might inhibit tumorigenesis. Finally, we show that the ERK2-IQGAP1 interaction does not require ERK2 phosphorylation or catalytic activity and does not involve known docking recruitment sites on ERK2, and we obtain an estimate of the dissociation constant (K-d) for this interaction of 8 m. These results prompt a re-evaluation of published findings and a refined model of IQGAP scaffolding.	[Bardwell, A. Jane; Lagunes, Leonila; Zebarjedi, Ronak; Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363	National Institutes of Health NIGMS [P50 GM76516]; United States Department of Education GAANN fellowship [P200A150181]; United States National Science Foundation Graduate Research Fellowship Program; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Education GAANN fellowship; United States National Science Foundation Graduate Research Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health NIGMS Grant P50 GM76516. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by United States Department of Education GAANN fellowship P200A150181 and the United States National Science Foundation Graduate Research Fellowship Program.	Abel AM, 2015, MOL IMMUNOL, V65, P336, DOI 10.1016/j.molimm.2015.02.012; Ang Boon K, 2007, J Mol Signal, V2, P1, DOI 10.1186/1750-2187-2-1; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Banon-Rodriguez I, 2014, EMBO J, V33, P129, DOI 10.1002/embj.201385946; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cheung KL, 2013, J BIOL CHEM, V288, P22378, DOI 10.1074/jbc.M112.444182; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Fang LK, 2015, CANCER CELL, V28, P183, DOI 10.1016/j.ccell.2015.07.004; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Gordon EA, 2013, CELL SIGNAL, V25, P2518, DOI 10.1016/j.cellsig.2013.08.004; Gorman JA, 2012, J IMMUNOL, V188, P6135, DOI 10.4049/jimmunol.1103487; Goto T, 2013, J BIOL CHEM, V288, P36351, DOI 10.1074/jbc.M113.520528; Goto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060865; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Heil A, 2011, J BIOL CHEM, V286, P7227, DOI 10.1074/jbc.M110.135095; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kim H, 2011, BIOCHEM J, V440, P309, DOI 10.1042/BJ20110419; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu J, 2014, J PROTEOME RES, V13, P1156, DOI 10.1021/pr400787p; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lu R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005200; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Malarkannan S, 2012, J IMMUNOL, V188, P2057, DOI 10.4049/jimmunol.1102439; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Molina DM, 2005, J BIOL CHEM, V280, P42051, DOI 10.1074/jbc.M510590200; Osman MA, 1998, J CELL BIOL, V142, P443, DOI 10.1083/jcb.142.2.443; Osman MA, 2013, BBA-REV CANCER, V1836, P166, DOI 10.1016/j.bbcan.2013.04.005; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Piserchio A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11127; Prowse CN, 2001, J BIOL CHEM, V276, P40817, DOI 10.1074/jbc.M105860200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sanchez-Laorden B, 2013, CANCER CELL, V23, P715, DOI 10.1016/j.ccr.2013.05.017; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Shannon KB, 2012, INT J CELL BIOL, DOI [10.1155/2012/894817(2012, DOI 10.1155/2012/894817(2012]; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; STRUHL K, 1991, METHOD ENZYMOL, V194, P520; Stuart DD, 2013, NAT MED, V19, P538, DOI 10.1038/nm.3195; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tekletsadik YK, 2012, J CELL SCI, V125, P2041, DOI 10.1242/jcs.098947; Wallrabe H, 2013, CYTOSKELETON, V70, P819, DOI 10.1002/cm.21146; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu Y, 2014, BIOMED REP, V2, P3, DOI 10.3892/br.2013.204; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710	87	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8750	8761		10.1074/jbc.M116.767087	http://dx.doi.org/10.1074/jbc.M116.767087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28396345	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000402153900021
J	Benard, O; Naor, Z; Seger, R				Benard, Outhiriaradjou; Naor, Zvi; Seger, Rony			RETRACTION: Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone (Retraction of Vol 276, Pg 4554, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Benard O, 2001, J BIOL CHEM, V276, P4554, DOI 10.1074/jbc.M006995200	1	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8855	8855		10.1074/jbc.A117.006995	http://dx.doi.org/10.1074/jbc.A117.006995			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550141	Green Published, hybrid			2022-12-28	WOS:000402153900038
J	Hu, ZW; Ma, MR; Chen, YX; Zhao, YF; Qiang, W; Li, YM				Hu, Zhi-Wen; Ma, Meng-Rong; Chen, Yong-Xiang; Zhao, Yu-Fen; Qiang, Wei; Li, Yan-Mei			Phosphorylation at Ser(8) as an intrinsic regulatory switch to regulate the morphologies and structures of Alzheimer's 40-residue beta-amyloid (A beta 40) fibrils (vol 292, pg 2611, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Hu ZW, 2017, J BIOL CHEM, V292, P2611, DOI 10.1074/jbc.M116.757179	1	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8846	8846		10.1074/jbc.A116.757179	http://dx.doi.org/10.1074/jbc.A116.757179			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550132	Green Published, hybrid			2022-12-28	WOS:000402153900029
J	Krautkramer, KA; Rey, FE; Denu, JM				Krautkramer, Kimberly A.; Rey, Federico E.; Denu, John M.			Chemical signaling between gut microbiota and host chromatin: What is your gut really saying?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHAIN FATTY-ACIDS; HISTONE-DEACETYLASE ACTIVITY; DEPENDENT HISTONE; DNA METHYLATION; CELLULAR-METABOLISM; ACETYL-COA; DIET; INHIBITION; MECHANISMS; NUTRITION	Mammals and their gut microbial communities share extensive and tightly coordinated co-metabolism of dietary substrates. A large number of microbial metabolites have been detected in host circulation and tissues and, in many cases, are linked to host metabolic, developmental, and immunological states. The presence of these metabolites in host tissues intersects with regulation of the host's epigenetic machinery. Although it is established that the host's epigenetic machinery is sensitive to levels of endogenous metabolites, the roles for microbial metabolites in epigenetic regulation are just beginning to be elucidated. This review focuses on eukaryotic chromatin regulation by endogenous and gut microbial metabolites and how these regulatory events may impact host developmental and metabolic phenotypes.	[Krautkramer, Kimberly A.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Morgridge Inst Res, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Krautkramer, Kimberly A.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA; [Rey, Federico E.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Morgridge Inst Res, Wisconsin Inst Discovery, Madison, WI 53715 USA.; Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA.; Rey, FE (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	ferey@wisc.edu; john.denu@wisc.edu	Krautkramer, Kimberly/AAR-7014-2020	Krautkramer, Kimberly/0000-0002-9227-0977	National Institutes of Health [F30 DK108494-01A1, DK108259-01, GM059789-15/P250VA]; National Institute of Food and Agriculture, United States Department of Agriculture [2016-67017-24416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK108494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, R37GM059785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health Grant F30 DK108494-01A1.; Supported by National Institutes of Health Grant DK108259-01 and by National Institute of Food and Agriculture, United States Department of Agriculture, under Award No. 2016-67017-24416.; Supported by National Institutes of Health Grant GM059789-15/P250VA.	Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Aufreiter S, 2009, AM J CLIN NUTR, V90, P116, DOI 10.3945/ajcn.2008.27345; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cascella B, 2012, BIOCHEMISTRY-US, V51, P8699, DOI 10.1021/bi3012466; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dimri M, 2010, CARCINOGENESIS, V31, P489, DOI 10.1093/carcin/bgp305; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Druart C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087560; Du JM, 2014, BBA-GENE REGUL MECH, V1839, P719, DOI 10.1016/j.bbagrm.2014.04.011; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia-Villalba R, 2013, J AGR FOOD CHEM, V61, P8797, DOI 10.1021/jf402498b; Gorres KL, 2014, J VIROL, V88, P8028, DOI 10.1128/JVI.00722-14; Goyal MS, 2015, P NATL ACAD SCI USA, V112, P14105, DOI 10.1073/pnas.1511465112; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kiss AK, 2012, FOOD CHEM, V131, P1015, DOI 10.1016/j.foodchem.2011.09.109; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Y., 2013, PLOS ONE, V8; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Majnik AV, 2015, EPIGENOMICS-UK, V7, P1173, DOI 10.2217/epi.15.74; Maurice CF, 2015, ISME J, V9, P2423, DOI 10.1038/ismej.2015.53; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Pompei A, 2007, J NUTR, V137, P2742, DOI 10.1093/jn/137.12.2742; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rajavelu A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-16; Rensvold JW, 2016, J BIOL CHEM, V291, P20827, DOI 10.1074/jbc.M116.727701; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sadhu MJ, 2013, GENETICS, V195, P831, DOI 10.1534/genetics.113.153981; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Strozzi GP, 2008, J CLIN GASTROENTEROL, V42, pS179, DOI 10.1097/MCG.0b013e31818087d8; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; THOMAS D, 1991, MOL GEN GENET, V226, P224, DOI 10.1007/BF00273607; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Vahid F, 2015, GENE, V562, P8, DOI 10.1016/j.gene.2015.02.045; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wong CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086787; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Zhao Y., 2015, COLD SPRING HARB PER, V7; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	99	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8582	8593		10.1074/jbc.R116.761577	http://dx.doi.org/10.1074/jbc.R116.761577			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389558	Green Published, hybrid			2022-12-28	WOS:000402153900007
J	Vernon, RM; Chong, PA; Lin, H; Yang, ZR; Zhou, QX; Aleksandrov, AA; Dawson, JE; Riordan, JR; Brouillette, CG; Thibodeau, PH; Forman-Kay, JD				Vernon, Robert M.; Chong, P. Andrew; Lin, Hong; Yang, Zhengrong; Zhou, Qingxian; Aleksandrov, Andrei A.; Dawson, Jennifer E.; Riordan, John R.; Brouillette, Christie G.; Thibodeau, Patrick H.; Forman-Kay, Julie D.			Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; cystic fibrosis transmembrane conductance regulator (CFTR); protein engineering; protein misfolding; protein stability	ATP-BINDING; DELTA-F508 CFTR; R-DOMAIN; MULTIDRUG-RESISTANCE; PROTEIN STABILITY; CHLORIDE CHANNEL; ABC TRANSPORTER; SEQUENCE; DESIGN; EVOLUTION	Characterization of the second nucleotide-binding domain (NBD2) of the cystic fibrosis transmembrane conductance regulator (CFTR) has lagged behind research into the NBD1 domain, in part because NBD1 contains the F508del mutation, which is the dominant cause of cystic fibrosis. Research on NBD2 has also been hampered by the overall instability of the domain and the difficulty of producing reagents. Nonetheless, multiple disease-causing mutations reside in NBD2, and the domain is critical for CFTR function, because channel gating involves NBD1/NBD2 dimerization, and NBD2 contains the catalytically active ATPase site in CFTR. Recognizing the paucity of structural and biophysical data on NBD2, here we have defined a bioinformatics-based method for manually identifying stabilizing substitutions in NBD2, and we used an iterative process of screening single substitutions against thermal melting points to both produce minimally mutated stable constructs and individually characterize mutations. We present a range of stable constructs with minimal mutations to help inform further research on NBD2. We have used this stabilized background to study the effects of NBD2 mutations identified in cystic fibrosis (CF) patients, demonstrating that mutants such as N1303K and G1349D are characterized by lower stability, as shown previously for some NBD1 mutations, suggesting a potential role for NBD2 instability in the pathology of CF.	[Vernon, Robert M.; Chong, P. Andrew; Lin, Hong; Dawson, Jennifer E.; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada; [Yang, Zhengrong; Zhou, Qingxian; Brouillette, Christie G.] Univ Alabama Birmingham, Struct Biol Ctr, Birmingham, AL 35294 USA; [Yang, Zhengrong; Zhou, Qingxian; Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Thibodeau, Patrick H.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA; [Aleksandrov, Andrei A.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Cyst Fibrosis Treatment & Res Ctr, Chapel Hill, NC 27599 USA; [Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto	Forman-Kay, JD (corresponding author), Hosp Sick Children, Program Mol Med, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.	forman@sickkids.ca		Dawson, Jennifer Erin/0000-0002-8387-6109; Forman-Kay, Julie/0000-0001-8265-972X	Cystic Fibrosis Foundation Therapeutics; Cystic Fibrosis Canada; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R01DK051870] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Cystic Fibrosis Foundation Therapeutics (to J. D. F.-K., P. H. T., C. G. B., and J. R. R.), from Cystic Fibrosis Canada (to J. D. F.-K.), and from the National Institutes of Health (to P. H. T. and J. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Chong PA, 2015, J BIOL CHEM, V290, P22862, DOI 10.1074/jbc.M115.641134; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Da Paula AC, 2010, J BIOL CHEM, V285, P27033, DOI 10.1074/jbc.M110.120352; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FERSHT A, 1998, STRUCTURE MECH PROTE, P508; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Goldstein RA, 2011, PROTEINS, V79, P1396, DOI 10.1002/prot.22964; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lehmann M, 2000, PROTEIN ENG, V13, P49, DOI 10.1093/protein/13.1.49; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Melin P, 2004, BIOCHEM PHARMACOL, V67, P2187, DOI 10.1016/j.bcp.2004.02.022; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Molinski SV, 2014, GENET MED, V16, P625, DOI 10.1038/gim.2014.4; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Ramalho AS, 2016, J CYST FIBROS, V15, P21, DOI 10.1016/j.jcf.2015.02.002; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Tian JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-370; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wainreb G, 2011, BIOINFORMATICS, V27, P3286, DOI 10.1093/bioinformatics/btr576; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhao X., 2008, PEDIAT PULMONARY, V43, P205	66	14	14	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14147	14164		10.1074/jbc.M116.772335	http://dx.doi.org/10.1074/jbc.M116.772335			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28655774	Green Published, hybrid			2022-12-28	WOS:000408439800020
J	Fortea, E; Lemieux, V; Potvin, L; Chikwana, V; Griffin, S; Hey, T; McCaskill, D; Narva, K; Tan, SY; Xu, XP; Vachon, V; Schwartz, JL				Fortea, Eva; Lemieux, Vincent; Potvin, Lena; Chikwana, Vimbai; Griffin, Samantha; Hey, Timothy; McCaskill, David; Narva, Kenneth; Tan, Sek Yee; Xu, Xiaoping; Vachon, Vincent; Schwartz, Jean-Louis			Cry6Aa1, a Bacillus thuringiensis nematocidal and insecticidal toxin, forms pores in planar lipid bilayers at extremely low concentrations and without the need of proteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRGIFERA-VIRGIFERA LECONTE; BRUSH-BORDER MEMBRANE; RAY CRYSTAL-STRUCTURE; HEMOLYSIN-E HLYE; DELTA-ENDOTOXIN; ESCHERICHIA-COLI; ION CHANNELS; CAENORHABDITIS-ELEGANS; OSMOTIC LYSIS; LARVAL MIDGUT	Cry6Aa1 is a Bacillus thuringiensis (Bt) toxin active against nematodes and corn rootworm insects. Its 3D molecular structure, which has been recently elucidated, is unique among those known for other Bt toxins. Typical three-domain Bt toxins permeabilize receptor-free planar lipid bilayers (PLBs) by forming pores at doses in the 1-50 mu g/ml range. Solubilization and proteolytic activation are necessary steps for PLB permeabilization. In contrast to other Bt toxins, Cry6Aa1 formed pores in receptor-free bilayers at doses as low as 200 pg/ml in a wide range of pH (5.5-9.5) and without the need of protease treatment. When Cry6Aa1 was preincubated with Western corn rootworm (WCRW) midgut juice or trypsin, 100 fg/ml of the toxin was sufficient to form pores in PLBs. The overall biophysical properties of the pores were similar for all three forms of the toxin (native, midgut juice-and trypsin-treated), with conductances ranging from 28 to 689 pS, except for their ionic selectivity, which was slightly cationic for the native and midgut juice-treated Cry6Aa1, whereas dual selectivity (to cations or anions) was observed for the pores formed by the trypsin-treated toxin. Enrichment of PLBs with WCRW midgut brush-border membrane material resulted in a 2000-fold reduction of the amount of native Cry6Aa1 required to form pores and affected the biophysical properties of both the native and trypsin-treated forms of the toxin. These results indicate that, although Cry6Aa1 forms pores, the molecular determinants of its mode of action are significantly different from those reported for other Bt toxins.	[Fortea, Eva; Lemieux, Vincent; Potvin, Lena; Vachon, Vincent; Schwartz, Jean-Louis] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ H3C 3J7, Canada; [Fortea, Eva; Lemieux, Vincent; Potvin, Lena; Vachon, Vincent; Schwartz, Jean-Louis] Univ Montreal, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada; [Lemieux, Vincent] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Chikwana, Vimbai; Griffin, Samantha; Hey, Timothy; McCaskill, David; Narva, Kenneth; Tan, Sek Yee; Xu, Xiaoping] Dow AgroSci LLC, Indianapolis, IN 46268 USA; [Schwartz, Jean-Louis] Univ Sherbrooke, Ctr SEVE Rech Sci Vegetal, Sherbrooke, PQ J1K 2R1, Canada	Universite de Montreal; Universite de Montreal; University of Sherbrooke; Dow Chemical Company; University of Sherbrooke	Schwartz, JL (corresponding author), POB 6128, Montreal, PQ H3C 3J7, Canada.	jean-louis.schwartz@umontreal.ca	schwartz, jean-louis/D-9938-2011	Narva, Kenneth/0000-0001-8094-6418	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 44052-12]; Dow AgroSciences Canada Inc., a Universite de Montreal graduate student scholarship; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dow AgroSciences Canada Inc., a Universite de Montreal graduate student scholarship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant (CRDPJ 44052-12 to J. L. S.), in partnership with Dow AgroSciences Canada Inc., a Universite de Montreal graduate student scholarship (to E. F.), and an NSERC undergraduate student research award (to V. L.). E. F., V. L., L. P., V. V., and J. L. S. declare that they have no conflicts of interest with the contents of this article. S. G., V. C., D. M., S. Y. T., and K. N. are employed by Dow AgroSciences, LLC. T. H. and X. X. are former employees of that company.	Akiba T, 2006, PROTEINS, V63, P243, DOI 10.1002/prot.20843; Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002; Allman E, 2009, AM J PHYSIOL-CELL PH, V297, pC1071, DOI 10.1152/ajpcell.00284.2009; [Anonymous], 2000, NON TRADITIONAL REF; Aragon P, 2012, AGR FOREST ENTOMOL, V14, P13, DOI 10.1111/j.1461-9563.2011.00532.x; Aragon P, 2010, J APPL ECOL, V47, P1026, DOI 10.1111/j.1365-2664.2010.01847.x; Aronson A, 2002, CELL MOL LIFE SCI, V59, P417, DOI 10.1007/s00018-002-8434-6; Aronson AI, 2001, FEMS MICROBIOL LETT, V195, P1, DOI 10.1111/j.1574-6968.2001.tb10489.x; Becker N, 2000, ENTOMOPATHOGENIC BAC, P383, DOI DOI 10.1007/978-94-017-1429-7_21; Boonserm P, 2006, J BACTERIOL, V188, P3391, DOI 10.1128/JB.188.9.3391-3401.2006; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Bradfisch G. A., 1999, US Patent, Patent No. [5,973,231, 5973231]; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; BULLA LA, 1980, CRC CR REV MICROBIOL, V8, P147, DOI 10.3109/10408418009081124; Carroll J, 1997, J INVERTEBR PATHOL, V70, P41, DOI 10.1006/jipa.1997.4656; CARROLL J, 1993, EUR J BIOCHEM, V214, P771, DOI 10.1111/j.1432-1033.1993.tb17979.x; Chauhan VM, 2013, ACS NANO, V7, P5577, DOI 10.1021/nn401856u; Dementiev A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0295-9; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Evdokimov AG, 2014, PROTEIN SCI, V23, P1491, DOI 10.1002/pro.2536; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Frutos R, 1999, CRIT REV BIOTECHNOL, V19, P227, DOI 10.1080/0738-859991229251; Galitsky N, 2001, ACTA CRYSTALLOGR D, V57, P1101, DOI 10.1107/S0907444901008186; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; GEORGE SG, 1973, BIOCHEM J, V134, P43, DOI 10.1042/bj1340043; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Head G. P., 2012, GM CROP FOOD, P144; Hibbard BE, 2010, J ECON ENTOMOL, V103, P2187, DOI 10.1603/EC10179; Hill, 2001, ION CHANNELS EXCITAB, P441; Huang JB, 2016, BIOCHEM BIOPH RES CO, V478, P307, DOI 10.1016/j.bbrc.2016.07.002; Hui F, 2012, BIOCHEMISTRY-US, V51, P9911, DOI 10.1021/bi301386q; Kaiser-Alexnat R, 2009, J INVERTEBR PATHOL, V100, P169, DOI 10.1016/j.jip.2009.01.003; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kirouac M, 2003, J MEMBRANE BIOL, V196, P51, DOI 10.1007/s00232-003-0624-0; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; KOLLER CN, 1992, BIOCHEM BIOPH RES CO, V184, P692, DOI 10.1016/0006-291X(92)90645-2; Li HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053079; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Loncar N, 2009, ARCH BIOL SCI, V61, P713, DOI 10.2298/ABS0904713L; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Luo H, 2013, APPL MICROBIOL BIOT, V97, P10135, DOI 10.1007/s00253-013-5249-3; Ma BL, 2009, FIELD CROP RES, V111, P189, DOI 10.1016/j.fcr.2008.12.006; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Masson L, 2004, BIOCHEMISTRY-US, V43, P12349, DOI 10.1021/bi048946z; McGaughey Wm. H., 1998, Israel Journal of Entomology, V32, P1; Milne R, 2008, J INVERTEBR PATHOL, V99, P166, DOI 10.1016/j.jip.2008.05.002; Morse RJ, 2001, STRUCTURE, V9, P409, DOI 10.1016/S0969-2126(01)00601-3; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Narva K. E., 1993, U. S. Patent, Patent No. [5236843, 5,236,843]; Narva KE, 1993, US patent, Patent No. [5186934, 5,186,934]; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Peyronnet O, 2001, J MEMBRANE BIOL, V184, P45, DOI 10.1007/s00232-001-0071-8; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Sanchis V, 2008, AGRON SUSTAIN DEV, V28, P11, DOI 10.1051/agro:2007054; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Schwartz JL, 1997, FEBS LETT, V412, P270, DOI 10.1016/S0014-5793(97)00801-6; SCHWARTZ JL, 2000, ENTOMOPATHOGENIC BAC, P199; Skibbe U, 1996, J INSECT PHYSIOL, V42, P777, DOI 10.1016/0022-1910(96)00019-4; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tan SY, 2016, INSECT BIOCHEM MOLEC, V75, P117, DOI 10.1016/j.ibmb.2016.06.006; Tzokov SB, 2006, J BIOL CHEM, V281, P23042, DOI 10.1074/jbc.M602421200; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Vaidyanathan MS, 2014, RSC ADV, V4, P4930, DOI 10.1039/c3ra45159c; van Frankenhuyzen K, 2000, ENTOMOPATHOGENIC BAC, P371, DOI [10.1007/978-94-017-1429-7_20, DOI 10.1007/978-94-017-1429-7_20]; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xu CC, 2015, BIOCHEM BIOPH RES CO, V462, P184, DOI 10.1016/j.bbrc.2015.04.068; Zhang FJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005389	80	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13122	13132		10.1074/jbc.M116.765941	http://dx.doi.org/10.1074/jbc.M116.765941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28623231	Green Published, hybrid			2022-12-28	WOS:000407465300004
J	Biesemann, A; Gorontzi, A; Barr, F; Gerke, V				Biesemann, Anja; Gorontzi, Alexandra; Barr, Francis; Gerke, Volker			Rab35 protein regulates evoked exocytosis of endothelial Weibel-Palade bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; endothelial cell; membrane trafficking; Rab; vascular biology; Calcium; endothelial cells; membrane traffic; von-Willebrand factor	VON-WILLEBRAND-FACTOR; GTPASE-ACTIVATING PROTEIN; NEURITE OUTGROWTH; BODY EXOCYTOSIS; ANNEXIN A2; CELLS; SECRETION; ARF6; RAB27A; MYRIP	Weibel-Palade bodies (WPB) are secretory organelles of endothelial cells that undergo evoked exocytosis following intracellular Ca2+ or cAMP elevation, thereby supplying the vasculature with factors controlling hemostasis. Several cytosolic and membrane-associated proteins, including the Rab family members Rab3, Rab15, and Rab27a, have been implicated in regulating the acute exocytosis of WPB. Here, we carried out a genome-wide screen to identify Rab pathways affecting WPB exocytosis. Overexpression of a specific subset of Rab GTPase-activating proteins (RabGAPs) inhibited histamine-evoked, Ca2+-dependent WPB exocytosis, presumably by inactivating the target Rab GTPases. Among these RabGAPs, we concentrated on TBC1D10A and showed that the inhibitory effect depends on its GAP activity. We confirmed that Rab35 was a target Rab of TBC1D10A in human endothelial cells; Rab35 interacted with TBC1D10A, and expression of the GAP-insensitive Rab35(Q67A) mutant rescued the inhibitory effect of TBC1D10A overexpression on WPB exocytosis. Furthermore, knockdown of Rab35 and expression of a dominant-negative Rab35 mutant both inhibited histamine-evoked secretion of the WPB cargos von Willebrand factor and P-selectin. Pulldown and co-immunoprecipitation experiments identified the ArfGAP with coiled-coil, Ank repeat, and pleckstrin homology domain-containing protein ACAP2 as an Rab35 effector in endothelial cells, and depletion as well as overexpression approaches revealed that ACAP2 acts as a negative regulator of WPB exocytosis. Interestingly, a known ACAP2 target, the small GTPase Arf6, supported histamine-evoked WPB exocytosis, as shown by knockdown and overexpression of a dominant-negative Arf6 mutant. Our data identify Rab35 as a novel regulator of WPB exocytosis, most likely acting through the downstream effectors ACAP2 and Arf6.	[Biesemann, Anja; Gorontzi, Alexandra; Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany; [Barr, Francis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Munster; University of Oxford	Gerke, V (corresponding author), Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Cells in Mot Cluster Excellence EXC CiM 1003, von Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de			German Research Council (DFG) [GE514/6-2, GE514/10-1]; Wellcome Trust Senior Investigator Award [097769/Z/11/Z]	German Research Council (DFG)(German Research Foundation (DFG)); Wellcome Trust Senior Investigator Award(Wellcome Trust)	This work was supported by German Research Council (DFG) Grants GE514/6-2 and GE514/10-1 (to V. G.) and Wellcome Trust Senior Investigator Award 097769/Z/11/Z (to F. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Brandherm I, 2013, BLOOD, V122, P1042, DOI 10.1182/blood-2012-12-475251; Cauvin C, 2016, CURR BIOL, V26, P120, DOI 10.1016/j.cub.2015.11.040; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Conte IL, 2016, J CELL SCI, V129, P592, DOI 10.1242/jcs.178285; Datta YH, 2001, THROMB HAEMOSTASIS, V86, P1148; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Gerke V, 2016, BIOL CHEM, V397, P995, DOI 10.1515/hsz-2016-0207; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huang J, 2012, BLOOD, V120, P1143, DOI 10.1182/blood-2012-01-408096; Imai A, 2011, J BIOL CHEM, V286, P33854, DOI 10.1074/jbc.M111.281394; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Klinkert K, 2016, TRAFFIC, V17, P1063, DOI 10.1111/tra.12422; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Mrozowska PS, 2016, J CELL BIOL, V213, P355, DOI 10.1083/jcb.201512024; Nightingale T, 2013, J THROMB HAEMOST, V11, P192, DOI 10.1111/jth.12225; Nightingale TD, 2009, BLOOD, V113, P5010, DOI 10.1182/blood-2008-09-181206; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pulido IR, 2011, TRAFFIC, V12, P1371, DOI 10.1111/j.1600-0854.2011.01248.x; Pulido IR, 2011, BBA-MOL CELL RES, V1813, P1038, DOI 10.1016/j.bbamcr.2010.11.007; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schuberth CE, 2015, J CELL SCI, V128, P1279, DOI 10.1242/jcs.154443; Valentijn KM, 2013, J THROMB HAEMOST, V11, P581, DOI 10.1111/jth.12160; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; Vischer UM, 2000, ARTERIOSCL THROM VAS, V20, P883, DOI 10.1161/01.ATV.20.3.883; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Zografou S, 2012, J CELL SCI, V125, P4780, DOI 10.1242/jcs.104174	48	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11631	11640		10.1074/jbc.M116.773333	http://dx.doi.org/10.1074/jbc.M116.773333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28566286	Green Published, hybrid			2022-12-28	WOS:000405485600004
J	Li, HR; Stumpfig, M; Zhang, CG; An, XX; Stubbe, J; Lill, R; Huang, MX				Li, Haoran; Stuempfig, Martin; Zhang, Caiguo; An, Xiuxiang; Stubbe, JoAnne; Lill, Roland; Huang, Mingxia			The diferric-tyrosyl radical cluster of ribonucleotide reductase and cytosolic iron-sulfur clusters have distinct and similar biogenesis requirements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; SMALL-SUBUNIT; PROTEIN BIOGENESIS; MATURATION; GLUTAREDOXIN; YEAST; PICOT; VITRO; DRE2	How each metalloprotein assembles the correct metal at the proper binding site presents challenges to the cell. The di-iron enzyme ribonucleotide reductase (RNR) uses a diferric-tyrosyl radical (Fe-2(III)-Y-center dot) cofactor to initiate nucleotide reduction. Assembly of this cofactor requires O-2, Fe-II, and a reducing equivalent. Recent studies show that RNR cofactor biosynthesis shares the same source of iron, in the form of [2Fe-2S]-GSH(2) from the monothiol glutaredoxin Grx3/4, and the same electron source, in the form of the Dre2-Tah18 electron transfer chain, with the cytosolic iron-sulfur protein assembly (CIA) machinery required for maturation of [4Fe-4S] clusters in cytosolic and nuclear proteins. Here, we further investigated the interplay between the formation of the Fe-2(III)-Y-center dot cofactor in RNR and the cellular iron-sulfur (Fe-S) protein biogenesis pathways by examining both the iron loading into the RNR beta subunit and the RNR catalytic activity in yeast mutants depleted of individual components of the mitochondrial iron-sulfur cluster assembly (ISC) and the CIA machineries. We found that both iron loading and cofactor assembly in RNR are dependent on the ISC machinery. Wealso found that Dre2 is required for RNR cofactor formation but appears to be dispensable for iron loading. None of the CIA components downstream of Dre2 was required for RNR cofactor formation. Thus, the pathways for RNR and Fe-S cluster biogenesis bifurcate after the Dre2-Tah18 step. We conclude that RNR cofactor biogenesis requires the ISC machinery to mature the Grx3/4 and Dre2 Fe-S proteins, which then function in iron and electron delivery to RNR, respectively.	[Li, Haoran; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stuempfig, Martin; Lill, Roland] Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany; [Zhang, Caiguo; Huang, Mingxia] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA; [Zhang, Caiguo; An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Philipps University Marburg; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Lill, R (corresponding author), Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.; Huang, MX (corresponding author), 12801 E 17th Ave,Mail Stop 8127, Aurora, CO 80045 USA.	lill@staff.uni-marburg.de; mingxia.huang@ucdenver.edu		Lill, Roland/0000-0002-8345-6518	National Institutes of Health [GM81393, CA125574]; Deutsche Forschungsgemeinschaft [SFB 987, SPP 1710, LI 415-5]; LOEWE program of the state of Hesse; Max-Planck Gesellschaft; NATIONAL CANCER INSTITUTE [R01CA125574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of the state of Hesse; Max-Planck Gesellschaft(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM81393 (to J. S. and M. H), and CA125574 (to M. H.) and by Deutsche Forschungsgemeinschaft (SFB 987, SPP 1710, LI 415-5), LOEWE program of the state of Hesse, and the Max-Planck Gesellschaft (to R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Burke D., 2000, METHODS YEAST GENETI; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Huang MX, 2014, J BIOL CHEM, V289, P28104, DOI 10.1074/jbc.R114.596684; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ortigosa AD, 2006, BIOCHEMISTRY-US, V45, P12282, DOI 10.1021/bi0610404; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Perlstein DL, 2005, BIOCHEMISTRY-US, V44, P15366, DOI 10.1021/bi051616+; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074	30	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11445	11451		10.1074/jbc.M117.786178	http://dx.doi.org/10.1074/jbc.M117.786178			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515324	Green Published, hybrid			2022-12-28	WOS:000405119600027
J	Logeman, BL; Wood, LK; Lee, J; Thiele, DJ				Logeman, Brandon L.; Wood, L. Kent; Lee, Jaekwon; Thiele, Dennis J.			Gene duplication and neo-functionalization in the evolutionary and functional divergence of the metazoan copper transporters Ctr1 and Ctr2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EVOLUTION; BINDING-SITES; SACCHAROMYCES-CEREVISIAE; STIMULATED ENDOCYTOSIS; WILSON DISEASE; METAL-BINDING; N-TERMINUS; IDENTIFICATION; PROTEIN; YEAST	Copper is an essential element for proper organismal development and is involved in a range of processes, including oxidative phosphorylation, neuropeptide biogenesis, and connective tissue maturation. The copper transporter (Ctr) family of integral membrane proteins is ubiquitously found in eukaryotes and mediates the high-affinity transport of Cu+ across both the plasma membrane and endomembranes. Although mammalian Ctr1 functions as a Cu+ transporter for Cu acquisition and is essential for embryonic development, a homologous protein, Ctr2, has been proposed to function as a low-affinity Cu transporter, a lysosomal Cu exporter, or a regulator of Ctr1 activity, but its functional and evolutionary relationship to Ctr1 is unclear. Here we report a biochemical, genetic, and phylogenetic comparison of metazoan Ctr1 and Ctr2, suggesting that Ctr2 arose over 550 million years ago as a result of a gene duplication event followed by loss of Cu+ transport activity. Using a random mutagenesis and growth selection approach, we identified amino acid substitutions inhumanand mouse Ctr2 proteins that support copper-dependent growth in yeast and enhance copper accumulation in Ctr1(-/-) mouse embryonic fibroblasts. These mutations revert Ctr2 to a more ancestral Ctr1-like state while maintaining endogenous functions, such as stimulating Ctr1 cleavage. We suggest key structural aspects of metazoan Ctr1 and Ctr2 that discriminate between their biological roles, providing mechanistic insights into the evolutionary, biochemical, and functional relationships between these two related proteins.	[Logeman, Brandon L.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Wood, L. Kent; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Lee, Jaekwon] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	Duke University; Duke University; Duke University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	dennis.thiele@duke.edu		Logeman, Brandon/0000-0002-9975-3541	National Institutes of Health [DK074192, DK079209, P30GM103335]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209, R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK074192 (to D. J. T.), DK079209 (to J. L.), and P30GM103335 (to the Nebraska Redox Biology Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Assis R, 2013, P NATL ACAD SCI USA, V110, P17409, DOI 10.1073/pnas.1313759110; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bertinato J, 2008, BIOCHEM J, V409, P731, DOI 10.1042/BJ20071025; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Blair BG, 2011, MOL PHARMACOL, V79, P157, DOI 10.1124/mol.110.068411; Brust A, 2013, MOL CELL PROTEOMICS, V12, P1488, DOI [10.1074/mcp.A112.023135, 10.1074/mcp.M112.023135]; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Chavez-Crooker P, 2001, J EXP BIOL, V204, P1433; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Deng C, 2010, P NATL ACAD SCI USA, V107, P21593, DOI 10.1073/pnas.1007883107; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Du XB, 2013, CHEM COMMUN, V49, P9134, DOI 10.1039/c3cc45360j; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Force A, 1999, GENETICS, V151, P1531; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Gomes FM, 2012, J INSECT PHYSIOL, V58, P211, DOI 10.1016/j.jinsphys.2011.09.008; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gupta A, 2012, CURR GENOMICS, V13, P124, DOI 10.2174/138920212799860661; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; HOPKIN SP, 1982, TISSUE CELL, V14, P703, DOI 10.1016/0040-8166(82)90060-X; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klevay LM, 2000, J NUTR, V130, p489S, DOI 10.1093/jn/130.2.489S; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; LUKASEWYCZ OA, 1990, ANN NY ACAD SCI, V587, P147, DOI 10.1111/j.1749-6632.1990.tb00142.x; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Luza Sandra C., 1996, American Journal of Clinical Nutrition, V63, p812S; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Ohrvik H, 2015, J TRACE ELEM MED BIO, V31, P178, DOI 10.1016/j.jtemb.2014.03.006; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Pascale MC, 2003, EXP CELL RES, V291, P377, DOI 10.1016/j.yexcr.2003.07.001; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Projecto-Garcia J, 2013, P NATL ACAD SCI USA, V110, P20669, DOI 10.1073/pnas.1315456110; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Pushie MJ, 2015, INORG CHEM, V54, P8544, DOI 10.1021/acs.inorgchem.5b01162; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Ramos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027276; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Rubino JT, 2011, METALLOMICS, V3, P61, DOI 10.1039/c0mt00044b; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rubino JT, 2010, J BIOL INORG CHEM, V15, P1033, DOI 10.1007/s00775-010-0663-9; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Schwab S, 2016, J INORG BIOCHEM, V158, P70, DOI 10.1016/j.jinorgbio.2015.12.021; Steiger D, 2010, J BIOL CHEM, V285, P17089, DOI 10.1074/jbc.M109.090282; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tapia L, 2004, BIOCHEM J, V378, P617, DOI 10.1042/BJ20031174; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; WEST AK, 1990, GENOMICS, V8, P513, DOI 10.1016/0888-7543(90)90038-V; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	86	19	19	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11531	11546		10.1074/jbc.M117.793356	http://dx.doi.org/10.1074/jbc.M117.793356			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28507097	hybrid, Green Published			2022-12-28	WOS:000405119600033
J	Zhu, W; He, XY; Hua, Y; Li, Q; Wang, JY; Gan, XQ				Zhu, Wei; He, Xinyu; Hua, Yue; Li, Qian; Wang, Jiyong; Gan, Xiaoqing			The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; SKELETAL DEVELOPMENT; TRANSCRIPTION FACTORS; ANGSTROM RESOLUTION; BONE-DEVELOPMENT; BETA INTERACTS; IMPORTIN BETA; UP-REGULATION; STEM-CELLS	Poly-ubiquitination-mediated RUNX2 degradation is an important cause of age- and inflammation-related bone loss. NEDD4 family E3 ubiquitin protein ligases are thought to be the major regulators of RUNX2 poly-ubiquitination. However, we observed a mono-ubiquitination of RUNX2 that was catalyzed by WWP2, a member of the NEDD4 family of E3 ubiquitin ligases. WWP2 has been reported to catalyze the mono-ubiquitination of Goosecoid in chondrocytes, facilitating craniofacial skeleton development. In this study, we found that osteogenic differentiation of mesenchymal stem cells promoted WWP2 expression and nuclear accumulation. Knockdown of Wwp2 in mesenchymal stem cells and osteoblasts led to significant deficiencies of osteogenesis, including decreased mineral deposition and down-regulation of osteogenic marker genes. Co-immunoprecipitation experiments showed the interaction of WWP2 with RUNX2 in vitro and in vivo. Mono-ubiquitination by WWP2 leads to RUNX2 transactivation, as evidenced by the wild type of WWP2, but not its ubiquitin ligase-dead mutant, augmenting RUNX2-reponsive reporter activity. Moreover, deletion of WWP2-dependent mono-ubiquitination resulted in striking defects of RUNX2 osteoblastic activity. In addition, ectopic expression of the constitutively active type 1A bone morphogenetic protein receptor enhanced WWP2-dependent RUNX2 ubiquitination and transactivation, demonstrating a regulatory role of bone morphogenetic protein signaling in the WWP2-RUNX2 axis. Taken together, our results provide evidence that WWP2 serves as a positive regulator of osteogenesis by augmenting RUNX2 transactivation in a nonproteolytic mono-ubiquitination manner.	[Zhu, Wei; He, Xinyu; Hua, Yue; Li, Qian; Wang, Jiyong; Gan, Xiaoqing] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China	Fudan University	Wang, JY; Gan, XQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China.	jiyongwang73@gmail.com; xiaoqinggan@fudan.edu.cn			National Natural Science Foundation of China [31471317, 31671466]; Shanghai Pujiang Program [14PJ1400600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was sponsored by National Natural Science Foundation of China Grants 31471317 and 31671466 and Shanghai Pujiang Program Grant 14PJ1400600. The authors declare that they have no conflicts of interest with the contents of this article.	Ali SA, 2010, P NATL ACAD SCI USA, V107, P4165, DOI 10.1073/pnas.1000620107; Avis JM, 1996, J CELL SCI, V109, P2423; Backstrom S, 2002, J MOL BIOL, V322, P259, DOI 10.1016/S0022-2836(02)00702-7; Bethel M, 2013, CURR OSTEOPOROS REP, V11, P99, DOI 10.1007/s11914-013-0135-6; Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gibon E, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0300-9; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jung JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004751; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paredes R, 2004, J STEROID BIOCHEM, V89-90, P269, DOI 10.1016/j.jsbmb.2004.03.076; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shrivats AR, 2015, ACS BIOMATER SCI ENG, V1, P1139, DOI 10.1021/acsbiomaterials.5b00294; Shu L, 2013, J BONE MINER RES, V28, P1925, DOI 10.1002/jbmr.1938; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weng JJ, 2013, BBA-GEN SUBJECTS, V1830, P2839, DOI 10.1016/j.bbagen.2012.12.021; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	48	26	26	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11178	11188		10.1074/jbc.M116.772277	http://dx.doi.org/10.1074/jbc.M116.772277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28500134	hybrid, Green Published			2022-12-28	WOS:000405119600005
J	Garcia-Villegas, R; Camacho-Villasana, Y; Shingu-Vazquez, MA; Cabrera-Orefice, A; Uribe-Carvajal, S; Fox, TD; Perez-Martinez, X				Garcia-Villegas, Rodolfo; Camacho-Villasana, Yolanda; Shingu-Vazquez, Miguel Angel; Cabrera-Orefice, Alfredo; Uribe-Carvajal, Salvador; Fox, Thomas D.; Perez-Martinez, Xochitl			The Cox1 C-terminal domain is a central regulator of cytochrome c oxidase biogenesis in yeast mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; IN-VIVO; TRANSLATION; GENE; STABILITY; SUBUNIT; HEME; SUPERCOMPLEXES; IDENTIFICATION	Cytochrome c oxidase (CcO) is the last electron acceptor in the respiratory chain. The CcO core is formed by mitochondrial DNA-encoded Cox1, Cox2, and Cox3 subunits. Cox1 synthesis is highly regulated; for example, if CcO assembly is blocked, Cox1 synthesis decreases. Mss51 activates translation of COX1 mRNA and interacts with Cox1 protein in high-molecular weight complexes (COA complexes) to form the Cox1 intermediary assembly module. Thus, Mss51 coordinates both Cox1 synthesis and assembly. We previously reported that the last 15 residues of the Cox1 C terminus regulate Cox1 synthesis by modulating an interaction of Mss51 with Cox14, another component of the COA complexes. Here, using site-directed mutagenesis of the mitochondrial COX1 gene from Saccharomyces cerevisiae, we demonstrate that mutations P521A/P522A and V524E disrupt the regulatory role of the Cox1 C terminus. These mutations, as well as C terminus deletion (Cox1 Delta C15), reduced binding of Mss51 and Cox14 to COA complexes. Mss51 was enriched in a translationally active form that maintains full Cox1 synthesis even if CcO assembly is blocked in these mutants. Moreover, Cox1 Delta C15, but not Cox1-P521A/P522A and Cox1-V524E, promoted formation of aberrant super-complexes in CcO assembly mutants lacking Cox2 or Cox4 subunits. The aberrant supercomplex formation depended on the presence of cytochrome b and Cox3, supporting the idea that supercomplex assembly factors associate with Cox3 and demonstrating that supercomplexes can be formed even if CcO is inactive and not fully assembled. Our results indicate that the Cox1 C-terminal end is a key regulator of CcO iogenesis and that it is important for supercomplex formation/stability.	[Garcia-Villegas, Rodolfo; Camacho-Villasana, Yolanda; Uribe-Carvajal, Salvador; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico; [Shingu-Vazquez, Miguel Angel] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Cabrera-Orefice, Alfredo] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, NL-6500 HB Nijmegen, Netherlands; [Fox, Thomas D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidad Nacional Autonoma de Mexico; Monash University; Radboud University Nijmegen; Cornell University	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Cabrera-Orefice, Alfredo/H-3464-2016	Cabrera-Orefice, Alfredo/0000-0002-2042-3794; Fox, Thomas/0000-0001-7629-3661; Uribe-Carvajal, Salvador/0000-0002-7028-8121	Consejo Nacional de Ciencia y Tecnologia [47514, 250726, 289024]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) UNAM [IN204414, IN209217]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by Consejo Nacional de Ciencia y Tecnologia Research Grant 47514 (to X. P.-M.) and Fellowships 250726 (to R. G.-V.) and 289024 (to A. C.-O.) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) UNAM Grants IN204414 and IN209217 (to X. P.-M.). This work is part of the Ph.D. thesis of R. G.-V. from the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico. The authors declare that they have no conflicts of interest with the contents of this article.	Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Bonnefoy N, 2007, METHOD CELL BIOL, V80, P525, DOI 10.1016/S0091-679X(06)80026-9; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; Burke D., 2000, METHODS YEAST GENETI; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; DECOSTER E, 1990, MOL GEN GENET, V224, P111, DOI 10.1007/BF00259457; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dunstan HM, 1997, GENETICS, V147, P87; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; Guthrie C., 2002, GUIDE YEAST GENETICS, V350, P3; Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; KLOECKENERGRUISSEM B, 1988, J BACTERIOL, V170, P1399, DOI 10.1128/jb.170.3.1399-1402.1988; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, FEBS LETT, V587, P943, DOI 10.1016/j.febslet.2013.02.022; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; MEUNIER B, 1993, EUR J BIOCHEM, V213, P129, DOI 10.1111/j.1432-1033.1993.tb17742.x; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Mayorga JP, 2016, J BIOL CHEM, V291, P9343, DOI 10.1074/jbc.M116.721985; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; POUTRE CG, 1987, GENETICS, V115, P637; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; Rompler K, 2016, J BIOL CHEM, V291, P23769, DOI 10.1074/jbc.M116.734665; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zamudio-Ochoa A, 2014, RNA BIOL, V11, P953, DOI 10.4161/rna.29780	58	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10912	10925		10.1074/jbc.M116.773077	http://dx.doi.org/10.1074/jbc.M116.773077			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490636	Green Published, hybrid			2022-12-28	WOS:000404391000014
J	Franco-Echevarria, E; Sanz-Aparicio, J; Brearley, CA; Gonzalez-Rubio, JM; Gonzalez, B				Franco-Echevarria, Elsa; Sanz-Aparicio, Julia; Brearley, Charles A.; Gonzalez-Rubio, Juana M.; Gonzalez, Beatriz			The crystal structure of mammalian inositol 1,3,4,5,6-pentakisphosphate 2-kinase reveals a new zinc-binding site and key features for protein function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mutation; inositol phosphate; structure-function; zinc; IP5 2-kinase; inositol hexakisphosphate	SUBSTRATE-BINDING; MOLECULAR REPLACEMENT; RECIPROCAL-SPACE; KINASE FAMILY; HEXAKISPHOSPHATE; PHOSPHATE; SPECIFICITY; RECOGNITION; SEQUENCE; RNA	Inositol 1,3,4,5,6-pentakisphosphate 2-kinases (IP5 2-Ks) are part of a family of enzymes in charge of synthesizing inositol hexakisphosphate (IP6) in eukaryotic cells. This protein and its product IP6 present many roles in cells, participating in mRNA export, embryonic development, and apoptosis. We reported previously that the full-length IP5 2-K from Arabidopsis thaliana is a zinc metallo-enzyme, including two separated lobes (the N- and C-lobes). We have also shown conformational changes in IP5 2-K and have identified the residues involved in substrate recognition and catalysis. However, the specific features of mammalian IP5 2-Ks remain unknown. To this end, we report here the first structure for a murine IP5 2-K in complex with ATP/IP5 or IP6. Our structural findings indicated that the general folding in N- and C-lobes is conserved with A. thaliana IP5 2-K. A helical scaffold in the C-lobe constitutes the inositol phosphate-binding site, which, along with the participation of the N-lobe, endows high specificity to this protein. However, we also noted large structural differences between the orthologues from these two eukaryotic kingdoms. These differences include a novel zinc-binding site and regions unique to the mammalian IP5 2-K, as an unexpected basic patch on the protein surface. In conclusion, our findings have uncovered distinct features of a mammalian IP5 2-K and set the stage for investigations into protein-protein or protein-RNA interactions important for IP5 2-K function and activity.	[Franco-Echevarria, Elsa; Sanz-Aparicio, Julia; Gonzalez-Rubio, Juana M.; Gonzalez, Beatriz] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Serrano 119, E-28006 Madrid, Spain; [Brearley, Charles A.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of East Anglia	Gonzalez, B (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xbeatriz@iqfr.csic.es	Sanz-Aparicio, Julia/F-6201-2013; Rubio, Juana Maria Gonzalez/AAQ-1604-2020; Gonzalez, Beatriz/M-1219-2014	Sanz-Aparicio, Julia/0000-0002-6849-8621; Gonzalez, Beatriz/0000-0002-0710-0202; Brearley, Charles/0000-0001-6179-9109; Gonzalez Rubio, Juana Maria/0000-0001-6979-2964	French Infrastructure for Integrated Structural Biology FRISBI [ANR-10-INSB-05]; Instruct, a Landmark ESFRI project; BBSRC [BB/M022978/1, BB/N002024/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N002024/1, BB/M022978/1] Funding Source: researchfish	French Infrastructure for Integrated Structural Biology FRISBI; Instruct, a Landmark ESFRI project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Data collection was performed at the XALOC-BL13 beamline at ALBA Synchrotron with the collaboration of ALBA staff. We thank Graham Chilvers, UEA SCI Faculty Analytical Facility, for assistance with ICP-OES. We acknowledge the support and the use of resources of the French Infrastructure for Integrated Structural Biology FRISBI ANR-10-INSB-05 and of Instruct, a Landmark ESFRI project.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Brehm MA, 2007, BIOCHEM J, V408, P335, DOI 10.1042/BJ20070382; Brehm MA, 2013, J CELL SCI, V126, P437, DOI 10.1242/jcs.110031; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Caddick SEK, 2008, FEBS LETT, V582, P1731, DOI 10.1016/j.febslet.2008.04.034; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; DeLano WL, 2002, PYMOL MOLECULAR GRAP; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Franco-Echevarria E, 2017, PROTEIN J, V36, P240, DOI 10.1007/s10930-017-9717-y; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gosein V, 2013, J BIOL CHEM, V288, P36788, DOI 10.1074/jbc.M113.512731; Gosein V, 2013, J BIOL CHEM, V288, P26908, DOI 10.1074/jbc.M113.487777; Gosein V, 2012, PROTEIN SCI, V21, P737, DOI 10.1002/pro.2049; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Banos-Sanz JI, 2012, J BIOL CHEM, V287, P29237, DOI 10.1074/jbc.M112.363671; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Onnebo SMN, 2007, CELL, V129, P647, DOI 10.1016/j.cell.2007.05.002; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; PHILLIPPY BQ, 1994, J BIOL CHEM, V269, P28393; PHILLIPPY BQ, 1988, ANAL BIOCHEM, V175, P162, DOI 10.1016/0003-2697(88)90374-0; Qian X, 2005, BIOCHEM J, V389, P389, DOI 10.1042/BJ20050297; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Scherer PC, 2016, P NATL ACAD SCI USA, V113, P3503, DOI 10.1073/pnas.1525580113; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verbsky J, 2005, P NATL ACAD SCI USA, V102, P8448, DOI 10.1073/pnas.0503656102; Verbsky JW, 2002, J BIOL CHEM, V277, P31857, DOI 10.1074/jbc.M205682200; Wang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5178; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	57	4	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10534	10548		10.1074/jbc.M117.780395	http://dx.doi.org/10.1074/jbc.M117.780395			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28450399	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000404115400015
J	Ghatak, S; Hascall, VC; Markwald, RR; Feghali-Bostwick, C; Artlett, CM; Gooz, M; Bogatkevich, GS; Atanelishvili, I; Silver, RM; Wood, J; Thannickal, VJ; Misra, S				Ghatak, Shibnath; Hascall, Vincent C.; Markwald, Roger R.; Feghali-Bostwick, Carol; Artlett, Carol M.; Gooz, Monika; Bogatkevich, Galina S.; Atanelishvili, Ilia; Silver, Richard M.; Wood, Jeanette; Thannickal, Victor J.; Misra, Suniti			Transforming growth factor 1 (TGF1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; differentiation; hyaluronan; NOx; reactive oxygen species (ROS)	SMOOTH-MUSCLE-CELLS; CONSTITUTIVELY REGULATES ACTIVATION; ANCHORAGE-INDEPENDENT GROWTH; FACTOR RECEPTOR ACTIVATION; COLLAGEN GENE-EXPRESSION; TGF-BETA; HYALURONIC-ACID; LUNG FIBROSIS; REACTIVE OXYGEN; SYSTEMIC-SCLEROSIS	Idiopathic pulmonary fibrosis (IPF) is a progressive clinical syndrome of fatal outcome. The lack of information about the signaling pathways that sustain fibrosis and the myofibroblast phenotype has prevented the development of targeted therapies for IPF. Our previous study showed that isolated fibrogenic lung fibroblasts have high endogenous levels of the hyaluronan receptor, CD44V6 (CD44 variant containing exon 6), which enhances the TGF1 autocrine signaling and induces fibroblasts to transdifferentiate into myofibroblasts. NADPH oxidase 4 (NOX4) enzyme, which catalyzes the reduction of O-2 to hydrogen peroxide (H2O2), has been implicated in the cardiac and lung myofibroblast phenotype. However, whether CD44V6 regulates NOX4 to mediate tissue repair and fibrogenesis is not well-defined. The present study assessed the mechanism of how TGF--1-induced CD44V6 regulates the NOX4/reactive oxygen species (ROS) signaling that mediates the myofibroblast differentiation. Specifically, we found that NOX4/ROS regulates hyaluronan synthesis and the transcription of CD44V6 via an effect upon AP-1 activity. Further, CD44V6 is part of a positive-feedback loop with TGF1/TGFRI signaling that acts to increase NOX4/ROS production, which is required for myofibroblast differentiation, myofibroblast differentiation, myofibroblast extracellular matrix production, myofibroblast invasion, and myofibroblast contractility. Both NOX4 and CD44v6 are up-regulated in the lungs of mice subjected to experimental lung injury and in cases of human IPF. Genetic (CD44v6 shRNA) or a small molecule inhibitor (CD44v6 peptide) targeting of CD44v6 abrogates fibrogenesis in murine models of lung injury. These studies support a function for CD44V6 in lung fibrosis and offer proof of concept for therapeutic targeting of CD44V6 in lung fibrosis disorders.	[Ghatak, Shibnath; Markwald, Roger R.; Misra, Suniti] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Feghali-Bostwick, Carol; Bogatkevich, Galina S.; Atanelishvili, Ilia; Silver, Richard M.] Med Univ South Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Gooz, Monika] Med Univ South Carolina, Coll Pharm Pharmaceut Biomed Sci, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA; [Artlett, Carol M.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; [Wood, Jeanette] Genkyotex, 16 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland; [Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation; Drexel University; Genkyotex; University of Alabama System; University of Alabama Birmingham	Ghatak, S; Misra, S (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu			National Institutes of Health (NIH) [1R03CA167722-01A1]; NIH Grants [1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, 1P20 GM103444]; NIH [1 R01HL113325, 1 P01HL107147]; pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina [5P30GM103339-03]; Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (NIH Grant) [P30 CA138313]; Shared Instrumentation Grant [S10 OD018113]; NATIONAL CANCER INSTITUTE [P30CA138313, R03CA167722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL113325, R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499, P30GM103342, P30GM103339, P20GM103444] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018113] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (NIH Grant); Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) Grant 1R03CA167722-01A1 (to S. M. and S. G.); NIH Grants 1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, and 1P20 GM103444 (to S. M., S. G., and R. R. M.); NIH Grants 1 R01HL113325 and 1 P01HL107147 (to V. C. H.); a pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant 5P30GM103339-03) at the Medical University of South Carolina (to S. M.); and the Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (NIH Grant P30 CA138313) and Shared Instrumentation Grant S10 OD018113. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Asano Y, 2006, J INVEST DERMATOL, V126, P1761, DOI 10.1038/sj.jid.5700331; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Basoni C, 2006, BIOCHEM BIOPH RES CO, V343, P609, DOI 10.1016/j.bbrc.2006.03.003; Beck-Schimmer B, 1998, J AM SOC NEPHROL, V9, P2283; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Denton CP, 1998, CLIN EXP IMMUNOL, V114, P293; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Dinarello C A, 1992, Semin Immunol, V4, P133; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evans HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4199; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Flannery CR, 1998, BIOCHEM BIOPH RES CO, V251, P824, DOI 10.1006/bbrc.1998.9561; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galuppo M, 2011, N-S ARCH PHARMACOL, V384, P21, DOI 10.1007/s00210-011-0637-7; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Ghatak S, 2017, J BIOL CHEM, V292, P10465, DOI 10.1074/jbc.M116.752451; Ghatak Shibnath, 2015, Int J Cell Biol, V2015, P834893, DOI 10.1155/2015/834893; Ghatak S, 2014, J BIOL CHEM, V289, P8545, DOI 10.1074/jbc.M113.539882; Ghatak S, 2014, J BIOL CHEM, V289, P7856, DOI 10.1074/jbc.M113.505065; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Ghatak S, 2008, CONNECT TISSUE RES, V49, P265, DOI 10.1080/03008200802147845; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Goransson V, 2001, MATRIX BIOL, V20, P129, DOI 10.1016/S0945-053X(01)00129-9; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2012, CELL MOL LIFE SCI, V69, P2365, DOI 10.1007/s00018-012-1012-7; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Henke C, 1996, AM J PATHOL, V149, P1639; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; HUNT TK, 1984, SURGERY, V96, P48; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jarman ER, 2014, AM J RESP CELL MOL, V50, P158, DOI 10.1165/rcmb.2013-0174OC; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Kinnula VL, 2008, ANTIOXID REDOX SIGN, V10, P727, DOI 10.1089/ars.2007.1942; Kinnula VL, 2008, ANTIOXID REDOX SIGN, V10, P249, DOI 10.1089/ars.2007.1912; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kosaki R, 1999, CANCER RES, V59, P1141; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Laurent UBG, 1996, ACTA NEUROL SCAND, V94, P194, DOI 10.1111/j.1600-0404.1996.tb07052.x; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lesley J, 2000, J BIOL CHEM, V275, P26967; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; Ley B, 2012, AM J RESP CRIT CARE, V185, P6, DOI 10.1164/rccm.201111-1960ED; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Li YJ, 2016, MATRIX BIOL, V55, P35, DOI 10.1016/j.matbio.2016.03.004; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MCANULTY RJ, 1995, EXP NEPHROL, V3, P96; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S., 2012, DELIVERY SYSTEMS TAR, P855; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P723; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Misra S, 2013, BIOORGAN MED CHEM, V21, P2551, DOI 10.1016/j.bmc.2013.02.033; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murakami M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00323; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pascal M, 2000, T ROY SOC TROP MED H, V94, P66, DOI 10.1016/S0035-9203(00)90443-7; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rangarajan S, 2016, DRUGS, V76, P291, DOI 10.1007/s40265-015-0523-6; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; SAARI H, 1991, ANN RHEUM DIS, V50, P389, DOI 10.1136/ard.50.6.389; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; SOUTHCOTT AM, 1995, AM J RESP CRIT CARE, V151, P1604, DOI 10.1164/ajrccm.151.5.7735620; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; TAMMI R, 1991, EXP CELL RES, V195, P524, DOI 10.1016/0014-4827(91)90405-J; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thannickal VJ, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S23; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Vaz ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136116; Vendrov AE, 2006, CIRC RES, V98, P1254, DOI 10.1161/01.RES.0000221214.37803.79; Vendrov AE, 2010, J BIOL CHEM, V285, P26545, DOI 10.1074/jbc.M110.143917; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; White B, 1996, RHEUM DIS CLIN N AM, V22, P695, DOI 10.1016/S0889-857X(05)70296-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yew NS, 2005, ADV GENET, V53, P189, DOI 10.1016/S0065-2660(05)53007-4; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zha LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107655; Zhang CY, 2012, MAR DRUGS, V10, P119, DOI 10.3390/md10010119; Zhang K, 1997, J IMMUNOL, V158, P954; ZHANG K, 1994, AM J PATHOL, V145, P114; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	155	51	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10490	10519		10.1074/jbc.M116.752469	http://dx.doi.org/10.1074/jbc.M116.752469			30	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28389561	Green Published, hybrid			2022-12-28	WOS:000404115400013
J	Zhang, JZ; Johnson, JL; He, J; Napolitano, G; Ramadass, M; Rocca, C; Kiosses, WB; Bucci, C; Xin, QS; Gavathiotis, E; Cuervo, AM; Cherqui, S; Catz, SD				Zhang, Jinzhong; Johnson, Jennifer L.; He, Jing; Napolitano, Gennaro; Ramadass, Mahalakshmi; Rocca, Celine; Kiosses, William B.; Bucci, Cecilia; Xin, Qisheng; Gavathiotis, Evripidis; Cuervo, Ana Maria; Cherqui, Stephanie; Catz, Sergio D.			Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cell biology; lysosomal storage disease; lysosome; membrane trafficking	OPTICAL RECONSTRUCTION MICROSCOPY; NEPHROPATHIC CYSTINOSIS; LYSOSOMAL MEMBRANE; OXIDATIVE-STRESS; SUBCELLULAR-LOCALIZATION; TRANSPORT; PROTEIN; ACTIVATION; CELLS; TFEB	The lysosomal storage disease cystinosis, caused by cystinosin deficiency, is characterized by cell malfunction, tissue failure, and progressive renal injury despite cystine-depletion therapies. Cystinosis is associated with defects in chaperone-mediated autophagy (CMA), but the molecular mechanisms are incompletely understood. Here, we show CMA substrate accumulation in cystinotic kidney proximal tubule cells. We also found mislocalization of the CMA lysosomal receptor LAMP2A and impaired substrate translocation into the lysosome caused by defective CMA in cystinosis. The impaired LAMP2A trafficking and localization were rescued either by the expression of wild-type cystinosin or by the disease-associated point mutant CTNS-K280R, which has no cystine transporter activity. Defective LAMP2A trafficking in cystinosis was found to associate with decreased expression of the small GTPase Rab11 and the Rab7 effector RILP. Defective Rab11 trafficking in cystinosis was rescued by treatment with small-molecule CMA activators. RILP expression was restored by up-regulation of the transcription factor EB (TFEB), which was down-regulated in cystinosis. Although LAMP2A expression is independent of TFEB, TFEB up-regulation corrected lysosome distribution and lysosomal LAMP2A localization in Ctns(-/-) cells but not Rab11 defects. The up-regulation of Rab11, Rab7, or RILP, but not its truncated form RILP-C33, rescued LAMP2A-defective trafficking in cystinosis, whereas dominant-negative Rab11 or Rab7 impaired LAMP2A trafficking. Treatment of cystinotic cells with a CMA activator increased LAMP2A localization at the lysosome and increased cell survival. Altogether, we show that LAMP2A trafficking is regulated by cystinosin, Rab11, and RILP and that CMA up-regulation is a potential clinically relevant mechanism to increase cell survival in cystinosis.	[Zhang, Jinzhong; Johnson, Jennifer L.; He, Jing; Napolitano, Gennaro; Ramadass, Mahalakshmi; Kiosses, William B.; Catz, Sergio D.] Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Rocca, Celine; Cherqui, Stephanie] Univ Calif San Diego, Div Genet, Dept Pediat, La Jolla, CA 92093 USA; [Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Via Provinciale Monteroni 165, I-73100 Lecce, Italy; [Xin, Qisheng; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Xin, Qisheng; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Scripps Research Institute; University of California System; University of California San Diego; University of Salento; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Bucci, Cecilia/F-6699-2012; Zhang, Jinzhong/E-5670-2012; Xin, Qisheng/F-4965-2015; Napolitano, Gennaro/O-5377-2016; Rocca, Céline/AAB-2940-2021	Bucci, Cecilia/0000-0002-6232-6183; Zhang, Jinzhong/0000-0002-2540-2749; Rocca, Céline/0000-0002-8706-3869; Catz, Sergio/0000-0002-1873-0277; Napolitano, Gennaro/0000-0002-8615-4654; Cuervo, Ana Maria/0000-0002-0771-700X; Gavathiotis, Evripidis/0000-0001-6319-8331	National Institutes of Health USPHS [HL088256, GM105894]; Cystinosis Research Foundation; National Institutes of Health [R01-DK090058]; Michael J. Fox Foundation (MJFF); RR Belfer; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090058, P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031782, R37AG021904, P30AG038072] Funding Source: NIH RePORTER	National Institutes of Health USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Cystinosis Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation (MJFF); RR Belfer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health USPHS Grants HL088256 and GM105894 (to S. D. C.), by Cystinosis Research Foundation fellowships (to J. Z. and J. H.), by National Institutes of Health Grant R01-DK090058 (to S. C.), by a Michael J. Fox Foundation (MJFF) grant (to A. M. C. and E. G.), and by the generous support of R&R Belfer (to A. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaki K, 1996, J BIOCHEM-TOKYO, V120, P1088; Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cherqui S, 2012, KIDNEY INT, V81, P127, DOI 10.1038/ki.2011.301; Cuervo AM, 1999, KIDNEY INT, V55, P529, DOI 10.1046/j.1523-1755.1999.00268.x; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DASILVA VA, 1985, NEW ENGL J MED, V313, P1460, DOI 10.1056/NEJM198512053132307; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Galarreta CI, 2015, AM J PHYSIOL-RENAL, V308, pF1155, DOI 10.1152/ajprenal.00591.2014; Gough NR, 1997, J CELL BIOL, V137, P1161, DOI 10.1083/jcb.137.5.1161; Hanneken A, 2006, INVEST OPHTH VIS SCI, V47, P3164, DOI 10.1167/iovs.04-1369; Harrison F, 2013, MOL THER, V21, P433, DOI 10.1038/mt.2012.214; He J, 2016, MOL BIOL CELL, V27, P572, DOI 10.1091/mbc.E15-05-0283; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Johnson JL, 2016, J BIOL CHEM, V291, P3423, DOI 10.1074/jbc.M115.705871; Johnson JL, 2013, MOL CELL BIOL, V33, P2950, DOI 10.1128/MCB.00417-13; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Kalatzis V, 2004, HUM MOL GENET, V13, P1361, DOI 10.1093/hmg/ddh152; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li WM, 2011, CELL MOL LIFE SCI, V68, P749, DOI 10.1007/s00018-010-0565-6; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Nevo N, 2010, NEPHROL DIAL TRANSPL, V25, P1059, DOI 10.1093/ndt/gfp553; Rega LR, 2016, KIDNEY INT, V89, P862, DOI 10.1016/j.kint.2015.12.045; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Sooparb S, 2004, KIDNEY INT, V65, P2135, DOI 10.1111/j.1523-1755.2004.00639.x; Taranta A, 2008, AM J PHYSIOL-RENAL, V294, pF1101, DOI 10.1152/ajprenal.00413.2007; Taranta A, 2012, HISTOCHEM CELL BIOL, V138, P351, DOI 10.1007/s00418-012-0958-8; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Vaisbich MH, 2011, NEPHRON EXTRA, V1, P73, DOI 10.1159/000331445; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wilmer MJ, 2010, AM J PHYSIOL-RENAL, V299, pF905, DOI 10.1152/ajprenal.00318.2010; Xu K., 2013, FAR FIELD OPTICAL NA, P27	53	42	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10328	10346		10.1074/jbc.M116.764076	http://dx.doi.org/10.1074/jbc.M116.764076			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28465352	Green Published, hybrid			2022-12-28	WOS:000404115400002
J	Jansen, S; Melkova, K; Trosanova, Z; Hanakova, K; Zachrdla, M; Novacek, J; Zupa, E; Zdrahal, Z; Hritz, J; Zidek, L				Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Hanakova, Katerina; Zachrdla, Milan; Novacek, Jiri; Zupa, Erik; Zdrahal, Zbynek; Hritz, Jozef; Zidek, Lukas			Quantitative mapping of microtubule-associated protein 2c ( MAP2c) phosphorylation and regulatory protein 14-3-3 zeta-binding sites reveals key differences between MAP2c and its homolog Tau (vol 292, pg 6715, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Novacek, Jiri/D-8551-2012; Zdrahal, Zbynek/D-9491-2012; Novacek, Jiri/AAQ-4739-2021	Novacek, Jiri/0000-0003-4013-3898; Novacek, Jiri/0000-0003-4013-3898				Jansen S, 2017, J BIOL CHEM, V292, P6715, DOI 10.1074/jbc.M116.771097	1	2	2	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10316	10316		10.1074/jbc.A116.771097	http://dx.doi.org/10.1074/jbc.A116.771097			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28623194	Green Published, hybrid			2022-12-28	WOS:000403580600039
J	Zhu, XJ; Yuan, XY; Wang, M; Fang, YK; Liu, YD; Zhang, XY; Yang, XQ; Li, Y; Li, JY; Li, FX; Dai, ZM; Qiu, MS; Zhang, Z; Zhang, ZY				Zhu, Xiao-Jing; Yuan, Xueyan; Wang, Min; Fang, Yukun; Liu, Yudong; Zhang, Xiaoyun; Yang, Xueqin; Li, Yan; Li, Jianying; Li, Feixue; Dai, Zhong-Min; Qiu, Mengsheng; Zhang, Ze; Zhang, Zunyi			A Wnt/Notch/Pax7 signaling network supports tissue integrity in tongue development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; PROGENITOR CELLS; STEM-CELLS; WNT; NOTCH; PAX7; ACTIVATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION	The tongue is one of the major structures involved in human food intake and speech. Tongue malformations such as aglossia, microglossia, and ankyloglossia are congenital birth defects, greatly affecting individuals' quality of life. However, the molecular basis of the tissue-tissue interactions that ensure tissue morphogenesis to form a functional tongue remains largely unknown. Here we show that ShhCre-mediated epithelial deletion of Wntless (Wls), the key regulator for intracellular Wnt trafficking, leads to lingual hypoplasia in mice. Disruption of epithelial Wnt production by Wls deletion in epithelial cells led to a failure in lingual epidermal stratification and loss of the lamina propria and the underlying superior longitudinal muscle in developing mouse tongues. These defective phenotypes resulted from a reduction in epithelial basal cells positive for the basal epidermal marker protein p63 and from impaired proliferation and differentiation in connective tissue and paired box 3 (Pax3)-and Pax7-positive muscle progenitor cells. We also found that epithelial Wnt production is required for activation of the Notch signaling pathway, which promotes proliferation of myogenic progenitor cells. Notch signaling in turn negatively regulated Wnt signaling during tongue morphogenesis. We further show that Pax7 is a direct Notch target gene in the embryonic tongue. In summary, our findings demonstrate a key role for the lingual epithelial signals in supporting the integrity of the lamina propria and muscular tissue during tongue development and that a Wnt/Notch/Pax7 genetic hierarchy is involved in this development.	[Zhu, Xiao-Jing; Yuan, Xueyan; Wang, Min; Fang, Yukun; Liu, Yudong; Zhang, Xiaoyun; Yang, Xueqin; Li, Yan; Li, Jianying; Li, Feixue; Dai, Zhong-Min; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Key Lab Mammalian Organogenesis & Regenerat, Coll Life & Environm Sci, Inst Life Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Ze] Tulane Univ, Tulane Med Ctr, Dept Ophthalmol, New Orleans, LA 70115 USA; [Liu, Yudong] Chonbuk Natl Univ, Sch Dent, Cluster Craniofacial Dev & Regenerat Res, Inst Oral Biosci, Jeonju 561756, South Korea; [Liu, Yudong] Chonbuk Natl Univ, Sch Dent, Program BK21, Jeonju 561756, South Korea	Hangzhou Normal University; Tulane University; Jeonbuk National University; Jeonbuk National University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, Key Lab Mammalian Organogenesis & Regenerat, Coll Life & Environm Sci, Inst Life Sci, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org		Dai, Zhong-Min/0000-0003-4083-1901	Natural Scientific Foundation of China [31371471, 81670971]; Science and Technology Plan Program of Zhejiang Province [2017C37163]; Natural Scientific Foundation of Zhejiang Province [LY16C120002, LY15C090008, LY15C120001]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Program of Zhejiang Province; Natural Scientific Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by Natural Scientific Foundation of China Grants 31371471 and 81670971; Science and Technology Plan Program of Zhejiang Province Grant 2017C37163; and Natural Scientific Foundation of Zhejiang Province Grants LY16C120002, LY15C090008, and LY15C120001. The authors declare that they have no conflicts of interest with the contents of this article.	Bailey EF, 2004, J APPL PHYSIOL, V96, P440, DOI 10.1152/japplphysiol.00733.2003; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Collu GM, 2014, CELL MOL LIFE SCI, V71, P3553, DOI 10.1007/s00018-014-1644-x; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Han D, 2012, DEVELOPMENT, V139, P1640, DOI 10.1242/dev.076653; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Iwasaki S, 2002, J ANAT, V201, P1, DOI 10.1046/j.1469-7580.2002.00073.x; Iwata J, 2013, J BIOL CHEM, V288, P29760, DOI 10.1074/jbc.M113.493551; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; Klein T, 1999, DEVELOPMENT, V126, P913; Komiya Yuko, 2008, Organogenesis, V4, P68; Li FX, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00590-16; Lin CX, 2011, DEV BIOL, V356, P40, DOI 10.1016/j.ydbio.2011.05.002; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Liu JR, 2011, TISSUE ENG PART B-RE, V17, P25, DOI [10.1089/ten.teb.2010.0489, 10.1089/ten.TEB.2010.0489]; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Mennerich D, 2001, EMBO J, V20, P7174, DOI 10.1093/emboj/20.24.7174; Messina G, 2009, GENE DEV, V23, P902, DOI 10.1101/gad.1797009; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nayak L, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0299-7; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Padilla-Benavides T, 2015, J CELL PHYSIOL, V230, P2990, DOI 10.1002/jcp.25031; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Parada C, 2015, CURR TOP DEV BIOL, V115, P31, DOI 10.1016/bs.ctdb.2015.07.023; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Ribatti D, 2014, INT J DEV BIOL, V58, P303, DOI 10.1387/ijdb.140143dr; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Santosh ABR, 2014, ONCOL REV, V8, P1, DOI 10.4081/oncol.2014.239; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wang RH, 2016, ONCOTARGET, V7, P5754, DOI 10.18632/oncotarget.6805; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2; Zhou HM, 2008, DEV BIOL, V315, P369, DOI 10.1016/j.ydbio.2007.12.020; Zhu X, 2014, J DENT RES, V93, P582, DOI 10.1177/0022034514531985; Zhu XJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004687; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473	52	23	24	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9409	9419		10.1074/jbc.M117.789438	http://dx.doi.org/10.1074/jbc.M117.789438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28438836	Green Published, hybrid			2022-12-28	WOS:000402538900033
J	Chuderland, D; Marmor, G; Shainskaya, A; Seger, R				Chuderland, Dana; Marmor, Goldie; Shainskaya, Alla; Seger, Rony			RETRACTION: Calcium-mediated interactions regulate the subcellular localization of extracellular signal-regulated kinases (Retraction of Vol 283, Pg 11176, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200	1	0	0	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8850	8850		10.1074/jbc.A117.709030	http://dx.doi.org/10.1074/jbc.A117.709030			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550136	Green Published, hybrid			2022-12-28	WOS:000402153900033
J	Zeidler, JD; Fernandes-Siqueira, LO; Carvalho, AS; Cararo-Lopes, E; Dias, MH; Ketzer, LA; Galina, A; Da Poian, AT				Zeidler, Julianna D.; Fernandes-Siqueira, Lorena O.; Carvalho, Ana S.; Cararo-Lopes, Eduardo; Dias, Matheus H.; Ketzer, Luisa A.; Galina, Antonio; Da Poian, Andrea T.			Short-term starvation is a strategy to unravel the cellular capacity of oxidizing specific exogenous/endogenous substrates in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						energy metabolism; fatty acid; glucose; glutamine; mitochondria; pyruvate; Crabtree effect; respirometry	HEPATOMA-CELLS; OXIDATIVE-PHOSPHORYLATION; METABOLISM; NEURONS; VIRUS; NEUROBLASTOMA; GLUTAMINE; AUTOPHAGY; PYRUVATE; CRABTREE	Mitochondrial oxidation of nutrients is tightly regulated in response to the cellular environment and changes in energy demands. In vitro studies evaluating the mitochondrial capacity of oxidizing different substrates are important for understanding metabolic shifts in physiological adaptations and pathological conditions, but may be influenced by the nutrients present in the culture medium or by the utilization of endogenous stores. One such influence is exemplified by the Crabtree effect (the glucose-mediated inhibition of mitochondrial respiration) as most in vitro experiments are performed in glucose-containing media. Here, using high-resolution respirometry, we evaluated the oxidation of endogenous or exogenous substrates by cell lines harboring different metabolic profiles. We found that a 1-h deprivation of the main energetic nutrients is an appropriate strategy to abolish interference of endogenous or undesirable exogenous substrates with the cellular capacity of oxidizing specific substrates, namely glutamine, pyruvate, glucose, or palmitate, in mitochondria. This approach primed mitochondria to immediately increase their oxygen consumption after the addition of the exogenous nutrients. All starved cells could oxidize exogenous glutamine, whereas the capacity for oxidizing palmitate was limited to human hepatocarcinoma Huh7 cells and to C2C12 mouse myoblasts that differentiated into myotubes. In the presence of exogenous glucose, starvation decreased the Crabtree effect in Huh7 and C2C12 cells and abrogated it in mouse neuroblastoma N2A cells. Interestingly, the fact that the Crabtree effect was observed only for mitochondrial basal respiration but not for the maximum respiratory capacity suggests it is not caused by a direct effect on the electron transport system.	[Zeidler, Julianna D.; Fernandes-Siqueira, Lorena O.; Carvalho, Ana S.; Galina, Antonio; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Av Carlos Chagas Filho 373,CCS,Bldg E,Sala 18, BR-21941902 Rio De Janeiro, RJ, Brazil; [Ketzer, Luisa A.] Univ Fed Rio de Janeiro, BR-25245390 Polo Xerem, Duque de Caxias, Brazil; [Cararo-Lopes, Eduardo; Dias, Matheus H.] Inst Butantan, Ctr Toxins Immune Response & Cell Signaling, BR-05503900 Sao Paulo, Brazil; [Cararo-Lopes, Eduardo] Univ Sao Paulo, Inst Quim, BR-05508000 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Butantan; Universidade de Sao Paulo	Zeidler, JD; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Av Carlos Chagas Filho 373,CCS,Bldg E,Sala 18, BR-21941902 Rio De Janeiro, RJ, Brazil.	julianna.zeidler@bioqmed.ufrj.br; dapoian@bioqmed.ufrj.br	Dias, Matheus/B-7271-2018; Da Poian, Andrea T./V-1699-2019; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Ketzer, Luisa Andrea/J-1652-2015	Zeidler, Julianna D./0000-0003-3168-1518; Dias, Matheus/0000-0002-2961-1142; Ketzer, Luisa Andrea/0000-0002-1127-116X	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant [FAPERJ E-26/201.167/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [MCT/CNPq 306669/2013-7]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Postdoctoral Fellowship FAPERJ [E-26/200.460/2015]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Postdoctoral Fellowship FAPESP [2012/20186-9]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Postdoctoral Fellowship FAPERJ; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Postdoctoral Fellowship FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant FAPERJ E-26/201.167/2014 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant MCT/CNPq 306669/2013-7. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Postdoctoral Fellowship FAPERJ E-26/200.460/2015. To whom correspondence may be addressed: Inst. de Bioquimica Medica Leopoldo de Meis, Universidade Federal do Rio de Janeiro. Av. Carlos Chagas Filho, 373, CCS, Bldg. E, sala 18, Rio de Janeiro, RJ 21941-902, Brazil. Tel.: 55-21-39386758; E-mail: julianna.zeidler@bioqmed.ufrj.br.; Recipient of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Postdoctoral Fellowship FAPESP 2012/20186-9.	ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Choi S, 2009, XENOBIOTICA, V39, P205, DOI 10.1080/00498250802613620; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; El-Bacha T, 2013, INT J BIOCHEM CELL B, V45, P41, DOI 10.1016/j.biocel.2012.09.021; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Goldring CEP, 2006, AM J PHYSIOL-CELL PH, V290, pC104, DOI 10.1152/ajpcell.00133.2005; HAMILTON SD, 1984, CLIN CHEM, V30, P226; Hammad N, 2016, BBA-BIOENERGETICS, V1857, P1139, DOI 10.1016/j.bbabio.2016.03.034; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Johnson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093597; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim-Muller JY, 2016, J BIOL CHEM, V291, P10162, DOI 10.1074/jbc.M115.705608; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Kogure T, 2004, CANCER CHEMOTH PHARM, V53, P296, DOI 10.1007/s00280-003-0725-6; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Liu LJ, 2014, J CLIN INVEST, V124, P768, DOI 10.1172/JCI69413; Liu ZJ, 2016, TUMOR BIOL, V37, P6661, DOI 10.1007/s13277-015-4479-7; MATSUMOTO K, 1994, NEUROL RES, V16, P460; Maus M, 1999, EUR J NEUROSCI, V11, P3215, DOI 10.1046/j.1460-9568.1999.00745.x; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pereira DSA, 2009, BIOCHEM J, V417, P717, DOI DOI 10.1042/BJ20080805; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; PRESSMAN BC, 1956, BIOCHIM BIOPHYS ACTA, V21, P458, DOI 10.1016/0006-3002(56)90182-2; RACKER E, 1974, MOL CELL BIOCHEM, V5, P17, DOI 10.1007/BF01874168; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Ramos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131766; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Seahorse Bioscience Inc, 2010, PREP BOV SER ALB BSA; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; SONNEWALD U, 1993, NEUROCHEM INT, V22, P19, DOI 10.1016/0197-0186(93)90064-C; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; SPOERRI PE, 1980, CELL TISSUE RES, V205, P411; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; THOMPSON JM, 1982, NEUROSCIENCE, V7, P1807, DOI 10.1016/0306-4522(82)90038-0; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; VANDERVALK JBF, 1990, EUR J PHARMACOL, V185, P99, DOI 10.1016/0014-2999(90)90215-R; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; ZIELKE HR, 1978, J CELL PHYSIOL, V95, P41	57	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14176	14187		10.1074/jbc.M117.786582	http://dx.doi.org/10.1074/jbc.M117.786582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28663370	Green Published, hybrid			2022-12-28	WOS:000408439800022
J	Chen, D; Jansson, A; Sim, D; Larsson, A; Nordlund, P				Chen, Dan; Jansson, Anna; Sim, Daniel; Larsson, Andreas; Nordlund, Par			Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR STABILITY; CRYSTAL-STRUCTURE; CANCER-THERAPY; IN-VITRO; INHIBITORS; RESISTANCE; BINDING; ANTIFOLATE; COMPLEX; TARGET	Thymidylate synthase (TS) is the sole enzyme responsible for de novo biosynthesis of thymidylate (TMP) and is essential for cell proliferation and survival. Inhibition of human TS (hTS) has been extensively investigated for cancer chemotherapy, but several aspects of its activity and regulation are still uncertain. In this study, we performed comprehensive structural and biophysical studies of hTS using crystallography and thermal shift assay and provided the first detailed structural information on the conformational changes induced by ligand binding to the hTS active site. We found that upon binding of the antifolate agents raltitrexed and nolatrexed, the two insert regions in hTS, the functions of which are unclear, undergo positional shifts toward the catalytic center. Weinvestigated the inactive conformation of hTS and found that the two insert regions are also involved in the conformational transition between the active and inactive state of hTS. Moreover, we identified a ligand-binding site in the dimer interface, suggesting that the cavity in the dimer interface could serve as an allosteric site of hTS to regulate the conformational switching between the active and inactive states. On the basis of these findings, we propose a regulatory mechanism of hTS activity that involves allosteric regulation of interactions of hTS with its own mRNA depending on cellular demands for TMP.	[Chen, Dan; Jansson, Anna; Larsson, Andreas; Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Lab 07 02, 61 Biopolis Dr Proteos, Singapore 138673, Singapore; [Sim, Daniel] Nanyang Technol Univ, Sch Biol Sci, Lab 07 01, 61 Biopolis Dr Proteos, Singapore 138673, Singapore; [Nordlund, Par] ASTAR, Inst Cellular & Mol Biol, 61 Biopolis Dr Proteos, Singapore 138673, Singapore; [Nordlund, Par] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); Karolinska Institutet	Nordlund, P (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Lab 07 02, 61 Biopolis Dr Proteos, Singapore 138673, Singapore.; Nordlund, P (corresponding author), ASTAR, Inst Cellular & Mol Biol, 61 Biopolis Dr Proteos, Singapore 138673, Singapore.; Nordlund, P (corresponding author), Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden.; Larsson, A (corresponding author), Nanyang Technol Univ, Sch Biol Sci, SBS 04s-45,60 Nanyang Dr, Singapore 639798, Singapore.	andreas.larsson@ntu.edu.sg; PNORDLUND@ntu.edu.sg		Chen, Dan/0000-0002-2790-5606; Larsson, Andreas/0000-0002-8706-3789	Australian Synchrotron and National Synchrotron Radiation Research Center	Australian Synchrotron and National Synchrotron Radiation Research Center	We acknowledge the Protein Production Platform at Nanyang Technological University for cloning and smallscale protein constructs screening of hTS. We thank the Australian Synchrotron and National Synchrotron Radiation Research Center for support during crystal data collection.	Ackland SP, 2006, UPDATE CANC THERAPEU, V1, P403, DOI DOI 10.1016/J.UCT.2006.09.001; Almog R, 2001, PROTEIN SCI, V10, P988, DOI 10.1110/ps.47601; Almqvist H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11040; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Berger SH, 2004, BBA-PROTEINS PROTEOM, V1696, P15, DOI 10.1016/j.bbapap.2003.09.005; Brunn ND, 2014, BIOSCIENCE REP, V34, P905, DOI 10.1042/BSR20140137; Cardinale D, 2011, P NATL ACAD SCI USA, V108, pE542, DOI 10.1073/pnas.1104829108; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAUMAN EB, 1994, BIOCHEMISTRY-US, V33, P1502, DOI 10.1021/bi00172a029; Fritz TA, 2002, BIOCHEMISTRY-US, V41, P7021, DOI 10.1021/bi012108c; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HORI TA, 1984, CANCER RES, V44, P703; Huang X, 2010, BIOCHEMISTRY-US, V49, P2475, DOI 10.1021/bi901457e; KAMB A, 1992, BIOCHEMISTRY-US, V31, P9883, DOI 10.1021/bi00156a005; Kitchens ME, 1999, MOL PHARMACOL, V56, P1063, DOI 10.1124/mol.56.5.1063; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P4266, DOI 10.1093/nar/28.21.4266; Lovelace LL, 2009, PROTEIN SCI, V18, P1628, DOI 10.1002/pro.171; Lovelace LL, 2005, ACTA CRYSTALLOGR D, V61, P622, DOI 10.1107/S0907444905005895; MATTHEWS DA, 1990, J MOL BIOL, V214, P923, DOI 10.1016/0022-2836(90)90346-N; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONTFORT WR, 1990, BIOCHEMISTRY-US, V29, P6964, DOI 10.1021/bi00482a004; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Phan J, 2001, J BIOL CHEM, V276, P14170, DOI 10.1074/jbc.M009493200; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Seno T, 1985, Basic Life Sci, V31, P241; Wang WG, 2001, CANCER RES, V61, P5505; Webber S, 1996, CANCER CHEMOTH PHARM, V37, P509, DOI 10.1007/s002800050422; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51	33	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13449	13458		10.1074/jbc.M117.787267	http://dx.doi.org/10.1074/jbc.M117.787267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH6KS	28634233	Green Published, hybrid			2022-12-28	WOS:000411286000002
J	Mathy, NW; Chen, XM				Mathy, Nicholas W.; Chen, Xian-Ming			Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chromatin remodeling; epigenetics; inflammation; long noncoding RNA (long ncRNA; lncRNA); NF-B; toll-like receptor (TLR); transcription regulation	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; REMODELING COMPLEXES; INTERFERON-GAMMA; KAWASAKI-DISEASE; IMMUNE-RESPONSE; CELIAC-DISEASE; CUTTING EDGE; ACTIVATION	Long non-coding RNAs (lncRNAs) have emerged as potential key regulators of the inflammatory response, particularly by modulating the transcriptional control of inflammatory genes. lncRNAs may act as an enhancer or suppressor to inflammatory transcription, function as scaffold molecules through interactions with RNA-binding proteins in chromatin remodeling complexes, and modulate dynamic and epigenetic control of inflammatory transcription in a gene-specific and time-dependent fashion. Here, we will review recent literature regarding the role of lncRNAs in transcriptional control of inflammatory responses. Better understanding of lncRNA regulation of inflammation will provide novel targets for the development of new therapeutic strategies.	[Mathy, Nicholas W.; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA	Creighton University	Chen, XM (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA.	xianmingchen@creighton.edu			National Institutes of Health [AI095532, AI116323]; Creighton Cancer and Smoking Disease Research Program Award [LB595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095532, R01AI116323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creighton Cancer and Smoking Disease Research Program Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants AI095532 and AI116323 and by the Creighton Cancer and Smoking Disease Research Program Award LB595 (to X.-M.C.). This is the first article in the Thematic Minireview Series: "Inflammatory transcription confronts homeostatic disruptions." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bouazoune K, 2009, NUCLEIC ACIDS RES, V37, P5279, DOI 10.1093/nar/gkp524; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2015, J INTERF CYTOK RES, V35, P79, DOI 10.1089/jir.2014.0120; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Dempsey L. A., 2013, NAT IMMUNOL, V14, P1036; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Elling R, 2016, EUR J IMMUNOL, V46, P504, DOI 10.1002/eji.201444558; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Fernandez-Jimenez N, 2014, HUM MOL GENET, V23, P1298, DOI 10.1093/hmg/ddt520; Fitzgerald DC, 2007, VET IMMUNOL IMMUNOP, V116, P59, DOI 10.1016/j.vetimm.2006.12.008; Fitzgerald KA, 2014, CURR OPIN IMMUNOL, V26, P140, DOI 10.1016/j.coi.2013.12.001; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huang ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19705; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jiang CJ, 2016, ONCOTARGET, V7, P7120, DOI 10.18632/oncotarget.6859; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Ko TM, 2015, CIRC RES, V116, P876, DOI 10.1161/CIRCRESAHA.116.305834; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Krawczyk M, 2014, ELIFE, V3, DOI 10.7554/eLife.01776; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li XL, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/870597; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Pearson MJ, 2016, ARTHRITIS RHEUMATOL, V68, P845, DOI 10.1002/art.39520; Peng XX, 2010, MBIO, V1, DOI 10.1128/mBio.00206-10; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; SHULMAN ST, 1989, CLIN IMMUNOL IMMUNOP, V53, pS141, DOI 10.1016/0090-1229(89)90079-2; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spurlock CF, 2014, ARTHRITIS RHEUMATOL, V66, P2947, DOI 10.1002/art.38805; St Laurent G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-504; Tong Q, 2016, FASEB J, V30, P1187, DOI 10.1096/fj.15-279166; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Xiong YL, 2015, BIOMED PHARMACOTHER, V72, P165, DOI 10.1016/j.biopha.2015.04.019; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12	70	167	173	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12375	12382		10.1074/jbc.R116.760884	http://dx.doi.org/10.1074/jbc.R116.760884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615453	hybrid, Green Published			2022-12-28	WOS:000406636900003
J	Sun, XJ; Kim, SP; Zhang, DM; Sun, H; Cao, Q; Lu, X; Ying, ZK; Li, LW; Henry, RR; Ciaraldi, TP; Taylor, SI; Quon, MJ				Sun, Xiao-Jian; Kim, Soohyun Park; Zhang, Dongming; Sun, Helen; Cao, Qi; Lu, Xin; Ying, Zhekang; Li, Liwu; Henry, Robert R.; Ciaraldi, Theodore P.; Taylor, Simeon I.; Quon, Michael J.			Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; PLECKSTRIN HOMOLOGY DOMAIN; NITRIC-OXIDE PRODUCTION; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ENDOTHELIAL DYSFUNCTION; SIGNALING PATHWAYS; IKK-BETA; RECIPROCAL RELATIONSHIPS; IMPAIRED REGULATION	Chronic inflammation may contribute to insulin resistance via molecular cross-talk between pathways for pro-inflammatory and insulin signaling. Interleukin 1 receptor-associated kinase 1 (IRAK-1) mediates pro-inflammatory signaling via IL-1 receptor/Toll-like receptors, which may contribute to insulin resistance, but this hypothesis is untested. Here, we used male Irak1 null (k/o) mice to investigate the metabolic role of IRAK-1. C57BL/6 wild-type (WT) and k/o mice had comparable body weights on low-fat and high-fat diets (LFD and HFD, respectively). After 12 weeks on LFD (but not HFD), k/o mice (versus WT) had substantially improved glucose tolerance (assessed by the intraperitoneal glucose tolerance test (IPGTT)). As assessed with the hyperinsulinemic euglycemic glucose clamp technique, insulin sensitivity was 30% higher in the Irak1 k/o mice on chow diet, but the Irak1 deletion did not affect IPGTT outcomes in mice on HFD, suggesting that the deletion did not overcome the impact of obesity on glucose tolerance. Moreover, insulin-stimulated glucose-disposal rates were higher in the k/o mice, but we detected no significant difference in hepatic glucose production rates (+/- insulin infusion). Positron emission/computed tomography scans indicated higher insulin-stimulated glucose uptake in muscle, but not liver, in Irak1 k/o mice in vivo. Moreover, insulin-stimulated phosphorylation of Akt was higher in muscle, but not in liver, from Irak1 k/o mice ex vivo. In conclusion, Irak1 deletion improved muscle insulin sensitivity, with the effect being most apparent in LFD mice.	[Sun, Xiao-Jian; Kim, Soohyun Park; Zhang, Dongming; Sun, Helen; Taylor, Simeon I.; Quon, Michael J.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Ying, Zhekang] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA; [Cao, Qi; Lu, Xin] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Sun, Xiao-Jian] Baltimore Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21201 USA; [Zhang, Dongming] Zhengzhou Univ, Affiliated Hosp 2, Zhengzhou 450014, Henan, Peoples R China; [Li, Liwu] Virginia Tech, Blacksburg, VA 24061 USA; [Henry, Robert R.; Ciaraldi, Theodore P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92166 USA; [Henry, Robert R.; Ciaraldi, Theodore P.] Univ Calif San Diego, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Zhengzhou University; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Sun, XJ (corresponding author), 660 W Redwood St,HH 594, Baltimore, MD 21201 USA.	xsun@som.umaryland.edu		QUON, MICHAEL/0000-0002-5289-3707	American Diabetes Association [1-13-BS-150, 1-14-BS-198]; NIEHS, National Institutes of Health [R01ES024516]; U. S. Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Review Award [I01CX00635]; Baltimore Veterans Affairs Medical Center Geriatric Research Clinical Center (GRECC); NIDDK, National Institutes of Health [5P30DK072488-12]; Ionis Pharmaceuticals; Aegerion Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024516] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000635] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U. S. Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Review Award; Baltimore Veterans Affairs Medical Center Geriatric Research Clinical Center (GRECC); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ionis Pharmaceuticals; Aegerion Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by American Diabetes Association Grants 1-13-BS-150 (to M. J. Q.) and 1-14-BS-198 (to X. J. S.), NIEHS, National Institutes of Health Grant R01ES024516 (to Z. Y.), U. S. Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Review Award I01CX00635, Baltimore Veterans Affairs Medical Center Geriatric Research Clinical Center (GRECC), and NIDDK, National Institutes of Health Grant 5P30DK072488-12 (to S. I. T.). S. I. T. has worked as a paid consultant for Ionis Pharmaceuticals and Aegerion Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Berglund M, 2008, SCAND J IMMUNOL, V67, P473, DOI 10.1111/j.1365-3083.2008.02096.x; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Chen H, 2003, AM J PHYSIOL-ENDOC M, V284, pE804, DOI 10.1152/ajpendo.00330.2002; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; Chen H, 2008, J BIOL CHEM, V283, P29228, DOI 10.1074/jbc.M802906200; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; COPPACK SW, 1994, J LIPID RES, V35, P177; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Eckardt K, 2011, REV ENDOCR METAB DIS, V12, P163, DOI 10.1007/s11154-011-9168-2; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Formoso G, 2006, MOL ENDOCRINOL, V20, P1153, DOI 10.1210/me.2005-0266; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Fujimoto Y, 2006, DIABETES, V55, P2479, DOI 10.2337/db05-1511; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Han SH, 2007, CURR OPIN LIPIDOL, V18, P58, DOI 10.1097/MOL.0b013e328012b627; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hommelberg PPH, 2010, CURR OPIN CLIN NUTR, V13, P647, DOI 10.1097/MCO.0b013e32833f1acd; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Jang HJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1077, DOI 10.1152/ajpendo.00578.2012; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Jiang ZY, 1999, DIABETES, V48, P1120, DOI 10.2337/diabetes.48.5.1120; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kewalramani G, 2010, CURR OPIN CLIN NUTR, V13, P382, DOI 10.1097/MCO.0b013e32833aabd9; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kim JA, 2005, ARTERIOSCL THROM VAS, V25, P889, DOI 10.1161/01.ATV.0000164044.42910.6b; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim OK, 2015, ANN NUTR METAB, V67, P218, DOI 10.1159/000440905; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lakoski SG, 2007, EXP MOL PATHOL, V82, P280, DOI 10.1016/j.yexmp.2007.02.002; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Maitra U, 2009, MOL IMMUNOL, V47, P420, DOI 10.1016/j.molimm.2009.08.023; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; McCarty MF, 2010, MED HYPOTHESES, V75, P276, DOI 10.1016/j.mehy.2009.12.027; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Mirbolooki MR, 2014, NUCL MED BIOL, V41, P10, DOI 10.1016/j.nucmedbio.2013.08.009; Mishra AK, 2016, METABOLISM, V65, P48, DOI 10.1016/j.metabol.2015.10.008; Moller DE, 1996, ENDOCRINOLOGY, V137, P2397, DOI 10.1210/en.137.6.2397; Muniyappa R, 2008, ENDOCRIN METAB CLIN, V37, P685, DOI 10.1016/j.ecl.2008.06.001; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Quon MJ, 2002, J CLIN ENDOCR METAB, V87, P949, DOI 10.1210/jc.87.2.949; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; RIZZA RA, 1981, DIABETES, V30, P377, DOI 10.2337/diabetes.30.5.377; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sperry JL, 2014, ANN SURG, V260, P698, DOI 10.1097/SLA.0000000000000918; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thorn SL, 2013, J NUCL MED, V54, P1637, DOI 10.2967/jnumed.112.110114; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	101	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12339	12350		10.1074/jbc.M117.779108	http://dx.doi.org/10.1074/jbc.M117.779108			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28572512	Green Published, hybrid			2022-12-28	WOS:000406053300028
J	Ma, CJ; Kwon, Y; Sung, P; Greene, EC				Ma, Chu Jian; Kwon, Youngho; Sung, Patrick; Greene, Eric C.			Human RAD52 interactions with replication protein A and the RAD51 presynaptic complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; SYNTHETICALLY LETHAL; MAMMALIAN RAD52; END RESECTION; REPAIR; EXCHANGE; GENE; INACTIVATION; MECHANISM	Rad52 is a highly conserved protein involved in the repair of DNA damage. Human RAD52 has been shown to mediate single-stranded DNA (ssDNA) and is synthetic lethal with mutations in other key recombination proteins. For this study, we used single-molecule imaging and ssDNA curtains to examine the binding interactions of human RAD52 with replication protein A (RPA)-coated ssDNA, and we monitored the fate of RAD52 during assembly of the presynaptic complex. We show that RAD52 binds tightly to the RPA-ssDNA complex and imparts an inhibitory effect on RPA turnover. We also found that during presynaptic complex assembly, most of the RPA and RAD52 was displaced from the ssDNA, but some RAD52-RPA-ssDNA complexes persisted as interspersed clusters surrounded by RAD51 filaments. Once assembled, the presence of RAD51 restricted formation of new RAD52-binding events, but additional RAD52 could bind once RAD51 dissociated from the ssDNA. Together, these results provide new insights into the behavior and dynamics of human RAD52 during presynaptic complex assembly and disassembly.	[Ma, Chu Jian; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kwon, Youngho; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Columbia University; Yale University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R35GM118026, R01ES007061, P01CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM118026 (to E.C.G.) and R01ES007061 and P01CA92584 (to P.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; BENDIXEN C, 1994, GENOMICS, V23, P300, DOI 10.1006/geno.1994.1503; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Bianco P R, 1998, Front Biosci, V3, pD570; Brouwer I, 2017, CELL REP, V18, P2845, DOI 10.1016/j.celrep.2017.02.068; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Chandramouly G, 2015, CHEM BIOL, V22, P1491, DOI 10.1016/j.chembiol.2015.10.003; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Chun J, 2013, MOL CELL BIOL, V33, P387, DOI 10.1128/MCB.00465-12; Ciccia A, 2016, MOL CELL, V64, P1017, DOI 10.1016/j.molcel.2016.11.036; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; Graham JS, 2011, NUCLEIC ACIDS RES, V39, P2249, DOI 10.1093/nar/gkq1140; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Hanamshet K, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090063; Heyer WD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016501; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Honda M, 2011, EMBO J, V30, P3368, DOI 10.1038/emboj.2011.238; Huang F, 2016, NUCLEIC ACIDS RES, V44, P4189, DOI 10.1093/nar/gkw087; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kass EM, 2016, MOL CELL, V62, P777, DOI 10.1016/j.molcel.2016.05.021; Kitao H, 2002, J BIOL CHEM, V277, P48944, DOI 10.1074/jbc.M208151200; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lisby M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016535; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Ma CJ, 2017, METHOD ENZYMOL, V582, P193, DOI 10.1016/bs.mie.2016.08.005; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; Navadgi VM, 2003, BIOCHEMISTRY-US, V42, P15237, DOI 10.1021/bi0350452; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Reddy G, 1997, MUTAT RES-FUND MOL M, V377, P53, DOI 10.1016/S0027-5107(97)00057-2; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sotiriou SK, 2016, MOL CELL, V64, P1127, DOI 10.1016/j.molcel.2016.10.038; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sullivan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147230; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430	86	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11702	11713		10.1074/jbc.M117.794545	http://dx.doi.org/10.1074/jbc.M117.794545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28551686	Green Published, hybrid			2022-12-28	WOS:000405485600010
J	Marulanda, J; Eimar, H; Mckee, MD; Berkvens, M; Nelea, V; Roman, H; Borras, T; Tamimi, F; Ferron, M; Murshed, M				Marulanda, Juliana; Eimar, Hazem; Mckee, Marc D.; Berkvens, Michelle; Nelea, Valentin; Roman, Hassem; Borras, Teresa; Tamimi, Faleh; Ferron, Mathieu; Murshed, Monzur			Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHENO-OCCIPITAL SYNCHONDROSIS; KEUTEL-SYNDROME; MOUSE MODEL; PFEIFFER SYNDROME; MUENKE SYNDROME; CRANIAL BASE; MUTATIONS; CARTILAGE; CALCIFICATION; GENE	Genetic and environmental factors may lead to abnormal growth of the orofacial skeleton, affecting the overall structure of the face. In this study, we investigated the craniofacial abnormalities in a mouse model for Keutel syndrome, a rare genetic disease caused by loss-of-function mutations in the matrix Gla protein (MGP) gene. Keutel syndrome patients show diffuse ectopic calcification of cartilaginous tissues and impaired midface development. Our comparative cephalometric analyses of micro-computed tomography images revealed a severe midface hypoplasia in Mgp(-/-) mice. In vivo reporter studies demonstrated that the Mgp promoter is highly active at the cranial sutures, cranial base synchondroses, and nasal septum. Interestingly, the cranial sutures of the mutant mice showed normal anatomical features. Although we observed a mild increase in mineralization of the spheno-occipital synchondrosis, it did not reduce the relative length of the cranial base in comparison with total skull length. Contrary to this, we found the nasal septum to be abnormally mineralized and shortened in Mgp(-/-) mice. Transgenic restoration of Mgp expression in chondrocytes fully corrected the craniofacial anomalies caused byMGPdeficiency, suggesting a local role for MGP in the developing nasal septum. Although there was no up-regulation of markers for hypertrophic chondrocytes, aTUNELassay showed a marked increase in apoptotic chondrocytes in the calcified nasal septum. Transmission electron microscopy confirmed unusual mineral deposits in the septal extracellular matrix of the mutant mice. Of note, the systemic reduction of the inorganic phosphate level was sufficient to prevent abnormal mineralization of the nasal septum in Mgp(-/-); Hyp compound mutants. Our work provides evidence that modulation of local and systemic factors regulating extracellular matrix mineralization can be possible therapeutic strategies to prevent ectopic cartilage calcification and some forms of congenital craniofacial anomalies in humans.	[Marulanda, Juliana; Eimar, Hazem; Mckee, Marc D.; Berkvens, Michelle; Nelea, Valentin; Tamimi, Faleh; Murshed, Monzur] McGill Univ, Fac Dent, Montreal, PQ H3A 1G1, Canada; [Mckee, Marc D.; Roman, Hassem] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Roman, Hassem; Murshed, Monzur] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Borras, Teresa] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27516 USA; [Ferron, Mathieu] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Murshed, Monzur] Shriners Hosp Children, 1003 Blvd Decarie, Montreal, PQ H4A 0A9, Canada	McGill University; McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Murshed, M (corresponding author), Shriners Hosp Children, 1003 Blvd Decarie, Montreal, PQ H4A 0A9, Canada.	monzur.murshed@mcgill.ca	McKee, Marc D/E-2187-2011	McKee, Marc D/0000-0001-8349-965X; Tamimi, Faleh/0000-0002-4618-8374	Le Reseau de Recherche en Sante Buccodentaire et Osseuse; NATIONAL EYE INSTITUTE [R01EY026220, R01EY013126] Funding Source: NIH RePORTER	Le Reseau de Recherche en Sante Buccodentaire et Osseuse; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Gerard Karsenty for critical reading of the manuscript. We also thank Mia Esser, Louise Marineau, and Maude Danis Ladouceur for animal husbandry. The core facility for skeletal phenotyping was supported by Le Reseau de Recherche en Sante Buccodentaire et Osseuse.	Al Dayeh AA, 2013, AM J ORTHOD DENTOFAC, V143, P773, DOI 10.1016/j.ajodo.2013.01.012; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Ayyildiz P., 2012, Firat Tip Dergisi, V17, P167; Borras T, 2015, INVEST OPHTH VIS SCI, V56, P2203, DOI 10.1167/iovs.15-16460; Chokdeemboon C, 2013, J CRANIOFAC SURG, V24, P150, DOI 10.1097/SCS.0b013e3182646454; Cielo CM, 2015, PAEDIATR RESPIR REV, V16, P189, DOI 10.1016/j.prrv.2014.11.003; COPRAY JCVM, 1986, J ANAT, V144, P99; DELAIRE J, 1986, CLEFT PALATE J, V23, P270; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Eimar H, 2016, J DENT RES, V95, P761, DOI 10.1177/0022034516637045; Forte AJ, 2014, PLAST RECONSTR SURG, V134, P285, DOI 10.1097/PRS.0000000000000360; Goldstein JA, 2014, PLAST RECONSTR SURG, V134, P504, DOI 10.1097/PRS.0000000000000419; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Hall BK, 2013, OR SURG OR MED OR PA, V115, P442, DOI 10.1016/j.oooo.2012.05.005; Hayano S, 2015, DEVELOPMENT, V142, P1357, DOI 10.1242/dev.118802; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; KVINNSLAND S, 1974, ANGLE ORTHOD, V44, P135; Laurita J, 2011, DEV DYNAM, V240, P2584, DOI 10.1002/dvdy.22752; Lee ER, 2009, DEV DYNAM, V238, P1547, DOI 10.1002/dvdy.21960; Lefebvre M, 2015, PRENATAL DIAG, V35, P675, DOI 10.1002/pd.4591; LUO GB, 1995, J BONE MINER RES, V10, P325; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Martelli H, 2008, PEDIATR DENT, V30, P464; Marulanda J, 2014, CURR PHARM DESIGN, V20, P5801, DOI 10.2174/1381612820666140212205848; Mehndiratta S, 2010, ARCH GYNECOL OBSTET, V282, P335, DOI 10.1007/s00404-010-1369-5; Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660; MOSS ML, 1968, PLAST RECONSTR SURG, V41, P536, DOI 10.1097/00006534-196806000-00004; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nah HD, 2012, CHILD NERV SYST, V28, P1483, DOI 10.1007/s00381-012-1778-9; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Palhazi P, 2015, AESTHET SURG J, V35, P242, DOI 10.1093/asj/sju079; Paliga JT, 2014, J CRANIOFAC SURG, V25, P202, DOI 10.1097/SCS.0000000000000386; Patel N, 2015, PLAST RECONSTR SURG, V135, p731E, DOI 10.1097/PRS.0000000000001062; Rosenberg P, 1997, PLAST RECONSTR SURG, V99, P1396, DOI 10.1097/00006534-199704001-00030; Sarnat B. G., 1967, ACTA OTO-LARYNGOL, V63, P467; SCOTT J. H., 1956, AMER JOUR ORTHODONT, V42, P381, DOI 10.1016/0002-9416(56)90165-8; Starling LD, 2012, BMJ CASE REP, V2012; Tie JK, 2016, J THROMB HAEMOST, V14, P236, DOI 10.1111/jth.13217; Tie JK, 2016, BLOOD, V127, P1847, DOI 10.1182/blood-2015-10-677633; Wang Y, 2015, J PEDIATR-US, V166, P819, DOI 10.1016/j.jpeds.2014.12.025; Watzka M, 2014, THROMB RES, V134, P856, DOI 10.1016/j.thromres.2014.07.004; Weaver KN, 2014, AM J MED GENET A, V164, P1062, DOI 10.1002/ajmg.a.36390; WHO RMo C. A, 2000, GLOB REG DAT CRAN AN; Wong KK, 2010, LARYNGOSCOPE, V120, P450, DOI 10.1002/lary.20769; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	52	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11400	11412		10.1074/jbc.M116.769802	http://dx.doi.org/10.1074/jbc.M116.769802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28487368	Green Published, hybrid			2022-12-28	WOS:000405119600023
J	Pasquali, CC; Islam, Z; Adamoski, D; Ferreira, IM; Righeto, RD; Bettini, J; Portugal, RV; Yue, WWY; Gonzalez, A; Dias, SMG; Ambrosio, ALB				Pasquali, Camila Cristina; Islam, Zeyaul; Adamoski, Douglas; Ferreira, Igor Monteze; Righeto, Ricardo Diogo; Bettini, Jefferson; Portugal, Rodrigo Villares; Yue, Wyatt Wai-yin; Gonzalez, Ana; Gomes Dias, Sandra Martha; Berteli Ambrosio, Andre Luis			The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; STRUCTURAL BASIS; RAT-KIDNEY; PROTEIN; GENOME; METABOLISM; SYSTEM; EXPRESSION; INSIGHTS	On the basis of tissue-specific enzyme activity and inhibition by catalytic products, Hans Krebs first demonstrated the existence of multiple glutaminases in mammals. Currently, two human genes are known to encode at least four glutaminase isoforms. However, the phylogeny of these medically relevant enzymes remains unclear, prompting us to investigate their origin and evolution. Using prokaryotic and eukaryotic glutaminase sequences, we built a phylogenetic tree whose topology suggested that the multidomain architecture was inherited from bacterial ancestors, probably simultaneously with the hosting of the proto-mitochondrion endo-symbiont. Wepropose an evolutionary model wherein the appearance of the most active enzyme isoform, glutaminase C (GAC), which is expressed in many cancers, was a late retrotransposition event that occurred in fishes from the Chondrichthyes class. The ankyrin (ANK) repeats in the glutaminases were acquired early in their evolution. To obtain information on ANK folding, we solved two high-resolution structures of the ANK repeat-containing C termini of both kidney-type glutaminase (KGA) and GLS2 isoforms (glutaminase B and liver-type glutaminase). We found that the glutaminase ANK repeats form unique intramolecular contacts through two highly conserved motifs; curiously, this arrangement occludes a region usually involved in ANK-mediated protein-protein interactions. We also solved the crystal structure of full-length KGA and present a small-angle X-ray scattering model for full-length GLS2. These structures explain these proteins' compromised ability to assemble into catalytically active supra-tetrameric filaments, as previously shown for GAC. Collectively, these results provide information about glutaminases that may aid in the design of isoform-specific glutaminase inhibitors.	[Pasquali, Camila Cristina; Islam, Zeyaul; Adamoski, Douglas; Ferreira, Igor Monteze; Gomes Dias, Sandra Martha; Berteli Ambrosio, Andre Luis] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Sao Paulo, Brazil; [Ferreira, Igor Monteze; Yue, Wyatt Wai-yin] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Righeto, Ricardo Diogo; Bettini, Jefferson; Portugal, Rodrigo Villares] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Nanotecnol, BR-13083970 Sao Paulo, Brazil; [Righeto, Ricardo Diogo] Univ Estadual Campinas, Sch Elect & Comp Engn, BR-13083852 Sao Paulo, Brazil; [Gonzalez, Ana] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Righeto, Ricardo Diogo] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4058 Basel, Switzerland	University of Oxford; Universidade Estadual de Campinas; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Basel	Dias, SMG (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Sao Paulo, Brazil.; Ambrosio, ALB (corresponding author), CNPEM, LNBio, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro 10-000, BR-13083970 Sao Paulo, Brazil.	sandra.dias@lnbio.cnpem.br; andre.ambrosio@lnbio.cnpem.br	Adamoski, Douglas/J-8570-2014; Dias, Sandra/AAB-7042-2019; Ambrosio, Andre/AAB-1178-2020; Bettini, Jefferson/G-4554-2013; Portugal, Rodrigo V/H-3951-2012; Islam, Zeyaul/AAZ-5625-2020	Adamoski, Douglas/0000-0001-5062-2586; Bettini, Jefferson/0000-0001-7316-0804; Portugal, Rodrigo V/0000-0002-8136-904X; Islam, Zeyaul/0000-0002-5444-3910	LNBio; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	LNBio; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank LNBio for accessibility to core facilities as well as for financial support. We are very grateful to Dr. Alessandra Girasole for expert technical support. We thank the Biotechnology group at the SGC Oxford for cloning and expression testing of glutaminase constructs. We thank Dr. Artur T. Cordeiro and Americo T. Ranzani for help with crystallographic data collection. We thank Dr. Wah Chiu for access to the cryo-electron microscopy facility at Baylor College of Medicine. We acknowledge the staff of all the beamlines used in this work. The KGA.ANK and GLS2.ANK data were collected during the RapiData 2015 Course for Data Collection and Structure Solving. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and National Institutes of Health, National Institute of General Medical Sciences Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; [Anonymous], 1987, FUNDAMENTALS COMP VE; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; Campos-Sandoval JA, 2007, INT J BIOCHEM CELL B, V39, P765, DOI 10.1016/j.biocel.2006.12.002; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V172, P162, DOI 10.1016/0003-9861(76)90062-X; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1951; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li YC, 2010, J VIROL, V84, P3331, DOI 10.1128/JVI.02332-09; Liu J, 2014, ONCOTARGET, V5, P2635, DOI 10.18632/oncotarget.1862; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Martin-Rufian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038380; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Olalla L, 2002, J BIOL CHEM, V277, P38939, DOI 10.1074/jbc.C200373200; Olalla L, 2008, J NEUROSCI RES, V86, P281, DOI 10.1002/jnr.21505; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Robin G, 2014, J MOL BIOL, V426, P3729, DOI 10.1016/j.jmb.2014.08.013; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szeliga M, 2015, NEUROCHEM INT, V88, P6, DOI 10.1016/j.neuint.2014.11.004; Szeliga M, 2014, TUMOR BIOL, V35, P1855, DOI 10.1007/s13277-013-1247-4; Takeda S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000416; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Heel M., 2012, INT TABLES CRYSTALLO, VF, P624, DOI [10.1107/97809553602060000875, DOI 10.1107/97809553602060000875]; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang C, 2016, ELIFE, V5, DOI 10.7554/eLife.10727	75	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11572	11585		10.1074/jbc.M117.787291	http://dx.doi.org/10.1074/jbc.M117.787291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28526749	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000405119600036
J	Joshi, KK; Sutherland, M; Chien, P				Joshi, Kamal Kishore; Sutherland, Madeleine; Chien, Peter			Cargo engagement protects protease adaptors from degradation in a substrate-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL CYCLE; AAA PLUS PROTEASE; REGULATED PROTEOLYSIS; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; PROTEINS; CLPXP; PHOSPHORYLATION; PROGRESSION; DELIVERY	Protein degradation in bacteria is a highly controlled process involving proteolytic adaptors that regulate protein degradation during cell cycle progression or during stress responses. Many adaptors work as scaffolds that selectively bind cargo and tether substrates to their cognate proteases to promote substrate destruction, whereas others primarily activate the target protease. Because adaptors must bind their cognate protease, all adaptors run the risk of being recognized by the protease as substrates themselves, a process that could limit their effectiveness. Here we use purified proteins in a reconstituted system and in vivo studies to show that adaptors of the ClpXP protease are readily degraded but that cargo binding inhibits this degradation. We found that this principle extends across several adaptor systems, including the hierarchical adaptors that drive the Caulobacter bacterial cell cycle and the quality control adaptor SspB. We also found that the ability of a cargo to protect its adaptor is adaptor substrate-specific, as adaptors with artificial degradation tags were not protected even though cargo binding is unaffected. Our work points to an optimization of inherent adaptor degradation and cargo binding that ensures that robust adaptor activity is maintained when high amounts of substrate must be delivered and that adaptors can be eliminated when their tasks have been completed.	[Joshi, Kamal Kishore; Sutherland, Madeleine; Chien, Peter] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Joshi, Kamal Kishore; Chien, Peter] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Chien, P (corresponding author), Univ Massachusetts, Mol & Cellular Biol Grad Program, Dept Biochem & Mol Biol, 240 Thatcher Rd,N325, Amherst, MA 01003 USA.	pchien@biochem.umass.edu	Joshi, Kamal/AFF-8135-2022	Sutherland, Madeleine/0000-0003-4099-9085; Joshi, Kamal Kishore/0000-0001-5816-6888	National Institutes of Health [R01GM111706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by National Institutes of Health Grant R01GM111706 (to P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Ades SE, 2004, CURR BIOL, V14, pR924, DOI 10.1016/j.cub.2004.10.015; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Bhat NH, 2013, MOL MICROBIOL, V88, P1083, DOI 10.1111/mmi.12241; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Chan CM, 2014, MOL MICROBIOL, V93, P426, DOI 10.1111/mmi.12671; Chien P, 2007, STRUCTURE, V15, P1296, DOI 10.1016/j.str.2007.08.008; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Collier J, 2016, CURR OPIN MICROBIOL, V30, P107, DOI 10.1016/j.mib.2016.01.010; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Davis J. J., 2010, THESIS; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Joshi KK, 2016, ANNU REV GENET, V50, P423, DOI 10.1146/annurev-genet-120215-035235; Joshi KK, 2015, CELL, V163, P419, DOI 10.1016/j.cell.2015.09.030; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sendersky E, 2014, PLANT J, V79, P118, DOI 10.1111/tpj.12543; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Smith SC, 2014, P NATL ACAD SCI USA, V111, P14229, DOI 10.1073/pnas.1407862111; Turgay K, 1998, EMBO J, V17, P6730; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	34	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10973	10982		10.1074/jbc.M117.786392	http://dx.doi.org/10.1074/jbc.M117.786392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28507098	hybrid, Green Published			2022-12-28	WOS:000404391000019
J	Tajima-Shirasaki, N; Ishil, KA; Takayama, H; Shirasaki, T; Iwama, H; Chikamoto, K; Saito, Y; Iwasaki, Y; Teraguchi, A; Lan, F; Kikuchi, A; Takeshita, Y; Murao, K; Matsugo, S; Kaneko, S; Misu, H; Takamura, T				Tajima-Shirasaki, Natsumi; Ishil, Kiyo-aki; Takayama, Hiroaki; Shirasaki, Takayoshi; Iwama, Hisakazu; Chikamoto, Keita; Saito, Yoshiro; Iwasaki, Yasumasa; Teraguchi, Atsushi; Lan, Fei; Kikuchi, Akihiro; Takeshita, Yumie; Murao, Koji; Matsugo, Seiichi; Kaneko, Shuichi; Misu, Hirofumi; Takamura, Toshinari			Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; ELEMENT-BINDING PROTEIN-1; INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; HEPATIC STEATOSIS; PROMOTER ACTIVITY; ADIPOSE-TISSUE; MOUSE-LIVER; FED RATS; MICE	Selenoprotein P (encoded by SELENOP in humans, Selenop in rat), a liver-derived secretory protein, induces resistance to insulin and vascular endothelial growth factor (VEGF) in type 2 diabetes. Suppression of selenoprotein P may provide a novel therapeutic approach to treating type 2 diabetes; however, few drugs inhibiting SELENOP expression in hepatocytes have been identified. The present findings demonstrate that eicosapentaenoic acid (EPA) suppresses SELENOP expression by inactivating sterol regulatory element-binding protein-1c (SREBP-1c, encoded by Srebf1 in rat) in H4IIEC3 hepatocytes. Treatment with EPA caused concentration-and time-dependent reduction in SELENOP promoter activity. EPA activated AMP-activated protein kinase (AMPK); however, the inhibitory effect of EPA on SELENOP promoter activity was not canceled with an AMPK inhibitor compound C and dominant-negative AMPK transfection. Deletion mutant promoter assays and computational analysis of transcription factor-binding sites conserved among the species resulted in identification of a sterol regulatory element (SRE)-like site in the SELENOP promoter. A chromatin immunoprecipitation (ChIP) assay revealed that EPA decreases binding of SREBP-1c to the SELENOP promoter. Knockdown of Srebf1 resulted in a significant down-regulation of Selenop expression. Conversely, SREBP-1c overexpression inhibited the suppressive effect of EPA. These data provide a novel mechanism of action for EPA involving improvement of systemic insulin sensitivity through the regulation of selenoprotein P production independently of the AMPK pathway and suggest an additional approach to developing anti-diabetic drugs.	[Tajima-Shirasaki, Natsumi; Ishil, Kiyo-aki; Takayama, Hiroaki; Chikamoto, Keita; Teraguchi, Atsushi; Lan, Fei; Kikuchi, Akihiro; Takeshita, Yumie; Misu, Hirofumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Hlth Med, Dept Endocrinol & Metab, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Tajima-Shirasaki, Natsumi; Ishil, Kiyo-aki; Takayama, Hiroaki; Shirasaki, Takayoshi; Kikuchi, Akihiro; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Hlth Med, Dept Syst Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Shirasaki, Takayoshi] Kanazawa Univ, Grad Sch Hlth Med, Dept Adv Med Technol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Ikenobe 1750-1, Miki, Kagawa 7610793, Japan; [Chikamoto, Keita; Matsugo, Seiichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Saito, Yoshiro] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Syst Life Sci, Kyotanabe, Kyoto 6100394, Japan; [Iwasaki, Yasumasa] Kochi Univ, Hlth Care Ctr, Kochi 7808520, Japan; [Murao, Koji] Kagawa Univ, Dept Adv Med, Ikenobe 1750-1, Miki, Kagawa 7610793, Japan; [Misu, Hirofumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kagawa University; Kanazawa University; Doshisha University; Kochi University; Kagawa University; Japan Science & Technology Agency (JST)	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Hlth Med, Dept Endocrinol & Metab, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	ttakamura@m-kanazawa.jp	Saito, Yoshiro/H-4597-2019; Takayama, Hiroaki/C-4694-2015	Saito, Yoshiro/0000-0002-0559-5889; Takayama, Hiroaki/0000-0003-4792-3868; Murao, Koji/0000-0002-7335-7196; Ishii, Kiyo-aki/0000-0001-9846-5575; Kikuchi, Akihiro/0000-0001-9332-1273	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science KAKENHI [16K09740, 16K09739]; Grants-in-Aid for Scientific Research [26253046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. M., S. K., and T. T.), and Japan Society for the Promotion of Science KAKENHI Grants 16K09740 (to H. M.) and 16K09739 (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Carpentier YA, 2006, AM J CLIN NUTR, V83, p1499S, DOI 10.1093/ajcn/83.6.1499S; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Choi HY, 2013, DIABETES METAB J, V37, P63, DOI 10.4093/dmj.2013.37.1.63; Dobrzyn A, 2005, BIOCHEM BIOPH RES CO, V332, P892, DOI 10.1016/j.bbrc.2005.05.026; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Honda M, 2011, GASTROENTEROLOGY, V141, P128, DOI 10.1053/j.gastro.2011.03.051; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Ishii H, 2009, J HEPATOL, V50, P562, DOI 10.1016/j.jhep.2008.10.031; Ishikura K, 2014, DIABETOLOGIA, V57, P1968, DOI 10.1007/s00125-014-3306-9; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Kohjima M, 2008, INT J MOL MED, V21, P507; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Misu H, 2017, NAT MED, V23, P508, DOI 10.1038/nm.4295; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Perez-Echarri N, 2009, BRIT J NUTR, V101, P1059, DOI 10.1017/S0007114508048307; Perez-Matute P, 2007, BRIT J NUTR, V97, P389, DOI 10.1017/S0007114507207627; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rossi AS, 2005, AM J PHYSIOL-REG I, V289, pR486, DOI 10.1152/ajpregu.00846.2004; Saito Y, 2002, EUR J BIOCHEM, V269, P5746, DOI 10.1046/j.1432-1033.2002.03298.x; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Suchankova G, 2005, BIOCHEM BIOPH RES CO, V326, P851, DOI 10.1016/j.bbrc.2004.11.114; Suzuki-Kemuriyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157580; Takayama H, 2014, J BIOL CHEM, V289, P335, DOI 10.1074/jbc.M113.479386; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Tanaka N, 2010, BIOCHEM PHARMACOL, V80, P1601, DOI 10.1016/j.bcp.2010.07.031; Ungerfeld R, 2004, REPROD NUTR DEV, V44, P89, DOI 10.1051/rnd:2004010; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200	54	27	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10791	10800		10.1074/jbc.M116.747006	http://dx.doi.org/10.1074/jbc.M116.747006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28465347	hybrid, Green Published			2022-12-28	WOS:000404391000004
J	de Valdivia, EG; Broselid, S; Kahn, R; Olde, B; Leeb-Lundberg, LMF				de Valdivia, Ernesto Gonzalez; Broselid, Stefan; Kahn, Robin; Olde, Bjorn; Leeb-Lundberg, L. M. Fredrik			G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-A; 30 GPR30; ACTIVATION; CALCINEURIN; ENDOCYTOSIS; REQUIRES; DYNAMICS; COMPLEX; OCCURS	G protein-coupled receptor 30 (GPR30), also called G protein-coupled estrogen receptor 1 (GPER1), is thought to play important roles in breast cancer and cardiometabolic regulation, but many questions remain about ligand activation, effector coupling, and subcellular localization. We showed recently that GPR30 interacts through the C-terminal type I PDZ motif with SAP97 and protein kinase A (PKA)-anchoring protein (AKAP) 5, which anchor the receptor in the plasma membrane and mediate an apparently constitutive decrease in cAMP production independently of G(i/o). Here, we show that GPR30 also constitutively increases ERK1/2 activity. Removing the receptor PDZ motif or knocking down specifically AKAP5 inhibited the increase, showing that this increase also requires the PDZ interaction. However, the increase was inhibited by pertussis toxin as well as by wortmannin but not by AG1478, indicating that Gi/o and phosphoinositide 3-kinase(PI3K) mediate the increase independently of epidermal growth factor receptor transactivation. FK506 and okadaic acid also inhibited the increase, implying that a protein phosphatase is involved. The proposed GPR30 agonist G-1 also increased ERK1/2 activity, but this increase was only observed at a level of receptor expression below that required for the constitutive increase. Furthermore, deleting the PDZmotif did not inhibit the G-1-stimulated increase. Based on these results, we propose that GPR30 increases ERK1/2 activity via two G(i/o)-mediated mechanisms, a PDZ-dependent, apparently constitutive mechanism and a PDZ-independent G-1-stimulated mechanism.	[de Valdivia, Ernesto Gonzalez; Broselid, Stefan; Leeb-Lundberg, L. M. Fredrik] Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden; [Kahn, Robin] Lund Univ, Dept Pediat, S-22184 Lund, Sweden; [Olde, Bjorn] Lund Univ, Dept Cardiol, S-22184 Lund, Sweden	Lund University; Lund University; Lund University	Leeb-Lundberg, LMF (corresponding author), Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden.	fredrik.leeb-lundberg@med.lu.se		Gonzalez de Valdivia, Ernesto/0000-0003-3722-6364	Swedish Cancer Foundation [CAN 2016/423]; Swedish Research Council [2016-02427]; NovoNordisk Foundation; Alfred Osterlund Foundation; Gunnar Nilsson Cancer Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk Foundation(Novo Nordisk Foundation); Alfred Osterlund Foundation; Gunnar Nilsson Cancer Foundation	This work was supported by Swedish Cancer Foundation (Grant CAN 2016/423), Swedish Research Council (Grant 2016-02427), the NovoNordisk Foundation, the Alfred Osterlund Foundation, and the Gunnar Nilsson Cancer Foundation (to L. M. F. L.-L.). The authors declare that they have no conflicts of interest with the contents of this article.	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gonzalez-Garcia JR, 2014, J CELL SCI, V127, P2749, DOI 10.1242/jcs.145045; Holstein DM, 2004, J BIOL CHEM, V279, P10060, DOI 10.1074/jbc.M312039200; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; Kenakin TP, 2009, TRENDS PHARMACOL SCI, V30, P460, DOI 10.1016/j.tips.2009.06.007; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; LEEBLUNDBERG LMF, 1994, J BIOL CHEM, V269, P24328; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Phagoo SB, 1999, MOL PHARMACOL, V56, P325, DOI 10.1124/mol.56.2.325; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rabhi I, 2004, MOL BIOTECHNOL, V26, P27, DOI 10.1385/MB:26:1:27; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Springael JY, 2007, CELL SIGNAL, V19, P1446, DOI 10.1016/j.cellsig.2007.01.022; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tran QK, 2015, J BIOL CHEM, V290, P13293, DOI 10.1074/jbc.M114.628743; Waters EM, 2015, J NEUROSCI, V35, P2384, DOI 10.1523/JNEUROSCI.1298-14.2015	41	25	25	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9932	9943		10.1074/jbc.M116.765875	http://dx.doi.org/10.1074/jbc.M116.765875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450397	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000403580600007
J	Wang, SZ; Borschel, WF; Heyman, S; Hsu, P; Nichols, CG				Wang, Shizhen; Borschel, William F.; Heyman, Sarah; Hsu, Phillip; Nichols, Colin G.			Conformational changes at cytoplasmic intersubunit interactions control Kir channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; POTASSIUM-CHANNEL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PIP2; ACTIVATION; MECHANISM; KIRBAC1.1; DYNAMICS; CURRENTS	The defining structural feature of inward-rectifier potassium (Kir) channels is the unique Kir cytoplasmic domain. Recently we showed that salt bridges located at the cytoplasmic domain subunit interfaces (CD-Is) of eukaryotic Kir channels control channel gating via stability of a novel inactivated closed state. The cytoplasmic domains of prokaryotic and eukaryotic Kir channels show similar conformational rearrangements to the common gating ligand, phosphatidylinositol bisphosphate (PIP2), although these exhibit opposite coupling to opening and closing transitions. In Kir2.1, mutation of one of these CD-I salt bridge residues (R204A) reduces apparent PIP2 sensitivity of channel activity, and here we show that Ala or Cys substitutions of the functionally equivalent residue (Arg-165) in the prokaryotic Kir channel KirBac1.1 also significantly decrease sensitivity of the channel to PIP2 (by 5-30-fold). To further understand the structural basis of CD-I control of Kir channel gating, we examined the effect of the R165A mutation on PIP2-induced changes in channel function and conformation. Single-channel analyses indicated that the R165A mutation disrupts the characteristic long interburst closed state of reconstituted KirBac1.1 in giant liposomes, resulting in a higher open probability due to more frequent opening bursts. Intramolecular FRET measurements indicate that, relative to wild-type channels, the R165A mutation results in splaying of the cytoplasmic domains away from the central axis and that PIP2 essentially induces opposite motions of the major beta-sheet in this channel mutant. We conclude that the removal of stabilizing CD-I salt bridges results in a collapsed state of the Kir domain.	[Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 South Euclid Ave, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 South Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Wang, Shizhen/N-6577-2017	Wang, Shizhen/0000-0003-1065-4756; Hsu, Phillip/0000-0002-3405-8046	National Institutes of Health [HL54171]; National Institutes of Health Training Grants [DK007120-38, HL007275-35, HL125241-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL125241, R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL54171 (to C.G.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Training Grants DK007120-38, HL007275-35, and HL125241-01.	Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Borschel WF, 2017, J GEN PHYSIOL, V149, P561, DOI 10.1085/jgp.201611719; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Lee SJ, 2016, J GEN PHYSIOL, V148, P227, DOI 10.1085/jgp.201611616; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Pattnaik BR, 2012, MOL GENET METAB, V105, P64, DOI 10.1016/j.ymgme.2011.10.004; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tristani-Firouzi M, 2010, PFLUG ARCH EUR J PHY, V460, P289, DOI 10.1007/s00424-010-0820-6; Wang SZ, 2016, NAT STRUCT MOL BIOL, V23, P31, DOI 10.1038/nsmb.3138; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; Xie LH, 2002, J GEN PHYSIOL, V120, P53, DOI 10.1085/jgp.20028576	39	3	3	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10087	10096		10.1074/jbc.M117.785154	http://dx.doi.org/10.1074/jbc.M117.785154			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446610	hybrid, Green Published			2022-12-28	WOS:000403580600020
J	Griffin, WC; Gao, J; Byrd, AK; Chib, S; Raney, KD				Griffin, Wezley C.; Gao, Jun; Byrd, Alicia K.; Chib, Shubeena; Raney, Kevin D.			A biochemical and biophysical model of G-quadruplex DNA recognition by positive coactivator of transcription 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; CHROMATIN-ASSOCIATED PROTEIN; TELOMERIC G-QUADRUPLEX; C-TERMINAL DOMAIN; COFACTOR PC4; GUANINE OXIDATION; BINDING PROTEIN; PIF1 HELICASE; DAMAGE SITES; P53 FUNCTION	DNA sequences that are guanine-rich have received considerable attention because of their potential to fold into a secondary, four-stranded DNA structure termed G-quadruplex (G4), which has been implicated in genomic instability and some human diseases. We have previously identified positive coactivator of transcription (PC4), a single-stranded DNA (ssDNA)-binding protein, as a novel G4 interactor. Here, to expand on these previous observations, we biochemically and biophysically characterized the interaction between PC4 and G4DNA. PC4 can bind alternative G4DNA topologies with a low nanomolar K-d value of similar to 2 nM, similar to that observed for ssDNA. In consideration of the different structural features between G4DNA and ssDNA, these binding data indicated that PC4 can interact with G4DNA in a manner distinct from ssDNA. The stoichiometry of the PC4-G4 complex was 1:1 for PC4 dimer: G4 substrate. PC4 did not enhance the rate of folding of G4DNA, and formation of the PC4-G4DNA complex did not result in unfolding of the G4DNA structure. We assembled a G4DNA structure flanked by duplex DNA. We find that PC4 can interact with this G4DNA, as well as the complementary C-rich strand. Molecular docking simulations and DNA footprinting experiments suggest a model where a PC4 dimer accommodates the DNA with one monomer on the G4 strand and the second monomer bound to the C-rich strand. Collectively, these data provide a novel mode of PC4 binding to a DNA secondary structure that remains within the framework of the model for binding to ssDNA. Additionally, consideration of the PC4-G4DNA interaction could provide insight into the biological functions of PC4, which remain incompletely understood.	[Griffin, Wezley C.; Gao, Jun; Byrd, Alicia K.; Chib, Shubeena; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.	RaneyKevinD@uams.edu		Griffin, Wezley/0000-0003-2062-1253; Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health [R01-GM098922]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM098922. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto Y, 2014, GENES CELLS, V19, P879, DOI 10.1111/gtc.12187; Altieri F, 2008, ANTIOXID REDOX SIGN, V10, P891, DOI 10.1089/ars.2007.1830; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; Brandsen J, 1997, NAT STRUCT BIOL, V4, P900, DOI 10.1038/nsb1197-900; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2016, J BIOL CHEM, V291, P18041, DOI 10.1074/jbc.M116.718478; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Cayrou C, 2015, GENOME RES, V25, P1873, DOI 10.1101/gr.192799.115; Chakravarthi BVSK, 2016, ONCOGENE, V35, P6330, DOI 10.1038/onc.2016.164; Chen L, 2014, J NEUROL SCI, V346, P293, DOI 10.1016/j.jns.2014.09.014; Chiarella S, 2013, NUCLEIC ACIDS RES, V41, P3228, DOI 10.1093/nar/gkt001; Cogoi S, 2016, BBA-GENE REGUL MECH, V1859, P663, DOI 10.1016/j.bbagrm.2016.02.002; Compe E, 2016, ANNU REV BIOCHEM, V85, P265, DOI 10.1146/annurev-biochem-060815-014857; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; de la Cruz OH, 2014, J PROTEOMICS, V111, P46, DOI 10.1016/j.jprot.2014.03.041; Dhanasekaran K, 2016, FEBS J, V283, P968, DOI 10.1111/febs.13653; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202; Fleming AM, 2013, CHEM RES TOXICOL, V26, P593, DOI 10.1021/tx400028y; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525-6535.2004; Fukuda A, 2003, J BIOL CHEM, V278, P14827, DOI 10.1074/jbc.M213172200; Gao J, 2015, CHEM COMMUN, V51, P7242, DOI 10.1039/c5cc00742a; Gao M, 2011, PROTEINS, V79, P1623, DOI 10.1002/prot.22987; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; de la Cruz OH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19611; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kim JM, 2015, NUCLEIC ACIDS RES, V43, P8868, DOI 10.1093/nar/gkv874; Kreig A, 2015, NUCLEIC ACIDS RES, V43, P7961, DOI 10.1093/nar/gkv749; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lech CJ, 2013, NUCLEIC ACIDS RES, V41, P2034, DOI 10.1093/nar/gks1110; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Liao MJ, 2011, J BIOL CHEM, V286, P7681, DOI 10.1074/jbc.M110.188532; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Mergny JL, 2001, P NATL ACAD SCI USA, V98, P3062, DOI 10.1073/pnas.051620698; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Mortusewicz O, 2016, ONCOGENE, V35, P761, DOI 10.1038/onc.2015.135; Mortusewicz O, 2008, J CELL BIOL, V183, P769, DOI 10.1083/jcb.200808097; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Noer SL, 2016, NUCLEIC ACIDS RES, V44, P464, DOI 10.1093/nar/gkv1320; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Pan ZQ, 1996, J BIOL CHEM, V271, P22111, DOI 10.1074/jbc.271.36.22111; Peng Y, 2012, CANCER GENE THER, V19, P690, DOI 10.1038/cgt.2012.52; Pratviel G, 2006, CHEM-EUR J, V12, P6018, DOI 10.1002/chem.200600539; Qian D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.416; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Ray S, 2013, BIOPHYS J, V104, P2235, DOI 10.1016/j.bpj.2013.04.004; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ross SA, 1996, NUCLEIC ACIDS RES, V24, P5062, DOI 10.1093/nar/24.24.5062; Safa L, 2016, J BIOL CHEM, V291, P21246, DOI 10.1074/jbc.M115.709667; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5; Swaminathan A, 2016, J BIOL CHEM, V291, P20303, DOI 10.1074/jbc.M116.744169; Tang WL, 2016, HUM MOL GENET, V25, P2060, DOI 10.1093/hmg/ddw079; Tao SL, 2015, AM J CANCER RES, V5, P1878; Tarsounas M, 2013, J MOL BIOL, V425, P4782, DOI 10.1016/j.jmb.2013.09.026; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Walker J. M., 2009, DNA PROTEIN INTERACT; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Wang ZX, 1998, MOL CELL, V1, P749, DOI 10.1016/S1097-2765(00)80074-X; Werten S, 1999, J BIOL CHEM, V274, P3693, DOI 10.1074/jbc.274.6.3693; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; Wu SY, 1998, J BIOL CHEM, V273, P12492, DOI 10.1074/jbc.273.20.12492; Zhang C, 2013, NUCLEIC ACIDS RES, V41, P7144, DOI 10.1093/nar/gkt443; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	80	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9567	9582		10.1074/jbc.M117.776211	http://dx.doi.org/10.1074/jbc.M117.776211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28416612	hybrid, Green Published			2022-12-28	WOS:000403113000010
J	Motomura, T; Suga, M; Hienerwadel, R; Nakagawa, A; Lai, TL; Nitschke, W; Kuma, T; Sugiura, M; Boussac, A; Shen, JR				Motomura, Taiki; Suga, Michihiro; Hienerwadel, Rainer; Nakagawa, Akiko; Thanh-Lan Lai; Nitschke, Wolfgang; Kuma, Takahiro; Sugiura, Miwa; Boussac, Alain; Shen, Jian-Ren			Crystal structure and redox properties of a novel cyanobacterial heme protein with a His/Cys heme axial ligation and a Per-Arnt-Sim (PAS)-like domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLVING PHOTOSYSTEM-II; THERMOSYNECHOCOCCUS-ELONGATUS; D1 PROTEIN; ANGSTROM RESOLUTION; SECONDARY-STRUCTURE; GENE-EXPRESSION; PAS DOMAINS; AMINO-ACID; PSBA GENES; 2 FORMS	Photosystem II catalyzes light-induced water oxidation leading to the generation of dioxygen indispensable for sustaining aerobic life on Earth. The Photosystem II reaction center is composed of D1 and D2 proteins encoded by psbA and psbD genes, respectively. In cyanobacteria, different psbA genes are present in the genome. The thermophilic cyanobacterium Thermosynechococcus elongatus contains three psbA genes: psbA1, psbA2, and psbA3, and a new c-type heme protein, Tll0287, was found to be expressed in a strain expressing the psbA2 gene only, but the structure and function of Tll0287 are unknown. Here we solved the crystal structure of Tll0287 at a 2.0 angstrom resolution. The overall structure of Tll0287 was found to be similar to some kinases and sensor proteins with a Per-Arnt-Sim-like domain rather than to other c-type cytochromes. The fifth and sixth axial ligands for the heme were Cys and His, instead of the His/Met or His/His ligand pairs observed for most of the c-type hemes. The redox potential, E-1/2, of Tll0287 was -255 +/- 20 mV versus normal hydrogen electrode at pH values above 7.5. Below this pH value, the E1/2 increased by approximate to 57 mV/pH unit at 15 degrees C, suggesting the involvement of a protonatable group with a pK(red) = 7.2 +/- 0.3. Possible functions of Tll0287 as a redox sensor under microaerobic conditions or a cytochrome subunit of an H2S-oxidizing system are discussed in view of the environmental conditions in which psbA2 is expressed, as well as phylogenetic analysis, structural, and sequence homologies.	[Motomura, Taiki; Shen, Jian-Ren] Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, Kamigori, Hyogo 6781297, Japan; [Motomura, Taiki; Suga, Michihiro; Nakagawa, Akiko; Kuma, Takahiro; Shen, Jian-Ren] Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan; [Motomura, Taiki; Suga, Michihiro; Nakagawa, Akiko; Kuma, Takahiro; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Hienerwadel, Rainer] CNRS CEA Aix Marseille Univ, Fac Sci Luminy, UMR 7265, Lab Genet & Biophys Plantes, F-13288 Marseille, France; [Nakagawa, Akiko; Sugiura, Miwa] Ehime Univ, Proteosci Res Ctr, Matsuyama, Ehime 7908577, Japan; [Thanh-Lan Lai; Boussac, Alain] CEA Saclay, UMR 9198, CNRS, iBiTec S,SB2SM, F-91191 Gif Sur Yvette, France; [Nitschke, Wolfgang] CNRS, UMR 7281, Lab Bioenerget & Ingn Prot, F-13402 Marseille 20, France	University of Hyogo; Okayama University; Okayama University; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Ehime University; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Shen, JR (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, Kamigori, Hyogo 6781297, Japan.; Shen, JR (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan.; Shen, JR (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp	Shen, Jian-Ren/B-2558-2011; Nitschke, Wolfgang/C-4812-2012	Nitschke, Wolfgang/0000-0003-2084-3032; Motomura, Taiki/0000-0002-9646-7347	University of Hyogo; Okayama University; KAKENHI [JP24000018, JP26840023, JP15H01642, JP16H06162]; Japan Society for the Promotion of Science [JP16H06296]; Inamori Foundation grant; Japan Science and Technology Agency [4018]; Bioenergy Program of CEA-DSV; Grants-in-Aid for Scientific Research [16H06162] Funding Source: KAKEN	University of Hyogo; Okayama University; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inamori Foundation grant; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Bioenergy Program of CEA-DSV; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a program for Leading Graduate Schools, "Next Generation Picobiology Pioneered by Photon Sciences" at the University of Hyogo, a program for promoting the enhancement of research universities at Okayama University; KAKENHI Grants JP24000018 (to J.-R. S.) and JP26840023, JP15H01642, JP16H06162, and JP16H06296 (to M. Suga) from Japan Society for the Promotion of Science; an Inamori Foundation grant (to M. Suga); Japan Science and Technology Agency (JST)-PRESTO Program 4018 (to M. Sugiura); and the Bioenergy Program of CEA-DSV (to T.-L. L. and A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARIELI B, 1994, J BIOL CHEM, V269, P5705; Boussac A, 2013, BBA-BIOENERGETICS, V1827, P1174, DOI 10.1016/j.bbabio.2013.06.002; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Burton MJ, 2016, P NATL ACAD SCI USA, V113, P3785, DOI 10.1073/pnas.1600211113; BUSTOS SA, 1990, J BACTERIOL, V172, P1998, DOI 10.1128/jb.172.4.1998-2004.1990; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; CAMPBELL D, 1995, EMBO J, V14, P5457, DOI 10.1002/j.1460-2075.1995.tb00232.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Diaz-Moreno I, 2014, BBA-BIOENERGETICS, V1837, P1305, DOI 10.1016/j.bbabio.2014.03.009; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glekas GD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413518; GOLDEN SS, 1995, J BACTERIOL, V177, P1651, DOI 10.1128/jb.177.7.1651-1654.1995; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hirano Y, 2012, BIOCHEMISTRY-US, V51, P6556, DOI 10.1021/bi3005522; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P599, DOI 10.1093/pcp/pce074; Kawakami K, 2011, J PHOTOCH PHOTOBIO B, V104, P9, DOI 10.1016/j.jphotobiol.2011.03.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kerfeld CA, 2003, J BIOL INORG CHEM, V8, P707, DOI 10.1007/s00775-003-0469-0; Kerfeld CA, 2003, PLANT CELL PHYSIOL, V44, P697, DOI 10.1093/pcp/pcg084; Kirilovsky D, 2004, J BIOL CHEM, V279, P52869, DOI 10.1074/jbc.M408206200; Kneuper H., 2010, SENSORY MECH BACTERI; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; PEISACH J, 1973, ANN NY ACAD SCI, V206, P310, DOI 10.1111/j.1749-6632.1973.tb43219.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pokkuluri PR, 2008, J MOL BIOL, V377, P1498, DOI 10.1016/j.jmb.2008.01.087; SANDER J, 2008, PHOTOSYNTHESIS ENERG, P745; SCHAEFER MR, 1989, J BIOL CHEM, V264, P7412; SCHAEFER MR, 1989, J BACTERIOL, V171, P3973, DOI 10.1128/jb.171.7.3973-3981.1989; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; SHEN JR, 1993, J BIOL CHEM, V268, P20408; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Sippola K, 1999, PLANT MOL BIOL, V41, P425, DOI 10.1023/A:1006347808475; Smith AT, 2012, J BIOL INORG CHEM, V17, P1071, DOI 10.1007/s00775-012-0920-1; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1922, DOI 10.1016/j.bbabio.2014.08.008; Sugiura M, 2014, RES CHEM INTERMEDIAT, V40, P3219, DOI 10.1007/s11164-014-1828-x; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1427, DOI 10.1016/j.bbabio.2013.12.011; Sugiura M, 2013, BIOCHEMISTRY-US, V52, P9426, DOI 10.1021/bi401213m; Sugiura M, 2012, J BIOL CHEM, V287, P13336, DOI 10.1074/jbc.M112.340323; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Ukita S, 2010, FEMS MICROBIOL LETT, V313, P61, DOI 10.1111/j.1574-6968.2010.02122.x; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; Vita N, 2013, ANAL CHEM, V85, P2891, DOI 10.1021/ac303511g; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu R, 2013, PROTEIN SCI, V22, P564, DOI 10.1002/pro.2237; Wydrzynski T, 2005, PHOTOSYSTEM, DOI [10.1007/1-4020-4254-X_6, DOI 10.1007/1-4020-4254-X_6]; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	85	9	9	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9599	9612		10.1074/jbc.M116.746263	http://dx.doi.org/10.1074/jbc.M116.746263			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28428249	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000403113000012
J	Rajgor, D; Fiuza, M; Parkinson, GT; Hanley, JG				Rajgor, Dipen; Fiuza, Maria; Parkinson, Gabrielle T.; Hanley, Jonathan G.			The PICK1 Ca2+ sensor modulates N-methyl-D-aspartate (NMDA) receptor-dependent microRNA-mediated translational repression in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTORS; DENDRITIC SPINES; RECYCLING ENDOSOMES; SYNAPTIC PLASTICITY; PDZ DOMAIN; TRAFFICKING; CALCIUM; BRAIN; GENE	MicroRNAs (miRNAs) are important regulators of localized mRNAtranslation in neuronal dendrites. The presence of RNA-induced silencing complex proteins in these compartments and the dynamic miRNA expression changes that occur in response to neuronal stimulation highlight their importance in synaptic plasticity. Previously, we demonstrated a novel interaction between the major RNA-induced silencing complex component Argounaute-2 (Ago2) and the BAR (bin/amphiphysin/rvs) domain protein PICK1. PICK1 recruits Ago2 to recycling endosomes in dendrites, where it inhibits miRNA-mediated translational repression. Chemical induction of long-term depression via NMDA receptor activation causes the dissociation of Ago2 from PICK1 and a consequent increase in dendritic miRNA-mediated gene silencing. The mechanism that underlies the regulation of PICK1-Ago2 binding is unknown. In this study, we demonstrate that the PICK1-Ago2 interaction is directly sensitive to Ca2+ ions so that high [Ca2+](free) reduces PICK1 binding to Ago2. Mutating a stretch of C-terminal Ca2+-binding residues in PICK1 results in a complete block of NMDA-induced PICK1-Ago2 disassociation in cortical neurons. Furthermore, the same mutant also blocks NMDA-stimulated miRNA-mediated gene silencing. This study defines a novel mechanism whereby elevated [Ca2+] induced by NMDA receptor activation modulates Ago2 and miRNA activity via PICK1. Our work suggests a Ca2+-dependent process to regulate miRNA activity in neurons in response to the induction of long-term depression.	[Hanley, Jonathan G.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; Univ Bristol, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk		Hanley, Jonathan/0000-0003-1704-4707; Parkinson, Gabrielle/0000-0003-4622-7502	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [1363798, BB/L021307/1] Funding Source: researchfish; Medical Research Council [MR/L011131/1] Funding Source: researchfish; BBSRC [BB/L021307/1] Funding Source: UKRI; MRC [MR/L011131/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Antoniou A, 2014, EMBO REP, V15, P548, DOI 10.1002/embr.201337631; Calabrese B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094787; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Dev KK, 2004, J BIOL CHEM, V279, P41393, DOI 10.1074/jbc.M404499200; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Hu ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4263; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jaafari N, 2012, J NEUROSCI, V32, P11618, DOI 10.1523/JNEUROSCI.5068-11.2012; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Li YH, 2016, NEUROCHEM INT, V98, P115, DOI 10.1016/j.neuint.2016.03.001; Loohuis NFMO, 2015, CELL REP, V11, P1876, DOI 10.1016/j.celrep.2015.05.040; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00064; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Sossa KG, 2006, MOL CELL NEUROSCI, V31, P574, DOI 10.1016/j.mcn.2005.11.011; Storchel PH, 2015, EMBO J, V34, P2237, DOI 10.15252/embj.201490643; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	37	10	10	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9774	9786		10.1074/jbc.M117.776302	http://dx.doi.org/10.1074/jbc.M117.776302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28404816	Green Published, hybrid			2022-12-28	WOS:000403113000026
J	Skegro, D; Stutz, C; Ollier, R; Svensson, E; Wassmann, P; Bourquin, F; Monney, T; Gn, S; Blein, S				Skegro, Darko; Stutz, Cian; Ollier, Romain; Svensson, Emelie; Wassmann, Paul; Bourquin, Florence; Monney, Thierry; Gn, Sunitha; Blein, Stanislas			Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGG ANTIBODIES; DESIGN; INFORMATION; HOMODIMER; PROGRESS; IMGT(R); CELLS; RISE	Bispecific antibodies (bsAbs) are of significant importance to the development of novel antibody-based therapies, and heavy chain (Hc) heterodimers represent a major class of bispecific drug candidates. Current technologies for the generation of Hc heterodimers are suboptimal and often suffer from contamination by homodimers posing purification challenges. Here, we introduce a new technology based on biomimicry wherein the protein-protein interfaces of two different immunoglobulin (Ig) constant domain pairs are exchanged in part or fully to design new heterodimeric domains. The method can be applied across Igs to design Fc heterodimers and bsAbs. We investigated interfaces from human IgA CH3, IgD CH3, IgG1 CH3, IgM CH4, T-cell receptor (TCR) alpha/beta, and TCR gamma/delta constant domain pairs, and we found that they successfully drive human IgG1 CH3 or IgM CH4 heterodimerization to levels similar to or above those of reference methods. A comprehensive interface exchange between the TCR alpha/beta constant domain pair and the IgG1 CH3 homodimer was evidenced by X-ray crystallography and used to engineer examples of bsAbs for cancer therapy. Parental antibody pairs were rapidly reformatted into scalable bsAbs that were free of homodimer traces by combining interface exchange, asymmetric Protein A binding, and the scFv x Fab format. In summary, we successfully built several new CH3- or CH4-based heterodimers that may prove useful for designing new bsAb-based therapeutics, and we anticipate that our approach could be broadly implemented across the Ig constant domain family. To our knowledge, CH4-based heterodimers have not been previously reported.	[Skegro, Darko; Stutz, Cian; Ollier, Romain; Svensson, Emelie; Wassmann, Paul; Bourquin, Florence; Monney, Thierry; Blein, Stanislas] Glenmark Pharmaceut SA, Biol Res, Dept Antibody Engn, Chemin Combeta 5, CH-2300 La Chaux De Fonds, Switzerland; [Gn, Sunitha] Glenmark Pharmaceut Ltd, Glenmark Res Ctr, Dept Drug Metab & Pharmacokinet, MIDC, Plot A-607, Mahape 400709, Navi Mumbai, India	Glenmark Pharmaceuticals Limited	Blein, S (corresponding author), Glenmark Pharmaceut SA, Biol Res, Dept Antibody Engn, Chemin Combeta 5, CH-2300 La Chaux De Fonds, Switzerland.	stanislas.blein@glenmarkpharma.com		Monney, Thierry/0000-0002-8566-541X; Wassmann, Paul/0000-0001-7391-1065				Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Fuh G., 2010, PCT Patent No, Patent No. [WO2010/108127, 2010108127]; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Goldstein N. I., 1996, PCT Patent No, Patent No. [WO1996/040210, 1996040210]; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Jimeno A, 2016, CANCER-AM CANCER SOC, V122, P3803, DOI 10.1002/cncr.30256; Junttila TT, 2014, CANCER RES, V74, P5561, DOI 10.1158/0008-5472.CAN-13-3622-T; Klein C, 2016, MABS-AUSTIN, V8, P1010, DOI 10.1080/19420862.2016.1197457; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kol A, 2014, PHARMACOL THERAPEUT, V143, P1, DOI 10.1016/j.pharmthera.2014.01.005; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; LINDHOFER H, 1995, J IMMUNOL, V155, P219; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moretti P, 2013, BMC P, V7, P9; Rothe M., 2007, PCT Patent No, Patent No. [WO2007/077028, 2007077028]; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Sheridan C, 2016, NAT BIOTECHNOL, V34, P1215, DOI 10.1038/nbt1216-1215; Sheridan C, 2015, NAT BIOTECHNOL, V33, P219, DOI 10.1038/nbt0315-219; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smith EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17943; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tustian AD, 2016, MABS-AUSTIN, V8, P828, DOI 10.1080/19420862.2016.1160192; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Von Kreudenstein TS, 2013, MABS-AUSTIN, V5, P646, DOI 10.4161/mabs.25632; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Xu YR, 2015, MABS-AUSTIN, V7, P231, DOI 10.4161/19420862.2015.989013	39	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9745	9759		10.1074/jbc.M117.782433	http://dx.doi.org/10.1074/jbc.M117.782433			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28450393	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000403113000024
J	Santamaria, S; Reglinska-Matveyev, N; Gierula, M; Camire, RM; Crawley, JTB; Lane, DA; Ahnstrom, J				Santamaria, Salvatore; Reglinska-Matveyev, Natalia; Gierula, Magdalena; Camire, Rodney M.; Crawley, James T. B.; Lane, David A.; Ahnstrom, Josefin			Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-FACTOR-PATHWAY; ACTIVATED PROTEIN-C; FACTOR-XA INHIBITION; B-DOMAIN; BLOOD-COAGULATION; ANTITHROMBIN-III; FACTOR VIIIA; TFPI-ALPHA; PROTHROMBINASE; RESIDUES	Tissue factor pathway inhibitor (TFPI), the main inhibitor of initiation of coagulation, exerts an important anticoagulant role through the factor Xa (FXa)-dependent inhibition of tissue factor/ factor VIIa. Protein S is a TFPI cofactor, enhancing the efficiency of FXa inhibition. TFPI can also inhibit prothrombinase assembly by directly interacting with coagulation factor V (FV), which has been activated by FXa. Because full-length TFPI associates with FV in plasma, we hypothesized that FV may influence TFPI inhibitory function. Using pure component FXa inhibition assays, we found that although FV alone did not influence TFPI-mediated FXa inhibition, it further enhanced TFPI in the presence of protein S, resulting in an similar to 8-fold reduction in K-i compared with TFPI alone. A FV variant (R709Q/R1018Q/R1545Q, FV Delta IIa) that cannot be cleaved/activated by thrombin or FXa also enhanced TFPI-mediated inhibition of FXa similar to 12-fold in the presence of protein S. In contrast, neither activated FV nor recombinant B-domain-deleted FV could enhance TFPI-mediated inhibition of FXa in the presence of protein S, suggesting a functional contribution of the B domain. Using TFPI and protein S variants, we show further that the enhancement of TFPI-mediated FXa inhibition by protein S and FV depends on a direct protein S/TFPI interaction and that the TFPI C-terminal tail is not essential for this enhancement. In FXa-catalyzed prothrombin activation assays, both FV and FV IIa (but not activated FV) enhanced TFPI function in the presence of protein S. These results demonstrate a new anticoagulant (cofactor) function of FV that targets the early phase of coagulation before prothrombinase assembly.	[Santamaria, Salvatore; Reglinska-Matveyev, Natalia; Gierula, Magdalena; Crawley, James T. B.; Lane, David A.; Ahnstrom, Josefin] Imperial Coll London, Ctr Haematol, Fac Med, London W12 0NN, England; [Camire, Rodney M.] Univ Penn, Dept Pediat, Div Hematol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Camire, Rodney M.] Childrens Hosp Philadelphia, Ctr Cell & Mol Therapeut, Philadelphia, PA 19104 USA	Imperial College London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ahnstrom, J (corresponding author), Imperial Coll London, Ctr Haematol, Fac Med, London W12 0NN, England.	j.ahnstrom@imperial.ac.uk	Crawley, James TB/A-9290-2008	Crawley, James TB/0000-0002-6723-7841; Santamaria, Salvatore/0000-0001-8670-7776; Lane, David/0000-0003-4283-3695	British Heart Foundation [PG/14/63/31036, FS/11/60/28940, FS/12/60/29874]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/14/63/31036, FS/11/60/28940, and FS/12/60/29874. The authors declare that they have no conflicts of interest with the contents of this article.	Ahnstrom J, 2012, BLOOD, V120, P5059, DOI 10.1182/blood-2012-05-432005; Ahnstrom J, 2011, BLOOD, V117, P6685, DOI 10.1182/blood-2010-11-317099; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; BROZE GJ, 1988, BLOOD, V71, P335; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Cunha MLR, 2015, BLOOD, V125, P1822, DOI 10.1182/blood-2014-08-592733; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Evenas P, 2000, THROMB HAEMOSTASIS, V84, P271, DOI 10.1055/s-0037-1614007; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Hansen JB, 1997, THROMB RES, V85, P413, DOI 10.1016/S0049-3848(97)00029-7; Heeb MJ, 2013, THROMB HAEMOSTASIS, V110, P275, DOI 10.1160/TH12-12-0953; Heeb MJ, 1999, J BIOL CHEM, V274, P36187, DOI 10.1074/jbc.274.51.36187; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; LAWSON JH, 1994, J BIOL CHEM, V269, P23357; Lu DS, 1996, BLOOD, V87, P4708, DOI 10.1182/blood.V87.11.4708.bloodjournal87114708; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MARCINIAK E, 1973, BRIT J HAEMATOL, V24, P391, DOI 10.1111/j.1365-2141.1973.tb01662.x; Mast AE, 1996, BLOOD, V87, P1845; Ndonwi M, 2012, J THROMB HAEMOST, V10, P1944, DOI 10.1111/j.1538-7836.2012.04834.x; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; NOVOTNY WF, 1991, BLOOD, V78, P387; Nyberg P, 1998, FEBS LETT, V433, P28, DOI 10.1016/S0014-5793(98)00877-1; Peraramelli S, 2014, J THROMB HAEMOST, V12, P1826, DOI 10.1111/jth.12713; Peraramelli S, 2016, THROMB HAEMOSTASIS, V115, P580, DOI 10.1160/TH15-04-0354; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Reglinska-Matveyev N, 2014, BLOOD, V123, P3979, DOI 10.1182/blood-2014-01-551812; ROSENBERG RD, 1984, J CLIN INVEST, V74, P1, DOI 10.1172/JCI111389; SANDERS NL, 1985, BLOOD, V66, P204; SHEN L, 1994, J BIOL CHEM, V269, P18735; Somajo S, 2015, THROMB HAEMOSTASIS, V113, P976, DOI 10.1160/TH14-09-0803; Thorelli E, 1998, J BIOL CHEM, V273, P16140, DOI 10.1074/jbc.273.26.16140; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; van Doorn P, 2017, J THROMB HAEMOST, V15, P140, DOI 10.1111/jth.13559; van't Veer C, 1999, THROMB HAEMOSTASIS, V82, P80; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110	45	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9335	9344		10.1074/jbc.M116.769570	http://dx.doi.org/10.1074/jbc.M116.769570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28420729	Green Published, hybrid			2022-12-28	WOS:000402538900027
J	Tanaka, BS; Nguyen, PT; Zhou, EYH; Yang, Y; Yarov-Yarovoy, V; Dib-Hajj, SD; Waxman, SG				Tanaka, Brian S.; Nguyen, Phuong T.; Zhou, Eray Yihui; Yang, Yong; Yarov-Yarovoy, Vladimir; Dib-Hajj, Sulayman D.; Waxman, Stephen G.			Gain-of-function mutation of a voltage-gated sodium channel Na(V)1.7 associated with peripheral pain and impaired limb development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSED-STATE INACTIVATION; SMALL FIBER NEUROPATHY; ROOT GANGLION NEURONS; IMMUNOREACTIVE NERVES; ELECTROPHYSIOLOGICAL PROPERTIES; PRIMARY ERYTHERMALGIA; SLOW-INACTIVATION; SENSORY NEURONS; ALPHA-SUBUNIT; DRG NEURONS	Dominant mutations in voltage-gated sodium channelNa(V)1.7 cause inherited erythromelalgia, a debilitating pain disorder characterized by severe burning pain and redness of the distal extremities. Na(V)1.7 is preferentially expressed within peripheral sensory and sympathetic neurons. Here, we describe a novel Na(V)1.7 mutation in an 11-year-old male with underdevelopment of the limbs, recurrent attacks of burning pain with erythema, and swelling in his feet and hands. Frequency and duration of the episodes gradually increased with age, and relief by cooling became less effective. The patient's sister had short stature and reported similar complaints of erythema and burning pain, but with less intensity. Genetic analysis revealed a novel missense mutation in Na(V)1.7 (2567G>C; p.Gly856Arg) in both siblings. The G856R mutation, located within the DII/S4-S5 linker of the channel, substitutes a highly conserved non-polar glycine by a positively charged arginine. Voltage-clamp analysis of G856R currents revealed that the mutation hyperpolarized (-11.2 mV) voltage dependence of activation and slowed deactivation but did not affect fast inactivation, compared with wildtype channels. A mutation of Gly-856 to aspartic acid was previously found in a family with limb pain and limb underdevelopment, and its functional assessment showed hyperpolarized activation, depolarized fast inactivation, and increased ramp current. Structural modeling using the Rosetta computational modeling suite provided structural clues to the divergent effects of the substitution of Gly-856 by arginine and aspartic acid. Although the proexcitatory changes in gating properties of G856R contribute to the pathophysiology of inherited erythromelalgia, the link to limb underdevelopment is not well understood.	[Tanaka, Brian S.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Tanaka, Brian S.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, 333 Cedar St, New Haven, CT 06510 USA; [Tanaka, Brian S.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA; [Nguyen, Phuong T.; Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Nguyen, Phuong T.; Yarov-Yarovoy, Vladimir] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Zhou, Eray Yihui; Yang, Yong] Peking Univ, Dept Dermatol, Hosp 1, Beijing 100034, Peoples R China; [Zhou, Eray Yihui] Tsinghua Univ, Dept Dermatol, Beijing Tsinghua Changgung Hosp, Beijing 102218, Peoples R China	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of California System; University of California Davis; University of California System; University of California Davis; Peking University; Tsinghua University	Waxman, SG (corresponding author), VA Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res Ctr, 950 Campbell Ave,Bldg 34, West Haven, CT 06516 USA.	stephen.waxman@yale.edu	Nguyen, Phuong T./AAT-6194-2020; Zhou, Eray/HHC-3301-2022; Yarov-Yarovoy, Vladimir/ABE-5454-2020; Waxman, Stephen/Z-2507-2019	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Waxman, Stephen/0000-0001-5718-7177; Tanaka, Brian/0000-0002-6678-6478	Medical Research Service and Rehabilitation Research Service; Department of Veterans Affairs; University of California, Davis startup funds	Medical Research Service and Rehabilitation Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); University of California, Davis startup funds(University of California System)	This work was supported by the Medical Research Service and Rehabilitation Research Service, the Department of Veterans Affairs (to S.D. D.-H. and S. G. W.), and University of California, Davis startup funds (to V. Y.-Y.). The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America with Yale University. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; BEVAN S, 1985, PROC R SOC SER B-BIO, V225, P299, DOI 10.1098/rspb.1985.0063; BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X; BLACK JA, 1995, MOL BRAIN RES, V34, P89, DOI 10.1016/0169-328X(95)00141-E; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Burns TM, 2005, BRIT J DERMATOL, V153, P174, DOI 10.1111/j.1365-2133.2005.06441.x; Cheng X, 2011, BRAIN, V134, P1972, DOI 10.1093/brain/awr143; CHIU SY, 1984, NATURE, V311, P156, DOI 10.1038/311156a0; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Ding YX, 2010, BONE, V46, P1591, DOI 10.1016/j.bone.2010.02.022; Djouhri L, 2003, J PHYSIOL-LONDON, V546, P565, DOI 10.1113/jphysiol.2002.026559; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Han CY, 2015, NEUROMOL MED, V17, P158, DOI 10.1007/s12017-015-8347-9; Han CY, 2012, BRAIN, V135, P2613, DOI 10.1093/brain/aws187; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hite RK, 2014, ELIFE, V3, DOI 10.7554/eLife.04366; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Hoeijmakers JGJ, 2012, BRAIN, V135, P345, DOI 10.1093/brain/awr349; HUKKANEN M, 1993, NEUROSCIENCE, V54, P969, DOI 10.1016/0306-4522(93)90588-7; Hurrell DJ, 1937, J ANAT, V72, P54; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stoffels M, 2016, ANNU REV GENOM HUM G, V17, P245, DOI 10.1146/annurev-genom-090413-025334; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang X., 2011, 261582010 GBT STAND; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	57	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9262	9272		10.1074/jbc.M117.778779	http://dx.doi.org/10.1074/jbc.M117.778779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28381558	Green Published, hybrid			2022-12-28	WOS:000402538900021
J	Polevoda, B; Joseph, R; Friedman, AE; Bennett, RP; Greiner, R; Zoysa, T; Stewart, RA; Smith, HC				Polevoda, Bogdan; Joseph, Rebecca; Friedman, Alan E.; Bennett, Ryan P.; Greiner, Rebecca; De Zoysa, Thareendra; Stewart, Ryan A.; Smith, Harold C.			DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytidine deaminase; DNA binding protein; human immunodeficiency virus (HIV); mass spectrometry (MS); protein cross-linking; RNA; RNA binding protein; APOBEC; HIV	ANTIVIRAL PROTEIN APOBEC3G; PHOTO-CROSS-LINKING; REVERSE TRANSCRIPTION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; 7SL RNA; FUNCTIONAL-ANALYSIS; IN-VITRO; P-BODIES; ENZYME	APOBEC3G (A3G) belongs to the AID/APOBEC protein family of cytidine deaminases (CDA) that bind to nucleic acids. A3G mutates the HIV genome by deamination of dC to dU, leading to accumulation of virus-inactivating mutations. Binding to cellular RNAs inhibits A3G binding to substrate single-stranded (ss) DNA and CDA activity. Bulk RNA and substrate ssDNA bind to the same three A3G tryptic peptides (amino acids 181-194, 314-320, and 345-374) that form parts of a continuously exposed protein surface extending from the catalytic domain in the C terminus of A3G to its N terminus. We show here that the A3G tyrosines 181 and 315 directly cross-linked ssDNA. Binding experiments showed that a Y315A mutation alone significantly reduced A3G binding to both ssDNA and RNA, whereas Y181A and Y182A mutations only moderately affected A3G nucleic acid binding. Consistent with these findings, the Y315A mutant exhibited little to no deaminase activity in an Escherichia coli DNA mutator reporter, whereas Y181A and Y182A mutants retained similar to 50% of wild-type A3G activity. The Y315A mutant also showed a markedly reduced ability to assemble into viral particles and had reduced antiviral activity. In uninfected cells, the impaired RNA-binding capacity of Y315A was evident by a shift of A3G from high-molecular-mass ribonucleoprotein complexes to low-molecular-mass complexes. We conclude that Tyr-315 is essential for coordinating ssDNA interaction with or entry to the deaminase domain and hypothesize that RNA bound to Tyr-315 may be sufficient to competitively inhibit ssDNA deaminase-dependent antiviral activity.	[Polevoda, Bogdan; Joseph, Rebecca; Greiner, Rebecca; De Zoysa, Thareendra; Smith, Harold C.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Friedman, Alan E.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Smith, Harold C.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Smith, Harold C.] Univ Rochester, Med Ctr, Ctr AIDS Res, Rochester, NY 14642 USA; [Bennett, Ryan P.; Stewart, Ryan A.; Smith, Harold C.] OyaGen Inc, Rochester, NY 14623 USA; [Friedman, Alan E.] Univ Buffalo State Univ New York, Dept Mat Design & Innovat, Buffalo, NY 14260 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Smith, HC (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Ctr RNA Biol, Rochester, NY 14642 USA.; Smith, HC (corresponding author), Univ Rochester, Med Ctr, Ctr AIDS Res, Rochester, NY 14642 USA.	harold.smith@rochester.edu	Polevoda, Bogdan/A-4880-2008; Friedman, Alan/Q-4858-2018	Friedman, Alan/0000-0002-4764-8168; Smith, Harold/0000-0001-6257-6791	National Institutes of Health [NIGMS110568]; University of Rochester Center for AIDS Research (CFAR), a National Institutes of Health [P30 AI078498]; DeKiewiet Summer Research Fellowship in Biology and Medicine; University of Rochester, Rochester [NY 14642]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS Research (CFAR), a National Institutes of Health; DeKiewiet Summer Research Fellowship in Biology and Medicine; University of Rochester, Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant NIGMS110568 (to H. C. S.) and by a grant from the University of Rochester Center for AIDS Research (CFAR), a National Institutes of Health-funded program by Grant P30 AI078498.; Supported by a DeKiewiet Summer Research Fellowship in Biology and Medicine.; Supported through the Summer Undergraduate Research Fellowship Program from the University of Rochester, Rochester, NY 14642.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Apolonia L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004609; Ara A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004024; Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Belanger K, 2015, VIROLOGY, V483, P141, DOI 10.1016/j.virol.2015.04.019; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Dang Y, 2011, J VIROL, V85, P5691, DOI 10.1128/JVI.00243-11; DIETZ TM, 1987, PHOTOCHEM PHOTOBIOL, V46, P971, DOI 10.1111/j.1751-1097.1987.tb04879.x; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Furukawa Ayako, 2009, Nucleic Acids Symp Ser (Oxf), P87, DOI 10.1093/nass/nrp044; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; GOTT JM, 1991, BIOCHEMISTRY-US, V30, P6290, DOI 10.1021/bi00239a030; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kramer K, 2014, NAT METHODS, V11, P1064, DOI [10.1038/NMETH.3092, 10.1038/nmeth.3092]; Kramer K, 2011, INT J MASS SPECTROM, V304, P184, DOI 10.1016/j.ijms.2010.10.009; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lapek JD, 2012, J CHROMATOGR B, V893, P34, DOI 10.1016/j.jchromb.2012.02.029; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Li XY, 2011, VIROLOGY, V414, P130, DOI 10.1016/j.virol.2011.03.014; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Ma JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064047; Marx A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18191; McDougall WM, 2011, BIOCHEM BIOPH RES CO, V412, P612, DOI 10.1016/j.bbrc.2011.08.009; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Pan YG, 2017, BIOCHEMISTRY-US, V56, P1473, DOI 10.1021/acs.biochem.6b01189; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polevoda B, 2016, METHODS, V107, P10, DOI 10.1016/j.ymeth.2016.03.006; Polevoda B, 2015, NUCLEIC ACIDS RES, V43, P9434, DOI 10.1093/nar/gkv970; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Smith HC, 2007, METHOD ENZYMOL, V424, P389, DOI 10.1016/S0076-6879(07)24018-2; Smith HC, 2017, RNA BIOL, V14, P1153, DOI 10.1080/15476286.2016.1259783; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tian CJ, 2007, NUCLEIC ACIDS RES, V35, P7288, DOI 10.1093/nar/gkm816; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wichroski Michael J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020041; WILLIS MC, 1994, NUCLEIC ACIDS RES, V22, P4947, DOI 10.1093/nar/22.23.4947; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; York A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005833; Zhang WY, 2010, J VIROL, V84, P12903, DOI 10.1128/JVI.01632-10	88	9	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8642	8656		10.1074/jbc.M116.767889	http://dx.doi.org/10.1074/jbc.M116.767889			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381554	Green Published, hybrid			2022-12-28	WOS:000402153900012
J	Seger, R; Hanoch, T; Rosenberg, R; Dantes, A; Merz, WE; Strauss, JF; Amsterdam, A				Seger, Rony; Hanoch, Tamar; Rosenberg, Revital; Dantes, Ada; Merz, Wolfgang E.; Strauss, Jerome F.; Amsterdam, Abraham			RETRACTION: The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis (Retraction of Vol 276, Pg 13957, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200	1	5	5	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8847	8847		10.1074/jbc.A117.006852	http://dx.doi.org/10.1074/jbc.A117.006852			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550133	Green Published, hybrid			2022-12-28	WOS:000402153900030
J	Yung, Y; Yao, Z; Aebersold, DM; Hanoch, T; Seger, R				Yung, Yuval; Yao, Zhong; Aebersold, Daniel M.; Hanoch, Tamar; Seger, Rony			RETRACTION: Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs (Retraction of Vol 276, Pg 35280, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													CHEN, Huanwen/B-1794-2008; Aebersold, Daniel Matthias/C-2946-2013	Aebersold, Daniel Matthias/0000-0002-9493-3834				Yung Y, 2001, J BIOL CHEM, V276, P35280, DOI 10.1074/jbc.M105995200	1	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8852	8852		10.1074/jbc.A117.105995	http://dx.doi.org/10.1074/jbc.A117.105995			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550138	Green Published, hybrid			2022-12-28	WOS:000402153900035
J	Zhu, J; Miao, QH; Tan, YG; Guo, HM; Liu, T; Wang, BB; Chen, ZY; Li, CF; Liu, GQ				Zhu, Jie; Miao, Qiuhong; Tan, Yonggui; Guo, Huimin; Liu, Teng; Wang, Binbin; Chen, Zongyan; Li, Chuanfeng; Liu, Guangqing			Inclusion of an Arg-Gly-Asp receptor-recognition motif into the capsid protein of rabbit hemorrhagic disease virus enables culture of the virus in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YOUNG-RABBITS; INTEGRINS; CALICIVIRUS; CELLS; ENTRY; VP60; GENE; EXPRESSION; PARTICLES; INFECTION	The fact that rabbit hemorrhagic disease virus (RHDV), an important member of the Caliciviridae family, cannot be propagated in vitro has greatly impeded the progress of investigations into the mechanisms of pathogenesis, translation, and replication of this and related viruses. In this study, we have successfully bypassed this obstacle by constructing a mutant RHDV (mRHDV) by using a reverse genetics technique. By changing two amino acids (S305R,N307D), we produced a specific receptor-recognition motif (Arg-Gly-Asp; called RGD) on the surface of the RHDV capsid protein. mRHDV was recognized by the intrinsic membrane receptor (integrin) of the RK-13 cells, which then gained entry and proliferated as well as imparted apparent cytopathic effects. After 20 passages, the titers of RHDV reached 1 x 10(4.3) 50% tissue culture infectious dose (TCID50)/ml at 72 h. Furthermore, mRHDV-infected rabbits showed typical rabbit plague symptoms and died within 48-72 h. After immunization with inactivated mRHDV, the rabbits survived wild-type RHDV infection, indicating that mRHDV could be a candidate virus strain for producing a vaccine against RHDV infection. In summary, this study offers a novel strategy for overcoming the challenges of proliferating RHDV in vitro. Because virus uptake via specific membrane receptors, several of which specifically bind to the RGD peptide motif, is a common feature of host cells, we believe that this the strategy could also be applied to other RNA viruses that currently lack suitable cell lines for propagation such as hepatitis E virus and norovirus.	[Zhu, Jie; Miao, Qiuhong; Tan, Yonggui; Guo, Huimin; Liu, Teng; Wang, Binbin; Chen, Zongyan; Li, Chuanfeng; Liu, Guangqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Liu, GQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.	liugq@shvri.ac.cn	chen, zongyan/ABG-9170-2021; Miao, Qiuhong/AAJ-1747-2020; Zhu, Jie/X-6219-2019	Miao, Qiuhong/0000-0003-3670-6227; Zhu, Jie/0000-0001-7941-4166	key research project of National Science and Technology [2016YFD0500108]; National Natural Science Foundation of China [31672572]; key project of Agricultural Science and Technology of Shanghai [2016043]; Fundamental Research Funds for the Central Institutes program [2016JB01]; Special Fund for Agro-scientific Research in the Public Interest [201303046]	key research project of National Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Agricultural Science and Technology of Shanghai; Fundamental Research Funds for the Central Institutes program; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the key research project of National Science and Technology (Grant 2016YFD0500108) (to G.L.), the National Natural Science Foundation of China (Grant 31672572) (to G.L.), the key project of Agricultural Science and Technology of Shanghai (Grant 2016043) (to G.L.), the Fundamental Research Funds for the Central Institutes program (Grant 2016JB01) (to G.L.), and the Special Fund for Agro-scientific Research in the Public Interest (Grant 201303046) (to G.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Arguello Villares JL, 1991, REV SCI TECH OIE, V10, P459; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cancellotti F.M., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P409; Carter RT, 2009, VET OPHTHALMOL, V12, P2, DOI 10.1111/j.1463-5224.2009.00726.x; Cheng YJ, 2013, ANTIVIR RES, V97, P227, DOI 10.1016/j.antiviral.2012.12.028; Cheshenko N, 2014, J VIROL, V88, P10026, DOI 10.1128/JVI.00725-14; Cordoba L, 2012, J GEN VIROL, V93, P2183, DOI 10.1099/vir.0.043711-0; CS L, 1987, KOREAN J VET RES, V27, P277; Farnos O, 2005, J BIOTECHNOL, V117, P215, DOI 10.1016/j.jbiotec.2005.01.013; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Ferreira PG, 2006, RES VET SCI, V81, P362, DOI 10.1016/j.rvsc.2006.02.001; Ferreira PG, 2004, RES VET SCI, V76, P83, DOI 10.1016/j.rvsc.2003.08.003; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Gil F, 2006, PLANT BIOTECHNOL J, V4, P135, DOI 10.1111/j.1467-7652.2005.00172.x; Gregg D A, 1991, Rev Sci Tech, V10, P435; Guo HM, 2016, ANTIVIR RES, V131, P85, DOI 10.1016/j.antiviral.2016.04.011; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Konig M, 1998, J VIROL, V72, P4492; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu GQ, 2006, J VIROL, V80, P6597, DOI 10.1128/JVI.02078-05; Liu S. J., 1984, Animal Husbandry and Veterinary Medicine (Xumu yu Shouyi), V16, P253; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Mikami D, 1999, RES VET SCI, V66, P237, DOI 10.1053/rvsc.1998.0266; Morisse J.-P., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P269; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; Nowotny N, 1997, ARCH VIROL, V142, P657, DOI 10.1007/s007050050109; Nystrom K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002188; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; Yoon CS, 2001, BIOCHEM BIOPH RES CO, V283, P668, DOI 10.1006/bbrc.2001.4838; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143467	44	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8605	8615		10.1074/jbc.M117.780924	http://dx.doi.org/10.1074/jbc.M117.780924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381555	Green Published, hybrid			2022-12-28	WOS:000402153900009
J	Upadhyay, AS; Stehling, O; Panayiotou, C; Rosser, R; Lill, R; Overby, AK				Upadhyay, Arunkumar S.; Stehling, Oliver; Panayiotou, Christakis; Roesser, Ralf; Lill, Roland; Overby, Anna K.			Cellular requirements for iron-sulfur cluster insertion into the antiviral radical SAM protein viperin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPHIPATHIC ALPHA-HELIX; HEPATITIS-C VIRUS; WEST NILE VIRUS; DNA METABOLISM; BIOGENESIS; REPLICATION; MMS19; IDENTIFICATION; MATURATION; INHIBIT	Viperin (RSAD2) is an interferon-stimulated antiviral protein that belongs to the radical S-adenosylmethionine (SAM) enzyme family. Viperin's iron-sulfur (Fe/S) cluster is critical for its antiviral activity against many different viruses. CIA1 (CIAO1), an essential component of the cytosolic iron-sulfur protein assembly (CIA) machinery, is crucial for Fe/S cluster insertion into viperin and hence for viperin's antiviral activity. In the CIA pathway, CIA1 cooperates with CIA2A, CIA2B, and MMS19 targeting factors to form various complexes that mediate the dedicated maturation of specific Fe/S recipient proteins. To date, however, the mechanisms of how viperin acquires its radical SAM Fe/S cluster to gain antiviral activity are poorly understood. Using co-immunoprecipitation and Fe-55-radiolabeling experiments, we therefore studied the roles of CIA2A, CIA2B, and MMS19 for Fe/S cluster insertion. CIA2B and MMS19 physically interacted with the C terminus of viperin and used CIA1 as the primary viperin-interacting protein. In contrast, CIA2A bound to viperin's N terminus in a CIA1-, CIA2B-, and MMS19-independent fashion. Of note, the observed interaction of both CIA2 isoforms with a single Fe/S target protein is unprecedented in the CIA pathway. Fe-55-radiolabeling experiments with human cells depleted of CIA1, CIA2A, CIA2B, or MMS19 revealed that CIA1, but none of the other CIA factors, is predominantly required for (55F)e/S cluster incorporation into viperin. Collectively, viperin maturation represents a novel CIA pathway with a minimal requirement of the CIA-targeting factors and represents a new paradigm for the insertion of the Fe/S cofactor into a radical SAM protein.	[Upadhyay, Arunkumar S.; Panayiotou, Christakis; Overby, Anna K.] Umea Univ, Dept Clin Microbiol, Virol, Bldg 6F, S-90185 Umea, Sweden; [Upadhyay, Arunkumar S.; Panayiotou, Christakis; Overby, Anna K.] Umea Univ, Lab Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Stehling, Oliver; Roesser, Ralf; Lill, Roland] Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany; [Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, Hans Meerwein Str, D-35043 Marburg, Germany	Umea University; Umea University; Philipps University Marburg	Overby, AK (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, Bldg 6F, S-90185 Umea, Sweden.; Lill, R (corresponding author), Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	lill@staff.uni-marburg.de; anna.overby@umu.se		Lill, Roland/0000-0002-8345-6518; Overby Wernstedt, Anna/0000-0001-6553-0940	Laboratory for Molecular Medicine Sweden (MIMS); Umea Center for Microbial Research (UCMR); Swedish Research Council [2011-2795]; Swedish Foundation for Strategic Research [ICA10-0059, FFL12-0089]; EMBO Short Term Fellowship [ASTF444-2015]; Deutsche Forschungsgemeinschaft [LI 415/6, SPP 1710, SPP 1927]	Laboratory for Molecular Medicine Sweden (MIMS); Umea Center for Microbial Research (UCMR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Laboratory for Molecular Medicine Sweden (MIMS), the Umea Center for Microbial Research (UCMR), Swedish Research Council Grant 2011-2795, Swedish Foundation for Strategic Research Grants ICA10-0059 and FFL12-0089 (to A. K. O.), and EMBO Short Term Fellowship ASTF444-2015) (to A. S. U.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Deutsche Forschungsgemeinschaft Grants LI 415/6, SPP 1710, and SPP 1927. To whom correspondence may be addressed: Institut fur Zytobiologie und Zytopathologie, Philipps-Universitat Marburg, Robert-Kochstr. 6, 35032 Marburg, Germany. Tel.: 49-6421-2866483; Fax: 49-6421-2866449; E-mail: lill@staff.uni-marburg.de.	Balk J, 2005, BIOCHEM SOC T, V33, P86, DOI 10.1042/BST0330086; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Paul VD, 2015, ELIFE, V4, DOI 10.7554/eLife.08231; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Seki M, 2013, J BIOL CHEM, V288, P16680, DOI 10.1074/jbc.M112.416602; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; van Wietmarschen N, 2012, J BIOL CHEM, V287, P43351, DOI 10.1074/jbc.M112.431270; Vashisht AA, 2015, J BIOL CHEM, V290, P14218, DOI 10.1074/jbc.M115.650762; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	39	22	24	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13879	13889		10.1074/jbc.M117.780122	http://dx.doi.org/10.1074/jbc.M117.780122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28615450	hybrid, Green Published			2022-12-28	WOS:000407942400029
J	Lin, WK; Bolton, EL; Cortopassi, WA; Wang, YW; O'Brien, F; Maciejewska, M; Jacobson, MP; Garnham, C; Ruas, M; Parrington, J; Lei, M; Sitsapesan, R; Galione, A; Terrar, DA				Lin, Wee K.; Bolton, Emma L.; Cortopassi, Wilian A.; Wang, Yanwen; O'Brien, Fiona; Maciejewska, Matylda; Jacobson, Matthew P.; Garnham, Clive; Ruas, Margarida; Parrington, John; Lei, Ming; Sitsapesan, Rebecca; Galione, Antony; Terrar, Derek A.			Synthesis of the Ca2+ - mobilizing messengers NAADP and cADPR by intracellular CD38 enzyme in the mouse heart: Role in beta-adrenoceptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; CARDIAC SARCOPLASMIC-RETICULUM; DINUCLEOTIDE PHOSPHATE NAADP; RYANODINE RECEPTOR; RELEASE CHANNELS; CALCIUM-RELEASE; ACCURATE DOCKING; PK(A) VALUES; FORCE-FIELD; EADOCK DSS	Nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP-ribose (cADPR) are Ca2+ -mobilizing messengers important for modulating cardiac excitation-contraction coupling and pathophysiology. CD38, which belongs to the ADP-ribosyl cyclase family, catalyzes synthesis of both NAADP and cADPR in vitro. However, it remains unclear whether this is the main enzyme for their production under physiological conditions. Here we show that membrane fractions from WT but not CD38(-/-) mouse hearts supported NAADP and cADPR synthesis. Membrane permeabilization of cardiac myocytes with saponin and/or Triton X-100 increased NAADP synthesis, indicating that intracellular CD38 contributes to NAADP production. The permeabilization also permitted immunostaining of CD38, with a striated pattern in WT myocytes, whereas CD38(-/-) myocytes and nonpermeabilized WT myocytes showed little or no staining, without striation. A component of beta-adrenoreceptor signaling in the heart involves NAADP and lysosomes. Accordingly, in the presence of isoproterenol, Ca2+ transients and contraction amplitudes were smaller in CD38(-/-) myocytes than in the WT. In addition, suppressing lysosomal function with bafilomycin A1 reduced the isoproterenol-induced increase in Ca2+ transients in cardiac myocytes from WT but not CD38(-/-) mice. Whole hearts isolated from CD38(-/-) mice and exposed to isoproterenol showed reduced arrhythmias. SAN4825, an ADP-ribosyl cyclase inhibitor that reduces cADPR and NAADP synthesis in mouse membrane fractions, was shown to bind to CD38 in docking simulations and reduced the isoproterenol-induced arrhythmias in WT hearts. These observations support generation of NAADP and cADPR by intracellular CD38, which contributes to effects of beta-adrenoreceptor stimulation to increase both Ca2+ transients and the tendency to disturb heart rhythm.	[Lin, Wee K.; Bolton, Emma L.; O'Brien, Fiona; Maciejewska, Matylda; Garnham, Clive; Ruas, Margarida; Parrington, John; Lei, Ming; Sitsapesan, Rebecca; Galione, Antony; Terrar, Derek A.] Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England; [Cortopassi, Wilian A.] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Cortopassi, Wilian A.; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wang, Yanwen] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9NT, Lancs, England	University of Oxford; University of Oxford; University of California System; University of California San Francisco; University of Manchester	Terrar, DA (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	derek.terrar@pharm.ox.ac.uk	Cortopassi, Wilian/P-3136-2014; Jacobson, Matthew/Y-5161-2018	Cortopassi, Wilian/0000-0001-8038-7847; Jacobson, Matthew/0000-0001-6262-655X; Terrar, Derek/0000-0001-9408-6594; Galione, Antony/0000-0002-4132-7646; Ruas, Margarida/0000-0002-4872-7618	British Heart Foundation (BHF); Medical Research Council; BHF Centre of Research Excellence (CRE); BHF; BHF CRE; Wellcome Trust	British Heart Foundation (BHF)(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF Centre of Research Excellence (CRE); BHF(British Heart Foundation); BHF CRE; Wellcome Trust(Wellcome Trust)	Funded by the British Heart Foundation (BHF), Medical Research Council, and BHF Centre of Research Excellence (CRE).; Funded by the BHF and BHF CRE.; Funded by a Wellcome Trust Senior Investigatorship and BHF CRE.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Aston D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40620; Bruzzone S., 2012, MESSENGER, V1, P34, DOI [10.1166/msr.2012.1007, DOI 10.1166/MSR.2012.1007]; Capel RA, 2015, J BIOL CHEM, V290, P30087, DOI 10.1074/jbc.M115.684076; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; De Flora Antonio, 1998, Cell Biochemistry and Biophysics, V28, P45; Dorian P, 2005, J CARDIOVASC PHARM T, V10, pS15, DOI 10.1177/10742484050100i403; Ferrero E, 2014, FRONT BIOSCI-LANDMRK, V19, P986, DOI 10.2741/4262; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Galfre E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031956; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Gul R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149125; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hara-Yokoyama M, 2012, STRUCTURE, V20, P1585, DOI 10.1016/j.str.2012.06.017; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; HOLMBERG SRM, 1990, BIOCHIM BIOPHYS ACTA, V1022, P187, DOI 10.1016/0005-2736(90)90113-3; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jamur MC, 2010, METHODS MOL BIOL, V588, P63, DOI 10.1007/978-1-59745-324-0_9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kannt A, 2012, N-S ARCH PHARMACOL, V385, P717, DOI 10.1007/s00210-012-0750-2; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li LW, 2015, J CELL SCI, V128, P951, DOI 10.1242/jcs.160689; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Liu Q, 2008, BIOCHEMISTRY-US, V47, P13966, DOI 10.1021/bi801642q; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Macgregor AT, 2007, CELL CALCIUM, V41, P537, DOI 10.1016/j.ceca.2006.10.005; MAHONY L, 1988, PEDIATR RES, V24, P639, DOI 10.1203/00006450-198811000-00020; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; MICHALAK M, 1988, BIOCHEM J, V253, P631, DOI 10.1042/bj2530631; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Nebel M, 2013, J BIOL CHEM, V288, P16017, DOI 10.1074/jbc.M112.441246; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Rakovic S, 1996, CURR BIOL, V6, P989, DOI 10.1016/S0960-9822(02)00643-7; Rakovic S, 1999, J BIOL CHEM, V274, P17820, DOI 10.1074/jbc.274.25.17820; Rakovic S., 2002, CYCLIC ADP RIBOSE NA, P319; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sikkel MB, 2013, CARDIOVASC RES, V98, P286, DOI 10.1093/cvr/cvt012; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SITSAPESAN R, 1994, CIRC RES, V75, P596, DOI 10.1161/01.RES.75.3.596; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Terrar D. A., 2015, MESSENGER, V4, P23; Venturi E, 2012, CARDIOVASC THER, V30, P109, DOI 10.1111/j.1755-5922.2010.00236.x; Wachter SB, 2012, CARDIOLOGY, V122, P104, DOI 10.1159/000339271; Xie GH, 2003, BIOCHEM BIOPH RES CO, V307, P713, DOI 10.1016/S0006-291X(03)01240-3; Zhang H., 2013, MESSENGER, V2, P44, DOI [DOI 10.1166/msr.2013.1020, 10.1166/msr.2013.1020, DOI 10.1166/MSR.2013.1020]; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zissimopoulos S, 2005, J BIOL CHEM, V280, P5475, DOI 10.1074/jbc.M412954200	70	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13243	13257		10.1074/jbc.M117.789347	http://dx.doi.org/10.1074/jbc.M117.789347			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28539361	Green Published, hybrid			2022-12-28	WOS:000407465300014
J	Schmidt, EGW; Hvam, ML; Antunes, F; Cameron, J; Viuff, D; Andersen, B; Kristensen, NN; Howard, KA				Schmidt, Esben G. W.; Hvam, Michael L.; Antunes, Filipa; Cameron, Jason; Viuff, Dorthe; Andersen, Birgitte; Kristensen, Nanna N.; Howard, Kenneth A.			Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONALLY MODIFIED ALBUMINS; PROXIMAL TUBULE CELLS; IGG TRANSPORT; FUNCTIONAL EXPRESSION; SERUM IGG; BINDING; TRANSCYTOSIS; ENDOCYTOSIS; HOMEOSTASIS; CATABOLISM	Albumin is the most abundant plasma protein involved in the transport of many compounds, such as fatty acids, bilirubin, and heme. The endothelial cellular neonatal Fc receptor (FcRn) has been suggested to play a central role in maintaining high albumin plasma levels through a cellular recycling pathway. However, direct mapping of this process is still lacking. This work presents the use of wild-type and engineered recombinant albumins with either decreased or increased FcRn affinity in combination with a low or high FcRn-expressing endothelium cell line to clearly define the FcRn involvement, intracellular pathway, and kinetics of albumin trafficking by flow cytometry, quantitative confocal microscopy, and an albumin-recycling assay. We found that cellular albumin internalization was proportional to FcRn expression and albumin-binding affinity. Albumin accumulation in early endosomes was independent of FcRn-binding affinity, but differences in FcRn-binding affinities significantly affected the albumin distribution between late endosomes and lysosomes. Unlike albumin with low FcRn-binding affinity, albumin with high FcRn-binding affinity was directed less to the lysosomes, suggestive of FcRn-directed albumin salvage from lysosomal degradation. Furthermore, the amount of recycled albumin in cell culture media corresponded to FcRn-binding affinity, with a similar to 3.3-fold increase after 1 h for the high FcR-nbinding albumin variant compared with wild-type albumin. Together, these findings uncover an FcRn-dependent endosomal cellular-sorting pathway that has great importance in describing fundamental mechanisms of intracellular albumin recycling and the possibility to tune albumin-based therapeutic effects by FcRn-binding affinity.	[Schmidt, Esben G. W.; Viuff, Dorthe; Andersen, Birgitte; Kristensen, Nanna N.] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Hvam, Michael L.; Howard, Kenneth A.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Antunes, Filipa; Cameron, Jason] Albumedix Ltd, Nottingham NG7 1FD, England	Novozymes; Aarhus University	Howard, KA (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.	kenh@inano.au.dk	Chen, Liang/Q-5337-2019	Chen, Liang/0000-0001-5845-2235; Howard, Kenneth/0000-0002-9407-278X; Kristensen, Nanna Ny/0000-0002-3493-2565				Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2014, J BIOL CHEM, V289, P13492, DOI 10.1074/jbc.M114.549832; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Baggio LL, 2008, GASTROENTEROLOGY, V134, P1137, DOI 10.1053/j.gastro.2008.01.017; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Brambell F. W. R., 1970, TRANSMISSION PASSIVE, P1; Brulisauer L, 2014, ANGEW CHEM INT EDIT, V53, P8392, DOI 10.1002/anie.201404238; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Ehrhardt C., 2008, DRUG ABSORPTION STUD, P640; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Gan Z, 2009, TRAFFIC, V10, P600, DOI 10.1111/j.1600-0854.2009.00887.x; Leitner K, 2006, PLACENTA, V27, P799, DOI 10.1016/j.placenta.2005.08.008; Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999; MAUNSBAC.AB, 1966, NATURE, V212, P546, DOI 10.1038/212546a0; MAUNSBACH AB, 1966, J ULTRA MOL STRUCT R, V15, P197, DOI 10.1016/S0022-5320(66)80108-9; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; PARK CH, 1984, J CLIN INVEST, V73, P767, DOI 10.1172/JCI111270; Peters T., 1996, ALL ALBUMIN BIOCH GE; Predescu D, 2004, AM J PHYSIOL-LUNG C, V287, pL895, DOI 10.1152/ajplung.00075.2004; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; SCHNITZER JE, 1993, J BIOL CHEM, V268, P7562; SCHNITZER JE, 1992, J BIOL CHEM, V267, P24544; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; Schultze, 1966, MOL BIOL HUMAN PROTE; Smith MEB, 2015, ORG BIOMOL CHEM, V13, P7946, DOI 10.1039/c5ob01205h; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; Verroust PJ, 2002, NEPHROL DIAL TRANSPL, V17, P1867, DOI 10.1093/ndt/17.11.1867; Viuff D, 2016, J CONTROL RELEASE, V223, P22, DOI 10.1016/j.jconrel.2015.12.019; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; Weflen AW, 2013, MOL BIOL CELL, V24, P2398, DOI 10.1091/mbc.E13-04-0174; Wu YL, 2010, REGUL PEPTIDES, V164, P83, DOI 10.1016/j.regpep.2010.05.003; Xie D, 2010, ANTIMICROB AGENTS CH, V54, P191, DOI 10.1128/AAC.00976-09	47	47	49	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13312	13322		10.1074/jbc.M117.794248	http://dx.doi.org/10.1074/jbc.M117.794248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637874	Green Published, hybrid			2022-12-28	WOS:000407465300018
J	Kokabu, S; Nakatomi, C; Matsubara, T; Ono, Y; Addison, WN; Lowery, JW; Urata, M; Hudnall, AM; Hitomi, S; Nakatomi, M; Sato, T; Osawa, K; Yoda, T; Rosen, V; Jimi, E				Kokabu, Shoichiro; Nakatomi, Chihiro; Matsubara, Takuma; Ono, Yusuke; Addison, William N.; Lowery, Jonathan W.; Urata, Mariko; Hudnall, Aaron M.; Hitomi, Suzuro; Nakatomi, Mitsushiro; Sato, Tsuyoshi; Osawa, Kenji; Yoda, Tetsuya; Rosen, Vicki; Jimi, Eijiro			The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basic helix-loop-helix (bHLH) transcription factor; mesenchymal stem cells (MSCs); MyoD; myogenesis; skeletal muscle; TLE	MUSCLE SATELLITE CELL; MARROW STROMAL CELLS; GROUCHO-RELATED GENE; STEM-CELLS; EXPRESSION; FAMILY; DOMAIN; PROTEINS; ENHANCER; MEMBER	Satellite cells are skeletal muscle stem cells that provide myonuclei for postnatal muscle growth, maintenance, and repair/regeneration in adults. Normally, satellite cells are mitotically quiescent, but they are activated in response to muscle injury, in which case they proliferate extensively and exhibit up-regulated expression of the transcription factor MyoD, a master regulator of myogenesis. MyoD forms a heterodimer with E proteins through their basic helix-loop-helix domain, binds to E boxes in the genome and thereby activates transcription at muscle-specific promoters. The central role of MyoD in muscle differentiation has increased interest in finding potential MyoD regulators. Here we identified transducin-like enhancer of split (TLE3), one of the Groucho/TLE family members, as a regulator of MyoD function during myogenesis. TLE3 was expressed in activated and proliferative satellite cells in which increased TLE3 levels suppressed myogenic differentiation, and, conversely, reduced TLE3 levels promoted myogenesis with a concomitant increase in proliferation. We found that, via its glutamine- and serine/proline-rich domains, TLE3 interferes with MyoD function by disrupting the association between the basic helix-loop-helix domain of MyoD and E proteins. Our findings indicate that TLE3 participates in skeletal muscle homeostasis by dampening satellite cell differentiation via repression of MyoD transcriptional activity.	[Kokabu, Shoichiro; Nakatomi, Chihiro; Matsubara, Takuma; Urata, Mariko; Jimi, Eijiro] Kyushu Dent Univ, Div Mol Signaling & Biochem, Dept Hlth Promot, Kitakyushu, Fukuoka 8038580, Japan; [Hitomi, Suzuro] Kyushu Dent Univ, Div Physiol, Dept Hlth Promot, Kitakyushu, Fukuoka 8038580, Japan; [Nakatomi, Mitsushiro] Kyushu Dent Univ, Div Anat, Dept Hlth Promot, Kitakyushu, Fukuoka 8038580, Japan; [Osawa, Kenji] Kyushu Dent Univ, Div Oral Med, Dept Sci Phys Funct, Kitakyushu, Fukuoka 8038580, Japan; [Kokabu, Shoichiro; Sato, Tsuyoshi; Yoda, Tetsuya] Saitama Med Univ, Fac Med, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Kokabu, Shoichiro; Rosen, Vicki] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Ono, Yusuke] Nagasaki Univ, Musculoskeletal Mol Biol Res Grp, Grad Sch Biomed Sci, Nagasaki 8528102, Japan; [Addison, William N.] McGill Univ, Shriners Hosp Children, Dept Human Genet, Res Unit, Montreal, PQ H4A 0A9, Canada; [Lowery, Jonathan W.; Hudnall, Aaron M.] Marian Univ, Coll Osteopath Med, Div Biomed Sci, Indianapolis, IN 46222 USA; [Jimi, Eijiro] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Oral Hlth Brain Hlth Total Hlth, Fukuoka 8128582, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Saitama Medical University; Harvard University; Harvard School of Dental Medicine; Nagasaki University; McGill University; Kyushu University	Kokabu, S (corresponding author), Kyushu Dent Univ, Div Mol Signaling & Biochem, Dept Hlth Promot, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r14kokabu@fa.kyu-dent.ac.jp	Matsubara, Takuma/B-5031-2019; Nakatomi, Chihiro/AAV-5575-2021	Matsubara, Takuma/0000-0002-8505-0431; Nakatomi, Chihiro/0000-0003-2049-6624; Addison, William/0000-0002-8587-8028; Kokabu, Shoichiro/0000-0002-6663-4327; Ono, Yusuke/0000-0002-4802-7507	Ministry of Education, Culture, Sports, Science and Technology of Japan [26870543]; Fukuoka Foundation for Sound Health	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health)	This work was supported by a grant obtained from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant 26870543 to S. K.). This work was also supported by the Fukuoka Foundation for Sound Health (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Kokabu S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3753581; Kokabu S, 2015, BIOCHEM BIOPH RES CO, V468, P568, DOI 10.1016/j.bbrc.2015.10.142; Kokabu S, 2014, FEBS LETT, V588, P614, DOI 10.1016/j.febslet.2013.12.031; Kokabu S, 2013, BIOCHEM BIOPH RES CO, V438, P205, DOI 10.1016/j.bbrc.2013.07.054; Kokabu S, 2011, MOL ENDOCRINOL, V25, P474, DOI 10.1210/me.2010-0305; Kokabu S, 2010, J BONE MINER RES, V25, P653, DOI 10.1359/jbmr.090736; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MIYASAKA H, 1993, J BIOL CHEM, V268, P22695; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Parkhurst SM, 1998, TRENDS GENET, V14, P130, DOI 10.1016/S0168-9525(98)01407-3; Pickles LM, 2002, STRUCTURE, V10, P751, DOI 10.1016/S0969-2126(02)00768-2; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; STIFANI S, 1992, NAT GENET, V2, P343, DOI 10.1038/ng1292-343a; Tada Y, 2014, ONCOTARGET, V5, P12317, DOI 10.18632/oncotarget.2640; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tsuka S, 2015, BIOCHEM BIOPH RES CO, V459, P437, DOI 10.1016/j.bbrc.2015.02.123; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Wang YK, 1997, DEVELOPMENT, V124, P2507; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang P, 2013, BIOCHEM BIOPH RES CO, V440, P454, DOI 10.1016/j.bbrc.2013.09.128; Zhu ZM, 1997, DEV DYNAM, V209, P233, DOI 10.1002/(SICI)1097-0177(199706)209:2<233::AID-AJA9>3.3.CO;2-D	52	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12885	12894		10.1074/jbc.M116.774570	http://dx.doi.org/10.1074/jbc.M116.774570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28607151	Green Published, hybrid			2022-12-28	WOS:000407220100018
J	Kemp, MG				Kemp, Michael G.			DNA damage-induced ATM- and Rad-3-related (ATR) kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor IIH (TFIIH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell cycle; cell signaling; DNA damage; DNA damage response; DNA repair; genomic instability; RNA polymerase; transcription; transcription factor	NUCLEOTIDE-EXCISION-REPAIR; CHECKPOINT ACTIVATION; TARGETING ATR; RNA-POLYMERASE; IN-VIVO; REPLICATION CHECKPOINT; HUMAN FIBROBLASTS; COUPLED REPAIR; UV-IRRADIATION; P53	The role of the DNA damage response protein kinase ataxia telangiectasia-mutated (ATM)- and Rad-3-related (ATR) in the cellular response to DNA damage during the replicative phase of the cell cycle has been extensively studied. However, little is known about ATR kinase function in cells that are not actively replicating DNA and that constitute most cells in the human body. Using small-molecule inhibitors of ATR kinase and overexpression of a kinase-inactive form of the enzyme, I show here that ATR promotes cell death in non-replicating/non-cycling cultured human cells exposed to N-acetoxy-2-acetylaminofluorene (NA-AAF), which generates bulky DNA adducts that block RNA polymerase movement. Immunoblot analyses of soluble protein extracts revealed that ATR and other cellular proteins containing SQ motifs become rapidly and robustly phosphorylated in non-cycling cells exposed to NA-AAF in a manner largely dependent on ATR kinase activity but independent of the essential nucleotide excision repair factor XPA. Although the topoisomerase I inhibitor camptothecin also activated ATR in non-cycling cells, other transcription inhibitors that do not directly damage DNA failed to do so. Interestingly, genetic and pharmacological inhibition of the XPB subunit of transcription factor IIH prevented the accumulation of the single-stranded DNA binding protein replication protein A (RPA) on damaged chromatin and severely abrogated ATR signaling in response to NA-AAF and camptothecin. Together, these results reveal a previously unknown role for transcription factor IIH in ATR kinase activation in non-replicating, non-cycling cells.	[Kemp, Michael G.] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Kemp, MG (corresponding author), Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA.	mike.kemp@wright.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745	University of North Carolina Center for Environmental Health and Susceptibility (National Institutes of Health) [P30ES010126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	University of North Carolina Center for Environmental Health and Susceptibility (National Institutes of Health); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a pilot project award (to M. G. K.) from the University of North Carolina Center for Environmental Health and Susceptibility (National Institutes of Health Grant P30ES010126). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alekseev S, 2014, CHEM BIOL, V21, P398, DOI 10.1016/j.chembiol.2013.12.014; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; CHEN YH, 1993, J BIOL CHEM, V268, P5849; CHEN YH, 1991, P NATL ACAD SCI USA, V88, P9583, DOI 10.1073/pnas.88.21.9583; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Donahue BA, 1996, J BIOL CHEM, V271, P10588, DOI 10.1074/jbc.271.18.10588; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; He QL, 2015, ANGEW CHEM INT EDIT, V54, P1859, DOI 10.1002/anie.201408817; Hess MT, 1996, NUCLEIC ACIDS RES, V24, P824, DOI 10.1093/nar/24.5.824; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Karnitz LM, 2015, CLIN CANCER RES, V21, P4780, DOI 10.1158/1078-0432.CCR-15-0479; Kaufmann WK, 2003, MUTAT RES-FUND MOL M, V532, P85, DOI 10.1016/j.mrfmmm.2003.08.012; Kemp MG, 2017, PHOTOCHEM PHOTOBIOL, V93, P178, DOI 10.1111/php.12641; Kemp MG, 2016, J BIOL CHEM, V291, P9330, DOI 10.1074/jbc.M116.719740; Klibanov SA, 2001, J CELL SCI, V114, P1867; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Ljungman M, 2001, ONCOGENE, V20, P5964, DOI 10.1038/sj.onc.1204734; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Llona-Minguez S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.10; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKay BC, 2000, MOL BIOL CELL, V11, P2543, DOI 10.1091/mbc.11.8.2543; Meek DW, 2015, BIOCHEM J, V469, P325, DOI 10.1042/BJ20150517; Munoz MJ, 2017, CELL REP, V18, P2868, DOI 10.1016/j.celrep.2017.02.066; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; O'Hagan HM, 2004, ONCOGENE, V23, P5505, DOI 10.1038/sj.onc.1207709; Ray A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159344; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Song J, 2017, PHOTOCHEM PHOTOBIOL, V93, P192, DOI 10.1111/php.12638; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; van Gijssel HE, 2003, LIFE SCI, V73, P1759, DOI 10.1016/S0024-3205(03)00506-X; van Oosterwijk MF, 1998, J BIOL CHEM, V273, P13599, DOI 10.1074/jbc.273.22.13599; vanOosterwijk MF, 1996, NUCLEIC ACIDS RES, V24, P4653, DOI 10.1093/nar/24.23.4653; Vendetti FP, 2017, SCI REP-UK, V7, DOI 10.1038/srep41892; Vendetti FP, 2015, ONCOTARGET, V6, P44289, DOI 10.18632/oncotarget.6247; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12424	12435		10.1074/jbc.M117.788406	http://dx.doi.org/10.1074/jbc.M117.788406			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28592488	Green Published, hybrid			2022-12-28	WOS:000406636900008
J	Domingo-Fernandez, R; Coll, RC; Kearney, J; Breit, S; O'Neill, LAJ				Domingo-Fernandez, Raquel; Coll, Rebecca C.; Kearney, Jay; Breit, Samuel; O'Neill, Luke A. J.			The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1 beta transcription and activate the NLRP3 inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NUCLEAR TRANSLOCATION; ALZHEIMERS-DISEASE; NALP3 INFLAMMASOME; ATP BINDING; CELL-DEATH; URIC-ACID; INTERLEUKIN-1-BETA; RELEASE; SHOCK	The NLRP3 inflammasome is a multiprotein complex that regulates the activation of caspase-1 leading to the maturation of the proinflammatory cytokines IL-1 beta and IL-18 and promoting pyroptosis. Classically, the NLRP3 inflammasome in murine macrophages is activated by the recognition of pathogen-associated molecular patterns and by many structurally unrelated factors. Understanding the precise mechanism of NLRP3 activation by such a wide array of stimuli remains elusive, but several signaling events, including cytosolic efflux and influx of select ions, have been suggested. Accordingly, several studies have indicated a role of anion channels in NLRP3 inflammasome assembly, but their direct involvement has not been shown. Here, we report that the chloride intracellular channel proteins CLIC1 and CLIC4 participate in the regulation of the NLRP3 inflammasome. Confocal microscopy and cell fractionation experiments revealed that upon LPS stimulation of macrophages, CLIC1 and CLIC4 translocated into the nucleus and cellular membrane. In LPS/ATP-stimulated bone marrow-derived macrophages (BMDMs), CLIC1 or CLIC4 siRNA transfection impaired transcription of IL-1 beta, ASC speck formation, and secretion of mature IL-1 beta. Collectively, our results demonstrate that CLIC1 and CLIC4 participate both in the priming signal for IL-1 beta and in NLRP3 activation.	[Domingo-Fernandez, Raquel; Kearney, Jay; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Pearse St, Dublin 2, Ireland; [Coll, Rebecca C.] Univ Queensland, IMB Ctr Inflammat & Dis Res, IMB, St Lucia, Qld 4072, Australia; [Breit, Samuel] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Breit, Samuel] Univ New South Wales, Sydney, NSW 2010, Australia	Trinity College Dublin; University of Queensland; St Vincents Hospital Sydney; University of New South Wales Sydney	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Pearse St, Dublin 2, Ireland.	laoneill@tcd.ie	Coll, Rebecca/J-2124-2014	Coll, Rebecca/0000-0002-7359-6023; O'Neill, Luke/0000-0002-4333-2748	European Research Council [268155_MicroInnate]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the European Research Council (268155_MicroInnate; to L.A.J.O.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Averaimo S, 2010, FEBS LETT, V584, P2076, DOI 10.1016/j.febslet.2010.02.073; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cross M, 2015, MOL CELL BIOCHEM, V398, P83, DOI 10.1007/s11010-014-2207-z; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Denoble AE, 2011, P NATL ACAD SCI USA, V108, P2088, DOI 10.1073/pnas.1012743108; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Jiang LL, 2012, J CELL SCI, V125, P5479, DOI 10.1242/jcs.110072; LALIBERTE R, 1994, J IMMUNOL, V153, P2168; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Legrand-Poels S, 2014, BIOCHEM PHARMACOL, V92, P131, DOI 10.1016/j.bcp.2014.08.013; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Malik M, 2012, P NATL ACAD SCI USA, V109, P6130, DOI 10.1073/pnas.1201351109; Malik M, 2010, J BIOL CHEM, V285, P23818, DOI 10.1074/jbc.M109.091611; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Marty V, 2005, GLIA, V49, P511, DOI 10.1002/glia.20138; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meng DM, 2013, MOL MED REP, V7, P1761, DOI 10.3892/mmr.2013.1429; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Peeters PM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-3; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Peter B, 2014, BIOCHEMISTRY-US, V53, P57, DOI 10.1021/bi401433f; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petroni RC, 2015, INFLAMMATION, V38, P2026, DOI 10.1007/s10753-015-0183-4; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Wang YL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/201614; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; Westwell-Roper C, 2014, IMMUNOL CELL BIOL, V92, P314, DOI 10.1038/icb.2014.4; Zeng WX, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0351-6	51	75	78	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12077	12087		10.1074/jbc.M117.797126	http://dx.doi.org/10.1074/jbc.M117.797126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28576828	Green Published, hybrid			2022-12-28	WOS:000406053300007
J	Polaski, JT; Webster, SM; Johnson, JE; Batey, RT				Polaski, Jacob T.; Webster, Samantha M.; Johnson, James E., Jr.; Batey, Robert T.			Cobalamin riboswitches exhibit a broad range of ability to discriminate between methylcobalamin and adenosylcobalamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLITE-BINDING RIBOSWITCHES; GENE-EXPRESSION; LIGAND-BINDING; PURINE RIBOSWITCH; STRUCTURAL BASIS; MESSENGER-RNA; BACTERIA; RECOGNITION; MECHANISMS; GUANINE	Riboswitches are a widely distributed class of regulatory RNAs in bacteria that modulate gene expression via small-molecule-induced conformational changes. Generally, these RNA elements are grouped into classes based upon conserved primary and secondary structure and their cognate effector molecule. Although this approach has been very successful in identifying new riboswitch families and defining their distributions, small sequence differences between structurally related RNAs can alter their ligand selectivity and regulatory behavior. Herein, we use a structure-based mutagenic approach to demonstrate that cobalamin riboswitches have a broad spectrum of preference for the two biological forms of cobalamin in vitro using isothermal titration calorimetry. This selectivity is primarily mediated by the interaction between a peripheral element of the RNA that forms a T-loop module and a subset of nucleotides in the cobalamin-binding pocket. Cell-based fluorescence reporter assays in Escherichia coli revealed that mutations that switch effector preference in vitro lead to differential regulatory responses in a biological context. These data demonstrate that a more comprehensive analysis of representative sequences of both previously and newly discovered classes of riboswitches might reveal subgroups of RNAs that respond to different effectors. Furthermore, this study demonstrates a second distinct means by which tertiary structural interactions in cobalamin riboswitches dictate ligand selectivity.	[Polaski, Jacob T.; Webster, Samantha M.; Johnson, James E., Jr.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Campus Box 596, Boulder, CO 80309 USA; [Johnson, James E., Jr.] InDevR, 2100 Cent Ave,Ste 106, Boulder, CO 80301 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 596, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625; Webster, Samantha/0000-0001-8351-1866; Polaski, Jacob/0000-0001-6570-1789	National Institutes of Health [R01 GM073850]; National Institutes of Health Biophysics Training Grant [T32 GM065103]; National Institutes of Health Ruth L. Kirschstein Fellowship [F32 GM095121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, F32GM095121, R01GM073850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM073850 (to R.T.B.). This work was also supported in part by National Institutes of Health Biophysics Training Grant T32 GM065103 (to J.T.P.) and National Institutes of Health Ruth L. Kirschstein Fellowship F32 GM095121 (to J.E.J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUFRERE R, 1986, MOL GEN GENET, V205, P358, DOI 10.1007/BF00430451; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barraud P, 2008, NUCLEIC ACIDS RES, V36, P4894, DOI 10.1093/nar/gkn462; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Ceres P, 2013, ACS SYNTH BIOL, V2, P463, DOI 10.1021/sb4000096; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; Choudhary PK, 2013, J BACTERIOL, V195, P5186, DOI 10.1128/JB.00730-13; DebRoy S, 2014, SCIENCE, V345, P937, DOI 10.1126/science.1255091; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Edwards AL, 2009, J MOL BIOL, V385, P938, DOI 10.1016/j.jmb.2008.10.074; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Gilbert Sunny D., 2009, V540, P97, DOI 10.1007/978-1-59745-558-9_8; Gilbert SD, 2009, STRUCTURE, V17, P857, DOI 10.1016/j.str.2009.04.009; Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Kim JN, 2007, P NATL ACAD SCI USA, V104, P16092, DOI 10.1073/pnas.0705884104; Kozlowski PM, 2016, DALTON T, V45, P4457, DOI 10.1039/c5dt04286k; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Polaski JT, 2016, CELL REP, V15, P1100, DOI 10.1016/j.celrep.2016.03.087; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2012, ANNU REV BIOPHYS, V41, P343, DOI 10.1146/annurev-biophys-101211-113224; Serganov A, 2009, CURR OPIN STRUC BIOL, V19, P251, DOI 10.1016/j.sbi.2009.02.002; Shanahan CA, 2011, J AM CHEM SOC, V133, P15578, DOI 10.1021/ja204650q; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Sherwood AV, 2016, ANNU REV MICROBIOL, V70, P361, DOI 10.1146/annurev-micro-091014-104306; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Weinberg Z, 2017, P NATL ACAD SCI USA, V114, pE2077, DOI 10.1073/pnas.1619581114; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31	39	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11650	11658		10.1074/jbc.M117.787176	http://dx.doi.org/10.1074/jbc.M117.787176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28483920	hybrid, Green Published			2022-12-28	WOS:000405485600006
J	Mori, T; Koyama, N; Tan, J; Segawa, T; Maeda, M; Town, T				Mori, Takashi; Koyama, Naoki; Tan, Jun; Segawa, Tatsuya; Maeda, Masahiro; Town, Terrence			Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; MODULATES BETA-SECRETASE; LONG-TERM POTENTIATION; GALLIC ACID; A-BETA; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; INFLAMMATION; BIOAVAILABILITY; NEUROTOXICITY	To date, there is no effective Alzheimer's disease (AD)-modifying therapy. Nonetheless, combination therapy holds promise, and nutraceuticals (natural dietary compounds with therapeutic properties) and their synthetic derivatives are well-tolerated candidates. We tested whether combination therapy with octyl gallate (OG) and ferulic acid (FA) improves cognition and mitigates AD-like pathology in the presenilin-amyloid beta-protein precursor (PSAPP) transgenic mouse model of cerebral amyloidosis. One-year-old mice with established beta-amyloid plaques received daily doses of OG and FA alone or in combination for 3 months. PSAPP mice receiving combination therapy had statistically significant improved cognitive function versus OG or FA single treatment on some (but not all) measures. We also observed additional statistically significant reductions in brain parenchymal and cerebral vascular beta-amyloid deposits as well as brain amyloid beta-protein abundance in OG-plus FA-treated versus singly-treated PSAPP mice. These effects coincided with enhanced nonamyloidogenic amyloid beta-protein precursor (APP) cleavage, increased beta-secretase activity, and beta-secretase inhibition. We detected elevated expression of nonamyloidogenic soluble APP-alpha and the beta-secretase candidate, a disintegrin and metalloproteinase domain-containing protein 10. Correspondingly, amyloidogenic beta-carboxyl-terminal APP fragment and beta-site APP-cleaving enzyme 1 expression levels were reduced. In parallel, the ratio of beta-to beta-carboxyl-terminal APP fragment was decreased. OG and FA combination therapy strikingly attenuated neuroinflammation, oxidative stress, and synaptotoxicity. Co-treatment afforded additional statistically significant benefits on some, but not all, of these outcome measures. Taken together, these data provide preclinical proof-of-concept for AD combination therapy.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi; Koyama, Naoki] Univ Kawagoe, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Univ Kawagoe, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Silver Child Dev Ctr, Rashid Lab Dev Neurobiol, Tampa, FL 33613 USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL 33613 USA; [Segawa, Tatsuya; Maeda, Masahiro] Immunobiol Labs Co Ltd, Fujioka, Gunma 3750005, Japan; [Town, Terrence] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, 1501 San Pablo St,Rm 337, Los Angeles, CA 90089 USA	Saitama Medical University; Saitama Medical University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Immuno-Biological Laboratories Co. Ltd.; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Saitama Med Ctr, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Univ Kawagoe, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Univ Kawagoe, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Town, T (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, 1501 San Pablo St,Rm 337, Los Angeles, CA 90089 USA.	t_mori@saitama-med.ac.jp; ttown@usc.edu			National Institutes of Health [R01NS076794]; Japan Society for the Promotion of Science [26430058]; Alzheimer's Association Zenith Fellows Award [ZEN-10-174633]; American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research [M11472]; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association Zenith Fellows Award(Alzheimer's Association); American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS076794 (to T. T.), Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 26430058 (to T. M.), Alzheimer's Association Zenith Fellows Award ZEN-10-174633 (to T. T.), American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research M11472 (to T. T.), and generous startup funds from the Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California (to T. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4248; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alzheimer's Disease International, 2015, GLOB IMP DEM WORLD A; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Barla F, 2009, BIOSCI BIOTECH BIOCH, V73, P2335, DOI 10.1271/bbb.90365; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Hajipour S, 2016, BASIC CLIN NEUROSCI, V7, P97, DOI 10.15412/J.BCN.03070203; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kim HS, 2004, BIOL PHARM BULL, V27, P120, DOI 10.1248/bpb.27.120; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kim MJ, 2011, MOL NUTR FOOD RES, V55, P1798, DOI 10.1002/mnfr.201100262; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kubo I, 2001, BIOORG MED CHEM LETT, V11, P347, DOI 10.1016/S0960-894X(00)00656-9; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Liu YQ, 2013, BIOORG MED CHEM LETT, V23, P6336, DOI 10.1016/j.bmcl.2013.09.071; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071913; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	71	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11310	11325		10.1074/jbc.M116.762658	http://dx.doi.org/10.1074/jbc.M116.762658			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512130	Green Published, hybrid			2022-12-28	WOS:000405119600015
J	Dowhan, W				Dowhan, William			Understanding phospholipid function: Why are there so many lipids?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MUTANT; D-SERINE DEHYDRATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; PHOSPHATIDYLGLYCEROPHOSPHATE SYNTHASE; CYTIDINE 5'-DIPHOSPHO-1,2-DIACYL-SN-GLYCEROL; CARDIOLIPIN SYNTHASE; TRANSFER PROTEIN; BOUND PYRUVATE; PURIFICATION	In the 1970s, phospholipids were still considered mere building blocks of the membrane lipid bilayer, but the subsequent realization that phospholipids could also serve as second messengers brought new interest to the field. Myown passion for the unique amphipathic properties of lipids led me to seek other, non-signaling functions for phospholipids, particularly in their interactions with membrane proteins. This seemed to be the last frontier in protein chemistry and enzymology to be conquered. I was fortunate to find my way to Eugene Kennedy's laboratory, where both membrane proteins and phospholipids were the foci of study, thus providing a jumping-off point for advancing our fundamental understanding of lipid synthesis, membrane protein biosynthesis, phospholipid and membrane protein trafficking, and the cellular roles of phospholipids. After purifying and characterizing enzymes of phospholipid biosynthesis in Escherichia coli and cloning of several of the genes encoding these enzymes in E. coli and Saccharomyces cerevisiae, I was in a position to alter phospholipid composition in a systematic manner during the cell cycle in these microorganisms. My group was able to establish, contrary tocommonassumption (derived from the fact that membrane proteins retain activity in detergent extracts) that phospholipid environment is a strong determining factor in the function of membrane proteins. We showed that molecular genetic alterations in membrane lipid composition result in many phenotypes, and uncovered direct lipid-protein interactions that govern dynamic structural and functional properties of membrane proteins. Here I present my personal "reflections" on how our understanding of phospholipid functions has evolved.	[Dowhan, William] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dowhan, W (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA.	william.dowhan@uth.tmc.edu			NIGMS, National Institutes of Health [GM20478, GM25047, GM35143, GM54273, GM56389, GM115969]; John Dunn Research Foundation; NIH; American Cancer Society; Guggenheim Fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020478, R01GM115969, F32GM020478, R01GM056389, R37GM020478] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); John Dunn Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Guggenheim Fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am most indebted to my mentors Walter Kauzmann (Princeton University), Esmond Snell (University of California, Berkeley), Eugene Kennedy (Harvard Medical School), and Gottfried Schatz (Biozentrum, Basel, Switzerland), all of whom unfortunately have passed away. My work has depended on support from collaborators William Wickner, Christian Raetz, Ronald Kaback, Mikhail Bogdanov, Eugenia Mileykovskaya, and Heidi Vitrac. I am grateful to George Carman (Rutgers University) for continuing mutual support, both personal and scientific. Special thanks go to my long-term technician Philip Heacock, 13 graduate students, and 21 postdoctoral fellows who made invaluable contributions to my research program. I greatly value the support and council of my colleagues John DeMoss, Henry Strobel, Robb Moses, and Charles McHenry, who remain as close friends. The support of my wife Jerilyn of 53 years has been invaluable in balancing my personal and professional life. My research program has been supported by the NIGMS, National Institutes of Health (Grants GM20478, GM25047, GM35143, GM54273, GM56389, and GM115969) since 1973 and an endowed chair from the John Dunn Research Foundation since 1998. I am especially thankful to have had Jean Chin as program officer for many of my NIH-funded years. She has been a strong supporter of lipid and membrane research. I wish to acknowledge the American Cancer Society for my postdoctoral fellowship awarded in 1969 and the Guggenheim Fellowship program for an award in 1983 for my faculty development leave. I owe much to the faculty and staff of the Department of Biochemistry and Molecular Biology at the McGovern Medical School at the University of Texas Health Sciences Center in Houston. I owe special thanks to the Journal of Biological Chemistry for the opportunity to serve on its Editorial Board, publishing 57 of my papers, and the invitation to submit this Reflection.	AITKEN JF, 1990, J BIOL CHEM, V265, P4711; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; CARMAN GM, 1979, J BIOL CHEM, V254, P8391; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P10710; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; DOWHAN W, 1970, J BIOL CHEM, V245, P4629; DOWHAN W, 1970, J BIOL CHEM, V245, P4618; Dowhan W., 2017, HDB HYDROCARBONS LIP, P1; Dowhan W, 2013, ANNU REV BIOCHEM, V82, P1, DOI 10.1146/annurev-biochem-012512-091530; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; FOX CF, 1965, P NATL ACAD SCI USA, V54, P891, DOI 10.1073/pnas.54.3.891; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; Gorter E, 1925, J EXP MED, V41, P439, DOI 10.1084/jem.41.4.439; HEACOCK PN, 1987, J BIOL CHEM, V262, P13044; HELMKAMP GM, 1974, J BIOL CHEM, V249, P6382; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRABAYASHI T, 1976, BIOCHEMISTRY-US, V15, P5205, DOI 10.1021/bi00669a002; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; KABACK HR, 1974, SCIENCE, V186, P882, DOI 10.1126/science.186.4167.882; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KENNEDY EP, 1966, J GEN PHYSIOL, V49, P347, DOI 10.1085/jgp.49.6.347; Kumar H, 2015, P NATL ACAD SCI USA, V112, P9004, DOI 10.1073/pnas.1509854112; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LI QX, 1990, J BIOL CHEM, V265, P4111; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Matsumoto K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00572; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; NEWMAN MJ, 1981, J BIOL CHEM, V256, P1804; Numata M, 2012, EXPERT REV RESP MED, V6, P243, DOI [10.1586/ers.12.21, 10.1586/ERS.12.21]; OHTA A, 1981, J BACTERIOL, V147, P552, DOI 10.1128/JB.147.2.552-562.1981; OHTA A, 1981, J BIOL CHEM, V256, P2219; RAETZ CRH, 1976, J BIOL CHEM, V251, P3242; RAETZ CRH, 1977, P NATL ACAD SCI USA, V74, P1412, DOI 10.1073/pnas.74.4.1412; RAETZ CRH, 1975, P NATL ACAD SCI USA, V72, P2274, DOI 10.1073/pnas.72.6.2274; RILEY WD, 1970, BIOCHEMISTRY-US, V9, P1485, DOI 10.1021/bi00809a002; ROSEMAN S, 1969, J GEN PHYSIOL, V54, pS138; SATRE M, 1978, J BIOL CHEM, V253, P479; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Simoni R, 2012, J BIOL CHEM, V287, P9509, DOI 10.1074/jbc.O112.000002; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Vitrac H, 2017, J BIOL CHEM, V292, P1613, DOI 10.1074/jbc.M116.765719; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Voelker DR, 2005, BIOCHEM SOC T, V33, P1141, DOI 10.1042/BST0331141; WICKNER W, 1974, J BIOL CHEM, V249, P6244; WIRTZ KWA, 1972, BIOCHIM BIOPHYS ACTA, V274, P606, DOI 10.1016/0005-2736(72)90207-6	62	31	32	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10755	10766		10.1074/jbc.X117.794891	http://dx.doi.org/10.1074/jbc.X117.794891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490630	Green Published, hybrid			2022-12-28	WOS:000404391000001
J	Marcinko, TM; Dong, J; LeBlanc, R; Daborowski, KV; Vachet, RW				Marcinko, Tyler M.; Dong, Jia; LeBlanc, Raquel; Daborowski, Kate V.; Vachet, Richard W.			Small molecule-mediated inhibition of-2-microglobulin-based amyloid fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; copper; HPLC; inhibitor; MS; -2-microglobulin; ion mobility	MOBILITY-MASS-SPECTROMETRY; ION-TETRACYCLINE INTERACTIONS; PROTEIN MISFOLDING DISEASES; CAPILLARY-ELECTROPHORESIS; COPPER(II) COMPLEXES; BIOLOGICAL-FLUIDS; BETA-2-MICROGLOBULIN; BETA(2)-MICROGLOBULIN; AGGREGATION; BINDING	In dialysis patients, -2 microglobulin (2m) can aggregate and eventually form amyloid fibrils in a condition known as dialysis-related amyloidosis, which deleteriously affects joint and bone function. Recently, several small molecules have been identified as potential inhibitors of 2m amyloid formation in vitro. Here we investigated whether these molecules are more broadly applicable inhibitors of 2m amyloid formation by studying their effect on Cu(II)-induced 2m amyloid formation. Using a variety of biophysical techniques, we also examined their inhibitory mechanisms. We found that two molecules, doxycycline and rifamycin SV, can inhibit 2m amyloid formation in vitro by causing the formation of amorphous, redissolvable aggregates. Rather than interfering with 2m amyloid formation at the monomer stage, we found that doxycycline and rifamycin SV exert their effect by binding to oligomeric species both in solution and in gas phase. Their binding results in a diversion of the expected Cu(II)-induced progression of oligomers toward a heterogeneous collection of oligomers, including trimers and pentamers, that ultimately matures into amorphous aggregates. Using ion mobility mass spectrometry, we show that both inhibitors promote the compaction of the initially formed 2m dimer, which causes the formation of other off-pathway and amyloid-incompetent oligomers that are isomeric with amyloid-competent oligomers in some cases. Overall, our results suggest that doxycycline and rifamycin are general inhibitors of Cu(II)-induced 2m amyloid formation. Interestingly, the putative mechanism of their activity is different depending on how amyloid formation is initiated with 2m, which underscores the complexity of how these structures assemble in vitro.	[Marcinko, Tyler M.; Dong, Jia; LeBlanc, Raquel; Daborowski, Kate V.; Vachet, Richard W.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Vachet, RW (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	rwvachet@chem.umass.edu		Marcinko, Tyler/0000-0003-0230-7308	National Institutes of Health [R01 GM 075092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM 075092. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antwi K, 2008, PROTEIN SCI, V17, P748, DOI 10.1110/ps.073249008; Beveridge R, 2013, ANALYST, V138, P32, DOI 10.1039/c2an35665a; Bleiholder C, 2013, J AM CHEM SOC, V135, P16926, DOI 10.1021/ja406197f; BRION M, 1986, INORG CHIM A-BIOINOR, V123, P61, DOI 10.1016/S0020-1693(00)84302-9; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Carazzone C, 2008, ELECTROPHORESIS, V29, P1502, DOI 10.1002/elps.200700677; Cerasoli E, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00017; Cheng B, 2013, BBA-GEN SUBJECTS, V1830, P4860, DOI 10.1016/j.bbagen.2013.06.029; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Dong J, 2014, BIOCHEMISTRY-US, V53, P1263, DOI 10.1021/bi4016583; Drueke TB, 2009, SEMIN DIALYSIS, V22, P378, DOI 10.1111/j.1525-139X.2009.00584.x; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; GEJYO F, 1986, KIDNEY INT, V30, P385, DOI 10.1038/ki.1986.196; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hyung SJ, 2012, PROTEOMICS, V12, P1547, DOI 10.1002/pmic.201100520; JEZOWSKABOJCZUK M, 1993, INORG CHEM, V32, P428, DOI 10.1021/ic00056a015; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Lanucara F, 2014, NAT CHEM, V6, P281, DOI [10.1038/NCHEM.1889, 10.1038/nchem.1889]; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Mendoza VL, 2010, BIOCHEMISTRY-US, V49, P1522, DOI 10.1021/bi901748h; Liang YF, 2012, BIOCHEMISTRY-US, V51, P3523, DOI 10.1021/bi3002727; Lim J, 2004, ANAL CHEM, V76, P3498, DOI 10.1021/ac049716t; Marshall KE, 2014, PRION, V8, P192, DOI 10.4161/pri.28860; Maurer MM, 2015, ANALYST, V14, P6782, DOI 10.1039/c5an00922g; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Mendoza VL, 2011, BIOCHEMISTRY-US, V50, P6711, DOI 10.1021/bi2004894; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Morgan CJ, 2001, J MOL BIOL, V309, P339, DOI 10.1006/jmbi.2001.4661; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Quaglia M, 2005, ELECTROPHORESIS, V26, P4055, DOI 10.1002/elps.200500313; Regazzoni L, 2011, ANAL CHIM ACTA, V685, P153, DOI 10.1016/j.aca.2010.11.025; Rennella E, 2010, J MOL BIOL, V401, P286, DOI 10.1016/j.jmb.2010.06.016; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Scarff CA, 2009, J AM SOC MASS SPECTR, V20, P625, DOI 10.1016/j.jasms.2008.11.023; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Seo J, 2016, ANGEW CHEM INT EDIT, V55, P14173, DOI 10.1002/anie.201606029; Soto-Ortega DD, 2011, BIOORGAN MED CHEM, V19, P2596, DOI 10.1016/j.bmc.2011.03.010; Srikanth R, 2009, BIOCHEMISTRY-US, V48, P9871, DOI 10.1021/bi901172y; Sun Y, 2016, J AM SOC MASS SPECTR, V27, P31, DOI 10.1007/s13361-015-1244-5; Williams DM, 2013, MASS SPECTROM REV, V32, P169, DOI 10.1002/mas.21358; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]	49	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10630	10638		10.1074/jbc.M116.774083	http://dx.doi.org/10.1074/jbc.M116.774083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28468825	hybrid, Green Published			2022-12-28	WOS:000404115400022
J	Caceres, CC; Bansal, PS; Navarro, S; Wilson, D; Don, L; Giacomin, P; Loukas, A; Daly, NL				Caceres, Claudia Cobos; Bansal, Paramjit S.; Navarro, Severine; Wilson, David; Don, Laurianne; Giacomin, Paul; Loukas, Alex; Daly, Norelle L.			An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANNEXIN A1; IN-VIVO; INHIBITORS; RESOLUTION; PROTEINS; COLITIS; PROGRAM; AC2-26; POTENT	Inflammatory bowel diseases (IBDs) are a set of complex and debilitating diseases for which there is no satisfactory treatment. Recent studies have shown that small peptides show promise for reducing inflammation in models of IBD. However, these small peptides are likely to be unstable and rapidly cleared from the circulation, and therefore, if not modified for better stability, represent non-viable drug leads. Wehypothesized that improving the stability of these peptides by grafting them into a stable cyclic peptide scaffold may enhance their therapeutic potential. Using this approach, we have designed a novel cyclic peptide that comprises a small bioactive peptide from the annexin A1 protein grafted into a sunflower trypsin inhibitor cyclic scaffold. We used native chemical ligation to synthesize the grafted cyclic peptide. This engineered cyclic peptide maintained the overall fold of the naturally occurring cyclic peptide, was more effective at reducing inflammation in a mouse model of acute colitis than the bioactive peptide alone, and showed enhanced stability in human serum. Our findings suggest that the use of cyclic peptides as structural backbones offers a promising approach for the treatment of IBD and potentially other chronic inflammatory conditions.	[Caceres, Claudia Cobos; Bansal, Paramjit S.; Navarro, Severine; Wilson, David; Don, Laurianne; Giacomin, Paul; Loukas, Alex; Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, AITHM, Cairns, Qld 4870, Australia	James Cook University	Loukas, A; Daly, NL (corresponding author), James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, AITHM, Cairns, Qld 4870, Australia.	alex.loukas@jcu.edu.au; norelle.daly@jcu.edu.au	Daly, Norelle/D-4302-2013; Loukas, Alex/B-7355-2014	Daly, Norelle/0000-0002-4697-6602; Cobos Caceres, Claudia/0000-0001-7434-8462; Loukas, Alex/0000-0002-0896-8441; Giacomin, Paul/0000-0002-6326-6792	National Health and Medical Research Council NHMRC [1020114]; Australian Research Council [FF110100226]	National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Recipient of fellowship support from National Health and Medical Research Council NHMRC (1020114).; Recipient of fellowship support from Australian Research Council (FF110100226).	Akgul S, 2006, SURG INNOV, V13, P102, DOI 10.1177/1553350606291337; AMENT ME, 1975, J PEDIATR-US, V86, P322, DOI 10.1016/S0022-3476(75)80958-9; Bettenworth D, 2011, AM J PATHOL, V179, P1230, DOI 10.1016/j.ajpath.2011.05.013; Chan L. Y., 2016, SCI REP, V6, P13; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; CIRINO G, 1993, BRIT J PHARMACOL, V108, P573, DOI 10.1111/j.1476-5381.1993.tb12843.x; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; de Paula-Silva M, 2016, BIOCHEM PHARMACOL, V115, P104, DOI 10.1016/j.bcp.2016.06.012; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; Flower R J, 2013, HDB BIOL ACTIVE PEPT, P631, DOI [10.1016/B978-0-12-385095-9.00086-5, DOI 10.1016/B978-0-12-385095-9.00086-5]; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Gunasekera S, 2013, INT J PEPT RES THER, V19, P43, DOI 10.1007/s10989-012-9331-y; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jendrny C, 2016, CHEMBIOCHEM, V17, P719, DOI 10.1002/cbic.201500539; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korsinczky MLJ, 2004, CURR PROTEIN PEPT SC, V5, P351, DOI 10.2174/1389203043379594; Kovacs-Nolan J, 2012, BBA-GEN SUBJECTS, V1820, P1753, DOI 10.1016/j.bbagen.2012.07.007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Molnar T, 2014, UNITED EUR GASTROENT, V2, P108, DOI 10.1177/2050640614520865; Navarro S, 2013, INT J PARASITOL, V43, P225, DOI 10.1016/j.ijpara.2012.11.005; Ouyang NT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041585; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Strong S. A., 2001, SURG TREATMENT EVIDE, P1; Stuqui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130803; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Tambuwala MM, 2016, INFLAMM BOWEL DIS, V22, P719, DOI 10.1097/MIB.0000000000000655; Wada S, 2013, J AGR FOOD CHEM, V61, P8807, DOI 10.1021/jf402515a; Wang LM, 2011, INT ARCH ALLERGY IMM, V154, P137, DOI 10.1159/000320228; Wangchuk P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12845; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	38	28	29	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10288	10294		10.1074/jbc.M117.779215	http://dx.doi.org/10.1074/jbc.M117.779215			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28473469	Green Published, hybrid			2022-12-28	WOS:000403580600036
J	Olsan, EE; Byndloss, MX; Faber, F; Rivera-Chavez, F; Tsolis, RM; Baumler, AJ				Olsan, Erin E.; Byndloss, Mariana X.; Faber, Franziska; Rivera-Chavez, Fabian; Tsolis, Renee M.; Baumler, Andreas J.			Colonization resistance: The deconvolution of a complex trait	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHAIN FATTY-ACIDS; ESCHERICHIA-COLI; INTESTINAL COLONIZATION; KLEBSIELLA-PNEUMONIAE; MICROBIAL ECOLOGY; RISK-FACTORS; SALMONELLA; INFECTION; BUTYRATE; INFLAMMATION	Carbapenemase-producing Enterobacteriaceae are an emerging threat to hospitals worldwide, and antibiotic exposure is a risk factor for developing fecal carriage that may lead to nosocomial infection. Here, we review how antibiotics reduce colonization resistance against Enterobacteriaceae to pinpoint possible control points for curbing their spread. Recent work identifies host-derived respiratory electron acceptors as a critical resource driving a post-antibiotic expansion of Enterobacteriaceae within the large bowel. By providing a conceptual framework for colonization resistance against Enterobacteriaceae, these mechanistic insights point to the metabolism of epithelial cells as a possible target for intervention strategies.	[Olsan, Erin E.; Byndloss, Mariana X.; Faber, Franziska; Rivera-Chavez, Fabian; Tsolis, Renee M.; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Byndloss, Mariana Xavier/ABD-5506-2021; Faber, Franziska/B-5601-2017; Rivera-Chávez, Fabian/ABD-5616-2021; Byndloss, Mariana X/D-9890-2014; Baumler, Andreas J/H-2301-2011	Byndloss, Mariana Xavier/0000-0002-2122-4156; Faber, Franziska/0000-0002-8700-6522; Byndloss, Mariana X/0000-0002-2122-4156; Baumler, Andreas J/0000-0001-9152-7809; Tsolis, Renee/0000-0001-9131-6657	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056765] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004209; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Daikos GL, 2010, J ANTIMICROB CHEMOTH, V65, P784, DOI 10.1093/jac/dkq005; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Doi Y, 2015, SEMIN RESP CRIT CARE, V36, P74, DOI 10.1055/s-0035-1544208; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Faber F, 2016, NATURE, V534, P697, DOI 10.1038/nature18597; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Garner CD, 2009, INFECT IMMUN, V77, P2691, DOI 10.1128/IAI.01570-08; HOVERSTAD T, 1986, SCAND J GASTROENTERO, V21, P997, DOI 10.3109/00365528608996411; ITOH K, 1989, INFECT IMMUN, V57, P559, DOI 10.1128/IAI.57.2.559-565.1989; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Jones SA, 2011, INFECT IMMUN, V79, P4218, DOI 10.1128/IAI.05395-11; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lowe CF, 2013, INFECT CONT HOSP EP, V34, P49, DOI 10.1086/668778; MEYNELL GG, 1963, BRIT J EXP PATHOL, V44, P209; Nedialkova LP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003844; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Razazi K, 2012, INTENS CARE MED, V38, P1769, DOI 10.1007/s00134-012-2675-0; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Rivera-Chavez F, 2015, ANNU REV MICROBIOL, V69, P31, DOI 10.1146/annurev-micro-091014-104108; SAITO K, 1961, Paediatr Jpn, V65, P394; SAITO K, 1961, Paediatr Jpn, V65, P385; Sandle GI, 1998, GUT, V43, P294, DOI 10.1136/gut.43.2.294; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Shanthi M, 2010, J Assoc Physicians India, V58 Suppl, P41; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Spees A. M., 2013, MBIO, V4; Spees AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003730; Stecher B, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0008-2014; Stecher B, 2013, FEMS MICROBIOL REV, V37, P793, DOI 10.1111/1574-6976.12024; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; VOLLAARD EJ, 1992, J ANTIMICROB CHEMOTH, V30, P685, DOI 10.1093/jac/30.5.685; Weigert A, 2008, NITRIC OXIDE-BIOL CH, V19, P95, DOI 10.1016/j.niox.2008.04.021; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yurist-Doutsch S, 2014, ANNU REV GENET, V48, P361, DOI 10.1146/annurev-genet-120213-092421; Zhao SY, 2016, EPIDEMIOL INFECT, V144, P695, DOI 10.1017/S0950268815001879; Zimmerman MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1405, DOI 10.1152/ajpgi.00543.2011	61	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8577	8581		10.1074/jbc.R116.752295	http://dx.doi.org/10.1074/jbc.R116.752295			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389556	Green Published, hybrid			2022-12-28	WOS:000402153900006
J	Carman, G; Taylor, A				Carman, George; Taylor, Alexandra			Masochistic enzymology: Dennis Vance's work on phosphatidylcholine (vol 292, pg 4753, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIGMS NIH HHS [R37 GM028140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carman G, 2017, J BIOL CHEM, V292, P4753, DOI 10.1074/jbc.O117.000002	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7160	7160		10.1074/jbc.A117.000002	http://dx.doi.org/10.1074/jbc.A117.000002			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28455407	Green Published, hybrid			2022-12-28	WOS:000400478300025
J	Prashek, J; Bouyain, S; Fu, MG; Li, Y; Berkes, D; Yao, XL				Prashek, Jennifer; Bouyain, Samuel; Fu, Mingui; Li, Yong; Berkes, Dusan; Yao, Xiaolan			Interaction between the PH and START domains of ceramide transfer protein competes with phosphatidylinositol 4-phosphate binding by the PH domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; fluorescence resonance energy transfer (FRET); isothermal titration calorimetry (ITC); lipid transport; phosphatidylinositol; sphingolipid; X-ray crystallography; AlphaScreen; ceramide transfer protein	PLECKSTRIN HOMOLOGY DOMAIN; ENDOPLASMIC-RETICULUM; NONVESICULAR TRAFFICKING; STRUCTURAL BASIS; TRANSPORT; CERT; PHOSPHORYLATION; ASSOCIATION; REFINEMENT; MECHANISM	De novo synthesis of the sphingolipid sphingomyelin requires non-vesicular transport of ceramide from the endoplasmic reticulum to the Golgi by the multidomain protein ceramide transfer protein (CERT). CERT's N-terminal pleckstrin homology (PH) domain targets it to the Golgi by binding to phosphatidylinositol 4-phosphate (PtdIns(4)P) in the Golgi membrane, whereas its C-terminal StAR-related lipid transfer domain (START) carries out ceramide transfer. Hyperphosphorylation of a serine-rich motif immediately after the PH domain decreases both PtdIns(4)P binding and ceramide transfer by CERT. This down-regulation requires both the PH and START domains, suggesting a possible inhibitory interaction between the two domains. In this study we show that isolated PH and START domains interact with each other. The crystal structure of a PH-START complex revealed that the START domain binds to the PH domain at the same site for PtdIns(4)P-binding, suggesting that the START domain competes with PtdIns(4)P for association with the PH domain. We further report that mutations disrupting the PH-START interaction increase both PtdIns(4)P-binding affinity and ceramide transfer activity of a CERT-serine-rich phosphorylation mimic. We also found that these mutations increase the Golgi localization of CERT inside the cell, consistent with enhanced PtdIns(4)P binding of the mutant. Collectively, our structural, biochemical, and cellular investigations provide important structural insight into the regulation of CERT function and localization.	[Prashek, Jennifer; Bouyain, Samuel; Yao, Xiaolan] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Fu, Mingui; Li, Yong] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Berkes, Dusan] Slovak Univ Technol Bratislava, Dept Organ Chem, Radlinskeho 9, Bratislava 81237, Slovakia	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Slovak University of Technology Bratislava	Yao, XL (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	yaoxia@umkc.edu	Berkes, Dusan/G-1741-2010	Berkes, Dusan/0000-0002-5717-5763; Yao, Xiaolan/0000-0002-6570-3730	National Institutes of Health [R15GM113200-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM113200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15GM113200-0. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACHARI A, 1992, BIOCHEMISTRY-US, V31, P10449, DOI 10.1021/bi00158a006; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; DeLano WL, 2002, PYMOL MOLECULAR GRAP; Duris A, 2011, ORG LETT, V13, P1642, DOI 10.1021/ol2001057; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; GALLAGHER T, 1994, BIOCHEMISTRY-US, V33, P4721, DOI 10.1021/bi00181a032; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2003, J MED CHEM, V46, P3688, DOI 10.1021/jm0300779; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Prashek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079590; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Tuuf J, 2011, BBA-BIOMEMBRANES, V1808, P229, DOI 10.1016/j.bbamem.2010.09.011; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200	47	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14217	14228		10.1074/jbc.M117.780007	http://dx.doi.org/10.1074/jbc.M117.780007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28652409	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000408439800025
J	Subramanian, L; Khan, AA; Allu, PKR; Kiranmayi, M; Sahu, BS; Sharma, S; Khullar, M; Mullasari, AS; Mahapatra, NR				Subramanian, Lakshmi; Khan, Abrar A.; Allu, Prasanna K. R.; Kiranmayi, Malapaka; Sahu, Bhavani S.; Sharma, Saurabh; Khullar, Madhu; Mullasari, Ajit S.; Mahapatra, Nitish R.			A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular; hypoxia; inflammation; metabolic disease; transcription; c-Rel; chromogranin; haplotype; single nucleotide polymorphisms; transcriptional regulation	NF-KAPPA-B; NECROSIS FACTOR-ALPHA; BLOOD-PRESSURE; CATECHOLAMINE RELEASE; INSULIN-RESISTANCE; RESPONSE ELEMENT; IN-VIVO; HYPERTENSION; PEPTIDE; HYPOXIA	The acidic glycoprotein chromogranin A (CHGA) is co-stored/co-secreted with catecholamines and crucial for secretory vesicle biogenesis in neuronal/neuroendocrine cells. CHGA is dysregulated in several cardiovascular diseases, but the underlying mechanisms are not well established. Here, we sought to identify common polymorphisms in the CHGA promoter and to explore the mechanistic basis of their plausible contribution to regulating CHGA protein levels in circulation. Resequencing of the CHGA promoter in an Indian population (n = 769) yielded nine single-nucleotide polymorphisms (SNPs): G-1106A, A-1018T, T-1014C, T-988G, G-513A, G-462A, T-415C, C-89A, and C-57T. Linkage disequilibrium (LD) analysis indicated strong LD among SNPs at the -1014, -988, -462, and -89 bp positions and between the -1018 and -57 bp positions. Haplotype analysis predicted five major promoter haplotypes that displayed differential promoter activities in neuronal cells; specifically, haplotype 2 (containing variant T alleles at -1018 and -57 bp) exhibited the highest promoter activity. Systematic computational and experimental analyses revealed that transcription factor c-Rel has a role in activating the CHGA promoter haplotype 2 under basal and pathophysiological conditions (viz. inflammation and hypoxia). Consistent with the higher in vitro CHGA promoter activity of haplotype 2, individuals carrying this haplotype had higher plasma CHGA levels, plasma glucose levels, diastolic blood pressure, and body mass index. In conclusion, these results suggest a functional role of the CHGA promoter haplotype 2 (occurring in a large proportion of the world population) in enhancing CHGA expression in haplotype 2 carriers who may be at higher risk for cardiovascular/metabolic disorders.	[Subramanian, Lakshmi; Khan, Abrar A.; Allu, Prasanna K. R.; Kiranmayi, Malapaka; Sahu, Bhavani S.; Mahapatra, Nitish R.] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Mullasari, Ajit S.] Madras Med Mission, Inst Cardiovasc Dis, Madras 600037, Tamil Nadu, India; [Sharma, Saurabh; Khullar, Madhu] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Mahapatra, NR (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	nmahapatra@iitm.ac.in	Mahapatra, Nitish R/D-4123-2014	Mahapatra, Nitish R/0000-0002-0695-3510	Department of Biotechnology [BT/PR9546/MED/12/349/2007]; Science and Engineering Research Board, Government of India [SR/SO/HS-084/2013A]; Ministry of Human Resource Development; Department of Biotechnology; Department of Science & Technology, Government of India; Ministry of Human Resource Development, Government of India; University Grants Commission, Government of India; Council of Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research, and Defence Research and Development Organization, Government of India	Department of Biotechnology; Science and Engineering Research Board, Government of India; Ministry of Human Resource Development; Department of Biotechnology; Department of Science & Technology, Government of India(Department of Science & Technology (India)); Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, and Defence Research and Development Organization, Government of India	This work was supported in part by Grant BT/PR9546/MED/12/349/2007 from the Department of Biotechnology and Grant SR/SO/HS-084/2013A from the Science and Engineering Research Board, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from the Ministry of Human Resource Development, Department of Biotechnology and Department of Science & Technology, Government of India.; Supported by a fellowship from the Ministry of Human Resource Development, Government of India.; Supported by a fellowship from the University Grants Commission, Government of India. Present address: Dept. of Medicine, University of California, San Francisco, CA.; Supported by a fellowship from Council of Scientific and Industrial Research, Government of India.; Supported by fellowships from the Council of Scientific and Industrial Research, and Defence Research and Development Organization, Government of India. Present address: Dept. of Integrative Biology and Physiology, University of Minnesota, MN.	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Allu PKR, 2014, J BIOL CHEM, V289, P4455, DOI 10.1074/jbc.M113.520916; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bandyopadhyay GK, 2015, DIABETES, V64, P104, DOI 10.2337/db13-1747; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Capellino S, 2008, J RHEUMATOL, V35, P91; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Cayla C, 2004, BIOCHEM PHARMACOL, V67, P469, DOI 10.1016/j.bcp.2003.09.029; Chandalia M, 2007, J DIABETES COMPLICAT, V21, P143, DOI 10.1016/j.jdiacomp.2006.11.003; Chen Y, 2008, KIDNEY INT, V74, P115, DOI 10.1038/ki.2008.113; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Chiron S, 2011, CIRC-CARDIOVASC GENE, V4, P437, DOI 10.1161/CIRCGENETICS.110.957886; Corti A., 2002, CHROMOGRANINS FUNCTI, P351; Estensen ME, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.008; FASCIOTTO BH, 1993, ENDOCRINOLOGY, V133, P461, DOI 10.1210/en.133.2.461; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Figueroa YG, 2002, EXP HEMATOL, V30, P1419, DOI 10.1016/S0301-472X(02)00934-7; Gaspar-Pereira S, 2012, AM J PATHOL, V180, P929, DOI 10.1016/j.ajpath.2011.11.007; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kesh K, 2015, J BIOL CHEM, V290, P14391, DOI 10.1074/jbc.M114.630129; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kiranmayi M, 2016, HYPERTENSION, V68, P334, DOI 10.1161/HYPERTENSIONAHA.116.06568; KOONG AC, 1994, CANCER RES, V54, P1425; Lan Q, 2007, IMMUNOGENETICS, V59, P839, DOI 10.1007/s00251-007-0253-3; Leeman JR, 2008, ONCOGENE, V27, P6770, DOI 10.1038/onc.2008.284; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; Mahapatra NR, 2008, CARDIOVASC RES, V80, P330, DOI 10.1093/cvr/cvn155; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; O'Connor DT, 1999, BLOOD PRESSURE, V8, P285, DOI 10.1080/080370599439508; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pemberton TJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-13; Rao FW, 2012, AM J HYPERTENS, V25, P29, DOI 10.1038/ajh.2011.163; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Sahu BS, 2010, CELL MOL LIFE SCI, V67, P861, DOI 10.1007/s00018-009-0208-y; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Sciolo V, 2009, INFLAMM BOWEL DIS, V15, P867, DOI 10.1002/ibd.20851; Sonawane PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016661; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Sun XH, 2012, AM J PATHOL, V181, P1513, DOI 10.1016/j.ajpath.2012.09.001; TAKIYYUDDIN MA, 1995, HYPERTENSION, V26, P213, DOI 10.1161/01.HYP.26.1.213; TAKIYYUDDIN MA, 1990, HYPERTENSION, V15, P237, DOI 10.1161/01.HYP.15.3.237; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tota B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00064; Tota B, 2012, FASEB J, V26, P2888, DOI 10.1096/fj.11-201111; Vaingankar SM, 2010, J HYPERTENS, V28, P817, DOI 10.1097/HJH.0b013e328336ed3e; van Luijn MM, 2016, J NEUROPATH EXP NEUR, V75, P86, DOI 10.1093/jnen/nlv004; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wen G, 2004, AM J HUM GENET, V74, P197, DOI 10.1086/381399; WU HJ, 1995, J CLIN INVEST, V96, P568, DOI 10.1172/JCI118069	56	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13970	13985		10.1074/jbc.M117.778134	http://dx.doi.org/10.1074/jbc.M117.778134			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28667172	hybrid, Green Published			2022-12-28	WOS:000408439800007
J	Hahl, P; Hunt, R; Bjes, ES; Skaff, A; Keightley, A; Smith, A				Hahl, Peter; Hunt, Rachel; Bjes, Edward S.; Skaff, Andrew; Keightley, Andrew; Smith, Ann			Identification of oxidative modifications of hemopexin and their predicted physiological relevance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE NITRATION; HEME-HEMOPEXIN; ALZHEIMERS-DISEASE; NITRIC-OXIDE; LIPID-PEROXIDATION; HISTIDINE-RESIDUES; RABBIT HEMOPEXIN; BINDING; BRAIN; HEMOGLOBIN	Hemopexin protects against heme toxicity in hemolytic diseases and conditions, sepsis, and sickle cell disease. This protection is sustained by heme-hemopexin complexes in biological fluids that resist oxidative damage during heme-driven inflammation. However, apo-hemopexin is vulnerable to inactivation by reactive nitrogen (RNS) and oxygen species (ROS) that covalently modify amino acids. The resultant nitration of amino acids is considered a specific effect reflecting biological events. Using LC-MS, we discovered low endogenous levels of tyrosine nitration in the peptide YYCFQGNQFLR in the heme-binding site of human hemopexin, which was similarly nitrated in rabbit and rat hemopexins. Immunoblotting and selective reaction monitoring were used to quantify tyrosine nitration of in vivo samples and when hemopexin was incubated in vitro with nitrating nitrite/myeloperoxidase/glucose oxidase. Significantly, heme binding by hemopexin declined as tyrosine nitration proceeded in vitro. Three nitrated tyrosines reside in the heme-binding site of hemopexin, and we found that one, Tyr-199, interacts directly with the hemering D propionate. Investigating the oxidative modifications of amino acids after incubation with tert-butyl hydroperoxide and hypochlorous acid in vitro, we identified additional covalent oxidative modifications on four tyrosine residues and one tryptophan residue of hemopexin. Importantly, three of the four modified tyrosines, some of which have more than one modification, cluster in the heme-binding site, supporting a hierarchy of vulnerable amino acids. We propose that during inflammation, apo-hemopexin is nitrated and oxidated in niches of the body containing activated RNS- and ROS-generating immune and endothelial cells, potentially impairing hemopexin's protective extracellular antioxidant function.	[Hahl, Peter; Hunt, Rachel; Bjes, Edward S.; Skaff, Andrew; Keightley, Andrew; Smith, Ann] Univ Missouri, Sch Biol Sci, Dept Mol Biol & Biochem, 5007 Rockhill Rd, Kansas City, MO 64110 USA; [Hunt, Rachel] Kansas Bur Invest, 7250 State Ave, Kansas City, KS 66112 USA	University of Missouri System; University of Missouri Kansas City	Smith, A (corresponding author), Univ Missouri, Sch Biol Sci, Dept Mol Biol & Biochem, 5007 Rockhill Rd, Kansas City, MO 64110 USA.	smithan@umkc.edu			National Institutes of Health [R21 DK064363]; Research Incentive Funds from School of Biological Sciences, University of Missouri-Kansas City, Kansas City, MO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK064363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Incentive Funds from School of Biological Sciences, University of Missouri-Kansas City, Kansas City, MO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work, with Institutional Review Board/Institutional Animal Care and Use (IRB/ACUC)) approval, was supported in part by National Institutes of Health Grant R21 DK064363 (to A. Smith) and Research Incentive Funds (to A. Smith) from the School of Biological Sciences, University of Missouri-Kansas City, Kansas City, MO. A patent application based upon this research with its predicted diagnostic implications has been filed (A. Smith, Serial No. 14/961,144). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Bian K, 2003, P NATL ACAD SCI USA, V100, P5712, DOI 10.1073/pnas.0931291100; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Chatterjee S, 2009, J IMMUNOL, V183, P4055, DOI 10.4049/jimmunol.0900593; Chen LF, 2011, J NEUROSURG, V114, P1159, DOI 10.3171/2010.10.JNS10861; DAVIES DM, 1979, BIOCHEM BIOPH RES CO, V91, P1504, DOI 10.1016/0006-291X(79)91235-X; Delanghe JR, 2010, CLIN CHIM ACTA, V411, P521, DOI 10.1016/j.cca.2010.01.006; Elphinstone RE, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1028-1; Eskew JD, 1999, J BIOL CHEM, V274, P638, DOI 10.1074/jbc.274.2.638; Garland P, 2016, STROKE, V47, P872, DOI 10.1161/STROKEAHA.115.011956; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hahl P, 2013, J NEUROCHEM, V125, P89, DOI 10.1111/jnc.12165; HANSTEIN A, 1968, J LAB CLIN MED, V71, P232; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Jung JY, 2015, J CRIT CARE, V30, P525, DOI 10.1016/j.jcrc.2014.12.009; Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3; KUSHNER I, 1972, J LAB CLIN MED, V80, P18; Lanone S, 2002, BIOCHEM J, V366, P399, DOI 10.1042/BJ20020339; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P229, DOI 10.1189/jlb.1208742; Lin T, 2012, J IMMUNOL, V189, P2017, DOI 10.4049/jimmunol.1103623; Lin TA, 2010, J INFECT DIS, V202, P624, DOI 10.1086/654929; Ma B, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0490-1; Madian AG, 2011, J PROTEOME RES, V10, P3959, DOI 10.1021/pr200140x; McCulloh R. J., 2016, ISBT SCI SER, V12, P119; Morgan W. T., 1984, PROTIDES BIOL FLUIDS, P219; MORGAN WT, 1988, J BIOL CHEM, V263, P8220; MORGAN WT, 1993, J BIOL CHEM, V268, P6256; MORGAN WT, 1984, J BIOL CHEM, V259, P2001; MORGAN WT, 1976, ARCH BIOCHEM BIOPHYS, V176, P431, DOI 10.1016/0003-9861(76)90185-5; MORGAN WT, 1976, ANN CLIN RES, V8, P223; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; SEARS DA, 1968, J LAB CLIN MED, V71, P484; Shen LM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040469; Shipulina N, 2000, J PROTEIN CHEM, V19, P239, DOI 10.1023/A:1007016105813; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; SMITH A, 1990, EUR J CELL BIOL, V53, P234; Smith A., 2013, HDB PORPHYRIN SCI, P311; Smith A., 2011, HDB PORPHYRIN SCI BI, P217; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; Spadaccio C, 2016, MOL BIOSYST, V12, P2168, DOI 10.1039/c6mb00152a; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P2021, DOI 10.1073/pnas.81.7.2021; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; Vallelian F, 2008, FREE RADICAL BIO MED, V45, P1150, DOI 10.1016/j.freeradbiomed.2008.07.013; VRETBLAD P, 1977, BIOCHEM J, V167, P759, DOI 10.1042/bj1670759; Willard BB, 2003, ANAL CHEM, V75, P2370, DOI 10.1021/ac034033j; Yu HL, 2003, PROTEOMICS, V3, P2240, DOI 10.1002/pmic.200300475; Zhang RZ, 2013, J NEUROIMMUNOL, V256, P38, DOI 10.1016/j.jneuroim.2013.01.002	56	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13658	13671		10.1074/jbc.M117.783951	http://dx.doi.org/10.1074/jbc.M117.783951			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28596380	Green Published, hybrid			2022-12-28	WOS:000407942400009
J	Mitrofan, CG; Appleby, SL; Nash, GB; Mallat, Z; Chilvers, ER; Upton, PD; Morrell, NW				Mitrofan, Claudia-Gabriela; Appleby, Sarah L.; Nash, Gerard B.; Mallat, Ziad; Chilvers, Edwin R.; Upton, Paul D.; Morrell, Nicholas W.			Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-alpha-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; LEUKOCYTE RECRUITMENT; EXPRESSION; INHIBITION; GENE; CALCIFICATION; ADHESION; ALK1; HYPERTENSION; INFLAMMATION	Bone morphogenetic proteins 9 and 10 (BMP9/BMP10) are circulating cytokines with important roles in endothelial homeostasis. The aim of this study was to investigate the roles of BMP9 and BMP10 in mediating monocyte-endothelial interactions using an in vitro flow adhesion assay. Herein, we report that whereas BMP9/BMP10 alone had no effect on monocyte recruitment, at higher concentrations both cytokines synergized with tumor necrosis factor-alpha (TNF alpha) to increase recruitment to the vascular endothelium. The BMP9/BMP10-mediated increase in monocyte recruitment in the presence of TNF alpha was associated with up-regulated expression levels of E-selectin, vascular cell adhesion molecule (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) on endothelial cells. Using siRNAs to type I and II BMP receptors and the signaling intermediaries (Smads), we demonstrated a key role for ALK2 in the BMP9/BMP10-induced surface expression of E-selectin, and both ALK1 and ALK2 in the up-regulation of VCAM-1 and ICAM-1. The type II receptors, BMPR-II and ACTR-IIA were both required for this response, as was Smad1/5. The up-regulation of cell surface adhesion molecules by BMP9/10 in the presence of TNF alpha was inhibited by LDN193189, which inhibits ALK2 but not ALK1. Furthermore, LDN193189 inhibited monocyte recruitment induced by TNF alpha and BMP9/10. BMP9/10 increased basal I kappa B alpha protein expression, but did not alter p65/RelA levels. Our findings suggest that higher concentrations of BMP9/BMP10 synergize with TNF alpha to induce the up-regulation of endothelial selectins and adhesion molecules, ultimately resulting in increased monocyte recruitment to the vascular endothelium. This process is mediated mainly via the ALK2 type I receptor, BMPR-II/ACTR-IIA type II receptors, and downstream Smad1/5 signaling.	[Mitrofan, Claudia-Gabriela; Appleby, Sarah L.; Mallat, Ziad; Chilvers, Edwin R.; Upton, Paul D.; Morrell, Nicholas W.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge CB2 0QQ, England; [Nash, Gerard B.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Cambridge; University of Birmingham	Morrell, NW (corresponding author), Univ Cambridge, Sch Clin Med, Dept Med, Cambridge CB2 0QQ, England.	nwm23@cam.ac.uk	Nash, Gerard B/E-4182-2010; Mallat, Ziad/D-4041-2012; wei, wei/HHR-8613-2022	Nash, Gerard B/0000-0002-5935-2831; Mallat, Ziad/0000-0003-0443-7878; Morrell, Nicholas/0000-0001-5700-9792; Chilvers, Edwin/0000-0002-4230-9677	Wellcome Trust [099824/Z/12/Z]; British Heart Foundation [RG/13/4/30107]; Medical Research Council Experimental Challenge Award [MR/KR020919/1]; Medical Research Council [MR/K020919/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10086] Funding Source: researchfish; MRC [MR/K020919/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Medical Research Council Experimental Challenge Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Ph.D. fellowship from the Wellcome Trust Grant 099824/Z/12/Z (to C.-G. M.), British Heart Foundation Programme Grant RG/13/4/30107 (to N. W. M.), and Medical Research Council Experimental Challenge Award MR/KR020919/1 (to N. W. M.). N. W. M. is a founder and director of Morphogen-IX. P. D. U. is a founder of Morphogen-IX.	Appleby SL, 2016, J IMMUNOL, V197, P3302, DOI 10.4049/jimmunol.1601219; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Butler LM, 2011, J VIROL, V85, P7321, DOI 10.1128/JVI.00021-11; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Christian F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010012; Csiszar A, 2006, AM J PATHOL, V168, P629, DOI 10.2353/ajpath.2006.050284; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH569, DOI 10.1152/ajpheart.00180.2008; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; D'Alessio P, 1998, FREE RADICAL BIO MED, V24, P979, DOI 10.1016/S0891-5849(97)00396-1; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herrera B, 2014, INT J MOL SCI, V15, P5199, DOI 10.3390/ijms15045199; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Horbelt D, 2015, J BIOL CHEM, V290, P3390, DOI 10.1074/jbc.M114.604397; Hurst LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14079; Jiang J, 2010, CARDIOVASC RES, V87, P366, DOI 10.1093/cvr/cvq013; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kim CW, 2013, ARTERIOSCL THROM VAS, V33, P1350, DOI 10.1161/ATVBAHA.112.300287; Kraehling JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13516; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Levet S, 2015, P NATL ACAD SCI USA, V112, pE3207, DOI 10.1073/pnas.1508386112; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; MATSUMORI A, 1994, BRIT HEART J, V72, P561; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Pachori AS, 2010, J MOL CELL CARDIOL, V48, P1255, DOI 10.1016/j.yjmcc.2010.01.010; POOLE JCF, 1958, J PATHOL BACTERIOL, V75, P245, DOI 10.1002/path.1700750202; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Saeed O, 2012, ARTERIOSCL THROM VAS, V32, P299, DOI 10.1161/ATVBAHA.111.240101; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Toshner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091334; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Venkatesh D, 2013, IMMUNITY, V38, P1025, DOI 10.1016/j.immuni.2013.01.012; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wolle J, 1996, ARTERIOSCL THROM VAS, V16, P1501, DOI 10.1161/01.ATV.16.12.1501; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004; Yao YC, 2008, ARTERIOSCL THROM VAS, V28, P2266, DOI 10.1161/ATVBAHA.108.176958; Yoshimatsu Y, 2013, P NATL ACAD SCI USA, V110, P18940, DOI 10.1073/pnas.1310479110; Yung LM, 2015, CARDIOVASC RES, V108, P278, DOI 10.1093/cvr/cvv221; Zhang F, 2002, ATHEROSCLEROSIS, V161, P381, DOI 10.1016/S0021-9150(01)00672-4; Zhang M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0214-3	67	33	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13714	13726		10.1074/jbc.M117.778506	http://dx.doi.org/10.1074/jbc.M117.778506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28646109	hybrid, Green Published			2022-12-28	WOS:000407942400019
J	Nevin, P; Gabbai, CC; Marians, KJ				Nevin, Philip; Gabbai, Carolina C.; Marians, Kenneth J.			Replisome-mediated translesion synthesis by a cellular replicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; ESCHERICHIA-COLI; ULTRAVIOLET-LIGHT; LEADING-STRAND; IN-VITRO; MUTAGENESIS; SPECIFICITY; DAMAGE; UV; FIDELITY	Genome integrity relies on the ability of the replisome to navigate ubiquitous DNA damage during DNA replication. The Escherichia coli replisome transiently stalls at leading-strand template lesions and can either reinitiate replication downstream of the lesion or recruit specialized DNA polymerases that can bypass the lesion via translesion synthesis. Previous results had suggested that the E. coli replicase might play a role in lesion bypass, but this possibility has not been tested in reconstituted DNA replication systems. We report here that the DNA polymerase III holoenzyme in a stalled E. coli replisome can directly bypass a single cyclobutane pyrimidine dimer or abasic site by translesion synthesis in the absence of specialized translesion synthesis polymerases. Bypass efficiency was proportional to deoxynucleotide concentrations equivalent to those found in vivo and was dependent on the frequency of primer synthesis downstream of the lesion. Translesion synthesis came at the expense of lesion-skipping replication restart. Replication of a cyclobutane pyrimidine dimer was accurate, whereas replication of an abasic site resulted in mainly -1 frameshifts. Lesion bypass was accompanied by an increase in base substitution frequency for the base preceding the lesion. These findings suggest that DNA damage at the replication fork can be replicated directly by the replisome without the need to activate error-prone pathways.	[Nevin, Philip; Gabbai, Carolina C.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu		Nevin, Philip/0000-0003-4891-7793	National Institutes of Health [GM34557]; NCI, National Institutes of Health, Cancer Center Core Support Grant [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R37GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM34557 (to K. J. M.) and NCI, National Institutes of Health, Cancer Center Core Support Grant P30CA008748 (to Memorial Sloan Kettering Cancer Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borden A, 2002, J BACTERIOL, V184, P2674, DOI 10.1128/JB.184.10.2674-2681.2002; BRIDGES BA, 1976, MOL GEN GENET, V144, P53, DOI 10.1007/BF00277304; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; Fuchs RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012682; Gabbai CB, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613257; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; HAGENSEE ME, 1987, P NATL ACAD SCI USA, V84, P4195, DOI 10.1073/pnas.84.12.4195; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LU C, 1986, P NATL ACAD SCI USA, V83, P619, DOI 10.1073/pnas.83.3.619; MAKI H, 1985, J BIOL CHEM, V260, P2982; Maor-Shoshani A, 2000, P NATL ACAD SCI USA, V97, P565, DOI 10.1073/pnas.97.2.565; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; MILLER JH, 1984, CELL, V37, P675, DOI 10.1016/0092-8674(84)90400-8; PazElizur T, 1996, J BIOL CHEM, V271, P24662, DOI 10.1074/jbc.271.40.24662; Pham PT, 1999, J BIOL CHEM, V274, P3705, DOI 10.1074/jbc.274.6.3705; Pham PT, 1998, J BIOL CHEM, V273, P23575, DOI 10.1074/jbc.273.36.23575; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; Schaaper RM, 2013, DNA REPAIR, V12, P73, DOI 10.1016/j.dnarep.2012.10.011; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; Sun B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10260; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; WELCH MM, 1982, J BACTERIOL, V152, P351; Wheeler LJ, 2005, DNA REPAIR, V4, P1450, DOI 10.1016/j.dnarep.2005.09.003; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; WU CA, 1992, J BIOL CHEM, V267, P4030; Yamada M, 2012, MOL MICROBIOL, V86, P1364, DOI 10.1111/mmi.12061; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; YATAGAI F, 1991, MOL GEN GENET, V230, P75, DOI 10.1007/BF00290653; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111	48	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13833	13842		10.1074/jbc.M117.800441	http://dx.doi.org/10.1074/jbc.M117.800441			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28642369	hybrid, Green Published			2022-12-28	WOS:000407942400020
J	Chen, ZG; Eggerman, TL; Bocharov, AV; Baranova, IN; Vishnyakova, TG; Kurlander, R; Patterson, AP				Chen, Zhigang; Eggerman, Thomas L.; Bocharov, Alexander V.; Baranova, Irina N.; Vishnyakova, Tatyana G.; Kurlander, Roger; Patterson, Amy P.			Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-INDUCED DEAMINASE; MULTIPLE HUMAN CANCERS; MESSENGER-RNA; APOBEC-1 OVEREXPRESSION; RETROVIRAL RESTRICTION; BREAST-CANCER; HSP90; DNA; HYPERMUTATION; REPLICATION	Apolipoprotein B mRNA-editing enzyme catalytic subunit 3 (APOBEC-3) enzymes are cytidine deaminases that are broadly and constitutively expressed. They are often up-regulated during carcinogenesis and candidate genes for causing the major single-base substitution in cancer-associated DNA mutations. Moreover, APOBEC-3s are involved in host innate immunity against many viruses. However, how APOBEC-3 mutational activity is regulated in normal and pathological conditions remains largely unknown. Heat shock protein levels are often elevated in both carcinogenesis and viral infection and are associated with DNA mutations. Here, using mutational analyses of hepatitis B virus (HBV), we found that Hsp90 stimulates deamination activity of APOBEC-3G (A3G), A3B, and A3C during co-expression in human liver HepG2 cells. Hsp90 directly stimulated A3G deamination activity when the purified proteins were used in in vitro reactions. Hsp40, -60, and -70 also had variable stimulatory effects in the cellular assay, but not in vitro. Sequencing analyses further demonstrated that Hsp90 increased both A3G cytosine mutation efficiency on HBV DNA and total HBV mutation frequency. In addition, Hsp90 shifted A3G's cytosine region selection in HBV DNA and increased A3G's 5' nucleoside preference for deoxycytidine (5' -CC). Furthermore, the Hsp90 inhibitor 17-N-allylamino-17-demethoxygeldanamycin dose dependently inhibited A3G and A3B mutational activity on HBV viral DNA. Hsp90 knockdown by siRNA or by Hsp90 active-site mutation also decreased A3G activity. These results indicate that heat shock proteins, in particular Hsp90, stimulate APOBEC-3-mediated DNA deamination activity, suggesting a potential physiological role in carcinogenesis and viral innate immunity.	[Chen, Zhigang; Eggerman, Thomas L.; Bocharov, Alexander V.; Baranova, Irina N.; Vishnyakova, Tatyana G.; Kurlander, Roger; Patterson, Amy P.] NIDDK, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Div Diabet Endocrinol & Metab Dis, Bethesda, MD 20892 USA; [Patterson, Amy P.] NHLBI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Patterson, AP (corresponding author), NHLBI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	amy.patterson@nih.gov						Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Caval V, 2015, NUCLEIC ACIDS RES, V43, P9340, DOI 10.1093/nar/gkv935; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chen ZG, 2012, J MOL BIOL, V418, P65, DOI 10.1016/j.jmb.2012.02.005; Chen ZG, 2010, RNA, V16, P1040, DOI 10.1261/rna.1863010; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Demorest ZL, 2011, J BIOL CHEM, V286, P26568, DOI 10.1074/jbc.M111.235721; Fontaine SN, 2015, J BIOL CHEM, V290, P13115, DOI 10.1074/jbc.M115.637595; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jarosz D, 2016, ADV CANCER RES, V129, P225, DOI 10.1016/bs.acr.2015.11.001; Khurana N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00100; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Koito A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00028; Lada AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005217; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Patterson AP, 2003, J BIOL CHEM, V278, P7600, DOI 10.1074/jbc.M201601200; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012	56	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13459	13479		10.1074/jbc.M116.760637	http://dx.doi.org/10.1074/jbc.M116.760637			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637869	Green Published, hybrid			2022-12-28	WOS:000407465300030
J	Franco, LH; Fleuri, AKA; Pellison, NC; Quirino, GFS; Horta, CV; de Carvalho, RVH; Oliveira, SC; Zamboni, DS				Franco, Luis H.; Fleuri, Anna K. A.; Pellison, Natalia C.; Quirino, Gustavo F. S.; Horta, Catarina V.; de Carvalho, Renan V. H.; Oliveira, Sergio C.; Zamboni, Dario S.			Autophagy downstream of endosomal Toll-like receptor signaling in macrophages is a key mechanism for resistance to Leishmania major infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1-BETA PRODUCTION; CUTANEOUS LEISHMANIASIS; MICE; MYD88; SUSCEPTIBILITY; AMAZONENSIS; ACTIVATION; IMMUNITY; REVEALS; UNC93B1	Leishmaniasis is caused by protozoan parasites of the genus Leishmania. In mammalians, these parasites survive and replicate in macrophages and parasite elimination by macrophages is critical for host resistance. Endosomal Toll-like receptors (TLRs) have been shown to be crucial for resistance to Leishmania major in vivo. For example, mice in the resistant C57BL/6 genetic background that are triple-deficient for TLR3, -7, and -9 (Tlr3/7/9(-/-)) are highly susceptible to L. major infection. Tlr3/7/9(-/-) mice are as susceptible as mice deficient in MyD88 or UNC93B1, a chaperone required for appropriate localization of endosomal TLRs, but the mechanisms are unknown. Here we found that macrophages infected with L. major undergo autophagy, which effectively accounted for restriction of parasite replication. Signaling via endosomal TLRs was required for autophagy because macrophages deficient for TLR3, -7, and 9, UNC93B1, or MyD88 failed to undergo L. major-induced autophagy. We also confirmed that Myd88(-/-), Tlr3/7/9(-/-), and Unc93b1(-/-) cells were highly permissive to L. major replication. Accordingly, shRNA-mediated suppression of Atg5, an E3 ubiquitin ligase essential for autophagosome elongation, in macrophages impaired the restriction of L. major replication in C57BL/6, but did not affect parasite replication in Myd88(-/-) or Unc93b1(-/-) macrophages. Rapamycin treatment reduced inflammatory lesions formed in the ears of Leishmania-infected C57BL/6 and Tlr3/7/9(-/-) mice, indicating that autophagy operates downstream of TLR signaling and is relevant for disease development in vivo. Collectively, our results indicate that autophagy contributes to macrophage resistance to L. major replication, and mechanistically explain the previously described endosomal TLR-mediated resistance to L. major infection.	[Franco, Luis H.; Fleuri, Anna K. A.; Pellison, Natalia C.; Quirino, Gustavo F. S.; Horta, Catarina V.; de Carvalho, Renan V. H.; Zamboni, Dario S.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cell Biol, BR-14049900 Ribeirao Preto, SP, Brazil; [Oliveira, Sergio C.] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Oliveira, Sergio C.; Zamboni, Dario S.] CNPq, Brasilia, DF, Brazil	Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Zamboni, DS (corresponding author), FMRP USP, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	dszamboni@fmrp.usp.br	de Carvalho, Renan V. H./AAC-7673-2019; Oliveira, Sergio Costa/AAG-5408-2021; Franco, Luis H/M-4636-2017; Zamboni, Dario S/D-3024-2012	de Carvalho, Renan V. H./0000-0001-5740-0652; Oliveira, Sergio Costa/0000-0003-4062-5577; Franco, Luis H/0000-0002-8143-1384; Zamboni, Dario S/0000-0002-7856-7512; Carvalho Pellison, Natalia/0000-0001-5963-0400	Fundacao de Apoio a Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo; PewProgram in Biomedical Sciences; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401577/2014-7, 445881/2014-3]; Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/08216-2, 2014/04684-4]	Fundacao de Apoio a Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo; PewProgram in Biomedical Sciences; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Apoio a Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo, PewProgram in Biomedical Sciences, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 401577/2014-7 and 445881/2014-3, Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2013/08216-2 and 2014/04684-4. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Cyrino LT, 2012, TISSUE CELL, V44, P401, DOI 10.1016/j.tice.2012.08.003; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Debus A, 2003, INFECT IMMUN, V71, P7215, DOI 10.1128/IAI.71.12.7215-7218.2003; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Franco Luis H., 2012, Journal of Parasitology Research, P165126, DOI 10.1155/2012/165126; Frank B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0974-3; Gallego C, 2011, INFECT IMMUN, V79, P2871, DOI 10.1128/IAI.01388-10; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; Kavoosi G, 2009, PARASITOLOGY, V136, P1193, DOI 10.1017/S0031182009990473; Kavoosi G, 2010, EXP PARASITOL, V124, P214, DOI 10.1016/j.exppara.2009.09.017; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kropf P, 2004, J LEUKOCYTE BIOL, V76, P48, DOI 10.1189/jlb.1003484; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Majer O, 2017, CURR OPIN IMMUNOL, V44, P26, DOI 10.1016/j.coi.2016.10.003; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Matte C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005690; Mitroulis I, 2009, PARASITOL INT, V58, P475, DOI 10.1016/j.parint.2009.07.002; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Revaz-Breton M, 2010, EUR J IMMUNOL, V40, P1697, DOI 10.1002/eji.200939821; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schaible UE, 1999, J CELL SCI, V112, P681; Schamber-Reis BLF, 2013, J BIOL CHEM, V288, P7127, DOI 10.1074/jbc.M112.407684; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823	43	35	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13087	13096		10.1074/jbc.M117.780981	http://dx.doi.org/10.1074/jbc.M117.780981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28607148	Green Published, hybrid			2022-12-28	WOS:000407465300001
J	Emery, AC; Xu, WQ; Eiden, MV; Eiden, LE				Emery, Andrew C.; Xu, Wenqin; Eiden, Maribeth V.; Eiden, Lee E.			Guanine nucleotide exchange factor Epac2-dependent activation of the GTP-binding protein Rap2A mediates cAMP-dependent growth arrest in neuroendocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; RECEPTOR TYROSINE KINASE; MAP KINASE; CYCLIC-AMP; R-RAS; COCAINE ADDICTION; PC12 CELLS; P38 MAPK; SPECIFICITY; PATHWAY	First messenger-dependent activation of MAP kinases in neuronal and endocrine cells is critical for cell differentiation and function and requires guanine nucleotide exchange factor (GEF)-mediated activation of downstream Ras family small GTPases, which ultimately lead to ERK, JNK, and p38 phosphorylation. Because there are numerous GEFs and also a host of Ras family small GTPases, it is important to know which specific GEF-small GTPase dyad functions in a given cellular process. Here we investigated the upstream activators and downstream effectors of signaling via the GEF Epac2 in the neuroendocrine NS-1 cell line. Three cAMP sensors, Epac2, PKA, and neuritogenic cAMP sensor-Rapgef2, mediate distinct cellular outputs: p38-dependent growth arrest, cAMP response element-binding protein-dependent cell survival, and ERK-dependent neuritogenesis, respectively, in these cells. Previously, we found that cAMP-induced growth arrest of PC12 and NS-1 cells requires Epac2-dependent activation of p38 MAP kinase, which posed the important question of how Epac2 engages p38 without simultaneously activating other MAP kinases in neuronal and endocrine cells. We now show that the small GTP-binding protein Rap2A is the obligate effector for, and GEF substrate of, Epac2 in mediating growth arrest through p38 activation in NS-1 cells. This new pathway is distinctly parcellated from the G protein-coupled receptor -> G(s) -> adenylate cyclase -> cAMP -> PKA -> cAMP response element-binding protein pathway mediating cell survival and the G protein-coupled receptor -> G(s) -> adenylate cyclase -> cAMP -> neuritogenic cAMP sensor-Rapgef2 -> B-Raf -> MEK -> ERK pathway mediating neuritogenesis in NS-1 cells.	[Emery, Andrew C.; Xu, Wenqin; Eiden, Lee E.] NIMH, Sect Mol Neurosci, Intramural Res Program, 9000 Rockville Pike,Bldg 49,Rm 5A38, Bethesda, MD 20892 USA; [Eiden, Maribeth V.] NIMH, Off Sci Director, Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Eiden, LE (corresponding author), NIMH, Sect Mol Neurosci, Intramural Res Program, 9000 Rockville Pike,Bldg 49,Rm 5A38, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov		Emery, Andrew/0000-0002-6760-2570	National Institute of Mental Health Intramural Research Program [MH002386, MH002592]; Brain and Behavior Research Foundation NARSAD Young Investigator Grant [21356]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386, Z01MH002592, Z01MH002386] Funding Source: NIH RePORTER	National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation NARSAD Young Investigator Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health Intramural Research Program Projects MH002386 (to L. E. E.) and MH002592 (to M. V. E.) and by Brain and Behavior Research Foundation NARSAD Young Investigator Grant 21356 (to A. C. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Ali D, 2004, MOL ENDOCRINOL, V18, P1721, DOI 10.1210/me.2003-0129; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Emery AC, 2016, PEPTIDES, V79, P39, DOI 10.1016/j.peptides.2016.03.003; Emery AC, 2014, J BIOL CHEM, V289, P10126, DOI 10.1074/jbc.M113.529321; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FARRELL FX, 1993, BIOCHEM J, V289, P349, DOI 10.1042/bj2890349; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kelley GG, 2009, ISLETS, V1, P260, DOI 10.4161/isl.1.3.9645; Knowles PJ, 2011, J NEUROENDOCRINOL, V23, P224, DOI 10.1111/j.1365-2826.2010.02100.x; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mor A, 2011, J INVEST DERMATOL, V131, P2040, DOI 10.1038/jid.2011.152; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; OVERBECK AF, 1995, MOL REPROD DEV, V42, P468, DOI 10.1002/mrd.1080420415; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tian XJ, 2001, J BIOL CHEM, V276, P47248, DOI 10.1074/jbc.M107407200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xia ZG, 2012, LEARN MEMORY, V19, P369, DOI 10.1101/lm.027128.112; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12220	12231		10.1074/jbc.M117.790329	http://dx.doi.org/10.1074/jbc.M117.790329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28546426	Green Published, hybrid			2022-12-28	WOS:000406053300019
J	Plante, S; Normant, V; Ramos-Torres, KM; Labbe, S				Plante, Samuel; Normant, Vincent; Ramos-Torres, Karla M.; Labbe, Simon			Cell-surface copper transporters and superoxide dismutase 1 are essential for outgrowth during fungal spore germination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; FORESPORE MEMBRANE; TRANSCRIPTION FACTORS; ASPERGILLUS-NIDULANS; ENVIRONMENTAL-STRESS; SPORULATING CELLS; METAL	During fungal spore germination, a resting spore returns to a conventional mode of cell division and resumes vegetative growth, but the requirements for spore germination are incompletely understood. Here, we show that copper is essential for spore germination in Schizosaccharomyces pombe. Germinating spores develop a single germ tube that emerges from the outer spore wall in a process called outgrowth. Under low-copper conditions, the copper transporters Ctr4 and Ctr5 are maximally expressed at the onset of outgrowth. In the case of Ctr6, its expression is broader, taking place before and during outgrowth. Spores lacking Ctr4, Ctr5, and the copper sensor Cuf1 exhibit complete germination arrest at outgrowth. In contrast, ctr6 deletion only partially interferes with formation of outgrowing spores. At outgrowth, Ctr4-GFP and Ctr5-Cherry first co-localize at the spore contour, followed by re-location to a middle peripheral spore region. Subsequently, they move away from the spore body to occupy the periphery of the nascent cell. After breaking of spore dormancy, Ctr6 localizes to the vacuole membranes that are enriched in the spore body relative to the germ tube. Using a copper-binding tracker, results showed that labile copper is preferentially localized to the spore body. Further analysis showed that Ctr4 and Ctr6 are required for copper-dependent activation of the superoxide dismutase 1 (SOD1) during spore germination. This activation is critical because the loss of SOD1 activity blocked spore germination at outgrowth. Taken together, these results indicate that cell-surface copper transporters and SOD1 are required for completion of the spore germination program.	[Plante, Samuel; Normant, Vincent; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Z-8,3201 Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada; [Ramos-Torres, Karla M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of Sherbrooke; University of California System; University of California Berkeley	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Z-8,3201 Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Ramos-Torres, Karla/0000-0002-4657-2237	Canadian Institutes of Health Research [MOP-CP-243929]; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health Chemical Biology Training Studentship T32 [GM066698]; NIGMS [GM79465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health Chemical Biology Training Studentship T32; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant MOP-CP-243929 from the Canadian Institutes of Health Research (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. 1 Recipient of an Alexander Graham Bell Canada; Recipient of an Alexander Graham Bell Canada Graduate Doctoral student-ship from the Natural Sciences and Engineering Research Council of Canada.; Supported in part by National Institutes of Health Chemical Biology Training Studentship T32 GM066698 and NIGMS Grant GM79465.	Ackerman CM, 2017, ANAL CHEM, V89, P22, DOI 10.1021/acs.analchem.6b04631; Barhoom S, 2008, EUKARYOT CELL, V7, P1098, DOI 10.1128/EC.00109-07; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bonazzi D, 2014, DEV CELL, V28, P534, DOI 10.1016/j.devcel.2014.01.023; Botts MR, 2010, CURR OPIN MICROBIOL, V13, P437, DOI 10.1016/j.mib.2010.05.003; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Das M, 2009, CURR BIOL, V19, P1314, DOI 10.1016/j.cub.2009.06.057; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Fukunishi K, 2014, MOL BIOL CELL, V25, P1549, DOI 10.1091/mbc.E13-12-0731; Garcia I, 2006, MOL MICROBIOL, V59, P836, DOI 10.1111/j.1365-2958.2005.04995.x; Geib E, 2016, CELL CHEM BIOL, V23, P587, DOI 10.1016/j.chembiol.2016.03.014; Geijer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-554; GRADEN JA, 1994, J AM CHEM SOC, V116, P9743, DOI 10.1021/ja00100a047; Hatanaka M, 2001, YEAST, V18, P207, DOI 10.1002/1097-0061(200102)18:3<207::AID-YEA661>3.0.CO;2-I; Herman PK, 1997, EMBO J, V16, P6171, DOI 10.1093/emboj/16.20.6171; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Itadani A, 2010, EUKARYOT CELL, V9, P1925, DOI 10.1128/EC.00022-10; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; Joseph-Strauss D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r241; KEENEY JB, 1994, GENETICS, V136, P849; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kloimwieder A, 2011, G3-GENES GENOM GENET, V1, P143, DOI 10.1534/g3.111.000323; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S., 2013, METALS IN CELLS, P163; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Matsuyama A, 2000, GENETICS, V155, P539; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Oiartzabal-Arano E, 2016, CURR GENET, V62, P371, DOI 10.1007/s00294-015-0556-0; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Plante S, 2014, J BIOL CHEM, V289, P10168, DOI 10.1074/jbc.M113.543678; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Shi LB, 2014, APPL ENVIRON MICROB, V80, P4502, DOI 10.1128/AEM.00153-14; SHIMODA C, 1980, CAN J MICROBIOL, V26, P741, DOI 10.1139/m80-129; Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Taricani L, 2002, J BIOL CHEM, V277, P10562, DOI 10.1074/jbc.M110686200; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Yao SH, 2016, FUNGAL GENET BIOL, V91, P32, DOI 10.1016/j.fgb.2016.03.006; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	57	9	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11896	11914		10.1074/jbc.M117.794677	http://dx.doi.org/10.1074/jbc.M117.794677			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28572514	Green Published, hybrid			2022-12-28	WOS:000405485600026
J	Albertolle, ME; Kim, D; Nagy, LD; Yun, CH; Pozzi, A; Savas, U; Johnson, EF; Guengerich, P				Albertolle, Matthew E.; Kim, Donghak; Nagy, Leslie D.; Yun, Chul-Ho; Pozzi, Ambra; Savas, Uzen; Johnson, Eric F.; Guengerich, Peter			Heme-thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOXIDE-BINDING PIGMENT; 20-HYDROXYEICOSATETRAENOIC ACID; T8590C POLYMORPHISM; KINETIC-ANALYSIS; NADPH OXIDASE; C-13-LABELED IODOACETANILIDE; LIVER MICROSOMES; N-ETHYLMALEIMIDE; BLOOD-PRESSURE; CYP4A11	Cytochrome P450 (P450, CYP) 4A11 is a human fatty acid omega-hydroxylase that catalyzes the oxidation of arachidonic acid to the eicosanoid 20-hydroxyeicosatetraenoic acid (20-HETE), which plays important roles in regulating blood pressure regulation. Variants of P450 4A11 have been associated with high blood pressure and resistance to anti-hypertensive drugs, and 20-HETE has both pro-and antihypertensive properties relating to increased vasoconstriction and natriuresis, respectively. These physiological activities are likely influenced by the redox environment, but the mechanisms are unclear. Here, we found that reducing agents (e. g. dithiothreitol and tris(2-carboxyethyl) phosphine) strongly enhanced the catalytic activity of P450 4A11, but not of 10 other human P450s tested. Conversely, added H2O2 attenuated P450 4A11 catalytic activity. Catalytic roles of five of the potentially eight implicated Cys residues of P450 4A11 were eliminated by site-directed mutagenesis. Using an isotope-coded dimedone/iododimedone-labeling strategy and mass spectrometry of peptides, we demonstrated that the heme-thiolate cysteine (Cys-457) is selectively sulfenylated in an H2O2 concentration-dependent manner. This sulfenylation could be reversed by reducing agents, including dithiothreitol and dithionite. Of note, we observed heme ligand cysteine sulfenylation of P450 4A11 ex vivo in kidneys and livers derived from CYP4A11 transgenic mice. We also detected sulfenylation of murine P450 4a12 and 4b1 heme peptides in kidneys. To our knowledge, reversible oxidation of the heme thiolate has not previously been observed in P450s and may have relevance for 20-HETE-mediated functions.	[Albertolle, Matthew E.; Kim, Donghak; Nagy, Leslie D.; Guengerich, Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 6388 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Kim, Donghak] Konkuk Univ, Dept Biol Sci, Seoul 05025, South Korea; [Yun, Chul-Ho] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju 61186, South Korea; [Pozzi, Ambra] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Pozzi, Ambra] Vet Affairs Med Ctr, Nashville, TN 37232 USA; [Savas, Uzen; Johnson, Eric F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Vanderbilt University; Konkuk University; Chonnam National University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Scripps Research Institute	Guengerich, P (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 6388 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Albertolle, Matthew E./0000-0003-4195-4006; Yun, Chul-Ho/0000-0003-2685-2968	National Institutes of Health [R35 CA090426, R01 GM118122, R01 DK095761, R01 CA162433, R01 HD004445, T32 ES007028, P30 CA068485]; Veterans Affairs [I01 BX002025-01]; National Research Foundation of Korea [NRF-2016R1A2B4006978]; American Heart Association [PRE33410007]; Veterans Affairs Senior Research Career Scientist award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA090426, R01CA162433, R01CA090426, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); National Research Foundation of Korea(National Research Foundation of Korea); American Heart Association(American Heart Association); Veterans Affairs Senior Research Career Scientist award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R35 CA090426 (to F. P. G.), R01 GM118122 (to F. P. G.), R01 DK095761 (to A. P.), R01 CA162433 (to A. P.), R01 HD004445 (to E. F. J.), and T32 ES007028 (to M. E. A.); Veterans Affairs Grant I01 BX002025-01 (to A. P.); and National Research Foundation of Korea Grant NRF-2016R1A2B4006978 (to C.-H. Y.). Some of the mass spectrometry work was funded in part by National Institutes of Health Grant P30 CA068485 (Vanderbilt-Ingram Cancer Center Support Grant). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by American Heart Association Predoctoral Fellowship PRE33410007.; Recipient of a Veterans Affairs Senior Research Career Scientist award.	ANFINSEN C, 1961, J BIOL CHEM, V236, P1361; Bodiga S, 2010, AM J PHYSIOL-LUNG C, V298, pL564, DOI 10.1152/ajplung.00298.2009; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; Capdevila JH, 2015, PROSTAG OTH LIPID M, V120, P40, DOI 10.1016/j.prostaglandins.2015.05.004; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Everse J.E.K.E., 1991, PEROXIDASES CHEM BIO, VI; Fan F, 2016, FRONT BIOSCI-LANDMRK, V21, P1427, DOI 10.2741/4465; Forman HJ, 2017, ARCH BIOCHEM BIOPHYS, V617, P26, DOI 10.1016/j.abb.2016.09.013; FRANKLIN MR, 1972, MOL PHARMACOL, V8, P711; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Garcia V, 2017, CURR OPIN NEPHROL HY, V26, P74, DOI 10.1097/MNH.0000000000000302; Goswami P, 2007, ARKIVOC, P82, DOI 10.3998/ark.5550190.0008.f09; Guengerich F P, 1998, Methods Mol Biol, V107, P77; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Han Y, 2013, CIRC J, V77, P1807, DOI 10.1253/circj.CJ-12-1211; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025; Hoch U, 2001, J BIOL CHEM, V276, P11339, DOI 10.1074/jbc.M009969200; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; Imai Y., 1978, CYTOCHROME P450, P37; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; Kawashima H, 2000, ARCH BIOCHEM BIOPHYS, V378, P333, DOI 10.1006/abbi.2000.1831; Kim D, 2014, BIOCHEMISTRY-US, V53, P6161, DOI 10.1021/bi500710e; Kurono S, 2006, BIOORGAN MED CHEM, V14, P8197, DOI 10.1016/j.bmc.2006.09.023; KUTHAN H, 1982, EUR J BIOCHEM, V126, P583, DOI 10.1111/j.1432-1033.1982.tb06820.x; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Lakhkar A, 2016, AM J PHYSIOL-HEART C, V310, pH1107, DOI 10.1152/ajpheart.00961.2015; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; LeBrun LA, 2002, J BIOL CHEM, V277, P12755, DOI 10.1074/jbc.M112155200; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Marnett L.J., 1986, CYTOCHROME P 450 STR, P29; Martinez S, 2014, J AM CHEM SOC, V136, P1186, DOI 10.1021/ja410462j; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; MURAKAMI K, 1967, J BIOL CHEM, V242, P1102; Niwayama S, 2003, BIOORG MED CHEM LETT, V13, P2913, DOI 10.1016/S0960-894X(03)00503-1; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; PARSONAGE D, 1995, BIOCHEMISTRY-US, V34, P435, DOI 10.1021/bi00002a007; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; Savas U, 2009, J BIOL CHEM, V284, P16541, DOI 10.1074/jbc.M902074200; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Shimada T, 2006, CHEM RES TOXICOL, V19, P288, DOI 10.1021/tx050291v; Shriner R. L., 1943, ORG SYNTH COLL, V2, P200; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Sreedhar B, 2007, SYNTHETIC COMMUN, V37, P4149, DOI 10.1080/00397910701574908; Sun CW, 1999, HYPERTENSION, V33, P414, DOI 10.1161/01.HYP.33.1.414; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666; Williams JS, 2011, J HYPERTENS, V29, P1913, DOI 10.1097/HJH.0b013e32834aa786; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Wu CC, 2011, PROSTAG OTH LIPID M, V96, P45, DOI 10.1016/j.prostaglandins.2011.06.006; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zabet-Moghaddam M, 2008, BIOORG MED CHEM LETT, V18, P4891, DOI 10.1016/j.bmcl.2008.07.069; Zeng QH, 2010, AM J PHYSIOL-HEART C, V299, pH1109, DOI 10.1152/ajpheart.00067.2010; Zhang R, 2011, HYPERTENS RES, V34, P645, DOI 10.1038/hr.2011.8	77	17	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11230	11242		10.1074/jbc.M117.792200	http://dx.doi.org/10.1074/jbc.M117.792200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28533430	Green Published, hybrid			2022-12-28	WOS:000405119600009
J	Balasubramaniam, SL; Gopalakrishnapillai, A; Petrelli, NJ; Barwe, SP				Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Petrelli, Nicholas J.; Barwe, Sonali P.			Knockdown of sodium-calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE UVOMORULIN; TIGHT JUNCTION FORMATION; NF-KAPPA-B; BETA-CATENIN; E-CADHERIN; PLASMA-MEMBRANE; GENE-EXPRESSION; OVARIAN-CANCER; ION CHANNELS; NA+-CA2+ EXCHANGER	Mesenchymal-to-epithelial transition (MET) and epithelialto- mesenchymal transition (EMT) are important processes in kidney development. Failure to undergo MET during development leads to the initiation of Wilms tumor, whereas EMT contributes to the development of renal cell carcinomas (RCC). The role of calcium regulators in governing these processes is becoming evident. We demonstrated earlier that Na+/Ca2+ exchanger 1 (NCX1), a major calcium exporter in renal epithelial cells, regulates epithelial cell motility. Here, we show for the first time that NCX1 mRNA and protein expression was downregulated in Wilms tumor and RCC. Knockdown of NCX1 in Madin-Darby canine kidney cells induced fibroblastic morphology, increased intercellular junctional distance, and induced paracellular permeability, loss of apico-basal polarity in 3D cultures, and anchorage-independent growth, accompanied by expression of mesenchymal markers. We also provide evidence that NCX1 interacts with and anchors E-cadherin to the cell surface independent of NCX1 ion transport activity. Consistent with destabilization of E-cadherin, NCX1 knockdown cells showed an increase in beta-catenin nuclear localization, enhanced transcriptional activity, and up-regulation of downstream targets of the beta-catenin signaling pathway. Taken together, knockdown of NCX1 in Madin-Darby canine kidney cells alters epithelial morphology and characteristics by destabilization of E-cadherin and induction of beta-catenin signaling.	[Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Barwe, Sonali P.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, 1701 Rockland Rd, Wilmington, DE 19803 USA; [Balasubramaniam, Sona Lakshme; Barwe, Sonali P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Petrelli, Nicholas J.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19718 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute	Barwe, SP (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, 1701 Rockland Rd, Wilmington, DE 19803 USA.	barwe@medsci.udel.edu	gopala, Anilkumar/AAG-2713-2021	Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X; Barwe, Sonali/0000-0003-4162-3004	Delaware-CTR ACCEL Grant [U54GM104941]; American Heart Association [10SDG260011]; DE INBRE Pilot Awards; Core Access Award [P20GM103446]; Biomolecular Core of the Center for Pediatric Research Grant [P30GM114736]; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104941, P30GM114736, P20GM103446] Funding Source: NIH RePORTER	Delaware-CTR ACCEL Grant; American Heart Association(American Heart Association); DE INBRE Pilot Awards; Core Access Award; Biomolecular Core of the Center for Pediatric Research Grant; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Delaware-CTR ACCEL Grant U54GM104941, American Heart Association Grant 10SDG260011, DE INBRE Pilot Awards and a Core Access Award for use of the Delaware Bioimaging Center (Grant P20GM103446), Biomolecular Core of the Center for Pediatric Research Grant P30GM114736, and the Nemours Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Anilkumar G, 2003, CANCER RES, V63, P2645; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Balasubramaniam SL, 2015, AM J PHYSIOL-CELL PH, V309, pC437, DOI 10.1152/ajpcell.00140.2015; Balasubramaniam SL, 2015, J BIOL CHEM, V290, P12463, DOI 10.1074/jbc.M114.629519; Barwe SP, 2012, J CELL SCI, V125, P5711, DOI 10.1242/jcs.108795; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bolinger MT, 2016, MOL CELL BIOL, V36, P2051, DOI 10.1128/MCB.00053-16; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Carmosino M, 2010, MOL BIOL CELL, V21, P3985, DOI 10.1091/mbc.E10-05-0456; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Chou AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138856; Cutcliffe C, 2005, CLIN CANCER RES, V11, P7986, DOI 10.1158/1078-0432.CCR-05-1354; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Deliot N, 2015, BBA-BIOMEMBRANES, V1848, P2512, DOI 10.1016/j.bbamem.2015.06.009; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Dreval V, 2005, CELL PHYSIOL BIOCHEM, V16, P119, DOI 10.1159/000087738; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dumanskiy Y. V., 2013, Experimental Oncology, V35, P325; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; Harada K, 2012, BJU INT, V110, pE1131, DOI 10.1111/j.1464-410X.2012.11297.x; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hohenstein P, 2015, GENE DEV, V29, P467, DOI 10.1101/gad.256396.114; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Januchowski R, 2014, BIOMED PHARMACOTHER, V68, P447, DOI 10.1016/j.biopha.2014.02.002; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Lee BH, 2002, BIOCHEM BIOPH RES CO, V297, P1218, DOI 10.1016/S0006-291X(02)02356-2; Lee WJ, 2005, J BIOL CHEM, V280, P27076, DOI 10.1074/jbc.M414142200; LI ZP, 1994, J BIOL CHEM, V269, P17434; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Mahdi SHA, 2015, ARCH BIOCHEM BIOPHYS, V583, P18, DOI 10.1016/j.abb.2015.07.008; Marciano DK, 2011, DEVELOPMENT, V138, P2099, DOI 10.1242/dev.056564; Modla S, 2015, METHODS MOL BIOL, V1217, P121, DOI 10.1007/978-1-4939-1523-1_8; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Munoz JJ, 2015, J UROLOGY, V194, P245, DOI 10.1016/j.juro.2014.11.097; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Orsulic S, 1999, J CELL SCI, V112, P1237; Ozcan A, 2012, ARCH PATHOL LAB MED, V136, P1541, DOI 10.5858/arpa.2012-0072-OA; Pacini L, 2013, CAN J PHYSIOL PHARM, V91, P1135, DOI 10.1139/cjpp-2012-0419; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Phillips BE, 2008, INVEST OPHTH VIS SCI, V49, P2568, DOI 10.1167/iovs.07-1204; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Schweigert A, 2016, PEDIATR SURG INT, V32, P1141, DOI 10.1007/s00383-016-3970-6; Srigley JR, 2009, MODERN PATHOL, V22, pS2, DOI 10.1038/modpathol.2009.70; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stock C, 2015, BBA-BIOMEMBRANES, V1848, P2638, DOI 10.1016/j.bbamem.2014.11.012; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Sullivan LP, 1998, PHYSIOL REV, V78, P1165, DOI 10.1152/physrev.1998.78.4.1165; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; van der Hagen EAE, 2015, NEPHRON, V131, P145, DOI 10.1159/000440655; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; VESTWEBER D, 1985, DEV BIOL, V112, P213, DOI 10.1016/0012-1606(85)90135-6; Wang GH, 2009, J BIOL CHEM, V284, P14469, DOI 10.1074/jbc.M808909200; Wang J, 2014, BIOCHEM BIOPH RES CO, V454, P547, DOI 10.1016/j.bbrc.2014.10.118; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yusenko MV, 2009, INT J BIOL SCI, V5, P517; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zhang XQ, 2017, ONCOTARGET, V8, P19566, DOI 10.18632/oncotarget.15361	80	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11388	11399		10.1074/jbc.M116.752352	http://dx.doi.org/10.1074/jbc.M116.752352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28550085	Green Published, hybrid			2022-12-28	WOS:000405119600022
J	Butler, MR; Ma, H; Yang, F; Belcher, J; Le, YZ; Mikoshiba, K; Biel, M; Michalakis, S; Iuso, A; Krizaj, D; Ding, XQ				Butler, Michael R.; Ma, Hongwei; Yang, Fan; Belcher, Joshua; Le, Yun-Zheng; Mikoshiba, Katsuhiko; Biel, Martin; Michalakis, Stylianos; Iuso, Anthony; Krizaj, David; Ding, Xi-Qin			Endoplasmic reticulum (ER) Ca2+-channel activity contributes to ER stress and cone death in cyclic nucleotide-gated channel deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CALCIUM-RELEASE; PROGRAMMED CELL-DEATH; PHOTORECEPTOR DEGENERATION; RETINITIS-PIGMENTOSA; ALZHEIMERS-DISEASE; INNER SEGMENTS; MOUSE MODELS; INTRACELLULAR CALCIUM; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS	Endoplasmic reticulum (ER) stress and mislocalization of improperly folded proteins have been shown to contribute to photoreceptor death in models of inherited retinal degenerative diseases. In particular, mice with cone cyclic nucleotide-gated (CNG) channel deficiency, a model for achromatopsia, display both early-onset ER stress and opsin mistrafficking. By 2 weeks of age, these mice show elevated signaling from all three arms of the ER-stress pathway, and by 1 month, cone opsin is improperly distributed away from its normal outer segment location to other retinal layers. This work investigated the role of Ca2+ release channels in ER stress, protein mislocalization, and cone death in a mouse model of CNG-channel deficiency. We examined whether preservation of luminal Ca2+ stores through pharmacological and genetic suppression of ER Ca2+ efflux protects cones by attenuating ER stress. We demonstrated that the inhibition of ER Ca2+ -efflux channels reduced all three arms of ERstress signaling while improving opsin trafficking to cone outer segments and decreasing cone death by 20-35%. Cone-specific gene deletion of the inositol-1,4,5-trisphosphate receptor type I (IP3R1) also significantly increased cone density in the CNGchannel- deficient mice, suggesting that IP3R1 signaling contributes to Ca2+ homeostasis and cone survival. Consistent with the important contribution of organellar Ca2+ signaling in this achromatopsia mouse model, significant differences in dynamic intraorganellar Ca2+ levels were detected in CNG-channel-deficient cones. These results thus identify a novel molecular link between Ca2+ homeostasis and cone degeneration, thereby revealing novel therapeutic targets to preserve cones in inherited retinal degenerative diseases.	[Butler, Michael R.; Ma, Hongwei; Yang, Fan; Belcher, Joshua; Le, Yun-Zheng; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Hirosawa Wako, Saitama 3510198, Japan; [Biel, Martin; Michalakis, Stylianos] Ludwig Maximilians Univ Munchen, CIPSM, D-81377 Munich, Germany; [Biel, Martin; Michalakis, Stylianos] Ludwig Maximilians Univ Munchen, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany; [Iuso, Anthony; Krizaj, David] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; RIKEN; University of Munich; University of Munich; Utah System of Higher Education; University of Utah	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Biel, Martin/G-1175-2014; Yang, Fan/I-5735-2019; Krrr, Daa/ABG-2688-2020; Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019	Biel, Martin/0000-0002-9974-3052; Krrr, Daa/0000-0003-4468-3029; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238	National Institutes of Health [P30EY021725, R01EY019490, R01EY020900, T32EY024234, R01EY022076, R01EY13870]; NEI [P30EY014800]; Willard L. Eccles Foundation; Research to Prevent Blindness; Moran Eye Institute at the University of Utah; Fight for Sight; Oklahoma Center for the Advancement of Science and Technology (OCAST); Japan Society for the Promotion of Science [25221002]; JST International Cooperative Research Project Solution-oriented Research for Science and Technology; Deutsche Forschungsgemeinschaft; NATIONAL EYE INSTITUTE [R01EY019490, R01EY020900, P30EY014800, R01EY022076, P30EY021725, R01EY013870, T32EY024234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Willard L. Eccles Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Moran Eye Institute at the University of Utah; Fight for Sight; Oklahoma Center for the Advancement of Science and Technology (OCAST); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST International Cooperative Research Project Solution-oriented Research for Science and Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants P30EY021725 and R01EY019490 (to X. D), R01EY020900 (to Y. L.), T32EY024234 (to A. I.), and R01EY022076, R01EY13870, and P30EY014800 from NEI. This work was also supported by the Willard L. Eccles Foundation; grants from Research to Prevent Blindness, the Moran Eye Institute at the University of Utah (to D. K.), The Fight for Sight (to M. R. B.), and the Oklahoma Center for the Advancement of Science and Technology (OCAST) (to X. Q. D.); Grant-in-aid for Scientific Research S, 25221002 (to K. M.) from the Japan Society for the Promotion of Science; the JST International Cooperative Research Project Solution-oriented Research for Science and Technology (to K. M.); and the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Barbara JG, 2002, BBA-PROTEINS PROTEOM, V1600, P12, DOI 10.1016/S1570-9639(02)00439-9; Bauer PO, 2011, BIOCHEM BIOPH RES CO, V416, P13, DOI 10.1016/j.bbrc.2011.10.096; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Caputo A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00422; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chiang WC, 2012, INVEST OPHTH VIS SCI, V53, P7159, DOI 10.1167/iovs.12-10222; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Csernoch L, 1999, J PHYSIOL-LONDON, V515, P843, DOI 10.1111/j.1469-7793.1999.843ab.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dizhoor AM, 2000, CELL SIGNAL, V12, P711, DOI 10.1016/S0898-6568(00)00134-0; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hackos DH, 1999, J GEN PHYSIOL, V113, P799, DOI 10.1085/jgp.113.6.799; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Korenbrot JI, 2002, ADV EXP MED BIOL, V514, P179; Krizaj D, 2005, EXP EYE RES, V81, P690, DOI 10.1016/j.exer.2005.04.007; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; Krizaj D, 2012, ADV EXP MED BIOL, V740, P873, DOI 10.1007/978-94-007-2888-2_39; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Le YZ, 2004, MOL VIS, V10, P1011; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leitner MG, 2016, BRIT J PHARMACOL, V173, P2555, DOI 10.1111/bph.13538; LI WWF, 1993, J BIOL CHEM, V268, P12003; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Ma EY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.332; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Park ES, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.67; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Perkins GA, 2003, MOL VIS, V9, P60; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shilling D, 2014, J NEUROSCI, V34, P6910, DOI 10.1523/JNEUROSCI.5441-13.2014; Shinohara T, 2008, MED HYPOTHESES, V70, P378, DOI 10.1016/j.mehy.2007.04.041; Shull GE, 2000, EUR J BIOCHEM, V267, P5284, DOI 10.1046/j.1432-1327.2000.01568.x; Son SM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.129; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Sugawara T, 2013, J NEUROSCI, V33, P12186, DOI 10.1523/JNEUROSCI.0545-13.2013; Szikra T, 2007, VISUAL NEUROSCI, V24, P733, DOI 10.1017/S0952523807070587; Szikra T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006723; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Tzekov R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007492; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Xing W, 2012, ADV EXP MED BIOL, V723, P739, DOI 10.1007/978-1-4614-0631-0_94; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang SB, 2011, NEUROCHEM RES, V36, P1175, DOI 10.1007/s11064-011-0457-7; Zhang T, 2015, HUM MOL GENET, V24, P1755, DOI 10.1093/hmg/ddu588; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	104	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11189	11205		10.1074/jbc.M117.782326	http://dx.doi.org/10.1074/jbc.M117.782326			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495882	Green Published, hybrid			2022-12-28	WOS:000405119600006
J	McReynolds, MR; Wang, WQ; Holleran, LM; Hanna-Rose, W				McReynolds, Melanie R.; Wang, Wenqing; Holleran, Lauren M.; Hanna-Rose, Wendy			Uridine monophosphate synthetase enables eukaryotic de novo NAD(+) biosynthesis from quinolinic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; REPRODUCTIVE DEVELOPMENT; C-ELEGANS; METABOLISM; NICOTINAMIDE; VITAMINS; SALVAGE; PATHWAY	NAD(+) biosynthesis is an attractive and promising therapeutic target for influencing health span and obesity-related phenotypes as well as tumor growth. Full and effective use of this target for therapeutic benefit requires a complete understanding of NAD(+) biosynthetic pathways. Here, we report a previously unrecognized role for a conserved phosphoribosyltransferase in NAD(+) biosynthesis. Because a required quinolinic acid phosphoribosyltransferase (QPRTase) is not encoded in its genome, Caenorhabditis elegans are reported to lack a de novo NAD(+) biosynthetic pathway. However, all the genes of the kynurenine pathway required for quinolinic acid (QA) production from tryptophan are present. Thus, we investigated the presence of de novo NAD(+) biosynthesis in this organism. By combining isotope- tracing and genetic experiments, we have demonstrated the presence of an intact de novo biosynthesis pathway for NAD(+) from tryptophan via QA, highlighting the functional conservation of this important biosynthetic activity. Supplementation with kynurenine pathway intermediates also boosted NAD(+) levels and partially reversed NAD(+)-dependent phenotypes caused by mutation of pnc-1, which encodes a nicotinamidase required for NAD(+) salvage biosynthesis, demonstrating contribution of de novo synthesis to NAD(+) homeostasis. By investigating candidate phosphoribosyltransferase genes in the genome, we determined that the conserved uridine monophosphate phosphoribosyltransferase (UMPS), which acts in pyrimidine biosynthesis, is required for NAD(+) biosynthesis in place of the missing QPRTase. We suggest that similar underground metabolic activity of UMPS may function in other organisms. This mechanism for NAD(+) biosynthesis creates novel possibilities for manipulating NAD(+) biosynthetic pathways, which is key for the future of therapeutics.	[McReynolds, Melanie R.; Wang, Wenqing; Holleran, Lauren M.; Hanna-Rose, Wendy] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Wang, Wenqing] ABLife Inc, Wuhan 430075, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hanna-Rose, W (corresponding author), 104D Life Sci Bldg, University Pk, PA 16802 USA.	wxh21@psu.edu		Hanna-Rose, Wendy/0000-0002-5566-4758	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086786] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Patterson and P. Smith and the Pennsylvania State Metabolomics Core Facility, Huck Institutes of the Life Sciences, for technical assistance and advice. tm alleles were provided by the Mitani Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other strains were provided by the Caenorhabditis Genetics Center, which is funded by National Institutes of Health Office of Research Infrastructure Programs Grant P40 OD010440.	Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; BRENNER S, 1974, GENETICS, V77, P71; C. elegans Consortium, 2012, G3 BETHESDA, V2, P1415; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Gossmann TI, 2012, FEBS J, V279, P3355, DOI 10.1111/j.1742-4658.2012.08559.x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang L, 2006, DEV BIOL, V300, P599, DOI 10.1016/j.ydbio.2006.08.024; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Majewski M, 2016, J PHYSIOL PHARMACOL, V67, P3; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Vrablik TL, 2011, DEV BIOL, V349, P387, DOI 10.1016/j.ydbio.2010.11.014; Vrablik TL, 2009, DEVELOPMENT, V136, P3637, DOI 10.1242/dev.028431; Wang WQ, 2015, J BIOL CHEM, V290, P26163, DOI 10.1074/jbc.M115.662916	21	10	10	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11147	11153		10.1074/jbc.C117.795344	http://dx.doi.org/10.1074/jbc.C117.795344			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28559281	Green Published, hybrid			2022-12-28	WOS:000405119600002
J	Ragunathan, P; Sielaff, H; Sundararaman, L; Biukovic, G; Manimekalai, MSS; Singh, D; Kundu, S; Wohland, T; Frasch, W; Dick, T; Gruber, G				Ragunathan, Priya; Sielaff, Hendrik; Sundararaman, Lavanya; Biukovic, Goran; Manimekalai, Malathy Sony Subramanian; Singh, Dhirendra; Kundu, Subhashri; Wohland, Thorsten; Frasch, Wayne; Dick, Thomas; Gruber, Gerhard			The uniqueness of subunit alpha of mycobacterial F-ATP synthases: An evolutionary variant for niche adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; F1FO-ATP SYNTHASE; F1F0-ATP SYNTHASE; ROTATION; PURIFICATION; MECHANISM; RESOLUTION; PROTEIN; MOTOR; SCATTERING	The F1F0 -ATP F-ATP) synthase is essential for growth of Mycobacterium tuberculosis, the causative agent of tuberculosis TB). In addition to their synthase function most F-ATP synthases possess an ATP-hydrolase activity, which is coupled to proton-pumping activity. However, the mycobacterial enzyme lacks this reverse activity, but the reason for this deficiency is unclear. Here, we report that a Mycobacterium-specific, 36-amino acid long C-terminal domain in the nucleotide- binding subunit alpha (Mt alpha) of F-ATP synthase suppresses its ATPase activity and determined the mechanism of suppression. First, we employed vesicles to show that in intact membrane-embedded mycobacterial F-ATP synthases deletion of the C-terminal domain enabled ATPase and protonpumping activity. We then generated a heterologous F-ATP synthase model system, which demonstrated that transfer of the mycobacterial C-terminal domain to a standard F-ATP synthase alpha subunit suppresses ATPase activity. Single-molecule rotation assays indicated that the introduction of this Mycobacterium-specific domain decreased the angular velocity of the power-stroke after ATP binding. Solution X-ray scattering data and NMR results revealed the solution shape of Mt alpha and the 3D structure of the subunit alpha C-terminal peptide (521)PDEHVEALDEDKLAKEAVKV(540) of M. tubercolosis Mt alpha 521-540)), respectively. Together with cross-linking studies, the solution structural data lead to a model, in which Mt alpha 521-540) comes in close proximity with subunit alpha residues 104 -109, whose interaction may influence the rotation of the camshaft-like subunit gamma. Finally, we propose that the unique segment Mt alpha 514 -549), which is accessible at the C terminus of mycobacterial subunit gamma, is a promising drug epitope.	[Ragunathan, Priya; Sielaff, Hendrik; Sundararaman, Lavanya; Manimekalai, Malathy Sony Subramanian; Singh, Dhirendra; Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Biukovic, Goran; Kundu, Subhashri; Dick, Thomas] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, 14 Med Dr, Singapore 117599, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117557, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Dept Chem, 14 Sci Dr 4, Singapore 117557, Singapore; [Wohland, Thorsten] Natl Univ Singapore, NUS Ctr Bioimaging Sci CBIS, 14 Sci Dr 4, Singapore 117557, Singapore; [Frasch, Wayne] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Arizona State University; Arizona State University-Tempe	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg	Dick, Thomas/AAC-4824-2019; Dick, Thomas/AAB-4109-2019; WOHLAND, THORSTEN/R-6404-2019; Wohland, Thorsten/H-8285-2012	Dick, Thomas/0000-0002-9604-9452; Singh, Dhirendra/0000-0002-5576-7052; Sielaff, Hendrik/0000-0001-5231-7286; Wohland, Thorsten/0000-0002-0148-4321	Nanyang Technological University; Ministry of Education; Ministry of Education, Singapore [MOE2011-T2-2-156, ARC 18/12]; Ministry of Health, Singapore, NMRC Grant [CBRG12nov049]; Ministry of Health, Singapore [MOE2012-T2-1-101]; National Institute of Health [R01GM097510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097510] Funding Source: NIH RePORTER	Nanyang Technological University(Nanyang Technological University); Ministry of Education; Ministry of Education, Singapore(Ministry of Education, Singapore); Ministry of Health, Singapore, NMRC Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Ministry of Health, Singapore(Ministry of Health-Singapore); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Ministry of Education, Singapore Grants MOE2011-T2-2-156 and ARC 18/12, Ministry of Health, Singapore, NMRC Grant CBRG12nov049 (to G. G.), Ministry of Health, Singapore Grant MOE2012-T2-1-101 (to T. W.), and National Institute of Health Grant R01GM097510 (to W. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a research scholarship from Nanyang Technological University.; Supported by a research scholarship from the Ministry of Education.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Biukovic G, 2013, ANTIMICROB AGENTS CH, V57, P168, DOI 10.1128/AAC.01039-12; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Cook GM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0015-2013; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; DeLano W.L, PYMOL MOL GRAPHICS S; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Glatter O., 1982, SMALL ANGLE XRAY SCA; Goude Renan, 2008, V465, P203, DOI [10.1007/978-1-59745-207-6_13, 10.3791/761]; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Guinier A., 1955, SMALL ANGLE SCATTERI; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Haagsma AC, 2009, ANTIMICROB AGENTS CH, V53, P1290, DOI 10.1128/AAC.01393-08; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024; HOFFMANN A, 1990, EUR J BIOCHEM, V194, P423, DOI 10.1111/j.1432-1033.1990.tb15635.x; Hotra A, 2016, FEBS J, V283, P1947, DOI 10.1111/febs.13715; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Kamariah N, 2016, J STRUCT BIOL, V193, P13, DOI 10.1016/j.jsb.2015.11.004; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Lu P, 2014, BBA-BIOENERGETICS, V1837, P1208, DOI 10.1016/j.bbabio.2014.01.022; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Pacheco-Moises F, 2002, J BIOENERG BIOMEMBR, V34, P269, DOI 10.1023/A:1020252401675; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; PEREZ JA, 1990, BIOCHEMISTRY-US, V29, P10503, DOI 10.1021/bi00498a013; Preiss L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500106; Priya R, 2013, J BIOENERG BIOMEMBR, V45, P121, DOI 10.1007/s10863-012-9486-4; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sielaff H, 2016, J BIOL CHEM, V291, P25351, DOI 10.1074/jbc.M116.745240; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430; Zharova TV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1101, DOI 10.1023/A:1026306611821	62	28	29	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11262	11279		10.1074/jbc.M117.784959	http://dx.doi.org/10.1074/jbc.M117.784959			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495884	Green Published, hybrid			2022-12-28	WOS:000405119600012
J	Temple, MJ; Cuskin, F; Basle, A; Hickey, N; Speciale, G; Williams, SJ; Gilbert, HJ; Lowe, EC				Temple, Max J.; Cuskin, Fiona; Basle, Arnaud; Hickey, Niall; Speciale, Gaetano; Williams, Spencer J.; Gilbert, Harry J.; Lowe, Elisabeth C.			A Bacteroidetes locus dedicated to fungal 1,6--glucan degradation: Unique substrate conformation drives specificity of the key endo-1,6--glucanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycosidase; glycoside hydrolase; microbiome; X-ray crystallography	HUMAN GUT MICROBIOTA; GLYCOSYL HYDROLASES; STRUCTURAL BASIS; TRICHODERMA-HARZIANUM; MOLECULAR REPLACEMENT; METABOLISM; SYMBIONT; ENDO-BETA-1,6-GLUCANASE; THETAIOTAOMICRON; CRYSTALLOGRAPHY	Glycans are major nutrients available to the human gut microbiota. The Bacteroides are generalist glycan degraders, and this function is mediated largely by polysaccharide utilization loci (PULs). The genomes of several Bacteroides species contain a PUL, PUL1,6--glucan, that was predicted to target mixed linked plant 1,3;1,4--glucans. To test this hypothesis we characterized the proteins encoded by this locus in Bacteroides thetaiotaomicron, a member of the human gut microbiota. We show here that PUL1,6--glucan does not orchestrate the degradation of a plant polysaccharide but targets a fungal cell wall glycan, 1,6--glucan, which is a growth substrate for the bacterium. The locus is up-regulated by 1,6--glucan and encodes two enzymes, a surface endo-1,6--glucanase, BT3312, and a periplasmic -glucosidase that targets primarily 1,6--glucans. The non-catalytic proteins encoded by PUL1,6--glucan target 1,6--glucans and comprise a surface glycan-binding protein and a SusD homologue that delivers glycans to the outer membrane transporter. We identified the central role of the endo-1,6--glucanase in 1,6--glucan depolymerization by deleting bt3312, which prevented the growth of B. thetaiotaomicron on 1,6--glucan. The crystal structure of BT3312 in complex with -glucosyl-1,6-deoxynojirimycin revealed a TIM barrel catalytic domain that contains a deep substrate-binding cleft tailored to accommodate the hook-like structure adopted by 1,6--glucan. Specificity is driven by the complementarity of the enzyme active site cleft and the conformation of the substrate. We also noted that PUL1,6--glucan is syntenic to many PULs from other Bacteroidetes, suggesting that utilization of yeast and fungal cell wall 1,6--glucans is a widespread adaptation within the human microbiota.	[Temple, Max J.; Cuskin, Fiona; Basle, Arnaud; Hickey, Niall; Gilbert, Harry J.; Lowe, Elisabeth C.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 2HH, Tyne & Wear, England; [Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Newcastle University - UK; University of Melbourne; University of Melbourne	Gilbert, HJ; Lowe, EC (corresponding author), Newcastle Univ, Med Sch, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE4 2HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk; Elisabeth.lowe@ncl.ac.uk	Hickey, Niall/S-2338-2019	Hickey, Niall/0000-0002-1722-0558; Lowe, Elisabeth/0000-0001-9812-0614; Temple, Max/0000-0003-4678-9396; Cuskin, Fiona/0000-0003-4287-4921; Basle, Arnaud/0000-0002-4899-3086	Wellcome Trust Grant [WT097907/Z/11/Z]; Biotechnology and Biological Research Council [BB/K020358/1]; BBSRC [BB/K020358/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K020358/1] Funding Source: researchfish	Wellcome Trust Grant(Wellcome Trust); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant WT097907/Z/11/Z and Biotechnology and Biological Research Council Grant BB/K020358/1. The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON KL, 1989, J BACTERIOL, V171, P3192, DOI 10.1128/jb.171.6.3192-3198.1989; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Blattner R, 2006, CARBOHYD RES, V341, P2115, DOI 10.1016/j.carres.2006.05.004; Boisrame A, 2009, APPL MICROBIOL BIOT, V82, P663, DOI 10.1007/s00253-008-1780-z; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DELACRUZ J, 1995, J BACTERIOL, V177, P1864, DOI 10.1128/jb.177.7.1864-1871.1995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Furstner A, 2003, CHEM-EUR J, V9, P307, DOI 10.1002/chem.200390025; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Henekendorff M, 2010, CHEM-EUR J, V16, P13982, DOI 10.1002/chem.201002313; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LORA JM, 1995, MOL GEN GENET, V247, P639, DOI 10.1007/BF00290356; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; MIAO SC, 1994, J BIOL CHEM, V269, P10975; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Urbanikova L, 2011, FEBS J, V278, P2105, DOI 10.1111/j.1742-4658.2011.08127.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van Bueren AL, 2015, APPL ENVIRON MICROB, V81, P3973, DOI 10.1128/AEM.00149-15; Wang D, 2017, APPL MICROBIOL BIOT, V101, P197, DOI 10.1007/s00253-016-7753-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	42	45	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10639	10650		10.1074/jbc.M117.787606	http://dx.doi.org/10.1074/jbc.M117.787606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28461332	Green Published, hybrid			2022-12-28	WOS:000404115400023
J	Yang, SZ; Xu, F; Zhou, T; Zhao, XY; McDonald, JM; Chen, YB				Yang, Shan-zhong; Xu, Fei; Zhou, Tong; Zhao, Xinyang; McDonald, Jay M.; Chen, Yabing			The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; histone methylation; long non-coding RNA (long ncRNA; lncRNA); pancreatic cancer; TRAIL; death receptor 5; DR5	TRAIL-INDUCED APOPTOSIS; MONOCLONAL-ANTIBODY; VASCULAR CALCIFICATION; GEMCITABINE; CELLS; COMBINATION; DISEASE; TRIAL; DR5; DIFFERENTIATION	Pancreatic cancer is a malignant neoplasm with a high mortality rate. Therapeutic agents that activate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis have shown promising efficacy, but many pancreatic cancers are resistant to TRAIL therapy. Epigenetic regulation plays important roles in tumor pathogenesis and resistance, and a recent study indicated that the long non-coding RNA HOX transcript antisense RNA (HOTAIR) is overexpressed in pancreatic cancer. However, the role of HOTAIR in pancreatic cancer resistance to anticancer agents is unknown. The present study determined the role of HOTAIR in pancreatic cancer TRAIL resistance and investigated the underlying molecular mechanisms. We observed that TRAIL-resistant pancreatic cancer cells had higher levels of HOTAIR expression, whereas TRAIL-sensitive pancreatic cancer cells had lower HOTAIR levels. Overexpressing HOTAIR in TRAIL-sensitive cells attenuated TRAIL-induced apoptosis, and shRNA-mediated HOTAIR knockdown in TRAIL-resistant PANC-1 cells sensitized them to TRAIL-induced apoptosis. These results support a causative effect of HOTAIR on TRAIL sensitivity. Mechanistically, we found that increased HOTAIR expression inhibited the expression of the TRAIL receptor death receptor 5 (DR5), whereas HOTAIR knockdown increased DR5 expression. We further demonstrated that HOTAIR regulates DR5 expression via the epigenetic regulator enhancer of zeste homolog 2 (EZH2) and that EZH2 controls histone H3 lysine 27 trimethylation on the DR5 gene. Taken together, these results demonstrate that high HOTAIR levels increase the resistance of pancreatic cancer cells to TRAIL-induced apoptosis via epigenetic regulation of DR5 expression. Our study therefore supports the notion that targeting HOTAIR function may represent a strategy to overcome TRAIL resistance in pancreatic cancer.	[Yang, Shan-zhong; Xu, Fei; McDonald, Jay M.; Chen, Yabing] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhou, Tong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Zhao, Xinyang] Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA; [McDonald, Jay M.; Chen, Yabing] Birmingham Vet Affairs Med Ctr, Res Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Chen, YB (corresponding author), 1825 Univ Blvd,614 Shelby Biomed Res Bldg, Birmingham, AL 35294 USA.	yabingchen@uabmc.edu		Zhao, Xinyang/0000-0001-6677-7072	Veterans Affairs Research Department Grants [BX002296, BX003617]; Veterans Affairs [IK6BX003617, I01BX002296] Funding Source: NIH RePORTER	Veterans Affairs Research Department Grants; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Research Department Grants BX002296 and BX003617 (Y.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avan A, 2012, MOL CANCER THER, V11, P1735, DOI 10.1158/1535-7163.MCT-12-0037; Bergmann L, 2015, EUR J CANCER, V51, P27, DOI 10.1016/j.ejca.2014.10.010; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen JF, 2012, J BONE MINER RES, V27, P1659, DOI 10.1002/jbmr.1607; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Joshi P, 2015, P NATL ACAD SCI USA, V112, P8650, DOI 10.1073/pnas.1500886112; Keane MM, 1999, CANCER RES, V59, P734; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kindler HL, 2012, ANN ONCOL, V23, P2834, DOI 10.1093/annonc/mds142; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057; Matsuzaki H, 2001, CLIN CANCER RES, V7, P407; Mayor S, 2015, LANCET ONCOL, V16, pE58, DOI 10.1016/S1470-2045(15)70017-3; Mocan T, 2014, J CANCER, V5, P679, DOI 10.7150/jca.9481; Montano M, 2011, TRANSL RES, V157, P157, DOI 10.1016/j.trsl.2011.02.001; Tran NT, 2016, EMBO REP, V17, P887, DOI 10.15252/embr.201541970; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Ozawa F, 2001, CANCER LETT, V163, P71, DOI 10.1016/S0304-3835(00)00660-1; Rajeshkumar NV, 2010, MOL CANCER THER, V9, P2582, DOI 10.1158/1535-7163.MCT-10-0370; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Takahashi Y, 2000, GENE DEV, V14, P804; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang S, 2010, CURR MED CHEM, V17, P3309, DOI 10.2174/092986710793176285; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Yuan KY, 2015, ONCOTARGET, V6, P25308, DOI 10.18632/oncotarget.4490; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516	45	55	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10390	10397		10.1074/jbc.M117.786830	http://dx.doi.org/10.1074/jbc.M117.786830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28476883	Green Published, hybrid			2022-12-28	WOS:000404115400006
J	Davies, AM; Allan, EG; Keeble, AH; Delgado, J; Cossins, BP; Mitropoulou, AN; Pang, MOY; Ceska, T; Beavil, AJ; Craggs, G; Westwood, M; Henry, AJ; McDonnell, JM; Sutton, BJ				Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Delgado, Jean; Cossins, Benjamin P.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Ceska, Tom; Beavil, Andrew J.; Craggs, Graham; Westwood, Marta; Henry, Alistair J.; McDonnell, James M.; Sutton, Brian J.			Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CONFORMATIONAL-CHANGES; MONOCLONAL-ANTIBODY; RECEPTOR COMPLEXES; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; AFFINITY; BINDING; DOMAIN; BENT	Immunoglobulin E and its interactions with receptors Fc is an element of RI and CD23 play a central role in allergic disease. Omalizumab, a clinically approved therapeutic antibody, inhibits the interaction between IgE and Fc is an element of RI, preventing mast cell and basophil activation, and blocks IgE binding to CD23 on B cells and anti-gen-presenting cells. We solved the crystal structure of the complex between an omalizumab-derived Fab and IgE-Fc, with one Fab bound to each C is an element of 3 domain. Free IgE-Fc adopts an acutely bent structure, but in the complex it is only partially bent, with large-scale conformational changes in the C is an element of 3 domains that inhibit the interaction with Fc is an element of RI. CD23 binding is inhibited sterically due to overlapping binding sites on each C is an element of 3 domain. Studies of omalizumab Fab binding in solution demonstrate the allosteric basis for Fc is an element of RI inhibition and, together with the structure, reveal how omalizumab may accelerate dissociation of receptor-bound IgE from Fc is an element of RI, exploiting the intrinsic flexibility and allosteric potential of IgE.	[Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Beavil, Andrew J.; McDonnell, James M.; Sutton, Brian J.] Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England; [Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Beavil, Andrew J.; McDonnell, James M.; Sutton, Brian J.] MRC, London SE1 1UL, England; [Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Beavil, Andrew J.; McDonnell, James M.; Sutton, Brian J.] Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Delgado, Jean; Cossins, Benjamin P.; Ceska, Tom; Craggs, Graham; Westwood, Marta; Henry, Alistair J.] UCB Celltech, 208 Bath Rd, Slough SL1 3WE, Berks, England	University of London; King's College London; University of London; King's College London; Celltech Group Ltd	McDonnell, JM; Sutton, BJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	james.mcdonnell@kcl.ac.uk; brian.sutton@kcl.ac.uk	Davies, Anna Marie/G-4575-2014	Davies, Anna Marie/0000-0003-1498-1594; Keeble, Anthony/0000-0002-4873-6960; Beavil, Andrew/0000-0002-0768-122X; Mitropoulou, Alkistis/0000-0002-1319-1294	Wellcome Trust [085944]; Medical Research Council [G0200486, G1000758, G1100090] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish; MRC [G0200486, G1100090] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Diamond Light Source for access to beamlines I02 and I03 (Proposal No. MX1220) that contributed to the results presented here. We thank Marty Rajaratnam (King's College London) for use of the in-house X-ray facility. We thank Katherine Cain and Pallavi Bhatta for molecular biology support, Hanna Hailu for protein expression, and Amanda Oxbrow and Sue Cross for protein purification. The Centre for Biomolecular Spectroscopy, King's College London, was established with Capital Award 085944 from the Wellcome Trust.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BEAVIL AJ, 1995, BIOCHEMISTRY-US, V34, P14449, DOI 10.1021/bi00044a023; Borthakur S, 2012, J BIOL CHEM, V287, P31457, DOI 10.1074/jbc.C112.397059; Borthakur S, 2011, BIOCHEMISTRY-US, V50, P4608, DOI 10.1021/bi200019y; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COHEN ES, 2014, MABS, V0006; DAVIS KG, 1990, BIOCHEM SOC T, V18, P935, DOI 10.1042/bst0180935; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dhaliwal B, 2014, ACTA CRYSTALLOGR F, V70, P305, DOI 10.1107/S2053230X14003355; Drinkwater N, 2014, NAT STRUCT MOL BIOL, V21, P397, DOI 10.1038/nsmb.2795; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hodis E, 2007, TRENDS BIOCHEM SCI, V32, P199, DOI 10.1016/j.tibs.2007.03.008; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holgate ST, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-17; HOLOWKA D, 1985, BIOCHEMISTRY-US, V24, P6260, DOI 10.1021/bi00343a033; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3475, DOI 10.1021/bi00283a026; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; Jensen RK, 2015, ACTA CRYSTALLOGR F, V71, P419, DOI 10.1107/S2053230X15004100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim B, 2012, NATURE, V491, P613, DOI 10.1038/nature11546; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lowe PJ, 2009, BRIT J CLIN PHARMACO, V68, P61, DOI 10.1111/j.1365-2125.2009.03401.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price NE, 2005, J BIOL CHEM, V280, P2324, DOI 10.1074/jbc.M409458200; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Shiung YY, 2012, IMMUNOBIOLOGY, V217, P676, DOI 10.1016/j.imbio.2011.11.006; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sutton BJ, 2015, IMMUNOL REV, V268, P222, DOI 10.1111/imr.12340; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wright JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11581; Wurzburg B. A., 2009, J MOL BIOL; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193; Yuan DP, 2013, J BIOL CHEM, V288, P21667, DOI 10.1074/jbc.M113.480657; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055; ZHENG Y, 1992, BIOCHEMISTRY-US, V31, P7446, DOI 10.1021/bi00148a004; ZHENG Y, 1991, BIOCHEMISTRY-US, V30, P9125, DOI 10.1021/bi00102a002	49	48	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9975	9987		10.1074/jbc.M117.776476	http://dx.doi.org/10.1074/jbc.M117.776476			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28438838	Green Published, hybrid			2022-12-28	WOS:000403580600011
J	Heirbaut, M; Lermyte, F; Martin, EM; Beelen, S; Sobott, F; Strelkov, SV; Weeks, SD				Heirbaut, Michelle; Lermyte, Frederik; Martin, Esther M.; Beelen, Steven; Sobott, Frank; Strelkov, Sergei V.; Weeks, Stephen D.			Specific sequences in the N-terminal domain of human small heat-shock protein HSPB6 dictate preferential hetero-oligomerization with the orthologue HSPB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; CHAPERONE-LIKE ACTIVITY; HETEROOLIGOMERIC COMPLEXES; MASS-SPECTROMETRY; SUBUNIT EXCHANGE; HSP20; POLYDISPERSITY; ARCHITECTURE; DIMERS; RATIO	Small heat-shock proteins (sHSPs) are a conserved group of molecular chaperones with important roles in cellular proteostasis. Although sHSPs are characterized by their small monomeric weight, they typically assemble into large polydisperse oligomers that vary in both size and shape but are principally composed of dimeric building blocks. These assemblies can include different sHSP orthologues, creating additional complexity that may affect chaperone activity. However, the structural and functional properties of such hetero-oligomers are poorly understood. We became interested in hetero-oligomer formation between human heat-shock protein family B (small) member 1 (HSPB1) and HSPB6, which are both highly expressed in skeletal muscle. When mixed in vitro, these two sHSPs form a polydisperse oligomer array composed solely of heterodimers, suggesting preferential association that is determined at the monomer level. Previously, we have shown that the sHSP N-terminal domains (NTDs), which have a high degree of intrinsic disorder, are essential for the biased formation. Here we employed iterative deletion mapping to elucidate how the NTD of HSPB6 influences its preferential association with HSPB1 and show that this region has multiple RLFDQXFG is necessary for subunit exchange among oligomers. Second, a site similar to 20 residues downstream of this motif determines the size of the resultant hetero-oligomers. Third, a region unique to HSPB6 dictates the preferential formation of heterodimers. In conclusion, the disordered NTD of HSPB6 helps regulate the size and stability of hetero-oligomeric complexes, indicating that terminal sHSP regions define the assembly properties of these proteins.	[Heirbaut, Michelle; Beelen, Steven; Strelkov, Sergei V.; Weeks, Stephen D.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium; [Lermyte, Frederik; Martin, Esther M.; Sobott, Frank] Univ Antwerp, Dept Chem, Biomol & Analyt Mass Spectrometry Grp, B-2020 Antwerp, Belgium; [Martin, Esther M.; Sobott, Frank] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Sobott, Frank] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	KU Leuven; University of Antwerp; University of Leeds; University of Leeds	Strelkov, SV; Weeks, SD (corresponding author), Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, Herestr 49,Box 822, B-3000 Leuven, Belgium.	sergei.strelkov@kuleuven.be; stephen.weeks@kuleuven.be	Weeks, Stephen D/G-6150-2017; Weeks, Stephen/N-4813-2019	Weeks, Stephen D/0000-0002-1360-0852; Weeks, Stephen/0000-0002-1360-0852; Sobott, Frank/0000-0001-9029-1865; Lermyte, Frederik/0000-0001-7371-4475	Hercules Foundation Flanders; European Community's Seventh Framework Programme under the BioStruct-X initiative [6131]	Hercules Foundation Flanders; European Community's Seventh Framework Programme under the BioStruct-X initiative	We thank The Hercules Foundation Flanders for funding the Synapt instrument. We acknowledge support from the European Community's Seventh Framework Programme under the BioStruct-X initiative (Project Number 6131) toward the Synchrotron SAXS measurements. We greatly appreciate the excellent support from the beamline scientists on the SWING beamline (Soleil Synchrotron, France).	Andley UP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095507; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; CLAUWAERT J, 1989, CURR EYE RES, V8, P397, DOI 10.3109/02713688908996387; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; den Engelsman J, 2009, J MOL BIOL, V393, P1022, DOI 10.1016/j.jmb.2009.08.052; Flenniken ML, 2009, CURR TOP MICROBIOL, V327, P71; Furnish EJ, 2010, J NEUROSURG, V112, P631, DOI 10.3171/2009.7.JNS09730; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Heirbaut M., 2015, BIG BOOK SMALL HEAT, P197; Heirbaut M, 2016, ARCH BIOCHEM BIOPHYS, V610, P41, DOI 10.1016/j.abb.2016.10.002; Heirbaut M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105892; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; James M, 2001, Curr Pharm Biotechnol, V2, P77; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; KATO K, 1994, J BIOL CHEM, V269, P15302; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lermyte F, 2015, J AM SOC MASS SPECTR, V26, P1068, DOI 10.1007/s13361-015-1124-z; MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Pasta SY, 2003, J BIOL CHEM, V278, P51159, DOI 10.1074/jbc.M307523200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Sluchanko NN, 2017, STRUCTURE, V25, P305, DOI 10.1016/j.str.2016.12.005; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; SPECTOR A, 1971, BIOCHEM J, V124, P337, DOI 10.1042/bj1240337; Srinivas PNBS, 2008, BIOCHEM J, V414, P453, DOI 10.1042/BJ20080544; Studer S, 2000, J BIOL CHEM, V275, P37212, DOI 10.1074/jbc.M004701200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Weeks SD, 2014, J STRUCT BIOL, V185, P342, DOI 10.1016/j.jsb.2013.12.009	56	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9944	9957		10.1074/jbc.M116.773515	http://dx.doi.org/10.1074/jbc.M116.773515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28487364	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000403580600008
J	Wang, YM; Landry, AP; Ding, HG				Wang, Yiming; Landry, Aaron P.; Ding, Huangen			The mitochondrial outer membrane protein mitoNEET is a redox enzyme catalyzing electron transfer from FMNH2 to oxygen or ubiquinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2FE-2S CLUSTERS; CRYSTAL-STRUCTURE; BREAST-CANCER; ESCHERICHIA-COLI; TUMOR-GROWTH; THIAZOLIDINEDIONE; IDENTIFICATION; CELLS; REDUCTASE; SURVIVAL	Increasing evidence suggests that mitoNEET, a target of the type II diabetes drug pioglitazone, is a key regulator of energy metabolism in mitochondria. MitoNEET is anchored to the mitochondrial outer membrane via its N-terminal alpha helix domain and hosts a redox-active [2Fe-2S] cluster in its C-terminal cytosolic region. The mechanism by which mitoNEET regulates energy metabolism in mitochondria, however, is not fully understood. Previous studies have shown that mitoNEET specifically interacts with the reduced flavin mononucleotide (FMNH2) and that FMNH2 can quickly reduce the mitoNEET [2Fe-2S] clusters. Here we report that the reduced mitoNEET [2Fe-2S] clusters can be readily oxidized by oxygen. In the presence of FMN, NADH, and flavin reductase, which reduces FMN to FMNH2 using NADH as the electron donor, mitoNEET mediates oxidation of NADH with a concomitant reduction of oxygen. Ubiquinone-2, an analog of ubiquinone-10, can also oxidize the reduced mitoNEET [2Fe-2S] clusters under anaerobic or aerobic conditions. Compared with oxygen, ubiquinone-2 is more efficient in oxidizing the mitoNEET [2Fe-2S] clusters, suggesting that ubiquinone could be an intrinsic electron acceptor of the reduced mitoNEET [2Fe-2S] clusters in mitochondria. Pioglitazone or its analog NL-1 appears to inhibit the electron transfer activity of mitoNEET by forming a unique complex with mitoNEET and FMNH2. The results suggest that mitoNEET is a redox enzyme that may promote oxidation of NADH to facilitate enhanced glycolysis in the cytosol and that pioglitazone may regulate energy metabolism in mitochondria by inhibiting the electron transfer activity of mitoNEET.	[Wang, Yiming; Landry, Aaron P.; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	National Institutes of Health [R15GM109399]; American Heart Association [13GRNT16890014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM109399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health Grant R15GM109399 and American Heart Association Grant 13GRNT16890014. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai F, 2015, P NATL ACAD SCI USA, V112, P3698, DOI 10.1073/pnas.1502960112; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geldenhuys WJ, 2016, BIOORG MED CHEM LETT, V26, P5350, DOI 10.1016/j.bmcl.2016.09.009; Geldenhuys WJ, 2010, BIOORG MED CHEM LETT, V20, P819, DOI 10.1016/j.bmcl.2009.12.088; Golinelli-Cohen MP, 2016, J BIOL CHEM, V291, P7583, DOI 10.1074/jbc.M115.711218; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; He QQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35205; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hippisley-Cox J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3477; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Huhner J, 2015, ELECTROPHORESIS, V36, P518, DOI 10.1002/elps.201400451; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; Inupakutika MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42571; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Kusminski CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4962; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2017, FREE RADICAL BIO MED, V102, P240, DOI 10.1016/j.freeradbiomed.2016.12.001; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Lapointe J, 2012, J CELL BIOL, V199, P215, DOI 10.1083/jcb.201203090; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024790; Lipper CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139699; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Roberts ME, 2013, BIOCHEMISTRY-US, V52, P8969, DOI 10.1021/bi401038w; Salem AF, 2012, CELL CYCLE, V11, P4174, DOI 10.4161/cc.22376; Smith LJ, 2008, BIOCHEM J, V411, P475, DOI 10.1042/BJ20071495; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Takahashi T, 2015, J PHARMACOL EXP THER, V352, P338, DOI 10.1124/jpet.114.220673; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P838, DOI 10.1016/j.bbrc.2016.08.034; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	46	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10061	10067		10.1074/jbc.M117.789800	http://dx.doi.org/10.1074/jbc.M117.789800			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28461337	Green Published, hybrid			2022-12-28	WOS:000403580600018
J	Wilson, MR; Zha, L; Balskus, EP				Wilson, Matthew R.; Zha, Li; Balskus, Emily P.			Natural product discovery from the human microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IN-VITRO RECONSTITUTION; COLIBACTIN BIOSYNTHESIS; METABOLITES; POLYKETIDE; ACTIVATION; INSIGHTS; MECHANISM; SEQUENCE; BACTERIA; REVEALS	Human-associated microorganisms have the potential to biosynthesize numerous secondary metabolites that may mediate important host-microbe and microbe-microbe interactions. However, there is currently a limited understanding of microbiome-derived natural products. A variety of complementary discovery approaches have begun to illuminate this microbial dark matter, which will in turn allow detailed mechanistic studies of the effects of these molecules on microbiome and host. Herein, we review recent efforts to uncover microbiome-derived natural products, describe the key approaches that were used to identify and characterize these metabolites, discuss potential functional roles of these molecules, and highlight challenges related to this emerging research area.	[Wilson, Matthew R.; Zha, Li; Balskus, Emily P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Balskus, EP (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Mallinckrodt Bldg 303N,12 Oxford St, Cambridge, MA 02318 USA.	balskus@chemistry.harvard.edu	ZHA, LI/Q-2540-2018	ZHA, LI/0000-0002-8465-0232; Schilling, Nadine Anna/0000-0002-2671-9094	American Cancer Society-New England Division Postdoctoral Fellowship [PF-16-122-01-CDD]; Damon Runyon-Rachleff Innovation Award; Smith Family Award for Excellence in Biomedical Research; Searle Scholars Program; Packard Fellowship for Science and Engineering; National Institutes of Health [1R01CA208834-01]; NATIONAL CANCER INSTITUTE [R01CA208834] Funding Source: NIH RePORTER	American Cancer Society-New England Division Postdoctoral Fellowship; Damon Runyon-Rachleff Innovation Award; Smith Family Award for Excellence in Biomedical Research; Searle Scholars Program; Packard Fellowship for Science and Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Studies of colibactin biosynthesis by the Balskus group have been supported, in whole or in part, by the Damon Runyon-Rachleff Innovation Award, the Smith Family Award for Excellence in Biomedical Research, the Searle Scholars Program, the Packard Fellowship for Science and Engineering, and by National Institutes of Health Grant 1R01CA208834-01. This is the first article in the Host-Microbiome Metabolic Interplay Minireview series. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by American Cancer Society-New England Division Postdoctoral Fellowship PF-16-122-01-CDD.	Balskus EP, 2015, NAT PROD REP, V32, P1534, DOI 10.1039/c5np00091b; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bian XY, 2015, CHEM SCI, V6, P3154, DOI 10.1039/c5sc00101c; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Biteen JS, 2016, ACS NANO, V10, P6, DOI 10.1021/acsnano.5b07826; Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112; Brachmann AO, 2015, CHEM COMMUN, V51, P13138, DOI 10.1039/c5cc02718g; Brady SF, 2009, NAT PROD REP, V26, P1488, DOI 10.1039/b817078a; Brady SF, 2000, ORG LETT, V2, P4043, DOI 10.1021/ol006680s; Brady SF, 2005, ANGEW CHEM INT EDIT, V44, P7063, DOI 10.1002/anie.200501941; Brotherton CA, 2015, ORG LETT, V17, P1545, DOI 10.1021/acs.orglett.5b00432; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Cantley AM, 2015, NAT PROD REP, V32, P888, DOI 10.1039/c4np00141a; Charlop-Powers Z, 2014, CURR OPIN MICROBIOL, V19, P70, DOI 10.1016/j.mib.2014.05.021; Chu J, 2016, NAT CHEM BIOL, V12, P1004, DOI 10.1038/nchembio.2207; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Cohen LJ, 2015, P NATL ACAD SCI USA, V112, pE4825, DOI 10.1073/pnas.1508737112; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; del Campo JSM, 2016, ACS CHEM BIOL, V11, P3035, DOI 10.1021/acschembio.6b00666; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Dubois D, 2011, J BIOL CHEM, V286, P35562, DOI 10.1074/jbc.M111.221960; Franke J, 2016, CELL CHEM BIOL, V23, P1179, DOI 10.1016/j.chembiol.2016.08.014; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Healy AR, 2016, J AM CHEM SOC, V138, P5426, DOI 10.1021/jacs.6b02276; Iqbal HA, 2016, J AM CHEM SOC, V138, P9341, DOI 10.1021/jacs.6b02921; Joice R, 2014, CELL METAB, V20, P731, DOI 10.1016/j.cmet.2014.10.003; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Koppel N, 2016, CELL CHEM BIOL, V23, P18, DOI 10.1016/j.chembiol.2015.12.008; Kuo J, 2016, ACS CHEM BIOL, V11, P2636, DOI 10.1021/acschembio.6b00489; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87; Li ZR, 2016, NAT CHEM BIOL, V12, P773, DOI 10.1038/nchembio.2157; Li ZR, 2015, CHEMBIOCHEM, V16, P1715, DOI 10.1002/cbic.201500239; Lowry B, 2015, SYNLETT, V26, P1008, DOI 10.1055/s-0034-1380264; Ly A, 2016, NAT PROTOC, V11, P1428, DOI 10.1038/nprot.2016.081; Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/NCHEMBIO.1884, 10.1038/nchembio.1884]; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Milshteyn A, 2014, CHEM BIOL, V21, P1211, DOI 10.1016/j.chembiol.2014.08.006; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Owen JG, 2015, P NATL ACAD SCI USA, V112, P4221, DOI 10.1073/pnas.1501124112; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Quinn RA, 2016, ISME J, V10, P1483, DOI 10.1038/ismej.2015.207; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Seyedsayamdost MR, 2014, P NATL ACAD SCI USA, V111, P7266, DOI 10.1073/pnas.1400019111; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Sidebottom AM, 2015, CURR OPIN CHEM BIOL, V24, P104, DOI 10.1016/j.cbpa.2014.10.014; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24; Tanasova M, 2012, CHEM REV, V112, P3578, DOI 10.1021/cr2001367; Tang XY, 2015, ACS CHEM BIOL, V10, P2841, DOI 10.1021/acschembio.5b00658; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Vizcaino MI, 2014, J AM CHEM SOC, V136, P9244, DOI 10.1021/ja503450q; Wang GYS, 2000, ORG LETT, V2, P2401, DOI 10.1021/ol005860z; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; Wilson MC, 2013, CHEM BIOL, V20, P636, DOI 10.1016/j.chembiol.2013.04.011; Wolkenberg SE, 2002, CHEM REV, V102, P2477, DOI 10.1021/cr010046q; Yang JY, 2011, CURR OPIN CHEM BIOL, V15, P79, DOI 10.1016/j.cbpa.2010.10.025; Yeh HH, 2016, ACS CHEM BIOL, V11, P2275, DOI 10.1021/acschembio.6b00213; Zha L, 2016, ACS CHEM BIOL, V11, P1287, DOI 10.1021/acschembio.6b00014; Ziemert N, 2016, NAT PROD REP, V33, P988, DOI 10.1039/c6np00025h; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	70	44	46	3	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8546	8552		10.1074/jbc.R116.762906	http://dx.doi.org/10.1074/jbc.R116.762906			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389564	Green Published, hybrid			2022-12-28	WOS:000402153900002
J	Lerat, H; Imache, MR; Polyte, J; Gaudin, A; Mercey, M; Donati, F; Baudesson, C; Higgs, MR; Picard, A; Magnan, C; Foufelle, F; Pawlotsky, JM				Lerat, Herve; Imache, Mohamed Rabah; Polyte, Jacqueline; Gaudin, Aurore; Mercey, Marion; Donati, Flora; Baudesson, Camille; Higgs, Martin R.; Picard, Alexandre; Magnan, Christophe; Foufelle, Fabienne; Pawlotsky, Jean-Michel			Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; hepatitis C virus (HCV); insulin resistance; transgenic mice; type 2 diabetes	INSULIN-RECEPTOR SUBSTRATE-1; SUSTAINED VIROLOGICAL RESPONSE; AMINO-ACID SUBSTITUTIONS; DIABETES-MELLITUS; DOWN-REGULATION; UP-REGULATION; CORE PROTEIN; TYROSINE PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; NONCIRRHOTIC PATIENTS	Virus-related type 2 diabetes is commonly observed in individuals infected with the hepatitis C virus (HCV); however, the underlying molecular mechanisms remain unknown. Our aim was to unravel these mechanisms using FL-N/35 transgenic mice expressing the full HCV ORF. We observed that these mice displayed glucose intolerance and insulin resistance. We also found that Glut-2 membrane expression was reduced in FL-N/35 mice and that hepatocyte glucose uptake was perturbed, partly accounting for the HCV-induced glucose intolerance in these mice. Early steps of the hepatic insulin signaling pathway, from IRS2 to PDK1 phosphorylation, were constitutively impaired in FL-N/35 primary hepatocytes via deregulation of TNF/SOCS3. Higher hepatic glucose production was observed in the HCV mice, despite higher fasting insulinemia, concomitant with decreased expression of hepatic gluconeogenic genes. Akt kinase activity was higher in HCV mice than in WT mice, but Akt-dependent phosphorylation of the forkhead transcription factor FoxO1 at serine 256, which triggers its nuclear exclusion, was lower in HCV mouse livers. These findings indicate an uncoupling of the canonical Akt/FoxO1 pathway in HCV protein-expressing hepatocytes. Thus, the expression of HCV proteins in the liver is sufficient to induce insulin resistance by impairing insulin signaling and glucose uptake. In conclusion, we observed a complete set of events leading to a prediabetic state in HCV-transgenic mice, providing a valuable mechanistic explanation for HCV-induced diabetes in humans.	[Lerat, Herve; Imache, Mohamed Rabah; Polyte, Jacqueline; Gaudin, Aurore; Mercey, Marion; Donati, Flora; Baudesson, Camille; Higgs, Martin R.; Pawlotsky, Jean-Michel] INSERM, U955, Team Pathophysiol & Therapy Chron Viral Hepatitis, F-94010 Creteil, France; [Lerat, Herve; Pawlotsky, Jean-Michel] Univ Paris Est Creteil Val de Marne, F-94010 Creteil, France; [Picard, Alexandre; Magnan, Christophe] Univ Paris Diderot, Unite Biol Fonct & Adaptat, Sorbonne Paris Cite, CNRS,UMR 8251, F-75013 Paris, France; [Foufelle, Fabienne] Ctr Rech Cordeliers, INSERM, UMRS 1138, F-75006 Paris, France; [Pawlotsky, Jean-Michel] Hop Henri Mondor, AP HP, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, F-94010 Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Lerat, H (corresponding author), INSERM, U955, Team Pathophysiol & Therapy Chron Viral Hepatitis, F-94010 Creteil, France.; Lerat, H (corresponding author), Univ Paris Est Creteil Val de Marne, F-94010 Creteil, France.	herve.lerat@inserm.fr	Higgs, Martin/AAK-2108-2021; LERAT, Hervé/D-4331-2019; Pawlotsky, Jean-Michel/R-8159-2018; magnan, christophe/AAJ-7622-2021	Higgs, Martin/0000-0002-8218-0089; LERAT, Hervé/0000-0002-8505-378X; magnan, christophe/0000-0002-7044-2571; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Picard, Alexandre/0000-0003-2564-7428; FOUFELLE, Fabienne/0000-0002-0752-622X	National Agency for Research on AIDS and Viral Hepatitis; French Direction Departementale de la Protection des Populations [94-028-7]; French Ministry of Research	National Agency for Research on AIDS and Viral Hepatitis; French Direction Departementale de la Protection des Populations; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the National Agency for Research on AIDS and Viral Hepatitis. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an agreement to perform research using animals, delivered by the French Direction Departementale de la Protection des Populations (Agreement 94-028-7). To whom correspondence should be addressed. Tel.: 33-1-4981-4711; Fax: 33-1-4981-4844; E-mail: herve.lerat@inserm.fr.; Recipient of a fellowship from the French Ministry of Research.; Recipient of a postdoctoral fellowship from the National Agency for Research on AIDS and Viral Hepatitis.	Alexander GJM, 2000, ANN INTERN MED, V133, P650, DOI 10.7326/0003-4819-133-8-200010170-00018; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; Anty R, 2007, EUR J GASTROEN HEPAT, V19, P671, DOI 10.1097/MEG.0b013e3281532b9a; Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; Banerjee A, 2010, J VIROL, V84, P5936, DOI 10.1128/JVI.02344-09; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Bernsmeier C, 2014, J VIRAL HEPATITIS, V21, P9, DOI 10.1111/jvh.12208; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Calzadilla-Bertot L, 2016, DIGEST LIVER DIS, V48, P283, DOI 10.1016/j.dld.2015.12.002; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Chen JZ, 2015, DIABETES, V64, P4088, DOI 10.2337/db15-0197; Chen LH, 2013, EUR J GASTROEN HEPAT, V25, P935, DOI 10.1097/MEG.0b013e32835fa988; Chouteau P, 2012, J HEPATOL, V57, P499, DOI 10.1016/j.jhep.2012.04.019; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; El-Saadany S, 2013, CAN J GASTROENTEROL, V27, pE13, DOI 10.1155/2013/562765; Eslam M, 2012, J CLIN GASTROENTEROL, V46, P228, DOI 10.1097/MCG.0b013e31822a2dc6; Foxton MR, 2006, AM J TRANSPLANT, V6, P1922, DOI 10.1111/j.1600-6143.2006.01408.x; Funaoka Y, 2011, J VIROL, V85, P5986, DOI 10.1128/JVI.02583-10; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Higgs MR, 2013, ONCOGENE, V32, P4683, DOI 10.1038/onc.2012.484; Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-0; Higgs MR, 2010, CANCER RES, V70, P4901, DOI 10.1158/0008-5472.CAN-09-4554; Hsu CS, 2008, LIVER INT, V28, P271, DOI 10.1111/j.1478-3231.2007.01626.x; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Hung CH, 2013, INTERVIROLOGY, V56, P166, DOI 10.1159/000343913; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Imazeki F, 2008, LIVER INT, V28, P355, DOI 10.1111/j.1478-3231.2007.01630.x; Kaddai V, 2011, EXPERT REV GASTROENT, V5, P503, DOI [10.1586/EGH.11.43, 10.1586/egh.11.43]; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2007, AM J GASTROENTEROL, V102, P570, DOI 10.1111/j.1572-0241.2006.01038.x; Kawamura Y, 2010, AM J MED, V123, P951, DOI 10.1016/j.amjmed.2010.05.013; Kim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008649; Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Kuo YC, 2014, LIVER INT, V34, P1358, DOI 10.1111/liv.12389; Lecube A, 2004, DIABETES CARE, V27, P1171, DOI 10.2337/diacare.27.5.1171; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Lubura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037026; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Matsui C, 2012, J VIROL, V86, P12903, DOI 10.1128/JVI.01418-12; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Mitsuyoshi H, 2008, HEPATOL RES, V38, P348, DOI 10.1111/j.1872-034X.2007.00280.x; Miyamoto H, 2007, J VIROL, V81, P1727, DOI 10.1128/JVI.01683-06; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Naing C, 2013, CURR DIABETES REP, V13, P428, DOI 10.1007/s11892-013-0370-3; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Negro F, 2011, CLIN RES HEPATOL GAS, V35, P358, DOI 10.1016/j.clinre.2011.01.011; Park SH, 2009, AM J GASTROENTEROL, V104, P1135, DOI 10.1038/ajg.2009.6; Parvaiz F, 2014, ARCH VIROL, V159, P1017, DOI 10.1007/s00705-013-1892-3; Pawlotsky JM, 2015, GASTROENTEROLOGY, V148, P468, DOI 10.1053/j.gastro.2015.01.002; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Serfaty L, 2012, GUT, V61, P1473, DOI 10.1136/gutjnl-2011-300749; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sumida Y, 2011, J GASTROEN HEPATOL, V26, P836, DOI 10.1111/j.1440-1746.2010.06568.x; Thompson AJ, 2012, GUT, V61, P128, DOI 10.1136/gut.2010.236158; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Tsochatzis E, 2009, ALIMENT PHARM THER, V30, P947, DOI 10.1111/j.1365-2036.2009.04094.x; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Uraki S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131346; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Wang CC, 2015, J GASTROEN HEPATOL, V30, P14, DOI 10.1111/jgh.12700; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	87	16	16	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12860	12873		10.1074/jbc.M117.785030	http://dx.doi.org/10.1074/jbc.M117.785030			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28559285	Green Published, hybrid			2022-12-28	WOS:000407220100016
J	Chen, CC; Montalbano, AP; Hussain, I; Lee, WR; Mendelson, CR				Chen, Chien-Cheng; Montalbano, Alina P.; Hussain, Imran; Lee, Wan-Ru; Mendelson, Carole R.			The transcriptional repressor GATAD2B mediates progesterone receptor suppression of myometrial contractile gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; inflammation; nuclear receptor; progesterone; transcription corepressor	NF-KAPPA-B; DAVID BIOINFORMATICS RESOURCES; PROTEOMICS FACILITIES PIPELINE; BREAST-CANCER CELLS; HUMAN PARTURITION; MI-2/NURD COMPLEX; HUMAN-PREGNANCY; LABOR; TERM; WITHDRAWAL	The mechanisms whereby progesterone (P-4), acting via the progesterone receptor (PR), inhibits proinflammatory/contractile gene expression during pregnancy are incompletely defined. Using immortalized human myometrial (hTERT-HM) cells stably expressing wild-type PR-A or PR-B (PRWT), we found that P-4 significantly inhibited IL-1 induction of the NF-B target genes, COX-2 and IL-8. P-4-PRWT transrepression occurred at the level of transcription initiation and was mediated by decreased recruitment of NF-B p65 and RNA polymerase II to COX-2 and IL-8 promoters. However, in cells stably expressing a PR-A or PR-B DNA-binding domain mutant (PRmDBD), P-4-mediated transrepression was significantly reduced, suggesting a critical role of the PR DBD. ChIP analysis of hTERT-HM cells stably expressing PRWT or PRmDBD revealed that P-4 treatment caused equivalent recruitment of PRWT and PRmDBD to COX-2 and IL-8 promoters, suggesting that PR inhibitory effects were not mediated by its direct DNA binding. Using immunoprecipitation, followed by MS, we identified a transcriptional repressor, GATA zinc finger domain-containing 2B (GATAD2B), that interacted strongly with PRWT but poorly with PRmDBD. P-4 treatment of PRWT hTERT-HM cells caused enhanced recruitment of endogenous GATAD2B to COX-2 and IL-8 promoters. Further, siRNA knockdown of endogenous GATAD2B significantly reduced P-4-PRWT transrepression of COX-2 and IL-8. Notably, GATAD2B expression was significantly decreased in pregnant mouse and human myometrium during labor. Our findings suggest that GATAD2B serves as an important mediator of P-4-PR suppression of proinflammatory and contractile genes during pregnancy. Decreased GATAD2B expression near term may contribute to the decline in PR function, leading to labor.	[Chen, Chien-Cheng; Montalbano, Alina P.; Hussain, Imran; Lee, Wan-Ru; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, North Texas March Dimes Birth Defects Ctr, Dallas, TX 75390 USA; [Chen, Chien-Cheng; Montalbano, Alina P.; Hussain, Imran; Lee, Wan-Ru; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, North Texas March Dimes Birth Defects Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carole.mendelson@utsouthwestern.edu		Hussain, Imran/0000-0003-1563-7656; Mendelson, Carole Ruth/0000-0003-1696-9791	Cancer Prevention Research Institute of Texas [RP120613]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD087150, P01HD011149] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Andrew Lemoff (University of Texas Southwestern Proteomics Core) for analysis of the mass spectrometry data as well as helpful discussion regarding this work. We also thank Dr. Linda Hynan (Division of Biostatistics, Department of Clinical Sciences) for help in statistical analysis of data from human myometrial samples. The UT Southwestern Proteomics Core is supported by the Cancer Prevention Research Institute of Texas (Grant RP120613).	Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Abdel-Hafiz HA, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-10; Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Amini P, 2016, ENDOCRINOLOGY, V157, P4434, DOI 10.1210/en.2016-1654; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; Chen CC, 2011, J BIOL CHEM, V286, P43091, DOI 10.1074/jbc.M111.295865; CHOW L, 1994, AM J OBSTET GYNECOL, V170, P788, DOI 10.1016/S0002-9378(94)70284-5; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Cox SM, 1997, HUM REPROD UPDATE, V3, P517, DOI 10.1093/humupd/3.5.517; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; FUCHS AR, 1984, AM J OBSTET GYNECOL, V150, P734, DOI 10.1016/0002-9378(84)90677-X; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gong ZH, 2006, MOL CELL BIOL, V26, P4519, DOI 10.1128/MCB.00409-06; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; HARDY DB, 2006, FETAL MATERNAL MED R, V17, P281; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Lee Y, 2012, J CELL MOL MED, V16, P2487, DOI 10.1111/j.1582-4934.2012.01567.x; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Li H, 2012, ONCOGENE, V31, P611, DOI 10.1038/onc.2011.253; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Nadeem L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11565; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Peters GA, 2017, ENDOCRINOLOGY, V158, P158, DOI 10.1210/en.2016-1537; POINTIS G, 1981, BIOL REPROD, V24, P801, DOI 10.1095/biolreprod24.4.801; Quiles I, 2009, MOL ENDOCRINOL, V23, P809, DOI 10.1210/me.2008-0454; Renthal NE, 2013, NAT REV ENDOCRINOL, V9, P391, DOI 10.1038/nrendo.2013.96; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Shynlova O, 2013, REPROD SCI, V20, P154, DOI 10.1177/1933719112446084; SIITERI PK, 1982, BIOL REPROD, V26, P1, DOI 10.1095/biolreprod26.1.1; Soloff MS, 2006, MOL HUM REPROD, V12, P619, DOI 10.1093/molehr/gal067; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Trudgian DC, 2012, J PROTEOME RES, V11, P6282, DOI 10.1021/pr300694b; Trudgian DC, 2011, PROTEOMICS, V11, P2790, DOI 10.1002/pmic.201000800; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; Williams KC, 2012, MOL ENDOCRINOL, V26, P1857, DOI 10.1210/me.2012-1199; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Xie N, 2012, MOL ENDOCRINOL, V26, P1370, DOI 10.1210/me.2012-1088	60	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12560	12576		10.1074/jbc.M117.791350	http://dx.doi.org/10.1074/jbc.M117.791350			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28576827	hybrid, Green Published			2022-12-28	WOS:000406636900021
J	Schott, MB; Rasineni, K; Weller, SG; Schulze, RJ; Sletten, AC; Casey, CA; McNiven, MA				Schott, Micah B.; Rasineni, Karuna; Weller, Shaun G.; Schulze, Ryan J.; Sletten, Arthur C.; Casey, Carol A.; McNiven, Mark A.			beta-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose triglyceride lipase (ATGL); adrenergic receptor; alcohol; cyclic AMP (cAMP); G protein-coupled receptor (GPCR); hepatocyte; lipid droplet; fatty liver	HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; LIPID DROPLETS; FATTY LIVER; HEPATIC GLUCONEOGENESIS; STIMULATED LIPOLYSIS; PROTEIN-KINASE; ATGL; METABOLISM; PROMOTES	In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the beta-adrenergic (beta-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to beta-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the beta-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). beta-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this beta-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in beta-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in both PKA activation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that beta-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.	[Schott, Micah B.; Weller, Shaun G.; Schulze, Ryan J.; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Sletten, Arthur C.] Mayo Clin, Div Gastroenterol & Hepatol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Rasineni, Karuna; Casey, Carol A.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Casey, Carol A.] Nebraska Western Iowa Hlth Care Syst Res Serv, Omaha, NE 68105 USA	Mayo Clinic; Mayo Clinic; University of Nebraska System; University of Nebraska Medical Center	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.; McNiven, MA (corresponding author), Mayo Clin, Ctr Basic Res Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	mmcniven.mark@mayo.edu			National Institutes of Health [5R01DK044650, 5RO1AA020735, 5T32DK007352, P30DK084567]; Department of Veterans Affairs; Optical Morphology Core of the Mayo Clinic Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044650, T32DK007352, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Optical Morphology Core of the Mayo Clinic Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants 5R01DK044650 (to M. A. M.), 5RO1AA020735 (to M. A. M. and C. A. C.), and 5T32DK007352 (to R. J. S. and M. B. S.); by funds from the Department of Veterans Affairs (to C. A. C); and by the Optical Morphology Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology, National Institutes of Health Grant P30DK084567. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or the National Institutes of Health.	Aquilano K, 2016, ONCOTARGET, V7, P23019, DOI 10.18632/oncotarget.8552; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle D. L., 2016, CURRENT PROTOCOLS CE, V72; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Casey CA, 2004, J APPL PHYSIOL, V96, P76, DOI 10.1152/japplphysiol.00375.2003; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Clemens DL, 2002, HEPATOLOGY, V35, P1196, DOI 10.1053/jhep.2002.32668; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; De A, 1999, ALCOHOL CLIN EXP RES, V23, P46, DOI 10.1111/j.1530-0277.1999.tb04022.x; DEBEER LJ, 1982, FEBS LETT, V140, P159, DOI 10.1016/0014-5793(82)80884-3; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Farah BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098155; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Ganesan M, 2015, AM J PHYSIOL-GASTR L, V309, pG566, DOI 10.1152/ajpgi.00183.2015; Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoffman P L, 1987, Alcohol Alcohol Suppl, V1, P749; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; KREBS HA, 1969, BIOCHEM J, V112, P117, DOI 10.1042/bj1120117; Li ZY, 2016, J ASIAN NAT PROD RES, V2, P1; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; McVicker BL, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/978136; MORGAN NG, 1983, J BIOL CHEM, V258, P5103; NAGY LE, 1988, P NATL ACAD SCI USA, V85, P6973, DOI 10.1073/pnas.85.18.6973; O'Shea RS, 2010, AM J GASTROENTEROL, V105, P14, DOI 10.1038/ajg.2009.593; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Rasineni K, 2014, ALCOHOL CLIN EXP RES, V38, P327, DOI 10.1111/acer.12271; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sathyanarayan A, 2017, CELL REP, V19, P1, DOI 10.1016/j.celrep.2017.03.026; Schroeder B, 2015, HEPATOLOGY, V61, P1896, DOI 10.1002/hep.27667; Schulze RJ, 2014, AUTOPHAGY, V10, P388, DOI 10.4161/auto.27486; Schulze RJ, 2013, J CELL BIOL, V203, P315, DOI 10.1083/jcb.201306140; Sekiya M, 2008, J LIPID RES, V49, P1829, DOI 10.1194/jlr.M800198-JLR200; Shen L, 2012, JOVE-J VIS EXP, DOI 10.3791/3917; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang Y, 2013, ADV CIV ENG, V2013, DOI 10.1155/2013/189105; Whitsett M, 2015, WORLD J HEPATOL, V7, P2041, DOI 10.4254/wjh.v7.i16.2041; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zhang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29539	70	36	37	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11815	11828		10.1074/jbc.M117.777748	http://dx.doi.org/10.1074/jbc.M117.777748			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28515323	Green Published, hybrid			2022-12-28	WOS:000405485600019
J	Kumazoe, M; Takai, M; Hiroi, S; Takeuchi, C; Kadomatsu, M; Nojiri, T; Onda, H; Bae, J; Huang, YH; Takamatsu, K; Yamashita, S; Kangawa, K; Tachibana, H				Kumazoe, Motofumi; Takai, Mika; Hiroi, Shun; Takeuchi, Chieri; Kadomatsu, Mai; Nojiri, Takashi; Onda, Hiroaki; Bae, Jaehoon; Huang, Yuhui; Takamatsu, Kanako; Yamashita, Shuya; Kangawa, Kenji; Tachibana, Hirofumi			The FOXO3/PGC-1 beta signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD44 EXPRESSION; GEMCITABINE; IDENTIFICATION; TARGET	In 95% of patients with pancreatic ductal adenocarcinoma, recurrence is observed following chemotherapy. Findings from several studies have indicated that cancer stem cells (CSCs) are resistant to anticancer agents and may be involved in cancer recurrence and metastasis. The CD44 protein is a major CSC marker, and CD44 also plays an indispensable role in the CSC properties in several cancers, including pancreatic cancer; however, no clinical approach exists to inhibit CD44 activity. Here, we have performed knock-in/knockdown experiments, and we demonstrate that the forkhead box O3 (FOXO3)/liver kinase B1 (LKB1)/AMP-activated protein kinase/peroxisome proliferator-activated receptor-gamma co-activator-1 beta (PGC-1 beta)/pyruvate dehydrogenase-A1 pathway is essential for CD44 expression and CSC properties. We observed that patients exhibiting high pyruvate dehydrogenase-A1 expression have a poor prognosis. Systemic PGC-1 beta knock-out mice are fertile and viable and do not exhibit an overt phenotype under normal conditions. This suggests that cGMP induction and PGC-1 beta inhibition represent potential strategies for treating patients with pancreatic ductal adenocarcinoma.	[Kumazoe, Motofumi; Takai, Mika; Hiroi, Shun; Takeuchi, Chieri; Kadomatsu, Mai; Bae, Jaehoon; Huang, Yuhui; Takamatsu, Kanako; Yamashita, Shuya; Tachibana, Hirofumi] Kyushu Univ, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Kumazoe, Motofumi; Nojiri, Takashi; Onda, Hiroaki; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan	Kyushu University; National Cerebral & Cardiovascular Center - Japan	Tachibana, H (corresponding author), Kyushu Univ, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994	Japan Society for the Promotion of Science (JSPS) KAKENHI [22228002, 15H02448]; JSPS KAKENHI [15K18821]; Grants-in-Aid for Scientific Research [15H02448] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 22228002 and 15H02448 (to H. T.), a grant-in-aid for JSPS fellows (to M. Kumazoe) (PD), and JSPS KAKENHI Grant 15K18821. The authors declare that they have no conflicts of interest with the contents of this article.	Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Buglioni A, 2016, ANNU REV MED, V67, P229, DOI 10.1146/annurev-med-052914-091923; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Fisher KW, 2015, MOL CELL BIOL, V35, P3866, DOI 10.1128/MCB.00528-15; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Kumazoe M, 2017, ONCOGENE, V36, P2643, DOI 10.1038/onc.2016.426; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032590; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Molejon MI, 2015, ONCOTARGET, V6, P7408, DOI 10.18632/oncotarget.3510; Nossaman VE, 2010, CARDIOL REV, V18, P190, DOI 10.1097/CRD.0b013e3181c8e14a; Ohara Y, 2013, CANCER SCI, V104, P1127, DOI 10.1111/cas.12198; Quint K, 2012, INT J ONCOL, V41, P2093, DOI 10.3892/ijo.2012.1648; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sergeant G, 2009, NAT REV CLIN ONCOL, V6, P580, DOI 10.1038/nrclinonc.2009.127; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Sulica R, 2015, CARDIOL THER, V4, P209, DOI 10.1007/s40119-015-0046-y; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; WARBURG O, 1956, SCIENCE, V124, P269; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; Zhao S, 2016, CLIN CANCER RES, V22, P5592, DOI 10.1158/1078-0432.CCR-15-3115	34	26	26	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10813	10823		10.1074/jbc.M116.772111	http://dx.doi.org/10.1074/jbc.M116.772111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28507102	Green Published, hybrid			2022-12-28	WOS:000404391000006
J	Segura, E; Bourdin, B; Tetreault, MP; Briot, J; Allen, BG; Mayer, G; Parent, L				Segura, Emilie; Bourdin, Benoite; Tetreault, Marie-Philippe; Briot, Julie; Allen, Bruce G.; Mayer, Gaetan; Parent, Lucie			Proteolytic cleavage of the hydrophobic domain in the Ca-V alpha 2 delta 1 subunit improves assembly and activity of cardiac Ca(V)1.2 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; CALCIUM-CHANNELS; ALPHA(2)DELTA SUBUNITS; SURFACE EXPRESSION; CA2+ CURRENTS; MEMBRANE; BIOSYNTHESIS; IDENTIFICATION; ARRHYTHMIA; ALPHA-2-SUBUNIT	Voltage-gated L-type Ca(V)1.2 channels in cardiomyocytes exist as heteromeric complexes with the pore-forming Ca-V alpha 1, Ca-V beta, and Ca-V alpha 2 delta 1 subunits. The full complement of subunits is required to reconstitute the native-like properties of L-type Ca2+ currents, but the molecular determinants responsible for the formation of the heteromeric complex are still being studied. Enzymatic treatment with phosphatidylinositol-specific phospholipase C, a phospholipase C specific for the cleavage of glycosylphosphatidylinositol (GPI)-anchored proteins, disrupted plasma membrane localization of the cardiac Ca-V alpha 2 delta 1 prompting us to investigate deletions of its hydrophobic transmembrane domain. Patch-clamp experiments indicated that the C-terminally cleaved Ca-V alpha 2 delta 1 proteins up-regulate Ca(V)1.2 channels. In contrast, deleting the residues before the single hydrophobic segment (Ca-V alpha 2 delta 1 Delta 1059-1063) impaired current up-regulation. Ca-V alpha 2 delta 1 mutants G1060I and G1061I nearly eliminated the cell-surface fluorescence of Ca-V alpha 2 delta 1, indicated by two-color flow cytometry assays and confocal imaging, and prevented Ca-V alpha 2 delta 1-mediated increase in peak current density and modulation of the voltage-dependent gating of Ca(V)1.2. These impacts were specific to substitutions with isoleucine residues because functional modulation was partially preserved in Ca-V alpha 2 delta 1 G1060A and G1061A proteins. Moreover, C-terminal fragments exhibited significantly altered mobility in denatured immunoblots of Ca-V alpha 2 delta 1 G1060I and Ca-V alpha 2 delta 1 G1061I, suggesting that these mutant proteins were impaired in proteolytic processing. Finally, Ca-V alpha 2 delta 1 Delta 1059-1063, but not Ca-V alpha 2 delta 1 G1060A, failed to co-immunoprecipitate with Ca(V)1.2. Altogether, our data support a model in which small neutral hydrophobic residues facilitate the post-translational cleavage of the Ca-V alpha 2 delta 1 subunit at the predicted membrane interface and further suggest that preventing GPI anchoring of Ca-V alpha 2 delta 1 averts its cell-surface expression, its interaction with Ca-V alpha 1, and modulation of Ca(V)1.2 currents.	[Segura, Emilie; Briot, Julie; Parent, Lucie] Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Allen, Bruce G.] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada; [Mayer, Gaetan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Segura, Emilie; Bourdin, Benoite; Tetreault, Marie-Philippe; Briot, Julie; Allen, Bruce G.; Mayer, Gaetan; Parent, Lucie] Univ Montreal, Inst Cardiol Montreal, Ctr Rech, Montreal, PQ H3C 3J7, Canada; [Segura, Emilie] Univ Paul Sabatier, I2MC, UMR 1048, Equipe 8,Inserm, 1 Ave Jean Poulhes BP 84225, F-31432 Toulouse 4, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Parent, L (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca	Allen, Bruce G/B-4693-2008	Allen, Bruce G/0000-0001-9000-9495; Briot, Julie/0000-0003-4154-6766	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation [G-15-0009329]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Operating Grant 130256 from the Canadian Institutes of Health Research and Grant G-15-0009329 from the Canadian Heart and Stroke Foundation (to L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; AMTHAUER R, 1993, P NATL ACAD SCI USA, V90, P3973, DOI 10.1073/pnas.90.9.3973; Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Bannister JP, 2012, HYPERTENSION, V60, P1006, DOI 10.1161/HYPERTENSIONAHA.112.199661; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bourdin B, 2016, JOVE-J VIS EXP, DOI 10.3791/54732; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Briot J., 2016, BIOCH MOL BIOL J; Calderon- Rivera A., 2012, CELL CALCIUM, V51, P22; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Elortza F, 2003, MOL CELL PROTEOMICS, V2, P1261, DOI 10.1074/mcp.M300079-MCP200; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson M. A. J., 2009, ESSENTIALS GLYCOBIOL; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; JAY SD, 1991, J BIOL CHEM, V266, P3287; Kadurin I, 2016, ELIFE, V5, DOI 10.7554/eLife.21143; Kadurin I, 2012, J BIOL CHEM, V287, P33554, DOI 10.1074/jbc.M112.378554; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Klugbauer N, 1999, J NEUROSCI, V19, P684; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Lugenbiel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116395; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MAYOR S, 1990, J BIOL CHEM, V265, P6164; MCCONVILLE MJ, 1994, BRAZ J MED BIOL RES, V27, P139; Muller A, 2012, BBA-BIOMEMBRANES, V1818, P117, DOI 10.1016/j.bbamem.2011.10.009; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Nosjean O, 1997, BBA-REV BIOMEMBRANES, V1331, P153, DOI 10.1016/S0304-4157(97)00005-1; Parent L., 1997, J MEMBR BIOL, V160; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Richard S, 2006, PROG BIOPHYS MOL BIO, V90, P118, DOI 10.1016/j.pbiomolbio.2005.05.005; Savalli N, 2016, J GEN PHYSIOL, V148, P147, DOI 10.1085/jgp.201611586; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Shishioh N, 2005, J BIOL CHEM, V280, P9728, DOI 10.1074/jbc.M413755200; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Song L, 2015, CURR MOL PHARMACOL, V8, P169, DOI 10.2174/1874467208666150507104555; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; STEVENS VL, 1995, BIOCHEM J, V310, P361, DOI 10.1042/bj3100361; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Voigt A., 2016, NEUROPHOTONICS, V3; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	73	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11109	11124		10.1074/jbc.M117.784355	http://dx.doi.org/10.1074/jbc.M117.784355			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28495885	Green Published, hybrid			2022-12-28	WOS:000404391000030
J	Chen, HB; Xu, XW; Wang, GP; Zhang, BY; Wang, G; Xin, GW; Liu, JJ; Jiang, Q; Zhang, HY; Zhang, CM				Chen, Huabo; Xu, Xiaowei; Wang, Guopeng; Zhang, Boyan; Wang, Gang; Xin, Guangwei; Liu, Junjun; Jiang, Qing; Zhang, Hongyin; Zhang, Chuanmao			CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G(1) phase to initiate a new cell cycle in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE; SUBCELLULAR-LOCALIZATION; NUCLEAR ACCUMULATION; D1 DEGRADATION; EXPRESSION; PHOSPHORYLATION; INHIBITION; PROLIFERATION; P21(CIP1); PREVENTS	CDK4 regulates G(1)/S phase transition in the mammalian cell cycle by phosphorylating retinoblastoma family proteins. However, the mechanism underlying the regulation of CDK4 activity is not fully understood. Here, we show that CDK4 protein is degraded by anaphase-promoting complex/ cyclosome (APC/C) during metaphase-anaphase transition in HeLa cells, whereas its main regulator, cyclin D1, remains intact but is sequestered in cytoplasm. CDK4 protein reaccumulates in the following G(1) phase and shuttles between the nucleus and the cytoplasm to facilitate the nuclear import of cyclin D1. Without CDK4, cyclin D1 cannot enter the nucleus. Point mutations that disrupt CDK4 and cyclin D1 interaction impair the nuclear import of cyclin D1 and the activity of CDK4. RNAi knockdown of CDK4 also induces cytoplasmic retention of cyclin D1 and G(0)/G(1) phase arrest of the cells. Collectively, our data demonstrate that CDK4 protein is degraded in late mitosis and reaccumulates in the following G(1) phase to facilitate the nuclear import of cyclin D1 for activation of CKD4 to initiate a new cell cycle in HeLa cells.	[Chen, Huabo; Xu, Xiaowei; Wang, Guopeng; Zhang, Boyan; Wang, Gang; Xin, Guangwei; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Chen, Huabo; Xu, Xiaowei; Wang, Guopeng; Zhang, Boyan; Wang, Gang; Xin, Guangwei; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Zhang, Hongyin] Peking Univ, Peking Univ Hosp, Canc Res Ctr, Beijing 100871, Peoples R China; [Liu, Junjun] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	Peking University; Peking University; Peking University; California State University System; California State Polytechnic University Pomona	Jiang, Q; Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.; Jiang, Q; Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.	jiangqing@pku.edu.cn; zhangcm@pku.edu.cn	Wang, Gang/Q-7267-2019	Xu, Xiaowei/0000-0001-6050-9536; Zhang, Boyan/0000-0001-7112-9870; Wang, Gang/0000-0002-0297-6467	National Natural Science Foundation of China (NSFC) [31371365, 31520103906, 31430051]; Ministry of Science and Technology of China [2016YFA0100501, 2016YFA0500201]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (NSFC) Grants 31371365, 31520103906, and 31430051 and Ministry of Science and Technology of China Grants 2016YFA0100501 and 2016YFA0500201. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; Baker GL, 2005, CELL CYCLE, V4, P330; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Barbash O, 2009, ONCOGENE, V28, P4317, DOI 10.1038/onc.2009.287; Coleman KG, 1997, J BIOL CHEM, V272, P18869, DOI 10.1074/jbc.272.30.18869; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Dhar KK, 1999, BRIT J CANCER, V81, P1174, DOI 10.1038/sj.bjc.6690826; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fry DW, 2001, J BIOL CHEM, V276, P16617, DOI 10.1074/jbc.M008867200; Fu JY, 2009, P NATL ACAD SCI USA, V106, P6939, DOI 10.1073/pnas.0900833106; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hitomi M, 1999, CURR BIOL, V9, P1075, DOI 10.1016/S0960-9822(99)80476-X; Holland TA, 2001, INT J CANCER, V95, P302, DOI 10.1002/1097-0215(20010920)95:5<302::AID-IJC1052>3.0.CO;2-#; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Liu QY, 2010, CELL RES, V20, P948, DOI 10.1038/cr.2010.89; Lu FM, 2003, CANCER RES, V63, P7056; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NISHI K, 1994, J BIOL CHEM, V269, P6320; Pestell RG, 1999, ENDOCR REV, V20, P501, DOI 10.1210/er.20.4.501; Retzer-Lidl M, 2007, INT J CANCER, V121, P66, DOI 10.1002/ijc.22619; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Stacey Dennis W, 2010, Genes Cancer, V1, P1189, DOI 10.1177/1947601911403475; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	41	22	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10131	10141		10.1074/jbc.M116.773226	http://dx.doi.org/10.1074/jbc.M116.773226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446612	Green Published, hybrid			2022-12-28	WOS:000403580600024
J	Guasp, P; Barnea, E; Gonzalez-Escribano, MF; Jimenez-Reinoso, A; Regueiro, JR; Admon, A; de Castro, JAL				Guasp, Pablo; Barnea, Eilon; Francisca Gonzalez-Escribano, M.; Jimenez-Reinoso, Anais; Regueiro, Jose R.; Admon, Arie; Lopez de Castro, Jose A.			The Behcet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; HLA CLASS-I; ENDOPLASMIC-RETICULUM; FUNCTIONAL INTERACTION; PRESENTED PEPTIDES; CRYSTAL-STRUCTURES; MOLECULES; BINDING; HLA-B27; ALLELES	A low-activity variant of endoplasmic reticulum aminopeptidase 1 (ERAP1), Hap10, is associated with the autoinflammatory disorder Behcet's disease (BD) in epistasis with HLA-B*51, which is the main risk factor for this disorder. The role of Hap10 in BD pathogenesis is unknown. We sought to define the effects of Hap10 on the HLA-B*51 peptidome and to distinguish these effects from those due to HLA-B*51 polymorphisms unrelated to disease. The peptidome of the BD-associated HLA-B*51:08 subtype expressed in a Hap10-positive cell line was isolated, characterized by mass spectrometry, and compared with the HLA-B*51:01 peptidome from cells expressing more active ERAP1 allotypes. We additionally performed synthetic peptide digestions with recombinant ERAP1 variants and estimated peptide-binding affinity with standard algorithms. In the BD-associated ERAP1 context of B*51:08, longer peptides were generated; of the two major HLA-B*51 subpeptidomes with Pro-2 and Ala-2, the former one was significantly reduced, and the latter was increased and showed more ERAP1-susceptible N-terminal residues. These effects were readily explained by the low activity of Hap10 and the differential susceptibility of X-Pro and X-Ala bonds to ERAP1 trimming and together resulted in a significantly altered peptidome with lower affinity. The differences due to ERAP1 were clearly distinguished from those due to HLA-B*51 subtype polymorphism, which affected residue frequencies at internal positions of the peptide ligands. The alterations in the nature and affinity of HLA-B*51.peptide complexes probably affect T-cell and natural killer cell recognition, providing a sound basis for the joint association of ERAP1 and HLA-B*51 with BD.	[Guasp, Pablo; Lopez de Castro, Jose A.] CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Guasp, Pablo; Lopez de Castro, Jose A.] Univ Autonoma, Madrid 28049, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Francisca Gonzalez-Escribano, M.] Hosp Univ Virgen Rocio IBiS, CSIC, US, Serv Inmunol, Seville 41013, Spain; [Jimenez-Reinoso, Anais; Regueiro, Jose R.] Univ Complutense Madrid, Sch Med, Dept Immunol, Hosp Octubre 12,Hlth Res Inst Imas12, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Technion Israel Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Complutense University of Madrid; Hospital Universitario 12 de Octubre	de Castro, JAL (corresponding author), Univ Autonoma, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, Madrid 28049, Spain.	aldecastro@cbm.csic.es	Jiménez Reinoso, Anaïs/K-2453-2014; González-Escribano, María Francisca/X-5554-2019; Regueiro, Jose/B-5499-2014	Jiménez Reinoso, Anaïs/0000-0001-8229-1881; Admon, Arie/0000-0003-0504-3950; Guasp, Pablo/0000-0002-3655-916X; Regueiro, Jose/0000-0001-8442-7762	Plan Nacional de I+D+i Research [SAF2014/51931-R]; Binational Science Foundation [2009393]; Complutense University [SAF2014-54708R, SAF2016-81876-REDT (Plan Nacional de I+D+i), 920631]; Ministry of Health, Social Services and Equality [FIS PI13/01118]; Fundacion Ramon Areces; Spanish Government [BES-2015-072729]	Plan Nacional de I+D+i Research; Binational Science Foundation(US-Israel Binational Science Foundation); Complutense University; Ministry of Health, Social Services and Equality; Fundacion Ramon Areces; Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by Plan Nacional de I+D+i Research Grant SAF2014/51931-R (to J. A. L. C.); Binational Science Foundation Grant 2009393 (to A. A.); Complutense University Grants SAF2014-54708R, SAF2016-81876-REDT (Plan Nacional de I+D+i), and 920631 (to J. R. R.); Ministry of Health, Social Services and Equality Grant FIS PI13/01118 (to M. F. G. E.); and an institutional grant of the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa. The authors declare that they have no conflicts of interest with the contents of this article.r Fellow of the Spanish Government (Grant BES-2015-072729).	Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; [Anonymous], 2017, Arthritis Rheumatol, V69, P686, DOI 10.1002/art.40073; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Cifaldi L, 2015, CANCER RES, V75, P824, DOI 10.1158/0008-5472.CAN-14-1643; COWAN EP, 1987, P NATL ACAD SCI USA, V84, P5014, DOI 10.1073/pnas.84.14.5014; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FALK K, 1995, IMMUNOGENETICS, V41, P165, DOI 10.1007/BF00182333; FLEISCHHAUER K, 1994, TISSUE ANTIGENS, V44, P311, DOI 10.1111/j.1399-0039.1994.tb02401.x; Garcia F, 1998, TISSUE ANTIGENS, V51, P1; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, P1416, DOI 10.1074/mcp.M112.019588; Gonzalez-Escribano MF, 1998, TISSUE ANTIGENS, V52, P78; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Guasp P, 2016, ARTHRITIS RHEUMATOL, V68, P505, DOI 10.1002/art.39430; HAMZAOUI K, 1988, CLIN EXP IMMUNOL, V71, P126; Hasan MS, 2017, CLIN EXP IMMUNOL, V188, P311, DOI 10.1111/cei.12939; Hearn A, 2009, J IMMUNOL, V183, P5526, DOI 10.4049/jimmunol.0803663; Hillen N, 2008, EUR J IMMUNOL, V38, P2993, DOI 10.1002/eji.200838632; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Kera J, 1999, TISSUE ANTIGENS, V54, P565, DOI 10.1034/j.1399-0039.1999.540605.x; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kotter I, 2001, TISSUE ANTIGENS, V58, P166, DOI 10.1034/j.1399-0039.2001.580304.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; de Castro JAL, 2016, MOL IMMUNOL, V77, P193, DOI 10.1016/j.molimm.2016.08.005; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Martin-Esteban A, 2016, ARTHRITIS RHEUMATOL, V68, P2466, DOI 10.1002/art.39734; Martin-Esteban A, 2014, J BIOL CHEM, V289, P3978, DOI 10.1074/jbc.M113.529610; Mizuki N, 2001, TISSUE ANTIGENS, V57, P457, DOI 10.1034/j.1399-0039.2001.057005457.x; Mizuki N, 2002, TISSUE ANTIGENS, V59, P118, DOI 10.1034/j.1399-0039.2002.590207.x; Ombrello MJ, 2015, CURR OPIN RHEUMATOL, V27, P349, DOI 10.1097/BOR.0000000000000189; Paul M, 2001, TISSUE ANTIGENS, V58, P185, DOI 10.1034/j.1399-0039.2001.580307.x; Rasmussen M, 2014, J IMMUNOL, V193, P4790, DOI 10.4049/jimmunol.1401689; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Sakaguchi T, 1997, IMMUNOGENETICS, V45, P259, DOI 10.1007/s002510050201; Sakaguchi T, 1997, IMMUNOGENETICS, V46, P245, DOI 10.1007/s002510050269; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Stamogiannos A, 2015, MOL IMMUNOL, V67, P426, DOI 10.1016/j.molimm.2015.07.010; SUZUKI Y, 1992, J RHEUMATOL, V19, P588; Takeuchi M, 2016, ANN RHEUM DIS, V75, P2208, DOI 10.1136/annrheumdis-2015-209059; Vilches C, 1997, TISSUE ANTIGENS, V50, P38, DOI 10.1111/j.1399-0039.1997.tb02831.x; Yabuki K, 1999, TISSUE ANTIGENS, V54, P273, DOI 10.1034/j.1399-0039.1999.540308.x; Yamaguchi Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3005; Yasuoka H, 2004, ARTHRITIS RHEUM-US, V50, P3658, DOI 10.1002/art.20597	52	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9680	9689		10.1074/jbc.M117.789180	http://dx.doi.org/10.1074/jbc.M117.789180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28446606	Green Published, hybrid			2022-12-28	WOS:000403113000018
J	Wedekind, JE; Dutta, D; Belashov, IA; Jenkins, JL				Wedekind, Joseph E.; Dutta, Debapratim; Belashov, Ivan A.; Jenkins, Jermaine L.			Metalloriboswitches: RNA-based inorganic ion sensors that regulate genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEAVY-METAL RESISTANCE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; TRANSCRIPTION TERMINATION; DRUG TARGETS; RIBOSWITCH; FLUORIDE; MANGANESE; SALMONELLA; MG2+	Divalent ions fulfill essential cellular roles and are required for virulence by certain bacteria. Free intracellular Mg2+ can approach 5 mM, but at this level Mn2+, Ni2+, or Co2+ can be growth-inhibitory, and magnesium fluoride is toxic. To maintain ion homeostasis, many bacteria have evolved ion sensors embedded in the 5 '- leader sequences of mRNAs encoding ion uptake or efflux channels. Here, we review current insights into these "metalloriboswitches," emphasizing ion-specific binding by structured RNA aptamers and associated conformational changes in downstream signal sequences. This riboswitch-effector interplay produces a layer of gene regulatory feedback that has elicited interest as an antibacterial target.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Wedekind, JE (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.; Wedekind, JE (corresponding author), Univ Rochester, Med Ctr, Ctr RNA Biol, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu	Dutta, Debapratim/HGV-1235-2022	Dutta, Debapratim/0000-0003-2044-2052; Jenkins, Jermaine/0000-0003-2548-3275; Belashov, Ivan/0000-0002-9426-0369	National Institutes of Health from NIGMS [GM063162]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063162] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM063162 from NIGMS (to J. E. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams S, 2015, J CAN DENT ASSOC, V81; Adler P., 1970, WHO MONOGR SER, V59, P1; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1984, J BACTERIOL, V158, P1; Arthus M, 1903, CR SOC BIOL, V55, P1481; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Blount KF, 2015, ANTIMICROB AGENTS CH, V59, P5736, DOI 10.1128/AAC.01282-15; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Breaker RR, 2012, CARIES RES, V46, P78, DOI 10.1159/000336397; Breaker RR, 2017, BIOCHEMISTRY-US, V56, P345, DOI 10.1021/acs.biochem.6b01269; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Breaker RR, 2009, FUTURE MICROBIOL, V4, P771, DOI 10.2217/FMB.09.46; Centers for Disease Control and Prevention, 2016, LIST OUTBR; Centers for Disease Control and Prevention, 2014, MULT OUTBR MULT RES; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dambach M, 2015, MOL CELL, V57, P1099, DOI 10.1016/j.molcel.2015.01.035; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Furukawa K, 2015, MOL CELL, V57, P1088, DOI 10.1016/j.molcel.2015.02.009; Garcia-Diez M, 2015, CLIM DYNAM, V45, P3141, DOI 10.1007/s00382-015-2529-x; Gu MZ, 2013, MOL MICROBIOL, V89, P123, DOI 10.1111/mmi.12263; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Howe JA, 2016, RNA BIOL, V13, P946, DOI 10.1080/15476286.2016.1216304; Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jin Y, 2017, ANGEW CHEM INT EDIT, V56, P4110, DOI 10.1002/anie.201606474; Kanduti Domen, 2016, Mater Sociomed, V28, P133, DOI 10.5455/msm.2016.28.133-137; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; Li SS, 2016, RNA, V22, P530, DOI 10.1261/rna.054890.115; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Li SS, 2012, BIOORG MED CHEM LETT, V22, P3317, DOI 10.1016/j.bmcl.2012.03.006; Lim SY, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0147-8; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Maret W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010066; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Martin JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004977; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Matzner D, 2015, J MED CHEM, V58, P3275, DOI 10.1021/jm500868e; McCown PJ, 2017, RNA, V23, P995, DOI 10.1261/rna.061234.117; Merino S, 2001, FEMS MICROBIOL LETT, V198, P189, DOI 10.1111/j.1574-6968.2001.tb10641.x; Meyer MM, 2011, RNA BIOL, V8, P5, DOI 10.4161/rna.8.1.13865; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Nelson JW, 2015, CHEM BIOL, V22, P527, DOI 10.1016/j.chembiol.2015.03.016; Nelson JW, 2014, BIOORG MED CHEM LETT, V24, P2969, DOI 10.1016/j.bmcl.2014.03.061; Nierhaus KH, 2014, J BACTERIOL, V196, P3817, DOI 10.1128/JB.02297-14; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Ott E, 2009, RNA BIOL, V6, P276, DOI 10.4161/rna.6.3.8342; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Peselis A, 2014, WIRES RNA, V5, P803, DOI 10.1002/wrna.1247; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Price IR, 2015, MOL CELL, V57, P1110, DOI 10.1016/j.molcel.2015.02.016; Qin R, 2006, BIOCHEMISTRY-US, V45, P793, DOI 10.1021/bi051558s; Ramesh A, 2011, J MOL BIOL, V407, P556, DOI 10.1016/j.jmb.2011.01.049; Ramesh A, 2010, RNA BIOL, V7, P77, DOI 10.4161/rna.7.1.10490; Reed GH, 1996, CURR OPIN STRUC BIOL, V6, P736, DOI 10.1016/S0959-440X(96)80002-9; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Rothrock MJ, 2015, POULTRY SCI, V94, P467, DOI 10.3382/ps/peu060; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sherwood AV, 2016, ANNU REV MICROBIOL, V70, P361, DOI 10.1146/annurev-micro-091014-104306; Shi YX, 2014, J BIOL CHEM, V289, P11353, DOI 10.1074/jbc.M113.517516; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Spinelli SV, 2008, FEMS MICROBIOL LETT, V280, P226, DOI 10.1111/j.1574-6968.2008.01065.x; Stockbridge RB, 2013, ELIFE, V2, DOI 10.7554/eLife.01084; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Thorsell AG, 2009, PROTEINS, V77, P242, DOI 10.1002/prot.22489; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Wakeman CA, 2014, J BACTERIOL, V196, P1206, DOI 10.1128/JB.01238-13; Wakeman CA, 2009, J MOL BIOL, V392, P723, DOI 10.1016/j.jmb.2009.07.033; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Warburg O, 1942, BIOCHEM Z, V310, P384; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Weinberg Z, 2017, P NATL ACAD SCI USA, V114, pE2077, DOI 10.1073/pnas.1619581114; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zhao G, 2011, EMBO J, V30, P1485, DOI 10.1038/emboj.2011.66	100	24	24	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9441	9450		10.1074/jbc.R117.787713	http://dx.doi.org/10.1074/jbc.R117.787713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28455443	Green Published, hybrid			2022-12-28	WOS:000403113000001
J	Healy, LD; Puy, C; Fernandez, JA; Mitrugno, A; Keshari, RS; Taku, NA; Chu, TT; Xu, X; Gruber, A; Lupu, F; Griffin, JH; McCarty, OJT				Healy, Laura D.; Puy, Cristina; Fernandez, Jose A.; Mitrugno, Annachiara; Keshari, Ravi S.; Taku, Nyiawung A.; Chu, Tiffany T.; Xu, Xiao; Gruber, Andras; Lupu, Florea; Griffin, John H.; McCarty, Owen J. T.			Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP-VEIN THROMBOSIS; ANTICOAGULANT ACTIVITY; CELL-DEATH; FACTOR-V; RECEPTOR; MICE; INFLAMMATION; COAGULATION; PLATELETS; SEPSIS	Activated protein C (APC) is a multifunctional serine protease with anticoagulant, cytoprotective, and anti-inflammatory activities. In addition to the cytoprotective effects of APC on endothelial cells, podocytes, and neurons, APC cleaves and detoxifies extracellular histones, a major component of neutrophil extracellular traps (NETs). NETs promote pathogen clearance but also can lead to thrombosis; the pathways that negatively regulate NETosis are largely unknown. Thus, we studied whether APC is capable of directly inhibiting NETosis via receptor-mediated cell signaling mechanisms. Here, by quantifying extracellular DNA or myeloperoxidase, we demonstrate that APC binds human leukocytes and prevents activated platelet supernatant or phorbol 12-myristate 13-acetate (PMA) from inducing NETosis. Of note, APC proteolytic activity was required for inhibiting NETosis. Moreover, antibodies against the neutrophil receptors endothelial protein C receptor (EPCR), protease-activated receptor 3 (PAR3), and macrophage-1 antigen (Mac-1) blocked APC inhibition of NETosis. Select mutations in the Gla and protease domains of recombinant APC caused a loss of NETosis. Interestingly, pretreatment of neutrophils with APC prior to induction of NETosis inhibited platelet adhesion to NETs. Lastly, in a nonhuman primate model of Escherichia coli-induced sepsis, pretreatment of animals with APC abrogated release of myeloperoxidase from neutrophils, a marker of neutrophil activation. These findings suggest that the anti-inflammatory function of APC at therapeutic concentrations may include the inhibition of NETosis in an EPCR-, PAR3-, and Mac-1-dependent manner, providing additional mechanistic insight into the diverse functions of neutrophils and APC in disease states including sepsis.	[Healy, Laura D.; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97230 USA; [Puy, Cristina; Mitrugno, Annachiara; Taku, Nyiawung A.; Chu, Tiffany T.; Gruber, Andras; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97230 USA; [Fernandez, Jose A.; Xu, Xiao; Griffin, John H.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Keshari, Ravi S.; Lupu, Florea] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	Oregon Health & Science University; Oregon Health & Science University; Scripps Research Institute; Oklahoma Medical Research Foundation	Healy, LD (corresponding author), Ctr Hlth & Healing 13B, 3303 SW Bond Ave, Portland, OR 97239 USA.	healyl@ohsu.edu	Lupu, Florea/AAV-3257-2021; Lupu, Florea/C-3162-2009; Fernandez, Jose A/A-3211-2008	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Fernandez, Jose A/0000-0002-0804-1865; Healy, Laura/0000-0002-3162-7100; Gruber, Andras/0000-0001-6212-2247; Griffin, John/0000-0002-4302-2547	National Institutes of Health [R01HL101972, R01GM116184, R01HL052246, R44HL117589, T32AI007472, R01GM097746, U19AI062629, P30GM114731]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL117589, R01HL052246, R01HL101972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007472, U19AI062629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116184, P30GM114731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL101972 (to O.J.T.M) and R01GM116184 (to O.J.T.M. and F.L.); R01HL052246 (to J.H.G.); R44HL117589 (to A.G.); T32AI007472 (to L.D.H); and R01GM097746, U19AI062629, and P30GM114731 (to F.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains supplemental Figs. S1-S4.	Aslan JE, 2012, METHODS MOL BIOL, V788, P91, DOI 10.1007/978-1-61779-307-3_7; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burnier L, 2013, BLOOD, V122, P807, DOI 10.1182/blood-2013-03-488957; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; D'Ursi P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S11; Dekker LV, 2000, BIOCHEM J, V347, P285, DOI 10.1042/0264-6021:3470285; Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1976, J BIOL CHEM, V251, P3052; Fink K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053103; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Fukudome K, 1996, J BIOL CHEM, V271, P17491, DOI 10.1074/jbc.271.29.17491; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Guo H, 2009, EUR J NEUROSCI, V29, P1119, DOI 10.1111/j.1460-9568.2009.06664.x; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; HANSON SR, 1993, J CLIN INVEST, V92, P2003, DOI 10.1172/JCI116795; Harmon S, 2008, J BIOL CHEM, V283, P30531, DOI 10.1074/jbc.M802338200; Healy LD, 2016, J IMMUNOL METHODS, V435, P77, DOI 10.1016/j.jim.2016.06.002; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; Iba T, 2015, THROMB RES, V135, P963, DOI 10.1016/j.thromres.2015.03.012; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Itakura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073063; Itakura A, 2013, AM J PHYSIOL-CELL PH, V305, pC348, DOI 10.1152/ajpcell.00108.2013; Liang HPH, 2015, BLOOD, V126, P2415, DOI 10.1182/blood-2015-05-644401; Lopez-Sagaseta J, 2012, BLOOD, V119, P2914, DOI 10.1182/blood-2011-05-353409; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; Madhusudhan T, 2016, NAT REV NEPHROL, V12, P94, DOI 10.1038/nrneph.2015.177; Madhusudhan T, 2012, BLOOD, V119, P874, DOI 10.1182/blood-2011-07-365973; MARLAR RA, 1982, BLOOD, V59, P1067; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; McCarty OJT, 2003, AM J PHYSIOL-CELL PH, V284, pC1223, DOI 10.1152/ajpcell.00403.2002; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Miike S, 2001, J IMMUNOL, V167, P6615, DOI 10.4049/jimmunol.167.11.6615; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Mosnier LO, 2009, BLOOD, V113, P5970, DOI 10.1182/blood-2008-10-183327; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Nieman MT, 2016, BLOOD, V128, P169, DOI 10.1182/blood-2015-11-636472; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Petaja J, 2001, AM J HEMATOL, V67, P210, DOI 10.1002/ajh.1110; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; SHEN L, 1994, J BIOL CHEM, V269, P18735; St-Onge M, 2010, FASEB J, V24, P2116, DOI 10.1096/fj.09-146167; Stavenuiter F, 2014, BLOOD, V124, P3480, DOI 10.1182/blood-2014-06-582775; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Tucker EI, 2012, BLOOD, V119, P4762, DOI 10.1182/blood-2011-10-386185; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; Wang YM, 2016, NAT MED, V22, P1050, DOI 10.1038/nm.4154; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200	77	63	71	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8616	8629		10.1074/jbc.M116.768309	http://dx.doi.org/10.1074/jbc.M116.768309			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28408624	Green Published, hybrid			2022-12-28	WOS:000402153900010
J	Yung, Y; Yao, Z; Hanoch, T; Seger, R				Yung, Yuval; Yao, Zhong; Hanoch, Tamar; Seger, Rony			RETRACTION: ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK (Retraction of Vol 275, Pg 15799, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													CHEN, Huanwen/B-1794-2008					Yung YV, 2000, J BIOL CHEM, V275, P15799, DOI 10.1074/jbc.M910060199	1	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8854	8854		10.1074/jbc.A117.910060	http://dx.doi.org/10.1074/jbc.A117.910060			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550140	Green Published, hybrid			2022-12-28	WOS:000402153900037
J	Bilova, T; Paudel, G; Shilyaev, N; Schmidt, R; Brauch, D; Tarakhovskaya, E; Milrud, S; Smolikova, G; Tissier, A; Vogt, T; Sinz, A; Brandt, W; Birkemeyer, C; Wessjohann, LA; Frolov, A				Bilova, Tatiana; Paudel, Gagan; Shilyaev, Nikita; Schmidt, Rico; Brauch, Dominic; Tarakhovskaya, Elena; Milrud, Svetlana; Smolikova, Galina; Tissier, Alain; Vogt, Thomas; Sinz, Andrea; Brandt, Wolfgang; Birkemeyer, Claudia; Wessjohann, Ludger A.; Frolov, Andrej			Global proteomic analysis of advanced glycation end products in the Arabidopsis proteome provides evidence for age-related glycation hot spots	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOXIDATIVE GLYCOSYLATION; GLUCOSE AUTOXIDATION; CARBONYLATION SITES; FAMILIES DATABASE; PROTEINS; METHYLGLYOXAL; PEPTIDES; IDENTIFICATION; ENDPRODUCTS; PREDICTION	Glycation is a post-translational modification resulting from the interaction of protein amino and guanidino groups with carbonyl compounds. Initially, amino groups react with reducing carbohydrates, yielding Amadori and Heyns compounds. Their further degradation results in formation of advanced glycation end products (AGEs), also originating from alpha-dicarbonyl products of monosaccharide autoxidation and primary metabolism. In mammals, AGEs are continuously formed during the life of the organism, accumulate in tissues, are well-known markers of aging, and impact age-related tissue stiffening and atherosclerotic changes. However, the role of AGEs in age-related molecular alterations in plants is still unknown. To fill this gap, we present here a comprehensive study of the age-related changes in the Arabidopsis thaliana glycated proteome, including the proteins affected and specific glycation sites therein. We also consider the qualitative and quantitative changes in glycation patterns in terms of the general metabolic background, pathways of AGE formation, and the status of plant anti-oxidative/ anti-glycative defense. Although the patterns of glycated proteins were only minimally influenced by plant age, the abundance of 96 AGE sites in 71 proteins was significantly affected in an age-dependent manner and clearly indicated the existence of age-related glycation hot spots in the plant proteome. Homology modeling revealed glutamyl and aspartyl residues in close proximity (less than 5 angstrom) to these sites in three aging-specific and eight differentially glycated proteins, four of which were modified in catalytic domains. Thus, the sites of glycation hot spots might be defined by protein structure that indicates, at least partly, site-specific character of glycation.	[Bilova, Tatiana; Paudel, Gagan; Brandt, Wolfgang; Wessjohann, Ludger A.; Frolov, Andrej] Leibniz Inst Plant Biochem IPB, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany; [Tissier, Alain; Vogt, Thomas] Leibniz Inst Plant Biochem IPB, Dept Cell & Metab Biol, D-06120 Halle, Saale, Germany; [Bilova, Tatiana; Paudel, Gagan; Brauch, Dominic; Birkemeyer, Claudia; Frolov, Andrej] Univ Leipzig, Fac Chem & Mineral, D-04103 Leipzig, Germany; [Bilova, Tatiana; Tarakhovskaya, Elena; Milrud, Svetlana; Smolikova, Galina] St Petersburg State Univ, Fac Biol, Dept Plant Physiol & Biochem, Univ Skaya Emb 7-9, St Petersburg 199034, Russia; [Shilyaev, Nikita; Milrud, Svetlana] St Petersburg State Univ, Fac Biol, Dept Biochem, St Petersburg 199034, Russia; [Schmidt, Rico; Sinz, Andrea] Martin Luther Univ Halle Wittenberg, Inst Pharm, D-06099 Halle, Saale, Germany; [Brauch, Dominic] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Stadt Seeland, Germany	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Leipzig University; Saint Petersburg State University; Saint Petersburg State University; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Frolov, A (corresponding author), Leibniz Inst Plant Biochem IPB, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany.; Bilova, T (corresponding author), St Petersburg State Univ, Fac Biol, Dept Plant Physiol & Biochem, Univ Skaya Emb 7-9, St Petersburg 199034, Russia.	bilova.tatiana@gmail.com; afrolov@ipb-halle.de	Tissier, Alain F/B-2108-2017; Smolikova, Galina/H-6269-2013; Frolov, Andrej A/V-5550-2018; Bilova, Tatiana E./M-2405-2015; Wessjohann, Ludger/AAZ-3838-2021; Tarakhovskaya, Elena R./I-7458-2013; Tarakhovskaya, Elena/Y-8165-2019; Birkemeyer, Claudia/L-8687-2015	Tissier, Alain F/0000-0002-9406-4245; Smolikova, Galina/0000-0001-5238-1851; Bilova, Tatiana E./0000-0002-6024-3667; Tarakhovskaya, Elena R./0000-0002-5341-2813; Tarakhovskaya, Elena/0000-0002-5341-2813; Wessjohann, Ludger A./0000-0003-2060-8235; Birkemeyer, Claudia/0000-0002-8538-8838				Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2002, BIOCHEM J, V364, P1; [Anonymous], 2017, MOL OP ENV MOE 2013; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Barnaby OS, 2011, CLIN CHIM ACTA, V412, P277, DOI 10.1016/j.cca.2010.10.018; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilova T, 2016, J BIOL CHEM, V291, P7621, DOI 10.1074/jbc.M115.678581; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Bollineni RC, 2014, FREE RADICAL BIO MED, V68, P186, DOI 10.1016/j.freeradbiomed.2013.11.030; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dammann P, 2012, J GERONTOL A-BIOL, V67, P573, DOI 10.1093/gerona/glr208; Deshmukh S, 2015, J CHROMATOGR A, V1388, P1, DOI 10.1016/j.chroma.2015.01.093; DiMario RJ, 2016, PLANT PHYSIOL, V171, P280, DOI 10.1104/pp.15.01990; Ehrlich H, 2010, J BIOMED MATER RES B, V92B, P542, DOI 10.1002/jbm.b.31551; Ehrlich H, 2009, INT J BIOL MACROMOL, V44, P51, DOI 10.1016/j.ijbiomac.2008.10.001; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Frolov A, 2008, ANN NY ACAD SCI, V1126, P253, DOI 10.1196/annals.1433.060; Frolov A, 2006, J MASS SPECTROM, V41, P1459, DOI 10.1002/jms.1117; Frolov A, 2017, J PLANT PHYSIOL, V208, P70, DOI 10.1016/j.jplph.2016.09.013; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Frolov A, 2014, J AGR FOOD CHEM, V62, P3626, DOI 10.1021/jf4050183; Fuentealba D, 2009, PHOTOCHEM PHOTOBIOL, V85, P185, DOI 10.1111/j.1751-1097.2008.00415.x; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Greifenhagen U, 2015, AMINO ACIDS, V47, P1065, DOI 10.1007/s00726-015-1940-2; Greifenhagen U, 2015, J PROTEOME RES, V14, P768, DOI 10.1021/pr500799m; HENLE T, 1994, Z LEBENSM UNTERS FOR, V199, P55, DOI 10.1007/BF01192954; HEYNS K, 1970, CHEM BER-RECL, V103, P2873, DOI 10.1002/cber.19701030925; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Hu H, 2015, DIABETES-METAB RES, V31, P127, DOI 10.1002/dmrr.2560; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laubinger S, 2004, PLANT CELL, V16, P2293, DOI 10.1105/tpc.104.024216; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Milkovska-Stamenova S, 2015, J AGR FOOD CHEM, V63, P5911, DOI 10.1021/jf505757m; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Paudel G, 2016, J EXP BOT, V67, P6283, DOI 10.1093/jxb/erw395; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Richards SL, 2015, J EXP BOT, V66, P37, DOI 10.1093/jxb/eru398; Saenz-Suarez H, 2016, TURK J BIOL, V40, P12, DOI 10.3906/biy-1501-71; Saito R, 2013, BIOSCI BIOTECH BIOCH, V77, P2038, DOI 10.1271/bbb.130353; Schmidt R, 2015, J MASS SPECTROM, V50, P613, DOI 10.1002/jms.3569; Schneider A, 2007, BIOL CHEM, V388, P1099, DOI 10.1515/BC.2007.114; Schwarzenbolz U., 1997, Z LEBENSM UNTERS FOR, DOI [10.1007/s002170050137, DOI 10.1007/S002170050137]; Sebekova K, 2001, EUR J NUTR, V40, P275, DOI 10.1007/s394-001-8356-3; Shimakawa G, 2014, BIOCHEM SOC T, V42, P543, DOI 10.1042/BST20130273; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Takagi D, 2014, PLANT CELL PHYSIOL, V55, P333, DOI 10.1093/pcp/pcu007; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P442, DOI 10.1271/bbb.60497; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Wessjohann LA, 2008, ADV SYNTH CATAL, V350, P107, DOI 10.1002/adsc.200600491; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Yadav SK, 2007, PROTEIN EXPRES PURIF, V51, P126, DOI 10.1016/j.pep.2006.07.007; Zhang B, 2008, ANAL CHEM, V80, P2379, DOI 10.1021/ac701810q; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j	74	33	34	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15758	15776		10.1074/jbc.M117.794537	http://dx.doi.org/10.1074/jbc.M117.794537			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28611063	hybrid, Green Published			2022-12-28	WOS:000411512200015
J	Muschiol, S; Erlendsson, S; Aschtgen, MS; Oliveira, V; Schmieder, P; de Lichtenberg, C; Teilum, K; Boesen, T; Akbey, U; Henriques-Normark, B				Muschiol, Sandra; Erlendsson, Simon; Aschtgen, Marie-Stephanie; Oliveira, Vitor; Schmieder, Peter; de Lichtenberg, Casper; Teilum, Kaare; Boesen, Thomas; Akbey, Umit; Henriques-Normark, Birgitta			Structure of the competence pilus major pilin ComGC in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbiology; nuclear magnetic resonance (NMR); protein structure; transformation; type IV pili; Streptococcus pneumoniae; horizontal gene transfer; major pilin; pneumococci	IV PILUS; NATURAL TRANSFORMATION; NEISSERIA-GONORRHOEAE; DIPOLAR COUPLINGS; DNA UPTAKE; PROTEIN; MACHINERY; ELECTROSTATICS; ASSOCIATION; PREDICTION	Type IV pili are important virulence factors on the surface of many pathogenic bacteria and have been implicated in a wide range of diverse functions, including attachment, twitching motility, biofilm formation, and horizontal gene transfer. The respiratory pathogen Streptococcus pneumoniae deploys type IV pili to take up DNA during transformation. These competence pili are composed of the major pilin protein ComGC and exclusively assembled during bacterial competence, but their biogenesis remains unclear. Here, we report the high resolution NMR structure of N-terminal truncated ComGC revealing a highly flexible and structurally divergent type IV pilin. It consists of only three -helical segments forming a well-defined electronegative cavity and confined electronegative and hydrophobic patches. The structure is particularly flexible between the first and second -helix with the first helical part exhibiting slightly slower dynamics than the rest of the pilin, suggesting that the first helix is involved in forming the pilus structure core and that parts of helices two and three are primarily surface-exposed. Taken together, our results provide the first structure of a type IV pilin protein involved in the formation of competence-induced pili in Gram-positive bacteria and corroborate the remarkable structural diversity among type IV pilin proteins.	[Muschiol, Sandra; Aschtgen, Marie-Stephanie; Oliveira, Vitor; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Muschiol, Sandra; Aschtgen, Marie-Stephanie; Oliveira, Vitor; Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Clin Microbiol, S-17176 Stockholm, Sweden; [Erlendsson, Simon; de Lichtenberg, Casper; Teilum, Kaare] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Linderstrom Lang Ctr Prot Sci, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Schmieder, Peter] Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany; [Boesen, Thomas; Akbey, Umit] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Akbey, Umit] Aarhus Univ, AIAS, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Henriques-Normark, Birgitta] Nanyang Technol Univ, SCELSE, Singapore 639798, Singapore; [Henriques-Normark, Birgitta] Nanyang Technol Univ, Lee Kong Chian Sch Med LKC, Singapore 639798, Singapore	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Copenhagen; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Aarhus University; Aarhus University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Muschiol, S; Henriques-Normark, B (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.; Muschiol, S; Henriques-Normark, B (corresponding author), Karolinska Univ Hosp, Dept Clin Microbiol, S-17176 Stockholm, Sweden.; Henriques-Normark, B (corresponding author), Nanyang Technol Univ, SCELSE, Singapore 639798, Singapore.; Henriques-Normark, B (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med LKC, Singapore 639798, Singapore.	sandra.muschiol@ki.se; birgitta.henriques@ki.se	Teilum, Kaare/K-4340-2014; de Lichtenberg, Casper/GFP-7668-2022; Teilum, Kaare/S-8410-2019; Akbey, Umit/I-9351-2012	Teilum, Kaare/0000-0001-6919-1982; de Lichtenberg, Casper/0000-0003-2975-8395; Akbey, Umit/0000-0003-3161-2969; aschtgen, marie-stephanie/0000-0003-2413-8226; Schmieder, Peter/0000-0001-9968-9327; Boesen, Thomas/0000-0002-5633-6844; Erlendsson, Simon/0000-0002-6378-870X	Swedish Research Council; Stockholm County Council; Karolinska Institutet; Swedish Foundation for Strategic Research (SSF); Knut and Alice Wallenberg Foundation; Carlsberg Foundation; Lundbeck Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Swedish Research Council, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, the Swedish Foundation for Strategic Research (SSF), the Knut and Alice Wallenberg Foundation, the Carlsberg Foundation, and the Lundbeck Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balaban M, 2014, P NATL ACAD SCI USA, V111, pE758, DOI 10.1073/pnas.1313860111; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Berry JL, 2016, STRUCTURE, V24, P926, DOI 10.1016/j.str.2016.04.001; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferrage F, 2010, J MAGN RESON, V207, P294, DOI 10.1016/j.jmr.2010.09.014; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Gold VAM, 2015, ELIFE, V4, DOI 10.7554/eLife.07380; Graupner S, 2000, J BACTERIOL, V182, P2184, DOI 10.1128/JB.182.8.2184-2190.2000; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Gurung I, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1177; Gurung I, 2016, MOL MICROBIOL, V99, P380, DOI 10.1111/mmi.13237; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kolappan S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13015; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laurenceau R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003473; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Maier B, 2015, TRENDS MICROBIOL, V23, P775, DOI 10.1016/j.tim.2015.09.002; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Piepenbrink KH, 2015, STRUCTURE, V23, P385, DOI 10.1016/j.str.2014.11.018; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Reardon PN, 2013, J BIOL CHEM, V288, P29260, DOI 10.1074/jbc.M113.498527; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Yao LS, 2009, J BIOMOL NMR, V43, P161, DOI 10.1007/s10858-009-9299-x	57	17	18	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14134	14146		10.1074/jbc.M117.787671	http://dx.doi.org/10.1074/jbc.M117.787671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28659339	Green Published, hybrid			2022-12-28	WOS:000408439800019
J	Houot, L; Navarro, R; Nouailler, M; Duche, D; Guerlesquin, F; Lloubes, R				Houot, Laetitia; Navarro, Romain; Nouailler, Matthieu; Duche, Denis; Guerlesquin, Francoise; Lloubes, Roland			Electrostatic interactions between the CTX phage minor coat protein and the bacterial host receptor TolA drive the pathogenic conversion of Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; OUTER-MEMBRANE INTEGRITY; COLI CELL-ENVELOPE; ESCHERICHIA-COLI; FILAMENTOUS PHAGE; 2-HYBRID SYSTEM; PAL COMPLEX; PSEUDOMONAS-AERUGINOSA; POLAR LOCALIZATION; ANALYSIS WORKBENCH	Vibrio cholerae is a natural inhabitant of aquatic environments and converts to a pathogen upon infection by a filamentous phage, CTX Phi, that transmits the cholera toxin-encoding genes. This toxigenic conversion of V. cholerae has evident implication in both genome plasticity and epidemic risk, but the early stages of the infection have not been thoroughly studied. CTX Phi transit across the bacterial periplasm requires binding between the minor coat protein named pIII and a bacterial inner-membrane receptor, TolA, which is part of the conserved Tol-Pal molecular motor. To gain insight into the TolA-pIII complex, we developed a bacterial two-hybrid approach, named Oxi-BTH, suited for studying the interactions between disulfide bond-folded proteins in the bacterial cytoplasm of an Escherichia coli reporter strain. We found that two of the four disulfide bonds of pIII are required for its interaction with TolA. By combining Oxi-BTH assays, NMR, and genetic studies, we also demonstrate that two intermolecular salt bridges between TolA and pIII provide the driving forces of the complex interaction. Moreover, we show that TolA residue Arg-325 involved in one of the two salt bridges is critical for proper functioning of the Tol-Pal system. Our results imply that to prevent host evasion, CTX Phi uses an infection strategy that targets a highly conserved protein of Gram-negative bacteria essential for the fitness of V. cholerae in its natural environment.	[Houot, Laetitia; Navarro, Romain; Nouailler, Matthieu; Duche, Denis; Guerlesquin, Francoise; Lloubes, Roland] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol,UMR7255, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Houot, L (corresponding author), Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol,UMR7255, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	lhouot@imm.cnrs.fr		Duche, Denis/0000-0002-4208-6661; LLOUBES, Roland/0000-0002-9520-1053	CNRS; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-14-CE09-0023]; Fondation pour la Recherche Medicale [SPF20100518724]; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported in part by CNRS and the Aix-Marseille Universite (to the R. L. and W. G. Laboratories) and Agence Nationale de la Recherche Grant ANR-14-CE09-0023 (to the R. L. research team). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Postdoctoral Fellowship FRM, SPF20100518724 from Fondation pour la Recherche Medicale. To whom correspondence should be addressed. Tel.: 33-491-164-663; Fax: 33-491-712-124; E-mail: E-mail: lhouot@imm.cnrs.fr.; Supported by a Ph.D. fellowship from the French Ministry of Research.	Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Basse MJ, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw007; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Bennett NJ, 2006, J MOL BIOL, V356, P266, DOI 10.1016/j.jmb.2005.11.069; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x; Boyd EF, 2000, INFECT IMMUN, V68, P1507, DOI 10.1128/IAI.68.3.1507-1513.2000; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Ceccarelli D, 2015, APPL ENVIRON MICROB, V81, P1909, DOI 10.1128/AEM.03540-14; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Deng LW, 2002, J MOL BIOL, V319, P603, DOI 10.1016/S0022-2836(02)00260-7; Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; Derouiche R, 1997, MICROBIOL-UK, V143, P3185, DOI 10.1099/00221287-143-10-3185; Faruque SM, 1998, INFECT IMMUN, V66, P5819, DOI 10.1128/IAI.66.12.5819-5825.1998; Fengler VHI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047756; Ford CG, 2012, J BIOL CHEM, V287, P36258, DOI 10.1074/jbc.M112.403386; Gao Y, 2016, J BACTERIOL, V198, P2818, DOI 10.1128/JB.00309-16; Gaspar JA, 2000, MOL MICROBIOL, V38, P262, DOI 10.1046/j.1365-2958.2000.02094.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; Goforth JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060765; Gonzalez MD, 2002, J BACTERIOL, V184, P6050, DOI 10.1128/JB.184.21.6050-6055.2002; Gray AN, 2015, ELIFE, V4, DOI 10.7554/eLife.07118; Gully D, 2006, PROTEOMICS, V6, P282, DOI 10.1002/pmic.200500115; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Hasan NA, 2013, APPL ENVIRON MICROB, V79, P5782, DOI 10.1128/AEM.01113-13; Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000; Heilpern AJ, 2003, J BACTERIOL, V185, P1037, DOI 10.1128/JB.185.3.1037-1044.2003; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Houot L, 2012, MICROBIOL-SGM, V158, P1964, DOI 10.1099/mic.0.057059-0; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jiang S, 2003, APPL ENVIRON MICROB, V69, P7541, DOI 10.1128/AEM.69.12.7541-7544.2003; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; Li C, 2012, J BIOL CHEM, V287, P19048, DOI 10.1074/jbc.M112.342246; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Lorenz SH, 2011, J MOL BIOL, V405, P989, DOI 10.1016/j.jmb.2010.11.030; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Mai-Prochnow A, 2015, FEMS MICROBIOL REV, V39, P465, DOI 10.1093/femsre/fuu007; Martin A, 2003, J MOL BIOL, V329, P599, DOI 10.1016/S0022-2836(03)00433-9; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Meury J, 1999, BIOL CELL, V91, P67, DOI 10.1016/S0248-4900(99)80032-X; Morgan SJ, 2016, J BACTERIOL, V198, P498, DOI 10.1128/JB.00338-15; Ng D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006109; Ouellette SP, 2014, ENV MICROBIOL REP, V6, P259, DOI 10.1111/1758-2229.12123; Pommier S, 2005, J BACTERIOL, V187, P7526, DOI 10.1128/JB.187.21.7526-7534.2005; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Santos TMA, 2014, MOL MICROBIOL, V92, P985, DOI 10.1111/mmi.12609; Sarkar A, 2002, INFECT IMMUN, V70, P4735, DOI 10.1128/IAI.70.8.4735-4742.2002; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; TOMASI M, 1979, EUR J BIOCHEM, V93, P621, DOI 10.1111/j.1432-1033.1979.tb12862.x; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10	73	7	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13584	13598		10.1074/jbc.M117.786061	http://dx.doi.org/10.1074/jbc.M117.786061			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28642371	Green Published, hybrid			2022-12-28	WOS:000407942400010
J	Chen, Y; Li, TL; Lin, XB; Li, X; Li, XD; Guo, ZH				Chen, Yaozong; Li, Tin Lok; Lin, Xingbang; Li, Xin; Li, Xiang David; Guo, Zhihong			Crystal structure of the thioesterification conformation of Bacillus subtilis o-succinylbenzoyl-CoA synthetase reveals a distinct substrate-binding mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; MENAQUINONE BIOSYNTHESIS; ACTIVE-SITE; FIREFLY LUCIFERASE; ESCHERICHIA-COLI; IDENTIFICATION; MECHANISM; INTERMEDIATE; SYNTHASE; INHIBITORS	o-Succinylbenzoyl-CoA (OSB-CoA) synthetase (MenE) is an essential enzyme in bacterial vitamin K biosynthesis and an important target in the development of new antibiotics. It is a member of the adenylating enzymes (ANL) family, which reconfigure their active site in two different active conformations, one for the adenylation half-reaction and the other for a thioesterification half-reaction, in a domain-alternation catalytic mechanism. Although several aspects of the adenylating mechanism in MenE have recently been uncovered, its thioesterification conformation remains elusive. Here, using a catalytically competent Bacillus subtilis mutant protein complexed with an OSB-CoA analogue, we determined MenE high-resolution structures to 1.76 and 1.90 angstrom resolution in a thioester-forming conformation. By comparison with the adenylation conformation, we found that MenE's C-domain rotates around the Ser-384 hinge by 139.5 degrees during domain-alternation catalysis. The structures also revealed a thioesterification active site specifically conserved among MenE orthologues and a substrate-binding mode distinct from those of many other acyl/aryl-CoA synthetases. Of note, using site-directed mutagenesis, we identified several residues that specifically contribute to the thioesterification half-reaction without affecting the adenylation half-reaction. Moreover, we observed a substantial movement of the activated succinyl group in the thioesterification half-reaction. These findings provide new insights into the domain-alternation catalysis of a bacterial enzyme essential for vitamin K biosynthesis and of its adenylating homologues in the ANL enzyme family.	[Chen, Yaozong; Li, Tin Lok; Lin, Xingbang; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Li, Xin; Li, Xiang David] Univ Hong Kong, Dept Chem, Pokfulam, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; University of Hong Kong	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk	Li, Xin/X-5971-2018; Li, Xiang/ABG-9385-2020; Li, Xin/U-2944-2019	Li, Xin/0000-0001-9698-1883; Li, Xiang/0000-0002-2797-4134; Li, Xin/0000-0001-9698-1883; Chen, Yaozong/0000-0001-5380-2339	Research Grants Council of the Government of HKSAR [CRF C7029-15G, AoE/P-705/16];  [GRF601413];  [N_HKUST621/13]	Research Grants Council of the Government of HKSAR; ; 	This work was supported by Grants GRF601413 and N_HKUST621/13 (to Z. G), and Grants CRF C7029-15G and AoE/P-705/16 (to X. D. L) from the Research Grants Council of the Government of HKSAR.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Chen MJ, 2011, BIOCHEMISTRY-US, V50, P5893, DOI 10.1021/bi200376x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YZ, 2016, BIOCHEMISTRY-US, V55, P6685, DOI 10.1021/acs.biochem.6b00889; Chen YZ, 2015, J BIOL CHEM, V290, P23971, DOI 10.1074/jbc.M115.676304; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DeLano W.L, PYMOL MOL GRAPHICS S; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Echols N, 2014, ACTA CRYSTALLOGR D, V70, P144, DOI 10.1107/S139900471302748X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2010, J BIOL CHEM, V285, P30159, DOI 10.1074/jbc.M110.147702; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Kim HU, 2008, PLANT J, V54, P272, DOI 10.1111/j.1365-313X.2008.03416.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law A, 2011, J BIOL CHEM, V286, P15577, DOI 10.1074/jbc.M111.219683; Li HJ, 2011, BIOCHEMISTRY-US, V50, P9532, DOI 10.1021/bi200877x; Li Z, 2015, STRUCTURE, V23, P2032, DOI 10.1016/j.str.2015.08.012; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nazi I, 2004, ANAL BIOCHEM, V324, P100, DOI 10.1016/j.ab.2003.09.005; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Song HG, 2016, J AM CHEM SOC, V138, P7244, DOI 10.1021/jacs.6b03437; Song HG, 2014, ACTA CRYSTALLOGR D, V70, P2959, DOI 10.1107/S1399004714019440; Sun YR, 2014, J BIOL CHEM, V289, P15867, DOI 10.1074/jbc.M113.535641; Sun YR, 2012, BIOCHEMISTRY-US, V51, P4580, DOI 10.1021/bi300486j; Sundlov JA, 2012, BIOCHEMISTRY-US, V51, P6493, DOI 10.1021/bi300934s; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Tian Y., 2008, THESIS; Tian Y, 2008, BIOCHEMISTRY-US, V47, P12434, DOI 10.1021/bi801311d; van Wyk M, 2007, CHEM COMMUN, P398, DOI 10.1039/b613527g; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu R, 2008, BIOCHEMISTRY-US, V47, P8026, DOI 10.1021/bi800698m; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	63	4	4	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12296	12310		10.1074/jbc.M117.790410	http://dx.doi.org/10.1074/jbc.M117.790410			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28559280	Green Published, hybrid			2022-12-28	WOS:000406053300025
J	Wang, XXX; Luo, YH; Wang, D; Adorini, L; Pruzanski, M; Dobrinskikh, E; Levi, M				Wang, Xiaoxin X.; Luo, Yuhuan; Wang, Dong; Adorini, Luciano; Pruzanski, Mark; Dobrinskikh, Evgenia; Levi, Moshe			A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL LIPID-METABOLISM; ELEMENT-BINDING PROTEINS; DIABETIC-NEPHROPATHY; AGING POPULATION; ACTIVATION; RESTRICTION; DECLINE; ASSOCIATION; EXPRESSION; AUTOPHAGY	Even in healthy individuals, renal function gradually declines during aging. However, an observed variation in the rate of this decline has raised the possibility of slowing or delaying age-related kidney disease. One of the most successful interventional measures that slows down and delays age-related kidney disease is caloric restriction. We undertook the present studies to search for potential factors that are regulated by caloric restriction and act as caloric restriction mimetics. Based on our prior studies with the bile acid-activated nuclear hormone receptor farnesoid X receptor (FXR) and G protein-coupled membrane receptor TGR5 that demonstrated beneficial effects of FXR and TGR5 activation in the kidney, we reasoned that FXR and TGR5 could be excellent candidates. We therefore determined the effects of aging and caloric restriction on the expression of FXR and TGR5 in the kidney. We found that FXR and TGR5 expression levels are decreased in the aging kidney and that caloric restriction prevents these age-related decreases. Interestingly, in long-lived Ames dwarf mice, renal FXR and TGR5 expression levels were also increased. A 2-month treatment of 22-monthold C57BL/6J mice with the FXR-TGR5 dual agonist INT-767 induced caloric restriction-like effects and reversed age-related increases in proteinuria, podocyte injury, fibronectin accumulation, TGF-beta expression, and, most notably, age-related impairments in mitochondrial biogenesis and mitochondrial function. Furthermore, in podocytes cultured in serum obtained from old mice, INT-767 prevented the increases in the proin-flammatory markers TNF-alpha, toll-like receptor 2 (TLR2), and TLR4. In summary, our results indicate that FXR and TGR5 may play an important role in modulation of age-related kidney disease.	[Wang, Xiaoxin X.; Luo, Yuhuan; Wang, Dong; Dobrinskikh, Evgenia; Levi, Moshe] Denver Vet Affairs Med Ctr, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Wang, Dong; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado Anschutz Med Campus, Aurora, CO 80045 USA; [Adorini, Luciano; Pruzanski, Mark] Intercept Pharmaceut, New York, NY 10001 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; Intercept Pharmaceuticals	Levi, M (corresponding author), Univ Colorado Denver, Dept Med, 12700 East 19th Ave,MC C281, Aurora, CO 80045 USA.; Levi, M (corresponding author), Vet Affairs Med Ctr, 12700 East 19th Ave,MC C281, Aurora, CO 80045 USA.	Moshe.Levi@ucdenver.edu	Wang, Dong/A-6518-2018; Adorini, Luciano/AAE-5149-2020		National Institutes of Health [NIA R01 AG049493, NIDDK R01 DK098336]; Intercept medical school Investigator Initiated Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intercept medical school Investigator Initiated Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants NIA R01 AG049493 and NIDDK R01 DK098336 and an Intercept medical school Investigator Initiated Study grant (to M.L.). Luciano Adorini and Mark Pruzanski are employees of Intercept. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelhafiz AH, 2010, NEPHRON CLIN PRACT, V116, pC19, DOI 10.1159/000314545; Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Bitzer M, 2016, ADV CHRONIC KIDNEY D, V23, P12, DOI 10.1053/j.ackd.2015.11.005; Choksi KB, 2011, AGING-US, V3, P754, DOI 10.18632/aging.100357; Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104; Fliser D, 1997, KIDNEY INT, V51, P1196, DOI 10.1038/ki.1997.163; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Jankauskas SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44430; Jiang T, 2005, KIDNEY INT, V68, P2608, DOI 10.1111/j.1523-1755.2005.00733.x; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kanasaki K, 2012, HYPERTENS RES, V35, P1121, DOI 10.1038/hr.2012.159; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; LUFT FC, 1980, AM J MED SCI, V279, P15, DOI 10.1097/00000441-198001000-00002; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Miyazaki-Anzai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108270; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Musso CG, 2011, NEPHRON PHYSIOL, V119, P1, DOI 10.1159/000328010; Perico N, 2011, CURR OPIN NEPHROL HY, V20, P312, DOI 10.1097/MNH.0b013e328344c327; Ribstein J, 2001, J HYPERTENS, V19, P2257, DOI 10.1097/00004872-200112000-00020; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Roda A, 2014, J PHARMACOL EXP THER, V350, P56, DOI 10.1124/jpet.114.214650; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; TAUCHI H, 1971, GERONTOLOGY, V17, P87, DOI 10.1159/000211811; Tonelli M, 2014, AM J PHYSIOL-RENAL, V306, pF469, DOI 10.1152/ajprenal.00063.2014; Tonelli M, 2014, NEPHROL DIAL TRANSPL, V29, P221, DOI 10.1093/ndt/gft519; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; Wang XXX, 2016, J AM SOC NEPHROL, V27, P1362, DOI 10.1681/ASN.2014121271; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zha Y, 2008, AM J NEPHROL, V28, P755, DOI 10.1159/000128607	37	30	34	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12018	12024		10.1074/jbc.C117.794982	http://dx.doi.org/10.1074/jbc.C117.794982			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28596381	Green Published, hybrid			2022-12-28	WOS:000406053300002
J	Mompean, M; Romano, V; Pantoja-Uceda, D; Stuani, C; Baralle, FE; Buratti, E; Laurents, DV				Mompean, Miguel; Romano, Valentina; Pantoja-Uceda, David; Stuani, Cristiana; Baralle, Francisco E.; Buratti, Emanuele; Laurents, Douglas V.			Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); microscopic imaging; nuclear magnetic resonance (NMR); protein aggregation; site-directed mutagenesis; structure-function; subcellular fractionation	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOIDOGENIC CORE REGION; NUCLEIC-ACID BINDING; IN-VIVO; STRUCTURAL DETERMINANTS; INCLUSION FORMATION; PHASE-SEPARATION; RNA RECOGNITION; NMR RELAXATION	Transactive response DNA-binding protein 43 (TDP-43) performs multiple tasks in mRNA processing, transport, and translational regulation, but it also forms aggregates implicated in amyotrophic lateral sclerosis. TDP-43's N-terminal domain (NTD) is important for these activities and dysfunctions; however, there is an open debate about whether or not it adopts a specifically folded, stable structure. Here, we studied NTD mutations designed to destabilize its structure utilizing NMR and fluorescence spectroscopies, analytical ultracentrifugation, splicing assays, and cell microscopy. The substitutions V31R and T32R abolished TDP-43 activity in splicing and aggregation processes, and even the rather mild L28A mutation severely destabilized the NTD, drastically reducing TDP-43's in vitro splicing activity and inducing aberrant localization and aggregation in cells. These findings strongly support the idea that a stably folded NTD is essential for correct TDP-43 function. The stably folded NTD also promotes dimerization, which is pertinent to the protein's activities and pathological aggregation, and we present an atomic-level structural model for the TDP-43 dimer based on NMR data. Leu-27 is evolutionarily well conserved even though it is exposed in the monomeric NTD. We found here that Leu-27 is buried in the dimer and that the L27A mutation promotes monomerization. In conclusion, our study sheds light on the structural and biological properties of the TDP-43 NTD, indicating that the NTD must be stably folded for TDP-43's physiological functions, and has implications for understanding the mechanisms promoting the pathological aggregation of this protein.	[Mompean, Miguel; Pantoja-Uceda, David; Laurents, Douglas V.] CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain; [Romano, Valentina; Stuani, Cristiana; Baralle, Francisco E.; Buratti, Emanuele] ICGEB, Padriciano 99, I-34149 Trieste, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); International Center for Genetic Engineering & Biotechnology (ICGEB)	Laurents, DV (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.; Buratti, E (corresponding author), ICGEB, Padriciano 99, I-34149 Trieste, Italy.	buratti@icgeb.org; dlaurents@iqfr.csic.es	Buratti, Emanuele/K-4691-2016; Pantoja-Uceda, David/J-8097-2014; Mompeán, Miguel/A-4909-2016; Laurents, Douglas/E-7527-2015	Buratti, Emanuele/0000-0002-1356-9074; Mompeán, Miguel/0000-0002-5608-3648; Pantoja-Uceda, David/0000-0003-4390-6972; Laurents, Douglas/0000-0002-4187-165X; Baralle, Francisco/0000-0002-4645-2809	European Union [JPND AC14/00037]; European Union Grant JPND RiMOdFTD, Italy, Ministero della Sanita/MIUR; Thierry Latran Foundation REHNPALS;  [SAF2013-49179-C2-2-R];  [SAF2016-76678-C2-2-R]	European Union(European Commission); European Union Grant JPND RiMOdFTD, Italy, Ministero della Sanita/MIUR; Thierry Latran Foundation REHNPALS; ; 	This work was supported by Grants SAF2013-49179-C2-2-R and SAF2016-76678-C2-2-R, European Union Grant JPND AC14/00037 (to D. V. L.), European Union Grant JPND RiMOdFTD, Italy, Ministero della Sanita/MIUR (to E. B.), and the Thierry Latran Foundation REHNPALS (to E. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Budini M, 2015, HUM MOL GENET, V24, P9, DOI 10.1093/hmg/ddu415; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Chang CK, 2016, FEBS J, V283, P1239, DOI 10.1111/febs.13676; Chang CK, 2013, FEBS LETT, V587, P575, DOI 10.1016/j.febslet.2013.01.038; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Goddard D., 2008, SPARKY 3; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23928; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Mihevc SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep33996; Mompean M, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00125; Mompean M, 2016, J PHYS CHEM LETT, V7, P1859, DOI 10.1021/acs.jpclett.6b00699; Mompean M, 2016, FEBS J, V283, P1242, DOI 10.1111/febs.13651; Mompean M, 2015, J PHYS CHEM LETT, V6, P2608, DOI 10.1021/acs.jpclett.5b00918; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ortega A, 2005, J AM CHEM SOC, V127, P12764, DOI 10.1021/ja053080l; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pawley NH, 2001, J BIOMOL NMR, V20, P149, DOI 10.1023/A:1011249816560; Qin HN, 2014, P NATL ACAD SCI USA, V111, P18619, DOI 10.1073/pnas.1413994112; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Romano V, 2015, PRION, V9, P1, DOI 10.1080/19336896.2015.1011885; Sasaguri H, 2016, BRAIN RES, V1647, P57, DOI 10.1016/j.brainres.2016.04.069; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Wei YY, 2016, BIOCHEM BIOPH RES CO, V473, P614, DOI 10.1016/j.bbrc.2016.03.158; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	61	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11992	12006		10.1074/jbc.M117.775965	http://dx.doi.org/10.1074/jbc.M117.775965			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28566288	Green Published, hybrid			2022-12-28	WOS:000405485600034
J	Lo, PK; Zhang, YS; Yao, Y; Wolfson, B; Yu, J; Han, SY; Duru, N; Zhou, Q				Lo, Pang-Kuo; Zhang, Yongshu; Yao, Yuan; Wolfson, Benjamin; Yu, Justine; Han, Shu-Yan; Duru, Nadire; Zhou, Qun			Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGF beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; EXPRESSION; METASTASIS; MIR-B-10; RB1CC1; MICROENVIRONMENT; BIOGENESIS; REGULATORS; CONVERSION	The normal myoepithelium has a tumor-suppressing nature and inhibits the progression of ductal carcinoma in situ (DCIS) into invasive ductal carcinoma (IDC). Conversely, a growing number of studies have shown that tumor-associated myoepithelial cells have a tumor-promoting effect. Moreover, the exact role of tumor-associated myoepithelial cells in the DCIS-to-IDC development remains undefined. To address this, we explored the role of tumor-associated myoepithelial cells in the DCIS-toIDC progression. We developed a direct coculture system to study the cell-cell interactions between DCIS cells and tumorassociated myoepithelial cells. Coculture studies indicated that tumor-associated myoepithelial cells promoted the invasive progression of a DCIS cell model in vitro, and mechanistic studies revealed that the interaction with DCIS cells stimulated tumor-associated myoepithelial cells to secrete TGF beta 1, which subsequently contributed to activating the TGF beta/Smads pathway in DCIS cells. We noted that activation of the TGF beta signaling pathway promoted the epithelial-mesenchymal transition, basal-like phenotypes, stemness, and invasiveness of DCIS cells. Importantly, xenograft studies further demonstrated that tumor-associated myoepithelial cells enhanced the DCIS-toIDC progression in vivo. Furthermore, we found that TGF beta mediated induction of oncogenic miR-10b-5p expression and down-regulation of RB1CC1, a miR-10b-5p-targeted tumorsuppressor gene, contributed to the invasive progression of DCIS. Our findings provide the first experimental evidence to directly support the paradigm that altered DCIS-associated myoepithelial cells promote the invasive progression of DCIS into IDC via TGF beta signaling activation.	[Lo, Pang-Kuo; Zhang, Yongshu; Yao, Yuan; Wolfson, Benjamin; Yu, Justine; Han, Shu-Yan; Duru, Nadire; Zhou, Qun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Han, Shu-Yan] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Integrat Chinese & Western Med, Beijing 100142, Peoples R China	University System of Maryland; University of Maryland Baltimore; Peking University	Zhou, Q (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Greenebaum Canc Ctr,Biomed Res Facil, 108 N Greene St,Rm 337, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu		Wolfson, Benjamin/0000-0001-5074-3193	NCI, National Institutes of Health [R01 CA157779, R01 CA163820]; NATIONAL CANCER INSTITUTE [T32CA154274, R01CA157779, R01CA163820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health, Grants R01 CA157779 and R01 CA163820 (to Q. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Allen MD, 2014, CANCER RES, V74, P5942, DOI 10.1158/0008-5472.CAN-14-1841; Allen MD, 2014, CLIN CANCER RES, V20, P344, DOI 10.1158/1078-0432.CCR-13-1504; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bahena-Ocampo I, 2016, EMBO REP, V17, P1081, DOI 10.15252/embr.201642700; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Choi JD, 2013, ONCOGENE, V32, P2421, DOI 10.1038/onc.2012.262; Choi Y, 2013, HUM PATHOL, V44, P2581, DOI 10.1016/j.humpath.2013.07.003; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Duru N, 2016, ONCOTARGET, V7, P47511, DOI 10.18632/oncotarget.10203; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gudjonsson T, 2002, J CELL SCI, V115, P39; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liz J, 2016, BBA-GENE REGUL MECH, V1859, P169, DOI 10.1016/j.bbagrm.2015.06.015; Lo PK, 2016, ONCOTARGET, V7, P65067, DOI 10.18632/oncotarget.11364; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; M'hamed IF, 2015, CELL ONCOL, V38, P433, DOI 10.1007/s13402-015-0239-3; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mardekian SK, 2016, HUM PATHOL, V49, P114, DOI 10.1016/j.humpath.2015.11.003; Mayorga ME, 2012, J CELL MOL MED, V16, P1106, DOI 10.1111/j.1582-4934.2011.01385.x; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Ochi Y, 2011, ONCOL REP, V26, P805, DOI 10.3892/or.2011.1329; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sivadas VP, 2014, TUMOR BIOL, V35, P2857, DOI 10.1007/s13277-013-1481-9; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang D, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019629, 10.1371/journal.pone.0019835]; Weinberg Robert, 2006, Cancer Res, V66, P11550, DOI 10.1158/0008-5472.CAN-06-3149; Xu H, 2014, CANCER GENE THER, V21, P60, DOI 10.1038/cgt.2013.82; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Yigit MV, 2013, ONCOGENE, V32, P1530, DOI 10.1038/onc.2012.173; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zdanov S, 2016, CANCER IMMUNOL RES, V4, P354, DOI 10.1158/2326-6066.CIR-15-0241; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999; Zhu YB, 2015, OBESITY, V23, P1014, DOI 10.1002/oby.21062	67	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11466	11484		10.1074/jbc.M117.775080	http://dx.doi.org/10.1074/jbc.M117.775080			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512126	Green Published, hybrid			2022-12-28	WOS:000405119600029
J	Madrid, M; Vazquez-Marin, B; Soto, T; Franco, A; Gomez-Gil, E; Vicente-Soler, J; Gacto, M; Perez, P; Cansado, J				Madrid, Marisa; Vazquez-Marin, Beatriz; Soto, Teresa; Franco, Alejandro; Gomez-Gil, Elisa; Vicente-Soler, Jero; Gacto, Mariano; Perez, Pilar; Cansado, Jose			Differential functional regulation of protein kinase C (PKC) orthologs in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; SCHIZOSACCHAROMYCES-POMBE; ACTIVATION; PMK1; DEGRADATION; HOMOLOG; ENCODES; STRESS; TARGET; PCK2P	The two PKC orthologs Pck1 and Pck2 in the fission yeast Schizosaccharomyces pombe operate in a redundant fashion to control essential functions, including morphogenesis and cell wall biosynthesis, as well as the activity of the cell integrity pathway and its core element, the MAPK Pmk1. We show here that, despite the strong structural similarity and functional redundancy of these two enzymes, the mechanisms regulating their maturation, activation, and stabilization have a remarkably distinct biological impact on both kinases. We found that, in contrast to Pck2, putative in vivo phosphorylation of Pck1 within the conserved activation loop, turn, and hydrophobic motifs is essential for Pck1 stability and biological functions. Constitutive Pck activation promoted dephosphorylation and destabilization of Pck2, whereas it enhanced Pck1 levels to interfere with proper downstream signaling to the cell integrity pathway via Pck2. Importantly, although catalytic activity was essential for Pck1 function, Pck2 remained partially functional independent of its catalytic activity. Our findings suggest that early divergence from a common ancestor in fission yeast involved important changes in the mechanisms regulating catalytic activation and stability of PKC family members to allow for flexible and dynamic control of downstream functions, including MAPK signaling.	[Madrid, Marisa; Vazquez-Marin, Beatriz; Soto, Teresa; Franco, Alejandro; Gomez-Gil, Elisa; Vicente-Soler, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain; [Perez, Pilar] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Madrid, M; Cansado, J (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain.	marisa@um.es; jcansado@um.es	Madrid, Marisa/K-7755-2014; Vicente-Soler, Jerónima/ABF-6293-2020; Franco, Alejandro/ABG-6823-2020; Pino, Teresa Soto/AAC-6096-2020; Perez, Pilar/B-4948-2010; Cansado, Jose/ABC-6872-2020; Madrid, Marisa/AAV-2154-2020; Cansado, Jose/K-5212-2014	Madrid, Marisa/0000-0002-7970-2587; Vicente-Soler, Jerónima/0000-0001-8759-6545; Franco, Alejandro/0000-0001-7461-3414; Pino, Teresa Soto/0000-0003-2965-318X; Perez, Pilar/0000-0003-3557-2247; Cansado, Jose/0000-0002-2342-8152; Madrid, Marisa/0000-0002-7970-2587; Vazquez, Beatriz/0000-0001-5334-2950	Ministerio de Economia y Competitividad [BFU2014-52828-P, BIO2015-69958-P]; Fundacion Seneca [19246/PI/14]; European Regional Development Fund - European Union	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Seneca(Fundacion Seneca); European Regional Development Fund - European Union	This work was supported by Ministerio de Economia y Competitividad Grants BFU2014-52828-P and BIO2015-69958-P, Fundacion Seneca Grant 19246/PI/14, and European Regional Development Fund co-funding from the European Union. The authors declare that they have no conflicts of interest with the contents of this article.	Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172; Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Arellano M, 1999, J CELL SCI, V112, P3569; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Graub R, 2003, J BASIC MICROB, V43, P473, DOI 10.1002/jobm.200310287; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37515; Madrid M, 2015, J CELL SCI, V128, P266, DOI 10.1242/jcs.158295; Madrid M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-34; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Sanchez-Mir L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088020; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Toda T, 1996, MOL CELL BIOL, V16, P6752; Viana RA, 2013, GENETICS, V195, P421, DOI 10.1534/genetics.113.154807; Wang Y, 2016, MOL BIOL CELL, V27, P410, DOI 10.1091/mbc.E15-09-0624	32	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11374	11387		10.1074/jbc.M117.786087	http://dx.doi.org/10.1074/jbc.M117.786087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28536259	Green Published, hybrid			2022-12-28	WOS:000405119600021
J	Azuma, Y; Zschoche, R; Hilvert, D				Azuma, Yusuke; Zschoche, Reinhard; Hilvert, Donald			The C-terminal peptide of Aquifex aeolicus riboflavin synthase directs encapsulation of native and foreign guests by a cage-forming lumazine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; cell compartmentalization; protein self-assembly; protein-protein interaction; synthetic biology; bacterial compartment; localization sequence; lumazine; riboflavin synthase; protein cage	CRYSTAL-STRUCTURE ANALYSIS; ENGINEERED PROTEIN CONTAINER; BACILLUS-SUBTILIS; BACTERIAL MICROCOMPARTMENTS; ANGSTROM RESOLUTION; STRUCTURAL BASIS; ENZYME ENCAPSULATION; QUATERNARY STRUCTURE; BINDING MODE; DRUG DESIGN	Encapsulation of specific enzymes in self-assembling protein cages is a hallmark of bacterial compartments that function as counterparts to eukaryotic organelles. The cage-forming enzyme lumazine synthase (LS) from Bacillus subtilis (BsLS), for example, encapsulates riboflavin synthase (BsRS), enabling channeling of lumazine from the site of its generation to the site of its conversion to vitamin B-2. Elucidating the molecular mechanisms underlying the assembly of these supramolecular complexes could help inform new approaches for metabolic engineering, nanotechnology, and drug delivery. To that end, we investigated a thermostable LS from Aquifex aeolicus (AaLS) and found that it also forms cage complexes with the cognate riboflavin synthase (AaRS) when both proteins are co-produced in the cytosol of Escherichia coli. A 12-amino acid-long peptide at the C terminus of AaRS serves as a specific localization sequence responsible for targeting the guest to the protein compartment. Sequence comparisons suggested that analogous peptide segments likely direct RS complexation by LS cages in other bacterial species. Covalent fusion of this peptide tag to heterologous guest molecules led to their internalization into AaLS assemblies both in vivo and in vitro, providing a firm foundation for creating tailored biomimetic nanocompartments for medical and biotechnological applications.	[Azuma, Yusuke; Zschoche, Reinhard; Hilvert, Donald] ETH, Lab Organ Chem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Lab Organ Chem, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Azuma, Yusuke/D-8030-2018	Azuma, Yusuke/0000-0003-3543-3159	ETH Zurich; European Research Council (Advanced ERC Grant) [ERC-dG-2012-321295]; Uehara Memorial Foundation Research Fellowship; ETH Zurich Postdoctoral Fellowship - Marie Curie Actions program; Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI)	ETH Zurich(ETH Zurich); European Research Council (Advanced ERC Grant)(European Research Council (ERC)); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); ETH Zurich Postdoctoral Fellowship - Marie Curie Actions program; Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI)	This work was generously supported by the ETH Zurich and the European Research Council (Advanced ERC Grant ERC-dG-2012-321295 to D. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Uehara Memorial Foundation Research Fellowship and an ETH Zurich Postdoctoral Fellowship (co-funded by the Marie Curie Actions program).; Recipient of a scholarship from the Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI).	Azuma Y, 2016, ANGEW CHEM INT EDIT, V55, P1531, DOI 10.1002/anie.201508414; BACHER A, 1980, J BIOL CHEM, V255, P632; BACHER A, 1986, J MOL BIOL, V187, P75, DOI 10.1016/0022-2836(86)90407-9; Beck T, 2015, ANGEW CHEM INT EDIT, V54, P937, DOI 10.1002/anie.201408677; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cassidy-Amstutz C, 2016, BIOCHEMISTRY-US, V55, P3461, DOI 10.1021/acs.biochem.6b00294; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Frank S, 2013, J BIOTECHNOL, V163, P273, DOI 10.1016/j.jbiotec.2012.09.002; Frey R, 2016, J AM CHEM SOC, V138, P10072, DOI 10.1021/jacs.6b04744; Frey R, 2016, CHEM COMMUN, V52, P10423, DOI 10.1039/c6cc05301g; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Gerhardt S, 2002, STRUCTURE, V10, P1371, DOI 10.1016/S0969-2126(02)00864-X; Haugland R P, 1995, Methods Mol Biol, V45, P205, DOI 10.1385/0-89603-308-2:205; Jakobson CM, 2015, J BIOL CHEM, V290, P24519, DOI 10.1074/jbc.M115.651919; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kim H, 2016, RSC ADV, V6, P19208, DOI 10.1039/c6ra00233a; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; Kumar P, 2011, ACTA CRYSTALLOGR D, V67, P131, DOI 10.1107/S0907444910053370; LADENSTEIN R, 1988, J MOL BIOL, V203, P1045, DOI 10.1016/0022-2836(88)90128-3; Ladenstein R, 2013, FEBS J, V280, P2537, DOI 10.1111/febs.12255; Lilavivat S, 2012, J AM CHEM SOC, V134, P13152, DOI 10.1021/ja302743g; Meining W, 2000, J MOL BIOL, V299, P181, DOI 10.1006/jmbi.2000.3742; Min J, 2014, RSC ADV, V4, P48596, DOI 10.1039/c4ra10187a; Morgunova E, 2005, BIOCHEMISTRY-US, V44, P2746, DOI 10.1021/bi047848a; Morgunova E, 2007, J BIOL CHEM, V282, P17231, DOI 10.1074/jbc.M701724200; Morgunova E, 2010, ACTA CRYSTALLOGR D, V66, P1001, DOI 10.1107/S0907444910029690; Mortl S, 1996, J BIOL CHEM, V271, P33201, DOI 10.1074/jbc.271.52.33201; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Persson K, 1999, PROTEIN SCI, V8, P2355; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; RITSERT K, 1995, J MOL BIOL, V253, P151, DOI 10.1006/jmbi.1995.0542; Rurup WF, 2014, J AM CHEM SOC, V136, P3828, DOI 10.1021/ja410891c; Sasaki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14663; SCHOTT K, 1990, J BIOL CHEM, V265, P4204; Seebeck FP, 2006, J AM CHEM SOC, V128, P4516, DOI 10.1021/ja058363s; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; Song Y, 2015, PHARM BIOL, V2015, P1, DOI DOI 10.1109/IFEEC.2015.7361560; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tamura A, 2015, BIOTECHNOL BIOENG, V112, P13, DOI 10.1002/bit.25322; Worsdorfer B, 2012, J AM CHEM SOC, V134, P909, DOI 10.1021/ja211011k; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Worsdorfer B., 2010, THESIS; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang XF, 2003, J MOL BIOL, V328, P167, DOI 10.1016/S0022-2836(03)00186-4; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zschoche R, 2015, J AM CHEM SOC, V137, P16121, DOI 10.1021/jacs.5b10588; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	52	13	14	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10321	10327		10.1074/jbc.C117.790311	http://dx.doi.org/10.1074/jbc.C117.790311			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28515315	Green Published, hybrid			2022-12-28	WOS:000404115400001
J	Hutchens, S; Liu, CY; Jursa, T; Shawlot, W; Chaffee, BK; Yin, WL; Gore, AC; Aschner, M; Smith, DR; Mukhopadhyay, S				Hutchens, Steven; Liu, Chunyi; Jursa, Thomas; Shawlot, William; Chaffee, Beth K.; Yin, Weiling; Gore, Andrea C.; Aschner, Michael; Smith, Donald R.; Mukhopadhyay, Somshuvra			Deficiency in the manganese efflux transporter SLC30A10 induces severe hypothyroidism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; INTELLECTUAL FUNCTION; ZINC TRANSPORTERS; DRINKING-WATER; EXPOSURE; PARKINSONISM; IMPAIRMENT; MUTATIONS; ESTROGEN; FAMILY	Manganese is an essential metal that becomes toxic at elevated levels. Loss-of-function mutations in SLC30A10, a cell-surface-localized manganese efflux transporter, cause a heritable manganese metabolism disorder resulting in elevated manganese levels and parkinsonian-like movement deficits. The underlying disease mechanisms are unclear; therefore, treatment is challenging. To understand the consequences of loss of SLC30A10 function at the organism level, we generated Slc30a10 knock-out mice. During early development, knock-outs were indistinguishable from controls. Surprisingly, however, after weaning and compared with controls, knock-out mice failed to gain weight, were smaller, and died prematurely (by similar to 6-8 weeks of age). At 6 weeks, manganese levels in the brain, blood, and liver of the knock-outs were similar to 20-60-fold higher than controls. Unexpectedly, histological analyses revealed that the brain and liver of the knock-outs were largely unaffected, but their thyroid exhibited extensive alterations. Because hypothyroidism leads to growth defects and premature death in mice, we assayed for changes in thyroid and pituitary hormones. At 6 weeks and compared with controls, the knock-outs had markedly reduced thyroxine levels (similar to 50-80%) and profoundly increased thyroid-stimulating hormone levels (similar to 800-1000-fold), indicating that Slc30a10 knock-out mice develop hypothyroidism. Importantly, a low-manganese diet produced lower tissue manganese levels in the knock-outs and rescued the phenotype, suggesting that manganese toxicity was the underlying cause. Our unanticipated discovery highlights the importance of determining the role of thyroid dysfunction in the onset and progression of manganese-induced disease and identifies Slc30a10 knock-out mice as a new model for studying thyroid biology.	[Hutchens, Steven; Liu, Chunyi; Yin, Weiling; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hutchens, Steven; Liu, Chunyi; Yin, Weiling; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Shawlot, William] Univ Texas Austin, Inst Cellular & Mol Biol, Mouse Genet Engn Facil, Austin, TX 78712 USA; [Jursa, Thomas; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Chaffee, Beth K.] MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Dept Vet Sci, Bastrop, TX 78602 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton, Austin, TX 78712 USA.	som@austin.utexas.edu	Liu, Chunyi/AAJ-9340-2021	Mukhopadhyay, Somshuvra/0000-0002-3420-7830	NIEHS, National Institutes of Health [R01-ES024812, R00-ES020844]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES020844, R01ES024812] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Grants R01-ES024812 and R00-ES020844 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; Beaudin SA, 2013, NEUROTOXICOL TERATOL, V38, P36, DOI 10.1016/j.ntt.2013.04.004; Behringer R, 2014, MANIPULATING MOUSE E, V4; Bhang SY, 2013, ENVIRON RES, V126, P9, DOI 10.1016/j.envres.2013.05.006; Bouchard M, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9504; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P138, DOI 10.1289/ehp.1002321; BUTHIEAU AM, 1983, ARCH TOXICOL, V54, P243, DOI 10.1007/BF01239208; BUTHIEAU AM, 1977, CR SOC BIOL, V171, P1024; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Ebert BL, 1999, BLOOD, V94, P1864; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hall J. E., 2016, TXB MED PHYSL, P951; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; KAWADA J, 1985, ENDOCRINOL JAPON, V32, P635; Kern CH, 2010, SYNAPSE, V64, P363, DOI 10.1002/syn.20736; Khan K, 2012, NEUROTOXICOLOGY, V33, P91, DOI 10.1016/j.neuro.2011.12.002; Khan K, 2011, ENVIRON HEALTH PERSP, V119, P1501, DOI 10.1289/ehp.1003397; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lucchini RG, 2014, NEUROTOXICOLOGY, V45, P309, DOI 10.1016/j.neuro.2014.05.006; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Moreno JA, 2011, TOXICOL SCI, V122, P121, DOI 10.1093/toxsci/kfr091; Morshed SA, 2012, IMMUNOL RES, V54, P191, DOI 10.1007/s12026-012-8312-8; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; National Toxicology Program, 1993, Natl Toxicol Program Tech Rep Ser, V428, P1; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Riojas-Rodriguez H, 2010, ENVIRON HEALTH PERSP, V118, P1465, DOI 10.1289/ehp.0901229; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Soldin OP, 2007, NEUROTOXICOLOGY, V28, P951, DOI 10.1016/j.neuro.2007.05.003; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Yin WL, 2015, ENDOCRINOLOGY, V156, P2918, DOI 10.1210/en.2015-1032; Zhong ML, 2012, HISTOCHEM CELL BIOL, V138, P605, DOI 10.1007/s00418-012-0979-3; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	54	46	48	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9760	9773		10.1074/jbc.M117.783605	http://dx.doi.org/10.1074/jbc.M117.783605			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28461334	Green Published, hybrid			2022-12-28	WOS:000403113000025
J	Ishikawa, Y; Mizuno, K; Bachinger, HP				Ishikawa, Yoshihiro; Mizuno, Kazunori; Bachinger, Hans Peter			Ziploc-ing the structure 2.0: Endoplasmic reticulum-resident peptidyl prolyl isomerases show different activities toward hydroxyproline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERASE; BASEMENT-MEMBRANE COLLAGEN; EHLERS-DANLOS-SYNDROME; RECESSIVE OSTEOGENESIS IMPERFECTA; CHICK TENDON COLLAGEN; TRIPLE-HELIX; CYCLOPHILIN-B; FK506-BINDING PROTEIN; III COLLAGEN; I COLLAGEN	Extracellular matrix proteins are biosynthesized in the rough endoplasmic reticulum (rER), and the triple-helical protein collagen is the most abundant extracellular matrix component in the human body. Many enzymes, molecular chaperones, and post-translational modifiers facilitate collagen biosynthesis. Collagen contains a large number of proline residues, so the cis/trans isomerization of proline peptide bonds is the rate-limiting step during triple-helix formation. Accordingly, the rER-resident peptidyl prolyl cis/trans isomerases (PPIases) play an important role in the zipper-like triple-helix formation in collagen. We previously described this process as "Ziploc-ing the structure" and now provide additional information on the activity of individual rER PPIases. We investigated the substrate preferences of these PPIases in vitro using type III collagen, the unhydroxylated quarter fragment of type III collagen, and synthetic peptides as substrates. We observed changes in activity of six rER-resident PPIases, cyclophilin B (encoded by the PPIB gene), FKBP13 (FKBP2), FKBP19 (FKBP11), FKBP22 (FKBP14), FKBP23 (FKBP7), and FKBP65 (FKBP10), due to posttranslational modifications of proline residues in the substrate. Cyclophilin B and FKBP13 exhibited much lower activity toward post- translationally modified substrates. In contrast, FKBP19, FKBP22, and FKBP65 showed increased activity toward hydroxyproline-containing peptide substrates. Moreover, FKBP22 showed a hydroxyproline- dependent effect by increasing the amount of refolded type III collagen in vitro and FKBP19 seems to interact with triple helical type I collagen. Therefore, we propose that hydroxyproline modulates the rate of Ziploc-ing of the triple helix of collagen in the rER.	[Ishikawa, Yoshihiro; Bachinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Mizuno, Kazunori; Bachinger, Hans Peter] Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Mizuno, Kazunori] Nippi Res Inst Biomatrix, Ibaraki 3020017, Japan	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children [85100, 85500]	Shriners Hospitals for Children	This work was supported by Shriners Hospitals for Children Grants 85100 and 85500 (to H. P. B.). The authors declare that they have no competing interests related to this work.	BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; Bella J, 2016, BIOCHEM J, V473, P1001, DOI 10.1042/BJ20151169; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Boudko SP, 2014, PROTEIN SCI, V23, P67, DOI 10.1002/pro.2391; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Islam M, 2013, J BIOL CHEM, V288, P35526, DOI 10.1074/jbc.M113.504530; JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mizuno K, 2013, J BIOL CHEM, V288, P19166, DOI 10.1074/jbc.M113.462002; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murray ML, 2014, AM J MED GENET A, V164, P1750, DOI 10.1002/ajmg.a.36492; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Schmelzer CEH, 2016, BBA-GEN SUBJECTS, V1860, P2169, DOI 10.1016/j.bbagen.2016.05.013; Szabadkai G, 2007, ADV EXP MED BIOL, V594, P64; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	54	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9273	9282		10.1074/jbc.M116.772657	http://dx.doi.org/10.1074/jbc.M116.772657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28385890	Green Published, hybrid			2022-12-28	WOS:000402538900022
J	Philpott, CC; Ryu, MS; Frey, A; Patel, S				Philpott, Caroline C.; Ryu, Moon-Suhn; Frey, Avery; Patel, Sarju			Cytosolic iron chaperones: Proteins delivering iron cofactors in the cytosol of mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						iron; iron metabolism; iron-sulfur protein; metalloprotein; molecular chaperone; BolA2; poly C-binding protein; glutaredoxin	SACCHAROMYCES-CEREVISIAE; SULFUR CLUSTER; DEOXYHYPUSINE HYDROXYLASE; MONOTHIOL GLUTAREDOXIN; FERRITIN DEGRADATION; HEME-BIOSYNTHESIS; GENE-EXPRESSION; PHP4 FUNCTION; HUMAN BOLA2; IN-VIVO	Eukaryotic cells contain hundreds of metalloproteins that are supported by intracellular systems coordinating the uptake and distribution of metal cofactors. Iron cofactors include heme, iron-sulfur clusters, and simple iron ions. Poly(rC)-binding proteins are multifunctional adaptors that serve as iron ion chaperones in the cytosolic/nuclear compartment, binding iron at import and delivering it to enzymes, for storage (ferritin) and export (ferroportin). Ferritin iron is mobilized by autophagy through the cargo receptor, nuclear co-activator 4. The monothiol glutaredoxin Glrx3 and BolA2 function as a [2Fe-2S] chaperone complex. These proteins form a core system of cytosolic iron cofactor chaperones in mammalian cells.	[Philpott, Caroline C.; Patel, Sarju] NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA; [Ryu, Moon-Suhn] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Frey, Avery] BioLegend, San Diego, CA 92110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Minnesota System; University of Minnesota Twin Cities	Philpott, CC (corresponding author), NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA.	Carolinep@mail.nih.gov		Ryu, Moon-Suhn/0000-0002-9533-9263	Intramural Research Program of the NIDDK; Office of Dietary Supplements, Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510, U54DK110858] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements, Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK and the Office of Dietary Supplements, Office of the Director, National Institutes of Health. This is the fifth article in the Thematic Minireview series "Metals in Biology 2017: Iron transport, storage, and the ramifications." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Arosio P, 2017, IUBMB LIFE, V69, P414, DOI 10.1002/iub.1621; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Banci L, 2015, J AM CHEM SOC, V137, P16133, DOI 10.1021/jacs.5b10592; Banci L, 2015, NAT CHEM BIOL, V11, P772, DOI [10.1038/NCHEMBIO.1892, 10.1038/nchembio.1892]; Banci L, 2013, J BIOL INORG CHEM, V18, P883, DOI 10.1007/s00775-013-1033-1; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Bellelli R, 2016, CELL REP, V14, P411, DOI 10.1016/j.celrep.2015.12.065; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Carmona F, 2017, BBA-GEN SUBJECTS, V1861, P522, DOI 10.1016/j.bbagen.2016.12.011; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; del Dedo JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005106; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Frey A. G., 2016, J BIOL CHEM, V292; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Ganz T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011668; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hare DJ, 2013, METALLOMICS, V5, P1656, DOI 10.1039/c3mt00227f; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; KONIJN AM, 1979, AM J HEMATOL, V6, P373, DOI 10.1002/ajh.2830060409; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lipper CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139699; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mangani S, 2003, J BIOL CHEM, V278, P3176, DOI 10.1074/jbc.M208794200; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Netz DJA, 2016, BIOCHEM J, V473, P2073, DOI 10.1042/BCJ20160416; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostareck-Lederer A, 2012, CURR PROTEIN PEPT SC, V13, P391, DOI 10.2174/138920312801619484; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Ryu MS, 2017, J CLIN INVEST, V127, P1786, DOI 10.1172/JCI90519; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Tan GQ, 2016, BIOCHEM BIOPH RES CO, V470, P226, DOI 10.1016/j.bbrc.2016.01.040; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Uzarska MA, 2016, ELIFE, V5, DOI 10.7554/eLife.16673; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Yannone SM, 2012, CURR OPIN BIOTECH, V23, P89, DOI 10.1016/j.copbio.2011.11.005; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang YH, 2010, ANTIOXID REDOX SIGN, V13, P999, DOI 10.1089/ars.2010.3129	85	74	76	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12764	12771		10.1074/jbc.R117.791962	http://dx.doi.org/10.1074/jbc.R117.791962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28615454	hybrid, Green Published			2022-12-28	WOS:000407220100006
J	Moffett, AS; Bender, KW; Huber, SC; Shukla, D				Moffett, Alexander S.; Bender, Kyle W.; Huber, Steven C.; Shukla, Diwakar			Molecular dynamics simulations reveal the conformational dynamics of Arabidopsis thaliana BRI1 and BAK1 receptor-like kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; molecular dynamics; plant molecular biology; protein kinase; signal transduction; BAK1; BRI1; Markov state models	BRASSINOSTEROID SIGNALING NETWORK; ALPHA-C HELIX; PROTEIN-KINASES; TYROSINE PHOSPHORYLATION; COMPUTATIONAL MICROSCOPE; STRUCTURAL-ANALYSIS; INTRINSIC DISORDER; EGF RECEPTOR; FORCE-FIELDS; ACTIVATION	The structural motifs responsible for activation and regulation of eukaryotic protein kinases in animals have been studied extensively in recent years, and a coherent picture of their activation mechanisms has begun to emerge. In contrast, non-animal eukaryotic protein kinases are not as well understood from a structural perspective, representing a large knowledge gap. To this end, we investigated the conformational dynamics of two key Arabidopsis thaliana receptor-like kinases, brassinosteroid-insensitive 1 (BRI1) and BRI1-associated kinase 1 (BAK1), through extensive molecular dynamics simulations of their fully phosphorylated kinase domains. Molecular dynamics simulations calculate the motion of each atom in a protein based on classical approximations of interatomic forces, giving researchers insight into protein function at unparalleled spatial and temporal resolutions. We found that in an otherwise active BAK1 the C helix is highly disordered, a hallmark of deactivation, whereas the BRI1 C helix is moderately disordered and displays swinging behavior similar to numerous animal kinases. An analysis of all known sequences in the A. thaliana kinome found that C helix disorder may be a common feature of plant kinases.	[Moffett, Alexander S.; Shukla, Diwakar] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Bender, Kyle W.; Huber, Steven C.; Shukla, Diwakar] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Huber, Steven C.] ARS, USDA, Global Change & Photosynthesis Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Shukla, D (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	diwakar@illinois.edu	Shukla, Diwakar/GRY-2518-2022; Bender, Kyle W/V-4678-2017; Bender, Kyle/AAJ-5993-2020; Huber, Steven/O-1664-2013	Shukla, Diwakar/0000-0003-4079-5381; Bender, Kyle W/0000-0002-1805-8097; Bender, Kyle/0000-0002-1805-8097; Huber, Steven/0000-0002-8562-0043; Moffett, Alexander/0000-0003-1631-2722	National Science Foundation [OCI-0725070, ACI-1238993]	National Science Foundation(National Science Foundation (NSF))	We thank the Blue Waters sustained petascale computing project, which is supported by National Science Foundation Awards OCI-0725070 and ACI-1238993, and the state of Illinois for providing computing time for this study.	Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bojar D, 2014, PLANT J, V78, P31, DOI 10.1111/tpj.12445; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Case D., 2015, AMBER, V14; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Huang H, 2012, J PHYS CHEM B, V116, P4465, DOI 10.1021/jp301628r; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kathiriya JJ, 2014, MOL BIOSYST, V10, P2876, DOI 10.1039/c4mb00224e; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malaney P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02035; McGibbon RT, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916292; Metzner P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021106; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oh MH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00175; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Palmieri L, 2013, DRUG DISCOV TODAY, V18, P407, DOI 10.1016/j.drudis.2012.11.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shukla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4397; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AP, 2015, J EXP BOT, V66, P1123, DOI 10.1093/jxb/erv026; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang WF, 2014, CURR OPIN PLANT BIOL, V21, P147, DOI 10.1016/j.pbi.2014.07.012; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wereszczynski J, 2012, METHODS MOL BIOL, V819, P515, DOI 10.1007/978-1-61779-465-0_30; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yan LM, 2012, CELL RES, V22, P1304, DOI 10.1038/cr.2012.74; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	66	29	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12643	12652		10.1074/jbc.M117.792762	http://dx.doi.org/10.1074/jbc.M117.792762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28559283	Green Published, hybrid			2022-12-28	WOS:000406636900028
J	Qian, WL; Gang, XX; Zhang, TL; Wei, L; Yang, XX; Li, Z; Yang, Y; Song, L; Wang, P; Peng, J; Cheng, DJ; Xia, QY				Qian, Wenliang; Gang, Xiaoxu; Zhang, Tianlei; Wei, Ling; Yang, Xinxin; Li, Zheng; Yang, Yan; Song, Liang; Wang, Peng; Peng, Jian; Cheng, Daojun; Xia, Qingyou			Protein kinase A-mediated phosphorylation of the Broad-Complex transcription factor in silkworm suppresses its transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; phosphorylation; post-translational modification (PTM); protein kinase A (PKA); signal transduction; 20-hydroxyecdysone; Broad-Complex; suppression	OXIDE SYNTHASE PHOSPHORYLATION; KRUPPEL HOMOLOG 1; NUCLEAR IMPORT; JUVENILE-HORMONE; GENE-EXPRESSION; BOMBYX-MORI; DROSOPHILA; 20-HYDROXYECDYSONE; METAMORPHOSIS; LOCALIZATION	The insect-specific transcription factor Broad-Complex (BR-C) is transcriptionally activated by the steroid 20-hydroxyecdysone (20E) and regulates the expression of many target genes involved in insect growth and development. However, although the transcriptional regulation of BR-C proteins has been well studied, how BR-C is regulated at post-transcription and -translation levels is poorly understood. To this end, using liquid chromatography-tandem mass spectrometry analysis, we identified residue Ser-186 as a phosphorylation site of BR-C in silkworm. Site-directed mutagenesis and treatment with specific kinase activators and inhibitors indicated that the Ser-186 residue in silkworm BR-C is phosphorylated by protein kinase A (PKA). Immunostaining assays disclosed that PKA-mediated phosphorylation of silkworm BR-C has no effect on its nuclear import. However, luciferase reporter analysis, electrophoretic mobility shift assays, and chromatin immunoprecipitation revealed that the PKA phosphorylation event suppresses the transcriptional activation of silkworm BR-C target genes and that this inhibition was caused by repression of BR-C binding to its DNA targets. Of note, both in vitro and ex vivo experiments disclosed that a continuous 20E signal inhibits the PKA-mediated BR-C phosphorylation and also the cAMP/PKA pathway, indicating that 20E's inhibitory effect on PKA-mediated phosphorylation of silkworm BR-C contributes to maintaining BR-C transcriptional activity. In conclusion, our findings indicate that PKA-mediated phosphorylation inhibits silkworm BR-C activity by interfering with its binding to DNA and that 20E signaling relieves PKA-mediated phosphorylation of BR-C, thereby maintaining its transcriptional activity.	[Qian, Wenliang; Gang, Xiaoxu; Zhang, Tianlei; Yang, Xinxin; Li, Zheng; Yang, Yan; Song, Liang; Wang, Peng; Peng, Jian; Cheng, Daojun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Wei, Ling] Southwest Univ, Sch Life Sci, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Cheng, DJ; Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	chengdj@swu.edu.cn; xiaqy@swu.edu.cn	Li, Zheng/HCH-4626-2022; yang, xin/HGU-9981-2022	Li, Zheng/0000-0002-7803-5401; Xia, Qingyou/0000-0002-9263-2886	National Natural Science Foundation of China [31272503, 31572464, 31172267]; municipal graduate student research innovation project of Chongqing [CYB14047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); municipal graduate student research innovation project of Chongqing	This work was supported by grants from the National Natural Science Foundation of China (31272503, 31572464, and 31172267) and the municipal graduate student research innovation project of Chongqing (CYB14047). The authors declare that they have no conflicts of interest with the contents of this article.	Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Blaker AL, 2009, ARTERIOSCL THROM VAS, V29, P2153, DOI 10.1161/ATVBAHA.109.197285; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Cakouros D, 2002, J CELL BIOL, V157, P985, DOI 10.1083/jcb.200201034; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Cheng DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109111; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Di Giacomo M, 2016, J BIOL CHEM, V291, P3821, DOI 10.1074/jbc.M115.680983; Diamond MI, 2015, J BIOL CHEM, V290, P9075, DOI 10.1074/jbc.M114.619874; DIBELLO PR, 1991, GENETICS, V129, P385; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Fimia GM, 2001, J CELL SCI, V114, P1971; Gradin K, 2002, J BIOL CHEM, V277, P23508, DOI 10.1074/jbc.M201307200; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Horovitz-Fried M, 2007, CELL SIGNAL, V19, P556, DOI 10.1016/j.cellsig.2006.08.005; Ibanez IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044502; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jing YP, 2016, J BIOL CHEM, V291, P12771, DOI 10.1074/jbc.M115.706028; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lorenzin F, 2016, ELIFE, V5, DOI 10.7554/eLife.15161; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Meng M, 2015, J BIOL CHEM, V290, P24438, DOI 10.1074/jbc.M115.651810; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Pereira J, 2009, YEAST, V26, P641, DOI 10.1002/yea.1711; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Qian WL, 2015, INT J MOL SCI, V16, P3335, DOI 10.3390/ijms16023335; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song L, 2017, J PROTEOMICS, V154, P49, DOI 10.1016/j.jprot.2016.11.018; Sun XP, 2006, ARCH INSECT BIOCHEM, V62, P116, DOI 10.1002/arch.20130; TAGAWA T, 1995, J CELL BIOL, V130, P255, DOI 10.1083/jcb.130.2.255; TRIPOULAS NA, 1986, DEV BIOL, V116, P328, DOI 10.1016/0012-1606(86)90136-3; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wagner L, 2007, ENDOTHELIUM-J ENDOTH, V14, P245, DOI 10.1080/10623320701606707; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; Wang W, 2005, J BIOL CHEM, V280, P16772, DOI 10.1074/jbc.M411537200; Ye LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08301; Zhang Z, 2016, NUCLEIC ACIDS RES, V44, pD1172, DOI 10.1093/nar/gkv1141; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	47	13	13	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12460	12470		10.1074/jbc.M117.775130	http://dx.doi.org/10.1074/jbc.M117.775130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584058	hybrid, Green Published			2022-12-28	WOS:000406636900011
J	Willems, AP; Gundogdu, M; Kempers, MJE; Giltay, JC; Pfundt, R; Elferink, M; Loza, BF; Fuijkschot, J; Ferenbach, AT; van Gassen, KLI; van Aalten, DMF; Lefeber, DJ				Willems, Anke P.; Gundogdu, Mehmet; Kempers, Marlies J. E.; Giltay, Jacques C.; Pfundt, Rolph; Elferink, Martin; Loza, Bettina F.; Fuijkschot, Joris; Ferenbach, Andrew T.; van Gassen, Koen L. I.; van Aalten, Daan M. F.; Lefeber, Dirk J.			Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycosyltransferase; metabolic disease; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); Congenital Disorders of Glycosylation; Host Cell Factor 1 (HCF-1); X-linked Intellectual Disability	TETRATRICOPEPTIDE REPEATS; HIPPOCAMPAL SYNAPSES; CYTOSOLIC PROTEINS; MISSENSE MUTATION; ACTIVE-SITE; GLYCOSYLATION; NUCLEAR; GLCNACYLATION; HCFC1; HCF-1	N-Acetylglucosamine (O-GlcNAc) transferase (OGT) regulates protein O-GlcNAcylation, an essential and dynamic post-translational modification. The O-GlcNAc modification is present on numerous nuclear and cytosolic proteins and has been implicated in essential cellular functions such as signaling and gene expression. Accordingly, altered levels of protein O-GlcNAcylation have been associated with developmental defects and neurodegeneration. However, mutations in the OGT gene have not yet been functionally confirmed in humans. Here, we report on two hemizygous mutations in OGT in individuals with X-linked intellectual disability (XLID) and dysmorphic features: one missense mutation (p.Arg284Pro) and one mutation leading to a splicing defect (c.463-6T>G). Both mutations reside in the tetratricopeptide repeats of OGT that are essential for substrate recognition. We observed slightly reduced levels of OGT protein and reduced levels of its opposing enzyme O-GlcNAcase in both patient-derived fibroblasts, but global O-GlcNAc levels appeared to be unaffected. Our data suggest that mutant cells attempt to maintain global O-GlcNAcylation by down-regulating O-GlcNAcase expression. We also found that the c.463-6T>G mutation leads to aberrant mRNA splicing, but no stable truncated protein was detected in the corresponding patient-derived fibroblasts. Recombinant OGT bearing the p.Arg284Pro mutation was prone to unfolding and exhibited reduced glycosylation activity against a complex array of glycosylation substrates and proteolytic processing of the transcription factor host cell factor 1, which is also encoded by an XLID-associated gene. We conclude that defects in O-GlcNAc homeostasis and host cell factor 1 proteolysis may play roles in mediation of XLID in individuals with OGT mutations.	[Willems, Anke P.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Kempers, Marlies J. E.; Pfundt, Rolph] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6500 HB Nijmegen, Netherlands; [Willems, Anke P.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab,Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gundogdu, Mehmet; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Giltay, Jacques C.; Elferink, Martin; van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Genet, NL-3508 AB Utrecht, Netherlands; [Loza, Bettina F.] VieCuri Hosp, Dept Paediat, NL-5900 BX Venlo, Netherlands; [Fuijkschot, Joris] Radboud Univ Nijmegen, Med Ctr, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; [Fuijkschot, Joris] Amalia Childrens Hosp, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Dundee; Utrecht University; Utrecht University Medical Center; VieCuri Medical Center; Radboud University Nijmegen	Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.; Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab,Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.; van Aalten, DMF (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Lefeber, Dirk DJ/A-2146-2014; Willems, Anke/S-5105-2017; Pfundt, Rolph/L-4576-2015	van Aalten, Daan/0000-0002-1499-6908; Ferenbach, Andrew/0000-0002-1562-7987; van Gassen, Koen/0000-0001-7934-0662; Gundogdu, Mehmet/0000-0003-0061-5243	Dutch Organization for Scientific Research VIDI Grant [91713359]; Wellcome Trust [110061]; University of Dundee Translational Medical Research Fund Ph.D. fellowship	Dutch Organization for Scientific Research VIDI Grant; Wellcome Trust(Wellcome TrustEuropean Commission); University of Dundee Translational Medical Research Fund Ph.D. fellowship	This work was supported by the Dutch Organization for Scientific Research VIDI Grant 91713359 (to D.J.L.), Wellcome Trust Investigator Award 110061 (to D.M. F.V.A.), and a University of Dundee Translational Medical Research Fund Ph.D. fellowship (to M.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Janetzko J, 2016, NAT CHEM BIOL, V12, P899, DOI [10.1038/NCHEMBIO.2173, 10.1038/nchembio.2173]; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Jolly LA, 2015, HUM MOL GENET, V24, P3335, DOI 10.1093/hmg/ddv083; Kapuria V, 2016, GENE DEV, V30, P960, DOI 10.1101/gad.275925.115; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; Myers SA, 2013, PROTEOMICS, V13, P982, DOI 10.1002/pmic.201200332; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Su C, 2017, J NEUROSCI, V37, P2125, DOI 10.1523/JNEUROSCI.3384-16.2017; Taylor EW, 2014, J NEUROSCI, V34, P10, DOI 10.1523/JNEUROSCI.4761-12.2014; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206; Zheng BW, 2016, NEUROL RES, V38, P177, DOI 10.1080/01616412.2015.1133485	45	44	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12621	12631		10.1074/jbc.M117.790097	http://dx.doi.org/10.1074/jbc.M117.790097			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584052	Green Published, hybrid			2022-12-28	WOS:000406636900026
J	Li, L; Wang, YS				Li, Lin; Wang, Yinsheng			Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; H4 ACETYLATION; HUMAN-CELLS; LYSINE 16; METHYLATION; CHROMATIN; DAMAGE; ACETYLTRANSFERASE; ACTIVATION; GENOME	Post-translational modifications of histone proteins regulate numerous cellular processes. Among these modifications, trimethylation of lysine 36 in histone H3 (H3K36me3) and acetylation of lysine 16 in histone H4 (H4K16ac) have important roles in transcriptional regulation and DNA damage response signaling. However, whether these two epigenetic histone marks are mechanistically linked remains unclear. Here we discovered a new pathway through which H3K36me3 stimulates H4K16ac upon DNA double-strand break (DSB) induction in human cells. In particular, we examined, using Western blot analysis, the levels of H3K36me3 and H4K16ac in cells after exposure to various DSB-inducing agents, including neocarzinostatin, gamma rays, and etoposide, and found that H3K36me3 and H4K16ac were both elevated in cells upon these treatments. We also observed that DSB-induced H4K16 acetylation was abolished in cells upon depletion of the histone methyltransferase gene SET-domain containing 2 (SETD2) and the ensuing loss of H3K36me3. Furthermore, the H3K36me3-mediated increase in H4K16ac necessitated lens epithelium-derived growth factor p75 splicing variant (LEDGF), which is a reader protein of H3K36me3, and the KAT5 (TIP60) histone acetyltransferase. Mechanistically, the chromatin-bound LEDGF, through its interaction with KAT5, promoted chromatin localization of KAT5, thereby stimulating H4K16 acetylation. In this study, we unveiled cross-talk between two important histone epigenetic marks and defined the function of this cross-talk in DNA DSB repair.	[Li, Lin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022		National Institutes of Health Grant [R21 ES025392]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025392] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R21 ES025392. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hayakawa T, 2010, J CELL SCI, V123, P1124, DOI 10.1242/jcs.060178; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Renaud E, 2016, NUCLEIC ACIDS RES, V44, P648, DOI 10.1093/nar/gkv1019; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sy SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/jbc.C109.023937; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wu JX, 2011, NAT STRUCT MOL BIOL, V18, P761, DOI 10.1038/nsmb.2078; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; Xiong L, 2009, J AM SOC MASS SPECTR, V20, P1172, DOI 10.1016/j.jasms.2009.02.014; Xu YF, 2014, NUCLEIC ACIDS RES, V42, P10960, DOI 10.1093/nar/gku781; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	45	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11951	11959		10.1074/jbc.M117.788224	http://dx.doi.org/10.1074/jbc.M117.788224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28546430	hybrid, Green Published			2022-12-28	WOS:000405485600030
J	McDougal, AD; Dewey, CF				McDougal, Anthony D.; Dewey, C. Forbes, Jr.			Modeling oxygen requirements in ischemic cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGY MARKUP LANGUAGE; HEART IN-VIVO; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; OXIDATIVE-PHOSPHORYLATION; COMPUTATIONAL MODEL; ENERGY-METABOLISM; MITOCHONDRIAL; CARDIOPROTECTION; PROTECTION	Heart disease remains the leading cause of death globally. Although reperfusion following myocardial ischemia can prevent death by restoring nutrient flow, ischemia/reperfusion injury can cause significant heart damage. The mechanisms that drive ischemia/reperfusion injury are not well understood; currently, few methods can predict the state of the cardiac muscle cell and its metabolic conditions during ischemia. Here, we explored the energetic sustainability of cardiomyocytes, using a model for cellular metabolism to predict the levels of ATP following hypoxia. We modeled glycolytic metabolism with a system of coupled ordinary differential equations describing the individual metabolic reactions within the cardiomyocyte over time. Reduced oxygen levels and ATP consumption rates were simulated to characterize metabolite responses to ischemia. By tracking biochemical species within the cell, our model enables prediction of the cell's condition up to the moment of reperfusion. The simulations revealed a distinct transition between energetically sustainable and unsustainable ATP concentrations for various energetic demands. Our model illustrates how even low oxygen concentrations allow the cell to perform essential functions. We found that the oxygen level required for a sustainable level of ATP increases roughly linearly with the ATP consumption rate. An extracellular O-2 concentration of similar to 0.007 mM could supply basic energy needs in non-beating cardiomyocytes, suggesting that increased collateral circulation may provide an important source of oxygen to sustain the cardiomyocyte during extended ischemia. Our model provides a time-dependent framework for studying various intervention strategies to change the outcome of reperfusion.	[McDougal, Anthony D.; Dewey, C. Forbes, Jr.] MIT, Dept Mech Engn, Rm 3-354,77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dewey, C. Forbes, Jr.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dewey, CF (corresponding author), MIT, Dept Mech Engn, Rm 3-354,77 Massachusetts Ave, Cambridge, MA 02139 USA.	cfdewey@mit.edu		McDougal, Anthony/0000-0002-9980-4193	Singapore-MIT Alliance, Computational and Systems Biology Program	Singapore-MIT Alliance, Computational and Systems Biology Program	This research was supported by the Singapore-MIT Alliance, Computational and Systems Biology Program. The authors declare that they have no conflicts of interest with the contents of this article.	Aon MA, 2012, WIRES SYST BIOL MED, V4, P599, DOI 10.1002/wsbm.1188; Ayyadurai VAS, 2011, CELL MOL BIOENG, V4, P28, DOI 10.1007/s12195-010-0143-x; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Bell CJ, 2006, J BIOL CHEM, V281, P28058, DOI 10.1074/jbc.M604540200; Bell RM, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0558-1; Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Cloutier M, 2009, J COMPUT NEUROSCI, V27, P391, DOI 10.1007/s10827-009-0152-8; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; DAS AM, 1990, CARDIOVASC RES, V24, P411, DOI 10.1093/cvr/24.5.411; DENTON RM, 1966, BIOCHEM J, V100, P407, DOI 10.1042/bj1000407; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Di Lisa F, 2011, ANTIOXID REDOX SIGN, V14, P881, DOI 10.1089/ars.2010.3375; Endeward V, 2012, J APPL PHYSIOL, V112, P1466, DOI 10.1152/japplphysiol.00835.2011; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718; Fillmore N, 2014, IUBMB LIFE, V66, P139, DOI 10.1002/iub.1253; Finney A, 2003, BIOCHEM SOC T, V31, P1472; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Fridovich I., 1982, SUPEROXIDE DISMUTASE, P79; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gauthier LD, 2013, BIOPHYS J, V105, P2832, DOI 10.1016/j.bpj.2013.11.007; Gauthier LD, 2013, BIOPHYS J, V105, P1045, DOI 10.1016/j.bpj.2013.07.006; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; HEARSE DJ, 1981, AM J CARDIOL, V47, P1321, DOI 10.1016/0002-9149(81)90266-6; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; JONES DP, 1978, J BIOL CHEM, V253, P4874; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Karlstadt A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-114; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Korzeniewski B, 2005, BIOPHYS CHEM, V116, P145, DOI 10.1016/j.bpc.2005.04.001; LAGADICGOSSMANN D, 1992, J PHYSIOL-LONDON, V458, P361, DOI 10.1113/jphysiol.1992.sp019422; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Moxley MA, 2016, J BIOL CHEM, V291, P2712, DOI 10.1074/jbc.M115.676619; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Orlowski P, 2011, INTERFACE FOCUS, V1, P408, DOI 10.1098/rsfs.2010.0025; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; RUMSEY WL, 1994, AM J PHYSIOL, V266, pH1676, DOI 10.1152/ajpheart.1994.266.4.H1676; Schriewer JM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000159; Schulz R, 2016, CARDIOVASC RES, V110, P4, DOI 10.1093/cvr/cvw041; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Seiler C, 2013, EUR HEART J, V34, P2674, DOI 10.1093/eurheartj/eht195; Smith AC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-102; Suzuki K, 2002, CIRCULATION, V106, pI270, DOI 10.1161/01.cir.0000032880.55215.92; Tepp K, 2010, ACTA BIOCHIM POL, V57, P421; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296; WONG LJ, 1976, J BIOL CHEM, V251, P5431; World Health Organization, 2014, WORLD HLTH STAT 2014; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497; Yaniv Y, 2008, ANN NY ACAD SCI, V1123, P69, DOI 10.1196/annals.1420.009; Yaniv Y, 2010, ANN NY ACAD SCI, V1188, P133, DOI 10.1111/j.1749-6632.2009.05093.x; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang P, 2015, CELL PHYSIOL BIOCHEM, V36, P2072, DOI 10.1159/000430174; Zhou LF, 2005, AM J PHYSIOL-HEART C, V288, pH2400, DOI 10.1152/ajpheart.01030.2004	66	16	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11760	11776		10.1074/jbc.M116.751826	http://dx.doi.org/10.1074/jbc.M116.751826			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28487363	hybrid, Green Published			2022-12-28	WOS:000405485600015
J	Robinson, LS; Lewis, WG; Lewis, AL				Robinson, Lloyd S.; Lewis, Warren G.; Lewis, Amanda L.			The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; COLONIC EPITHELIAL GLYCOPROTEINS; BIFIDOBACTERIUM-BIFIDUM PRL2010; INFLAMMATORY-BOWEL-DISEASE; COMPLETE GENOME SEQUENCE; DE-ORTHO-ACETYLATION; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; MICROBIAL DYSBIOSIS; INTESTINAL MUCINS	The gut harbors many symbiotic, commensal, and pathogenic microbes that break down and metabolize host carbohydrates. Sialic acids are prominent outermost carbohydrates on host glycoproteins called mucins and protect underlying glycan chains from enzymatic degradation. Sialidases produced by some members of the colonic microbiota can promote the expansion of several potential pathogens (e.g. Clostridium difficile, Salmonella, and Escherichia coli) that do not produce sialidases. O-Acetyl ester modifications of sialic acids help resist the action of many sialidases and are present at high levels in the mammalian colon. However, some gut bacteria, in turn, produce sialylate-O-acetylesterases to remove them. Here, we investigated O-acetyl ester removal and sialic acid degradation by Bacteroidetes sialate-O-acetylesterases and sialidases, respectively, and subsequent utilization of host sialic acids by both commensal and pathogenic E. coli strains. In vitro foraging studies demonstrated that sialidase-dependent E. coli growth on mucin is enabled by Bacteroides EstA, a sialate O-acetylesterase acting on glycosidically linked sialylate-O-acetylesterase substrates, particularly at neutral pH. Biochemical studies suggested that spontaneous migration of O-acetyl esters on the sialic acid side chain, which can occur at colonic pH, may serve as a switch controlling EstA-assisted sialic acid liberation. Specifically, EstA did not act on O-acetyl esters in their initial 7-position. However, following migration to the 9-position, glycans with O-acetyl esters became susceptible to the sequential actions of bacterial esterases and sialidases. We conclude that EstA specifically unlocks the nutritive potential of 9-O-acetylated mucus sialic acids for foraging by bacteria that otherwise are prevented from accessing this carbon source.	[Robinson, Lloyd S.; Lewis, Amanda L.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lewis, Warren G.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lewis, WG (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	WarrenGLewisPhD@gmail.com; allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Lewis, Amanda/0000-0001-6195-3030	Burroughs-Wellcome Fund Preterm Birth Initiative; NIAID, National Institutes of Health Grant [R01 AI114635]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114635] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund Preterm Birth Initiative; NIAID, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Burroughs-Wellcome Fund Preterm Birth Initiative (to A. L. L.) and the NIAID, National Institutes of Health Grant R01 AI114635 (to W. G. L. and A. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2008, HISTOL HISTOPATHOL, V23, P862, DOI 10.14670/HH-23.863; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; BARTON NW, 1973, J BIOL CHEM, V248, P7353; BAYLISS CE, 1982, MICRON, V13, P35, DOI 10.1016/0047-7206(82)90136-4; BITTERMAN W, 1969, DIS COLON RECTUM, V12, P96, DOI 10.1007/BF02629003; Comway T., 2015, METABOLISM BACTERIAL, P343; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; CORFIELD AP, 1988, CLIN SCI, V74, P71, DOI 10.1042/cs0740071; CROUCHER SC, 1983, APPL ENVIRON MICROB, V45, P1025, DOI 10.1128/AEM.45.3.1025-1033.1983; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; DIAZ S, 1989, J BIOL CHEM, V264, P19416; DRZENIEK R, 1973, HISTOCHEM J, V5, P271, DOI 10.1007/BF01004994; Egan M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu056; Egan M, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0282-7; Egan M, 2014, APPL ENVIRON MICROB, V80, P4414, DOI 10.1128/AEM.01114-14; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; FAILLARD H, 1959, H-S Z PHYSIOL CHEM, V317, P257, DOI 10.1515/bchm2.1959.317.1.257; Faillard H., 1972, BIOCH ACTA LIBS B, V5B, P1246; FRASER AG, 1981, J MED MICROBIOL, V14, P63, DOI 10.1099/00222615-14-1-63; HIGA HH, 1989, J BIOL CHEM, V264, P19435; HOSKINS LC, 1968, GASTROENTEROLOGY, V54, P210; HOSKINS LC, 1981, DIGEST DIS SCI, V26, P769, DOI 10.1007/BF01309606; HOSKINS LC, 1963, GASTROENTEROLOGY, V44, P456; Huang YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9141; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Juge N, 2016, BIOCHEM SOC T, V44, P166, DOI 10.1042/BST20150226; KAMERLING JP, 1987, EUR J BIOCHEM, V162, P601, DOI 10.1111/j.1432-1033.1987.tb10681.x; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Lewis A. L., 2009, BIOINFORMATICS GLYCO, P69; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Meyn LA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.011; Milani C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15782; Munyaka PM, 2016, J BASIC MICROB, V56, P986, DOI 10.1002/jobm.201500726; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; NEUBERGER A, 1972, BIOCHEM J, V129, P683, DOI 10.1042/bj1290683; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Park KH, 2013, BBA-PROTEINS PROTEOM, V1834, P1510, DOI 10.1016/j.bbapap.2013.04.028; Peris-Bondia F., 2013, GENOME ANNOUNC, V1; Phansopa C, 2015, BIOCHEM J, V472, P157, DOI 10.1042/BJ20150388; POON H, 1983, CAN J BIOCHEM CELL B, V61, P868, DOI 10.1139/o83-111; Press AG, 1998, ALIMENT PHARM THER, V12, P673; Pudlo NA, 2015, MBIO, V6, DOI 10.1128/mBio.01282-15; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; REID PE, 1975, CAN J BIOCHEM CELL B, V53, P388, DOI 10.1139/o75-053; REID PE, 1975, CAN J BIOCHEM CELL B, V53, P1328, DOI 10.1139/o75-180; Reister M, 2014, J BIOTECHNOL, V187, P106, DOI 10.1016/j.jbiotec.2014.07.442; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rogier EW, 2014, PATHOGENS, V3, P390, DOI 10.3390/pathogens3020390; SCHAUER R, 1968, H-S Z PHYSIOL CHEM, V349, P961, DOI 10.1515/bchm2.1968.349.2.961; Schulz EC, 2010, J MOL BIOL, V397, P341, DOI 10.1016/j.jmb.2010.01.028; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Steenbergen SM, 2006, J BACTERIOL, V188, P6195, DOI 10.1128/JB.00466-06; Steenbergen SM, 2009, J BACTERIOL, V191, P7134, DOI 10.1128/JB.01000-09; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065; Zitomersky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063686	77	41	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11861	11872		10.1074/jbc.M116.769232	http://dx.doi.org/10.1074/jbc.M116.769232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28526748	Green Published, hybrid			2022-12-28	WOS:000405485600023
J	Sanders, MA; Haynes, B; Nangia-Makker, P; Polin, LA; Shekhar, MP				Sanders, Matthew A.; Haynes, Brittany; Nangia-Makker, Pratima; Polin, Lisa A.; Shekhar, Malathy P.			Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; colon cancer; DNA damage response; small molecule; ubiquitin; platinum therapy; replication fork arrest; tumor growth inhibition; ubiquitin conjugation	FANCONI ANEMIA/BRCA PATHWAY; DNA-POLYMERASE-ETA; 2 HUMAN HOMOLOGS; DAMAGE BYPASS; CELL-CYCLE; Y-FAMILY; REPAIR; REPLICATION; CANCER; UBIQUITIN	Platinum drug-induced cross-link repair requires the concerted activities of translesion synthesis (TLS), Fanconi anemia (FA), and homologous recombination repair pathways. The E2 ubiquitin-conjugating enzyme RAD6 is essential for TLS. Here, we show that RAD6 plays a universal role in platinum-based drug tolerance. Using a novel RAD6-selective small-molecule inhibitor (SMI#9) targeting the RAD6 catalytic site, we demonstrate that SMI#9 potentiates the sensitivities of cancer cells with innate or acquired cisplatin or oxaliplatin resistance. 5-Iododeoxyuridine/5-chlorodeoxyuridine pulse-labeling experiments showed that RAD6 is necessary for overcoming cisplatin-induced replication fork stalling, as replication-restart was impaired in both SMI#9-pretreated and RAD6B-silenced cells. Consistent with the role of RAD6/TLS in late-S phase, SMI#9-induced DNA replication inhibition occurred preferentially in mid/late-S phase. The compromised DNA repair and chemosensitization induced by SMI#9 or RAD6B depletion were associated with decreased platinum drug-induced proliferating cell nuclear antigen (PCNA) and FANCD2 monoubiquitinations (surrogate markers of TLS and FA pathway activation, respectively) and with attenuated FANCD2, RAD6, H2AX, and POL foci formation and cisplatin-adduct removal. SMI#9 pretreatment synergistically increased cisplatin inhibition of MDA-MB-231 triple-negative breast cancer cell proliferation and tumor growth. Using an isogenic HCT116 colon cancer model of oxaliplatin resistance, we further show that H2AX and monoubiquitinated PCNA and FANCD2 are constitutively up-regulated in oxaliplatin-resistant HCT116 (HCT116-OxR) cells and that H2AX, PCNA, and FANCD2 monoubiquitinations are induced by oxaliplatin in parental HCT116 cells. SMI#9 pretreatment sensitized HCT116-OxR cells to oxaliplatin. These data deepen insights into the vital role of RAD6/TLS in platinum drug tolerance and reveal clinical benefits of targeting RAD6 with SMI#9 for managing chemoresistant cancers.	[Sanders, Matthew A.; Haynes, Brittany; Nangia-Makker, Pratima; Polin, Lisa A.; Shekhar, Malathy P.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Sanders, Matthew A.; Haynes, Brittany; Polin, Lisa A.; Shekhar, Malathy P.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Nangia-Makker, Pratima; Shekhar, Malathy P.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Shekhar, MP (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Oncol, 421 E Canfield Ave, Detroit, MI 48201 USA.	shekharm@karmanos.org		Shekhar, Malathy/0000-0003-2721-7202	National Institutes of Health from the NCI [R21CA178117]; Molecular Therapeutics Program of Karmanos Cancer Institute; Initiative for Maximizing Student Diversity Award from the National Institutes of Health [R25GM058905]; Ruth L. Kirschstein NRSA from the National Institutes of Health [T32-CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531, R21CA178117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058905] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Therapeutics Program of Karmanos Cancer Institute; Initiative for Maximizing Student Diversity Award from the National Institutes of Health; Ruth L. Kirschstein NRSA from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R21CA178117 from the NCI (to M. P. S.) and a grant from the Molecular Therapeutics Program of Karmanos Cancer Institute (to M. P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Initiative for Maximizing Student Diversity Award R25GM058905 and Ruth L. Kirschstein NRSA T32-CA009531 from the National Institutes of Health.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arora S, 2010, DNA REPAIR, V9, P745, DOI 10.1016/j.dnarep.2010.03.010; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Fu DC, 2013, CELL CYCLE, V12, P803, DOI 10.4161/cc.23755; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Haynes B, 2015, MUTAT RES-REV MUTAT, V763, P258, DOI 10.1016/j.mrrev.2014.11.005; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hung SH, 2017, P NATL ACAD SCI USA, V114, pE2205, DOI 10.1073/pnas.1612633114; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; KOKEN MHM, 1992, GENOMICS, V12, P447, DOI 10.1016/0888-7543(92)90433-S; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Liu M, 2013, ONCOL LETT, V5, P983, DOI 10.3892/ol.2012.1093; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Lyakhovich A, 2003, MOL CELL BIOL, V23, P2463, DOI 10.1128/MCB.23.7.2463-2475.2003; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Parker JL, 2009, EMBO J, V28, P3657, DOI 10.1038/emboj.2009.303; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Salehan MR, 2013, BRIT J BIOMED SCI, V70, P31, DOI 10.1080/09674845.2013.11669927; Sanders MA, 2013, MOL CANCER THER, V12, P373, DOI 10.1158/1535-7163.MCT-12-0793; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2002, CANCER RES, V62, P2115; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tian F, 2013, P NATL ACAD SCI USA, V110, P13558, DOI 10.1073/pnas.1306534110; Tuduri S, 2010, CHROMOSOME RES, V18, P91, DOI 10.1007/s10577-009-9098-y; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Wang HX, 2014, ADV MECH ENG, DOI 10.1155/2014/971756; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Yokochi T, 2007, CURR PROTOC CELL BIO, P10; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156	58	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10347	10363		10.1074/jbc.M117.792192	http://dx.doi.org/10.1074/jbc.M117.792192			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28490629	hybrid, Green Published			2022-12-28	WOS:000404115400003
J	Borlepawar, A; Rangrez, AY; Bernt, A; Christen, L; Sossalla, S; Frank, D; Frey, N				Borlepawar, Ankush; Rangrez, Ashraf Yusuf; Bernt, Alexander; Christen, Lynn; Sossalla, Samuel; Frank, Derk; Frey, Norbert			TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; SCHIZOPHRENIA-RELATED PROTEIN; SERUM RESPONSE FACTOR; MUSCLE RING FINGER-1; CARDIAC-HYPERTROPHY; IN-VIVO; NUCLEAR RECEPTORS; TRIPARTITE MOTIF; COACTIVATOR HTIF1; FAMILY PROTEINS	We have previously shown that dysbindin is a potent inducer of cardiomyocyte hypertrophy via activation of Rho-dependent serum-response factor (SRF) signaling. We have now performed a yeast two-hybrid screen using dysbindin as bait against a cardiac cDNA library to identify the cardiac dysbindin interactome. Among several putative binding proteins, we identified tripartite motif-containing protein 24 (TRIM24) and confirmed this interaction by co-immunoprecipitation and co-immunostaining. Another tripartite motif (TRIM) family protein, TRIM32, has been reported earlier as an E3 ubiquitin ligase for dysbindin in skeletal muscle. Consistently, we found that TRIM32 also degraded dysbindin in neonatal rat ventricular cardiomyocytes as well. Surprisingly, however, TRIM24 did not promote dysbindin decay but rather protected dysbindin against degradation by TRIM32. Correspondingly, TRIM32 attenuated the activation of SRF signaling and hypertrophy due to dysbindin, whereas TRIM24 promoted these effects in neonatal rat ventricular cardiomyocytes. This study also implies that TRIM32 is a key regulator of cell viability and apoptosis in cardiomyocytes via simultaneous activation of p53 and caspase-3/-7 and inhibition of X-linked inhibitor of apoptosis. In conclusion, we provide here a novel mechanism of post-translational regulation of dysbindin and hypertrophy via TRIM24 and TRIM32 and show the importance of TRIM32 in cardiomyocyte apoptosis in vitro.	[Borlepawar, Ankush; Rangrez, Ashraf Yusuf; Bernt, Alexander; Christen, Lynn; Sossalla, Samuel; Frank, Derk; Frey, Norbert] Univ Med Ctr Kiel, Dept Internal Med Cardiol Angiol Intens Care 3, D-24105 Kiel, Germany; [Borlepawar, Ankush; Rangrez, Ashraf Yusuf; Bernt, Alexander; Sossalla, Samuel; Frank, Derk; Frey, Norbert] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research	Rangrez, AY; Frey, N (corresponding author), Univ Med Ctr Kiel, Dept Internal Med 3, D-24105 Kiel, Germany.	ashraf.rangrez@uk-sh.de; norbert.frey@uk-sh.de	Frey, Norbert/A-9695-2010; Rangrez, Ashraf/H-4988-2016; Sossalla, Samuel/AAF-3611-2020; Frey, Norbert/M-7749-2019	Rangrez, Ashraf/0000-0003-2630-9754; Frey, Norbert/0000-0001-7611-378X; Sossalla, Samuel/0000-0001-8034-2673; Borlepawar, Ankush/0000-0001-8858-1388	German Research Foundation (DFG) [RA2717/2-1]; Federal Ministry of Education and Research (BMBF) [SYMBOL-HF]; DZHK (German Centre for Cardiovascular Research); Deutsche Forschungsgemeinschaft [FR1289/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DZHK (German Centre for Cardiovascular Research); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by German Research Foundation (DFG) Grant RA2717/2-1 (to A. Y. R. and N. F.) and Federal Ministry of Education and Research (BMBF) e:Med Grant SYMBOL-HF (to D. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the DZHK (German Centre for Cardiovascular Research).; Supported by Deutsche Forschungsgemeinschaft Grant FR1289/5-1.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Chen LJ, 2016, CLIN SCI, V130, P813, DOI 10.1042/CS20150619; Chen SN, 2012, CIRC RES, V111, P907, DOI 10.1161/CIRCRESAHA.112.270207; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Cohen S, 2014, J CELL BIOL, V204, P747, DOI 10.1083/jcb.201304167; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fei EK, 2010, J BIOL CHEM, V285, P38630, DOI 10.1074/jbc.M110.107912; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Fielitz J, 2007, P NATL ACAD SCI USA, V104, P4377, DOI 10.1073/pnas.0611726104; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Frank D, 2014, J MOL CELL CARDIOL, V72, P196, DOI 10.1016/j.yjmcc.2014.03.016; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132639; Ghiani CA, 2011, ASN NEURO, V3, DOI 10.1042/AN20110010; Groner AC, 2016, CANCER CELL, V29, P846, DOI 10.1016/j.ccell.2016.04.012; Hattangadi DK, 2004, BIOCHEM PHARMACOL, V68, P1699, DOI 10.1016/j.bcp.2004.06.033; Hillje AL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.487; Hornle M, 2011, ONCOGENE, V30, P575, DOI 10.1038/onc.2010.434; Jain AK, 2014, MOL CELL BIOL, V34, P2695, DOI 10.1128/MCB.01705-12; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jiang SM, 2015, J HEPATOL, V62, P371, DOI 10.1016/j.jhep.2014.09.026; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; LeDouarin B, 1997, BIOCHEM SOC T, V25, P605, DOI 10.1042/bst0250605; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Liu J, 2014, CELL DEATH DIFFER, V21, P1792, DOI 10.1038/cdd.2014.121; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miao ZF, 2015, VIRCHOWS ARCH, V466, P525, DOI 10.1007/s00428-015-1737-4; Mokhonova EI, 2015, HUM MOL GENET, V24, P2873, DOI 10.1093/hmg/ddv049; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Nicklas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030445; Nihonmatsu-Kikuchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015886; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Owen MJ, 2004, J CLIN INVEST, V113, P1255, DOI 10.1172/JCI200421470; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Rangrez AY, 2016, J BIOL CHEM, V291, P4128, DOI 10.1074/jbc.M115.689620; Rangrez AY, 2013, J CELL BIOL, V203, P643, DOI 10.1083/jcb.201303052; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Schlossarek S, 2014, J MOL CELL CARDIOL, V71, P25, DOI 10.1016/j.yjmcc.2013.12.016; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Seeger TS, 2010, CIRC RES, V106, P880, DOI 10.1161/CIRCRESAHA.109.213256; Shieh Perry B, 2011, Handb Clin Neurol, V101, P125, DOI 10.1016/B978-0-08-045031-5.00009-8; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Su M, 2014, INT J MOL SCI, V15, P9302, DOI 10.3390/ijms15069302; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wang H, 2014, J BIOL CHEM, V289, P29060, DOI 10.1074/jbc.M114.590927; Wang JW, 2014, ONCOL RES, V22, P39, DOI 10.3727/096504014X14078436005012; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928; Xue DW, 2015, TUMOR BIOL, V36, P6849, DOI 10.1007/s13277-015-3393-3	64	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10180	10196		10.1074/jbc.M116.752543	http://dx.doi.org/10.1074/jbc.M116.752543			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28465353	Green Published, hybrid			2022-12-28	WOS:000403580600028
J	Rathore, U; Saha, P; Kesavardhana, S; Kumar, AA; Datta, R; Devanarayanan, S; Das, R; Mascola, JR; Varadarajan, R				Rathore, Ujjwal; Saha, Piyali; Kesavardhana, Sannula; Kumar, Aditya Arun; Datta, Rohini; Devanarayanan, Sivasankar; Das, Raksha; Mascola, John R.; Varadarajan, Raghavan			Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; B-CELL RESPONSES; STRUCTURAL BASIS; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODY; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE	The gp120 subunit of the HIV-1 envelope (Env) protein is heavily glycosylated at similar to 25 glycosylation sites, of which similar to 7-8 are located in the V1/V2 and V3 variable loops and the others in the remaining core gp120 region. Glycans partially shield Env from recognition by the host immune system and also are believed to be indispensable for proper folding of gp120 and for viral infectivity. Previous attempts to alter glycosylation sites in Env typically involved mutating the glycosylated asparagine residues to structurally similar glutamines or alanines. Here, we confirmed that such mutations at multiple glycosylation sites greatly diminish viral infectivity and result in significantly reduced binding to both neutralizing and non-neutralizing antibodies. Therefore, using an alternative approach, we combined evolutionary information with structure-guided design and yeast surface display to produce properly cleaved HIV-1 Env variants that lack all 15 core gp120 glycans, yet retain conformational integrity and multiple-cycle viral infectivity and bind to several broadly neutralizing antibodies (bNAbs), including trimer-specific antibodies and a germline-reverted version of the bNAb VRC01. Our observations demonstrate that core gp120 glycans are not essential for folding, and hence their likely primary role is enabling immune evasion. We also show that our glycan removal approach is not strain restricted. Glycan-deficient Env derivatives can be used as priming immunogens because they should engage and activate a more divergent set of germlines than fully glycosylated Env. In conclusion, these results clarify the role of core gp120 glycosylation and illustrate a general method for designing glycan-free folded protein derivatives.	[Rathore, Ujjwal; Saha, Piyali; Kesavardhana, Sannula; Kumar, Aditya Arun; Datta, Rohini; Devanarayanan, Sivasankar; Das, Raksha; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20814 USA; [Varadarajan, Raghavan] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.; Varadarajan, R (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India.	varadar@mbu.iisc.ernet.in	Mascola, John/AAI-7193-2021; Datta, Rohini/ABB-7867-2020; Rathore, Ujjwal/AAD-9974-2021	Rathore, Ujjwal/0000-0002-0329-7431; Datta, Rohini/0000-0003-2693-1922	National Institutes of Health from NIAID [R01A1118366-01]; Department of Biotechnology and Department of Science and Technology, Government of India [BT/PR4791/MED/29/465/2012]; Council of Scientific and Industrial Research, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118366] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Biotechnology and Department of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01A1118366-01 from NIAID and Department of Biotechnology and Department of Science and Technology, Government of India, Grant BT/PR4791/MED/29/465/2012. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipients of a fellowship from the Council of Scientific and Industrial Research, Government of India.	Arakawa T, 2010, J PHARM SCI-US, V99, P1674, DOI 10.1002/jps.21974; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bolmstedt A, 1996, J ACQ IMMUN DEF SYND, V12, P213, DOI 10.1097/00042560-199607000-00001; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cole KS, 2004, J VIROL, V78, P1525, DOI 10.1128/JVI.78.3.1525-1539.2004; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freund NT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005238; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Ghimire D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43711; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang X, 2012, VIROLOGY, V423, P97, DOI 10.1016/j.virol.2011.11.023; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kesavardhana S, 2014, J VIROL, V88, P9590, DOI 10.1128/JVI.00494-14; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuiken C, 2010, HIV SEQUENCE COMPEND; Kulp DW, 2013, CURR OPIN VIROL, V3, P322, DOI 10.1016/j.coviro.2013.05.010; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; LEE WR, 1992, P NATL ACAD SCI USA, V89, P2213, DOI 10.1073/pnas.89.6.2213; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore Michael D., 2009, V485, P87, DOI 10.1007/978-1-59745-170-3_7; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2013, NATURE, V496, P441, DOI 10.1038/nature12091; Murad W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S12; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Ohgimoto S, 1998, J VIROL, V72, P8365, DOI 10.1128/JVI.72.10.8365-8370.1998; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Ping LH, 2013, J VIROL, V87, P7218, DOI 10.1128/JVI.03577-12; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Rathore U, 2014, BBA-PROTEINS PROTEOM, V1844, P1891, DOI 10.1016/j.bbapap.2014.05.010; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sagt CMJ, 2000, APPL ENVIRON MICROB, V66, P4940, DOI 10.1128/AEM.66.11.4940-4944.2000; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schiffner T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-72; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shcherbakov DN, 2015, ACTA NATURAE, V7, P11, DOI 10.32607/20758251-2015-7-4-11-21; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Si ZH, 2001, J VIROL, V75, P4208, DOI 10.1128/JVI.75.9.4208-4218.2001; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Stansell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124784; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Timilsina U, 2016, SCI REP-UK, V6, DOI 10.1038/srep27403; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van den Kerkhof TLGM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-102; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wibmer CK, 2016, J VIROL, V90, P10220, DOI 10.1128/JVI.01357-16; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Wu SJ, 2010, PROTEIN ENG DES SEL, V23, P643, DOI 10.1093/protein/gzq037; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; WU Z, 1995, J VIROL, V69, P2271, DOI 10.1128/JVI.69.4.2271-2278.1995; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	143	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10197	10219		10.1074/jbc.M117.788919	http://dx.doi.org/10.1074/jbc.M117.788919			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446609	Green Published, hybrid			2022-12-28	WOS:000403580600029
J	Kishore, A; Hall, RA				Kishore, Ayush; Hall, Randy A.			Disease-associated extracellular loop mutations in the adhesion G protein-coupled receptor G1 (ADGRG1; GPR56) differentially regulate downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILATERAL FRONTOPARIETAL POLYMICROGYRIA; CELL-ADHESION; TETHERED AGONIST; GPCR; ANGIOGENESIS; MIGRATION; BRAIN; GPR56/ADGRG1; TRAFFICKING; EXPRESSION	Mutations to the adhesion G protein-coupled receptor ADGRG1 (G1; also known as GPR56) underlie the neurological disorder bilateral frontoparietal polymicrogyria. Disease-associated mutations in G1 studied to date are believed to induce complete loss of receptor function through disruption of either receptor trafficking or signaling activity. Given that N-terminal truncation of G1 and other adhesion G protein-coupled receptors has been shown to significantly increase the receptors' constitutive signaling, we examined two different bilateral frontoparietal polymicrogyria-inducing extracellular loop mutations (R565W and L640R) in the context of both full-length and N-terminally truncated (Delta NT) G1. Interestingly, we found that these mutations reduced surface expression of full-length G1 but not G1-Delta NT in HEK-293 cells. Moreover, the mutations ablated receptor-mediated activation of serum response factor luciferase, a classic measure of G alpha(12/13)-mediated signaling, but had no effect on G1-mediated signaling to nuclear factor of activated T cells (NFAT) luciferase. Given these differential signaling results, we sought to further elucidate the pathway by which G1 can activate NFAT luciferase. We found no evidence that Delta NT activation of NFAT is dependent on G alpha(q/11)-mediated or beta-arrestin-mediated signaling but rather involves liberation of G beta gamma subunits and activation of calcium channels. These findings reveal that disease-associated mutations to the extracellular loops of G1 differentially alter receptor trafficking, depending on the presence of the N terminus, and differentially alter signaling to distinct downstream pathways.	[Kishore, Ayush; Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA	Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	rhall3@emory.edu		Hall, Randy/0000-0002-8318-8728	National Institutes of Health [R01-NS72394]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01-NS72394 (to R. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Chang GW, 2016, CELL REP, V15, P1757, DOI 10.1016/j.celrep.2016.04.053; Chiang NY, 2017, J INVEST DERMATOL, V137, P727, DOI 10.1016/j.jid.2016.10.031; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Duner P, 2016, J CLIN ENDOCR METAB, V101, P4637, DOI 10.1210/jc.2016-1884; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Giera S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7121; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hu QX, 2014, J BIOL CHEM, V289, P24215, DOI 10.1074/jbc.M114.549816; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jeong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068781; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Kishore A, 2016, HANDB EXP PHARMACOL, V234, P127, DOI 10.1007/978-3-319-41523-9_7; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liebscher I, 2014, ANN NY ACAD SCI, V1333, P43, DOI 10.1111/nyas.12580; Luo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100043; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Peng YM, 2011, J LEUKOCYTE BIOL, V90, P735, DOI 10.1189/jlb.0211092; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2013, TRENDS PHARMACOL SCI, V34, P470, DOI 10.1016/j.tips.2013.06.002; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Saito Y, 2013, LEUKEMIA, V27, P1637, DOI 10.1038/leu.2013.75; Santos-Silva R, 2015, NEUROPEDIATRICS, V46, P134, DOI 10.1055/s-0034-1399754; Scholz N, 2015, CELL REP, V11, P866, DOI 10.1016/j.celrep.2015.04.008; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; White JP, 2014, P NATL ACAD SCI USA, V111, P15756, DOI 10.1073/pnas.1417898111; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220; Wu MP, 2013, FEBS J, V280, P6097, DOI 10.1111/febs.12529; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543	48	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9711	9720		10.1074/jbc.M117.780551	http://dx.doi.org/10.1074/jbc.M117.780551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28424266	hybrid, Green Published			2022-12-28	WOS:000403113000021
J	Li, Z; Shanmuganathan, A; Ruetz, M; Yamada, K; Lesniak, NA; Krautler, B; Brunold, TC; Koutmos, M; Banerjee, R				Li, Zhu; Shanmuganathan, Aranganathan; Ruetz, Markus; Yamada, Kazuhiro; Lesniak, Nicholas A.; Kraeutler, Bernhard; Brunold, Thomas C.; Koutmos, Markos; Banerjee, Ruma			Coordination chemistry controls the thiol oxidase activity of the B-12-trafficking protein CblC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METHIONINE SYNTHASE; ZETA VALENCE QUALITY; GAUSSIAN-BASIS SETS; KOHN-SHAM THEORY; B-12 TRAFFICKING; CORRELATION-ENERGY; ATOMS LI; COBALAMIN; DENSITY; ADENOSYLCOBALAMIN	The cobalamin or B-12 cofactor supports sulfur and one-carbon metabolism and the catabolism of odd-chain fatty acids, branched-chain amino acids, and cholesterol. CblC is a B(12-)processing enzyme involved in an early cytoplasmic step in the cofactor-trafficking pathway. It catalyzes the glutathione (GSH)-dependent dealkylation of alkylcobalamins and the reductive decyanation of cyanocobalamin. CblC from Caenorhabditis elegans (ceCblC) also exhibits a robust thiol oxidase activity, converting reduced GSH to oxidized GSSG with concomitant scrubbing of ambient dissolved O-2. The mechanism of thiol oxidation catalyzed by ceCblC is not known. In this study, we demonstrate that novel coordination chemistry accessible to ceCblC-bound cobalamin supports its thiol oxidase activity via a glutathionyl-cobalamin intermediate. Deglutathionylation of glutathionyl-cobalamin by a second molecule of GSH yields GSSG. The crystal structure of ceCblC provides insights into how architectural differences at the alpha-and beta-faces of cobalamin promote the thiol oxidase activity of ceCblC but mute it in wild-type human CblC. The R161G and R161Q mutations in human CblC unmask its latent thiol oxidase activity and are correlated with increased cellular oxidative stress disease. In summary, we have uncovered key architectural features in the cobalamin-binding pocket that support unusual cob(II)alamin coordination chemistry and enable the thiol oxidase activity of ceCblC.	[Li, Zhu; Ruetz, Markus; Lesniak, Nicholas A.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Shanmuganathan, Aranganathan; Yamada, Kazuhiro; Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Kraeutler, Bernhard] Univ Innsbruck, Inst Organ Chem, Innrain 80-82, A-6020 Innsbruck, Austria; [Kraeutler, Bernhard] Univ Innsbruck, Ctr Mol Biosci, Innrain 80-82, A-6020 Innsbruck, Austria; [Brunold, Thomas C.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA; University of Innsbruck; University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Li, Zhu/0000-0003-1536-9401; Koutmos, Markos/0000-0003-0933-6312	NCI, National Institutes of Health (NIH) [ACB-12002]; NIGMS, NIH [AGM-12006]; Argonne National Laboratory [AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GM/CA at the Advanced Photon Source is funded by NCI, National Institutes of Health (NIH), Grant ACB-12002 and NIGMS, NIH, Grant AGM-12006. This research utilized resources at the Advanced Photon Source, operated for the United States Department of Energy Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRASCA V, 1988, BIOCHEMISTRY-US, V27, P8458, DOI 10.1021/bi00422a025; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Gherasim C, 2015, J BIOL CHEM, V290, P11393, DOI 10.1074/jbc.M115.637132; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; HOFFMAN MZ, 1973, J PHYS CHEM-US, V77, P990, DOI 10.1021/j100627a005; ISHIDA A, 1993, J NUTR SCI VITAMINOL, V39, P115, DOI 10.3177/jnsv.39.115; JACOBSEN DW, 1984, BIOCHEMISTRY-US, V23, P2017, DOI 10.1021/bi00304a021; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; KRAUTLER B, 1989, J AM CHEM SOC, V111, P8936; KRAUTLER B, 1987, HELV CHIM ACTA, V70, P1268, DOI 10.1002/hlca.19870700506; KUTZELNIGG W, 1990, IGLO METHOD AB INITI, V23; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; LEXA D, 1976, J AM CHEM SOC, V98, P2652, DOI 10.1021/ja00425a039; Li Z, 2014, J AM CHEM SOC, V136, P16108, DOI 10.1021/ja5077316; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neese F, 2002, INORG CHIM ACTA, V337, P181, DOI 10.1016/S0020-1693(02)01031-9; Neese F, 2003, J CHEM PHYS, V118, P3939, DOI 10.1063/1.1540619; Neese F, 2001, J CHEM PHYS, V115, P11080, DOI 10.1063/1.1419058; Neese F., 2014, ORCA AB INITIO DENSI; Nilges MJ., 1979, THESIS, P1; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; PILBROW JR, 1982, B12, P431; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Suarez-Moreira E, 2006, DALTON T, P5269, DOI 10.1039/b610158e; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Zheng DH, 1997, J ELECTROANAL CHEM, V429, P61, DOI 10.1016/S0022-0728(96)05021-8	55	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9733	9744		10.1074/jbc.M117.788554	http://dx.doi.org/10.1074/jbc.M117.788554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28442570	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000403113000023
J	Saint-Pol, J; Billard, M; Dornier, E; Eschenbrenner, E; Danglot, L; Boucheix, C; Charrin, S; Rubinstein, E				Saint-Pol, Julien; Billard, Martine; Dornier, Emmanuel; Eschenbrenner, Etienne; Danglot, Lydia; Boucheix, Claude; Charrin, Stephanie; Rubinstein, Eric			New insights into the tetraspanin Tspan5 using novel monoclonal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEASE 10 ADAM10; TRANSMEMBRANE DOMAINS; STRUCTURAL DOMAINS; NOTCH ACTIVATION; ALPHA-SECRETASE; INTEGRIN; CD151; EXPRESSION; PROTEIN; ALPHA-3-BETA-1	Tspan5 is a member of a subgroup of tetraspanins referred to as TspanC8. These tetraspanins directly interact with the metalloprotease ADAM10, regulate its exit from the endoplasmic reticulum and subsequent trafficking, and differentially regulate its ability to cleave various substrates and activate Notch signaling. The study of Tspan5 has been limited by the lack of good antibodies. This study provides new insights into Tspan5 using new monoclonal antibodies (mAbs), including two mAbs recognizing both Tspan5 and the highly similar tetraspanin Tspan17. Using these mAbs, we show that endogenous Tspan5 associates with ADAM10 in human cell lines and in mouse tissues where it is the most abundant, such as the brain, the lung, the kidney, or the intestine. We also uncover two TspanC8-specific motifs in the large extracellular domain of Tspan5 that are important for ADAM10 interaction and exit from the endoplasmic reticulum. One of the anti-Tspan5 mAbs does not recognize Tspan5 associated with ADAM10, providing a convenient way to measure the fraction of Tspan5 not associated with ADAM10. This fraction is minor in the cell lines tested, and it increases upon transfection of cells with TspanC8 tetraspanins such as Tspan15 or Tspan33 that inhibit Notch signaling. Finally, two antibodies inhibit ligand-induced Notch signaling, and this effect is stronger in cells depleted of the TspanC8 tetraspanin Tspan14, further indicating that Tspan5 and Tspan14 can compensate for each other in Notch signaling.	[Saint-Pol, Julien; Billard, Martine; Eschenbrenner, Etienne; Boucheix, Claude; Charrin, Stephanie; Rubinstein, Eric] INSERM, U935, 14 Av Paul Vaillant Couturier, F-94807 Villejuif, France; [Saint-Pol, Julien; Billard, Martine; Dornier, Emmanuel; Eschenbrenner, Etienne; Boucheix, Claude; Charrin, Stephanie; Rubinstein, Eric] Univ Paris Sud, Inst Andre Lwoff, F-94807 Villejuif, France; [Dornier, Emmanuel] INSERM, U1004, F-94807 Villejuif, France; [Danglot, Lydia] Univ Paris Diderot, CNRS, UMR7592, Sorbonne Paris Cite,Inst Jacques Monod, F-75205 Paris, France; [Danglot, Lydia] INSERM, ERL U950, F-75205 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rubinstein, E (corresponding author), INSERM, U935, 14 Av Paul Vaillant Couturier, F-94807 Villejuif, France.	eric.rubinstein@inserm.fr	DANGLOT, Lydia/G-5684-2013; CHARRIN, Stephanie/B-2892-2019; Rubinstein, Eric/B-4650-2019; Dornier, Emmanuel/GWZ-2821-2022	DANGLOT, Lydia/0000-0001-6190-6605; Rubinstein, Eric/0000-0001-7623-9665; Dornier, Emmanuel/0000-0002-3482-8637; Boucheix, Claude/0000-0003-4184-7008; Saint-Pol, Julien/0000-0002-2676-0791; Charrin, Stephanie/0000-0002-4942-3990	INSERM; NRB-Vaincre le Cancer; Institut National du Cancer; Institut du Cancer et d'Immunogenetique	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NRB-Vaincre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); Institut du Cancer et d'Immunogenetique	This work was supported in part by core funding from INSERM and by specific grants from the NRB-Vaincre le Cancer, Institut du Cancer et d'Immunogenetique, and the Institut National du Cancer. The authors declare that they have no conflicts of interest with the contents of this article.	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Baldwin G, 2008, J BIOL CHEM, V283, P35445, DOI 10.1074/jbc.M806394200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Homsi Y, 2014, BIOPHYS J, V107, P100, DOI 10.1016/j.bpj.2014.05.028; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Palmer TD, 2014, CANCER RES, V74, P173, DOI 10.1158/0008-5472.CAN-13-0275; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Serru V, 2000, BBA-PROTEIN STRUCT M, V1478, P159, DOI 10.1016/S0167-4838(00)00022-4; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sterk LMT, 2002, J CELL SCI, V115, P1161; Todd SC, 1998, BBA-GENE STRUCT EXPR, V1399, P101, DOI 10.1016/S0167-4781(98)00087-6; Tu LY, 2006, J CELL SCI, V119, P5077, DOI 10.1242/jcs.03285; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Zimmerman B, 2016, CELL, V167, P1041, DOI 10.1016/j.cell.2016.09.056; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	45	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9551	9566		10.1074/jbc.M116.765669	http://dx.doi.org/10.1074/jbc.M116.765669			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28428248	Green Published, hybrid			2022-12-28	WOS:000403113000009
J	Budelier, MM; Cheng, WWL; Bergdoll, L; Chen, ZW; Janetka, JW; Abramson, J; Krishnan, K; Mydock-McGrane, L; Covey, DF; Whitelegge, JP; Evers, AS				Budelier, Melissa M.; Cheng, Wayland W. L.; Bergdoll, Lucie; Chen, Zi-Wei; Janetka, James W.; Abramson, Jeff; Krishnan, Kathiresan; Mydock-McGrane, Laurel; Covey, Douglas F.; Whitelegge, Julian P.; Evers, Alex S.			Photoaffinity labeling with cholesterol analogues precisely maps a cholesterol-binding site in voltage-dependent anion channel-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; INNER MEMBRANES; PROTEIN; VDAC; LIPIDS; OUTER; CRYSTALLOGRAPHY; PURIFICATION; DETERGENTS	Voltage-dependent anion channel-1 (VDAC1) is a highly regulated beta-barrel membrane protein that mediates transport of ions and metabolites between the mitochondria and cytosol of the cell. VDAC1 co-purifies with cholesterol and is functionally regulated by cholesterol, among other endogenous lipids. Molecular modeling studies based on NMR observations have suggested five cholesterol-binding sites in VDAC1, but direct experimental evidence for these sites is lacking. Here, to determine the sites of cholesterol binding, we photolabeled purified mouse VDAC1 (mVDAC1) with photoactivatable cholesterol analogues and analyzed the photolabeled sites with both top-down mass spectrometry (MS), and bottom-upMSpaired with a clickable, stable isotope-labeled tag, FLI-tag. Using cholesterol analogues with a diazirine in either the 7 position of the steroid ring (LKM38) or the aliphatic tail (KK174), we mapped a binding pocket in mVDAC1 localized to Thr(83) and Glu(73), respectively. When Glu(73) was mutated to a glutamine, KK174 no longer photolabeled this residue, but instead labeled the nearby Tyr(62) within this same binding pocket. The combination of analytical strategies employed in this work permits detailed molecular mapping of a cholesterol-binding site in a protein, including an orientation of the sterol within the site. Our work raises the interesting possibility that cholesterol-mediated regulation of VDAC1 may be facilitated through a specific binding site at the functionally important Glu(73) residue.	[Budelier, Melissa M.; Cheng, Wayland W. L.; Chen, Zi-Wei; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA; [Budelier, Melissa M.; Janetka, James W.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Krishnan, Kathiresan; Mydock-McGrane, Laurel; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Chen, Zi-Wei; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA; [Bergdoll, Lucie; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Abramson, Jeff] Tata Inst Fundamental Res, Inst Stem Cell Biol & Regenerat Med, Nation Ctr Biol Sci, Bangalore 560065, Karnataka, India	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR)	Evers, AS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Campus Box 8054, St Louis, MO 63110 USA.	eversa@wustl.edu	bergdoll, lucie/M-9346-2018; Janetka, James/A-8216-2011	bergdoll, lucie/0000-0001-6068-238X; Evers, Alex/0000-0002-0342-0575; Janetka, James/0000-0002-9888-5411; Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [R01GM108799, R01GM078844, R21AI120490-01, P01GM47969, T32-GM108539, R01HL067773, T32 HL007275]; National Science Foundation [DGE-1143954]; Taylor Family Institute for Innovative Psychiatric Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108799, P01GM047969, R01GM078844, T32GM108539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Taylor Family Institute for Innovative Psychiatric Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM108799, R01GM078844, R21AI120490-01, P01GM47969, T32-GM108539, and R01HL067773, and T32 HL007275, National Science Foundation Grant DGE-1143954, and the Taylor Family Institute for Innovative Psychiatric Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aufschnaiter A, 2017, CELL TISSUE RES, V367, P125, DOI 10.1007/s00441-016-2463-1; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Budelier MM, 2017, ANAL CHEM, V89, P2636, DOI 10.1021/acs.analchem.6b05003; Castellano BM, 2017, SCIENCE, V355, P1306, DOI 10.1126/science.aag1417; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chen ZW, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011445; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Crimi M, 2011, BBA-MOL CELL RES, V1813, P551, DOI 10.1016/j.bbamcr.2010.09.014; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; DEPINTO V, 1989, EUR J BIOCHEM, V183, P179; FREITAG H, 1982, EUR J BIOCHEM, V123, P629; Galdiero S, 2007, CURR PROTEIN PEPT SC, V8, P63, DOI 10.2174/138920307779941541; Guner H, 2014, J AM SOC MASS SPECTR, V25, P464, DOI 10.1007/s13361-013-0789-4; HALLERMAYER G, 1974, H-S Z PHYSIOL CHEM, V355, P279, DOI 10.1515/bchm2.1974.355.1.279; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PARSONS DF, 1967, BIOCHIM BIOPHYS ACTA, V135, P362, DOI 10.1016/0005-2736(67)90132-0; POPP B, 1995, BIOCHEMISTRY-US, V34, P3352, DOI 10.1021/bi00010a026; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Ujwal R, 2012, JOVE-J VIS EXP, DOI 10.3791/3383; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge J, 2006, EXPERT REV PROTEOMIC, V3, P585, DOI 10.1586/14789450.3.6.585; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Xia Y, 2013, CHEM REV, V113, P7880, DOI 10.1021/cr300419p; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	42	40	42	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9294	9304		10.1074/jbc.M116.773069	http://dx.doi.org/10.1074/jbc.M116.773069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28396346	hybrid, Green Published			2022-12-28	WOS:000402538900024
J	Casillas-Ituarte, NN; Cruz, CHB; Lins, RD; DiBartola, AC; Howard, J; Liang, XW; Hook, M; Viana, IFT; Sierra-Hernandez, MR; Lower, SK				Casillas-Ituarte, Nadia N.; Cruz, Carlos H. B.; Lins, Roberto D.; DiBartola, Alex C.; Howard, Jessica; Liang, Xiaowen; Hoeoek, Magnus; Viana, Isabelle F. T.; Sierra-Hernandez, M. Roxana; Lower, Steven K.			Amino acid polymorphisms in the fibronectin-binding repeats of fibronectin-binding protein A affect bond strength and fibronectin conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); fibronectin; molecular dynamics; single-nucleotide polymorphism (SNP); Staphylococcus aureus (S; aureus); surface plasmon resonance (SPR); binding; bond; energy; ligand	RESISTANT STAPHYLOCOCCUS-AUREUS; DYNAMIC FORCE SPECTROSCOPY; RECEPTOR-LIGAND BONDS; PRESSURE TRANSIENTS; HOT-SPOT; SELECTIN; MOLECULE; DISSOCIATION; COMPLEXES; FIBRINOGEN	The Staphylococcus aureus cell surface contains cell wall anchored proteins such as fibronectin-binding protein A (FnBPA) that bind to host ligands (e.g. fibronectin; Fn) present in the extracellular matrix of tissue or coatings on cardiac implants. Recent clinical studies have found a correlation between cardiovascular infections caused by S. aureus and nonsynonymous SNPs in FnBPA. Atomic force microscopy (AFM), surface plasmon resonance (SPR), and molecular simulations were used to investigate interactions between Fn and each of eight 20-mer peptide variants containing amino acids Ala, Asn, Gln, His, Ile, and Lys at positions equivalent to 782 and/or 786 in Fn-binding repeat-9 of FnBPA. Experimentally measured bond lifetimes and dissociation constants determined by mechanically dissociating the Fn<bold>peptide complex at loading rates relevant to the cardiovascular system</bold>, varied from the lowest-affinity H782A/K786A peptide (0.011 s, 747 m) to the highest-affinity H782Q/K786N peptide (0.192 s, 15.7 m). These atomic force microscopy results tracked remarkably well to metadynamics simulations in which peptide detachment was defined solely by the free-energy landscape. Simulations and SPR experiments suggested that an Fn conformational change may enhance the stability of the binding complex for peptides with K786I or H782Q/K786I app = 0.2-0.5 m, compared with the lowest-affinity double-alanine peptide Together, these findings demonstrate that amino acid substitutions in Fn-binding repeat-9 can significantly affect bond strength and influence the conformation of Fn upon binding. They provide a mechanistic explanation for the observation of nonsynonymous SNPs in fnbA among clinical isolates of S. aureus that cause endovascular infections.	[Casillas-Ituarte, Nadia N.; DiBartola, Alex C.; Howard, Jessica; Sierra-Hernandez, M. Roxana; Lower, Steven K.] Ohio State Univ, 125 S Oval Mall,275 Mendenhall Lab, Columbus, OH 43210 USA; [Cruz, Carlos H. B.; Lins, Roberto D.; Viana, Isabelle F. T.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50740465 Recife, PE, Brazil; [Liang, Xiaowen; Hoeoek, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA	University System of Ohio; Ohio State University; Fundacao Oswaldo Cruz; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Lower, SK (corresponding author), Ohio State Univ, 125 S Oval Mall,275 Mendenhall Lab, Columbus, OH 43210 USA.; Lins, RD (corresponding author), Av Prof Moraes Rego S-N,Campus UFPE, BR-50740465 Recife, PE, Brazil.	roberto.lins@cpqam.fiocruz.br; Lower.9@osu.edu	Viana, Isabelle/M-4435-2017; Lower, Steven/A-2440-2008; Lins, Roberto/J-7511-2012	Viana, Isabelle/0000-0003-4648-6635; Lower, Steven/0000-0001-9796-0830; Lins, Roberto/0000-0002-3983-8025; bezerra da cruz, carlos henrique/0000-0003-3490-1213; Liang, Xiaowen/0000-0002-6174-2951; Sierra Hernandez, Roxana/0000-0001-8566-8170	Brazilian National Scientific Computing Center (LNCC); National Institutes of Health [R01 HL119648]; National Science Foundation [EAR-1424138]; American Heart Association Fellowship [14POST20460073]; Fundacao do Amparo a Ciencia e Tecnologia (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Joanna S. Diehl Trust [03171990]; Division Of Earth Sciences [1424138] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER	Brazilian National Scientific Computing Center (LNCC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association Fellowship(American Heart Association); Fundacao do Amparo a Ciencia e Tecnologia (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Joanna S. Diehl Trust; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 HL119648, National Science Foundation Grant EAR-1424138, and American Heart Association Fellowship 14POST20460073 (to N. N. C.-I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Fundacao do Amparo a Ciencia e Tecnologia (FACEPE), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; Supported by Joanna S. Diehl Trust 03171990.	Albrecht VS, 2015, J CLIN MICROBIOL, V53, P3478, DOI 10.1128/JCM.01371-15; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERENDSEN HJC, 1987, COMPUT PHYS COMMUN, V44, P233, DOI 10.1016/0010-4655(87)90078-6; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Bozna BL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.192674; Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u; Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Casillas-Ituarte NN, 2012, J BIOL CHEM, V287, P6693, DOI 10.1074/jbc.M111.285692; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Chandran KB, 1997, ANN BIOMED ENG, V25, P926; Chandran KB, 1998, ANN BIOMED ENG, V26, P546, DOI 10.1114/1.79; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; Cheung LSL, 2012, BIOPHYS J, V102, P407, DOI 10.1016/j.bpj.2012.01.004; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Eichenberger EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141436; El-Kirat-Chatel S, 2013, MOL MICROBIOL, V89, P649, DOI 10.1111/mmi.12301; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Farrance OE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001489; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hos NJ, 2015, J INFECTION, V70, P153, DOI 10.1016/j.jinf.2014.09.005; HUFF S, 1994, J BIOL CHEM, V269, P15563; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Li YJ, 2013, J MOL RECOGNIT, V26, P46, DOI 10.1002/jmr.2242; Liang XW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159118; Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Lower SK, 2010, BIOPHYS J, V99, P2803, DOI 10.1016/j.bpj.2010.08.063; Ma WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124941; Meadows PY, 2003, LANGMUIR, V19, P9566, DOI 10.1021/la035217w; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Miskei M, 2017, NUCLEIC ACIDS RES, V45, pD228, DOI 10.1093/nar/gkw1019; Neundlinger I, 2014, J BIOL CHEM, V289, P21673, DOI 10.1074/jbc.M113.529875; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oh YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33909; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; Rotzschke O, 1999, P NATL ACAD SCI USA, V96, P7445, DOI 10.1073/pnas.96.13.7445; Sarangapani KK, 2011, J BIOL CHEM, V286, P32749, DOI 10.1074/jbc.M111.240044; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Taylor ES, 2017, PROTEINS, V85, P561, DOI 10.1002/prot.25220; te Riet J, 2007, J CELL SCI, V120, P3965, DOI 10.1242/jcs.004010; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633; Wildling L, 2012, J BIOL CHEM, V287, P105, DOI 10.1074/jbc.M111.304873; Xiong YQ, 2015, INFECT IMMUN, V83, P4772, DOI 10.1128/IAI.01074-15; Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012; Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v; Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	86	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8797	8810		10.1074/jbc.M117.786012	http://dx.doi.org/10.1074/jbc.M117.786012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28400484	Green Published, hybrid			2022-12-28	WOS:000402153900025
